Citrus Sinensis ID: 046728
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 325 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LSC2 | 361 | PTI1-like tyrosine-protei | no | no | 0.723 | 0.650 | 0.493 | 9e-65 | |
| Q8GX23 | 670 | Proline-rich receptor-lik | no | no | 0.72 | 0.349 | 0.452 | 6e-55 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.723 | 0.360 | 0.429 | 1e-54 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.713 | 0.326 | 0.442 | 1e-53 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.713 | 0.323 | 0.422 | 4e-53 | |
| Q9LS95 | 700 | Putative proline-rich rec | no | no | 0.72 | 0.334 | 0.440 | 2e-52 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.732 | 0.463 | 0.412 | 3e-52 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.729 | 0.330 | 0.414 | 3e-52 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.772 | 0.397 | 0.423 | 6e-52 | |
| Q9XI96 | 699 | Proline-rich receptor-lik | no | no | 0.72 | 0.334 | 0.439 | 9e-50 |
| >sp|Q9LSC2|Y3589_ARATH PTI1-like tyrosine-protein kinase At3g15890 OS=Arabidopsis thaliana GN=At3g15890 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 247 bits (630), Expect = 9e-65, Method: Compositional matrix adjust.
Identities = 123/249 (49%), Positives = 171/249 (68%), Gaps = 14/249 (5%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
QIAVKRLK + + E++FAVEVEIL R+RH+NLL +RG+ A G ERL+VY+YM N SL++
Sbjct: 63 QIAVKRLKEWSNREEIDFAVEVEILARIRHKNLLSVRGYCAEGQERLLVYEYMQNLSLVS 122
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKVA 148
HLHG+ + +CLLDW +R+ IAI SA+ IA D++ASNVLLD++FEA+V
Sbjct: 123 HLHGQHSAECLLDWTKRMKIAISSAQAIAYLHDHATPHIVHGDVRASNVLLDSEFEARVT 182
Query: 149 DFGFAKLIPDGVT-HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPL 207
DFG+ KL+PD T T+ K GY++PE GK S++ DVYSFG+LL+ L+S K+PL
Sbjct: 183 DFGYGKLMPDDDTGDGATKAKSNNGYISPECDASGKESETSDVYSFGILLMVLVSGKRPL 242
Query: 208 EKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRP 267
E+L R I +WV P V + F I D RL + ++LK +VL+ L C ++P+ RP
Sbjct: 243 ERLNPTTTRCITEWVLPLVYERNFGEIVDKRLSEEHVAEKLKKVVLVGLMCAQTDPDKRP 302
Query: 268 TMTDVVDWL 276
TM++VV+ L
Sbjct: 303 TMSEVVEML 311
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 2 |
| >sp|Q8GX23|PERK5_ARATH Proline-rich receptor-like protein kinase PERK5 OS=Arabidopsis thaliana GN=PERK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 214 bits (546), Expect = 6e-55, Method: Compositional matrix adjust.
Identities = 115/254 (45%), Positives = 159/254 (62%), Gaps = 20/254 (7%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
++AVK LK + + E EF EV+I+ RV HR+L+ L G+ G +RL+VY+++PN++L
Sbjct: 336 EVAVKSLKLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNTLEF 395
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKVA 148
HLHG+ P +LDW RV IA+GSA G+A DIKA+N+LLD FE KVA
Sbjct: 396 HLHGKGRP--VLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLDFSFETKVA 453
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLE 208
DFG AKL D TH++TRV GT GYLAPEYA GK+SD DV+SFGV+LLELI+ + PL+
Sbjct: 454 DFGLAKLSQDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPPLD 513
Query: 209 KLPGGVKRDIVQWVTP----YVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPE 264
L G ++ +V W P Q G + +ADPRL+ ++ ++ M A +
Sbjct: 514 -LTGEMEDSLVDWARPLCLKAAQDGDYNQLADPRLELNYSHQEMVQMASCAAAAIRHSAR 572
Query: 265 NRPTMTDVVDWLKG 278
RP M+ +V L+G
Sbjct: 573 RRPKMSQIVRALEG 586
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (543), Expect = 1e-54, Method: Compositional matrix adjust.
Identities = 109/254 (42%), Positives = 165/254 (64%), Gaps = 19/254 (7%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
++AVK+LK + + E EF EVEI+ RV HR+L+ L G+ G +RL+VY+++PN++L
Sbjct: 304 EVAVKQLKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEF 363
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKVA 148
HLHG+ P ++W R+ IA+GSA+G++ DIKASN+L+D FEAKVA
Sbjct: 364 HLHGKGRP--TMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVA 421
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLE 208
DFG AK+ D TH++TRV GT GYLAPEYA GK+++ DV+SFGV+LLELI+ ++P++
Sbjct: 422 DFGLAKIASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVD 481
Query: 209 KLPGGVKRDIVQWVTPYV----QKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPE 264
V +V W P + ++G FE +AD ++ +++R+++ MV A C +
Sbjct: 482 ANNVYVDDSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSAR 541
Query: 265 NRPTMTDVVDWLKG 278
RP M+ +V L+G
Sbjct: 542 RRPRMSQIVRALEG 555
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 210 bits (534), Expect = 1e-53, Method: Compositional matrix adjust.
Identities = 111/251 (44%), Positives = 158/251 (62%), Gaps = 19/251 (7%)
Query: 43 IAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITH 102
+AVK+LK + + + EF EVEI+ RV HR+L+ L G+ ERL++Y+Y+PN +L H
Sbjct: 378 VAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHH 437
Query: 103 LHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKVAD 149
LHG+ P +L+W RRV IAIGSA+G+A DIK++N+LLD +FEA+VAD
Sbjct: 438 LHGKGRP--VLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVAD 495
Query: 150 FGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEK 209
FG AKL TH++TRV GT GYLAPEYA GK++D DV+SFGV+LLELI+ +KP+++
Sbjct: 496 FGLAKLNDSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQ 555
Query: 210 LPGGVKRDIVQWVTPYVQK----GAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPEN 265
+ +V+W P + K G F + D RL+ + +++ M+ A C +
Sbjct: 556 YQPLGEESLVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPK 615
Query: 266 RPTMTDVVDWL 276
RP M VV L
Sbjct: 616 RPRMVQVVRAL 626
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 208 bits (530), Expect = 4e-53, Method: Compositional matrix adjust.
Identities = 106/251 (42%), Positives = 158/251 (62%), Gaps = 19/251 (7%)
Query: 43 IAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITH 102
+A+K+LK+++A+ EF EVEI+ RV HR+L+ L G+ R ++Y+++PN++L H
Sbjct: 395 VAIKQLKSVSAEGYREFKAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYH 454
Query: 103 LHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKVAD 149
LHG+ P +L+W RRV IAIG+A+G+A DIK+SN+LLD +FEA+VAD
Sbjct: 455 LHGKNLP--VLEWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVAD 512
Query: 150 FGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEK 209
FG A+L +H++TRV GT GYLAPEYA GK++D DV+SFGV+LLELI+ +KP++
Sbjct: 513 FGLARLNDTAQSHISTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDT 572
Query: 210 LPGGVKRDIVQWVTP----YVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPEN 265
+ +V+W P ++KG + DPRL+ + ++ M+ A C +
Sbjct: 573 SQPLGEESLVEWARPRLIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALK 632
Query: 266 RPTMTDVVDWL 276
RP M VV L
Sbjct: 633 RPRMVQVVRAL 643
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LS95|PERK6_ARATH Putative proline-rich receptor-like protein kinase PERK6 OS=Arabidopsis thaliana GN=PERK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 206 bits (524), Expect = 2e-52, Method: Compositional matrix adjust.
Identities = 112/254 (44%), Positives = 160/254 (62%), Gaps = 20/254 (7%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+IAVK LK + + E EF EV+I+ RV HR L+ L G+ G +R++VY+++PN +L
Sbjct: 361 EIAVKSLKAGSGQGEREFQAEVDIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEF 420
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKVA 148
HLHG+ +LDW R+ IA+GSA+G+A DIKASN+LLD FEAKVA
Sbjct: 421 HLHGKSGK--VLDWPTRLKIALGSAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVA 478
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLE 208
DFG AKL D VTH++TR+ GT GYLAPEYA GK++D DV+SFGV+LLEL++ ++P++
Sbjct: 479 DFGLAKLSQDNVTHVSTRIMGTFGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVD 538
Query: 209 KLPGGVKRDIVQWVTPY----VQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPE 264
L G ++ +V W P Q G + + DPRL+ ++ ++ MV A +
Sbjct: 539 -LTGEMEDSLVDWARPICLNAAQDGDYSELVDPRLENQYEPHEMAQMVACAAAAVRHSAR 597
Query: 265 NRPTMTDVVDWLKG 278
RP M+ +V L+G
Sbjct: 598 RRPKMSQIVRALEG 611
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 206 bits (523), Expect = 3e-52, Method: Compositional matrix adjust.
Identities = 106/257 (41%), Positives = 162/257 (63%), Gaps = 19/257 (7%)
Query: 41 DQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
+++AVK+LK +A+ E EF EV I+ ++ HRNL+ L G+ G +RL+VY+++PN++L
Sbjct: 206 NEVAVKQLKVGSAQGEKEFQAEVNIISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNTLE 265
Query: 101 THLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKV 147
HLHG+ P ++W R+ IA+ S++G++ DIKA+N+L+D FEAKV
Sbjct: 266 FHLHGKGRPT--MEWSLRLKIAVSSSKGLSYLHENCNPKIIHRDIKAANILIDFKFEAKV 323
Query: 148 ADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPL 207
ADFG AK+ D TH++TRV GT GYLAPEYA GK+++ DVYSFGV+LLELI+ ++P+
Sbjct: 324 ADFGLAKIALDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVYSFGVVLLELITGRRPV 383
Query: 208 EKLPGGVKRDIVQWVTPY----VQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNP 263
+ +V W P +++ FE +AD +L +++R+++ MV A C
Sbjct: 384 DANNVYADDSLVDWARPLLVQALEESNFEGLADIKLNNEYDREEMARMVACAAACVRYTA 443
Query: 264 ENRPTMTDVVDWLKGGL 280
RP M VV L+G +
Sbjct: 444 RRRPRMDQVVRVLEGNI 460
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 205 bits (522), Expect = 3e-52, Method: Compositional matrix adjust.
Identities = 106/256 (41%), Positives = 160/256 (62%), Gaps = 19/256 (7%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
++AVK+LK +++ E EF EV I+ RV HR+L+ L G+ +RL+VY+++PN++L
Sbjct: 378 EVAVKQLKEGSSQGEREFQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEF 437
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKVA 148
HLHG+ P ++W R+ IA+GSA+G++ DIKASN+L+D FEAKVA
Sbjct: 438 HLHGKGRP--TMEWSSRLKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVA 495
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLE 208
DFG AK+ D TH++TRV GT GYLAPEYA GK+++ DV+SFGV+LLELI+ ++P++
Sbjct: 496 DFGLAKIASDTNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPID 555
Query: 209 KLPGGVKRDIVQWVTPYVQK----GAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPE 264
+V W P + + G FE + D +L +++++++ MV A C S
Sbjct: 556 VNNVHADNSLVDWARPLLNQVSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAP 615
Query: 265 NRPTMTDVVDWLKGGL 280
RP M V L+G +
Sbjct: 616 RRPRMDQVARVLEGNI 631
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 204 bits (519), Expect = 6e-52, Method: Compositional matrix adjust.
Identities = 113/267 (42%), Positives = 164/267 (61%), Gaps = 16/267 (5%)
Query: 43 IAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+AVKRLK N A E++F EVE + HRNLL LRGF + ER++VY YMPN S+ +
Sbjct: 326 VAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVAS 385
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKVA 148
L + + LDW RR IA+G+A G+ D+KA+N+LLD DFEA V
Sbjct: 386 RLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVG 445
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLE 208
DFG AKL+ +H+TT V+GT+G++APEY G+ S+ DV+ FG+LLLELI+ +K L+
Sbjct: 446 DFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALD 505
Query: 209 KLPGGVKRDI-VQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRP 267
++ + + WV Q+G + + D L KF+R +L+ +V +AL CT NP +RP
Sbjct: 506 FGRSAHQKGVMLDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRP 565
Query: 268 TMTDVVDWLKG-GLGRRTKDVKDVAGE 293
M++V+ L+G GL R + ++ GE
Sbjct: 566 KMSEVMKMLEGDGLAERWEATQNGTGE 592
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XI96|PERK7_ARATH Proline-rich receptor-like protein kinase PERK7 OS=Arabidopsis thaliana GN=PERK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (501), Expect = 9e-50, Method: Compositional matrix adjust.
Identities = 112/255 (43%), Positives = 160/255 (62%), Gaps = 21/255 (8%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYA-GGDERLIVYDYMPNHSLI 100
+IAVK LK + + E EF EVEI+ RV HR+L+ L G+ + G +RL+VY+++PN +L
Sbjct: 360 EIAVKSLKAGSGQGEREFQAEVEIISRVHHRHLVSLVGYCSNAGGQRLLVYEFLPNDTLE 419
Query: 101 THLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKV 147
HLHG+ ++DW R+ IA+GSA+G+A DIKASN+LLD +FEAKV
Sbjct: 420 FHLHGKSG--TVMDWPTRLKIALGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKV 477
Query: 148 ADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPL 207
ADFG AKL D TH++TRV GT GYLAPEYA GK+++ DV+SFGV+LLELI+ + P+
Sbjct: 478 ADFGLAKLSQDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRGPV 537
Query: 208 EKLPGGVKRDIVQWVTP----YVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNP 263
+ L G ++ +V W P Q G + + DP L+ ++ ++ MV A +
Sbjct: 538 D-LSGDMEDSLVDWARPLCMRVAQDGEYGELVDPFLEHQYEPYEMARMVACAAAAVRHSG 596
Query: 264 ENRPTMTDVVDWLKG 278
RP M+ +V L+G
Sbjct: 597 RRRPKMSQIVRTLEG 611
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 325 | ||||||
| 255539625 | 363 | serine-threonine protein kinase, plant-t | 0.846 | 0.757 | 0.754 | 1e-121 | |
| 224134619 | 340 | predicted protein [Populus trichocarpa] | 0.796 | 0.761 | 0.772 | 1e-120 | |
| 356534177 | 365 | PREDICTED: PTI1-like tyrosine-protein ki | 0.910 | 0.810 | 0.646 | 1e-120 | |
| 224122508 | 334 | predicted protein [Populus trichocarpa] | 0.867 | 0.844 | 0.694 | 1e-117 | |
| 357444191 | 410 | Somatic embryogenesis receptor kinase [M | 0.769 | 0.609 | 0.745 | 1e-116 | |
| 225455633 | 375 | PREDICTED: PTI1-like tyrosine-protein ki | 0.775 | 0.672 | 0.743 | 1e-115 | |
| 356574448 | 347 | PREDICTED: PTI1-like tyrosine-protein ki | 0.747 | 0.700 | 0.765 | 1e-113 | |
| 356529320 | 351 | PREDICTED: PTI1-like tyrosine-protein ki | 0.821 | 0.760 | 0.710 | 1e-112 | |
| 356561730 | 333 | PREDICTED: PTI1-like tyrosine-protein ki | 0.756 | 0.738 | 0.749 | 1e-111 | |
| 449465178 | 366 | PREDICTED: PTI1-like tyrosine-protein ki | 0.833 | 0.740 | 0.658 | 1e-105 |
| >gi|255539625|ref|XP_002510877.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223549992|gb|EEF51479.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 440 bits (1132), Expect = e-121, Method: Compositional matrix adjust.
Identities = 221/293 (75%), Positives = 257/293 (87%), Gaps = 18/293 (6%)
Query: 43 IAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITH 102
+AVKRLK ++AKAEMEFAVEVEILGRVRH+NLLGLRGFYAGGDERLIVYDYMPNHSLITH
Sbjct: 70 VAVKRLKAMSAKAEMEFAVEVEILGRVRHKNLLGLRGFYAGGDERLIVYDYMPNHSLITH 129
Query: 103 LHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKVAD 149
LHG+LA DCLLDW RR+ IAIGSAEG+A DIKASNVLLDT+F+AKVAD
Sbjct: 130 LHGQLASDCLLDWTRRMKIAIGSAEGLAYLHHKASPHIIHRDIKASNVLLDTEFQAKVAD 189
Query: 150 FGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEK 209
FGFAKLIPDGVTH+TTRVKGTLGYLAPEYAMWGKVS++CDVYSFG+LLLE+ISAKKPLEK
Sbjct: 190 FGFAKLIPDGVTHLTTRVKGTLGYLAPEYAMWGKVSENCDVYSFGILLLEIISAKKPLEK 249
Query: 210 LPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTM 269
LPGGVKRDIVQWVTPY+QKGA++ IAD RLKG+++R QLKS ++IA+RCTDSNPENRP+M
Sbjct: 250 LPGGVKRDIVQWVTPYIQKGAYDQIADSRLKGRYDRTQLKSAIMIAMRCTDSNPENRPSM 309
Query: 270 TDVVDWLKGGLGRRTKDVK----DVAGEDDEDNDDNDTDFEERYFKMEQSNIR 318
T+VVDWLKG L +R+K+V V ++DE+N+DN TD+EE F ME+ ++R
Sbjct: 310 TEVVDWLKGDLRKRSKEVSYVQNKVGEDEDEENNDNGTDYEEG-FGMEKFHLR 361
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224134619|ref|XP_002321867.1| predicted protein [Populus trichocarpa] gi|222868863|gb|EEF05994.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 437 bits (1125), Expect = e-120, Method: Compositional matrix adjust.
Identities = 211/273 (77%), Positives = 239/273 (87%), Gaps = 14/273 (5%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+ VKRLK ++AKAEMEFAVEVEILGRVRH+NLLGLRGFYAGGDERLIVYDYMPNHSLI
Sbjct: 38 RTTVKRLKAMSAKAEMEFAVEVEILGRVRHKNLLGLRGFYAGGDERLIVYDYMPNHSLIA 97
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKVA 148
HLHG+LA DCLLDWHRR++I IGSAEGIA DIKASNVLLDT+F+AKVA
Sbjct: 98 HLHGQLAVDCLLDWHRRMNIVIGSAEGIAYLHHEANPHIIHRDIKASNVLLDTEFQAKVA 157
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLE 208
DFGFAKL+P+GVTHMTTRVKGTLGYLAPEYAMWGKVS+SCDVYSFG+LLLE+ISAKKPLE
Sbjct: 158 DFGFAKLMPEGVTHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIISAKKPLE 217
Query: 209 KLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPT 268
KLPGGV+RDIVQWVTPYVQKGAF+HIADPRLKG+++R QL++ ++IA+RCTDSNPENRP+
Sbjct: 218 KLPGGVRRDIVQWVTPYVQKGAFDHIADPRLKGRYDRAQLETAIMIAMRCTDSNPENRPS 277
Query: 269 MTDVVDWLKGGLGRRTKDVKDVAGEDDEDNDDN 301
M VV+WL GGLG RTK V V DED + +
Sbjct: 278 MMKVVEWLNGGLG-RTKGVSVVEDMVDEDEEQD 309
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356534177|ref|XP_003535634.1| PREDICTED: PTI1-like tyrosine-protein kinase At3g15890-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 436 bits (1121), Expect = e-120, Method: Compositional matrix adjust.
Identities = 221/342 (64%), Positives = 259/342 (75%), Gaps = 46/342 (13%)
Query: 8 CFLLASPAVFIQNINNG-----LEILMLLLLLR----------------------RETGD 40
CFL IQN N EI L LLR R +
Sbjct: 8 CFLCEKEQSEIQNANKKNRDYPWEIYTLKELLRATNNFHQDSKIGEGGFGSVYWGRTSKG 67
Query: 41 DQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
+IAVKRLKT+ AKAEMEFAVEVE+LGRVRH+NLLGLRGFYAGGDERLIVYDYMPNHSL+
Sbjct: 68 VEIAVKRLKTMTAKAEMEFAVEVEVLGRVRHKNLLGLRGFYAGGDERLIVYDYMPNHSLL 127
Query: 101 THLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKV 147
THLHG+LA DCLLDW RR+SIAIG+AEG+ DIKASNVLLDT+FEAKV
Sbjct: 128 THLHGQLATDCLLDWPRRMSIAIGAAEGLVYLHHEANPHIIHRDIKASNVLLDTEFEAKV 187
Query: 148 ADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPL 207
ADFGFAKLIP+GV+H+TTRVKGTLGYLAPEYAMWGKVS SCDVYSFG+LLLE++SAKKP+
Sbjct: 188 ADFGFAKLIPEGVSHLTTRVKGTLGYLAPEYAMWGKVSGSCDVYSFGILLLEIVSAKKPI 247
Query: 208 EKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRP 267
EKLPGGVKRDIVQWVTP+VQKG F HIADP+LKG F+ +QLKS+V+IA+RCTD++PE RP
Sbjct: 248 EKLPGGVKRDIVQWVTPHVQKGNFIHIADPKLKGHFDLEQLKSVVMIAMRCTDNSPEKRP 307
Query: 268 TMTDVVDWLKGGLGRRTKDVKDVAGEDDEDNDDNDTDFEERY 309
TM +VV+WLKGG+GRR K++ ++ + ++D +EE Y
Sbjct: 308 TMQEVVEWLKGGIGRRKKEIPYLSYKTEDDK------YEENY 343
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122508|ref|XP_002318854.1| predicted protein [Populus trichocarpa] gi|222859527|gb|EEE97074.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 426 bits (1095), Expect = e-117, Method: Compositional matrix adjust.
Identities = 209/301 (69%), Positives = 247/301 (82%), Gaps = 19/301 (6%)
Query: 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNL 74
+V+ + G E ++ L L QIAVKRLK +++KAEMEFAVEVE+LGRVRH+NL
Sbjct: 38 SVYWGQTSTGTEAIIFLFNLLF-----QIAVKRLKAMSSKAEMEFAVEVEMLGRVRHKNL 92
Query: 75 LGLRGFYAGGDERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA---- 130
LGLRGFYAGG+ERLIVYDYMPNHSLI HLHG++A DCLLDW+RR++I IGSAEGIA
Sbjct: 93 LGLRGFYAGGNERLIVYDYMPNHSLIAHLHGQVAEDCLLDWNRRMNIIIGSAEGIAYLHH 152
Query: 131 ---------DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMW 181
DIKASNVLLD +F+AKVADFGFAKLIP+GV+H+TTRVKGTLGYLAPEYAMW
Sbjct: 153 EANPHIIHRDIKASNVLLDVEFQAKVADFGFAKLIPEGVSHLTTRVKGTLGYLAPEYAMW 212
Query: 182 GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241
GKVS+SCDVYSFG+LLLE+ISAKKPLEKLPGGVKRDIVQW TPYVQKGAF+HIAD RLKG
Sbjct: 213 GKVSESCDVYSFGILLLEIISAKKPLEKLPGGVKRDIVQWATPYVQKGAFDHIADLRLKG 272
Query: 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGRRTKDVKDVAGEDDEDNDDN 301
+++R QL ++IA+RC+D+N ENRP+M VV+WL GGLG RTK+V DV DED +
Sbjct: 273 RYDRAQLNLAIMIAMRCSDTNAENRPSMMKVVEWLNGGLG-RTKEVSDVEDMVDEDEYEE 331
Query: 302 D 302
+
Sbjct: 332 E 332
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357444191|ref|XP_003592373.1| Somatic embryogenesis receptor kinase [Medicago truncatula] gi|355481421|gb|AES62624.1| Somatic embryogenesis receptor kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1090), Expect = e-116, Method: Compositional matrix adjust.
Identities = 196/263 (74%), Positives = 235/263 (89%), Gaps = 13/263 (4%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+IAVKRLKT+ AKAEMEFAVEVE+LGRVRH+NLLGLRGFYAGGDERLIVYDYM NHSL+T
Sbjct: 71 EIAVKRLKTMTAKAEMEFAVEVEVLGRVRHKNLLGLRGFYAGGDERLIVYDYMSNHSLLT 130
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKVA 148
HLHG+LA DCLLDW RR+SI +G+AEG+A DIKASNVLLDT+F+AKVA
Sbjct: 131 HLHGQLASDCLLDWPRRMSITVGAAEGLAYLHHEANPHIIHRDIKASNVLLDTEFQAKVA 190
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLE 208
DFGFAKLIP GV+H+TTRVKGTLGYLAPEYAMWGKVS+SCDVYSFG+LLLE+ISAKKP+E
Sbjct: 191 DFGFAKLIPAGVSHLTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIISAKKPIE 250
Query: 209 KLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPT 268
KLPGG+KRDIVQWVTPYVQKG F+HIADP+LKG F+ +QLKS+++IA+RCTDS+P+ RP+
Sbjct: 251 KLPGGIKRDIVQWVTPYVQKGVFKHIADPKLKGNFDLEQLKSVIMIAVRCTDSSPDKRPS 310
Query: 269 MTDVVDWLKGGLGRRTKDVKDVA 291
M +VV+WLK G+ +R K++ +++
Sbjct: 311 MIEVVEWLKDGVSKRKKEIPNLS 333
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225455633|ref|XP_002271284.1| PREDICTED: PTI1-like tyrosine-protein kinase At3g15890-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 421 bits (1081), Expect = e-115, Method: Compositional matrix adjust.
Identities = 197/265 (74%), Positives = 232/265 (87%), Gaps = 13/265 (4%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
R + +IAVKRLK ++AKAEMEFAVEVEILGRVRH+NLLGLRGFYAGGDERLIVYD+M
Sbjct: 60 RTSKGVEIAVKRLKAMSAKAEMEFAVEVEILGRVRHKNLLGLRGFYAGGDERLIVYDFMA 119
Query: 96 NHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTD 142
N SLITHLHG+L+ +CLLDW RR++IA+GSAEG+A DIKASNVLLD++
Sbjct: 120 NQSLITHLHGQLSAECLLDWPRRMNIALGSAEGVAYLHHEANPHIIHRDIKASNVLLDSE 179
Query: 143 FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
F+AKVADFGFAKL+P+GVTH+TTRVKGTLGYLAPEYAMWGKVS+SCDVYSFG+LLLE+IS
Sbjct: 180 FQAKVADFGFAKLLPEGVTHLTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIIS 239
Query: 203 AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSN 262
AKKP+EKLPGGVKRDIVQW TPYVQKGA+ HIADPRLKGKF+R QLK + +A++CTD+N
Sbjct: 240 AKKPIEKLPGGVKRDIVQWATPYVQKGAYHHIADPRLKGKFDRSQLKLAITVAMKCTDNN 299
Query: 263 PENRPTMTDVVDWLKGGLGRRTKDV 287
P+NRP+M +VV WLKG +GRR +V
Sbjct: 300 PDNRPSMMEVVGWLKGDVGRRKNEV 324
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574448|ref|XP_003555359.1| PREDICTED: PTI1-like tyrosine-protein kinase At3g15890-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 416 bits (1068), Expect = e-113, Method: Compositional matrix adjust.
Identities = 196/256 (76%), Positives = 227/256 (88%), Gaps = 13/256 (5%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
R + +IAVKRLKT+ AKAEMEFAVEVE+LGRVRH+NLLGLRGFYAGGDERLIVYDYMP
Sbjct: 69 RTSKGIEIAVKRLKTMTAKAEMEFAVEVEVLGRVRHKNLLGLRGFYAGGDERLIVYDYMP 128
Query: 96 NHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTD 142
NHSL+THLHG+LA DCLLDW RR++IAIG+AEG+ DIKASNVLL T+
Sbjct: 129 NHSLLTHLHGQLATDCLLDWPRRMTIAIGAAEGLGYLHHEANPHIIHRDIKASNVLLGTE 188
Query: 143 FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
FEAKVADFGFAKLIP+GV+H+TTRVKGTLGYLAPEYAMWGKVS SCDVYSFG+LLLE++S
Sbjct: 189 FEAKVADFGFAKLIPEGVSHLTTRVKGTLGYLAPEYAMWGKVSGSCDVYSFGILLLEILS 248
Query: 203 AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSN 262
AKKP+EKLPGGVKRDIVQWVTP+VQKG F HIADP+LKG F+ +QLKS+V+IA+RCTD++
Sbjct: 249 AKKPIEKLPGGVKRDIVQWVTPHVQKGNFLHIADPKLKGHFDLEQLKSVVMIAMRCTDNS 308
Query: 263 PENRPTMTDVVDWLKG 278
PE RP+M +VV+WLKG
Sbjct: 309 PEKRPSMAEVVEWLKG 324
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356529320|ref|XP_003533243.1| PREDICTED: PTI1-like tyrosine-protein kinase At3g15890-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 412 bits (1058), Expect = e-112, Method: Compositional matrix adjust.
Identities = 201/283 (71%), Positives = 238/283 (84%), Gaps = 16/283 (5%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
R + QIAVKRLKT+ AKAEMEFAVEVE+LGRVRH+NLLGLRGFYAGGDERLIVYDYMP
Sbjct: 64 RTSKSVQIAVKRLKTMTAKAEMEFAVEVEVLGRVRHQNLLGLRGFYAGGDERLIVYDYMP 123
Query: 96 NHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTD 142
NHSL+THLHG LA +C LDW RR+SIAIG+AEG+A DIKASNVLLD +
Sbjct: 124 NHSLLTHLHGPLAKECQLDWPRRMSIAIGAAEGLAYLHHESTPHIIHRDIKASNVLLDPE 183
Query: 143 FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
F+AKVADFGFAKL+PDGVTH+TT+VKGTLGYLAPEYAMWGKVS+SCDVYSFG+LLLE+IS
Sbjct: 184 FQAKVADFGFAKLVPDGVTHLTTKVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIIS 243
Query: 203 AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSN 262
AKKP+EK PGGVKRDIVQWVTPYV KG F +IADP+LKGKF+ +QLK++ IALRCTDS+
Sbjct: 244 AKKPIEKFPGGVKRDIVQWVTPYVNKGLFNNIADPKLKGKFDLEQLKNVTTIALRCTDSS 303
Query: 263 PENRPTMTDVVDWLKGGLGRR--TKDVKDVAGED-DEDNDDND 302
+ RP+M +VVDWLK G+G +++ ++ ++ DE ND +D
Sbjct: 304 ADKRPSMKEVVDWLKNGVGSTWGEENIPTLSIKNGDEGNDKDD 346
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356561730|ref|XP_003549132.1| PREDICTED: PTI1-like tyrosine-protein kinase At3g15890-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 409 bits (1051), Expect = e-111, Method: Compositional matrix adjust.
Identities = 194/259 (74%), Positives = 223/259 (86%), Gaps = 13/259 (5%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
R + QIAVKRLKT+ AKAEMEFAVEVE+LGRVRH+NLLGLRGFYAGGDERLIVYDYMP
Sbjct: 73 RTSKGVQIAVKRLKTMTAKAEMEFAVEVEVLGRVRHKNLLGLRGFYAGGDERLIVYDYMP 132
Query: 96 NHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTD 142
NHSL+THLHG LA C LDW RR+SIAIG+AEG+A DIKASNVLLD +
Sbjct: 133 NHSLLTHLHGPLAKKCQLDWPRRMSIAIGTAEGLAYLHHESTPHIIHRDIKASNVLLDAE 192
Query: 143 FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
F+AKVADFGFAKL+PDGVTH+TT+VKGTLGYLAPEYAMWGKVS+SCDVYSFG+LLLE+IS
Sbjct: 193 FQAKVADFGFAKLVPDGVTHLTTKVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIIS 252
Query: 203 AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSN 262
AKKP+EK PG VKRDIVQWVTPY+ KG F +IADP+LKGKF+ +QLK++ IALRCTDS+
Sbjct: 253 AKKPIEKFPGEVKRDIVQWVTPYINKGLFNNIADPKLKGKFDLEQLKNVTTIALRCTDSS 312
Query: 263 PENRPTMTDVVDWLKGGLG 281
+ RP+M +VVDWLK G+G
Sbjct: 313 ADKRPSMKEVVDWLKNGVG 331
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449465178|ref|XP_004150305.1| PREDICTED: PTI1-like tyrosine-protein kinase At3g15890-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 387 bits (994), Expect = e-105, Method: Compositional matrix adjust.
Identities = 189/287 (65%), Positives = 227/287 (79%), Gaps = 16/287 (5%)
Query: 43 IAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITH 102
IAVKRLK + AKAEMEFAVEVEIL RVRH NLLGLRGFYAGG+ERLIVYDYMPNHSL++H
Sbjct: 68 IAVKRLKAMTAKAEMEFAVEVEILARVRHENLLGLRGFYAGGEERLIVYDYMPNHSLLSH 127
Query: 103 LHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKVAD 149
LHG+LA CLLDW RRV+IAIG+A+G++ DIKASNVLLD+ FEAKVAD
Sbjct: 128 LHGQLADQCLLDWKRRVNIAIGAAKGLSYLHHEAQPHIIHRDIKASNVLLDSHFEAKVAD 187
Query: 150 FGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEK 209
FGFAKLIPDGV+H+TTRVKGTLGYLAPEYAMWGKV++SCDVYSFG+LLLE++S +KPLEK
Sbjct: 188 FGFAKLIPDGVSHLTTRVKGTLGYLAPEYAMWGKVAESCDVYSFGILLLEIVSGRKPLEK 247
Query: 210 LPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTM 269
LP G KRDIVQW TPY Q F+ IADPRL ++ + LKS+V IALRCTD N E+RP+M
Sbjct: 248 LPNGTKRDIVQWATPYAQTEDFDQIADPRLNQNYDVNDLKSIVTIALRCTDGNAESRPSM 307
Query: 270 TDVVDWLKGGLGRRTKDVKDVAGEDD--EDNDDNDTDFEERYFKMEQ 314
VV WLK GL + K++ + + ED D ++E+++ + E+
Sbjct: 308 KQVVAWLKDGLDTK-KEMPHLKNNETPREDEDQGQENYEKKHTEYEE 353
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 325 | ||||||
| TAIR|locus:2035099 | 350 | AT1G52540 [Arabidopsis thalian | 0.72 | 0.668 | 0.516 | 3.4e-61 | |
| TAIR|locus:2093900 | 361 | AT3G15890 [Arabidopsis thalian | 0.723 | 0.650 | 0.493 | 1.2e-58 | |
| TAIR|locus:2139474 | 670 | PERK5 "proline-rich extensin-l | 0.726 | 0.352 | 0.449 | 1.5e-51 | |
| TAIR|locus:2093999 | 700 | PERK6 "proline-rich extensin-l | 0.72 | 0.334 | 0.440 | 2.4e-51 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.729 | 0.363 | 0.425 | 1.3e-50 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.729 | 0.366 | 0.425 | 2.2e-50 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.769 | 0.395 | 0.421 | 1.5e-49 | |
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.726 | 0.332 | 0.444 | 1.5e-49 | |
| TAIR|locus:2019938 | 718 | PERK11 "proline-rich extensin- | 0.747 | 0.338 | 0.421 | 8.5e-49 | |
| TAIR|locus:2010282 | 699 | PERK7 "proline-rich extensin-l | 0.72 | 0.334 | 0.439 | 1.1e-48 |
| TAIR|locus:2035099 AT1G52540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 626 (225.4 bits), Expect = 3.4e-61, P = 3.4e-61
Identities = 128/248 (51%), Positives = 173/248 (69%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
QIAVKRLK +++ E++FAVEVEIL R+RH+NLL +RG+ A G ERLIVYDYMPN SL++
Sbjct: 64 QIAVKRLKAWSSREEIDFAVEVEILARIRHKNLLSVRGYCAEGQERLIVYDYMPNLSLVS 123
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKVA 148
HLHG+ + + LLDW RR++IA+ SA+ IA D++ASNVLLD++FEA+V
Sbjct: 124 HLHGQHSSESLLDWTRRMNIAVSSAQAIAYLHHFATPRIVHGDVRASNVLLDSEFEARVT 183
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLE 208
DFG+ KL+PD + +T+ +GYL+PE GK SD DVYSFGVLLLEL++ K+P E
Sbjct: 184 DFGYDKLMPDDGANKSTK-GNNIGYLSPECIESGKESDMGDVYSFGVLLLELVTGKRPTE 242
Query: 209 KLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPT 268
++ KR I +WV P V + F I D RL GK+ ++LK +VL+ L C E RPT
Sbjct: 243 RVNLTTKRGITEWVLPLVYERKFGEIVDQRLNGKYVEEELKRIVLVGLMCAQRESEKRPT 302
Query: 269 MTDVVDWL 276
M++VV+ L
Sbjct: 303 MSEVVEML 310
|
|
| TAIR|locus:2093900 AT3G15890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 602 (217.0 bits), Expect = 1.2e-58, P = 1.2e-58
Identities = 123/249 (49%), Positives = 171/249 (68%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
QIAVKRLK + + E++FAVEVEIL R+RH+NLL +RG+ A G ERL+VY+YM N SL++
Sbjct: 63 QIAVKRLKEWSNREEIDFAVEVEILARIRHKNLLSVRGYCAEGQERLLVYEYMQNLSLVS 122
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKVA 148
HLHG+ + +CLLDW +R+ IAI SA+ IA D++ASNVLLD++FEA+V
Sbjct: 123 HLHGQHSAECLLDWTKRMKIAISSAQAIAYLHDHATPHIVHGDVRASNVLLDSEFEARVT 182
Query: 149 DFGFAKLIPDGVT-HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPL 207
DFG+ KL+PD T T+ K GY++PE GK S++ DVYSFG+LL+ L+S K+PL
Sbjct: 183 DFGYGKLMPDDDTGDGATKAKSNNGYISPECDASGKESETSDVYSFGILLMVLVSGKRPL 242
Query: 208 EKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRP 267
E+L R I +WV P V + F I D RL + ++LK +VL+ L C ++P+ RP
Sbjct: 243 ERLNPTTTRCITEWVLPLVYERNFGEIVDKRLSEEHVAEKLKKVVLVGLMCAQTDPDKRP 302
Query: 268 TMTDVVDWL 276
TM++VV+ L
Sbjct: 303 TMSEVVEML 311
|
|
| TAIR|locus:2139474 PERK5 "proline-rich extensin-like receptor kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 535 (193.4 bits), Expect = 1.5e-51, P = 1.5e-51
Identities = 115/256 (44%), Positives = 160/256 (62%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
++AVK LK + + E EF EV+I+ RV HR+L+ L G+ G +RL+VY+++PN++L
Sbjct: 336 EVAVKSLKLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNTLEF 395
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKVA 148
HLHG+ P +LDW RV IA+GSA G+A DIKA+N+LLD FE KVA
Sbjct: 396 HLHGKGRP--VLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLDFSFETKVA 453
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLE 208
DFG AKL D TH++TRV GT GYLAPEYA GK+SD DV+SFGV+LLELI+ + PL+
Sbjct: 454 DFGLAKLSQDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPPLD 513
Query: 209 KLPGGVKRDIVQWVTPY----VQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPE 264
L G ++ +V W P Q G + +ADPRL+ ++ ++ M A +
Sbjct: 514 -LTGEMEDSLVDWARPLCLKAAQDGDYNQLADPRLELNYSHQEMVQMASCAAAAIRHSAR 572
Query: 265 NRPTMTDVVDWLKGGL 280
RP M+ +V L+G +
Sbjct: 573 RRPKMSQIVRALEGDM 588
|
|
| TAIR|locus:2093999 PERK6 "proline-rich extensin-like receptor kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 533 (192.7 bits), Expect = 2.4e-51, P = 2.4e-51
Identities = 112/254 (44%), Positives = 160/254 (62%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+IAVK LK + + E EF EV+I+ RV HR L+ L G+ G +R++VY+++PN +L
Sbjct: 361 EIAVKSLKAGSGQGEREFQAEVDIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEF 420
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKVA 148
HLHG+ +LDW R+ IA+GSA+G+A DIKASN+LLD FEAKVA
Sbjct: 421 HLHGKSGK--VLDWPTRLKIALGSAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVA 478
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLE 208
DFG AKL D VTH++TR+ GT GYLAPEYA GK++D DV+SFGV+LLEL++ ++P++
Sbjct: 479 DFGLAKLSQDNVTHVSTRIMGTFGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVD 538
Query: 209 KLPGGVKRDIVQWVTPY----VQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPE 264
L G ++ +V W P Q G + + DPRL+ ++ ++ MV A +
Sbjct: 539 -LTGEMEDSLVDWARPICLNAAQDGDYSELVDPRLENQYEPHEMAQMVACAAAAVRHSAR 597
Query: 265 NRPTMTDVVDWLKG 278
RP M+ +V L+G
Sbjct: 598 RRPKMSQIVRALEG 611
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 526 (190.2 bits), Expect = 1.3e-50, P = 1.3e-50
Identities = 109/256 (42%), Positives = 166/256 (64%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
++AVK+LK + + E EF EVEI+ RV HR+L+ L G+ G +RL+VY+++PN++L
Sbjct: 304 EVAVKQLKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEF 363
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKVA 148
HLHG+ P ++W R+ IA+GSA+G++ DIKASN+L+D FEAKVA
Sbjct: 364 HLHGKGRPT--MEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVA 421
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLE 208
DFG AK+ D TH++TRV GT GYLAPEYA GK+++ DV+SFGV+LLELI+ ++P++
Sbjct: 422 DFGLAKIASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVD 481
Query: 209 KLPGGVKRDIVQWVTPYV----QKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPE 264
V +V W P + ++G FE +AD ++ +++R+++ MV A C +
Sbjct: 482 ANNVYVDDSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSAR 541
Query: 265 NRPTMTDVVDWLKGGL 280
RP M+ +V L+G +
Sbjct: 542 RRPRMSQIVRALEGNV 557
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 524 (189.5 bits), Expect = 2.2e-50, P = 2.2e-50
Identities = 109/256 (42%), Positives = 164/256 (64%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
++AVK+LK + + E EF EVEI+ RV HR+L+ L G+ G +RL+VY+++PN++L
Sbjct: 299 EVAVKQLKVGSGQGEREFQAEVEIISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNLEL 358
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKVA 148
HLHG P ++W R+ IA+GSA+G++ DIKASN+L+D FEAKVA
Sbjct: 359 HLHGEGRPT--MEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVA 416
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLE 208
DFG AK+ D TH++TRV GT GYLAPEYA GK+++ DV+SFGV+LLELI+ ++P++
Sbjct: 417 DFGLAKIASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVD 476
Query: 209 KLPGGVKRDIVQWVTPYV----QKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPE 264
V +V W P + ++G FE +AD ++ ++R+++ MV A C +
Sbjct: 477 ANNVYVDDSLVDWARPLLNRASEQGDFEGLADAKMNNGYDREEMARMVACAAACVRHSAR 536
Query: 265 NRPTMTDVVDWLKGGL 280
RP M+ +V L+G +
Sbjct: 537 RRPRMSQIVRALEGNV 552
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 516 (186.7 bits), Expect = 1.5e-49, P = 1.5e-49
Identities = 112/266 (42%), Positives = 163/266 (61%)
Query: 43 IAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+AVKRLK N A E++F EVE + HRNLL LRGF + ER++VY YMPN S+ +
Sbjct: 326 VAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVAS 385
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKVA 148
L + + LDW RR IA+G+A G+ D+KA+N+LLD DFEA V
Sbjct: 386 RLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVG 445
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLE 208
DFG AKL+ +H+TT V+GT+G++APEY G+ S+ DV+ FG+LLLELI+ +K L+
Sbjct: 446 DFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALD 505
Query: 209 KLPGGVKRDIV-QWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRP 267
++ ++ WV Q+G + + D L KF+R +L+ +V +AL CT NP +RP
Sbjct: 506 FGRSAHQKGVMLDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRP 565
Query: 268 TMTDVVDWLKG-GLGRRTKDVKDVAG 292
M++V+ L+G GL R + ++ G
Sbjct: 566 KMSEVMKMLEGDGLAERWEATQNGTG 591
|
|
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 516 (186.7 bits), Expect = 1.5e-49, P = 1.5e-49
Identities = 115/259 (44%), Positives = 164/259 (63%)
Query: 43 IAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITH 102
+AVK+LK + + + EF EVEI+ RV HR+L+ L G+ ERL++Y+Y+PN +L H
Sbjct: 378 VAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHH 437
Query: 103 LHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKVAD 149
LHG+ P +L+W RRV IAIGSA+G+A DIK++N+LLD +FEA+VAD
Sbjct: 438 LHGKGRP--VLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVAD 495
Query: 150 FGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEK 209
FG AKL TH++TRV GT GYLAPEYA GK++D DV+SFGV+LLELI+ +KP+++
Sbjct: 496 FGLAKLNDSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQ 555
Query: 210 L-PGGVKRDIVQWVTPYVQK----GAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPE 264
P G + +V+W P + K G F + D RL+ + +++ M+ A C +
Sbjct: 556 YQPLG-EESLVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGP 614
Query: 265 NRPTMTDVVDWL--KGGLG 281
RP M VV L +G +G
Sbjct: 615 KRPRMVQVVRALDSEGDMG 633
|
|
| TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 509 (184.2 bits), Expect = 8.5e-49, P = 8.5e-49
Identities = 112/266 (42%), Positives = 165/266 (62%)
Query: 43 IAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITH 102
+A+K+LK+++A+ EF EVEI+ RV HR+L+ L G+ R ++Y+++PN++L H
Sbjct: 395 VAIKQLKSVSAEGYREFKAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYH 454
Query: 103 LHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKVAD 149
LHG+ P +L+W RRV IAIG+A+G+A DIK+SN+LLD +FEA+VAD
Sbjct: 455 LHGKNLP--VLEWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVAD 512
Query: 150 FGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLE- 208
FG A+L +H++TRV GT GYLAPEYA GK++D DV+SFGV+LLELI+ +KP++
Sbjct: 513 FGLARLNDTAQSHISTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDT 572
Query: 209 KLPGGVKRDIVQWVTPY----VQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPE 264
P G + +V+W P ++KG + DPRL+ + ++ M+ A C +
Sbjct: 573 SQPLG-EESLVEWARPRLIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSAL 631
Query: 265 NRPTMTDVVDWL--KGGLGRRTKDVK 288
RP M VV L + L T VK
Sbjct: 632 KRPRMVQVVRALDTRDDLSDLTNGVK 657
|
|
| TAIR|locus:2010282 PERK7 "proline-rich extensin-like receptor kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 508 (183.9 bits), Expect = 1.1e-48, P = 1.1e-48
Identities = 112/255 (43%), Positives = 160/255 (62%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG-GDERLIVYDYMPNHSLI 100
+IAVK LK + + E EF EVEI+ RV HR+L+ L G+ + G +RL+VY+++PN +L
Sbjct: 360 EIAVKSLKAGSGQGEREFQAEVEIISRVHHRHLVSLVGYCSNAGGQRLLVYEFLPNDTLE 419
Query: 101 THLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKV 147
HLHG+ ++DW R+ IA+GSA+G+A DIKASN+LLD +FEAKV
Sbjct: 420 FHLHGKSGT--VMDWPTRLKIALGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKV 477
Query: 148 ADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPL 207
ADFG AKL D TH++TRV GT GYLAPEYA GK+++ DV+SFGV+LLELI+ + P+
Sbjct: 478 ADFGLAKLSQDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRGPV 537
Query: 208 EKLPGGVKRDIVQWVTPY----VQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNP 263
+ L G ++ +V W P Q G + + DP L+ ++ ++ MV A +
Sbjct: 538 D-LSGDMEDSLVDWARPLCMRVAQDGEYGELVDPFLEHQYEPYEMARMVACAAAAVRHSG 596
Query: 264 ENRPTMTDVVDWLKG 278
RP M+ +V L+G
Sbjct: 597 RRRPKMSQIVRTLEG 611
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.XV.3095.1 | hypothetical protein (287 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 325 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-32 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-30 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-29 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-29 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-21 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-20 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-19 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-18 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-17 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-16 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-15 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-14 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-12 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-12 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-11 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-11 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-10 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-10 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-09 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-09 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-09 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-09 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-09 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-09 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-08 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-08 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-08 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-08 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-07 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-07 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-07 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-06 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-06 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-06 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-06 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-06 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-05 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-05 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-05 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-05 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-05 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-04 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-04 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-04 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-04 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 0.001 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 0.001 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.001 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.001 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 0.001 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 0.002 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 0.002 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 0.002 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.003 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 0.003 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.004 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-32
Identities = 63/262 (24%), Positives = 117/262 (44%), Gaps = 41/262 (15%)
Query: 32 LLLRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90
L + ++AVK LK + + EF E I+ ++ H N++ L G + IV
Sbjct: 20 LKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIV 79
Query: 91 YDYMPNHSLITHL---HGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNV 137
+YM L+++L +L+ LL + A+ A G+ D+ A N
Sbjct: 80 MEYMEGGDLLSYLRKNRPKLSLSDLLSF------ALQIARGMEYLESKNFIHRDLAARNC 133
Query: 138 LLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLL 197
L+ + K++DFG ++ + D + K + ++APE GK + DV+SFGVLL
Sbjct: 134 LVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLL 193
Query: 198 LELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD--PRLKGKFNRDQLKSMVLI 254
E+ + ++P + ++++ Y++ G P + +
Sbjct: 194 WEIFTLGEQPYPGMSN---EEVLE----YLKNGYRLPQPPNCP-----------PELYDL 235
Query: 255 ALRCTDSNPENRPTMTDVVDWL 276
L+C +PE+RPT +++V+ L
Sbjct: 236 MLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-31
Identities = 53/182 (29%), Positives = 89/182 (48%), Gaps = 17/182 (9%)
Query: 42 QIAVKRLKTLNAKAEME-FAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
++A+K +K ++ + +E E+EIL ++ H N++ L G + + +V +Y SL
Sbjct: 20 KVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79
Query: 101 THLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLD-TDFEAKVAD 149
L L + I + EG+ D+K N+LLD + + K+AD
Sbjct: 80 DLLKENEGK---LSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLAD 136
Query: 150 FGFAKLIPDGVTHMTTRVKGTLGYLAPE-YAMWGKVSDSCDVYSFGVLLLELISAKKPLE 208
FG +KL+ + + T V GT Y+APE G S+ D++S GV+L EL K +
Sbjct: 137 FGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYELPELKDLIR 195
Query: 209 KL 210
K+
Sbjct: 196 KM 197
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 3e-30
Identities = 64/249 (25%), Positives = 115/249 (46%), Gaps = 34/249 (13%)
Query: 42 QIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
++AVK LK + + EF E I+ ++ H N++ L G + +IV +YMP L+
Sbjct: 30 EVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLL 89
Query: 101 THLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVADF 150
+L R L +S A+ A G+ D+ A N L+ + K++DF
Sbjct: 90 DYL--RKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDF 147
Query: 151 GFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEK 209
G ++ + D + K + ++APE GK + DV+SFGVLL E+ + ++P
Sbjct: 148 GLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPG 207
Query: 210 LPGGVKRDIVQWVTPYVQKGAFEHIAD--PRLKGKFNRDQLKSMVLIALRCTDSNPENRP 267
+ ++++ Y++KG P + + L+C +PE+RP
Sbjct: 208 MSN---AEVLE----YLKKGYRLPKPPNCP-----------PELYKLMLQCWAEDPEDRP 249
Query: 268 TMTDVVDWL 276
T +++V+ L
Sbjct: 250 TFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 4e-30
Identities = 71/250 (28%), Positives = 109/250 (43%), Gaps = 25/250 (10%)
Query: 35 RRETGDDQIAVKRLKTLNAK--AEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
+ TG +AVK LK + K + E+ IL R+ H N++ L + D +V +
Sbjct: 20 HKGTGK-IVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVME 78
Query: 93 YMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIG--SAEGIA--DIKASNVLLDTDFEAK 146
Y L +L G L+ D ++ + + GI D+K N+LLD + K
Sbjct: 79 YCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVK 138
Query: 147 VADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDS-CDVYSFGVLLLELISAKK 205
+ADFG AK + + +TT V GT Y+APE + G DV+S GV+L EL++ K
Sbjct: 139 IADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKP 197
Query: 206 PLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIAL--RCTDSNP 263
P G D Q I P L+ + S L +C + +P
Sbjct: 198 P---FSGENILD---------QLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDP 245
Query: 264 ENRPTMTDVV 273
RPT +++
Sbjct: 246 SKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 6e-29
Identities = 65/264 (24%), Positives = 114/264 (43%), Gaps = 44/264 (16%)
Query: 33 LLRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91
L ++ ++AVK LK + + +F E ++ ++ H N++ L G + +V
Sbjct: 16 LKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVL 75
Query: 92 DYMPNHSLITHLHGRLAPDCL-----LDWHRRVSIAIGSAEGIA----------DIKASN 136
+YM L+ +L L +S AI A+G+ D+ A N
Sbjct: 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARN 135
Query: 137 VLLDTDFEAKVADFGFAKLIPDGVTHMTTR-----VKGTLGYLAPEYAMWGKVSDSCDVY 191
L+ D K++DFG ++ + D + ++ ++APE G + DV+
Sbjct: 136 CLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----WMAPESLKDGIFTSKSDVW 191
Query: 192 SFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL-KGKFNRDQLK 249
SFGVLL E+ + P L + V Y++KG RL K ++ D+L
Sbjct: 192 SFGVLLWEIFTLGATPYPGLS-------NEEVLEYLRKGY-------RLPKPEYCPDELY 237
Query: 250 SMVLIALRCTDSNPENRPTMTDVV 273
+ L C +PE+RPT +++V
Sbjct: 238 E---LMLSCWQLDPEDRPTFSELV 258
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 7e-29
Identities = 68/253 (26%), Positives = 111/253 (43%), Gaps = 39/253 (15%)
Query: 35 RRETGDDQIAVKRLKTLNAKAEMEFAV-EVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93
++TG +A+K +K K + E + E++IL +++H N++ L + D+ +V +Y
Sbjct: 20 DKKTGK-LVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEY 78
Query: 94 MPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSA------EGIA--DIKASNVLLDTDF 143
L L GRL+ D R I SA +GI D+K N+LLD D
Sbjct: 79 CEGGDLFDLLKKRGRLSEDEA----RFYLRQILSALEYLHSKGIVHRDLKPENILLDEDG 134
Query: 144 EAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISA 203
K+ADFG A+ + G +TT V GT Y+APE + + D++S GV+L EL++
Sbjct: 135 HVKLADFGLARQLDPG-EKLTTFV-GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTG 192
Query: 204 KKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNR----DQLKSMVLIALRCT 259
K P + F+ I P+ + K ++ +
Sbjct: 193 KPP--------------FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLI---RKLL 235
Query: 260 DSNPENRPTMTDV 272
+PE R T +
Sbjct: 236 VKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-26
Identities = 64/250 (25%), Positives = 114/250 (45%), Gaps = 32/250 (12%)
Query: 37 ETGDDQIAVKRLKTLNAKAEM-EFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
E + ++AVK LK ++ E EF E I+ ++ H N++ L G G+ IV +YMP
Sbjct: 25 EGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMP 84
Query: 96 NHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEA 145
L+ L L + +A+ A+G+ D+ A N L+ +
Sbjct: 85 GGDLLDFLRKHGEK---LTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVV 141
Query: 146 KVADFGFAKLI-PDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-A 203
K++DFG ++ I D K + ++APE GK + DV+SFGVLL E+ +
Sbjct: 142 KISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLG 201
Query: 204 KKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNP 263
++P + ++++ ++ G RL + + + L+C +P
Sbjct: 202 EQPYPGMSN---EEVLE----LLEDG-------YRL--PRPENCPDELYELMLQCWAYDP 245
Query: 264 ENRPTMTDVV 273
E+RPT +++V
Sbjct: 246 EDRPTFSELV 255
|
Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-21
Identities = 56/171 (32%), Positives = 91/171 (53%), Gaps = 13/171 (7%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
++A+K LK+ + + +F EV+ L R+RH++L+ L + G+ I+ + M SL+
Sbjct: 32 RVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLA 91
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVADFG 151
L R +L + +A AEG+A D+ A N+L+ D KVADFG
Sbjct: 92 FL--RSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFG 149
Query: 152 FAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
A+LI + V ++++ K + APE A G S DV+SFG+LL E+ +
Sbjct: 150 LARLIKEDV-YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 1e-20
Identities = 66/243 (27%), Positives = 99/243 (40%), Gaps = 43/243 (17%)
Query: 43 IAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITH 102
+A+K +K + + + + E++IL + +H N++ G Y DE IV ++ SL
Sbjct: 28 VAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDL 87
Query: 103 LHGRLAPDCLLDWHRRVSIAIGSAE-----------GIA--DIKASNVLLDTDFEAKVAD 149
L IA E GI DIKA+N+LL +D E K+ D
Sbjct: 88 LKSTNQTLTESQ------IAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLID 141
Query: 150 FGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEK 209
FG + + D T GT ++APE D++S G+ +EL K P +
Sbjct: 142 FGLSAQLSDTKARNTM--VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSE 199
Query: 210 LPGGVKRDIVQWVTPYVQKGAFEHIAD---PRLK-GKFNRDQLKSMVLIALRCTDSNPEN 265
LP K F IA P L+ + D+ K + +C NPE
Sbjct: 200 LP--------------PMKALF-KIATNGPPGLRNPEKWSDEFKDFL---KKCLQKNPEK 241
Query: 266 RPT 268
RPT
Sbjct: 242 RPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 1e-20
Identities = 55/193 (28%), Positives = 95/193 (49%), Gaps = 24/193 (12%)
Query: 36 RETGDDQIAVKRLKTLNAKAE--MEFAVEVEILGRVRHRNLLGLRGFY--AGGDERLIVY 91
++TG+ +AVK ++ E E+ IL ++H N++ G + I
Sbjct: 22 KDTGE-LMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80
Query: 92 DYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLL 139
+Y+ SL + L G+L P+ ++ R+ + I EG+A DIK +N+L+
Sbjct: 81 EYVSGGSLSSLLKKFGKL-PEPVI---RKYTRQI--LEGLAYLHSNGIVHRDIKGANILV 134
Query: 140 DTDFEAKVADFGFAKLIPDGVTHMTTR-VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLL 198
D+D K+ADFG AK + D T T V+GT ++APE + + D++S G ++
Sbjct: 135 DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVI 194
Query: 199 ELISAKKPLEKLP 211
E+ + K P +L
Sbjct: 195 EMATGKPPWSELG 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 75/249 (30%), Positives = 119/249 (47%), Gaps = 46/249 (18%)
Query: 39 GDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHS 98
G ++AVK LK E F E +I+ ++RH L+ L + + IV +YM S
Sbjct: 29 GTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGS 87
Query: 99 LITHLH---GR-LAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFE 144
L+ L G+ L L+D +A AEG+A D+ A N+L+ +
Sbjct: 88 LLDFLKSGEGKKLRLPQLVD------MAAQIAEGMAYLESRNYIHRDLAARNILVGENLV 141
Query: 145 AKVADFGFAKLIPDG--VTHMTTR--VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLEL 200
K+ADFG A+LI D + +K T APE A +G+ + DV+SFG+LL E+
Sbjct: 142 CKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANYGRFTIKSDVWSFGILLTEI 197
Query: 201 IS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCT 259
++ + P PG R++++ V++G PR ++L ++ L+C
Sbjct: 198 VTYGRVP---YPGMTNREVLE----QVERG----YRMPRPPN--CPEELYDLM---LQCW 241
Query: 260 DSNPENRPT 268
D +PE RPT
Sbjct: 242 DKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-20
Identities = 68/239 (28%), Positives = 112/239 (46%), Gaps = 34/239 (14%)
Query: 43 IAVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
+AVK LK T++ K +F E +I+ ++RH L+ L + IV + M SL+
Sbjct: 33 VAVKTLKPGTMDPK---DFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89
Query: 101 THLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVADF 150
+L G L + + +A A G+A D+ A NVL+ + KVADF
Sbjct: 90 EYLQGGAGRALKL--PQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADF 147
Query: 151 GFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEK 209
G A++I + + K + + APE A++ + S DV+SFG+LL E+++ + P
Sbjct: 148 GLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP--- 204
Query: 210 LPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPT 268
PG +++Q V +G R+ K + I L C +P++RPT
Sbjct: 205 YPGMTNAEVLQ----QVDQGY-------RMPCPPGCP--KELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 1e-19
Identities = 74/244 (30%), Positives = 117/244 (47%), Gaps = 37/244 (15%)
Query: 39 GDDQIAVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER--LIVYDYM 94
G ++A+K LK T++ +A F E +++ ++RH L+ L YA E IV +YM
Sbjct: 29 GTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL---YAVVSEEPIYIVTEYM 82
Query: 95 PNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFE 144
SL+ L G + L + V +A A G+A D++A+N+L+ +
Sbjct: 83 SKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV 140
Query: 145 AKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAK 204
KVADFG A+LI D K + + APE A++G+ + DV+SFG+LL EL
Sbjct: 141 CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL--TT 198
Query: 205 KPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPE 264
K PG V R+++ V++G + P +S+ + +C PE
Sbjct: 199 KGRVPYPGMVNREVLD----QVERG-YRMPCPPECP--------ESLHDLMCQCWRKEPE 245
Query: 265 NRPT 268
RPT
Sbjct: 246 ERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-18
Identities = 65/197 (32%), Positives = 93/197 (47%), Gaps = 21/197 (10%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
++AVK LK ++ A F E ++ +RH NL+ L G G+ IV +YM SL+
Sbjct: 31 KVAVKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVD 89
Query: 102 HLHGR----LAPDCLLDWHRRVSIAIGSAEGIA----DIKASNVLLDTDFEAKVADFGFA 153
+L R + L + V + E D+ A NVL+ D AKV+DFG A
Sbjct: 90 YLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLA 149
Query: 154 KLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPG 212
K G VK T APE K S DV+SFG+LL E+ S + P ++P
Sbjct: 150 KEASQGQDSGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP- 204
Query: 213 GVKRDIVQWVTPYVQKG 229
++ V P+V+KG
Sbjct: 205 ------LKDVVPHVEKG 215
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 84.0 bits (206), Expect = 4e-18
Identities = 59/254 (23%), Positives = 96/254 (37%), Gaps = 28/254 (11%)
Query: 44 AVKRLK---TLNAKAEMEFAVEVEILGRVRH-RNLLGLRGFYAGGDERLIVYDYMPNHSL 99
A+K L +K F E++IL + H N++ L F+ +V +Y+ SL
Sbjct: 26 ALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSL 85
Query: 100 ITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTD-FEAKVA 148
L L + + I + DIK N+LLD D K+
Sbjct: 86 EDLLKKIGRKGPLSE-SEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLI 144
Query: 149 DFGFAKLIPDGVTHMTTRVK-----GTLGYLAPEYAM---WGKVSDSCDVYSFGVLLLEL 200
DFG AKL+PD + + GT GY+APE + S S D++S G+ L EL
Sbjct: 145 DFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYEL 204
Query: 201 ISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTD 260
++ P E + + +A P K+ + +
Sbjct: 205 LTGLPPFEGEKN---SSATSQTLKIILELPTPSLASPLSP-SNPELISKAASDLLKKLLA 260
Query: 261 SNPENRPTMTDVVD 274
+P+NR + + +
Sbjct: 261 KDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-18
Identities = 73/242 (30%), Positives = 123/242 (50%), Gaps = 33/242 (13%)
Query: 39 GDDQIAVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER--LIVYDYM 94
G+ ++AVK LK T++ ++ +E E +I+ ++RH L+ L YA E IV +YM
Sbjct: 29 GNTKVAVKTLKPGTMSPESFLE---EAQIMKKLRHDKLVQL---YAVVSEEPIYIVTEYM 82
Query: 95 PNHSLITHL---HGR-LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAK 146
SL+ L GR L L+D +V+ + E + D++++N+L+ K
Sbjct: 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCK 142
Query: 147 VADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKP 206
+ADFG A+LI D K + + APE A++G+ + DV+SFG+LL EL++ K
Sbjct: 143 IADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT--KG 200
Query: 207 LEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENR 266
PG R++++ V++G + +D S+ + L+C +PE R
Sbjct: 201 RVPYPGMNNREVLE----QVERG---------YRMPCPQDCPISLHELMLQCWKKDPEER 247
Query: 267 PT 268
PT
Sbjct: 248 PT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (193), Expect = 9e-17
Identities = 61/193 (31%), Positives = 85/193 (44%), Gaps = 29/193 (15%)
Query: 33 LLRRETGDDQI-AVKRLKTLNAKAEMEFAVEVE-------ILGRVRHRNLLGLRGFYAGG 84
LL R+ ++ A+K LK K ++ EVE IL R+ H ++ L YA
Sbjct: 10 LLVRKKDTGKLYAMKVLK----KKKIIKRKEVEHTLTERNILSRINHPFIVKL--HYAFQ 63
Query: 85 DERLI--VYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIA-IGSA------EGIA--DIK 133
E + V +Y P L +HL + R A I A GI D+K
Sbjct: 64 TEEKLYLVLEYAPGGELFSHLSKEG---RFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 134 ASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSF 193
N+LLD D K+ DFG AK + + T GT YLAPE + + D +S
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGKAVDWWSL 179
Query: 194 GVLLLELISAKKP 206
GVLL E+++ K P
Sbjct: 180 GVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 69/251 (27%), Positives = 108/251 (43%), Gaps = 42/251 (16%)
Query: 34 LRRETGDDQIAVKRLKTLNAKAE--MEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91
L ETGD +A+K++ K E E+++L ++H N++ G D I+
Sbjct: 20 LNLETGD-FVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL 78
Query: 92 DYMPNHSL--ITHLHGRLAPDCLLDWHRRVSIAI-----GSA----EGIA--DIKASNVL 138
+Y N SL I G P+ L V++ + G A +G+ DIKA+N+L
Sbjct: 79 EYAENGSLRQIIKKFGPF-PESL------VAVYVYQVLQGLAYLHEQGVIHRDIKAANIL 131
Query: 139 LDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLL 198
D K+ADFG A + D V+ V GT ++APE S + D++S G ++
Sbjct: 132 TTKDGVVKLADFGVATKLND-VSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVI 190
Query: 199 ELISAKKPLEKL-PGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALR 257
EL++ P L P IVQ P + +G + D ++
Sbjct: 191 ELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKD-----------------FLMQ 233
Query: 258 CTDSNPENRPT 268
C +P RPT
Sbjct: 234 CFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 60/258 (23%), Positives = 113/258 (43%), Gaps = 33/258 (12%)
Query: 38 TGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNH 97
Q VK + +N+ E A +G+++H N++ L G ++++Y+
Sbjct: 713 KNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGK 768
Query: 98 SLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI-------------ADIKASNVLLDTDFE 144
+L L L W RR IAIG A+ + ++ +++D E
Sbjct: 769 NLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE 821
Query: 145 AKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAK 204
+ +L G+ T+ + Y+APE +++ D+Y FG++L+EL++ K
Sbjct: 822 PHL------RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGK 875
Query: 205 KPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK--FNRDQLKSMVLIALRCTDSN 262
P + GV IV+W + DP ++G N++++ ++ +AL CT ++
Sbjct: 876 SPAD-AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATD 934
Query: 263 PENRPTMTDVVDWLKGGL 280
P RP DV+ L+
Sbjct: 935 PTARPCANDVLKTLESAS 952
|
Length = 968 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 62/196 (31%), Positives = 100/196 (51%), Gaps = 20/196 (10%)
Query: 39 GDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER--LIVYDYMPN 96
G ++A+K LK E F E +I+ ++RH L+ L YA E IV ++M
Sbjct: 29 GTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPL---YAVVSEEPIYIVTEFMGK 84
Query: 97 HSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAK 146
SL+ L + L + V +A A+G+A D++A+N+L+ + K
Sbjct: 85 GSLLDFL--KEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCK 142
Query: 147 VADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKP 206
+ADFG A+LI D K + + APE A++G+ + DV+SFG+LL EL++ K
Sbjct: 143 IADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT--KG 200
Query: 207 LEKLPGGVKRDIVQWV 222
PG V R++++ V
Sbjct: 201 RVPYPGMVNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-16
Identities = 65/239 (27%), Positives = 100/239 (41%), Gaps = 27/239 (11%)
Query: 39 GDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHS 98
G +A+K ++ A +E +F E +++ ++ H NL+ L G IV +YM N
Sbjct: 27 GKIDVAIKMIRE-GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGC 85
Query: 99 LITHLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----DIKASNVLLDTDFEAKVADFG 151
L+ +L G+L + LLD V A+ E D+ A N L+ D KV+DFG
Sbjct: 86 LLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFG 145
Query: 152 FAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKL 210
A+ + D + K + + PE + + S DV+SFGVL+ E+ S K P E+
Sbjct: 146 LARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205
Query: 211 PGG-VKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPT 268
V + Y K A + I C PE+RP
Sbjct: 206 SNSEVVESVSAGYRLYRPKLAPTEVYT-----------------IMYSCWHEKPEDRPA 247
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-16
Identities = 68/264 (25%), Positives = 107/264 (40%), Gaps = 49/264 (18%)
Query: 42 QIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
+AVK LK T + A +F E E+L +H N++ G GD ++V++YM + L
Sbjct: 37 LVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLN 96
Query: 101 THL--HGRLA-------PDCL-LDWHRRVSIAIGSAEGIA----------DIKASNVLLD 140
L HG A L + + IA+ A G+ D+ N L+
Sbjct: 97 KFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG 156
Query: 141 TDFEAKVADFGFAKLIPDGVTHMTTRVKGT----LGYLAPEYAMWGKVSDSCDVYSFGVL 196
D K+ DFG ++ D T RV G + ++ PE M+ K + DV+SFGV+
Sbjct: 157 YDLVVKIGDFGMSR---DVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVV 213
Query: 197 LLELISAKKPLEKLPGGVKRDIVQWVTPYVQKG---AFEHIADPRLKGKFNRDQLKSMVL 253
L E+ + K P+ E I RL + R +
Sbjct: 214 LWEIFTYGK-----------------QPWYGLSNEEVIECITQGRLLQR-PRTCPSEVYD 255
Query: 254 IALRCTDSNPENRPTMTDVVDWLK 277
I L C +P+ R + D+ + L+
Sbjct: 256 IMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-16
Identities = 70/246 (28%), Positives = 107/246 (43%), Gaps = 32/246 (13%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL-IVYDYMPNHSLI 100
++AVK +K N F E ++ ++RH NL+ L G L IV +YM SL+
Sbjct: 31 KVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 88
Query: 101 THLHGR----LAPDCLLDWHRRVSIAIGSAEGIA----DIKASNVLLDTDFEAKVADFGF 152
+L R L DCLL + V A+ E D+ A NVL+ D AKV+DFG
Sbjct: 89 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGL 148
Query: 153 AKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLP 211
K + K + + APE K S DV+SFG+LL E+ S + P ++P
Sbjct: 149 TK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204
Query: 212 GGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTD 271
++ V P V+KG D ++ + +C + RP+
Sbjct: 205 -------LKDVVPRVEKGYKMDAPDGCPPVVYD---------VMKQCWHLDAATRPSFLQ 248
Query: 272 VVDWLK 277
+ + L+
Sbjct: 249 LREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 8e-16
Identities = 50/183 (27%), Positives = 90/183 (49%), Gaps = 16/183 (8%)
Query: 43 IAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+A+K LK + K ++F E I+G+ H N++ L G +I+ +YM N SL
Sbjct: 35 VAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDK 94
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVADFG 151
L D + V + G A G+ D+ A N+L++++ KV+DFG
Sbjct: 95 FLREN---DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFG 151
Query: 152 FAKLIPDGVTHMTTRV-KGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEK 209
++ + D TT+ K + + APE + K + + DV+SFG+++ E++S ++P
Sbjct: 152 LSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211
Query: 210 LPG 212
+
Sbjct: 212 MSN 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 63/254 (24%), Positives = 113/254 (44%), Gaps = 25/254 (9%)
Query: 42 QIAVKRLKTLNAKAEM-EFAVEVEILGRVRHRNLLGLRGFY--AGGDERLIVYDYMPNHS 98
Q+AVK L + +F E+EIL + H N++ +G GG ++ +Y+P+ S
Sbjct: 35 QVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGS 94
Query: 99 LITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVA 148
L +L R ++ R + + +G+ D+ A N+L++++ K++
Sbjct: 95 LRDYLQ-RHRDQ--INLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKIS 151
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLG--YLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKP 206
DFG AK++P+ + + G + APE K S + DV+SFGV L EL + P
Sbjct: 152 DFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDP 211
Query: 207 LEKLPGGVKRDIVQWVTPYVQKGAFEHIAD-PRLKGKFNR-DQLKSMVL-IALRCTDSNP 263
+ P R I + E + + RL R V + C ++ P
Sbjct: 212 SQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERL----PRPPSCPDEVYDLMKLCWEAEP 267
Query: 264 ENRPTMTDVVDWLK 277
++RP+ D++ +
Sbjct: 268 QDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 3e-15
Identities = 63/273 (23%), Positives = 113/273 (41%), Gaps = 65/273 (23%)
Query: 32 LLLRRETGDDQIAVKR--LKTLNAKAEMEFAV-EVEILGRVRHRNLLGLRGFYAGGDERL 88
L+RR++ +K L ++ K E E A+ EV+IL ++ H N++ + +
Sbjct: 17 YLVRRKSDGKLYVLKEIDLSNMSEK-EREDALNEVKILKKLNHPNIIKYYESFEEKGKLC 75
Query: 89 IVYDYMPNHSLITHLHGRLAP------DCLLDW-----------------HRRVSIAIGS 125
IV +Y L + + + +LDW HR
Sbjct: 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHR-------- 127
Query: 126 AEGIADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKV- 184
DIK N+ L ++ K+ DFG +K++ V T V GT YL+PE +
Sbjct: 128 -----DIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE--LCQNKP 179
Query: 185 -SDSCDVYSFGVLLLELISAKKPLE--KLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241
+ D++S G +L EL + K P E L + + KG + P +
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK---------ILKGQY-----PPIPS 225
Query: 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274
+++ + L+++V L+ +PE RP++ ++
Sbjct: 226 QYSSE-LRNLVSSLLQ---KDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 5e-15
Identities = 62/245 (25%), Positives = 102/245 (41%), Gaps = 29/245 (11%)
Query: 39 GDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHS 98
G +A+K +K + +E EF E +++ ++ H L+ L G IV +YM N
Sbjct: 27 GQYDVAIKMIKE-GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC 85
Query: 99 LITHLHG---RLAPDCLLDWHRRVSIAIGSAEGIA----DIKASNVLLDTDFEAKVADFG 151
L+ +L R P LL+ + V + E D+ A N L+D KV+DFG
Sbjct: 86 LLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFG 145
Query: 152 FAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKL 210
++ + D + K + + PE ++ K S DV++FGVL+ E+ S K P E+
Sbjct: 146 LSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER- 204
Query: 211 PGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKS--MVLIALRCTDSNPENRPT 268
+ E ++ + R L S + I C E RPT
Sbjct: 205 --------------FNNSETVEKVSQGL---RLYRPHLASEKVYAIMYSCWHEKAEERPT 247
Query: 269 MTDVV 273
++
Sbjct: 248 FQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 27/188 (14%)
Query: 43 IAVKRLKTLNA-KAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+A+K L+ + KA E E ++ V H +++ L G +LI MP L+
Sbjct: 39 VAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLIT-QLMPLGCLLD 97
Query: 102 HLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVA 148
++ + LL+W ++ A+G++ D+ A NVL+ T K+
Sbjct: 98 YVRNHKDNIGSQYLLNWCVQI------AKGMSYLEEKRLVHRDLAARNVLVKTPQHVKIT 151
Query: 149 DFGFAKLIPDGVTHMTTRVKG---TLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AK 204
DFG AKL+ +G + ++A E + + DV+S+GV + EL++
Sbjct: 152 DFGLAKLLDVDEKEY--HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGA 209
Query: 205 KPLEKLPG 212
KP E +P
Sbjct: 210 KPYEGIPA 217
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 3e-14
Identities = 58/248 (23%), Positives = 104/248 (41%), Gaps = 36/248 (14%)
Query: 36 RETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRG-FYAGGDERLIVYDY 93
+ TG A+K++ + + + E++ L ++ G FY G+ IV +Y
Sbjct: 23 KPTGK-IYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEIS-IVLEY 80
Query: 94 MPNHSL--ITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA-----------DIKASNVLLD 140
M SL + G++ L IA +G+ DIK SN+L++
Sbjct: 81 MDGGSLADLLKKVGKIPEPVL------AYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN 134
Query: 141 TDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLEL 200
+ E K+ADFG +K++ + + T V GT+ Y++PE S + D++S G+ LLE
Sbjct: 135 SKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYAADIWSLGLTLLEC 193
Query: 201 ISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTD 260
K P +++Q + G P L + + + + C
Sbjct: 194 ALGKFPFLPPGQPSFFELMQ----AICDG-----PPPSLPAEEFSPEFRDFI---SACLQ 241
Query: 261 SNPENRPT 268
+P+ RP+
Sbjct: 242 KDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-14
Identities = 47/170 (27%), Positives = 89/170 (52%), Gaps = 10/170 (5%)
Query: 43 IAVKRLKT-LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+A+K LK K +F E I+G+ H N++ L G +I+ +YM N +L
Sbjct: 36 VAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDK 95
Query: 102 HLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----DIKASNVLLDTDFEAKVADFGFAK 154
+L G + L+ R ++ + + D+ A N+L++++ E KV+DFG ++
Sbjct: 96 YLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSR 155
Query: 155 LIPDG--VTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
++ D T+ T+ K + + APE + K + + DV+SFG+++ E++S
Sbjct: 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-14
Identities = 63/249 (25%), Positives = 111/249 (44%), Gaps = 43/249 (17%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
++A+K + A +E +F E +++ ++ H L+ L G IV ++M N L+
Sbjct: 30 KVAIKAINE-GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN 88
Query: 102 HL---HGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVA 148
+L G+L+ D LL S+ EG+ D+ A N L+ + KV+
Sbjct: 89 YLRQRQGKLSKDMLL------SMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVS 142
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPL 207
DFG + + D ++ K + + PE + K S DV+SFGVL+ E+ + K P
Sbjct: 143 DFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF 202
Query: 208 EKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG-KFNRDQLKSMVL--IALRCTDSNPE 264
EK ++V+ ++ +G + R +L SM + + C PE
Sbjct: 203 EKKS---NYEVVEMIS----------------RGFRLYRPKLASMTVYEVMYSCWHEKPE 243
Query: 265 NRPTMTDVV 273
RPT +++
Sbjct: 244 GRPTFAELL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-14
Identities = 66/244 (27%), Positives = 112/244 (45%), Gaps = 42/244 (17%)
Query: 42 QIAVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSL 99
++AVK LK T++ +A +E E ++ ++H L+ L + I+ +YM SL
Sbjct: 32 KVAVKTLKPGTMSVQAFLE---EANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSL 88
Query: 100 ITHLH----GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEA 145
+ L G++ L+D+ ++ AEG+A D++A+NVL+
Sbjct: 89 LDFLKSDEGGKVLLPKLIDFSAQI------AEGMAYIERKNYIHRDLRAANVLVSESLMC 142
Query: 146 KVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AK 204
K+ADFG A++I D K + + APE +G + DV+SFG+LL E+++ K
Sbjct: 143 KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGK 202
Query: 205 KPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPE 264
P PG D++ +Q+G PR++ + + I C E
Sbjct: 203 IP---YPGMSNSDVMS----ALQRG----YRMPRME-----NCPDELYDIMKTCWKEKAE 246
Query: 265 NRPT 268
RPT
Sbjct: 247 ERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 8e-14
Identities = 49/177 (27%), Positives = 83/177 (46%), Gaps = 24/177 (13%)
Query: 43 IAVKRLKT-LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+A+K LK K +F E I+G+ H N++ L G +IV +YM N SL
Sbjct: 35 VAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDA 94
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA--------------DIKASNVLLDTDFEAKV 147
L D V +G GIA D+ A N+L++++ KV
Sbjct: 95 FLRKH-------DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKV 147
Query: 148 ADFGFAKLIPDG--VTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
+DFG ++++ D + T K + + APE + K + + DV+S+G+++ E++S
Sbjct: 148 SDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 9e-14
Identities = 53/171 (30%), Positives = 90/171 (52%), Gaps = 11/171 (6%)
Query: 43 IAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGF-YAGGDERL-IVYDYMPNHSLI 100
+AVK+L+ A+ +F E+EIL ++H N++ +G Y+ G L +V +Y+P SL
Sbjct: 36 VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLR 95
Query: 101 THLHG---RLAPDCLLDWHRRVSIA---IGSAEGI-ADIKASNVLLDTDFEAKVADFGFA 153
+L RL LL + ++ +GS + D+ N+L++++ K+ DFG
Sbjct: 96 DYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT 155
Query: 154 KLIPDGVTHMTTRVKGT--LGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
K++P + R G + + APE K S + DV+SFGV+L EL +
Sbjct: 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-13
Identities = 61/261 (23%), Positives = 115/261 (44%), Gaps = 56/261 (21%)
Query: 42 QIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
++AVK + TL + +F E EIL + H N++ L G IV + +P SL+
Sbjct: 21 EVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80
Query: 101 THLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVADF 150
T L + L + + +++ +A G+ D+ A N L+ + K++DF
Sbjct: 81 TFLRKKKNR---LTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDF 137
Query: 151 GFAKLIPDGVTHMTTRVKGT-LGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEK 209
G ++ G+ ++ +K + + APE +G+ + DV+S+G+LL E S
Sbjct: 138 GMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFS------- 190
Query: 210 LPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKS-------------MVLIAL 256
G TPY P + + R++++S + + L
Sbjct: 191 --LG--------DTPY-----------PGMSNQQTRERIESGYRMPAPQLCPEEIYRLML 229
Query: 257 RCTDSNPENRPTMTDVVDWLK 277
+C +PENRP+ +++ + L+
Sbjct: 230 QCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 57/246 (23%), Positives = 107/246 (43%), Gaps = 39/246 (15%)
Query: 40 DDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSL 99
++A+K ++ A +E +F E +++ ++ H L+ L G +V+++M + L
Sbjct: 28 KRKVAIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCL 86
Query: 100 ITHLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAK 146
+L G+ + + LL + + EG+A D+ A N L+ + K
Sbjct: 87 SDYLRAQRGKFSQETLLG------MCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVK 140
Query: 147 VADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKP 206
V+DFG + + D +T K + + +PE + K S DV+SFGVL+ E+ S K
Sbjct: 141 VSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK- 199
Query: 207 LEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQL--KSMVLIALRCTDSNPE 264
TPY + E + + + +L +S+ + C PE
Sbjct: 200 ----------------TPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPE 243
Query: 265 NRPTMT 270
+RP+ +
Sbjct: 244 DRPSFS 249
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-13
Identities = 62/253 (24%), Positives = 107/253 (42%), Gaps = 55/253 (21%)
Query: 39 GDDQIAVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPN 96
G ++A+K LK +++ +A F E ++ +++H L+ L + I+ +YM N
Sbjct: 29 GHTKVAIKSLKQGSMSPEA---FLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIITEYMEN 84
Query: 97 HSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAK 146
SL+ L L ++ + +A AEG+A D++A+N+L+ K
Sbjct: 85 GSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCK 142
Query: 147 VADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKK 205
+ADFG A+LI D K + + APE +G + DV+SFG+LL E+++ +
Sbjct: 143 IADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRI 202
Query: 206 PLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVL----------IA 255
P PG +++Q N ++ M +
Sbjct: 203 P---YPGMTNPEVIQ-----------------------NLERGYRMPRPDNCPEELYELM 236
Query: 256 LRCTDSNPENRPT 268
C PE RPT
Sbjct: 237 RLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 3e-13
Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 45/204 (22%)
Query: 35 RRETGDDQIAVKRLKTLNAKAEMEFAV----EVEILGRVRHRNLLGLRGFY--AGGDERL 88
++TG+ +A+K+++ N K F + E+++L ++RH N++ L+ G
Sbjct: 20 NKKTGE-LVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIY 76
Query: 89 IVYDYMPN--HSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASN 136
+V++YM + L+ + + EG+ DIK SN
Sbjct: 77 MVFEYMDHDLTGLLDSPEVKFTES-----QIK-CYMKQLLEGLQYLHSNGILHRDIKGSN 130
Query: 137 VLLDTDFEAKVADFGFAKLI-PDGVTHMTTRVKGTLGYLAPE-------YAMWGKVSDSC 188
+L++ D K+ADFG A+ T RV TL Y PE Y +V
Sbjct: 131 ILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGATRYG--PEV---- 183
Query: 189 DVYSFGVLLLELISAKKPLEKLPG 212
D++S G +L EL KP+ G
Sbjct: 184 DMWSVGCILAELFL-GKPI--FQG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-13
Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 33/202 (16%)
Query: 42 QIAVKRLKT-LNAKAEMEFAVEVEILGRVRHRNLLGLRG--FYAGGDERLIVYDYMPNHS 98
++AVK +K + A+A F E ++ ++ H+NL+ L G + G IV + M +
Sbjct: 31 KVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVILHNG---LYIVMELMSKGN 84
Query: 99 LITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVA 148
L+ L R L+ + + ++ AEG+ D+ A N+L+ D AKV+
Sbjct: 85 LVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVS 142
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPL 207
DFG A++ GV + VK T APE K S DV+S+GVLL E+ S + P
Sbjct: 143 DFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
Query: 208 EKLPGGVKRDIVQWVTPYVQKG 229
K+ ++ V V+KG
Sbjct: 199 PKMS-------LKEVKECVEKG 213
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-13
Identities = 58/252 (23%), Positives = 107/252 (42%), Gaps = 31/252 (12%)
Query: 33 LLRRETGDDQIAVKR--LKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90
++R + + A+K L +++ K + E+ IL V H N++ + + G++ IV
Sbjct: 18 KVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV 77
Query: 91 YDYMPNHSLITHLHGRLAPDCLLD----WHRRVSIAIG----SAEGIA--DIKASNVLLD 140
+Y P L + R L+ W + + G + I D+K++N+LL
Sbjct: 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV 137
Query: 141 TDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLEL 200
+ K+ D G +K++ M GT Y+APE S D++S G LL E+
Sbjct: 138 ANDLVKIGDLGISKVLKKN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEM 194
Query: 201 ISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTD 260
+ P E R + Q + VQ+G + P + +++D L++ +
Sbjct: 195 ATFAPPFE------ARSM-QDLRYKVQRGKY-----PPIPPIYSQD-LQNFI---RSMLQ 238
Query: 261 SNPENRPTMTDV 272
P+ RP +
Sbjct: 239 VKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-13
Identities = 43/147 (29%), Positives = 74/147 (50%), Gaps = 13/147 (8%)
Query: 66 LGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIA 122
+G + H ++ L G G +L+ P SL+ H+ L P LL+W V IA
Sbjct: 63 MGSLDHAYIVRLLGICPGASLQLVT-QLSPLGSLLDHVRQHRDSLDPQRLLNWC--VQIA 119
Query: 123 IG----SAEGIA--DIKASNVLLDTDFEAKVADFGFAKLI-PDGVTHMTTRVKGTLGYLA 175
G + ++ A N+LL +D ++ADFG A L+ PD + + K + ++A
Sbjct: 120 KGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179
Query: 176 PEYAMWGKVSDSCDVYSFGVLLLELIS 202
E ++G+ + DV+S+GV + E++S
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 56/259 (21%), Positives = 116/259 (44%), Gaps = 42/259 (16%)
Query: 32 LLLRRETGDDQIAVKRLKTLNAKAEMEFA-VEVEILGRVRHRNLLGLRGFYAGGDERLIV 90
LL++ D + A+K ++ + + +E + E +L +++H N++ + + IV
Sbjct: 17 LLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV 76
Query: 91 YDYMPNHSLITHL---HGRLAP-DCLLDWHRRVSIAIGSAEGIA----DIKASNVLLDTD 142
+Y L+ + G+L P D +L W ++ + + DIK+ N+ L +
Sbjct: 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN 136
Query: 143 FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKV--SDSCDVYSFGVLLLEL 200
+ K+ DFG A+L+ + T V GT Y+ PE +W + ++ D++S G +L EL
Sbjct: 137 GKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPE--IWENMPYNNKSDIWSLGCILYEL 193
Query: 201 ISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN------RDQLKSMVLI 254
+ K P Q +++++ +G + +L+S++
Sbjct: 194 CTLKHPF-------------------QANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQ 234
Query: 255 ALRCTDSNPENRPTMTDVV 273
+ NP +RP+ T ++
Sbjct: 235 MFK---RNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-12
Identities = 57/180 (31%), Positives = 87/180 (48%), Gaps = 21/180 (11%)
Query: 38 TGDDQIAVKRLKTLNAKAEME-FAVEVEILGRVRHRNLLGLRGFYA--GGDERLIVYDYM 94
TG+ +AVK LK + + E+ IL + H N++ +G + GG ++ +Y+
Sbjct: 32 TGE-MVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90
Query: 95 PNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFE 144
P SL +L P L+ + + A EG+A D+ A NVLLD D
Sbjct: 91 PLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL 145
Query: 145 AKVADFGFAKLIPDGVTHMTTRVKGT--LGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
K+ DFG AK +P+G + R G + + A E K S + DV+SFGV L EL++
Sbjct: 146 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 65/256 (25%), Positives = 105/256 (41%), Gaps = 35/256 (13%)
Query: 33 LLRRETGDDQIAVKR--LKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90
L RR D + K L L+ K + E+ IL ++H N++ + + LI
Sbjct: 18 LYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE 77
Query: 91 YDYMPNHSL---ITHLHGRLAPDCLLDWHRRVSIAIGSA------EGI--ADIKASNVLL 139
+Y +L I G+L + ++ W I SA GI DIK N+ L
Sbjct: 78 MEYANGGTLYDKIVRQKGQLFEEEMVLW---YLFQIVSAVSYIHKAGILHRDIKTLNIFL 134
Query: 140 DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLE 199
K+ DFG +K++ + T V GT Y++PE K + D+++ G +L E
Sbjct: 135 TKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYNFKSDIWALGCVLYE 193
Query: 200 LISAKKPLEKL-PGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRC 258
L++ K+ + P + IVQ G + + L S+V
Sbjct: 194 LLTLKRTFDATNPLNLVVKIVQ--------GNYTPVVSVYSSE------LISLV---HSL 236
Query: 259 TDSNPENRPTMTDVVD 274
+PE RPT +V+D
Sbjct: 237 LQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 61/249 (24%), Positives = 102/249 (40%), Gaps = 32/249 (12%)
Query: 42 QIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
+AVK LK+ + +F E I+ + H NL+ L G ++V + P SL+
Sbjct: 25 PVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLL 83
Query: 101 THLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVADF 150
L L+ A+ A G+ D+ A N+LL +D + K+ DF
Sbjct: 84 DRLRKDALGHFLI--STLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDF 141
Query: 151 GFAKLIPDGVTH--MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPL 207
G + +P H M +K + APE S + DV+ FGV L E+ + ++P
Sbjct: 142 GLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPW 201
Query: 208 EKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRP 267
L G I++ + E + P + + + L+C NP +RP
Sbjct: 202 AGLSG---SQILKKI-----DKEGERLERP-------EACPQDIYNVMLQCWAHNPADRP 246
Query: 268 TMTDVVDWL 276
T + ++L
Sbjct: 247 TFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-12
Identities = 67/246 (27%), Positives = 104/246 (42%), Gaps = 37/246 (15%)
Query: 43 IAVKRLKTLNAKAEMEFAV-EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+A+KR+ + ++ EV+ + + H N++ + GDE +V Y+ SL+
Sbjct: 29 VAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLL- 87
Query: 102 HLHGRLAPDCLLDWHRRVSIAI---GSAEGIA----------DIKASNVLLDTDFEAKVA 148
+ P LD IA +G+ DIKA N+LL D K+A
Sbjct: 88 DIMKSSYPRGGLD---EAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIA 144
Query: 149 DFGFAKLIPDGVTHMTTRVK----GTLGYLAPEYAMWGKVSDS-CDVYSFGVLLLELISA 203
DFG + + DG T +V+ GT ++APE D D++SFG+ +EL +
Sbjct: 145 DFGVSASLADGGD-RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATG 203
Query: 204 KKPLEKL-PGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSN 262
P K P V +Q P + E AD + K R +I+L C +
Sbjct: 204 AAPYSKYPPMKVLMLTLQNDPP-----SLETGADYKKYSKSFRK------MISL-CLQKD 251
Query: 263 PENRPT 268
P RPT
Sbjct: 252 PSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 61/250 (24%), Positives = 106/250 (42%), Gaps = 32/250 (12%)
Query: 34 LRRETGDDQIAVKRLKT-LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
L+ +T +AVK K L + +++F E IL + H N++ L G IV +
Sbjct: 16 LKDKT---PVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVME 72
Query: 93 YMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTD 142
+P ++ L + L + V A+ +A G+A D+ A N L+ +
Sbjct: 73 LVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN 129
Query: 143 FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
K++DFG ++ DG+ + + + + APE +G+ S DV+S+G+LL E S
Sbjct: 130 NVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189
Query: 203 AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSN 262
+ PG + + V + + D K + RC D
Sbjct: 190 LG--VCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYK-------------VMQRCWDYK 234
Query: 263 PENRPTMTDV 272
PENRP +++
Sbjct: 235 PENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 53/187 (28%), Positives = 92/187 (49%), Gaps = 24/187 (12%)
Query: 43 IAVK--RLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
+AVK R++ + K E A E+++L ++H NL+ G ++ I +Y +L
Sbjct: 28 MAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLE 87
Query: 101 THL-HGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVAD 149
L HGR+ + ++ R ++ + EG+A DIK +N+ LD + K+ D
Sbjct: 88 ELLEHGRILDEHVI---RVYTLQL--LEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGD 142
Query: 150 FGFAKLIPDGVTHMTTRVKGTLG---YLAPEYAMWGKVSD---SCDVYSFGVLLLELISA 203
FG A + + T M V+ G Y+APE GK + D++S G ++LE+ +
Sbjct: 143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATG 202
Query: 204 KKPLEKL 210
K+P +L
Sbjct: 203 KRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-12
Identities = 48/166 (28%), Positives = 77/166 (46%), Gaps = 9/166 (5%)
Query: 43 IAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITH 102
+AVK LK + E EF E ++ ++H NL+ L G I+ ++M +L+ +
Sbjct: 34 VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 92
Query: 103 LH----GRLAPDCLLDWHRRVSIAIGSAEGIA----DIKASNVLLDTDFEAKVADFGFAK 154
L + LL ++S A+ E D+ A N L+ + KVADFG ++
Sbjct: 93 LRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 152
Query: 155 LIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLEL 200
L+ K + + APE + K S DV++FGVLL E+
Sbjct: 153 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 5e-12
Identities = 62/248 (25%), Positives = 109/248 (43%), Gaps = 31/248 (12%)
Query: 42 QIAVKRLKTLNAKA-EMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
++AVK LK + A + EF E ++ ++ H ++ L G G+ ++V + P L+
Sbjct: 25 EVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGV-CKGEPLMLVMELAPLGPLL 83
Query: 101 THL--HGRLAPDCLLDWHRRVSIAIGSAEGIA----DIKASNVLLDTDFEAKVADFGFAK 154
+L + L + +V++ + E D+ A NVLL +AK++DFG ++
Sbjct: 84 KYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSR 143
Query: 155 LIPDGVTHMTTRVKGT--LGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLP 211
+ G + G L + APE +GK S DV+S+GV L E S KP ++
Sbjct: 144 ALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK 203
Query: 212 GGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQL--KSMVLIALRCTDSNPENRPTM 269
G V ++ G + R + + + I L C PE+RPT
Sbjct: 204 GAE-------VIAMLESG-----------ERLPRPEECPQEIYSIMLSCWKYRPEDRPTF 245
Query: 270 TDVVDWLK 277
+++ +
Sbjct: 246 SELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 60/261 (22%), Positives = 103/261 (39%), Gaps = 64/261 (24%)
Query: 35 RRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94
R TG ++A+K+++ L + + E+ I+ +H N++ Y GDE +V +YM
Sbjct: 40 DRATGK-EVAIKKMR-LRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYM 97
Query: 95 PNHSL--------------------------ITHLHGRLAPDCLLDWHRRVSIAIGSAEG 128
SL + +LH + + + HR
Sbjct: 98 DGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVI---HR----------- 140
Query: 129 IADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSC 188
DIK+ N+LL D K+ADFGFA + + + V GT ++APE
Sbjct: 141 --DIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRKDYGPKV 197
Query: 189 DVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQ- 247
D++S G++ +E+ + P + P ++ + KG P LK
Sbjct: 198 DIWSLGIMCIEMAEGEPPYLREPP------LRALFLITTKGI------PPLKNPEKWSPE 245
Query: 248 LKSMVLIALRCTDSNPENRPT 268
K + +C +PE RP+
Sbjct: 246 FKDFL---NKCLVKDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 35/138 (25%), Positives = 66/138 (47%), Gaps = 17/138 (12%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
D+K +N+ LD + K+ DFG AK++ + T V GT Y++PE + D+
Sbjct: 135 DLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNHMSYDEKSDI 193
Query: 191 YSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKS 250
+S G L+ EL + P R+ +Q + +++G F R+ +++ +L
Sbjct: 194 WSLGCLIYELCALSPPFT------ARNQLQ-LASKIKEGKF-----RRIPYRYS-SELNE 240
Query: 251 MVLIALRCTDSNPENRPT 268
+I + +P+ RP+
Sbjct: 241 --VIKS-MLNVDPDKRPS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 27/79 (34%), Positives = 36/79 (45%), Gaps = 2/79 (2%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
DIK N+LLD + DF A + +TT GT GY+APE S + D
Sbjct: 125 DIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDW 182
Query: 191 YSFGVLLLELISAKKPLEK 209
+S GV E + K+P
Sbjct: 183 WSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 3e-11
Identities = 49/211 (23%), Positives = 85/211 (40%), Gaps = 59/211 (27%)
Query: 36 RETGDDQI-AVKRLKTLNAKAEME---FAV--EVEILGRVRHRNLLGLRGFYAGGDERLI 89
R+ +I A+K++K K + F E+++L ++H N++GL + +
Sbjct: 20 RDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL 79
Query: 90 VYDYMP--------NHSL-----------------ITHLHGRLAPDCLLDW--HRRVSIA 122
V+++M + S+ + +LH W HR
Sbjct: 80 VFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN--------WILHR----- 126
Query: 123 IGSAEGIADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWG 182
D+K +N+L+ +D K+ADFG A+ MT +V T Y APE
Sbjct: 127 --------DLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGA 177
Query: 183 KV-SDSCDVYSFGVLLLELISAKKPLEKLPG 212
+ D++S G + EL+ + P LPG
Sbjct: 178 RHYGVGVDMWSVGCIFAELLL-RVPF--LPG 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 52/196 (26%), Positives = 87/196 (44%), Gaps = 32/196 (16%)
Query: 43 IAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITH 102
+AVK LK A +F E E+L ++H +++ G GD ++V++YM + L
Sbjct: 38 VAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKF 97
Query: 103 LHGRLAPDCL-------------LDWHRRVSIAIGSAEGIA----------DIKASNVLL 139
L PD + L + + IA A G+ D+ N L+
Sbjct: 98 LRAH-GPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV 156
Query: 140 DTDFEAKVADFGFAKLIPDGVTHMTTRVKG----TLGYLAPEYAMWGKVSDSCDVYSFGV 195
+ K+ DFG ++ D + RV G + ++ PE M+ K + DV+SFGV
Sbjct: 157 GANLLVKIGDFGMSR---DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 213
Query: 196 LLLELIS-AKKPLEKL 210
+L E+ + K+P +L
Sbjct: 214 ILWEIFTYGKQPWFQL 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 58/245 (23%), Positives = 107/245 (43%), Gaps = 45/245 (18%)
Query: 42 QIAVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSL 99
++AVK +K +++ +A + E ++ ++H L+ L + I+ ++M SL
Sbjct: 32 KVAVKTMKPGSMSVEAFLA---EANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSL 87
Query: 100 ITHLHG----RLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEA 145
+ L + L+D+ ++ AEG+A D++A+N+L+
Sbjct: 88 LDFLKSDEGSKQPLPKLIDFSAQI------AEGMAFIEQRNYIHRDLRAANILVSASLVC 141
Query: 146 KVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKK 205
K+ADFG A++I D K + + APE +G + DV+SFG+LL+E+++ +
Sbjct: 142 KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201
Query: 206 PLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQL--KSMVLIALRCTDSNP 263
PY E I + R + + + I +RC + P
Sbjct: 202 -----------------IPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRP 244
Query: 264 ENRPT 268
E RPT
Sbjct: 245 EERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-11
Identities = 47/181 (25%), Positives = 85/181 (46%), Gaps = 30/181 (16%)
Query: 43 IAVKRLKT-LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+A+K LK+ K +F E I+G+ H N++ L G +I+ ++M N +L +
Sbjct: 35 VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDS 94
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA--------------DIKASNVLLDTDFEAKV 147
L D V +G GIA D+ A N+L++++ KV
Sbjct: 95 FLR-------QNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKV 147
Query: 148 ADFGFAKLIPDGVTHMTTRVKGTLG------YLAPEYAMWGKVSDSCDVYSFGVLLLELI 201
+DFG ++ + D + T +LG + APE + K + + DV+S+G+++ E++
Sbjct: 148 SDFGLSRFLEDDTSDPT--YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 205
Query: 202 S 202
S
Sbjct: 206 S 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-11
Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 26/198 (13%)
Query: 46 KRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHLH- 104
KR+K K E E +IL +V R ++ L Y D +V M L H++
Sbjct: 36 KRIK--KRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH 93
Query: 105 --------GRL----APDC--LLDWHRRVSIAIGSAEGIADIKASNVLLDTDFEAKVADF 150
GR A C L D H+ + D+K N+LLD +++D
Sbjct: 94 MGEAGFEEGRAVFYAAEICCGLEDLHQERIV-------YRDLKPENILLDDHGHIRISDL 146
Query: 151 GFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKL 210
G A +P+G T + RV GT+GY+APE + + S D ++ G LL E+I+ + P ++
Sbjct: 147 GLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204
Query: 211 PGGVKRDIVQWVTPYVQK 228
+KR+ V+ + VQ+
Sbjct: 205 KKKIKREEVERLVKEVQE 222
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 52/190 (27%), Positives = 88/190 (46%), Gaps = 19/190 (10%)
Query: 35 RRETGDDQIAVKRLKTL-NAKAEMEFAV-EVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
+ TG+ +A+K+ K + + + A+ EV++L ++RH N++ L+ + +V++
Sbjct: 22 NKATGE-IVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80
Query: 93 YMPN--HSLITHLHGRLAPDC--LLDWHRRVSIAIGSAEGIA--DIKASNVLLDTDFEAK 146
Y+ L+ G L PD W +IA + I DIK N+L+ K
Sbjct: 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLK 140
Query: 147 VADFGFAKLIPDGVTHMTTRVKGTLGYLAPE----YAMWGKVSDSCDVYSFGVLLLELIS 202
+ DFGFA+ + T T Y APE +GK DV++ G ++ EL+
Sbjct: 141 LCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGK---PVDVWAIGCIMAELLD 197
Query: 203 AKKPLEKLPG 212
+PL PG
Sbjct: 198 G-EPL--FPG 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 49/194 (25%), Positives = 86/194 (44%), Gaps = 29/194 (14%)
Query: 43 IAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITH 102
+AVK LK + A +F E E+L ++H++++ G G L+V++YM + L
Sbjct: 38 VAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRF 97
Query: 103 LH-----------GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDT 141
L G L + ++IA A G+ D+ N L+
Sbjct: 98 LRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157
Query: 142 DFEAKVADFGFAKLIPDGVTHMTTRVKG----TLGYLAPEYAMWGKVSDSCDVYSFGVLL 197
K+ DFG ++ D + RV G + ++ PE ++ K + D++SFGV+L
Sbjct: 158 GLVVKIGDFGMSR---DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVL 214
Query: 198 LELIS-AKKPLEKL 210
E+ + K+P +L
Sbjct: 215 WEIFTYGKQPWYQL 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 54/183 (29%), Positives = 82/183 (44%), Gaps = 13/183 (7%)
Query: 33 LLRRETGDDQIAVKRLK---TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89
+ + + + A+K LK L K A E IL + H ++ + + +
Sbjct: 36 IAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95
Query: 90 VYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIA---IGSAEGI-ADIKASNVLLDTDF 143
+ +++ L THL GR D +H + +A + S + I D+K N+LLD
Sbjct: 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG 155
Query: 144 EAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISA 203
KV DFGFAK +PD T + GT YLAPE + D ++ GVLL E I+
Sbjct: 156 HVKVTDFGFAKKVPD----RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
Query: 204 KKP 206
P
Sbjct: 212 YPP 214
|
Length = 329 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 57/184 (30%), Positives = 81/184 (44%), Gaps = 16/184 (8%)
Query: 46 KRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHLHG 105
KR+K K E E IL +V R ++ L Y D +V M L H++
Sbjct: 36 KRIK--KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYN 93
Query: 106 RLAPDCLLDWHRRVSIAIGSAEGIADI----------KASNVLLDTDFEAKVADFGFAKL 155
P D R + A G+ D+ K N+LLD +++D G A
Sbjct: 94 MGNPG--FDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQ 151
Query: 156 IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVK 215
IP+G T + RV GT+GY+APE K + S D + G L+ E+I + P K VK
Sbjct: 152 IPEGET-VRGRV-GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK 209
Query: 216 RDIV 219
R+ V
Sbjct: 210 REEV 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 61/257 (23%), Positives = 110/257 (42%), Gaps = 44/257 (17%)
Query: 36 RETGDDQIAVKRLKTLNAKAEME-FAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94
+ETG A ++ + ++ E+E F VE++IL +H N++GL Y ++ I+ ++
Sbjct: 27 KETG--LFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84
Query: 95 PN---HSLITHL-----HGRLAPDCL-----LDW-HRRVSIAIGSAEGIADIKASNVLLD 140
S++ L ++ C L++ H I D+KA N+LL
Sbjct: 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIH-------RDLKAGNILLT 137
Query: 141 TDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDS-----CDVYSFGV 195
D + K+ADFG + + T + GT ++APE D+ D++S G+
Sbjct: 138 LDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPYDYKADIWSLGI 196
Query: 196 LLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIA 255
L+EL + P +L R +++ + K + P D LK
Sbjct: 197 TLIELAQMEPPHHEL--NPMRVLLK-----ILKSEPPTLDQPSKWSSSFNDFLK------ 243
Query: 256 LRCTDSNPENRPTMTDV 272
C +P++RPT ++
Sbjct: 244 -SCLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 56/197 (28%), Positives = 87/197 (44%), Gaps = 31/197 (15%)
Query: 35 RRETGDDQIAVKRLKTLNAKAEMEFAV--EVEILGRVRHRNLLGLRGFYAGG--DERLIV 90
R T + +A+K+++ N + + + E+ +L +RH N++ L+ G D +V
Sbjct: 27 RDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86
Query: 91 YDYMPNHSLITHLHGRLAP------DCL-------LDW-HRRVSIAIGSAEGIADIKASN 136
+Y L + L P CL L + H I D+K SN
Sbjct: 87 MEYC-EQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIH-------RDLKVSN 138
Query: 137 VLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSD-SCDVYSFGV 195
+LL K+ADFG A+ MT +V TL Y APE + + D+++ G
Sbjct: 139 LLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGC 197
Query: 196 LLLELISAKKPLEKLPG 212
+L EL+ A KPL LPG
Sbjct: 198 ILAELL-AHKPL--LPG 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 55/188 (29%), Positives = 85/188 (45%), Gaps = 13/188 (6%)
Query: 32 LLLRRETGDDQIAVKRLK--TLNAKAEMEFA-VEVEILGRV-RHRNLLGLRGFYAGGDER 87
LL + D+ AVK LK + ++E E +L +H L L + D
Sbjct: 12 LLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL 71
Query: 88 LIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIG--SAEGIA--DIKASNVLLDT 141
V +Y+ L+ H+ GR + + + + GI D+K NVLLD+
Sbjct: 72 FFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDS 131
Query: 142 DFEAKVADFGFAKL-IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLEL 200
+ K+ADFG K I GVT T+ GT Y+APE + + D ++ GVLL E+
Sbjct: 132 EGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEM 189
Query: 201 ISAKKPLE 208
++ + P E
Sbjct: 190 LAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 49/174 (28%), Positives = 88/174 (50%), Gaps = 12/174 (6%)
Query: 41 DQIAVKRLKTLNAKAEM-EFAVEVEILGRVRHRNLLGLRGFYA--GGDERLIVYDYMPNH 97
+Q+AVK LK + + + E+EIL + H N++ +G GG+ ++ +++P+
Sbjct: 34 EQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG 93
Query: 98 SLITHLHGRLAPDCLLDWHR-RVSIA-----IGSAEGI-ADIKASNVLLDTDFEAKVADF 150
SL +L L + V I +GS + + D+ A NVL++++ + K+ DF
Sbjct: 94 SLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDF 153
Query: 151 GFAKLIPDGVTHMTTR--VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
G K I + T + + + + APE + K + DV+SFGV L EL++
Sbjct: 154 GLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 3e-10
Identities = 52/192 (27%), Positives = 87/192 (45%), Gaps = 27/192 (14%)
Query: 43 IAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITH 102
+AVK LK + A +F E E+L ++H +++ G GD ++V++YM + L
Sbjct: 38 VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 97
Query: 103 L--HGRLA-------PDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDF 143
L HG A L + + IA A G+ D+ N L+ +
Sbjct: 98 LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 157
Query: 144 EAKVADFGFAKLIPDGVTHMTTRVKG----TLGYLAPEYAMWGKVSDSCDVYSFGVLLLE 199
K+ DFG ++ D + RV G + ++ PE M+ K + DV+S GV+L E
Sbjct: 158 LVKIGDFGMSR---DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWE 214
Query: 200 LIS-AKKPLEKL 210
+ + K+P +L
Sbjct: 215 IFTYGKQPWYQL 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 39/95 (41%), Positives = 55/95 (57%), Gaps = 9/95 (9%)
Query: 121 IAIG----SAEGIA--DIKASNVLLDTDFEAKVADFGFAKL-IPDGVTHMTTRVKGTLGY 173
IAIG ++GI D+K NV+LD++ K+ADFG K + DGVT T GT Y
Sbjct: 110 IAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDY 167
Query: 174 LAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLE 208
+APE + S D ++FGVLL E+++ + P E
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 47/197 (23%)
Query: 43 IAVKRLKTLNAKAEME-FAV----EVEILGRVRHRNLLGLRGFYAGG--DERLIVYDYMP 95
+A+K+LK + E E F + E+ IL +++H N++ ++ G D+ +V +Y+
Sbjct: 33 VALKKLKM---EKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE 89
Query: 96 N--HSLITHLHGRLAP---DCLL------------DW--HRRVSIAIGSAEGIADIKASN 136
+ SL+ + CL+ +W HR D+K SN
Sbjct: 90 HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHR-------------DLKTSN 136
Query: 137 VLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKV-SDSCDVYSFGV 195
+LL+ K+ DFG A+ + T V TL Y APE + K S + D++S G
Sbjct: 137 LLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGC 195
Query: 196 LLLELISAKKPLEKLPG 212
+ EL++ KKPL PG
Sbjct: 196 IFAELLT-KKPL--FPG 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-10
Identities = 57/185 (30%), Positives = 83/185 (44%), Gaps = 16/185 (8%)
Query: 46 KRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHLHG 105
KR+K K E E +IL +V R ++ L Y D +V M L H++
Sbjct: 36 KRIK--KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYN 93
Query: 106 RLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVADFGFAKL 155
P D R V A G+ D+K N+LLD +++D G A
Sbjct: 94 MGNPG--FDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVE 151
Query: 156 IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVK 215
IP+G T + RV GT+GY+APE + + S D + G L+ E+I K P + VK
Sbjct: 152 IPEGET-IRGRV-GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK 209
Query: 216 RDIVQ 220
R+ V+
Sbjct: 210 REEVE 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-10
Identities = 56/253 (22%), Positives = 116/253 (45%), Gaps = 27/253 (10%)
Query: 32 LLLRRETGDDQIAVKRLKT--LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89
+L++ + Q +K + ++ K E EV +L ++H N++ + + I
Sbjct: 17 ILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYI 76
Query: 90 VYDYMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGIA----DIKASNVLLDT 141
V DY L ++ + D +LDW ++ +A+ DIK+ N+ L
Sbjct: 77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK 136
Query: 142 DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELI 201
D K+ DFG A+++ V T + GT YL+PE ++ D+++ G +L E+
Sbjct: 137 DGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENRPYNNKSDIWALGCVLYEMC 195
Query: 202 SAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDS 261
+ K E G +K +++ + +G++ P + ++ D L+++V +
Sbjct: 196 TLKHAFEA--GNMKNLVLKII-----RGSY-----PPVSSHYSYD-LRNLVSQLFK---R 239
Query: 262 NPENRPTMTDVVD 274
NP +RP++ +++
Sbjct: 240 NPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-10
Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 43 IAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSL--- 99
+AVK++ + EV I+ +H N++ + Y GDE +V +++ +L
Sbjct: 48 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 107
Query: 100 ITHL---HGRLAPDCLLDWHRRVSIAIGSAEGIA--DIKASNVLLDTDFEAKVADFGFAK 154
+TH ++A CL ++++ A+G+ DIK+ ++LL D K++DFGF
Sbjct: 108 VTHTRMNEEQIAAVCLAVLK---ALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCA 164
Query: 155 LIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGV 214
+ V + V GT ++APE D++S G++++E++ + P P
Sbjct: 165 QVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 223
Query: 215 KRDIVQWVTPYVQKGAFEHIADPRLKGKFNR 245
+++ P K H P LKG +R
Sbjct: 224 AMKMIRDNLPPKLKNL--HKVSPSLKGFLDR 252
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 7e-10
Identities = 47/187 (25%), Positives = 83/187 (44%), Gaps = 30/187 (16%)
Query: 43 IAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPN----- 96
+A+K LK K + EF E E++ ++H N++ L G ++++Y+ +
Sbjct: 38 VAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHE 97
Query: 97 -------HSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----------ADIKASNVLL 139
HS + G LD + IAI A G+ D+ A N L+
Sbjct: 98 FLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV 157
Query: 140 DTDFEAKVADFGFAKLIPDGVTHMTTRVKGT----LGYLAPEYAMWGKVSDSCDVYSFGV 195
K++DFG ++ D + RV+ + ++ PE ++GK + D++SFGV
Sbjct: 158 GEGLTVKISDFGLSR---DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGV 214
Query: 196 LLLELIS 202
+L E+ S
Sbjct: 215 VLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 8e-10
Identities = 58/232 (25%), Positives = 105/232 (45%), Gaps = 44/232 (18%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSL--ITHLHGRLAPDCLLDWHRRV 119
E+E L + H N++ GF + I +Y+P S+ +GR + + +V
Sbjct: 58 EIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV 117
Query: 120 --SIAIGSAEGI--ADIKASNVLLDTDFEAKVADFGFAKL---IPDGVTHMTTRVKGTLG 172
+A ++GI D+KA N+L+D D K++DFG +K I D +M+ ++G++
Sbjct: 118 LEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS--MQGSVF 175
Query: 173 YLAPE--------YAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTP 224
++APE Y+ KV D++S G ++LE+ + ++P W
Sbjct: 176 WMAPEVIHSYSQGYS--AKV----DIWSLGCVVLEMFAGRRP--------------WSDE 215
Query: 225 YVQKGAFEHIADPRLKGKFNRDQLKSMVLIALR----CTDSNPENRPTMTDV 272
F+ + + R D ++ +AL C NP+NRPT ++
Sbjct: 216 EAIAAMFK-LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTAREL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 63/256 (24%), Positives = 109/256 (42%), Gaps = 45/256 (17%)
Query: 38 TGDDQIAVKRLKTLNAKAE-MEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPN 96
+G ++AVK L+ E EF E ++ H N++ L G + + I+ + M
Sbjct: 24 SGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEG 83
Query: 97 HSLITHLHGRLA---PDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLL---- 139
L+++L LL + I + A+G D+ A N L+
Sbjct: 84 GDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKG 143
Query: 140 -DTDFEAKVADFGFAKLIPDGVTHMTTRVKGT----LGYLAPEYAMWGKVSDSCDVYSFG 194
D D K+ DFG A+ D R +G + ++APE + GK + DV+SFG
Sbjct: 144 YDADRVVKIGDFGLAR---DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFG 200
Query: 195 VLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN-RDQLKSMV 252
VL+ E+++ ++P P ++++Q +V G RL+ N D++ ++
Sbjct: 201 VLMWEILTLGQQP---YPALNNQEVLQ----HVTAGG-------RLQKPENCPDKIYQLM 246
Query: 253 LIALRCTDSNPENRPT 268
C +P RPT
Sbjct: 247 ---TNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 56/201 (27%), Positives = 80/201 (39%), Gaps = 38/201 (18%)
Query: 33 LLRRETGDDQIAVKRLKTLN-------AKAEMEFAVEVEILGRVRHRNLLGLRGFYA-GG 84
L+R+ G D + +K L AK E ++L VR L + YA
Sbjct: 18 LVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL-VTLHYAFQT 76
Query: 85 DERL-IVYDYMPNHSLITHLHGR----------------LAPDCLLDWHRRVSIAIGSAE 127
D +L ++ DY+ L THL+ R LA D L H+ I
Sbjct: 77 DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL---HQLGII------ 127
Query: 128 GIADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKV--S 185
DIK N+LLD++ + DFG +K GT+ Y+APE G
Sbjct: 128 -YRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHD 186
Query: 186 DSCDVYSFGVLLLELISAKKP 206
+ D +S GVL EL++ P
Sbjct: 187 KAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 1e-09
Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 27/174 (15%)
Query: 44 AVKRL---KTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
A+K L K + K E IL +RH L+ L G + +V +Y+P L
Sbjct: 30 ALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELF 89
Query: 101 THLH--GRLAPDCLLDWHR----RVSIAIG--SAEGIA--DIKASNVLLDTDFEAKVADF 150
+HL GR R +V +A+ + I D+K N+LLD+D K+ DF
Sbjct: 90 SHLRKSGRFP----EPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDF 145
Query: 151 GFAKLIPDGVTHMTTRVKGTLGYLAPEYAM---WGKVSDSCDVYSFGVLLLELI 201
GFAK + T+ GT YLAPE + +GK + D ++ G+L+ E++
Sbjct: 146 GFAKRVKGR-TYTLC---GTPEYLAPEIILSKGYGK---AVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 31/202 (15%)
Query: 36 RETGDDQIAVKR--LKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93
RETG+ +A+K+ L+ L + E++ L +H ++ L + G ++V +Y
Sbjct: 22 RETGE-TVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80
Query: 94 MPNHSLITHLHGRLAP----------DCLLDWHRRVSIAIGSAEGIA--DIKASNVLLDT 141
MP L L P LL +A A GI D+K +N+L+
Sbjct: 81 MP-SDLSEVLRDEERPLPEAQVKSYMRMLLK-----GVAYMHANGIMHRDLKPANLLISA 134
Query: 142 DFEAKVADFGFAKLI-PDGVTHMTTRVKGTLGYLAPEYAMWG--KVSDSCDVYSFGVLLL 198
D K+ADFG A+L + + +V T Y APE ++G K D+++ G +
Sbjct: 135 DGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPEL-LYGARKYDPGVDLWAVGCIFA 192
Query: 199 ELISAKKPLEKLPGGVKRDIVQ 220
EL+ PL PG + DI Q
Sbjct: 193 ELL-NGSPL--FPG--ENDIEQ 209
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 44/170 (25%), Positives = 80/170 (47%), Gaps = 12/170 (7%)
Query: 43 IAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+A+ L+ + K F E LG+ H N++ L G G+ +IV +YM N +L +
Sbjct: 36 VAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDS 95
Query: 102 HL---HGRLAPDCLLDWHRRVSIAIGSAEGIADIK----ASNVLLDTDFEAKVADFGFAK 154
L G+L L+ ++ + + + A VL+++D K++ GF +
Sbjct: 96 FLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKIS--GFRR 153
Query: 155 LIPDGV--THMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
L D + T K + + APE + S + DV+SFG+++ E++S
Sbjct: 154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 47/186 (25%), Positives = 72/186 (38%), Gaps = 26/186 (13%)
Query: 46 KRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHLH- 104
KRLK K E E +IL +V R ++ L + D+ +V M L H++
Sbjct: 29 KRLK--KRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYN 86
Query: 105 ----GRLAPDC----------LLDWHRRVSIAIGSAEGIADIKASNVLLDTDFEAKVADF 150
G L H+R + D+K NVLLD +++D
Sbjct: 87 VGEPGFPEARAIFYAAQIICGLEHLHQRRIV-------YRDLKPENVLLDDHGNVRISDL 139
Query: 151 GFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKL 210
G A + G GT GY+APE S D ++ G L E+I+ + P +
Sbjct: 140 GLAVELKGGKK--IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197
Query: 211 PGGVKR 216
V++
Sbjct: 198 KEKVEK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 32/76 (42%), Positives = 43/76 (56%), Gaps = 1/76 (1%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
D+K NVLLD D K+ADFG K +G + GT Y+APE K ++S D
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEG-KASTFCGTPDYIAPEILKGQKYNESVDW 179
Query: 191 YSFGVLLLELISAKKP 206
+SFGVLL E++ + P
Sbjct: 180 WSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 62/247 (25%), Positives = 103/247 (41%), Gaps = 30/247 (12%)
Query: 34 LRRETGDDQIAVKRLKTLNAKAEMEFAV-----EVEILGRVRHRNLLGLRGFYAGGDERL 88
L + GD AVK + + + AV E+ +L +++H N++ G D
Sbjct: 20 LNLDDGD-FFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLY 78
Query: 89 IVYDYMPNHSLITHL--HGRLAPDCLLDWHRRV--SIAIGSAEGIA--DIKASNVLLDTD 142
I + +P SL L +G + + R++ + DIK +N+L+DT+
Sbjct: 79 IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN 138
Query: 143 FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAM-WGKVSDSCDVYSFGVLLLELI 201
K+ADFG AK + + KG+ ++APE G + D++S G +LE+
Sbjct: 139 GVVKLADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMA 196
Query: 202 SAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDS 261
+ K P +L G V V + I D D+ K + L+C
Sbjct: 197 TGKPPWSQLEG------VAAVFKIGRSKELPPIPDHL------SDEAKDFI---LKCLQR 241
Query: 262 NPENRPT 268
+P RPT
Sbjct: 242 DPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 47/152 (30%), Positives = 74/152 (48%), Gaps = 25/152 (16%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLI---PDGVTHMTTRVKGTLGYLAPEYAMWGKV-SD 186
D+ A N+LL + K+ DFG A+ I PD V R+ L ++APE +++ KV +
Sbjct: 198 DLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP--LKWMAPE-SIFDKVYTT 254
Query: 187 SCDVYSFGVLLLELIS-AKKPLEKLPG-GVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244
DV+SFGVLL E+ S P PG + + + + + A E+
Sbjct: 255 QSDVWSFGVLLWEIFSLGASP---YPGVQIDEEFCRRLKEGTRMRAPEYATP-------- 303
Query: 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVDWL 276
+ I L C +NPE+RPT +++V+ L
Sbjct: 304 -----EIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 47/184 (25%), Positives = 81/184 (44%), Gaps = 19/184 (10%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+IA+K + +++ E+ + ++HRN++ G + I + +P SL
Sbjct: 35 RIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSA 94
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSA--EGIA----------DIKASNVLLDT-DFEAKVA 148
L + P L + + I EG+ DIK NVL++T K++
Sbjct: 95 LLRSKWGP---LKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKIS 151
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGK--VSDSCDVYSFGVLLLELISAKKP 206
DFG +K + G+ T GTL Y+APE G D++S G ++E+ + K P
Sbjct: 152 DFGTSKRLA-GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
Query: 207 LEKL 210
+L
Sbjct: 211 FIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSL---ITHLHGRL-APDCLLDWHR 117
EV +L +++H N++ + IV +Y L I G L + D +L W
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108
Query: 118 RVSIAIGSAEGIA----DIKASNVLLDTD-FEAKVADFGFAKLIPDGVTHMTTRVKGTLG 172
++S+ + DIK+ N+ L + AK+ DFG A+ + D + T V GT
Sbjct: 109 QISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPY 167
Query: 173 YLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFE 232
YL+PE ++ D++S G +L EL + K P E + + + + +G F
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG-------NNLHQLVLKICQGYFA 220
Query: 233 HIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVV 273
I+ F+RD L+S++ + + P +RP++T ++
Sbjct: 221 PISP-----NFSRD-LRSLISQLFKVS---PRDRPSITSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 27/81 (33%), Positives = 45/81 (55%), Gaps = 1/81 (1%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
DIKA N+LL+ + +AK+ADFG + + D + T V GT ++APE ++ D+
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYNNKADI 182
Query: 191 YSFGVLLLELISAKKPLEKLP 211
+S G+ +E+ K P +
Sbjct: 183 WSLGITAIEMAEGKPPYSDIH 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-09
Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 12/199 (6%)
Query: 48 LKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPN---HSLITHLH 104
L +N + E E +L ++ ++ + + IV +Y N H L+
Sbjct: 35 LSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQR 94
Query: 105 GRLAPDCLLDWHRRVSIAIG-----SAEGI-ADIKASNVLLDTDFEAKVADFGFAKLIPD 158
GR P+ + W + I +G S + + DIK+ N+ LD K+ D G AKL+ D
Sbjct: 95 GRPLPEDQV-WRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD 153
Query: 159 GVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLE-KLPGGVKRD 217
T V GT YL+PE ++ DV++ GV+L E + K P + G +
Sbjct: 154 NTNFANTIV-GTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212
Query: 218 IVQWVTPYVQKGAFEHIAD 236
I++ V P V + + +A
Sbjct: 213 IIRGVFPPVSQMYSQQLAQ 231
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 37/95 (38%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 121 IAIG----SAEGIA--DIKASNVLLDTDFEAKVADFGFAKL-IPDGVTHMTTRVKGTLGY 173
IAIG ++GI D+K NV+LD + K+ADFG K I G T T GT Y
Sbjct: 110 IAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTPDY 167
Query: 174 LAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLE 208
+APE + S D ++FGVLL E+++ + P +
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 33/79 (41%), Positives = 45/79 (56%), Gaps = 5/79 (6%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAK--LIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSC 188
D+K N+LLDTD K+ADFG K ++ D T GT Y+APE + K + S
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDA---KTCTFCGTPDYIAPEILLGQKYNTSV 177
Query: 189 DVYSFGVLLLELISAKKPL 207
D +SFGVLL E++ + P
Sbjct: 178 DWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-09
Identities = 47/151 (31%), Positives = 68/151 (45%), Gaps = 28/151 (18%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDG---VTHMTTRVKGTLGYLAPEYAMWGKVSDS 187
D+ A N +LD F KVADFG A+ I D H T K + ++A E K +
Sbjct: 123 DLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTK 182
Query: 188 CDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFE---HIADPR--LKGK 242
DV+SFGVLL EL++ P PY +F+ ++ R L+ +
Sbjct: 183 SDVWSFGVLLWELMTRGAP-----------------PYPDVDSFDITVYLLQGRRLLQPE 225
Query: 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVV 273
+ D L + L C PE RPT +++V
Sbjct: 226 YCPDPLYE---VMLSCWHPKPEMRPTFSELV 253
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 4e-09
Identities = 47/176 (26%), Positives = 79/176 (44%), Gaps = 40/176 (22%)
Query: 62 EVEILGRVRHRNLLGLRG-FYAGGDERL----IVYDYMPN--HSLITHLHGRLAPDCLLD 114
E+++L +RH N++GL E IV + M H +I P L D
Sbjct: 49 EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS------PQPLTD 102
Query: 115 WHRRVSI--------AIGSAEGIA--DIKASNVLLDTDFEAKVADFGFAKLI---PDGVT 161
H + + + SA + D+K SN+L++++ + K+ DFG A+ + D
Sbjct: 103 DHIQYFLYQILRGLKYLHSA-NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161
Query: 162 HMT----TRVKGTLGYLAPEYAM-WGKVSDSCDVYSFGVLLLELISAKKPLEKLPG 212
+T TR Y APE + + + + D++S G + EL+ +KPL PG
Sbjct: 162 FLTEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKPL--FPG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 47/195 (24%), Positives = 90/195 (46%), Gaps = 25/195 (12%)
Query: 89 IVYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----DIKASNVLLDT 141
+V MP L+ ++ R+ LL+W +++ + E + D+ A NVL+ +
Sbjct: 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKS 144
Query: 142 DFEAKVADFGFAKLIP-DGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLEL 200
K+ DFG A+L+ D + K + ++A E + + + DV+S+GV + EL
Sbjct: 145 PNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWEL 204
Query: 201 IS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCT 259
++ KP + +P R+I ++KG E + P + + +I ++C
Sbjct: 205 MTFGAKPYDGIPA---REIPD----LLEKG--ERLPQPPI-------CTIDVYMIMVKCW 248
Query: 260 DSNPENRPTMTDVVD 274
+ E RP ++VD
Sbjct: 249 MIDSECRPRFRELVD 263
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 5e-09
Identities = 63/260 (24%), Positives = 104/260 (40%), Gaps = 45/260 (17%)
Query: 42 QIAVKRLKTLNAKA-EMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
Q+AVK L ++ E +F +E I+ + H+N++ L G R I+ + M L
Sbjct: 38 QVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLK 97
Query: 101 THL-HGRLAPD--CLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDT---DFE 144
+ L R P+ L + A A+G DI A N LL
Sbjct: 98 SFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRV 157
Query: 145 AKVADFGFAKLI-------PDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLL 197
AK+ADFG A+ I G + + ++ PE + G + DV+SFGVLL
Sbjct: 158 AKIADFGMARDIYRASYYRKGGRAMLPIK------WMPPEAFLDGIFTSKTDVWSFGVLL 211
Query: 198 LELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALR 257
E+ S PG ++++++VT + + P + I
Sbjct: 212 WEIFSLG--YMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYR-------------IMTD 256
Query: 258 CTDSNPENRPTMTDVVDWLK 277
C PE+RP +++ ++
Sbjct: 257 CWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 5e-09
Identities = 53/192 (27%), Positives = 84/192 (43%), Gaps = 32/192 (16%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAV-EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94
TG+ +A+K +K L + E E+ +L RH N++ G Y D+ IV +Y
Sbjct: 25 IATGE-LVAIKVIK-LEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82
Query: 95 PNHSL--ITH-LHGRLAPDCLLDWHRRVSIAIGSAE---GIA----------DIKASNVL 138
SL I G L+ IA E G+A DIK +N+L
Sbjct: 83 GGGSLQDIYQVTRGPLSELQ---------IAYVCRETLKGLAYLHETGKIHRDIKGANIL 133
Query: 139 LDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYA---MWGKVSDSCDVYSFGV 195
L D + K+ADFG + + + + + GT ++APE A G CD+++ G+
Sbjct: 134 LTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGYDGKCDIWALGI 192
Query: 196 LLLELISAKKPL 207
+EL + P+
Sbjct: 193 TAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 5e-09
Identities = 55/192 (28%), Positives = 81/192 (42%), Gaps = 30/192 (15%)
Query: 46 KRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHLHG 105
KR+K K E E +IL +V + ++ L Y D +V M L H++
Sbjct: 36 KRIK--KRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYN 93
Query: 106 RLAPD--------------C-LLDWHRRVSIAIGSAEGIA--DIKASNVLLDTDFEAKVA 148
P C L D HR E D+K N+LLD +++
Sbjct: 94 MGNPGFEEERALFYAAEILCGLEDLHR---------ENTVYRDLKPENILLDDYGHIRIS 144
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLE 208
D G A IP+G + + RV GT+GY+APE + + S D + G L+ E+I + P
Sbjct: 145 DLGLAVKIPEGES-IRGRV-GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR 202
Query: 209 KLPGGVKRDIVQ 220
VKR+ V
Sbjct: 203 GRKEKVKREEVD 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-09
Identities = 61/255 (23%), Positives = 101/255 (39%), Gaps = 43/255 (16%)
Query: 42 QIAVKRLKTLNAKAEME-FAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMPNHSL 99
++AVK LK +E E E++I+ + H N++ L G G L++ +Y L
Sbjct: 67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126
Query: 100 ITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVAD 149
+ L + + L +S + A+G+A D+ A NVLL K+ D
Sbjct: 127 LNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICD 184
Query: 150 FGFAKLIPDGVTHMTTRVKGT----LGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKK 205
FG A+ I + ++ VKG + ++APE + DV+S+G+LL E+ S
Sbjct: 185 FGLARDIMNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLG- 240
Query: 206 PLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQ----LKSMVLIALRCTDS 261
PY +K + Q + I C D+
Sbjct: 241 ----------------SNPYPGMPVDSKFYKL-IKEGYRMAQPEHAPAEIYDIMKTCWDA 283
Query: 262 NPENRPTMTDVVDWL 276
+P RPT +V +
Sbjct: 284 DPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 47/171 (27%), Positives = 78/171 (45%), Gaps = 21/171 (12%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSI 121
E+++L + H N++ L + + +V+++M + L + R L S
Sbjct: 48 EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRG---LPESLIKSY 103
Query: 122 AIGSAEGIA----------DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTL 171
+G+A D+K N+L++T+ K+ADFG A+ V T V T
Sbjct: 104 LYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTR 162
Query: 172 GYLAPEYAMWGKV-SDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQW 221
Y APE + K S D++S G + EL+S ++PL PG K +I Q
Sbjct: 163 WYRAPELLLGDKGYSTPVDIWSVGCIFAELLS-RRPL--FPG--KSEIDQL 208
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 6e-09
Identities = 71/278 (25%), Positives = 117/278 (42%), Gaps = 57/278 (20%)
Query: 40 DDQIAVKRLKTLNAKAEM----EFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
+ ++AVK T+N A + EF E ++ +++ L G + G L+V + M
Sbjct: 36 ETRVAVK---TVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMA 92
Query: 96 NHSLITHLH----------GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKAS 135
+ L ++L GR P + +A A+G+A D+ A
Sbjct: 93 HGDLKSYLRSLRPEAENNPGRPPPTL----QEMIQMAAEIADGMAYLNAKKFVHRDLAAR 148
Query: 136 NVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTL--GYLAPEYAMWGKVSDSCDVYSF 193
N ++ DF K+ DFG + I + + KG L ++APE G + S D++SF
Sbjct: 149 NCMVAHDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSF 207
Query: 194 GVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD---PRLKGKFNRDQLK 249
GV+L E+ S A++P + L + V +V G + D R+ L
Sbjct: 208 GVVLWEITSLAEQPYQGLSN-------EQVLKFVMDGGYLDQPDNCPERVT------DLM 254
Query: 250 SMVLIALRCTDSNPENRPTMTDVVDWLKGGLGRRTKDV 287
M C NP+ RPT ++V+ LK L +V
Sbjct: 255 RM------CWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 45/173 (26%), Positives = 84/173 (48%), Gaps = 12/173 (6%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSL-- 99
Q+AVK++ + EV I+ H N++ + Y GDE +V +++ +L
Sbjct: 49 QVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD 108
Query: 100 -ITHL---HGRLAPDCLLDWHRRVSIAIGSAEGIA--DIKASNVLLDTDFEAKVADFGFA 153
+TH ++A CL +++ +G+ DIK+ ++LL +D K++DFGF
Sbjct: 109 IVTHTRMNEEQIATVCLSVLR---ALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFC 165
Query: 154 KLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKP 206
+ V + V GT ++APE D++S G++++E+I + P
Sbjct: 166 AQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 7e-09
Identities = 46/174 (26%), Positives = 89/174 (51%), Gaps = 12/174 (6%)
Query: 42 QIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSL- 99
Q+AVK++ + E+ F EV I+ +H N++ + Y GDE +V +++ +L
Sbjct: 46 QVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104
Query: 100 --ITHLHGRLAPDCLLDWHRRV--SIAIGSAEGIA--DIKASNVLLDTDFEAKVADFGFA 153
+TH R+ + + V +++ A+G+ DIK+ ++LL +D K++DFGF
Sbjct: 105 DIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFC 162
Query: 154 KLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPL 207
+ V + V GT ++APE D++S G++++E++ + P
Sbjct: 163 AQVSKEVPRRKSLV-GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 8e-09
Identities = 51/185 (27%), Positives = 90/185 (48%), Gaps = 11/185 (5%)
Query: 37 ETGDDQIAVKRL-KTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
ET +A+K L +T KA +EF E I+ + H +L+ L G +L+ MP
Sbjct: 33 ETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVT-QLMP 91
Query: 96 NHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----DIKASNVLLDTDFEAKVA 148
+ L+ ++H + LL+W +++ + E D+ A NVL+ + K+
Sbjct: 92 HGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKIT 151
Query: 149 DFGFAKLIP-DGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKP 206
DFG A+L+ D + K + ++A E + K + DV+S+GV + EL++ KP
Sbjct: 152 DFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
Query: 207 LEKLP 211
+ +P
Sbjct: 212 YDGIP 216
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 8e-09
Identities = 60/255 (23%), Positives = 110/255 (43%), Gaps = 44/255 (17%)
Query: 48 LKTLNAKAEM----EFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHL 103
+KT+N A M EF E ++ +++ L G + G L++ + M L ++L
Sbjct: 41 IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 100
Query: 104 HGRLAPD-------CLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAK 146
L P+ + + +A A+G+A D+ A N ++ DF K
Sbjct: 101 RS-LRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159
Query: 147 VADFGFAKLIPDGVTHMTTRVKGTLG--YLAPEYAMWGKVSDSCDVYSFGVLLLELIS-A 203
+ DFG + I + + KG L +++PE G + DV+SFGV+L E+ + A
Sbjct: 160 IGDFGMTRDIYE-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 218
Query: 204 KKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALR-CTDSN 262
++P + + + V +V +G + P D M+ +R C N
Sbjct: 219 EQPYQGMSN-------EQVLRFVMEGGL--LDKP--------DNCPDMLFELMRMCWQYN 261
Query: 263 PENRPTMTDVVDWLK 277
P+ RP+ +++ +K
Sbjct: 262 PKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 8e-09
Identities = 65/261 (24%), Positives = 106/261 (40%), Gaps = 58/261 (22%)
Query: 49 KTLNAKAEM----EFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHLH 104
KT+N A M EF E ++ +++ L G + G L+V + M L ++L
Sbjct: 42 KTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLR 101
Query: 105 GR---------LAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEA 145
R L P L + + +A A+G+A D+ A N ++ D
Sbjct: 102 SRRPEAENNPGLGPPTLQKFIQ---MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158
Query: 146 KVADFGFAKLI-------PDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLL 198
K+ DFG + I G + R ++APE G + DV+SFGV+L
Sbjct: 159 KIGDFGMTRDIYETDYYRKGGKGLLPVR------WMAPESLKDGVFTTKSDVWSFGVVLW 212
Query: 199 ELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVL-IAL 256
E+ + A++P + L + V +V G H+ P + +L +
Sbjct: 213 EMATLAEQPYQGLSN-------EEVLKFVIDGG--HLDLP--------ENCPDKLLELMR 255
Query: 257 RCTDSNPENRPTMTDVVDWLK 277
C NP+ RPT ++V LK
Sbjct: 256 MCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 40/142 (28%), Positives = 65/142 (45%), Gaps = 18/142 (12%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
DIKA+N+LL + + K+ADFG + + ++ T V GT ++APE + D+
Sbjct: 123 DIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEKADI 181
Query: 191 YSFGVLLLELISAKKPLEKL-PGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249
+S G+ +EL + PL L P V I + P P L+G K
Sbjct: 182 WSLGITAIELAKGEPPLSDLHPMRVLFLIPK-NNP------------PSLEGNKFSKPFK 228
Query: 250 SMVLIALRCTDSNPENRPTMTD 271
V + C + +P+ RP+ +
Sbjct: 229 DFVSL---CLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 64/272 (23%), Positives = 112/272 (41%), Gaps = 64/272 (23%)
Query: 43 IAVKRLKT-LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+AVK L+ N A +F EV+IL R++ N++ L G D ++ +YM N L
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 102 HLHGRLAPD-------------CLL--DWHRRVSIAIGSAEGIA----------DIKASN 136
L D CL + + +A+ A G+ D+ N
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRN 168
Query: 137 VLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG----TLGYLAPEYAMWGKVSDSCDVYS 192
L+ + K+ADFG ++ + G + R++G + ++A E + GK + + DV++
Sbjct: 169 CLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 193 FGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMV 252
FGV L E++ K PY + + I + G+F RDQ + +
Sbjct: 226 FGVTLWEILMLCKE----------------QPYGELTDEQVIEN---AGEFFRDQGRQVY 266
Query: 253 L------------IALRCTDSNPENRPTMTDV 272
L + L+C + RP+ +D+
Sbjct: 267 LFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-08
Identities = 59/254 (23%), Positives = 111/254 (43%), Gaps = 33/254 (12%)
Query: 33 LLRRETGDDQIAVKRLKTLNAKAEMEFAV--EVEILGRVRHRNLLGLRGFYAGGDERLIV 90
L RR+ + +K++ + A E ++L + H N++ + +IV
Sbjct: 18 LCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV 77
Query: 91 YDYMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGS--AEGIA--DIKASNVLLDT- 141
+Y P +L ++ R L D +L + ++ +A+ + I D+K N+LLD
Sbjct: 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH 137
Query: 142 DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELI 201
K+ DFG +K++ V GT Y++PE + D+++ G +L EL
Sbjct: 138 KMVVKIGDFGISKIL--SSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELA 195
Query: 202 SAKKPLE--KLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCT 259
S K+ E LP V + + G F I+D +++ D L+ ++L L
Sbjct: 196 SLKRAFEAANLPALVLK---------IMSGTFAPISD-----RYSPD-LRQLILSMLN-- 238
Query: 260 DSNPENRPTMTDVV 273
+P RP ++ ++
Sbjct: 239 -LDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 46/186 (24%), Positives = 86/186 (46%), Gaps = 26/186 (13%)
Query: 43 IAVKRLKT-LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+AVK L+ + A +F E++I+ R+++ N++ L G D ++ +YM N L
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGS--------AEGIA----------DIKASNVLLDTDF 143
L R + S++I + A G+ D+ N L+ +
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHY 166
Query: 144 EAKVADFGFAKLIPDGVTHMTTRVKG----TLGYLAPEYAMWGKVSDSCDVYSFGVLLLE 199
K+ADFG ++ + G + R++G + ++A E + GK + + DV++FGV L E
Sbjct: 167 TIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 200 LISAKK 205
+ + K
Sbjct: 224 MFTLCK 229
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 32/81 (39%), Positives = 50/81 (61%), Gaps = 5/81 (6%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRV-KGTLGYLAPEYAMWGK--VSDS 187
DIK++N+LL ++ K+ DFGF+K+ V+ R GT Y+APE +W + S
Sbjct: 168 DIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE--IWRRKPYSKK 225
Query: 188 CDVYSFGVLLLELISAKKPLE 208
D++S GVLL EL++ K+P +
Sbjct: 226 ADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 62 EVEILGRVRH---RNLLGLRGFYAGGDERLIVYDYMPNHSLITHLH-GRLAPDCLLDWHR 117
EV +L ++R N+ G Y G I+ +Y S+ T + G +A + R
Sbjct: 49 EVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR 108
Query: 118 RVSIAIG--SAEGIA--DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGY 173
V +A+ G+ DIKA+N+L+ K+ DFG A L+ + +T V GT +
Sbjct: 109 EVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYW 167
Query: 174 LAPEYAMWGKVSDS-CDVYSFGVLLLELISAKKPLEKLP 211
+APE GK D+ D++S G+ + E+ + P +
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD 206
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 46/176 (26%), Positives = 84/176 (47%), Gaps = 18/176 (10%)
Query: 42 QIAVKRLKTLNAKAEMEFAV-EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSL- 99
++A+K++ L + + E + E+ ++ +H N++ Y GDE +V +Y+ SL
Sbjct: 46 EVAIKQM-NLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT 104
Query: 100 --ITHL---HGRLAPDCLLDWHRRVSIAIG--SAEGIA--DIKASNVLLDTDFEAKVADF 150
+T G++A C R A+ + + DIK+ N+LL D K+ DF
Sbjct: 105 DVVTETCMDEGQIAAVC-----RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDF 159
Query: 151 GFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKP 206
GF I + +T V GT ++APE D++S G++ +E++ + P
Sbjct: 160 GFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 14/152 (9%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
DIK SN+LL + K+ DFG + + V + GT Y+APE S + DV
Sbjct: 130 DIKPSNILLTRKGQVKLCDFGVSG---ELVNSLAGTFTGTSFYMAPERIQGKPYSITSDV 186
Query: 191 YSFGVLLLELISAKKPL--EKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQL 248
+S G+ LLE+ + P E P +++ ++ V E +P K++ +
Sbjct: 187 WSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI---VNMPNPELKDEPGNGIKWSEE-F 242
Query: 249 KSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278
K + +C + +P RPT D+++ W+K
Sbjct: 243 KDFI---KQCLEKDPTRRPTPWDMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 57/256 (22%), Positives = 107/256 (41%), Gaps = 46/256 (17%)
Query: 43 IAVKRLKTL-NAKAEMEFAV-----EVEILGRVRHRNLLGLRG-------------FYAG 83
+AVK++ + N +E E V E+ ++ R+ H +++ + G + AG
Sbjct: 28 MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAG 87
Query: 84 GDERLIVYDYMP--NHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIADIKASNVLLD- 140
G ++ Y +I + L L ++ + D+K +N+L+D
Sbjct: 88 GSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH---------RDVKGANLLIDS 138
Query: 141 TDFEAKVADFGFA-KLIPD--GVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLL 197
T ++ADFG A +L G ++ GT+ ++APE + SCDV+S G ++
Sbjct: 139 TGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVI 198
Query: 198 LELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALR 257
+E+ +A K P ++ + A + P RD + LR
Sbjct: 199 IEMATA-----KPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRD-------VTLR 246
Query: 258 CTDSNPENRPTMTDVV 273
C + PE+RP +++
Sbjct: 247 CLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 47/179 (26%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI-THLHGRLAPDCLLDWHRRVS 120
E+EIL V H N++ + E ++ ++M SL TH+ L D R++
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF---LADVARQI- 177
Query: 121 IAIGSAEGIA----------DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGT 170
GIA DIK SN+L+++ K+ADFG ++++ + + V GT
Sbjct: 178 -----LSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GT 231
Query: 171 LGYLAPE-------------YAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKR 216
+ Y++PE YA D++S GV +LE L + P GV R
Sbjct: 232 IAYMSPERINTDLNHGAYDGYA--------GDIWSLGVSILEFY-----LGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 41/145 (28%), Positives = 62/145 (42%), Gaps = 19/145 (13%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGT--LGYLAPEYAMWGKVSDSC 188
D+ A NVLL T AK++DFG +K + + + G + + APE + K S
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKS 179
Query: 189 DVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQ 247
DV+SFGVL+ E S +KP + + G VT ++ G E + P +
Sbjct: 180 DVWSFGVLMWEAFSYGQKPYKGMKGNE-------VTQMIESG--ERMECP-------QRC 223
Query: 248 LKSMVLIALRCTDSNPENRPTMTDV 272
M + C + RP V
Sbjct: 224 PPEMYDLMKLCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 31/79 (39%), Positives = 47/79 (59%), Gaps = 3/79 (3%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAK-LIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCD 189
D+K NV+LD++ K+ADFG K + DGVT T GT Y+APE + S D
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTFCGTPDYIAPEIIAYQPYGKSVD 183
Query: 190 VYSFGVLLLELISAKKPLE 208
+++GVLL E+++ + P +
Sbjct: 184 WWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 52/255 (20%), Positives = 101/255 (39%), Gaps = 33/255 (12%)
Query: 37 ETGDDQ-IAVKRL-KTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY- 93
E G + + VK L KT + + EF E+++ ++ H+N++ L G + ++ +Y
Sbjct: 31 EEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYT 90
Query: 94 ----MPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLL 139
+ T L ++V++ A G+ D+ A N L+
Sbjct: 91 DLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV 150
Query: 140 DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLE 199
+ E KV+ +K + + + L +LAPE S DV+SFGVL+ E
Sbjct: 151 SSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWE 210
Query: 200 LISAKK-PLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRC 258
+ + + P L + + + +L+ + + RC
Sbjct: 211 VFTQGELPFYGLSD----------EEVLNR-----LQAGKLELPVPEGCPSRLYKLMTRC 255
Query: 259 TDSNPENRPTMTDVV 273
NP++RP+ +++V
Sbjct: 256 WAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 31 LLLLRRETGDDQIAVKRLK---TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87
+ L+R + A+K + + K E E +L V H ++ L F+ D+R
Sbjct: 17 VHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL--FWTEHDQR 74
Query: 88 LI--VYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIG--SAEGIA--DIKASNVLL 139
+ + +Y+P L ++L GR + L + + A+ ++ I D+K N+LL
Sbjct: 75 FLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL 134
Query: 140 DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLE 199
D + K+ DFGFAK + D T + GT YLAPE + + D ++ G+L+ E
Sbjct: 135 DKEGHIKLTDFGFAKKLRD----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYE 190
Query: 200 LISAKKPL-EKLPGGVKRDIV 219
++ P + P G+ I+
Sbjct: 191 MLVGYPPFFDDNPFGIYEKIL 211
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 32/77 (41%), Positives = 45/77 (58%), Gaps = 4/77 (5%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSD-SCD 189
D+K N+LLD++ K+ DFGFAK + G T GT Y+APE + K D S D
Sbjct: 118 DLKPENLLLDSNGYVKLVDFGFAKKLKSG--QKTWTFCGTPEYVAPEIIL-NKGYDFSVD 174
Query: 190 VYSFGVLLLELISAKKP 206
+S G+LL EL++ + P
Sbjct: 175 YWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 64/271 (23%), Positives = 109/271 (40%), Gaps = 46/271 (16%)
Query: 36 RETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94
+AVK L+ + A +F EV+IL R+ N+ L G ++ +YM
Sbjct: 42 NADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYM 101
Query: 95 PNHSLITHLHGRLAPD-------------CLLDWHRRVSIAIG-----SAEGI-ADIKAS 135
N L L +A LL + IA G S + D+
Sbjct: 102 ENGDLNQFLQKHVAETSGLACNSKSLSFSTLL--YMATQIASGMRYLESLNFVHRDLATR 159
Query: 136 NVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGT----LGYLAPEYAMWGKVSDSCDVY 191
N L+ ++ K+ADFG ++ + + RV+G + ++A E + GK + DV+
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLYSSDYY---RVQGRAPLPIRWMAWESVLLGKFTTKSDVW 216
Query: 192 SFGVLLLELIS--AKKPLEKLPGGVKRDIVQWV---TPYVQKGAFEHIADPRLKGKFNRD 246
+FGV L E+++ ++P E L Q V + + I PR
Sbjct: 217 AFGVTLWEILTLCREQPYEHLTD-------QQVIENAGHFFRDDGRQIYLPRPPN----- 264
Query: 247 QLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277
K + + L C + E+RPT ++ +L+
Sbjct: 265 CPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 32/77 (41%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
D+K NV+LD D K+ADFG K G +T GT Y+APE K + S D
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKYTFSVDW 179
Query: 191 YSFGVLLLELISAKKPL 207
+SFGVLL E++ + P
Sbjct: 180 WSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 4/93 (4%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVT-HMTTRVKGTLGYLAPEYAMWGKVSDSCD 189
D+K++N+ L K+ DFGF+K D V+ + + GT YLAPE + S D
Sbjct: 194 DLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKAD 253
Query: 190 VYSFGVLLLELISAKKPLEKLPGGVKRDIVQWV 222
++S GV+L EL++ +P + G +R+I+Q V
Sbjct: 254 MWSLGVILYELLTLHRPFK---GPSQREIMQQV 283
|
Length = 478 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 57/192 (29%), Positives = 85/192 (44%), Gaps = 20/192 (10%)
Query: 31 LLLLRRETGDDQ---IAVKRLKTL----NAKAEMEFAVEVEILGRVRHRNLLGLR-GFYA 82
+ +R+ TG D A+K LK N K E IL V+H ++ L F
Sbjct: 12 VFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT 71
Query: 83 GGDERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGS--AEGIA--DIKASN 136
GG LI+ +Y+ L HL G D + +S+A+ +GI D+K N
Sbjct: 72 GGKLYLIL-EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPEN 130
Query: 137 VLLDTDFEAKVADFGFAK--LIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFG 194
+LLD K+ DFG K + VTH GT+ Y+APE M + D +S G
Sbjct: 131 ILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEYMAPEILMRSGHGKAVDWWSLG 187
Query: 195 VLLLELISAKKP 206
L+ ++++ P
Sbjct: 188 ALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 52/186 (27%), Positives = 78/186 (41%), Gaps = 15/186 (8%)
Query: 35 RRETGDDQIAVKRL--KTLNAKAEMEFA-VEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91
R TG A K+L K L + E A VE IL +V R ++ L + + +V
Sbjct: 14 MRATGK-LYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVM 72
Query: 92 DYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDT 141
M L H++ + R G+ D+K NVLLD
Sbjct: 73 TIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDN 132
Query: 142 DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELI 201
D +++D G A + DG + T GT G++APE + S D ++ GV L E+I
Sbjct: 133 DGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMI 191
Query: 202 SAKKPL 207
+A+ P
Sbjct: 192 AARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-08
Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 3/85 (3%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGT--LGYLAPEYAMWGKVSDSC 188
D+ A NVLL AK++DFG +K + ++ R G L + APE + K S
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRS 179
Query: 189 DVYSFGVLLLELIS-AKKPLEKLPG 212
DV+S+G+ + E S +KP +K+ G
Sbjct: 180 DVWSYGITMWEAFSYGQKPYKKMKG 204
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 49/166 (29%), Positives = 74/166 (44%), Gaps = 36/166 (21%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRR--- 118
EV L ++RH N + +G Y +V +Y A D +L+ H++
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGS----------ASD-ILEVHKKPLQ 113
Query: 119 ----VSIAIGSAEGIA----------DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164
+I G+ +G+A DIKA N+LL K+ADFG A L+ + +
Sbjct: 114 EVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV- 172
Query: 165 TRVKGTLGYLAPE--YAM-WGKVSDSCDVYSFGVLLLELISAKKPL 207
GT ++APE AM G+ DV+S G+ +EL K PL
Sbjct: 173 ----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 42/142 (29%), Positives = 64/142 (45%), Gaps = 19/142 (13%)
Query: 80 FYAGGDERLI--VYDYMPNHSLITHLHGRLAPDCLLDWHR----RVSIAIGSAEGIA--- 130
YA D++ + V +YMP L+ + P+ W R V +A+ + +
Sbjct: 109 HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE---KWARFYTAEVVLALDAIHSMGFIH 165
Query: 131 -DIKASNVLLDTDFEAKVADFGFA-KLIPDGVTHMTTRVKGTLGYLAPEYAMW----GKV 184
D+K N+LLD K+ADFG K+ +G+ T V GT Y++PE G
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYY 224
Query: 185 SDSCDVYSFGVLLLELISAKKP 206
CD +S GV L E++ P
Sbjct: 225 GRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 4e-08
Identities = 40/176 (22%), Positives = 82/176 (46%), Gaps = 18/176 (10%)
Query: 42 QIAVKRLKTLNAKAEMEFAV-EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
++A+K++ L + + E + E+ ++ +++ N++ + GDE +V +Y+ SL
Sbjct: 46 EVAIKQI-NLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT 104
Query: 101 THLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVADF 150
+ + +D + ++ + + DIK+ NVLL D K+ DF
Sbjct: 105 D-----VVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDF 159
Query: 151 GFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKP 206
GF I + +T V GT ++APE D++S G++ +E++ + P
Sbjct: 160 GFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-08
Identities = 32/79 (40%), Positives = 46/79 (58%), Gaps = 3/79 (3%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKL-IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCD 189
D+K N+LLD + K+ADFG K I +GVT TT GT Y+APE + S D
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEILQELEYGPSVD 178
Query: 190 VYSFGVLLLELISAKKPLE 208
++ GVL+ E+++ + P E
Sbjct: 179 WWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 47/182 (25%), Positives = 79/182 (43%), Gaps = 46/182 (25%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVS- 120
E++I+ ++H N++GL Y GD +V D M L ++D R++
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM---------ASDLKK--VVDRKIRLTE 118
Query: 121 -----IAIGSAEGIA----------DIKASNVLLDTDFEAKVADFGFAK-----LIPDGV 160
I + G+ D+ +N+ +++ K+ADFG A+ D +
Sbjct: 119 SQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178
Query: 161 T---------HMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKL 210
+ MT++V TL Y APE M K + D++S G + EL++ KPL
Sbjct: 179 SKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT-GKPL--F 234
Query: 211 PG 212
PG
Sbjct: 235 PG 236
|
Length = 335 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 5e-08
Identities = 27/87 (31%), Positives = 44/87 (50%), Gaps = 2/87 (2%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
D+K NVLLD +++D G A + DG T T+ GT GY+APE S D
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSYPVDW 177
Query: 191 YSFGVLLLELISAKKPLEKLPGGVKRD 217
++ G + E+++ + P + V ++
Sbjct: 178 FAMGCSIYEMVAGRTPFKDHKEKVAKE 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 5e-08
Identities = 45/170 (26%), Positives = 73/170 (42%), Gaps = 35/170 (20%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPN--HSLITHLHGRLAPDCLLDWHRRV 119
E+ +L ++H N++ L + +V++Y + G L+P+ +
Sbjct: 48 EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIK------ 101
Query: 120 SIAIGSAEGIA----------DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169
SI G+A D+K N+L++ D K+ADFG A+ + T V
Sbjct: 102 SIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV- 160
Query: 170 TLGYLAPE-------YAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPG 212
TL Y APE Y S + D++S G + E+I+ KPL PG
Sbjct: 161 TLWYRAPEILLGSKHY------STAVDIWSVGCIFAEMIT-GKPL--FPG 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 5e-08
Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 45/229 (19%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERLIVYDY-MPNHSLITHLHGRLAPDCLLDWHRRVS 120
EV+ L R++H N + +G Y +V +Y + + S + +H + + + +
Sbjct: 75 EVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AA 129
Query: 121 IAIGSAEGIA----------DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGT 170
I G+ +G+A DIKA N+LL + K+ADFG A + + + GT
Sbjct: 130 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GT 184
Query: 171 LGYLAPEYAMW---GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQ 227
++APE + G+ DV+S G+ +EL K PL +
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------------- 229
Query: 228 KGAFEHIA---DPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVV 273
A HIA P L+ D ++ V C P++RPT +++
Sbjct: 230 MSALYHIAQNESPTLQSNEWSDYFRNFV---DSCLQKIPQDRPTSEELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-08
Identities = 40/150 (26%), Positives = 63/150 (42%), Gaps = 19/150 (12%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
DIK SN+L+++ + K+ DFG + + + + T V GT Y++PE GK + DV
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELINSIAD--TFV-GTSTYMSPERIQGGKYTVKSDV 185
Query: 191 YSFGVLLLELISAKKPLEKLPGGVKRD-----IVQWVTPYVQKGAFEHIADPRL-KGKFN 244
+S G+ ++EL K P I+ + VQ+ PRL F
Sbjct: 186 WSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP------PRLPSSDFP 239
Query: 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVD 274
D + C +P RPT +
Sbjct: 240 ED----LRDFVDACLLKDPTERPTPQQLCA 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 6e-08
Identities = 46/178 (25%), Positives = 83/178 (46%), Gaps = 22/178 (12%)
Query: 42 QIAVKRLKTLNAKAEMEFAV-EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
++A+K++ L + + E + E+ ++ ++ N++ Y GDE +V +Y+ SL
Sbjct: 46 EVAIKQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 104
Query: 101 THL------HGRLAPDC-----LLDW-HRRVSIAIGSAEGIADIKASNVLLDTDFEAKVA 148
+ G++A C LD+ H I DIK+ N+LL D K+
Sbjct: 105 DVVTETCMDEGQIAAVCRECLQALDFLHSNQVIH-------RDIKSDNILLGMDGSVKLT 157
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKP 206
DFGF I + +T V GT ++APE D++S G++ +E++ + P
Sbjct: 158 DFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-08
Identities = 38/160 (23%), Positives = 75/160 (46%), Gaps = 11/160 (6%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHL--HGRLAPDCLLDWHRRV 119
E+ +L ++H N++ G D I +Y+P S+ L +G + ++ R++
Sbjct: 56 EIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI 115
Query: 120 SIAIG--SAEGIA--DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTR-----VKGT 170
+ GI DIK +N+L+D K++DFG +K + T ++G+
Sbjct: 116 LKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 171 LGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKL 210
+ ++APE + D++S G L++E+++ K P
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-08
Identities = 56/224 (25%), Positives = 90/224 (40%), Gaps = 31/224 (13%)
Query: 31 LLLLRRETGDDQIAVKRLKTLN-------AKAEMEFAVEVEILGRVRHRNLLGLRGFYAG 83
+ L+R+ +G D + +K L AK E ++L +R L +
Sbjct: 16 VFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 75
Query: 84 GDERL-IVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGS---------AEGIA--D 131
D +L ++ DY+ L THL R + V I G GI D
Sbjct: 76 TDTKLHLILDYINGGELFTHLSQRERFK-----EQEVQIYSGEIVLALEHLHKLGIIYRD 130
Query: 132 IKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKV--SDSCD 189
IK N+LLD++ + DFG +K + GT+ Y+AP+ G + D
Sbjct: 131 IKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVD 190
Query: 190 VYSFGVLLLELISAKKPL-----EKLPGGVKRDIVQWVTPYVQK 228
+S GVL+ EL++ P + + R I++ PY Q+
Sbjct: 191 WWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 234
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-08
Identities = 56/192 (29%), Positives = 80/192 (41%), Gaps = 21/192 (10%)
Query: 31 LLLLRRETGDDQIAVKRLKT---LNAKAEMEFAVEVEILGR-VRHRNLLGLRGFYAGGDE 86
+LL R + + AVK L+ L K E E +L + V+H L+GL + D+
Sbjct: 11 VLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 70
Query: 87 RLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIA-IGSAEGI--------ADIKASNV 137
V DY+ L HL C L+ R A I SA G D+K N+
Sbjct: 71 LYFVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENI 127
Query: 138 LLDTDFEAKVADFGFAK--LIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGV 195
LLD+ + DFG K + +G T+ GT YLAPE + D + G
Sbjct: 128 LLDSQGHIVLTDFGLCKENIEHNGT---TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGA 184
Query: 196 LLLELISAKKPL 207
+L E++ P
Sbjct: 185 VLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 8e-08
Identities = 56/194 (28%), Positives = 82/194 (42%), Gaps = 29/194 (14%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI------------ 89
++AV +LK + M+ + E+L R R GD + I
Sbjct: 16 EVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENN 75
Query: 90 ---VYDYMPNHSLITHL---HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLL 139
V DY L+T L RL D + + IAI S + DIK N+L+
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 135
Query: 140 DTDFEAKVADFGFA-KLIPDGVTHMTTRVKGTLGYLAPEY--AMW---GKVSDSCDVYSF 193
D + ++ADFG KL+ DG + V GT Y++PE AM GK CD +S
Sbjct: 136 DMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEDGKGKYGPECDWWSL 194
Query: 194 GVLLLELISAKKPL 207
GV + E++ + P
Sbjct: 195 GVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 8e-08
Identities = 32/79 (40%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKL-IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCD 189
D+K NVLLD + K+ADFG K I +G T T+ GT Y+APE S D
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEILQEMLYGPSVD 178
Query: 190 VYSFGVLLLELISAKKPLE 208
++ GVLL E++ P E
Sbjct: 179 WWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 52/191 (27%), Positives = 85/191 (44%), Gaps = 28/191 (14%)
Query: 40 DDQIAVKRLKTLNAKAEMEFAV--EVEILGRVRHRNLLGLRGFYAGGDERL--------- 88
+ +A+K+++ N K E++IL ++ HRN++ L+ + L
Sbjct: 32 GELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAF 91
Query: 89 -IVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNV 137
+V++YM +H L+ L L S EG+ DIK SN+
Sbjct: 92 YLVFEYM-DHDLMGLLESGLVH---FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNI 147
Query: 138 LLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVL 196
LL+ + K+ADFG A+L + T TL Y PE + + + DV+S G +
Sbjct: 148 LLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 207
Query: 197 LLELISAKKPL 207
L EL + KKP+
Sbjct: 208 LGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 42/182 (23%), Positives = 87/182 (47%), Gaps = 6/182 (3%)
Query: 30 LLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89
++ + R + Q+AVK + + EV I+ +H+N++ + Y G+E +
Sbjct: 36 IVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWV 95
Query: 90 VYDYMPNHSLITHL-HGRLAPDCLLDWHRRV--SIAIGSAEGIA--DIKASNVLLDTDFE 144
+ +++ +L + RL + + V ++ ++G+ DIK+ ++LL D
Sbjct: 96 LMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR 155
Query: 145 AKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAK 204
K++DFGF I V + V GT ++APE D++S G++++E++ +
Sbjct: 156 VKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
Query: 205 KP 206
P
Sbjct: 215 PP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 50/193 (25%), Positives = 85/193 (44%), Gaps = 17/193 (8%)
Query: 31 LLLLRRETGDDQIAVKRLKTLN-------AKAEMEFAVEVEILGRVRHRNLLGLRGFYAG 83
+ L+R+ TG D + +K L AK E +L VR L +
Sbjct: 16 VFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ 75
Query: 84 GDERL-IVYDYMPNHSLITHLHGR--LAPDCLLDWHRRVSIAIGSAEGIA----DIKASN 136
+ +L ++ DY+ + THL+ R + D + + + +A+ + DIK N
Sbjct: 76 TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLEN 135
Query: 137 VLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKV--SDSCDVYSFG 194
+LLD++ + DFG +K T GT+ Y+APE + GK + D +S G
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE-IIRGKGGHGKAVDWWSLG 194
Query: 195 VLLLELISAKKPL 207
+L+ EL++ P
Sbjct: 195 ILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 69/266 (25%), Positives = 106/266 (39%), Gaps = 54/266 (20%)
Query: 43 IAVKRLK-TLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
+AVK LK K + E+E++ + +H+N++ L G +V +Y + +L
Sbjct: 45 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLR 104
Query: 101 THLHGRLAP--DCLLDWHRR----------VSIAIGSAEGIA----------DIKASNVL 138
L R P D R VS A A G+ D+ A NVL
Sbjct: 105 DFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164
Query: 139 LDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL-----APEYAMWGKV-SDSCDVYS 192
+ D K+ADFG A+ + H+ K T G L APE A++ +V + DV+S
Sbjct: 165 VTEDHVMKIADFGLAR----DIHHIDYYRKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWS 219
Query: 193 FGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKS-- 250
FGVLL E+ + GG +PY E + + + Q +
Sbjct: 220 FGVLLWEIFT--------LGG---------SPYPGIPVEELFKLLKEGYRMEKPQNCTQE 262
Query: 251 MVLIALRCTDSNPENRPTMTDVVDWL 276
+ + C P RPT +V+ L
Sbjct: 263 LYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 58/205 (28%), Positives = 87/205 (42%), Gaps = 27/205 (13%)
Query: 31 LLLLRRETGDDQIAVKRL--KTLNAKAEME--FAVEVEILGRVRHRNLLGLRGFYAGGDE 86
+LL +R++ AVK L KT+ K E A +L ++H L+GL + ++
Sbjct: 11 VLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEK 70
Query: 87 RLIVYDYMPNHSLITHLHGRLAPDCLLDWHRR-----VSIAIGSAEGI----ADIKASNV 137
V DY+ L HL C L+ R V+ AIG + D+K N+
Sbjct: 71 LYFVLDYVNGGELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENI 127
Query: 138 LLDTDFEAKVADFGFAK--LIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGV 195
LLD+ + DFG K + P+ T+ GT YLAPE + D + G
Sbjct: 128 LLDSQGHVVLTDFGLCKEGVEPEET---TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGA 184
Query: 196 LLLELISAKKPLEKLPGGVKRDIVQ 220
+L E++ LP RD+ Q
Sbjct: 185 VLYEMLYG------LPPFYSRDVSQ 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 44/184 (23%), Positives = 80/184 (43%), Gaps = 25/184 (13%)
Query: 42 QIAVKRLKTLNAKAEMEFAV-----EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPN 96
++AVK++ E + V E+++L ++H ++ G + I +YMP
Sbjct: 29 ELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPG 88
Query: 97 HSLITHL--HGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFE 144
S+ L +G L + R++ EG+ DIK +N+L D+
Sbjct: 89 GSVKDQLKAYGALTETVTRKYTRQI------LEGVEYLHSNMIVHRDIKGANILRDSAGN 142
Query: 145 AKVADFGFAKLIPDGVTHMT--TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
K+ DFG +K + + T V GT +++PE DV+S G ++E+++
Sbjct: 143 VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
Query: 203 AKKP 206
K P
Sbjct: 203 EKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 65/255 (25%), Positives = 108/255 (42%), Gaps = 42/255 (16%)
Query: 42 QIAVKRLK-TLNAKAEME-FAVEVEILGRVRHRNLLGLRGFYAGGDER------LIVYDY 93
++AVK +K + ++EME F E + H N++ L G E +++ +
Sbjct: 28 KVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPF 87
Query: 94 MPN---HSLITHLHGRLAPDC--LLDWHRRVSIAIGSAEGIA----------DIKASNVL 138
M + HS + L+ RL DC L V A G+ D+ A N +
Sbjct: 88 MKHGDLHSFL--LYSRLG-DCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCM 144
Query: 139 LDTDFEAKVADFGFAKLIPDGVTHMTTRV-KGTLGYLAPEYAMWGKVSDSCDVYSFGVLL 197
L+ + VADFG +K I +G + R+ K + ++A E + DV+SFGV +
Sbjct: 145 LNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTM 204
Query: 198 LELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALR 257
E+ A + PG +I Y+++G RLK D L + +
Sbjct: 205 WEI--ATRGQTPYPGVENSEIYD----YLRQGN-------RLKQP--PDCLDGLYSLMSS 249
Query: 258 CTDSNPENRPTMTDV 272
C NP++RP+ +
Sbjct: 250 CWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 25/152 (16%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLI---PDGVTHMTTRVKGTLGYLAPEYAMWGKV-SD 186
D+ A N+LL + K+ DFG A+ I PD V + R+ L ++APE +++ KV +
Sbjct: 199 DLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP--LKWMAPE-SIFDKVYTT 255
Query: 187 SCDVYSFGVLLLELIS-AKKPLEKLPG-GVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244
DV+SFGVLL E+ S P PG + + Q + + A E+ A P +
Sbjct: 256 QSDVWSFGVLLWEIFSLGASP---YPGVQINEEFCQRLKDGTRMRAPEN-ATPEIYR--- 308
Query: 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVDWL 276
I L C +P+ RPT + +V+ L
Sbjct: 309 ---------IMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 54/194 (27%), Positives = 90/194 (46%), Gaps = 22/194 (11%)
Query: 31 LLLLRRETGDDQ---IAVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLR-GFYAGG 84
+ L+R+ TG D A+K LK TL + + +E +IL V H ++ L F G
Sbjct: 12 VFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG 71
Query: 85 DERLIVYDYMPNHSLITHLHGRLAPDCLLD------WHRRVSIAIGSAEGIA----DIKA 134
LI+ D++ L T RL+ + + + +++A+ + D+K
Sbjct: 72 KLYLIL-DFLRGGDLFT----RLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKP 126
Query: 135 SNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFG 194
N+LLD + K+ DFG +K D GT+ Y+APE + S D +SFG
Sbjct: 127 ENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFCGTVEYMAPEVVNRRGHTQSADWWSFG 185
Query: 195 VLLLELISAKKPLE 208
VL+ E+++ P +
Sbjct: 186 VLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 61/257 (23%), Positives = 106/257 (41%), Gaps = 50/257 (19%)
Query: 38 TGDDQIAVKRL----KTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93
++ +AVK++ K N K + + EV+ L +++H N + +G Y +V +Y
Sbjct: 44 HTNEVVAVKKMSYSGKQTNEKWQ-DIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102
Query: 94 -MPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTD 142
+ + S + +H + + + +I G+ +G+A DIKA N+LL
Sbjct: 103 CLGSASDLLEVHKKPLQEVEI-----AAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP 157
Query: 143 FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMW---GKVSDSCDVYSFGVLLLE 199
+ K+ADFG A + + GT ++APE + G+ DV+S G+ +E
Sbjct: 158 GQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 212
Query: 200 LISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIA---DPRLKGKFNRDQLKSMVLIAL 256
L K PL + A HIA P L+ D + V
Sbjct: 213 LAERKPPLFNMNA---------------MSALYHIAQNDSPTLQSNEWTDSFRGFVDY-- 255
Query: 257 RCTDSNPENRPTMTDVV 273
C P+ RP +++
Sbjct: 256 -CLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 54/267 (20%), Positives = 109/267 (40%), Gaps = 62/267 (23%)
Query: 43 IAVKRLKT-LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+AVK L+ N A +F E++I+ R++ N++ L D ++ +YM N L
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 102 HLHGRLAPDCLLDWHRR-------VSIAIGSAEGIA----------DIKASNVLLDTDFE 144
L + + +A A G+ D+ N L+ ++
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT 168
Query: 145 AKVADFGFAKLIPDGVTHMTTRVKG----TLGYLAPEYAMWGKVSDSCDVYSFGVLLLEL 200
K+ADFG ++ + G + R++G + +++ E + GK + + DV++FGV L E+
Sbjct: 169 IKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
Query: 201 ISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL---KGKFNRDQLKSMVL---- 253
++ ++ + ++D ++ G+F RDQ + + L
Sbjct: 226 LT----------------------LCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPA 263
Query: 254 --------IALRCTDSNPENRPTMTDV 272
+ L C N + RP+ ++
Sbjct: 264 LCPDSLYKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 52/197 (26%), Positives = 82/197 (41%), Gaps = 25/197 (12%)
Query: 32 LLLRRETGDDQIAVKRLK---TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88
++ + TGD A+K +K L + F E +IL + L+ + D
Sbjct: 19 VVREKATGD-IYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLY 77
Query: 89 IVYDYMPNH---SLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----DIKASNVLLDT 141
+V +Y P SL+ + D + + +AI S + DIK NVL+D
Sbjct: 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR 137
Query: 142 DFEAKVADFG-FAKLIPDGVTHMTTRVKGTLGYLAPEY---------AMWGKVSDSCDVY 191
K+ADFG A+L + + + V GT Y+APE +G CD +
Sbjct: 138 TGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLTTMNGDGKGTYGV---ECDWW 193
Query: 192 SFGVLLLELISAKKPLE 208
S GV+ E+I + P
Sbjct: 194 SLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 55/189 (29%), Positives = 80/189 (42%), Gaps = 18/189 (9%)
Query: 31 LLLLRRETGDDQIAVKRLK--TLNAKAEMEFAV-EVEILGRVRHRNLLGLRGFYAGGDER 87
++L+R + A+K LK + AK E+ + E +L RH L L+ + D
Sbjct: 11 VILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRL 70
Query: 88 LIVYDYMPNHSLITHL-HGRLAPDCLLDWHRRVSIAIGSAEGI--------ADIKASNVL 138
V +Y L HL R+ + D R I SA G D+K N++
Sbjct: 71 CFVMEYANGGELFFHLSRERVFSE---DRARFYGAEIVSALGYLHSCDVVYRDLKLENLM 127
Query: 139 LDTDFEAKVADFGFAKL-IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLL 197
LD D K+ DFG K I DG T GT YLAPE + D + GV++
Sbjct: 128 LDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 185
Query: 198 LELISAKKP 206
E++ + P
Sbjct: 186 YEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 35/139 (25%), Positives = 59/139 (42%), Gaps = 15/139 (10%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
D+K SN+L+++ + K+ DFG + + + + GT Y+APE S D+
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMAPERIQGNDYSVKSDI 182
Query: 191 YSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL-KGKFNRDQLK 249
+S G+ L+EL + + P I + + V + PRL GKF+
Sbjct: 183 WSLGLSLIELATGRFPYPP-ENDPPDGIFELLQYIVNEPP------PRLPSGKFS----P 231
Query: 250 SMVLIALRCTDSNPENRPT 268
C +P RP+
Sbjct: 232 DFQDFVNLCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 51/191 (26%), Positives = 90/191 (47%), Gaps = 35/191 (18%)
Query: 42 QIAVKRLKTLNAKAEM-EFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMPNHSL 99
++AVK LK+ + ++ + E+E++ + +H+N++ L G ++ +Y +L
Sbjct: 52 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 100 ITHLHGR------------LAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNV 137
+L R P+ L + VS A A G+ D+ A NV
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171
Query: 138 LLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLG-----YLAPEYAMWGKV-SDSCDVY 191
L+ D K+ADFG A+ + H+ K T G ++APE A++ ++ + DV+
Sbjct: 172 LVTEDNVMKIADFGLAR----DIHHIDYYKKTTNGRLPVKWMAPE-ALFDRIYTHQSDVW 226
Query: 192 SFGVLLLELIS 202
SFGVLL E+ +
Sbjct: 227 SFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 49/183 (26%), Positives = 86/183 (46%), Gaps = 12/183 (6%)
Query: 33 LLRRETGDDQIAVKRLKTLNAKAEMEFAVEVE--ILGRVRHRNLLGLRGFYAGGDERL-I 89
L+R T Q +K+L NA A E E +L +++H N++ R + G D L I
Sbjct: 18 LVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI 77
Query: 90 VYDYMPNHSLITHL---HGRLAPDC-LLDWHRRVSIAIG--SAEGIA--DIKASNVLLDT 141
V + L L G+L P+ +++W ++++A+ + I D+K NV L
Sbjct: 78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTR 137
Query: 142 DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELI 201
KV D G A+++ + M + + GT Y++PE + DV++ G + E+
Sbjct: 138 TNIIKVGDLGIARVL-ENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMA 196
Query: 202 SAK 204
+ K
Sbjct: 197 TLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 49/210 (23%), Positives = 82/210 (39%), Gaps = 52/210 (24%)
Query: 80 FYAGGDERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA--------- 130
F GG L VY +P H L GR IA+ +G+
Sbjct: 80 FMDGGS--LDVYRKIPEHVL-----GR--------------IAVAVVKGLTYLWSLKILH 118
Query: 131 -DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCD 189
D+K SN+L++T + K+ DFG + + V + GT Y+APE + D
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERISGEQYGIHSD 175
Query: 190 VYSFGVLLLELISAKKPLEKLPGG----VKRDIVQWVTPYVQKGAFEHIADPRLK-GKFN 244
V+S G+ +EL + P ++ + ++Q + P L G+F+
Sbjct: 176 VWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV---------DEDPPVLPVGQFS 226
Query: 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVD 274
+ V +C P+ RP +++D
Sbjct: 227 ----EKFVHFITQCMRKQPKERPAPENLMD 252
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 49/168 (29%), Positives = 81/168 (48%), Gaps = 25/168 (14%)
Query: 62 EVEILGRVRHRNLLGLR-----GFYAGGDERLIVYDYMPNHSLITHLHGRLAPDCLLDWH 116
E++IL R +H N++G+ + ++ IV + M T L+ + L + H
Sbjct: 53 EIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-----TDLYKLIKTQHLSNDH 107
Query: 117 --------RRVSIAIGSAEGI-ADIKASNVLLDTDFEAKVADFGFAKLI-PDGV-THMTT 165
R I SA + D+K SN+LL+T+ + K+ DFG A++ P+ T T
Sbjct: 108 IQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLT 167
Query: 166 RVKGTLGYLAPEYAMWGK-VSDSCDVYSFGVLLLELISAKKPLEKLPG 212
T Y APE + K + + D++S G +L E++S +PL PG
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL--FPG 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 4e-07
Identities = 45/177 (25%), Positives = 86/177 (48%), Gaps = 20/177 (11%)
Query: 42 QIAVKRLKTLNAKAEMEFAV-EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
++A++++ L + + E + E+ ++ ++ N++ Y GDE +V +Y+ SL
Sbjct: 47 EVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105
Query: 101 THL------HGRLAPDCLLDWHRRVSIAI---GSAEGI-ADIKASNVLLDTDFEAKVADF 150
+ G++A C R A+ S + I DIK+ N+LL D K+ DF
Sbjct: 106 DVVTETCMDEGQIAAVC-----RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDF 160
Query: 151 GF-AKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKP 206
GF A++ P+ + + GT ++APE D++S G++ +E+I + P
Sbjct: 161 GFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 59/195 (30%), Positives = 86/195 (44%), Gaps = 31/195 (15%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVR------HRNLLGLRG--------FYAGGDER 87
++AV ++K M+ + E+L R RN+L + G YA DE
Sbjct: 16 EVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVL-VNGDCQWITTLHYAFQDEN 74
Query: 88 --LIVYDYMPNHSLITHL---HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVL 138
+V DY L+T L RL D + + +AI S + DIK NVL
Sbjct: 75 YLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVL 134
Query: 139 LDTDFEAKVADFGFA-KLIPDGVTHMTTRVKGTLGYLAPEY--AM---WGKVSDSCDVYS 192
LD + ++ADFG K+ DG + V GT Y++PE AM GK CD +S
Sbjct: 135 LDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPEILQAMEDGMGKYGPECDWWS 193
Query: 193 FGVLLLELISAKKPL 207
GV + E++ + P
Sbjct: 194 LGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 46/211 (21%)
Query: 44 AVKRLKTLNAKAE-MEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
A+KR+K +K + +FA E+E+L ++ H N++ L G + +Y P+ +L+
Sbjct: 38 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 97
Query: 102 HLHGR--LAPDCLLDWHRRVSIAIGSAEGIA--------------------DIKASNVLL 139
L L D + + S + + D+ A N+L+
Sbjct: 98 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 157
Query: 140 DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLG-----YLAPEYAMWGKVSDSCDVYSFG 194
++ AK+ADFG ++ VK T+G ++A E + + + DV+S+G
Sbjct: 158 GENYVAKIADFGLSR-------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 210
Query: 195 VLLLELIS----------AKKPLEKLPGGVK 215
VLL E++S + EKLP G +
Sbjct: 211 VLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 241
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 54/191 (28%), Positives = 85/191 (44%), Gaps = 25/191 (13%)
Query: 62 EVEILGRVRHRNLLGLRG-FYAGGDERLIVYDYMPNHSLITHL-HGRLAPDCLLDWHRRV 119
E+++L ++G G FY+ G E I ++M SL L + P+ +L +V
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKEAKRIPEEILG---KV 108
Query: 120 SIAIGSAEGIA-----------DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVK 168
SIA+ G+A D+K SN+L+++ E K+ DFG + + D M
Sbjct: 109 SIAV--LRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFV 163
Query: 169 GTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQK 228
GT Y++PE S D++S G+ L+EL + P+ P K + P V
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP--PPDAKELEAIFGRPVVDG 221
Query: 229 GAFE-HIADPR 238
E H PR
Sbjct: 222 EEGEPHSISPR 232
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 5e-07
Identities = 47/196 (23%), Positives = 90/196 (45%), Gaps = 33/196 (16%)
Query: 42 QIAVKRLKT--LNAKAEMEFA-VEVEILGRV-RHRNLLGLRGFYAGGDERLI--VYDYMP 95
+ A+K L L + ++++ +E E+L R+ H ++ L +Y DE + V +Y P
Sbjct: 28 EYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL--YYTFQDEENLYFVLEYAP 85
Query: 96 NHSLITHLH--GRLAPDCLLDWHRRVSIAIGS--AEGIA--DIKASNVLLDTDFEAKVAD 149
N L+ ++ G L C + + +A+ ++GI D+K N+LLD D K+ D
Sbjct: 86 NGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITD 145
Query: 150 FGFAKLIPDGVTHMTTRVK-------------------GTLGYLAPEYAMWGKVSDSCDV 190
FG AK++ + + + GT Y++PE S D+
Sbjct: 146 FGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDL 205
Query: 191 YSFGVLLLELISAKKP 206
++ G ++ ++++ K P
Sbjct: 206 WALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-07
Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSL--ITHLHGRLAPDCLLDWHRRV 119
E+ ++ +H N++ G Y ++ I +Y SL I H+ G L+ + + + R
Sbjct: 56 EIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLS-ELQIAYVCRE 114
Query: 120 SIAIGSAEGIA----------DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169
++ +G+A DIK +N+LL + + K+ADFG A I + + + G
Sbjct: 115 TL-----QGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-G 168
Query: 170 TLGYLAPEYAMW---GKVSDSCDVYSFGVLLLELISAKKPLEKL-PGGVKRDIVQWVTPY 225
T ++APE A G + CD+++ G+ +EL + P+ L P R +
Sbjct: 169 TPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP---MRALF-----L 220
Query: 226 VQKGAFEHIADPRLKGKFN-RDQLKSMVLIALRCTDSNPENRPT 268
+ K F+ P+LK K + V I+L NP+ RPT
Sbjct: 221 MSKSNFQ---PPKLKDKTKWSSTFHNFVKISL---TKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 61/241 (25%), Positives = 106/241 (43%), Gaps = 35/241 (14%)
Query: 40 DDQIAVKRL----KTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY-M 94
+ +A+K++ K N K + + EV L ++RH N + RG Y +V +Y +
Sbjct: 40 SEVVAIKKMSYSGKQSNEKWQ-DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98
Query: 95 PNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFE 144
+ S + +H + + + ++ G+ +G+A D+KA N+LL
Sbjct: 99 GSASDLLEVHKKPLQEVEI-----AAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL 153
Query: 145 AKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMW---GKVSDSCDVYSFGVLLLELI 201
K+ DFG A ++ + GT ++APE + G+ DV+S G+ +EL
Sbjct: 154 VKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208
Query: 202 SAKKPLEKLPG-GVKRDIVQWVTPYVQKG----AFEHIADPRLKGKFNRDQLKSMVLIAL 256
K PL + I Q +P +Q G F + D L+ K +D+ S VL+
Sbjct: 209 ERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ-KIPQDRPTSEVLLKH 267
Query: 257 R 257
R
Sbjct: 268 R 268
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 44/143 (30%), Positives = 65/143 (45%), Gaps = 19/143 (13%)
Query: 80 FYAGGDERLI--VYDYMPNHSLITHLHGRLAPDCLLDWHR----RVSIAIGSAEGIA--- 130
FYA D+R + V +YMP L+ + P+ W R V +A+ + +
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KWARFYTAEVVLALDAIHSMGFIH 165
Query: 131 -DIKASNVLLDTDFEAKVADFGFA-KLIPDGVTHMTTRVKGTLGYLAPEYAMW----GKV 184
D+K N+LLD K+ADFG K+ +G+ T V GT Y++PE G
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYY 224
Query: 185 SDSCDVYSFGVLLLELISAKKPL 207
CD +S GV L E++ P
Sbjct: 225 GRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-07
Identities = 48/176 (27%), Positives = 72/176 (40%), Gaps = 23/176 (13%)
Query: 43 IAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+AVK + TL + +F E IL + H N++ L G IV + + +T
Sbjct: 23 VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT 82
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA--------------DIKASNVLLDTDFEAKV 147
L +V I E A D+ A N L+ K+
Sbjct: 83 FLRTEGP-------RLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKI 135
Query: 148 ADFGFAKLIPDGVTHMTTRVKGT-LGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
+DFG ++ DGV T +K + + APE +G+ S DV+SFG+LL E S
Sbjct: 136 SDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 40/155 (25%), Positives = 64/155 (41%), Gaps = 20/155 (12%)
Query: 64 EILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHLH--------GRLAPDCLLDW 115
E RH L+ L + D V +Y L+ H+H C++
Sbjct: 54 ETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVV-- 111
Query: 116 HRRVSIAIGSAEGIA--DIKASNVLLDTDFEAKVADFGFAKLIPDGVTH--MTTRVKGTL 171
+ + I D+K N+LLDT+ K+ADFG K +G+ T+ GT
Sbjct: 112 ---LGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTP 165
Query: 172 GYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKP 206
+LAPE + + D + GVL+ E++ + P
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 9e-07
Identities = 48/189 (25%), Positives = 82/189 (43%), Gaps = 33/189 (17%)
Query: 43 IAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+A+K LK +N + EF E ++ + H N++ L G ++++Y+ L
Sbjct: 37 VAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHE 96
Query: 102 HLHGRLAP--------------DCLLDWHRRVSIAIGSAEGI----------ADIKASNV 137
L R +P LD + IAI A G+ D+ A N+
Sbjct: 97 FLIMR-SPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNI 155
Query: 138 LLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGT----LGYLAPEYAMWGKVSDSCDVYSF 193
L+ K++D G ++ I + RV+ + ++ PE M+GK S D++SF
Sbjct: 156 LIGEQLHVKISDLGLSREIYSADYY---RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSF 212
Query: 194 GVLLLELIS 202
GV+L E+ S
Sbjct: 213 GVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 9/88 (10%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLI-PDGVTHMTTRVKGTLGYLAPEYAMWGK-VSDSC 188
DIK N+L++++ K+ DFG A++ PD HMT V T Y APE M + + +
Sbjct: 128 DIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYYRAPEILMGSRHYTSAV 186
Query: 189 DVYSFGVLLLELIS------AKKPLEKL 210
D++S G + EL+ A+ P+++L
Sbjct: 187 DIWSVGCIFAELLGRRILFQAQSPIQQL 214
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 17/155 (10%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERLIVYD-YMPNHSLITHLHGRLAPDCLLDWHRRVS 120
E+ +L + H N++GL + D Y+ H + L+ + L D H +
Sbjct: 64 ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFL 123
Query: 121 IA--------IGSAEGIA--DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGT 170
+ I SA GI D+K SN+ ++ D E K+ DFG A+ D MT V T
Sbjct: 124 VYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARHTDD---EMTGYV-AT 178
Query: 171 LGYLAPEYAM-WGKVSDSCDVYSFGVLLLELISAK 204
Y APE + W + + D++S G ++ EL++ K
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 50/186 (26%), Positives = 87/186 (46%), Gaps = 27/186 (14%)
Query: 43 IAVKRLKTLNAKAEM-EFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
+AVK LK ++ + E+E++ + +H+N++ L G ++ +Y +L
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106
Query: 101 THLHGRLAP------------DCLLDWHRRVSIAIGSAEGIA----------DIKASNVL 138
+L R P + L + VS A A G+ D+ A NVL
Sbjct: 107 EYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL 166
Query: 139 LDTDFEAKVADFGFAKLIPD-GVTHMTTRVKGTLGYLAPEYAMWGKV-SDSCDVYSFGVL 196
+ D K+ADFG A+ + + TT + + ++APE A++ +V + DV+SFGVL
Sbjct: 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVL 225
Query: 197 LLELIS 202
L E+ +
Sbjct: 226 LWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 27/80 (33%), Positives = 39/80 (48%), Gaps = 6/80 (7%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDS--- 187
D+K SN+LLD K+ DFG + + D TR G Y+APE +
Sbjct: 140 DVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDI 197
Query: 188 -CDVYSFGVLLLELISAKKP 206
DV+S G+ L+EL + + P
Sbjct: 198 RADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 52/189 (27%), Positives = 84/189 (44%), Gaps = 15/189 (7%)
Query: 31 LLLLRRETGDDQIAVKRLK---TLNAKAEMEFAVEVEILGR-VRHRNLLGLRGFYAGGDE 86
+LL +R+ AVK L+ LN K + E +L + V+H L+GL + ++
Sbjct: 11 VLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEK 70
Query: 87 RLIVYDYMPNHSLITHLHG-RLAPDCLLDWH-RRVSIAIGSAEGIA----DIKASNVLLD 140
V D++ L HL R P+ ++ ++ A+G I D+K N+LLD
Sbjct: 71 LYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD 130
Query: 141 TDFEAKVADFGFAKLIPDGVTH--MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLL 198
+ + DFG K +G+ TT GT YLAPE ++ D + G +L
Sbjct: 131 SQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLY 187
Query: 199 ELISAKKPL 207
E++ P
Sbjct: 188 EMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 21/137 (15%)
Query: 80 FYAGGDERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----DIKAS 135
+Y GGD L+ +L++ RL D + + +AI S + DIK
Sbjct: 82 YYVGGD--LL--------TLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPD 131
Query: 136 NVLLDTDFEAKVADFGFA-KLIPDGVTHMTTRVKGTLGYLAPEY--AM---WGKVSDSCD 189
NVLLD + ++ADFG +L+ DG V GT Y++PE AM G+ CD
Sbjct: 132 NVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYISPEILQAMEDGKGRYGPECD 190
Query: 190 VYSFGVLLLELISAKKP 206
+S GV + E++ + P
Sbjct: 191 WWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 60/250 (24%), Positives = 106/250 (42%), Gaps = 31/250 (12%)
Query: 43 IAVKRLKT---LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSL 99
+A+K+++ ++AKA + E+++L ++ H N++ + +E IV + L
Sbjct: 30 VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDL 89
Query: 100 ---ITHL--HGRLAPDCLLDWHRRVSIAIGSAEGI-------ADIKASNVLLDTDFEAKV 147
I H RL P+ + W V + + E + DIK +NV + K+
Sbjct: 90 SRMIKHFKKQKRLIPEKTV-WKYFVQLC-SALEHMHSRRVMHRDIKPANVFITATGVVKL 147
Query: 148 ADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPL 207
D G + T + V GT Y++PE + D++S G LL E+ + + P
Sbjct: 148 GDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
Query: 208 EKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRP 267
G K ++ Y E P L ++L+ +V + C + +PE RP
Sbjct: 207 Y----GDKMNL------YSLCKKIEQCDYPPLPSDHYSEELRQLVNM---CINPDPEKRP 253
Query: 268 TMTDVVDWLK 277
+T V D K
Sbjct: 254 DITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 65/254 (25%), Positives = 112/254 (44%), Gaps = 34/254 (13%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
+ETG A K ++T + + ++ VE+EIL H ++ L G + + I+ ++ P
Sbjct: 34 KETGA-LAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92
Query: 96 N---HSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----DIKASNVLLDTDFEAKVA 148
+++ L L + R++ A+ + D+KA NVLL D + K+A
Sbjct: 93 GGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLA 152
Query: 149 DFGFAKLIPDGVTHMTTRVK--GTLGYLAPEYAMWGKVSDS-----CDVYSFGVLLLELI 201
DFG + V + R GT ++APE M + D+ D++S G+ L+E+
Sbjct: 153 DFGVSA---KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 209
Query: 202 SAKKPLEKL-PGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTD 260
+ P +L P V I + P ++ P RD LK AL D
Sbjct: 210 QIEPPHHELNPMRVLLKIAKSEPP--------TLSQPSKWSMEFRDFLK----TAL---D 254
Query: 261 SNPENRPTMTDVVD 274
+PE RP+ +++
Sbjct: 255 KHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 50/190 (26%), Positives = 86/190 (45%), Gaps = 35/190 (18%)
Query: 43 IAVKRLKTLNAKAEM-EFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
+AVK LK ++ + E+E++ + +H+N++ L G ++ +Y +L
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106
Query: 101 THLHGRLAP------------DCLLDWHRRVSIAIGSAEGIA----------DIKASNVL 138
L R P + L + VS A A G+ D+ A NVL
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166
Query: 139 LDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLG-----YLAPEYAMWGKV-SDSCDVYS 192
+ D K+ADFG A+ GV + K + G ++APE A++ +V + DV+S
Sbjct: 167 VTEDNVMKIADFGLAR----GVHDIDYYKKTSNGRLPVKWMAPE-ALFDRVYTHQSDVWS 221
Query: 193 FGVLLLELIS 202
FG+L+ E+ +
Sbjct: 222 FGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 28/76 (36%), Positives = 39/76 (51%), Gaps = 1/76 (1%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
DIKA+NVLL + K+ADFG A + D T V GT ++APE D+
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKADI 184
Query: 191 YSFGVLLLELISAKKP 206
+S G+ +EL + P
Sbjct: 185 WSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-06
Identities = 42/181 (23%), Positives = 74/181 (40%), Gaps = 10/181 (5%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL--IVYDY 93
RE Q+ +K E+++L ++H ++ G E+ I +Y
Sbjct: 28 RELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEY 87
Query: 94 MPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSAEGIA----DIKASNVLLDTDFEAKV 147
MP S+ L +G L + R++ + DIK +N+L D+ K+
Sbjct: 88 MPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKL 147
Query: 148 ADFGFAKLIPDGVTHMT--TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKK 205
DFG +K + T V GT +++PE DV+S G ++E+++ K
Sbjct: 148 GDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKP 207
Query: 206 P 206
P
Sbjct: 208 P 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 43/160 (26%), Positives = 77/160 (48%), Gaps = 24/160 (15%)
Query: 62 EVEILGRVRHRNLLGLRG-FYAGGDERLIVYDYMPNHSL--ITHLHGRLAPDCLLDWHRR 118
E+++L ++G G FY+ G E I ++M SL + GR+ P+ +L +
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKKAGRI-PENILG---K 103
Query: 119 VSIAIGSAEGIA-----------DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRV 167
+SIA+ G+ D+K SN+L+++ E K+ DFG + + D M
Sbjct: 104 ISIAV--LRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF 158
Query: 168 KGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPL 207
GT Y++PE + D++S G+ L+E+ + P+
Sbjct: 159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 62/243 (25%), Positives = 103/243 (42%), Gaps = 45/243 (18%)
Query: 48 LKTLNAKAEMEFAV---EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSL--ITH 102
+K + + +FAV E+ ++ +H N++ G Y D+ I ++ SL I H
Sbjct: 39 IKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH 98
Query: 103 LHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKVAD 149
+ G L+ IA S E + DIK +N+LL + K+AD
Sbjct: 99 VTGPLS---------ESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLAD 149
Query: 150 FGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMW---GKVSDSCDVYSFGVLLLELISAKKP 206
FG + I + + + GT ++APE A G + CD+++ G+ +EL + P
Sbjct: 150 FGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP 208
Query: 207 LEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN-RDQLKSMVLIALRCTDSNPEN 265
+ L R + + K F+ P+LK K + V +AL NP+
Sbjct: 209 MFDLHP--MRALF-----LMTKSNFQ---PPKLKDKMKWSNSFHHFVKMAL---TKNPKK 255
Query: 266 RPT 268
RPT
Sbjct: 256 RPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 3e-06
Identities = 42/143 (29%), Positives = 63/143 (44%), Gaps = 17/143 (11%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
DIKA+NVLL E K+ADFG A + D T V GT ++APE D+
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKADI 184
Query: 191 YSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKS 250
+S G+ +EL + P +L ++ P P L+G +++ LK
Sbjct: 185 WSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP------------PTLEGNYSK-PLKE 231
Query: 251 MVLIALRCTDSNPENRPTMTDVV 273
V C + P RPT +++
Sbjct: 232 FVEA---CLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 55/216 (25%), Positives = 91/216 (42%), Gaps = 52/216 (24%)
Query: 44 AVKRLKTLNAKAE-MEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
A+K LK ++ + +FA E+E+L ++ H N++ L G I +Y P +L+
Sbjct: 33 AIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLD 92
Query: 102 HL---------------HGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASN 136
L HG + L + + A A G+ D+ A N
Sbjct: 93 FLRKSRVLETDPAFAKEHGTAST---LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARN 149
Query: 137 VLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLG-----YLAPEYAMWGKVSDSCDVY 191
VL+ + +K+ADFG ++ VK T+G ++A E + + DV+
Sbjct: 150 VLVGENLASKIADFGLSR-------GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVW 202
Query: 192 SFGVLLLELIS----------AKKPLEKLPGGVKRD 217
SFGVLL E++S + EKLP G + +
Sbjct: 203 SFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME 238
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 50/186 (26%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 42 QIAVKRLKTLNAKAEMEFA---VEVEILGRVRHRNLLGLRGFYAGGDERLI-VYDYMPNH 97
++A+K L+T + E + A E + R+ H N++ L L V++Y+P
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGR 64
Query: 98 SLITHL--HGRLAPDCLLDWHRRV--SIAIGSAEGIA--DIKASNVLL---DTDFEAKVA 148
+L L G L +V ++A +GI D+K N+++ AKV
Sbjct: 65 TLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVL 124
Query: 149 DFGFAKLIPD----GVTHMT--TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
DFG L+P V +T T V GT Y APE V+ + D+Y++G++ LE ++
Sbjct: 125 DFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLT 184
Query: 203 AKKPLE 208
++ ++
Sbjct: 185 GQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 50/179 (27%), Positives = 84/179 (46%), Gaps = 23/179 (12%)
Query: 42 QIAVKRLK-----TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD-YMP 95
++AVK+L ++AK E+ +L ++H N++GL + D Y+
Sbjct: 44 RVAVKKLSRPFQSIIHAKRTYR---ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 100
Query: 96 NHSLITHLHGRLAPDCLLDWHRRVSIA--------IGSAEGI-ADIKASNVLLDTDFEAK 146
H + L+ + L D H + I I SA+ I D+K SN+ ++ D E K
Sbjct: 101 THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELK 160
Query: 147 VADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAM-WGKVSDSCDVYSFGVLLLELISAK 204
+ DFG A+ D MT V T Y APE + W + + D++S G ++ EL++ +
Sbjct: 161 ILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 47/186 (25%), Positives = 87/186 (46%), Gaps = 27/186 (14%)
Query: 43 IAVKRLKTLNAKAEM-EFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
+AVK LK + ++ + E+E++ + +H+N++ L G ++ +Y +L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 101 THLHGRL------------APDCLLDWHRRVSIAIGSAEGIA----------DIKASNVL 138
+L R PD + + VS A G+ D+ A NVL
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169
Query: 139 LDTDFEAKVADFGFAKLIPD-GVTHMTTRVKGTLGYLAPEYAMWGKV-SDSCDVYSFGVL 196
+ + K+ADFG A+ + + TT + + ++APE A++ +V + DV+SFGVL
Sbjct: 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVL 228
Query: 197 LLELIS 202
+ E+ +
Sbjct: 229 MWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 5e-06
Identities = 53/191 (27%), Positives = 79/191 (41%), Gaps = 20/191 (10%)
Query: 31 LLLLRRETGDDQIAVKRLKTLNAKAEMEFA---VEVEILGRVRHRNLLGLRGFYAGGDER 87
++L+R + A+K LK A+ E A E +L RH L L+ + D
Sbjct: 11 VILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRL 70
Query: 88 LIVYDYMPNHSLITHL-HGRLAPDCLLDWHRRVSIAIGSAEGI--------ADIKASNVL 138
V +Y+ L HL R+ + D R I SA D+K N++
Sbjct: 71 CFVMEYVNGGELFFHLSRERVFSE---DRTRFYGAEIVSALDYLHSGKIVYRDLKLENLM 127
Query: 139 LDTDFEAKVADFGFAKLIPDGVTHMTTRVK--GTLGYLAPEYAMWGKVSDSCDVYSFGVL 196
LD D K+ DFG K +G+T T GT YLAPE + D + GV+
Sbjct: 128 LDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 184
Query: 197 LLELISAKKPL 207
+ E++ + P
Sbjct: 185 MYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 25/84 (29%), Positives = 41/84 (48%), Gaps = 9/84 (10%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKL--------IPDGVTHMTTRVKGTLGYLAPEYAMWG 182
D+K N+L+D++ K+ DFG +K+ + D R+ GT Y+APE +
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE-DKRIVGTPDYIAPEVILGQ 176
Query: 183 KVSDSCDVYSFGVLLLELISAKKP 206
S + D +S G +L E + P
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 28/89 (31%), Positives = 42/89 (47%), Gaps = 4/89 (4%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSD-SCD 189
D+K +N+LLD +++D G A H + GT GY+APE G D S D
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSAD 178
Query: 190 VYSFGVLLLELISAKKPLEKLPGGVKRDI 218
+S G +L +L+ P + K +I
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 6e-06
Identities = 29/80 (36%), Positives = 40/80 (50%), Gaps = 1/80 (1%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
DIKA+NVLL + K+ADFG A + D T V GT ++APE D+
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFKADI 184
Query: 191 YSFGVLLLELISAKKPLEKL 210
+S G+ +EL + P L
Sbjct: 185 WSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 6e-06
Identities = 26/80 (32%), Positives = 39/80 (48%), Gaps = 4/80 (5%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSD-SCD 189
D+K +N+LLD +++D G A H + GT GY+APE G D S D
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTAYDSSAD 178
Query: 190 VYSFGVLLLELISAKKPLEK 209
+S G +L +L+ P +
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 6e-06
Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 11/146 (7%)
Query: 71 HRNLLGLRGFYAGGDERLIVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIG--SA 126
H L+GL + V +Y+ L+ H+ +L + + +S+A+
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 114
Query: 127 EGIA--DIKASNVLLDTDFEAKVADFGFAK--LIPDGVTHMTTRVKGTLGYLAPEYAMWG 182
GI D+K NVLLD++ K+ D+G K L P T + GT Y+APE
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRGE 171
Query: 183 KVSDSCDVYSFGVLLLELISAKKPLE 208
S D ++ GVL+ E+++ + P +
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 7e-06
Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 11/143 (7%)
Query: 74 LLGLRGFYAGGDERLIVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIG--SAEGI 129
L+GL + +V +Y+ L+ H+ +L + + + IA+ GI
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGI 117
Query: 130 A--DIKASNVLLDTDFEAKVADFGFAKLIPDGVT--HMTTRVKGTLGYLAPEYAMWGKVS 185
D+K NVLLD D K+ D+G K +G+ T+ GT Y+APE +
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 186 DSCDVYSFGVLLLELISAKKPLE 208
S D ++ GVL+ E+++ + P +
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 7e-06
Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 21/160 (13%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPN---HSLITHLHGRLAPDCLLDWHRR 118
E+ ++ ++H N++ L ++ ++V++YM + TH LD +
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGV-----RGALDPNTV 102
Query: 119 VSIAIGSAEGIA----------DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVK 168
S +GIA D+K N+L++ E K+ADFG A+ V + V
Sbjct: 103 KSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV 162
Query: 169 GTLGYLAPEYAMWGKV-SDSCDVYSFGVLLLELISAKKPL 207
TL Y AP+ + + S S D++S G ++ E+I+ +PL
Sbjct: 163 -TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG-RPL 200
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 8e-06
Identities = 31/83 (37%), Positives = 45/83 (54%), Gaps = 8/83 (9%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAM-WGKVSDSCD 189
D+K SN+L++ + + K+ DFG A+ I D MT V T Y APE + W K D
Sbjct: 133 DLKPSNILINENCDLKICDFGLAR-IQD--PQMTGYVS-TRYYRAPEIMLTWQKYDVEVD 188
Query: 190 VYSFGVLLLELISAKKPLEKLPG 212
++S G + E++ KPL PG
Sbjct: 189 IWSAGCIFAEMLEG-KPL--FPG 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 8e-06
Identities = 61/290 (21%), Positives = 122/290 (42%), Gaps = 39/290 (13%)
Query: 43 IAVKRLKTLNA-KAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+A+K L+ + KA E E ++ V + ++ L G +LI MP L+
Sbjct: 39 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 97
Query: 102 HLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAK 154
++ + LL+W +++ + E D+ A NVL+ T K+ DFG AK
Sbjct: 98 YVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAK 157
Query: 155 LI-PDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPG 212
L+ D + K + ++A E + + DV+S+GV + EL++ KP + +P
Sbjct: 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 217
Query: 213 GVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDV 272
++ ++KG E + P + + +I ++C + ++RP ++
Sbjct: 218 -------SEISSILEKG--ERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFREL 261
Query: 273 VDWLKGGLGRRTKDVKD-----VAGEDDEDNDDNDTDFEERYFKMEQSNI 317
+ +K +D V D+ + + TD M++ ++
Sbjct: 262 I-------IEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDM 304
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 9e-06
Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKL-IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCD 189
D+K NVLLD + K+ D+G K I G T T+ GT Y+APE S D
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVD 178
Query: 190 VYSFGVLLLELISAKKPLE 208
++ GVL+ E+++ + P +
Sbjct: 179 WWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 9e-06
Identities = 50/191 (26%), Positives = 78/191 (40%), Gaps = 21/191 (10%)
Query: 31 LLLLRRETGDDQIAVKRLK---TLNAKAEMEFAVEVEIL-GRVRHRNLLGLRGFYAGGDE 86
+LL + + AVK L+ L K + E +L V+H L+GL + D+
Sbjct: 11 VLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADK 70
Query: 87 RLIVYDYMPNHSLITHLHGRLAPDCLLDWHRR-----VSIAIGSAEGIA----DIKASNV 137
V DY+ L HL + R ++ A+G + D+K N+
Sbjct: 71 LYFVLDYVNGGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENI 127
Query: 138 LLDTDFEAKVADFGFAKLIPDGVTH--MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGV 195
LLD+ + DFG K +G+ H T+ GT YLAPE + D + G
Sbjct: 128 LLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGA 184
Query: 196 LLLELISAKKP 206
+L E++ P
Sbjct: 185 VLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 9e-06
Identities = 44/191 (23%), Positives = 90/191 (47%), Gaps = 11/191 (5%)
Query: 30 LLLLLRRETGDDQIAVKRLKTLNAKAEMEFAV--EVEILGRVRHRNLLGLRGFYAGGDER 87
++L R + + +A+K+ K E++ E+++L ++ N++ L+ + +
Sbjct: 16 VVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKL 75
Query: 88 LIVYDYMPNH--SLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----DIKASNVLLDT 141
+V++Y+ + L+ + + P+ + + ++ AI DIK N+L+
Sbjct: 76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH 135
Query: 142 DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELI 201
+ K+ DFGFA+ + +G T T Y +PE + + D++S G +L EL
Sbjct: 136 NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGEL- 194
Query: 202 SAKKPLEKLPG 212
S +PL PG
Sbjct: 195 SDGQPL--FPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 24/160 (15%)
Query: 62 EVEILGRVRHRNLLGLRG-FYAGGDERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRR 118
E+++L ++G G FY+ G E I ++M SL L GR+ P+ +L +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKKAGRI-PEQILG---K 107
Query: 119 VSIAIGSAEGIA-----------DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRV 167
VSIA+ +G+ D+K SN+L+++ E K+ DFG + + D M
Sbjct: 108 VSIAV--IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF 162
Query: 168 KGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPL 207
GT Y++PE S D++S G+ L+E+ + P+
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 40/140 (28%), Positives = 63/140 (45%), Gaps = 13/140 (9%)
Query: 80 FYAGGDER--LIVYDYMPNHSLITHLHGRLAPDCLLDWHR-RVSIAIGSAEGIA----DI 132
F A D++ +V +YMP L+ + P+ ++ V +A+ + + D+
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDV 168
Query: 133 KASNVLLDTDFEAKVADFGFA-KLIPDGVTHMTTRVKGTLGYLAPEYAMW----GKVSDS 187
K N+LLD K+ADFG K+ G+ T V GT Y++PE G
Sbjct: 169 KPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRE 227
Query: 188 CDVYSFGVLLLELISAKKPL 207
CD +S GV L E++ P
Sbjct: 228 CDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 30/83 (36%), Positives = 46/83 (55%), Gaps = 5/83 (6%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAM-WGKVSDSCD 189
D+K SN+LL+ + + K+ DFG A+ + MT V T Y APE + + + + D
Sbjct: 133 DLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPELLLNCSEYTTAID 191
Query: 190 VYSFGVLLLELISAKKPLEKLPG 212
V+S G + EL+ +KPL PG
Sbjct: 192 VWSVGCIFAELLG-RKPL--FPG 211
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 23/82 (28%), Positives = 45/82 (54%), Gaps = 1/82 (1%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
DI A NVL+ + K+ DFG ++ + D + ++ K + ++APE + + + + DV
Sbjct: 132 DIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDV 191
Query: 191 YSFGVLLLELIS-AKKPLEKLP 211
+ FGV + E++ KP + +
Sbjct: 192 WMFGVCMWEILMLGVKPFQGVK 213
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 44/195 (22%), Positives = 78/195 (40%), Gaps = 40/195 (20%)
Query: 43 IAVKRLKT-LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+AVK LK +A + +F E ++ H N++ L G A G ++++YM L
Sbjct: 38 VAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 97
Query: 102 HLHGR------------------LAPDCLLDWHRRVSIAIGSAEGIA----------DIK 133
L R L ++ IA A G+A D+
Sbjct: 98 FLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157
Query: 134 ASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGT------LGYLAPEYAMWGKVSDS 187
N L+ + K+ADFG ++ I + K + + ++ PE + + +
Sbjct: 158 TRNCLVGENMVVKIADFGLSRNI-----YSADYYKASENDAIPIRWMPPESIFYNRYTTE 212
Query: 188 CDVYSFGVLLLELIS 202
DV+++GV+L E+ S
Sbjct: 213 SDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 60/275 (21%), Positives = 101/275 (36%), Gaps = 33/275 (12%)
Query: 19 QNINNGLEILMLLLLLRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGL 77
I NG +LL R ++ VK L+ + ++ F EV+ + H N+L
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 78 RGFYAGGDERLIVYDYMPNHSLITHL-----HGRLAPDCLLDWHRRVSIAIG-----SAE 127
G L+V ++ P L +L + +A G A+
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 128 GI-ADIKASNVLLDTDFEAKVADFGFA-KLIPDGVTHMTTRVKGTLGYLAPEYA------ 179
I +D+ N L D K+ D+G A + P+ L +LAPE
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQD 180
Query: 180 -MWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237
+ + +++S GV + EL + A +P L + V V + + P
Sbjct: 181 LLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-------EQVLKQVVREQDIKLPKP 233
Query: 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDV 272
+L K++ + M L +PE RPT +V
Sbjct: 234 QLDLKYSDRWYEVMQFCWL-----DPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 52/216 (24%), Positives = 94/216 (43%), Gaps = 52/216 (24%)
Query: 44 AVKRLKTLNAKAE-MEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
A+KR+K +K + +FA E+E+L ++ H N++ L G + +Y P+ +L+
Sbjct: 26 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 85
Query: 102 HL---------------HGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASN 136
L + + L + + A A G+ D+ A N
Sbjct: 86 FLRKSRVLETDPAFAIANSTAST---LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 142
Query: 137 VLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLG-----YLAPEYAMWGKVSDSCDVY 191
+L+ ++ AK+ADFG ++ VK T+G ++A E + + + DV+
Sbjct: 143 ILVGENYVAKIADFGLSR-------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVW 195
Query: 192 SFGVLLLELIS----------AKKPLEKLPGGVKRD 217
S+GVLL E++S + EKLP G + +
Sbjct: 196 SYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 231
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 22/78 (28%), Positives = 33/78 (42%), Gaps = 5/78 (6%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
DIK N+L+D K+ DFG ++ + GT YLAPE + D
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPETILGVGDDKMSDW 176
Query: 191 YSFGVLLLELISAKKPLE 208
+S G ++ E + P
Sbjct: 177 WSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 55/190 (28%), Positives = 80/190 (42%), Gaps = 18/190 (9%)
Query: 31 LLLLRRETGDDQIAVK--RLKTLNAKAEMEFAV-EVEILGRVRHRNLLGLRGFYAGGDER 87
++L+R + A+K R + + AK E+ V E +L RH L L+ + D
Sbjct: 11 VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 70
Query: 88 LIVYDYMPNHSLITHL-HGRLAPDCLLDWHRRVSIAIGSAEGI--------ADIKASNVL 138
V +Y L HL R+ + + R I SA DIK N++
Sbjct: 71 CFVMEYANGGELFFHLSRERVFTE---ERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 127
Query: 139 LDTDFEAKVADFGFAKL-IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLL 197
LD D K+ DFG K I DG T T GT YLAPE + D + GV++
Sbjct: 128 LDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 185
Query: 198 LELISAKKPL 207
E++ + P
Sbjct: 186 YEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-05
Identities = 38/166 (22%), Positives = 76/166 (45%), Gaps = 24/166 (14%)
Query: 73 NLLGLRGFYAGGDERLIVYDYMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGS--AEG 128
N++ L + D +V + L +H+ + +C+ W + +A+ + EG
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREG 105
Query: 129 IA--DIKASNVLLDTDFEAKVADFG-FAKLIP----DGVTHMTTRVKGTLGYLAPEYAMW 181
I D+ +N+LLD ++ F ++++ + V +M Y APE
Sbjct: 106 IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM---------YCAPEVGGI 156
Query: 182 GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKR----DIVQWVT 223
+ +++CD +S G +L EL++ K +E P G+ +I +WV+
Sbjct: 157 SEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVS 202
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 37/214 (17%)
Query: 34 LRRETGDDQIAVKRLKTLNAKAEMEFAV--EVEILGRVRHRNLLGLRG-FYAGGDE---- 86
+ +TG +A+K++ N K E++IL +++H N++ L D+
Sbjct: 28 RQIKTGR-VVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86
Query: 87 RLIVYDYMP--NHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKA 134
R VY P +H L L P L + + EGI DIKA
Sbjct: 87 RGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKA 143
Query: 135 SNVLLDTDFEAKVADFGFAKLI----------PDGVTHMTTRVKGTLGYLAPEYAM-WGK 183
+N+L+D K+ADFG A+ G T T + T Y PE + +
Sbjct: 144 ANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERR 203
Query: 184 VSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRD 217
+ + D++ G + E+ + ++P+ L G D
Sbjct: 204 YTTAVDIWGIGCVFAEMFT-RRPI--LQGKSDID 234
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 41/229 (17%)
Query: 69 VRHRNLLG-LRGFYAGGDERLIVYDYMPNHSLITHLH-GRLAPDCL---LDWHRRVSIAI 123
+ H+N+L L G+ ++Y YM +L L RL L + V +AI
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124
Query: 124 GSAEGIA----------DIKASNVLLDTDFEAKVADFGFAK-LIPDGVTHMTTRVKGTLG 172
A G++ DI A N ++D + + K+ D ++ L P + +
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 173 YLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFE 232
++A E + + S + DV+SFGVLL EL++ + TPYV+ FE
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMTLGQ-----------------TPYVEIDPFE 227
Query: 233 ---HIADP-RLKGKFN-RDQLKSMVLIALRCTDSNPENRPTMTDVVDWL 276
++ D RL N D+L +++ C +PE RP+ + +V L
Sbjct: 228 MAAYLKDGYRLAQPINCPDELFAVMAC---CWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 26/87 (29%), Positives = 46/87 (52%), Gaps = 9/87 (10%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIP----DGVTHMTTRVKGTLGYLAPEYAM-WGKVS 185
D+K SN+L++ D E ++ DFG A+ + + MT V T Y APE + + +
Sbjct: 132 DLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV-ATRWYRAPELLLSLPEYT 190
Query: 186 DSCDVYSFGVLLLELISAKKPLEKLPG 212
+ D++S G + E++ ++ L PG
Sbjct: 191 TAIDMWSVGCIFAEML-GRRQL--FPG 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 10/155 (6%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDER--LIVYDYMPNHSLITHL--HGRLAPDCLLDWHR 117
E+++L +RH ++ G +E+ I +YMP S+ L +G L + + R
Sbjct: 54 EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR 113
Query: 118 RVSIAIGSAEGIA----DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT--TRVKGTL 171
++ + DIK +N+L D+ K+ DFG +K I T V GT
Sbjct: 114 QILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 172 GYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKP 206
+++PE DV+S ++E+++ K P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 54/191 (28%), Positives = 78/191 (40%), Gaps = 19/191 (9%)
Query: 31 LLLLRRETGDDQIAVKRLKTLNAKAEMEFA---VEVEILGRVRHRNLLGLRGFYAGGDER 87
++L++ + A+K LK A+ E A E +L RH L L+ + D
Sbjct: 11 VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 70
Query: 88 LIVYDYMPNHSLITHL-HGRLAPDCLLDWHRRVSIAIGSAEGI---------ADIKASNV 137
V +Y L HL R+ + D R I SA D+K N+
Sbjct: 71 CFVMEYANGGELFFHLSRERVFSE---DRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 127
Query: 138 LLDTDFEAKVADFGFAKL-IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVL 196
+LD D K+ DFG K I DG T T GT YLAPE + D + GV+
Sbjct: 128 MLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 185
Query: 197 LLELISAKKPL 207
+ E++ + P
Sbjct: 186 MYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 39/149 (26%), Positives = 65/149 (43%), Gaps = 22/149 (14%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEY---AMWGKVSD- 186
D+K SNVL++ + + K+ DFG + + D V T G Y+APE + K D
Sbjct: 129 DVKPSNVLINRNGQVKLCDFGISGYLVDSVA--KTIDAGCKPYMAPERINPELNQKGYDV 186
Query: 187 SCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL-KGKFNR 245
DV+S G+ ++EL + + P + W TP+ Q P+L KF+
Sbjct: 187 KSDVWSLGITMIELATGRFPYD-----------SWKTPFQQLKQVVEEPSPQLPAEKFSP 235
Query: 246 DQLKSMVLIALRCTDSNPENRPTMTDVVD 274
+ +C N + RP +++
Sbjct: 236 E----FQDFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 50/195 (25%), Positives = 83/195 (42%), Gaps = 27/195 (13%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFY-----AGGDERL- 88
R Q+A ++ + E E +E+ +L + HRN+ G + G D++L
Sbjct: 36 RHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95
Query: 89 IVYDYMPNHSLITHLHGRLAPDCLL-DWHRRVSIAIGSAEGIA----------DIKASNV 137
+V ++ S +T L + L DW + I G+A DIK NV
Sbjct: 96 LVMEFCGAGS-VTDLVKNTKGNALKEDWIAYICREI--LRGLAHLHAHKVIHRDIKGQNV 152
Query: 138 LLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSC-----DVYS 192
LL + E K+ DFG + + V T + GT ++APE + D+ D++S
Sbjct: 153 LLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDYRSDIWS 211
Query: 193 FGVLLLELISAKKPL 207
G+ +E+ PL
Sbjct: 212 LGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 60/262 (22%), Positives = 110/262 (41%), Gaps = 35/262 (13%)
Query: 26 EILMLLLLLRRETGDDQIAVKRLK---TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYA 82
E+ LL R+ +A+K+++ ++AKA + E+++L ++ H N++ +
Sbjct: 17 EVYRATCLLDRKP----VALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72
Query: 83 GGDERLIVYDYMPNHSL---ITHL--HGRLAPDCLLDWHRRVSIAIGSAEGI-------A 130
+E IV + L I + RL P+ + W V + + E +
Sbjct: 73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV-WKYFVQLC-SAVEHMHSRRVMHR 130
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
DIK +NV + K+ D G + T + V GT Y++PE + D+
Sbjct: 131 DIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDI 189
Query: 191 YSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKS 250
+S G LL E+ + + P G K ++ QK E P L + ++L+
Sbjct: 190 WSLGCLLYEMAALQSPFY----GDKMNLFS----LCQK--IEQCDYPPLPTEHYSEKLRE 239
Query: 251 MVLIALRCTDSNPENRPTMTDV 272
+V + C +P+ RP + V
Sbjct: 240 LVSM---CIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 4e-05
Identities = 40/178 (22%), Positives = 68/178 (38%), Gaps = 44/178 (24%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSD---- 186
D+K +NVL++ + + K+ DFG + + V + G Y+APE G +
Sbjct: 128 DVKPTNVLVNGNGQVKLCDFGVSGNL---VASLAKTNIGCQSYMAPERIKSGGPNQNPTY 184
Query: 187 --SCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244
DV+S G+ +LE+ + P P +I + Q A P L ++
Sbjct: 185 TVQSDVWSLGLSILEMALGRYP---YPPETYANI------FAQLSAIVDGDPPTLPSGYS 235
Query: 245 ---RDQLKSMVLIALRCTDSNPENRPTM----------------TDVVDWLKGGLGRR 283
+D + C + P RPT D+ +W+ G L R+
Sbjct: 236 DDAQDFVAK-------CLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWVTGALKRK 286
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 37/123 (30%), Positives = 55/123 (44%), Gaps = 6/123 (4%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
D+K N+LLD + DFG KL T GT YLAPE + + + D
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176
Query: 191 YSFGVLLLELISAKKPL--EKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQL 248
++ GVLL E+++ P E + + R I+Q P F+ A L G +RD
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVN-EMYRKILQ--EPLRFPDGFDRDAKDLLIGLLSRDPT 233
Query: 249 KSM 251
+ +
Sbjct: 234 RRL 236
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 30/76 (39%), Positives = 44/76 (57%), Gaps = 7/76 (9%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLI---PDGVTHMTTRVKGTLGYLAPEYAMWGKV-SD 186
D+ A N+LL + K+ DFG A+ I PD V R+ L ++APE ++ +V +
Sbjct: 204 DLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP--LKWMAPE-TIFDRVYTI 260
Query: 187 SCDVYSFGVLLLELIS 202
DV+SFGVLL E+ S
Sbjct: 261 QSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 51/178 (28%), Positives = 77/178 (43%), Gaps = 16/178 (8%)
Query: 44 AVKRL--KTLNAKAEMEFAV-EVEILGRVRHRN---LLGLRGFYAGGDERLIVYDYMPNH 97
A+K L K + AK E+ + E IL R ++GL+ + + +V DYM
Sbjct: 22 AMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGG 81
Query: 98 SLITHLH--GRLAPDCLLDWHRRVSIAIGSAEG----IADIKASNVLLDTDFEAKVADFG 151
L HL GR + D + + +A+ D+K N+LLD + DFG
Sbjct: 82 ELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFG 141
Query: 152 FAKLIPDGVTHMTTRV-KGTLGYLAPEYAMWGK-VSDSCDVYSFGVLLLELISAKKPL 207
+K + + TT GT YLAPE + K + D +S GVL+ E+ P
Sbjct: 142 LSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 32/82 (39%), Positives = 43/82 (52%), Gaps = 11/82 (13%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKL--IPDGV-THMTTRVKGTLGYLAPEYAMWGKVSDS 187
D+K N+L+D K+ADFG A+ IP V TH TL Y APE + G S
Sbjct: 126 DLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV----TLWYRAPEVLL-GSPRYS 180
Query: 188 C--DVYSFGVLLLELISAKKPL 207
D++S G + E+ + KKPL
Sbjct: 181 TPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 26/77 (33%), Positives = 40/77 (51%), Gaps = 4/77 (5%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
D+K N+LLD D K+ DFGFAK+ V T + GT Y+APE + + D
Sbjct: 156 DLKPENLLLDKDGFIKMTDFGFAKV----VDTRTYTLCGTPEYIAPEILLNVGHGKAADW 211
Query: 191 YSFGVLLLELISAKKPL 207
++ G+ + E++ P
Sbjct: 212 WTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 7e-05
Identities = 42/139 (30%), Positives = 63/139 (45%), Gaps = 34/139 (24%)
Query: 90 VYDYMPNHSLITHLHGRLAPDCLLDWHRR-------VSIA-IGSAEGI-ADIKASNVLLD 140
V++YM T LH + + L D H+R ++ I S I D+K SN+LL+
Sbjct: 87 VFEYME-----TDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN 141
Query: 141 TDFEAKVADFGFAKLI-----PDGVTHMTTRVKGTLGYLAPE-------YAMWGKVSDSC 188
+D K+ADFG A+ + +T V T Y APE Y +
Sbjct: 142 SDCRVKLADFGLARSLSELEENPENPVLTDYV-ATRWYRAPEILLGSTRY------TKGV 194
Query: 189 DVYSFGVLLLELISAKKPL 207
D++S G +L E++ KPL
Sbjct: 195 DMWSVGCILGEMLLG-KPL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 7e-05
Identities = 26/75 (34%), Positives = 42/75 (56%), Gaps = 2/75 (2%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKV-SDSCD 189
D+K N+L++T+ K+ADFG A+ V T V TL Y APE + K S + D
Sbjct: 125 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVD 183
Query: 190 VYSFGVLLLELISAK 204
++S G + E+++ +
Sbjct: 184 IWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 23/76 (30%), Positives = 34/76 (44%), Gaps = 4/76 (5%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
D+K N L+D K+ DFG +K G+ V G+ Y+APE + D
Sbjct: 126 DLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRGKGYDFTVDY 181
Query: 191 YSFGVLLLELISAKKP 206
+S G +L E + P
Sbjct: 182 WSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 27/75 (36%), Positives = 41/75 (54%), Gaps = 5/75 (6%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAM-WGKVSDSCD 189
D+K SNV ++ D E ++ DFG A+ D MT V T Y APE + W + + D
Sbjct: 143 DLKPSNVAVNEDCELRILDFGLARQADD---EMTGYV-ATRWYRAPEIMLNWMHYNQTVD 198
Query: 190 VYSFGVLLLELISAK 204
++S G ++ EL+ K
Sbjct: 199 IWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 9e-05
Identities = 39/161 (24%), Positives = 71/161 (44%), Gaps = 22/161 (13%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERL--IVYDYMPNHSLITHL--HGRLAPDCLLDWHR 117
E+++L + H ++ G ER I ++MP S+ L +G L + + R
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR 113
Query: 118 RVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT--T 165
++ EG++ DIK +N+L D+ K+ DFG +K + T
Sbjct: 114 QI------LEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK 167
Query: 166 RVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKP 206
V GT +++PE D++S G ++E+++ K P
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 9e-05
Identities = 50/192 (26%), Positives = 86/192 (44%), Gaps = 29/192 (15%)
Query: 43 IAVKR--LKTLNA-KAEMEFAV---EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPN 96
IAVK+ L T N AE E+ EV++L ++H N++ G + I +++P
Sbjct: 27 IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPG 86
Query: 97 HSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFE 144
S+ + L+ G L + +++ +G+A DIK +NV+L +
Sbjct: 87 GSISSILNRFGPLPEPVFCKYTKQI------LDGVAYLHNNCVVHRDIKGNNVMLMPNGI 140
Query: 145 AKVADFGFAK---LIPDGVTH--MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLE 199
K+ DFG A+ + TH M + GT ++APE D++S G + E
Sbjct: 141 IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFE 200
Query: 200 LISAKKPLEKLP 211
+ + K PL +
Sbjct: 201 MATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 29/83 (34%), Positives = 44/83 (53%), Gaps = 4/83 (4%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSD-SCD 189
D+K N+L++ + E K+ADFG A+ V + V TL Y P+ K+ S D
Sbjct: 124 DLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSID 182
Query: 190 VYSFGVLLLELISAKKPLEKLPG 212
++S G + EL +A +PL PG
Sbjct: 183 MWSAGCIFAELANAGRPL--FPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 61/256 (23%), Positives = 106/256 (41%), Gaps = 36/256 (14%)
Query: 42 QIAVKRLK-TLNAKAEME-FAVEVEILGRVRHRNLLGLRGFYAGGDER------LIVYDY 93
++AVK +K ++ +E+E F E + H N++ L G +++ +
Sbjct: 29 KVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPF 88
Query: 94 MPNHSLITHL-HGRLAPDCL-LDWHRRVSIAIGSAEGIA----------DIKASNVLLDT 141
M + L + L + RL L + + A G+ D+ A N +L
Sbjct: 89 MKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRE 148
Query: 142 DFEAKVADFGFAKLIPDGVTHMTTRV-KGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLEL 200
D VADFG +K I G + R+ K + ++A E + DV++FGV + E+
Sbjct: 149 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 208
Query: 201 ISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTD 260
A + PG +I Y++ G RLK D L + + C
Sbjct: 209 --ATRGQTPYPGVENHEIYD----YLRHGN-------RLKQP--EDCLDELYDLMYSCWR 253
Query: 261 SNPENRPTMTDVVDWL 276
++P++RPT T + + L
Sbjct: 254 ADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 27/78 (34%), Positives = 42/78 (53%), Gaps = 5/78 (6%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT-TRVKGTLGYLAPEYAMWGKVSDSCD 189
D+K N+L+ +D + K+ADFG A++ M T V TL Y APE + + D
Sbjct: 132 DLKPQNILVTSDGQVKIADFGLARIYSF---EMALTSVVVTLWYRAPEVLLQSSYATPVD 188
Query: 190 VYSFGVLLLELISAKKPL 207
++S G + EL ++PL
Sbjct: 189 MWSVGCIFAELFR-RRPL 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 50/222 (22%), Positives = 78/222 (35%), Gaps = 57/222 (25%)
Query: 33 LLRRETGDDQIAVKRLKTLNAKAEM-------EFAVEVEILGRVRHRNLLGLRGFYAGGD 85
L+R + A+K L+ K++M E +IL ++ L +Y+ D
Sbjct: 19 LVRDKDTGQVYAMKVLR----KSDMIKRNQIAHVRAERDILADADSPWIVKL--YYSFQD 72
Query: 86 ER--LIVYDYMPNHSLITHL--HGRLAPDCLLDWHR----RVSIAIGSAEGIA----DIK 133
E +V +YMP L+ L + R + +A+ S + DIK
Sbjct: 73 EEHLYLVMEYMPGGDLMNLLIRKDVFPEE----TARFYIAELVLALDSVHKLGFIHRDIK 128
Query: 134 ASNVLLDTDFEAKVADFGFAKLIPDG----------------------------VTHMTT 165
N+L+D D K+ADFG K +
Sbjct: 129 PDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRAN 188
Query: 166 RVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPL 207
GT Y+APE CD +S GV+L E++ P
Sbjct: 189 STVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 27/82 (32%), Positives = 40/82 (48%), Gaps = 6/82 (7%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDS--- 187
D+K +N+LL T+ K+ DFG + + T V GT ++APE + D
Sbjct: 153 DVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQYDYSYD 211
Query: 188 --CDVYSFGVLLLELISAKKPL 207
CDV+S G+ +EL PL
Sbjct: 212 ARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 33/204 (16%)
Query: 48 LKTLNAKAEM----EFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHL 103
+KTL KAE EF E + R++H N++ L G +++ Y + L L
Sbjct: 40 IKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFL 99
Query: 104 HGR------------------LAPDCLLDWHRRVSIAIG----SAEGIA--DIKASNVLL 139
R L P + H IA G S+ + D+ NVL+
Sbjct: 100 VMRSPHSDVGSTDDDKTVKSTLEPADFV--HIVTQIAAGMEFLSSHHVVHKDLATRNVLV 157
Query: 140 DTDFEAKVADFG-FAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLL 198
K++D G F ++ + + +++PE M+GK S D++S+GV+L
Sbjct: 158 FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLW 217
Query: 199 ELISAKKPLEKLPGGVKRDIVQWV 222
E+ S L+ G +D+++ +
Sbjct: 218 EVFSYG--LQPYCGYSNQDVIEMI 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 27/86 (31%), Positives = 42/86 (48%), Gaps = 6/86 (6%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDS--- 187
DIK N+LL + E K+ DFG + + + T + GT ++APE + D+
Sbjct: 138 DIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAPEVIACDEQPDASYD 196
Query: 188 --CDVYSFGVLLLELISAKKPLEKLP 211
DV+S G+ +EL K PL +
Sbjct: 197 ARSDVWSLGITAIELADGKPPLCDMH 222
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 29/85 (34%), Positives = 42/85 (49%), Gaps = 6/85 (7%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDS--- 187
D+K +N+LL T+ K+ DFG + + T V GT ++APE + DS
Sbjct: 149 DVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQLDSTYD 207
Query: 188 --CDVYSFGVLLLELISAKKPLEKL 210
CDV+S G+ +EL PL L
Sbjct: 208 ARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 34/154 (22%), Positives = 62/154 (40%), Gaps = 33/154 (21%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLI-------------PDGVTH--MTT--RVKGTLGY 173
D+K N+LL E + D+G A + + MT ++ GT Y
Sbjct: 138 DLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDY 197
Query: 174 LAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEH 233
+APE + S+S D+Y+ GV+L ++++ P + G +K ++
Sbjct: 198 MAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG--------------RKISYRD 243
Query: 234 -IADPRLKGKFNRDQLKSMVLIALRCTDSNPENR 266
I P + R+ + IA++ +P R
Sbjct: 244 VILSPIEVAPY-REIPPFLSQIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 25/77 (32%), Positives = 40/77 (51%), Gaps = 3/77 (3%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
D+K N+L+ + + K+ADFG A++ T V TL Y APE + + D+
Sbjct: 135 DLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEVLLQSSYATPVDL 192
Query: 191 YSFGVLLLELISAKKPL 207
+S G + E+ +KPL
Sbjct: 193 WSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 7/79 (8%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGT----LGYLAPEYAMWGKVSD 186
D+ A NVLL AK+ DFG A+ I + ++ VKG + ++APE +
Sbjct: 237 DVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTV 293
Query: 187 SCDVYSFGVLLLELISAKK 205
DV+S+G+LL E+ S K
Sbjct: 294 QSDVWSYGILLWEIFSLGK 312
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 11/86 (12%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKL--IP-DGVTHMTTRVKGTLGYLAPEYAMWGK-VSD 186
D+K N+L+D + K+ADFG A+ +P TH TL Y APE + + S
Sbjct: 124 DLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEILLGSRQYST 179
Query: 187 SCDVYSFGVLLLELISAKKPLEKLPG 212
D++S G + E+++ ++PL PG
Sbjct: 180 PVDIWSIGCIFAEMVN-RRPL--FPG 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 23/74 (31%), Positives = 40/74 (54%), Gaps = 2/74 (2%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
D+K SN+++ +D K+ DFG A+ G + M T T Y APE + ++ D+
Sbjct: 144 DLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 201
Query: 191 YSFGVLLLELISAK 204
+S G ++ E++ K
Sbjct: 202 WSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 56/246 (22%), Positives = 106/246 (43%), Gaps = 29/246 (11%)
Query: 43 IAVKRLKT---LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSL 99
+A+K+++ ++AKA + E+++L ++ H N++ + +E IV + L
Sbjct: 30 VALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDL 89
Query: 100 ---ITHL--HGRLAPDCLLDWHRRVSIAIGSAEGIA------DIKASNVLLDTDFEAKVA 148
I H RL P+ + W V + + DIK +NV + K+
Sbjct: 90 SRMIKHFKKQKRLIPERTI-WKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLG 148
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLE 208
D G + T + V GT Y++PE + D++S G LL E+ + + P
Sbjct: 149 DLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207
Query: 209 KLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPT 268
G K ++ + ++K + P L ++L+ +V RC + +PE RP
Sbjct: 208 ----GDKMNLYS-LCKKIEKCDY-----PPLPADHYSEELRDLV---SRCINPDPEKRPD 254
Query: 269 MTDVVD 274
++ V+
Sbjct: 255 ISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 26/78 (33%), Positives = 41/78 (52%), Gaps = 5/78 (6%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT-TRVKGTLGYLAPEYAMWGKVSDSCD 189
D+K N+L+ + + K+ADFG A++ M T V TL Y APE + + D
Sbjct: 133 DLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWYRAPEVLLQSTYATPVD 189
Query: 190 VYSFGVLLLELISAKKPL 207
++S G + E+ +KPL
Sbjct: 190 MWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 8/93 (8%)
Query: 123 IGSAEGI-ADIKASNVLLDTDFEAKVADFGFAKLIPDG----VTHMTTRVKGTLGYLAPE 177
I SA + D+K N+L++ D E K+ DFG A+ + MT V T Y APE
Sbjct: 121 IHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-ATRWYRAPE 179
Query: 178 YAM-WGKVSDSCDVYSFGVLLLELISAKKPLEK 209
+ + + + DV+S G +L EL+ +KP+ K
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELL-GRKPVFK 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 4e-04
Identities = 26/85 (30%), Positives = 42/85 (49%), Gaps = 6/85 (7%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSD---- 186
D+KA N+L D + K+ADFG + + + + GT ++APE M D
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYD 186
Query: 187 -SCDVYSFGVLLLELISAKKPLEKL 210
DV+S G+ L+E+ + P +L
Sbjct: 187 YKADVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 65/286 (22%), Positives = 114/286 (39%), Gaps = 65/286 (22%)
Query: 39 GDDQIAVKRLKTLNAKAE-MEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNH 97
G +AVK LK + +E + E +L +V H +++ L G + L++ +Y
Sbjct: 29 GYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYG 88
Query: 98 SLITHLH--GRLAPDCLLDWHRR------------------VSIAIGSAEGIA------- 130
SL + L ++ P L R +S A + G+
Sbjct: 89 SLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKL 148
Query: 131 ---DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTL--GYLAPEYAMWGKVS 185
D+ A NVL+ + K++DFG ++ + + +++ R KG + ++A E +
Sbjct: 149 VHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK-RSKGRIPVKWMAIESLFDHIYT 207
Query: 186 DSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR----LKG 241
DV+SFGVLL E+++ GG PY IA R LK
Sbjct: 208 TQSDVWSFGVLLWEIVTL--------GG---------NPY------PGIAPERLFNLLKT 244
Query: 242 KFNRDQ----LKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGRR 283
+ ++ + M + L C P+ RPT D+ L+ + +
Sbjct: 245 GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 23/74 (31%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
D+K SN+++ +D K+ DFG A+ G + M T T Y APE + ++ D+
Sbjct: 151 DLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 191 YSFGVLLLELISAK 204
+S G ++ E+I
Sbjct: 209 WSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 7e-04
Identities = 39/149 (26%), Positives = 62/149 (41%), Gaps = 23/149 (15%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGT----LGYLAPEYAMWGKVSD 186
D+ A N+LL K+ DFG A+ I + ++ VKG + ++APE +
Sbjct: 239 DLAARNILLTHGRITKICDFGLARDIRNDSNYV---VKGNARLPVKWMAPESIFNCVYTF 295
Query: 187 SCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNR 245
DV+S+G+LL E+ S P +P V + + + + E A
Sbjct: 296 ESDVWSYGILLWEIFSLGSSPYPGMP--VDSKFYKMIKEGYRMLSPEC-APSE------- 345
Query: 246 DQLKSMVLIALRCTDSNPENRPTMTDVVD 274
M I C D++P RPT +V
Sbjct: 346 -----MYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 43/177 (24%), Positives = 76/177 (42%), Gaps = 35/177 (19%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPN---HSLITHLHGRLAPDCLLDWHRR 118
E+ +L +++H NL+ L + + +V++Y + + L + G + H
Sbjct: 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-------VPEHLI 102
Query: 119 VSIAIGSAEGIA----------DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVK 168
I + + + D+K N+L+ + K+ DFGFA+++ T V
Sbjct: 103 KKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV- 161
Query: 169 GTLGYLAPEYAMWGKVSD-----SCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQ 220
T Y APE V D DV++ G + EL++ +PL PG K D+ Q
Sbjct: 162 ATRWYRAPELL----VGDTQYGPPVDVWAIGCVFAELLTG-QPL--WPG--KSDVDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.001
Identities = 26/82 (31%), Positives = 40/82 (48%), Gaps = 6/82 (7%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSC-- 188
DIK NVLL + E K+ DFG + + V T + GT ++APE + D+
Sbjct: 136 DIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYD 194
Query: 189 ---DVYSFGVLLLELISAKKPL 207
D++S G+ +E+ PL
Sbjct: 195 FKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 56/241 (23%), Positives = 102/241 (42%), Gaps = 59/241 (24%)
Query: 32 LLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HRNLLG-------LRGFYAG 83
L+ +++TG V +K L KA+M +E E +G +R R++L ++ FY+
Sbjct: 19 LVQKKDTGH----VYAMKILR-KADM---LEKEQVGHIRAERDILVEADSLWVVKMFYSF 70
Query: 84 GDER--LIVYDYMPNHSLITHLHGR--LAPDCLLDWHRRVSIAIGSAEGIA----DIKAS 135
D+ ++ +++P ++T L + L + + +AI S + DIK
Sbjct: 71 QDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPD 130
Query: 136 NVLLDTDFEAKVADFGFAK----------------LIPDGVT--HMTTRVK--------- 168
N+LLD+ K++DFG +P T +M ++ K
Sbjct: 131 NLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRR 190
Query: 169 -------GTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPL-EKLPGGVKRDIVQ 220
GT Y+APE M + CD +S GV++ E++ P + P + ++
Sbjct: 191 QLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMN 250
Query: 221 W 221
W
Sbjct: 251 W 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 22/71 (30%), Positives = 37/71 (52%), Gaps = 2/71 (2%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
D+K SN+++ +D K+ DFG A+ M T T Y APE + ++ D+
Sbjct: 148 DLKPSNIVVKSDCTLKILDFGLARTA--CTNFMMTPYVVTRYYRAPEVILGMGYKENVDI 205
Query: 191 YSFGVLLLELI 201
+S G ++ EL+
Sbjct: 206 WSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 31/134 (23%), Positives = 46/134 (34%), Gaps = 43/134 (32%)
Query: 131 DIKASNVLLDTDFEAKVADFGF-----------------------------------AKL 155
DIK N+L+D D K+ DFG +L
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRL 185
Query: 156 IPDGVTHMT--TRVK-----GTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKP-L 207
P R GT Y+APE + + CD +S GV+L E++ + P L
Sbjct: 186 KPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFL 245
Query: 208 EKLPGGVKRDIVQW 221
P + ++ W
Sbjct: 246 ADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 42/185 (22%), Positives = 75/185 (40%), Gaps = 43/185 (23%)
Query: 80 FYAGGDER--LIVYDYMPNHSLITHLHGR--LAPDCLLDWHRRVSIAIGSAEGIA----D 131
FY+ D+R ++ +++P ++T L + L+ + + +AI + + D
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRD 126
Query: 132 IKASNVLLDTDFEAKVADFGFAKLIPDG--------VTH----------MTTRVK----- 168
IK N+LLD K++DFG + +TH M ++ K
Sbjct: 127 IKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWK 186
Query: 169 -----------GTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPL-EKLPGGVKR 216
GT Y+APE M + CD +S GV++ E++ P + P R
Sbjct: 187 KNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYR 246
Query: 217 DIVQW 221
++ W
Sbjct: 247 KVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 15/87 (17%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSC-- 188
D+K SN+LLD + K+ DFG + + D + TR G Y+APE ++ S
Sbjct: 133 DVKPSNILLDRNGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPE-----RIDPSARD 185
Query: 189 ------DVYSFGVLLLELISAKKPLEK 209
DV+S G+ L E+ + K P K
Sbjct: 186 GYDVRSDVWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 32/142 (22%), Positives = 58/142 (40%), Gaps = 17/142 (11%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
D+ +N++L D + + DFG AK T V GT+ Y PE + DV
Sbjct: 139 DLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADV 196
Query: 191 YSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKS 250
++FG +L ++ + + P +++ T V E + +P L + +
Sbjct: 197 WAFGCILYQMCTLQPPF------YSTNMLSLATKIV-----EAVYEP-LPEGMYSEDVTD 244
Query: 251 MVLIALRCTDSNPENRPTMTDV 272
++ C + E RP + V
Sbjct: 245 VI---TSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 51/234 (21%), Positives = 87/234 (37%), Gaps = 56/234 (23%)
Query: 44 AVKRLK---TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
A+K L+ LN E +IL + ++ L + D V DY+P ++
Sbjct: 30 AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89
Query: 101 THL-HGRLAPDCLLDWH-RRVSIAIGSAEGIA----DIKASNVLLDTDFEAKVADFGFA- 153
+ L + P+ L ++ +++AI S + DIK N+L+D D K+ DFG
Sbjct: 90 SLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCT 149
Query: 154 --------------------KLIP-------------DGVTHMTTRVK------------ 168
+ P D + + R
Sbjct: 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLV 209
Query: 169 GTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKP-LEKLPGGVKRDIVQW 221
GT Y+APE + + CD +S GV+L E++ + P L P + ++ W
Sbjct: 210 GTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 18/160 (11%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERL-------IVYDYMPNHSLITHLHGRLAPDCL-- 112
E+ +L ++H N++GL + D L +V +M H +L+ D +
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTP-DLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF 122
Query: 113 LDWHRRVSIAIGSAEGIA--DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGT 170
L + + A GI D+K N+ ++ D E K+ DFG A+ + MT V T
Sbjct: 123 LVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVV-T 178
Query: 171 LGYLAPEYAM-WGKVSDSCDVYSFGVLLLELISAKKPLEK 209
Y APE + W + + D++S G ++ E+++ KPL K
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPLFK 217
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.002
Identities = 20/51 (39%), Positives = 26/51 (50%), Gaps = 5/51 (9%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIP----DGVTHMTTRVKGTLGYLAPE 177
D+KA+N+L+ D K+ADFG A+ T RV TL Y PE
Sbjct: 144 DMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 26/154 (16%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGT----LGYLAPEYAMWGKVSD 186
D+ A NVLL K+ DFG A+ I +++ KG+ + ++APE +
Sbjct: 262 DLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KGSTFLPVKWMAPESIFDNLYTT 318
Query: 187 SCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRD 246
DV+S+G+LL E+ S L G ++ T Y + + +A P D
Sbjct: 319 LSDVWSYGILLWEIFS-------LGGTPYPGMIVDSTFYNKIKSGYRMAKP--------D 363
Query: 247 QLKSMVL-IALRCTDSNPENRPT---MTDVVDWL 276
V I ++C +S PE RP+ ++D+V+ L
Sbjct: 364 HATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 24/75 (32%), Positives = 40/75 (53%), Gaps = 5/75 (6%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAM-WGKVSDSCD 189
D+K N+ ++ D E K+ DFG A+ MT V T Y APE + W + + D
Sbjct: 142 DLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV-TRWYRAPEVILNWMHYNQTVD 197
Query: 190 VYSFGVLLLELISAK 204
++S G ++ E+++ K
Sbjct: 198 IWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 28/86 (32%), Positives = 46/86 (53%), Gaps = 7/86 (8%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKL-IPDGVTHMT-TRVKGTLGYLAPEY--AMWGKVSD 186
D+K N+L + D + K+ DFG A++ D T + T T Y APE + + K +
Sbjct: 128 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP 187
Query: 187 SCDVYSFGVLLLELISAKKPLEKLPG 212
+ D++S G + E+++ KPL PG
Sbjct: 188 AIDIWSIGCIFAEVLTG-KPL--FPG 210
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 23/71 (32%), Positives = 39/71 (54%), Gaps = 2/71 (2%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
D+K SN+++ +D K+ DFG A+ G + M T T Y APE + ++ D+
Sbjct: 143 DLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 200
Query: 191 YSFGVLLLELI 201
+S G ++ E+I
Sbjct: 201 WSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 325 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.7 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.69 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.67 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.66 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.62 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.58 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.54 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.54 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.47 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.46 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.34 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.33 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.32 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.17 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.13 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.04 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.03 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.01 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.98 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.97 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.6 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.57 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.5 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.37 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.26 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.18 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.11 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.05 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.01 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 97.94 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 97.81 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.77 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.57 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.56 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.53 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.53 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.37 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.17 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.16 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.05 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.96 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 96.84 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.62 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.61 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.36 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.32 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.28 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 95.97 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 95.93 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.84 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 95.8 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 95.5 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 94.51 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 94.38 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 93.92 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 93.03 | |
| PLN02236 | 344 | choline kinase | 92.85 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 92.13 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 91.74 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 91.65 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 91.28 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 91.09 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 90.95 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 89.44 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 88.62 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 87.62 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 86.66 | |
| smart00146 | 202 | PI3Kc Phosphoinositide 3-kinase, catalytic domain. | 84.39 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 84.18 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 84.01 | |
| cd05168 | 293 | PI4Kc_III_beta Phosphoinositide 4-kinase (PI4K), T | 82.04 | |
| cd00142 | 219 | PI3Kc_like Phosphoinositide 3-kinase (PI3K)-like f | 81.65 | |
| cd05170 | 307 | PIKKc_SMG1 Suppressor of morphogenetic effect on g | 81.47 | |
| cd00893 | 289 | PI4Kc_III Phosphoinositide 4-kinase (PI4K), Type I | 80.83 | |
| cd05164 | 222 | PIKKc Phosphoinositide 3-kinase-related protein ki | 80.77 | |
| cd00892 | 237 | PIKKc_ATR ATR (Ataxia telangiectasia and Rad3-rela | 80.46 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 80.41 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 80.36 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=337.60 Aligned_cols=251 Identities=22% Similarity=0.309 Sum_probs=210.7
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecc-cChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC-eEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKT-LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD-ERLIVY 91 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lV~ 91 (325)
....++.||+| ..+.|++++|+.+++.+|+|.+.. .++...+++.+|+++++.++|||||.+||+|..+. .++|+|
T Consensus 80 dle~~~~lG~G--~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 80 DLERLGVLGSG--NGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HhhhhhhcccC--CCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 56778899999 555599999999999999999953 35677789999999999999999999999999988 599999
Q ss_pred EecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhh-----cCCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 92 DYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEG-----IADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 92 e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~-----~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|||.+|||.++++ ++.++...-.++.++..++.|+|. ||||||+|+|++..|.+||||||.++.+.+. ..
T Consensus 158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a 234 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IA 234 (364)
T ss_pred hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hc
Confidence 9999999999996 567888888899999999999996 4899999999999999999999999987664 56
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
.++.||..|||||.+.+..|+.++||||||++++|+++|++||... ..........+.. +. .+.++..+
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~-~~~~~~~~~Ll~~---------Iv-~~ppP~lP 303 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP-NPPYLDIFELLCA---------IV-DEPPPRLP 303 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc-CCCCCCHHHHHHH---------Hh-cCCCCCCC
Confidence 6788999999999999999999999999999999999999999764 1111111111111 11 11123344
Q ss_pred H-HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 245 R-DQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 245 ~-~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
. .+++++.+++..||++||.+|||++++++ |++...
T Consensus 304 ~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 304 EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred cccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 4 48999999999999999999999999998 887543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=341.32 Aligned_cols=254 Identities=22% Similarity=0.352 Sum_probs=209.6
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh-------hhHHHHHHHHHHHHccCCCCccceeeEEEc
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA-------KAEMEFAVEVEILGRVRHRNLLGLRGFYAG 83 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (325)
+..-|.+.+.+|+| +++.|-++..+.++++||||++++... .....+.+|+++|++|+|||||+++++|..
T Consensus 170 ~~d~yii~~~LGsG--afg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSG--AFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred hcceeEeeeeecCC--ceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 56677888999999 888899999999999999999964211 122346789999999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhhh--ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC---CceEEeeecccc
Q 046728 84 GDERLIVYDYMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD---FEAKVADFGFAK 154 (325)
Q Consensus 84 ~~~~~lV~e~~~~gsL~~~l--~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~---~~~kL~Dfg~~~ 154 (325)
.+..|+||||++||+|.+++ ++.+.+.....+++|+..|+.|+|.. |||||+|||++.+ ..+||+|||+|+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999999999999 56677888899999999999999975 8999999999866 779999999999
Q ss_pred ccCCCcceeeccCCCCcCCCCccccccCC---CCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccc
Q 046728 155 LIPDGVTHMTTRVKGTLGYLAPEYAMWGK---VSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAF 231 (325)
Q Consensus 155 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (325)
..+.. ....+.+||+.|.|||++.+.. +..++||||+||+||-+++|.+||.+...... +..++..+.+
T Consensus 328 ~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s------l~eQI~~G~y 399 (475)
T KOG0615|consen 328 VSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS------LKEQILKGRY 399 (475)
T ss_pred ccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc------HHHHHhcCcc
Confidence 87754 3355678999999999998764 34588999999999999999999986543210 0111222222
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 232 EHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
.. -++.+...+++..+||.+||..||++|||++++++ ||+...
T Consensus 400 ~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 400 AF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred cc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 21 23556789999999999999999999999999999 998543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-49 Score=323.74 Aligned_cols=248 Identities=18% Similarity=0.297 Sum_probs=206.5
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEec--ccChhhHHHHHHHHHHHHccCCCCccceee-EEEcCCe-EE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRG-FYAGGDE-RL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~-~~~~~~~-~~ 88 (325)
..|.+.++||.| +|+.||++.+..+|..||.|.++ ..+....+....|+.+|++|+|||||++++ .|..+.+ ++
T Consensus 19 ~~y~Il~~IG~G--sFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 19 ADYQILKKIGRG--SFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHcCC--cchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 348999999999 78889999999999999999886 335666678889999999999999999999 4555555 88
Q ss_pred EEEEecCCCChhhhh------ccCCCCCCccCHHHHHHHHHHHHhh--------cCCCCCCceeeCCCCceEEeeecccc
Q 046728 89 IVYDYMPNHSLITHL------HGRLAPDCLLDWHRRVSIAIGSAEG--------IADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 89 lV~e~~~~gsL~~~l------~~~~~~~~~~~~~~~~~~~~~~~~~--------~rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
||||||.+|||.+.| +..++++.++.++.|+..|+...|. ||||||.||+++.+|.+||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 999999999999999 3568889999999999999999998 38999999999999999999999999
Q ss_pred ccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccc
Q 046728 155 LIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHI 234 (325)
Q Consensus 155 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (325)
.+...... ....+||+.||+||++...+|+.+|||||+||++|||+.-++||.+.. ..+. ...+..
T Consensus 177 ~l~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~L-~~KI~q------ 242 (375)
T KOG0591|consen 177 FLSSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLSL-CKKIEQ------ 242 (375)
T ss_pred HhcchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHHH-HHHHHc------
Confidence 87765443 445679999999999999999999999999999999999999998642 1111 111111
Q ss_pred cCccccCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 235 ADPRLKGKFN-RDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 235 ~~~~~~~~~~-~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
... ++.| ...+..+.+||..|+..||+.||+...++..+..-
T Consensus 243 --gd~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 243 --GDY-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred --CCC-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 111 2334 66788999999999999999999976666655543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=321.70 Aligned_cols=248 Identities=22% Similarity=0.343 Sum_probs=205.8
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
-.|.+.++||.| +++.||.++++.++..||||.+.+. .+...+-+..|+.+|+.++|||||.+++++.+++.+|+|
T Consensus 10 ~~y~~~~~iG~G--sfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 10 GDYELSREIGSG--SFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccceehhhccCc--ceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 457788888888 8889999999999999999999754 677778889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC------CceEEeeeccccccCC
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD------FEAKVADFGFAKLIPD 158 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~------~~~kL~Dfg~~~~~~~ 158 (325)
||||.||||.+||+ +++++..+..+..|++.|++++|.. |||||+|||++.+ -.+||+|||+++.+..
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 99999999999994 5688889999999999999999974 8999999999865 4689999999998875
Q ss_pred CcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 159 GVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 159 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
. ....+.+|++.|||||++....|+.|+|+||+|+++|+|++|..||......+....+.. ...
T Consensus 168 ~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k--------------~~~ 231 (429)
T KOG0595|consen 168 G--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKK--------------GNE 231 (429)
T ss_pred h--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc--------------ccc
Confidence 3 345667899999999999999999999999999999999999999975443222111111 111
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
.....+...+..+.+|+-..+..+|.+|.++.+... +|..
T Consensus 232 ~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 232 IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred ccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 122333455566778888888999999988887765 4443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=334.40 Aligned_cols=257 Identities=20% Similarity=0.283 Sum_probs=218.1
Q ss_pred cccceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeE
Q 046728 4 HRNICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGF 80 (325)
Q Consensus 4 ~~~~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (325)
+..|...-..+|+.-+.||+| ||..+|.++...+|..||+|++.+. .....+++.+|+++.++|+|||||+++++
T Consensus 9 p~~i~D~~~~~Y~~g~~LGkG--gFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~ 86 (592)
T KOG0575|consen 9 PEVIEDPRSKRYKRGRFLGKG--GFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF 86 (592)
T ss_pred CCeeecCCcceeeeeeeeccC--cceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE
Confidence 344444444778889999999 8899999999999999999999752 45666789999999999999999999999
Q ss_pred EEcCCeEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccc
Q 046728 81 YAGGDERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 81 ~~~~~~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
|++.+.+|||+|+|..++|..+++ ..+.+.++..+..|+..++.|+|.+ ||||..|+|++++.++||+|||+|.
T Consensus 87 FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt 166 (592)
T KOG0575|consen 87 FEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLAT 166 (592)
T ss_pred eecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceee
Confidence 999999999999999999999996 6688999999999999999999987 7999999999999999999999999
Q ss_pred ccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccc
Q 046728 155 LIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHI 234 (325)
Q Consensus 155 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (325)
.+.... .+..+.+||+.|.|||++.....+..+||||+||++|.|++|++||...... +. +..+
T Consensus 167 ~le~~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk---et------------y~~I 230 (592)
T KOG0575|consen 167 QLEYDG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK---ET------------YNKI 230 (592)
T ss_pred eecCcc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH---HH------------HHHH
Confidence 876442 3345678999999999999999999999999999999999999999754321 11 1111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 235 ADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
..... ..|...+.+..+||.++|+.||.+|||+++|+. ||+...
T Consensus 231 k~~~Y--~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 231 KLNEY--SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF 276 (592)
T ss_pred HhcCc--ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence 11111 234577889999999999999999999999998 885443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=327.54 Aligned_cols=249 Identities=27% Similarity=0.400 Sum_probs=196.8
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
+.+++++.||+|.+ |.||+.+-.. ...||+|.++... -....|.+|+++|++|+|++||++++++..+..++||||
T Consensus 206 ~~l~l~~~LG~G~F--G~V~~g~~~~-~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 206 EELKLIRELGSGQF--GEVWLGKWNG-STKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred HHHHHHHHhcCCcc--ceEEEEEEcC-CCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 45689999999954 5566554333 3479999997643 334578899999999999999999999999889999999
Q ss_pred ecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 93 YMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|++.|+|.+|++. .++....+.+..|++.++.|+..+ |||.++||||+++..|||+|||+++...++.....
T Consensus 282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~ 361 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS 361 (468)
T ss_pred ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence 9999999999975 122233344444444444444442 89999999999999999999999996666555544
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
....-++.|.|||.+..+.|+.|||||||||+||||+| |+.||...+..+... ..+.+.+.+.
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~----------------~le~GyRlp~ 425 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLE----------------LLERGYRLPR 425 (468)
T ss_pred CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHH----------------HHhccCcCCC
Confidence 44445789999999999999999999999999999998 899987765422221 2234455677
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
|..+|+++.+||..||..+|++|||++.+...|+....
T Consensus 426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 78899999999999999999999999999998887654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=315.74 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=207.2
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
-...|.++++||+| +++.|+++++..+++.+|+|.+++. ..........|.++|.+++||+||+++-.|++...+
T Consensus 23 ~~~dF~~lkviGkG--~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 23 GPDDFEILKVIGKG--SFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred Chhheeeeeeeecc--CCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 35678999999999 8899999999999999999999753 233456788899999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 88 LIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
|+|++|+.||.|.-+|+ +++.+..+.-+...+..|++++|.+ |||||+|||++.+|.++|+|||+|+..-.. .
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-~ 179 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-G 179 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC-C
Confidence 99999999999999994 5688888889999999999999987 899999999999999999999999954332 2
Q ss_pred eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 162 HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
..+.+++||+.|+|||++....|+.++|.||||+++|+|++|.+||.........+. +.... ..
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~---------------I~~~k-~~ 243 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDK---------------ILKGK-LP 243 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHH---------------HhcCc-CC
Confidence 335568899999999999999999999999999999999999999976443111111 11110 11
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCC----CHHHHHH--HHhcc
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRP----TMTDVVD--WLKGG 279 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rp----s~~~il~--~l~~~ 279 (325)
..+...+.+.++|+.++|..||++|. ++.+|-+ ++..+
T Consensus 244 ~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 244 LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 22344778999999999999999995 5666655 44433
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=315.08 Aligned_cols=262 Identities=22% Similarity=0.285 Sum_probs=210.7
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh-hhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA-KAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..+.|++..+||.| ..+.|+.++....+..||||++..... .....+.+|++.|+.++||||++++..|..+..+|+
T Consensus 24 n~~~YeL~e~IG~G--~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 24 NAKDYELQEVIGVG--ASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred CccceeEEEEEecc--ceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence 35789999999999 458899999999999999999975432 335789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhc----cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 90 VYDYMPNHSLITHLH----GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 90 V~e~~~~gsL~~~l~----~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
||+||.+|++.+.++ ..+++..+..+.+++.-++.|+|.+ ||||+.|||++.+|.|||+|||.+..+.....
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 999999999999884 5577778888899999999999875 89999999999999999999998876655332
Q ss_pred ee--e-ccCCCCcCCCCcccccc--CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccC
Q 046728 162 HM--T-TRVKGTLGYLAPEYAMW--GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD 236 (325)
Q Consensus 162 ~~--~-~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (325)
.. . .++.||++|+|||++.. ..|+.|+||||||++..|+++|..||...++-...-. ...+..+.+..
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~-------tLqn~pp~~~t 254 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL-------TLQNDPPTLLT 254 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH-------HhcCCCCCccc
Confidence 21 1 55689999999999653 3799999999999999999999999988765221100 00111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 237 PRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 237 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
..+.-.....++..+.+++..||..||.+|||++++++ ||+....
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 12222333556779999999999999999999999998 8887643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=303.45 Aligned_cols=257 Identities=16% Similarity=0.261 Sum_probs=203.7
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
-|+.+.++|+| ++|.|++++++.+|+.||||.+... ++...+-.++|+++|++++|||+|.++.+|.....+++|+
T Consensus 3 kYE~LgkvGEG--SYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 3 KYEKLGKVGEG--SYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred HHhhhhccccC--cceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 46778899999 8999999999999999999998632 3444556778999999999999999999999999999999
Q ss_pred EecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 92 DYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 92 e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|||+. ++.+-+. ..++...+..+..|+..|+.++|.+ |||||+|||++.+|.+||||||+|+.+..... .-
T Consensus 81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd-~Y 158 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD-NY 158 (396)
T ss_pred eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc-hh
Confidence 99976 6666662 4467777889999999999999986 89999999999999999999999998874222 22
Q ss_pred ccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhh-hc--------ccccccccccc
Q 046728 165 TRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQW-VT--------PYVQKGAFEHI 234 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~-~~--------~~~~~~~~~~~ 234 (325)
...+.|.+|+|||++.+ .+|+..+||||+||++.||++|.+.|++.++-+....+.. +. -......|..+
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 34568999999999987 5899999999999999999999999987665443322221 11 11112223333
Q ss_pred cCccccCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 235 ADPRLKGK-----FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 235 ~~~~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.-+..... .-+..+.-+.+|++.||..||++|+|.++++.
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 22222211 22456668999999999999999999999996
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=329.27 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=216.4
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
...|+++-+.||+| +.+.|-++++..+|+.+|||++.+. .......+.+|+-+|+.++||||+++++++++..++
T Consensus 10 tiGpwkLgkTLG~G--stg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l 87 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKG--STGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL 87 (786)
T ss_pred cccceeccccccCC--CCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence 35688999999999 8999999999999999999999754 344456888999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhh--ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 88 LIVYDYMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l--~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
|+|+||++||.|++|+ ++.+.+..+..+++|+..++.+.|.+ ||+||+|+|++..+++||+|||+|.....+..
T Consensus 88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence 9999999999999999 68899999999999999999999986 89999999999999999999999997766543
Q ss_pred eeeccCCCCcCCCCccccccCCCC-CcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 162 HMTTRVKGTLGYLAPEYAMWGKVS-DSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
..+.+|++.|.|||++.+.+|. .++||||+|||||-|+||..||.+.. .+..... +..+.|
T Consensus 168 --LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LLlK----V~~G~f--------- 229 (786)
T KOG0588|consen 168 --LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLLLK----VQRGVF--------- 229 (786)
T ss_pred --ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHHHH----HHcCcc---------
Confidence 4557899999999999999884 68999999999999999999997422 2222221 223333
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccCC
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLGR 282 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~~ 282 (325)
.+|..++.++.+||.+|+..||++|+|.++|++ ||......
T Consensus 230 -~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 230 -EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred -cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence 344677889999999999999999999999999 88876543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=319.03 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=192.4
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCe-EEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcCC-eEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQ-IAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD-ERLI 89 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~-vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~l 89 (325)
...+.+.||.| +++.||.. ...|+. ||||.+.... ......|.+|+.+|.+++|||||+++|++.+.. ..++
T Consensus 42 ~l~~~~~iG~G--~~g~V~~~--~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 42 ELPIEEVLGSG--SFGTVYKG--KWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred HhhhhhhcccC--CceeEEEE--EeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence 34556667777 66667733 344566 9999997543 233569999999999999999999999998887 7999
Q ss_pred EEEecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc-----CCCCCCceeeCCCC-ceEEeeeccccccCCC
Q 046728 90 VYDYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI-----ADIKASNVLLDTDF-EAKVADFGFAKLIPDG 159 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~-----rdlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~ 159 (325)
||||+++|+|.++++. .++....+.+..+++.++.|+|.. |||||+|+|++.++ ++||+|||+++.....
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999999954 344444555666666666666653 79999999999997 9999999999876653
Q ss_pred cceeeccCCCCcCCCCccccc--cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 160 VTHMTTRVKGTLGYLAPEYAM--WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 160 ~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
... .....||..|||||++. ...|+.|+||||||+++|||+||..||....... .. ..+...
T Consensus 198 ~~~-~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~---~~------------~~v~~~ 261 (362)
T KOG0192|consen 198 KTS-MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ---VA------------SAVVVG 261 (362)
T ss_pred ccc-ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH---HH------------HHHHhc
Confidence 222 22256999999999999 5689999999999999999999999998755311 11 111122
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
..++..+..+++.+..||.+||..||++||++.+++..|+.+..
T Consensus 262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 33445555688899999999999999999999999998886654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=324.50 Aligned_cols=257 Identities=19% Similarity=0.284 Sum_probs=211.8
Q ss_pred ceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 7 ICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 7 ~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
++...+-...|-...+.|.|+.+.||.++...+++.||||.+.........-+.+|+.+|+..+|+|||++++.|.-++.
T Consensus 265 v~~~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de 344 (550)
T KOG0578|consen 265 VVSQGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE 344 (550)
T ss_pred eccCCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce
Confidence 33333333334444444555899999999999999999999986555555678899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhh-ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 87 RLIVYDYMPNHSLITHL-HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
+|+||||++||+|.+.+ +..+++.++..+++.+..|++++|+. ||||.+|||++.+|.+||+|||+|..+.....
T Consensus 345 LWVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred eEEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999999999999999 45688899999999999999999985 89999999999999999999999998876654
Q ss_pred eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 162 HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
. ..+.+||+.|||||+.....|+.+.||||||++++||+-|.+||..... ...+ +.-...+.+..
T Consensus 425 K-R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P---lrAl-----------yLIa~ng~P~l 489 (550)
T KOG0578|consen 425 K-RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP---LRAL-----------YLIATNGTPKL 489 (550)
T ss_pred c-cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh---HHHH-----------HHHhhcCCCCc
Confidence 3 4456799999999999999999999999999999999999999975322 1111 11111222333
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
..+..+++.+.+++.+||..||++|+|+.++|+ +|+.
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 455778899999999999999999999999998 8753
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=316.29 Aligned_cols=249 Identities=23% Similarity=0.385 Sum_probs=206.9
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc----Ch-hhHHHHHHHHHHHHccC-CCCccceeeEEEc
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL----NA-KAEMEFAVEVEILGRVR-HRNLLGLRGFYAG 83 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 83 (325)
.....|.+.+.||+| +++.|+.+++..++..||+|++... .. ...+.+.+|+.+++.++ ||||++++.++..
T Consensus 14 ~~~g~y~~~~~lG~G--sfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSG--SFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred cccCceeeeeeecCC--CCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 445688999999999 8888999999999999999977642 12 23456778999999998 9999999999999
Q ss_pred CCeEEEEEEecCCCChhhhh--ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC-CceEEeeecccccc
Q 046728 84 GDERLIVYDYMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD-FEAKVADFGFAKLI 156 (325)
Q Consensus 84 ~~~~~lV~e~~~~gsL~~~l--~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~-~~~kL~Dfg~~~~~ 156 (325)
...+++|||||.||+|.+++ ++++.+..+..+++|+..|+.++|.+ |||||+|+|++.+ +.+||+|||++...
T Consensus 92 ~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 92 PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 99999999999999999999 36788888999999999999999986 8999999999999 99999999999987
Q ss_pred CCCcceeeccCCCCcCCCCccccccCC-CC-CcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccc
Q 046728 157 PDGVTHMTTRVKGTLGYLAPEYAMWGK-VS-DSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHI 234 (325)
Q Consensus 157 ~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (325)
. .......+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||...... .. +..+
T Consensus 172 ~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~---~l------------~~ki 235 (370)
T KOG0583|consen 172 P-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP---NL------------YRKI 235 (370)
T ss_pred C-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH---HH------------HHHH
Confidence 3 1122345578999999999999877 75 6899999999999999999999762211 11 1111
Q ss_pred cCccccCCCCHHH-HHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 235 ADPRLKGKFNRDQ-LKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 235 ~~~~~~~~~~~~~-~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
..... ..+..+ ++++..|+.+||..||.+|+|+.+|+. ||+.
T Consensus 236 ~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 236 RKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred hcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 12211 223334 889999999999999999999999998 9986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=313.77 Aligned_cols=249 Identities=21% Similarity=0.320 Sum_probs=209.8
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 87 (325)
...|.|-+.||.| +++.|++|+...+++.+|||++.+. ...-.+.+..|-..|.+| +||.|++++..|++...+
T Consensus 72 ~~DF~Fg~~lGeG--SYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 72 PNDFKFGKILGEG--SYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred hhhcchhheeccc--cceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3578999999999 8889999999999999999998642 122234566799999999 799999999999999999
Q ss_pred EEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 88 LIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
|+|+||+++|+|.++|+ +.+++.+...+..++.-|++++|++ |||||+|||++.+++++|+|||.++.+.....
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 99999999999999995 6688889999999999999999986 89999999999999999999999998865322
Q ss_pred e------------eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccc
Q 046728 162 H------------MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKG 229 (325)
Q Consensus 162 ~------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 229 (325)
. ....++||..|.+||++..+..+..+|+|+|||++|.|+.|.+||.+... ..+
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---yli----------- 295 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---YLI----------- 295 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH---HHH-----------
Confidence 1 12447899999999999999999999999999999999999999975432 111
Q ss_pred ccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 230 AFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
|.++..- .-.+++.+++.+.+||++.|..||.+|+|+++|-+ +|+++
T Consensus 296 -FqkI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 296 -FQKIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred -HHHHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 1122111 12455677789999999999999999999999998 66654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=307.12 Aligned_cols=262 Identities=20% Similarity=0.255 Sum_probs=211.1
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcC--CeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG--DERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 88 (325)
..|+-+++||.| .++.||++++..+|+.||+|.+.... .....-..+|+.||++|+||||+++.+..... ..+|
T Consensus 117 ~~feki~kIGeG--Tyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 117 DSFEKIEKIGEG--TYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred HHHHHHHHhcCc--chhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 357888999999 99999999999999999999997543 55555677899999999999999999998766 6899
Q ss_pred EEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 89 IVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
+|+|||++ ||..++.. .+++.++..+.+|+..++.++|.. ||||..|||+|.+|.+||+|||+|+.......
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 99999976 99998854 478889999999999999999984 89999999999999999999999998776555
Q ss_pred eeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcc--
Q 046728 162 HMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR-- 238 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 238 (325)
......+-|.+|+|||++.+. .|+.++|+||+|||+.||++|.+.|.+....+....+-.+........|....-+.
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~ 353 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT 353 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence 445556789999999999876 69999999999999999999999997765444444433333332222232111110
Q ss_pred -cc---------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHh
Q 046728 239 -LK---------GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLK 277 (325)
Q Consensus 239 -~~---------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~ 277 (325)
.+ ......+++...+|+..+|..||.+|.|+.++++ +|.
T Consensus 354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 00 0112456778999999999999999999999998 773
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=291.14 Aligned_cols=244 Identities=23% Similarity=0.336 Sum_probs=209.6
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..|.+++.+|.| +||.|-+++.+.++..+|+|++.+.. ....+...+|..+|+.+.||+++++++.+.+.+.+++
T Consensus 44 ~dfe~~~tlGtG--SFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 44 QDFERLKTLGTG--SFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred hhhhheeeeccC--ccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 567888999999 88889999999999999999997543 3444577789999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 90 VYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||||.+||.|..+++. ++++..+.-+..++..|+.++|++ |||||+|||+|.+|.+||+|||.++.+...
T Consensus 122 vmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r---- 197 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR---- 197 (355)
T ss_pred EEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc----
Confidence 9999999999999964 899999999999999999999998 899999999999999999999999987654
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
+.+.+||+.|+|||++.+.+++.++|.|||||++|||+.|.+||..... ...++++.... ..+
T Consensus 198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---------------~~iY~KI~~~~--v~f 260 (355)
T KOG0616|consen 198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---------------IQIYEKILEGK--VKF 260 (355)
T ss_pred EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---------------HHHHHHHHhCc--ccC
Confidence 4567899999999999999999999999999999999999999986543 12233333332 256
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH--HHhcc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRP-----TMTDVVD--WLKGG 279 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~~ 279 (325)
|..+++.+.+|++..|+.|-.+|. -..+|.+ ||++.
T Consensus 261 P~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 261 PSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred CcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 677888999999999999999993 3455655 66543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=308.77 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=206.7
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
...|.+++.||.| ++|.||+++.+.+|..+|+|++++. .......+..|-.+|...++|.||+++-.|++...+|
T Consensus 140 ~~DFe~Lk~IgkG--AfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 140 LDDFELLKVIGKG--AFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred cccchhheeeccc--cceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 4678999999999 8999999999999999999999864 3445567788999999999999999999999999999
Q ss_pred EEEEecCCCChhhhh--ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC---
Q 046728 89 IVYDYMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG--- 159 (325)
Q Consensus 89 lV~e~~~~gsL~~~l--~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--- 159 (325)
|||||.+|||+..+| .+.+++..+..+..+...|+..+|.+ |||||+|+|||..|++||+|||+|.-+...
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 999999999999999 46688888888999999999999876 799999999999999999999999643210
Q ss_pred --------------------cce----e-------------------eccCCCCcCCCCccccccCCCCCcccchhHHHH
Q 046728 160 --------------------VTH----M-------------------TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVL 196 (325)
Q Consensus 160 --------------------~~~----~-------------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~i 196 (325)
... . ....+||+-|+|||++.+..|+..+|.||||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 000 0 011359999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCC-CccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHH
Q 046728 197 LLELISAKKPLEKLPG-GVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPT---MTDV 272 (325)
Q Consensus 197 l~el~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~~i 272 (325)
+|||+.|.+||.+... ...+.+..|-.. +..+.....+.+..+||++|+. ||++|.- ++||
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~--------------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EI 442 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRET--------------LKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEI 442 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhh--------------ccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence 9999999999987644 334444444321 1222234456899999999999 9999974 8888
Q ss_pred HH--HHhcc
Q 046728 273 VD--WLKGG 279 (325)
Q Consensus 273 l~--~l~~~ 279 (325)
-. ||+++
T Consensus 443 K~HPfF~~v 451 (550)
T KOG0605|consen 443 KKHPFFKGV 451 (550)
T ss_pred hcCCccccC
Confidence 77 88765
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=304.79 Aligned_cols=249 Identities=22% Similarity=0.298 Sum_probs=211.2
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
...|+-++.||.| +|+.||++....+++.||||++... .......+.+|+.++.+++++||.++|+.|..+..+|++
T Consensus 12 ~~~~~~~~~IgrG--sfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRG--SFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhcccc--ccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 3456777888888 8888999999999999999999754 344456888999999999999999999999999999999
Q ss_pred EEecCCCChhhhhc-cC-CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 91 YDYMPNHSLITHLH-GR-LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 91 ~e~~~~gsL~~~l~-~~-~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||||.||++.+.++ +. +.+..+..+.+.+..++.++|.. ||||+.|||+...|.+||+|||.+..+.......
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr- 168 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR- 168 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc-
Confidence 99999999999995 23 36777888999999999999986 7999999999999999999999999888765554
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
.++.||+.|||||++.+..|+.++||||||++.+||++|.+||....+.. .+ .+.....++...
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr---------------vl-flIpk~~PP~L~ 232 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR---------------VL-FLIPKSAPPRLD 232 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce---------------EE-EeccCCCCCccc
Confidence 67889999999999998899999999999999999999999997654311 11 111222223333
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
..+++.+++++..||++||+.|||+.++++ +++..
T Consensus 233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 233 GDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 477889999999999999999999999997 77664
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=306.14 Aligned_cols=267 Identities=19% Similarity=0.289 Sum_probs=207.2
Q ss_pred eeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCC
Q 046728 8 CFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGD 85 (325)
Q Consensus 8 ~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 85 (325)
+-.+...|..+++||.| .+|.||+++...++..||||.+++. .....---.+|+..|++|+ ||||++++.++.+.+
T Consensus 5 ~~~~m~RY~~i~klGDG--TfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 5 QVIFMDRYTVIRKLGDG--TFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred ehhHHHHHHHHHHhcCC--cceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 34566789999999999 8899999999999999999999753 2333334457999999998 999999999998887
Q ss_pred -eEEEEEEecCCCChhhhhccC---CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccC
Q 046728 86 -ERLIVYDYMPNHSLITHLHGR---LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIP 157 (325)
Q Consensus 86 -~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~ 157 (325)
.+|+|||||+. +|.+.++++ +++..+..|..|+..++.+.|.+ ||+||+|||+..+..+||+|||+|+...
T Consensus 83 ~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 83 RILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred ceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 89999999965 999999644 67788899999999999999986 7999999999999999999999999766
Q ss_pred CCcceeeccCCCCcCCCCccccc-cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCcc-chhhhhhcccccc-------
Q 046728 158 DGVTHMTTRVKGTLGYLAPEYAM-WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVK-RDIVQWVTPYVQK------- 228 (325)
Q Consensus 158 ~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~------- 228 (325)
..... ...+.|.+|+|||++. .+.|+.+.||||+||+++|+.+-++.|.+...-+. ..+.+.+ .....
T Consensus 162 SkpPY--TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VL-GtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 SKPPY--TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVL-GTPDKDSWPEGY 238 (538)
T ss_pred cCCCc--chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHh-CCCccccchhHH
Confidence 54332 3456899999999876 55789999999999999999999999976533211 1111110 00000
Q ss_pred -------cccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 229 -------GAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 229 -------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
-.+.......+....+ ..+.++.+||.+|+..||++|||+.++++ +++....
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 0111111111122222 37789999999999999999999999999 7765543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=296.15 Aligned_cols=243 Identities=21% Similarity=0.351 Sum_probs=207.1
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
-+...|+|.+.||+| .++.|-++.....|+.||||.+.+. +..+...+.+|++||+.|+||||+.++.+|++.+.
T Consensus 50 nlkHRyE~~etLGkG--TYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 50 NLKHRYEITETLGKG--TYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred chhhHHHHHHHhcCC--cccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence 456789999999999 8899999999999999999999753 45666789999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 87 RLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
+.|||||..+|.|++|+. +.+++..+..+++|+..|.-|.|.+ ||||.+|||+|.++++||+|||++..+....
T Consensus 128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 999999999999999994 6688999999999999999999976 7999999999999999999999999776543
Q ss_pred ceeeccCCCCcCCCCccccccCCCC-CcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 161 THMTTRVKGTLGYLAPEYAMWGKVS-DSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
...+++|++-|.+||+..+.+|. +.+|.||||++||.+.+|..||.+.+- ..++ + ++..+.+..
T Consensus 208 --fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lv---r-QIs~GaYrE------ 272 (668)
T KOG0611|consen 208 --FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLV---R-QISRGAYRE------ 272 (668)
T ss_pred --HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHH---H-HhhcccccC------
Confidence 35678999999999999998885 679999999999999999999976432 1111 1 122222221
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
+..+....-||.+||..||++|.|+++|..
T Consensus 273 -----P~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 273 -----PETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred -----CCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 122346777999999999999999999998
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=322.96 Aligned_cols=254 Identities=25% Similarity=0.395 Sum_probs=203.7
Q ss_pred cchhHHhhccCccceeeeeEEEeccCC-----CCeEEEEEecccChh-hHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETG-----DDQIAVKRLKTLNAK-AEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~-----~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
+...+++.||+| +|+.|++++.... ...||||.++..... ..++|.+|++++..++|||||+++|++..++.
T Consensus 486 ~~i~~~~eLGeg--aFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 486 SDIVFKEELGEG--AFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred hheeehhhhcCc--hhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 345789999999 6777887776543 357999999865544 77899999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhccCCC------C----CCccCHHHHHHHHHHHHhhc----------CCCCCCceeeCCCCceE
Q 046728 87 RLIVYDYMPNHSLITHLHGRLA------P----DCLLDWHRRVSIAIGSAEGI----------ADIKASNVLLDTDFEAK 146 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~~~~------~----~~~~~~~~~~~~~~~~~~~~----------rdlkp~Nil~~~~~~~k 146 (325)
.|+|+|||..|||.+||+.+-+ . ...+.-...+.+|.|+|.|+ |||..+||||.++..||
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEE
Confidence 9999999999999999942211 1 11144555555555555554 89999999999999999
Q ss_pred EeeeccccccCCCcceeec-cCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcc
Q 046728 147 VADFGFAKLIPDGVTHMTT-RVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTP 224 (325)
Q Consensus 147 L~Dfg~~~~~~~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~ 224 (325)
|+|||+++........+.. ...-+++||+||.+..+.|+++||||||||+|||+++ |..||++....+.-+.++.
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~--- 720 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA--- 720 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc---
Confidence 9999999977665554432 3345789999999999999999999999999999998 8999998776544433321
Q ss_pred cccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCCCc
Q 046728 225 YVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGRRT 284 (325)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~ 284 (325)
+.+ ...+..++.++++||..||..+|.+|||+.+|-.+|+.+..++.
T Consensus 721 ------------g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 721 ------------GQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred ------------CCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 222 34567788999999999999999999999999999998776544
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=290.37 Aligned_cols=250 Identities=19% Similarity=0.243 Sum_probs=209.3
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..+++++.||.| ..|.||+++-..++..+|+|++.+.. ..-..+...|-+||+.++||.+..+|+.|+.+...|+
T Consensus 77 ~~f~llk~LG~G--diG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 77 RHFRLLKRLGCG--DIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred HHHHHHHHcCCC--CceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 468899999999 88889999999999999999997543 3334577789999999999999999999999999999
Q ss_pred EEEecCCCChhhhhc----cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC--
Q 046728 90 VYDYMPNHSLITHLH----GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG-- 159 (325)
Q Consensus 90 V~e~~~~gsL~~~l~----~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-- 159 (325)
|||||+||+|....+ +++++..+.-+...+..|+.|+|-+ |||||+||||.++|.+.|+||.++......
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999999999998885 4577788888999999999999998 799999999999999999999887644210
Q ss_pred ------------------------------c-c----------------------eeeccCCCCcCCCCccccccCCCCC
Q 046728 160 ------------------------------V-T----------------------HMTTRVKGTLGYLAPEYAMWGKVSD 186 (325)
Q Consensus 160 ------------------------------~-~----------------------~~~~~~~~t~~y~aPE~~~~~~~~~ 186 (325)
. . .....++||-.|.|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0 0112346999999999999999999
Q ss_pred cccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCC
Q 046728 187 SCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENR 266 (325)
Q Consensus 187 ~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R 266 (325)
++|+|+|||++|||++|..||.+... ...+..+....+.-+..+..+..+++||++.|.+||.+|
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~---------------~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNN---------------KETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCc---------------hhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhh
Confidence 99999999999999999999987543 233444444444444445777899999999999999999
Q ss_pred CC----HHHHHH--HHhcc
Q 046728 267 PT----MTDVVD--WLKGG 279 (325)
Q Consensus 267 ps----~~~il~--~l~~~ 279 (325)
.- +.+|-+ +|++.
T Consensus 380 lg~~rGA~eIK~HpFF~gV 398 (459)
T KOG0610|consen 380 LGSKRGAAEIKRHPFFEGV 398 (459)
T ss_pred hccccchHHhhcCccccCC
Confidence 98 888887 77764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=306.51 Aligned_cols=246 Identities=24% Similarity=0.313 Sum_probs=208.6
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
..|.+++.||.| +++.||+.+++++.+.||+|.+.+. .......+.+|++|++.++||||+.++++|++..++|+|
T Consensus 2 e~yhv~e~iG~G--sfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEG--SFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCC--ccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 357889999999 8888999999999999999999754 344566788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
+|||.| +|..++. +.+++..+..+..++..|+.++|.+ ||+||+|||++.++.+|+||||+++.+.... ...
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-~vl 157 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-SVL 157 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc-eee
Confidence 999977 9999994 5688888999999999999999997 6999999999999999999999999887643 334
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
....||+-|||||+..+.+|+..+|+||+||++||+++|++||.... +.+.+... ..... ..+
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I---------~~d~v--~~p 220 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSI---------LKDPV--KPP 220 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHH---------hcCCC--CCc
Confidence 45679999999999999999999999999999999999999997532 12222211 11111 223
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
...+..+..++...|.+||.+|.|..+++. +.++.
T Consensus 221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 221 STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 467789999999999999999999999997 55543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=297.13 Aligned_cols=257 Identities=46% Similarity=0.773 Sum_probs=210.1
Q ss_pred hhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC-eEEEEEEecCCC
Q 046728 19 QNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD-ERLIVYDYMPNH 97 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lV~e~~~~g 97 (325)
..||.| |++.||...-.. +..||||.+.........+|.+|+.++.+++|||+|+++|+|.+.. +.++|+||+++|
T Consensus 81 ~~ig~G--gfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nG 157 (361)
T KOG1187|consen 81 NLIGEG--GFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNG 157 (361)
T ss_pred cceecC--CCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCC
Confidence 577777 788888665444 3899999886543221456999999999999999999999999988 599999999999
Q ss_pred ChhhhhccCCCCCCccCHHHHHHHHHHHHhhc-------------CCCCCCceeeCCCCceEEeeeccccccCC-Cccee
Q 046728 98 SLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI-------------ADIKASNVLLDTDFEAKVADFGFAKLIPD-GVTHM 163 (325)
Q Consensus 98 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-------------rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~-~~~~~ 163 (325)
+|.++++..... .+.|...+.+|+++|.++ |||||.|||+|++..+||+|||+|+.... .....
T Consensus 158 sL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~ 235 (361)
T KOG1187|consen 158 SLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVS 235 (361)
T ss_pred CHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcccccee
Confidence 999999764332 678998888888887765 79999999999999999999999975544 22211
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc-CC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK-GK 242 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 242 (325)
... .||..|+|||++..+..+.++||||||+++.|++||+.|..............|.++....+.+..+.++.+. ..
T Consensus 236 ~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~ 314 (361)
T KOG1187|consen 236 TTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGE 314 (361)
T ss_pred eec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCC
Confidence 111 6999999999999889999999999999999999999888765444455578888888888888889998876 44
Q ss_pred CCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 243 FNR-DQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 243 ~~~-~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.+. .....+..+..+|+..+|.+||++.+|++.|+....
T Consensus 315 ~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 315 YPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred CChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 443 566778899999999999999999999998865443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=296.71 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=200.8
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC--eEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD--ERLIV 90 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lV 90 (325)
......+.||.| +++.|+++....++...|||.+...+....+.+.+|+++|++++|||||+++|...... .+++.
T Consensus 17 ~~~~~~~~lG~G--s~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRG--SFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCc--cceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 346777888887 88889999998889999999997654343667899999999999999999999854444 68899
Q ss_pred EEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC-CCceEEeeeccccccCC--Cc
Q 046728 91 YDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT-DFEAKVADFGFAKLIPD--GV 160 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~-~~~~kL~Dfg~~~~~~~--~~ 160 (325)
|||+++|+|.+++.+ .+++..+..+.+++..++.++|++ +||||+|||++. ++.+||+|||+++.... ..
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 999999999999953 478889999999999999999975 799999999999 79999999999987763 12
Q ss_pred ceeeccCCCCcCCCCccccccCC-CCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 161 THMTTRVKGTLGYLAPEYAMWGK-VSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
........||+.|+|||++..+. ...++|||||||++.||+||..||... .....++.. +.....
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~---------ig~~~~ 240 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLL---------IGREDS 240 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHH---------HhccCC
Confidence 22233467999999999998633 335999999999999999999999763 011111111 111111
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
.+..+..++.+..++|.+|+..||++|||++++++ +++...
T Consensus 241 ~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 241 LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 22556678889999999999999999999999999 665433
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=275.14 Aligned_cols=264 Identities=17% Similarity=0.251 Sum_probs=205.8
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChh--hHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAK--AEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
..|..++++|+| .++.||++++..+|+.||||.++..... ......+|+.+|+.++||||+.++++|-+.+.+.+|
T Consensus 2 ~rY~~~~~lGEG--~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEG--TYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCc--ceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence 357888999999 8888999999999999999999754322 234678899999999999999999999999999999
Q ss_pred EEecCCCChhhhhccC---CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 91 YDYMPNHSLITHLHGR---LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
+||++. +|...|++. +.+..+..|..++..++.++|.+ |||||.|+|++.+|.+||+|||+++.........
T Consensus 80 fEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred EEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 999965 999999643 56667888888998899998875 9999999999999999999999999887654443
Q ss_pred eccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccC------
Q 046728 164 TTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD------ 236 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 236 (325)
.. .+-|.+|+|||++.+. .|+..+||||.||++.||+-|.+-|.+.++-+....+-..........|+....
T Consensus 159 ~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 159 TH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 33 3679999999998865 689999999999999999999988877554333222211111111112211110
Q ss_pred ----c-cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 237 ----P-RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 237 ----~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
+ ..........+..+.+|+.+||.+||.+|+|+.|+++ +|.+..
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 0 0001122345667899999999999999999999998 887643
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=302.50 Aligned_cols=243 Identities=19% Similarity=0.330 Sum_probs=207.0
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe-EEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE-RLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~l 89 (325)
..|.+++++|.| +||..++++++.++..+|+|.+... +........+|+.++++++|||||.+.+.|..++. .+|
T Consensus 4 ~~Ye~~~~iG~G--afG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 4 DNYEVLRQVGRG--AFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred chhhhhhhcCcc--ccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 468899999999 8888999999999999999998643 33444467889999999999999999999988887 999
Q ss_pred EEEecCCCChhhhhc----cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 90 VYDYMPNHSLITHLH----GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 90 V~e~~~~gsL~~~l~----~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
||+||+||++.+.|. ..+.++.+..|+.|+.+|++++|.. ||||+.|||++.++.++|+|||+++.++....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 999999999999993 3467788999999999999999964 89999999999999999999999999887642
Q ss_pred eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 162 HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
...+..||+-|++||++.+.+|+.|+|||||||++|||++-+.+|........ +.+ +. +....
T Consensus 162 -~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L------i~k---------i~-~~~~~ 224 (426)
T KOG0589|consen 162 -LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL------ILK---------IN-RGLYS 224 (426)
T ss_pred -hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH------HHH---------Hh-hccCC
Confidence 34556799999999999999999999999999999999999999976443111 111 11 11234
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
+.+...+.++..||+.||..+|+.||++.+++.
T Consensus 225 Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~ 257 (426)
T KOG0589|consen 225 PLPSMYSSELRSLVKSMLRKNPEHRPSALELLR 257 (426)
T ss_pred CCCccccHHHHHHHHHHhhcCCccCCCHHHHhh
Confidence 566778899999999999999999999999997
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=276.01 Aligned_cols=253 Identities=17% Similarity=0.223 Sum_probs=201.2
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEc-----CC
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG-----GD 85 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~ 85 (325)
..++|.+++.+|+| |+..|+++++..++..+|+|++.-...+..+..++|++..++++||||++++++... ..
T Consensus 19 n~~Ryri~~~LgeG--Gfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEG--GFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred cCceEEEeeeecCC--CceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 46889999999999 888899999999999999999987677888899999999999999999999987533 34
Q ss_pred eEEEEEEecCCCChhhhhcc------CCCCCCccCHHHHHHHHHHHHhh------cCCCCCCceeeCCCCceEEeeeccc
Q 046728 86 ERLIVYDYMPNHSLITHLHG------RLAPDCLLDWHRRVSIAIGSAEG------IADIKASNVLLDTDFEAKVADFGFA 153 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~------~rdlkp~Nil~~~~~~~kL~Dfg~~ 153 (325)
..|++++|+..|+|.+.+.. -+++..++.++..+-.++..+|+ ||||||.|||+++.+.++|.|||.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 58999999999999999943 35666778888888888888885 4899999999999999999999998
Q ss_pred cccCCCccee--------eccCCCCcCCCCccccccC---CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhh
Q 046728 154 KLIPDGVTHM--------TTRVKGTLGYLAPEYAMWG---KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWV 222 (325)
Q Consensus 154 ~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~---~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~ 222 (325)
....-..... -.....|..|+|||++... ..+.++|||||||+||.|+.|..||...-.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---------- 246 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---------- 246 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh----------
Confidence 7554211110 0112378999999998744 467899999999999999999999964321
Q ss_pred cccccccccc-cccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 223 TPYVQKGAFE-HIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 223 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
..+.+. -+.+..+..+....++..+.+||+.|+..||.+||++.+++..++.+
T Consensus 247 ----~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 ----QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ----cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 011111 11222333333344888999999999999999999999999988754
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=293.47 Aligned_cols=243 Identities=16% Similarity=0.178 Sum_probs=186.2
Q ss_pred hHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChh---hHHHHHHHHHHHHccCCCCccceeeEEEc----CCeEE
Q 046728 16 VFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAK---AEMEFAVEVEILGRVRHRNLLGLRGFYAG----GDERL 88 (325)
Q Consensus 16 ~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 88 (325)
.....+..|.|+++.||.+.. +++.||||.+...... ....+.+|+.+|++++||||+++++++.+ ....+
T Consensus 21 ~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~ 98 (283)
T PHA02988 21 DKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLS 98 (283)
T ss_pred CCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceE
Confidence 334334455558888887764 6789999999754322 24577899999999999999999999876 35688
Q ss_pred EEEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhh-----cCCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 89 IVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEG-----IADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~-----~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
+|||||++|+|.++++. .++......+..++..++.++|. ||||||+||+++.++.+||+|||++.......
T Consensus 99 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 99 LILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred EEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999999999953 34445556677778888888875 48999999999999999999999988654322
Q ss_pred eeeccCCCCcCCCCcccccc--CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 162 HMTTRVKGTLGYLAPEYAMW--GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
....++..|+|||++.+ ..++.++|||||||++|||++|..||....... .... +.....
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~~------------i~~~~~ 239 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYDL------------IINKNN 239 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHHH------------HHhcCC
Confidence 12357889999999976 578999999999999999999999997543211 1111 101111
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
+...+...++.+.+|+.+||+.||++|||+.++++.|+..
T Consensus 240 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1223345677899999999999999999999999988754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=306.30 Aligned_cols=247 Identities=22% Similarity=0.291 Sum_probs=209.5
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 88 (325)
..|.|+++||+| +||.|.++..+.+++.+|||.+++. ..+.....+.|..|+...+ ||+++.++..|++..++|
T Consensus 368 ~~F~~l~vLGkG--sFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 368 DDFRLLAVLGRG--SFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cceEEEEEeccC--cCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 468899999999 8889999999999999999999864 3555668888999999884 999999999999999999
Q ss_pred EEEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 89 IVYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
+||||+.||++..+.+ +.+++..+.-+...+..+++++|.+ ||||.+|||+|..|.+||+|||+|+..-.. ...
T Consensus 446 fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~-g~~ 524 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ-GDR 524 (694)
T ss_pred EEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC-CCc
Confidence 9999999999777776 6788888889999999999999998 799999999999999999999999854322 235
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
+.+++||+.|+|||++....|+.++|.|||||++|||+.|+.||.+.+..+.. ..+.... ...
T Consensus 525 TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F---------------dsI~~d~--~~y 587 (694)
T KOG0694|consen 525 TSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF---------------DSIVNDE--VRY 587 (694)
T ss_pred cccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---------------HHHhcCC--CCC
Confidence 67899999999999999999999999999999999999999999875543222 2222221 245
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH--HHhcc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPT-----MTDVVD--WLKGG 279 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps-----~~~il~--~l~~~ 279 (325)
|..++.+...+|+++|..+|++|.- +++|.. +|+++
T Consensus 588 P~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 588 PRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred CCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 5678889999999999999999975 456655 66654
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=294.34 Aligned_cols=261 Identities=20% Similarity=0.255 Sum_probs=200.0
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
...|.+++.||.| +++.||++++..++..||+|.+... ......++.+|++++++++||||+++++++.+++..++|
T Consensus 4 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAG--NGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCC--CCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 3567888999999 7778999999999999999998753 344556899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhh-----cCCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 91 YDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEG-----IADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~-----~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
|||+++|+|.++++. .+++..+..+..++..++.++|. ||||||+|||++.++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 158 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 158 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---
Confidence 999999999999953 35556667788889999999985 48999999999999999999999987654322
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccc--ccc-----------
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQ--KGA----------- 230 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~--~~~----------- 230 (325)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||.............. +... ...
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR--PVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc--cccccccCCccccCcccccc
Confidence 2334689999999999988899999999999999999999999964332111100000 0000 000
Q ss_pred --------------------cccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 231 --------------------FEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 231 --------------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
...+.............++++.+||.+||..||++|||++++++ ||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 00000000000111235678999999999999999999999998 88753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=284.06 Aligned_cols=271 Identities=18% Similarity=0.257 Sum_probs=210.9
Q ss_pred ceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEec--ccChhhHHHHHHHHHHHHccCCCCccceeeEEEc-
Q 046728 7 ICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG- 83 (325)
Q Consensus 7 ~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 83 (325)
-.|.+...|..++.||.| ++|.|+.+....+|..||||++. -.+....++..+|+.+++.++|+||+.+.+++..
T Consensus 16 ~~~~i~~~y~~~~~iG~G--AyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~ 93 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRG--AYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPP 93 (359)
T ss_pred eEEeccceecccccccCc--ceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccc
Confidence 456777777888999999 88889999999999999999997 3456667799999999999999999999999865
Q ss_pred ----CCeEEEEEEecCCCChhhhhccC--CCCCCccCHHHHHHHHHHHHhh----cCCCCCCceeeCCCCceEEeeeccc
Q 046728 84 ----GDERLIVYDYMPNHSLITHLHGR--LAPDCLLDWHRRVSIAIGSAEG----IADIKASNVLLDTDFEAKVADFGFA 153 (325)
Q Consensus 84 ----~~~~~lV~e~~~~gsL~~~l~~~--~~~~~~~~~~~~~~~~~~~~~~----~rdlkp~Nil~~~~~~~kL~Dfg~~ 153 (325)
-..+|+|+|+| +.+|.+.++.. +++..+..+..|+..++.+.|+ ||||||.|+|++.++.+||+|||+|
T Consensus 94 ~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 94 SRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred cccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccce
Confidence 35689999999 56999999533 6777778888999999999987 4899999999999999999999999
Q ss_pred cccCCCc-ceeeccCCCCcCCCCccccc-cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccc
Q 046728 154 KLIPDGV-THMTTRVKGTLGYLAPEYAM-WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAF 231 (325)
Q Consensus 154 ~~~~~~~-~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (325)
+...... ....+..+.|.+|+|||++. ...|+.+.||||+||++.||++|++.|.+...-.....+..+........+
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 9875421 11123456899999999876 457999999999999999999999999875544333333332222222222
Q ss_pred ccccCcc---------ccC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 232 EHIADPR---------LKG-----KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 232 ~~~~~~~---------~~~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
..+.+.. ..+ ...+..++...+|+.+||..||.+|+|+++++. .|....
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 2222100 001 112356678999999999999999999999998 777654
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=282.99 Aligned_cols=248 Identities=21% Similarity=0.271 Sum_probs=208.2
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEe
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~ 93 (325)
-|.++.+||+| ++++|+++.|+.+|+.||||.+.. ....+++.+|+.+|.+++.|+||+++|.|.....+||||||
T Consensus 34 VFDi~~KLGEG--SYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 34 VFDIVGKLGEG--SYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHhcCC--cchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 36788999999 899999999999999999999976 44567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeecc
Q 046728 94 MPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTR 166 (325)
Q Consensus 94 ~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 166 (325)
|--|++.+.++ ..+.+..+..+.+.-.-+++|+|-+ ||||+.|||++.+|..||+|||.+..+++.-.. .++
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-RNT 188 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-RNT 188 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-hCc
Confidence 99999999994 4467777777777778888888875 799999999999999999999999988764333 455
Q ss_pred CCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHH
Q 046728 167 VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRD 246 (325)
Q Consensus 167 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (325)
..||+.|+|||++..-.|+.++||||||++..||..|++||....+ ....|.....+...-..+..
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP--------------MRAIFMIPT~PPPTF~KPE~ 254 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP--------------MRAIFMIPTKPPPTFKKPEE 254 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc--------------cceeEeccCCCCCCCCChHh
Confidence 6799999999999988999999999999999999999999976432 12222222223222334456
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 247 QLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 247 ~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
-+.++.+++++||...|++|-|+-++++ +++...
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 6889999999999999999999999997 666543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=299.14 Aligned_cols=231 Identities=23% Similarity=0.435 Sum_probs=193.5
Q ss_pred hhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCCCC
Q 046728 19 QNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHS 98 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~gs 98 (325)
+=+|+| +.+.|++-+ -.++.||||+++... ..++..|++|+||||+.|.|+|....-+|||||||..|-
T Consensus 130 eWlGSG--aQGAVF~Gr--l~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 130 EWLGSG--AQGAVFLGR--LHNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhccC--cccceeeee--ccCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 446777 555565433 346789999986522 247889999999999999999999999999999999999
Q ss_pred hhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCCCcC
Q 046728 99 LITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLG 172 (325)
Q Consensus 99 L~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~ 172 (325)
|...++. .+.+...++|..+|+.+++|+|.| ||||.-||||+.+..|||+|||-++-+..... ...++||..
T Consensus 199 L~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST--kMSFaGTVa 276 (904)
T KOG4721|consen 199 LYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST--KMSFAGTVA 276 (904)
T ss_pred HHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhh--hhhhhhhHh
Confidence 9999963 355667789999999999999987 89999999999999999999999987765432 344789999
Q ss_pred CCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHH
Q 046728 173 YLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMV 252 (325)
Q Consensus 173 y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (325)
|||||++.+.+.+.|+||||||||||||+||..||..... ......+....+..+.+..+++-+.
T Consensus 277 WMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds---------------sAIIwGVGsNsL~LpvPstcP~Gfk 341 (904)
T KOG4721|consen 277 WMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS---------------SAIIWGVGSNSLHLPVPSTCPDGFK 341 (904)
T ss_pred hhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch---------------heeEEeccCCcccccCcccCchHHH
Confidence 9999999999999999999999999999999999975432 2233344455566677888999999
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 253 LIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 253 ~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
-||++||...|..||||.+|+..|.
T Consensus 342 lL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 342 LLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred HHHHHHHhcCCCCCccHHHHHHHHh
Confidence 9999999999999999999998765
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=297.92 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=189.0
Q ss_pred cchhHHhhccCccceeeeeEEEec-----cCCCCeEEEEEecccC-hhhHHHHHHHHHHHHcc-CCCCccceeeEEEcC-
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRR-----ETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGG- 84 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~-----~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~- 84 (325)
..|.+.+.||.| +++.||++.. ..++..||+|.+.... ......+.+|+.++..+ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G--~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 7 DRLRLGKVLGHG--AFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hHceeeeEeccC--CcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 357788999999 7778888863 3345789999987432 34456788999999999 899999999988654
Q ss_pred CeEEEEEEecCCCChhhhhccC----------------------------------------------------------
Q 046728 85 DERLIVYDYMPNHSLITHLHGR---------------------------------------------------------- 106 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~~~---------------------------------------------------------- 106 (325)
..+++|||||++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4588999999999999998532
Q ss_pred ------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce-eeccCCCCcCCCC
Q 046728 107 ------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH-MTTRVKGTLGYLA 175 (325)
Q Consensus 107 ------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~t~~y~a 175 (325)
+....+..+..++..++.++|.. |||||+|||++.++.+||+|||+++........ ......++..|+|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 11112234566888888888874 799999999999999999999999865432221 1222345678999
Q ss_pred ccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHH
Q 046728 176 PEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLI 254 (325)
Q Consensus 176 PE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (325)
||++.+..++.++|||||||++|||++ |..||....... ...... ..+ .....+...++.+.+|
T Consensus 245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~----~~~---------~~~~~~~~~~~~l~~l 309 (338)
T cd05102 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQRL----KDG---------TRMRAPENATPEIYRI 309 (338)
T ss_pred cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHH----hcC---------CCCCCCCCCCHHHHHH
Confidence 999988889999999999999999997 999997543211 111100 000 0112233456789999
Q ss_pred HHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 255 ALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 255 i~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
+.+||..||++|||+.++++.|+.++.
T Consensus 310 i~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 310 MLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=294.66 Aligned_cols=251 Identities=18% Similarity=0.262 Sum_probs=199.4
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|.+++.||.| +++.||+++...+++.||+|.+... .......+.+|+.++..++||||+++++++.+....|+|
T Consensus 2 ~y~~~~~ig~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 2 DFQILTQVGQG--GYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CcEEEEEEeec--CCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence 57788999999 7888999999999999999999743 223345788899999999999999999999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|||+++|+|.++++ ..+.+..+..+..++..++.++|.. |||||+|||++.++.+||+|||++..... ..
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~ 155 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YA 155 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----cc
Confidence 99999999999995 3456667777888999999999975 79999999999999999999999986543 22
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..... .+. .+. .....
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----~~~---~~~-~~~~~ 226 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE-----TLQ---RPV-YDDPR 226 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc-----ccc---CCC-CCccc
Confidence 345689999999999988999999999999999999999999975433211111100000 000 000 00111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
...+.++.+||.+||..+|.+|||++++++ ||...
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 345778999999999999999999999998 77653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=290.99 Aligned_cols=250 Identities=20% Similarity=0.302 Sum_probs=213.6
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecc--cChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKT--LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
+..-|.+.+.||.| -|..|-+++|.-+|..||||++.+ .+.-....+.+|+++|+.+.|||||++|.+..+...+|
T Consensus 16 IAGLYDLekTlG~G--HFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRG--HFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred eeeeehhhhhhcCC--ceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence 44556899999999 788899999999999999999964 35555678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhh---ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeC-CCCceEEeeeccccccCCCc
Q 046728 89 IVYDYMPNHSLITHL---HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLD-TDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 89 lV~e~~~~gsL~~~l---~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~ 160 (325)
+|+|.-.+|+|++|| ...+.+..+..++.|+..|+.|.|.+ |||||+|+.+. .-|-+||+|||++..+..+.
T Consensus 94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999999999 35688888999999999999999976 89999999885 45889999999999877654
Q ss_pred ceeeccCCCCcCCCCccccccCCCCC-cccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 161 THMTTRVKGTLGYLAPEYAMWGKVSD-SCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
. ..+.+|+..|.|||++.+..|+. ++||||||+|||.+.+|++||....+++-..++.- -
T Consensus 174 k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImD---------------C-- 234 (864)
T KOG4717|consen 174 K--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMD---------------C-- 234 (864)
T ss_pred h--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhc---------------c--
Confidence 4 45678999999999999998874 79999999999999999999987665433322211 1
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
+-..|...+.++.+||..||..||.+|.|.++|.. ||+..-+
T Consensus 235 KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 235 KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 11345678899999999999999999999999998 9987643
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=292.30 Aligned_cols=242 Identities=23% Similarity=0.273 Sum_probs=196.7
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|.+++.||.| +++.||+++...+++.||+|.+.... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 2 ~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 2 DLERIKTVGTG--TFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CceeeeeeecC--CCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 46778899998 78889999999999999999986422 23345788899999999999999999999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|||+++|+|.++++ ..+++.....+..++..++.++|.. |||||+|||++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~---- 155 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT---- 155 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc----
Confidence 99999999999994 3356666777888999999999986 7999999999999999999999998654321
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
....|++.|+|||++.+..++.++|||||||++|+|++|..||........ ...+ ... ....+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~---~~~i------------~~~--~~~~~ 218 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI---YEKI------------LAG--KLEFP 218 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH------------HhC--CcCCC
Confidence 234589999999999988899999999999999999999999975432111 1110 000 01223
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH--HHhc
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPT-----MTDVVD--WLKG 278 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps-----~~~il~--~l~~ 278 (325)
...++.+.+||.+||..||.+||+ ++++++ ||..
T Consensus 219 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 219 RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 345678999999999999999995 999998 7764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=295.12 Aligned_cols=240 Identities=20% Similarity=0.279 Sum_probs=192.6
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPN 96 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~ 96 (325)
.||+| +++.||++++..+++.||+|.+... ......++.+|+.++++++||||+++++++...+..|+||||+++
T Consensus 2 ~lG~G--~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 2 LLGKG--TFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred eeeeC--CCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 56777 8888999999999999999999743 233445778899999999999999999999999999999999999
Q ss_pred CChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCCC
Q 046728 97 HSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGT 170 (325)
Q Consensus 97 gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t 170 (325)
|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||+++....... ......||
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~gt 158 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGT 158 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cccceecC
Confidence 99999984 3456666777888999999999986 79999999999999999999999875332211 12234689
Q ss_pred cCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHH
Q 046728 171 LGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKS 250 (325)
Q Consensus 171 ~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (325)
+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+. . . ....+...+++
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~~~----~--------~--~~~~p~~~~~~ 221 (323)
T cd05571 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELIL----M--------E--EIRFPRTLSPE 221 (323)
T ss_pred ccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHHHHH----c--------C--CCCCCCCCCHH
Confidence 99999999998889999999999999999999999996532211 111100 0 0 01223456778
Q ss_pred HHHHHHHccCCCCCCCC-----CHHHHHH--HHhcc
Q 046728 251 MVLIALRCTDSNPENRP-----TMTDVVD--WLKGG 279 (325)
Q Consensus 251 ~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~~ 279 (325)
+.+||.+||..||++|| ++.++++ ||...
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 222 AKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999999999999999 8999997 77653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=308.30 Aligned_cols=248 Identities=21% Similarity=0.239 Sum_probs=203.7
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-CCCccceeeE-EEc------C
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HRNLLGLRGF-YAG------G 84 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~-~~~------~ 84 (325)
...++.+.|.+| ||+.||+|....++..+|+|++...+....+.+.+|+++|++|. |+|||.|++. ... .
T Consensus 37 ~~v~V~~vLAEG--GFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEG--GFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEEccC--CcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 456788999999 99999999999998999999998778899999999999999995 9999999993 221 2
Q ss_pred CeEEEEEEecCCCChhhhhc----cCCCCCCccCHHHHHHHHHHHHhhc------CCCCCCceeeCCCCceEEeeecccc
Q 046728 85 DERLIVYDYMPNHSLITHLH----GRLAPDCLLDWHRRVSIAIGSAEGI------ADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~----~~~~~~~~~~~~~~~~~~~~~~~~~------rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
.+++|+||||.||.|-+++. .++.+.+++.++.++..|+..+|.+ ||||-+|+|++.+|.+||||||.+.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 46789999999999999994 5588999999999999999999985 8999999999999999999999987
Q ss_pred ccCCCccee--------eccCCCCcCCCCcccc---ccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhc
Q 046728 155 LIPDGVTHM--------TTRVKGTLGYLAPEYA---MWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVT 223 (325)
Q Consensus 155 ~~~~~~~~~--------~~~~~~t~~y~aPE~~---~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 223 (325)
-........ .-....|+.|+|||++ .+.+.+.|+|||||||+||.||+...||..-..
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------- 263 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------- 263 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence 433221100 0112478999999986 467899999999999999999999999975311
Q ss_pred ccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 224 PYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
-. +.......+..+.++..+.+||..||+.||++||++-+++..+-.+..
T Consensus 264 la--------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 264 LA--------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred ee--------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 01 112222334446788999999999999999999999999997766654
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=289.45 Aligned_cols=248 Identities=24% Similarity=0.316 Sum_probs=198.7
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh--------------hhHHHHHHHHHHHHccCCCCccceee
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA--------------KAEMEFAVEVEILGRVRHRNLLGLRG 79 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~iv~~~~ 79 (325)
.|++++.||.| .+|.|.+++...+++.||||++.+... ...++..+|+.+|++++|||||+++.
T Consensus 98 qy~l~~eiG~G--~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 98 QYELIKEIGSG--QYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred heehhhhhcCC--ccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 57899999999 888899999999999999999964211 11247888999999999999999999
Q ss_pred EEEcC--CeEEEEEEecCCCChhhhhc-cC-CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeec
Q 046728 80 FYAGG--DERLIVYDYMPNHSLITHLH-GR-LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFG 151 (325)
Q Consensus 80 ~~~~~--~~~~lV~e~~~~gsL~~~l~-~~-~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg 151 (325)
+..+. +.+|+|+|||..|.+...-- +. +.+.+++.+++.+..++.|+|.+ |||||+|+|++++|++||+|||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFG 255 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFG 255 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccc
Confidence 98775 56899999999998754442 22 56677888999999999999986 8999999999999999999999
Q ss_pred cccccCCCcce----eeccCCCCcCCCCccccccCC----CCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhc
Q 046728 152 FAKLIPDGVTH----MTTRVKGTLGYLAPEYAMWGK----VSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVT 223 (325)
Q Consensus 152 ~~~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~----~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 223 (325)
.+.....+... ......||+.|+|||+..++. .+.+.||||+||+||.|+.|+.||.+...
T Consensus 256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~----------- 324 (576)
T KOG0585|consen 256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE----------- 324 (576)
T ss_pred eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-----------
Confidence 99866322111 112246999999999987632 35689999999999999999999965321
Q ss_pred ccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 224 PYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
-..+.++....+..+..+++...+.+||.++|.+||++|++..+|.. |...
T Consensus 325 ----~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 325 ----LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred ----HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 22244555555555666678889999999999999999999999987 5443
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=289.89 Aligned_cols=259 Identities=18% Similarity=0.247 Sum_probs=194.6
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
.|.+++.||.| +++.||++++..+++.||+|.+... .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~y~~~~~lg~g--~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 2 KFEVLGVVGEG--AYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CceEEEEeccc--CCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 46778889888 7778999999999999999998643 2333457888999999999999999999999999999999
Q ss_pred EecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 92 DYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 92 e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
||++++++..+.. ..+++..+..+..++..++.++|.. |||||+||+++.++.++|+|||++............
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 9999876665543 3355666778889999999999975 799999999999999999999999876543322233
Q ss_pred cCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccc---------cccccccccC
Q 046728 166 RVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYV---------QKGAFEHIAD 236 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~ 236 (325)
...++..|+|||++.+..++.++|||||||++|+|++|..||...........+....... ....+.....
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07848 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF 239 (287)
T ss_pred ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence 3468899999999998889999999999999999999999997643221111111100000 0000000000
Q ss_pred ccc------cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 237 PRL------KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 237 ~~~------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
+.. ........+..+.+||.+||+.||++|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 00111235678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=295.95 Aligned_cols=243 Identities=25% Similarity=0.316 Sum_probs=196.9
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..|.+.+.||.| +++.||+++...+++.||+|.+... .......+.+|+.++++++||||+++++++.+++..++
T Consensus 18 ~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 18 SDFEMGETLGTG--SFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred hheEEEEEEEec--CCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 567888999999 7888999999999999999998642 22334578899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 90 VYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 90 V~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||||+.+|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||++.......
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--- 172 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--- 172 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc---
Confidence 999999999999995 3355566677788899999999975 7999999999999999999999998664432
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..... +.... ...
T Consensus 173 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~------------i~~~~--~~~ 234 (329)
T PTZ00263 173 -FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF---RIYEK------------ILAGR--LKF 234 (329)
T ss_pred -ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH---HHHHH------------HhcCC--cCC
Confidence 2346899999999999888999999999999999999999999653321 11111 11111 122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH--HHhc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPT-----MTDVVD--WLKG 278 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps-----~~~il~--~l~~ 278 (325)
+...+..+.+||.+||..||.+||+ ++++++ |++.
T Consensus 235 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 235 PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 2335678999999999999999997 688886 7654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=286.07 Aligned_cols=248 Identities=23% Similarity=0.282 Sum_probs=195.4
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
|..++.||+| +++.||++....+++.||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 2 f~~~~~lg~G--~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 2 FRHYRVLGKG--GFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred ceEEEEEecC--CCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence 4567889888 78889999999999999999986422 223346778999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 92 DYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 92 e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
|||++|+|.+++.. .+++..+..+..++..++.++|.. |||||+|||++.++.++|+|||++........
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 157 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-- 157 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe--
Confidence 99999999888742 245556667778888889999875 79999999999999999999999986543222
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.....||..|+|||++.+..++.++|||||||++|+|++|..||............. .. +.. .....
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~--------~~~--~~~~~ 224 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---RR--------VKE--DQEEY 224 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH---HH--------hhc--ccccC
Confidence 223468999999999998899999999999999999999999997643321111110 00 000 01123
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH--HHhcc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPT-----MTDVVD--WLKGG 279 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps-----~~~il~--~l~~~ 279 (325)
+...+..+.+|+.+||..||.+||+ ++++++ ||+..
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 3456778999999999999999997 889988 77654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=276.82 Aligned_cols=263 Identities=21% Similarity=0.258 Sum_probs=206.9
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEc--CCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAG--GDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 88 (325)
+-|..+.+|++| ++|.||.++++.+++.||+|.++... .....--.+|+.+|.+++|||||.+..+..- -+.+|
T Consensus 76 ~efe~lnrI~EG--tyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 76 EEFEKLNRIEEG--TYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHhhcccC--cceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 457888999999 89999999999999999999997532 2223356789999999999999999998754 46799
Q ss_pred EEEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 89 IVYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
+|||||+. ||...+. +.+...++..+..|+..++.++|.+ |||||+|+|+++.|.+||+|||+|+..+....
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 99999976 8888884 4577788889999999999999985 99999999999999999999999998877643
Q ss_pred eeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccC----
Q 046728 162 HMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD---- 236 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 236 (325)
.. ...+-|.+|+|||++.+. .|+++.|+||+|||+.||+++.+.|.+...-+..+.+-..........|+.+..
T Consensus 233 ~~-T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 233 PY-TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred cC-cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 33 334579999999998865 689999999999999999999999987654333333322222233333332221
Q ss_pred ----------ccccCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 237 ----------PRLKGKFNRD-QLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 237 ----------~~~~~~~~~~-~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
..++..+... .++.-.+|+..+|.+||.+|.|+++.++ ||.+.
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 1222222222 5678899999999999999999999998 88874
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=290.53 Aligned_cols=263 Identities=18% Similarity=0.204 Sum_probs=198.3
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
...|.+.+.||.| +++.||++.+..++..+|+|.+... .......+.+|++++++++||||+++++++.++...++|
T Consensus 4 ~~~y~~~~~lg~g--~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAG--NGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred hhhhheeccccCC--CCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 3568889999999 7778999999999999999998753 334456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhh-----cCCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 91 YDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEG-----IADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~-----~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
|||+++|+|.++++. .++...+..+..++..++.++|. |+||||+|||++.++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--- 158 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 158 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc---
Confidence 999999999999953 35555667788888899999985 37999999999999999999999987553321
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhh-hccccc-----------ccc-
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQW-VTPYVQ-----------KGA- 230 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~-~~~~~~-----------~~~- 230 (325)
.....++..|+|||++.+..++.++|+|||||++|+|++|..||.............. ...... ...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL 238 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence 2234588999999999988899999999999999999999999965332111100000 000000 000
Q ss_pred ----------------cccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 231 ----------------FEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 231 ----------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
...+.............+.++.+||.+||..||++|||+.+++. ||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 00000000000001124567999999999999999999999998 88754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=290.43 Aligned_cols=239 Identities=20% Similarity=0.264 Sum_probs=191.4
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPN 96 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~ 96 (325)
.||.| +++.||++++..+++.||+|.+... .......+.+|+.+++.++||||+++++++...+..|+||||+++
T Consensus 2 ~lG~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 2 LLGKG--TFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred eeeeC--CCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 56777 8888999999999999999999643 233445677899999999999999999999999999999999999
Q ss_pred CChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCCC
Q 046728 97 HSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGT 170 (325)
Q Consensus 97 gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t 170 (325)
|+|..++. ..+++..+..+..++..++.++|.+ |||||+|||++.++.+||+|||++........ ......||
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~gt 158 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGT 158 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccccccCC
Confidence 99998884 3356677788889999999999986 79999999999999999999999875322211 12234589
Q ss_pred cCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHH
Q 046728 171 LGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKS 250 (325)
Q Consensus 171 ~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (325)
+.|+|||++.+..++.++|||||||++|+|++|..||........... . ... ....+..+++.
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~---~------------~~~--~~~~p~~~~~~ 221 (323)
T cd05595 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL---I------------LME--EIRFPRTLSPE 221 (323)
T ss_pred cCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH---H------------hcC--CCCCCCCCCHH
Confidence 999999999988999999999999999999999999965332111100 0 000 01223456778
Q ss_pred HHHHHHHccCCCCCCCC-----CHHHHHH--HHhc
Q 046728 251 MVLIALRCTDSNPENRP-----TMTDVVD--WLKG 278 (325)
Q Consensus 251 ~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~ 278 (325)
+.+||.+||..||++|| ++.++++ ||.+
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 222 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred HHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 99999999999999998 8999987 6654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=312.89 Aligned_cols=252 Identities=24% Similarity=0.314 Sum_probs=198.8
Q ss_pred cchhHHhhccCccceeeeeEEEeccCC---CCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETG---DDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~---~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
+..++.+.||.|.+|.++-..+.+..+ ...||||.+... +......|.+|..+|++++|||||+++|++.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 345677889999766666666666665 346999999754 5666679999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhccC---CCCCCccCHHHHHHHHHHHHhhc----------CCCCCCceeeCCCCceEEeeeccccc
Q 046728 89 IVYDYMPNHSLITHLHGR---LAPDCLLDWHRRVSIAIGSAEGI----------ADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~----------rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
|++|||+||||..||++. .-....+.....+.+++++|.|+ |||..+|||++....+||+|||+|+.
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHh
Confidence 999999999999999643 11133455666666777776664 89999999999999999999999995
Q ss_pred cCCCcceeeccC-CCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhccccccccccc
Q 046728 156 IPDGVTHMTTRV-KGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEH 233 (325)
Q Consensus 156 ~~~~~~~~~~~~-~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (325)
............ .-+..|||||.+..+.|+.|+|||||||++||++| |..||......+. .. .
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v---~~------------~ 916 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV---LL------------D 916 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH---HH------------H
Confidence 555444433322 34578999999999999999999999999999999 8999976543221 11 1
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 234 IADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
+...+ +.+.|..++..+.++|.+||..+|++||++..|++.+..+.
T Consensus 917 ~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 917 VLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred HHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 11222 44667788999999999999999999999999999776664
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=286.96 Aligned_cols=258 Identities=15% Similarity=0.178 Sum_probs=192.0
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
..|.+++.||.| +++.||.+++..+++.||+|.+.... ......+.+|++++++++||||+++++++.+....++||
T Consensus 5 ~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEG--TYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccceEeeEEecC--CCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 357888999999 77889999999999999999986432 223446778999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 92 DYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 92 e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||+. |+|.+++.. .++...+..+..++..+++++|.. |||||+|||++.++.+||+|||++......... .
T Consensus 83 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~-~ 160 (288)
T cd07871 83 EYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT-Y 160 (288)
T ss_pred eCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc-c
Confidence 9996 499998843 234455677888999999999985 799999999999999999999998765432221 2
Q ss_pred ccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccc---------c
Q 046728 165 TRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEH---------I 234 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------~ 234 (325)
....++..|+|||++.+ ..++.++||||+||++|+|+||..||...........+...........+.. .
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 23457889999998875 4688999999999999999999999976433221111111000000000110 0
Q ss_pred cCcccc----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 235 ADPRLK----GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 235 ~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
..+... .......++++.+||.+||..||.+|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000 0011235678999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=290.53 Aligned_cols=239 Identities=21% Similarity=0.278 Sum_probs=191.6
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPN 96 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~ 96 (325)
.||+| +++.||++++..+++.||+|.+... .......+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 2 ~lG~G--~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 2 LLGKG--TFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred eeeeC--CCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 56777 8889999999999999999999643 233445788899999999999999999999999999999999999
Q ss_pred CChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCCC
Q 046728 97 HSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGT 170 (325)
Q Consensus 97 gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t 170 (325)
|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||++........ ......||
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~~gt 158 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKTFCGT 158 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccccccCC
Confidence 99998884 3356666777888999999999985 79999999999999999999999875332211 12334689
Q ss_pred cCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHH
Q 046728 171 LGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKS 250 (325)
Q Consensus 171 ~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (325)
+.|+|||++.+..++.++|||||||++|+|++|..||....... ..... ... ....+...+++
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~~~~------------~~~--~~~~p~~~~~~ 221 (328)
T cd05593 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELI------------LME--DIKFPRTLSAD 221 (328)
T ss_pred cCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HHHHh------------ccC--CccCCCCCCHH
Confidence 99999999998889999999999999999999999996532211 11100 000 11233456778
Q ss_pred HHHHHHHccCCCCCCCC-----CHHHHHH--HHhc
Q 046728 251 MVLIALRCTDSNPENRP-----TMTDVVD--WLKG 278 (325)
Q Consensus 251 ~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~ 278 (325)
+.+||.+||..||++|| ++.++++ ||..
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 99999999999999997 8999997 5543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=288.84 Aligned_cols=254 Identities=21% Similarity=0.279 Sum_probs=213.5
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh---hhHHHHHHHHHHHHccC-CCCccceeeEEEcC
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA---KAEMEFAVEVEILGRVR-HRNLLGLRGFYAGG 84 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 84 (325)
-.+...|.+.+.||.| .|+.|+.+.+..+|+.+|+|.+.+... .....+.+|+++|+++. ||||+.++++|++.
T Consensus 31 ~~~~~~Y~l~~~lG~G--~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRG--QFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred ccccccEEehhhhCCC--CceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 3455668888999999 888899999999999999999975432 23458889999999997 99999999999999
Q ss_pred CeEEEEEEecCCCChhhhhccC-CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC----CceEEeeeccccc
Q 046728 85 DERLIVYDYMPNHSLITHLHGR-LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD----FEAKVADFGFAKL 155 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~----~~~kL~Dfg~~~~ 155 (325)
..+++|||+|.||.|.+.+... +++..+.....++..++.++|.+ |||||+|+|+... +.++++|||++..
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 9999999999999999999665 88888889999999999999986 7999999999643 4799999999998
Q ss_pred cCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccccc
Q 046728 156 IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIA 235 (325)
Q Consensus 156 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (325)
... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||........... +..+.+
T Consensus 189 ~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~-------i~~~~~---- 255 (382)
T KOG0032|consen 189 IKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA-------ILRGDF---- 255 (382)
T ss_pred ccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH-------HHcCCC----
Confidence 776 3345567899999999999989999999999999999999999999987553222221 111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 236 DPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
....+.+...+..+.++|..|+..||.+|+|+.++++ |+.+.
T Consensus 256 --~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 256 --DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred --CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 2234556778899999999999999999999999999 77654
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=289.12 Aligned_cols=250 Identities=19% Similarity=0.248 Sum_probs=194.2
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
..+.+++.||.| +++.||+++...+++.||||.+... .......+.+|+++++.++|+||+++++++.....+++||
T Consensus 74 ~~~~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 74 SELERVNRIGSG--AGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHhhhhhccCC--CCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 457888999999 7888999999989999999998643 3344567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccC
Q 046728 92 DYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRV 167 (325)
Q Consensus 92 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 167 (325)
||+.+|+|.+... ..+..+..+..++..++.++|.. |||||+|||++.++.+||+|||++........ .....
T Consensus 152 e~~~~~~L~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~ 228 (353)
T PLN00034 152 EFMDGGSLEGTHI--ADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSS 228 (353)
T ss_pred ecCCCCccccccc--CCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-ccccc
Confidence 9999999976542 23445567888999999999975 79999999999999999999999986543221 12234
Q ss_pred CCCcCCCCcccccc-----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 168 KGTLGYLAPEYAMW-----GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 168 ~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
.||..|+|||++.. ...+.++|||||||++|+|++|..||................ ......
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-------------~~~~~~ 295 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-------------MSQPPE 295 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-------------ccCCCC
Confidence 68999999998753 223568999999999999999999997332211111111000 000112
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
.+...+.++.+||.+||..||++|||+.++++ ||....
T Consensus 296 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 296 APATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 23456678999999999999999999999998 777643
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=291.75 Aligned_cols=239 Identities=20% Similarity=0.268 Sum_probs=191.0
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPN 96 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~ 96 (325)
.||+| +++.||++++..+++.||+|.+... ......++.+|.+++..++||||+++++++......|+||||+++
T Consensus 2 ~lG~G--~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 2 LLGKG--TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred eeeeC--CCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46777 8888999999999999999999642 233445777899999999999999999999999999999999999
Q ss_pred CChhhhhc--cCCCCCCccCHHHHHHHHHHHHhh-----cCCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCC
Q 046728 97 HSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEG-----IADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169 (325)
Q Consensus 97 gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~-----~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 169 (325)
|+|..++. ..+++..+..+..++..++.++|. ||||||+|||++.++.+||+|||++......... .....|
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~g 158 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MKTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-cccccC
Confidence 99999884 345666777888999999999996 3899999999999999999999998754322211 223458
Q ss_pred CcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHH
Q 046728 170 TLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249 (325)
Q Consensus 170 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (325)
|..|+|||++.+..++.++|||||||++|+|++|..||........ .... ... ....+...++
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~---~~~i------------~~~--~~~~p~~~~~ 221 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELI------------LME--EIRFPRTLSP 221 (325)
T ss_pred CcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH---HHHH------------hcC--CCCCCCCCCH
Confidence 9999999999988999999999999999999999999965332111 1100 000 0112334567
Q ss_pred HHHHHHHHccCCCCCCCC-----CHHHHHH--HHhc
Q 046728 250 SMVLIALRCTDSNPENRP-----TMTDVVD--WLKG 278 (325)
Q Consensus 250 ~~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~ 278 (325)
++.+||.+||..||++|+ ++.++++ ||..
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 899999999999999997 8999997 6654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=270.60 Aligned_cols=255 Identities=19% Similarity=0.244 Sum_probs=210.4
Q ss_pred eeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEec--ccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC
Q 046728 8 CFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD 85 (325)
Q Consensus 8 ~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (325)
+-.+...|.+-++||+| .|+.|+-+-+..+|+.+|+|+++ +.+....+.+.+|+.|-+.|+||||+++++.+....
T Consensus 6 ~~~f~d~y~l~e~igkG--~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~ 83 (355)
T KOG0033|consen 6 STKFSDNYDVKEELGKG--AFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES 83 (355)
T ss_pred ccccchhhhHHHHHccC--chHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccc
Confidence 34567789999999999 77778888899999999999985 345556779999999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhh--ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC---CCceEEeeecccccc
Q 046728 86 ERLIVYDYMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT---DFEAKVADFGFAKLI 156 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l--~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~---~~~~kL~Dfg~~~~~ 156 (325)
..|+|+|++.|++|..-| +.-+++..+-.+.+|+..++.+.|.. ||+||.|.++.. ...+||+|||++..+
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred eeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999999999997766 22355666677889999999999874 899999999953 345999999999988
Q ss_pred CCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccC
Q 046728 157 PDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD 236 (325)
Q Consensus 157 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (325)
.. ......+.||+.|+|||++...+|+..+||||.|++||-++.|.+||.+.+.....+.+. .+ .
T Consensus 164 ~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~-------~g------~ 228 (355)
T KOG0033|consen 164 ND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK-------AG------A 228 (355)
T ss_pred CC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh-------cc------c
Confidence 73 344556789999999999999999999999999999999999999998644322221111 11 1
Q ss_pred ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 237 PRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 237 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
....++.+...+++..+|+.+||..||++|+|+.|+++ |+.+.
T Consensus 229 yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 229 YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 12234567788899999999999999999999999998 77653
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=287.22 Aligned_cols=238 Identities=19% Similarity=0.285 Sum_probs=189.6
Q ss_pred ccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCCC
Q 046728 21 INNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNH 97 (325)
Q Consensus 21 i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~g 97 (325)
||+| +++.||++++..+++.||+|.+... .......+..|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 lg~G--~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKG--SFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG 78 (312)
T ss_pred CCcC--CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence 4555 8889999999999999999998642 2344457788999999999999999999999999999999999999
Q ss_pred Chhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCCCc
Q 046728 98 SLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTL 171 (325)
Q Consensus 98 sL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~ 171 (325)
+|.+++. ..++......+..++..++.++|.. |||||+|||++.++.++|+|||++........ ......||+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~ 157 (312)
T cd05585 79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFCGTP 157 (312)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccccCCc
Confidence 9999994 3456666777888999999999985 79999999999999999999999875433221 223456899
Q ss_pred CCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHH
Q 046728 172 GYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSM 251 (325)
Q Consensus 172 ~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (325)
.|+|||++.+..++.++|||||||++|+|++|..||....... .. .. +... ....+...++.+
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~---~~---~~---------~~~~--~~~~~~~~~~~~ 220 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE---MY---RK---------ILQE--PLRFPDGFDRDA 220 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH---HH---HH---------HHcC--CCCCCCcCCHHH
Confidence 9999999998899999999999999999999999997533211 10 00 0000 112334566789
Q ss_pred HHHHHHccCCCCCCCCC---HHHHHH--HHhc
Q 046728 252 VLIALRCTDSNPENRPT---MTDVVD--WLKG 278 (325)
Q Consensus 252 ~~li~~cl~~dp~~Rps---~~~il~--~l~~ 278 (325)
.+||.+||..||++||+ +.++++ ||..
T Consensus 221 ~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 221 KDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred HHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence 99999999999999975 677776 6654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=293.88 Aligned_cols=251 Identities=19% Similarity=0.240 Sum_probs=197.3
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..|.+++.||.| +++.||++++..+++.||+|.+... .......+.+|+.+++.++||||+++++++.++...|+
T Consensus 43 ~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 43 EDFDVIKVIGRG--AFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred HHcEEEEEEeeC--CCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 457788889988 7888999999999999999999642 22333457789999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcc-CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 90 VYDYMPNHSLITHLHG-RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|||||++|+|.++++. .+++..+..+..++..++.++|.+ |||||+|||++.++.+||+|||++...........
T Consensus 121 v~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~ 200 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC 200 (370)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccC
Confidence 9999999999999854 355566667788899999999975 79999999999999999999999986654332223
Q ss_pred ccCCCCcCCCCccccccC----CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 165 TRVKGTLGYLAPEYAMWG----KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~----~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
....||+.|+|||++.+. .++.++|||||||++|+|++|..||........ ...+.. . ...+.
T Consensus 201 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~i~~---~-------~~~~~ 267 (370)
T cd05596 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YSKIMD---H-------KNSLT 267 (370)
T ss_pred CCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH---HHHHHc---C-------CCcCC
Confidence 345689999999998653 378899999999999999999999976432111 010000 0 00111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH--HHhc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPEN--RPTMTDVVD--WLKG 278 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~~il~--~l~~ 278 (325)
.+.....+..+.+||.+||..+|.+ |+|++++++ ||+.
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 268 FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 1222346788999999999999988 999999998 7764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=293.82 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=190.1
Q ss_pred chhHHhhccCccceeeeeEEEeccC-----CCCeEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCe
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRET-----GDDQIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~-----~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 86 (325)
.|.+.+.||.| +++.||.+.... ++..||+|.+... .......+.+|+++++.+ +||||+++++++.....
T Consensus 39 ~~~~~~~LG~G--~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 39 NLQFGKTLGAG--AFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HceehheecCC--CcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 47889999999 677788776433 3457999999743 344456788999999999 89999999999999999
Q ss_pred EEEEEEecCCCChhhhhccC------------------------------------------------------------
Q 046728 87 RLIVYDYMPNHSLITHLHGR------------------------------------------------------------ 106 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~~------------------------------------------------------------ 106 (325)
.++|||||++|+|.++++..
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999999999998421
Q ss_pred ------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce-eeccCCC
Q 046728 107 ------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH-MTTRVKG 169 (325)
Q Consensus 107 ------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~ 169 (325)
++...++.+..++..++.++|.. |||||+|||++.++.++|+|||++......... ......+
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~ 276 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCC
Confidence 11122345677888888888864 799999999999999999999999865433221 1222335
Q ss_pred CcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHH
Q 046728 170 TLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQL 248 (325)
Q Consensus 170 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (325)
+..|+|||++.+..++.++|||||||++|+|++ |..||........ ..... ........+...+
T Consensus 277 ~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~~~~-------------~~~~~~~~~~~~~ 341 (374)
T cd05106 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FYKMV-------------KRGYQMSRPDFAP 341 (374)
T ss_pred ccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HHHHH-------------HcccCccCCCCCC
Confidence 667999999988889999999999999999997 9999975432110 00000 0111111222345
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 249 KSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 249 ~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
+++.+++.+||..||++|||+.++++.|++++
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 78999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=283.47 Aligned_cols=255 Identities=22% Similarity=0.344 Sum_probs=189.8
Q ss_pred cchhHHhhccCccceeeeeEEEecc----------------CCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCcc
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRE----------------TGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLL 75 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~----------------~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv 75 (325)
..|.+.++||.| +++.||++... .++..||+|.+... .......+.+|++++.+++||||+
T Consensus 5 ~~~~~~~~lg~G--~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 5 GHLLFKEKLGEG--QFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhCeeeeEeccc--CCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 457788999998 77778887632 23457999998753 344556799999999999999999
Q ss_pred ceeeEEEcCCeEEEEEEecCCCChhhhhccCC---------------------CCCCccCHHHHHHHHHHHHhhc----C
Q 046728 76 GLRGFYAGGDERLIVYDYMPNHSLITHLHGRL---------------------APDCLLDWHRRVSIAIGSAEGI----A 130 (325)
Q Consensus 76 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~----r 130 (325)
++++++.+....++||||+.+|+|.+++.... +....+.+..++..++.++|.. |
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 99999999999999999999999999984321 1112345778888888888875 7
Q ss_pred CCCCCceeeCCCCceEEeeeccccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh--CCCCC
Q 046728 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS--AKKPL 207 (325)
Q Consensus 131 dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t--g~~pf 207 (325)
||||+|||++.++.+||+|||++......... ......++..|+|||++.+..++.++||||||+++|+|++ +..||
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 99999999999999999999999865443222 2223345788999999988889999999999999999987 56777
Q ss_pred CCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 046728 208 EKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278 (325)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~ 278 (325)
....... ............. .......+..+++.+.+|+.+||..||++|||+++|.+.|++
T Consensus 243 ~~~~~~~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 243 GELTDEQ---VIENAGEFFRDQG------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CcCCHHH---HHHHHHHHhhhcc------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 6543221 1111111000000 000111223456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=295.89 Aligned_cols=266 Identities=18% Similarity=0.262 Sum_probs=203.7
Q ss_pred CCcccceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-C-----CCcc
Q 046728 2 QNHRNICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-H-----RNLL 75 (325)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~iv 75 (325)
..||.++| .|.+++.||+| +|+.|+.+.+..+++.||||+++. .+....+-..|+.+|..|+ | -|+|
T Consensus 179 v~~d~i~~----rY~V~e~LGkG--tFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~V 251 (586)
T KOG0667|consen 179 VVNDHIAY----RYEVLEVLGKG--SFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIV 251 (586)
T ss_pred EecceeEE----EEEEEEEeccc--ccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEE
Confidence 45778888 67999999999 899999999999999999999986 4455567778999999997 4 3999
Q ss_pred ceeeEEEcCCeEEEEEEecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC--Cce
Q 046728 76 GLRGFYAGGDERLIVYDYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD--FEA 145 (325)
Q Consensus 76 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~--~~~ 145 (325)
+++++|...++.|||+|.+ .-+|.++++. .++...+..+..|+..++..+|.+ +||||+|||+.+. ..+
T Consensus 252 rm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~v 330 (586)
T KOG0667|consen 252 RMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRI 330 (586)
T ss_pred Eeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCce
Confidence 9999999999999999999 4599999963 255566778888999999999886 6999999999765 469
Q ss_pred EEeeeccccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhc--
Q 046728 146 KVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVT-- 223 (325)
Q Consensus 146 kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~-- 223 (325)
||+|||.++...... .+...++.|+|||++.+.+|+.+.||||||||+.||++|.+.|.+....+....+..+.
T Consensus 331 KVIDFGSSc~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~ 406 (586)
T KOG0667|consen 331 KVIDFGSSCFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGL 406 (586)
T ss_pred eEEecccccccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCC
Confidence 999999999765532 25567899999999999999999999999999999999998886543322211111000
Q ss_pred -------------ccccc--cccc-----c-----------------ccC---c----cccCCCCHHHHHHHHHHHHHcc
Q 046728 224 -------------PYVQK--GAFE-----H-----------------IAD---P----RLKGKFNRDQLKSMVLIALRCT 259 (325)
Q Consensus 224 -------------~~~~~--~~~~-----~-----------------~~~---~----~~~~~~~~~~~~~~~~li~~cl 259 (325)
+.... +... . ... + .+...........+.++|.+||
T Consensus 407 Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L 486 (586)
T KOG0667|consen 407 PPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCL 486 (586)
T ss_pred CCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHh
Confidence 00000 0000 0 000 0 0001111234457899999999
Q ss_pred CCCCCCCCCHHHHHH--HHhcc
Q 046728 260 DSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 260 ~~dp~~Rps~~~il~--~l~~~ 279 (325)
..||.+|+|+.++++ ||...
T Consensus 487 ~~dP~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 487 EWDPAERITPAQALNHPFLTGT 508 (586)
T ss_pred ccCchhcCCHHHHhcCcccccc
Confidence 999999999999999 88844
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=292.72 Aligned_cols=249 Identities=22% Similarity=0.337 Sum_probs=188.8
Q ss_pred chhHHhhccCccceeeeeEEEec-----cCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCe
Q 046728 14 PAVFIQNINNGLEILMLLLLLRR-----ETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~-----~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 86 (325)
.|.+.+.||+| +++.||.+.. ..++..||+|.++.. .......+.+|+.++..+ +||||+++++++.....
T Consensus 36 ~~~~~~~LG~G--~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 36 RLSFGKTLGAG--AFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred HeehhheecCC--ccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 58889999999 6777877753 344678999998642 234445788999999999 89999999999999999
Q ss_pred EEEEEEecCCCChhhhhccC------------------------------------------------------------
Q 046728 87 RLIVYDYMPNHSLITHLHGR------------------------------------------------------------ 106 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~~------------------------------------------------------------ 106 (325)
.++|||||++|+|.++++..
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999999999998531
Q ss_pred -----------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee-e
Q 046728 107 -----------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM-T 164 (325)
Q Consensus 107 -----------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~-~ 164 (325)
++...+..+..++..++.++|.. |||||+|||++.++.++|+|||++.......... .
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 273 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence 11112344667888888888865 7999999999999999999999998665432211 1
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
....++..|+|||++.+..++.++|||||||++|+|++ |..||...+... .....+. . ......
T Consensus 274 ~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~----~---------~~~~~~ 338 (375)
T cd05104 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIK----E---------GYRMLS 338 (375)
T ss_pred CCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHH----h---------CccCCC
Confidence 22335667999999998899999999999999999998 889986543211 1111111 0 011111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
+...+.++.+|+.+||..||++|||+.++++.|+..
T Consensus 339 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 339 PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 223456899999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=291.70 Aligned_cols=258 Identities=18% Similarity=0.192 Sum_probs=194.0
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
..|.+++.||.| +++.||++.+..+++.||+|.... ..+.+|++++++++||||+++++++......++|||
T Consensus 92 ~~y~~~~~lg~G--~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 92 AGFSILETFTPG--AEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred CCcEEEEEEcCC--CCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 468889999999 788899999999999999997542 356789999999999999999999999999999999
Q ss_pred ecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeecc
Q 046728 93 YMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTR 166 (325)
Q Consensus 93 ~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 166 (325)
++. ++|..++. ..++...++.+..++..++.++|.+ |||||+|||++.++.++|+|||++.............
T Consensus 164 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 164 RYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence 994 68988884 3455666778889999999999985 7999999999999999999999997543322222334
Q ss_pred CCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCcc-----chhhhhhccc-ccccccc--------
Q 046728 167 VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVK-----RDIVQWVTPY-VQKGAFE-------- 232 (325)
Q Consensus 167 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-----~~~~~~~~~~-~~~~~~~-------- 232 (325)
..||+.|+|||++.+..++.++|||||||++|+|++|..||........ ......+... .....+.
T Consensus 243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~ 322 (391)
T PHA03212 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322 (391)
T ss_pred ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence 5689999999999988999999999999999999999988754321100 0000000000 0000000
Q ss_pred ----c-----ccCccccC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 233 ----H-----IADPRLKG--KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 233 ----~-----~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
. ...+..+. ......+.++.+||.+||..||++|||++++++ ||+.+
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 0 00000000 001235678999999999999999999999998 88764
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=293.83 Aligned_cols=250 Identities=21% Similarity=0.302 Sum_probs=194.5
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|.+++.||.| +++.||++++..+++.||+|.+... .......+.+|+.++++++||||+++++++.+.+.+++|
T Consensus 2 ~f~~~~~LG~G--~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIG--AFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred CceEEEEEeec--CCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence 57788999999 8888999999999999999999643 233445788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc---
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT--- 161 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--- 161 (325)
||||++|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++.++.++|+|||++........
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 99999999999984 3455666677888999999999986 79999999999999999999999764311000
Q ss_pred -------------------------------------------eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHH
Q 046728 162 -------------------------------------------HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLL 198 (325)
Q Consensus 162 -------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ 198 (325)
.......||..|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence 0012346899999999999888999999999999999
Q ss_pred HHHhCCCCCCCCCCCccc-hhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHH--ccCCCCCCCCCHHHHHH-
Q 046728 199 ELISAKKPLEKLPGGVKR-DIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALR--CTDSNPENRPTMTDVVD- 274 (325)
Q Consensus 199 el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~--cl~~dp~~Rps~~~il~- 274 (325)
||++|..||......... ....+ ...+..+....+++++.+||.+ |+..+|..||+++++++
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~--------------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINW--------------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHcc--------------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999999754321111 00000 0011112223456788999988 55666667999999998
Q ss_pred -HHhcc
Q 046728 275 -WLKGG 279 (325)
Q Consensus 275 -~l~~~ 279 (325)
||+..
T Consensus 306 p~f~~~ 311 (381)
T cd05626 306 PFFSEV 311 (381)
T ss_pred cccCCC
Confidence 77653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=280.20 Aligned_cols=248 Identities=21% Similarity=0.378 Sum_probs=193.7
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCC-----CeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGD-----DQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~-----~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
..+.+.+.||.| +++.||.+.....+ ..||+|.+... .......+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~~~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 5 SAVRFLEELGEG--AFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred HHcchhhcccCc--cCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 367899999999 67778877755444 68999998643 34445678899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhccC------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCc
Q 046728 87 RLIVYDYMPNHSLITHLHGR------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFE 144 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~~------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~ 144 (325)
.+++|||+++|+|.+++... ++...++.+..++..++.++|.. +||||+||+++.++.
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc
Confidence 99999999999999999532 12223456778888888888875 799999999999999
Q ss_pred eEEeeeccccccCCCcc-eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhh
Q 046728 145 AKVADFGFAKLIPDGVT-HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWV 222 (325)
Q Consensus 145 ~kL~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~ 222 (325)
++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+..... ....+
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~~i 239 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIEMI 239 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH
Confidence 99999999875533221 11223346788999999988889999999999999999998 999997643311 11111
Q ss_pred cccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 046728 223 TPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278 (325)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~ 278 (325)
. .......+..+++++.+|+.+||..||++|||+.+|+++|++
T Consensus 240 ~-------------~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 R-------------SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H-------------cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1 011112345677899999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=284.54 Aligned_cols=267 Identities=16% Similarity=0.216 Sum_probs=196.1
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
|.-...|.+++.||.| +++.||.++...+++.||+|.+.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 1 ~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (303)
T cd07869 1 FGKADSYEKLEKLGEG--SYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETL 78 (303)
T ss_pred CCccccceEeeeEEec--CCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeE
Confidence 3445678889999999 78889999999899999999987432 22234677899999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 88 LIVYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
++||||+. ++|.+++. ..+.+..+..+..++..++.++|.. |||||+|||++.++.+||+|||++.......
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred EEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 99999995 68888874 2356666788889999999999985 7999999999999999999999987543322
Q ss_pred ceeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCcc-chhhhhhcccccccccc------
Q 046728 161 THMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVK-RDIVQWVTPYVQKGAFE------ 232 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~------ 232 (325)
.. .....++..|+|||++.+ ..++.++||||+||++|+|++|..||........ ...+...........+.
T Consensus 158 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 158 HT-YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred cc-CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 11 223457899999998865 4578899999999999999999999976432100 00000000000000000
Q ss_pred cccCccccCCCC---------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 233 HIADPRLKGKFN---------RDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 233 ~~~~~~~~~~~~---------~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
...........+ ...++.+.+|+.+||..||++|||+.++++ ||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 000000000000 113457889999999999999999999998 88754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=294.50 Aligned_cols=250 Identities=19% Similarity=0.266 Sum_probs=196.7
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|.+++.||.| +++.||++++..+++.||||.+... .......+.+|+.+++.++||||+++++++.++..+|+|
T Consensus 2 ~y~~~~~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 2 DFESIKVIGRG--AFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CceEEEEEEec--CCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence 46778999999 7888999999999999999999643 233445678899999999999999999999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce--
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH-- 162 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~-- 162 (325)
||||++|+|.+++. +.+++..+..+..++..++.++|.. |||||+|||++.++.++|+|||++..+......
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 99999999999984 3466777788899999999999986 799999999999999999999998754321100
Q ss_pred -----------------------------------eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCC
Q 046728 163 -----------------------------------MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPL 207 (325)
Q Consensus 163 -----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 207 (325)
......||+.|+|||++....++.++|||||||++|+|++|..||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 011235899999999999888999999999999999999999999
Q ss_pred CCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHH--HHhcc
Q 046728 208 EKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPT---MTDVVD--WLKGG 279 (325)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~~il~--~l~~~ 279 (325)
....... ....+... ...+..+.....++.+.+||.+|+. +|.+|++ ++++++ ||+..
T Consensus 240 ~~~~~~~---~~~~i~~~----------~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 240 CSDNPQE---TYRKIINW----------KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHH---HHHHHHcC----------CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 7543211 11111000 0001111112456789999999996 9999998 999998 77543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=294.40 Aligned_cols=249 Identities=22% Similarity=0.293 Sum_probs=198.8
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|.+++.||.| +++.||+++...+++.||||.+.... ......+.+|+.++..++||||+++++++.++...++|
T Consensus 2 ~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 2 DFEVIKVIGRG--AFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CceEEEEEEeC--CcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 46778899999 88889999999999999999997432 23445788899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc----
Q 046728 91 YDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV---- 160 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---- 160 (325)
|||+++++|.+++.. .+++..+..+..++..++.++|.. |||||+|||++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 999999999999953 466667778888999999999985 7999999999999999999999998665433
Q ss_pred ------------------------ceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccc
Q 046728 161 ------------------------THMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKR 216 (325)
Q Consensus 161 ------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~ 216 (325)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 11123346899999999999889999999999999999999999999764421111
Q ss_pred hhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH--HHhc
Q 046728 217 DIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPT-MTDVVD--WLKG 278 (325)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-~~~il~--~l~~ 278 (325)
..+.... .....+.....++.+.+||.+||. ||.+||+ ++++++ ||+.
T Consensus 240 ---~~i~~~~----------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 240 ---NKIINWK----------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred ---HHHhccC----------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 0000000 011111122257889999999997 9999999 999998 7764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=292.48 Aligned_cols=238 Identities=23% Similarity=0.314 Sum_probs=196.6
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|.=++.||-| +||.||.+++..+.+.||||.+.-. +.+-...+.+|+..|.+++|||++.+.|+|......|+|
T Consensus 27 lf~dLrEIGHG--SFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 27 LFSDLREIGHG--SFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHhcCC--ccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 35667889999 8888999999999999999999633 333345788899999999999999999999999999999
Q ss_pred EEecCCCChhhhh---ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 91 YDYMPNHSLITHL---HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 91 ~e~~~~gsL~~~l---~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||||-| +-.|.+ +..+.+-.+..++.....++.|+|+| ||||+.|||++++|.|||+|||.+.....
T Consensus 105 MEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----- 178 (948)
T KOG0577|consen 105 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----- 178 (948)
T ss_pred HHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence 999955 665555 66777878888888889999999987 89999999999999999999999987654
Q ss_pred eccCCCCcCCCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 164 TTRVKGTLGYLAPEYAM---WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
.+.++||+.|||||++. .+.|+.++||||||+++.|+.-+.+|+..+..- ..+..+.....+
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM---------------SALYHIAQNesP 243 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---------------SALYHIAQNESP 243 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH---------------HHHHHHHhcCCC
Confidence 45578999999999986 357999999999999999999999998765431 111222222222
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.....+-+..+..++..||.+-|.+|||.++++.
T Consensus 244 tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 244 TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 2334566788999999999999999999999997
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=301.28 Aligned_cols=242 Identities=21% Similarity=0.303 Sum_probs=193.6
Q ss_pred hhHHhhccCccceeeeeEEEeccCC-CCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEe
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETG-DDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~ 93 (325)
|.+.+.||.| +++.||.+.+..+ ++.||+|.+..........+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus 69 y~~~~~lg~G--~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 69 YVLTTLVGRN--PTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred EEEEEEEEeC--CCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 7888899988 7777898887777 788999987665555556788899999999999999999999999999999999
Q ss_pred cCCCChhhhhccC------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc-e
Q 046728 94 MPNHSLITHLHGR------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT-H 162 (325)
Q Consensus 94 ~~~gsL~~~l~~~------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~ 162 (325)
+++|+|.++++.. +++..+..++.++..++.++|.. |||||+|||++.++.+||+|||+++....... .
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 226 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence 9999999888532 44445566778889999999875 89999999999999999999999987654322 1
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ........ .+. ..+
T Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---~~~~~~~~----~~~---------~~~ 290 (478)
T PTZ00267 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---REIMQQVL----YGK---------YDP 290 (478)
T ss_pred cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH----hCC---------CCC
Confidence 22345689999999999988899999999999999999999999965322 11111100 000 012
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.+..++..+.+||.+||..||++|||+.+++.
T Consensus 291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 23345678999999999999999999999986
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=291.35 Aligned_cols=251 Identities=18% Similarity=0.235 Sum_probs=196.1
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..|.+++.||.| +++.||++++..+++.||+|.+.+. .......+.+|+.+++.++||||+++++++.++...|+
T Consensus 43 ~~y~~~~~lG~G--~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 43 EDYDVVKVIGRG--AFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred HHCeEEEEEEec--CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 457788889888 8888999999999999999998642 22334467789999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcc-CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 90 VYDYMPNHSLITHLHG-RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|||||++|+|.++++. .+++..+..+..++..++.++|.+ |||||+|||++.++.+||+|||++...........
T Consensus 121 v~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~ 200 (370)
T cd05621 121 VMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRC 200 (370)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceec
Confidence 9999999999999953 355666777888999999999985 79999999999999999999999987654333333
Q ss_pred ccCCCCcCCCCccccccC----CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 165 TRVKGTLGYLAPEYAMWG----KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~----~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
....||+.|+|||++.+. .++.++||||+||++|+|++|..||........ ... .... ...+.
T Consensus 201 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~---~~~---i~~~-------~~~~~ 267 (370)
T cd05621 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT---YSK---IMDH-------KNSLN 267 (370)
T ss_pred ccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH---HHH---HHhC-------CcccC
Confidence 455699999999998754 377899999999999999999999975432110 000 0000 00111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH--HHhc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPEN--RPTMTDVVD--WLKG 278 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~~il~--~l~~ 278 (325)
.+.....+..+.+++..|+..++.+ |+|++++++ |++.
T Consensus 268 ~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 268 FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 1222345778999999999865543 889999998 8875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=287.87 Aligned_cols=244 Identities=23% Similarity=0.282 Sum_probs=191.7
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHH---HccCCCCccceeeEEEcCCeEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEIL---GRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l---~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
|.+++.||.| +++.||.++...+++.||||.+... .......+..|..++ +.++||||+++++++.+....|
T Consensus 1 y~i~~~lg~G--~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRG--HFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred CeEEEEEeec--CCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence 4567889988 7778999999999999999999743 223344666676665 4567999999999999999999
Q ss_pred EEEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 89 IVYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
+||||+++|+|..+++ +.+++..+..+..++..++.++|.. |||||+||+++.++.+||+|||++........ .
T Consensus 79 lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~ 157 (324)
T cd05589 79 FVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD-R 157 (324)
T ss_pred EEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC-c
Confidence 9999999999998885 3567777788899999999999986 79999999999999999999999875332211 2
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||........ ... +.... ...
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~---~~~------------i~~~~--~~~ 220 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV---FDS------------IVNDE--VRY 220 (324)
T ss_pred ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH---HHH------------HHhCC--CCC
Confidence 2345689999999999988899999999999999999999999975432111 110 00000 112
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH--HHhc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRP-----TMTDVVD--WLKG 278 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~ 278 (325)
+...++.+.++|.+||..||++|| ++.++++ |++.
T Consensus 221 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 221 PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 334567899999999999999999 5788877 6654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=294.26 Aligned_cols=250 Identities=21% Similarity=0.278 Sum_probs=193.9
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|.+++.||.| +++.||++++..+++.||+|.+.... ......+.+|+.++++++||||+++++++.++..+|+|
T Consensus 2 ~f~~~~~LG~G--~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIG--AFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CcEEEEEEEeC--CCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence 47788999999 78889999999999999999986432 23345788899999999999999999999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc----
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV---- 160 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---- 160 (325)
||||++|+|.+++. +.+++..+..+..++..+++++|.. |||||+|||++.++.++|+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 99999999999984 3356666777888999999999985 7999999999999999999999975321000
Q ss_pred ------------------------------------------ceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHH
Q 046728 161 ------------------------------------------THMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLL 198 (325)
Q Consensus 161 ------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ 198 (325)
........||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence 00011245899999999999889999999999999999
Q ss_pred HHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHH-
Q 046728 199 ELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPT---MTDVVD- 274 (325)
Q Consensus 199 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~~il~- 274 (325)
||++|..||........ ...+. .. ...+..+.....++++.++|.+|+ .+|++|++ ++++++
T Consensus 240 elltG~~Pf~~~~~~~~---~~~i~---~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 240 EMLVGQPPFLAQTPLET---QMKVI---NW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHhCCCCCCCCCHHHH---HHHHH---cc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 99999999975432110 00000 00 011111222345678889998876 59999997 999887
Q ss_pred -HHhcc
Q 046728 275 -WLKGG 279 (325)
Q Consensus 275 -~l~~~ 279 (325)
||+..
T Consensus 306 p~f~~~ 311 (382)
T cd05625 306 PFFKTI 311 (382)
T ss_pred CCcCCc
Confidence 77653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=290.18 Aligned_cols=244 Identities=20% Similarity=0.282 Sum_probs=194.6
Q ss_pred cchhHHhhccCccceeeeeEEEeccCC-CCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETG-DDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~-~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
..|.+++.||.| +++.||++....+ +..||+|.+... .......+.+|+.+++.++||||+++++++.+....+
T Consensus 30 ~~y~~~~~ig~G--~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 30 EDFNFIRTLGTG--SFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhcEEEEEEeec--CCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 357888999999 7778898876554 478999998642 2334457888999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 89 IVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
+||||+++|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++.++.++|+|||++......
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--- 184 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--- 184 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC---
Confidence 9999999999999994 3455666677888999999999985 799999999999999999999999865432
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+ .... ..
T Consensus 185 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~i------------~~~~--~~ 246 (340)
T PTZ00426 185 -TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL---IYQKI------------LEGI--IY 246 (340)
T ss_pred -cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH---HHHHH------------hcCC--CC
Confidence 223468999999999998889999999999999999999999997543211 11100 0000 11
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH--HHhcc
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRP-----TMTDVVD--WLKGG 279 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~~ 279 (325)
.+...++.+.++|.+||..||++|+ |++++++ ||...
T Consensus 247 ~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 247 FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 2334567889999999999999995 8999998 77653
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=293.46 Aligned_cols=257 Identities=22% Similarity=0.261 Sum_probs=197.5
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCC--CCeEEEEEecc---cChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETG--DDQIAVKRLKT---LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~--~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
.+...+.++||+|++|.++....+...+ ...||+|.... .......++++|+++|++++|||||+++|+......
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 4455667999999666665555555444 22389999874 357777899999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhccC---CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC
Q 046728 87 RLIVYDYMPNHSLITHLHGR---LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 159 (325)
+++|||+|+||+|.+|++.. ++......+..+.+.++.|+|+. |||-++|||++.++.+||+|||++.....
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~- 314 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ- 314 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc-
Confidence 99999999999999999642 33334455555566666666664 89999999999999999999999885431
Q ss_pred cceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 160 VTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 160 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
.........-++.|+|||.+....|+.++|||||||++||+++ |..||.+..... +.. .+...+
T Consensus 315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v~~------------kI~~~~ 379 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---VKA------------KIVKNG 379 (474)
T ss_pred eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---HHH------------HHHhcC
Confidence 1111112235789999999999999999999999999999998 788997755321 111 111222
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCCCc
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGRRT 284 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~ 284 (325)
.+.+.+...+..+..++.+||..||++|||+.++.++|+.+.....
T Consensus 380 ~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 380 YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 3334455667889999999999999999999999999998775444
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=277.97 Aligned_cols=249 Identities=20% Similarity=0.304 Sum_probs=192.5
Q ss_pred cchhHHhhccCccceeeeeEEEecc---CCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRE---TGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~---~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
..|.+.+.||+| +++.||.+... ..+..||+|.++.. .......+.+|+..+++++||||+++++++..+...+
T Consensus 5 ~~~~~~~~ig~G--~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 5 KSIKIERILGTG--RFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred HHeEEeeeeccc--CCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 346778889999 66777776543 34678999999754 3344457889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 89 IVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
+||||+++|+|.+++.. .++...++.+..++..++.++|.. |||||+||+++.++.++++|||.+........
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~ 162 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI 162 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence 99999999999999853 355566778888888899999875 79999999999999999999998765432221
Q ss_pred eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 162 HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
.......++..|+|||.+.+..++.++|||||||++|++++ |..||....... ....+. . ...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~----~---------~~~ 226 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKAVE----D---------GFR 226 (266)
T ss_pred hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHH----C---------CCC
Confidence 11222335678999999998899999999999999999775 999997543211 111110 0 111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
.+.+..++..+.+++.+||..+|++|||+++|++.|+..
T Consensus 227 ~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 123345667899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=291.65 Aligned_cols=250 Identities=21% Similarity=0.233 Sum_probs=197.5
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|.+.+.||.| +++.||+++...+++.||+|.+... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 2 ~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 2 DFDVKSLVGRG--HFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CceEEEEEEec--cCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence 46778899999 7888999999999999999999743 233455788899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 91 YDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
|||+++|+|.++++. .+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||++..........
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 999999999999953 356666777888999999999975 7999999999999999999999998765443333
Q ss_pred eccCCCCcCCCCccccc------cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 164 TTRVKGTLGYLAPEYAM------WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~------~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
.....||+.|+|||++. ...++.++|||||||++|+|++|..||........ ...+. ... .
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~~i~---~~~-------~ 226 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT---YNNIM---NFQ-------R 226 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH---HHHHH---cCC-------C
Confidence 33446899999999986 34678899999999999999999999965432111 00000 000 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
.+..+.....++.+.+|+..||. +|.+|||++++++ ||+..
T Consensus 227 ~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 227 FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 01111223456789999999998 9999999999997 77653
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=288.55 Aligned_cols=264 Identities=17% Similarity=0.251 Sum_probs=192.4
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC-----CeE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG-----DER 87 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 87 (325)
|.+.+.||.| +++.||.+.+..+++.||||.+... ......++.+|+.++++++||||+++++++... ...
T Consensus 2 y~i~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 2 YKIQEVIGKG--SYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred eEEEEEEeec--CCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5677889998 7888999999999999999998632 233445788999999999999999999987543 247
Q ss_pred EEEEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 88 LIVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
|+|||||. ++|.+++.. .++...+..+..++..++.++|.. |||||+|||++.++.+||+|||++........
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999994 699998843 466667778889999999999985 79999999999999999999999985433211
Q ss_pred e--eeccCCCCcCCCCcccccc--CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhh------------hccc
Q 046728 162 H--MTTRVKGTLGYLAPEYAMW--GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQW------------VTPY 225 (325)
Q Consensus 162 ~--~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~------------~~~~ 225 (325)
. ......+|..|+|||++.+ ..++.++|||||||++|+|++|..||...........+.. +...
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 1 1123468999999999875 5788999999999999999999999965432111100000 0000
Q ss_pred ccccccccccCccc--cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 226 VQKGAFEHIADPRL--KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 226 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
.....+........ .....+..++.+.+++.+||..||++|||++++++ ||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 00000000000000 00001234567899999999999999999999998 8876543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=275.18 Aligned_cols=246 Identities=26% Similarity=0.400 Sum_probs=198.4
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
..|.+.++||.| +++.||.+.... +..||+|.+..........+..|+++++.++||||+++++++.+....++|||
T Consensus 6 ~~y~~~~~ig~g--~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 6 EEFTLERKLGSG--YFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHhhhhccC--CCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 568999999999 777888888777 88999999987666566789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 93 YMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|+++++|.++++. .+.......+..++..+++++|.. +||||+||+++.++.++|+|||.+...........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~ 162 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS 162 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccccc
Confidence 9999999999953 234445566778888888888875 69999999999999999999999987654322222
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
...++..|+|||.+....++.++||||||+++|+|++ |..||...... ....... .....+.
T Consensus 163 -~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~~-------------~~~~~~~ 225 (261)
T cd05148 163 -DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQIT-------------AGYRMPC 225 (261)
T ss_pred -CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHH-------------hCCcCCC
Confidence 2335678999999988889999999999999999998 89999654321 1111111 0111223
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~ 278 (325)
+...++.+.+++.+||..||.+|||+.++++.|+.
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 34566789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=276.66 Aligned_cols=247 Identities=24% Similarity=0.396 Sum_probs=192.5
Q ss_pred cchhHHhhccCccceeeeeEEEeccC-----CCCeEEEEEecccChh-hHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRET-----GDDQIAVKRLKTLNAK-AEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
..|.+.+.||.| +++.||++.... ++..||+|.+...... ....+.+|+++++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g--~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 5 DTIVLKRELGEG--AFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred HHhhHHhhcccc--CCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 457899999999 777888876543 3578999999754333 45689999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhccC----------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceE
Q 046728 87 RLIVYDYMPNHSLITHLHGR----------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAK 146 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~~----------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~k 146 (325)
.++||||+++++|.++++.. ++...+..+..++..+++++|.. +||||+||+++.++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEE
Confidence 99999999999999999532 22333455677888888888875 79999999999999999
Q ss_pred EeeeccccccCCCcc-eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcc
Q 046728 147 VADFGFAKLIPDGVT-HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTP 224 (325)
Q Consensus 147 L~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~ 224 (325)
|+|||++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||........ .....
T Consensus 163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~~~~- 238 (280)
T cd05049 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IECIT- 238 (280)
T ss_pred ECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHH-
Confidence 999999875433221 11222335678999999998899999999999999999998 9999865433211 11111
Q ss_pred cccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 225 YVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
.+. ....+...+..+.+++.+||..||++|||+.++++.|+
T Consensus 239 ---~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 ---QGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---cCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 100 11122345678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=267.32 Aligned_cols=249 Identities=21% Similarity=0.303 Sum_probs=201.4
Q ss_pred hHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc----ChhhH----HHHHHHHHHHHcc-CCCCccceeeEEEcCCe
Q 046728 16 VFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL----NAKAE----MEFAVEVEILGRV-RHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 16 ~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~----~~~~~----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 86 (325)
.--+.+|.| +.+.|.-+.++.++..+|+|++... +.+.. ..-.+|+.||+++ .||+|+.+.++|+.+..
T Consensus 20 ~pkeilgrg--vss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 20 EPKEILGRG--VSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred ChHHHhccc--chhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 334556666 7777888889999999999998521 11222 2344699999999 69999999999999999
Q ss_pred EEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 87 RLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
.++|+|.|+.|.|+||+. -.++++....+.+++..+..++|+. |||||+|||++++.+++|+|||.++.+..+.
T Consensus 98 ~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge 177 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGE 177 (411)
T ss_pred hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCch
Confidence 999999999999999994 4477888899999999999999985 8999999999999999999999999887765
Q ss_pred ceeeccCCCCcCCCCccccccC------CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccc
Q 046728 161 THMTTRVKGTLGYLAPEYAMWG------KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHI 234 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~~------~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (325)
.. ...+||++|.|||.+... .|+..+|+||+|+++|.++.|.+||..... ..+...+..+.+
T Consensus 178 kL--relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------mlMLR~ImeGky--- 245 (411)
T KOG0599|consen 178 KL--RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------MLMLRMIMEGKY--- 245 (411)
T ss_pred hH--HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------HHHHHHHHhccc---
Confidence 43 345799999999998743 578889999999999999999999964221 111122222322
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 235 ADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
....+.+.+.+....+||.+||..||.+|+|+++++. |+..+.-
T Consensus 246 ---qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~ 291 (411)
T KOG0599|consen 246 ---QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ 291 (411)
T ss_pred ---ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence 2345677899999999999999999999999999998 7765543
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=286.16 Aligned_cols=249 Identities=21% Similarity=0.298 Sum_probs=193.5
Q ss_pred hhHHhhccCccceeeeeEEEecc---CCCCeEEEEEeccc----ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCe
Q 046728 15 AVFIQNINNGLEILMLLLLLRRE---TGDDQIAVKRLKTL----NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~---~~~~~vaiK~~~~~----~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 86 (325)
|.+++.||.| +++.||+++.. .+++.||+|.+... .......+..|.++++.+ +||||+++++++.....
T Consensus 2 y~~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (332)
T cd05614 2 FELLKVLGTG--AYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK 79 (332)
T ss_pred ceEEEEEeec--CCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence 5678899999 77778887764 46789999998642 223345678899999999 59999999999999999
Q ss_pred EEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 87 RLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
.++||||+++|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++.++.++|+|||++.......
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 999999999999999984 3466777788888999999999975 7999999999999999999999998654433
Q ss_pred ceeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 161 THMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
........||..|+|||++.+. .++.++|||||||++|+|++|..||............ ... +.. .
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~---~~~--------~~~--~ 226 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV---SRR--------ILK--C 226 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH---HHH--------Hhc--C
Confidence 3333345689999999998865 4788999999999999999999999643221111000 000 000 0
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH--HHhc
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRP-----TMTDVVD--WLKG 278 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~ 278 (325)
....+...++.+.+|+.+||..||++|| +++++++ ||+.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 227 DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 1123344667899999999999999999 7889987 7764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=287.76 Aligned_cols=267 Identities=18% Similarity=0.220 Sum_probs=198.4
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC--
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD-- 85 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 85 (325)
.+...|.+++.||.| +++.||.+.+..++..||+|.+... ......++.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 18 TVLKRYQQLKPIGSG--AQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhhceEEEEEeecC--CCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 456778889999999 7788999999999999999998643 3344567889999999999999999999986543
Q ss_pred ----eEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccC
Q 046728 86 ----ERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIP 157 (325)
Q Consensus 86 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~ 157 (325)
..|+||||+. ++|.+.++..++...+..+..++..++.++|.. |||||+|||++.++.++|+|||++....
T Consensus 96 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 96 EEFQDVYLVMELMD-ANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred cccceeEEEEeCCC-cCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 4799999996 478887766667777778889999999999986 7999999999999999999999997543
Q ss_pred CCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhh-h-----------h----
Q 046728 158 DGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIV-Q-----------W---- 221 (325)
Q Consensus 158 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~-~-----------~---- 221 (325)
... ......+|..|+|||++.+..++.++|||||||++|+|++|..||............ . .
T Consensus 175 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 175 TNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred cCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 321 123345889999999999889999999999999999999999999754321110000 0 0
Q ss_pred hcccc-ccccccc-----ccCccc---cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 222 VTPYV-QKGAFEH-----IADPRL---KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 222 ~~~~~-~~~~~~~-----~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
+.... ....+.. ...... ........++.+.+||.+||..||++|||+.++++ ||.....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 00000 0000000 000000 00111224567899999999999999999999998 8876443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=283.87 Aligned_cols=240 Identities=22% Similarity=0.314 Sum_probs=187.4
Q ss_pred hhccCccceeeeeEEEecc---CCCCeEEEEEeccc----ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 19 QNINNGLEILMLLLLLRRE---TGDDQIAVKRLKTL----NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~---~~~~~vaiK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
+.||.| +++.||.++.. .+++.||+|.+... .......+.+|+.+++.++||||+++++++..+...|+||
T Consensus 2 ~~lg~G--~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 2 KVLGKG--GYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred ceeeec--CCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence 568888 77788888753 45789999998642 2233346778999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 92 DYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 92 e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
||+++|+|.+++.. .+.+..+..+..++..++.++|.. |||||+|||++.++.+||+|||++........ ...
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 158 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTH 158 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-ccc
Confidence 99999999999843 344455566778899999999975 79999999999999999999999874332221 123
Q ss_pred cCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCH
Q 046728 166 RVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNR 245 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (325)
...||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..... +... ....+.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~---~~~~~------------~~~~--~~~~~~ 221 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---KTIDK------------ILKG--KLNLPP 221 (323)
T ss_pred ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH---HHHHH------------HHcC--CCCCCC
Confidence 346899999999999888999999999999999999999999753321 11110 0001 012234
Q ss_pred HHHHHHHHHHHHccCCCCCCCC-----CHHHHHH--HHhc
Q 046728 246 DQLKSMVLIALRCTDSNPENRP-----TMTDVVD--WLKG 278 (325)
Q Consensus 246 ~~~~~~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~ 278 (325)
..++.+.+||.+||..||++|| +++++++ |+..
T Consensus 222 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 222 YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 4567899999999999999999 8999988 6653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=289.89 Aligned_cols=251 Identities=19% Similarity=0.245 Sum_probs=192.9
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|++++.||.| +++.||++++..+++.||+|++.... ......+..|..++.+++||||+++++.+.+...+|+|
T Consensus 2 ~y~~~~~LG~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 2 DFESLKVIGRG--AFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CceEeEEEEeC--CCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence 46788999999 78889999999999999999996432 23345678899999999999999999999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc---
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT--- 161 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--- 161 (325)
||||++|+|.+++. +.+++..+..+..++..++.++|.+ |||||+|||++.++.++|+|||+++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 99999999999994 4466777888899999999999986 79999999999999999999999875432110
Q ss_pred -------------------------------eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 046728 162 -------------------------------HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKL 210 (325)
Q Consensus 162 -------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 210 (325)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0012346899999999999889999999999999999999999999754
Q ss_pred CCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccC--CCCCCCCCHHHHHH--HHhcc
Q 046728 211 PGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTD--SNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~--~dp~~Rps~~~il~--~l~~~ 279 (325)
..... ...+.... ..+..+.....++++.+||.+++. .++..||++++|++ ||++.
T Consensus 240 ~~~~~---~~~i~~~~----------~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 240 TPQET---YKKVMNWK----------ETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHH---HHHHHcCc----------CcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCC
Confidence 32111 11110000 000111112355678888887554 23335689999998 77654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=283.59 Aligned_cols=246 Identities=20% Similarity=0.297 Sum_probs=191.5
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEEEEEecC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMP 95 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lV~e~~~ 95 (325)
.||.| +++.||++++..+++.||+|.++.. .......+..|..++..+ +||||+++++++.+...+|+|||||+
T Consensus 2 ~lG~G--~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 2 VIGRG--SYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred eEeeC--CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 56777 8888999999999999999999743 223345678899999998 79999999999999999999999999
Q ss_pred CCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCC
Q 046728 96 NHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169 (325)
Q Consensus 96 ~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 169 (325)
+|+|.+++. ..+++..+..+..++..++.++|.. |||||+||+++.++.++|+|||++........ ......|
T Consensus 80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~g 158 (329)
T cd05588 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TTSTFCG 158 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-ccccccC
Confidence 999998883 4567777888889999999999985 79999999999999999999999874322111 1233568
Q ss_pred CcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCc--cchhhhhhcccccccccccccCccccCCCCHHH
Q 046728 170 TLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGV--KRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQ 247 (325)
Q Consensus 170 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (325)
|..|+|||++.+..++.++|+|||||++|+|++|..||....... ......+... .+.... ...+..+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~--------~~~~~~--~~~p~~~ 228 (329)
T cd05588 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ--------VILEKQ--IRIPRSL 228 (329)
T ss_pred CccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH--------HHHcCC--CCCCCCC
Confidence 999999999998889999999999999999999999996432111 0000001100 011111 1233456
Q ss_pred HHHHHHHHHHccCCCCCCCCC------HHHHHH--HHhc
Q 046728 248 LKSMVLIALRCTDSNPENRPT------MTDVVD--WLKG 278 (325)
Q Consensus 248 ~~~~~~li~~cl~~dp~~Rps------~~~il~--~l~~ 278 (325)
+..+.+||.+||..||++||| ++++++ |+..
T Consensus 229 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 229 SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 678999999999999999997 678886 6754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=284.32 Aligned_cols=240 Identities=23% Similarity=0.237 Sum_probs=189.8
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEEEEEecC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMP 95 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lV~e~~~ 95 (325)
.||.| +++.||+++...+++.||+|.+... .......+..|..++..+ +||||+++++++.+.+.+|+||||++
T Consensus 2 ~lg~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 2 VLGKG--SFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred eeeeC--CCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence 56777 8888999999999999999998642 223345677788888877 69999999999999999999999999
Q ss_pred CCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCC
Q 046728 96 NHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169 (325)
Q Consensus 96 ~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 169 (325)
+|+|.+++. ..+++..+..+..++..++.++|.+ |||||+|||++.++.++|+|||++........ ......|
T Consensus 80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~~~~g 158 (320)
T cd05590 80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTSTFCG 158 (320)
T ss_pred CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-ccccccc
Confidence 999999884 3466666777888999999999975 79999999999999999999999875432211 1233568
Q ss_pred CcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHH
Q 046728 170 TLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249 (325)
Q Consensus 170 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (325)
|+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+ .... ...+...+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~i------------~~~~--~~~~~~~~~ 221 (320)
T cd05590 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEAI------------LNDE--VVYPTWLSQ 221 (320)
T ss_pred CccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHHHH------------hcCC--CCCCCCCCH
Confidence 999999999998889999999999999999999999997543211 11111 0010 112234567
Q ss_pred HHHHHHHHccCCCCCCCCCH------HHHHH--HHhcc
Q 046728 250 SMVLIALRCTDSNPENRPTM------TDVVD--WLKGG 279 (325)
Q Consensus 250 ~~~~li~~cl~~dp~~Rps~------~~il~--~l~~~ 279 (325)
++.+||.+||..||++||++ +++++ ||+..
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 89999999999999999998 77877 77653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=279.80 Aligned_cols=263 Identities=17% Similarity=0.238 Sum_probs=194.8
Q ss_pred hHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEe
Q 046728 16 VFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93 (325)
Q Consensus 16 ~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~ 93 (325)
.++++||.|.++++.|+++....+++.||+|.+... .......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 368899999999999999999999999999999753 233345677899999999999999999999999999999999
Q ss_pred cCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce---
Q 046728 94 MPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH--- 162 (325)
Q Consensus 94 ~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~--- 162 (325)
+++|+|.+++.. .++...++.+..++..++.++|.. |||||+||+++.++.++++||+...........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999999843 245556677888899999999975 799999999999999999999865433221110
Q ss_pred ---eeccCCCCcCCCCcccccc--CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccc---------c
Q 046728 163 ---MTTRVKGTLGYLAPEYAMW--GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQ---------K 228 (325)
Q Consensus 163 ---~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~---------~ 228 (325)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||......... ......... .
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHhcCCccccccccchhh
Confidence 0112246678999999875 35889999999999999999999999754321110 000000000 0
Q ss_pred cc----------cccc------------cCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 229 GA----------FEHI------------ADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 229 ~~----------~~~~------------~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
.. .... .......+.....++.+.+|+.+||..||++|||++++++ ||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 00 0000 0000001122345678999999999999999999999998 887643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=293.24 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=193.5
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|++++.||.| +++.||+++...+++.||+|.+.... ......+.+|+.+++.++||||+++++.+.+++.+|+|
T Consensus 2 ~y~~~~~lG~G--~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 2 MFVKIKTIGIG--AFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CceEEEEEEeC--CCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence 57889999999 78889999999999999999986422 22345678899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc----
Q 046728 91 YDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV---- 160 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---- 160 (325)
||||++|+|.+++.. .+++..+..+..++..++.++|.. |||||+|||++.++.++|+|||++..+....
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 999999999999943 355566677888999999999975 7999999999999999999999975321000
Q ss_pred --------------------------------------ceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh
Q 046728 161 --------------------------------------THMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202 (325)
Q Consensus 161 --------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t 202 (325)
........||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence 000112468999999999998889999999999999999999
Q ss_pred CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCC---CHHHHHH--HHh
Q 046728 203 AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRP---TMTDVVD--WLK 277 (325)
Q Consensus 203 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp---s~~~il~--~l~ 277 (325)
|..||........... +... ......+.....++.+.+||.+|+ .+|.+|+ |+.++++ ||+
T Consensus 240 G~~Pf~~~~~~~~~~~---i~~~----------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~ 305 (376)
T cd05598 240 GQPPFLADTPAETQLK---VINW----------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFK 305 (376)
T ss_pred CCCCCCCCCHHHHHHH---Hhcc----------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcC
Confidence 9999975432111100 0000 001111122345678888999876 5999999 8999998 776
Q ss_pred c
Q 046728 278 G 278 (325)
Q Consensus 278 ~ 278 (325)
.
T Consensus 306 ~ 306 (376)
T cd05598 306 G 306 (376)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=273.89 Aligned_cols=246 Identities=23% Similarity=0.365 Sum_probs=192.5
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
..|.++++||.| +++.||++.. .++..||+|.+.... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 6 ~~~~~~~~lg~g--~~g~v~~~~~-~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 6 ESIKLVKKLGAG--QFGEVWMGYY-NNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred HHeEEeeecCCc--CCceEEEEEe-cCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 457888999999 7778888874 456789999986533 335688999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 93 YMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|+++++|.++++.. ++....+.+..++..++.++|.. +||||+||+++.++.++|+|||++...........
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 99999999999532 23334556777888888888875 79999999999999999999999987654333222
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ....+.. . ...+.
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~----~---------~~~~~ 225 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQR----G---------YRMPR 225 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHHc----C---------CCCCC
Confidence 23345678999999988888999999999999999998 999996543211 1111110 0 01112
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~ 278 (325)
....+..+.+++.+||..+|++|||++++.++|+.
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 23456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=274.36 Aligned_cols=242 Identities=21% Similarity=0.260 Sum_probs=189.3
Q ss_pred ccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCCC
Q 046728 21 INNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNH 97 (325)
Q Consensus 21 i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~g 97 (325)
||.| +++.||++.+..+++.||+|.+.... ......+..|+.+++.++||||+++.+++......++||||+++|
T Consensus 1 lg~G--~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKG--GFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCC--CceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence 4555 88899999999999999999986432 222346778999999999999999999999999999999999999
Q ss_pred Chhhhhcc------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccC
Q 046728 98 SLITHLHG------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRV 167 (325)
Q Consensus 98 sL~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 167 (325)
+|.+++.. .+++..+..+..++..++.++|.. |||||+||+++.++.++|+|||++......... ....
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~ 157 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGY 157 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-cccc
Confidence 99887732 245556677888899999999875 799999999999999999999999765543222 2234
Q ss_pred CCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHH
Q 046728 168 KGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQ 247 (325)
Q Consensus 168 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (325)
.||..|+|||++.+..++.++|||||||++|+|++|..||............ .. .+... ....+..+
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~--~~---------~~~~~--~~~~~~~~ 224 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQ---------RILND--SVTYPDKF 224 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH--HH---------hhccc--CCCCcccC
Confidence 6889999999999889999999999999999999999999754321111000 00 00000 11223456
Q ss_pred HHHHHHHHHHccCCCCCCCC-----CHHHHHH--HHhc
Q 046728 248 LKSMVLIALRCTDSNPENRP-----TMTDVVD--WLKG 278 (325)
Q Consensus 248 ~~~~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~ 278 (325)
++.+.+++.+||..||++|| +++++++ ||+.
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 77899999999999999999 7788887 7865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=288.14 Aligned_cols=251 Identities=19% Similarity=0.226 Sum_probs=195.0
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..|.+++.||.| +++.||++++..+++.||+|.+... .......+.+|..+++.++||||+++++++.++...++
T Consensus 43 ~~y~i~~~lG~G--~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 43 EDYEVVKVIGRG--AFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred hhcEEEEEEeec--CCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 578888999998 7888999999999999999998642 22333467789999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcc-CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 90 VYDYMPNHSLITHLHG-RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|||||++|+|.++++. .+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||++...........
T Consensus 121 v~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~ 200 (371)
T cd05622 121 VMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 200 (371)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccc
Confidence 9999999999999953 355556667788999999999985 79999999999999999999999987654333333
Q ss_pred ccCCCCcCCCCccccccC----CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 165 TRVKGTLGYLAPEYAMWG----KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~----~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
....||+.|+|||++.+. .++.++|||||||++|+|++|..||....... ....+.. . ...+.
T Consensus 201 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i~~---~-------~~~~~ 267 (371)
T cd05622 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---TYSKIMN---H-------KNSLT 267 (371)
T ss_pred cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH---HHHHHHc---C-------CCccc
Confidence 445699999999998753 37889999999999999999999997533211 0000000 0 00111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH--HHhc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPEN--RPTMTDVVD--WLKG 278 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~~il~--~l~~ 278 (325)
.+.....+..+.+||..|+..++.+ |++++++++ |++.
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 268 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 1223456788999999999844433 789999998 6654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=273.26 Aligned_cols=247 Identities=22% Similarity=0.281 Sum_probs=194.5
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEe
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~ 93 (325)
.+.+.+.||.| +++.||++.....+..||+|.+... ......+.+|+++++.++||||+++++++......++||||
T Consensus 7 ~~~~~~~ig~g--~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 7 DITMKHKLGGG--QYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HeEEeeecCCc--ccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 35677888888 6777898888888999999998753 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 94 MPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 94 ~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
+++++|.+++... ++....+.+..++..++.++|.. +||||+||+++.++.++|+|||++............
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~ 163 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence 9999999998532 33444566677888888888865 799999999999999999999999876544332222
Q ss_pred cCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 166 RVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
....+..|+|||.+.+..++.++|||||||++|+|++ |..||........ ..... .......+
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~~~~~-------------~~~~~~~~ 227 (263)
T cd05052 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLE-------------KGYRMERP 227 (263)
T ss_pred CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHH-------------CCCCCCCC
Confidence 2334567999999988889999999999999999998 8999865432111 11100 11112233
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
...+..+.+++.+||..||++|||+.++++.|+.+
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 45667899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=291.27 Aligned_cols=249 Identities=18% Similarity=0.263 Sum_probs=192.5
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|.+++.||.| +++.||+++...+++.||||.+... .......+.+|++++++++||||+++++++.+....|+|
T Consensus 2 ~y~~~~~lG~G--~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 2 DFHTVKVIGKG--AFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CceEeEEEeec--CCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence 46788999999 7888999999999999999998642 233445788899999999999999999999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc---
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT--- 161 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--- 161 (325)
||||++|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++.++.++|+|||+++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 99999999999984 3455666777888999999999985 79999999999999999999999863321000
Q ss_pred ---------e----------------------------------eeccCCCCcCCCCccccccCCCCCcccchhHHHHHH
Q 046728 162 ---------H----------------------------------MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLL 198 (325)
Q Consensus 162 ---------~----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ 198 (325)
. ......||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence 0 001235899999999999888999999999999999
Q ss_pred HHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCC---CCHHHHHH-
Q 046728 199 ELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENR---PTMTDVVD- 274 (325)
Q Consensus 199 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R---ps~~~il~- 274 (325)
+|++|..||........ ...+... . ..+..+.....+.++.+||.+|+. +|.+| +|+.++++
T Consensus 240 elltG~~Pf~~~~~~~~---~~~i~~~--~--------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 240 ECLIGWPPFCSENSHET---YRKIINW--R--------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhcCCCCCCCCCHHHH---HHHHHcc--C--------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999975432111 1000000 0 001111112356789999999997 77775 59999998
Q ss_pred -HHhc
Q 046728 275 -WLKG 278 (325)
Q Consensus 275 -~l~~ 278 (325)
||..
T Consensus 306 p~~~~ 310 (377)
T cd05629 306 PFFRG 310 (377)
T ss_pred CCcCC
Confidence 7764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=272.42 Aligned_cols=250 Identities=18% Similarity=0.247 Sum_probs=196.7
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecc---cChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKT---LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|.+.+.||.| +++.||.++...+++.||||.+.. ........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 3 ~~~i~~~l~~g--~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 3 NFQIEKKIGRG--QFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred ceeeeeeeccC--CCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 57788999999 777899999998999999998753 2344455788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcc------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 91 YDYMPNHSLITHLHG------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
|||+++|+|.+++.. .+++..+..+..++..++.++|.. +||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999988831 134445667788888889998875 7999999999999999999999988665432
Q ss_pred ceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 161 THMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
.. .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... ......+. .....
T Consensus 161 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~------------~~~~~ 226 (267)
T cd08228 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKIE------------QCDYP 226 (267)
T ss_pred HH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHHh------------cCCCC
Confidence 21 123457889999999988888999999999999999999999996532211 11111110 01111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
.......+..+.+++.+||..+|++|||+.++++.|+.+
T Consensus 227 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 112234567899999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=281.28 Aligned_cols=239 Identities=24% Similarity=0.322 Sum_probs=186.2
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEEEEEecC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMP 95 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lV~e~~~ 95 (325)
.||.| +++.||+++...+++.||+|.+... .......+..|..++..+ +||||+++++++......++||||++
T Consensus 2 ~lG~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 2 VLGKG--SFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred eeeeC--CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 57777 8888999999999999999998642 122334555677777655 89999999999999999999999999
Q ss_pred CCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCC
Q 046728 96 NHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169 (325)
Q Consensus 96 ~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 169 (325)
+|+|.++++ ..+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||++....... .......|
T Consensus 80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~g 158 (316)
T cd05592 80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFCG 158 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-CccccccC
Confidence 999999984 3466666777888999999999985 7999999999999999999999997543322 22234568
Q ss_pred CcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHH
Q 046728 170 TLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249 (325)
Q Consensus 170 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (325)
|+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+. .. ....+...+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~~~i~------------~~--~~~~~~~~~~ 221 (316)
T cd05592 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LFDSIL------------ND--RPHFPRWISK 221 (316)
T ss_pred CccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH------------cC--CCCCCCCCCH
Confidence 999999999998889999999999999999999999997543211 111000 00 1122344567
Q ss_pred HHHHHHHHccCCCCCCCCCHH-HHHH--HHhc
Q 046728 250 SMVLIALRCTDSNPENRPTMT-DVVD--WLKG 278 (325)
Q Consensus 250 ~~~~li~~cl~~dp~~Rps~~-~il~--~l~~ 278 (325)
++.+|+.+||..||++||++. ++++ |+..
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence 889999999999999999875 5655 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=282.11 Aligned_cols=239 Identities=23% Similarity=0.257 Sum_probs=188.7
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEEEEEecC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMP 95 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lV~e~~~ 95 (325)
.||.| +++.||+++...+++.||+|.+... .......+..|..++..+ +||||+++++++.+....|+||||++
T Consensus 2 ~lG~G--~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 2 VLGKG--SFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred ccccC--CCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 56777 8888999999999999999998643 223344677789988876 79999999999999999999999999
Q ss_pred CCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCC
Q 046728 96 NHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169 (325)
Q Consensus 96 ~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 169 (325)
+|+|..++. ..+++..+..+..++..++.++|.+ |||||+|||++.++.++|+|||++......... .....|
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~g 158 (321)
T cd05591 80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT-TTTFCG 158 (321)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc-cccccc
Confidence 999998884 3355566677888999999999975 799999999999999999999998754322211 233458
Q ss_pred CcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHH
Q 046728 170 TLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249 (325)
Q Consensus 170 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (325)
|..|+|||++.+..++.++|||||||++|+|++|..||....... ....+ .... ...+...+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~~i------------~~~~--~~~p~~~~~ 221 (321)
T cd05591 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFESI------------LHDD--VLYPVWLSK 221 (321)
T ss_pred CccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHHHH------------HcCC--CCCCCCCCH
Confidence 999999999998889999999999999999999999997543211 11111 0000 112233567
Q ss_pred HHHHHHHHccCCCCCCCC-------CHHHHHH--HHhc
Q 046728 250 SMVLIALRCTDSNPENRP-------TMTDVVD--WLKG 278 (325)
Q Consensus 250 ~~~~li~~cl~~dp~~Rp-------s~~~il~--~l~~ 278 (325)
++.+|+.+||..||++|| +++++++ |+..
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 899999999999999999 8888987 6644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=283.18 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=191.8
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCC-CCccceeeEEEcCCeEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRH-RNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lV 90 (325)
|.+++.||.| +++.||+++...+++.||+|.+... .......+..|..++..++| ++|+++++++.+.+..|+|
T Consensus 2 y~~~~~lg~G--~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (324)
T cd05587 2 FNFLMVLGKG--SFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 79 (324)
T ss_pred ceEEEEEeec--cCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence 6778899998 8888999999999999999998642 23344577889999999965 5688899999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|||+++|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++.++.++|+|||++......... .
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~ 158 (324)
T cd05587 80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT-T 158 (324)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc-e
Confidence 99999999999984 3356666777888999999999975 799999999999999999999998743222111 2
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
....||..|+|||++.+..++.++||||+||++|+|+||..||...... .....+. .. ....+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~------------~~--~~~~~ 221 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQSIM------------EH--NVSYP 221 (324)
T ss_pred eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHH------------cC--CCCCC
Confidence 2345899999999999888999999999999999999999999754321 1111110 00 11223
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH--HHhc
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPTM-----TDVVD--WLKG 278 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps~-----~~il~--~l~~ 278 (325)
...++++.+++.+||..||++|++. +++++ ||+.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 222 KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 4466789999999999999999986 67765 5543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=271.56 Aligned_cols=253 Identities=23% Similarity=0.264 Sum_probs=196.0
Q ss_pred eeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 8 CFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 8 ~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
.......|++.+.||.| +++.||.++...+++.||+|.+..........+.+|+.++++++||||+++++++......
T Consensus 4 ~~~~~~~y~~~~~lg~g--~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 4 RRNPQHDYELIQRVGSG--TYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL 81 (267)
T ss_pred ccCchhhcchhheeecC--CCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence 34456678999999999 7778999999889999999999754444556788899999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 88 LIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
++||||+++++|.++++ ..+++..+..+..++..+++++|.. +||||+||+++.++.++|+|||++........
T Consensus 82 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999999999999884 3345556677888888999999875 79999999999999999999999986643221
Q ss_pred eeeccCCCCcCCCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 162 HMTTRVKGTLGYLAPEYAM---WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
. .....++..|+|||.+. ...++.++|+||+||++|+|++|..||.......... . .....+. .+.
T Consensus 162 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~---~----~~~~~~~---~~~ 230 (267)
T cd06646 162 K-RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---L----MSKSNFQ---PPK 230 (267)
T ss_pred c-cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---e----eecCCCC---CCC
Confidence 1 12235788999999874 3457789999999999999999999986433211100 0 0000000 000
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDW 275 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~ 275 (325)
.......+..+.+||.+||..||++|||++++++.
T Consensus 231 --~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 231 --LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred --CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 01122356789999999999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=276.41 Aligned_cols=251 Identities=22% Similarity=0.377 Sum_probs=195.1
Q ss_pred cchhHHhhccCccceeeeeEEEec-----cCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRR-----ETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
..|.+.+.||.| +++.||++.. ..++..+|+|.+..........+.+|++++++++||||+++++++.....+
T Consensus 5 ~~~~~~~~lg~G--~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEG--AFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCc--CCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 346788899999 6777887764 234567999999876666667899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccC---------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEe
Q 046728 88 LIVYDYMPNHSLITHLHGR---------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVA 148 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~ 148 (325)
++||||+++++|.+++... ++....+.+..++..++.++|.. |||||+||+++.++.++|+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEec
Confidence 9999999999999998522 34445566778888888888875 7999999999999999999
Q ss_pred eeccccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccc
Q 046728 149 DFGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYV 226 (325)
Q Consensus 149 Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~ 226 (325)
|||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ......
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~i~--- 236 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECIT--- 236 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH---
Confidence 99999865432221 1222335678999999988889999999999999999998 899986543211 111110
Q ss_pred cccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 227 QKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.+. ....+...+..+.+|+.+||..||.+|||+++++..|+.+..
T Consensus 237 -~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 237 -QGR---------VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred -cCC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 000 011122355689999999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=285.69 Aligned_cols=268 Identities=18% Similarity=0.232 Sum_probs=198.9
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC--
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG-- 84 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 84 (325)
+.+...|.+.+.||.| +++.||.+.+...++.||||.+... .......+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~ 97 (364)
T cd07875 20 FTVLKRYQNLKPIGSG--AQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS 97 (364)
T ss_pred hchhcceeEEEEeecC--CCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccc
Confidence 4556788999999999 7788999999999999999998643 334456788899999999999999999987543
Q ss_pred ----CeEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccccc
Q 046728 85 ----DERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLI 156 (325)
Q Consensus 85 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~ 156 (325)
..+|+||||+. ++|.+++...++...+..+..++..+++++|.. |||||+|||++.++.+||+|||++...
T Consensus 98 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 98 LEEFQDVYIVMELMD-ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred ccccCeEEEEEeCCC-CCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 35799999996 588888866666667778889999999999975 799999999999999999999999865
Q ss_pred CCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhh-hh-----------hcc
Q 046728 157 PDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIV-QW-----------VTP 224 (325)
Q Consensus 157 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~-~~-----------~~~ 224 (325)
..... .....+|..|+|||++.+..++.++|||||||++|+|++|..||...........+ .. ..+
T Consensus 177 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 177 GTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred CCCCc--ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 43221 22345899999999999889999999999999999999999999754321110000 00 000
Q ss_pred cc----c-ccc-----cccccCccc---cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 225 YV----Q-KGA-----FEHIADPRL---KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 225 ~~----~-~~~-----~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
.. . ... +........ ........+..+.+||.+||..||.+|||++++++ ||.....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 326 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 326 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccC
Confidence 00 0 000 000000000 00111123457899999999999999999999998 8875443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=281.07 Aligned_cols=246 Identities=20% Similarity=0.323 Sum_probs=190.1
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEEEEEecC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMP 95 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lV~e~~~ 95 (325)
.||+| +++.||+++...+++.||+|.+... .......+.+|..++.++ +||||+++++++......++||||++
T Consensus 2 ~lG~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 2 VIGRG--SYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred eeeeC--CCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 56777 8889999999999999999999743 233445677899988877 79999999999999999999999999
Q ss_pred CCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCC
Q 046728 96 NHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169 (325)
Q Consensus 96 ~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 169 (325)
+|+|..++. ..+++..+..+..++..++.++|.. |||||+||+++.++.++|+|||++........ ......|
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~~~g 158 (329)
T cd05618 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTFCG 158 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccccccC
Confidence 999998884 3466667778888999999999985 79999999999999999999999875322211 1233568
Q ss_pred CcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCcc--chhhhhhcccccccccccccCccccCCCCHHH
Q 046728 170 TLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVK--RDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQ 247 (325)
Q Consensus 170 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (325)
|..|+|||++.+..++.++|||||||++|+|++|..||........ .....+.... +... ....+...
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------i~~~--~~~~p~~~ 228 (329)
T cd05618 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------ILEK--QIRIPRSL 228 (329)
T ss_pred CccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH--------HhcC--CCCCCCCC
Confidence 9999999999988999999999999999999999999964221110 0001111110 1111 11233456
Q ss_pred HHHHHHHHHHccCCCCCCCCC------HHHHHH--HHhc
Q 046728 248 LKSMVLIALRCTDSNPENRPT------MTDVVD--WLKG 278 (325)
Q Consensus 248 ~~~~~~li~~cl~~dp~~Rps------~~~il~--~l~~ 278 (325)
+..+.+||.+||..||++||| +.++++ ||+.
T Consensus 229 ~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 229 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred CHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 678999999999999999998 467776 6644
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=272.65 Aligned_cols=259 Identities=19% Similarity=0.251 Sum_probs=196.4
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcC--C-eE--EE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG--D-ER--LI 89 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~-~~--~l 89 (325)
+.-.+.+|.| +|+.||.+.-..++..||||.+-.... .-.+|+++|++++|||||++..+|... . .+ .+
T Consensus 26 ~~~~~liG~G--sFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 26 YEAVRLIGSG--SFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEeeEEEeec--ccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 3557788888 777788888888899999999854221 112499999999999999999887543 2 23 49
Q ss_pred EEEecCCCChhhhhc------cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC-CceEEeeeccccccCC
Q 046728 90 VYDYMPNHSLITHLH------GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD-FEAKVADFGFAKLIPD 158 (325)
Q Consensus 90 V~e~~~~gsL~~~l~------~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~-~~~kL~Dfg~~~~~~~ 158 (325)
||||++. +|.++++ .+++.-.+.-+..|+..++.++|.+ |||||+|+|+|.+ |.+||||||.|+.+..
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 9999976 9999986 4466667788999999999999986 8999999999966 8999999999998876
Q ss_pred CcceeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhh------------ccc
Q 046728 159 GVTHMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWV------------TPY 225 (325)
Q Consensus 159 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~------------~~~ 225 (325)
+..... ...|..|+|||++.+. .|+.+.||||.|||+.||+-|++-|.+.++......+..+ ++.
T Consensus 179 ~epniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 179 GEPNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred CCCcee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 655433 3468899999998865 6999999999999999999999999886554433322211 111
Q ss_pred ccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccCC
Q 046728 226 VQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLGR 282 (325)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~~ 282 (325)
.....+..+....+........+++..+|+.++|.++|.+|.|+.+++. +|.++...
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 1111112222211111234557789999999999999999999999997 88877654
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=286.30 Aligned_cols=262 Identities=19% Similarity=0.237 Sum_probs=195.4
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC-----eE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD-----ER 87 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 87 (325)
|.+++.||.| +++.||++.+..+++.||+|.+... ......++.+|+.+++.++||||+++++++.... ..
T Consensus 2 ~~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 2 VEPDRPIGYG--AFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CcccceeeeC--CCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 5678889998 8888999999889999999998642 3344567889999999999999999999998776 78
Q ss_pred EEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 88 LIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
|+||||+. ++|.+++. ..++...+..+..++..++.++|.. |||||+|||++.++.+||+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99999996 58888873 3456666778889999999999985 79999999999999999999999986544332
Q ss_pred eeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccc--------cc
Q 046728 162 HMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGA--------FE 232 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~ 232 (325)
.......++..|+|||++.+. .++.++||||+||++|+|++|..||...........+........... ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 238 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence 222334578899999998764 478899999999999999999999976543222111111000000000 00
Q ss_pred cccCcccc-------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 233 HIADPRLK-------GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 233 ~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
.+...... .......++++.+||.+||..||++|||++++++ ||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 00000000 0112234678999999999999999999999998 88763
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=280.82 Aligned_cols=239 Identities=23% Similarity=0.262 Sum_probs=186.6
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEEEEEecC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMP 95 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lV~e~~~ 95 (325)
.||.| +++.||+++...++..||+|.+.... ......+..|..++... +||||+++++++.+.+..|+||||+.
T Consensus 2 ~lg~G--~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 2 VLGKG--SFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred eeeeC--CCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 57777 88899999999999999999997421 22334566788888765 89999999999999999999999999
Q ss_pred CCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCC
Q 046728 96 NHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169 (325)
Q Consensus 96 ~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 169 (325)
+|+|..++.. .++...+..+..++..++.++|.+ |||||+|||++.++.++|+|||++........ ......|
T Consensus 80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g 158 (316)
T cd05620 80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RASTFCG 158 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-ceeccCC
Confidence 9999999843 455666677888999999999975 79999999999999999999999874322211 1234568
Q ss_pred CcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHH
Q 046728 170 TLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249 (325)
Q Consensus 170 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (325)
|..|+|||++.+..++.++|||||||++|+|++|..||...... .....+.. . ....+...+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~~~------------~--~~~~~~~~~~ 221 (316)
T cd05620 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESIRV------------D--TPHYPRWITK 221 (316)
T ss_pred CcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHh------------C--CCCCCCCCCH
Confidence 99999999999889999999999999999999999999754321 11111100 0 0112234567
Q ss_pred HHHHHHHHccCCCCCCCCCH-HHHHH--HHhc
Q 046728 250 SMVLIALRCTDSNPENRPTM-TDVVD--WLKG 278 (325)
Q Consensus 250 ~~~~li~~cl~~dp~~Rps~-~~il~--~l~~ 278 (325)
++.+||.+||..||++||++ +++++ ||+.
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence 89999999999999999997 46764 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=269.78 Aligned_cols=245 Identities=19% Similarity=0.258 Sum_probs=192.9
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-----hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-----AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
..|...+.||.| +++.||.+....+++.||+|.+.... ......+.+|++++++++||||+++++++......
T Consensus 2 ~~~~~~~~lg~g--~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQG--AFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETL 79 (263)
T ss_pred CcccccceecCC--CceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeE
Confidence 457788899999 77789999988889999999886422 12234688899999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 88 LIVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
++|+||+++++|.+++.. .++......+..++..++.++|.. +||+|+||+++.++.++|+|||++........
T Consensus 80 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 999999999999999853 345556677888888899988864 79999999999999999999999876543221
Q ss_pred eee--ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 162 HMT--TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 162 ~~~--~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
... ....++..|+|||++.+..++.++||||||+++|+|++|..||...... ...... .....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~------------~~~~~ 224 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---AAIFKI------------ATQPT 224 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---HHHHHH------------hccCC
Confidence 111 2234778899999999888999999999999999999999999653221 000000 00111
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
....+...+..+.++|.+||..+|++|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 225 NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 12233456678999999999999999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=256.45 Aligned_cols=244 Identities=25% Similarity=0.370 Sum_probs=205.6
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..|.+-+.||+| -||.||+++.+.++..||+|++.+.. .....++.+|+++-+.|+||||++++++|.+...+|+
T Consensus 22 ~dfeigr~Lgkg--kFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 22 DDFEIGRPLGKG--KFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred hhccccccccCC--ccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 467888999998 66689999999999999999986432 3334588899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhc----cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 90 VYDYMPNHSLITHLH----GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 90 V~e~~~~gsL~~~l~----~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
++||..+|+|...++ .++++.....+..|++-|+.+.|.. |||||+|+|++..+.+|++|||-+..-. .
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~ 176 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---S 176 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC---C
Confidence 999999999999996 3477888899999999999999975 8999999999999999999999987654 2
Q ss_pred eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 162 HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
....+.+||.-|.+||+..+...+.++|+|++|+++||++.|.+||.....+. .+..+..-. .
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---------------tYkrI~k~~--~ 239 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---------------TYKRIRKVD--L 239 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---------------HHHHHHHcc--c
Confidence 33456789999999999999999999999999999999999999997644211 122222211 1
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
..+..++..+.+||.+|+..+|.+|.+..++++ |+..
T Consensus 240 ~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 240 KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 334667789999999999999999999999998 6653
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=270.43 Aligned_cols=244 Identities=25% Similarity=0.392 Sum_probs=188.0
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
+.|.+++.||.| +++.||++... ++..+|+|.+.... .....+.+|+++++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~lg~G--~~~~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSG--QFGVVHLGKWR-AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCC--cCceEEEEEec-cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 346778899998 66778887654 45679999886432 334578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccC---CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 93 YMPNHSLITHLHGR---LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 93 ~~~~gsL~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
|+++|+|.++++.. ++......+..++..++.++|.. +||||+||+++.++.++|+|||.+............
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 99999999999532 44455667778888888888875 799999999999999999999998865443322222
Q ss_pred cCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 166 RVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
...++..|+|||++.+..++.++|+||||+++|+|++ |..||...... .....+.. +. ....+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~i~~----~~---------~~~~~ 223 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEMISR----GF---------RLYRP 223 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHC----CC---------CCCCC
Confidence 2235668999999988889999999999999999999 89999654321 11111110 00 01112
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVDWL 276 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l 276 (325)
...+..+.+++.+||..+|.+|||+.++++.|
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 23456799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=279.93 Aligned_cols=247 Identities=21% Similarity=0.303 Sum_probs=192.1
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEEEEEecC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMP 95 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lV~e~~~ 95 (325)
.||.| +++.||+++...+++.||+|.+... .......+.+|..++.++ +||||+++++++.+...+|+||||++
T Consensus 2 ~lG~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 2 VIGRG--SYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred eeeeC--CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 57777 8888999999999999999999753 233445678899999998 69999999999999999999999999
Q ss_pred CCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCC
Q 046728 96 NHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169 (325)
Q Consensus 96 ~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 169 (325)
+|+|..++. ..+++..+..+..++..++.++|.. |||||+|||++.++.++|+|||++........ ......|
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g 158 (327)
T cd05617 80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TTSTFCG 158 (327)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ceecccC
Confidence 999998884 4567777788889999999999975 79999999999999999999999875322211 1234568
Q ss_pred CcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHH
Q 046728 170 TLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249 (325)
Q Consensus 170 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (325)
|+.|+|||++.+..++.++|||||||++|+|++|..||.................. +... ....+...+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~--------~~~~--~~~~p~~~~~ 228 (327)
T cd05617 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV--------ILEK--PIRIPRFLSV 228 (327)
T ss_pred CcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH--------HHhC--CCCCCCCCCH
Confidence 99999999999889999999999999999999999999653322111111111111 0011 1123344667
Q ss_pred HHHHHHHHccCCCCCCCCCH------HHHHH--HHhcc
Q 046728 250 SMVLIALRCTDSNPENRPTM------TDVVD--WLKGG 279 (325)
Q Consensus 250 ~~~~li~~cl~~dp~~Rps~------~~il~--~l~~~ 279 (325)
.+.+++.+||..||++|+++ +++++ |+...
T Consensus 229 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 229 KASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 89999999999999999984 57776 66543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=280.88 Aligned_cols=239 Identities=25% Similarity=0.334 Sum_probs=189.8
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEEEEEecC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMP 95 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lV~e~~~ 95 (325)
.||.| +++.||+++...+++.||+|.+... .......+..|..++..+ +||||+++++++.+.+.+|+||||++
T Consensus 2 ~lG~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 2 VLGKG--SFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred eeeeC--CCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 57777 7888999999999999999999743 223345677899999888 69999999999999999999999999
Q ss_pred CCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCC
Q 046728 96 NHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169 (325)
Q Consensus 96 ~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 169 (325)
+|+|..++. ..+++..+..+..++..++.++|.. |||||+||+++.++.++|+|||++........ ......|
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g 158 (318)
T cd05570 80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTSTFCG 158 (318)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccceec
Confidence 999999884 3466677778888999999999975 79999999999999999999999874322111 1223458
Q ss_pred CcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHH
Q 046728 170 TLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249 (325)
Q Consensus 170 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (325)
+..|+|||++.+..++.++|||||||++|+|++|..||...... ...... ... ....+...+.
T Consensus 159 ~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~~~i------------~~~--~~~~~~~~~~ 221 (318)
T cd05570 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELFQSI------------LED--EVRYPRWLSK 221 (318)
T ss_pred CccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHHHHH------------HcC--CCCCCCcCCH
Confidence 99999999999889999999999999999999999999653321 111110 000 0112334567
Q ss_pred HHHHHHHHccCCCCCCCCCH-----HHHHH--HHhc
Q 046728 250 SMVLIALRCTDSNPENRPTM-----TDVVD--WLKG 278 (325)
Q Consensus 250 ~~~~li~~cl~~dp~~Rps~-----~~il~--~l~~ 278 (325)
.+.+||.+||..||++|||+ .++++ |++.
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 89999999999999999999 88887 6654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=285.59 Aligned_cols=252 Identities=21% Similarity=0.263 Sum_probs=189.7
Q ss_pred cchhHHhhccCccceeeeeEEEeccCC-----CCeEEEEEeccc-ChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCC
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETG-----DDQIAVKRLKTL-NAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGD 85 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~-----~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 85 (325)
..+.+.+.||+| +++.||.+..... +..||||.+... .......+.+|++++++++ ||||+++++++....
T Consensus 37 ~~~~~~~~LG~G--~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 37 DGLVLGRILGSG--AFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cceehhheecCC--CCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 456788999999 7777887765332 346999999643 3334457889999999996 999999999999999
Q ss_pred eEEEEEEecCCCChhhhhccCC----------------------------------------------------------
Q 046728 86 ERLIVYDYMPNHSLITHLHGRL---------------------------------------------------------- 107 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------------- 107 (325)
..|+|||||++|+|.++++...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999884310
Q ss_pred ----------------------------------------CCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC
Q 046728 108 ----------------------------------------APDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF 143 (325)
Q Consensus 108 ----------------------------------------~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~ 143 (325)
+...+..+..++..++.++|.. +||||+|||++.++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC
Confidence 1111234666788888888874 79999999999999
Q ss_pred ceEEeeeccccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhh
Q 046728 144 EAKVADFGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQW 221 (325)
Q Consensus 144 ~~kL~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~ 221 (325)
.++|+|||++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||........ ....
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~~~~ 352 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--FYNK 352 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--HHHH
Confidence 9999999999865432221 1222346778999999988889999999999999999997 8999865322110 0000
Q ss_pred hcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 222 VTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
+ ........+...+..+.+++.+||..||++|||+.++.+.|+.+.+
T Consensus 353 ~-------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 353 I-------------KSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred H-------------hcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0 0011112234566789999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=274.80 Aligned_cols=247 Identities=22% Similarity=0.292 Sum_probs=193.5
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
|+.++.||+| +++.||++....+++.||+|.+.... ......+.+|+.+++.++||||+++++.+.+++..++||
T Consensus 2 y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 2 FRHYRVLGKG--GFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred ceEEEEEecC--CCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence 5667889988 77889999988889999999986422 222345778999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 92 DYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 92 e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||+++|+|.+++.. .+++..+..+..++..++.++|.. +||||+||++++++.++|+|||++........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 157 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-- 157 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc--
Confidence 99999999988732 345556677788888999999875 79999999999999999999999886543222
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.....|+..|+|||++.+..++.++||||+|+++|+|++|..||............. .. +.. .....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~---~~--------~~~--~~~~~ 224 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE---RR--------VKE--DQEEY 224 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH---HH--------hhh--ccccc
Confidence 123458899999999988889999999999999999999999997543211111100 00 000 01122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH--HHhc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRP-----TMTDVVD--WLKG 278 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~ 278 (325)
+...+..+.+|+.+||..||++|| +++++++ ||..
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 345677899999999999999999 8889987 6654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=278.84 Aligned_cols=265 Identities=14% Similarity=0.207 Sum_probs=196.3
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
..|.+++.||.| +++.||+++...+++.||+|.+.... ......+.+|++++++++||||+++++++..++..++||
T Consensus 6 ~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEG--TYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEeccc--CCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 457888999999 78889999998899999999986432 223346778999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 92 DYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 92 e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||+.+ +|.+++.. .++...+..+..++..++.++|.. |||||+||+++.++.++|+|||++......... .
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~ 161 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT-Y 161 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc-c
Confidence 99965 88888843 244455666778899999999975 799999999999999999999998765433222 1
Q ss_pred ccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccc---------
Q 046728 165 TRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHI--------- 234 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 234 (325)
....++..|+|||++.+ ..++.++|||||||++|+|+||..||...........+...........+..+
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 22357889999998865 45788999999999999999999999765432221111111000000000000
Q ss_pred cCcccc----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 235 ADPRLK----GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 235 ~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
..+... .......++++.+||.+||..||.+|||+.++++ ||+....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 000000 0111245678999999999999999999999998 8887553
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=274.58 Aligned_cols=250 Identities=18% Similarity=0.251 Sum_probs=198.7
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
..|.+++.||.| +++.||++....+++.||+|.+..........+.+|+.+++.++||||+++++.+..+...++|||
T Consensus 20 ~~y~~~~~lg~g--~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQG--ASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cceeeEEEecCC--CCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 467788889888 677899998888899999999976555555688899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc-CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccC
Q 046728 93 YMPNHSLITHLHG-RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRV 167 (325)
Q Consensus 93 ~~~~gsL~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 167 (325)
|+++++|.+++++ .+.......+..++..++.++|.. +||||+||+++.++.++|+|||++......... ....
T Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~ 176 (296)
T cd06654 98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTM 176 (296)
T ss_pred ccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-cCcc
Confidence 9999999999954 345566677888888899998875 799999999999999999999998765433221 1223
Q ss_pred CCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHH
Q 046728 168 KGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQ 247 (325)
Q Consensus 168 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (325)
.++..|+|||.+.+..++.++|||||||++|+|++|..||........ ..... .........+...
T Consensus 177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~~------------~~~~~~~~~~~~~ 242 (296)
T cd06654 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIA------------TNGTPELQNPEKL 242 (296)
T ss_pred cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHHh------------cCCCCCCCCcccc
Confidence 578899999999888889999999999999999999999965432110 00000 0000011223456
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 248 LKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 248 ~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
+..+.+|+.+||..||++|||+.++++ ||...
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred CHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 678999999999999999999999998 77653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=278.93 Aligned_cols=240 Identities=23% Similarity=0.290 Sum_probs=187.2
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEEEEEecC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMP 95 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lV~e~~~ 95 (325)
.||.| +++.||+++...+++.||+|.+.... ......+..|..++... +||||+++++++.+.+..++||||++
T Consensus 2 ~lG~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 2 MLGKG--SFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred eeeeC--CCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 56777 88889999999999999999997431 22334566678888765 89999999999999999999999999
Q ss_pred CCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCC
Q 046728 96 NHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169 (325)
Q Consensus 96 ~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 169 (325)
+|+|.+++.. .++......+..++..++.++|.. |||||+|||++.++.++|+|||++........ ......|
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g 158 (316)
T cd05619 80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCTFCG 158 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceeeecC
Confidence 9999999953 355666677888999999999975 79999999999999999999999875322211 1233468
Q ss_pred CcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHH
Q 046728 170 TLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249 (325)
Q Consensus 170 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (325)
|..|+|||++.+..++.++||||+||++|+|++|..||...... .....+. . . ....+...+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i~----~--------~--~~~~~~~~~~ 221 (316)
T cd05619 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSIR----M--------D--NPCYPRWLTR 221 (316)
T ss_pred CccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHH----h--------C--CCCCCccCCH
Confidence 99999999999888999999999999999999999999754321 1111110 0 0 0112234567
Q ss_pred HHHHHHHHccCCCCCCCCCHH-HHHH--HHhcc
Q 046728 250 SMVLIALRCTDSNPENRPTMT-DVVD--WLKGG 279 (325)
Q Consensus 250 ~~~~li~~cl~~dp~~Rps~~-~il~--~l~~~ 279 (325)
++.+|+.+||..||++||++. ++.+ ||+..
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence 899999999999999999996 6765 66553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=271.28 Aligned_cols=262 Identities=22% Similarity=0.311 Sum_probs=192.3
Q ss_pred hhHHhhccCccceeeeeEEE----eccCCCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcC--CeE
Q 046728 15 AVFIQNINNGLEILMLLLLL----RRETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG--DER 87 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~----~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 87 (325)
+.+++.||.| +++.||++ ....++..||+|.+.... ......+.+|++++++++||||+++++++... ...
T Consensus 6 ~~~~~~lg~g--~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEG--HFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccC--CCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 4888999999 55556553 344567889999987532 33456788999999999999999999987653 458
Q ss_pred EEEEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 88 LIVYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
++||||+++++|.+++. ..++...+..+..++..++.++|.. +||||+||+++.++.++|+|||++.........
T Consensus 84 ~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163 (283)
T ss_pred EEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence 89999999999999985 3466667778888888999999875 799999999999999999999999866543221
Q ss_pred e--eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 163 M--TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 163 ~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
. .....++..|+|||.+....++.++||||||+++|+|+||..||...+.... ..............+.........
T Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd05080 164 YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLERGMR 242 (283)
T ss_pred hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhhcCCC
Confidence 1 1122356679999999888899999999999999999999999865332111 111000000000011111111112
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
.+.+...+..+.+++.+||..||++|||++++++.|+.+
T Consensus 243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 223445677999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=283.45 Aligned_cols=266 Identities=17% Similarity=0.209 Sum_probs=196.8
Q ss_pred ceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcC
Q 046728 7 ICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG 84 (325)
Q Consensus 7 ~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (325)
....+...|.+++.||.| +++.||.+.+..+++.||+|.+.... ......+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07878 9 TVWEVPERYQNLTPVGSG--AYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPA 86 (343)
T ss_pred HHhhhhhhhhhheecccC--CCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccc
Confidence 445677889999999999 78889999999999999999986432 23345677899999999999999999987543
Q ss_pred ------CeEEEEEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccc
Q 046728 85 ------DERLIVYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFA 153 (325)
Q Consensus 85 ------~~~~lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~ 153 (325)
...+++++++ +++|.++++ ..+++..+..+..++..++.++|.+ |||||+||+++.++.+||+|||++
T Consensus 87 ~~~~~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 87 TSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred ccccccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence 3478999998 789988885 3567777888999999999999975 799999999999999999999999
Q ss_pred cccCCCcceeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccc
Q 046728 154 KLIPDGVTHMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFE 232 (325)
Q Consensus 154 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (325)
...... .....+|..|+|||++.+ ..++.++|||||||++|+|++|..||.........................
T Consensus 166 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 166 RQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred eecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 865432 223468899999999876 468899999999999999999999996533211100000000000000000
Q ss_pred cccC----------ccccC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 233 HIAD----------PRLKG----KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 233 ~~~~----------~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
.+.. +.... ......++.+.+||.+||..||++|||+.++++ ||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0000 00000 001123456889999999999999999999998 88764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=285.42 Aligned_cols=247 Identities=21% Similarity=0.284 Sum_probs=201.3
Q ss_pred hHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecC
Q 046728 16 VFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95 (325)
Q Consensus 16 ~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~ 95 (325)
+..-+||-|+.|.+++..+ ++-.-.||||.++. +.-...+|..|..+|+.++|||+|+++|+|.....+|||+|||.
T Consensus 270 tMkhKLGGGQYGeVYeGvW--KkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVW--KKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred eeeeccCCCcccceeeeee--eccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 3445677775555444444 34457899999976 44456799999999999999999999999999999999999999
Q ss_pred CCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhh----cCCCCCCceeeCCCCceEEeeeccccccCCCcceeeccC
Q 046728 96 NHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEG----IADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRV 167 (325)
Q Consensus 96 ~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~----~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 167 (325)
.|+|.+|++. .++.-..+....||+.++.|+.. ||||.+.|||+.++..+|++|||+++.+..+........
T Consensus 347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGA 426 (1157)
T KOG4278|consen 347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGA 426 (1157)
T ss_pred CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCc
Confidence 9999999953 23333455667788888888765 389999999999999999999999999988766555444
Q ss_pred CCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHH
Q 046728 168 KGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRD 246 (325)
Q Consensus 168 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (325)
.=++.|.|||-+..+.|+.|+|||+||++|||+.| |..||.+...+.. ..+...+.+...+..
T Consensus 427 KFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV----------------Y~LLEkgyRM~~PeG 490 (1157)
T KOG4278|consen 427 KFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----------------YGLLEKGYRMDGPEG 490 (1157)
T ss_pred cCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH----------------HHHHhccccccCCCC
Confidence 45788999999999999999999999999999987 8999876443222 223345556677889
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 247 QLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 247 ~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
+++.+.+||..||..+|.+||++.++-+.|+.++.
T Consensus 491 CPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 491 CPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred CCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 99999999999999999999999999999988764
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=274.03 Aligned_cols=253 Identities=17% Similarity=0.224 Sum_probs=201.1
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
.+.|.+++.||.| +++.||++....+++.||+|.+..........+.+|+.+++.++||||+++++++..+...++||
T Consensus 18 ~~~y~~~~~lg~g--~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQG--ASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccC--CCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 3667888999999 67789999988889999999997555455567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc-CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeecc
Q 046728 92 DYMPNHSLITHLHG-RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTR 166 (325)
Q Consensus 92 e~~~~gsL~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 166 (325)
||+++++|.+++.. .++......+..++..++.++|.. +||||+||+++.++.++|+|||++......... ...
T Consensus 96 e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~~~ 174 (297)
T cd06656 96 EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RST 174 (297)
T ss_pred cccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-cCc
Confidence 99999999999853 345556677888888888888865 799999999999999999999998765443222 223
Q ss_pred CCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHH
Q 046728 167 VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRD 246 (325)
Q Consensus 167 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (325)
..++..|+|||.+.+..++.++|+||||+++|++++|..||.......... ............+..
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--------------~~~~~~~~~~~~~~~ 240 (297)
T cd06656 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--------------LIATNGTPELQNPER 240 (297)
T ss_pred ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--------------eeccCCCCCCCCccc
Confidence 357889999999988888999999999999999999999996533211000 000000111122344
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 247 QLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 247 ~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
.+..+.+|+.+||..||++|||++++++ ||+....
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 5677899999999999999999999998 8876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=265.12 Aligned_cols=263 Identities=16% Similarity=0.221 Sum_probs=199.5
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh--hhHHHHHHHHHHHHccCCCC-ccceeeEEEcCC----
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA--KAEMEFAVEVEILGRVRHRN-LLGLRGFYAGGD---- 85 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~---- 85 (325)
..|..+++||+| +++.||.++...+|+.||+|.+..... .......+|+.+++.++|+| |+++++++.+..
T Consensus 11 ~~~~~~eklGeG--tyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 11 FDYEKVEKLGEG--TYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHhCCC--CceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 457888889999 899999999999999999999975433 34456788999999999999 999999998776
Q ss_pred --eEEEEEEecCCCChhhhhcc------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccc
Q 046728 86 --ERLIVYDYMPNHSLITHLHG------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFA 153 (325)
Q Consensus 86 --~~~lV~e~~~~gsL~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~ 153 (325)
.+++|+||+.. +|..|+.. .++...+..+..|+..++.++|++ |||||+|||++..|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 78999999955 99999943 233345788999999999999987 799999999999999999999999
Q ss_pred cccCCCcceeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccc
Q 046728 154 KLIPDGVTHMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFE 232 (325)
Q Consensus 154 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (325)
+........ ..+..+|..|+|||++.+. .|+...||||+||++.||+++++.|.+.........+-..........|+
T Consensus 168 ra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 168 RAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 976643322 2234578999999999876 78999999999999999999999997654422111111111111112222
Q ss_pred cccC--------cccc-----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 233 HIAD--------PRLK-----GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 233 ~~~~--------~~~~-----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
.+.. +... ....+..++...+|+.+||..+|.+|.|+..+++ +|...
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 2110 0000 0011222358999999999999999999999998 56654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=282.13 Aligned_cols=255 Identities=24% Similarity=0.328 Sum_probs=202.9
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
+...|.++||+|.+|. |-++. ..++..||+|+++... ......|.+|+++|.+++||||++++|+|..++.+++||
T Consensus 538 s~L~~~ekiGeGqFGE--VhLCe-veg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGE--VHLCE-VEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred hheehhhhhcCcccce--eEEEE-ecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 4567899999995554 55554 3336899999998543 455589999999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCC----CCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 92 DYMPNHSLITHLHGRL----APDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 92 e~~~~gsL~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||+++|+|.+|+.... .......+..|++.++.|+.++ ||+.+.|||++.++++||+|||+++-+..+....
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 9999999999995442 2334566888999999998876 8999999999999999999999999666655544
Q ss_pred e-ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh--CCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 164 T-TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS--AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 164 ~-~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
. ...+-+++|+|||.+..+.++.++|+|+||+++||+++ +..||....++...+...- +..-......
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~---------~~~~~~~~~~ 765 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGE---------FFRDQGRQVV 765 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhh---------hcCCCCccee
Confidence 3 34456789999999999999999999999999999876 7889987655433222211 1111112223
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
...|.-++..+.+||.+||..|-++|||++++...|++.
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 345667888999999999999999999999999988753
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=268.09 Aligned_cols=248 Identities=23% Similarity=0.297 Sum_probs=194.6
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
...|.+.+.||.| +++.||.++...+++.||+|.++.........+.+|+.+++.++||||+++++++......++||
T Consensus 8 ~~~~~~~~~lg~g--~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSG--TYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCC--CCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 3578999999999 77789999999999999999987655455567888999999999999999999999999999999
Q ss_pred EecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 92 DYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 92 e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
||+++++|.+++. +.+++..++.+..++..++.++|.+ +||||+||+++.++.++|+|||++........ ...
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 164 (267)
T cd06645 86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-KRK 164 (267)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-ccc
Confidence 9999999999984 4466677778888899999999875 79999999999999999999999876543221 123
Q ss_pred cCCCCcCCCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 166 RVKGTLGYLAPEYAM---WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
...|+..|+|||++. ...++.++|+|||||++|+|++|..||............. ... ...+.. .
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~-------~~~---~~~~~~--~ 232 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT-------KSN---FQPPKL--K 232 (267)
T ss_pred cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh-------ccC---CCCCcc--c
Confidence 345889999999874 4467889999999999999999999986543211110000 000 000000 0
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.....+..+.+++.+||..||++|||++++++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11134567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=280.35 Aligned_cols=243 Identities=23% Similarity=0.333 Sum_probs=191.5
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lV 90 (325)
|.+++.||.| +++.||+++...+++.||+|.+.... ......+..|..++..+ +||+|+++++++.+.+..++|
T Consensus 2 f~~~~~lg~G--~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05616 2 FNFLMVLGKG--SFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV 79 (323)
T ss_pred ceEEEEEeeC--CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence 5678889998 77889999999999999999987432 22334566788888877 589999999999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|||+++|+|.+++. ..+++..+..+..++..++.++|.+ |||||+|||++.++.+||+|||++........ ..
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~-~~ 158 (323)
T cd05616 80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-TT 158 (323)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-cc
Confidence 99999999999884 3466677788889999999999985 79999999999999999999999875432211 12
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
....||+.|+|||++.+..++.++|||||||++|+|+||..||...... .....+. .. ....+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i~------------~~--~~~~p 221 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSIM------------EH--NVAYP 221 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHHHH------------hC--CCCCC
Confidence 3356899999999999889999999999999999999999999754321 1111110 00 01223
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH--HHh
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPTM-----TDVVD--WLK 277 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps~-----~~il~--~l~ 277 (325)
...+.++.+|+.+||..||++|++. .++.+ ||+
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~ 261 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 261 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcC
Confidence 4566789999999999999999984 66665 444
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=272.25 Aligned_cols=248 Identities=21% Similarity=0.362 Sum_probs=189.6
Q ss_pred cchhHHhhccCccceeeeeEEEe----ccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLR----RETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~----~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
..+++.+.||+| +++.||++. +..++..||+|.+... .......+.+|+.+++.++||||+++++++..+...
T Consensus 5 ~~~~~~~~lg~g--~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 5 SAVRFMEELGEC--AFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhceeeeecccc--CCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 346788999999 666788776 3445688999999743 334446788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccC-------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCc
Q 046728 88 LIVYDYMPNHSLITHLHGR-------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFE 144 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~ 144 (325)
|+||||+.+++|.+++... ++....+.+..++..++.++|.. +||||+||+++.++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc
Confidence 9999999999999998422 12223345667788888888875 799999999999999
Q ss_pred eEEeeeccccccCCCcc-eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhh
Q 046728 145 AKVADFGFAKLIPDGVT-HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWV 222 (325)
Q Consensus 145 ~kL~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~ 222 (325)
++|+|||++........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.... .....+
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~~~ 239 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIEMV 239 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH
Confidence 99999999986543322 11223345678999999988889999999999999999998 89998654321 111111
Q ss_pred cccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 046728 223 TPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278 (325)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~ 278 (325)
.. . ...+.+..+++.+.+++.+||..||++||++.+|++.|+.
T Consensus 240 ~~----~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 RK----R---------QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred Hc----C---------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 10 0 0112233456789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=271.76 Aligned_cols=247 Identities=22% Similarity=0.365 Sum_probs=192.1
Q ss_pred cchhHHhhccCccceeeeeEEEec-----cCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRR-----ETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
+.+.+.++||.| +++.||.+.. ..++..+|+|.+..........+.+|+++++.++||||+++++++.+....
T Consensus 5 ~~~~~~~~lg~g--~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEG--AFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCc--cCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 456788999999 7777887753 334668999998876666677899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccC-----------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceE
Q 046728 88 LIVYDYMPNHSLITHLHGR-----------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAK 146 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~k 146 (325)
++||||+++++|.++++.. ++...++.+..++..++.++|.. +||||+|||+++++.++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEE
Confidence 9999999999999998532 33344566777888888888875 79999999999999999
Q ss_pred EeeeccccccCCCccee-eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcc
Q 046728 147 VADFGFAKLIPDGVTHM-TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTP 224 (325)
Q Consensus 147 L~Dfg~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~ 224 (325)
|+|||++.......... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||........ .....
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~~~- 238 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---IECIT- 238 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---HHHHH-
Confidence 99999987554322211 122335678999999988889999999999999999998 8999865332111 11100
Q ss_pred cccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 225 YVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
.......+..+++.+.+|+.+||..||++||+++++++.|+
T Consensus 239 ------------~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 ------------QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ------------cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00011222345678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=283.36 Aligned_cols=267 Identities=17% Similarity=0.231 Sum_probs=198.2
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC--
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG-- 84 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 84 (325)
+.+...|.+++.||.| +++.||.+.+..+++.||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 90 (355)
T cd07874 13 FTVLKRYQNLKPIGSG--AQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKS 90 (355)
T ss_pred hhhhhceeEEEEeeec--CCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccc
Confidence 3456778889999999 7888999999888999999998643 334456788899999999999999999998644
Q ss_pred ----CeEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccccc
Q 046728 85 ----DERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLI 156 (325)
Q Consensus 85 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~ 156 (325)
...++||||+.+ +|.+++...++...+..+..++..++.++|.. |||||+|||++.++.+||+|||++...
T Consensus 91 ~~~~~~~~lv~e~~~~-~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 91 LEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ccccceeEEEhhhhcc-cHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 347999999964 78888876667677778889999999999975 799999999999999999999999865
Q ss_pred CCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchh-hhh-----------h--
Q 046728 157 PDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDI-VQW-----------V-- 222 (325)
Q Consensus 157 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~-~~~-----------~-- 222 (325)
..... .....+|..|+|||++.+..++.++|||||||++|+|++|..||.+......... ... .
T Consensus 170 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 170 GTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred CCccc--cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 43221 2334689999999999988899999999999999999999999975432111000 000 0
Q ss_pred --ccccc-ccc-----cccccCccc---cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 223 --TPYVQ-KGA-----FEHIADPRL---KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 223 --~~~~~-~~~-----~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
..... ... +........ ........+..+.+||.+||..||++|||+.++++ ||....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 00000 000 000000000 00111224567899999999999999999999999 786543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=289.41 Aligned_cols=263 Identities=16% Similarity=0.174 Sum_probs=190.3
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcC-----
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG----- 84 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 84 (325)
.....|.+.+.||.| +++.||++.+..+++.||||.+.... ....+|+.+++.++||||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G--~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 63 SPNKSYKLGNIIGNG--SFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CcCCeEEEeEEEEeC--CCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 344578889999999 78889999999999999999885422 2344699999999999999999887432
Q ss_pred ---CeEEEEEEecCCCChhhhhc------cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC-ceEEeee
Q 046728 85 ---DERLIVYDYMPNHSLITHLH------GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF-EAKVADF 150 (325)
Q Consensus 85 ---~~~~lV~e~~~~gsL~~~l~------~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~-~~kL~Df 150 (325)
..+++||||+++ +|.+++. ..++...+..+..++..++.++|.. |||||+|||++.++ .+||+||
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 246799999964 7877763 2244445566777889999999985 79999999998664 6999999
Q ss_pred ccccccCCCcceeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcc-----
Q 046728 151 GFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTP----- 224 (325)
Q Consensus 151 g~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~----- 224 (325)
|+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.........+.....
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99986644322 2234578999999988754 689999999999999999999999976433211111100000
Q ss_pred -------cccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 225 -------YVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 225 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
......+..+....+....+...++++.+||.+||..||.+|||+.++++ ||+.+..
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 00000111111111222223345678999999999999999999999998 9887654
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=266.80 Aligned_cols=250 Identities=19% Similarity=0.263 Sum_probs=195.9
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|.+.+.||.| +++.||++....++..||+|.+... .......+.+|+.+++.++||||+++++++..++..++|
T Consensus 3 ~y~~~~~ig~g--~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 3 NFRIEKKIGRG--QFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred hhhhhhhhccc--CCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 57889999999 7778999998888999999987642 233445788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcc------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 91 YDYMPNHSLITHLHG------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
|||+++++|.+++.. .+++...+.+..++..++.++|.. +||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999999998852 234444566777888888888865 7999999999999999999999987654432
Q ss_pred ceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 161 THMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
.. .....++..|+|||++.+..++.++|+||||+++|+|++|..||........ .... .+......
T Consensus 161 ~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~---------~~~~~~~~ 226 (267)
T cd08229 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SLCK---------KIEQCDYP 226 (267)
T ss_pred cc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH----HHhh---------hhhcCCCC
Confidence 21 1234588899999999888899999999999999999999999965322110 0000 00001111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
...+...+..+.+++.+||..||++|||+.+|++.++++
T Consensus 227 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 112234677899999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=271.53 Aligned_cols=265 Identities=22% Similarity=0.316 Sum_probs=193.1
Q ss_pred cchhHHhhccCccceeeeeEEEe----ccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEc--CCe
Q 046728 13 SPAVFIQNINNGLEILMLLLLLR----RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG--GDE 86 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 86 (325)
..+.+++.||+| +++.||.+. +..++..||+|.+..........+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g--~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKG--NFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCC--CCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 467889999999 667788776 445678999999987666667789999999999999999999998643 356
Q ss_pred EEEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC
Q 046728 87 RLIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 159 (325)
+++||||+++|+|.+++.. .++......+..++..++.++|.. +||||+||+++.++.++|+|||++......
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 8999999999999999953 245556677788888889998875 799999999999999999999999876543
Q ss_pred cceee--ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 160 VTHMT--TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 160 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
..... ....++..|+|||++.+..++.++||||||+++|||+++..|+.......................+......
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc
Confidence 22111 1122345699999998888999999999999999999988776433211000000000000000000000111
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
....+.+...+..+.+|+.+||..+|++|||+.++++.|+.+
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111122344567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=280.35 Aligned_cols=252 Identities=21% Similarity=0.277 Sum_probs=210.1
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCC--CeEEEEEecc-cChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGD--DQIAVKRLKT-LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~--~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
+..++-+.||.|++|..++..+..-..| -.||||.-+. ..++..+.|..|.-+|++++||||++++|++.+ ...||
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 3456778999999998877777665333 4689999876 567778899999999999999999999999974 45899
Q ss_pred EEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 90 VYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 90 V~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
|||.++-|.|..|++ ..++......+..|+.-|+.|+++. |||..+|||+..+-.+||+|||+++++.+....
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 999999999999994 4455666677888999999999885 799999999999999999999999999887776
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
......-++.|+|||.+....|+.++|||.||+++||++. |..||.+....+.- ...+.+-+.
T Consensus 548 kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI----------------~~iEnGeRl 611 (974)
T KOG4257|consen 548 KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI----------------GHIENGERL 611 (974)
T ss_pred hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE----------------EEecCCCCC
Confidence 6665567889999999988899999999999999999986 99999875442221 122333456
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
+.|+.+++.+..|+.+||.+||.+||++.++...|...+.
T Consensus 612 P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 612 PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 7788999999999999999999999999999987776653
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=279.65 Aligned_cols=238 Identities=21% Similarity=0.284 Sum_probs=183.8
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHH-HHHccCCCCccceeeEEEcCCeEEEEEEecC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVE-ILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~ 95 (325)
.||.| +++.||+++...+++.||+|.+.... .....++..|.. +++.++||||+++++++.+....++||||++
T Consensus 2 ~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 2 VIGKG--SFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred eeeeC--CCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 56777 88889999999999999999986421 222334555544 5678899999999999999999999999999
Q ss_pred CCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCC
Q 046728 96 NHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169 (325)
Q Consensus 96 ~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 169 (325)
+|+|..++.. .+.+..+..+..++..++.++|.. |||||+|||++.++.+||+|||++........ ......|
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g 158 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TTSTFCG 158 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-ccccccC
Confidence 9999998843 355566677888999999999985 79999999999999999999999875332211 1233468
Q ss_pred CcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHH
Q 046728 170 TLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249 (325)
Q Consensus 170 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (325)
|+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+ .... ...+...++
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~i------------~~~~--~~~~~~~~~ 221 (323)
T cd05575 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---MYDNI------------LNKP--LRLKPNISV 221 (323)
T ss_pred ChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH---HHHHH------------HcCC--CCCCCCCCH
Confidence 999999999998889999999999999999999999997533211 11000 0000 112234567
Q ss_pred HHHHHHHHccCCCCCCCCCH----HHHHH--HHh
Q 046728 250 SMVLIALRCTDSNPENRPTM----TDVVD--WLK 277 (325)
Q Consensus 250 ~~~~li~~cl~~dp~~Rps~----~~il~--~l~ 277 (325)
.+.++|.+||..||.+||++ .++++ ||.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~ 255 (323)
T cd05575 222 SARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFS 255 (323)
T ss_pred HHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcC
Confidence 89999999999999999997 46665 554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=281.92 Aligned_cols=236 Identities=21% Similarity=0.325 Sum_probs=185.8
Q ss_pred hhccCccceeeeeEEEecc---CCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEe
Q 046728 19 QNINNGLEILMLLLLLRRE---TGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~ 93 (325)
+.||.| +++.||++++. .+++.||+|.+.... .....++.+|++++++++||||+++++++.+....|+||||
T Consensus 2 ~~lg~G--~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQG--SFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeC--CCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 567888 77778887753 568899999997432 22344677899999999999999999999999999999999
Q ss_pred cCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccC
Q 046728 94 MPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRV 167 (325)
Q Consensus 94 ~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 167 (325)
+++|+|.+++.. .+++..+..+..++..++.++|.+ |||||+||+++.++.++|+|||++........ .....
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 158 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAYSF 158 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ceecc
Confidence 999999999843 356677788899999999999986 79999999999999999999999876543321 12335
Q ss_pred CCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHH
Q 046728 168 KGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQ 247 (325)
Q Consensus 168 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (325)
.|+..|+|||++.+..++.++|||||||++|+|++|..||...... .....+. .. ....+...
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~~i~------------~~--~~~~p~~~ 221 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETMTMIL------------KA--KLGMPQFL 221 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHHHHHH------------cC--CCCCCCCC
Confidence 6899999999998888899999999999999999999999653221 1111100 00 01223445
Q ss_pred HHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 046728 248 LKSMVLIALRCTDSNPENRPT-----MTDVVD 274 (325)
Q Consensus 248 ~~~~~~li~~cl~~dp~~Rps-----~~~il~ 274 (325)
++.+.+||.+||..||++||| ++++++
T Consensus 222 ~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~ 253 (318)
T cd05582 222 SPEAQSLLRALFKRNPANRLGAGPDGVEEIKR 253 (318)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhC
Confidence 678999999999999999999 455654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=270.35 Aligned_cols=249 Identities=19% Similarity=0.253 Sum_probs=194.1
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
.+.+++.||.| +++.||++.+..+++.||+|.+... .......+.+|++++++++||||+++++.+......++|||
T Consensus 2 ~~~~~~~lg~g--~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHG--NGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccC--CCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 46788889988 7788999999999999999998643 34445678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCC
Q 046728 93 YMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVK 168 (325)
Q Consensus 93 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~ 168 (325)
|+++++|..+. .+++..+..+..++..+++++|.. +||||+||+++.++.++|+|||++....... .....
T Consensus 80 ~~~~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~~~~~ 154 (279)
T cd06619 80 FMDGGSLDVYR--KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---AKTYV 154 (279)
T ss_pred cCCCCChHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---ccCCC
Confidence 99999997654 244555667888899999999876 6999999999999999999999997654321 22346
Q ss_pred CCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchh-hhhhcccccccccccccCccccCCCCHHH
Q 046728 169 GTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDI-VQWVTPYVQKGAFEHIADPRLKGKFNRDQ 247 (325)
Q Consensus 169 ~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (325)
++..|+|||++.+..++.++|+||||+++|+|++|..||........... .... ................
T Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~ 225 (279)
T cd06619 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL---------QCIVDEDPPVLPVGQF 225 (279)
T ss_pred CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH---------HHHhccCCCCCCCCcC
Confidence 88999999999988899999999999999999999999975432111100 0000 0000000011112335
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 248 LKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 248 ~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
++++.+++.+||..||++||+++++++ ||..
T Consensus 226 ~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 226 SEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred CHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence 568999999999999999999999998 6654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=269.24 Aligned_cols=249 Identities=18% Similarity=0.261 Sum_probs=197.0
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
.|.+++.||.| +++.||+++...++..||+|.+... .......+.+|++++++++||||+++++.+......++|||
T Consensus 2 ~~~~~~~ig~g--~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKG--NYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhccc--CCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 47899999999 7788999999888999999988643 34445688899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc-----CCCCCCccCHHHHHHHHHHHHhh-----cCCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 93 YMPNHSLITHLHG-----RLAPDCLLDWHRRVSIAIGSAEG-----IADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 93 ~~~~gsL~~~l~~-----~~~~~~~~~~~~~~~~~~~~~~~-----~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
|+++++|..+++. .+++..+..+..++..++.++|. |+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 9999999999864 45666677888899999999984 48999999999999999999999987653321
Q ss_pred eeccCCCCcCCCCccccccC------CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccC
Q 046728 163 MTTRVKGTLGYLAPEYAMWG------KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD 236 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~------~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (325)
.....++..|+|||.+.+. .++.++|+|||||++|+|++|..||............. .+..
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~------------~~~~ 224 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS------------AIVD 224 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH------------HHhh
Confidence 1223477889999998644 34789999999999999999999996533211111100 0000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 237 PRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 237 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
......+..++.++.++|.+||..+|++||+++++++ ||....
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 225 -GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred -cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 0112234457788999999999999999999999998 776543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=270.64 Aligned_cols=248 Identities=20% Similarity=0.317 Sum_probs=190.6
Q ss_pred cchhHHhhccCccceeeeeEEEeccC-----CCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRET-----GDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
..+.+++.||.| +++.||.++... .++.||+|.+.... ......+.+|..++.+++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G--~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 5 STVRFMEELGED--RFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHHhCCC--CCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 357899999999 677788877543 35789999997543 2334578889999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhccC------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCc
Q 046728 87 RLIVYDYMPNHSLITHLHGR------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFE 144 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~~------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~ 144 (325)
.++++||+.+++|.+++... +....+..+..++..+++++|.. |||||+||++++++.
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc
Confidence 99999999999999998421 12222445667888888888875 799999999999999
Q ss_pred eEEeeeccccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhh
Q 046728 145 AKVADFGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWV 222 (325)
Q Consensus 145 ~kL~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~ 222 (325)
+||+|||+++........ ......+++.|+|||.+.++.++.++|||||||++|||++ |..||...... .....+
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~i 239 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVIEMI 239 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH
Confidence 999999998865433221 1223345778999999988889999999999999999998 88888654321 111111
Q ss_pred cccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 046728 223 TPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278 (325)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~ 278 (325)
.. .. ....+..++..+.+|+.+||+.+|++|||+.+|+..|+.
T Consensus 240 ~~------------~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 RN------------RQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred Hc------------CC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 10 00 112234566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=268.08 Aligned_cols=242 Identities=20% Similarity=0.346 Sum_probs=193.6
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEe
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~ 93 (325)
|.+.+.||.| +++.||++.+..+++.+|+|.+... .......+.+|+.+++.++||||+++++.+.++..+++||||
T Consensus 2 y~~~~~lg~g--~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 2 YNVLRVVGEG--SFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred ceEEEEeecc--CCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 5677889999 7778999999999999999998642 344556788899999999999999999999999999999999
Q ss_pred cCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 94 MPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 94 ~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
+++|+|.+++.. .+++...+.+..++..++.++|.. +||||+||+++.++.++|+|||.+......... ..
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~ 158 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY-AC 158 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc-cc
Confidence 999999998842 245566677888999999999875 699999999999999999999998766543222 22
Q ss_pred cCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCH
Q 046728 166 RVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNR 245 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (325)
...++..|+|||++.+..++.++|+||||+++|+|++|..||...... ...... ..+. ..+.+.
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~----~~~~---------~~~~~~ 222 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK---NLILKV----CQGS---------YKPLPS 222 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH---HHHHHH----hcCC---------CCCCCc
Confidence 345888999999998888999999999999999999999999653211 111000 0010 112233
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046728 246 DQLKSMVLIALRCTDSNPENRPTMTDVVDW 275 (325)
Q Consensus 246 ~~~~~~~~li~~cl~~dp~~Rps~~~il~~ 275 (325)
..+..+.+|+.+||..||++|||+.++++.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 456789999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=286.48 Aligned_cols=250 Identities=19% Similarity=0.275 Sum_probs=194.2
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|.+++.||.| +++.||+++...+++.||+|.+... .......+..|..++..++||||+++++.+.+...+|+|
T Consensus 2 ~f~~~~~lG~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 2 DFESLKVIGRG--AFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CceEEEEEeeC--CCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 46778899999 7888999999999999999999642 233445778899999999999999999999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc---
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT--- 161 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--- 161 (325)
||||++|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++.++.++|+|||++........
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 99999999999984 3466677788889999999999985 79999999999999999999999875432110
Q ss_pred -------------------------------eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 046728 162 -------------------------------HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKL 210 (325)
Q Consensus 162 -------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 210 (325)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 0011346899999999999889999999999999999999999999764
Q ss_pred CCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHH--HHhcc
Q 046728 211 PGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPT---MTDVVD--WLKGG 279 (325)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~~il~--~l~~~ 279 (325)
........ +... ...+..+.....++++.+||.+|+ .||.+|++ ++++++ ||+..
T Consensus 240 ~~~~~~~~---i~~~----------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 240 TPQETYRK---VMNW----------KETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CHHHHHHH---HHcC----------CCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence 33111110 0000 000011111235678899999877 49999985 788887 77653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=273.89 Aligned_cols=255 Identities=20% Similarity=0.261 Sum_probs=184.4
Q ss_pred chhHHhhccCccceeeeeEEEeccC-CCCeEEEEEecccC--hhhHHHHHHHHHHHHcc---CCCCccceeeEEE-----
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRET-GDDQIAVKRLKTLN--AKAEMEFAVEVEILGRV---RHRNLLGLRGFYA----- 82 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~----- 82 (325)
.|.+++.||.| +++.||++++.. +++.||+|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 2 ~Y~~~~~lg~G--~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 2 QYECVAEIGEG--AYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CcceeeEeccC--CCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 57888999999 788899998754 46889999886422 22234566777777766 6999999999875
Q ss_pred cCCeEEEEEEecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccc
Q 046728 83 GGDERLIVYDYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 83 ~~~~~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
.....++||||+. ++|.+++.. .++...+..+..++..++.++|.. |||||+|||++.++.++|+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 2455899999995 699999853 244556677888999999999875 7999999999999999999999998
Q ss_pred ccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccc-hhhhhhccccccccccc
Q 046728 155 LIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKR-DIVQWVTPYVQKGAFEH 233 (325)
Q Consensus 155 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~ 233 (325)
..... .......+|..|+|||++.+..++.++|||||||++|+|++|.+||......... .+..... ......+..
T Consensus 159 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~-~~~~~~~~~ 235 (290)
T cd07862 159 IYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG-LPGEEDWPR 235 (290)
T ss_pred eccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC-CCChhhchh
Confidence 65443 1223345899999999998888999999999999999999999999764331111 1111000 000000000
Q ss_pred ---ccCccc-------cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 234 ---IADPRL-------KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 234 ---~~~~~~-------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
...... .....+..++.+.+|+.+||..||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000 00111245678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=269.74 Aligned_cols=253 Identities=20% Similarity=0.254 Sum_probs=199.1
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
....|.++++||.| +++.||+++...+++.||+|.+..........+.+|+.+++.++||||+++++.+..+...++|
T Consensus 10 ~~~~y~i~~~lg~g--~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 10 PNEVWEIIGELGDG--AFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred cchhhhhhheecCC--CCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 34668999999998 8888999999999999999999876666677899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 91 YDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 91 ~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
|||+++++|..++. ..++...+..+..++..++.++|.. +||||+||+++.++.++|+|||++.........
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~- 166 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR- 166 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccc-
Confidence 99999999988773 2356667778888899999988875 799999999999999999999988754332111
Q ss_pred eccCCCCcCCCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 164 TTRVKGTLGYLAPEYAM-----WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
.....++..|+|||.+. ...++.++|+|||||++|+|++|..||........ ..... .. ..
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~-----~~-------~~ 232 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIA-----KS-------EP 232 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHHHh-----cC-------CC
Confidence 12234788999999885 33467899999999999999999999965332110 00000 00 00
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
.....+...+.++.++|.+||..||++||+++++++ ||....
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 233 PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 011223345668999999999999999999999998 776543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=267.15 Aligned_cols=249 Identities=24% Similarity=0.383 Sum_probs=193.6
Q ss_pred cchhHHhhccCccceeeeeEEEeccCC---CCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETG---DDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~---~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
..|++.+.||.| +++.||.+....+ ...||+|.+... .......+.+|+.++++++||||+++++.+......+
T Consensus 4 ~~~~~~~~lg~g--~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGG--EFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred HHceeeeEecCC--ccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 357788999999 7777888776543 457999998643 3444567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC-c
Q 046728 89 IVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG-V 160 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-~ 160 (325)
+||||+++++|.+++.. .++...++.+..++..++.++|.. +||||+||++++++.++|+|||++...... .
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 99999999999999853 345556677788888888888875 799999999999999999999999876521 1
Q ss_pred ceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 161 THMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...... . ..
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~----~---------~~ 225 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAVE----D---------GY 225 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHHH----c---------CC
Confidence 112222335678999999998889999999999999999998 999986543211 111110 0 00
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
..+.+...++.+.+|+.+||..+|++||+++++++.|+.+
T Consensus 226 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1112234567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=272.76 Aligned_cols=250 Identities=22% Similarity=0.365 Sum_probs=193.5
Q ss_pred chhHHhhccCccceeeeeEEEecc-----CCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRE-----TGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
.|.+.+.||.| +++.||+++.. .++..|++|.+..........+.+|++++++++||||+++++++......+
T Consensus 6 ~~~~~~~lg~g--~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 6 DIVLKRELGEG--AFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HeEEeeeeccc--CCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 35677889998 77778887643 345679999997766666678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhccC------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceE
Q 046728 89 IVYDYMPNHSLITHLHGR------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAK 146 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~~------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~k 146 (325)
+||||+++++|.+++... ++....+.+..++..++.++|.. |||||+||+++.++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 999999999999999532 22234456677778888888875 79999999999999999
Q ss_pred EeeeccccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcc
Q 046728 147 VADFGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTP 224 (325)
Q Consensus 147 L~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~ 224 (325)
|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|+| |..||....... ......
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~~- 239 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIECIT- 239 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHh-
Confidence 9999999765443221 1223346788999999988889999999999999999998 999986543211 111110
Q ss_pred cccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 225 YVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.+. ....+...+..+.+++.+||..||++|||++++++.|+.+..
T Consensus 240 ---~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 240 ---QGR---------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ---CCC---------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 110 111123356789999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=268.28 Aligned_cols=244 Identities=26% Similarity=0.401 Sum_probs=189.1
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
+.|++.+.||+| +++.||+++... +..||+|.+.... .....+.+|+.++++++||||+++++++......++|||
T Consensus 4 ~~~~~~~~lg~G--~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTG--QFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCc--ccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 346788899998 677788886543 4569999987533 234578999999999999999999999998888999999
Q ss_pred ecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 93 YMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 93 ~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
|+.+|+|.++++. .+....++.+..++..++.++|.. +||||.||+++.++.++|+|||++............
T Consensus 80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 9999999999953 345556677888888899988875 799999999999999999999998866543322222
Q ss_pred cCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 166 RVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
...++..|+|||.+.+..++.++|||||||++|+|++ |..||........ .... ... .....+
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~~----~~~---------~~~~~~ 223 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---VEKV----SQG---------LRLYRP 223 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHH----hcC---------CCCCCC
Confidence 2335678999999988889999999999999999998 9999865432111 1110 000 001112
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVDWL 276 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l 276 (325)
...+..+.+++.+||..||++|||+.+++.-|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 23457899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=292.33 Aligned_cols=247 Identities=23% Similarity=0.278 Sum_probs=195.0
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC--
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD-- 85 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 85 (325)
.....|.+.+.||.| +++.||+++...+++.||||.+... +......+.+|+.++..++|+|+++++..+....
T Consensus 29 ~~~~rY~i~~~LG~G--~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 29 EQAKKYWISRVLGSG--ATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccCCCEEEEEEEecC--CCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 455788899999999 8888999999999999999998643 3445567888999999999999999988775432
Q ss_pred ------eEEEEEEecCCCChhhhhccC------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEee
Q 046728 86 ------ERLIVYDYMPNHSLITHLHGR------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVAD 149 (325)
Q Consensus 86 ------~~~lV~e~~~~gsL~~~l~~~------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~D 149 (325)
.+++||||+++|+|.++++.+ +.+..+..+..++..++.++|.. |||||+|||++.++.+||+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 367999999999999998532 34445566788899999999974 89999999999999999999
Q ss_pred eccccccCCCcc-eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccc
Q 046728 150 FGFAKLIPDGVT-HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQK 228 (325)
Q Consensus 150 fg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 228 (325)
||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .... ... .
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~---~~~~---~~~-~ 259 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---EVMH---KTL-A 259 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHH---HHh-c
Confidence 999986543221 1223456899999999999889999999999999999999999999653221 1111 000 0
Q ss_pred cccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 229 GAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
+ ...+.+...++++.+|+.+||..||.+|||+.++++
T Consensus 260 ~---------~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 260 G---------RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred C---------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 0 011234456778999999999999999999999987
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=277.01 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=188.6
Q ss_pred cchhHHhhccCccceeeeeEEEecc-----CCCCeEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEc-C
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRE-----TGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAG-G 84 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-~ 84 (325)
..|.+.+.||.| +++.||.+... .+++.||+|++... .......+..|++++.++ +||||+++++++.. +
T Consensus 7 ~~~~i~~~lG~G--~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 7 DRLKLGKPLGRG--AFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHhhhhcccccC--cCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 368999999999 77778887643 33578999998643 233445778899999999 79999999998764 4
Q ss_pred CeEEEEEEecCCCChhhhhccC----------------------------------------------------------
Q 046728 85 DERLIVYDYMPNHSLITHLHGR---------------------------------------------------------- 106 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~~~---------------------------------------------------------- 106 (325)
..+++||||+++++|.+++...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5688999999999999998421
Q ss_pred -----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce-eeccCCCCcCCCCc
Q 046728 107 -----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH-MTTRVKGTLGYLAP 176 (325)
Q Consensus 107 -----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aP 176 (325)
++...+..+..++..++.++|.. |||||.||+++.++.++|+|||++..+...... ......++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 12222345567788888888874 799999999999999999999999865432221 12223456789999
Q ss_pred cccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHH
Q 046728 177 EYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIA 255 (325)
Q Consensus 177 E~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 255 (325)
|++.+..++.++|||||||++|+|++ |..||........ ... .... ......+...++++.+++
T Consensus 245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~----~~~~---------~~~~~~~~~~~~~~~~l~ 309 (337)
T cd05054 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCR----RLKE---------GTRMRAPEYATPEIYSIM 309 (337)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHH----HHhc---------cCCCCCCccCCHHHHHHH
Confidence 99998899999999999999999998 9999965322111 000 0000 011112234557899999
Q ss_pred HHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 256 LRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 256 ~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.+||..+|++||+++++++.|+.++.
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=274.12 Aligned_cols=251 Identities=20% Similarity=0.300 Sum_probs=193.6
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCC----eEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDD----QIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~----~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
...|..++.||+| +++.||++....++. .||+|.+... ......++.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSG--AFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecC--CCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 4567888999999 777888887655544 4899998643 345556888999999999999999999998764 5
Q ss_pred EEEEEEecCCCChhhhhccC---CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC
Q 046728 87 RLIVYDYMPNHSLITHLHGR---LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 159 (325)
.++|++|+++|+|.++++.. ++....+.+..++..++.++|.. |||||+||+++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 77999999999999999542 34445567788889999999985 799999999999999999999999876543
Q ss_pred ccee-eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 160 VTHM-TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 160 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
.... .....++..|+|||++.+..++.++||||||+++|+|++ |..||...+........ ..
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~----------------~~ 226 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----------------EK 226 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----------------hC
Confidence 2221 122234678999999998899999999999999999998 99998654322111110 01
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
....+.+..++..+.+++.+||..||++|||+.+++..|.....
T Consensus 227 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 227 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 11112223455678999999999999999999999998876654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=265.25 Aligned_cols=240 Identities=24% Similarity=0.348 Sum_probs=186.8
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCCCC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHS 98 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~gs 98 (325)
.||.| +++.||.+....+++.||+|.+... .......+.+|++++++++||||+++++++......++||||+++++
T Consensus 2 ~lg~g--~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 2 RIGRG--NFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred ccCcc--cCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 56777 7788999999888999999987643 34455678999999999999999999999999999999999999999
Q ss_pred hhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee-ccCCCC
Q 046728 99 LITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT-TRVKGT 170 (325)
Q Consensus 99 L~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~-~~~~~t 170 (325)
|.++++. .+....++.+..++..++.++|.. +||||+||+++.++.++|+|||++........... .....+
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 159 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence 9999953 244555677888888899999864 79999999999999999999999875443211111 111234
Q ss_pred cCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHH
Q 046728 171 LGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249 (325)
Q Consensus 171 ~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (325)
..|+|||.+.+..++.++||||||+++|+|++ |..||........... . . .......+...+.
T Consensus 160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~---~----~---------~~~~~~~~~~~~~ 223 (252)
T cd05084 160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA---I----E---------QGVRLPCPELCPD 223 (252)
T ss_pred eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH---H----H---------cCCCCCCcccCCH
Confidence 56999999988889999999999999999998 8888864332111000 0 0 0011122334567
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 250 SMVLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 250 ~~~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
.+.+|+.+||..||++|||+.++++.|+
T Consensus 224 ~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 224 AVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 8999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=270.34 Aligned_cols=247 Identities=21% Similarity=0.286 Sum_probs=194.4
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
|...+.||+| +++.||++....+++.||+|.+.... ......+.+|+.++++++|++++++++.+.+.+..++||
T Consensus 2 f~~~~~ig~G--~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 2 FRQYRVLGKG--GFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred ceeeEEeecC--CCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 4566788888 88889999999999999999986421 222346778999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 92 DYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 92 e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||+++++|.+++.. .++...+..+..++..++.++|.. +||||+||+++.++.++|+|||++........
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 157 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-- 157 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--
Confidence 99999999998842 255556677888899999999975 79999999999999999999999876543222
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.....|+..|+|||++.+..++.++||||+|+++|+|++|..||................. ......
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-------------~~~~~~ 224 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-------------EVQEEY 224 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh-------------hhhhhc
Confidence 1234589999999999988899999999999999999999999975432211111110000 001112
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH--HHhc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPT-----MTDVVD--WLKG 278 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps-----~~~il~--~l~~ 278 (325)
+...++++.+|+.+||..||++||| ++++++ |+++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 225 SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 2345678999999999999999999 889998 8765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=267.67 Aligned_cols=246 Identities=26% Similarity=0.370 Sum_probs=190.4
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
..+.+.+.||.| +++.||++... +++.||+|.+.... .....+.+|+.++++++||||+++++++......++|||
T Consensus 6 ~~~~~~~~lg~g--~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 6 TSIQLLRKLGAG--QFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hheeeEEEeccc--CCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 457888999999 67778887754 45789999987533 335678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 93 YMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|+.+++|.+++... ++......+..++..++.++|.. +||||+||+++.++.++|+|||++...........
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR 161 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc
Confidence 99999999999542 34445566777777888888864 79999999999999999999999987654322222
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+....... ..+. . ....+.
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~~----~---------~~~~~~ 225 (261)
T cd05068 162 EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL---QQVD----Q---------GYRMPC 225 (261)
T ss_pred CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHH----c---------CCCCCC
Confidence 22223457999999988889999999999999999999 99999654321111 1110 0 001112
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~ 278 (325)
+...+..+.+++.+||..+|++||+++++++.|++
T Consensus 226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 23456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=267.81 Aligned_cols=248 Identities=25% Similarity=0.394 Sum_probs=190.9
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
..+|++.++||.| +++.||+++...+ ..||+|.+.... ....++.+|+++++.++||||+++++.+. ....++||
T Consensus 5 ~~~~~~~~~lg~g--~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQG--CFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 79 (262)
T ss_pred hHHeeEeeecCCC--CCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEE
Confidence 4678899999999 6777888876554 569999997533 23457889999999999999999999875 45579999
Q ss_pred EecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 92 DYMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 92 e~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||+++|+|.++++.. ++......+..++..++.++|.. +||||+||+++.++.++|+|||.+..........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999999999642 33345566778888888888874 7999999999999999999999998665433222
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
.....++..|+|||+..+..++.++|+||||+++|+|+| |..||......... .. . .. .....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~---~~---~-~~---------~~~~~ 223 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---DQ---V-ER---------GYRMP 223 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH---HH---H-hc---------CCCCC
Confidence 223345678999999988889999999999999999999 88888654321111 00 0 00 00112
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
.....+..+.+|+.+||..||++|||+.+++++|+..+
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 23456678999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=277.87 Aligned_cols=244 Identities=23% Similarity=0.328 Sum_probs=191.1
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCCeEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lV 90 (325)
|.+.+.||.| +++.||+++...+++.||+|.+... .......+..|..++..+. |++|+++++++.+.+.+|+|
T Consensus 2 f~~~~~lg~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05615 2 FNFLMVLGKG--SFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV 79 (323)
T ss_pred ceEEEEEEec--CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence 4677889998 8888999999999999999998743 2233446778899998885 67888999999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|||+++|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++.++.++|+|||++........ ..
T Consensus 80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~-~~ 158 (323)
T cd05615 80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-TT 158 (323)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-cc
Confidence 99999999999984 3467777888889999999999975 79999999999999999999999875432221 12
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
....||..|+|||++.+..++.++||||+||++|+|++|..||...... .....+. ... ...+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~------------~~~--~~~p 221 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQSIM------------EHN--VSYP 221 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHH------------hCC--CCCC
Confidence 2345899999999999888999999999999999999999999754321 1111110 000 1123
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH--HHhc
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPTM-----TDVVD--WLKG 278 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps~-----~~il~--~l~~ 278 (325)
...+..+.+++.+||..||.+|++. +++.+ |++.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence 3456789999999999999999984 45554 4443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=280.02 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=192.9
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
..+...||.| .||.||..+..++ ||||.++.. +.+..+.|.+|+..+++=+|.||+-|+|++..+.. .||+.
T Consensus 394 v~l~~rIGsG--sFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 394 VLLGERIGSG--SFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred hhccceeccc--cccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 3456678888 6666776665553 999999743 56667799999999999999999999999988777 99999
Q ss_pred ecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC-cceee
Q 046728 93 YMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG-VTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-~~~~~ 164 (325)
+|+|-+|+.++|. .+.......+.+|++.+++|+|+. ||||..|||+.++++|||+|||++.....- .....
T Consensus 468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~ 547 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQL 547 (678)
T ss_pred hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecccccc
Confidence 9999999999964 345556678888899999999985 899999999999999999999999754432 11122
Q ss_pred ccCCCCcCCCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 165 TRVKGTLGYLAPEYAM---WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
....|...|+|||++. ..+|+..+||||||+|+|||+||..||..... +.+.|+- ..+.+ .+. ..
T Consensus 548 ~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~----dqIifmV---GrG~l----~pd-~s 615 (678)
T KOG0193|consen 548 EQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR----DQIIFMV---GRGYL----MPD-LS 615 (678)
T ss_pred CCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh----hheEEEe---ccccc----Ccc-ch
Confidence 3345888999999986 45799999999999999999999999973222 1121211 01100 011 01
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.....+++++.+|+..||.+++++||++.+|+..|+.++.
T Consensus 616 ~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 616 KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 2235677899999999999999999999999998887765
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=272.23 Aligned_cols=259 Identities=18% Similarity=0.239 Sum_probs=196.1
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
.|.+.+.||.| +++.||++.+..++..+|+|.+... ......++.+|++++++++||||+++++++.+++.+++|||
T Consensus 2 ~~~~~~~lg~G--~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 2 DFEKLGELGAG--NGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CceEEeeccCC--CCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 36778889999 7778999999989999999998643 33445578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhh-----cCCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 93 YMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEG-----IADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 93 ~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~-----~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
|+++++|.++++ ..+++.....+..++..++.++|. |+||||+||+++.++.++|+|||++....... ..
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~ 156 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---AN 156 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---cc
Confidence 999999999995 335566677888999999999985 37999999999999999999999987543321 23
Q ss_pred cCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccc---------------
Q 046728 166 RVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGA--------------- 230 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--------------- 230 (325)
...++..|+|||++.+..++.++|+||||+++|+|++|..||.......................
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRP 236 (308)
T ss_pred cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccch
Confidence 34688999999999888889999999999999999999999864332111111100000000000
Q ss_pred ------cccccCccccCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 231 ------FEHIADPRLKGKFN-RDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 231 ------~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
........ .+..+ ...+.++.+|+.+||..||++|||+.++++ ||..
T Consensus 237 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 237 MAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred hhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 00000000 00111 125678999999999999999999999998 7864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=266.68 Aligned_cols=247 Identities=19% Similarity=0.314 Sum_probs=199.3
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
.|.+++.||.| +++.||+++...+++.||+|.+.... ......+.+|+++++.++|||++++++++.++...++|+|
T Consensus 2 ~y~~~~~lg~g--~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKG--SFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhhcCC--CCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 57889999998 88889999998899999999987532 3444578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc-CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccC
Q 046728 93 YMPNHSLITHLHG-RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRV 167 (325)
Q Consensus 93 ~~~~gsL~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 167 (325)
|+++++|.+++.. .++...+..+..++..++.++|.. +||+|+||+++.++.++|+|||++........ .....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 158 (274)
T cd06609 80 YCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRNTF 158 (274)
T ss_pred eeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-ccccc
Confidence 9999999999964 466677788888999999998875 79999999999999999999999987654322 22334
Q ss_pred CCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHH-
Q 046728 168 KGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRD- 246 (325)
Q Consensus 168 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 246 (325)
.++..|+|||.+.+..++.++||||||+++|+|+||..||....... ...... .. ........
T Consensus 159 ~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~----~~---------~~~~~~~~~ 222 (274)
T cd06609 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VLFLIP----KN---------NPPSLEGNK 222 (274)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---HHHHhh----hc---------CCCCCcccc
Confidence 57888999999998889999999999999999999999996533211 110000 00 01111111
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 247 QLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 247 ~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
++..+.+++.+||..||++|||++++++ ||...
T Consensus 223 ~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 223 FSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 5678999999999999999999999998 77653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=277.73 Aligned_cols=251 Identities=22% Similarity=0.267 Sum_probs=192.6
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|.+++.||+| +++.||+++...+++.||+|.+.+. .......+.+|..++..++|+||+++++++.++..+|+|
T Consensus 2 ~y~~~~~lG~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 2 DFEILKVIGRG--AFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CceEEEEEEec--CCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence 46788999999 7788999999999999999998642 223345678899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 91 YDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
|||+++|+|.+++.. .+++..+..+..++..++.++|.. |||||+|||++.++.++|+|||++..........
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 999999999999943 456667778889999999999986 7999999999999999999999987655433322
Q ss_pred eccCCCCcCCCCcccccc-----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 164 TTRVKGTLGYLAPEYAMW-----GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
.....||+.|+|||++.. ..++.++|||||||++|+|++|..||........ .. ....... ...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~---~~---~i~~~~~-----~~~ 228 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YG---KIMNHKE-----HFQ 228 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH---HH---HHHcCCC-----ccc
Confidence 233458999999999863 3578899999999999999999999965332111 00 0000000 000
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH--HHhc
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPEN--RPTMTDVVD--WLKG 278 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~~il~--~l~~ 278 (325)
. .......+..+.+||.+|+..++++ |++++++++ ||..
T Consensus 229 ~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 229 F-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred C-CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 0 1112336678999999988654443 789999998 7765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=268.47 Aligned_cols=237 Identities=21% Similarity=0.280 Sum_probs=181.2
Q ss_pred ccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCCC
Q 046728 21 INNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNH 97 (325)
Q Consensus 21 i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~g 97 (325)
||.| +++.||+++...+++.||+|.+.... ......+..|++++++++||||+++++++.++...++||||++++
T Consensus 1 lg~G--~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKG--GFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCC--CceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence 4555 88899999999999999999986321 122335567999999999999999999999999999999999999
Q ss_pred Chhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCC
Q 046728 98 SLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169 (325)
Q Consensus 98 sL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 169 (325)
+|.+++.. .+....+..+..++..++.++|.. |||||+||+++.++.++|+|||++........ .....+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~ 156 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAG 156 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eeccCC
Confidence 99988842 234444556777888888888875 79999999999999999999999886654322 223458
Q ss_pred CcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHH
Q 046728 170 TLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249 (325)
Q Consensus 170 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (325)
+..|+|||++.+..++.++||||+||++|+|++|..||.......... ...... ...... .....+++
T Consensus 157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~--~~~~~~---------~~~~~~-~~~~~~~~ 224 (277)
T cd05607 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--ELKRRT---------LEDEVK-FEHQNFTE 224 (277)
T ss_pred CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH--HHHHHh---------hccccc-cccccCCH
Confidence 899999999998889999999999999999999999996543211110 000000 000010 11134567
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHH
Q 046728 250 SMVLIALRCTDSNPENRPTMTDVV 273 (325)
Q Consensus 250 ~~~~li~~cl~~dp~~Rps~~~il 273 (325)
++.+|+.+||..||++||++.+++
T Consensus 225 ~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 225 ESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred HHHHHHHHHhccCHhhCCCCccch
Confidence 899999999999999999995544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=271.75 Aligned_cols=251 Identities=18% Similarity=0.257 Sum_probs=200.2
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
+.|.+++.||.| +++.||.+.+..+++.||+|.+..........+.+|+.+++.++|||++++++++......++|+|
T Consensus 19 ~~y~~~~~lg~g--~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQG--ASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecC--CCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 457888899998 777899999889999999999876554555688899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc-CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccC
Q 046728 93 YMPNHSLITHLHG-RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRV 167 (325)
Q Consensus 93 ~~~~gsL~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 167 (325)
|+.+++|..++.. .++...+..+..++..++.++|.+ +||||+||+++.++.++|+|||++......... ....
T Consensus 97 ~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~ 175 (296)
T cd06655 97 YLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RSTM 175 (296)
T ss_pred ecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-CCCc
Confidence 9999999999853 356667777888888888888875 799999999999999999999998865443221 2233
Q ss_pred CCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHH
Q 046728 168 KGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQ 247 (325)
Q Consensus 168 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (325)
.++..|+|||.+.+..++.++|+|||||++|+|++|..||........ ...... .. ......+...
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~---~~~~~~----~~-------~~~~~~~~~~ 241 (296)
T cd06655 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIAT----NG-------TPELQNPEKL 241 (296)
T ss_pred CCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHh----cC-------CcccCCcccC
Confidence 578899999999888899999999999999999999999965432110 000000 00 0001123345
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 248 LKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 248 ~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
++.+.+||.+||..||++|||+.+++. ||....
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 678999999999999999999999998 887644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=274.12 Aligned_cols=242 Identities=27% Similarity=0.444 Sum_probs=180.1
Q ss_pred HHhhccCccceeeeeEEEecc----CCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 17 FIQNINNGLEILMLLLLLRRE----TGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 17 ~~~~i~~G~~~~~~v~~~~~~----~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
+.+.||.|.+| .|+.+... ..+..|+||.++.. .......+.+|++.+++++||||++++|++......++||
T Consensus 3 ~~~~ig~G~fg--~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFG--KVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSE--EEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EeeEEccCCCc--EEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccc
Confidence 45778999555 56655544 44678999999643 4445779999999999999999999999999888899999
Q ss_pred EecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc-e
Q 046728 92 DYMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT-H 162 (325)
Q Consensus 92 e~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~ 162 (325)
|||++|+|.++++.. ++....+.+..+++.++.++|.. ++|+++||+++.++.+||+|||++........ .
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999653 44455667778888888888875 79999999999999999999999987633222 2
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
..........|+|||.+....++.++||||||+++|||++ |..||..... ......+. ...+.
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~~~~-------------~~~~~ 224 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIEKLK-------------QGQRL 224 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHHHHH-------------TTEET
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccc-------------ccccc
Confidence 2233446778999999998889999999999999999999 6888865422 11111111 11112
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWL 276 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l 276 (325)
..+..++..+.++|.+||..||++|||++++++.|
T Consensus 225 ~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 33345667899999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=264.83 Aligned_cols=248 Identities=19% Similarity=0.254 Sum_probs=197.9
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
...|..++.||.| +++.||.+....++..||+|.+... .......+.+|+.++++++||||+++++++.+....++|
T Consensus 3 ~~~y~~~~~lg~g--~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 3 EELFTKLERIGKG--SFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HHhhhhhhhcccC--CCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 3457888999999 7778999998888999999998743 344556888999999999999999999999999999999
Q ss_pred EEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 91 YDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 91 ~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
|||+++|+|.+++. +.++......+..++..++.++|.. +||+|+||+++.++.++|+|||++......... ..
T Consensus 81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~ 159 (277)
T cd06640 81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-RN 159 (277)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc-cc
Confidence 99999999999985 3345555666777888888888875 699999999999999999999999765443221 22
Q ss_pred cCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCH
Q 046728 166 RVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNR 245 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (325)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||........... ...........
T Consensus 160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~----------------~~~~~~~~~~~ 223 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL----------------IPKNNPPTLTG 223 (277)
T ss_pred cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh----------------hhcCCCCCCch
Confidence 23477889999999888899999999999999999999999965432111000 01111223345
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 246 DQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 246 ~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
..+..+.+++.+||..+|++||+++++++ |+..
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06640 224 EFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVK 258 (277)
T ss_pred hhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhh
Confidence 67788999999999999999999999998 6654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=266.15 Aligned_cols=243 Identities=27% Similarity=0.411 Sum_probs=188.2
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEe
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~ 93 (325)
.+.+.+.||.| +++.||+++.. ++..+|+|.+.... .....+.+|++++++++||||+++++++......++||||
T Consensus 5 ~~~~~~~lg~G--~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 5 ELTFLKELGSG--QFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HcchhhhhccC--CCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 46789999999 66778888764 46689999986432 2234688899999999999999999999999999999999
Q ss_pred cCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeecc
Q 046728 94 MPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTR 166 (325)
Q Consensus 94 ~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 166 (325)
+++++|.++++. .++......+..++..++.++|.. +||||+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 999999999953 234455667778888888888875 7999999999999999999999988654432221222
Q ss_pred CCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCH
Q 046728 167 VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNR 245 (325)
Q Consensus 167 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (325)
..++..|+|||.+.+..++.++|+||||+++|++++ |..||........ ..... .......+.
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~-------------~~~~~~~~~ 224 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---VESVS-------------AGYRLYRPK 224 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---HHHHH-------------cCCcCCCCC
Confidence 224457999999998889999999999999999999 8999865432111 11110 001112223
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 046728 246 DQLKSMVLIALRCTDSNPENRPTMTDVVDWL 276 (325)
Q Consensus 246 ~~~~~~~~li~~cl~~dp~~Rps~~~il~~l 276 (325)
..+..+.+++.+||..+|++|||++++++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 4567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=266.01 Aligned_cols=246 Identities=27% Similarity=0.458 Sum_probs=190.9
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
...|.+++.||.| +++.||.+... ++..||+|.+..... ....+.+|+.++++++|||++++++++. ....++||
T Consensus 5 ~~~~~~~~~ig~g--~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (260)
T cd05070 5 RESLQLIKKLGNG--QFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT 79 (260)
T ss_pred hHHhhhhheeccc--cCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence 3567899999999 77788888654 556799999875332 3457889999999999999999999875 45688999
Q ss_pred EecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 92 DYMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 92 e~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||+++++|.++++.. ++......+..++..++.++|.. +||||+||++++++.++|+|||++..........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999999999532 34445677788888888888875 7999999999999999999999998665433222
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... ........ ....+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~-------------~~~~~ 223 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQVER-------------GYRMP 223 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHc-------------CCCCC
Confidence 222335678999999988889999999999999999999 88998654321 11111110 01112
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~ 278 (325)
.+...+..+.+|+.+||..+|++|||+.++.++|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 234556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=267.16 Aligned_cols=246 Identities=23% Similarity=0.378 Sum_probs=190.8
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
...|.++++||.| +++.||++... +++.||+|.+..... ....+.+|+.++++++|||++++++++. ....++||
T Consensus 5 ~~~~~~~~~ig~G--~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 5 RETLKLVKKLGAG--QFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred hHHceeeeeeccC--ccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 4567889999999 77789988754 567899999875332 3457889999999999999999999874 45689999
Q ss_pred EecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 92 DYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 92 e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||+.+++|.+++.. .++......+..++..++.++|.. +||||+||+++.++.++|+|||++..........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 99999999999843 234445566778888899999875 7999999999999999999999998665332222
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
.....++..|+|||.+.+..++.++||||||+++|++++ |..||........ ...+. .....+
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~-------------~~~~~~ 223 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQNLE-------------RGYRMP 223 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HHHHH-------------cCCCCC
Confidence 223345678999999988889999999999999999999 9999975432111 11110 001112
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~ 278 (325)
.+...+.++.+++.+||..+|++|||+++++++|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 223355689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=274.31 Aligned_cols=265 Identities=14% Similarity=0.189 Sum_probs=195.8
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
..|.+++.||.| +++.||.++...+++.||+|.+... .......+.+|+.+++.++||||+++++++......++||
T Consensus 6 ~~y~~~~~lg~g--~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 6 ETYIKLDKLGEG--TYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cceEEeeEeccC--cCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 467888999999 7788999999889999999998643 2333446778999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 92 DYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 92 e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||+. ++|.+++.. .++...+..+..++..++.++|.. +||||+||+++.++.++|+|||++......... .
T Consensus 84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~ 161 (301)
T cd07873 84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-Y 161 (301)
T ss_pred eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc-c
Confidence 9996 599988843 244455677788889999999985 799999999999999999999998764432221 1
Q ss_pred ccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccc---------
Q 046728 165 TRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHI--------- 234 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 234 (325)
....++..|+|||++.+. .++.++|||||||++|+|++|..||...........+...........+...
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence 223468899999988654 5788999999999999999999999764332111111100000001111110
Q ss_pred cCcccc----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 235 ADPRLK----GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 235 ~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
..+... .......++.+.+||.+||..||.+|||++++++ ||+...+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 000000 0112345678999999999999999999999998 8876543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=264.89 Aligned_cols=241 Identities=20% Similarity=0.331 Sum_probs=192.3
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecc--cChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKT--LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
|.+.+.||.| +++.+|++....++..|++|.+.. ........+.+|+.+++.++|||++++++++.+.+..++|||
T Consensus 2 ~~~~~~l~~g--~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 2 FEILNKIGKG--SFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred ceEeEEecCC--CCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 5667889988 777899999988999999999863 244556688899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 93 YMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|+++++|.++++.. ++......+..++..++.++|.. +||||+||+++.++.++|+|||++......... .
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-~ 158 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-A 158 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch-h
Confidence 99999999999542 34445566777888888888875 799999999999999999999998866543222 2
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
....++..|+|||++.+..++.++|+||||+++|+|++|..||..... ....... ..+ .....+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~----~~~---------~~~~~~ 222 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALILKI----IRG---------VFPPVS 222 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH----HcC---------CCCCCc
Confidence 234578899999999988899999999999999999999999965431 1111110 000 011222
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
...+..+.+++.+||..+|++||++.++++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 355678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=267.85 Aligned_cols=250 Identities=20% Similarity=0.263 Sum_probs=198.9
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
..|.+++.||.| +++.||.++...++..||+|.+..........+..|+.++++++||||+++++++..+...++|||
T Consensus 5 ~~~~i~~~l~~g--~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 5 DIWEIIGELGDG--AFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hHHHHHHHhcCC--CCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 358899999999 777899999888899999999986666666789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 93 YMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 93 ~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
|+++++|.+++.. .+++..+..+..++..++.++|.. +||||+||+++.++.++|+|||++......... ..
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~ 161 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK-RD 161 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc-cc
Confidence 9999999999843 366677788889999999999864 799999999999999999999988765433222 22
Q ss_pred cCCCCcCCCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 166 RVKGTLGYLAPEYAM-----WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
...++..|+|||.+. ...++.++|+||||+++|+|++|..||....... ..... ..... ..
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~---~~~~~----~~~~~-------~~ 227 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR---VLLKI----LKSEP-------PT 227 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH---HHHHH----hcCCC-------CC
Confidence 335788999999875 3456789999999999999999999996543211 01000 00000 01
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
...+...+..+.++|.+||..+|++|||++++++ |+...
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 1122345678999999999999999999999998 77654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=271.64 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=191.7
Q ss_pred chhHHhhccCccceeeeeEEEec-----cCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCe
Q 046728 14 PAVFIQNINNGLEILMLLLLLRR-----ETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~-----~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 86 (325)
+|.+.+.||.| +++.||.+.. ...+..||+|.+... .......+.+|+++++++ +||||+++++++...+.
T Consensus 36 ~~~~~~~ig~G--~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 36 NLSFGKTLGAG--AFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HeEEcceeecc--CCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 56778899999 6777877753 334568999998753 334445788999999999 79999999999999999
Q ss_pred EEEEEEecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCC
Q 046728 87 RLIVYDYMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 158 (325)
.++||||+.+|+|.++++.. ++......+..++..++.++|.. +||||+||+++.++.++|+|||++.....
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 99999999999999999532 34455667778888888888875 69999999999999999999999986544
Q ss_pred Ccce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccC
Q 046728 159 GVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD 236 (325)
Q Consensus 159 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (325)
.... ......++..|+|||.+.+..++.++||||+||++|+|++ |..||........ ..... .
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~-------------~ 258 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLI-------------K 258 (302)
T ss_pred CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHH-------------H
Confidence 3221 1222345678999999988889999999999999999998 9999875432111 10100 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 237 PRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 237 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
.......+...++.+.+++.+||..+|++|||+.++++.|+..
T Consensus 259 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 259 EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111122233457899999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=267.02 Aligned_cols=248 Identities=19% Similarity=0.222 Sum_probs=194.6
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
..|++++.||+| +++.||.+....+++.||+|.+... .......+.+|+++++.++||||+++++++.....+++||
T Consensus 5 ~~~~~~~~ig~g--~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAG--NGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCC--CCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 568999999999 7788999999888999999988643 3444568899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhh-----cCCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 92 DYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEG-----IADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 92 e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~-----~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||+++++|.++++. .+.......+..++..++.++|. |+||+|+||+++.++.++|+|||++....... .
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---~ 159 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---A 159 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---c
Confidence 99999999998853 34555667777888888888874 37999999999999999999999987543221 2
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCcc-----chhhhhhcccccccccccccCccc
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVK-----RDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
....++..|+|||++.+..++.++|+|||||++|++++|..||........ ......... ......
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~ 230 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ---------IVQEPP 230 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH---------HhhccC
Confidence 234688999999999888899999999999999999999999975433110 001111110 000000
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.......++..+.+|+.+||..||++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~ 265 (284)
T cd06620 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCA 265 (284)
T ss_pred CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 01111235678999999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=264.01 Aligned_cols=249 Identities=18% Similarity=0.282 Sum_probs=195.4
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecc---cChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKT---LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|.+.+.||.| +++.||.+....+++.||+|.++. ........+.+|+.++++++|+|++++++++...+..++|
T Consensus 3 ~y~~~~~lg~g--~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 3 NFKIEKKIGKG--QFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred ceeeeeeeccC--CceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 46788889999 778899999988899999998853 2334456888999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcc------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 91 YDYMPNHSLITHLHG------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
|||+++|+|.+++.. .++...+..+..++..++.++|.. +||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999999998842 134445567777888888888875 7999999999999999999999987654432
Q ss_pred ceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 161 THMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ..... ...+ ..
T Consensus 161 ~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~----~~~~---------~~ 225 (267)
T cd08224 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKK----IEKC---------DY 225 (267)
T ss_pred cc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH-HHHhh----hhcC---------CC
Confidence 21 1223578889999999888899999999999999999999999964331100 00000 0000 01
Q ss_pred CCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 241 GKFN-RDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 241 ~~~~-~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
.+.+ ...+..+.++|.+||..+|++|||+.+|++.|+++
T Consensus 226 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 226 PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1122 25667899999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=269.34 Aligned_cols=248 Identities=25% Similarity=0.304 Sum_probs=188.1
Q ss_pred cchhHHhhccCccceeeeeEEEeccC-----CCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRET-----GDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~-----~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
..|.+.+.||.| +++.||.+.... .+..||+|.+... .......+.+|+.+++.++|+||+++++++.+...
T Consensus 6 ~~~~~~~~lg~g--~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 6 DSITLLRALGHG--AFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHcEeeeECCCC--CCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 346778889998 677788887766 6788999998643 34444578899999999999999999999998889
Q ss_pred EEEEEEecCCCChhhhhccC---------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC---ceEEeee
Q 046728 87 RLIVYDYMPNHSLITHLHGR---------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF---EAKVADF 150 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~~---------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~---~~kL~Df 150 (325)
.++||||+++++|.+++... ++...++.+..++..++.++|.. +||||+||+++.++ .++|+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 99999999999999999532 22233445677777888888875 79999999998654 5999999
Q ss_pred ccccccCCCccee-eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccc
Q 046728 151 GFAKLIPDGVTHM-TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQK 228 (325)
Q Consensus 151 g~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 228 (325)
|+++......... ......+..|+|||++.+..++.++|||||||++|+|++ |..||...+.... ...+. .
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---~~~~~----~ 236 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---MEFVT----G 236 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHH----c
Confidence 9998664322211 112234567999999988889999999999999999997 9999975443211 11110 0
Q ss_pred cccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 046728 229 GAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278 (325)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~ 278 (325)
......+..++..+.+++.+||..+|++|||+.++++.|++
T Consensus 237 ---------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 237 ---------GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred ---------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 00112234456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=277.10 Aligned_cols=251 Identities=22% Similarity=0.268 Sum_probs=192.4
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|.+++.||+| +++.||+++...+++.||+|.+.+. .......+.+|..++..++|+||+++++++.+....++|
T Consensus 2 ~y~~~~~lG~G--~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 2 DFEILKVIGRG--AFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CceEEEEEEeC--CCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence 46788899999 7788999999999999999998642 122234577899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 91 YDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
|||+++|+|.++++. .+++..+..+..++..++.++|.+ |||||+|||++.++.++|+|||++..........
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 999999999999953 355666777888999999999986 7999999999999999999999987654433333
Q ss_pred eccCCCCcCCCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 164 TTRVKGTLGYLAPEYAM-----WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
.....||+.|+|||++. ...++.++|||||||++|+|++|..||....... ....+... ...+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~---~~~~i~~~--~~~~------- 227 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TYGKIMNH--KERF------- 227 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH---HHHHHhCC--Cccc-------
Confidence 33456899999999986 2457889999999999999999999997533211 11111000 0000
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH--HHhc
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPEN--RPTMTDVVD--WLKG 278 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~~il~--~l~~ 278 (325)
..+......++.+.+|+.+|+..++.+ |++++++++ ||..
T Consensus 228 ~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 001112345778999999988665544 689999998 7764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=269.27 Aligned_cols=254 Identities=21% Similarity=0.352 Sum_probs=187.4
Q ss_pred cchhHHhhccCccceeeeeEEEeccCC--------------CCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccce
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETG--------------DDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGL 77 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~--------------~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~ 77 (325)
..|.+.+.||.| +++.||++..... ...||+|.+... .......+.+|++++++++|||++++
T Consensus 5 ~~~~~~~~lg~G--~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEG--QFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCC--CCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 357888999999 6777887766432 235899998643 34445678999999999999999999
Q ss_pred eeEEEcCCeEEEEEEecCCCChhhhhccC--------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceee
Q 046728 78 RGFYAGGDERLIVYDYMPNHSLITHLHGR--------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLL 139 (325)
Q Consensus 78 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~ 139 (325)
++++......++||||+.+++|.+++... +.....+.+..++..+++++|.. +||||+||++
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 99999999999999999999999998432 11122344667778888888875 7999999999
Q ss_pred CCCCceEEeeeccccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh--CCCCCCCCCCCccc
Q 046728 140 DTDFEAKVADFGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS--AKKPLEKLPGGVKR 216 (325)
Q Consensus 140 ~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t--g~~pf~~~~~~~~~ 216 (325)
+.++.+||+|||++......... ......++..|+|||.+.+..++.++|+|||||++|+|++ +..||.......
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-- 240 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-- 240 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH--
Confidence 99999999999999765433221 1222335678999999988889999999999999999998 667776533211
Q ss_pred hhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 217 DIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
........... .........+...++.+.+|+.+||..||++|||+++|++.|+
T Consensus 241 -~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 -VIENTGEFFRN------QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -HHHHHHHhhhh------ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11110000000 0000111222345678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=262.76 Aligned_cols=240 Identities=23% Similarity=0.312 Sum_probs=185.8
Q ss_pred hccCccceeeeeEEE--eccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecC
Q 046728 20 NINNGLEILMLLLLL--RRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~--~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~ 95 (325)
+||+| +++.||.+ +...++..||+|.+... .......+.+|+.+++.++||||+++++++. ....++||||++
T Consensus 2 ~lg~G--~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSG--NFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE 78 (257)
T ss_pred cCCCc--CCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence 57777 66667766 44566789999998643 2344568889999999999999999999875 456789999999
Q ss_pred CCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee--eccC
Q 046728 96 NHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM--TTRV 167 (325)
Q Consensus 96 ~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~ 167 (325)
+|+|.+++.. .++......+..++..++.++|.. +||||.||+++.++.++|+|||++.......... ....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 9999999943 356666778888899999999875 7999999999999999999999998765433221 1122
Q ss_pred CCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHH
Q 046728 168 KGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRD 246 (325)
Q Consensus 168 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (325)
.++..|+|||.+....++.++|+|||||++|||++ |..||....... ....+. .....+.+..
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~i~-------------~~~~~~~~~~ 222 (257)
T cd05116 159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQMIE-------------SGERMECPQR 222 (257)
T ss_pred CCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH-------------CCCCCCCCCC
Confidence 34578999999988888999999999999999998 999997543211 111111 1111223345
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 046728 247 QLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278 (325)
Q Consensus 247 ~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~ 278 (325)
.++++.+||.+||..||++|||+.+|...|++
T Consensus 223 ~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 223 CPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 66789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=267.65 Aligned_cols=260 Identities=20% Similarity=0.301 Sum_probs=191.1
Q ss_pred chhHHhhccCccceeeeeEEEe----ccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC--Ce
Q 046728 14 PAVFIQNINNGLEILMLLLLLR----RETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG--DE 86 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~----~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 86 (325)
-|.+++.||+| +++.||+++ +..++..||+|.+... .......+.+|++++++++|||++++++++... ..
T Consensus 5 ~~~~~~~lg~g--~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEG--HFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCC--CceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 35888999999 677788776 4566889999998743 344456788999999999999999999998775 56
Q ss_pred EEEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC
Q 046728 87 RLIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 159 (325)
.++||||+++++|.+++.. .++......+..++..++.++|.. |||||+||+++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 8899999999999999843 244455677778888888888875 799999999999999999999999866443
Q ss_pred cce--eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccc---cccc
Q 046728 160 VTH--MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGA---FEHI 234 (325)
Q Consensus 160 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 234 (325)
... ......++..|+|||++.+..++.++||||||+++|+|+|+..|+........ . ...+...... ....
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~-~---~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL-K---MIGPTHGQMTVTRLVRV 238 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh-h---hcccccccccHHHHHHH
Confidence 221 12234467789999999888899999999999999999998776532110000 0 0000000000 0000
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 235 ADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
.......+.+..++..+.+|+.+||..||++|||++++++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 001111222345677899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=275.47 Aligned_cols=231 Identities=22% Similarity=0.278 Sum_probs=180.1
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHH-HHHccCCCCccceeeEEEcCCeEEEEEEecC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVE-ILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~ 95 (325)
.||.| +++.||++++..+++.||+|.+.... ......+..|.. +++.++||||+++++++.+.+..++|||||+
T Consensus 2 ~lg~G--~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 2 VIGKG--SFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred eeeeC--CCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 56777 88899999999999999999986422 222334555554 6788899999999999999999999999999
Q ss_pred CCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCC
Q 046728 96 NHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169 (325)
Q Consensus 96 ~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 169 (325)
+|+|..++. ..+.+..+..+..++..++.++|.. |||||+||+++.++.+||+|||++........ ......|
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g 158 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TTSTFCG 158 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-ccccccC
Confidence 999998884 3355666677888999999999985 79999999999999999999999875322211 1233468
Q ss_pred CcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHH
Q 046728 170 TLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249 (325)
Q Consensus 170 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (325)
|+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+ ... ....+...+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i------------~~~--~~~~~~~~~~ 221 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYDNI------------LHK--PLQLPGGKTV 221 (321)
T ss_pred CcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHHHH------------hcC--CCCCCCCCCH
Confidence 99999999999888999999999999999999999999754321 111110 000 1122334567
Q ss_pred HHHHHHHHccCCCCCCCCCHH
Q 046728 250 SMVLIALRCTDSNPENRPTMT 270 (325)
Q Consensus 250 ~~~~li~~cl~~dp~~Rps~~ 270 (325)
.+.+++.+||..||.+||++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 222 AACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHHccCCHhhcCCCC
Confidence 899999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=265.29 Aligned_cols=246 Identities=19% Similarity=0.243 Sum_probs=194.3
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEec
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~ 94 (325)
|.+++.||.| +++.||++....++..+++|.+..........+.+|+++++.++|||++++++++......++||||+
T Consensus 7 ~~i~~~lg~g--~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDG--AFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccC--CCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 5788899999 77789999998889999999997666666678889999999999999999999999999999999999
Q ss_pred CCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccC
Q 046728 95 PNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRV 167 (325)
Q Consensus 95 ~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 167 (325)
++++|..++. ..++...+..+..++..++.++|.. +||||+||+++.++.++|+|||++........ .....
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 163 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDSF 163 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-ccccc
Confidence 9999988874 2355566777888899999999885 79999999999999999999999876543221 12234
Q ss_pred CCCcCCCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 168 KGTLGYLAPEYAM-----WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 168 ~~t~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
.++..|+|||++. +..++.++|+|||||++|+|++|..||........ ..... ... .+ ...
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~-----~~~-----~~--~~~ 229 (282)
T cd06643 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLKIA-----KSE-----PP--TLA 229 (282)
T ss_pred cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHHHh-----hcC-----CC--CCC
Confidence 5888999999884 34577899999999999999999999965432110 00000 000 00 111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHh
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLK 277 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~ 277 (325)
.+...+..+.+||.+||..||++|||+.++++ |+.
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 266 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVT 266 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEe
Confidence 23345678999999999999999999999998 554
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=275.83 Aligned_cols=234 Identities=23% Similarity=0.279 Sum_probs=180.8
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHH-HHHccCCCCccceeeEEEcCCeEEEEEEecC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVE-ILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~ 95 (325)
.||.| +++.||++++..+++.||+|.+.... ......+..|.. +++.++||||+++++++...+..++||||++
T Consensus 2 ~lg~G--~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 2 VIGKG--SFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred eeeeC--CCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 56777 88889999999999999999986421 122234444444 5677899999999999999999999999999
Q ss_pred CCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCC
Q 046728 96 NHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169 (325)
Q Consensus 96 ~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 169 (325)
+|+|.+++.. .+.+..+..+..++..++.++|.+ |||||+|||++.++.++|+|||++........ ......|
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~~~~g 158 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTSTFCG 158 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-CcccccC
Confidence 9999999843 345556666788999999999985 79999999999999999999999875432211 1234468
Q ss_pred CcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHH
Q 046728 170 TLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249 (325)
Q Consensus 170 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (325)
|+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+. .. ....+...++
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~------------~~--~~~~~~~~~~ 221 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNIL------------NK--PLQLKPNITN 221 (325)
T ss_pred CccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHHHHH------------hC--CcCCCCCCCH
Confidence 999999999998889999999999999999999999997533211 111110 00 0122335667
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHH
Q 046728 250 SMVLIALRCTDSNPENRPTMTDVV 273 (325)
Q Consensus 250 ~~~~li~~cl~~dp~~Rps~~~il 273 (325)
.+.++|.+||..||.+||++.+.+
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 222 SARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCH
Confidence 899999999999999999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=299.59 Aligned_cols=249 Identities=18% Similarity=0.327 Sum_probs=194.4
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEc--CCeE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG--GDER 87 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 87 (325)
-..|.+++.||.| +++.||++++..++..||+|.+... .......+..|+.++++|+||||++++++|.+ ...+
T Consensus 12 l~~YeIl~kLG~G--gFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 12 LNEYEVIKKIGNG--RFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cCCEEEEEEEecC--CCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3578899999999 8888999999999999999998642 34455688899999999999999999998854 4568
Q ss_pred EEEEEecCCCChhhhhcc------CCCCCCccCHHHHHHHHHHHHhh-----------cCCCCCCceeeCC---------
Q 046728 88 LIVYDYMPNHSLITHLHG------RLAPDCLLDWHRRVSIAIGSAEG-----------IADIKASNVLLDT--------- 141 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~-----------~rdlkp~Nil~~~--------- 141 (325)
|+|||||++|+|.++|.. .+++..++.++.+++.++.++|. ||||||+|||++.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 999999999999999853 36666778899999999999995 4899999999964
Q ss_pred --------CCceEEeeeccccccCCCcceeeccCCCCcCCCCcccccc--CCCCCcccchhHHHHHHHHHhCCCCCCCCC
Q 046728 142 --------DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMW--GKVSDSCDVYSFGVLLLELISAKKPLEKLP 211 (325)
Q Consensus 142 --------~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 211 (325)
.+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|+||..||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 23589999999986543221 233468999999999864 357899999999999999999999996533
Q ss_pred CCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 212 GGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
. .......+.. . +. ......+..+.+||..||..+|.+|||+.+++. ||+...
T Consensus 248 ~--~~qli~~lk~---~--------p~---lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 248 N--FSQLISELKR---G--------PD---LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred c--HHHHHHHHhc---C--------CC---CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 2 1111111100 0 00 011234578999999999999999999999996 777543
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=263.07 Aligned_cols=247 Identities=24% Similarity=0.326 Sum_probs=196.0
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
..|.+.+.||.| +++.||.+....+++.+++|.+..........+.+|++++++++||||+++++++.+...++++||
T Consensus 3 ~~~~~~~~l~~g--~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSG--TYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCC--CceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 356778889988 777899999888889999999986555566789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 93 YMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 93 ~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
|+.+++|.+++. ..+++..+..+..++..++.++|.+ +||+|+||+++.++.++|+|||++......... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~ 159 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK-RK 159 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc-cc
Confidence 999999999884 3456667777888899999998875 699999999999999999999998765442211 22
Q ss_pred cCCCCcCCCCccccccC---CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 166 RVKGTLGYLAPEYAMWG---KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~---~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
...++..|+|||.+.+. .++.++|+||||+++|+|++|..||........... . ....+ ... ...
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~---~----~~~~~---~~~--~~~ 227 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL---I----SKSNF---PPP--KLK 227 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---H----HhccC---CCc--ccc
Confidence 34578889999998776 788899999999999999999999975432111000 0 00000 000 111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.....+.++.+++.+||..+|++|||+++++.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 23456778999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=279.49 Aligned_cols=249 Identities=22% Similarity=0.283 Sum_probs=187.1
Q ss_pred hhHHhhccCccceeeeeEEEec-----cCCCCeEEEEEecccC-hhhHHHHHHHHHHHHccC-CCCccceeeEEEcCCeE
Q 046728 15 AVFIQNINNGLEILMLLLLLRR-----ETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDER 87 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~-----~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 87 (325)
+.+.+.||+| +++.||+++. ...+..||+|.+.... ......+.+|+.++.++. ||||+++++++......
T Consensus 39 ~~~~~~lG~G--~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 39 LVLGRTLGSG--AFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred eehhhhccCC--CceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 5677899999 7777888874 3345689999997542 333457889999999997 99999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCC-----------------------------------------------------------
Q 046728 88 LIVYDYMPNHSLITHLHGRLA----------------------------------------------------------- 108 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 108 (325)
++|||||++|+|.++++..-.
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999953210
Q ss_pred -----------------------------------C------CCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC
Q 046728 109 -----------------------------------P------DCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF 143 (325)
Q Consensus 109 -----------------------------------~------~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~ 143 (325)
. ...+.+..++..++.++|.. |||||+|||++.++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~ 276 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK 276 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC
Confidence 0 01122445777778888864 79999999999999
Q ss_pred ceEEeeeccccccCCCcc-eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhh
Q 046728 144 EAKVADFGFAKLIPDGVT-HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQW 221 (325)
Q Consensus 144 ~~kL~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~ 221 (325)
.++|+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||...+..... ...
T Consensus 277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~--~~~ 354 (401)
T cd05107 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF--YNA 354 (401)
T ss_pred EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH--HHH
Confidence 999999999986533221 11222346788999999988889999999999999999998 88898654321110 000
Q ss_pred hcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 222 VTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
.....+...+...+..+.+|+.+||..+|++||++.+|++.|+.++
T Consensus 355 -------------~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 355 -------------IKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -------------HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0011112233445678999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=264.89 Aligned_cols=248 Identities=19% Similarity=0.255 Sum_probs=196.1
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
.-|..++.||.| +++.||.+....+++.||+|.+... .......+.+|+.++++++||||+++++++..+...++||
T Consensus 4 ~~y~~~~~l~~g--~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKG--SFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCC--CCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 457788999998 7778999988888899999998643 2344567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc-CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeecc
Q 046728 92 DYMPNHSLITHLHG-RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTR 166 (325)
Q Consensus 92 e~~~~gsL~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 166 (325)
||+++++|.+++.. .+.+..+..+..++..++.++|.. +||+|+||+++.++.++|+|||++......... ...
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~ 160 (277)
T cd06642 82 EYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-RNT 160 (277)
T ss_pred EccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchh-hhc
Confidence 99999999999853 345556667778888888888865 799999999999999999999998765543221 222
Q ss_pred CCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHH
Q 046728 167 VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRD 246 (325)
Q Consensus 167 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (325)
..++..|+|||.+.+..++.++|+||||+++|+|++|..||......... ... ...........
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~-------------~~~~~~~~~~~ 224 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---FLI-------------PKNSPPTLEGQ 224 (277)
T ss_pred ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---hhh-------------hcCCCCCCCcc
Confidence 35788899999999888899999999999999999999998643321110 000 00011112234
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 247 QLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 247 ~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
.+..+.+++.+||..+|++|||+.++++ |+...
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 225 YSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 5678999999999999999999999998 77643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=268.93 Aligned_cols=250 Identities=21% Similarity=0.310 Sum_probs=190.2
Q ss_pred hhHHhhccCccceeeeeEEEeccC-----CCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRET-----GDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
|.+.+.||.| +++.||++.... +...|++|.+.... ......+.+|+++++.++||||+++++.+......+
T Consensus 2 ~~~~~~lg~g--~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 2 LVLGKTLGEG--EFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred ccccccccCc--CCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 5677889998 677788876542 23578999886432 344567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhccC--------------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCcee
Q 046728 89 IVYDYMPNHSLITHLHGR--------------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVL 138 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~~--------------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil 138 (325)
+||||+.+|+|.+++... ++...++.+..++..++.++|.+ |||||+||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 999999999999998532 11223356667788888888875 799999999
Q ss_pred eCCCCceEEeeeccccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccc
Q 046728 139 LDTDFEAKVADFGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKR 216 (325)
Q Consensus 139 ~~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~ 216 (325)
+++++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.....
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-- 237 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-- 237 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH--
Confidence 999999999999999865432221 1122335678999999988889999999999999999998 999996543211
Q ss_pred hhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCC
Q 046728 217 DIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGR 282 (325)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 282 (325)
...... .......+...+.++.+++.+||+.+|++||++.++++.|+.+..+
T Consensus 238 -~~~~~~-------------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 238 -LFNLLK-------------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred -HHHHHh-------------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 111111 1111222344567899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=276.69 Aligned_cols=239 Identities=22% Similarity=0.279 Sum_probs=184.4
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHH-HHHccCCCCccceeeEEEcCCeEEEEEEecC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVE-ILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~ 95 (325)
.||.| +++.||++++..+++.||+|.+... .......+..|.. +++.++||||+++++++..++..++||||++
T Consensus 2 ~lG~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 2 VIGKG--SFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred ceeeC--CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 57777 8889999999999999999998642 2233345555554 4677899999999999999999999999999
Q ss_pred CCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCC
Q 046728 96 NHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169 (325)
Q Consensus 96 ~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 169 (325)
+|+|..++. ..+++..+..+..++..++.++|.. |||||+|||++.++.++|+|||++........ ......|
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~~g 158 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTTTFCG 158 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-CcccccC
Confidence 999998884 3356666777889999999999985 79999999999999999999999875322211 1233468
Q ss_pred CcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHH
Q 046728 170 TLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249 (325)
Q Consensus 170 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (325)
|..|+|||++.+..++.++|||||||++|+|++|..||....... ..... .... ....+..+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~~------------~~~~--~~~~~~~~~ 221 (325)
T cd05604 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MYDNI------------LHKP--LVLRPGASL 221 (325)
T ss_pred ChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HHHHH------------HcCC--ccCCCCCCH
Confidence 999999999998889999999999999999999999997543211 11110 0000 011234567
Q ss_pred HHHHHHHHccCCCCCCCCCHH----HHHH--HHhc
Q 046728 250 SMVLIALRCTDSNPENRPTMT----DVVD--WLKG 278 (325)
Q Consensus 250 ~~~~li~~cl~~dp~~Rps~~----~il~--~l~~ 278 (325)
.+.++|.+||..||.+||++. ++++ ||+.
T Consensus 222 ~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 222 TAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred HHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 889999999999999999875 5554 5543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=270.85 Aligned_cols=251 Identities=23% Similarity=0.323 Sum_probs=190.9
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCC--eEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDD--QIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~--~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 89 (325)
.|.+.+.||.| +++.||++....++. .+|+|.+... .......+.+|+.++.++ +||||+++++++.....+++
T Consensus 8 ~~~~~~~lg~G--~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 8 DIKFQDVIGEG--NFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hceeeeeecCC--CCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 56788899999 777899998776654 4688877643 334455788899999999 89999999999999999999
Q ss_pred EEEecCCCChhhhhccC------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEE
Q 046728 90 VYDYMPNHSLITHLHGR------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKV 147 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~~------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL 147 (325)
||||+++++|.++++.. ++...++.+..++..+++++|.. |||||+|||++.++.++|
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEe
Confidence 99999999999999532 22334566777888888888875 799999999999999999
Q ss_pred eeeccccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccc
Q 046728 148 ADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYV 226 (325)
Q Consensus 148 ~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~ 226 (325)
+|||++....... .......+..|+|||.+.+..++.++|||||||++|+|+| |..||........ .....
T Consensus 166 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~~--- 237 (303)
T cd05088 166 ADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YEKLP--- 237 (303)
T ss_pred CccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH---HHHHh---
Confidence 9999986432111 1111224567999999988888999999999999999998 9999965432111 11000
Q ss_pred cccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCCCc
Q 046728 227 QKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGRRT 284 (325)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~ 284 (325)
.......+...++.+.+|+.+||..+|++|||+++++..|+.++....
T Consensus 238 ----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 238 ----------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred ----------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 001112223356689999999999999999999999998887765443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=267.29 Aligned_cols=247 Identities=20% Similarity=0.342 Sum_probs=189.2
Q ss_pred cchhHHhhccCccceeeeeEEEeccC-----CCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRET-----GDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~-----~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
..|.+.+.||.| +++.||.+.... ++..||+|.+... .......+.+|+++++.++||||+++++++.....
T Consensus 6 ~~~~~~~~lg~g--~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 6 EKITLIRELGQG--SFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred HHeeEEeEecCC--CCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 456778899999 666677766543 3478999998643 33445578899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhccCCC------------CCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeee
Q 046728 87 RLIVYDYMPNHSLITHLHGRLA------------PDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADF 150 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Df 150 (325)
.++||||+++|+|.+++..... ...+..+..++..++.++|.. +||||+||+++.++.++|+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCc
Confidence 9999999999999999954221 223455677888888888875 799999999999999999999
Q ss_pred ccccccCCCcc-eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccc
Q 046728 151 GFAKLIPDGVT-HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQK 228 (325)
Q Consensus 151 g~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 228 (325)
|+++....... .......++..|+|||.+.+..++.++|||||||++|++++ |..||....... ...... .
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~~----~ 236 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKFVI----D 236 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHHHh----c
Confidence 99876544322 11223346788999999988889999999999999999998 899986533211 111111 0
Q ss_pred cccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 229 GAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
......+...+..+.+++.+||..+|++|||+.++++.|+
T Consensus 237 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 237 ---------GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0011223334678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=274.86 Aligned_cols=251 Identities=22% Similarity=0.252 Sum_probs=192.3
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|.+++.||+| +++.||+++...+++.||+|.+... .......+.+|..++..++|+||+++++++.+.+..|+|
T Consensus 2 ~y~i~~~lG~G--~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 2 DFEIIKVIGRG--AFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CceEEEEEeeC--CCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 46778899999 7888999999999999999998642 223334577899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 91 YDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
|||+++|+|.++++. .+++..+..+..++..++.++|.. |||||+|||++.++.++|+|||++..........
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence 999999999999953 355566677888999999999975 7999999999999999999999998665443333
Q ss_pred eccCCCCcCCCCcccccc-----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 164 TTRVKGTLGYLAPEYAMW-----GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ....+... ...+ .
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~~i~~~--~~~~------~ 228 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TYGKIMNH--EERF------Q 228 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH---HHHHHHcC--CCcc------c
Confidence 334568999999999875 457889999999999999999999997533211 11100000 0000 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH--HHhc
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPEN--RPTMTDVVD--WLKG 278 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~~il~--~l~~ 278 (325)
.+......++++.+|+.+|+..++.+ |++++++++ ||+.
T Consensus 229 -~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 229 -FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred -CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 01112345678999999999876654 468999987 6654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=269.27 Aligned_cols=250 Identities=23% Similarity=0.324 Sum_probs=190.9
Q ss_pred cchhHHhhccCccceeeeeEEEeccC-----CCCeEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCC
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRET-----GDDQIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGD 85 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~-----~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 85 (325)
..|.+.+.||.| +++.||++.... +...||+|.+... .......+.+|+++++++ +||||+++++++..+.
T Consensus 12 ~~~~~~~~ig~g--~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 12 DRLTLGKPLGEG--AFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred hHeEEeeEeccc--ccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 456778889988 777788877653 3368999998743 334445788999999999 7999999999999999
Q ss_pred eEEEEEEecCCCChhhhhccC------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC
Q 046728 86 ERLIVYDYMPNHSLITHLHGR------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF 143 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~~------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~ 143 (325)
..++||||+++|+|.++++.. ++...++.+..++..++.++|.. +||||+||+++.++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH 169 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC
Confidence 999999999999999999532 22223455778888888888875 79999999999999
Q ss_pred ceEEeeeccccccCCCccee-eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhh
Q 046728 144 EAKVADFGFAKLIPDGVTHM-TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQW 221 (325)
Q Consensus 144 ~~kL~Dfg~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~ 221 (325)
.++|+|||++.......... .....++..|+|||.+.+..++.++|||||||++|++++ |..||...........
T Consensus 170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~--- 246 (293)
T cd05053 170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL--- 246 (293)
T ss_pred eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH---
Confidence 99999999998654432211 122234567999999988889999999999999999997 8999865432211111
Q ss_pred hcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 222 VTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
.. .......+...+..+.+|+.+||..||++|||+.++++.|+.+.
T Consensus 247 ~~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 247 LK-------------EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HH-------------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 00 01111223345678999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=262.05 Aligned_cols=242 Identities=24% Similarity=0.396 Sum_probs=186.0
Q ss_pred hhccCccceeeeeEEEeccCCC---CeEEEEEecccCh-hhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEec
Q 046728 19 QNINNGLEILMLLLLLRRETGD---DQIAVKRLKTLNA-KAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~~~~---~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~ 94 (325)
++||.| +++.||++.....+ ..||+|.+..... .....+.+|+++++.++||||+++++++. ....++||||+
T Consensus 1 ~~ig~G--~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHG--NFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCcc--CceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 357777 77778877654443 7899999874332 34567889999999999999999999876 45689999999
Q ss_pred CCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec--c
Q 046728 95 PNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT--R 166 (325)
Q Consensus 95 ~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~--~ 166 (325)
++|+|.+++.. .+++..+..+..++..++.++|.. +||||+||+++.++.++|+|||++............ .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 99999999953 355566778888899999998875 799999999999999999999999866543322111 1
Q ss_pred CCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCH
Q 046728 167 VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNR 245 (325)
Q Consensus 167 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (325)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ....... . .....+.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~~----~---------~~~~~~~ 221 (257)
T cd05060 158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLES----G---------ERLPRPE 221 (257)
T ss_pred ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHc----C---------CcCCCCC
Confidence 123467999999988889999999999999999998 999996543211 1111110 0 0112233
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 246 DQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 246 ~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
..+..+.+++.+||..+|++|||+.++++.|+..
T Consensus 222 ~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 222 ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 4567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=261.86 Aligned_cols=240 Identities=23% Similarity=0.324 Sum_probs=183.9
Q ss_pred ccCccceeeeeEEEec--cCCCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCCC
Q 046728 21 INNGLEILMLLLLLRR--ETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNH 97 (325)
Q Consensus 21 i~~G~~~~~~v~~~~~--~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~g 97 (325)
||.| +++.||.+.. ..++..||+|.+.... ......+.+|+.++++++||||+++++++. ....++||||++++
T Consensus 3 ig~G--~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 3 LGSG--NFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred cCCC--CcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 6677 7777887643 3455679999986543 344467889999999999999999999875 45689999999999
Q ss_pred Chhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee--ccCC
Q 046728 98 SLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT--TRVK 168 (325)
Q Consensus 98 sL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~--~~~~ 168 (325)
+|.+++.. .++...++.+..++..++.++|.. +||||+||+++.++.++|+|||++........... ....
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence 99999953 355566777888888899998875 69999999999999999999999986544322211 1122
Q ss_pred CCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHH
Q 046728 169 GTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQ 247 (325)
Q Consensus 169 ~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (325)
++..|+|||.+.+..++.++||||||+++|++++ |..||........ ...+. ...+...+...
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~-------------~~~~~~~~~~~ 223 (257)
T cd05115 160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV---MSFIE-------------QGKRLDCPAEC 223 (257)
T ss_pred CCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHHH-------------CCCCCCCCCCC
Confidence 3568999999988889999999999999999996 9999975433211 11110 11112233455
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 248 LKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 248 ~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
++++.+++.+||..||++||++.+|.+.|+..
T Consensus 224 ~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 224 PPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 67899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=262.75 Aligned_cols=241 Identities=29% Similarity=0.363 Sum_probs=191.9
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
..+.+.+.||.| +++.||.+.. .++.||+|.+..... ...++.+|+.+++.++|+||+++++++.+....++|||
T Consensus 6 ~~~~~~~~ig~g--~~g~v~~~~~--~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 6 KELKLGATIGKG--EFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhccceeeeecC--CCceEEEEEe--cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 457788999998 7778888764 378899999976443 56689999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 93 YMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|+++++|.++++. .++......+..++..++.++|.. +||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 9999999999953 245556677888888888888875 79999999999999999999999986643221
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
....+..|+|||.+....++.++|+||||+++|++++ |..||...+.... ..... . ......
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~----~---------~~~~~~ 220 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPHVE----K---------GYRMEA 220 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHh----c---------CCCCCC
Confidence 2234667999999988888999999999999999997 9999865432111 11110 0 011122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~ 278 (325)
+...++.+.+++.+||..+|++|||++++++.|+.
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 23456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=267.34 Aligned_cols=247 Identities=23% Similarity=0.384 Sum_probs=193.4
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHH--HHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEM--EFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
|++++.||+| +++.||+++...+++.||+|.+......... ...+|+.++++++||||+++++++.+....++|||
T Consensus 1 y~~~~~lg~G--~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSG--GFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEE--SSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeC--CCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccc
Confidence 4567889999 8888999999999999999999865443332 34569999999999999999999999999999999
Q ss_pred ecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeecc
Q 046728 93 YMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTR 166 (325)
Q Consensus 93 ~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 166 (325)
|+.+++|.+++. ..++...+..+..++..++.++|.. +||||+||+++.++.++|+|||.+...... ......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~~~~~~ 157 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-NENFNP 157 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST-TSEBSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccc
Confidence 999999999995 5566777888899999999999885 799999999999999999999999864222 222334
Q ss_pred CCCCcCCCCccccc-cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCH
Q 046728 167 VKGTLGYLAPEYAM-WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNR 245 (325)
Q Consensus 167 ~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (325)
..++..|+|||++. +..++.++|+||+|+++|+|++|..||................. .. ... ......
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~---~~-~~~------~~~~~~ 227 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK---RP-LPS------SSQQSR 227 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH---TH-HHH------HTTSHT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc---cc-ccc------cccccc
Confidence 56889999999998 77899999999999999999999999976411111111111000 00 000 000111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 246 DQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 246 ~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.....+.++|.+||..||++|||+.++++
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12378999999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=267.18 Aligned_cols=249 Identities=18% Similarity=0.324 Sum_probs=187.5
Q ss_pred ccchhHHhhccCccceeeeeEEEecc-----CCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRE-----TGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD 85 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (325)
...|++.+.||.| +++.||.+... .++..||+|.+... ......++.+|+.+++.++||||+++++++..+.
T Consensus 5 ~~~~~~~~~ig~G--~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 5 REKITMSRELGQG--SFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred HHHceeeeeeccc--cCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4567888999999 67778876643 33567999998642 2334457889999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhccCCC------------CCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEee
Q 046728 86 ERLIVYDYMPNHSLITHLHGRLA------------PDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVAD 149 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~D 149 (325)
..++||||+++|+|.++++.... ...+..+..++..++.++|.. +||||+||++++++.++|+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence 99999999999999999953211 112344566788888888875 79999999999999999999
Q ss_pred eccccccCCCccee-eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhccccc
Q 046728 150 FGFAKLIPDGVTHM-TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQ 227 (325)
Q Consensus 150 fg~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 227 (325)
||++.......... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~~~~---- 235 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRFVM---- 235 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----
Confidence 99987654432221 112235678999999988889999999999999999999 688886543211 111100
Q ss_pred ccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 046728 228 KGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278 (325)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~ 278 (325)
.... ...+...+..+.+++.+||..||++|||+.++++.|++
T Consensus 236 ~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 EGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 0000 11223345689999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=261.55 Aligned_cols=242 Identities=22% Similarity=0.323 Sum_probs=193.1
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
.|.+++.||.| +++.+++++...+++.|++|.+... +.....++.+|++++++++|+||+++++++.+....++||
T Consensus 1 ~y~~~~~ig~g--~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKG--AFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEeccc--CCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence 36788999999 6667888888899999999988643 3555668889999999999999999999999999999999
Q ss_pred EecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 92 DYMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 92 e~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||+++++|.+++... ++...+..+..++..++.++|.. +||+|+||+++.++.+||+|||.+........ .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~ 157 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M 157 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence 999999999999543 44555667778888888888874 79999999999999999999999986654332 2
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.....++..|.|||++.+..++.++|+||||+++|+|++|..||....... .... .. .+. ....
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~~~~---~~-~~~---------~~~~ 221 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN---LVVK---IV-QGN---------YTPV 221 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH---HHHH---HH-cCC---------CCCC
Confidence 233458899999999988788899999999999999999999996532211 1100 00 010 0111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
....+..+.+++.+||..+|++|||++++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 222 VSVYSSELISLVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred ccccCHHHHHHHHHHcccCcccCCCHHHHhh
Confidence 2445678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=263.30 Aligned_cols=249 Identities=20% Similarity=0.314 Sum_probs=196.9
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
.|.+.+.||.| +++.||.+....+++.||+|.+... ......++.+|+++++.++||||+++++.+......++|+|
T Consensus 2 ~~~~~~~ig~g--~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAG--NSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCC--CCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 46889999999 7777999999989999999998754 34455678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhh-c----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 93 YMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEG-I----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~-~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|+.+++|.+++. ..+++.....+..++..++.++|. . +||||+||+++.++.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-- 157 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-- 157 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--
Confidence 999999999995 334555667788889999999998 4 799999999999999999999998755432111
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||........ .......... ... ....+
T Consensus 158 -~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~---------~~~-~~~~~ 225 (265)
T cd06605 158 -TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIV---------NEP-PPRLP 225 (265)
T ss_pred -cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHh---------cCC-CCCCC
Confidence 14578899999999888899999999999999999999999965421100 0111111000 000 11112
Q ss_pred HH-HHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 245 RD-QLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 245 ~~-~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
.. .+..+.++|.+||..||++|||+.+++. ||+.
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 22 6778999999999999999999999998 7764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=263.77 Aligned_cols=246 Identities=26% Similarity=0.419 Sum_probs=191.7
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
..|.+.+.||.| +++.||++... +++.||+|.+.... .....+.+|+.++++++|||++++++++.+....++|||
T Consensus 6 ~~~~i~~~ig~g--~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 6 ESLKLERKLGAG--QFGEVWMGTWN-GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hheeeeeeeccC--cceEEEEEEEc-CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 467888999999 77788888754 45789999987532 345678999999999999999999999999899999999
Q ss_pred ecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 93 YMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|+++++|.+++... ++......+..++..++.++|.. +||||+||+++.++.++|+|||++...........
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR 161 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhh
Confidence 99999999999542 34445567777888888888875 79999999999999999999999886654222212
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.....+..|+|||.+.+..++.++|+||+|+++|++++ |..||...... ........ ......
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~~-------------~~~~~~ 225 (261)
T cd05034 162 EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQVER-------------GYRMPR 225 (261)
T ss_pred hccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc-------------CCCCCC
Confidence 22234568999999998889999999999999999998 99999653321 11111100 001122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~ 278 (325)
+...+.++.+++.+||..+|++||+++++.+.|+.
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 23346789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=272.45 Aligned_cols=269 Identities=18% Similarity=0.240 Sum_probs=201.3
Q ss_pred eeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC-
Q 046728 8 CFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG- 84 (325)
Q Consensus 8 ~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 84 (325)
.|.+...|..++.||.| +++.||.+++..+++.||+|.+... ......++.+|+.++++++||||+++++++...
T Consensus 11 ~~~~~~~y~~~~~lg~g--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (353)
T cd07850 11 TFTVLKRYQNLKPIGSG--AQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK 88 (353)
T ss_pred hhhhhcceEEEEEeccC--CCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC
Confidence 34567788999999999 7888999999999999999998642 334445778899999999999999999988643
Q ss_pred -----CeEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccc
Q 046728 85 -----DERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 85 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
...|+||||+. ++|.+.+...++...+..+..++..++.++|.. |||||+||+++.++.++|+|||++..
T Consensus 89 ~~~~~~~~~lv~e~~~-~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 89 SLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred CccccCcEEEEEeccC-CCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 35799999995 589998876677777778889999999999985 79999999999999999999999986
Q ss_pred cCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhh-hhh------------
Q 046728 156 IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIV-QWV------------ 222 (325)
Q Consensus 156 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~-~~~------------ 222 (325)
...... .....++..|+|||++.+..++.++|||||||++|+|++|..||...........+ ...
T Consensus 168 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 168 AGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred CCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 544322 22345788999999999889999999999999999999999999654321100000 000
Q ss_pred ---ccccc------ccccccccCccc----cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 223 ---TPYVQ------KGAFEHIADPRL----KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 223 ---~~~~~------~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
..... ...+........ ....+...++.+.++|.+||..||++|||+.++++ ||+....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 00000 000000000000 00012234667899999999999999999999998 8886554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=259.68 Aligned_cols=239 Identities=23% Similarity=0.344 Sum_probs=184.0
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCCCC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHS 98 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~gs 98 (325)
.||.| +++.||++.. .++..||+|.+.... ......+.+|++++++++||||+++++++......++||||+++++
T Consensus 2 ~ig~g--~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 2 LLGKG--NFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred ccCCC--CCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 56777 8888998874 467899999986543 3334578899999999999999999999999999999999999999
Q ss_pred hhhhhccC---CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCCCc
Q 046728 99 LITHLHGR---LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTL 171 (325)
Q Consensus 99 L~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~ 171 (325)
|.+++... +.....+.+..++..++.++|.. +||||+||+++.++.++|+|||++...............++.
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI 158 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence 99998532 34445566777788888888864 799999999999999999999998754433222222223456
Q ss_pred CCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHH
Q 046728 172 GYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKS 250 (325)
Q Consensus 172 ~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (325)
.|+|||++.+..++.++||||||+++|++++ |..||....... ...... . ......+...+..
T Consensus 159 ~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~~~~~----~---------~~~~~~~~~~~~~ 222 (250)
T cd05085 159 KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---AREQVE----K---------GYRMSCPQKCPDD 222 (250)
T ss_pred cccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHH----c---------CCCCCCCCCCCHH
Confidence 7999999988888999999999999999998 999996543211 111110 0 0111223345678
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 251 MVLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 251 ~~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
+.+++.+||..+|++|||+.++++.|.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=261.03 Aligned_cols=241 Identities=23% Similarity=0.389 Sum_probs=191.9
Q ss_pred hhccCccceeeeeEEEeccCC---CCeEEEEEecccChh-hHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEec
Q 046728 19 QNINNGLEILMLLLLLRRETG---DDQIAVKRLKTLNAK-AEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~~~---~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~ 94 (325)
+.||.| +++.||.+..... +..|++|.+...... ....+.+|+..++.++|+|++++++++.+....++||||+
T Consensus 1 ~~ig~g--~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEG--AFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccC--CceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 357777 7788999888866 889999999754333 3568889999999999999999999999999999999999
Q ss_pred CCCChhhhhccC-----------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC
Q 046728 95 PNHSLITHLHGR-----------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 95 ~~gsL~~~l~~~-----------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 159 (325)
++++|.+++... +++.....+..++..++.++|.. +||||+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999542 45566777888888888888875 799999999999999999999999876543
Q ss_pred cc-eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 160 VT-HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 160 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
.. .......++..|+|||.+....++.++||||+|+++|+|++ |..||...... ........
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~------------- 222 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLEYLRK------------- 222 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHc-------------
Confidence 21 11223457888999999988889999999999999999999 69999765321 11111110
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
......+...+..+.+++.+||..||.+|||+.++++.|+
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112233445778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=278.75 Aligned_cols=258 Identities=18% Similarity=0.208 Sum_probs=191.0
Q ss_pred cchhHHhhccCccceeeeeEEEe--ccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLR--RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
..|.+++.||.| +++.||++. +...+..||+|.+... ....+|++++++++||||+++++++......++|
T Consensus 92 ~~y~i~~~Lg~G--~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 92 MQYNILSSLTPG--SEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred CceEEEEeecCC--CCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 458889999999 555666664 3445688999998652 2356799999999999999999999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce-e
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH-M 163 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~-~ 163 (325)
||++. ++|.+++. ..++...++.+..++..++.++|.. |||||+|||++.++.++|+|||++......... .
T Consensus 165 ~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 165 MPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred ehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 99995 68998883 3466667788889999999999985 799999999999999999999999765543222 1
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccc--c----------
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGA--F---------- 231 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~---------- 231 (325)
.....||..|+|||++.+..++.++|||||||++|+|++|..||.+............+........ +
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 323 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK 323 (392)
T ss_pred ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence 2235689999999999988999999999999999999999999976543221111111000000000 0
Q ss_pred -----ccccCccccCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 232 -----EHIADPRLKGK---FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 232 -----~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
.....+....+ .....+.++.++|.+||..||++|||+.++++ ||..
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred HHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 00000000000 01123567889999999999999999999998 8864
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=293.05 Aligned_cols=253 Identities=20% Similarity=0.269 Sum_probs=192.3
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
.+|.+++.||.| +++.||++....+++.||+|.+... ......++.+|++++++++||||+++++++.+++..++
T Consensus 2 grYeIi~~LGkG--gfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKG--GMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY 79 (932)
T ss_pred CCeEEEEEEecC--CCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence 357788999999 8888999999999999999998642 23345678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCC-----C--------CCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecc
Q 046728 90 VYDYMPNHSLITHLHGRL-----A--------PDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGF 152 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~~~-----~--------~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~ 152 (325)
||||++||+|.+++.... . ...++.+..++..+++++|.. |||||+||+++.++.++|+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 999999999999885311 1 112345667888888888875 79999999999999999999999
Q ss_pred ccccCCCcc-----------------eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCcc
Q 046728 153 AKLIPDGVT-----------------HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVK 215 (325)
Q Consensus 153 ~~~~~~~~~-----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~ 215 (325)
+........ .......||+.|+|||++.+..++.++|||||||++|+|+||..||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 986521100 011224589999999999988999999999999999999999999975332111
Q ss_pred chhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcccC
Q 046728 216 RDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRP-TMTDVVDWLKGGLG 281 (325)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-s~~~il~~l~~~~~ 281 (325)
... . ....+. ........++.+.+++.+||..||++|| +++++.+.|+..+.
T Consensus 240 ~~~----------~---~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 240 SYR----------D---VILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhh----------h---hccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 000 0 000000 0011234567889999999999999996 56666666665543
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=263.31 Aligned_cols=247 Identities=21% Similarity=0.293 Sum_probs=187.0
Q ss_pred hhHHhhccCccceeeeeEEEeccCC---CCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe---
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETG---DDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE--- 86 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~---~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--- 86 (325)
|.+.+.||.| +++.||.+....+ +..||+|.+... .......+..|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G--~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEG--EFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcC--CCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 3567888888 7777887775543 478999998743 33445688899999999999999999998765544
Q ss_pred ---EEEEEEecCCCChhhhhcc--------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeec
Q 046728 87 ---RLIVYDYMPNHSLITHLHG--------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFG 151 (325)
Q Consensus 87 ---~~lV~e~~~~gsL~~~l~~--------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg 151 (325)
.++||||+++|+|..++.. .++......+..++..++.++|.. +||||+||++++++.++|+|||
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCcc
Confidence 7899999999999998832 123334455778888888888875 7999999999999999999999
Q ss_pred cccccCCCccee-eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhccccccc
Q 046728 152 FAKLIPDGVTHM-TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKG 229 (325)
Q Consensus 152 ~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 229 (325)
+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....... ....... +
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~~~----~ 231 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYLRH----G 231 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----C
Confidence 998654432221 111234668999999988889999999999999999999 889886543211 1111110 0
Q ss_pred ccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 230 AFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
.....+...+..+.+++.+||..||++|||+.++++.|+.+
T Consensus 232 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 ---------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01122344567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=260.48 Aligned_cols=243 Identities=19% Similarity=0.248 Sum_probs=193.9
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
..|++.+.||.| +++.+|.+....+++.|++|.+..... ...+.+|++++++++||||+++++++......|+++|
T Consensus 3 ~~y~~~~~i~~g--~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEG--SYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCC--CCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 357889999999 777889998888889999999875322 6689999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 93 YMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 93 ~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
|+.+++|.+++.. .++...+..+..++..++.++|.. +||+|+||+++.++.++|+|||++......... ..
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~-~~ 157 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK-RN 157 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc-cc
Confidence 9999999999842 345566677888888888888864 799999999999999999999999876543321 22
Q ss_pred cCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCH
Q 046728 166 RVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNR 245 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (325)
...++..|+|||.+.+..++.++||||||+++|+|++|..||........... .. . ........+.
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~---~~----~-------~~~~~~~~~~ 223 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM---IP----N-------KPPPTLSDPE 223 (256)
T ss_pred cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh---hc----c-------CCCCCCCchh
Confidence 23478899999999888899999999999999999999999975332111000 00 0 0000112234
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 246 DQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 246 ~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
..+..+.+++.+||..||++|||+.+++.
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 45678999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=268.97 Aligned_cols=254 Identities=17% Similarity=0.210 Sum_probs=187.7
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
|++++.||.| +++.||.+....+++.||+|.+... .......+.+|+.++++++||||+++++++.++...++|||
T Consensus 2 y~~~~~l~~g--~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 2 YTKIEKIGEG--TYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred ceEeeEeccc--CceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 5677889888 7788999999888999999998643 22334578889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc-----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 93 YMPNHSLITHLHG-----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 93 ~~~~gsL~~~l~~-----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
|+. ++|.+++.. .+++..+..+..++..++.++|.. +||||+||+++.++.++|+|||++.........
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~- 157 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV- 157 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc-
Confidence 997 689888842 345556677889999999999986 799999999999999999999998765432211
Q ss_pred eccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchh-hhhhccccccc---------cc-
Q 046728 164 TTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDI-VQWVTPYVQKG---------AF- 231 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~---------~~- 231 (325)
.....++..|+|||++.+. .++.++|||||||++|+|+||..||........... ...... .... .+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGT-PTEDVWPGVTSLPDYK 236 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC-CChhhhhcchhhHHHH
Confidence 1223467889999988654 468899999999999999999999975432110000 000000 0000 00
Q ss_pred ---ccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 232 ---EHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 232 ---~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
........ .......++++.+||.+||..||++|||+.++++
T Consensus 237 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 237 NTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 0112235678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=263.30 Aligned_cols=245 Identities=24% Similarity=0.392 Sum_probs=187.8
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
.++.+.+.||.| +++.||++....+ ..||+|.+.... .....+.+|++++++++|||++++++++. ....++|||
T Consensus 6 ~~~~~~~~ig~g--~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05069 6 ESLRLDVKLGQG--CFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE 80 (260)
T ss_pred HHeeeeeeecCc--CCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence 457788889998 7778898876554 469999886432 33457888999999999999999999875 456889999
Q ss_pred ecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 93 YMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|+.+++|.++++.. ++......+..++..++.++|.. +||||+||++++++.++|+|||++...........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 99999999999542 22334456777888888888875 79999999999999999999999986644322222
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
....++..|+|||...+..++.++||||||+++|+|++ |..||....... ...+... ......
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~-------------~~~~~~ 224 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVER-------------GYRMPC 224 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc-------------CCCCCC
Confidence 22345678999999988889999999999999999999 899997543211 1111100 011122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~ 278 (325)
+...+..+.+++.+||..||++||++++++++|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 34566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=265.49 Aligned_cols=248 Identities=22% Similarity=0.269 Sum_probs=193.3
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
|...+.||+| +++.||.+....+++.||+|.+.... ......+.+|++++++++|+|++++++.+..++..++||
T Consensus 2 ~~~~~~lg~G--~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 2 FRQYRVLGKG--GFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred ceEEEEEecC--CCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence 3456778888 77889999999999999999986432 222345778999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 92 DYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 92 e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||+.+++|.+++.. .++...+..+..++..++.++|.. |||||+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-- 157 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-- 157 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc--
Confidence 99999999988842 355666778888999999999875 79999999999999999999999876543221
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.....|+..|+|||++.+..++.++|+||||+++|+|++|..||............ ...... . ....
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~---~~~~~~--------~--~~~~ 224 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV---DRRVLE--------T--EEVY 224 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhhhc--------c--cccc
Confidence 12346899999999998888999999999999999999999999754321111110 000000 0 0112
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH--HHhcc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPT-----MTDVVD--WLKGG 279 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps-----~~~il~--~l~~~ 279 (325)
+...+..+.+|+..||..||++||+ ++++++ ||...
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 2345668899999999999999999 778887 77654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=264.24 Aligned_cols=250 Identities=20% Similarity=0.331 Sum_probs=190.0
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCC----eEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDD----QIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~----~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
..|.+++.||.| +++.||.+....+++ .|++|.+... ......++..|+..+++++||||+++++++. ....
T Consensus 7 ~~~~~~~~lg~G--~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~ 83 (279)
T cd05111 7 TELRKLKLLGSG--VFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL 83 (279)
T ss_pred hhceeccccCcc--CCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence 456778899999 777788888766665 4778877533 2334457788888999999999999999875 4557
Q ss_pred EEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 88 LIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
++|+||+++|+|.++++. .++......+..++..++.++|.. +||||+||+++.++.++|+|||+++......
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 899999999999999943 345556677888999999999975 7999999999999999999999998664332
Q ss_pred ce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 161 TH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 161 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
.. ......++..|+|||.+.+..++.++||||||+++||+++ |..||.........+. +. .+
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~---~~----~~--------- 227 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL---LE----KG--------- 227 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HH----CC---------
Confidence 21 1223346778999999988889999999999999999998 9999965432111111 10 10
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.....+...+..+.+++.+||..||++|||+.++++.|..+..
T Consensus 228 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 228 ERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0111122244578889999999999999999999998877553
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=264.69 Aligned_cols=253 Identities=21% Similarity=0.326 Sum_probs=187.6
Q ss_pred chhHHhhccCccceeeeeEEEecc----------------CCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccc
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRE----------------TGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLG 76 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~----------------~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~ 76 (325)
.|++.+.||.| +++.||+++.. .+...||+|.+... .......+.+|+++++.++||||++
T Consensus 6 ~~~~~~~lg~G--~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 6 RLTFKEKLGEG--QFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hceeeeeccCC--CCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 47889999999 77778877432 23457899998743 3445568899999999999999999
Q ss_pred eeeEEEcCCeEEEEEEecCCCChhhhhccCCCC-------------CCccCHHHHHHHHHHHHhhc----CCCCCCceee
Q 046728 77 LRGFYAGGDERLIVYDYMPNHSLITHLHGRLAP-------------DCLLDWHRRVSIAIGSAEGI----ADIKASNVLL 139 (325)
Q Consensus 77 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-------------~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~ 139 (325)
+++++...+..++||||+.+|+|.+++...... ..+..+..++..++.++|.. +||||+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 999999999999999999999999999543211 13455667778888888875 7999999999
Q ss_pred CCCCceEEeeeccccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh--CCCCCCCCCCCccc
Q 046728 140 DTDFEAKVADFGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS--AKKPLEKLPGGVKR 216 (325)
Q Consensus 140 ~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t--g~~pf~~~~~~~~~ 216 (325)
+.++.++|+|||++..+...... ......++..|+|||+..++.++.++|+|||||++|||++ |..||.........
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 99999999999998865433221 1222334678999999888889999999999999999998 77888654322111
Q ss_pred hhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 217 DIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
.......... ......+.+..+++.+.+|+.+||..||++|||+.+|++.|+
T Consensus 244 ---~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 244 ---ENTGEFFRDQ------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ---HHHHHHHhhc------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1000000000 000111222345578999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=276.03 Aligned_cols=245 Identities=24% Similarity=0.344 Sum_probs=206.7
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
|.+++.||+| .++.|-++++.-++..||||.+.+. +......+.+|+++|+.|+|||||+++++......+|+|||
T Consensus 58 y~i~~tig~g--~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 58 YVIIKTIGKG--NFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred eeeeeeeccc--eeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 6788999999 8888999999999999999999754 45555678999999999999999999999999999999999
Q ss_pred ecCCCChhhhh--ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeecc
Q 046728 93 YMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTR 166 (325)
Q Consensus 93 ~~~~gsL~~~l--~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 166 (325)
|+.+|.+++|+ ++++.+..+...+.|+..|++|+|.. ||||++|+|++.+.++||+|||++..+... ....+
T Consensus 136 ya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~--~~lqt 213 (596)
T KOG0586|consen 136 YASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG--LMLQT 213 (596)
T ss_pred eccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc--ccccc
Confidence 99999999999 56777888899999999999999985 899999999999999999999999987743 33456
Q ss_pred CCCCcCCCCccccccCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc--CCC
Q 046728 167 VKGTLGYLAPEYAMWGKV-SDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK--GKF 243 (325)
Q Consensus 167 ~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 243 (325)
.+|++.|.|||++.+..| +..+|+||+|+++|-|+.|..||.+..- ..+...-+. -..
T Consensus 214 ~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-------------------k~Lr~rvl~gk~rI 274 (596)
T KOG0586|consen 214 FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-------------------KELRPRVLRGKYRI 274 (596)
T ss_pred cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-------------------ccccchheeeeecc
Confidence 789999999999998876 5689999999999999999999975321 111111111 123
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccCC
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLGR 282 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~~ 282 (325)
+..++.++.+||+++|..+|.+|++.+++.. |.....++
T Consensus 275 p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 275 PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred cceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 3455668999999999999999999999998 65554443
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=267.10 Aligned_cols=249 Identities=21% Similarity=0.292 Sum_probs=195.6
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEe
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~ 93 (325)
-+.....||.| +++.||++....++..||||.+..........+.+|+.++++++||||+++++.+..++..++||||
T Consensus 23 ~~~~~~~lg~g--~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 23 YLDSFIKIGEG--STGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHhhhhcccCC--CCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 34444566666 8888999998888999999998765556666888999999999999999999999999999999999
Q ss_pred cCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCC
Q 046728 94 MPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVK 168 (325)
Q Consensus 94 ~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~ 168 (325)
+++++|.+++. ..++......+..++..++.++|.. |||||+||+++.++.++|+|||++......... .....
T Consensus 101 ~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~~ 179 (292)
T cd06658 101 LEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSLV 179 (292)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Cceee
Confidence 99999999884 3456667778888899999999875 799999999999999999999998755432221 22345
Q ss_pred CCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHH
Q 046728 169 GTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQL 248 (325)
Q Consensus 169 ~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (325)
++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ....... ...+.. ......+
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~~~---------~~~~~~--~~~~~~~ 245 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMRRIRD---------NLPPRV--KDSHKVS 245 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh---------cCCCcc--ccccccC
Confidence 7889999999988889999999999999999999999996533211 1110000 000000 1112355
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 249 KSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 249 ~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
..+.+++.+||..||++|||++++++ ||+..
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence 67899999999999999999999998 77643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=265.93 Aligned_cols=262 Identities=18% Similarity=0.256 Sum_probs=197.1
Q ss_pred HHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEec
Q 046728 17 FIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94 (325)
Q Consensus 17 ~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~ 94 (325)
+..+||+|.|+.+.++++++..+++.||+|.+... .......+.+|+++++.++||||+++++++.+....+++|||+
T Consensus 2 ~~~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (314)
T cd08216 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM 81 (314)
T ss_pred chhhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEecc
Confidence 45678888888888888898899999999998643 4555678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc-----
Q 046728 95 PNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT----- 161 (325)
Q Consensus 95 ~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~----- 161 (325)
++|+|.++++. .+.+..+..+..++..++.++|.. +||||+||+++.++.++|+|||.+........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 99999999853 244555667788899999999986 79999999999999999999998875532211
Q ss_pred -eeeccCCCCcCCCCccccccC--CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccc----cccccc---
Q 046728 162 -HMTTRVKGTLGYLAPEYAMWG--KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPY----VQKGAF--- 231 (325)
Q Consensus 162 -~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~----~~~~~~--- 231 (325)
.......++..|+|||++... .++.++|+|||||++|+|++|..||...+.... ........ ......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhh
Confidence 011223467789999998753 578899999999999999999999975432111 00000000 000000
Q ss_pred ------------ccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 232 ------------EHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 232 ------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
...............++.++.+|+.+||..||++|||++++++ ||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 0000011112223456778999999999999999999999998 887654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=265.83 Aligned_cols=254 Identities=23% Similarity=0.370 Sum_probs=191.1
Q ss_pred cchhHHhhccCccceeeeeEEEeccCC----------------CCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCcc
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETG----------------DDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLL 75 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~----------------~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv 75 (325)
..|.+++.||.| +++.||++..... +..||+|.+... .......+.+|++++++++||||+
T Consensus 5 ~~~~~~~~lg~G--~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 5 QPLNFVEKLGEG--QFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhCcccccccCC--CCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 567899999999 6777887665443 356899998743 344566888999999999999999
Q ss_pred ceeeEEEcCCeEEEEEEecCCCChhhhhccC-------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCcee
Q 046728 76 GLRGFYAGGDERLIVYDYMPNHSLITHLHGR-------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVL 138 (325)
Q Consensus 76 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~-------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil 138 (325)
++++++..+...++||||+++++|.+++... ++...++.+..++..++.++|.+ +||||+||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 9999999999999999999999999998532 23344566777888888888875 699999999
Q ss_pred eCCCCceEEeeeccccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh--CCCCCCCCCCCcc
Q 046728 139 LDTDFEAKVADFGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS--AKKPLEKLPGGVK 215 (325)
Q Consensus 139 ~~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t--g~~pf~~~~~~~~ 215 (325)
++.++.++|+|||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ +..||...+...
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~- 241 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ- 241 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH-
Confidence 999999999999998765433221 1223346778999999988889999999999999999998 677876543211
Q ss_pred chhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 216 RDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
........... .........+...+.++.+|+.+||..||++|||+.+++++|+
T Consensus 242 --~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 242 --VIENAGHFFRD------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHhcccc------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11111000000 0011111222345578999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=268.03 Aligned_cols=249 Identities=19% Similarity=0.218 Sum_probs=195.1
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh---hhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA---KAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|.+.+.||.| +++.||.+....+++.||+|.+..... .....+..|+++++.++||||+++++.+.+....++|
T Consensus 2 ~y~~~~~ig~g--~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 2 HFKKIKLLGKG--DVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred ceEEeeeecCC--ccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence 45677888888 777899999998999999999865322 2445788899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 91 YDYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
|||+.+++|.+++.. .+++.....+..++..++.++|.. +||||+||+++.++.++|+|||++.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 999999999999853 345556666778888888998875 799999999999999999999998754321110
Q ss_pred ----------------------------eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCc
Q 046728 163 ----------------------------MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGV 214 (325)
Q Consensus 163 ----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~ 214 (325)
......|+..|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 1112357888999999998889999999999999999999999996543211
Q ss_pred cchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCC----HHHHHH--HHhcc
Q 046728 215 KRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPT----MTDVVD--WLKGG 279 (325)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps----~~~il~--~l~~~ 279 (325)
.. ..+.......+.....+..+.+++.+||..||++||| ++++++ ||+..
T Consensus 240 ~~---------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 240 TF---------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HH---------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 10 0000111111112226788999999999999999999 999998 88763
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=258.72 Aligned_cols=247 Identities=23% Similarity=0.276 Sum_probs=205.2
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..|.|+++||+| .++.|.+++.+.+++.+|||++++. ..+....-..|-++|+..+||.+..+.-.|+..+.+|+
T Consensus 168 ~dFdfLKvLGkG--TFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 168 EDFDFLKVLGKG--TFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred chhhHHHHhcCC--ccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 468999999999 8899999999999999999999764 34444566779999999999999999999999999999
Q ss_pred EEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 90 VYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 90 V~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||||..||.|.-+++ ..+++....-+...+..|+.|+|+. ||+|.+|.|+|.+|.+||+|||+|+--- ..-..
T Consensus 246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~g~t 324 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KYGDT 324 (516)
T ss_pred EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc-cccce
Confidence 999999999998884 4477788888999999999999987 7999999999999999999999998322 12223
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
..+++||+.|.|||++....|+.++|.|.+|+++|||++|+.||........ ++-+.-.. ..+
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL---------------FeLIl~ed--~kF 387 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL---------------FELILMED--LKF 387 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH---------------HHHHHhhh--ccC
Confidence 5678999999999999999999999999999999999999999986443211 11111121 245
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH--HHhcc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPT-----MTDVVD--WLKGG 279 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps-----~~~il~--~l~~~ 279 (325)
|..++++...|+...|..||.+|.. +.+|.+ +|.++
T Consensus 388 Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 388 PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 6778889999999999999999963 566665 55443
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=267.23 Aligned_cols=250 Identities=23% Similarity=0.312 Sum_probs=189.7
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCC--eEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDD--QIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~--~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 89 (325)
.|.+.+.||.| +++.||.+....++. .+++|.++.. .......+.+|++++.++ +||||+++++++......++
T Consensus 3 ~~~~~~~lg~g--~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 3 DIKFEDVIGEG--NFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred cceeeeeecCC--CcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 46788899999 777888887665553 5789888742 344456788999999999 79999999999999999999
Q ss_pred EEEecCCCChhhhhccC------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEE
Q 046728 90 VYDYMPNHSLITHLHGR------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKV 147 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~~------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL 147 (325)
||||+++++|.++++.. ++...+..+..++..++.++|.. |||||+||+++.++.++|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence 99999999999999532 22234466777888888888875 799999999999999999
Q ss_pred eeeccccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccc
Q 046728 148 ADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYV 226 (325)
Q Consensus 148 ~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~ 226 (325)
+|||++...... ........+..|+|||++.+..++.++|||||||++|+|++ |..||....... .....
T Consensus 161 ~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~~~~---- 231 (297)
T cd05089 161 ADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LYEKL---- 231 (297)
T ss_pred CCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH----
Confidence 999998643221 11111123457999999988889999999999999999997 999996543211 11100
Q ss_pred cccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCCC
Q 046728 227 QKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGRR 283 (325)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 283 (325)
........+..++..+.+|+.+||..+|.+|||++++++.|+.+....
T Consensus 232 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 232 ---------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ---------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 011111223346678999999999999999999999999888776433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=262.19 Aligned_cols=248 Identities=23% Similarity=0.378 Sum_probs=191.3
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCC---eEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDD---QIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~---~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
.|+..+.||.| +++.||+++...++. .||+|.+... .......+.+|++++++++|||++++++++.+....++
T Consensus 6 ~~~~~~~lg~g--~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 6 HITKQKVIGAG--EFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HceEeeEecCC--CCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 45667888988 677788888765543 7999998643 34445678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 90 VYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
||||+++++|.++++. .++......+..++..+++++|.. +||||+||+++.++.++|+|||++.........
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 9999999999999953 345556677888888899998875 799999999999999999999998866432221
Q ss_pred eec--cCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 163 MTT--RVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 163 ~~~--~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
... ....+..|+|||++.+..++.++|||||||++|+|++ |..||...... .....+. . ..
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~~~~~i~----~---------~~ 227 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---EVMKAIN----D---------GF 227 (268)
T ss_pred ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHHHHh----c---------CC
Confidence 111 1123457999999988888999999999999999997 99999653321 1111110 0 01
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
..+.....+..+.+++.+||..+|++||++.++++.|+++
T Consensus 228 ~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1122234567899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=263.99 Aligned_cols=248 Identities=21% Similarity=0.342 Sum_probs=192.3
Q ss_pred cchhHHhhccCccceeeeeEEEeccC-----CCCeEEEEEecccChh-hHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRET-----GDDQIAVKRLKTLNAK-AEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
+.|..++.||.| +++.||+++... +.+.|++|.+...... ....+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~~~~~~lg~g--~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRG--EFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred Hhceeeeeeccc--ceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 567888999998 778888888543 3567999988653333 45689999999999999999999999999899
Q ss_pred EEEEEEecCCCChhhhhcc-----------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeec
Q 046728 87 RLIVYDYMPNHSLITHLHG-----------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFG 151 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~-----------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg 151 (325)
.++||||+++|+|.++++. .++......+..++..+++++|.. +||||+||+++.++.++++|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 9999999999999999953 244555677778888888999875 7999999999999999999999
Q ss_pred cccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccc
Q 046728 152 FAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGA 230 (325)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (325)
++...............++..|+|||.+.+...+.++||||||+++|+|++ |..||....... ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~~------- 232 (275)
T cd05046 163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRLQ------- 232 (275)
T ss_pred cccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHHH-------
Confidence 987554332222233346778999999988888899999999999999998 788886433211 111110
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 231 FEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
........+...+..+.+++.+||..||++|||+.+++..|+
T Consensus 233 -----~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 -----AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -----cCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 011111122345678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=258.33 Aligned_cols=239 Identities=23% Similarity=0.361 Sum_probs=185.4
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEecccChh-hHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCCCC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAK-AEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHS 98 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~gs 98 (325)
.||.| +++.||.+.... ++.||+|.+...... ....+.+|++++++++||||+++++++.+....++||||+.+++
T Consensus 2 ~lg~g--~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 2 KIGKG--NFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred ccccC--CCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 56777 788899998777 899999998754333 45688999999999999999999999999999999999999999
Q ss_pred hhhhhccC---CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee-ccCCCC
Q 046728 99 LITHLHGR---LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT-TRVKGT 170 (325)
Q Consensus 99 L~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~-~~~~~t 170 (325)
|.+++... ++....+.+..++..++.++|.. |||||+||+++.++.++|+|||++........... .....+
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP 158 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence 99999432 34444566677777888888865 79999999999999999999999886543222111 122235
Q ss_pred cCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHH
Q 046728 171 LGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249 (325)
Q Consensus 171 ~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (325)
..|+|||.+.++.++.++|+||||+++|+|++ |..||........... .. . ......+...+.
T Consensus 159 ~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~---~~----~---------~~~~~~~~~~~~ 222 (251)
T cd05041 159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER---IE----S---------GYRMPAPQLCPE 222 (251)
T ss_pred eccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH---Hh----c---------CCCCCCCccCCH
Confidence 67999999988889999999999999999999 8888865432111111 00 0 001122334567
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 250 SMVLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 250 ~~~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
.+.+++.+||..+|.+|||++++++.|+
T Consensus 223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 223 EIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 8999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=262.32 Aligned_cols=249 Identities=21% Similarity=0.283 Sum_probs=191.2
Q ss_pred chhHHhhccCccceeeeeEEEeccCC---CCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETG---DDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
.+.+.+.||.| +++.||.+..... ...||+|...... ......+.+|+++++.++||||+++++++.+ ...++
T Consensus 7 ~~~~~~~lg~g--~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 7 DITLGRCIGEG--QFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hceeeeeeCCc--cceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 46778889988 6777888765433 4578999887543 4556689999999999999999999998875 45789
Q ss_pred EEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 90 VYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
||||+++|+|.+++.. .+....++.+..++..++.++|.. +||||+||+++.++.++|+|||++.........
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 163 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY 163 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccce
Confidence 9999999999999953 244555566777888888888875 699999999999999999999999866544322
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
......++..|+|||.+....++.++||||||+++|++++ |..||........ ..... .....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~~-------------~~~~~ 227 (270)
T cd05056 164 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRIE-------------NGERL 227 (270)
T ss_pred ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHH-------------cCCcC
Confidence 2222234567999999988889999999999999999986 9999965432111 11110 00011
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
..+...+..+.+++.+||..+|++|||+.+++..|+.+..
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 2234556789999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=262.85 Aligned_cols=243 Identities=20% Similarity=0.265 Sum_probs=186.9
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcC------C
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGG------D 85 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~------~ 85 (325)
..|.+.+.||.| +++.||+++...+++.||+|.+.... .....+.+|+.+++++ +||||+++++++... .
T Consensus 6 ~~y~~~~~lg~g--~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 6 GIFELVELVGNG--TYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhHHHheeec--CCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 457888999998 77889999999999999999987533 3345788899999999 799999999998653 4
Q ss_pred eEEEEEEecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccC
Q 046728 86 ERLIVYDYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIP 157 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~ 157 (325)
..++||||+.+++|.+++.. .+++..+..+..++..++.++|.. +||||+||+++.++.++|+|||++....
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 58899999999999999853 234445566778888888888876 7999999999999999999999987654
Q ss_pred CCcceeeccCCCCcCCCCcccccc-----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccc
Q 046728 158 DGVTHMTTRVKGTLGYLAPEYAMW-----GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFE 232 (325)
Q Consensus 158 ~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (325)
.... ......|+..|+|||++.+ ..++.++|+||+||++|+|++|..||......... .... .
T Consensus 163 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~---~~~~----~---- 230 (272)
T cd06637 163 RTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---FLIP----R---- 230 (272)
T ss_pred cccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH---HHHh----c----
Confidence 3221 1233458889999999863 35778999999999999999999999643221110 0000 0
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 233 HIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
...........+..+.+|+.+||..||.+|||+.++++
T Consensus 231 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 ----NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ----CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00011112235568999999999999999999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=263.45 Aligned_cols=251 Identities=22% Similarity=0.313 Sum_probs=193.9
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCC----eEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDD----QIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD 85 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~----~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (325)
-...+.+++.||.| +++.||.+....++. .||+|.+... .......+.+|..+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~lg~G--~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 5 KETELKKVKVLGSG--AFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred chhheeeeeecCCC--CCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 34567888999999 777888887666655 4899998643 44455688899999999999999999999875 4
Q ss_pred eEEEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCC
Q 046728 86 ERLIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 158 (325)
..+++++|+++|+|.++++. .++....+.+..++..++.++|.. |||||+||++++++.+||+|||+++....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 57899999999999999953 345566778888999999999875 79999999999999999999999987653
Q ss_pred Cccee-eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccC
Q 046728 159 GVTHM-TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD 236 (325)
Q Consensus 159 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (325)
..... .....++..|+|||...+..++.++|||||||++|||++ |..||....... ...+.. .
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~-------- 226 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLE----K-------- 226 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----C--------
Confidence 32211 112234678999999988889999999999999999998 899986533211 111111 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 237 PRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 237 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
....+.+...+..+.+++.+||..||++|||+.++++.|+...
T Consensus 227 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 227 -GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred -CCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0111222345678999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=264.22 Aligned_cols=251 Identities=21% Similarity=0.345 Sum_probs=188.1
Q ss_pred cchhHHhhccCccceeeeeEEEecc-----CCCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRE-----TGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
..|.+.+.||.| +++.||++... ..+..||+|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 6 ~~~~i~~~lg~G--~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 6 EKITLLRELGQG--SFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHceeeeeecCC--CCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 467889999999 66667766433 234589999886432 3344578889999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhccCCC------------CCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeee
Q 046728 87 RLIVYDYMPNHSLITHLHGRLA------------PDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADF 150 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Df 150 (325)
.++||||+++|+|.++++.... ...+..+..++..++.++|.. |||||+||+++.++.++|+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Df 163 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDF 163 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcC
Confidence 9999999999999999953211 112344667888888888875 799999999999999999999
Q ss_pred ccccccCCCccee-eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccc
Q 046728 151 GFAKLIPDGVTHM-TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQK 228 (325)
Q Consensus 151 g~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 228 (325)
|+++......... .....++..|+|||.+.+..++.++|+|||||++|+|++ |..||....... ...... .
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~~~~----~ 236 (288)
T cd05061 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKFVM----D 236 (288)
T ss_pred CccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----c
Confidence 9987554322211 112235677999999988889999999999999999998 788886532211 111100 0
Q ss_pred cccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 229 GAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
+. ....+...++.+.+++.+||..||++|||+.++++.|+..+.
T Consensus 237 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 237 GG---------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred CC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 00 011123345789999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=280.16 Aligned_cols=246 Identities=17% Similarity=0.316 Sum_probs=201.8
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEec----ccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe--
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLK----TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE-- 86 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 86 (325)
.+.+|-.+||.| ++-.||++-+..+|..||--.++ ..++....+|..|+.+|+.|+||||++++++|.+...
T Consensus 40 Ry~k~~evLGrG--afKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 40 RYLKFDEVLGRG--AFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred ceeehhhhcccc--cceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 345778889999 89999999999999998876553 2346666899999999999999999999999987655
Q ss_pred EEEEEEecCCCChhhhh--ccCCCCCCccCHHHHHHHHHHHHhhc------CCCCCCceeeCCC-CceEEeeeccccccC
Q 046728 87 RLIVYDYMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSAEGI------ADIKASNVLLDTD-FEAKVADFGFAKLIP 157 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l--~~~~~~~~~~~~~~~~~~~~~~~~~~------rdlkp~Nil~~~~-~~~kL~Dfg~~~~~~ 157 (325)
+-+|+|.+..|+|..|+ +++.+.+.+..|.+||..++.++|++ ||||-+||||+.+ |.|||+|+|+|..+.
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 67999999999999999 46678888999999999999999986 8999999999866 899999999999876
Q ss_pred CCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 158 DGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 158 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
.... ....||+.|||||++. ..|+..+||||||+++.||+|+..||..... ..+- +.++..+
T Consensus 198 ~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-----~AQI---------YKKV~SG 259 (632)
T KOG0584|consen 198 KSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-----PAQI---------YKKVTSG 259 (632)
T ss_pred cccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-----HHHH---------HHHHHcC
Confidence 5432 2357999999999998 7899999999999999999999999976543 2221 2222222
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
-.+..+..-..++++++|.+|+.. .++|||+.++|. ||..-
T Consensus 260 iKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 260 IKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred CCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 222222233356899999999999 999999999998 77753
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=259.26 Aligned_cols=240 Identities=25% Similarity=0.396 Sum_probs=185.4
Q ss_pred hccCccceeeeeEEEeccC-CC--CeEEEEEecccCh-hhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecC
Q 046728 20 NINNGLEILMLLLLLRRET-GD--DQIAVKRLKTLNA-KAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~-~~--~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~ 95 (325)
.||.| +++.||.+.... ++ ..||+|.+..... .....+.+|++++++++||||+++++++.. ...++||||++
T Consensus 2 ~ig~g--~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 2 KLGDG--SFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred cCCcc--CcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 56777 777888887654 33 3699999976554 566789999999999999999999999988 88999999999
Q ss_pred CCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce--eec
Q 046728 96 NHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH--MTT 165 (325)
Q Consensus 96 ~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~--~~~ 165 (325)
+++|.+++... +.......+..++..+++++|.. +||||+||+++.++.++|+|||++......... ...
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE 158 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence 99999999543 34445566777888888888875 799999999999999999999999876542221 112
Q ss_pred cCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 166 RVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
...++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ....... .......+
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~------------~~~~~~~~ 223 (257)
T cd05040 159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKIDK------------EGERLERP 223 (257)
T ss_pred CCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHh------------cCCcCCCC
Confidence 2346778999999988889999999999999999998 999996432211 1111100 00011122
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
...+..+.+++.+||..+|++|||+.+++++|.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=268.07 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=189.5
Q ss_pred cchhHHhhccCccceeeeeEEEecc-------CCCCeEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEc
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRE-------TGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAG 83 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~-------~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 83 (325)
..|.+.+.||.| +++.||++++. .....||+|.+... .......+.+|+++++++ +||||+++++++..
T Consensus 12 ~~~~~~~~lg~G--~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 12 DRLVLGKPLGEG--CFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHeeeeeeecCC--CcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 467788999999 77788888653 23457999998743 334456788999999999 69999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhccCC------------------CCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC
Q 046728 84 GDERLIVYDYMPNHSLITHLHGRL------------------APDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT 141 (325)
Q Consensus 84 ~~~~~lV~e~~~~gsL~~~l~~~~------------------~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~ 141 (325)
....++||||+++|+|.+++.... +......+..++..++.++|.. +||||+||+++.
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 169 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE 169 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC
Confidence 899999999999999999995421 1122334567888888888875 799999999999
Q ss_pred CCceEEeeeccccccCCCccee-eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhh
Q 046728 142 DFEAKVADFGFAKLIPDGVTHM-TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIV 219 (325)
Q Consensus 142 ~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~ 219 (325)
++.++|+|||+++......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.......
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~- 248 (314)
T cd05099 170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL- 248 (314)
T ss_pred CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH-
Confidence 9999999999998654322111 111224467999999988889999999999999999999 8889865432211111
Q ss_pred hhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 220 QWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.. . ......+...+.++.+|+.+||..||++|||+.++++.|+....
T Consensus 249 --~~----~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 249 --LR----E---------GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred --HH----c---------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 00 0 00112233456689999999999999999999999998887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=268.43 Aligned_cols=251 Identities=23% Similarity=0.307 Sum_probs=190.2
Q ss_pred cchhHHhhccCccceeeeeEEEeccC-------CCCeEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEc
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRET-------GDDQIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAG 83 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~-------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 83 (325)
..|.+.+.||+| +++.||+++... ....+|+|.+... .......+..|+.+++.+ +||||+++++++..
T Consensus 18 ~~~~i~~~lg~G--~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 18 DRLVLGKPLGEG--CFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred HHeEEeeeeccC--CCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 467888999999 677788876533 2357999998743 234456788899999999 79999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhccC------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC
Q 046728 84 GDERLIVYDYMPNHSLITHLHGR------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT 141 (325)
Q Consensus 84 ~~~~~lV~e~~~~gsL~~~l~~~------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~ 141 (325)
....|+||||+.+|+|.+++... ++....+.+..++..+++++|.. |||||+||+++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 175 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence 99999999999999999999532 22223445677888888888875 799999999999
Q ss_pred CCceEEeeeccccccCCCccee-eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhh
Q 046728 142 DFEAKVADFGFAKLIPDGVTHM-TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIV 219 (325)
Q Consensus 142 ~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~ 219 (325)
++.++|+|||.+.......... .....++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+.....
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~--- 252 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF--- 252 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH---
Confidence 9999999999987654322111 111224567999999988889999999999999999998 88888654321111
Q ss_pred hhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 220 QWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.... .......+...+..+.+|+.+||..+|++|||+.++++.|+.+..
T Consensus 253 ~~~~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 253 KLLK-------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHH-------------cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 1100 011112234456789999999999999999999999998887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=259.40 Aligned_cols=246 Identities=22% Similarity=0.382 Sum_probs=190.0
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
...+.+.+.||.| +++.||++... ++..||+|.+... ......+.+|++++++++|+|++++++.+.. ...++||
T Consensus 5 ~~~~~~~~~lg~g--~~~~vy~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 5 RESLKLEKKLGAG--QFGEVWMATYN-KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred ccceeEEeEecCc--cceEEEEEEec-CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 4567888999999 77789888743 4567999988653 3345678899999999999999999999887 7789999
Q ss_pred EecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 92 DYMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 92 e~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||+++++|.+++... ++....+.+..++..++.++|.. +||||+||+++.++.++|+|||.+..........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 999999999999542 23334566778888999998875 7999999999999999999999997654432222
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
.....++..|+|||++....++.++|+||||+++|++++ |..||....... ...+.. .....+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~-------------~~~~~~ 223 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALE-------------RGYRMP 223 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHh-------------CCCCCC
Confidence 222335677999999988889999999999999999999 899997543211 111110 001112
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~ 278 (325)
.+...+..+.+++.+||..+|++||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 223456789999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=270.94 Aligned_cols=252 Identities=22% Similarity=0.299 Sum_probs=186.0
Q ss_pred cchhHHhhccCccceeeeeEEEec-----cCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEc-C
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRR-----ETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAG-G 84 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~-----~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-~ 84 (325)
..|.+.+.||.| +++.||.+.. ..+++.||||.+... .......+.+|+.++.++ +||||+++++++.. +
T Consensus 7 ~~~~~~~~lG~G--~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 7 DRLKLGKPLGRG--AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hHhcccccccCC--ccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 458999999999 7777888763 345788999999743 233445788999999999 68999999998755 4
Q ss_pred CeEEEEEEecCCCChhhhhccCC---------------------------------------------------------
Q 046728 85 DERLIVYDYMPNHSLITHLHGRL--------------------------------------------------------- 107 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~~~~--------------------------------------------------------- 107 (325)
...++|||||++|+|.++++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 56789999999999999985321
Q ss_pred ------------CCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce-eeccCCCC
Q 046728 108 ------------APDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH-MTTRVKGT 170 (325)
Q Consensus 108 ------------~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~t 170 (325)
+......+..++..++.++|.. |||||.||+++.++.++|+|||++......... ......++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence 1111233556777778888764 799999999999999999999998865332211 11223356
Q ss_pred cCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHH
Q 046728 171 LGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249 (325)
Q Consensus 171 ~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (325)
..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...... ..+ .....+...++
T Consensus 245 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~----~~~---------~~~~~~~~~~~ 309 (343)
T cd05103 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRL----KEG---------TRMRAPDYTTP 309 (343)
T ss_pred cceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHHHH----hcc---------CCCCCCCCCCH
Confidence 77999999988889999999999999999997 899986532211 111100 000 01111223456
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 250 SMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 250 ~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.+.+++.+||..||++|||+.+|++.|+.++.
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 79999999999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=261.38 Aligned_cols=241 Identities=23% Similarity=0.333 Sum_probs=182.9
Q ss_pred hccCccceeeeeEEEeccCCCC--eEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEEEEEecC
Q 046728 20 NINNGLEILMLLLLLRRETGDD--QIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMP 95 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~--~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lV~e~~~ 95 (325)
.||.| +++.||.++...++. .+++|.+... .......+.+|++++.++ +||||+++++++......++||||++
T Consensus 2 ~lg~g--~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEG--NFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCC--CCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 46777 888899888776664 5788988743 345556888999999999 79999999999999999999999999
Q ss_pred CCChhhhhccC------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccc
Q 046728 96 NHSLITHLHGR------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFA 153 (325)
Q Consensus 96 ~gsL~~~l~~~------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~ 153 (325)
+|+|.++++.. ++......+..++..++.++|.. +||||+||+++.++.++|+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 99999998532 22334456677788888888875 799999999999999999999998
Q ss_pred cccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccc
Q 046728 154 KLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFE 232 (325)
Q Consensus 154 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (325)
....... .......+..|+|||++.+..++.++||||||+++|+|++ |..||...+... ......
T Consensus 160 ~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~~--------- 225 (270)
T cd05047 160 RGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKLP--------- 225 (270)
T ss_pred cccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHHHh---------
Confidence 6322111 1111223567999999988889999999999999999997 999996533211 111100
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 233 HIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
.......+...+..+.+|+.+||..||.+|||+.+++..|+.++
T Consensus 226 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 226 ----QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ----CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00111222345568999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=266.43 Aligned_cols=254 Identities=20% Similarity=0.246 Sum_probs=184.7
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHcc---CCCCccceeeEEEc-----C
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRV---RHRNLLGLRGFYAG-----G 84 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~-----~ 84 (325)
|.+++.||.| +++.||+++...+++.||+|.+.... ......+.+|+++++.+ +||||+++++++.. .
T Consensus 2 y~~~~~lg~g--~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 2 YEPVAEIGVG--AYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred ceEeeEEeec--CCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 5677889888 78889999999999999999986422 22223556677777766 69999999998764 3
Q ss_pred CeEEEEEEecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccccc
Q 046728 85 DERLIVYDYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLI 156 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~ 156 (325)
...++||||+. ++|.++++. .++...+..+..++..++.++|.. |||||+||+++.++.++|+|||++...
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 45789999997 489888853 245566778889999999999975 799999999999999999999999865
Q ss_pred CCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccc-hhhhhhccccccccccc--
Q 046728 157 PDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKR-DIVQWVTPYVQKGAFEH-- 233 (325)
Q Consensus 157 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~-- 233 (325)
..... .....+|..|+|||++.+..++.++||||+||++|+|++|.+||......... ........ .....+..
T Consensus 159 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 235 (288)
T cd07863 159 SCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL-PPEDDWPRDV 235 (288)
T ss_pred cCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCC-CChhhCcccc
Confidence 43221 22345788999999998888999999999999999999999999654322111 11100000 00000000
Q ss_pred -----ccCcc---ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 234 -----IADPR---LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 234 -----~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
...+. ......+..+..+.+|+.+||..||++|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 000111245677899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=272.87 Aligned_cols=255 Identities=15% Similarity=0.202 Sum_probs=186.4
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
..|.+++.||.| +++.||+++...+++.||+|..... ....|+.++++++||||+++++++......++|||
T Consensus 66 ~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 66 LGYTVIKTLTPG--SEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred cCcEEEEEecCC--CCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 357888999998 7788999999999999999986432 23468999999999999999999999999999999
Q ss_pred ecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 93 YMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 93 ~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
|+. ++|.+++. ..++...++.+..++..++.++|.. |||||+|||++.++.++|+|||++....... ...
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~ 214 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--AFL 214 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--ccc
Confidence 995 68988884 2355666778889999999999985 7999999999999999999999987543221 122
Q ss_pred cCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccch--------hhhhhccc-ccccccc----
Q 046728 166 RVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRD--------IVQWVTPY-VQKGAFE---- 232 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~--------~~~~~~~~-~~~~~~~---- 232 (325)
...||..|+|||++.+..++.++|||||||++|+|+++..|+.......... ....+... .....+.
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 294 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG 294 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence 3458999999999998899999999999999999998655543322211000 00000000 0000000
Q ss_pred -----cccC--ccccC-------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 233 -----HIAD--PRLKG-------KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 233 -----~~~~--~~~~~-------~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
.... ...+. ......+..+.+||.+||..||++|||+.++++ ||+.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0000 00000 001123456778999999999999999999998 7764
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=263.61 Aligned_cols=251 Identities=18% Similarity=0.253 Sum_probs=198.8
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
..|.+++.||.| +++.||.+....++..||+|.+..........+.+|+.++++++||||+++++++......++|+|
T Consensus 19 ~~~~~~~~lg~g--~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQG--ASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCC--CCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 567888999988 677889998888889999999875444555678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc-CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccC
Q 046728 93 YMPNHSLITHLHG-RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRV 167 (325)
Q Consensus 93 ~~~~gsL~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 167 (325)
|+++++|.+++.. .++...+..+..++..++.++|.. +||+|+||+++.++.++|+|||++......... ....
T Consensus 97 ~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~-~~~~ 175 (293)
T cd06647 97 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTM 175 (293)
T ss_pred cCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-cccc
Confidence 9999999999954 345556677788888888888875 699999999999999999999988765443222 2223
Q ss_pred CCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHH
Q 046728 168 KGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQ 247 (325)
Q Consensus 168 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (325)
.++..|+|||.+....++.++|+||||+++|++++|..||........... .. ..+......+...
T Consensus 176 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~---~~-----------~~~~~~~~~~~~~ 241 (293)
T cd06647 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IA-----------TNGTPELQNPEKL 241 (293)
T ss_pred cCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee---hh-----------cCCCCCCCCcccc
Confidence 578889999999888889999999999999999999999965432111000 00 0000011123345
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 248 LKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 248 ~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
+..+.+++.+||..+|++||++++++. ||+...
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 678999999999999999999999998 887654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=286.61 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=194.0
Q ss_pred hHHhhccCccceeeeeEEEeccCCC---CeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 16 VFIQNINNGLEILMLLLLLRRETGD---DQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 16 ~~~~~i~~G~~~~~~v~~~~~~~~~---~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
++.++||.| .|+.|+.-+=+..+ ..||||.++... ......|..|..||.++.||||+++.|+......++||+
T Consensus 632 ~Ie~VIGaG--EFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 632 KIEKVIGAG--EFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred EEEEEEecc--cccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 455678888 55556655444443 579999998653 455568999999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCC---CCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 92 DYMPNHSLITHLHGRL---APDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 92 e~~~~gsL~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|||++|+|..||+..- .--+..-..+.++.+++|+..+ |||.++|||++.+-.||++|||+++.+.++.....
T Consensus 710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~y 789 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 789 (996)
T ss_pred hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccc
Confidence 9999999999997532 2222333344445555554443 89999999999999999999999997765442222
Q ss_pred ccC--CCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 165 TRV--KGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 165 ~~~--~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
.+. .-+++|.|||.+....++.+|||||+|+++||.++ |..||..+...+..+ ....+.+.
T Consensus 790 tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIk----------------aIe~gyRL 853 (996)
T KOG0196|consen 790 TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK----------------AIEQGYRL 853 (996)
T ss_pred cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHH----------------HHHhccCC
Confidence 222 23578999999999999999999999999999875 999998766533322 22344556
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCC
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGR 282 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 282 (325)
+.|.+++..+.+||..||++|-++||++.+|+..|..+...
T Consensus 854 PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 854 PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 77889999999999999999999999999999999887643
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=262.26 Aligned_cols=248 Identities=22% Similarity=0.370 Sum_probs=190.6
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCC---eEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDD---QIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~---~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
.+.+.+.||.| +++.||.+....++. .||+|.+... .......+..|+.++++++||||+++++++.++...++
T Consensus 5 ~~~~~~~lg~g--~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 5 CVKIEEVIGAG--EFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HeEEEeEecCC--CCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 35677889888 777888887766554 6999998753 44556689999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccC---CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 90 VYDYMPNHSLITHLHGR---LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
||||+.+++|.++++.. +.....+.+..++..++.++|.. +||||+||+++.++.++|+|||++.........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence 99999999999998532 34445566777888888888875 699999999999999999999998765432221
Q ss_pred ee--ccC--CCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 163 MT--TRV--KGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 163 ~~--~~~--~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
.. ... ..+..|+|||.+.+..++.++|||||||++||+++ |..||...... ....++. .
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~-------------~ 226 (269)
T cd05065 163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIE-------------Q 226 (269)
T ss_pred cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHH-------------c
Confidence 11 111 12357999999998889999999999999999886 99998653321 1111111 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
....+.+..++..+.+++.+||..+|++||++++++..|+..
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011122345567899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=259.72 Aligned_cols=241 Identities=20% Similarity=0.345 Sum_probs=190.2
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEc-CCeEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG-GDERLIVY 91 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lV~ 91 (325)
|++++.||.| +++.||.++...+++.||+|.+... .......+.+|++++++++|||++++++.+.. ...+++||
T Consensus 2 y~~~~~lg~g--~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 2 YCFVRVVGKG--SYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred ceEEEEecCC--CCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 6788999998 7888999999888999999998642 23445578889999999999999999998764 44688999
Q ss_pred EecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 92 DYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 92 e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||+++++|.++++. .+++..+..+..++..++.++|.. +||||+||+++.++.++|+|||++.........
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 158 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM- 158 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCc-
Confidence 99999999999853 245556677888888888888875 799999999999999999999999866433221
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.....++..|+|||++.+..++.++|+||+|+++|+|++|..||...+.. .... .. ..+. ....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~~~~---~~-~~~~---------~~~~ 222 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---SLVY---RI-IEGK---------LPPM 222 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HHHH---HH-HhcC---------CCCC
Confidence 22345788999999999888999999999999999999999998643211 1000 00 0000 1122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
+...++.+.+++.+||..||++|||+.++++
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 223 PKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 3456678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=274.12 Aligned_cols=239 Identities=22% Similarity=0.286 Sum_probs=183.3
Q ss_pred ccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHcc---CCCCccceeeEEEcCCeEEEEEEec
Q 046728 21 INNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRV---RHRNLLGLRGFYAGGDERLIVYDYM 94 (325)
Q Consensus 21 i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~lV~e~~ 94 (325)
||.| +++.||++++..+++.||+|.+.... .........|..++... +||||+++++++.+....|+||||+
T Consensus 1 lG~G--~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKG--TFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM 78 (330)
T ss_pred CCCC--CceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence 4555 88899999999999999999986421 22233455677777665 6999999999999999999999999
Q ss_pred CCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCC
Q 046728 95 PNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVK 168 (325)
Q Consensus 95 ~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~ 168 (325)
++|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++.++.++|+|||++........ ......
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~ 157 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTFC 157 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccCcc
Confidence 9999999884 3466677788889999999999985 79999999999999999999999875432221 123456
Q ss_pred CCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHH
Q 046728 169 GTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQ 247 (325)
Q Consensus 169 ~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (325)
||..|+|||++.+. .++.++|||||||++|+|++|..||....... ....+ ..+. ... .....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~---~~~~i----~~~~--------~~~-~~~~~ 221 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ---MYRNI----AFGK--------VRF-PKNVL 221 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH---HHHHH----HcCC--------CCC-CCccC
Confidence 89999999998754 47899999999999999999999996533211 11100 0000 000 01235
Q ss_pred HHHHHHHHHHccCCCCCCCC----CHHHHHH--HHhc
Q 046728 248 LKSMVLIALRCTDSNPENRP----TMTDVVD--WLKG 278 (325)
Q Consensus 248 ~~~~~~li~~cl~~dp~~Rp----s~~~il~--~l~~ 278 (325)
++.+.+|+.+||..||.+|| +++++++ ||..
T Consensus 222 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 222 SDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 67889999999999999998 6788887 6654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=266.21 Aligned_cols=263 Identities=16% Similarity=0.205 Sum_probs=194.7
Q ss_pred HHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEec
Q 046728 17 FIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94 (325)
Q Consensus 17 ~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~ 94 (325)
+...||.|.|+++.||.+++..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 2 LQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred hHHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence 35689999999999999999999999999998642 3344567888999999999999999999999999999999999
Q ss_pred CCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee---
Q 046728 95 PNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM--- 163 (325)
Q Consensus 95 ~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~--- 163 (325)
.+++|.++++.. +++..+..+..++..+++++|.. |||||+||+++.++.++++||+.+..........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 999999998542 44455567888899999999974 7999999999999999999997654322111100
Q ss_pred ---eccCCCCcCCCCccccccC--CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcc--cc----------
Q 046728 164 ---TTRVKGTLGYLAPEYAMWG--KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTP--YV---------- 226 (325)
Q Consensus 164 ---~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~--~~---------- 226 (325)
.....++..|+|||++.+. .++.++|||||||++|+|++|..||......... ...... ..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccccccchh
Confidence 0112345679999998763 4788999999999999999999999654321110 000000 00
Q ss_pred --------------------cccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 227 --------------------QKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 227 --------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
............+..+.....++.+.+|+.+||..||++|||++++++ ||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 000000111112222334557788999999999999999999999998 8876654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=260.64 Aligned_cols=246 Identities=21% Similarity=0.322 Sum_probs=185.3
Q ss_pred hHHhhccCccceeeeeEEEeccCCCC--eEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC------C
Q 046728 16 VFIQNINNGLEILMLLLLLRRETGDD--QIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG------D 85 (325)
Q Consensus 16 ~~~~~i~~G~~~~~~v~~~~~~~~~~--~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~ 85 (325)
.+.+.||.| +++.||.+....++. .||+|.++.. .......+..|+++++.++||||+++++++... .
T Consensus 2 ~i~~~ig~G--~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 2 ALGKTLGEG--EFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred ccccccCcc--cCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 356788888 777888887766654 6899988643 345556888999999999999999999986432 2
Q ss_pred eEEEEEEecCCCChhhhhc-cC-------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccc
Q 046728 86 ERLIVYDYMPNHSLITHLH-GR-------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFA 153 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~-~~-------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~ 153 (325)
..++||||+.+|+|.+++. .+ ++......+..++..++.++|.. |||||+|||++.++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 4689999999999998872 11 23344566777888888898875 799999999999999999999999
Q ss_pred cccCCCccee-eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhccccccccc
Q 046728 154 KLIPDGVTHM-TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAF 231 (325)
Q Consensus 154 ~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (325)
.......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ....... .+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~----~~~- 231 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDYLR----QGN- 231 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH----cCC-
Confidence 8765432221 122245678999999998889999999999999999999 78998653321 1111110 000
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 232 EHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
....+...+..+.+++.+||..||++|||++++++.|+..
T Consensus 232 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 --------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0112234566799999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=260.33 Aligned_cols=242 Identities=18% Similarity=0.298 Sum_probs=190.1
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh---------hhHHHHHHHHHHHHccCCCCccceeeEEEcCC
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA---------KAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD 85 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (325)
+.+.+.||.| +++.||.+....+++.||+|.+..... .....+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~ig~g--~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (267)
T cd06628 2 WIKGALIGSG--SFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD 79 (267)
T ss_pred ccccceeecC--CCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Confidence 4566788888 777899999888899999998864321 12246778999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC
Q 046728 86 ERLIVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 159 (325)
..++||||+++++|.+++.. .++...+..+..++..+++++|.. +||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 99999999999999999953 355566677888899999999875 799999999999999999999998866532
Q ss_pred cce-----eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccc
Q 046728 160 VTH-----MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHI 234 (325)
Q Consensus 160 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (325)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ....... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~----~------ 226 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QAIFKIG----E------ 226 (267)
T ss_pred cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HHHHHHh----c------
Confidence 111 111234788999999998888899999999999999999999999753221 0000000 0
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 235 ADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
......+...+..+.++|.+||..||.+||++.++++
T Consensus 227 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 ---NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111233456678999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=259.37 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=194.6
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccC---CCCccceeeEEEcCCeEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVR---HRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~l 89 (325)
-|++++.||.| +++.+|.+....+++.||+|.+... ......++.+|+.++++++ |||++++++++..+...++
T Consensus 2 ~y~~~~~l~~g--~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRG--AYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheecc--CCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 36788999998 8888999999889999999998643 3444567888999999996 9999999999999999999
Q ss_pred EEEecCCCChhhhhcc-CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 90 VYDYMPNHSLITHLHG-RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||||+++++|.++++. .++...++.+..++..++.++|.. +||+|+||+++.++.++|+|||++......... .
T Consensus 80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~ 158 (277)
T cd06917 80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK-R 158 (277)
T ss_pred EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc-c
Confidence 9999999999999854 345556677778888888888875 799999999999999999999999876554322 2
Q ss_pred ccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 165 TRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
....++..|+|||.+.++ .++.++|+||||+++|+|++|..||........ ..... .. ..+.+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~~~----~~-----~~~~~~--- 223 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MMLIP----KS-----KPPRLE--- 223 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hhccc----cC-----CCCCCC---
Confidence 234588899999988754 568899999999999999999999965432110 00000 00 001110
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
....+.++.+++.+||..||++||++.++++ |+++..
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 224 DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 1125568999999999999999999999998 776543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=266.91 Aligned_cols=251 Identities=21% Similarity=0.295 Sum_probs=190.3
Q ss_pred cchhHHhhccCccceeeeeEEEecc-------CCCCeEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEc
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRE-------TGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAG 83 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~-------~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 83 (325)
..|.+.+.||.| +++.||.++.. ..+..||+|.+... .......+.+|+.+++.+ +||||+++++++..
T Consensus 15 ~~~~~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 15 DKLTLGKPLGEG--CFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHeeecceeecc--CCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 456778899999 77778877632 23457999998643 234456788999999999 79999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhccCCC------------------CCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC
Q 046728 84 GDERLIVYDYMPNHSLITHLHGRLA------------------PDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT 141 (325)
Q Consensus 84 ~~~~~lV~e~~~~gsL~~~l~~~~~------------------~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~ 141 (325)
....++||||+.+|+|.+++..... ......+..++..++.++|.. |||||+||+++.
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~ 172 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTE 172 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcC
Confidence 9999999999999999999954211 112344567888888888875 799999999999
Q ss_pred CCceEEeeeccccccCCCccee-eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhh
Q 046728 142 DFEAKVADFGFAKLIPDGVTHM-TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIV 219 (325)
Q Consensus 142 ~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~ 219 (325)
++.++|+|||++.......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||...+.... .
T Consensus 173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~ 249 (304)
T cd05101 173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL---F 249 (304)
T ss_pred CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH---H
Confidence 9999999999998665432221 222335678999999988889999999999999999998 7888865432111 1
Q ss_pred hhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 220 QWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
..+. . ......+...+..+.+|+.+||..+|++|||+.++++.|+.+..
T Consensus 250 ~~~~----~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 250 KLLK----E---------GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHH----c---------CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 1110 0 00112233456789999999999999999999999999887664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=260.75 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=190.8
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCC---CeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGD---DQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~---~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
..|.+.+.||+| +++.||++....++ ..+|+|.+... .......+.+|+.++++++||||+++++++.+++..+
T Consensus 4 ~~~~~~~~lg~g--~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAG--EFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHeEeeeeeccc--CCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 356778899999 67778887765443 37999998643 2344568889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhccC---CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 89 IVYDYMPNHSLITHLHGR---LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
+||||+++++|.+++... ++....+.+..++..++.++|.. +||||+||+++.++.++|+|||++........
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 999999999999999532 34445566777888888888875 79999999999999999999999987654322
Q ss_pred eee--ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 162 HMT--TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 162 ~~~--~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
... ....++..|+|||.+.+..++.++|+||||+++|++++ |..||....... ....+.. .
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~~-------------~ 225 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIEE-------------G 225 (267)
T ss_pred eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHhC-------------C
Confidence 211 11223567999999998889999999999999999886 999996543211 1111110 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
...+.+...++.+.+++.+||..+|++|||+.++++.|+..
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11122334567899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=264.41 Aligned_cols=242 Identities=25% Similarity=0.383 Sum_probs=194.8
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|.+++.||.| +++.||.++...+++.||+|.+... .......+.+|++++++++||||+++++++.+....++|
T Consensus 2 ~y~~~~~ig~g--~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 2 DFEFIKTLGTG--SFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred ceEEEEEeecC--CCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence 46778899999 7788999999889999999998642 223445788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|||+++++|.++++ ..+++.....+..++..++.++|.. +||+|.||+++.++.++|+|||++...... .
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~ 155 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----T 155 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----C
Confidence 99999999999984 3456666777888899999999875 799999999999999999999999876543 2
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
....+++.|+|||.+.+...+.++||||||+++|+|++|..||...... ...... ... ....+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~------------~~~--~~~~~ 218 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYEKI------------LEG--KVRFP 218 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH------------hcC--CccCC
Confidence 2345888999999998888889999999999999999999999654311 111100 000 11223
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH--HHhc
Q 046728 245 RDQLKSMVLIALRCTDSNPENRP-----TMTDVVD--WLKG 278 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~ 278 (325)
...+..+.+++.+||..||.+|+ +++++++ |++.
T Consensus 219 ~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 219 SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence 34567899999999999999999 8888886 5543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=262.77 Aligned_cols=245 Identities=20% Similarity=0.264 Sum_probs=188.1
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc-CCCCccceeeEEEc------
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAG------ 83 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~------ 83 (325)
-...|++.+.||.| +++.||+++...+++.||+|.+... ......+..|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g--~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNG--TYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccC--CCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 34678889999988 8888999999999999999998653 33445788899999999 79999999999853
Q ss_pred CCeEEEEEEecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccc
Q 046728 84 GDERLIVYDYMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 84 ~~~~~lV~e~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
....++||||+.+|+|.+++... +++..+..+..++..++.++|.. +||+|+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 45789999999999999998532 33444566777888999999875 79999999999999999999999875
Q ss_pred cCCCcceeeccCCCCcCCCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccc
Q 046728 156 IPDGVTHMTTRVKGTLGYLAPEYAM-----WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGA 230 (325)
Q Consensus 156 ~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (325)
...... ......++..|+|||.+. ...++.++|+|||||++|+|++|..||...........
T Consensus 171 ~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~------------ 237 (282)
T cd06636 171 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL------------ 237 (282)
T ss_pred hhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh------------
Confidence 543211 122345788999999876 34578899999999999999999999965322110000
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 231 FEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
..............+..+.+||.+||..||.+|||+.++++
T Consensus 238 ---~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 ---IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00000111122345678999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=258.64 Aligned_cols=243 Identities=24% Similarity=0.394 Sum_probs=191.6
Q ss_pred hHHhhccCccceeeeeEEEeccCCC----CeEEEEEecccChh-hHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 16 VFIQNINNGLEILMLLLLLRRETGD----DQIAVKRLKTLNAK-AEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 16 ~~~~~i~~G~~~~~~v~~~~~~~~~----~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.+.+.||.| +++.||.++....+ ..||+|.+...... ....+..|+.+++.++|+||+++++++.+.+..+++
T Consensus 2 ~~~~~lg~g--~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 2 TLGKKLGEG--AFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred cccceeccC--CCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 467788888 77788888887765 89999999754332 566889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 91 YDYMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
|||+++++|.+++... ++......+..++..++.++|.. +||||+||+++.++.++|+|||++.........
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 9999999999999532 56666777888888888888875 799999999999999999999999876654222
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...... ........ . ...
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~~----~---------~~~ 223 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLEYLKK----G---------YRL 223 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhc----C---------CCC
Confidence 2212336788999999987889999999999999999998 78888653221 11111100 0 011
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWL 276 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l 276 (325)
..+...+.++.+++.+||..||++|||+.+++++|
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 22233667899999999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=263.93 Aligned_cols=246 Identities=21% Similarity=0.355 Sum_probs=188.1
Q ss_pred chhHHhhccCccceeeeeEEEeccC-----CCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRET-----GDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~-----~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
.|.+++.||.| +++.||.++... ++..||+|.+... .......+.+|+.++++++||||+++++++.++...
T Consensus 6 ~~~~~~~lg~g--~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 6 NIEYVRDIGQG--AFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hceeccccccc--ccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 46788899888 777888887542 5678999998653 334456788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccC------------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceee
Q 046728 88 LIVYDYMPNHSLITHLHGR------------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLL 139 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~~------------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~ 139 (325)
++||||+++|+|.+++... ++....+.+..++..++.++|.. +||||+||++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~ 163 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV 163 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe
Confidence 9999999999999999532 11223356778888888888874 7999999999
Q ss_pred CCCCceEEeeeccccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccch
Q 046728 140 DTDFEAKVADFGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRD 217 (325)
Q Consensus 140 ~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~ 217 (325)
+.++.++|+|||++......... .......+..|+|||.+.+..++.++|||||||++|+|++ |..||.+.... .
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~---~ 240 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE---E 240 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---H
Confidence 99999999999998755432211 1222234667999999988889999999999999999998 88888643321 1
Q ss_pred hhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 218 IVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
...... .+ .. ...+...+.++.+|+.+||..||++|||+.++++.|+
T Consensus 241 ~~~~~~----~~--------~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 241 VIYYVR----DG--------NV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHh----cC--------CC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 111110 00 00 1122345678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=259.19 Aligned_cols=244 Identities=25% Similarity=0.393 Sum_probs=187.0
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEe
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~ 93 (325)
.+.+.+.||.| +++.||++... .+..+|+|.+.... .....+.+|++++++++|||++++++++......++||||
T Consensus 5 ~~~~~~~ig~g--~~g~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 5 ELTLVQEIGSG--QFGLVWLGYWL-EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred HeEEEeeecCc--ccceEEEEEEe-CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 46678889998 77788888764 36789999986532 2235788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeecc
Q 046728 94 MPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTR 166 (325)
Q Consensus 94 ~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 166 (325)
+++++|.++++. .++...++.+..++..++.++|.. +||||+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 999999999853 244555667777888888888864 7999999999999999999999987654332211222
Q ss_pred CCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCH
Q 046728 167 VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNR 245 (325)
Q Consensus 167 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (325)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ....... .+ .....+.
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~----~~---------~~~~~~~ 224 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVETIN----AG---------FRLYKPR 224 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHh----CC---------CCCCCCC
Confidence 234578999999988889999999999999999998 89998643321 1111110 00 0001112
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 246 DQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 246 ~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
..+..+.+|+.+||..+|++|||++++++.|.
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 24578999999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=263.88 Aligned_cols=246 Identities=21% Similarity=0.287 Sum_probs=193.3
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEec
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~ 94 (325)
+.....||.| +++.||.+....+++.||+|.+..........+.+|+.+++.++|||++++++++..+...++||||+
T Consensus 23 ~~~~~~ig~g--~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEG--STGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCC--CceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 3445567766 88889999988889999999987544444567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcc-CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCC
Q 046728 95 PNHSLITHLHG-RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169 (325)
Q Consensus 95 ~~gsL~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 169 (325)
++++|..++.. .++...++.+..++..++.++|.. +||||+||+++.++.++|+|||++......... .....+
T Consensus 101 ~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~~~ 179 (297)
T cd06659 101 QGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVG 179 (297)
T ss_pred CCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-ccceec
Confidence 99999998853 455666778888999999999875 799999999999999999999998755433221 223458
Q ss_pred CcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHH
Q 046728 170 TLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249 (325)
Q Consensus 170 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (325)
+..|+|||++.+..++.++|||||||++|+|++|..||....... ....+... . ..........+.
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~----~-------~~~~~~~~~~~~ 245 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMKRLRDS----P-------PPKLKNAHKISP 245 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhcc----C-------CCCccccCCCCH
Confidence 899999999988889999999999999999999999996533211 11111100 0 000111233456
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHH--HHh
Q 046728 250 SMVLIALRCTDSNPENRPTMTDVVD--WLK 277 (325)
Q Consensus 250 ~~~~li~~cl~~dp~~Rps~~~il~--~l~ 277 (325)
.+.++|.+||..+|++||+++++++ |+.
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~ 275 (297)
T cd06659 246 VLRDFLERMLTREPQERATAQELLDHPFLL 275 (297)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhhChhhc
Confidence 7899999999999999999999998 554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=257.85 Aligned_cols=245 Identities=23% Similarity=0.323 Sum_probs=192.4
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh--hhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA--KAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
|.+.+.||.| +++.+|.+....+++.|++|.+..... .....+.+|+.+++.++|+||+++++.+.+....++|+|
T Consensus 2 y~~~~~lg~G--~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 2 WQRGNKIGGG--TFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred ceeeeEeecC--CCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 5667889888 777889998888899999999875433 366789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccC--CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec-
Q 046728 93 YMPNHSLITHLHGR--LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT- 165 (325)
Q Consensus 93 ~~~~gsL~~~l~~~--~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~- 165 (325)
|+++++|.+++... +.......+..++..++.++|.. +||+|+||+++.++.++|+|||++............
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 99999999999543 55666677788888889998875 699999999999999999999999876543332211
Q ss_pred --cCCCCcCCCCccccccCC---CCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 166 --RVKGTLGYLAPEYAMWGK---VSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 166 --~~~~t~~y~aPE~~~~~~---~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
...++..|+|||++.+.. .+.++||||||+++|++++|..||....... ....... . .....
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~--~~~~~~~----~-------~~~~~ 226 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF--QIMFHVG----A-------GHKPP 226 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH--HHHHHHh----c-------CCCCC
Confidence 245788999999998765 7889999999999999999999996532111 0000000 0 00001
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.+.....++.+.+++.+||..+|++|||+.+++.
T Consensus 227 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 227 IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1112234678899999999999999999999886
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=259.04 Aligned_cols=239 Identities=30% Similarity=0.405 Sum_probs=185.2
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEE-EcCCeEEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFY-AGGDERLIVYD 92 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lV~e 92 (325)
.|.+.+.||.| +++.||++.. .+..||+|.+.... ....+.+|+.++++++|+|++++++++ ..+...++|||
T Consensus 7 ~~~~~~~lg~g--~~~~v~~~~~--~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 7 ELKLLQTIGKG--EFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred hCeeeeeeccc--CCCeEEEEEE--cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 56778899999 6667887754 36789999986532 345788999999999999999999975 45567899999
Q ss_pred ecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 93 YMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|+++++|.++++.. ++....+.+..++..++.++|.. +||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---- 156 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 156 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC----
Confidence 99999999999542 33445567778888888998875 7999999999999999999999987544322
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.....+..|+|||++.+..++.++|||||||++|+|++ |..||..... ......+. . ......
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~----~---------~~~~~~ 220 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVE----K---------GYKMDA 220 (256)
T ss_pred CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHh----c---------CCCCCC
Confidence 12234567999999988889999999999999999998 9999864321 11111110 0 011122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~ 278 (325)
+...++.+.+++.+||..+|++|||+.+++++|++
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 34456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=258.32 Aligned_cols=239 Identities=21% Similarity=0.332 Sum_probs=186.1
Q ss_pred hhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCCCC
Q 046728 19 QNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHS 98 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~gs 98 (325)
..||+| +++.||.++...++..||+|.+..........+.+|+.+++.++|+||+++++++..+...++|+||+++++
T Consensus 14 ~~lg~g--~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 91 (268)
T cd06624 14 VVLGKG--TYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS 91 (268)
T ss_pred EEEecC--CceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCC
Confidence 356666 888899999888899999999987666667789999999999999999999999999999999999999999
Q ss_pred hhhhhccC---C--CCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC-CCceEEeeeccccccCCCcceeeccCC
Q 046728 99 LITHLHGR---L--APDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT-DFEAKVADFGFAKLIPDGVTHMTTRVK 168 (325)
Q Consensus 99 L~~~l~~~---~--~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~ 168 (325)
|.++++.. + ....+..+..++..++.++|.. +||||.||+++. ++.++|+|||++......... .....
T Consensus 92 L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~ 170 (268)
T cd06624 92 LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC-TETFT 170 (268)
T ss_pred HHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc-cccCC
Confidence 99999542 2 3334456777888899988875 799999999976 678999999998765432221 22234
Q ss_pred CCcCCCCccccccCC--CCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHH
Q 046728 169 GTLGYLAPEYAMWGK--VSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRD 246 (325)
Q Consensus 169 ~t~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (325)
++..|+|||.+.+.. ++.++|+||||+++|+|++|..||......... .+. ..........+..
T Consensus 171 ~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~-----------~~~~~~~~~~~~~ 236 (268)
T cd06624 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFK-----------VGMFKIHPEIPES 236 (268)
T ss_pred CCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhh-----------hhhhccCCCCCcc
Confidence 788999999987543 788999999999999999999999653221100 000 0000011223345
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 247 QLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 247 ~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.++++.+++.+||..+|++|||+.+++.
T Consensus 237 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 237 LSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 6678999999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=254.00 Aligned_cols=252 Identities=21% Similarity=0.260 Sum_probs=199.8
Q ss_pred eecccchhHH-hhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcC--
Q 046728 9 FLLASPAVFI-QNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGG-- 84 (325)
Q Consensus 9 ~~~~~~~~~~-~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-- 84 (325)
+++...|.+- ++||.| -.|.|..+.++.+++.+|+|++... .+..+|+++.-.. .|||||.++++|++.
T Consensus 57 ~~itedY~is~qvLG~G--inGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAG--INGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred ccchhhheehhhhhccc--cCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 3444455443 456666 7777888899999999999998642 2556788887777 599999999998664
Q ss_pred --CeEEEEEEecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC---CCceEEeeec
Q 046728 85 --DERLIVYDYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT---DFEAKVADFG 151 (325)
Q Consensus 85 --~~~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~---~~~~kL~Dfg 151 (325)
.-+.+|||.++||.|++.|++ .+.++++..+.+++..|++++|.+ |||||+|+|... +..+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 446799999999999999953 377888889999999999999975 899999999964 4579999999
Q ss_pred cccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccc
Q 046728 152 FAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAF 231 (325)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (325)
+++....... ..+.+-|+.|.|||++....|+..+|+||+|+++|-|++|.+||+...+... ..+..
T Consensus 210 FAK~t~~~~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai-----------spgMk 276 (400)
T KOG0604|consen 210 FAKETQEPGD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMK 276 (400)
T ss_pred cccccCCCcc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC-----------ChhHH
Confidence 9997654322 3445679999999999988999999999999999999999999987654211 11111
Q ss_pred ccccC--ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 232 EHIAD--PRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 232 ~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
..+.. -..+.+.+...++...++|+.+|..+|.+|.|++++++ |+....
T Consensus 277 ~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 277 RRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 12221 22344667899999999999999999999999999998 888654
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=280.52 Aligned_cols=261 Identities=14% Similarity=0.171 Sum_probs=187.3
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCC------CCccceeeEEEcC-C
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRH------RNLLGLRGFYAGG-D 85 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~~~-~ 85 (325)
..|.+++.||.| +++.||++.+..+++.||||++.... .....+..|+++++.++| ++++++++++... .
T Consensus 129 ~~y~i~~~lG~G--~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 129 QRFKILSLLGEG--TFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CcEEEEEEEEec--cCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 457888999999 88889999999999999999996432 223345567777777654 4588888888764 5
Q ss_pred eEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhh-c----CCCCCCceeeCCCC---------------
Q 046728 86 ERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEG-I----ADIKASNVLLDTDF--------------- 143 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~-~----rdlkp~Nil~~~~~--------------- 143 (325)
.+|+||+++ +++|.+++. +.+....+..+..++..++.++|. . |||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 688999998 779999884 346667778889999999999995 2 89999999998665
Q ss_pred -ceEEeeeccccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhh
Q 046728 144 -EAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWV 222 (325)
Q Consensus 144 -~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~ 222 (325)
.+||+|||.+...... .....||..|+|||++.+..++.++|||||||++|||++|..||...........+...
T Consensus 285 ~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 360 (467)
T PTZ00284 285 CRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360 (467)
T ss_pred ceEEECCCCccccCccc----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 4999999987643221 23456899999999999989999999999999999999999999764432111111110
Q ss_pred ccccccc------------cccccc--Ccccc-----------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--H
Q 046728 223 TPYVQKG------------AFEHIA--DPRLK-----------GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--W 275 (325)
Q Consensus 223 ~~~~~~~------------~~~~~~--~~~~~-----------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~ 275 (325)
....... .+.... .+... .......++.+.+||.+||..||++|||++++++ |
T Consensus 361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440 (467)
T ss_pred cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence 0000000 000000 00000 0000112456889999999999999999999998 8
Q ss_pred HhcccC
Q 046728 276 LKGGLG 281 (325)
Q Consensus 276 l~~~~~ 281 (325)
|.....
T Consensus 441 ~~~~~~ 446 (467)
T PTZ00284 441 VLKYYP 446 (467)
T ss_pred ccccCC
Confidence 886544
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=266.09 Aligned_cols=251 Identities=18% Similarity=0.289 Sum_probs=174.9
Q ss_pred hhccCccceeeeeEEEecc--CCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEc--CCeEEEEEEec
Q 046728 19 QNINNGLEILMLLLLLRRE--TGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG--GDERLIVYDYM 94 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lV~e~~ 94 (325)
++||.| +++.||+++.. .+++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+
T Consensus 7 ~~lG~G--~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 7 CKVGRG--TYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred cccccC--CCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 467777 88889988855 457899999986532 22357789999999999999999999854 45688999999
Q ss_pred CCCChhhhhcc-----------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceee----CCCCceEEeeeccccc
Q 046728 95 PNHSLITHLHG-----------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLL----DTDFEAKVADFGFAKL 155 (325)
Q Consensus 95 ~~gsL~~~l~~-----------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~----~~~~~~kL~Dfg~~~~ 155 (325)
. ++|.+++.. .++...+..+..|+..+++++|.. |||||+|||+ +..+.+||+|||++..
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 5 588887731 133444567888999999999975 7999999999 4567899999999986
Q ss_pred cCCCcc--eeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccc------hhhhhhcc--
Q 046728 156 IPDGVT--HMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKR------DIVQWVTP-- 224 (325)
Q Consensus 156 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~------~~~~~~~~-- 224 (325)
...... .......+|+.|+|||++.+. .++.++||||+||++|+|++|.+||......... .....+..
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 643321 112335689999999998764 5889999999999999999999999654321110 00000000
Q ss_pred -ccccccccc-------------ccCc-----cc---cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 225 -YVQKGAFEH-------------IADP-----RL---KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 225 -~~~~~~~~~-------------~~~~-----~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
......+.. .... .+ ........+..+.+||.+||..||.+|||++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000 0000 00 00000112346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=261.02 Aligned_cols=264 Identities=23% Similarity=0.343 Sum_probs=193.9
Q ss_pred cchhHHhhccCccceeeeeEEEecc----CCCCeEEEEEecccChh-hHHHHHHHHHHHHccCCCCccceeeEEEc--CC
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRE----TGDDQIAVKRLKTLNAK-AEMEFAVEVEILGRVRHRNLLGLRGFYAG--GD 85 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~----~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 85 (325)
..+.+++.||.| +++.||+++.. .++..||+|.+...... ....+.+|+++++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g--~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEG--HFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccC--CCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 456788999999 77788888743 44788999999754433 46689999999999999999999999877 56
Q ss_pred eEEEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCC
Q 046728 86 ERLIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 158 (325)
..++||||+++++|.+++.. .++......+..++..++.++|.. +||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 78999999999999999953 245555677788888888888875 69999999999999999999999987653
Q ss_pred Cccee--eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccC
Q 046728 159 GVTHM--TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD 236 (325)
Q Consensus 159 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (325)
..... .....++..|+|||.+.+..++.++||||||+++|+|++|..||.................. ....+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQM-IVTRLLELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccc-cHHHHHHHHH
Confidence 22211 11223456799999998888999999999999999999999998653321110000000000 0000000001
Q ss_pred ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 237 PRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 237 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
.......+..++.++.+|+.+||..+|++|||+.++++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111122334557899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=257.14 Aligned_cols=244 Identities=21% Similarity=0.303 Sum_probs=176.6
Q ss_pred hccCccceeeeeEEEecc--CCCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCC
Q 046728 20 NINNGLEILMLLLLLRRE--TGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPN 96 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~--~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~ 96 (325)
.||.| +++.||++... .++..+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 2 ~lg~G--~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNG--WFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred ccccc--CCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 57777 77778877543 345679999986433 33445788899999999999999999999998899999999999
Q ss_pred CChhhhhccCC-------CCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee-e
Q 046728 97 HSLITHLHGRL-------APDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM-T 164 (325)
Q Consensus 97 gsL~~~l~~~~-------~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~-~ 164 (325)
|+|.++++... ....+..+..++..++.++|.. +||||+||+++.++.++|+|||++.......... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 99999995321 1123345667888888888864 7999999999999999999999987544332221 2
Q ss_pred ccCCCCcCCCCccccccC-------CCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccC
Q 046728 165 TRVKGTLGYLAPEYAMWG-------KVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD 236 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~-------~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (325)
....++..|+|||++.+. .++.++|+||||+++|+|++ |..||........ .... ... .......
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~---~~~-~~~~~~~ 232 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYT---VRE-QQLKLPK 232 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHH---hhc-ccCCCCC
Confidence 234467889999988642 35789999999999999996 9999965432111 1000 000 0001111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 237 PRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 237 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
+ ......++.+.+++..|| .+|++|||+++|+..|+
T Consensus 233 ~----~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 233 P----RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred C----ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1 112234567889999999 68999999999998775
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=264.57 Aligned_cols=254 Identities=18% Similarity=0.226 Sum_probs=187.1
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
|.+++.||.| +++.||.++...++..||+|.+... .......+.+|+.++++++||||+++++++.+....++|+|
T Consensus 2 y~~~~~l~~g--~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 2 YEKLEKIGEG--TYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred ceeEEEeccc--CCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 6778889988 7778999999999999999998643 22223467789999999999999999999999999999999
Q ss_pred ecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 93 YMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 93 ~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
|+. ++|.+++. ..++...++.+..++..++.++|.. +||||+||+++.++.++|+|||++.......... .
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~ 157 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-S 157 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc-C
Confidence 996 58888774 3356667788889999999999975 7999999999999999999999998654332211 2
Q ss_pred cCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccc---------------cccc
Q 046728 166 RVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPY---------------VQKG 229 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~---------------~~~~ 229 (325)
...++..|+|||++.+. .++.++|||||||++|+|+||..||....... ......... ....
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhccccc
Confidence 23467899999988764 46889999999999999999988864322211 000000000 0000
Q ss_pred ccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 230 AFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.+.............+..++++.+||.+||..||.+|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000000000112345678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=257.64 Aligned_cols=243 Identities=19% Similarity=0.257 Sum_probs=187.0
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-----hhhHHHHHHHHHHHHccCCCCccceeeEEEc--CCe
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-----AKAEMEFAVEVEILGRVRHRNLLGLRGFYAG--GDE 86 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 86 (325)
.|...+.||+| +++.||++....++..||+|.+.... ......+.+|+.++++++||||+++++++.+ ...
T Consensus 3 ~~~~~~~lg~g--~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 3 NWRRGKLLGQG--AFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CccccceecCC--CCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCE
Confidence 35677889998 77789999998889999999885321 2334568889999999999999999999875 356
Q ss_pred EEEEEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 87 RLIVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
.++++||+++++|.+++.. .++....+.+..++..++.++|.. +||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 7899999999999999853 355556667888888999998875 7999999999999999999999987653311
Q ss_pred ce--eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 161 TH--MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 161 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
.. ......++..|+|||.+.+..++.++|+||+||++|+|++|..||....... .... .....
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~---~~~~------------~~~~~ 225 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA---AIFK------------IATQP 225 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH---HHHH------------HhcCC
Confidence 11 1122347889999999988888999999999999999999999996532110 0000 00011
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.....+...++.+.+++ +||..+|++|||++++++
T Consensus 226 ~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11233445667788888 688899999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=258.68 Aligned_cols=241 Identities=22% Similarity=0.388 Sum_probs=192.2
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
|++.+.||.| +++.+|+++...+++.||+|.+... .......+.+|+.++++++||||+++++++......++|||
T Consensus 2 y~~~~~lg~g--~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 2 YVKVKKIGEG--SFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred ceEEEEeccC--CceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 5678899999 7778888898889999999998632 33445688899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 93 YMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|+.+++|.+++.. .+++...+.+..++..++.++|.. +||+|+||+++.++.++|+|||++......... .
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~ 158 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL-A 158 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh-h
Confidence 9999999999853 244556677888999999999875 699999999999999999999999865443221 1
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
....++..|+|||++.+..++.++|+||||+++|+|++|..||...... .... ... .+ .....+
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~~---~~~-~~---------~~~~~~ 222 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---NLVL---KII-RG---------SYPPVS 222 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH---HHHH---HHh-cC---------CCCCCc
Confidence 2235788899999998888899999999999999999999998643211 1100 000 00 011223
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
...+..+.++|.+||..+|++||++.++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 455678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=256.00 Aligned_cols=248 Identities=21% Similarity=0.303 Sum_probs=200.2
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh-hhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEe
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA-KAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~ 93 (325)
|.+.+.||.| +++.+|++....+++.|++|.+..... .....+.+|+..+..++|||++++++++......++||||
T Consensus 3 ~~~~~~i~~g--~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 3 LERVKVLGQG--SSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred ceeeeeeeec--CCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 5677899999 777899999999999999999875433 4456899999999999999999999999999999999999
Q ss_pred cCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhh-c----CCCCCCceeeCCCCceEEeeeccccccCCCcceeecc
Q 046728 94 MPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEG-I----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTR 166 (325)
Q Consensus 94 ~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~-~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 166 (325)
+++++|.+++. ..+++...+.+..++..++.++|. . +||+|+||+++.++.++|+|||.+.......... ..
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~-~~ 159 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-NT 159 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-cc
Confidence 99999999995 345666678888999999999998 5 6999999999999999999999998765433221 23
Q ss_pred CCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHH
Q 046728 167 VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRD 246 (325)
Q Consensus 167 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (325)
..++..|+|||.+.+..++.++|+||||+++|+|++|..||..............+.. . .....+..
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~------------~-~~~~~~~~ 226 (264)
T cd06623 160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD------------G-PPPSLPAE 226 (264)
T ss_pred eeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc------------C-CCCCCCcc
Confidence 3478889999999888889999999999999999999999976542111111111110 0 01122233
Q ss_pred -HHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 247 -QLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 247 -~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
.+..+.++|.+||..+|++|||+.++++ |++.
T Consensus 227 ~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 227 EFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 6678999999999999999999999998 7764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=257.21 Aligned_cols=244 Identities=20% Similarity=0.328 Sum_probs=188.8
Q ss_pred hhHHhhccCccceeeeeEEEeccC-CCCeEEEEEeccc----------ChhhHHHHHHHHHHHHc-cCCCCccceeeEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRET-GDDQIAVKRLKTL----------NAKAEMEFAVEVEILGR-VRHRNLLGLRGFYA 82 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~-~~~~vaiK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~ 82 (325)
|++.+.||.| +++.||.+.... +++.+|+|.+... ......++..|+.++.+ ++||||+++++++.
T Consensus 2 y~~~~~ig~G--~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 79 (269)
T cd08528 2 YAVLEHLGSG--AFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL 79 (269)
T ss_pred chhhhhhcCC--CCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc
Confidence 6789999999 777888888777 6789999987521 22334567788888875 69999999999999
Q ss_pred cCCeEEEEEEecCCCChhhhhcc------CCCCCCccCHHHHHHHHHHHHhh-----cCCCCCCceeeCCCCceEEeeec
Q 046728 83 GGDERLIVYDYMPNHSLITHLHG------RLAPDCLLDWHRRVSIAIGSAEG-----IADIKASNVLLDTDFEAKVADFG 151 (325)
Q Consensus 83 ~~~~~~lV~e~~~~gsL~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~-----~rdlkp~Nil~~~~~~~kL~Dfg 151 (325)
.++..++||||+++++|.+++.. .++....+.+..++..++.++|. |+||+|.||+++.++.++|+|||
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 80 ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEeccc
Confidence 99999999999999999988732 24444556677788888888884 37999999999999999999999
Q ss_pred cccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccc
Q 046728 152 FAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAF 231 (325)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (325)
++....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ....
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~~~~---------- 224 (269)
T cd08528 160 LAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---LATK---------- 224 (269)
T ss_pred ceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---HHHH----------
Confidence 998655432 2233457889999999998889999999999999999999999986432111 0000
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 232 EHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
+......+......++.+.+++.+||..||++|||+.++...++
T Consensus 225 --~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 225 --IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --HhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00011111111234578999999999999999999999998775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=257.94 Aligned_cols=246 Identities=20% Similarity=0.268 Sum_probs=193.5
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
-|.+++.||.| +++.||++....++..||+|.+... .......+.+|+.++++++||||+++++++..+...++|||
T Consensus 5 ~~~~~~~ig~G--~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKG--SFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeec--CCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 35678888888 7778999988888999999998632 23444578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc-CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccC
Q 046728 93 YMPNHSLITHLHG-RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRV 167 (325)
Q Consensus 93 ~~~~gsL~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 167 (325)
|+++++|.+++.. .++...+..+..++..++.++|.. +||+|+||+++.++.++|+|||++......... ....
T Consensus 83 ~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~~ 161 (277)
T cd06641 83 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTF 161 (277)
T ss_pred eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhh-hccc
Confidence 9999999999853 345556677778888888888765 699999999999999999999998765442211 1223
Q ss_pred CCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHH
Q 046728 168 KGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQ 247 (325)
Q Consensus 168 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (325)
.++..|+|||.+.+..++.++|+|||||++|+|++|..||........ ...+ .. ..........
T Consensus 162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~----~~---------~~~~~~~~~~ 225 (277)
T cd06641 162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV---LFLI----PK---------NNPPTLEGNY 225 (277)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH---HHHH----hc---------CCCCCCCccc
Confidence 578889999999888889999999999999999999999964332111 0000 00 0011223345
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 248 LKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 248 ~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
+.++.+++.+||..+|++||++.++++ ||..
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 226 SKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence 678999999999999999999999998 6654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=259.88 Aligned_cols=247 Identities=20% Similarity=0.302 Sum_probs=194.9
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEec
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~ 94 (325)
+.-.+.||.| +++.||.+....+++.|++|.+..........+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 21 ~~~~~~lg~g--~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 21 LDNFVKIGEG--STGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhcceEeccC--CCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 4445678888 78889999988889999999987655555667889999999999999999999999999999999999
Q ss_pred CCCChhhhhcc-CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCC
Q 046728 95 PNHSLITHLHG-RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169 (325)
Q Consensus 95 ~~gsL~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 169 (325)
++++|.+++.. .++...+..+..++..++.++|.+ |||+|+||+++.++.++|+|||.+......... .....+
T Consensus 99 ~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~ 177 (285)
T cd06648 99 EGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RKSLVG 177 (285)
T ss_pred CCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-cccccC
Confidence 99999999853 345556677888999999999985 799999999999999999999988755433222 122357
Q ss_pred CcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHH
Q 046728 170 TLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249 (325)
Q Consensus 170 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (325)
+..|+|||.+.+..++.++|+||||+++|+|++|..||....... ....... .. .+. ...+...+.
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~---~~~~~~~----~~-----~~~--~~~~~~~~~ 243 (285)
T cd06648 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ---AMKRIRD----NL-----PPK--LKNLHKVSP 243 (285)
T ss_pred CccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH---HHHHHHh----cC-----CCC--CcccccCCH
Confidence 889999999988889999999999999999999999996532211 1111000 00 000 111223567
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 250 SMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 250 ~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
.+.+++.+||..+|++|||+.++++ |++.
T Consensus 244 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 274 (285)
T cd06648 244 RLRSFLDRMLVRDPAQRATAAELLNHPFLAK 274 (285)
T ss_pred HHHHHHHHHcccChhhCcCHHHHccCccccc
Confidence 8999999999999999999999997 7665
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=261.38 Aligned_cols=257 Identities=18% Similarity=0.243 Sum_probs=191.2
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
|.+.+.||.| +++.||++....+++.||+|.+.... ......+.+|+.++++++|||++++++++.++...++|||
T Consensus 2 y~~~~~l~~g--~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 2 YKILGRIGEG--AHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred ceEEeecccC--CCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 5677889888 77789999988889999999987543 3445678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 93 YMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 93 ~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
|+ +++|.+++.. .++...+..+..++..++.++|.+ +||||+||+++.++.++|+|||++............
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 99 9999999842 355666778888999999999876 699999999999999999999999876544322223
Q ss_pred cCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchh-hhhhccc--------cccccccccc
Q 046728 166 RVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDI-VQWVTPY--------VQKGAFEHIA 235 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~-~~~~~~~--------~~~~~~~~~~ 235 (325)
...++..|+|||.+.+. .++.++||||+|+++|+|++|.+||........... ....... .....+..+.
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 34588899999988654 468899999999999999999888765332111000 0000000 0000000000
Q ss_pred Ccccc----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 236 DPRLK----GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 236 ~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
..... .......+..+.+||.+||..||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000 0111234578999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=275.25 Aligned_cols=243 Identities=22% Similarity=0.354 Sum_probs=203.4
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCCCCh
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSL 99 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~gsL 99 (325)
++|+| .+|.||-+++..+....|||-+...+....+-+.+|+.+.++|+|.|||+++|.+..+..+-|.||-.+||+|
T Consensus 582 VLGKG--TYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKG--TYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecC--ceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 46777 9999999999999999999999877777777899999999999999999999999999988999999999999
Q ss_pred hhhhc---cCC--CCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeC-CCCceEEeeeccccccCCCcceeeccCCC
Q 046728 100 ITHLH---GRL--APDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLD-TDFEAKVADFGFAKLIPDGVTHMTTRVKG 169 (325)
Q Consensus 100 ~~~l~---~~~--~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 169 (325)
.+.++ +.+ ++..+--+.+|+..++.|+|.. ||||.+|+|++ -.|.+||+|||-++.+..-.. -+.++.|
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TETFTG 738 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTETFTG 738 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCc-ccccccc
Confidence 99995 334 5566778899999999999975 89999999997 568999999999998765333 3566789
Q ss_pred CcCCCCccccccC--CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHH
Q 046728 170 TLGYLAPEYAMWG--KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQ 247 (325)
Q Consensus 170 t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (325)
|..|||||++..+ .|+.++|||||||++-||.||++||........ ..| ++.--..-++.|..+
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-------------AMF-kVGmyKvHP~iPeel 804 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-------------AMF-KVGMYKVHPPIPEEL 804 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-------------hhh-hhcceecCCCCcHHH
Confidence 9999999999866 588999999999999999999999976432111 000 000011124677889
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 248 LKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 248 ~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
+.+...+|.+|+..||.+||++.+++. +|+..
T Consensus 805 saeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 805 SAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 999999999999999999999999998 88755
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=255.85 Aligned_cols=246 Identities=20% Similarity=0.339 Sum_probs=192.9
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC------hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN------AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
|...+.||.| +++.||.++...+++.||+|.+.... ......+..|+.++++++||||+++++++.+....+
T Consensus 2 ~~~~~~lg~g--~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 2 WLKGQQLGTG--AFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFN 79 (268)
T ss_pred ccccceecCc--CceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEE
Confidence 4556788888 78889999988889999999986422 223467889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC-ceEEeeeccccccCCCcc
Q 046728 89 IVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF-EAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~ 161 (325)
+||||+.+++|.++++ ..+++.....+..++..++.++|.. +||+|.||+++.++ .++|+|||.+........
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 9999999999999994 3355666778889999999999875 79999999998775 599999999876654311
Q ss_pred e---eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 162 H---MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 162 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
. ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||............... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------~~~~ 227 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI------------ASAT 227 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHH------------hccC
Confidence 1 112235788999999998888899999999999999999999999643321111111100 0011
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.....+...++++.+++.+||..+|++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 112344567788999999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=255.90 Aligned_cols=244 Identities=26% Similarity=0.329 Sum_probs=179.6
Q ss_pred hccCccceeeeeEEEeccC---CCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEE-cCCeEEEEEEec
Q 046728 20 NINNGLEILMLLLLLRRET---GDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYA-GGDERLIVYDYM 94 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lV~e~~ 94 (325)
.||.| +++.||.+.... ....||+|.+... .......+.+|+.+++.++||||+++++++. .+...++||||+
T Consensus 2 ~lg~g--~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 2 VIGKG--HFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred ccccc--CCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 46777 777788776432 3467999998542 3445568889999999999999999999765 455688999999
Q ss_pred CCCChhhhhccC---CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce---ee
Q 046728 95 PNHSLITHLHGR---LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH---MT 164 (325)
Q Consensus 95 ~~gsL~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~---~~ 164 (325)
.+|+|.++++.. ......+.+..++..++.++|.. |||||+|||++.++.++|+|||++......... ..
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 999999999542 22233455667888888888875 799999999999999999999998765432211 11
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhC-CCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISA-KKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
....++..|+|||.+.+..++.++|||||||++|+|++| .+||..... ......+. .+ .....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~----~~---------~~~~~ 223 (262)
T cd05058 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYLL----QG---------RRLLQ 223 (262)
T ss_pred ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHh----cC---------CCCCC
Confidence 123356789999999888899999999999999999995 556643221 11111110 00 01112
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
+...++.+.+++.+||..+|++||++.++++.|+....
T Consensus 224 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 224 PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 23345689999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=276.75 Aligned_cols=256 Identities=19% Similarity=0.175 Sum_probs=190.2
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
...|.+.+.||.| +++.||++.+...++.||||.... ..+.+|++++++++||||+++++++..+...++||
T Consensus 168 ~~gy~i~~~Lg~G--~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPG--SEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccC--CCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 3457888899998 888899999999999999996432 24567999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce-e
Q 046728 92 DYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH-M 163 (325)
Q Consensus 92 e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~-~ 163 (325)
|++. ++|.+++.. .++...++.+..++..++.++|.. |||||+|||++.++.++|+|||+++........ .
T Consensus 240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 9994 699988843 355566778888899999999875 799999999999999999999999865432221 1
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCc--------cchhhhhhcccccccccccc-
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGV--------KRDIVQWVTPYVQKGAFEHI- 234 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~--------~~~~~~~~~~~~~~~~~~~~- 234 (325)
.....||..|+|||++.+..++.++|||||||++|||++|..|+....... ....+....... ..+...
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~--~~~~~~~ 396 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV--DEFPQHA 396 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc--ccCCCCc
Confidence 223468999999999998889999999999999999999877654332110 011111110000 000000
Q ss_pred ---------------cCccccCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 235 ---------------ADPRLKGKFN---RDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 235 ---------------~~~~~~~~~~---~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
..+......+ ...+..+.+||.+||..||.+|||+.++++ ||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0000000111 134557899999999999999999999998 7753
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=262.65 Aligned_cols=250 Identities=21% Similarity=0.322 Sum_probs=190.4
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCC----eEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDD----QIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~----~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
..++.++.||.| +++.||.+....++. .||+|.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~~~~~~~lg~G--~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 7 TELKRVKVLGSG--AFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhceeccccccC--CCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 445677889999 777888887766654 5789988643 233344788999999999999999999998654 46
Q ss_pred EEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 88 LIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
++|++|+++|+|.+++.. .++...++.+..++..++.++|.. +||||+||+++.++.+||+|||++.......
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcc
Confidence 799999999999999853 244556677888999999999976 6999999999999999999999998654332
Q ss_pred ce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 161 TH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 161 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
.. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.... ..+.. . .
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~---~~~~~----~---------~ 227 (303)
T cd05110 164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI---PDLLE----K---------G 227 (303)
T ss_pred cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH----C---------C
Confidence 21 1222335678999999988889999999999999999997 8999865432111 11111 0 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
...+.+...+..+.+++.+||..+|++||++.++++.|+.+..
T Consensus 228 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 228 ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0111123345678999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=260.91 Aligned_cols=258 Identities=16% Similarity=0.243 Sum_probs=191.3
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
.|.+++.||.| +++.||++....+++.||+|.+... .......+.+|+.++++++|||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g--~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 2 KYEKLSKIGEG--SYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred ceeeeeeeccc--CCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 46778889888 7788999998888999999988642 2233456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 92 DYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 92 e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
||+++++|..++.. .++...++.+..++..++.++|.+ +||||+||+++.++.++|+|||++......... ..
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~ 158 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-YT 158 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccc-cc
Confidence 99999888877742 356666788888999999999875 799999999999999999999999876543221 22
Q ss_pred cCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhh-hhccccc-------cccc-cccc
Q 046728 166 RVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQ-WVTPYVQ-------KGAF-EHIA 235 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~-~~~~~~~-------~~~~-~~~~ 235 (325)
...++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+........... ....... ...+ ....
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence 3347788999999875 457889999999999999999999997644321111110 0000000 0000 0000
Q ss_pred CccccCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 236 DPRLKGK-----FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 236 ~~~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.+..... .....+..+.+|+.+||..||++|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000 01234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=259.68 Aligned_cols=246 Identities=21% Similarity=0.323 Sum_probs=186.2
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc-CCCCccceeeEEE-----cC
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYA-----GG 84 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~-----~~ 84 (325)
....|.+++.||.| +++.||.+....+++.+|+|.+.... .....+.+|+.+++.+ +||||+++++++. ++
T Consensus 16 ~~~~~~~~~~lg~g--~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 16 PSDTWEIIETIGKG--TYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred cccceeeeeeeccC--CCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 45578899999999 77789999998899999999886432 2345678899999999 6999999999873 34
Q ss_pred CeEEEEEEecCCCChhhhhccC------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccc
Q 046728 85 DERLIVYDYMPNHSLITHLHGR------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~~~------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
...++||||+++++|.++++.. +.+..+..+..++..++.++|.. |||||+||+++.++.++|+|||++.
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCcee
Confidence 5689999999999999887422 33334455778888899999874 7999999999999999999999988
Q ss_pred ccCCCcceeeccCCCCcCCCCcccccc-----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccc
Q 046728 155 LIPDGVTHMTTRVKGTLGYLAPEYAMW-----GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKG 229 (325)
Q Consensus 155 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 229 (325)
........ .....++..|+|||++.. ..++.++||||+||++|+|++|..||........ ... .. ..
T Consensus 173 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~~~-~~----~~ 244 (286)
T cd06638 173 QLTSTRLR-RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--LFK-IP----RN 244 (286)
T ss_pred ecccCCCc-cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--Hhh-cc----cc
Confidence 65432221 223458899999998753 3478899999999999999999999965432110 000 00 00
Q ss_pred ccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 230 AFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
. .. ....+...+..+.+||.+||..||++|||+.++++
T Consensus 245 ~-----~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 245 P-----PP--TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred C-----CC--cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 00 00112234567999999999999999999999987
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=262.69 Aligned_cols=247 Identities=19% Similarity=0.217 Sum_probs=187.2
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|.+++.||.| +++.||++.+..+++.||+|.+.... ......+.+|+++++.++||||+++++.+..+...++|
T Consensus 2 ~y~~~~~l~~g--~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 2 DFETIKLISNG--AYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CceEeeEeecC--CCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence 35678889999 77789999999999999999987532 23345778899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc---
Q 046728 91 YDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT--- 161 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--- 161 (325)
|||+++++|.++++. .+++.....+..++..++.++|.. +||||.||+++.++.++|+|||+++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 999999999999943 344555666778888889998875 79999999999999999999998864211100
Q ss_pred -----------eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccc
Q 046728 162 -----------HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGA 230 (325)
Q Consensus 162 -----------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (325)
.......++..|+|||.+....++.++|+|||||++|+|++|..||.+...... .... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~---~~~~----~~~~ 232 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL---FGQV----ISDD 232 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH----Hhcc
Confidence 011123467889999999888899999999999999999999999975432111 1100 0000
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 046728 231 FEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWL 276 (325)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l 276 (325)
.. . +......+..+.++|.+||..||++||++..+.+.|
T Consensus 233 ~~---~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 233 IE---W----PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred cC---C----CCccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 00 0 011124567899999999999999999854444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=289.33 Aligned_cols=250 Identities=24% Similarity=0.299 Sum_probs=205.7
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
...|.++++||.| +||.|.+++++.+++.+|+|++++. ......-|..|-.+|-.-+.+=|+.++-.|++...+|
T Consensus 74 ~~DfeilKvIGrG--aFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 74 AEDFEILKVIGRG--AFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred HHhhHHHHHhccc--ccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 4679999999999 7788999999999999999999863 2344457888999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 89 IVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
+||+|++||||...+. +.++++.+.-+...+.+|++.+|.+ |||||+|||+|..|++||+|||.|-.+.....-
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 9999999999999994 4567777778888899999999986 799999999999999999999999999877776
Q ss_pred eeccCCCCcCCCCcccccc-----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 163 MTTRVKGTLGYLAPEYAMW-----GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
.....+|||-|.|||++.. +.|+..+|.||+||++|||++|..||+...-. +.+.++.+-
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv---------------eTY~KIm~h 296 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV---------------ETYGKIMNH 296 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH---------------HHHHHHhch
Confidence 6777889999999999863 56889999999999999999999999764321 011111111
Q ss_pred --cccCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHH--HHhcc
Q 046728 238 --RLKGKFNRDQLKSMVLIALRCTDSNPENRPT---MTDVVD--WLKGG 279 (325)
Q Consensus 238 --~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~~il~--~l~~~ 279 (325)
.+.-+.....|+...+||++.+. +|+.|.. ++++-+ ||.++
T Consensus 297 k~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 297 KESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred hhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 11112224578899999988665 8899998 999988 66654
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=256.72 Aligned_cols=243 Identities=19% Similarity=0.251 Sum_probs=187.6
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC------hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN------AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
|++.+.||.| +++.||.+.. .+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+....+
T Consensus 2 ~~~~~~ig~g--~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 2 WTKGEVLGKG--AYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred ccccceEecc--CCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEE
Confidence 4567788888 7777888865 467899999886421 223356888999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc--
Q 046728 89 IVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV-- 160 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-- 160 (325)
+||||+++++|.+++.. .+++..+..+..++..++.++|.. +||+|+||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 99999999999999943 355666677888899999998875 7999999999999999999999987653211
Q ss_pred ---ceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 161 ---THMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 161 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
........++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ....... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~~~~------------~~ 224 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AMFYIGA------------HR 224 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HHHHhhh------------cc
Confidence 111123457889999999998888999999999999999999999996532111 0000000 00
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
......+...+..+.++|.+||..+|++||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0111223446678999999999999999999999986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=267.94 Aligned_cols=251 Identities=18% Similarity=0.297 Sum_probs=192.4
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEec--ccChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCC
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLK--TLNAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGD 85 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 85 (325)
---++-|+++++||.| |.+.||++.... .+.+|+|.+. ..+......|.+|+.+|.+|. |.+|+++++|-..++
T Consensus 357 ~Vkg~~Yeilk~iG~G--GSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSG--GSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred EECcchhhHHHhhcCC--CcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 3345779999999999 888899998655 4566777664 346677789999999999994 999999999999999
Q ss_pred eEEEEEEecCCCChhhhhccCC---CCCCccCHHHHHHHHHHHHhhcC----CCCCCceeeCCCCceEEeeeccccccCC
Q 046728 86 ERLIVYDYMPNHSLITHLHGRL---APDCLLDWHRRVSIAIGSAEGIA----DIKASNVLLDTDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~r----dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 158 (325)
.+|+||||= .-+|..+|+..- ..-.+..+..++..|+.+.|.+| ||||.|+|+-. |.+||+|||+|.....
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 999999976 459999995432 22245667788999999999875 99999999965 5999999999998876
Q ss_pred Ccce-eeccCCCCcCCCCccccccCC-----------CCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccc
Q 046728 159 GVTH-MTTRVKGTLGYLAPEYAMWGK-----------VSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYV 226 (325)
Q Consensus 159 ~~~~-~~~~~~~t~~y~aPE~~~~~~-----------~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 226 (325)
.... ....++||+.||+||.+.... .+.++||||||||||+|++|..||..... .+..
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~~aK----- 581 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----QIAK----- 581 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----HHHH-----
Confidence 5544 345578999999999886432 46799999999999999999999965332 1111
Q ss_pred cccccccccCccccCCCCHHH-HHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 227 QKGAFEHIADPRLKGKFNRDQ-LKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
+..+.++.-..+++.-- ..++.++++.||..||.+|||+.++|+ +|+-
T Consensus 582 ----l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 582 ----LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ----HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 12222332222222111 123999999999999999999999998 5554
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=258.52 Aligned_cols=242 Identities=20% Similarity=0.275 Sum_probs=194.9
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
|.+.+.||.| +++.||.++...++..||+|.+.... ......+.+|++++++++||||+++++.+..+...++|+
T Consensus 2 y~~~~~i~~g--~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 2 FELLRVIGKG--AFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred ceEEEEeccC--CCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence 5677889988 78889999998889999999996432 244568899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 92 DYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 92 e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
||+.+++|.+++.. .+.+..+..+..++..++.++|.+ +||+|+||+++.++.++|+|||.+........ ..
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~ 157 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TT 157 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc--cc
Confidence 99999999999953 356667778888999999999975 79999999999999999999999887654322 22
Q ss_pred cCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCH
Q 046728 166 RVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNR 245 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (325)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||............... .. .....+.
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------~~--~~~~~~~ 223 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ------------ET--ADVLYPA 223 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh------------cc--ccccCcc
Confidence 345788999999998888899999999999999999999999765432111111100 00 1122334
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCH--HHHHH
Q 046728 246 DQLKSMVLIALRCTDSNPENRPTM--TDVVD 274 (325)
Q Consensus 246 ~~~~~~~~li~~cl~~dp~~Rps~--~~il~ 274 (325)
..+..+.++|.+||..||.+||++ +++++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 456889999999999999999999 76654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=255.41 Aligned_cols=241 Identities=19% Similarity=0.336 Sum_probs=191.7
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecc--cChhhHHHHHHHHHHHHccCCCCccceeeEEEc--CCeEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKT--LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG--GDERLIV 90 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lV 90 (325)
|.+++.||.| +++.||++.+..+++.||+|.+.. .......++..|++++++++||||+++++++.. +...+++
T Consensus 2 y~~~~~lg~g--~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 2 YEVLETIGKG--SFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred ceeeeeeccC--CCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 5677888888 888899999999999999999863 234555678899999999999999999998754 4568999
Q ss_pred EEecCCCChhhhhcc------CCCCCCccCHHHHHHHHHHHHh-----hc----CCCCCCceeeCCCCceEEeeeccccc
Q 046728 91 YDYMPNHSLITHLHG------RLAPDCLLDWHRRVSIAIGSAE-----GI----ADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~------~~~~~~~~~~~~~~~~~~~~~~-----~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
|||+++++|.+++.. .++...++.+..++..++.++| .. +||+|+||+++.++.++|+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999843 3455566778889999999999 43 79999999999999999999999987
Q ss_pred cCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccccc
Q 046728 156 IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIA 235 (325)
Q Consensus 156 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (325)
....... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ........ .+
T Consensus 160 ~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~----~~------ 225 (265)
T cd08217 160 LGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLASKIK----EG------ 225 (265)
T ss_pred ccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHHHHh----cC------
Confidence 6554321 2234578899999999888889999999999999999999999975331 11111111 11
Q ss_pred CccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 236 DPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.....+...+..+.+++.+||..+|++|||+++|++
T Consensus 226 ---~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 226 ---KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ---CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 111233456678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=260.04 Aligned_cols=250 Identities=18% Similarity=0.269 Sum_probs=189.9
Q ss_pred cchhHHhhccCccceeeeeEEEeccC----CCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEc-CCe
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRET----GDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG-GDE 86 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~ 86 (325)
..|.+.+.||+| +++.||.+.... ++..|++|.+... .......+.+|+.++++++|||++++++++.. +..
T Consensus 6 ~~~~~~~~i~~g--~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 6 DRVTLSDLLQEG--TFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hheEEeeeeccc--CCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 345677889999 777788887665 3578999988643 34555678899999999999999999998765 567
Q ss_pred EEEEEEecCCCChhhhhccC----------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecc
Q 046728 87 RLIVYDYMPNHSLITHLHGR----------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGF 152 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~~----------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~ 152 (325)
.+++++|+++++|.+++... ++......+..++..++.++|.. +||||+||+++.++.++|+|||+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence 89999999999999998432 33344556667777888888865 79999999999999999999999
Q ss_pred ccccCCCccee-eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccc
Q 046728 153 AKLIPDGVTHM-TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGA 230 (325)
Q Consensus 153 ~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (325)
++.+....... .....++..|+|||++.+..++.++||||||+++|++++ |..||..... .....+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~------ 234 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLKD------ 234 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHHc------
Confidence 98654432221 122345678999999988889999999999999999999 9999965322 111111110
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 231 FEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
......+..+++.+.+++.+||..||++|||+.++++.|+.+.
T Consensus 235 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 235 -------GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred -------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0111122335678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=255.58 Aligned_cols=243 Identities=19% Similarity=0.231 Sum_probs=187.9
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-----ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC--Ce
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-----NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG--DE 86 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 86 (325)
.|++.+.||.| +++.||.+....++..||+|.+... .......+.+|++++++++||||+++++++.+. ..
T Consensus 3 ~~~~~~~l~~g--~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 3 NWRLGKLLGQG--AFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred cceEeeEEecC--CceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 46677889998 7778999998888999999987532 123345788899999999999999999998764 46
Q ss_pred EEEEEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 87 RLIVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
+++||||+++++|.+++.. .++....+.+..++..++.++|.. +||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 7899999999999999843 345556677888888999999875 6999999999999999999999987553211
Q ss_pred ce--eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 161 TH--MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 161 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
.. ......++..|+|||++.+..++.++|+||||+++|+|++|..||........ . .. .....
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~-~~------------~~~~~ 225 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--I-FK------------IATQP 225 (265)
T ss_pred ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--H-HH------------HhcCC
Confidence 11 11223578899999999888889999999999999999999999965322110 0 00 00011
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.....+...+..+.+++.+||. +|++||+++++++
T Consensus 226 ~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1223345667789999999995 9999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=257.91 Aligned_cols=244 Identities=22% Similarity=0.313 Sum_probs=188.0
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCC------
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGD------ 85 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~------ 85 (325)
..|.+.+.||.| +++.+|+++...+++.+++|.+..... ....+.+|+.+++++ +||||+++++++....
T Consensus 6 ~~y~~~~~l~~g--~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 6 GIFELVEVIGEG--TYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred hheeheeeecCC--CCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 467889999999 777899999988899999999875433 345788999999999 7999999999986644
Q ss_pred eEEEEEEecCCCChhhhhcc------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccc
Q 046728 86 ERLIVYDYMPNHSLITHLHG------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
.+++||||+++++|.++++. .++...+..+..++..++.++|.. +||+|+||+++.++.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 48999999999999988842 345556677888899999998875 79999999999999999999999876
Q ss_pred cCCCcceeeccCCCCcCCCCccccccC-----CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccc
Q 046728 156 IPDGVTHMTTRVKGTLGYLAPEYAMWG-----KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGA 230 (325)
Q Consensus 156 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (325)
....... .....++..|+|||.+... .++.++||||||+++|+|++|..||....... .... .. ..
T Consensus 163 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~-~~----~~- 233 (275)
T cd06608 163 LDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--ALFK-IP----RN- 233 (275)
T ss_pred cccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HHHH-hh----cc-
Confidence 5432221 2234588899999987542 46778999999999999999999996432211 1100 00 00
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 231 FEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.......+...+..+.+||.+||..||++|||++++++
T Consensus 234 ------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 234 ------PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ------CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00011112335678999999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=265.35 Aligned_cols=251 Identities=22% Similarity=0.291 Sum_probs=188.6
Q ss_pred cchhHHhhccCccceeeeeEEEeccCC-------CCeEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEc
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETG-------DDQIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAG 83 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~-------~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 83 (325)
..|.+.+.||.| +++.||.+..... ...||+|.+... .......+.+|+++++++ +||||+++++++..
T Consensus 12 ~~~~i~~~ig~G--~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 12 TRLTLGKPLGEG--CFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred hHeeecceeccc--cCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 357889999999 7777888865432 236899988643 334456888999999999 79999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhccCC------------------CCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC
Q 046728 84 GDERLIVYDYMPNHSLITHLHGRL------------------APDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT 141 (325)
Q Consensus 84 ~~~~~lV~e~~~~gsL~~~l~~~~------------------~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~ 141 (325)
....++||||+++|+|.+++.... .....+.+..++..++.++|.. |||||+||+++.
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~ 169 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE 169 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence 999999999999999999995321 1112233566788888888865 799999999999
Q ss_pred CCceEEeeeccccccCCCccee-eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhh
Q 046728 142 DFEAKVADFGFAKLIPDGVTHM-TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIV 219 (325)
Q Consensus 142 ~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~ 219 (325)
++.++|+|||+++......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||...+.....
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--- 246 (334)
T cd05100 170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF--- 246 (334)
T ss_pred CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH---
Confidence 9999999999987654322111 111224567999999988889999999999999999998 88888654321111
Q ss_pred hhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 220 QWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
..+. . ......+...+..+.+|+.+||..+|++|||+.++++.|+.+..
T Consensus 247 ~~~~----~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 247 KLLK----E---------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHH----c---------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 1100 0 01112223455689999999999999999999999998887763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=257.52 Aligned_cols=240 Identities=23% Similarity=0.323 Sum_probs=181.0
Q ss_pred hccCccceeeeeEEEeccCC------CCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 20 NINNGLEILMLLLLLRRETG------DDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
.||.| +++.||.++.... ++.||||.+.... ......+.+|+++++.++||||+++++++......++|||
T Consensus 2 ~lg~g--~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSG--AFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccc--cceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 46677 7777888776433 3689999886432 3445688899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccC---------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC-----ceEEeeecccc
Q 046728 93 YMPNHSLITHLHGR---------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF-----EAKVADFGFAK 154 (325)
Q Consensus 93 ~~~~gsL~~~l~~~---------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~-----~~kL~Dfg~~~ 154 (325)
|+++++|.++++.. +....++.+..++..++.++|.. +||||+||+++.++ .++|+|||++.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 99999999999532 12233445666777777777765 79999999999877 89999999987
Q ss_pred ccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccc
Q 046728 155 LIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFE 232 (325)
Q Consensus 155 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (325)
........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...... .....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~~--------- 227 (269)
T cd05044 160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHVT--------- 227 (269)
T ss_pred ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHHh---------
Confidence 65433221 1122235678999999998889999999999999999998 99998643321 1111110
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 233 HIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
.......+...+..+.+++.+||..+|++|||++++++.|+
T Consensus 228 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 228 ----AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ----cCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00111223456778999999999999999999999999876
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=259.60 Aligned_cols=244 Identities=22% Similarity=0.300 Sum_probs=190.0
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
.+.|.+.+.||.| +++.||.+....+++.||+|.+... .......+.+|+.+++.++||||+++++++.+....+
T Consensus 14 ~~~y~~~~~lg~g--~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 14 EKLFTDLREIGHG--SFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred chhhhhheeecCC--CCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 4567888999999 7778999998888999999988632 2334457889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 89 IVYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
+||||+. |+|.+++. ..++...+..+..++..++.++|.. +||+|+||+++.++.++|+|||++......
T Consensus 92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9999996 57777763 3355666677888899999999975 799999999999999999999998765432
Q ss_pred eeeccCCCCcCCCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 162 HMTTRVKGTLGYLAPEYAM---WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
....++..|+|||++. ...++.++||||||+++|+|++|..||........ .... ....
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~---~~~~------------~~~~ 230 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHI------------AQND 230 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH---HHHH------------hcCC
Confidence 2345788899999874 34678899999999999999999999864321110 0000 0000
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
.........+..+.++|.+||..||++|||+.+++. |+..
T Consensus 231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 231 SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 011112335678999999999999999999999997 6553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=260.07 Aligned_cols=259 Identities=20% Similarity=0.329 Sum_probs=192.0
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
.|.+.+.||.| +++.+|++....+++.||+|.+... .......+.+|++++++++|+||+++++++..++..++||
T Consensus 2 ~y~~~~~i~~g--~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 2 KYEVLGVVGEG--AYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred ceeEEEEeccc--CCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 46778889888 7778999999888999999988642 3344568889999999999999999999999999999999
Q ss_pred EecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 92 DYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 92 e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
||+.++.+..+.. ..+....+..+..++..++.++|.. +||+|+||+++.++.++|+|||++............
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 9998876666553 2355566777888899999998875 799999999999999999999998876554332233
Q ss_pred cCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhh-hcc--------ccccccc----
Q 046728 166 RVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQW-VTP--------YVQKGAF---- 231 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~-~~~--------~~~~~~~---- 231 (325)
...++..|+|||++.+. .++.++|+||||+++|+|++|..||.............. ... ......+
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence 34578889999999877 788999999999999999999999975432111000000 000 0000000
Q ss_pred -ccccCc-cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 232 -EHIADP-RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 232 -~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
...... ......+..++.++.+||.+||..+|++|||+++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000 0000112234778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=254.01 Aligned_cols=241 Identities=24% Similarity=0.292 Sum_probs=190.6
Q ss_pred ccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCCC
Q 046728 21 INNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNH 97 (325)
Q Consensus 21 i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~g 97 (325)
||.| +++.||+++...+++.||+|.+.... ......+.+|+.+++.++||||+++++.+.++...++||||++++
T Consensus 1 lg~g--~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVG--GFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCC--CceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence 4555 78889999998889999999986432 244567889999999999999999999999999999999999999
Q ss_pred Chhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCCCc
Q 046728 98 SLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTL 171 (325)
Q Consensus 98 sL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~ 171 (325)
+|.+++.. .++...+..+..++..++.++|.. +||+|+||+++.++.++|+|||++....... ......++.
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~ 156 (262)
T cd05572 79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTP 156 (262)
T ss_pred cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCc
Confidence 99999953 345566667778888888888875 7999999999999999999999998765432 122345788
Q ss_pred CCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHH
Q 046728 172 GYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSM 251 (325)
Q Consensus 172 ~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (325)
.|+|||.+.+..++.++|+||+|+++|+|++|..||....... ......+ .........+...++.+
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~------------~~~~~~~~~~~~~~~~~ 223 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIYNDI------------LKGNGKLEFPNYIDKAA 223 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHHHHH------------hccCCCCCCCcccCHHH
Confidence 9999999988888999999999999999999999997544211 1111110 00011112233346789
Q ss_pred HHHHHHccCCCCCCCCC-----HHHHHH--HHhc
Q 046728 252 VLIALRCTDSNPENRPT-----MTDVVD--WLKG 278 (325)
Q Consensus 252 ~~li~~cl~~dp~~Rps-----~~~il~--~l~~ 278 (325)
.++|.+||..||++||+ +.++++ ||++
T Consensus 224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 224 KDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred HHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 99999999999999999 899998 8865
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=254.15 Aligned_cols=240 Identities=21% Similarity=0.362 Sum_probs=189.7
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
|.+++.||.| +++.+|++....+++.+|+|.+... .......+.+|++++++++|||++++++.+......++|||
T Consensus 2 y~~~~~lg~g--~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 2 YEKIRVVGRG--AFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred ceEEEEeccc--CceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 5677889988 7778999998889999999998643 33445688899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC-CceEEeeeccccccCCCccee
Q 046728 93 YMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD-FEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 93 ~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
|+++++|.+++... +++..+..+..++..++.++|.. +||+|+||+++.+ +.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-- 157 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--
Confidence 99999999999542 44555677778888888898875 7999999999855 4689999999987654322
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||........ ..... . ....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~----~---------~~~~~~ 221 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLKIM----S---------GTFAPI 221 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HHHHH----h---------cCCCCC
Confidence 2234578899999999888889999999999999999999999965332111 10000 0 001112
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
+...+..+.+++.+||..||++|||+.++++
T Consensus 222 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 2345678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=256.95 Aligned_cols=246 Identities=20% Similarity=0.304 Sum_probs=193.3
Q ss_pred HhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCCC
Q 046728 18 IQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNH 97 (325)
Q Consensus 18 ~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~g 97 (325)
..+||.| +++.||.+....++..||+|.+..........+.+|+.+++.++|||++++++.+...+..++||||++++
T Consensus 25 ~~~lg~g--~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEG--STGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCC--CCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 4566666 88889999888899999999987555555668899999999999999999999999999999999999999
Q ss_pred Chhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCCCcC
Q 046728 98 SLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLG 172 (325)
Q Consensus 98 sL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~ 172 (325)
+|.+++. ..++......+..++..++.++|.. +||+|.||+++.++.++|+|||++......... .....++..
T Consensus 103 ~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~ 181 (292)
T cd06657 103 ALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKSLVGTPY 181 (292)
T ss_pred cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccc-ccccccCcc
Confidence 9999884 3456666777888888889998874 799999999999999999999988755433221 122357889
Q ss_pred CCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHH
Q 046728 173 YLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMV 252 (325)
Q Consensus 173 y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (325)
|+|||.+.+..++.++|+||+|+++|+|++|..||........ ....... . ... .......+..+.
T Consensus 182 y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~~~~~-----~----~~~--~~~~~~~~~~l~ 247 (292)
T cd06657 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRDN-----L----PPK--LKNLHKVSPSLK 247 (292)
T ss_pred ccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhh-----C----Ccc--cCCcccCCHHHH
Confidence 9999999888889999999999999999999999965332111 1100000 0 000 011123456789
Q ss_pred HHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 253 LIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 253 ~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
+++.+||..||.+||++.++++ ||....
T Consensus 248 ~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 248 GFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 9999999999999999999998 887655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=254.32 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=193.4
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
.|++.+.||.| +++.||.+....++..+|+|.+.... ......+.+|+.+++.++|+|++++++.+..+...++|||
T Consensus 2 ~y~~~~~lg~g--~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 2 DYELIEVIGVG--ATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred cceeeeeecCC--CCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 46778889988 77788988888889999999986432 3355688899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccC-----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce-
Q 046728 93 YMPNHSLITHLHGR-----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH- 162 (325)
Q Consensus 93 ~~~~gsL~~~l~~~-----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~- 162 (325)
++++++|.++++.. +.+..+..+..++..++.++|.. +||+|+||++++++.++|+|||++.........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999999999532 44555677888899999998875 799999999999999999999999866543222
Q ss_pred --eeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 163 --MTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 163 --~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
......++..|+|||.+... .++.++|+||||+++|+|++|..||...+.... ....... ..+..
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~----------~~~~~ 227 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQN----------DPPSL 227 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhcC----------CCCCc
Confidence 12233578899999998866 788999999999999999999999975433111 1111000 00011
Q ss_pred cC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 240 KG-KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 240 ~~-~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.. .....++..+.+++.+||..||++|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11 112356778999999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=267.01 Aligned_cols=268 Identities=17% Similarity=0.242 Sum_probs=195.2
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcC----
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG---- 84 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 84 (325)
|.+...|.+.+.||.| +++.||.+....++..||+|.+..........+.+|++++++++||||+++++++...
T Consensus 1 ~~~~~~y~~~~~Lg~g--~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 1 FDLGSRYMDLRPLGCG--SNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred CCcCcceEEEEEecCC--CCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 4567888999999998 7788999999999999999999765556667788999999999999999999876543
Q ss_pred ----------CeEEEEEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeC-CCCceEEe
Q 046728 85 ----------DERLIVYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLD-TDFEAKVA 148 (325)
Q Consensus 85 ----------~~~~lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~-~~~~~kL~ 148 (325)
...++||||+. ++|.+++. ..+.+..+..++.++..++.++|.. |||||+||+++ .++.++|+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999996 59988884 4467777888899999999999976 79999999997 45678999
Q ss_pred eeccccccCCCccee--eccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccc
Q 046728 149 DFGFAKLIPDGVTHM--TTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPY 225 (325)
Q Consensus 149 Dfg~~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 225 (325)
|||++.......... .....++..|+|||.+.. ..++.++|||||||++|+|++|..||................+.
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999997654321111 112346888999998754 45788999999999999999999999654321110000000000
Q ss_pred ccc----c---ccc-cccCccccC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 226 VQK----G---AFE-HIADPRLKG-----KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 226 ~~~----~---~~~-~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
... . ... ......... ...+..+.++.+||.+||..||++|||++++++ ||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 000 0 000 000000000 011235678999999999999999999999997 88753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=261.13 Aligned_cols=258 Identities=17% Similarity=0.237 Sum_probs=189.0
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
.|.+++.||.| +++.||.+....+++.||+|.+.... ......+.+|+++++.++||||+++++++.++...++||
T Consensus 2 ~y~~~~~lg~g--~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 2 KYENLGLVGEG--SYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred ceeEeeeeccC--CCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 46678899999 77789999988889999999885422 223457888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 92 DYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 92 e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
||+.+++|..+... .+.....+.+..++..++.++|.. +||+|+||+++.++.++|+|||++......... ..
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-~~ 158 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-YT 158 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc-cC
Confidence 99999888887742 355566677778888888888875 699999999999999999999998865443221 22
Q ss_pred cCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccc-hhhhhhccccc-------------ccc
Q 046728 166 RVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKR-DIVQWVTPYVQ-------------KGA 230 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~-------------~~~ 230 (325)
...++..|+|||++.+. .++.++||||||+++|+|++|.+||......... ........... ...
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence 34578899999988753 4678999999999999999999998643321100 00000000000 000
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 231 FEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
..............+..+..+.+|+.+||..+|++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000000112345678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=256.49 Aligned_cols=250 Identities=21% Similarity=0.306 Sum_probs=193.5
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCC----eEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDD----QIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~----~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
..|.+.+.||.| +++.||++....++. .||+|.+.... ......+.+|+.++++++|||++++++++.. ...
T Consensus 7 ~~~~~~~~ig~g--~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 7 TELEKIKVLGSG--AFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHcEEcceecCC--CCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 456778899999 677788877655443 68999886543 3445688899999999999999999999887 788
Q ss_pred EEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 88 LIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
++||||+++|+|.+++.. .++...+..+..++..++.++|.. +||||+||+++.++.++|+|||++.......
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 999999999999999953 355666778888888999999875 7999999999999999999999998765432
Q ss_pred ceee-ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 161 THMT-TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 161 ~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
.... ....++..|+|||.+....++.++|+||||+++|++++ |..||........ ...+.. .
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~~-------------~ 227 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI---PDLLEK-------------G 227 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH---HHHHhC-------------C
Confidence 2211 11223567999999988889999999999999999998 9999976433211 111110 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.....+...+..+.+++.+||..||++|||+.++++.|++...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 228 ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0112223345678999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=257.22 Aligned_cols=232 Identities=22% Similarity=0.326 Sum_probs=177.1
Q ss_pred hccCccceeeeeEEEeccCCCC-------eEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 20 NINNGLEILMLLLLLRRETGDD-------QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~-------~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
.||.| +++.||++.+...+. .||+|.+..........+.+|..+++.++||||+++++++..+...++|||
T Consensus 2 ~lg~G--~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 2 SLGQG--TFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCcc--cchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 56777 888899888765433 488998876555556688899999999999999999999999899999999
Q ss_pred ecCCCChhhhhccC---CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCc--------eEEeeeccccccC
Q 046728 93 YMPNHSLITHLHGR---LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFE--------AKVADFGFAKLIP 157 (325)
Q Consensus 93 ~~~~gsL~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~--------~kL~Dfg~~~~~~ 157 (325)
|+++|+|.++++.. ++....+.+..++..++.++|.. |||||+||+++.++. ++++|||.+....
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 99999999999532 34445566778888888888875 799999999987654 6999999886543
Q ss_pred CCcceeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCC-CCCCCCCCCccchhhhhhccccccccccccc
Q 046728 158 DGVTHMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAK-KPLEKLPGGVKRDIVQWVTPYVQKGAFEHIA 235 (325)
Q Consensus 158 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (325)
.. ....++..|+|||++.+. .++.++||||||+++|+|++|. .||........ .....
T Consensus 160 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~~~~~------------ 219 (258)
T cd05078 160 PK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---LQFYE------------ 219 (258)
T ss_pred Cc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---HHHHH------------
Confidence 31 224578889999999864 5788999999999999999984 55543221110 00000
Q ss_pred CccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 046728 236 DPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWL 276 (325)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l 276 (325)
. ....+...+.++.+|+.+||+.||++|||++++++.|
T Consensus 220 -~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 220 -D--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -c--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 0112223346789999999999999999999999866
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=253.84 Aligned_cols=232 Identities=17% Similarity=0.267 Sum_probs=176.6
Q ss_pred hccCccceeeeeEEEeccCC------------CCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 20 NINNGLEILMLLLLLRRETG------------DDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~------------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
.||+| +++.||.+..... ...|++|.+..........+.+|+.+++.++||||+++++++......
T Consensus 2 ~lg~G--~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 2 HLGRG--TRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred ccccC--CcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 57777 7777887764322 235899988765555556788899999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCc-------eEEeeeccc
Q 046728 88 LIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFE-------AKVADFGFA 153 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~-------~kL~Dfg~~ 153 (325)
++||||+.+|+|..+++. .++....+.+..++..+++++|.. |||||+|||++.++. ++++|||++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 999999999999998853 245556677888899999999875 799999999986654 899999998
Q ss_pred cccCCCcceeeccCCCCcCCCCccccc-cCCCCCcccchhHHHHHHHHH-hCCCCCCCCCCCccchhhhhhccccccccc
Q 046728 154 KLIPDGVTHMTTRVKGTLGYLAPEYAM-WGKVSDSCDVYSFGVLLLELI-SAKKPLEKLPGGVKRDIVQWVTPYVQKGAF 231 (325)
Q Consensus 154 ~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (325)
...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||........... . ....
T Consensus 160 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~---~-----~~~~ 226 (262)
T cd05077 160 ITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF---Y-----EGQC 226 (262)
T ss_pred ccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH---H-----hcCc
Confidence 754321 2235788899999886 456889999999999999997 58888764322111000 0 0000
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 046728 232 EHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWL 276 (325)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l 276 (325)
......+.++.+||.+||..||++||++.+|++-|
T Consensus 227 ----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 227 ----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 01112346789999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=266.35 Aligned_cols=270 Identities=19% Similarity=0.244 Sum_probs=197.1
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEc---
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG--- 83 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 83 (325)
|.+...|.+.+.||.| +++.||.+....+++.||+|.+... .......+.+|+.++++++||||+++++++..
T Consensus 1 ~~~~~~y~~~~~lg~g--~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 1 FDVGSRYKPIENIGSG--AYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred CchhhceeeeeeeecC--CCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 4566788889999998 7778999999999999999998643 22344577889999999999999999998753
Q ss_pred -CCeEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccccc
Q 046728 84 -GDERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLI 156 (325)
Q Consensus 84 -~~~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~ 156 (325)
....++||||+. ++|.+++. ..++...+..+..++..++.++|.. |||||+||+++.++.++|+|||++...
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 79 DFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred CCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 356899999995 68999884 3356666778888999999999875 799999999999999999999999765
Q ss_pred CCCcce---eeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccc
Q 046728 157 PDGVTH---MTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFE 232 (325)
Q Consensus 157 ~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (325)
...... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.......................+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 432211 1123457889999998865 457899999999999999999999996543211111100000000000000
Q ss_pred cccC---------ccccCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 233 HIAD---------PRLKGK-----FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 233 ~~~~---------~~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
.... ...... ..+..++.+.++|.+||..||++|||+.+++. ||+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 0000 000000 11335778999999999999999999999998 8876543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=254.99 Aligned_cols=255 Identities=21% Similarity=0.267 Sum_probs=192.9
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEc--CCeEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG--GDERLIVY 91 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lV~ 91 (325)
|..++.||.| +++.||.+....+++.||+|.+... ......++.+|++++++++||||+++++++.. ...+++||
T Consensus 3 ~~~~~~lg~g--~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 3 IVELSRLGEG--AGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred eEEEEEeccC--CceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 5667888888 7778999998888999999998743 33445678999999999999999999998854 34689999
Q ss_pred EecCCCChhhhhcc------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 92 DYMPNHSLITHLHG------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 92 e~~~~gsL~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
||+++++|.+++.. .++...+..+..++..++.++|.. +||+|+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 99999999988742 234444566788888888888875 79999999999999999999999875543221
Q ss_pred eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCC--CccchhhhhhcccccccccccccCccc
Q 046728 162 HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPG--GVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ....+...+.... ....+..
T Consensus 161 ---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~--- 230 (287)
T cd06621 161 ---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPELKD--- 230 (287)
T ss_pred ---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----Cchhhcc---
Confidence 223477889999999888899999999999999999999999975422 1111111111110 0000000
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
........++.+.+++.+||..+|++|||+.+++. |++....
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 01111235678999999999999999999999999 8865543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=253.21 Aligned_cols=241 Identities=22% Similarity=0.309 Sum_probs=189.3
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-----hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-----AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
|...+.||.| +++.||.+....++..|++|.+.... ......+.+|+++++.++||||+++++++.+....++
T Consensus 2 ~~~~~~ig~g--~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 2 WRKGELLGSG--SFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred ccccceeeec--CCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEE
Confidence 4456778888 77889999888889999999886432 3345678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 90 VYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
|+||+++++|.++++. .++......+..++..++.++|.. +||+|+||+++.++.++|+|||++....... .
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~ 157 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--F 157 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--c
Confidence 9999999999999953 245555666778888888888865 7999999999999999999999988654432 1
Q ss_pred eccCCCCcCCCCccccccCC-CCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGK-VSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
.....++..|+|||.+.... ++.++|+||||+++|+|++|..||....... ...... .......
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~-------------~~~~~~~ 222 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AVFKIG-------------RSKELPP 222 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HHHHHH-------------hcccCCC
Confidence 22345788999999987666 8899999999999999999999996543110 000000 0000112
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.+...++.+.+++.+||..+|++|||+++++.
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 23445678999999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=256.44 Aligned_cols=249 Identities=22% Similarity=0.316 Sum_probs=190.0
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCCeEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lV~ 91 (325)
.+.+.+.||.| +++.||.+.+..+++.||+|.+... .......+.+|+.++.++. ||||+++++++......+++|
T Consensus 5 ~~~~~~~lg~G--~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRG--AFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCC--CceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 46778899998 7788999999999999999998643 2344567889999999996 999999999999999999999
Q ss_pred EecCCCChhhhh-------ccCCCCCCccCHHHHHHHHHHHHhh-----cCCCCCCceeeCCCCceEEeeeccccccCCC
Q 046728 92 DYMPNHSLITHL-------HGRLAPDCLLDWHRRVSIAIGSAEG-----IADIKASNVLLDTDFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 92 e~~~~gsL~~~l-------~~~~~~~~~~~~~~~~~~~~~~~~~-----~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 159 (325)
||+. +++.++. ...+++..+..+..++..++.++|. ||||||+||+++.++.++|+|||++......
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 9985 4655443 1235555667788888889988874 3799999999999999999999998765432
Q ss_pred cceeeccCCCCcCCCCccccccC---CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccC
Q 046728 160 VTHMTTRVKGTLGYLAPEYAMWG---KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD 236 (325)
Q Consensus 160 ~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (325)
... ....++..|+|||.+.+. .++.++||||+||++|+|++|..||..... .......... . ..
T Consensus 162 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-~-----~~ 228 (288)
T cd06616 162 IAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK-G-----DP 228 (288)
T ss_pred Ccc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-C-----CC
Confidence 221 223578899999998865 688999999999999999999999965331 1111110000 0 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 237 PRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 237 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
+.+....+...+..+.+|+.+||..||++|||+++++. ||+.
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 11112222456778999999999999999999999998 7765
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=253.70 Aligned_cols=244 Identities=22% Similarity=0.293 Sum_probs=175.5
Q ss_pred hccCccceeeeeEEEecc--CCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCC
Q 046728 20 NINNGLEILMLLLLLRRE--TGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPN 96 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~--~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~ 96 (325)
+||.| +++.||++... .....+|+|.+... .......+.+|+.+++.++||||+++++.+.+....++||||+++
T Consensus 2 ~lg~G--~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNG--WFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCcc--CCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 57777 66677776433 23457899987643 233445788999999999999999999999999999999999999
Q ss_pred CChhhhhccCC-------CCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee-e
Q 046728 97 HSLITHLHGRL-------APDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM-T 164 (325)
Q Consensus 97 gsL~~~l~~~~-------~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~-~ 164 (325)
|+|.+++.... .......+..++..+++++|.. |||||+|||++.++.++|+|||++.......... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 99999995321 1223456777888888888875 7999999999999999999999987543322111 1
Q ss_pred ccCCCCcCCCCcccccc-------CCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccC
Q 046728 165 TRVKGTLGYLAPEYAMW-------GKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD 236 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (325)
....++..|+|||++.. ..++.++|||||||++|+|++ |..||....... .... ..... ...+.
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~---~~~~~-~~~~~- 231 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VLKQ---VVREQ-DIKLP- 231 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHH---Hhhcc-CccCC-
Confidence 22335677999998753 346789999999999999999 788886543211 1000 00000 00111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 237 PRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 237 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
.+......+..+.+++..|| .||++|||+++|++.|.
T Consensus 232 ---~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 ---KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ---CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11223345677888999999 59999999999999774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=254.85 Aligned_cols=241 Identities=20% Similarity=0.271 Sum_probs=186.3
Q ss_pred ccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCCC
Q 046728 21 INNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNH 97 (325)
Q Consensus 21 i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~g 97 (325)
||.| +++.||.+....+++.||+|.+.... ......+..|+.++++++||||+++++++...+..|+||||++++
T Consensus 1 lg~g--~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKG--GFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCC--CceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence 4555 88889999988899999999986422 223446678999999999999999999999999999999999999
Q ss_pred Chhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCC
Q 046728 98 SLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169 (325)
Q Consensus 98 sL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 169 (325)
+|.+++.. .+++..+..+..++..++.++|.. +||+|+||+++.++.++|+|||.+........ .....+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~ 156 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAG 156 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--cccccC
Confidence 99999843 344555666778888888888875 79999999999999999999999876543211 222357
Q ss_pred CcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHH
Q 046728 170 TLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249 (325)
Q Consensus 170 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (325)
+..|+|||.+.+..++.++|+||||+++|+|++|..||.............. ... ......+...++
T Consensus 157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------~~~------~~~~~~~~~~~~ 223 (277)
T cd05577 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR-------RTL------EMAVEYPDKFSP 223 (277)
T ss_pred CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh-------ccc------cccccCCccCCH
Confidence 7889999999888889999999999999999999999965432111111100 000 001122344577
Q ss_pred HHHHHHHHccCCCCCCCC-----CHHHHHH--HHhc
Q 046728 250 SMVLIALRCTDSNPENRP-----TMTDVVD--WLKG 278 (325)
Q Consensus 250 ~~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~ 278 (325)
.+.++|.+||..||++|| ++.++++ ||..
T Consensus 224 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 224 EAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred HHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 899999999999999999 7777887 7754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=259.20 Aligned_cols=261 Identities=17% Similarity=0.213 Sum_probs=192.2
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh-----hhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA-----KAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
|.+.+.||.| +++.||++....+++.||+|.+..... .....+..|++++++++|+||+++++++.+....++
T Consensus 2 y~~~~~lg~g--~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 2 YEKGKKLGEG--TYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred ceeeeeeeec--cccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence 5667888888 788899999888899999999975332 233467789999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 90 VYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
||||+ +|+|.+++.. .++...++.+..++..++.++|.. +||+|+||+++.++.++|+|||++.........
T Consensus 80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence 99999 8999999953 345556777888999999999875 699999999999999999999999876543221
Q ss_pred eeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhh-hhhccccccccc------ccc
Q 046728 163 MTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIV-QWVTPYVQKGAF------EHI 234 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~-~~~~~~~~~~~~------~~~ 234 (325)
.....++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||............ ..... .....+ ...
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 236 (298)
T cd07841 159 -MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGT-PTEENWPGVTSLPDY 236 (298)
T ss_pred -ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCC-Cchhhhhhccccccc
Confidence 122346778999998864 45788999999999999999998777653321110000 00000 000000 000
Q ss_pred cCcccc-----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 235 ADPRLK-----GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 235 ~~~~~~-----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
...... .......+..+.++|.+||..||++|||+.++++ ||++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 000000 0111334678999999999999999999999998 787643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=266.64 Aligned_cols=269 Identities=18% Similarity=0.252 Sum_probs=196.3
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC--
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG-- 84 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 84 (325)
|.+...|.+.+.||.| +++.||.+++..+++.||||.+... ......++.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~y~~~~~lg~G--~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~ 78 (337)
T cd07858 1 FEVDTKYVPIKPIGRG--AYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR 78 (337)
T ss_pred CccccceeEEEEeccC--CCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccc
Confidence 3456678889999999 7788999999999999999998642 233445778899999999999999999987654
Q ss_pred ---CeEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccc
Q 046728 85 ---DERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 85 ---~~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
...++|+||+. ++|.+++. ..+++..+..+..++..++.++|.. +||||+||+++.++.++|+|||++..
T Consensus 79 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 79 EAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred cccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 34799999995 68988884 3456667788888999999999975 79999999999999999999999986
Q ss_pred cCCCcceeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccc
Q 046728 156 IPDGVTHMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHI 234 (325)
Q Consensus 156 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (325)
...... ......++..|+|||.+.. ..++.++|||||||++|+|++|..||..............+...........+
T Consensus 158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 158 TSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred cCCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 644321 1223357889999998764 46889999999999999999999999654221100000000000000000000
Q ss_pred c-----------Ccccc---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 235 A-----------DPRLK---GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 235 ~-----------~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
. ..... .......++++.+||.+||..||++|||++++++ ||.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 0 00000 0011345678999999999999999999999998 8876543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=268.64 Aligned_cols=246 Identities=21% Similarity=0.300 Sum_probs=191.7
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCC-CCeEEEEEecccChh-hHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETG-DDQIAVKRLKTLNAK-AEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
.+...+.++||.|.+|.+....+....+ ...||||.+...... ....|.+|+.+|.+|+|||++++||+..+ ....+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 3456788999999554444333333222 247999999754433 56799999999999999999999999987 67889
Q ss_pred EEEecCCCChhhhhccCCCCC----CccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 90 VYDYMPNHSLITHLHGRLAPD----CLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~~~~~~----~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
|||.++.|+|.+.+++..... ..-.+..|++.+++|+... |||...|+++...-.|||+|||+.+.+.....
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999999999999997632222 2234667788888887764 79999999999999999999999998876543
Q ss_pred e--eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 162 H--MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 162 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
. ......-.+.|+|||.+....|+.++|||+|||++|||+| |..||.+..+.... +.+. .+
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL---------------~~iD-~~ 331 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL---------------KNID-AG 331 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH---------------Hhcc-cc
Confidence 3 2334445778999999999999999999999999999998 79999876542221 1121 22
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
-+.+.+..+++++++++.+||..+|++||||..|.+
T Consensus 332 erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 234556789999999999999999999999999985
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=262.31 Aligned_cols=251 Identities=18% Similarity=0.296 Sum_probs=173.6
Q ss_pred hhccCccceeeeeEEEeccC--CCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEc--CCeEEEEEEec
Q 046728 19 QNINNGLEILMLLLLLRRET--GDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG--GDERLIVYDYM 94 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lV~e~~ 94 (325)
.+||.| +++.||+++... ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+
T Consensus 7 ~~lG~G--~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRG--TYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccC--CCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 357777 788899888554 46789999986532 23467789999999999999999998853 56688999999
Q ss_pred CCCChhhhhcc-----------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceee----CCCCceEEeeeccccc
Q 046728 95 PNHSLITHLHG-----------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLL----DTDFEAKVADFGFAKL 155 (325)
Q Consensus 95 ~~gsL~~~l~~-----------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~----~~~~~~kL~Dfg~~~~ 155 (325)
. ++|.+++.. .++...+..+..++..++.++|.. |||||+|||+ +.++.+||+|||+++.
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 5 588887731 123333556778899999999875 7999999999 4567899999999987
Q ss_pred cCCCcce--eeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchh-------hhhhcc-
Q 046728 156 IPDGVTH--MTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDI-------VQWVTP- 224 (325)
Q Consensus 156 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~-------~~~~~~- 224 (325)
....... ......+|..|+|||++.+. .++.++|||||||++|+|+||.+||........... ......
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 6543221 12234578999999998764 578999999999999999999999965332111000 000000
Q ss_pred -ccccccccc---------ccC---------ccc---cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 225 -YVQKGAFEH---------IAD---------PRL---KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 225 -~~~~~~~~~---------~~~---------~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
......+.. ... ..+ ........+..+.+|+.+||..||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 000000000 000 000 00011123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=257.68 Aligned_cols=245 Identities=20% Similarity=0.298 Sum_probs=185.2
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcC-----C
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGG-----D 85 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-----~ 85 (325)
..+|.+.+.||.| +++.||.+....+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++... .
T Consensus 21 ~~~y~~~~~l~~g--~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKG--TYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecC--CCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 3567888889888 77889999998899999999986532 2345778899999999 799999999998653 3
Q ss_pred eEEEEEEecCCCChhhhhcc------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccc
Q 046728 86 ERLIVYDYMPNHSLITHLHG------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
..++||||+++++|.++++. .+.+..++.+..++..++.++|.. +||||+||+++.++.++|+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 58999999999999998842 234445566777788888888874 79999999999999999999999886
Q ss_pred cCCCcceeeccCCCCcCCCCccccccC-----CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccc
Q 046728 156 IPDGVTHMTTRVKGTLGYLAPEYAMWG-----KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGA 230 (325)
Q Consensus 156 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (325)
....... .....++..|+|||++... .++.++|||||||++|+|++|..||........ ..... ...
T Consensus 178 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~~~~-----~~~ 249 (291)
T cd06639 178 LTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LFKIP-----RNP 249 (291)
T ss_pred ccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HHHHh-----cCC
Confidence 5432221 1234578899999987643 367899999999999999999999975432111 10000 000
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 231 FEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
. . ....+...+..+.+||.+||..+|++|||+.++++
T Consensus 250 ~-----~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 250 P-----P--TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred C-----C--CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 0 00112234567999999999999999999999987
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=250.10 Aligned_cols=271 Identities=17% Similarity=0.229 Sum_probs=212.5
Q ss_pred cchhHH-hhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEEE
Q 046728 13 SPAVFI-QNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 13 ~~~~~~-~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lV 90 (325)
.-|++. +.||+| +++.|-.+....++..+|||++.+.......++.+|++++++. .|+||+.++++|+++..+|+|
T Consensus 77 d~YkLt~e~LGeG--AyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 77 DMYKLTSELLGEG--AYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHHHhHHHHhcCc--cceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence 334443 457888 7778888889999999999999988788889999999999999 599999999999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhh----cCCCCCCceeeCCCC---ceEEeeeccccccC--CC
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEG----IADIKASNVLLDTDF---EAKVADFGFAKLIP--DG 159 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~----~rdlkp~Nil~~~~~---~~kL~Dfg~~~~~~--~~ 159 (325)
||-+.||+|..+|+ ..+++..+..+.+.++.+++++|. |||+||+|||..... -+|||||.+..-.. ..
T Consensus 155 fEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred EecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 99999999999994 458888888999999999999996 589999999997765 48999997765332 21
Q ss_pred cc----eeeccCCCCcCCCCccccc---c--CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCc--------cchhhhhh
Q 046728 160 VT----HMTTRVKGTLGYLAPEYAM---W--GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGV--------KRDIVQWV 222 (325)
Q Consensus 160 ~~----~~~~~~~~t~~y~aPE~~~---~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~--------~~~~~~~~ 222 (325)
.+ ....+.+|+..|||||+.. + ..|+.++|.||||+|+|-|+.|.+||.+.-+.+ ++...+.+
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 11 1223456888999999753 2 357889999999999999999999997654333 23333333
Q ss_pred cccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccCCCcccccccc
Q 046728 223 TPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLGRRTKDVKDVA 291 (325)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~~~~~~~~~~~ 291 (325)
-..++.+.++. +...+..++.+..+|+...+..|+.+|.++.++++ |++....+.......+.
T Consensus 315 FesIQEGkYeF------PdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalptp~v~ 379 (463)
T KOG0607|consen 315 FESIQEGKYEF------PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPTPQVL 379 (463)
T ss_pred HHHHhccCCcC------ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCCCccc
Confidence 33333333332 23456789999999999999999999999999998 88877665444443333
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=254.29 Aligned_cols=247 Identities=22% Similarity=0.314 Sum_probs=187.2
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh----------hhHHHHHHHHHHHHccCCCCccceeeEEEcC
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA----------KAEMEFAVEVEILGRVRHRNLLGLRGFYAGG 84 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (325)
|...+.||.| +++.||.+....+++.||+|.+..... ...+.+..|+.++++++|||++++++++...
T Consensus 3 ~~~~~~lg~g--~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 80 (272)
T cd06629 3 WVKGELIGKG--TYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE 80 (272)
T ss_pred eeecceeccc--CceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC
Confidence 4566788888 788899999888899999998753211 1123677899999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCC
Q 046728 85 DERLIVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 158 (325)
...++||||+.+++|.++++. .+....+..+..++..++.++|.. +||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 999999999999999999854 344455566778888899999875 79999999999999999999999876543
Q ss_pred Ccce-eeccCCCCcCCCCccccccCC--CCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccccc
Q 046728 159 GVTH-MTTRVKGTLGYLAPEYAMWGK--VSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIA 235 (325)
Q Consensus 159 ~~~~-~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (325)
.... ......++..|+|||.+.... ++.++|+||||+++|++++|..||....... .... .. .. ..
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~-~~----~~----~~ 229 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--AMFK-LG----NK----RS 229 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--HHHH-hh----cc----cc
Confidence 2111 122345788999999987654 7889999999999999999999995432110 0000 00 00 00
Q ss_pred CccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 236 DPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
...........++..+.+++.+||..+|++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 011111222345778999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=265.35 Aligned_cols=270 Identities=19% Similarity=0.252 Sum_probs=195.5
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC---
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG--- 84 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 84 (325)
|.+...|.+.+.||.| +++.||.+.+..+++.||+|.+... ......++.+|+.++++++||||+++++++...
T Consensus 1 ~~~~~~y~i~~~lg~G--~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (336)
T cd07849 1 FDVGPRYQNLSYIGEG--AYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE 78 (336)
T ss_pred CccccceEEEEEEEec--CCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccc
Confidence 4567788999999999 7788999999999999999998632 233445788899999999999999999987544
Q ss_pred --CeEEEEEEecCCCChhhhhcc-CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccC
Q 046728 85 --DERLIVYDYMPNHSLITHLHG-RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIP 157 (325)
Q Consensus 85 --~~~~lV~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~ 157 (325)
...++|+||+. ++|.++++. .+++..+..+..++..++.++|.. |||||+||+++.++.++|+|||++....
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 79 SFNDVYIVQELME-TDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred ccceEEEEehhcc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 35799999996 588888753 456667777888999999999975 7999999999999999999999987654
Q ss_pred CCcce--eeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccc
Q 046728 158 DGVTH--MTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHI 234 (325)
Q Consensus 158 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (325)
..... ......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||.......................+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 32211 1122457889999998754 46888999999999999999999999653211100000000000000000000
Q ss_pred c-----------CccccCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 235 A-----------DPRLKGK---FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 235 ~-----------~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
. ......+ ..+..+.++.++|.+||..||++|||+.++++ ||+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0 0000000 01234567999999999999999999999998 8886653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=257.25 Aligned_cols=247 Identities=19% Similarity=0.272 Sum_probs=186.1
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-hhhHHHHHHHHHH-HHccCCCCccceeeEEEcCCeEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-AKAEMEFAVEVEI-LGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
.|.+++.||.| +++.||++....++..||+|.+.... .....++..|..+ ++.++||||+++++++..+...++||
T Consensus 2 ~~~~~~~ig~g--~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 2 DLEVIEELGRG--AYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CceEEEEeccc--CCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 46778889988 77789999999999999999987532 2334456666665 56668999999999999999999999
Q ss_pred EecCCCChhhhhcc------CCCCCCccCHHHHHHHHHHHHhhc-----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 92 DYMPNHSLITHLHG------RLAPDCLLDWHRRVSIAIGSAEGI-----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 92 e~~~~gsL~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~~-----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
||++ |+|.++++. .+++..++.+..++..++.++|.. |||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9996 688887743 244555667888889999999864 7999999999999999999999988654321
Q ss_pred ceeeccCCCCcCCCCcccccc----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccC
Q 046728 161 THMTTRVKGTLGYLAPEYAMW----GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD 236 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~----~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (325)
. .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||....... ..... ...
T Consensus 159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~----~~~--------- 222 (283)
T cd06617 159 A--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLKQ----VVE--------- 222 (283)
T ss_pred c--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHHH----HHh---------
Confidence 1 122457889999998864 346889999999999999999999996422110 00000 000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 237 PRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 237 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
..........++.++.++|.+||..+|++|||++++++ |++..
T Consensus 223 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 223 EPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred cCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 00000011235678999999999999999999999998 77754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=261.01 Aligned_cols=262 Identities=20% Similarity=0.226 Sum_probs=189.7
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcC--CeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG--DERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 88 (325)
..|.+.+.||.| +++.||.+....+++.||+|.+.... ......+.+|+.++++++|+|++++++++... +..+
T Consensus 7 ~~y~~~~~ig~g--~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 7 TEFEKLNRIGEG--TYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cceeEeeeeeec--CCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 457788889998 77889999998899999999986432 22233566799999999999999999998755 5689
Q ss_pred EEEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 89 IVYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
+||||+. ++|.+++. ..++...+..+..++..++.++|.. +||||+||+++.++.++|+|||++........
T Consensus 85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 9999996 48888874 3355666777888999999999875 79999999999999999999999987654322
Q ss_pred eeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccc------
Q 046728 162 HMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHI------ 234 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 234 (325)
.. ....++..|+|||++.+ ..++.++||||+||++|+|++|..||.......................+...
T Consensus 164 ~~-~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07845 164 PM-TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242 (309)
T ss_pred CC-CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence 21 12235778999999865 45789999999999999999999999754332211111110000000000000
Q ss_pred ---cCccccCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 235 ---ADPRLKGK----FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 235 ---~~~~~~~~----~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
..+..... .....++.+.+||.+||..||++|||++++++ ||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 00000000 01124678899999999999999999999998 8864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=254.89 Aligned_cols=213 Identities=20% Similarity=0.306 Sum_probs=163.7
Q ss_pred CeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCCCChhhhhcc---CCCCCCccCHHH
Q 046728 41 DQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHLHG---RLAPDCLLDWHR 117 (325)
Q Consensus 41 ~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~ 117 (325)
..||+|.+..........+.+|+.+++.++||||+++++++......++||||+++|+|..+++. .++....+.+..
T Consensus 45 ~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~ 124 (274)
T cd05076 45 LRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQ 124 (274)
T ss_pred eeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHH
Confidence 45899998754444456788899999999999999999999999999999999999999999842 345556677888
Q ss_pred HHHHHHHHHhhc----CCCCCCceeeCCCC-------ceEEeeeccccccCCCcceeeccCCCCcCCCCcccccc-CCCC
Q 046728 118 RVSIAIGSAEGI----ADIKASNVLLDTDF-------EAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMW-GKVS 185 (325)
Q Consensus 118 ~~~~~~~~~~~~----rdlkp~Nil~~~~~-------~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~ 185 (325)
++..++.++|.. |||||+||+++..+ .++++|||++...... ....++..|+|||.+.+ ..++
T Consensus 125 qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~ 199 (274)
T cd05076 125 QLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLS 199 (274)
T ss_pred HHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCC
Confidence 888889998875 79999999997543 4899999987643221 12346788999998875 4678
Q ss_pred CcccchhHHHHHHHHH-hCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCC
Q 046728 186 DSCDVYSFGVLLLELI-SAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPE 264 (325)
Q Consensus 186 ~~~DiwSlG~il~el~-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~ 264 (325)
.++||||||+++|+++ +|..||............. . ....+...++.+.++|.+||..+|+
T Consensus 200 ~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~---------------~~~~~~~~~~~~~~li~~cl~~~p~ 261 (274)
T cd05076 200 TAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE---K---------------KHRLPEPSCKELATLISQCLTYEPT 261 (274)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHH---h---------------ccCCCCCCChHHHHHHHHHcccChh
Confidence 9999999999999995 6899986543221111000 0 0011112335789999999999999
Q ss_pred CCCCHHHHHHHH
Q 046728 265 NRPTMTDVVDWL 276 (325)
Q Consensus 265 ~Rps~~~il~~l 276 (325)
+|||+.++++.|
T Consensus 262 ~Rps~~~il~~L 273 (274)
T cd05076 262 QRPSFRTILRDL 273 (274)
T ss_pred hCcCHHHHHHhh
Confidence 999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=257.11 Aligned_cols=258 Identities=20% Similarity=0.251 Sum_probs=190.7
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcC--CeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG--DERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 88 (325)
..|.+.+.||.| +++.||.+....+++.||+|.++... ......+.+|+.++++++||||+++++++... ...|
T Consensus 5 ~~y~~~~~lg~g--~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEG--TYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCC--CCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 468899999999 77889999998889999999996432 22233567899999999999999999998877 8899
Q ss_pred EEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 89 IVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
+||||+. ++|.+++.. .++....+.+..++..+++++|.. +||||+||+++.++.++|+|||++........
T Consensus 83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 9999996 599888842 255666778888999999999976 69999999999999999999999886654321
Q ss_pred eeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcc--------------cc
Q 046728 162 HMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTP--------------YV 226 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~--------------~~ 226 (325)
. .....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||................. ..
T Consensus 162 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 162 P-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred c-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 1 1223467889999988754 468899999999999999999999975433211110000000 00
Q ss_pred cccccccccCccccCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 227 QKGAFEHIADPRLKGKFNRD-QLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
....+.......+....+.. .++.+.+||.+||..||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00001111111111122222 4778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=259.15 Aligned_cols=259 Identities=15% Similarity=0.187 Sum_probs=186.8
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
.-..|.+++.||.| +++.||++....+++.||+|.+.... ......+.+|++++++++||||+++++++.+....++
T Consensus 3 ~~~~y~~~~~lg~g--~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 3 KLETYKKLDKLGEG--SYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred CccceeEEEEEeec--CCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 34567888999998 77789999988889999999986432 2223456789999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 90 VYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
||||+.+ +|.+++.. .+....+..+..++..++.++|.. +||||+||+++.++.++|+|||++.........
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 9999974 99998843 345556677888999999999975 799999999999999999999998754322111
Q ss_pred eeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCcc-chhhhhhcccccccccccc------
Q 046728 163 MTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVK-RDIVQWVTPYVQKGAFEHI------ 234 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~------ 234 (325)
.....++..|+|||++.+ ..++.++||||+|+++|+|++|..||........ ...+...........+...
T Consensus 160 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 160 -YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred -ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 112236788999998875 4578899999999999999999999965431100 0000000000000000000
Q ss_pred --------cCccccCCCCHHHH--HHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 235 --------ADPRLKGKFNRDQL--KSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 235 --------~~~~~~~~~~~~~~--~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
....+. ......+ ..+.+++.+||..+|++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 239 KPYSFPFYPPRPLI-NHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccCChhHH-HhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 0001122 67889999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=259.45 Aligned_cols=253 Identities=17% Similarity=0.236 Sum_probs=185.7
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
|..++.||.| +++.||+++...+++.||||.+.... ......+.+|++++++++||||+++++++.+....++|||
T Consensus 2 y~~~~~l~~g--~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 2 FQKVEKIGEG--TYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred ceeeeeecCC--CceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 5678888888 88889999998889999999886432 2233578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 93 YMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|+. ++|.+++.. .++...+..+..++..++.++|.. +||+|+||+++.++.++|+|||++......... .
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~-~ 157 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-Y 157 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc-c
Confidence 995 689888842 234455667778888888888875 799999999999999999999998765432211 1
Q ss_pred ccCCCCcCCCCccccccCC-CCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccc--c-------------
Q 046728 165 TRVKGTLGYLAPEYAMWGK-VSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQ--K------------- 228 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~--~------------- 228 (325)
....++..|+|||++.+.. ++.++||||||+++|+|+||..||...... ............ .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 2234678899999887544 578899999999999999999999653321 111110000000 0
Q ss_pred cccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 229 GAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
..+........ .......++++.++|.+||..||++|||+++++.
T Consensus 236 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 236 PSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 0011235567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=254.10 Aligned_cols=249 Identities=22% Similarity=0.299 Sum_probs=196.1
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
...|.+.+.||.| +++.||.+....++..|++|.+..... ....+.+|++.++.++|+|++++++++......++|+
T Consensus 18 ~~~~~~~~~l~~g--~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 18 RELYKNLEKIGEG--ASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred cccchHhHhccCC--CCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 3457788899999 777889998888889999999976444 4567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 92 DYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 92 e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||+++++|.+++.. .++......+..++..++.++|.. +||+|+||+++.++.++|+|||++........ ..
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 173 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KR 173 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hh
Confidence 99999999999954 355566677788888888888865 69999999999999999999998876543322 12
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ..... .. ........
T Consensus 174 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--~~~~~-----~~-------~~~~~~~~ 239 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--LFLIT-----TK-------GIPPLKNP 239 (286)
T ss_pred ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-----hc-------CCCCCcch
Confidence 233477889999999888899999999999999999999999864332110 00000 00 00001112
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
...+..+.++|.+||..+|.+|||+.++++ ||+.
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 235678999999999999999999999997 7776
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=252.80 Aligned_cols=239 Identities=26% Similarity=0.360 Sum_probs=184.0
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
..|.+.+.||.| +++.||.+. ..++.||+|.+.... ....+.+|+.+++.++|||++++++++... ..++|||
T Consensus 6 ~~~~~~~~lg~g--~~g~v~~~~--~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 6 QKLTLGEIIGEG--EFGAVLQGE--YTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred HHceeeeeeccC--CCCceEecc--cCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 457788899998 677788664 467889999986532 235788999999999999999999998654 4799999
Q ss_pred ecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 93 YMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|+++++|.+++... ++......+..++..++.++|.. |||||+||+++.++.++|+|||++.......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 99999999999532 33344566777888888888875 7999999999999999999999987543321
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |..||........ .... .. ......
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~~~----~~---------~~~~~~ 218 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV---KECV----EK---------GYRMEP 218 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH---HHHH----hC---------CCCCCC
Confidence 11234567999999988889999999999999999998 9999865432111 1111 01 111122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~ 278 (325)
+...+..+.+++.+||..+|++||++.+++..|+.
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 23456789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=244.92 Aligned_cols=243 Identities=20% Similarity=0.309 Sum_probs=189.2
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecc-cChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCCeEEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKT-LNAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lV~e 92 (325)
..++..||.| +-+.||+++...++...|||.+.. .+.+..+++...+.++.+-+ +|+||+.+|+|..+..+++-||
T Consensus 94 l~~l~dlGsG--tcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 94 LENLGDLGSG--TCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred hhhHHhhcCC--CccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 4678889998 677799999999999999999974 45667778999999888875 9999999999999999999999
Q ss_pred ecCC--CChhhhhccCCCCCCccCHHHHHHHHHHHHhh-----cCCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 93 YMPN--HSLITHLHGRLAPDCLLDWHRRVSIAIGSAEG-----IADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 93 ~~~~--gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-----~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
.|.- .-|...+++..++..+-.+...+..|+.|+.. |||+||+|||+|+.|++||||||++..+.+.. ...
T Consensus 172 lMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--Aht 249 (391)
T KOG0983|consen 172 LMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AHT 249 (391)
T ss_pred HHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc--ccc
Confidence 8732 12333445556776666777777778888754 38999999999999999999999999887643 334
Q ss_pred cCCCCcCCCCcccccc---CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 166 RVKGTLGYLAPEYAMW---GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
..+|-+.|||||.+.- ..|+.++||||||++++|+.||+.||.....+ ..+...+ .+. ..+.+ +
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkv---ln~------ePP~L--~ 316 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKV---LNE------EPPLL--P 316 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHH---Hhc------CCCCC--C
Confidence 4568889999999863 36889999999999999999999999764331 1111111 000 01111 2
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
....+++.+.+++..||..|+.+||.-.++++
T Consensus 317 ~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 317 GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred cccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 22348899999999999999999999999886
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=250.16 Aligned_cols=244 Identities=22% Similarity=0.270 Sum_probs=174.3
Q ss_pred hccCccceeeeeEEEeccCC--CCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCC
Q 046728 20 NINNGLEILMLLLLLRRETG--DDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPN 96 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~--~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~ 96 (325)
.||.| +++.||+++...+ ...+++|.+.... ......+.+|+.+++.++||||+++++.+.+....++||||+++
T Consensus 2 ~lg~G--~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNG--WFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCC--cCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 47777 7777888764333 3456777776432 34456899999999999999999999999999999999999999
Q ss_pred CChhhhhccCC------CCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc-ceeec
Q 046728 97 HSLITHLHGRL------APDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV-THMTT 165 (325)
Q Consensus 97 gsL~~~l~~~~------~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 165 (325)
|+|.++++... ....+..+..++..++.++|.. +||||+|||++.++.++|+|||++....... .....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 159 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED 159 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence 99999996421 1122345677888888898875 7999999999999999999999986432211 11122
Q ss_pred cCCCCcCCCCcccccc-------CCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 166 RVKGTLGYLAPEYAMW-------GKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
...++..|+|||++.. ..++.++||||||+++|+|++ +..||...... .....+ ... ....+..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~---~~~-~~~~~~~- 231 (268)
T cd05086 160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLNHV---IKD-QQVKLFK- 231 (268)
T ss_pred CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---Hhh-cccccCC-
Confidence 3457889999998753 235779999999999999997 56677543221 111100 000 0011111
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
+......++.+.+++..|| .+|++|||++++++.|.
T Consensus 232 ---~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 ---PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ---CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1222345678899999999 68999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=250.42 Aligned_cols=231 Identities=20% Similarity=0.321 Sum_probs=176.9
Q ss_pred hccCccceeeeeEEEeccCCC----------CeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 20 NINNGLEILMLLLLLRRETGD----------DQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
.||.| +++.||.+....++ ..|++|.+...... ...+.+|++++++++||||+++++++.. ...++
T Consensus 2 ~lg~G--~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 2 HLGQG--TFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred ccccc--ccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 56777 77788888877665 35888887653333 5688899999999999999999999887 77899
Q ss_pred EEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC-------ceEEeeeccccc
Q 046728 90 VYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF-------EAKVADFGFAKL 155 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~-------~~kL~Dfg~~~~ 155 (325)
||||+++|+|.+++.. .++...++.+..++..+++++|.. +||||+||+++.++ .++|+|||++..
T Consensus 78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~ 157 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157 (259)
T ss_pred EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence 9999999999999953 244455677778888899999875 79999999999887 799999999886
Q ss_pred cCCCcceeeccCCCCcCCCCccccccC--CCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccc
Q 046728 156 IPDGVTHMTTRVKGTLGYLAPEYAMWG--KVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFE 232 (325)
Q Consensus 156 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (325)
... .....++..|+|||.+... .++.++||||||+++|+|++ |..||.......... +.. ..
T Consensus 158 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~---~~~---~~---- 222 (259)
T cd05037 158 VLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---FYQ---DQ---- 222 (259)
T ss_pred ccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH---HHh---cC----
Confidence 543 1123466789999998876 68899999999999999999 577776543211110 000 00
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 233 HIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
.. .+......+.+++.+||..+|.+|||+.++++.|+
T Consensus 223 ----~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 ----HR----LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ----CC----CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 00111268899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=256.67 Aligned_cols=257 Identities=19% Similarity=0.258 Sum_probs=188.9
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC--CeEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG--DERLIV 90 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lV 90 (325)
|.++++||.| +++.||++....+++.||+|.+... .......+.+|++++++++|||++++++++... ...++|
T Consensus 1 y~~~~~l~~g--~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEG--TYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccC--CCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 4567888888 7888999999888999999999754 233445788899999999999999999999888 889999
Q ss_pred EEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 91 YDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
|||++ ++|.+++.. .++...++.+..++..++.++|.. +||+|+||++++++.++|+|||++..........
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 79 FEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred ecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 99996 489888843 355666777888888889888876 6999999999999999999999998765543222
Q ss_pred eccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccC------
Q 046728 164 TTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD------ 236 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 236 (325)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.......................+.....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 223346788999998764 3578899999999999999999999975443211111110000000000000000
Q ss_pred --------ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 237 --------PRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 237 --------~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
..+.......+++.+.+++.+||..+|++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000001113678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=260.25 Aligned_cols=270 Identities=18% Similarity=0.223 Sum_probs=196.2
Q ss_pred cceeecccchhHH-hhccCccceeeeeEEEeccCCCCeEEEEEecccChhh--------------HHHHHHHHHHHHccC
Q 046728 6 NICFLLASPAVFI-QNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKA--------------EMEFAVEVEILGRVR 70 (325)
Q Consensus 6 ~~~~~~~~~~~~~-~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~--------------~~~~~~E~~~l~~l~ 70 (325)
++-+++...|..+ +.||.| +++.||++....+++.||+|.+....... ...+.+|++++++++
T Consensus 1 ~~~~~~~~ry~~~~~~ig~G--~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 78 (335)
T PTZ00024 1 NMSFSISERYIQKGAHLGEG--TYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK 78 (335)
T ss_pred CCccccccchhhhhhcccCC--CceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC
Confidence 3567888888766 558888 78889999988899999999986432111 124778999999999
Q ss_pred CCCccceeeEEEcCCeEEEEEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCc
Q 046728 71 HRNLLGLRGFYAGGDERLIVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFE 144 (325)
Q Consensus 71 h~~iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~ 144 (325)
||||+++++++......++||||+. |+|.+++.. .++......+..++..++.++|.. +||+|+||+++.++.
T Consensus 79 h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 79 HENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI 157 (335)
T ss_pred CcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC
Confidence 9999999999999999999999996 699998843 356666778888999999999875 699999999999999
Q ss_pred eEEeeeccccccCCCcc-------------eeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 046728 145 AKVADFGFAKLIPDGVT-------------HMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKL 210 (325)
Q Consensus 145 ~kL~Dfg~~~~~~~~~~-------------~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~ 210 (325)
++|+|||++........ .......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999986652110 011122357789999998754 4688999999999999999999999755
Q ss_pred CCCccchhhhhhcccccccccccc------------cCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HH
Q 046728 211 PGGVKRDIVQWVTPYVQKGAFEHI------------ADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WL 276 (325)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l 276 (325)
........+...........+... ..... .......+..+.++|.+||..+|++|||+++++. |+
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDL-KTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccH-HHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 432111100000000000000000 00000 0011234667899999999999999999999998 77
Q ss_pred hcc
Q 046728 277 KGG 279 (325)
Q Consensus 277 ~~~ 279 (325)
+..
T Consensus 317 ~~~ 319 (335)
T PTZ00024 317 KSD 319 (335)
T ss_pred CCC
Confidence 643
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=251.34 Aligned_cols=240 Identities=21% Similarity=0.323 Sum_probs=186.3
Q ss_pred ccCccceeeeeEEEeccCCCCeEEEEEecccCh---hhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCCC
Q 046728 21 INNGLEILMLLLLLRRETGDDQIAVKRLKTLNA---KAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNH 97 (325)
Q Consensus 21 i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~g 97 (325)
||.| +++.||.+....+++.|++|.+..... .....+.+|++++++++|||++++++.+..+...|+||||+.++
T Consensus 1 lg~g--~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKG--AYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCC--CceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence 3455 888899999998899999999865432 44567888999999999999999999999999999999999999
Q ss_pred Chhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc-------eee
Q 046728 98 SLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT-------HMT 164 (325)
Q Consensus 98 sL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-------~~~ 164 (325)
+|.++++. .+++..+..+..++..++.++|.. +||+|+||+++.++.++|+|||++........ ...
T Consensus 79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence 99999953 456666778889999999999875 79999999999999999999999875443211 012
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
....++..|+|||.......+.++|+||||+++|++++|..||....... ..... .......+..
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~------------~~~~~~~~~~ 223 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE---IFQNI------------LNGKIEWPED 223 (265)
T ss_pred cCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH------------hcCCcCCCcc
Confidence 23357788999999988888999999999999999999999996543211 11100 0000011111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCH---HHHHH--HHh
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPTM---TDVVD--WLK 277 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps~---~~il~--~l~ 277 (325)
...+..+.+++.+||..+|++|||+ .++++ ||+
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~ 261 (265)
T cd05579 224 VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261 (265)
T ss_pred ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcccc
Confidence 1136789999999999999999999 66665 554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=251.18 Aligned_cols=239 Identities=19% Similarity=0.236 Sum_probs=182.1
Q ss_pred ccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHc---cCCCCccceeeEEEcCCeEEEEEEec
Q 046728 21 INNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGR---VRHRNLLGLRGFYAGGDERLIVYDYM 94 (325)
Q Consensus 21 i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~---l~h~~iv~~~~~~~~~~~~~lV~e~~ 94 (325)
||+| +++.||+++...+++.||+|.+.... ......+.+|..+++. .+|||++.+++++...+..++||||+
T Consensus 2 lg~G--~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 2 IGRG--GFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred cccC--CCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 5666 88889999998889999999886422 1222233444444443 47999999999999999999999999
Q ss_pred CCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCC
Q 046728 95 PNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVK 168 (325)
Q Consensus 95 ~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~ 168 (325)
++|+|.+++. +.++...+..+..++..++.++|.. +||||+||+++.++.++|+|||++....... .....
T Consensus 80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~ 156 (279)
T cd05633 80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASV 156 (279)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccCcC
Confidence 9999999884 3466667778888999999999875 7999999999999999999999987554321 12335
Q ss_pred CCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHH
Q 046728 169 GTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQ 247 (325)
Q Consensus 169 ~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (325)
++..|+|||.+.+ ..++.++|+||+||++|+|++|..||............... .......+...
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--------------~~~~~~~~~~~ 222 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--------------LTVNVELPDSF 222 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh--------------hcCCcCCcccc
Confidence 8999999998864 46789999999999999999999999754332211111100 00111233456
Q ss_pred HHHHHHHHHHccCCCCCCCC-----CHHHHHH--HHhc
Q 046728 248 LKSMVLIALRCTDSNPENRP-----TMTDVVD--WLKG 278 (325)
Q Consensus 248 ~~~~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~ 278 (325)
+.++.++|.+||..||++|| |+.++++ |++.
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 77899999999999999999 6999998 7765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=260.37 Aligned_cols=264 Identities=17% Similarity=0.241 Sum_probs=196.1
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcCC-----eE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD-----ER 87 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 87 (325)
|.+.+.||.| +++.||+++...++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.... ..
T Consensus 2 y~i~~~ig~g--~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 2 YELLKPIGSG--AYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred ceeeeeecCC--CCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5677889999 78889999988889999999987533 444568889999999999999999999987765 78
Q ss_pred EEEEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 88 LIVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
|+||||+. ++|.++++. .++...+..+..++..++.++|.. +||||.||+++.++.++|+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999996 589998854 355566677888888899998875 79999999999999999999999987655421
Q ss_pred --eeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccc-------
Q 046728 162 --HMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAF------- 231 (325)
Q Consensus 162 --~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------- 231 (325)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+...........+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 112234578889999999877 7889999999999999999999999764421111100000000000000
Q ss_pred -cc-ccCcccc-----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 232 -EH-IADPRLK-----GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 232 -~~-~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
.. +...... ....+..+..+.++|.+||..+|++|||++++++ ||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00 0000000 0011235678999999999999999999999998 8987554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=257.02 Aligned_cols=267 Identities=18% Similarity=0.205 Sum_probs=193.0
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecc--cChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcC--
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKT--LNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGG-- 84 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-- 84 (325)
.+...|.+.+.||.| +++.||.+....+++.||+|.+.. ........+.+|+.+++++ +||||+++++++...
T Consensus 4 ~~~~~y~~~~~lg~g--~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 4 HILRKYEILQKLGKG--AYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred hhhhHHHHhHhhcCC--CCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 356678999999999 777789888888899999998853 2233445677899999999 999999999998643
Q ss_pred CeEEEEEEecCCCChhhhhcc-CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC
Q 046728 85 DERLIVYDYMPNHSLITHLHG-RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 159 (325)
...++||||+. ++|.++++. .+.......+..++..++.++|.. +||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 46899999996 599998854 344455566778888888888875 799999999999999999999999866443
Q ss_pred cce----eeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccc--------
Q 046728 160 VTH----MTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYV-------- 226 (325)
Q Consensus 160 ~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~-------- 226 (325)
... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...................
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 221 2223457889999998764 457889999999999999999999996543221111000000000
Q ss_pred ----cccccccccCccc--cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 227 ----QKGAFEHIADPRL--KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 227 ----~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
....+........ .....+..+.++.++|.+||..||++|||+.++++ |++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0000000000000 00111225678999999999999999999999998 77765
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=268.36 Aligned_cols=247 Identities=21% Similarity=0.258 Sum_probs=204.7
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEec
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~ 94 (325)
..+++.||.| +||.||++..+.++-.-|.|.|...+.+....++-|+.||..++||+||++++.|...+.+||+.|||
T Consensus 34 WeIiGELGDG--AFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 34 WEIIGELGDG--AFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHhhhcCc--cchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 4688899999 88899999999888888999998878888889999999999999999999999999999999999999
Q ss_pred CCCChhhhh---ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccC
Q 046728 95 PNHSLITHL---HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRV 167 (325)
Q Consensus 95 ~~gsL~~~l---~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 167 (325)
.||.+...+ ...+.+..+..++.++.-|+.++|+. ||||+.|||++-+|.++|+|||.+....... .....+
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-qkRDsF 190 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-QKRDSF 190 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHH-hhhccc
Confidence 999998887 34578888889999999999999985 8999999999999999999999987654332 234457
Q ss_pred CCCcCCCCcccccc-----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc-cC
Q 046728 168 KGTLGYLAPEYAMW-----GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL-KG 241 (325)
Q Consensus 168 ~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 241 (325)
.||+.|||||+..+ .+|+.++||||||++|.||..+.+|......- ..+-++..... ..
T Consensus 191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM---------------RVllKiaKSePPTL 255 (1187)
T KOG0579|consen 191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM---------------RVLLKIAKSEPPTL 255 (1187)
T ss_pred cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH---------------HHHHHHhhcCCCcc
Confidence 79999999998764 47899999999999999999999997654321 11111111111 11
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
..|..-+..+.+++++||..||..||++.++++ |++..
T Consensus 256 lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 256 LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 334556778999999999999999999999998 77754
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=253.52 Aligned_cols=239 Identities=22% Similarity=0.305 Sum_probs=184.9
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
+-|...+.||.| +++.||+++...++..||+|.+... .......+.+|++++++++|||++++++++.++...++
T Consensus 25 ~~f~~~~~lg~G--~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHG--SFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred hhhhhhheeccC--CCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 346788889888 7778999998888999999998642 23344578889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 90 VYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 90 V~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
||||+. |+|.+++. ..++...+..+..++..++.++|.. +||+|+||+++.++.++|+|||++......
T Consensus 103 v~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 103 VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred EEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 999996 58877773 2244455566777888888888875 799999999999999999999988754332
Q ss_pred eeccCCCCcCCCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 163 MTTRVKGTLGYLAPEYAM---WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
....++..|+|||.+. ...++.++|||||||++|+|++|..||........ ... +.....
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~------------~~~~~~ 241 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYH------------IAQNES 241 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHH------------HHhccC
Confidence 2345788899999874 34678899999999999999999999865321110 000 000011
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
........++.+.+|+.+||..+|.+||++.++++
T Consensus 242 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 276 (317)
T cd06635 242 PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276 (317)
T ss_pred CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHh
Confidence 11122345667999999999999999999999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=251.19 Aligned_cols=241 Identities=22% Similarity=0.394 Sum_probs=188.8
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
|.+.+.||.| +++.||++....++..||+|.+... .......+.+|+++++.++|+||+++++.+......++|+|
T Consensus 2 ~~~~~~l~~g--~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 2 YEIIKKIGEG--SFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred ceEEEEecCC--CcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 5667788888 7778999999999999999998642 22344577889999999999999999999999999999999
Q ss_pred ecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCc-eEEeeeccccccCCCccee
Q 046728 93 YMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFE-AKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 93 ~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~-~kL~Dfg~~~~~~~~~~~~ 163 (325)
|+++++|.+++... +.+.....+..++..++.++|.. +||||.||++++++. ++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~- 158 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL- 158 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccc-
Confidence 99999999998432 34455677788888899999875 799999999998854 699999999876543221
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ...... ...+ ...
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~---------~~~ 222 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKIC-QGYF---------API 222 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHh-cccC---------CCC
Confidence 223457889999999988889999999999999999999999996432111 111000 0000 111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
....+..+.+++.+||..+|++|||+.++++
T Consensus 223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 2344568999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=247.55 Aligned_cols=239 Identities=18% Similarity=0.239 Sum_probs=181.3
Q ss_pred hhccCccceeeeeEEEeccCCCCeEEEEEecccCh---hhHHHHHHHHHHH-HccCCCCccceeeEEEcCCeEEEEEEec
Q 046728 19 QNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA---KAEMEFAVEVEIL-GRVRHRNLLGLRGFYAGGDERLIVYDYM 94 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~lV~e~~ 94 (325)
+.||.| +++.||.+....+++.||+|.+..... .....+..|..++ ...+|||++++++++..++..++||||+
T Consensus 2 ~~l~~g--~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKG--AFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL 79 (260)
T ss_pred ccCCcC--CCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence 456777 788899999988999999999865322 2222344455444 4458999999999999999999999999
Q ss_pred CCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCC
Q 046728 95 PNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVK 168 (325)
Q Consensus 95 ~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~ 168 (325)
++++|.++++. .++...+..+..++..++.++|.. +||+|+||+++.++.++|+|||++..... .....
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~ 154 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFV 154 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCC
Confidence 99999999953 456667788889999999999986 79999999999999999999998875433 22345
Q ss_pred CCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHH
Q 046728 169 GTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQL 248 (325)
Q Consensus 169 ~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (325)
++..|+|||.+.+..++.++||||||+++|+|++|..||........ .... ..... .........++
T Consensus 155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~----~~~~~------~~~~~~~~~~~ 221 (260)
T cd05611 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV---FDNI----LSRRI------NWPEEVKEFCS 221 (260)
T ss_pred CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH---HHHH----Hhccc------CCCCcccccCC
Confidence 78899999999888889999999999999999999999965432111 1100 00000 00111223456
Q ss_pred HHHHHHHHHccCCCCCCCCCH---HHHHH--HHh
Q 046728 249 KSMVLIALRCTDSNPENRPTM---TDVVD--WLK 277 (325)
Q Consensus 249 ~~~~~li~~cl~~dp~~Rps~---~~il~--~l~ 277 (325)
+.+.+++.+||..||++|||+ ++++. ||.
T Consensus 222 ~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~ 255 (260)
T cd05611 222 PEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255 (260)
T ss_pred HHHHHHHHHHccCCHHHccCCCcHHHHHcChHhh
Confidence 789999999999999999966 46554 554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=253.21 Aligned_cols=257 Identities=16% Similarity=0.206 Sum_probs=185.2
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
..|.+++.||.| +++.||.+....++..||+|.+.... ......+.+|+++++.++|+||+++++++..+...++||
T Consensus 5 ~~y~~~~~ig~g--~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEG--SYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEec--CCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 567888999988 77889999988889999999986432 222346778999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 92 DYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 92 e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||+. ++|.+++.. .+....+..+..++..++.++|.. +||||+||+++.++.++|+|||++......... .
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~ 160 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT-Y 160 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-C
Confidence 9995 688777732 234445666778888899998875 799999999999999999999998754332211 1
Q ss_pred ccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhh-hhc-cccccc---------cc-
Q 046728 165 TRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQ-WVT-PYVQKG---------AF- 231 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~-~~~-~~~~~~---------~~- 231 (325)
....++..|+|||++.+. .++.++||||||+++|+|++|..||........ .... +.. ...... .+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHcCCCChhhhhhhhhccccc
Confidence 223468899999998754 578899999999999999999999975432110 0000 000 000000 00
Q ss_pred cccc----CccccC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 232 EHIA----DPRLKG-KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 232 ~~~~----~~~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.... ...+.. ......+..+.+++.+|+..||++|||+++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000 000000 000112467889999999999999999999885
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=274.99 Aligned_cols=266 Identities=16% Similarity=0.223 Sum_probs=181.3
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCC-CCeEEE------------------EEecccChhhHHHHHHHHHHHHccCC
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETG-DDQIAV------------------KRLKTLNAKAEMEFAVEVEILGRVRH 71 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~-~~~vai------------------K~~~~~~~~~~~~~~~E~~~l~~l~h 71 (325)
+...|.+++.||.| +++.||++..... +..+++ |.+.. .......+.+|+.++++++|
T Consensus 146 ~~~~Y~ii~~LG~G--~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 146 FLAHFRVIDDLPAG--AFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNH 222 (501)
T ss_pred hhhccEEEeEecCC--CCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCC
Confidence 44678899999999 6777777653322 111222 22211 22344578899999999999
Q ss_pred CCccceeeEEEcCCeEEEEEEecCCCChhhhhccC-CC------CCCccCHHHHHHHHHHHHhhc----CCCCCCceeeC
Q 046728 72 RNLLGLRGFYAGGDERLIVYDYMPNHSLITHLHGR-LA------PDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLD 140 (325)
Q Consensus 72 ~~iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~------~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~ 140 (325)
|||+++++++...+..|+|++++ +++|..++... +. ...+..+..++..++.++|.+ |||||+|||++
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 99999999999999999999999 45888877321 11 122345778889999999975 79999999999
Q ss_pred CCCceEEeeeccccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCC-CCCCCCccchhh
Q 046728 141 TDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPL-EKLPGGVKRDIV 219 (325)
Q Consensus 141 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf-~~~~~~~~~~~~ 219 (325)
.++.+||+|||++..+............||..|+|||++.+..++.++|||||||++|||++|..++ ............
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 9999999999999876544333333456899999999999889999999999999999999987544 322221111111
Q ss_pred hhhcccc-cccccc--------cccCccc---cCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 220 QWVTPYV-QKGAFE--------HIADPRL---KGKF-----NRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 220 ~~~~~~~-~~~~~~--------~~~~~~~---~~~~-----~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
..+.... ....+. .+..... .... ....+..+.++|.+||..||.+|||+.+++. ||....
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 1100000 000000 0000000 0000 0123456788899999999999999999998 776543
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=253.90 Aligned_cols=256 Identities=19% Similarity=0.261 Sum_probs=187.9
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEe
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~ 93 (325)
|.+++.||.| +++.||+++...++..||||.+.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 y~~~~~l~~g--~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 2 FKQLEKLGEG--TYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred ceEeeeeccC--CceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 5678899999 78889999999899999999987532 23345677899999999999999999999999999999999
Q ss_pred cCCCChhhhhcc-----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 94 MPNHSLITHLHG-----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 94 ~~~gsL~~~l~~-----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
+++ +|.+++.. .+.+..+..+..++..+++++|.. +||||+||++++++.++|+|||++......... .
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~ 157 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-F 157 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc-c
Confidence 975 89888843 245556677888899999999875 799999999999999999999999765432221 1
Q ss_pred ccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccC-ccc---
Q 046728 165 TRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD-PRL--- 239 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--- 239 (325)
....++..|++||++.+. .++.++|+||||+++|+|++|..||.......................+..+.. +..
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 223467889999988654 568899999999999999999999976433211110000000000000000000 000
Q ss_pred --------cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 240 --------KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 240 --------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.....+..+..+.+++.+||..||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00111234678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=250.67 Aligned_cols=247 Identities=21% Similarity=0.275 Sum_probs=183.8
Q ss_pred hhHHhhccCccceeeeeEEEecc---CCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC----
Q 046728 15 AVFIQNINNGLEILMLLLLLRRE---TGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD---- 85 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~---~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 85 (325)
|.+.+.||.| +++.||.+... .+++.||||.+... ......++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g--~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKG--EFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCC--CCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 4677889998 66778877643 34689999998643 3445567889999999999999999999876532
Q ss_pred --eEEEEEEecCCCChhhhhcc--------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeec
Q 046728 86 --ERLIVYDYMPNHSLITHLHG--------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFG 151 (325)
Q Consensus 86 --~~~lV~e~~~~gsL~~~l~~--------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg 151 (325)
..+++++|+.+|+|.+++.. .++......+..++..++.++|.. +||||+||+++.++.++|+|||
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccc
Confidence 24789999999999888731 123334466777888888888865 7999999999999999999999
Q ss_pred cccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhccccccc
Q 046728 152 FAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKG 229 (325)
Q Consensus 152 ~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 229 (325)
++......... ......++..|++||.+....++.++|||||||++|+|++ |..||...... ....+... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~---~~ 232 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLIK---GN 232 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHHc---CC
Confidence 98865432211 1222335678999999988888999999999999999999 88888654321 11111110 00
Q ss_pred ccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 230 AFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
....+...+..+.+++.+||..+|++|||+.+++..|+.+
T Consensus 233 ----------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 ----------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011234556899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=252.64 Aligned_cols=238 Identities=21% Similarity=0.288 Sum_probs=184.7
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecc---cChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKT---LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|..++.||.| +++.||+++...++..||+|.+.. .......++.+|+++++.++|+|++++++++......++|
T Consensus 16 ~~~~~~~lg~g--~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 16 LFSDLREIGHG--SFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHheeeC--CCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 36677888888 777899999988899999999863 2334445788899999999999999999999999999999
Q ss_pred EEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 91 YDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 91 ~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
|||+. |+|.+++. ..++...+..+..++..++.++|.. +||+|+||+++.++.++|+|||++......
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---- 168 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence 99996 58877763 2245555666777888888888875 799999999999999999999998765432
Q ss_pred eccCCCCcCCCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 164 TTRVKGTLGYLAPEYAM---WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
....++..|+|||.+. ...++.++|||||||++|+|++|..||........ .... ......
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~------------~~~~~~ 232 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHI------------AQNESP 232 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH---HHHH------------hhcCCC
Confidence 2345788999999874 34578899999999999999999999865321110 0000 000001
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.......+..+.+||.+||..+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 1112346678999999999999999999999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=249.27 Aligned_cols=242 Identities=21% Similarity=0.240 Sum_probs=186.1
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
..+.+++.+..|.|+++.||++.+..++..+|+|.+........ |......+ +|||++++++.+...+..++||
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~ 88 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM 88 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence 45677788855555899999999999999999999865321111 22223323 7999999999999999999999
Q ss_pred EecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC-ceEEeeeccccccCCCcceee
Q 046728 92 DYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF-EAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 92 e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||+++++|.++++. .++...+..+..++..++.++|.. +||||+||+++.++ .++|+|||++.......
T Consensus 89 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~---- 164 (267)
T PHA03390 89 DYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS---- 164 (267)
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc----
Confidence 99999999999954 466777788888999999999875 79999999999988 99999999988654321
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
...++..|+|||++.+..++.++|+||+|+++|+|++|..||........ ....+.... .......
T Consensus 165 -~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~------------~~~~~~~ 230 (267)
T PHA03390 165 -CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKRQ------------QKKLPFI 230 (267)
T ss_pred -cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHhh------------cccCCcc
Confidence 23578899999999988899999999999999999999999974432211 111111000 0011223
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCC-HHHHHH--HHh
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPT-MTDVVD--WLK 277 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps-~~~il~--~l~ 277 (325)
...++.+.++|.+||..||.+||+ ++++++ ||+
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 231 KNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred cccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 357788999999999999999996 699997 664
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=253.95 Aligned_cols=255 Identities=18% Similarity=0.229 Sum_probs=187.1
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
|.+++.||.| +++.||.+....++..||+|.+.... ......+.+|+++++.++|||++++++++.+.+..++|||
T Consensus 1 y~~~~~l~~g--~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEG--TYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCC--CCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence 4677889888 77789999988899999999986432 2333568889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 93 YMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|+. ++|.+++.. .++....+.+..++..+++++|.. +||+|+||+++.++.++|+|||++......... .
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~ 156 (283)
T cd07835 79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-Y 156 (283)
T ss_pred ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-c
Confidence 995 699999843 245566677888889999999876 799999999999999999999999765432211 1
Q ss_pred ccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCcc-chhhhhhcccc--------cccc----
Q 046728 165 TRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVK-RDIVQWVTPYV--------QKGA---- 230 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~--------~~~~---- 230 (325)
....++..|+|||++.+. .++.++|+||||+++|+|++|..||........ ........... ....
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 222467889999988654 568899999999999999999999965432110 00000000000 0000
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 231 FEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
+....... ........+..+.++|.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 237 FPKWARQD-LSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred cccccccc-hhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000 00112345578999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=253.35 Aligned_cols=255 Identities=18% Similarity=0.227 Sum_probs=190.5
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
|.+++.||.| +++.+|.+....+++.+++|.+.... ......+.+|++++++++||||+++++++..+...++|||
T Consensus 1 y~~~~~i~~g--~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEG--TYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecC--CCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence 4567788888 77789999998889999999986432 2345678889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 93 YMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 93 ~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
|+++ +|.+++.. .++...+..+..++..++.++|.. +||||+||+++.++.++|+|||.+........ ...
T Consensus 79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-~~~ 156 (283)
T cd05118 79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PYT 156 (283)
T ss_pred ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-ccc
Confidence 9965 88888843 455666777888899999999876 79999999999999999999999886655431 122
Q ss_pred cCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccch-hhhhhcccccccccccccC-------
Q 046728 166 RVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRD-IVQWVTPYVQKGAFEHIAD------- 236 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~------- 236 (325)
...++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.......... ....... .....+.....
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGT-PDPEVWPKFTSLARNYKF 235 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC-CchHhcccchhhhhhhhh
Confidence 24577889999998766 67889999999999999999999996543211100 0000000 00000000000
Q ss_pred -----cc-ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 237 -----PR-LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 237 -----~~-~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.. .........+.++.++|.+||..||.+||++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 001122356788999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=262.50 Aligned_cols=247 Identities=23% Similarity=0.271 Sum_probs=202.4
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
..+.+..||-| ||+.|=+++-......+|+|++++. +......+..|-++|...+.|.||+++..|.+...+|++
T Consensus 421 dl~~iaTLGvG--gFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 421 DLKRIATLGVG--GFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhcccC--ccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 35567778888 5555655555555557899998753 456667888999999999999999999999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||-|-||.|...++ +.+.+....-+...+..|..|+|.+ |||||+|++++.+|.+||.|||+++.+..+.. +
T Consensus 499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K--T 576 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK--T 576 (732)
T ss_pred HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc--e
Confidence 99999999999995 5577778888889999999999998 79999999999999999999999999877544 5
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
-+++||+.|.|||++.+...+.++|.||||+++||+++|.+||.+.+.-. . +..+..+--...+|
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk---t------------Yn~ILkGid~i~~P 641 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK---T------------YNLILKGIDKIEFP 641 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH---H------------HHHHHhhhhhhhcc
Confidence 56899999999999999999999999999999999999999998654311 1 11111111123456
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH--HHhcc
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPT-----MTDVVD--WLKGG 279 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps-----~~~il~--~l~~~ 279 (325)
..++....+||++.+..+|.+|.- +.+|-. ||.+.
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 677888999999999999999986 666665 87754
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=245.77 Aligned_cols=242 Identities=23% Similarity=0.319 Sum_probs=192.4
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEec
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~ 94 (325)
|.+.+.||.| +++.+|.+....+++.|++|.+..........+.+|+..+++++|||++++++.+......++++||+
T Consensus 2 y~~~~~l~~g--~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 2 FEILEKIGKG--GFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred ceeeeeeccC--CceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 4567788888 77889999988889999999997655556678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccC
Q 046728 95 PNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRV 167 (325)
Q Consensus 95 ~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 167 (325)
++++|.+++.. .++......+..++..++.++|.. +||+|+||+++.++.++|+|||.+........ ....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~ 157 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTM 157 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccce
Confidence 99999999843 345556677788888888888875 79999999999999999999999887655432 2334
Q ss_pred CCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHH
Q 046728 168 KGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQ 247 (325)
Q Consensus 168 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (325)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||........... .. ...... .......
T Consensus 158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~----~~~~~~-------~~~~~~~ 223 (253)
T cd05122 158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK---IA----TNGPPG-------LRNPEKW 223 (253)
T ss_pred ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HH----hcCCCC-------cCccccc
Confidence 578899999999888889999999999999999999999975432111000 00 000000 0111223
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 248 LKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 248 ~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
+..+.+++.+||..||++|||+.++++
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 578999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=248.29 Aligned_cols=241 Identities=23% Similarity=0.381 Sum_probs=192.5
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
|.+.+.||.| +++.+|.+....++..||+|.+.... ......+.+|+++++.++|||++++++.+......++|+|
T Consensus 2 y~~~~~l~~g--~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 2 YEIIKQIGKG--SFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred ceEEeeeccC--CCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 5667888888 88889999998889999999987542 3556688899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccC------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 93 YMPNHSLITHLHGR------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 93 ~~~~gsL~~~l~~~------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
|+++++|.++++.. ++......+..++..++.++|.. +||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 158 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD- 158 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcc-
Confidence 99999999999542 44455667778888888888875 69999999999999999999999986655431
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
......++..|+|||.+....++.++|+||+|+++|+|++|..||...... ...... ... ....
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~----~~~---------~~~~ 222 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---ELALKI----LKG---------QYPP 222 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HHHHHH----hcC---------CCCC
Confidence 222345788899999998888899999999999999999999998643211 111000 000 0112
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.+...+..+.+++.+||..+|++|||+.++++
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 23355678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=250.41 Aligned_cols=253 Identities=18% Similarity=0.214 Sum_probs=183.8
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccC-CCCccceeeEEEcC--CeEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGG--DERLIV 90 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~lV 90 (325)
|++++.||.| +++.||++....+++.||+|.+... .........+|+.++.++. |||++++++++.+. +..++|
T Consensus 1 y~~~~~lg~g--~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEG--TFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeecccc--ccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 4677889888 7778999999889999999998643 2222334557899999985 99999999999887 889999
Q ss_pred EEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 91 YDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
|||+. ++|.+++.. .++...+..+..++..++.++|.. +||+|+||+++. +.++|+|||++.........
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~- 155 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY- 155 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc-
Confidence 99996 588888853 355666777888889999999875 799999999999 99999999999866443221
Q ss_pred eccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhh-hhc--------ccccc--ccc
Q 046728 164 TTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQ-WVT--------PYVQK--GAF 231 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~-~~~--------~~~~~--~~~ 231 (325)
....++..|+|||++.. ..++.++||||+||++|+|++|..||............. ... ..... ..+
T Consensus 156 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 156 -TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred -CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 22347889999997654 456889999999999999999999996543211100000 000 00000 000
Q ss_pred --ccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 232 --EHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.......+ .......+..+.+||.+||..+|++|||++++++
T Consensus 235 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 235 NFPSKKGTGL-RKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cCcccccccH-HHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000 0011245789999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=247.89 Aligned_cols=239 Identities=19% Similarity=0.267 Sum_probs=190.6
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
|.+.+.||.| +++.+|++.+..+++.+|+|.+... ......++.+|+.++++++||||+++++++.+....++|||
T Consensus 2 y~~~~~i~~g--~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 2 FKVLKKLGKG--SYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred ceEeeeecCC--CceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 5677889988 7778999988888999999998643 33445577889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 93 YMPNHSLITHLHG------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 93 ~~~~gsL~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
|+++++|.+++.. .+....++.+..++..++.++|.. +||+|.||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~-- 157 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM-- 157 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC--
Confidence 9999999999843 234445567777888888888875 7999999999999999999999998765541
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
.....++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... ..... .. .....
T Consensus 158 -~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~~----~~---------~~~~~ 220 (256)
T cd08530 158 -AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRYKV----QR---------GKYPP 220 (256)
T ss_pred -cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----hc---------CCCCC
Confidence 222457889999999988888999999999999999999999996543211 11100 01 11112
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.+...+.++.+++.+||..+|++|||+.++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 23356678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=247.26 Aligned_cols=244 Identities=20% Similarity=0.249 Sum_probs=190.0
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-----ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC--C
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-----NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG--D 85 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 85 (325)
..|.+.+.||.| +++.||.+....++..||+|.+... .......+.+|++++++++||||+++++++.+. .
T Consensus 2 ~~~~~~~~lg~g--~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 79 (264)
T cd06653 2 VNWRLGKLLGRG--AFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEK 79 (264)
T ss_pred CceeeeeeEccC--CCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCC
Confidence 457778899998 7778999998888999999987521 233445788899999999999999999998764 4
Q ss_pred eEEEEEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC
Q 046728 86 ERLIVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 159 (325)
.+++||||+++++|.+++.. .+.......+..++..++.++|.. +||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 58899999999999999853 345566677888999999999875 699999999999999999999999865321
Q ss_pred cc--eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 160 VT--HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 160 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
.. .......++..|+|||++.+..++.++|+|||||++|++++|..||...... ..... ....
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~-------------~~~~ 224 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AAIFK-------------IATQ 224 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HHHHH-------------HHcC
Confidence 11 1112245788999999998888899999999999999999999999653221 11100 0011
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
......+...++.+.+++.+||. +|..|||+.++++
T Consensus 225 ~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 225 PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11223455677889999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=256.26 Aligned_cols=257 Identities=15% Similarity=0.234 Sum_probs=185.3
Q ss_pred hhHHhhccCccceeeeeEEEeccC--CCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcC--CeE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRET--GDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG--DER 87 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 87 (325)
|.+.+.||.| +++.||.+.... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 y~~~~~ig~g--~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 2 YEIEGCIGRG--TYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred ceEEEEeccC--CcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence 5667788888 778899998888 78999999997532 33345778899999999999999999999888 789
Q ss_pred EEEEEecCCCChhhhhcc-------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC----CCceEEeeecc
Q 046728 88 LIVYDYMPNHSLITHLHG-------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT----DFEAKVADFGF 152 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~-------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~----~~~~kL~Dfg~ 152 (325)
++||||+.+ +|.+++.. .+++..++.+..++..++.++|.. |||||+||+++. ++.+||+|||+
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999999964 77776631 234455667888899999999875 799999999999 89999999999
Q ss_pred ccccCCCcc--eeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchh-------hhhh
Q 046728 153 AKLIPDGVT--HMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDI-------VQWV 222 (325)
Q Consensus 153 ~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~-------~~~~ 222 (325)
+........ .......++..|+|||.+.+. .++.++||||||+++|+|++|..||........... ...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 886544322 112234578889999988754 578899999999999999999999976543321000 0000
Q ss_pred ccc-----------cccccccc----ccC-----ccccCCCC--HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 223 TPY-----------VQKGAFEH----IAD-----PRLKGKFN--RDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 223 ~~~-----------~~~~~~~~----~~~-----~~~~~~~~--~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
... .....+.. ... ..+..... ...+.++.+++.+||..||++|||+.++++
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 00000000 000 00000000 134567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=256.20 Aligned_cols=259 Identities=16% Similarity=0.191 Sum_probs=185.9
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcCC-----
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD----- 85 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 85 (325)
..|.+++.||.| +++.||.+....+++.||+|.+.... ......+.+|++++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g--~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 12 SKYEKLAKIGQG--TFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hheEEEEEeecC--CCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 357888999998 77889999999999999999886422 222345678999999999999999999986543
Q ss_pred ---eEEEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccc
Q 046728 86 ---ERLIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 86 ---~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
..++||||+. ++|.+++.. .++...++.+..++..++.++|.+ +||||+||+++.++.++|+|||++..
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 3599999995 588888743 356666778888999999999986 69999999999999999999999986
Q ss_pred cCCCcce---eeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccc
Q 046728 156 IPDGVTH---MTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAF 231 (325)
Q Consensus 156 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (325)
....... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+..+........+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 5432211 11233467889999988754 3688999999999999999999999654322111111111111000000
Q ss_pred ccc---------cCc-c----ccCC-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 232 EHI---------ADP-R----LKGK-FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 232 ~~~---------~~~-~----~~~~-~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
... ..+ . .... .....+..+.+||.+||..||++|||++++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 000 0 0000 00112456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=288.13 Aligned_cols=252 Identities=21% Similarity=0.369 Sum_probs=191.7
Q ss_pred hHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecC
Q 046728 16 VFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95 (325)
Q Consensus 16 ~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~ 95 (325)
...+.||+| +++.||++....++..||+|.+...... ...|++.+++++||||+++++++.+....++||||++
T Consensus 693 ~~~~~ig~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 693 KEENVISRG--KKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred CcccEEccC--CCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 334567777 7788999998888999999998643321 2346889999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCccCHHHHHHHHHHHHhh-------cCCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCC
Q 046728 96 NHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEG-------IADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVK 168 (325)
Q Consensus 96 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-------~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~ 168 (325)
+|+|.++++. +.......+..+++.++.++|. ||||||+||+++.++..++. ||........ ....
T Consensus 767 ~g~L~~~l~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~ 839 (968)
T PLN00113 767 GKNLSEVLRN-LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCF 839 (968)
T ss_pred CCcHHHHHhc-CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCcc
Confidence 9999999964 5556667788899999999992 48999999999998887775 6554432211 1235
Q ss_pred CCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccC--CCCHH
Q 046728 169 GTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG--KFNRD 246 (325)
Q Consensus 169 ~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 246 (325)
+|..|+|||++.+..++.++|||||||++|||+||..||..... .......|..............++.+.. .....
T Consensus 840 ~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (968)
T PLN00113 840 ISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQN 918 (968)
T ss_pred ccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCCCCccHH
Confidence 78899999999988999999999999999999999999954322 2223334433222222222223333322 22345
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 247 QLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 247 ~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
...++.+++.+||..||++|||+.++++.|+....
T Consensus 919 ~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 919 EIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 56678899999999999999999999999997754
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=252.64 Aligned_cols=241 Identities=21% Similarity=0.287 Sum_probs=183.7
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
|....+||.| +++.||.++...+++.|++|.+... .......+.+|+++++.++|||++++++++.+....|+||
T Consensus 23 ~~~~~~lg~g--~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 23 FVGLHEIGHG--SFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred hhcceeeccC--CCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 3444567777 8888999999889999999998642 2333457888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 92 DYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 92 e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||+. |+|.+++.. .++...+..+..++..++.++|.. +||+|+||+++.++.++|+|||++..... .
T Consensus 101 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~ 174 (313)
T cd06633 101 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----A 174 (313)
T ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----C
Confidence 9995 588877732 244455566778888888888875 79999999999999999999998864322 2
Q ss_pred ccCCCCcCCCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 165 TRVKGTLGYLAPEYAM---WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
....++..|+|||++. ...++.++||||||+++|+|++|..||......... .... . .....
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~---~~~~----~--------~~~~~ 239 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIA----Q--------NDSPT 239 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHH----h--------cCCCC
Confidence 2345788999999984 356788999999999999999999998654321110 0000 0 00001
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
......+..+.+|+.+||..+|++||++.++++ |++.
T Consensus 240 ~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 240 LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 111234457899999999999999999999997 6654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=266.60 Aligned_cols=194 Identities=25% Similarity=0.338 Sum_probs=164.8
Q ss_pred hHHhhccCccceeeeeEEEeccCCCCeEEEEEecc-cChhhHHHHHHHHHHHHccCCCCccceeeEEEcC------CeEE
Q 046728 16 VFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKT-LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG------DERL 88 (325)
Q Consensus 16 ~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~ 88 (325)
..-+.||+| |++.||..+++.+|+.||||.++. .......++.+|+++|++|+|||||+++++=++. ....
T Consensus 16 ~~~e~LG~G--a~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 16 EMDERLGKG--AFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eehhhhcCC--ccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 445788888 889999999999999999999974 3455667899999999999999999999986544 3578
Q ss_pred EEEEecCCCChhhhhc-----cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeC--CCC--ceEEeeeccccc
Q 046728 89 IVYDYMPNHSLITHLH-----GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLD--TDF--EAKVADFGFAKL 155 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~-----~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~--~~~--~~kL~Dfg~~~~ 155 (325)
+|||||+||||...+. .++++...+.+...+..|+.++|.+ |||||.||++- .+| ..||+|||+|+-
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 9999999999999994 3477888888888999999999864 89999999994 333 489999999998
Q ss_pred cCCCcceeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCC
Q 046728 156 IPDGVTHMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGG 213 (325)
Q Consensus 156 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~ 213 (325)
+.++. .....+||..|.+||++.. ..|+..+|.|||||++|+++||..||-...+.
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 77654 3445689999999999994 78899999999999999999999999765443
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=260.74 Aligned_cols=264 Identities=17% Similarity=0.219 Sum_probs=192.0
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC---
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG--- 84 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 84 (325)
++...|...+.||.| +++.||.+....+++.||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g--~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 89 (342)
T cd07879 12 ELPERYTSLKQVGSG--AYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG 89 (342)
T ss_pred ccccceEEEEEeeec--CCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence 345567788999998 7778999998888999999998642 222334678899999999999999999998654
Q ss_pred ---CeEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccC
Q 046728 85 ---DERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIP 157 (325)
Q Consensus 85 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~ 157 (325)
..+++|+||+. .+|..++...++...+..+..++..++.++|.+ |||||+||+++.++.++|+|||++....
T Consensus 90 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 90 DEFQDFYLVMPYMQ-TDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred CCCceEEEEecccc-cCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 34689999995 488887765567777777888999999999875 7999999999999999999999987543
Q ss_pred CCcceeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccc--------cc
Q 046728 158 DGVTHMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYV--------QK 228 (325)
Q Consensus 158 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~--------~~ 228 (325)
... ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||................... ..
T Consensus 169 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 169 AEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 321 22346788999999875 457889999999999999999999997543211100000000000 00
Q ss_pred c---cc----ccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 229 G---AF----EHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 229 ~---~~----~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
. .+ .......+ ....+..++.+.+||.+||..||++|||+++++. ||+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDF-STLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred cchHHHHhhcCCcccchH-HHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0 00 00000000 0001134567899999999999999999999996 8887654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=261.78 Aligned_cols=267 Identities=17% Similarity=0.203 Sum_probs=197.7
Q ss_pred ceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC
Q 046728 7 ICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG 84 (325)
Q Consensus 7 ~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (325)
..+.+...|.+.+.||.| +++.||.++...+++.||+|.+... +......+.+|+.++++++|||++++++++...
T Consensus 9 ~~~~~~~~y~~~~~ig~g--~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07851 9 TVWEVPDRYQNLSPVGSG--AYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPA 86 (343)
T ss_pred ceecccCceEEEEEeccC--CceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcc
Confidence 456677888999999998 7778999999999999999998642 233445778899999999999999999988665
Q ss_pred Ce------EEEEEEecCCCChhhhhcc-CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccc
Q 046728 85 DE------RLIVYDYMPNHSLITHLHG-RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFA 153 (325)
Q Consensus 85 ~~------~~lV~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~ 153 (325)
.. .++|+||+ +++|.+++.. .++...+..+..++..++.++|.. +||||+||+++.++.++|+|||++
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 87 SSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccccccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 54 89999999 6799998853 466667778888999999999875 799999999999999999999999
Q ss_pred cccCCCcceeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccc
Q 046728 154 KLIPDGVTHMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFE 232 (325)
Q Consensus 154 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (325)
...... .....++..|+|||.+.+ ..++.++||||||+++|++++|..||...........+.............
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 166 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred cccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence 865432 223457888999998865 367889999999999999999999996543211111000000000000000
Q ss_pred ccc-----------CccccCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 233 HIA-----------DPRLKGK---FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 233 ~~~-----------~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
.+. ....... .....++.+.++|.+||..||++|||+.+|++ ||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 000 0000000 01124678999999999999999999999998 887543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=253.06 Aligned_cols=256 Identities=15% Similarity=0.185 Sum_probs=183.5
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccC-CCCccceeeEEEcCCe----
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDE---- 86 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~---- 86 (325)
.|++.+.||.| +++.||++....+++.||+|.+.... ......+.+|+.++++++ ||||+++++++.....
T Consensus 2 ~y~~~~~lg~g--~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 2 AYEKLEKIGEG--TYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CceEeeEeccc--CCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 36677889888 77789999998899999999886432 223357888999999995 7999999999876655
Q ss_pred -EEEEEEecCCCChhhhhcc-------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC-CCceEEeeeccc
Q 046728 87 -RLIVYDYMPNHSLITHLHG-------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT-DFEAKVADFGFA 153 (325)
Q Consensus 87 -~~lV~e~~~~gsL~~~l~~-------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~-~~~~kL~Dfg~~ 153 (325)
.|+||||+++ +|.+++.. .+++..++.+..++..++.++|.. +||+|+||+++. ++.++|+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999975 89888842 234556677888888888888875 799999999998 889999999998
Q ss_pred cccCCCcceeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCcc-chhhhhhccccccccc
Q 046728 154 KLIPDGVTHMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVK-RDIVQWVTPYVQKGAF 231 (325)
Q Consensus 154 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 231 (325)
......... .....+++.|+|||++.+ ..++.++|+||||+++|+|++|..||........ ..+..... ......+
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 236 (295)
T cd07837 159 RAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG-TPTEQVW 236 (295)
T ss_pred eecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC-CCChhhC
Confidence 865432211 112246788999998865 3578899999999999999999999975432111 00000000 0000000
Q ss_pred cccc-----------CccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 232 EHIA-----------DPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 232 ~~~~-----------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.... .+.......+..++.+.++|.+||..||++|||+++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 000000111245678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=246.80 Aligned_cols=240 Identities=18% Similarity=0.229 Sum_probs=182.1
Q ss_pred ccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHH---HHHccCCCCccceeeEEEcCCeEEEEEEec
Q 046728 21 INNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVE---ILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94 (325)
Q Consensus 21 i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~---~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~ 94 (325)
||+| +++.||.+++..+++.||+|.+.... ......+..|.. +++..+||+|+++++++...+..++||||+
T Consensus 2 ig~g--~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 2 IGRG--GFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred cccC--CCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence 5666 88889999999899999999986422 111223334433 444457999999999999999999999999
Q ss_pred CCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCC
Q 046728 95 PNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVK 168 (325)
Q Consensus 95 ~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~ 168 (325)
.||+|..++. ..+++..+..+..++..++.++|.. +||||+||+++.++.++|+|||++....... .....
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~~~ 156 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASV 156 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcCcC
Confidence 9999998884 3456667788888999999999875 7999999999999999999999987554321 22346
Q ss_pred CCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHH
Q 046728 169 GTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQ 247 (325)
Q Consensus 169 ~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (325)
|+..|+|||++.++ .++.++||||+|+++|+|++|..||............... . ......+...
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~----------~~~~~~~~~~ 222 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----L----------TMAVELPDSF 222 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh----h----------ccCCCCCCcC
Confidence 88999999998754 6889999999999999999999999764322111111000 0 0011223345
Q ss_pred HHHHHHHHHHccCCCCCCCC-----CHHHHHH--HHhcc
Q 046728 248 LKSMVLIALRCTDSNPENRP-----TMTDVVD--WLKGG 279 (325)
Q Consensus 248 ~~~~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~~ 279 (325)
+..+.+++.+||..+|++|| ++.++++ |++..
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 67899999999999999999 9999997 77653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=253.02 Aligned_cols=260 Identities=20% Similarity=0.259 Sum_probs=187.7
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcCC----
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD---- 85 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 85 (325)
...|.+.+.||.| +++.||++....+++.||+|.+.... ......+.+|+++++.++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g--~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 6 VDKFDIIGQIGEG--TYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhheeeeeccc--CCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 3467888999998 77789999988889999999986432 233346778999999999999999999987654
Q ss_pred ------eEEEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecc
Q 046728 86 ------ERLIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGF 152 (325)
Q Consensus 86 ------~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~ 152 (325)
.+++|+||+++ ++.+++.. .++...+..+..++..++.++|.. +||||+||++++++.+||+|||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence 78999999975 77777743 355566778888999999999975 79999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccc
Q 046728 153 AKLIPDGVTHMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAF 231 (325)
Q Consensus 153 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (325)
+...............++..|+|||.+.+. .++.++|||||||++|+|++|..||...........+...........+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 986654332212223457789999988643 4688999999999999999999999653321111111110000000011
Q ss_pred ccccCcc-------------ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 232 EHIADPR-------------LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 232 ~~~~~~~-------------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
+.+.... .........+..+.+++.+||..||++|||+.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1000000 000011234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=243.65 Aligned_cols=244 Identities=22% Similarity=0.306 Sum_probs=194.0
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcC--CeEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG--DERLIV 90 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lV 90 (325)
|...+.||.| +++.+|.+....+++.|++|.+.... ......+.+|+..+++++||||+++++.+... ...++|
T Consensus 2 ~~~~~~i~~g--~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 2 WTRGELLGRG--SFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred ceeeeEeeec--CceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 4556778888 78889999998889999999986543 34566888999999999999999999999888 889999
Q ss_pred EEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce-e
Q 046728 91 YDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH-M 163 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~-~ 163 (325)
+||+.+++|.+++.. .++......+..++..++.++|.. +||+|+||+++.++.++|+|||.+......... .
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 999999999999953 355566677888888888888875 699999999999999999999999876654321 1
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.....++..|+|||.+....++.++||||||+++|+|++|..||..... ....... +.........
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~---------~~~~~~~~~~ 225 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYK---------IGSSGEPPEI 225 (260)
T ss_pred ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHh---------ccccCCCcCC
Confidence 2234578899999999888899999999999999999999999975441 0011111 1111111223
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
+...+..+.+++.+||..||++||++.++++
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 3445788999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=251.15 Aligned_cols=261 Identities=19% Similarity=0.263 Sum_probs=187.0
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
.|.+.+.||.| +++.||+++...+++.||+|.+.... ......+.+|++++++++||||+++++++.+....++||
T Consensus 3 ~y~~~~~l~~g--~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 3 QYEKVEKIGEG--TYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred ceEEEEEecCC--CCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 46778889888 77789999988889999999986432 233356888999999999999999999999999999999
Q ss_pred EecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC-CCceEEeeeccccccCCCcce
Q 046728 92 DYMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT-DFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 92 e~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~-~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
||++ ++|.+++... .....+..+..++..++.++|.. +||+|+||+++. ++.+||+|||++.........
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 9995 5888887432 22334456777888999999875 799999999985 567999999999765432211
Q ss_pred eeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCcc-chhhhhhccccccccccc------c
Q 046728 163 MTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVK-RDIVQWVTPYVQKGAFEH------I 234 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~------~ 234 (325)
.....++..|+|||++.+. .++.++||||+|+++|+|+||..||........ ........ ......+.. .
T Consensus 160 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 160 -FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILG-TPNEETWPGVTSLPDY 237 (294)
T ss_pred -cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCChhhccccccchhh
Confidence 1223467889999988654 578899999999999999999999975432111 00000000 000000000 0
Q ss_pred cC--ccccC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 235 AD--PRLKG----KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 235 ~~--~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
.. +.... ...+..++++.+++.+||..||++||++.++++ ||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 00 00000 011335678999999999999999999999998 77653
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=254.37 Aligned_cols=266 Identities=17% Similarity=0.253 Sum_probs=193.7
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEc-CC
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG-GD 85 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~ 85 (325)
+.+...|.+++.||.| +++.||++....+++.||+|.+... .......+..|+.++++++||||+++++++.. ..
T Consensus 6 ~~~~~~y~~~~~ig~g--~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 6 FEITNRYVDLQPVGMG--AFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred eccccceEEEEeeccc--CCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 5567778899999998 7888999999999999999987532 23334577889999999999999999999865 56
Q ss_pred eEEEEEEecCCCChhhhhcc-CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 86 ERLIVYDYMPNHSLITHLHG-RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
..++|+||+ +++|.++++. .+....+..+..++..++.++|.. +||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 788999999 6699988853 445555566778888899999875 799999999999999999999998754332
Q ss_pred ceeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhh---------hhcccccccc
Q 046728 161 THMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQ---------WVTPYVQKGA 230 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~---------~~~~~~~~~~ 230 (325)
.....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||............. +.........
T Consensus 162 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 162 ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred ---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 122356788999998765 468899999999999999999999996533210000000 0000000000
Q ss_pred cccccCccccCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 231 FEHIADPRLKGKF-----NRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 231 ~~~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
...+......... .+..+..+.++|.+||..+|++|||+++++. |++....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~ 296 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD 296 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence 0000000000011 1234678999999999999999999999998 7765443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=252.03 Aligned_cols=242 Identities=21% Similarity=0.331 Sum_probs=193.1
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCCeEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 89 (325)
.|.+.+.||.| +++.||.+....+++.||+|.+... .......+.+|.+++++++ ||||+++++++.++...++
T Consensus 2 ~y~~~~~lg~g--~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 2 DFKFGKIIGEG--SFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred CceEeeeecCC--CceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence 46777888888 8888999999889999999998642 2333457888999999998 9999999999999999999
Q ss_pred EEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc--
Q 046728 90 VYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT-- 161 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 161 (325)
||||+++++|.+++.. .++...++.+..++..++.++|.. +||+|+||+++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 9999999999999953 366667788888999999999876 69999999999999999999999886654321
Q ss_pred -----------------eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcc
Q 046728 162 -----------------HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTP 224 (325)
Q Consensus 162 -----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 224 (325)
.......++..|+|||++....++.++|+||||+++|++++|..||...... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~- 235 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---LTFQKIL- 235 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHH-
Confidence 1122335778999999998888899999999999999999999999754310 0000000
Q ss_pred cccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Q 046728 225 YVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTM----TDVVD 274 (325)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~----~~il~ 274 (325)
......+...++.+.+++.+||..||++|||+ +++++
T Consensus 236 -------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 236 -------------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -------------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 01112234456789999999999999999999 87775
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=248.55 Aligned_cols=248 Identities=21% Similarity=0.328 Sum_probs=187.1
Q ss_pred hhHHhhccCccceeeeeEEEecc---CCCCeEEEEEecccC----hhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCe
Q 046728 15 AVFIQNINNGLEILMLLLLLRRE---TGDDQIAVKRLKTLN----AKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~---~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 86 (325)
|.+.+.||.| +++.||.++.. .++..||+|.+.... .....++.+|+++++++ +|+||+++++.+..+..
T Consensus 2 y~~~~~lg~G--~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (290)
T cd05613 2 FELLKVLGTG--AYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK 79 (290)
T ss_pred ceeeeeeccC--CcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence 5677889999 67778887764 467899999986422 22345778899999999 59999999999999999
Q ss_pred EEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 87 RLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
.++||||+++++|.+++. ..+....+..+..++..++.++|.. |||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 999999999999999984 3345556666777888888888875 7999999999999999999999988654432
Q ss_pred ceeeccCCCCcCCCCccccccC--CCCCcccchhHHHHHHHHHhCCCCCCCCCCCcc-chhhhhhcccccccccccccCc
Q 046728 161 THMTTRVKGTLGYLAPEYAMWG--KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVK-RDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
........++..|+|||.+.+. .++.++||||||+++|+|++|..||........ ........ . .
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~----~--------~ 227 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL----K--------S 227 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhh----c--------c
Confidence 2222334578899999998753 467899999999999999999999964221111 11100000 0 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH--HHhc
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRP-----TMTDVVD--WLKG 278 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~ 278 (325)
..+.+...++.+.+++.+||..||++|| +++++++ |++.
T Consensus 228 --~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 273 (290)
T cd05613 228 --EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273 (290)
T ss_pred --CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccccc
Confidence 0122334567899999999999999997 7788877 5654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=242.74 Aligned_cols=241 Identities=22% Similarity=0.292 Sum_probs=192.5
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh--hhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA--KAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
|++.+.||.| +++.+|.+....+++.|++|.+..... .....+.+|++++++++|||++++++++.+....++|||
T Consensus 2 y~~~~~l~~g--~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 2 YQLGDLIGRG--AFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred ceeeeEEccc--CCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 5677889888 777899998888899999999975433 455688999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeecc
Q 046728 93 YMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTR 166 (325)
Q Consensus 93 ~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 166 (325)
|+++++|.+++.. .++......+..++..++.++|.. +||+|+||+++.++.++|+|||++......... ...
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~ 158 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DAS 158 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-ccc
Confidence 9999999999853 355556677788888888888875 799999999999999999999999876553322 123
Q ss_pred CCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHH
Q 046728 167 VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRD 246 (325)
Q Consensus 167 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (325)
..++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... ...... . . ......+..
T Consensus 159 ~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~---~~~~~~---~-~---------~~~~~~~~~ 222 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM---AALFRI---V-Q---------DDHPPLPEG 222 (254)
T ss_pred cccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH---HHHHHH---h-c---------cCCCCCCCC
Confidence 45788999999988777889999999999999999999999653310 000000 0 0 001122334
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 247 QLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 247 ~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.+..+.+++.+||..+|++|||+.+++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 5678999999999999999999999885
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=265.88 Aligned_cols=246 Identities=21% Similarity=0.301 Sum_probs=197.5
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc-CCCCccceeeEEEc-----CCeEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAG-----GDERL 88 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-----~~~~~ 88 (325)
++|+..||.| ..+.|+++++..+++.+|+|++.. +.....++..|.++++.. +|||++.++++|.. ++++|
T Consensus 21 ~ei~evig~G--tygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 21 FEIIEVIGNG--TYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred cEEEEEEeec--cceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 4678899999 777788888889999999999865 334455888899999998 69999999999853 57899
Q ss_pred EEEEecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 89 IVYDYMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
+|||||.+||+.|.+++. +.+..+..+......+++++|.. ||||..|||++.++.|||+|||++..+...
T Consensus 98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT- 176 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST- 176 (953)
T ss_pred EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecc-
Confidence 999999999999999654 34444455556666677777654 899999999999999999999999877653
Q ss_pred ceeeccCCCCcCCCCccccccC-----CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccccc
Q 046728 161 THMTTRVKGTLGYLAPEYAMWG-----KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIA 235 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (325)
.....++.||+.|||||++... .|+..+|+||||++..||.-|.+|+..+-+ ....|..+.
T Consensus 177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP--------------mraLF~IpR 242 (953)
T KOG0587|consen 177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP--------------MRALFLIPR 242 (953)
T ss_pred cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch--------------hhhhccCCC
Confidence 3445677899999999999754 467799999999999999999999976432 123344444
Q ss_pred CccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 236 DPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
.+.++...+..-++++.++|..||..|.++||+..++++ ++.+
T Consensus 243 NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 243 NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 555555556778899999999999999999999999997 5543
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=247.96 Aligned_cols=248 Identities=21% Similarity=0.297 Sum_probs=186.8
Q ss_pred hhHHhhccCccceeeeeEEEecc---CCCCeEEEEEecccC----hhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCe
Q 046728 15 AVFIQNINNGLEILMLLLLLRRE---TGDDQIAVKRLKTLN----AKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~---~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 86 (325)
|.+.+.||.| +++.||.++.. .++..||+|.+.... .....++.+|++++.++ +||||+++++.+..+..
T Consensus 2 ~~~~~~ig~G--~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~ 79 (288)
T cd05583 2 FELLRVLGTG--AYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK 79 (288)
T ss_pred ceEEEEeccC--CCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence 5667889999 66678777643 456889999986422 23345788899999999 59999999999999999
Q ss_pred EEEEEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 87 RLIVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
.++||||+++|+|.+++.. .+....+..+..++..++.++|.. +||+|.||+++.++.++|+|||++.......
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 9999999999999999843 345556677788889999999875 7999999999999999999999987655433
Q ss_pred ceeeccCCCCcCCCCccccccCC--CCCcccchhHHHHHHHHHhCCCCCCCCCCCc-cchhhhhhcccccccccccccCc
Q 046728 161 THMTTRVKGTLGYLAPEYAMWGK--VSDSCDVYSFGVLLLELISAKKPLEKLPGGV-KRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
........++..|+|||.+.+.. .+.++|+||||+++|+|++|..||....... ...... .. ...
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~----~~--------~~~ 227 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR----RI--------LKS 227 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH----HH--------Hcc
Confidence 22223345788999999987654 6789999999999999999999996432110 000000 00 000
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~ 278 (325)
..+.+..++..+.+++.+||..||++|||+.++...|+.
T Consensus 228 --~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 --KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 112234456789999999999999999998777665543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=269.66 Aligned_cols=249 Identities=21% Similarity=0.352 Sum_probs=188.2
Q ss_pred hHHhhccCccceeeeeEEEe--ccCC-----CCeEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCe
Q 046728 16 VFIQNINNGLEILMLLLLLR--RETG-----DDQIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 16 ~~~~~i~~G~~~~~~v~~~~--~~~~-----~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 86 (325)
.+-+.+|+| .++.|+++. .... ...||||.++.. .......+..|+++|+.+ +||||+.++|++..+..
T Consensus 299 ~~~~~lg~g--~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 299 KLGKYLGEG--AFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred cccceeecc--cccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 455678888 555555554 3322 457999999743 345567899999999999 69999999999999999
Q ss_pred EEEEEEecCCCChhhhhcc-C-----------------CCCCCccCHHHHHHHHHHHHhh----cCCCCCCceeeCCCCc
Q 046728 87 RLIVYDYMPNHSLITHLHG-R-----------------LAPDCLLDWHRRVSIAIGSAEG----IADIKASNVLLDTDFE 144 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~-~-----------------~~~~~~~~~~~~~~~~~~~~~~----~rdlkp~Nil~~~~~~ 144 (325)
.++|+|||..|+|.+|++. + +.....+.+..|++.++.++.. ||||.++|||+..+..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV 456 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE
Confidence 9999999999999999953 2 2222334444444444444443 2899999999999999
Q ss_pred eEEeeeccccccCCCcceeeccCCC--CcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhh
Q 046728 145 AKVADFGFAKLIPDGVTHMTTRVKG--TLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQW 221 (325)
Q Consensus 145 ~kL~Dfg~~~~~~~~~~~~~~~~~~--t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~ 221 (325)
+||+|||+++..............+ +..|+|||.+....|+.++||||||++||||+| |..||.+.+.. .+...
T Consensus 457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~--~~l~~- 533 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT--EELLE- 533 (609)
T ss_pred EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH--HHHHH-
Confidence 9999999999766554444332222 456999999999899999999999999999998 89999763311 11111
Q ss_pred hcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 222 VTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
....+.+...|..+++++.++|..||..+|++||++.++.++|+..+.
T Consensus 534 ------------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 534 ------------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred ------------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 223344556667778999999999999999999999999999988654
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=255.01 Aligned_cols=263 Identities=16% Similarity=0.180 Sum_probs=193.5
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC--
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD-- 85 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 85 (325)
++...|.+++.||.| +++.||.+....++..||+|.+... .......+.+|+++++.++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 12 EVPDRYRDLKQVGSG--AYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred ccccceEEEEEeeec--CCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 455668889999999 7778999998888999999998542 2333457889999999999999999999987653
Q ss_pred ----eEEEEEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccccc
Q 046728 86 ----ERLIVYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLI 156 (325)
Q Consensus 86 ----~~~lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~ 156 (325)
.+++||||+ +++|.+++. ..++...+..+..++..++.++|.. |||||+||+++.++.++|+|||++...
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 358999999 779988884 3566667777888999999999875 799999999999999999999998865
Q ss_pred CCCcceeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccc--------
Q 046728 157 PDGVTHMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQ-------- 227 (325)
Q Consensus 157 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~-------- 227 (325)
... .....++..|+|||.+.+ ..++.++|+||||+++|++++|..||....................
T Consensus 169 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 169 DSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred ccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 432 123357888999998875 3578899999999999999999999975432111000000000000
Q ss_pred ccc-------cccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 228 KGA-------FEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 228 ~~~-------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
... ........+ .......++.+.++|.+|+..||++|||+.+++. ||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred chhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 000 000000000 0111245567899999999999999999999997 888654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=240.87 Aligned_cols=243 Identities=23% Similarity=0.268 Sum_probs=184.1
Q ss_pred HHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEEEEEec
Q 046728 17 FIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYM 94 (325)
Q Consensus 17 ~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lV~e~~ 94 (325)
=+..||.| +++.|.+..++.+|+..|||.+... ....++++..|.....+- ++||||+++|.......-|+-||.|
T Consensus 68 dlg~iG~G--~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 68 DLGEIGNG--AFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHhcCC--cchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 35667777 8888999999999999999999754 346677888898877776 7999999999998889999999999
Q ss_pred CCCChhhhh-------ccCCCCCCccCHHHHHHHHHHHHhh-----cCCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 95 PNHSLITHL-------HGRLAPDCLLDWHRRVSIAIGSAEG-----IADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 95 ~~gsL~~~l-------~~~~~~~~~~~~~~~~~~~~~~~~~-----~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
.-||..+. +.++++..+-.+.....-|+.++.. |||+||+|||++..|.+||||||++..+.++..
T Consensus 146 -d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA- 223 (361)
T KOG1006|consen 146 -DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA- 223 (361)
T ss_pred -hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH-
Confidence 45776555 3456666555555555556666643 499999999999999999999999987765322
Q ss_pred eeccCCCCcCCCCccccccC--CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 163 MTTRVKGTLGYLAPEYAMWG--KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
...-+|-.+|+|||.+... .|+.+||+||||++|||++||..||.+... ...++.+.+. +..+.+. .
T Consensus 224 -kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-vfeql~~Vv~-----gdpp~l~----~ 292 (361)
T KOG1006|consen 224 -KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-VFEQLCQVVI-----GDPPILL----F 292 (361)
T ss_pred -hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-HHHHHHHHHc-----CCCCeec----C
Confidence 2334577889999998743 588999999999999999999999976543 1111111111 1111111 0
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.......+..+..+|..|+.+|-+.||+..++..
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1112457789999999999999999999999987
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=256.67 Aligned_cols=242 Identities=22% Similarity=0.307 Sum_probs=201.4
Q ss_pred HhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecC
Q 046728 18 IQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95 (325)
Q Consensus 18 ~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~ 95 (325)
.++||+| -|+.||-.+++++|+.||||.+.+. .+....++.+|++||.+++||.||.+.-.|++.+.+++|||-+
T Consensus 569 devLGSG--QFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl- 645 (888)
T KOG4236|consen 569 DEVLGSG--QFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL- 645 (888)
T ss_pred HhhccCC--cceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-
Confidence 4677888 6677999999999999999999754 3444568899999999999999999999999999999999999
Q ss_pred CCChhhhh----ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC---CceEEeeeccccccCCCcceee
Q 046728 96 NHSLITHL----HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD---FEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 96 ~gsL~~~l----~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~---~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
+|+..+.| ++++++....-...|+..|+.++|-. .||||+|+|+.+. ..+||||||++++.++....
T Consensus 646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR-- 723 (888)
T KOG4236|consen 646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR-- 723 (888)
T ss_pred cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh--
Confidence 56877777 57788887788889999999999975 6999999999654 57999999999998875443
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
...+||+.|.|||++.+..|+..-|+||+|+++|.-++|.+||....+ ..+. ++...|.- ++..+
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQ-------IQNAaFMy------Pp~PW 788 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQ-------IQNAAFMY------PPNPW 788 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHH-------hhcccccc------CCCch
Confidence 345799999999999999999999999999999999999999965322 2222 22222221 23456
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
.++++...+||...|+..-.+|-|.++.+. ||+..
T Consensus 789 ~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 789 SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 888999999999999999999999999997 88765
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=254.62 Aligned_cols=264 Identities=17% Similarity=0.191 Sum_probs=191.5
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC---
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG--- 84 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 84 (325)
.+...|.+.+.||.| +++.||.+....+++.||+|.+... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G--~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 14 EVPERYQNLSPVGSG--AYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred hccCceEEEEEeeec--CCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence 455677888999999 7777899988888999999998643 233345778899999999999999999988643
Q ss_pred ---CeEEEEEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccccc
Q 046728 85 ---DERLIVYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLI 156 (325)
Q Consensus 85 ---~~~~lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~ 156 (325)
...+++++++ +++|.++++ ..++...+..+..++..+++++|.. |||||+||+++.++.++|+|||++...
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 3467888887 789988874 3456666777888999999999976 799999999999999999999998754
Q ss_pred CCCcceeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccccc
Q 046728 157 PDGVTHMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIA 235 (325)
Q Consensus 157 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (325)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+..............+.
T Consensus 171 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 171 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred ccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 332 223457889999998865 467889999999999999999999996533211111000000000000000000
Q ss_pred C-----------cccc---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 236 D-----------PRLK---GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 236 ~-----------~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
. .... .......++.+.++|.+||..||.+|||+.++++ ||....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 0 0000 0001124567899999999999999999999998 887654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=247.69 Aligned_cols=255 Identities=19% Similarity=0.241 Sum_probs=189.0
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
|.+.+.||.| +++.||.++...+++.||+|.+... .......+..|+.++++++|||++++++++.+....++|||
T Consensus 1 y~~~~~ig~g--~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEG--TYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred Ceeehccccc--CcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence 3566788888 7888999999999999999998754 23344577889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 93 YMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 93 ~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
|+. ++|.+++.. .++...+..+..++..++.++|.. +||+|+||+++.++.++|+|||++......... ..
T Consensus 79 ~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~~ 156 (282)
T cd07829 79 YCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YT 156 (282)
T ss_pred CcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-cC
Confidence 997 599999953 356666777888888888888875 799999999999999999999998866543221 12
Q ss_pred cCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccch-hhhhhcc--------cc----ccccc
Q 046728 166 RVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRD-IVQWVTP--------YV----QKGAF 231 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~-~~~~~~~--------~~----~~~~~ 231 (325)
...++..|+|||.+.+. .++.++|+||||+++|+|++|..||.......... ....... .. ....+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 23356789999998766 78899999999999999999999996543211100 0000000 00 00001
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 232 EHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
........ ....+..+..+.++|.+||..||++||+++++++
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 237 PKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 11000000 0111223678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=248.50 Aligned_cols=237 Identities=24% Similarity=0.319 Sum_probs=194.1
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 87 (325)
...|.|+.+||+| +++.|.++.++.+...+|||++++. +.....--+.|-++|... +-|.++.++..|++.+.+
T Consensus 348 ~tDFnFl~VlGKG--SFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 348 ATDFNFLMVLGKG--SFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred ecccceEEEeccC--ccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 3568899999999 8889999999999999999999753 222233344577777776 588999999999999999
Q ss_pred EEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 88 LIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
|+||||+.||+|--.|+ +++.+..+.-+...+++++-++|.. ||||.+|+|++..|.+||+|||+++----. .
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~-~ 504 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD-G 504 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC-C
Confidence 99999999999988885 5678888888899999999999986 799999999999999999999999832211 2
Q ss_pred eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 162 HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
..+.+++||+-|+|||++...+|+.++|.||+|++||||+.|++||.+....... +. +.+. ..
T Consensus 505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF---~a------------I~eh--nv 567 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---QA------------IMEH--NV 567 (683)
T ss_pred cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HH------------HHHc--cC
Confidence 2345688999999999999999999999999999999999999999875432221 11 1111 12
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCC
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPT 268 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps 268 (325)
..+..++.+..++.+..|...|.+|..
T Consensus 568 syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 568 SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred cCcccccHHHHHHHHHHhhcCCccccC
Confidence 456778889999999999999999964
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=244.80 Aligned_cols=254 Identities=20% Similarity=0.268 Sum_probs=184.3
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHcc---CCCCccceeeEEEcCCe---
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRV---RHRNLLGLRGFYAGGDE--- 86 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~--- 86 (325)
|.+.+.||.| +++.||+++...+++.||+|.+.... ......+.+|+.+++++ +|||++++++++.....
T Consensus 1 y~~~~~l~~g--~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEG--AYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEeccc--CceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 4567788888 77789999998889999999996322 22234566788877766 59999999999988776
Q ss_pred --EEEEEEecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccccc
Q 046728 87 --RLIVYDYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLI 156 (325)
Q Consensus 87 --~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~ 156 (325)
.+++|||+. ++|.+++.. .++...++.+..++..++.++|.. +||+|+||+++.++.++|+|||++...
T Consensus 79 ~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 79 LKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred ceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 899999996 489888843 245556677888888888888875 699999999999999999999998876
Q ss_pred CCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccch-hhhhhccccc--------
Q 046728 157 PDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRD-IVQWVTPYVQ-------- 227 (325)
Q Consensus 157 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~-~~~~~~~~~~-------- 227 (325)
...... ....++..|+|||.+.+..++.++|+|||||++|+|++|.+||.......... ..........
T Consensus 158 ~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 158 SFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred cCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 443221 22346888999999998889999999999999999999999987543211110 0000000000
Q ss_pred --ccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 228 --KGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 228 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
...+...... ......+..++.+.+++.+||..||++||+++++++
T Consensus 236 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 236 LPRSSFPSYTPR-SFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cchhhccccccc-chhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000 001112345678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=218.59 Aligned_cols=256 Identities=18% Similarity=0.248 Sum_probs=196.5
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
|.-.++||+| .++.|++++...+++.||+|.+... +........+|+.+++.++|.|||+++++...+..+-+|+|
T Consensus 4 ydkmekigeg--tygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 4 YDKMEKIGEG--TYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred hHHHHhhcCC--cceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 5567889999 8889999999999999999998643 34445678899999999999999999999999999999999
Q ss_pred ecCCCChhhhh---ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 93 YMPNHSLITHL---HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 93 ~~~~gsL~~~l---~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
|| +.+|..|. .+-+....+.++..|+..++.+.|++ ||+||+|.+++.+|.+||+|||+++.++........
T Consensus 82 ~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysa 160 (292)
T KOG0662|consen 82 FC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA 160 (292)
T ss_pred Hh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence 99 45888777 34456666778888888888888886 899999999999999999999999988765433322
Q ss_pred cCCCCcCCCCccccccCC-CCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhccccccccccccc---Ccccc
Q 046728 166 RVKGTLGYLAPEYAMWGK-VSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIA---DPRLK 240 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 240 (325)
. .-|..|++|.++.+.. |++..|+||-||++.|+.. |++.|.+....+....+-|.........++.+. +....
T Consensus 161 e-vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 161 E-VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred e-eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 2 3688999999998764 7899999999999999987 677776654443333333333222333332221 11111
Q ss_pred CCC-----C----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 241 GKF-----N----RDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 241 ~~~-----~----~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
+.. + +.+...-++|+++.+.-+|.+|+++++.++
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111 1 234446788999999999999999999887
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=250.53 Aligned_cols=262 Identities=17% Similarity=0.227 Sum_probs=186.6
Q ss_pred hhHHhhccCccceeeeeEEEeccCC--CCeEEEEEeccc--ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcC----C
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETG--DDQIAVKRLKTL--NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGG----D 85 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~--~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~----~ 85 (325)
|.+.+.||.| +++.||+++...+ +..||+|.+... .......+.+|+.+++++ +||||+++++..... .
T Consensus 2 y~~~~~lg~G--~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 2 YELIKELGQG--AYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred ceEEEEcccc--CCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 5677888888 7778888888877 889999998642 223345778899999999 599999999875332 4
Q ss_pred eEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC
Q 046728 86 ERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 159 (325)
.++++++|+. ++|.+++. ..++...+..+..++..++.++|.. |||||+|||++.++.++|+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 5789999985 68998884 3355666777888999999999975 799999999999999999999999865432
Q ss_pred cce---eeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhh-h--------hhcccc
Q 046728 160 VTH---MTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIV-Q--------WVTPYV 226 (325)
Q Consensus 160 ~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~-~--------~~~~~~ 226 (325)
... ......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||............ . ......
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 211 1223458889999998765 46889999999999999999999999653311100000 0 000000
Q ss_pred cccc------cccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 227 QKGA------FEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 227 ~~~~------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
.... ......... .......+..+.+++.+||..||++|||+.+++. ||.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPF-ESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhHHHHHHhccccCCcch-HhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 0000 000000000 0011223568999999999999999999999998 887654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=246.06 Aligned_cols=249 Identities=18% Similarity=0.286 Sum_probs=186.7
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-hhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 89 (325)
...|.+.+.||.| +++.||++....+++.||+|.+.... .....++..|..++.+. .||||+++++++.+....++
T Consensus 14 ~~~~~~~~~lg~g--~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSG--TCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred cchheeeeEeecc--CCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 3567889999999 77789999988889999999997532 33445667777777776 49999999999999999999
Q ss_pred EEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhh-----cCCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 90 VYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEG-----IADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 90 V~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~-----~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
||||+. ++|.+++. ..++......+..++..++.++|. |+||+|+||+++.++.++|+|||++........
T Consensus 92 v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 92 CMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred EeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 999984 57766663 334555556788888889998885 279999999999999999999999876543222
Q ss_pred eeeccCCCCcCCCCccccccCC----CCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 162 HMTTRVKGTLGYLAPEYAMWGK----VSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~~~----~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
. ....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...... ......... . .
T Consensus 171 ~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~---~--------~ 235 (296)
T cd06618 171 K--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKILQ---E--------E 235 (296)
T ss_pred c--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHHhc---C--------C
Confidence 1 2234778899999987543 788999999999999999999999643221 111111000 0 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
....+....++.++.+|+.+||..||++||+++++++ |+..
T Consensus 236 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 236 PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 0001111235678999999999999999999999998 7664
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=239.36 Aligned_cols=233 Identities=24% Similarity=0.342 Sum_probs=184.6
Q ss_pred ccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCCCChh
Q 046728 24 GLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100 (325)
Q Consensus 24 G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~gsL~ 100 (325)
|.|+++.+|.+....+++.||+|.+.... ......+..|+.++++++||||+++++.+..+...++||||+++++|.
T Consensus 2 g~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 81 (250)
T cd05123 2 GKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF 81 (250)
T ss_pred CCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHH
Confidence 34488899999988889999999986532 224557888999999999999999999999999999999999999999
Q ss_pred hhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCCCcCCC
Q 046728 101 THLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL 174 (325)
Q Consensus 101 ~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~ 174 (325)
+++.. .++......+..++..++.++|.. +||+|.||+++.++.++|+|||++........ ......++..|+
T Consensus 82 ~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~ 160 (250)
T cd05123 82 SHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFCGTPEYL 160 (250)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCCcCCcccc
Confidence 99953 356666777888899999999875 79999999999999999999999886544321 122345788999
Q ss_pred CccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHH
Q 046728 175 APEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLI 254 (325)
Q Consensus 175 aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (325)
|||...+...+.++|+||||+++|++++|..||..... ......+ ... ....+...+..+.++
T Consensus 161 ~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~------------~~~--~~~~~~~~~~~l~~~ 223 (250)
T cd05123 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKI------------LKD--PLRFPEFLSPEARDL 223 (250)
T ss_pred ChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH------------hcC--CCCCCCCCCHHHHHH
Confidence 99999887888999999999999999999999965432 1111110 000 112333446789999
Q ss_pred HHHccCCCCCCCCCH---HHHHH
Q 046728 255 ALRCTDSNPENRPTM---TDVVD 274 (325)
Q Consensus 255 i~~cl~~dp~~Rps~---~~il~ 274 (325)
+.+||..||++|||+ +++++
T Consensus 224 i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 224 ISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred HHHHhcCCHhhCCCcccHHHHHh
Confidence 999999999999999 55554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=283.17 Aligned_cols=243 Identities=23% Similarity=0.278 Sum_probs=196.2
Q ss_pred HHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEec
Q 046728 17 FIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94 (325)
Q Consensus 17 ~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~ 94 (325)
..+-+..|.|.+|.||.+....+|...|+|-+.-. .......+.+|..++..++|||+|+++|+-.+.+..+|.||||
T Consensus 1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC 1316 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYC 1316 (1509)
T ss_pred eccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHh
Confidence 34455667779999999999999999999977532 2444567889999999999999999999999999999999999
Q ss_pred CCCChhhhhc-cC-CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc---eeec
Q 046728 95 PNHSLITHLH-GR-LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT---HMTT 165 (325)
Q Consensus 95 ~~gsL~~~l~-~~-~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~ 165 (325)
++|+|.+.+. ++ ..+.....+..|+..++.++|.+ |||||.||+++.+|.+|++|||.|..+..... ...+
T Consensus 1317 ~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~ 1396 (1509)
T KOG4645|consen 1317 EGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQ 1396 (1509)
T ss_pred ccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHH
Confidence 9999999994 32 34444556788999999999986 79999999999999999999999987765421 1234
Q ss_pred cCCCCcCCCCccccccC---CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 166 RVKGTLGYLAPEYAMWG---KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~---~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
...||+.|||||++.+. .-..++||||+|||+.||+||+.||..... ...++..+. .+. .++
T Consensus 1397 ~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--e~aIMy~V~----~gh---------~Pq 1461 (1509)
T KOG4645|consen 1397 SMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--EWAIMYHVA----AGH---------KPQ 1461 (1509)
T ss_pred hhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--hhHHHhHHh----ccC---------CCC
Confidence 45799999999999864 356799999999999999999999976543 222222221 111 234
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.|..++++-.++|.+||..||.+|-++.|+++
T Consensus 1462 ~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1462 IPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred CchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 55668999999999999999999999988887
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=258.85 Aligned_cols=238 Identities=20% Similarity=0.298 Sum_probs=194.7
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 89 (325)
+...|.+...+|.| +++.+-.+.+..+++..++|++.+.. ..-.+|+.++... +|||++++++++.++.+.|+
T Consensus 320 ~~~~y~~~~~~~~g--s~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEG--SFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCC--Cccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeee
Confidence 55667888888888 77888888999999999999997641 1334577777777 69999999999999999999
Q ss_pred EEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceee-CCCCceEEeeeccccccCCCccee
Q 046728 90 VYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLL-DTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 90 V~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~-~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
|||.+.|+-+.+.+. ......++..|..++..|+.++|++ |||||+|||+ ++.+.++|+|||.++.....
T Consensus 394 v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---- 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---- 469 (612)
T ss_pred eehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence 999999998888874 2222345667999999999999987 7999999999 68899999999999876654
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
..+.+-|..|.|||++....|+.++|+||||++||+|++|+.||...+.+ .++... ...+.+
T Consensus 470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~----------------i~~~~~ 531 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTR----------------IQMPKF 531 (612)
T ss_pred hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHh----------------hcCCcc
Confidence 23335678899999999889999999999999999999999999877765 111111 111223
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HH
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WL 276 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l 276 (325)
....|...++||++||..||.+||++.++.. |+
T Consensus 532 s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 532 SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 3567889999999999999999999999998 88
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=250.52 Aligned_cols=247 Identities=22% Similarity=0.271 Sum_probs=196.5
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
|...++||+| |++.|+-+....+|+-+|.|.+.+.. ........+|-+++.+++.+.||.+--.|++++.+|+||
T Consensus 187 F~~~RvlGkG--GFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 187 FRVYRVLGKG--GFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred eeeeEEEecc--cccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 4567889999 88899999999999999999885421 233346778999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 92 DYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 92 e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
..|.||||.-+|.+ .+++..+.-+..++..++..+|.. ||+||+|||+|+.|++.|+|+|+|..+..+...
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~- 343 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI- 343 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCcc-
Confidence 99999999888843 456666677777777777777765 799999999999999999999999987765443
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
...+||.+|||||++.+..|+...|.|||||++|||+.|+.||.....-+....+.... ... ....
T Consensus 344 -~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~-----------~~~--~~ey 409 (591)
T KOG0986|consen 344 -RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT-----------LED--PEEY 409 (591)
T ss_pred -ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH-----------hcc--hhhc
Confidence 33479999999999999999999999999999999999999997544322221111110 000 1234
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH--HHhc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPT-----MTDVVD--WLKG 278 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps-----~~~il~--~l~~ 278 (325)
+..++++..+|.+..|..||++|.- ++++-+ +|+.
T Consensus 410 ~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 410 SDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred ccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 4678889999999999999999975 456655 5554
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=243.79 Aligned_cols=254 Identities=20% Similarity=0.302 Sum_probs=184.8
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-hhhHHHHHHHHHHHHccC-CCCccceeeEEEcCCeEEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lV~e 92 (325)
|.+.+.||.| +++.||.++...+++.|+||.+.... ........+|+..+++++ |||++++++++.++...++|||
T Consensus 1 y~~~~~ig~g--~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDG--TFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccC--CceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 4577888888 78889999988889999999986432 223335567999999998 9999999999999999999999
Q ss_pred ecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 93 YMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|+ +|+|.+++.. .++...+..+..++..++.++|.. +||+|+||+++.++.++|+|||.+........ .
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 155 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--Y 155 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--c
Confidence 99 7899998853 345556677888888888888875 69999999999999999999999986544222 1
Q ss_pred ccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccch-hhh---------hhccccccccc--
Q 046728 165 TRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRD-IVQ---------WVTPYVQKGAF-- 231 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~-~~~---------~~~~~~~~~~~-- 231 (325)
....++..|+|||++.. ..++.++|+||||+++|+|++|..||.......... ... |..........
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 22357888999998754 457889999999999999999999996543211100 000 00000000000
Q ss_pred --ccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 232 --EHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.......+ .......+..+.+++.+||..||++|||+++++.
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 236 RFPQFAPTSL-HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccH-HHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000 0001122567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=242.22 Aligned_cols=240 Identities=18% Similarity=0.324 Sum_probs=184.3
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-----ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-----NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
|.+.+.||.| +++.||.++....+..+++|.++.. ......++..|+.++++++||||+++++++.+....++
T Consensus 2 y~i~~~ig~g--~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 2 YILQQRLGKG--SFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred ceeeeeecCC--CCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEE
Confidence 6678889999 7888998888777766777766431 22333467789999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcc------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC
Q 046728 90 VYDYMPNHSLITHLHG------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 159 (325)
||||+++++|.+++.. .+++..++.+..++..++.++|.. +||+|+||+++. +.++|+|||.+......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 9999999999988742 244555677788888888888875 699999999975 57999999998765433
Q ss_pred cceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 160 VTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 160 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ....... . ...
T Consensus 159 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~---~~~~~~~------------~-~~~ 221 (260)
T cd08222 159 CDL-ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRI------------V-EGP 221 (260)
T ss_pred ccc-ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHH------------H-cCC
Confidence 221 2234578899999998877888999999999999999999999854221 1111100 0 011
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
....+...+.++.++|.+||..||++||++.++++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11233456778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=244.07 Aligned_cols=252 Identities=21% Similarity=0.264 Sum_probs=199.5
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEec--cc-----ChhhHHHHHHHHHHHHccCCCCccceeeEE-
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLK--TL-----NAKAEMEFAVEVEILGRVRHRNLLGLRGFY- 81 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~--~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 81 (325)
.+..+|.++-.||.| ||+.||++-.....+.||+|+-. +. .....+...+|..|.+.|+||.||+++++|
T Consensus 460 tLn~RYLlLhLLGrG--GFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRG--GFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS 537 (775)
T ss_pred chHHHHHHHHHhccc--cHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence 467788999999999 99999999999999999999753 21 122234677899999999999999999998
Q ss_pred EcCCeEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc------CCCCCCceeeCC---CCceEEeee
Q 046728 82 AGGDERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI------ADIKASNVLLDT---DFEAKVADF 150 (325)
Q Consensus 82 ~~~~~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~------rdlkp~Nil~~~---~~~~kL~Df 150 (325)
.+.+.+|-|+|||+|.+|.-|++ ..++++.+.++..++..|+.|+... -||||.|||+.. .|.+||+||
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred eccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 45678999999999999999994 5578889999999999999998876 499999999953 478999999
Q ss_pred ccccccCCCcce------eeccCCCCcCCCCccccccC----CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhh
Q 046728 151 GFAKLIPDGVTH------MTTRVKGTLGYLAPEYAMWG----KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQ 220 (325)
Q Consensus 151 g~~~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~----~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~ 220 (325)
|+++++.+.... .+....||.+|.+||++.-+ ..+.++||||+||++|.+++|+.||...... .++.+
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdILq 695 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDILQ 695 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHHh
Confidence 999998764332 23456799999999998744 3688999999999999999999999764321 11111
Q ss_pred hhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 221 WVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
. +.... -.+...+..+..+.+...+|.+||.+.-++|....++..
T Consensus 696 e-NTIlk--------AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 696 E-NTILK--------ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred h-hchhc--------ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1 00000 111122333567789999999999999999999998886
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=248.76 Aligned_cols=260 Identities=17% Similarity=0.187 Sum_probs=184.4
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh--hhHHHHHHHHHHHHccCCCCccceeeEEEcC-----
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA--KAEMEFAVEVEILGRVRHRNLLGLRGFYAGG----- 84 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 84 (325)
...|.+.+.||.| +++.||++....+++.||+|.+..... .....+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g--~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEG--TFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccC--CCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 3567888999998 788899999999999999998864322 2234567899999999999999999987543
Q ss_pred ---CeEEEEEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccc
Q 046728 85 ---DERLIVYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 85 ---~~~~lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
..+++||||+.+ +|...+. ..++...+..+..++..++.++|.. +||||+||+++.++.++|+|||++.
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 346899999964 7777764 2456667778888999999999985 7999999999999999999999998
Q ss_pred ccCCCcceee----------ccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhc
Q 046728 155 LIPDGVTHMT----------TRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVT 223 (325)
Q Consensus 155 ~~~~~~~~~~----------~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 223 (325)
.......... ....++..|+|||.+.+. .++.++|||||||++|+|++|.+||................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 6543222111 122457789999987654 57889999999999999999999996543321111110000
Q ss_pred cccccccc------cccc----CccccC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 224 PYVQKGAF------EHIA----DPRLKG---KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 224 ~~~~~~~~------~~~~----~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.......+ .... ...... ......++.+.+++.+||..||++|||+.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000 0000 000000 001123467899999999999999999999986
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=242.70 Aligned_cols=258 Identities=13% Similarity=0.098 Sum_probs=179.7
Q ss_pred eeecccchhHHhhccCccceeeeeEEEeccCC---CCeEEEEEecccChhhH-----------HHHHHHHHHHHccCCCC
Q 046728 8 CFLLASPAVFIQNINNGLEILMLLLLLRRETG---DDQIAVKRLKTLNAKAE-----------MEFAVEVEILGRVRHRN 73 (325)
Q Consensus 8 ~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~---~~~vaiK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~~ 73 (325)
.-...+.|.+.+.||+| +++.||.+....+ +..+|+|.......... .....+...+..+.|++
T Consensus 7 ~~i~~~~y~i~~~LG~G--~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 7 IDITGKEWKIDKLIGCG--GFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred eccCCCceEEeeEEecC--CCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 33456788999999999 7788999987777 66777876532221110 11223344555678999
Q ss_pred ccceeeEEEcCC----eEEEEEEecCCCChhhhhccC--CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC
Q 046728 74 LLGLRGFYAGGD----ERLIVYDYMPNHSLITHLHGR--LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF 143 (325)
Q Consensus 74 iv~~~~~~~~~~----~~~lV~e~~~~gsL~~~l~~~--~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~ 143 (325)
++++++...... ..+++++++. .++.+.++.. .+...+..+..++..++.++|.. |||||+|||++.++
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN 163 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence 999998765433 3478888874 4676666432 34445667888999999999975 89999999999999
Q ss_pred ceEEeeeccccccCCCcce------eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccch
Q 046728 144 EAKVADFGFAKLIPDGVTH------MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRD 217 (325)
Q Consensus 144 ~~kL~Dfg~~~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~ 217 (325)
.++|+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-- 241 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-- 241 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH--
Confidence 9999999999866432111 11224589999999999988999999999999999999999999976532111
Q ss_pred hhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 218 IVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
....... .....+..+.. .....++.+.+++..||..+|++||+++++++.|+
T Consensus 242 ~~~~~~~----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKC----DFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHH----HHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0000000 00011111111 11234578999999999999999999999998763
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=233.97 Aligned_cols=214 Identities=19% Similarity=0.287 Sum_probs=169.7
Q ss_pred ceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCCCChhhhhcc
Q 046728 26 EILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHLHG 105 (325)
Q Consensus 26 ~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 105 (325)
|.++.||++++..+++.||+|.+.... .+.+|...+....|||++++++++.+....++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 377889999999999999999997532 233455555566799999999999999999999999999999999843
Q ss_pred --CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCCCcCCCCcccc
Q 046728 106 --RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYA 179 (325)
Q Consensus 106 --~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 179 (325)
.++...+..+..++..++.++|.. |||||+||+++.++.++|+|||.+....... ....++..|+|||.+
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~aPE~~ 154 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCAPEVG 154 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccCCccc
Confidence 355666778888999999999875 7999999999999999999999876554321 223456779999999
Q ss_pred ccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHcc
Q 046728 180 MWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCT 259 (325)
Q Consensus 180 ~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 259 (325)
.+..++.++|+||+|+++|+|++|..||...+.... . ......+...++.+.++|.+||
T Consensus 155 ~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~---------~~~~~~~~~~~~~~~~li~~~l 213 (237)
T cd05576 155 GISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------T---------HTTLNIPEWVSEEARSLLQQLL 213 (237)
T ss_pred CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------c---------ccccCCcccCCHHHHHHHHHHc
Confidence 888889999999999999999999988754321100 0 0001123345678999999999
Q ss_pred CCCCCCCCCH
Q 046728 260 DSNPENRPTM 269 (325)
Q Consensus 260 ~~dp~~Rps~ 269 (325)
..||++|||+
T Consensus 214 ~~dp~~R~~~ 223 (237)
T cd05576 214 QFNPTERLGA 223 (237)
T ss_pred cCCHHHhcCC
Confidence 9999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=267.11 Aligned_cols=245 Identities=20% Similarity=0.287 Sum_probs=184.9
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC-----
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG----- 84 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 84 (325)
+...|+-+..||+| |||.||+++.+-+|+.+|||+|... +.....++.+|+.++.+|+|||||+|+..|...
T Consensus 477 Y~~DFEEL~lLGkG--GFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKG--GFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCC--CCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 55678889999999 9999999999999999999999743 445556888999999999999999999765310
Q ss_pred --------------------------------------------------------------------------------
Q 046728 85 -------------------------------------------------------------------------------- 84 (325)
Q Consensus 85 -------------------------------------------------------------------------------- 84 (325)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeEEEEEEecCCCChhhhhcc-CCC--CCCccCHHHHHHHHHHHHh
Q 046728 85 ----------------------------------DERLIVYDYMPNHSLITHLHG-RLA--PDCLLDWHRRVSIAIGSAE 127 (325)
Q Consensus 85 ----------------------------------~~~~lV~e~~~~gsL~~~l~~-~~~--~~~~~~~~~~~~~~~~~~~ 127 (325)
..+||=||||+.-+|.++++. .+. ...++.+++++.-++.|.|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 025789999999788888843 332 5678899999999999999
Q ss_pred hc----CCCCCCceeeCCCCceEEeeeccccccC----C-------------CcceeeccCCCCcCCCCccccccC---C
Q 046728 128 GI----ADIKASNVLLDTDFEAKVADFGFAKLIP----D-------------GVTHMTTRVKGTLGYLAPEYAMWG---K 183 (325)
Q Consensus 128 ~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~----~-------------~~~~~~~~~~~t~~y~aPE~~~~~---~ 183 (325)
.. |||||.|||+++++.|||+|||++.... . ..........||.-|+|||++.+. .
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 85 8999999999999999999999998621 0 011123445799999999999865 4
Q ss_pred CCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC--CCHHHHHHHHHHHHHccCC
Q 046728 184 VSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK--FNRDQLKSMVLIALRCTDS 261 (325)
Q Consensus 184 ~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~ 261 (325)
|+.|+|+||||||++||+. ||... ..+ . ..+..+.++.++.+ +..+.-+.-..+|..|++.
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~Ts---MER--a---------~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~h 857 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTS---MER--A---------SILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSH 857 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCch---HHH--H---------HHHHhcccCCCCCCcccccccchHHHHHHHHHhcC
Confidence 9999999999999999987 45321 110 0 01111222222212 1222223455689999999
Q ss_pred CCCCCCCHHHHHH
Q 046728 262 NPENRPTMTDVVD 274 (325)
Q Consensus 262 dp~~Rps~~~il~ 274 (325)
||++|||+.++++
T Consensus 858 dP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 858 DPSKRPTATELLN 870 (1351)
T ss_pred CCccCCCHHHHhh
Confidence 9999999999997
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=236.96 Aligned_cols=262 Identities=18% Similarity=0.239 Sum_probs=190.0
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCC----eEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEc
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDD----QIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG 83 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~----~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (325)
+.-+.|+.++.||.| .++-||++....++. .+|||.++.. .........+|+.+++.++||||+.+..+|..
T Consensus 21 e~l~~ye~ig~Ig~G--TYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRG--TYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS 98 (438)
T ss_pred HHHHHhhccceeccc--ccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence 334456777778777 899999996665533 6899999753 22233477889999999999999999999876
Q ss_pred -CCeEEEEEEecCCCChhhhhc-------cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC----CceEE
Q 046728 84 -GDERLIVYDYMPNHSLITHLH-------GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD----FEAKV 147 (325)
Q Consensus 84 -~~~~~lV~e~~~~gsL~~~l~-------~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~----~~~kL 147 (325)
+..+++++||.+. +|.+.|+ ..++...+.++..|+.-++.|+|+. |||||.|||+..+ |.|||
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEe
Confidence 7889999999977 9999883 2355566788889999999999984 9999999999877 89999
Q ss_pred eeeccccccCCCcce--eeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccch------h
Q 046728 148 ADFGFAKLIPDGVTH--MTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRD------I 218 (325)
Q Consensus 148 ~Dfg~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~------~ 218 (325)
+|+|+++.+.+.... .....+-|+.|+|||++.+. .|+.+.||||.||++.||+|..+.|.+........ .
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 999999988764332 23445679999999999876 58999999999999999999998886532211111 0
Q ss_pred ---hhhhcccccccccccccC-c-----------cccCC--------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 219 ---VQWVTPYVQKGAFEHIAD-P-----------RLKGK--------FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 219 ---~~~~~~~~~~~~~~~~~~-~-----------~~~~~--------~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
+-.+........++.+.. + ..... .....++...+|+.++|.+||-+|+|++++++
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 000001111111111100 0 00000 00112345889999999999999999999998
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=239.46 Aligned_cols=262 Identities=16% Similarity=0.240 Sum_probs=192.1
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-CC-----CccceeeEEEcC
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HR-----NLLGLRGFYAGG 84 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~iv~~~~~~~~~ 84 (325)
+...|.+++.+|+| .++.|..+.....+..||||+++.. ........-|++++.++. +. -++.+.++|.-.
T Consensus 87 l~~Ry~i~~~lGeG--tFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEG--TFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccceehhhhhcCC--cccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 47789999999999 6666777777777999999999763 233445666999999994 21 355666778889
Q ss_pred CeEEEEEEecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhcC----CCCCCceeeCC---------------
Q 046728 85 DERLIVYDYMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGIA----DIKASNVLLDT--------------- 141 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~r----dlkp~Nil~~~--------------- 141 (325)
.+.|||+|.+ |-|+.++++.. ++...+..+..|+..++.++|.++ ||||+|||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999998 66999999642 455566778888988999999875 99999999942
Q ss_pred -----CCceEEeeeccccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccc
Q 046728 142 -----DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKR 216 (325)
Q Consensus 142 -----~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~ 216 (325)
+..++++|||.+....... ...+.|..|+|||++.+.+++.++||||+||||+|++||...|....+.+-.
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence 1348999999998654432 3456789999999999999999999999999999999999999876654433
Q ss_pred hhhhhhcccccccccccc----------------cCcc--------c-----cCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 046728 217 DIVQWVTPYVQKGAFEHI----------------ADPR--------L-----KGKFNRDQLKSMVLIALRCTDSNPENRP 267 (325)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~----------------~~~~--------~-----~~~~~~~~~~~~~~li~~cl~~dp~~Rp 267 (325)
.+++.+....+....... ...+ . ..........++.+||++||.+||.+|+
T Consensus 319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri 398 (415)
T KOG0671|consen 319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI 398 (415)
T ss_pred HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence 344332221111111000 0000 0 0001112334699999999999999999
Q ss_pred CHHHHHH--HHhccc
Q 046728 268 TMTDVVD--WLKGGL 280 (325)
Q Consensus 268 s~~~il~--~l~~~~ 280 (325)
|+.|++. ||....
T Consensus 399 Tl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 399 TLREALSHPFFARLT 413 (415)
T ss_pred cHHHHhcCHHhhcCC
Confidence 9999998 777543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=263.66 Aligned_cols=140 Identities=21% Similarity=0.320 Sum_probs=122.1
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..|.+++.||.| +++.||++....+++.||||.+... .......+..|+.++..++||||+++++++.....+|+
T Consensus 4 ~~y~i~~~LG~G--~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 4 EEFVIVKPISRG--AFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred CCEEEEEEEecC--CCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 356778899998 8888999999999999999998643 23344678889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccc
Q 046728 90 VYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 90 V~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
||||+.+++|.++++ +.+.+..++.+..++..++.++|.. |||||+|||++.++.++|+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999984 3355666788889999999999975 7999999999999999999999886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=237.29 Aligned_cols=257 Identities=21% Similarity=0.283 Sum_probs=177.9
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc--CCCCccceeeEEEcCC----e
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV--RHRNLLGLRGFYAGGD----E 86 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~~~~~~~~~~----~ 86 (325)
.|..+++.||+| .++.||++. -.++.||||++.. .....|.+|-+|.+.. +|+||++|+++-.... +
T Consensus 210 ~pl~l~eli~~G--rfg~V~Kaq--L~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 210 DPLQLLELIGRG--RFGCVWKAQ--LDNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred CchhhHHHhhcC--ccceeehhh--ccCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 467899999999 677788665 5569999999975 3345788899998875 7999999999876554 8
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCccCHHHHH------HHHHHHHhh-------------cCCCCCCceeeCCCCceEE
Q 046728 87 RLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRV------SIAIGSAEG-------------IADIKASNVLLDTDFEAKV 147 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~------~~~~~~~~~-------------~rdlkp~Nil~~~~~~~kL 147 (325)
+++|++|.+.|+|.+|++... .+|.... .-+++++|. |||||..|||+..++++.|
T Consensus 283 ywLVt~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred eeEEeeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 999999999999999996432 3444443 344444442 3799999999999999999
Q ss_pred eeeccccccCCCcce-eeccCCCCcCCCCccccccCC-CC-----CcccchhHHHHHHHHHhCCCCCC-CCCCCccchhh
Q 046728 148 ADFGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGK-VS-----DSCDVYSFGVLLLELISAKKPLE-KLPGGVKRDIV 219 (325)
Q Consensus 148 ~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~-~~-----~~~DiwSlG~il~el~tg~~pf~-~~~~~~~~~~~ 219 (325)
+|||+|.++..+... ..-..+||.+|||||++.+.. +. .+.||||+|.|+|||+++..-+. +.++.....+.
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 999999988754332 233467999999999998652 22 26899999999999998755443 11111111111
Q ss_pred hhhcccccccccc-cccCccccCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 220 QWVTPYVQKGAFE-HIADPRLKGKFN-----RDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 220 ~~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
..+.....-..+. .+.....++..+ ..-..-+.+.++.||+.||+.|.|+.-+.+++.++.-
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 1111000000000 000111111111 1223468999999999999999999999998887653
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=252.11 Aligned_cols=250 Identities=22% Similarity=0.290 Sum_probs=201.1
Q ss_pred hhHHhhccCccceeeeeEEEeccCC--CCeEEEEEec-ccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETG--DDQIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~--~~~vaiK~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
.+-.++||.|++|+++...+-.... +-+||||.+. ....+...++.+|+-.|.+|+|||++++++++.... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 4556777888666654444443322 4579999885 345566779999999999999999999999987655 78999
Q ss_pred EecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce-e
Q 046728 92 DYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH-M 163 (325)
Q Consensus 92 e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~-~ 163 (325)
+|+++|+|.+|++ +.+..+..+.|..|++.+++|++.+ |||-.+|+||.....+|++|||+++.+...... .
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 9999999999994 4455667889999999999999986 799999999999999999999999987754333 2
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
.....-.+.|+|-|.+....|+.++|||||||++||++| |..|+.+.+..+..+.. ..+-+..
T Consensus 857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll----------------e~geRLs 920 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL----------------EKGERLS 920 (1177)
T ss_pred ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH----------------hccccCC
Confidence 233345678999999998899999999999999999998 99999887654433322 2222345
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.|+.++.++..+|.+||..|++.||+++++...|.+...
T Consensus 921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 667888899999999999999999999999998887654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-33 Score=228.36 Aligned_cols=260 Identities=16% Similarity=0.200 Sum_probs=194.0
Q ss_pred HHhhccCccceeeeeEEEeccCCCCeEEEEEecc--cChhhHHHHHHHHHHHHccCCCCccceeeEEEc--------CCe
Q 046728 17 FIQNINNGLEILMLLLLLRRETGDDQIAVKRLKT--LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG--------GDE 86 (325)
Q Consensus 17 ~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------~~~ 86 (325)
+.+.-..|+|.++.|+++++..+++.||+|++-. ..........+|+.++..++|+|++.++.++.. ...
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 3344444444888999999999999999997643 223334466789999999999999999887643 244
Q ss_pred EEEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC
Q 046728 87 RLIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 159 (325)
+|+||.+|+. +|...+.+ +++...+..+.+.+..++++.|.. ||+||.|+|++.+|.+||+|||+++.+...
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~ 177 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTS 177 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecc
Confidence 8999999976 89888854 366667778888888899998864 899999999999999999999999866543
Q ss_pred ccee---eccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccccc
Q 046728 160 VTHM---TTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIA 235 (325)
Q Consensus 160 ~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (325)
.... -.+.+-|.+|++||.+.+. .|+.+.|||..||++.+|+||.+-|.+.........+...........|+...
T Consensus 178 ~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d 257 (376)
T KOG0669|consen 178 KNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVD 257 (376)
T ss_pred cccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcc
Confidence 3222 1234468999999998865 68999999999999999999999998766555555555444444444443322
Q ss_pred Cccc---------cC---------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHh
Q 046728 236 DPRL---------KG---------KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLK 277 (325)
Q Consensus 236 ~~~~---------~~---------~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~ 277 (325)
.-.+ .. ..+...+++..+|+.+++..||.+||+++++++ ||.
T Consensus 258 ~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~ 319 (376)
T KOG0669|consen 258 NLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW 319 (376)
T ss_pred cchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence 1111 00 001122447889999999999999999999998 554
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=232.40 Aligned_cols=259 Identities=21% Similarity=0.225 Sum_probs=178.7
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc--CCCCccceeeEEEcC---
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV--RHRNLLGLRGFYAGG--- 84 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~~~~~~~~~--- 84 (325)
.+.+...+++.||+|++| .||. +...|..||||++...+ ...+.+|.+|...+ +|+||+.|++.-..+
T Consensus 208 TiarqI~L~e~IGkGRyG--EVwr--G~wrGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFG--EVWR--GRWRGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hhhheeEEEEEecCcccc--ceee--ccccCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 345556788899999555 4663 33447889999997633 34678888888875 999999999875433
Q ss_pred -CeEEEEEEecCCCChhhhhcc-CCCCCCccCHHHHHHHHHHHHh------------hcCCCCCCceeeCCCCceEEeee
Q 046728 85 -DERLIVYDYMPNHSLITHLHG-RLAPDCLLDWHRRVSIAIGSAE------------GIADIKASNVLLDTDFEAKVADF 150 (325)
Q Consensus 85 -~~~~lV~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~~~~~~~~~------------~~rdlkp~Nil~~~~~~~kL~Df 150 (325)
.++|+|++|-+.|||.||+.. .++...++.+...++.++.++| +|||||..||||..++.+.|+|+
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 358999999999999999953 2333334444444444444444 23899999999999999999999
Q ss_pred ccccccCCCcce---eeccCCCCcCCCCccccccCC----C--CCcccchhHHHHHHHHHh----------CCCCCCCCC
Q 046728 151 GFAKLIPDGVTH---MTTRVKGTLGYLAPEYAMWGK----V--SDSCDVYSFGVLLLELIS----------AKKPLEKLP 211 (325)
Q Consensus 151 g~~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~----~--~~~~DiwSlG~il~el~t----------g~~pf~~~~ 211 (325)
|+|......... ..+..+||-+|||||++.... | -..+||||||.++||++- -+.||.+..
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 999876654322 345678999999999997432 2 236999999999999985 467887654
Q ss_pred CCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 212 GGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
+.+.... .+++.+....+........ ...+....+..||+.||..+|..|.|+--|-+.|.++.
T Consensus 441 p~DPs~e--eMrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 441 PSDPSFE--EMRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCCCCHH--HHhcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 4332211 1111111111111111111 11234456888999999999999999998888887655
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=242.64 Aligned_cols=258 Identities=19% Similarity=0.219 Sum_probs=195.0
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC------CCCccceeeEEEc
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR------HRNLLGLRGFYAG 83 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~ 83 (325)
.+...|.++...|.| -|+.|+-++....++.||||+|.. +.--.+.=..|+++|++|+ --|.++++..|..
T Consensus 429 ~LD~RY~V~~~~GkG--vFs~Vvra~D~~r~~~vAiKIIRn-NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKG--VFSTVVRARDQARGQEVAIKIIRN-NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhcceeEEEeccccc--eeeeeeeccccCCCCeeEEEEeec-chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 567788888888988 788899999999999999999975 2222233446999999995 2489999999999
Q ss_pred CCeEEEEEEecCCCChhhhhc-----cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC-CceEEeeeccc
Q 046728 84 GDERLIVYDYMPNHSLITHLH-----GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD-FEAKVADFGFA 153 (325)
Q Consensus 84 ~~~~~lV~e~~~~gsL~~~l~-----~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~-~~~kL~Dfg~~ 153 (325)
.+++|+|+|-+. -+|.+.++ ..+....+..+..|+.+|+..+... .||||+||||++. ..+||||||.|
T Consensus 506 knHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 506 KNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred cceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence 999999999984 48999994 2466677888999999999998875 6999999999876 56899999999
Q ss_pred cccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccc-----ccc
Q 046728 154 KLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPY-----VQK 228 (325)
Q Consensus 154 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~-----~~~ 228 (325)
........ ..+.-+.+|+|||++.+.+|+...|+||+||+|||+.||...|++.+.........-+..- +..
T Consensus 585 ~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 585 SFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred cccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 87665432 2234567899999999999999999999999999999999999776554433322211100 000
Q ss_pred ccccc---------------------------ccCc-----------cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 046728 229 GAFEH---------------------------IADP-----------RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMT 270 (325)
Q Consensus 229 ~~~~~---------------------------~~~~-----------~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 270 (325)
+.|.. ...+ .-.+...+.....+.+|+.+||..||++|.|..
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 00000 0000 001112244566899999999999999999999
Q ss_pred HHHH
Q 046728 271 DVVD 274 (325)
Q Consensus 271 ~il~ 274 (325)
++|.
T Consensus 742 qAL~ 745 (752)
T KOG0670|consen 742 QALK 745 (752)
T ss_pred HHhc
Confidence 9987
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=225.84 Aligned_cols=244 Identities=20% Similarity=0.292 Sum_probs=197.2
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 88 (325)
..|.++++||.| ++..|.+++..++.+.+|+|++++. +.+.......|-.+..+- +||.+|-++.+|++...++
T Consensus 250 ~df~ll~vigrg--syakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 250 QDFDLLRVIGRG--SYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccceeeeeecCc--chhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 457788999988 8999999999999999999999753 344456778888888888 7999999999999999999
Q ss_pred EEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 89 IVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
+|.||.+||+|--+++ ..+++..+.-+...+.+|+.++|.. ||||.+|+|++..|.+||+|||+++--.... .
T Consensus 328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g-d 406 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG-D 406 (593)
T ss_pred EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCC-c
Confidence 9999999999977773 4577788888999999999999986 7999999999999999999999998432222 2
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
.+.+++||+.|.|||++.+..|+..+|.|+||++++||+.|+.||.-...... ......-.+..+....+ .
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~-------d~ntedylfqvilekqi--r 477 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNP-------DMNTEDYLFQVILEKQI--R 477 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCc-------ccchhHHHHHHHhhhcc--c
Confidence 35678899999999999999999999999999999999999999964321100 01112222334444443 3
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCC
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPT 268 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps 268 (325)
.|..++-....+++.-|.+||.+|..
T Consensus 478 iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 478 IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 44566667888999999999999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=221.02 Aligned_cols=232 Identities=25% Similarity=0.351 Sum_probs=182.3
Q ss_pred eeeeeEEEeccCCCCeEEEEEecccChhh-HHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCCCChhhhhcc
Q 046728 27 ILMLLLLLRRETGDDQIAVKRLKTLNAKA-EMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHLHG 105 (325)
Q Consensus 27 ~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 105 (325)
+++.+|.+....+++.||+|.+....... ...+.+|++.+++++|+|++++++.+......++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 36788999988889999999997644433 57899999999999999999999999999999999999999999999853
Q ss_pred C--CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCCCcCCCCcccc
Q 046728 106 R--LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYA 179 (325)
Q Consensus 106 ~--~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 179 (325)
. ++....+.+..++..++.++|.. +||+|.||+++.++.++|+|||.+....... ......++..|++||.+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVL 158 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCHHHH
Confidence 2 45555667778888888888875 6999999999999999999999998765532 22334578899999999
Q ss_pred ccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC-CCHHHHHHHHHHHHHc
Q 046728 180 MWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK-FNRDQLKSMVLIALRC 258 (325)
Q Consensus 180 ~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~c 258 (325)
....++.++|+||||+++|++++|..||..... .......... ...... .....+.++.+++.+|
T Consensus 159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~i~~~ 224 (244)
T smart00220 159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIGK------------PKPPFPPPEWKISPEAKDLIRKL 224 (244)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhc------------cCCCCccccccCCHHHHHHHHHH
Confidence 878888999999999999999999999965211 1111111110 000000 0111557899999999
Q ss_pred cCCCCCCCCCHHHHHH
Q 046728 259 TDSNPENRPTMTDVVD 274 (325)
Q Consensus 259 l~~dp~~Rps~~~il~ 274 (325)
|..+|++||++.++++
T Consensus 225 l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 225 LVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccCCchhccCHHHHhh
Confidence 9999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=239.61 Aligned_cols=248 Identities=23% Similarity=0.361 Sum_probs=191.0
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
|.-++-||.| +|+.|.++++..+...+|.|.+.+.+ ......+..|-.||..-+++-||+++-.|++++.+|+||
T Consensus 631 Fvkik~iGvG--AFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 631 FVKIKTIGVG--AFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred eEEEeeeccc--ccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 4556777777 88889999999999999999997643 333446777999999999999999999999999999999
Q ss_pred EecCCCChhhhh--ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccC--CC----
Q 046728 92 DYMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIP--DG---- 159 (325)
Q Consensus 92 e~~~~gsL~~~l--~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~--~~---- 159 (325)
+|.+||++-.+| .+.+.+..+.-+...+.-|+...|.+ |||||+|||||.+|.+||+|||+|.-+. ..
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 999999998888 35577777777888888888888875 8999999999999999999999997431 10
Q ss_pred ---cce--------------------------------eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCC
Q 046728 160 ---VTH--------------------------------MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAK 204 (325)
Q Consensus 160 ---~~~--------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~ 204 (325)
... .....+||..|+|||++....|+..+|.||.|+|||||+.|+
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence 000 001135999999999999999999999999999999999999
Q ss_pred CCCCCC-CCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHH--HHhc
Q 046728 205 KPLEKL-PGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPT---MTDVVD--WLKG 278 (325)
Q Consensus 205 ~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~~il~--~l~~ 278 (325)
.||-.. +.+....++.|-... -.+....++++..+||.+++. +++.|.- +++|-. ||+.
T Consensus 869 ~pf~~~tp~~tq~kv~nw~~~l--------------~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 869 PPFLADTPGETQYKVINWRNFL--------------HIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred CCccCCCCCcceeeeeehhhcc--------------ccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence 999765 334444444443211 112234567788888876543 6777763 455554 7765
Q ss_pred c
Q 046728 279 G 279 (325)
Q Consensus 279 ~ 279 (325)
+
T Consensus 934 I 934 (1034)
T KOG0608|consen 934 I 934 (1034)
T ss_pred c
Confidence 5
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=241.90 Aligned_cols=236 Identities=19% Similarity=0.275 Sum_probs=178.0
Q ss_pred hHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEEEEEec
Q 046728 16 VFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYM 94 (325)
Q Consensus 16 ~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lV~e~~ 94 (325)
.--+.+|.|++|+ + ..++...++.||||.+-. +......+|++.++.- +|||||++++.-.+....||..|.|
T Consensus 512 ~~~eilG~Gs~Gt--~-Vf~G~ye~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 512 SPKEILGYGSNGT--V-VFRGVYEGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred ccHHHcccCCCCc--E-EEEEeeCCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 4456778885554 2 346778899999999854 3344677899999999 5999999999999999999999999
Q ss_pred CCCChhhhhccC------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC---C--CceEEeeeccccccCCC
Q 046728 95 PNHSLITHLHGR------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT---D--FEAKVADFGFAKLIPDG 159 (325)
Q Consensus 95 ~~gsL~~~l~~~------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~---~--~~~kL~Dfg~~~~~~~~ 159 (325)
.. +|.+++... ...-..+....|+..+++++|.+ |||||+||||+. + .+++|+|||+|+++..+
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 55 999999642 11123356777888888888886 899999999976 2 46899999999998865
Q ss_pred cce--eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhC-CCCCCCCCCCccchhhhhhcccccccccccccC
Q 046728 160 VTH--MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISA-KKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD 236 (325)
Q Consensus 160 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (325)
..+ ...+..||.+|+|||++.....+.++||+|+||++|+.++| ..||...-..+. ++. .....+..+.
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NIl------~~~~~L~~L~- 736 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NIL------TGNYTLVHLE- 736 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hhh------cCccceeeec-
Confidence 443 34567799999999999988888899999999999999985 999965321100 000 0000010110
Q ss_pred ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 237 PRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 237 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
+ ..+. +..+||.+|+.+||..||++.+|+.
T Consensus 737 -----~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 737 -----P-LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -----c-CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0 0111 8999999999999999999999996
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=240.64 Aligned_cols=258 Identities=14% Similarity=0.146 Sum_probs=163.3
Q ss_pred cchhHHhhccCccceeeeeEEEeccCC----CCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeE------EE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETG----DDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGF------YA 82 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~------~~ 82 (325)
..|.+.+.||+| +++.||++....+ +..||+|.+...... ..+.++ .+....+.++..+... ..
T Consensus 132 ~~y~l~~~LG~G--~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 132 DDFVLGKKLGEG--AFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred CCeEEeEEEeeC--CCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 357788899999 8888999999888 899999998642211 111111 1122222333332222 23
Q ss_pred cCCeEEEEEEecCCCChhhhhccCCC----------------------CCCccCHHHHHHHHHHHHhhc----CCCCCCc
Q 046728 83 GGDERLIVYDYMPNHSLITHLHGRLA----------------------PDCLLDWHRRVSIAIGSAEGI----ADIKASN 136 (325)
Q Consensus 83 ~~~~~~lV~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~----rdlkp~N 136 (325)
.....++|+||+.+++|.++++.... ...+..+..++..++.++|.. |||||+|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 45678999999999999998853210 011234677888889999875 8999999
Q ss_pred eeeCC-CCceEEeeeccccccCCCcceeeccCCCCcCCCCccccccC----------------------CCCCcccchhH
Q 046728 137 VLLDT-DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWG----------------------KVSDSCDVYSF 193 (325)
Q Consensus 137 il~~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----------------------~~~~~~DiwSl 193 (325)
||++. ++.+||+|||++..+............+++.|+|||.+... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99985 57899999999986654433334455689999999966422 13446799999
Q ss_pred HHHHHHHHhCCCCCCCCCCCccchhhhhhccc-ccccccccccCccccCC------CCHHHHHHHHHHHHHccCCCCCCC
Q 046728 194 GVLLLELISAKKPLEKLPGGVKRDIVQWVTPY-VQKGAFEHIADPRLKGK------FNRDQLKSMVLIALRCTDSNPENR 266 (325)
Q Consensus 194 G~il~el~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~dp~~R 266 (325)
||++|||+++..|+... .......+... .....+........... ..........+||.+||..||++|
T Consensus 366 GviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 99999999877664321 00000000000 00000000000000000 000112345689999999999999
Q ss_pred CCHHHHHH--HHhccc
Q 046728 267 PTMTDVVD--WLKGGL 280 (325)
Q Consensus 267 ps~~~il~--~l~~~~ 280 (325)
||+.++++ ||....
T Consensus 442 ~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 442 ISAKAALAHPYFDREG 457 (566)
T ss_pred CCHHHHhCCcCcCCCC
Confidence 99999998 887543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=217.74 Aligned_cols=268 Identities=19% Similarity=0.238 Sum_probs=194.6
Q ss_pred cccceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEE
Q 046728 4 HRNICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFY 81 (325)
Q Consensus 4 ~~~~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (325)
.|+.-|....+|-=++-+|.| .. .|..+-+.-.++.||+|.+... .....++..+|+.++..++|+|+++++.+|
T Consensus 8 ~~~s~ftv~~Ry~nL~p~~~g--~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~f 84 (369)
T KOG0665|consen 8 PDSSTFTVPKRYVNLKPIGSG--AQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVF 84 (369)
T ss_pred CCCcceeeeeeeeeecccCCC--Cc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeecc
Confidence 344445555555556666666 44 6777777788999999988543 233345788999999999999999999998
Q ss_pred EcC------CeEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeec
Q 046728 82 AGG------DERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFG 151 (325)
Q Consensus 82 ~~~------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg 151 (325)
... ...|+|||++ .++|.+.++-.+....+..+..|..-+++++|.. |||||+||++..++.+|+.|||
T Consensus 85 tP~~~l~~~~e~y~v~e~m-~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 85 TPQKTLEEFQEVYLVMELM-DANLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred CccccHHHHHhHHHHHHhh-hhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccch
Confidence 654 3479999999 5699999986677777888899999999999975 7999999999999999999999
Q ss_pred cccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccc-hhhh----------
Q 046728 152 FAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKR-DIVQ---------- 220 (325)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~-~~~~---------- 220 (325)
++...... ........|..|+|||++.+..+...+||||+||++.||++|...|.+...-+.. .+.+
T Consensus 164 ~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 164 LARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred hhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 99865443 3444567889999999999888999999999999999999999988653221111 1110
Q ss_pred -hhcc----------cccccccccccCc-cccC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHh
Q 046728 221 -WVTP----------YVQKGAFEHIADP-RLKG--KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLK 277 (325)
Q Consensus 221 -~~~~----------~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~ 277 (325)
.+.+ .-....+...... ..+. ...+-...-+.+|+.+||..||++|.|++++++ .++
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0000 0000011111110 0011 111223446889999999999999999999998 565
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=200.59 Aligned_cols=190 Identities=23% Similarity=0.317 Sum_probs=148.8
Q ss_pred hHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEEEEEe
Q 046728 16 VFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDY 93 (325)
Q Consensus 16 ~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lV~e~ 93 (325)
.-+..||.| +++.|-+.++..+|...|+|.+... +....++..+|+++.... .+|++|.|+|.+.+...+||-||.
T Consensus 49 ~~i~elGrG--ayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 49 VGIEELGRG--AYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhcCC--ccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 345667777 8888888999999999999999743 455566788888876655 799999999999999999999999
Q ss_pred cCCCChhhhhccC------CCCCCccCHHHHHHHHHHHHhh-----cCCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 94 MPNHSLITHLHGR------LAPDCLLDWHRRVSIAIGSAEG-----IADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 94 ~~~gsL~~~l~~~------~~~~~~~~~~~~~~~~~~~~~~-----~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
|. -||..|.+.. .++..+-.+.-.+..|+.++|. |||+||+|||++..|++|+||||++.++.++...
T Consensus 127 M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk 205 (282)
T KOG0984|consen 127 MD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK 205 (282)
T ss_pred hh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH
Confidence 94 5888887433 3333334444445555555554 3899999999999999999999999988764322
Q ss_pred eeccCCCCcCCCCcccccc----CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 046728 163 MTTRVKGTLGYLAPEYAMW----GKVSDSCDVYSFGVLLLELISAKKPLEKL 210 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~----~~~~~~~DiwSlG~il~el~tg~~pf~~~ 210 (325)
. -..|--.|+|||.+.. ..|+-++||||||+++.||.+++.||...
T Consensus 206 t--~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 206 T--MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred H--HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 1 1345567999998863 36889999999999999999999999653
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=217.14 Aligned_cols=248 Identities=20% Similarity=0.238 Sum_probs=192.3
Q ss_pred hhHHhhccCccceeeeeEEEeccCC---CCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEE-cCCeEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETG---DDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYA-GGDERLI 89 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~---~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~l 89 (325)
+.+...+-+|-+|..+..+++...+ .+.|-+|.++.. ++-....+..|.-+++-+.|||+..+.++.. +....++
T Consensus 286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V 365 (563)
T KOG1024|consen 286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFV 365 (563)
T ss_pred eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceE
Confidence 4556677889666655555554443 356888888643 4555568889999999999999999999964 4566889
Q ss_pred EEEecCCCChhhhhc-----cC-----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccc
Q 046728 90 VYDYMPNHSLITHLH-----GR-----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 90 V~e~~~~gsL~~~l~-----~~-----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
+++++.-|+|..|+. +. ....+......|+++|+.++|.+ .||..+||++++.-++||+|-.+++.
T Consensus 366 ~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRD 445 (563)
T KOG1024|consen 366 LYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRD 445 (563)
T ss_pred EEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccc
Confidence 999998899999995 11 12223455667888888888877 49999999999999999999999986
Q ss_pred cCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhccccccccccc
Q 046728 156 IPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEH 233 (325)
Q Consensus 156 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (325)
+...... -...--.+..||+||.+.+..|+.++|+||||+++|||+| |..||...++ ..+..
T Consensus 446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP----------------fEm~~ 509 (563)
T KOG1024|consen 446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP----------------FEMEH 509 (563)
T ss_pred cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH----------------HHHHH
Confidence 6554332 1222235778999999999999999999999999999998 8999865442 22233
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 046728 234 IADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278 (325)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~ 278 (325)
....+.+...|.++++++..+|.-||..+|++|||+++++..|.+
T Consensus 510 ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 510 YLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 444566677788999999999999999999999999999987654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=226.37 Aligned_cols=197 Identities=21% Similarity=0.279 Sum_probs=167.3
Q ss_pred eeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC----hhhH----HHHHHHHHHHHccC---CCCccc
Q 046728 8 CFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN----AKAE----MEFAVEVEILGRVR---HRNLLG 76 (325)
Q Consensus 8 ~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~----~~~~~E~~~l~~l~---h~~iv~ 76 (325)
.+.--+.|+.++.+|+| ++|.|+++.++.....|+||.+.+.. .+-+ ..+.-|++||..|+ |+||++
T Consensus 556 ~~~k~s~yttlq~lG~G--AyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlK 633 (772)
T KOG1152|consen 556 EYKKFSDYTTLQPLGEG--AYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILK 633 (772)
T ss_pred eecccccceeeeecccc--ccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhh
Confidence 34445678899999999 88889999999999999999997532 1111 13445999999997 999999
Q ss_pred eeeEEEcCCeEEEEEEec-CCCChhhhh--ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEee
Q 046728 77 LRGFYAGGDERLIVYDYM-PNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVAD 149 (325)
Q Consensus 77 ~~~~~~~~~~~~lV~e~~-~~gsL~~~l--~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~D 149 (325)
++++|++++.+|++||-- ++-+|+++| +.++.+..+..+++|+..+...+|.. ||||-+|++++.+|.+||+|
T Consensus 634 lLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 634 LLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred hhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEee
Confidence 999999999999999875 556899999 67788999999999999999988874 89999999999999999999
Q ss_pred eccccccCCCcceeeccCCCCcCCCCccccccCCC-CCcccchhHHHHHHHHHhCCCCCCC
Q 046728 150 FGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKV-SDSCDVYSFGVLLLELISAKKPLEK 209 (325)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~ 209 (325)
||.+.....+. -..+.||..|.|||++.+..| +...|||++|++||.+.+...||+.
T Consensus 714 fgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 714 FGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99988654432 235679999999999999887 5569999999999999999999964
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=224.83 Aligned_cols=260 Identities=17% Similarity=0.253 Sum_probs=167.1
Q ss_pred ccchhHHhhccCccceeeeeEEEec----------------cCCCCeEEEEEecccChhhHHHH--------------HH
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRR----------------ETGDDQIAVKRLKTLNAKAEMEF--------------AV 61 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~----------------~~~~~~vaiK~~~~~~~~~~~~~--------------~~ 61 (325)
...|.+.++||+| +++.||+... ...++.||||.+..........| ..
T Consensus 144 ~d~F~i~~~LG~G--gFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 144 SDDFQLRDKLGGG--NFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccCceEeeEeecC--CCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 4468889999999 6667776642 23456899999865433322233 33
Q ss_pred HHHHHHccCCCCc-----cceeeEEEc--------CCeEEEEEEecCCCChhhhhccCCC--------------------
Q 046728 62 EVEILGRVRHRNL-----LGLRGFYAG--------GDERLIVYDYMPNHSLITHLHGRLA-------------------- 108 (325)
Q Consensus 62 E~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~-------------------- 108 (325)
|+..+.+++|.++ +++++++.. ....++||||+++++|.++++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6666777765543 667777643 3568999999999999999863211
Q ss_pred ------CCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCCCcCCCCccc
Q 046728 109 ------PDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEY 178 (325)
Q Consensus 109 ------~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~ 178 (325)
...+..+..++..++.++|.. |||||+|||++.++.++|+|||++...............+++.|+|||.
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 012334566777788888874 7999999999999999999999997654332222222234789999998
Q ss_pred cccCC--------------------C--CCcccchhHHHHHHHHHhCCC-CCCCCCCCccchhhhhhccccccccccccc
Q 046728 179 AMWGK--------------------V--SDSCDVYSFGVLLLELISAKK-PLEKLPGGVKRDIVQWVTPYVQKGAFEHIA 235 (325)
Q Consensus 179 ~~~~~--------------------~--~~~~DiwSlG~il~el~tg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (325)
+.... + ..+.||||+||++|+|+++.. ||.....- ......+-. ....+....
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f-~~~~~~~~~---~~~~~r~~~ 457 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLF-NTELRQYDN---DLNRWRMYK 457 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhh-hhHHhhccc---hHHHHHhhc
Confidence 75322 1 124799999999999999875 66432110 000000000 000011111
Q ss_pred CccccCCCCHHHHHHHHHHHHHccCCCC---CCCCCHHHHHH--HHh
Q 046728 236 DPRLKGKFNRDQLKSMVLIALRCTDSNP---ENRPTMTDVVD--WLK 277 (325)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~li~~cl~~dp---~~Rps~~~il~--~l~ 277 (325)
............++...+|+++||..+| .+|+|++++++ ||.
T Consensus 458 ~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 458 GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 1111112233456789999999999866 68999999998 663
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=211.68 Aligned_cols=129 Identities=19% Similarity=0.290 Sum_probs=107.7
Q ss_pred ceeecc-cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-----C---CCccce
Q 046728 7 ICFLLA-SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-----H---RNLLGL 77 (325)
Q Consensus 7 ~~~~~~-~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~~iv~~ 77 (325)
|.-.|. .+|..+++||=| -|+.||++....+.+.||+|+.+. .....+....|+.+|++++ | .+||++
T Consensus 71 IGD~F~~gRY~v~rKLGWG--HFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 71 IGDVFNGGRYHVQRKLGWG--HFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred ccccccCceEEEEEecccc--ccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 344555 778899999888 777899999999999999999975 3455557788999999984 2 489999
Q ss_pred eeEEE----cCCeEEEEEEecCCCChhhhhc----cCCCCCCccCHHHHHHHHHHHHhhc-----CCCCCCceee
Q 046728 78 RGFYA----GGDERLIVYDYMPNHSLITHLH----GRLAPDCLLDWHRRVSIAIGSAEGI-----ADIKASNVLL 139 (325)
Q Consensus 78 ~~~~~----~~~~~~lV~e~~~~gsL~~~l~----~~~~~~~~~~~~~~~~~~~~~~~~~-----rdlkp~Nil~ 139 (325)
++.|. ++.++|+|+|+. |.+|..+|. ..++-..+..+.+|+..+++|+|.- -||||+|||+
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 99985 457899999999 779999883 4577778889999999999999975 4999999999
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-30 Score=230.86 Aligned_cols=249 Identities=24% Similarity=0.310 Sum_probs=198.9
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
=.-.|.++..+|+| .++.||+++++.++...|+|.++........-+.+|+-+++..+||||+.+++.|...+..|+.
T Consensus 13 P~ddyellqrvgsg--TygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 13 PQDDYELLQRVGSG--TYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred CccchhheeeecCC--cccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 34567889999999 9999999999999999999999987777777888999999999999999999999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||||.||+|.+..+ +.+++.++....+.....+.++|++ ||||..||++++.|-+||+|||.+...+..... .
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K-r 169 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK-R 169 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhh-h
Confidence 99999999999885 4466666666677777788888875 799999999999999999999999877654333 3
Q ss_pred ccCCCCcCCCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 165 TRVKGTLGYLAPEYAM---WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
..+.||+.|+|||+.. .+.|...+|||++|+...|+.-.++|....-.......+ ....+. .+.+
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm-------TkS~~q---pp~l-- 237 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM-------TKSGFQ---PPTL-- 237 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh-------hccCCC---CCcc--
Confidence 3456999999999875 568999999999999999999888886543221111111 111111 1111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.-...-++.+.++++.|+..+|.+|||++.++.
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111234567999999999999999999999886
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-30 Score=209.52 Aligned_cols=251 Identities=19% Similarity=0.265 Sum_probs=187.7
Q ss_pred CccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC-----eEEEEEEecC
Q 046728 23 NGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD-----ERLIVYDYMP 95 (325)
Q Consensus 23 ~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lV~e~~~ 95 (325)
+|.|+|+.||-+.+-.+++.||+|++... +-.+.+++.+|+.++..++|.||+..++..+... ++|+|+|.+.
T Consensus 61 IGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ 140 (449)
T KOG0664|consen 61 IGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ 140 (449)
T ss_pred ccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH
Confidence 45559999999999999999999998643 3344568999999999999999999999876543 4688999995
Q ss_pred CCChhhhh--ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCC
Q 046728 96 NHSLITHL--HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169 (325)
Q Consensus 96 ~gsL~~~l--~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 169 (325)
. +|...| -..++.+.+..+..|+..++.|+|+- |||||.|.|++.+..+||||||+++.............+-
T Consensus 141 S-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVV 219 (449)
T KOG0664|consen 141 S-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVV 219 (449)
T ss_pred h-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHH
Confidence 5 888887 24577778888999999999999974 8999999999999999999999999776544443333346
Q ss_pred CcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccc--------cccccccccCcccc
Q 046728 170 TLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYV--------QKGAFEHIADPRLK 240 (325)
Q Consensus 170 t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~ 240 (325)
|-.|+|||++.+. .|+.+.||||+||++.|++.++..|.....-...+.+.-..... ..+....+.....+
T Consensus 220 TQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k 299 (449)
T KOG0664|consen 220 TQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLR 299 (449)
T ss_pred HHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCC
Confidence 7789999999876 58999999999999999999999886554433333332111100 01111111111111
Q ss_pred CC---------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 241 GK---------FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 241 ~~---------~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.+ .+.....+..+++.+++..||+.|++..+.+.
T Consensus 300 ~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 300 APDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred CCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 11 11233456788899999999999999999987
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-26 Score=191.50 Aligned_cols=204 Identities=26% Similarity=0.452 Sum_probs=171.2
Q ss_pred ccCccceeeeeEEEeccCCCCeEEEEEecccChh-hHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCCCCh
Q 046728 21 INNGLEILMLLLLLRRETGDDQIAVKRLKTLNAK-AEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSL 99 (325)
Q Consensus 21 i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~gsL 99 (325)
||.| +++.+|.+....+++.+++|.+...... ....+.+|++.++.+.|++++++++++......++++||+.+++|
T Consensus 1 l~~g--~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEG--GFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcC--CceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 4555 7788999998888999999999764332 345788999999999999999999999999999999999998999
Q ss_pred hhhhccC---CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC-CCceEEeeeccccccCCCcceeeccCCCCc
Q 046728 100 ITHLHGR---LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT-DFEAKVADFGFAKLIPDGVTHMTTRVKGTL 171 (325)
Q Consensus 100 ~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~ 171 (325)
.+++... ++......+..++..+++++|.. +||+|.||+++. .+.++|+|||.+........ ......+..
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~ 157 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGTP 157 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCCC
Confidence 9999543 55566677888888888888875 699999999999 89999999999986654321 112234678
Q ss_pred CCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHH
Q 046728 172 GYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKS 250 (325)
Q Consensus 172 ~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (325)
.|++||.+... ..+.++|+|++|++++++ ..
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------~~ 189 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------PE 189 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------HH
Confidence 89999998876 778899999999999998 36
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHH
Q 046728 251 MVLIALRCTDSNPENRPTMTDVVDW 275 (325)
Q Consensus 251 ~~~li~~cl~~dp~~Rps~~~il~~ 275 (325)
+.+++.+|+..||++||++.++++.
T Consensus 190 ~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 190 LKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHhhCCcccCcCHHHHhhC
Confidence 8889999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=196.08 Aligned_cols=253 Identities=18% Similarity=0.253 Sum_probs=186.7
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc-CCCCccceeeE-EEcCCeE
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGF-YAGGDER 87 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~-~~~~~~~ 87 (325)
.+..-|.+.+.+|+| -|+.+-+++|+.+.+.+|+|.+.... .....|.+|+..-..| .|.||+.-+++ |++.+.+
T Consensus 21 ~l~d~y~I~k~lgeG--~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEG--RFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred chhhhhhHHHHhccc--ceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 455678999999999 66779999999999999999998743 4456899999988888 49999988876 7777888
Q ss_pred EEEEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeC--CCCceEEeeeccccccCCCc
Q 046728 88 LIVYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLD--TDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~--~~~~~kL~Dfg~~~~~~~~~ 160 (325)
+++||||+.|+|..-+. .++.+.-...++.|++.|+.++|+. ||||.+||||- +.-++||||||+....+...
T Consensus 98 vF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred EEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 89999999999999884 3455555678899999999999984 99999999994 33589999999988655432
Q ss_pred ceeeccCCCCcCCCCccccccC---C--CCCcccchhHHHHHHHHHhCCCCCCCCCCCcc--chhhhhhccccccccccc
Q 046728 161 THMTTRVKGTLGYLAPEYAMWG---K--VSDSCDVYSFGVLLLELISAKKPLEKLPGGVK--RDIVQWVTPYVQKGAFEH 233 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~~---~--~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~ 233 (325)
.. ..-+..|.+||+.... . ..+.+|+|.||+++|.++||.+||......+. ....+|.... .
T Consensus 178 ~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk-----~-- 246 (378)
T KOG1345|consen 178 KY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK-----N-- 246 (378)
T ss_pred hh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc-----C--
Confidence 21 1235579999976532 2 36789999999999999999999974332221 1122222111 0
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHH---HH--HHhccc
Q 046728 234 IADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDV---VD--WLKGGL 280 (325)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~i---l~--~l~~~~ 280 (325)
+.+ +.....+++.+..+.++-|..+|++|=...++ .. |.+...
T Consensus 247 ---~~~-P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i 294 (378)
T KOG1345|consen 247 ---PAL-PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLI 294 (378)
T ss_pred ---ccC-chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhh
Confidence 111 11224467788889999999999999433333 33 665544
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=207.67 Aligned_cols=263 Identities=21% Similarity=0.302 Sum_probs=193.1
Q ss_pred cccchhHHhhccCccceeeeeEEEeccC---CCCeEEEEEecccChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCCe
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRET---GDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDE 86 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 86 (325)
+..-|..+.+||+| .|+.|+++.... .++.||+|.+.. .+...++.+|+++|..+. +.||+++.+++..+++
T Consensus 34 ~~~~~~~v~kigeG--sFssv~~a~~~~~~~~~~~valk~i~~--ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEG--SFSSVYKATDIEQDTKRRYVALKAIYR--TSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhcccccc--chhhhhhhhHhhhccccceEeeeeccc--ccCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 34567889999999 777888888777 788999999975 344568999999999994 9999999999999999
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC-CCceEEeeeccccccCC-C-
Q 046728 87 RLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT-DFEAKVADFGFAKLIPD-G- 159 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~-~~~~kL~Dfg~~~~~~~-~- 159 (325)
+.+||||+++.+..+++.. ++-..+..+...+..|+.+.|.. |||||.|+|.+. .++-.|.|||++..... .
T Consensus 110 v~ivlp~~~H~~f~~l~~~-l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS-LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred eEEEecccCccCHHHHHhc-CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 9999999999999998865 45666788888999999988874 899999999984 47789999999982210 0
Q ss_pred -----c------------------------------------ceeeccCCCCcCCCCccccccC-CCCCcccchhHHHHH
Q 046728 160 -----V------------------------------------THMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLL 197 (325)
Q Consensus 160 -----~------------------------------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il 197 (325)
. ........||++|+|||++... ..++++||||.|+++
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 0 0011234699999999998754 578999999999999
Q ss_pred HHHHhCCCCCCCCCCCccc--hhh--------hhhc----c--ccc----------ccccccc-----cC-cc--ccCCC
Q 046728 198 LELISAKKPLEKLPGGVKR--DIV--------QWVT----P--YVQ----------KGAFEHI-----AD-PR--LKGKF 243 (325)
Q Consensus 198 ~el~tg~~pf~~~~~~~~~--~~~--------~~~~----~--~~~----------~~~~~~~-----~~-~~--~~~~~ 243 (325)
..++++..||...+++..- ++. .... . ... ...+..+ .. .. +....
T Consensus 269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~ 348 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI 348 (418)
T ss_pred ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence 9999999999654432211 000 0000 0 000 0001111 00 00 01111
Q ss_pred C-HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 244 N-RDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 244 ~-~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
. ...+..+.+|+.+|++.||.+|+|++++|. +|..
T Consensus 349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 349 GSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 1 223458999999999999999999999998 6663
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=190.57 Aligned_cols=264 Identities=16% Similarity=0.204 Sum_probs=197.4
Q ss_pred ceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCC
Q 046728 7 ICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGD 85 (325)
Q Consensus 7 ~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 85 (325)
+-+.....|.+++++|.| -.+.|+-..+..+++.++||+++. -..+.+.+|+.||..|+ ||||++++++..+..
T Consensus 32 i~wg~~ddYeivrk~GRG--KYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~ 106 (338)
T KOG0668|consen 32 IDWGNQDDYEIVRKVGRG--KYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPE 106 (338)
T ss_pred eeccccchHHHHHHHcCc--cHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence 456677889999999999 777788888889999999999964 22458899999999996 999999999998764
Q ss_pred --eEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC-CceEEeeeccccccCC
Q 046728 86 --ERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD-FEAKVADFGFAKLIPD 158 (325)
Q Consensus 86 --~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~-~~~kL~Dfg~~~~~~~ 158 (325)
...+|+||..+.+....... +....+..+..++..|+++.|++ ||+||.|++++.. -.++|+|.|+|.....
T Consensus 107 SktpaLiFE~v~n~Dfk~ly~t-l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 107 SKTPSLIFEYVNNTDFKQLYPT-LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred ccCchhHhhhhccccHHHHhhh-hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 46799999988877766643 66777888999999999999986 7999999999965 5699999999987665
Q ss_pred CcceeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccc-----------
Q 046728 159 GVTHMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYV----------- 226 (325)
Q Consensus 159 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~----------- 226 (325)
+... +..+.+..|.-||++..- .|+-.-|+|||||++..|+....||..-.+ ..+....+.+..
T Consensus 186 ~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d--N~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 186 GKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred Ccee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC--CHHHHHHHHHHhChHHHHHHHHH
Confidence 4332 334578889999998754 578899999999999999999999864322 211111111000
Q ss_pred ----cccccccccCcccc-------CCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 227 ----QKGAFEHIADPRLK-------GKFNRD-QLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 227 ----~~~~~~~~~~~~~~-------~~~~~~-~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
....+..+.....+ ....+. .+++..+|+.+.|..|-.+|+|+.|++. +|....
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 01111111111000 011111 3478999999999999999999999997 666544
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=189.52 Aligned_cols=193 Identities=28% Similarity=0.430 Sum_probs=159.1
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChh-hHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEe
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAK-AEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~ 93 (325)
|.+.+.||.| +++.+|.+....+++.+|+|.+...... ....+.+|++.+..++|+|++++++.+......++++||
T Consensus 1 ~~~~~~i~~g--~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEG--AFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecC--CCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 3456778888 7778999998888899999999865444 567888999999999999999999999998999999999
Q ss_pred cCCCChhhhhccC---CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeecc
Q 046728 94 MPNHSLITHLHGR---LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTR 166 (325)
Q Consensus 94 ~~~gsL~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 166 (325)
+.+++|.+++... ++......+..++..++.++|.. +||+|.||+++.++.++|+|||.+.............
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 9999999999532 44455566777777777787765 6999999999999999999999998765542111223
Q ss_pred CCCCcCCCCcccc-ccCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 046728 167 VKGTLGYLAPEYA-MWGKVSDSCDVYSFGVLLLELISAKKPLEK 209 (325)
Q Consensus 167 ~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 209 (325)
..++..|++||.+ ....++.++|+||||+++|+|++|..||..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 4567789999998 556778899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=182.30 Aligned_cols=162 Identities=19% Similarity=0.175 Sum_probs=121.0
Q ss_pred CChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhcCCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCCCcCC
Q 046728 97 HSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGIADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGY 173 (325)
Q Consensus 97 gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y 173 (325)
|||.++++. .+++..++.+..++..++.++|..+ ||+|||++.++.+++ ||++....... ..||+.|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--kp~Nil~~~~~~~~~--fG~~~~~~~~~------~~g~~~y 70 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--KSGNILLTWDGLLKL--DGSVAFKTPEQ------SRVDPYF 70 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccEeEcCccceee--ccceEeecccc------CCCcccc
Confidence 689999952 3778888999999999999999988 999999999999999 99988654422 2578999
Q ss_pred CCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHH--HH
Q 046728 174 LAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK--SM 251 (325)
Q Consensus 174 ~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 251 (325)
+|||++.+..++.++|||||||++|||+||..||...... ............. . .+. ........+. .+
T Consensus 71 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~-----~-~~~-~~~~~~~~~~~~~~ 141 (176)
T smart00750 71 MAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPA-----D-DPR-DRSNLESVSAARSF 141 (176)
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhcc-----C-Ccc-ccccHHHHHhhhhH
Confidence 9999999999999999999999999999999999643221 1111110000000 0 000 0011233444 69
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 252 VLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 252 ~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
.+++.+||..||++|||+.++++.+.
T Consensus 142 ~~~i~~cl~~~p~~Rp~~~~ll~~~~ 167 (176)
T smart00750 142 ADFMRVCASRLPQRREAANHYLAHCR 167 (176)
T ss_pred HHHHHHHHhcccccccCHHHHHHHHH
Confidence 99999999999999999999998544
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-25 Score=221.09 Aligned_cols=192 Identities=16% Similarity=0.166 Sum_probs=132.1
Q ss_pred ccCC-CCccceeeEE-------EcCCeEEEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCC
Q 046728 68 RVRH-RNLLGLRGFY-------AGGDERLIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADI 132 (325)
Q Consensus 68 ~l~h-~~iv~~~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdl 132 (325)
.++| +||.++++++ .....++.+|||+ +++|.+++.. .++...++.++.|+..++.++|.. |||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3445 5777777776 2234567888987 6699999953 366677888999999999999975 799
Q ss_pred CCCceeeCCC-------------------CceEEeeeccccccCCCc---------------ceeeccCCCCcCCCCccc
Q 046728 133 KASNVLLDTD-------------------FEAKVADFGFAKLIPDGV---------------THMTTRVKGTLGYLAPEY 178 (325)
Q Consensus 133 kp~Nil~~~~-------------------~~~kL~Dfg~~~~~~~~~---------------~~~~~~~~~t~~y~aPE~ 178 (325)
||+|||++.. +.+|++|||+++...... ........||+.|+|||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 9999999654 445566666654321100 000111347888999999
Q ss_pred cccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHc
Q 046728 179 AMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRC 258 (325)
Q Consensus 179 ~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 258 (325)
+.+..++.++|||||||++|||+++.+|+..... ...... . .... +......+....++.+|
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~----~----~~~~-----~~~~~~~~~~~~~~~~~ 248 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLR----H----RVLP-----PQILLNWPKEASFCLWL 248 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHH----H----hhcC-----hhhhhcCHHHHHHHHHh
Confidence 9988999999999999999999998888643110 000000 0 0000 00011123466788899
Q ss_pred cCCCCCCCCCHHHHHH--HHhc
Q 046728 259 TDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 259 l~~dp~~Rps~~~il~--~l~~ 278 (325)
|..||.+|||+.++++ ||..
T Consensus 249 L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 249 LHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred CCCChhhCcChHHHhhchhhhh
Confidence 9999999999999998 7765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-24 Score=205.98 Aligned_cols=254 Identities=17% Similarity=0.206 Sum_probs=189.3
Q ss_pred hHHhhccCccceeeeeEEEeccCCCCeEEEEEec-----ccChhhH-HHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 16 VFIQNINNGLEILMLLLLLRRETGDDQIAVKRLK-----TLNAKAE-MEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 16 ~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~-----~~~~~~~-~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
.....+|.|++| .+..+........++.|... ..+.... ..+..|+.+-..++|||++..+..+.+.....-
T Consensus 321 ~~~~~~g~ga~g--~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYG--SVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ 398 (601)
T ss_pred CccceeeecccC--ceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh
Confidence 677888999666 56666666666656666543 1121111 236678888889999999988888777766666
Q ss_pred EEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc--
Q 046728 90 VYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT-- 161 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 161 (325)
+||||++ +|..++.. .+....+-.+++|+.-+++++|.+ ||+||+|+++..+|.+||+|||.+..+.....
T Consensus 399 ~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 6999999 99999954 577778888999999999999876 79999999999999999999999986654322
Q ss_pred -eeeccCCCCcCCCCccccccCCCCC-cccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 162 -HMTTRVKGTLGYLAPEYAMWGKVSD-SCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 162 -~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
.......|+-+|.|||++....|.. ..||||.|+++..|.+|+.||............ ...........-
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~--------~~~~~~~~~~~~ 549 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT--------NNYSDQRNIFEG 549 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh--------hccccccccccC
Confidence 3455677999999999999999976 699999999999999999999765433222100 000000000111
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
.......++.+...+|.+||+.||.+|.|+++|++ |++++.
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 12233566778999999999999999999999998 998754
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-24 Score=176.15 Aligned_cols=239 Identities=21% Similarity=0.282 Sum_probs=182.9
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecc--cChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKT--LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
...++.+|.+.- .+..| +++..|..+++|+++. ........|.+|+-.++.+.||||+++++.+.....+.++.
T Consensus 191 ~lnl~tkl~e~h--sgelw--rgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 191 SLNLITKLAESH--SGELW--RGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhhhhhhccCC--Ccccc--cccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 456777888773 34455 3445566788888863 23333447888999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCC----CCCCccCHHHHHHHHHHHHhhcC------CCCCCceeeCCCCceEEe--eeccccccCCC
Q 046728 92 DYMPNHSLITHLHGRL----APDCLLDWHRRVSIAIGSAEGIA------DIKASNVLLDTDFEAKVA--DFGFAKLIPDG 159 (325)
Q Consensus 92 e~~~~gsL~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~r------dlkp~Nil~~~~~~~kL~--Dfg~~~~~~~~ 159 (325)
.|++.|+|+..+++.. ...+++.+...++.++.++|++- -|....++++++.+.+|. |--++.
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf----- 341 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF----- 341 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-----
Confidence 9999999999998652 33455566666666666667662 788899999998776654 322111
Q ss_pred cceeeccCCCCcCCCCccccccCCCC---CcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccC
Q 046728 160 VTHMTTRVKGTLGYLAPEYAMWGKVS---DSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD 236 (325)
Q Consensus 160 ~~~~~~~~~~t~~y~aPE~~~~~~~~---~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (325)
......-.+.|++||.+...+-+ .++|+|||++++||+.|+..||...+. ..+..++.-
T Consensus 342 ---qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp---------------mecgmkial 403 (448)
T KOG0195|consen 342 ---QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP---------------MECGMKIAL 403 (448)
T ss_pred ---eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc---------------hhhhhhhhh
Confidence 12223457889999999876543 479999999999999999999977554 344455666
Q ss_pred ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 237 PRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 237 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
.+++...++..+..+..|+.-|+..||.+||.++.|+-.|+.+
T Consensus 404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 7788888899999999999999999999999999999988754
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.9e-21 Score=169.80 Aligned_cols=171 Identities=18% Similarity=0.094 Sum_probs=127.1
Q ss_pred cccchhHHhhccCccceeeeeEEEeccC-CCCeEEEEEeccc-----ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRET-GDDQIAVKRLKTL-----NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG 84 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (325)
+...|.+.+.||.| +++.||++.+.. +++.||||.+... .......+.+|+++|++++|+|+++.+.. .
T Consensus 16 ~~~~Y~~~~~IG~G--~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 16 LSARFVETAVLKRD--VFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccCCceEccEEeec--CcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 45668899999988 888899998776 6778899987532 22335578899999999999999853322 2
Q ss_pred CeEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCC-CCCceeeCCCCceEEeeeccccccCCC
Q 046728 85 DERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADI-KASNVLLDTDFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdl-kp~Nil~~~~~~~kL~Dfg~~~~~~~~ 159 (325)
...|+|||||+|++|... .. .....+..++..++.++|.. ||| ||+|||++.++.++|+|||+++.+...
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~----~~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~ 165 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP----HGDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR 165 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc----cchHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence 457999999999999732 11 11246788888999999974 899 999999999999999999999976543
Q ss_pred ccee-------eccCCCCcCCCCccccccC------CCCCcccch
Q 046728 160 VTHM-------TTRVKGTLGYLAPEYAMWG------KVSDSCDVY 191 (325)
Q Consensus 160 ~~~~-------~~~~~~t~~y~aPE~~~~~------~~~~~~Diw 191 (325)
.... ..+..++..|.|||.+.-. ..+..+|-|
T Consensus 166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 166 GALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 2111 1234578889999988632 233456766
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.3e-19 Score=157.95 Aligned_cols=250 Identities=25% Similarity=0.336 Sum_probs=182.4
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh---hhHHHHHHHHHHHHccCCC-CccceeeEEEcCCeEEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA---KAEMEFAVEVEILGRVRHR-NLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lV 90 (325)
|.+.+.||.| +++.||.+... ..+++|.+..... .....+.+|..++..+.|+ +++++.+.+......+++
T Consensus 2 ~~~~~~l~~g--~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEG--SFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLV 76 (384)
T ss_pred ceeEEeecCC--CCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEE
Confidence 4567788877 67888888877 7889999864322 2466899999999999877 799999999877778999
Q ss_pred EEecCCCChhhhhcc-----CCCCCCccCHHHHHHHHHHHHhh----cCCCCCCceeeCCCC-ceEEeeeccccccCCCc
Q 046728 91 YDYMPNHSLITHLHG-----RLAPDCLLDWHRRVSIAIGSAEG----IADIKASNVLLDTDF-EAKVADFGFAKLIPDGV 160 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~-----~~~~~~~~~~~~~~~~~~~~~~~----~rdlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~ 160 (325)
++++.++++.+++.. .+.......+..++..++.++|. |||+||+||+++..+ .++++|||.+.......
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999999977753 35555667777788877777875 489999999999988 79999999998655433
Q ss_pred ce-----eeccCCCCcCCCCcccccc---CCCCCcccchhHHHHHHHHHhCCCCCCCCCCC-ccchhhhhhccccccccc
Q 046728 161 TH-----MTTRVKGTLGYLAPEYAMW---GKVSDSCDVYSFGVLLLELISAKKPLEKLPGG-VKRDIVQWVTPYVQKGAF 231 (325)
Q Consensus 161 ~~-----~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 231 (325)
.. ......++..|+|||.+.+ ..++...|+||+|+++++++++..||...... ........+......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence 22 2345679999999999987 57788999999999999999999997654321 011111111111000
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 232 EHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.................+.+++..|+..+|..|.+......
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 234 --SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred --ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 00000000000223357889999999999999999887776
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.5e-19 Score=159.61 Aligned_cols=254 Identities=18% Similarity=0.174 Sum_probs=185.0
Q ss_pred chhHHhhccCccceeeeeEEEeccCCC-CeEEEEEecccChhhHHHHHHHHHHHHccCC----CCccceeeEE-EcCCeE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGD-DQIAVKRLKTLNAKAEMEFAVEVEILGRVRH----RNLLGLRGFY-AGGDER 87 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h----~~iv~~~~~~-~~~~~~ 87 (325)
.|++.++||+| +++.||++....++ ..+|+|............+..|..++..+.. +++..+++.. ......
T Consensus 19 ~~~i~~~iG~G--~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEG--GFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeecccc--CCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 67889999999 88889999887774 6788888765433322367788999998862 5888888888 477788
Q ss_pred EEEEEecCCCChhhhhc----cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC-----CceEEeeecccc
Q 046728 88 LIVYDYMPNHSLITHLH----GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD-----FEAKVADFGFAK 154 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~----~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~-----~~~kL~Dfg~~~ 154 (325)
|+||+.+ |.+|.++.. +.++...++.+..|+..++..+|.. |||||+|+++... ..+.|.|||+++
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9999998 889999773 3466667777778888888888874 8999999999765 359999999998
Q ss_pred --ccCCCcc-----ee--eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccc
Q 046728 155 --LIPDGVT-----HM--TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPY 225 (325)
Q Consensus 155 --~~~~~~~-----~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 225 (325)
....... .. .....||..|+++.+..+...+.+.|+||++.++.++..|..||.............. .
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~---~ 252 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK---D 252 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH---H
Confidence 3322211 11 1234599999999999999999999999999999999999999966543222111110 0
Q ss_pred ccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCC
Q 046728 226 VQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGR 282 (325)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 282 (325)
..... ........+..+..+...+-..+..++|....+...|+.....
T Consensus 253 ~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 253 PRKLL---------TDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred hhhhc---------cccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 00000 0001122334666666666679999999999999988776644
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.6e-20 Score=167.11 Aligned_cols=207 Identities=23% Similarity=0.387 Sum_probs=146.4
Q ss_pred HHccCCCCccceeeEEEcCCeEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc-----------CCCCC
Q 046728 66 LGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI-----------ADIKA 134 (325)
Q Consensus 66 l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-----------rdlkp 134 (325)
|+.+.|.|+.+++|.+.++...++|.+||+.|+|.+.+.. ...-+++........++++|+ +.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecc
Confidence 4678999999999999999999999999999999999954 233355555554444444443 69999
Q ss_pred CceeeCCCCceEEeeeccccccCCC-cceeeccCCCCcCCCCccccccC---C----CCCcccchhHHHHHHHHHhCCCC
Q 046728 135 SNVLLDTDFEAKVADFGFAKLIPDG-VTHMTTRVKGTLGYLAPEYAMWG---K----VSDSCDVYSFGVLLLELISAKKP 206 (325)
Q Consensus 135 ~Nil~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~---~----~~~~~DiwSlG~il~el~tg~~p 206 (325)
.||+++..+.+||+|||+....... ............-|.|||.+... . .+.+.|+||||++++|++++..|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998876431 01111111234569999998863 1 36689999999999999999999
Q ss_pred CCCCCCCcc-chhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCC
Q 046728 207 LEKLPGGVK-RDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGR 282 (325)
Q Consensus 207 f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 282 (325)
|........ ..++..+.. .......+.+... ....+++..++.+||..+|++||+++++-..++.....
T Consensus 158 ~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccccCChHHHHHHHHh-----cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 976433222 222222222 0011111111111 14445799999999999999999999999988876653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-20 Score=150.95 Aligned_cols=254 Identities=17% Similarity=0.193 Sum_probs=188.5
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCCeE
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDER 87 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 87 (325)
+.....|.++++||+| +|+.+|++.+..+|..||||.-..... ..++..|..+.+.|+ ...|..+..+..+...-
T Consensus 11 ~iv~gky~lvrkiGsG--SFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSG--SFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred heeccceEEEEeecCC--chhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 3345568899999999 888899999999999999998754222 236778999999996 46777778888888888
Q ss_pred EEEEEecCCCChhhhh---ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeC---CCCceEEeeeccccccC
Q 046728 88 LIVYDYMPNHSLITHL---HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLD---TDFEAKVADFGFAKLIP 157 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l---~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~---~~~~~kL~Dfg~~~~~~ 157 (325)
.+||+.. |.||.+.. ..+++.+.++-...|+..-+.++|.. |||||+|+|+. ...++.|+|||+++...
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999998 77877666 56677777777888888888888864 89999999996 34679999999999776
Q ss_pred CCcce------eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccc
Q 046728 158 DGVTH------MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAF 231 (325)
Q Consensus 158 ~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (325)
+.... ......||..|.+-....+...+.+-|+=|+|.+|.++--|..||.+.......+-..
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE----------- 234 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE----------- 234 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH-----------
Confidence 53221 1223458889988877777788899999999999999999999998765533322222
Q ss_pred ccccCccccCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 232 EHIADPRLKGK---FNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 232 ~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
.+.+..+..+ .-..+|.++.-.+.-|-..-=++-|.-.-+-+.|..+
T Consensus 235 -kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 235 -KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred -HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 2222111111 1134566788888888888888888876666644433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=151.48 Aligned_cols=254 Identities=15% Similarity=0.150 Sum_probs=188.5
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCCeEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lV~ 91 (325)
-.|.+-++||.| +|+.++.-+...+++.||||.-...+ ..-++..|....+.|. .++|..++-+=..+.+-.+|+
T Consensus 28 ~hyrVGkKIGeG--sFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEG--SFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccC--cceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 357788999999 77888888888999999999876533 2347888999999994 788888876667777788999
Q ss_pred EecCCCChhhhh---ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC-----ceEEeeeccccccCCC
Q 046728 92 DYMPNHSLITHL---HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF-----EAKVADFGFAKLIPDG 159 (325)
Q Consensus 92 e~~~~gsL~~~l---~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~-----~~kL~Dfg~~~~~~~~ 159 (325)
|.. |.||.|.. -.+++.+.+.-++.|+...+++.|.+ |||||+|+||...+ .+.++|||+++...+.
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 998 76776655 56677788888888888888888887 89999999997554 4899999999987664
Q ss_pred ccee------eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccc
Q 046728 160 VTHM------TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEH 233 (325)
Q Consensus 160 ~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (325)
.... .....||..||+-....+...+.+-|+=|||=++.+++-|..||.+........-.+.+...........
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~ 262 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEV 262 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHH
Confidence 3321 2234699999999988888999999999999999999999999987655444333332222111111111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 234 IADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
.-..++.++..-+.-.-..+=.+-|.-+-+...|...+
T Consensus 263 ---------Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 263 ---------LCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred ---------HHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 11335566666666666677778888777766555544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-20 Score=171.79 Aligned_cols=219 Identities=24% Similarity=0.304 Sum_probs=167.6
Q ss_pred ccCccceeeeeEEEeccCC---CCeEEEEEecccC--hhhHHHHHHHHHHHHccC-CCCccceeeEEEcCCeEEEEEEec
Q 046728 21 INNGLEILMLLLLLRRETG---DDQIAVKRLKTLN--AKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDERLIVYDYM 94 (325)
Q Consensus 21 i~~G~~~~~~v~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lV~e~~ 94 (325)
+|.| +++.|.+++...+ +...|+|.+.+.. .........|-.++..++ ||.+++++-.++.+...+++++|.
T Consensus 2 lg~g--~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQG--SYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCcC--CCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 4555 6666776665544 6678888876432 111125566888899996 999999999999999999999999
Q ss_pred CCCChhhhhccC--CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCC
Q 046728 95 PNHSLITHLHGR--LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVK 168 (325)
Q Consensus 95 ~~gsL~~~l~~~--~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~ 168 (325)
.+|+|...+... +.+.....+...++.++.++|.+ ||+|++||+++.+|.+++.|||+++........ +
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-----c 154 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-----C 154 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-----c
Confidence 999998888533 33334445556667777777665 799999999999999999999999865543322 7
Q ss_pred CCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHH
Q 046728 169 GTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQL 248 (325)
Q Consensus 169 ~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (325)
||..|||||+.. ....++|.||||++.++|+||..||.. +.... +.. .....++..+
T Consensus 155 gt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~----Il~----------~~~~~p~~l~ 211 (612)
T KOG0603|consen 155 GTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKR----ILK----------AELEMPRELS 211 (612)
T ss_pred cchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHH----Hhh----------hccCCchhhh
Confidence 999999999997 678899999999999999999999965 11111 001 1235678888
Q ss_pred HHHHHHHHHccCCCCCCCCCH
Q 046728 249 KSMVLIALRCTDSNPENRPTM 269 (325)
Q Consensus 249 ~~~~~li~~cl~~dp~~Rps~ 269 (325)
....+++..++..+|..|.-.
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhcc
Confidence 999999999999999999654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-19 Score=150.86 Aligned_cols=166 Identities=14% Similarity=0.161 Sum_probs=119.6
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhH---HH------HHHHHHHHHccCCCCccceeeEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAE---ME------FAVEVEILGRVRHRNLLGLRGFY 81 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~---~~------~~~E~~~l~~l~h~~iv~~~~~~ 81 (325)
+...|..++.+|.| +++.||++.. ++..+|||.+........ .. +.+|++.+.+++||+|..+.+++
T Consensus 29 l~~~y~~~~~l~~~--~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 29 LSYNIKTIKVFRNI--DDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred hhCceEEEEEecCC--CceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 35567888999988 8888998654 466899999964322222 22 57899999999999999999886
Q ss_pred EcC--------CeEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhh----cCCCCCCceeeCCCCceEEee
Q 046728 82 AGG--------DERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEG----IADIKASNVLLDTDFEAKVAD 149 (325)
Q Consensus 82 ~~~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~----~rdlkp~Nil~~~~~~~kL~D 149 (325)
... ...++||||++|.+|.++.. .++ ....++..++..+|. |||+||.||+++.++ ++|+|
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE--ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh--ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 533 35789999999999988742 222 234566666666776 489999999999888 99999
Q ss_pred eccccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHH
Q 046728 150 FGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLEL 200 (325)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el 200 (325)
||........... ........++.++|+||||+++..+
T Consensus 178 fg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 178 LSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred CCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHH
Confidence 9987644221110 0122233566899999999986654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.3e-18 Score=148.10 Aligned_cols=191 Identities=16% Similarity=0.174 Sum_probs=133.9
Q ss_pred CCCCccceeeEEEc---------------------------CCeEEEEEEecCCCChhhhhcc-CCCCCCccCHHHHHHH
Q 046728 70 RHRNLLGLRGFYAG---------------------------GDERLIVYDYMPNHSLITHLHG-RLAPDCLLDWHRRVSI 121 (325)
Q Consensus 70 ~h~~iv~~~~~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~~~ 121 (325)
+|||||++.++|.+ +...|+||.-+.. +|.+|+.. ..+.....-+..|+..
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHH
Confidence 59999999988743 2357999999855 99999943 2344444556777888
Q ss_pred HHHHHhhc----CCCCCCceeeC--CC--CceEEeeeccccccCC-----CcceeeccCCCCcCCCCccccccCC-----
Q 046728 122 AIGSAEGI----ADIKASNVLLD--TD--FEAKVADFGFAKLIPD-----GVTHMTTRVKGTLGYLAPEYAMWGK----- 183 (325)
Q Consensus 122 ~~~~~~~~----rdlkp~Nil~~--~~--~~~kL~Dfg~~~~~~~-----~~~~~~~~~~~t~~y~aPE~~~~~~----- 183 (325)
++.++|.| ||+|.+|||+. ++ ..++++|||+|..-.. ...+......|+-..+|||+....+
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av 432 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV 432 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence 88888765 79999999993 33 4588999999864332 1112233345788899999987432
Q ss_pred -CCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCC
Q 046728 184 -VSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSN 262 (325)
Q Consensus 184 -~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d 262 (325)
...++|.|+.|.+.||+++...||+.... .......+.. ...+..+..+++.+.+|+-..|+.|
T Consensus 433 vny~kAD~WA~GalaYEIfg~~NPFY~rGe-----------m~L~~r~Yqe----~qLPalp~~vpp~~rqlV~~lL~r~ 497 (598)
T KOG4158|consen 433 VNYEKADTWAAGALAYEIFGRSNPFYKRGE-----------MLLDTRTYQE----SQLPALPSRVPPVARQLVFDLLKRD 497 (598)
T ss_pred eccchhhhhhhhhhHHHHhccCCcccccch-----------heechhhhhh----hhCCCCcccCChHHHHHHHHHhcCC
Confidence 13589999999999999999999976211 0011111111 1123445566778999999999999
Q ss_pred CCCCCCHHHHHHHH
Q 046728 263 PENRPTMTDVVDWL 276 (325)
Q Consensus 263 p~~Rps~~~il~~l 276 (325)
|++|+|+.-..+.|
T Consensus 498 pskRvsp~iAANvl 511 (598)
T KOG4158|consen 498 PSKRVSPNIAANVL 511 (598)
T ss_pred ccccCCccHHHhHH
Confidence 99999977666533
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.8e-19 Score=171.25 Aligned_cols=234 Identities=17% Similarity=0.229 Sum_probs=161.1
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-h---hhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-A---KAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
-+.+.+++|.+ .|-.+..+++..+- |+||.+-+.+ . ....+..+|++ ...++|||++++.-+...+.-.|+
T Consensus 24 e~~~~~~LGst--RFlKv~r~k~~eG~--vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGST--RFLKVARAKDREGL--VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYL 98 (1431)
T ss_pred ceeeecccCch--hhhhhhhccCCCce--EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHH
Confidence 46788889888 77778877776653 8899885433 2 22334444555 555689999999988888888889
Q ss_pred EEEecCCCChhhhhccC--CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccc--cCCCcc
Q 046728 90 VYDYMPNHSLITHLHGR--LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKL--IPDGVT 161 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~~--~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~--~~~~~~ 161 (325)
|=+|..+ +|.|.+..+ +..-+.+-+..|+..|+.-+|.+ +|||.+|||++.=+.+.|+||..-+. +.++..
T Consensus 99 vRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 99 VRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 9999965 899988543 22223345566777777777754 79999999999999999999976542 222222
Q ss_pred e----eeccCCCCcCCCCccccccC----------C-CCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhccc
Q 046728 162 H----MTTRVKGTLGYLAPEYAMWG----------K-VSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPY 225 (325)
Q Consensus 162 ~----~~~~~~~t~~y~aPE~~~~~----------~-~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~ 225 (325)
. .-.+...-.+|.|||.+... + .+++-||||+||++.|+++ |++||.- .....+
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----------SQL~aY 247 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----------SQLLAY 247 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----------HHHHhH
Confidence 1 11122244579999988541 1 4668899999999999988 6888831 000111
Q ss_pred ccc------cccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046728 226 VQK------GAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDW 275 (325)
Q Consensus 226 ~~~------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~ 275 (325)
... ..++.+. +..++.||..|++.||++|.|+++.++-
T Consensus 248 r~~~~~~~e~~Le~Ie------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 248 RSGNADDPEQLLEKIE------------DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hccCccCHHHHHHhCc------------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111 1111111 2368889999999999999999999973
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.9e-18 Score=162.54 Aligned_cols=207 Identities=20% Similarity=0.190 Sum_probs=144.0
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
....|..|+.|..| +++.||+++|+.+.+.+|+ .+++.+ -+.+. ++....+|.+|
T Consensus 81 ~e~df~~Iklisng--Aygavylvrh~~trqrfa~-kiNkq~-----lilRn--ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNG--AYGAVYLVRHKETRQRFAM-KINKQN-----LILRN--ILTFAGNPFVV--------------- 135 (1205)
T ss_pred CccccceeEeeccC--CCCceeeeeccccccchhh-cccccc-----hhhhc--cccccCCccee---------------
Confidence 34567889999999 7788999999999999999 444311 11111 44444566555
Q ss_pred EEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhcCCCCCCceeeCCCCceEEeeeccccccCCCcc---------
Q 046728 91 YDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIADIKASNVLLDTDFEAKVADFGFAKLIPDGVT--------- 161 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--------- 161 (325)
||-...++..- .........+.+.+.+...|||+||+|.+|..-|.+|++|||+++.-.....
T Consensus 136 ------gDc~tllk~~g--~lPvdmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~ 207 (1205)
T KOG0606|consen 136 ------GDCATLLKNIG--PLPVDMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIE 207 (1205)
T ss_pred ------chhhhhcccCC--CCcchhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchH
Confidence 45555554321 1112223344444444455699999999999999999999999885432211
Q ss_pred -----eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCc-----cchhhhhhccccccccc
Q 046728 162 -----HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGV-----KRDIVQWVTPYVQKGAF 231 (325)
Q Consensus 162 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~ 231 (325)
......+||+.|+|||++....|+..+|+|++|+++|+++.|..||.+...++ ..+.+.|.
T Consensus 208 k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp--------- 278 (1205)
T KOG0606|consen 208 KDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP--------- 278 (1205)
T ss_pred HHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc---------
Confidence 11233579999999999999999999999999999999999999998874322 22222221
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 046728 232 EHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTM 269 (325)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 269 (325)
......++++.+++.++|+.+|..|.-.
T Consensus 279 ----------E~dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 279 ----------EEDEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred ----------ccCcCCCHHHHHHHHHHHHhChHhhccc
Confidence 1123345689999999999999999543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.4e-17 Score=133.72 Aligned_cols=133 Identities=14% Similarity=0.065 Sum_probs=96.2
Q ss_pred HhhccCccceeeeeEEEeccCCCCeEEEEEecccChh--h------------------------HHHHHHHHHHHHccCC
Q 046728 18 IQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAK--A------------------------EMEFAVEVEILGRVRH 71 (325)
Q Consensus 18 ~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h 71 (325)
...||.| +++.||.+... +|+.||||+++..... . ......|++++.++.+
T Consensus 2 ~~~ig~G--~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 78 (190)
T cd05147 2 NGCISTG--KEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVT 78 (190)
T ss_pred CCccccc--cceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHH
Confidence 4567888 88889999886 7899999999643211 1 1122359999999988
Q ss_pred CCccceeeEEEcCCeEEEEEEecCCCChhhhh--ccCCCCCCccCHHHHHHHHHHHH-hh----cCCCCCCceeeCCCCc
Q 046728 72 RNLLGLRGFYAGGDERLIVYDYMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSA-EG----IADIKASNVLLDTDFE 144 (325)
Q Consensus 72 ~~iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l--~~~~~~~~~~~~~~~~~~~~~~~-~~----~rdlkp~Nil~~~~~~ 144 (325)
+++.....+.. ...++||||+.++++.... ...++...+..+..++..++.++ |. ||||||+|||++ ++.
T Consensus 79 ~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 79 AGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 77643332222 2238999999887776543 23455556677788888888887 55 389999999998 478
Q ss_pred eEEeeecccccc
Q 046728 145 AKVADFGFAKLI 156 (325)
Q Consensus 145 ~kL~Dfg~~~~~ 156 (325)
++|+|||++...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.9e-17 Score=137.81 Aligned_cols=221 Identities=16% Similarity=0.168 Sum_probs=129.0
Q ss_pred HhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCC----------CCccceeeEE---
Q 046728 18 IQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRH----------RNLLGLRGFY--- 81 (325)
Q Consensus 18 ~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~~iv~~~~~~--- 81 (325)
.+.||.| +++.|+-+.+..+++.+|+|.+.... ....+.+.+|.-....+.+ -.++.-++..
T Consensus 17 ~~~i~~g--~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 17 GRIIGKG--GFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEE--TTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred ccccccC--CceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 3456666 88889999999999999999885332 2334566666554444321 1222222221
Q ss_pred ------EcCC--------eEEEEEEecCCCChhhhhcc---CCCCCC------ccCHHHHHHHHHHHHhhc----CCCCC
Q 046728 82 ------AGGD--------ERLIVYDYMPNHSLITHLHG---RLAPDC------LLDWHRRVSIAIGSAEGI----ADIKA 134 (325)
Q Consensus 82 ------~~~~--------~~~lV~e~~~~gsL~~~l~~---~~~~~~------~~~~~~~~~~~~~~~~~~----rdlkp 134 (325)
.... ..+++|+-+. +||.+++.. .-.... .+.+..|+..+.+.+|.+ +||+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~ 173 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKP 173 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SG
T ss_pred CCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccce
Confidence 1111 1367888884 589888731 111111 123334445555556654 69999
Q ss_pred CceeeCCCCceEEeeeccccccCCCcceeeccCCCCcCCCCccccccC--------CCCCcccchhHHHHHHHHHhCCCC
Q 046728 135 SNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWG--------KVSDSCDVYSFGVLLLELISAKKP 206 (325)
Q Consensus 135 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--------~~~~~~DiwSlG~il~el~tg~~p 206 (325)
+|++++.+|.++|+||+.....+.. ... ...+..|.+||..... .++.+.|.|+||+++|.|+++..|
T Consensus 174 ~nfll~~~G~v~Lg~F~~~~r~g~~--~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP 249 (288)
T PF14531_consen 174 ENFLLDQDGGVFLGDFSSLVRAGTR--YRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP 249 (288)
T ss_dssp GGEEE-TTS-EEE--GGGEEETTEE--EEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred eeEEEcCCCCEEEcChHHHeecCce--eec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence 9999999999999999877654432 111 2345778999976532 467889999999999999999999
Q ss_pred CCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCC
Q 046728 207 LEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENR 266 (325)
Q Consensus 207 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R 266 (325)
|........... . -.... +.++.+..||.++|+.||++|
T Consensus 250 f~~~~~~~~~~~-------------------~-f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 250 FGLSSPEADPEW-------------------D-FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TCCCGGGSTSGG-------------------G-GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCccccccc-------------------c-chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 975322111000 0 01222 677899999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.4e-16 Score=127.14 Aligned_cols=184 Identities=15% Similarity=0.089 Sum_probs=129.8
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChh----hHHHHHHHHHHHHccC-CCCccceeeEEEcCCeEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAK----AEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 88 (325)
|+-....|+.| +|+.|+++.. ++..++.+.+....-. ....+.+|+++|++|. |+++.+++++ ...+
T Consensus 3 ~~~~~~~l~~~--~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~ 74 (218)
T PRK12274 3 PPAVNEPLKSD--TFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRH 74 (218)
T ss_pred CcccceeecCC--CcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEE
Confidence 44556778888 7778887765 6788888887653221 1125788999999995 6889998886 3479
Q ss_pred EEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCC-CCCceeeCCCCceEEeeeccccccCCCcce-
Q 046728 89 IVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADI-KASNVLLDTDFEAKVADFGFAKLIPDGVTH- 162 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdl-kp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~- 162 (325)
++|+|+.|.+|.+.+.. ....+..++..++..+|.. ||| ||.|||++.++.++|+|||++.........
T Consensus 75 lvmeyI~G~~L~~~~~~-----~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR-----GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred EEEeeecCccHHhhhhh-----hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 99999999998765421 1235667777788888875 799 799999999999999999999855433210
Q ss_pred ---e--------eccCCCCcCCCCccccccC-CCC-CcccchhHHHHHHHHHhCCCCCCCC
Q 046728 163 ---M--------TTRVKGTLGYLAPEYAMWG-KVS-DSCDVYSFGVLLLELISAKKPLEKL 210 (325)
Q Consensus 163 ---~--------~~~~~~t~~y~aPE~~~~~-~~~-~~~DiwSlG~il~el~tg~~pf~~~ 210 (325)
. ......++.|++|+...-. ..+ ...+.++.|.-+|.++|+..|+.+.
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0011245566666643321 333 4567888899999999999887543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.8e-18 Score=151.20 Aligned_cols=166 Identities=24% Similarity=0.379 Sum_probs=117.5
Q ss_pred eEEEEEEecCCCChhhhhccC-CCC----CCccCHHHHHHHHHHHHhh--cCCCCCCceeeCCCCceEEeeeccccccCC
Q 046728 86 ERLIVYDYMPNHSLITHLHGR-LAP----DCLLDWHRRVSIAIGSAEG--IADIKASNVLLDTDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~~-~~~----~~~~~~~~~~~~~~~~~~~--~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 158 (325)
..||.|++|.-++|.++|..+ ..+ ..++.++.++.-+..+ .+ ++|+||.||++..+..+||.|||+......
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~ 408 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDK 408 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-ccchhhhccccccccccchhhhhhhhhheeeccc
Confidence 478999999999999999532 222 2334455555544444 22 389999999999999999999999887665
Q ss_pred Cc-----ceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccc
Q 046728 159 GV-----THMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFE 232 (325)
Q Consensus 159 ~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (325)
.. ........||..|++||.+.+..|+.++||||||++|+|+++ -..+|.. .+.+.
T Consensus 409 ~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------------------~~t~~ 470 (516)
T KOG1033|consen 409 DETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------------------IATLT 470 (516)
T ss_pred CCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------------------HHhhh
Confidence 43 122344579999999999999999999999999999999988 3433321 12222
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 046728 233 HIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTD 271 (325)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~ 271 (325)
.+.+..+++.+..+.+ .-..|+.+++.+.|.+||++.+
T Consensus 471 d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 471 DIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHH
Confidence 3333333323333333 3456899999999999995443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.2e-16 Score=128.22 Aligned_cols=135 Identities=16% Similarity=0.098 Sum_probs=99.7
Q ss_pred HhhccCccceeeeeEEEeccCCCCeEEEEEecccChh--------------------------hHHHHHHHHHHHHccCC
Q 046728 18 IQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAK--------------------------AEMEFAVEVEILGRVRH 71 (325)
Q Consensus 18 ~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h 71 (325)
.+.||.| +++.||.+... +|+.||||.+...... ....+..|.+.+.++.|
T Consensus 2 ~~~ig~G--~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 78 (190)
T cd05145 2 NGCISTG--KEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYE 78 (190)
T ss_pred CceeecC--CCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4567888 88889999877 8999999998743210 01234578999999999
Q ss_pred CCccceeeEEEcCCeEEEEEEecCCCChhhh-hc-cCCCCCCccCHHHHHHHHHHHHhh-c----CCCCCCceeeCCCCc
Q 046728 72 RNLLGLRGFYAGGDERLIVYDYMPNHSLITH-LH-GRLAPDCLLDWHRRVSIAIGSAEG-I----ADIKASNVLLDTDFE 144 (325)
Q Consensus 72 ~~iv~~~~~~~~~~~~~lV~e~~~~gsL~~~-l~-~~~~~~~~~~~~~~~~~~~~~~~~-~----rdlkp~Nil~~~~~~ 144 (325)
+++.....+... ..++||||++|+++... +. ..++......+..++..++..+|. . |||||+||+++ ++.
T Consensus 79 ~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 79 AGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCCCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 987544444332 24899999988765433 32 334445667788888888888887 3 79999999998 789
Q ss_pred eEEeeeccccccCC
Q 046728 145 AKVADFGFAKLIPD 158 (325)
Q Consensus 145 ~kL~Dfg~~~~~~~ 158 (325)
++|+|||++.....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.6e-16 Score=127.37 Aligned_cols=129 Identities=12% Similarity=0.089 Sum_probs=93.5
Q ss_pred HhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc-----CCCCccceeeEEEcCC---eEE-
Q 046728 18 IQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-----RHRNLLGLRGFYAGGD---ERL- 88 (325)
Q Consensus 18 ~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~---~~~- 88 (325)
.+.||+| +++.||. +..+... +||++..........+.+|+.+++.+ .||||++++++++++. .++
T Consensus 7 ~~~LG~G--~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 7 QSPLGTG--RHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cceecCC--CceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3567888 6777774 4455555 69988764444556889999999999 5799999999998874 434
Q ss_pred EEEEe--cCCCChhhhhccC-CCCCCccCHHHHHHHHH-HHHhhc----CCCCCCceeeCC----CCceEEeeeccc
Q 046728 89 IVYDY--MPNHSLITHLHGR-LAPDCLLDWHRRVSIAI-GSAEGI----ADIKASNVLLDT----DFEAKVADFGFA 153 (325)
Q Consensus 89 lV~e~--~~~gsL~~~l~~~-~~~~~~~~~~~~~~~~~-~~~~~~----rdlkp~Nil~~~----~~~~kL~Dfg~~ 153 (325)
+|||| +.+|+|.+++++. +.+. ..+..++..++ .++|.+ |||||+|||++. +..++|+||+.+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 89999 5579999999642 2222 23444544444 788876 799999999974 347999995433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=6.5e-17 Score=153.51 Aligned_cols=253 Identities=20% Similarity=0.248 Sum_probs=191.1
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCC-CCeEEEEEeccc--ChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCCeE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETG-DDQIAVKRLKTL--NAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDER 87 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~-~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 87 (325)
..+|.+++.||+| ++..+..+....+ ...+|.|.+... ......+...|..+-+.+. |+|++.+++...+....
T Consensus 19 ~~~~~~~~~ig~g--s~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~ 96 (601)
T KOG0590|consen 19 NSQYKLSRSIGKG--SFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY 96 (601)
T ss_pred ccccccccccccc--ccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccc
Confidence 5678889999988 7777777766544 456777777543 2344445666888888886 99999999999999999
Q ss_pred EEEEEecCCCChhhhh-cc---CCCCCCccCHHHHHHHHHHHHh-----hcCCCCCCceeeCCCC-ceEEeeeccccccC
Q 046728 88 LIVYDYMPNHSLITHL-HG---RLAPDCLLDWHRRVSIAIGSAE-----GIADIKASNVLLDTDF-EAKVADFGFAKLIP 157 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l-~~---~~~~~~~~~~~~~~~~~~~~~~-----~~rdlkp~Nil~~~~~-~~kL~Dfg~~~~~~ 157 (325)
+++++|..|+++.+-+ .. .......-.++.++..++.+.| .++|+||+|.+++..+ ..+++|||++....
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 9999999999999888 42 3445566778888888888888 3489999999999999 99999999998776
Q ss_pred C--CcceeeccCCC-CcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccc
Q 046728 158 D--GVTHMTTRVKG-TLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEH 233 (325)
Q Consensus 158 ~--~~~~~~~~~~~-t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (325)
. +.........| ++.|.|||...+. ......|+||.|+++.-+++|..||....... .....|....
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~-------- 247 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK-------- 247 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc--------
Confidence 6 33333445568 9999999999874 45678999999999999999999986533221 1111111100
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 234 IADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
.......+...+....+++.+++..+|+.|.+.+++.. |+..
T Consensus 248 ---~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 248 ---GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ---cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 11112344566677888999999999999999999886 7765
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.5e-15 Score=142.92 Aligned_cols=186 Identities=16% Similarity=0.180 Sum_probs=145.7
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC---CCCccceeeEEEcCCeEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR---HRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~ 88 (325)
++-|.+-+.||.| +++.||++.+.. ++.||+|+-+-...+ +|.--.+++.+|+ -+.|+.+...+.-.+.-+
T Consensus 697 ~~~~~I~~e~G~g--~y~~vy~a~~~~-~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 697 GEKFCISKEIGEG--SYGSVYVATHSN-GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred ceeEEEEeeeccc--cceEEEEeecCC-CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 3445677889999 999999999888 999999998765555 3444455666665 346667777666677778
Q ss_pred EEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeC-------CCCceEEeeeccccc
Q 046728 89 IVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLD-------TDFEAKVADFGFAKL 155 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~-------~~~~~kL~Dfg~~~~ 155 (325)
+|++|.+.|+|.+++. +.+++..++.+..++...+..+|.+ +||||+|+|+. +...++|+|||.+-.
T Consensus 771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 9999999999999995 3456666777778888888888875 79999999994 234699999999864
Q ss_pred cC---CCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCC
Q 046728 156 IP---DGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKK 205 (325)
Q Consensus 156 ~~---~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~ 205 (325)
+. +... -....+|-.|-++|+..+.+++..+|-|-++.+++.|+.|..
T Consensus 851 m~lfp~~~~--F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 851 MKLFPDGTK--FKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeEcCCCcE--EeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 43 2211 223457888999999999999999999999999999999875
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.1e-14 Score=117.80 Aligned_cols=130 Identities=18% Similarity=0.214 Sum_probs=101.0
Q ss_pred hhccCccceeeeeEEEeccCCCCeEEEEEecccCh--------hhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 19 QNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA--------KAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
+.||+| +++.||.+.. .+..|++|....... ....++.+|+.++..++|+++.....++.+....++|
T Consensus 2 ~~l~~G--~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 77 (211)
T PRK14879 2 KLIKRG--AEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIV 77 (211)
T ss_pred cccccC--ceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEE
Confidence 467777 7788888875 567799997653211 1123677899999999999988777777777888999
Q ss_pred EEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccc
Q 046728 91 YDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
|||++|++|.+++..... ....+..++..++..+|.. +|++|.|||++ ++.++|+|||.+..
T Consensus 78 ~e~~~G~~L~~~~~~~~~--~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNGM--EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhccH--HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999999854322 4456777777777788764 79999999999 78899999998764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.5e-14 Score=119.80 Aligned_cols=138 Identities=12% Similarity=0.069 Sum_probs=100.1
Q ss_pred chhHHhhccCccceeeeeEEEe-ccCCCCeEEEEEecccChh------------------------hHHHHHHHHHHHHc
Q 046728 14 PAVFIQNINNGLEILMLLLLLR-RETGDDQIAVKRLKTLNAK------------------------AEMEFAVEVEILGR 68 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~-~~~~~~~vaiK~~~~~~~~------------------------~~~~~~~E~~~l~~ 68 (325)
-|.+.+.||.| +++.||.+. +..+++.||+|.+...... ....+..|++++++
T Consensus 29 ~~~i~~~Lg~G--~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 29 LSAIGGCISTG--KEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred hHHhCCeeccC--cceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 46788899999 888899998 6778999999998643210 11235679999999
Q ss_pred cCCC--CccceeeEEEcCCeEEEEEEecCCCChhhhh-cc-CCCCCCccCHHHHHHHHHHHHhhc-----CCCCCCceee
Q 046728 69 VRHR--NLLGLRGFYAGGDERLIVYDYMPNHSLITHL-HG-RLAPDCLLDWHRRVSIAIGSAEGI-----ADIKASNVLL 139 (325)
Q Consensus 69 l~h~--~iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l-~~-~~~~~~~~~~~~~~~~~~~~~~~~-----rdlkp~Nil~ 139 (325)
+.+. .+.++++. ...++||||+.+++|..+. .. .........+..++..+++.+|.. +||||+||++
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 9753 23333332 2358999999998887665 22 222233456788888888888743 7999999999
Q ss_pred CCCCceEEeeeccccccCC
Q 046728 140 DTDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 140 ~~~~~~kL~Dfg~~~~~~~ 158 (325)
+ ++.++|+|||.+.....
T Consensus 183 ~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 183 H-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred E-CCCEEEEEChhhhccCC
Confidence 9 78999999998875433
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.47 E-value=5.1e-13 Score=110.69 Aligned_cols=125 Identities=18% Similarity=0.244 Sum_probs=95.0
Q ss_pred ccCccceeeeeEEEeccCCCCeEEEEEecccC---h-----hhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 21 INNGLEILMLLLLLRRETGDDQIAVKRLKTLN---A-----KAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 21 i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
||+| +++.||.+. ..+..|++|...... . ....++.+|++++..++|+++....-++......++|||
T Consensus 2 ig~G--~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 2 IAKG--AEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCC--ceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEE
Confidence 5666 888899887 456789999864321 1 112467789999999988876655555556667899999
Q ss_pred ecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccc
Q 046728 93 YMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 93 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
|++|++|.+++..... .+..++..++..+|.. +|++|.||+++ ++.++++|||++..
T Consensus 78 ~~~g~~l~~~~~~~~~-----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcHH-----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999998753211 6677777888888874 79999999999 78999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.46 E-value=3e-13 Score=112.08 Aligned_cols=133 Identities=14% Similarity=0.059 Sum_probs=94.6
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChh----------------------hHHHHHHHHHHHHccCCC
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAK----------------------AEMEFAVEVEILGRVRHR 72 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~E~~~l~~l~h~ 72 (325)
|.+.+.||.| +++.||.+... +++.||||.+...... .......|+.++.++.|+
T Consensus 17 ~~~~~~i~~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 93 (198)
T cd05144 17 ESLGNQIGVG--KESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE 93 (198)
T ss_pred hhcCCccccC--cceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence 4556778888 77788888764 6899999987542200 111356789999999776
Q ss_pred C--ccceeeEEEcCCeEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceE
Q 046728 73 N--LLGLRGFYAGGDERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAK 146 (325)
Q Consensus 73 ~--iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~k 146 (325)
+ +...++ ....++||||++|++|...... .....+..++..++..+|.. +||||.||+++.++.++
T Consensus 94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCCCceee----cCCceEEEEEeCCcchhhcccc----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 4 444433 2456899999999998775431 22345556666666666654 79999999999999999
Q ss_pred EeeeccccccCC
Q 046728 147 VADFGFAKLIPD 158 (325)
Q Consensus 147 L~Dfg~~~~~~~ 158 (325)
|+|||++.....
T Consensus 166 liDfg~~~~~~~ 177 (198)
T cd05144 166 IIDWPQMVSTDH 177 (198)
T ss_pred EEECCccccCCC
Confidence 999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.3e-12 Score=124.25 Aligned_cols=128 Identities=18% Similarity=0.174 Sum_probs=97.2
Q ss_pred HHhhccCccceeeeeEEEeccCCCCeEEEEEe-ccc-C------hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 17 FIQNINNGLEILMLLLLLRRETGDDQIAVKRL-KTL-N------AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 17 ~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~-~~~-~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
..+.||.| +++.||++.... ..+++|.. .+. . .....++.+|+++++.++|++++....+..+....+
T Consensus 337 ~~~~iG~G--~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 337 PDHLIGKG--AEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred ccceeccC--CcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 35677888 777788866433 33444432 111 1 112346888999999999999988777777777789
Q ss_pred EEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccc
Q 046728 89 IVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
+||||+++++|.+++.. ...+..++..++.++|.. |||||+||++ .++.++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~~------~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLEG------NPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHHH------HHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999998852 245777888888888874 8999999999 677999999999875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=5.1e-13 Score=122.18 Aligned_cols=245 Identities=19% Similarity=0.179 Sum_probs=174.8
Q ss_pred ccchhHHhhccCccceeeeeEEEec--cCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCCe
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRR--ETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDE 86 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~--~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 86 (325)
...+.+...+|.-.|+.+.+|..+. ..++..+|+|.-+.. .+....+=.+|+...++++ |++.++.+..+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 3445566677772248888999998 888899999984432 2233345556888888885 9999999999999999
Q ss_pred EEEEEEecCCCChhhhhccC---CCCCCccCHHHHHHH----HHHHHhhc----CCCCCCceeeCCC-CceEEeeecccc
Q 046728 87 RLIVYDYMPNHSLITHLHGR---LAPDCLLDWHRRVSI----AIGSAEGI----ADIKASNVLLDTD-FEAKVADFGFAK 154 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~~~~~----~~~~~~~~----rdlkp~Nil~~~~-~~~kL~Dfg~~~ 154 (325)
.++-+|.| +.+|.++.+.. +.+...+........ ++...|.- -|+||.||+...+ ..++++|||+..
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred ceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 99999999 57999888533 455555666665555 66655553 4999999999999 889999999998
Q ss_pred ccCCCccee----eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccc
Q 046728 155 LIPDGVTHM----TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGA 230 (325)
Q Consensus 155 ~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (325)
.+....... .....+...|++||... +-++.++|++|+|.+..+..++..++...... .
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~---------- 334 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS------S---------- 334 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC------C----------
Confidence 877654221 12225778899999876 57889999999999999999887765432111 1
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 231 FEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
|..+....+...+-...+.++...+.+|++.+|-.|++++.+.+
T Consensus 335 W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 WSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11111111122222233445666888999999999999998887
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=5.6e-12 Score=103.33 Aligned_cols=132 Identities=15% Similarity=0.105 Sum_probs=88.3
Q ss_pred HhhccCccceeeeeEEEeccCCCCeEEEEEecccChh--hHHH----------------------HHHHHHHHHccCCC-
Q 046728 18 IQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAK--AEME----------------------FAVEVEILGRVRHR- 72 (325)
Q Consensus 18 ~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~- 72 (325)
.+.||+| +++.||.+... +++.||||.+...... .... ...|.+.+..+.+.
T Consensus 2 ~~~lg~G--~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 78 (187)
T cd05119 2 GGPIGTG--KEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAG 78 (187)
T ss_pred Ccccccc--cceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcC
Confidence 3567777 88889998876 7889999988642211 1111 13466666666433
Q ss_pred -CccceeeEEEcCCeEEEEEEecCCCChhhh-hccCCCCCCccCHHHHHHHHHHHHhh-----cCCCCCCceeeCCCCce
Q 046728 73 -NLLGLRGFYAGGDERLIVYDYMPNHSLITH-LHGRLAPDCLLDWHRRVSIAIGSAEG-----IADIKASNVLLDTDFEA 145 (325)
Q Consensus 73 -~iv~~~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~-----~rdlkp~Nil~~~~~~~ 145 (325)
.+.+.++. ...++||||++++++... +...........+..++..++..+|. |+||||+||+++ ++.+
T Consensus 79 ~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 79 VPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCCCceEec----CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 23444432 246899999998544321 11111114556777888888888887 489999999999 8899
Q ss_pred EEeeeccccccC
Q 046728 146 KVADFGFAKLIP 157 (325)
Q Consensus 146 kL~Dfg~~~~~~ 157 (325)
+|+|||.+....
T Consensus 154 ~liDfg~a~~~~ 165 (187)
T cd05119 154 YIIDVPQAVEID 165 (187)
T ss_pred EEEECccccccc
Confidence 999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.33 E-value=4.9e-12 Score=99.41 Aligned_cols=127 Identities=13% Similarity=0.165 Sum_probs=97.2
Q ss_pred HhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCC--CCccceeeEEEcCCeEEEEEEecC
Q 046728 18 IQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRH--RNLLGLRGFYAGGDERLIVYDYMP 95 (325)
Q Consensus 18 ~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lV~e~~~ 95 (325)
++.||.| +...+|.+.... ..+++|....... ...+..|+.+++.++| .++.+++++....+..+++|||+.
T Consensus 3 ~~~i~~g--~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 3 IKLLKGG--LTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred ceecccc--cccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 5667888 677788877544 6899999865332 4578899999999975 589999988888888999999999
Q ss_pred CCChhhhhccCCCCCCccCHHHHHHHHHHHHhh-------cCCCCCCceeeCCCCceEEeeeccccc
Q 046728 96 NHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEG-------IADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 96 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-------~rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
++++..+ +.........++..++..+|. |+|++|.||+++..+.++++|||.+..
T Consensus 77 g~~~~~~-----~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV-----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC-----CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8877654 112223455566666666665 379999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=8.4e-12 Score=106.14 Aligned_cols=124 Identities=15% Similarity=0.103 Sum_probs=88.1
Q ss_pred eeeeeEEEeccCCCCeEEEEEecccC-------------hhhHHHHHHHHHHHHccCCCCc--cceeeEEEcC-C---eE
Q 046728 27 ILMLLLLLRRETGDDQIAVKRLKTLN-------------AKAEMEFAVEVEILGRVRHRNL--LGLRGFYAGG-D---ER 87 (325)
Q Consensus 27 ~~~~v~~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~-~---~~ 87 (325)
|.+.+|.+... +..+++|.+.... .....++.+|++++..|+|+++ ++.+++.... . ..
T Consensus 44 g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~ 121 (239)
T PRK01723 44 GRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRA 121 (239)
T ss_pred CCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceee
Confidence 67777777643 6789999874311 1233577889999999988774 6666654332 2 23
Q ss_pred EEEEEecCC-CChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccc
Q 046728 88 LIVYDYMPN-HSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 88 ~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
++|||+++| .+|.+++.... .......++..++..+|.. +||||.|||++.++.++|+|||.+..
T Consensus 122 ~lV~e~l~G~~~L~~~l~~~~---l~~~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 122 DILIERIEGARDLVALLQEAP---LSEEQWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred eEEEEecCCCCCHHHHHhcCC---CCHHHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 599999997 68988885421 1123345666777777764 79999999999888999999998764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.5e-11 Score=104.76 Aligned_cols=191 Identities=15% Similarity=0.229 Sum_probs=127.1
Q ss_pred HHHHHccCCCCccceeeEEEcC-----CeEEEEEEecCCCChhhhhcc------CCCCCCccCHHHHHHHHHHHHhhc--
Q 046728 63 VEILGRVRHRNLLGLRGFYAGG-----DERLIVYDYMPNHSLITHLHG------RLAPDCLLDWHRRVSIAIGSAEGI-- 129 (325)
Q Consensus 63 ~~~l~~l~h~~iv~~~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~~-- 129 (325)
+.-+-++-|.|+++++.++.+. ....++.||++.|++.++|+. .+....+..|..++..++.++|+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 4445566799999999998654 347899999999999999952 355567788999999999999985
Q ss_pred ----CCCCCCceeeCCCCceEEeeeccccccCCC----cceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHH
Q 046728 130 ----ADIKASNVLLDTDFEAKVADFGFAKLIPDG----VTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELI 201 (325)
Q Consensus 130 ----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 201 (325)
+++.-+.|++..+|-+|+.-- ........ .......-.+.+.|.|||.-.....+.++|||+||+...+|.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 699999999998877776531 11100000 000111123567899999766556678999999999999998
Q ss_pred hCCCCCCC-CCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 202 SAKKPLEK-LPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 202 tg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.+..--.. ...-.....+..+ .... .. ..-..+++.|++-.|+.||++..++.
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~--------i~~l-en-----------~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANV--------IIGL-EN-----------GLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcceeehhhhhhhh--------eeec-cC-----------ccccCcCcccccCCCCCCcchhhhhc
Confidence 87553211 1110010000000 0001 11 12234778999999999999998875
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=8.4e-10 Score=102.56 Aligned_cols=185 Identities=15% Similarity=0.049 Sum_probs=127.8
Q ss_pred cccchhHHhhccCccceeeeeEE-EeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLL-LRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..+||.+ -....+...+|- ...+.++..|.|+..+...........+-++-|+.++||||++|++.++.....|+
T Consensus 11 ~~fpY~l----e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~yl 86 (690)
T KOG1243|consen 11 SQFPYDL----EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYL 86 (690)
T ss_pred ccCCccc----ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEE
Confidence 3466776 333333444553 44556678888988875444444567788999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhh-----cCCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 90 VYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEG-----IADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-----~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|+|-+ -.|..+++... ....-.-..++..|+.++|. |+||.-+.++|+..|.-||++|.++........ ..
T Consensus 87 vTErV--~Pl~~~lk~l~-~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~ 162 (690)
T KOG1243|consen 87 VTERV--RPLETVLKELG-KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PA 162 (690)
T ss_pred Eeecc--ccHHHHHHHhH-HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-cc
Confidence 99998 37888886532 22222345678888888862 479999999999999999999988764332211 01
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKK 205 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~ 205 (325)
....--..|..|+.+.. -....|.|-|||++++++.|..
T Consensus 163 ~~~~~~~s~~~P~~~~~--s~~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 163 KSLYLIESFDDPEEIDP--SEWSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred ccchhhhcccChhhcCc--cccchhhhhHHHHHHHHhCccc
Confidence 11111223556664432 1246799999999999999933
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.3e-10 Score=105.34 Aligned_cols=135 Identities=15% Similarity=0.166 Sum_probs=82.3
Q ss_pred hhccCccceeeeeEEEeccCCCCeEEEEEecccChh----------------------------------hHH------H
Q 046728 19 QNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAK----------------------------------AEM------E 58 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~----------------------------------~~~------~ 58 (325)
+-||+| +.+.|+.++...+|+.||||++...-.. ... .
T Consensus 125 ~Plasa--SiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD 202 (537)
T PRK04750 125 KPLASA--SIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELD 202 (537)
T ss_pred hhhcCC--CccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhC
Confidence 346665 9999999998877999999998632100 011 1
Q ss_pred HHHHHHHHHccC----CCCccceeeEEEc-CCeEEEEEEecCCCChhhhh--cc-CCC-----CCCccCHHHHHHHHHHH
Q 046728 59 FAVEVEILGRVR----HRNLLGLRGFYAG-GDERLIVYDYMPNHSLITHL--HG-RLA-----PDCLLDWHRRVSIAIGS 125 (325)
Q Consensus 59 ~~~E~~~l~~l~----h~~iv~~~~~~~~-~~~~~lV~e~~~~gsL~~~l--~~-~~~-----~~~~~~~~~~~~~~~~~ 125 (325)
+.+|...+.+++ +.+.+.+-.++.+ ....++||||+.|++|.++- .. ..+ +..+..++.|+ ...
T Consensus 203 ~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi---f~~ 279 (537)
T PRK04750 203 LMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV---FRD 279 (537)
T ss_pred HHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---HhC
Confidence 233444444442 3334444444433 34567999999999997743 21 111 00011111111 111
Q ss_pred HhhcCCCCCCceeeCCCC----ceEEeeeccccccCC
Q 046728 126 AEGIADIKASNVLLDTDF----EAKVADFGFAKLIPD 158 (325)
Q Consensus 126 ~~~~rdlkp~Nil~~~~~----~~kL~Dfg~~~~~~~ 158 (325)
.--|+|+||.||+++.++ .++++|||++..+..
T Consensus 280 GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 280 GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 223589999999999887 999999999987755
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.5e-09 Score=100.35 Aligned_cols=141 Identities=13% Similarity=0.089 Sum_probs=83.8
Q ss_pred HHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhH----------------------------------------
Q 046728 17 FIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAE---------------------------------------- 56 (325)
Q Consensus 17 ~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~---------------------------------------- 56 (325)
.+..--.|+++.+.|+.++- .+|+.||||+.........
T Consensus 119 ~fd~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFEEKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCCCcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 33333344449999999975 4689999999853211100
Q ss_pred HHHHHHHHHHHccC----CCCccceeeEEE-cCCeEEEEEEecCCCChhhhhccCCCCCCccCHHHHH-HHHHHHHhh--
Q 046728 57 MEFAVEVEILGRVR----HRNLLGLRGFYA-GGDERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRV-SIAIGSAEG-- 128 (325)
Q Consensus 57 ~~~~~E~~~l~~l~----h~~iv~~~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~-- 128 (325)
-.+.+|...+.+++ |.+-+.+-.++. .....++||||++|++|.++............+...+ ...+..+|.
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCC
Confidence 01334555555552 333333333432 2345789999999999988764211111111222222 112222222
Q ss_pred --cCCCCCCceeeCCCCceEEeeeccccccCC
Q 046728 129 --IADIKASNVLLDTDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 129 --~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 158 (325)
|+|+||.||+++.++.++++|||++..+..
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 489999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.4e-10 Score=103.91 Aligned_cols=236 Identities=17% Similarity=0.132 Sum_probs=160.5
Q ss_pred cchhHHhhccCccceeeeeEEEecc-CCCCeEEEEEecccC--hhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRE-TGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 88 (325)
-.+.++.+||.| .++.++.+... .++..+++|.+.... ......-..|+.+.-.+ -|.+++.+...|......+
T Consensus 265 ~df~~v~~i~~~--~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 265 TDFGLVSKISDG--NFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred CCcceeEEccCC--ccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 357788888888 55556655544 678889999775322 22222333466666666 4888998888887777888
Q ss_pred EEEEecCCCChhhhh--ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC-CceEEeeeccccccCCCcc
Q 046728 89 IVYDYMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD-FEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 89 lV~e~~~~gsL~~~l--~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~ 161 (325)
+-.|||+++++...+ ...+.+...+....++..++.++|.+ .|+||.||++..+ +..++.|||+...+...
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~-- 420 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS-- 420 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee--
Confidence 999999999876665 45567777888888888888888875 5999999999886 77889999988642211
Q ss_pred eeeccCC-CCcCC-CCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 162 HMTTRVK-GTLGY-LAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 162 ~~~~~~~-~t~~y-~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
..... .+..| .+|.......+..++|++|||..+.+..++..--.... + +..+....+
T Consensus 421 --~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~----------~~~i~~~~~ 480 (524)
T KOG0601|consen 421 --SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------Q----------SLTIRSGDT 480 (524)
T ss_pred --cccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------c----------ceeeecccc
Confidence 11122 23333 35555666678899999999999999888765321111 0 111111111
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
+..+.....+..+.+.+...++..||++.++..
T Consensus 481 --p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 481 --PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred --cCCCchHHhhhhhhhhhcCCccccchhhhhhcc
Confidence 111223367778888999999999999988765
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.2e-10 Score=110.85 Aligned_cols=231 Identities=17% Similarity=0.119 Sum_probs=162.5
Q ss_pred cceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCCCChhh
Q 046728 25 LEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101 (325)
Q Consensus 25 ~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~gsL~~ 101 (325)
+++++.+..++....+...++|..... ..........+-+++-..++|.++.....+......++|++|..+++|..
T Consensus 814 S~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~S 893 (1205)
T KOG0606|consen 814 SGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPS 893 (1205)
T ss_pred CCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCchh
Confidence 347788888888888866666655321 22222334444555555567888777666666777899999999999999
Q ss_pred hhccC--CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC----------------
Q 046728 102 HLHGR--LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG---------------- 159 (325)
Q Consensus 102 ~l~~~--~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~---------------- 159 (325)
-++.. .+...+..+...+....++++.. +|++|.|.+...++..+++|||.......-
T Consensus 894 kl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~ 973 (1205)
T KOG0606|consen 894 KLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPR 973 (1205)
T ss_pred hhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccc
Confidence 88643 34455667777777777777654 799999999999999999999733322110
Q ss_pred ---------cc-----eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccc
Q 046728 160 ---------VT-----HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPY 225 (325)
Q Consensus 160 ---------~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 225 (325)
.. .......+|+.|.+||.+.+...+..+|+|++|+++++.++|.+||.....+..
T Consensus 974 ~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~---------- 1043 (1205)
T KOG0606|consen 974 RLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQI---------- 1043 (1205)
T ss_pred cccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhh----------
Confidence 00 012234589999999999998999999999999999999999999976543221
Q ss_pred ccccccccccCccccC-CCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 046728 226 VQKGAFEHIADPRLKG-KFNRDQLKSMVLIALRCTDSNPENRPTMT 270 (325)
Q Consensus 226 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 270 (325)
+..+....... ..+...+.+..+++...+..+|.+|..+.
T Consensus 1044 -----f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1044 -----FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred -----hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 22222222222 22345567889999999999999998766
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.4e-09 Score=85.28 Aligned_cols=123 Identities=13% Similarity=0.110 Sum_probs=82.3
Q ss_pred hhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCcc-ceeeEEEcCCeEEEEEEecCCC
Q 046728 19 QNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLL-GLRGFYAGGDERLIVYDYMPNH 97 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~lV~e~~~~g 97 (325)
+.++.| ....+|.+.. ++..|++|....... ....+..|+.+++.+.+.+++ +++... ....++||||++|.
T Consensus 4 ~~l~~G--~~~~vy~~~~--~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~ 76 (170)
T cd05151 4 SPLKGG--MTNKNYRVEV--ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS 76 (170)
T ss_pred eecCCc--ccCceEEEEE--CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence 456666 5566776664 367899998754322 223567899999998654444 454443 23457999999998
Q ss_pred ChhhhhccCCCCCCccCHHHHHHHHHHHHh---------hcCCCCCCceeeCCCCceEEeeeccccc
Q 046728 98 SLITHLHGRLAPDCLLDWHRRVSIAIGSAE---------GIADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 98 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~---------~~rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
++.+.- ........++..++..+| .|+|++|.||+++ ++.++++||+.+..
T Consensus 77 ~l~~~~------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 77 ELLTED------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccccc------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 876531 111234455666666666 4589999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.60 E-value=5.1e-07 Score=82.12 Aligned_cols=205 Identities=14% Similarity=0.228 Sum_probs=140.0
Q ss_pred eeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEc----CCeEEEEEEecCC-CChhhh
Q 046728 28 LMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG----GDERLIVYDYMPN-HSLITH 102 (325)
Q Consensus 28 ~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lV~e~~~~-gsL~~~ 102 (325)
....|++....+|..+++|.+.............-++.++++.|+|||++..+|.. +..+++|++|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35577888888999999999943222223344556889999999999999999863 4568999999876 567665
Q ss_pred hc----c-------------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 103 LH----G-------------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 103 l~----~-------------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
.= . ..++..+|.++.|+..|+...|.- +-|.|.+|++++..+++|...|..-.+..+.
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~- 447 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP- 447 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC-
Confidence 51 0 123345788889999999988875 5899999999999999998887765443321
Q ss_pred eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCC-CCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 162 HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKP-LEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
.+| + ..-++-|.-.||.++.-+.||..- +... .......
T Consensus 448 ------------~~~--l---e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d--------------~~~~s~~--------- 487 (655)
T KOG3741|consen 448 ------------TEP--L---ESQQQNDLRDLGLLLLALATGTENSNRTD--------------STQSSHL--------- 487 (655)
T ss_pred ------------Ccc--h---hHHhhhhHHHHHHHHHHHhhccccccccc--------------chHHHHH---------
Confidence 011 1 123567899999999999998542 1100 0000000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.......+-++++++......++++ -++++++.
T Consensus 488 ~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp 520 (655)
T KOG3741|consen 488 TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLP 520 (655)
T ss_pred HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence 0122345567778888888888876 57777765
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.9e-07 Score=72.50 Aligned_cols=126 Identities=22% Similarity=0.256 Sum_probs=80.8
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEe-ccc--ChhhH-----HHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRL-KTL--NAKAE-----MEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~-~~~--~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
.++.|+.+. ++.... -|..+++|.- ++. .+.-. .+-.+|+.++.+++--.|..-.=+..+.+.-.|+|
T Consensus 3 ~i~~GAEa~--i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 3 LIKQGAEAI--IYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred hhhCCccee--EEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEE
Confidence 467775555 444321 2445777753 221 12211 25557999999986444443333455667778999
Q ss_pred EecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHh----hcCCCCCCceeeCCCCceEEeeeccccc
Q 046728 92 DYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAE----GIADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 92 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~----~~rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
||.+|..|.+++... . ......+-..+.-+| .|+||.++||+++..+ +.++|||++..
T Consensus 79 e~I~G~~lkd~l~~~-~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA-R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc-c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999998999888543 1 334444444444444 4589999999998774 99999999873
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.50 E-value=4.9e-07 Score=75.84 Aligned_cols=81 Identities=12% Similarity=0.140 Sum_probs=56.0
Q ss_pred hhccCccceeeeeEEEeccCCCCeEEEEEecccCh-hhHHHHHHHHHHHHccCC--CCccceeeEEEcCC---eEEEEEE
Q 046728 19 QNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA-KAEMEFAVEVEILGRVRH--RNLLGLRGFYAGGD---ERLIVYD 92 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~---~~~lV~e 92 (325)
+.|+.| ....+|.+.... |..+++|....... .....+..|.++++.+++ .++.+++.+..... ..++|||
T Consensus 4 ~~l~~G--~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGG--QSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCC--ccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 345666 666677776543 57899999764322 134578889999999965 34566777665532 5689999
Q ss_pred ecCCCChhhh
Q 046728 93 YMPNHSLITH 102 (325)
Q Consensus 93 ~~~~gsL~~~ 102 (325)
|++|.++.+.
T Consensus 81 ~i~G~~l~~~ 90 (223)
T cd05154 81 RVDGRVLRDR 90 (223)
T ss_pred EeCCEecCCC
Confidence 9999877554
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.9e-06 Score=68.12 Aligned_cols=131 Identities=16% Similarity=0.135 Sum_probs=78.2
Q ss_pred hhccCccceeeeeEEEeccC------CCCeEEEEEeccc-------------C---------hhhHHH----HHHHHHHH
Q 046728 19 QNINNGLEILMLLLLLRRET------GDDQIAVKRLKTL-------------N---------AKAEME----FAVEVEIL 66 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~~------~~~~vaiK~~~~~-------------~---------~~~~~~----~~~E~~~l 66 (325)
..||.|-.+. ||.+.... .+..+|||+.+.. + ...... ..+|+..|
T Consensus 3 g~i~~GKEa~--V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L 80 (197)
T cd05146 3 GCISTGKESV--VLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNL 80 (197)
T ss_pred CccccCcceE--EEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHH
Confidence 4577885544 66666543 3578999987421 0 011112 22799999
Q ss_pred HccCC--CCccceeeEEEcCCeEEEEEEecCCCChhh-hhccC-CCCCCccCHHHHHHHHHHHH-hh----cCCCCCCce
Q 046728 67 GRVRH--RNLLGLRGFYAGGDERLIVYDYMPNHSLIT-HLHGR-LAPDCLLDWHRRVSIAIGSA-EG----IADIKASNV 137 (325)
Q Consensus 67 ~~l~h--~~iv~~~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~-~~~~~~~~~~~~~~~~~~~~-~~----~rdlkp~Ni 137 (325)
+++.. -++.+.+++ ...++||||+.++.+.. .+++. +.......+..++..++..+ |. |+||++.||
T Consensus 81 ~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 81 KRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 99852 455566654 45789999996643321 12211 12122223344444444433 43 489999999
Q ss_pred eeCCCCceEEeeecccccc
Q 046728 138 LLDTDFEAKVADFGFAKLI 156 (325)
Q Consensus 138 l~~~~~~~kL~Dfg~~~~~ 156 (325)
+++ ++.+.|+|||.+...
T Consensus 157 L~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred EEE-CCcEEEEECCCceeC
Confidence 997 468999999977644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.7e-05 Score=70.89 Aligned_cols=254 Identities=15% Similarity=0.123 Sum_probs=140.0
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc-CCCCccceeeE-----E-Ec
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGF-----Y-AG 83 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~-----~-~~ 83 (325)
+.++...-+.||.| +.+.+|-.....+ .+.|++.+.......+. +..|-.. .||-+..=+.+ + -+
T Consensus 9 ~ge~i~~gr~LgqG--gea~ly~l~e~~d---~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~ 80 (637)
T COG4248 9 YGEPIPPGRPLGQG--GEADLYTLGEVRD---QVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGR 80 (637)
T ss_pred cCcccCCCccccCC--ccceeeecchhhc---hhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCC
Confidence 45566666778888 7777776653332 46788866544433222 2223333 56644431111 0 11
Q ss_pred CCe-EEEEEEecCCC-Chhhhhc-----cCCCCC---CccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEee
Q 046728 84 GDE-RLIVYDYMPNH-SLITHLH-----GRLAPD---CLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVAD 149 (325)
Q Consensus 84 ~~~-~~lV~e~~~~g-sL~~~l~-----~~~~~~---~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~D 149 (325)
... .-++|+..++. .+..+++ ...++. ..+...+.++.+..-+|.+ +|++++|+|+++++.+.|.|
T Consensus 81 ~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 81 RGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred ccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEc
Confidence 222 55888888663 3444442 111111 1122223344444444433 79999999999999999998
Q ss_pred eccccccCCCcceeeccCCCCcCCCCccccccC-----CCCCcccchhHHHHHHHHHhC-CCCCCCCCCCccc-hhhhhh
Q 046728 150 FGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWG-----KVSDSCDVYSFGVLLLELISA-KKPLEKLPGGVKR-DIVQWV 222 (325)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~DiwSlG~il~el~tg-~~pf~~~~~~~~~-~~~~~~ 222 (325)
-..-....++... .+ .+|...|.+||.-.-. .-+...|-|-||+++++++.| +.||.+....... ...+
T Consensus 161 sDsfqi~~ng~~~-~c-pVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E-- 236 (637)
T COG4248 161 SDSFQINANGTLH-LC-PVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE-- 236 (637)
T ss_pred ccceeeccCCceE-ec-ccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--
Confidence 5443333232222 22 3588899999976533 335679999999999999886 9999775321110 0000
Q ss_pred ccccccccccccc--Ccccc----CCCCHHHHHHHHHHHHHccCCC--CCCCCCHHHHHHHHh
Q 046728 223 TPYVQKGAFEHIA--DPRLK----GKFNRDQLKSMVLIALRCTDSN--PENRPTMTDVVDWLK 277 (325)
Q Consensus 223 ~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~~li~~cl~~d--p~~Rps~~~il~~l~ 277 (325)
.-+..+.|.-.. ..+++ .....-+++.+..|..+|+... +.-|||++.-+..|.
T Consensus 237 -~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~ 298 (637)
T COG4248 237 -TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALD 298 (637)
T ss_pred -hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Confidence 000111111111 11111 1112345678888999999654 568999887665443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=9.1e-07 Score=82.43 Aligned_cols=184 Identities=17% Similarity=0.142 Sum_probs=120.0
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCC-ccceeeEEEcCCeEEEEEEe
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRN-LLGLRGFYAGGDERLIVYDY 93 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lV~e~ 93 (325)
+.+.-.+++| +.+.+++++...+.-.+ .+.+... ....-++++|.+++||| .+..++-+...+..++++++
T Consensus 244 s~~fh~fvK~--altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 244 SEFFHNFVKG--ALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred hHHHHHHHHH--HhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 3456667777 77888888777765554 6666442 34556899999999999 77777777778889999999
Q ss_pred cCCC-Chhhhhcc---CCCCCCccCHHHHHHHHHHHHhhcCCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCC
Q 046728 94 MPNH-SLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGIADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169 (325)
Q Consensus 94 ~~~g-sL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 169 (325)
|.++ +...-+.. .+.+-+.....+.-...+..+|..-...++||+.++ +..++.||+....+.... ......+
T Consensus 316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~ 392 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRDNILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIG 392 (829)
T ss_pred hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcccccccc-cccccccccCCcccCccc--ccccCCC
Confidence 9887 22221100 000000000001111111111111123455776665 688999999988776643 3345678
Q ss_pred CcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 046728 170 TLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEK 209 (325)
Q Consensus 170 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 209 (325)
++.|+|||+...+.+....|+||+|.-..++.-|.+|-..
T Consensus 393 ~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 393 TPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred CCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 9999999999989999999999999877777777776543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.11 E-value=3e-05 Score=61.83 Aligned_cols=135 Identities=18% Similarity=0.246 Sum_probs=86.6
Q ss_pred HHhhccCccceeeeeEEEeccCCCCeEEEEEec-cc-------ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 17 FIQNINNGLEILMLLLLLRRETGDDQIAVKRLK-TL-------NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 17 ~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~-~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
.+..+..|+.+ .|+ +....|+..+||.-. +. ..-...+..+|+.++.+++--.|.--.=++.+...-.
T Consensus 11 ~l~likQGAEA--rv~--~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEA--RVP--RGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQ 86 (229)
T ss_pred cceeeecccee--eEe--eeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCe
Confidence 45667778555 333 455678888888542 11 1222346678999999986444443333566667778
Q ss_pred EEEEecCC-CChhhhhccCCCC---CCc-cCHHHHHHHHHHHHhh----cCCCCCCceeeCCCC---ceEEeeeccccc
Q 046728 89 IVYDYMPN-HSLITHLHGRLAP---DCL-LDWHRRVSIAIGSAEG----IADIKASNVLLDTDF---EAKVADFGFAKL 155 (325)
Q Consensus 89 lV~e~~~~-gsL~~~l~~~~~~---~~~-~~~~~~~~~~~~~~~~----~rdlkp~Nil~~~~~---~~kL~Dfg~~~~ 155 (325)
|+|||.+| -++.+|+...+.. +.. ....+.+-..+.-+|. |+||..+||++..++ .+.++|||++..
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99999965 3788888533221 111 3455555555555554 489999999997554 358999999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.05 E-value=4.1e-05 Score=62.36 Aligned_cols=94 Identities=19% Similarity=0.174 Sum_probs=54.0
Q ss_pred HHHHHHHHHHccCCC--CccceeeEEEcCCeEEEEEEecC--CCChhhhhccCCCCCCccCHHHHHHH-HHHHHh----h
Q 046728 58 EFAVEVEILGRVRHR--NLLGLRGFYAGGDERLIVYDYMP--NHSLITHLHGRLAPDCLLDWHRRVSI-AIGSAE----G 128 (325)
Q Consensus 58 ~~~~E~~~l~~l~h~--~iv~~~~~~~~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~~-~~~~~~----~ 128 (325)
...+|++.|.++..- ++.+.+++. ..++||||+. |..+.......+.......+..++.. .....| .
T Consensus 54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~giv 129 (188)
T PF01163_consen 54 WAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIV 129 (188)
T ss_dssp HHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEE
T ss_pred HHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCce
Confidence 555799999999754 456666442 3579999997 54454433322222333334444333 222232 2
Q ss_pred cCCCCCCceeeCCCCceEEeeecccccc
Q 046728 129 IADIKASNVLLDTDFEAKVADFGFAKLI 156 (325)
Q Consensus 129 ~rdlkp~Nil~~~~~~~kL~Dfg~~~~~ 156 (325)
|+|+.+.||+++++ .+.++|||.+...
T Consensus 130 HGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 130 HGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp ESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred ecCCChhhEEeecc-eEEEEecCcceec
Confidence 48999999999887 9999999977643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.01 E-value=2.5e-06 Score=80.24 Aligned_cols=140 Identities=16% Similarity=0.212 Sum_probs=91.1
Q ss_pred HHHHHhh-----cCCCCCCceeeCCCCceEEeeeccccccCCCccee--------eccCCCCcCCCCccccccCCCCCcc
Q 046728 122 AIGSAEG-----IADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM--------TTRVKGTLGYLAPEYAMWGKVSDSC 188 (325)
Q Consensus 122 ~~~~~~~-----~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~ 188 (325)
++.++|. |++|.|++|.++..+..||+.|+.+.......... ..-......|.|||++.....+.++
T Consensus 111 gl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~~~s 190 (700)
T KOG2137|consen 111 GLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNTPAS 190 (700)
T ss_pred hhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccccccc
Confidence 4445554 36999999999999999999998876544311110 0011245679999999988888999
Q ss_pred cchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 046728 189 DVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRP 267 (325)
Q Consensus 189 DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 267 (325)
|++|+|++.|.+.. |..-+............. ........-....+++++.+=+.+++..++.-||
T Consensus 191 d~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-------------~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp 257 (700)
T KOG2137|consen 191 DVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-------------NLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRP 257 (700)
T ss_pred cceeeeeEEEEEecCCcchhhccCCcchhhhhh-------------cccccccccccccCcHHHHHHHHHHhcCCcccCc
Confidence 99999999999984 444443321111111100 0000000111245667888888899999999999
Q ss_pred CHHHHHH
Q 046728 268 TMTDVVD 274 (325)
Q Consensus 268 s~~~il~ 274 (325)
++..+..
T Consensus 258 ~~~~l~~ 264 (700)
T KOG2137|consen 258 TLDLLLS 264 (700)
T ss_pred chhhhhc
Confidence 8777765
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00012 Score=63.14 Aligned_cols=118 Identities=15% Similarity=0.091 Sum_probs=74.4
Q ss_pred cCCCCeEEEEEecccChh-hH----------HHHHHHHHHHHccCCC--CccceeeEEEc-----CCeEEEEEEecCCC-
Q 046728 37 ETGDDQIAVKRLKTLNAK-AE----------MEFAVEVEILGRVRHR--NLLGLRGFYAG-----GDERLIVYDYMPNH- 97 (325)
Q Consensus 37 ~~~~~~vaiK~~~~~~~~-~~----------~~~~~E~~~l~~l~h~--~iv~~~~~~~~-----~~~~~lV~e~~~~g- 97 (325)
.-+|+.+.||......-. .. ..+.+|...+.++..- .+.+..++.+. ...-++|||++++.
T Consensus 42 ~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~ 121 (268)
T PRK15123 42 ELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTI 121 (268)
T ss_pred EECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCc
Confidence 345677888866432211 11 1477899988888422 23334444432 23468999999875
Q ss_pred ChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC-------CCceEEeeecccc
Q 046728 98 SLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT-------DFEAKVADFGFAK 154 (325)
Q Consensus 98 sL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~-------~~~~kL~Dfg~~~ 154 (325)
+|.+++... ........+..++..++.-+|.. +|+++.|||++. ...+.|+||+.+.
T Consensus 122 sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 122 SLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred cHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 788887421 11122234555666666666654 799999999975 4679999999775
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00025 Score=58.95 Aligned_cols=100 Identities=18% Similarity=0.203 Sum_probs=70.3
Q ss_pred HHHHHHHHHHHHccCCC--CccceeeEEEcC----CeEEEEEEecCCC-Chhhhhcc--CCCCCCccCHHHHHHHHHHHH
Q 046728 56 EMEFAVEVEILGRVRHR--NLLGLRGFYAGG----DERLIVYDYMPNH-SLITHLHG--RLAPDCLLDWHRRVSIAIGSA 126 (325)
Q Consensus 56 ~~~~~~E~~~l~~l~h~--~iv~~~~~~~~~----~~~~lV~e~~~~g-sL~~~l~~--~~~~~~~~~~~~~~~~~~~~~ 126 (325)
..+..+|...+..|..- .+.+.+++.+.. ..-++|+|++++. +|.+++.. ..+......+..++..++.-+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 34677888888887422 244555555442 2357999999874 79998864 233344456667777777777
Q ss_pred hhc----CCCCCCceeeCCCC---ceEEeeeccccc
Q 046728 127 EGI----ADIKASNVLLDTDF---EAKVADFGFAKL 155 (325)
Q Consensus 127 ~~~----rdlkp~Nil~~~~~---~~kL~Dfg~~~~ 155 (325)
|.. +|+++.|||++.++ .+.|+||+-+..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 764 79999999999887 799999987764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00011 Score=62.18 Aligned_cols=129 Identities=18% Similarity=0.132 Sum_probs=81.7
Q ss_pred HHhhccCccceeeeeEEEeccCCCCeEEEEEecccC----------------------hhhHHHHHHHHHHHHccCCC--
Q 046728 17 FIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN----------------------AKAEMEFAVEVEILGRVRHR-- 72 (325)
Q Consensus 17 ~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~-- 72 (325)
+-..||.|-.+ .||.+... .+.++|||.=.... .-+.....+|+++|.+|...
T Consensus 95 iG~~IGvGKEs--dVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 95 IGTKIGVGKES--DVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred hccccccCccc--eEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 44678888554 46666544 57899999532111 11122455799999999644
Q ss_pred CccceeeEEEcCCeEEEEEEecCCCChhhhhccCCCC-CCccCHHHHHHHHHHHHhhcCCCCCCceeeCCCCceEEeeec
Q 046728 73 NLLGLRGFYAGGDERLIVYDYMPNHSLITHLHGRLAP-DCLLDWHRRVSIAIGSAEGIADIKASNVLLDTDFEAKVADFG 151 (325)
Q Consensus 73 ~iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~rdlkp~Nil~~~~~~~kL~Dfg 151 (325)
.|.+-+++ +...+||||.+|-.|...--...+. ...-.+...+..+....-.|+|+.+-||+++++|.++++||-
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwP 247 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWP 247 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCc
Confidence 56655544 4567999999886654432111111 112234445555555555568999999999999999999984
Q ss_pred c
Q 046728 152 F 152 (325)
Q Consensus 152 ~ 152 (325)
-
T Consensus 248 Q 248 (304)
T COG0478 248 Q 248 (304)
T ss_pred c
Confidence 3
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00063 Score=57.37 Aligned_cols=72 Identities=8% Similarity=-0.030 Sum_probs=49.8
Q ss_pred hhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCC--ccceeeEEEcCCeEEEEEEecCC
Q 046728 19 QNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRN--LLGLRGFYAGGDERLIVYDYMPN 96 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lV~e~~~~ 96 (325)
..||.| .+..+|.. .+..+++|...... ......+|.++++.+..-. +.+.+++..+.....+|||+++|
T Consensus 7 ~~i~~G--~t~~~y~~----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEG--GNGESYTH----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCC--CCcceeEe----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 456777 66666752 24457788876422 2345688999999985332 46777777777778899999988
Q ss_pred CC
Q 046728 97 HS 98 (325)
Q Consensus 97 gs 98 (325)
.+
T Consensus 79 ~~ 80 (226)
T TIGR02172 79 KR 80 (226)
T ss_pred cc
Confidence 63
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00026 Score=66.47 Aligned_cols=139 Identities=14% Similarity=0.118 Sum_probs=81.3
Q ss_pred hhccCccceeeeeEEEeccCCCCeEEEEEecccChhh----------------------------------------HHH
Q 046728 19 QNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKA----------------------------------------EME 58 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~----------------------------------------~~~ 58 (325)
...-.++.+.++|+.+.=.. |+.||||+..-.-... .-.
T Consensus 129 ~~~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElD 207 (517)
T COG0661 129 EPEPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELD 207 (517)
T ss_pred CCCchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhC
Confidence 33445566888999887544 8999999985211100 002
Q ss_pred HHHHHHHHHccC----CCCccceeeEEE-cCCeEEEEEEecCCCChhhhh--cc-CCCCCCccCHHHHHHHHHHHH-h--
Q 046728 59 FAVEVEILGRVR----HRNLLGLRGFYA-GGDERLIVYDYMPNHSLITHL--HG-RLAPDCLLDWHRRVSIAIGSA-E-- 127 (325)
Q Consensus 59 ~~~E~~~l~~l~----h~~iv~~~~~~~-~~~~~~lV~e~~~~gsL~~~l--~~-~~~~~~~~~~~~~~~~~~~~~-~-- 127 (325)
+.+|..-+.+++ ..--+++=.++. -.....++|||+.|-.+.+.. +. ..+.+.+.....+. ..-+.. +
T Consensus 208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~-f~~q~~~dgf 286 (517)
T COG0661 208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA-FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH-HHHHHHhcCc
Confidence 224555555552 222223333332 245678999999998888775 22 12211111111111 111111 2
Q ss_pred hcCCCCCCceeeCCCCceEEeeeccccccCCC
Q 046728 128 GIADIKASNVLLDTDFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 128 ~~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 159 (325)
-|.|.+|.||+++.+|++.+.|||+...+...
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 24799999999999999999999999877653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0021 Score=52.86 Aligned_cols=121 Identities=12% Similarity=0.080 Sum_probs=77.6
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEecccC----------------hhhHHHHHHHHHHHHccC------CCCccce
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTLN----------------AKAEMEFAVEVEILGRVR------HRNLLGL 77 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~~iv~~ 77 (325)
.||.| +.-.+|.. ..+....||+..... .....+..+|+.....+. +.+|.++
T Consensus 8 ~i~~G--~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 8 LIAQG--GERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred ccccC--CCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 46666 55555532 334456799886544 122345666666666555 8899999
Q ss_pred eeEEEcCCeEEEEEEecCC------CChhhhhccC-CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC---C
Q 046728 78 RGFYAGGDERLIVYDYMPN------HSLITHLHGR-LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD---F 143 (325)
Q Consensus 78 ~~~~~~~~~~~lV~e~~~~------gsL~~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~---~ 143 (325)
+|+.+++.-.-+|+|...+ -||.++++.. ++. .....+....+++..+ +|++|.||++..+ .
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 9999999888899988643 2678888432 222 3334444444444333 6999999999533 2
Q ss_pred -ceEEee
Q 046728 144 -EAKVAD 149 (325)
Q Consensus 144 -~~kL~D 149 (325)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 578888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00035 Score=57.85 Aligned_cols=63 Identities=14% Similarity=0.217 Sum_probs=41.7
Q ss_pred CeEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhh----cCCCCCCceeeCCCCceEEeeecccc
Q 046728 85 DERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEG----IADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~----~rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
...++||||++|..|.++.. +.+ .....+..++.-+|. |+|.+|.|++++.+ .++++||+..+
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~--i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED--IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred eEEEEEEEEecCeecccchh--cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECcccc
Confidence 44579999999988876542 111 122233333444444 47999999999865 59999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0028 Score=54.06 Aligned_cols=76 Identities=11% Similarity=0.085 Sum_probs=52.2
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCCeEEEEEEecCCCC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDERLIVYDYMPNHS 98 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lV~e~~~~gs 98 (325)
.|..|. ....||.+... +..+++|...... ...+..|+++++.+. +--+.+++++....+..++||++.+|.+
T Consensus 5 ~~~~g~-~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 78 (244)
T cd05150 5 RVTEGQ-SGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP 78 (244)
T ss_pred ecCCCC-CcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence 455664 33566766543 3578888876533 335677999998884 4445677777776667899999999877
Q ss_pred hhh
Q 046728 99 LIT 101 (325)
Q Consensus 99 L~~ 101 (325)
|..
T Consensus 79 l~~ 81 (244)
T cd05150 79 AAA 81 (244)
T ss_pred HhH
Confidence 653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.002 Score=60.62 Aligned_cols=142 Identities=16% Similarity=0.124 Sum_probs=81.8
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhh-------------------------------HH------
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKA-------------------------------EM------ 57 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-------------------------------~~------ 57 (325)
|.-+...-.|+-+.+.|+.++-.. |+.||||+-+..-... .+
T Consensus 161 f~~f~~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~EL 239 (538)
T KOG1235|consen 161 FSEFDEEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQEL 239 (538)
T ss_pred HHhcCcchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhc
Confidence 344444556667888999888666 8999999875321111 01
Q ss_pred HHHHHHHHHHcc----CCCC---ccceeeEEEc-CCeEEEEEEecCCCChhhhh---ccCCCCCCccCHHHHHHHHHHHH
Q 046728 58 EFAVEVEILGRV----RHRN---LLGLRGFYAG-GDERLIVYDYMPNHSLITHL---HGRLAPDCLLDWHRRVSIAIGSA 126 (325)
Q Consensus 58 ~~~~E~~~l~~l----~h~~---iv~~~~~~~~-~~~~~lV~e~~~~gsL~~~l---~~~~~~~~~~~~~~~~~~~~~~~ 126 (325)
.|.+|.+-..++ .|-+ -|++=.++.+ .....++||||.|..+.+.- +...+...+.....+. .+.+++
T Consensus 240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~-~~~qIf 318 (538)
T KOG1235|consen 240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEA-YLEQIF 318 (538)
T ss_pred chHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHH-HHHHHH
Confidence 223444444443 3444 1222233322 34578999999998775543 2333333222211111 122222
Q ss_pred ---hhcCCCCCCceeeCC----CCceEEeeeccccccCC
Q 046728 127 ---EGIADIKASNVLLDT----DFEAKVADFGFAKLIPD 158 (325)
Q Consensus 127 ---~~~rdlkp~Nil~~~----~~~~kL~Dfg~~~~~~~ 158 (325)
.-|+|-+|.||+++. ++.+.+.|||+......
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 235899999999983 57899999999886554
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.017 Score=47.17 Aligned_cols=91 Identities=22% Similarity=0.229 Sum_probs=64.8
Q ss_pred HHHHHHHHccCC-CCccceeeEEEcCCeEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc---------
Q 046728 60 AVEVEILGRVRH-RNLLGLRGFYAGGDERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI--------- 129 (325)
Q Consensus 60 ~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 129 (325)
.+|.-++..+.+ +++.+++|++- .++|.||...+++.... ..+..-....|.....+|++++..+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358889999964 69999999983 46799999776654221 0011111245677777777766554
Q ss_pred ----CCCCCCceeeCCCCceEEeeeccccc
Q 046728 130 ----ADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 130 ----rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
.|++|+|+-+++++.+|++|......
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 39999999999999999999876553
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0036 Score=51.67 Aligned_cols=138 Identities=12% Similarity=0.120 Sum_probs=88.4
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-----C-hhhHHHHHHHHHHHHccCC--CCccceeeEEE---
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-----N-AKAEMEFAVEVEILGRVRH--RNLLGLRGFYA--- 82 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-----~-~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~--- 82 (325)
+...++.=..|+||.++|+..... |+.+=+|.-... . +.....|.+|+..+.+|.. -.+.+.. ++.
T Consensus 17 ~~~wve~pN~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k 93 (216)
T PRK09902 17 EGDWVEEPNYRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVK 93 (216)
T ss_pred CCceecCCCcCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeec
Confidence 334455566777799999876533 336778876411 1 3455689999999999842 2244443 221
Q ss_pred cC--CeEEEEEEecCC-CChhhhhccC-C---CCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCc--eEEee
Q 046728 83 GG--DERLIVYDYMPN-HSLITHLHGR-L---APDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFE--AKVAD 149 (325)
Q Consensus 83 ~~--~~~~lV~e~~~~-gsL~~~l~~~-~---~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~--~kL~D 149 (325)
.+ .+-+||+|-..| -||.+++.+. + +......+...+..++.-+|.. +|+.+.||+++.++. +.++|
T Consensus 94 ~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lID 173 (216)
T PRK09902 94 IEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLD 173 (216)
T ss_pred cCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEE
Confidence 11 235799997754 5888888432 2 2222235556666666666654 799999999986667 99999
Q ss_pred ecccc
Q 046728 150 FGFAK 154 (325)
Q Consensus 150 fg~~~ 154 (325)
|-.++
T Consensus 174 lEk~r 178 (216)
T PRK09902 174 LEKSR 178 (216)
T ss_pred hhccc
Confidence 97655
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.00087 Score=61.85 Aligned_cols=165 Identities=18% Similarity=0.183 Sum_probs=95.7
Q ss_pred HHHHHHHHHHccCCCCccceeeEEEcCC-eEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhcCCCCCCc
Q 046728 58 EFAVEVEILGRVRHRNLLGLRGFYAGGD-ERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIADIKASN 136 (325)
Q Consensus 58 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~rdlkp~N 136 (325)
++.--+++++.+.|+|+..++++..... ...+|||++ +-||.+.+..+.. ...... +| ...+.|
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l-----~~~s~~------~~---~~~~~~ 92 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNL-----KDESLL------AH---GVLHLN 92 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhccc-----chhhhc------cc---ccceeh
Confidence 5566789999999999999998876543 367999999 5599998864321 111111 11 111222
Q ss_pred eeeCCCCceEEeeeccccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccc
Q 046728 137 VLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKR 216 (325)
Q Consensus 137 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~ 216 (325)
+ .+.+| . +... | | .+.++|+||||+|.++.++..|..-+.........
T Consensus 93 ~-------~~~td----~-~~t~-------------~--~-----~~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l 140 (725)
T KOG1093|consen 93 I-------IYITD----H-FLTK-------------Y--P-----SPIGPKSDVWSLGFIILELYLGISLEAELTESEYL 140 (725)
T ss_pred h-------hhccc----c-cccc-------------C--C-----CCCCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHH
Confidence 2 22333 0 0000 0 1 11124999999999999999988877544332222
Q ss_pred hhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 217 DIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
..+..+... ......+... -...-.++..+..+...|+-..|..||...++.+
T Consensus 141 ~~i~k~~~~--d~~~~~~a~e---~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 141 EILLKYYTD--DQELLSTAME---HLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HHHHHhccC--chhHHHHHHH---HHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 222211110 0000000000 0112345677889999999999999998877776
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0052 Score=51.60 Aligned_cols=77 Identities=12% Similarity=0.204 Sum_probs=50.5
Q ss_pred hhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCC--CccceeeEEE---cCCeEEEEEEe
Q 046728 19 QNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHR--NLLGLRGFYA---GGDERLIVYDY 93 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~~~---~~~~~~lV~e~ 93 (325)
+.++.| ....+|.+.... ..+++|..... .....+..|..+++.+... .+.+++.... .....+++|++
T Consensus 3 ~~l~~G--~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 3 RPLSGG--FSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEES--SSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred ccCCCC--CeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 456667 444466666444 48899997653 4556788899999988522 3556665432 23347899999
Q ss_pred cCCCChhh
Q 046728 94 MPNHSLIT 101 (325)
Q Consensus 94 ~~~gsL~~ 101 (325)
++|.++..
T Consensus 77 i~g~~~~~ 84 (239)
T PF01636_consen 77 IPGRPLDD 84 (239)
T ss_dssp ESSEEHHH
T ss_pred eccccccc
Confidence 99887766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.0066 Score=61.22 Aligned_cols=185 Identities=17% Similarity=0.189 Sum_probs=117.8
Q ss_pred HHHHHHHHHccCCCCccceeeEEEcCCe----EEEEEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhcCCC
Q 046728 59 FAVEVEILGRVRHRNLLGLRGFYAGGDE----RLIVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGIADI 132 (325)
Q Consensus 59 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~rdl 132 (325)
...|+..+.+..|+|++.++.+-..... ..+..++|+..++...++. ..+....+.+..+....+.+.|.+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~--- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL--- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh---
Confidence 3447777888899999999988644322 2356688888888887743 233344455666667777777765
Q ss_pred CCCceeeC----------CCCceEEe--eeccccccCCCcceeeccCCCCcCCCCccccccCCCCC--cccchhHHHHHH
Q 046728 133 KASNVLLD----------TDFEAKVA--DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSD--SCDVYSFGVLLL 198 (325)
Q Consensus 133 kp~Nil~~----------~~~~~kL~--Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~--~~DiwSlG~il~ 198 (325)
+-.|..+. ..+.+..+ ||+.++...+....... ..+..+.+||......+.. ..|+|.+|..+.
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~--~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSD--LLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhh--cCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 44455543 23445555 88877766554333222 2345577888777655544 479999999999
Q ss_pred HHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 199 ELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 199 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.+..+..+-.... .... ..+........+++.+|+..++++|+++.+++.
T Consensus 384 ~~~~~~~i~~~~~------------------~~~~--------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 384 QLSQGEDISEKSA------------------VPVS--------LLDVLSTSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred hhhhcCccccccc------------------chhh--------hhccccchhhhhhhhhhcchhhhhccchhhhhh
Confidence 9888765421100 0000 001111115777888999999999999999998
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.011 Score=47.12 Aligned_cols=128 Identities=15% Similarity=0.175 Sum_probs=75.5
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCcc-ceeeEEEcCCeEEEEEEe
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLL-GLRGFYAGGDERLIVYDY 93 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~lV~e~ 93 (325)
....+.|++| .++.||+.... +..+|+|.-...++ ...+..|++++..+.-.++. +++.+ +..++.|||
T Consensus 24 ~~v~~~L~KG--~~s~Vyl~~~~--~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~ 93 (201)
T COG2112 24 LRVEKELAKG--TTSVVYLGEWR--GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEY 93 (201)
T ss_pred hhhhhhhhcc--cccEEEEeecc--CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhh
Confidence 3566789999 66667766533 45799998765433 34788899999999755554 34433 234456999
Q ss_pred cCCCChhhhhccCCCCCCccCHHHHHHHHHHHH-hhcCCC-CCCceeeCCCCceEEeeecccc
Q 046728 94 MPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSA-EGIADI-KASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 94 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~rdl-kp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
..|-+|.+.-... ..+........ ...++.+ -.|..| .|...++..++.+.|+||..|.
T Consensus 94 i~G~~L~~~~~~~-~rk~l~~vlE~-a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 94 IDGRPLGKLEIGG-DRKHLLRVLEK-AYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hcCcchhhhhhcc-cHHHHHHHHHH-HHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 9887887655321 11111111111 2222221 112333 3444555555599999998776
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.016 Score=47.48 Aligned_cols=126 Identities=19% Similarity=0.238 Sum_probs=75.9
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecc---cCh------------------hhHHHHHHHHHHHHcc--
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKT---LNA------------------KAEMEFAVEVEILGRV-- 69 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~---~~~------------------~~~~~~~~E~~~l~~l-- 69 (325)
.+++|++-||.|... +.||+++ -+|+.+|+|.+.. ... ....-|..|.+...+|
T Consensus 37 ~~I~flefLg~g~~~-~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHD-GYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CcEeeeeecCCCCce-eEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 788999999999552 5677665 3456999999321 000 1112566788887777
Q ss_pred -CCCCc--cceeeEEEcC------------------CeEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhh
Q 046728 70 -RHRNL--LGLRGFYAGG------------------DERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEG 128 (325)
Q Consensus 70 -~h~~i--v~~~~~~~~~------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 128 (325)
++.++ |+.+|+..-. ...-||.||.+... .+....+..+...+..+.....-
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------~~~~~~~~~~~~dl~~~~k~gI~ 186 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------PLQIRDIPQMLRDLKILHKLGIV 186 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------ccchhHHHHHHHHHHHHHHCCee
Confidence 35677 8999987322 11347888876643 12222223333333333332223
Q ss_pred cCCCCCCceeeCCCCceEEeeeccc
Q 046728 129 IADIKASNVLLDTDFEAKVADFGFA 153 (325)
Q Consensus 129 ~rdlkp~Nil~~~~~~~kL~Dfg~~ 153 (325)
.+|+++.|.. .-+|+|||.+
T Consensus 187 ~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 187 PRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred eccCcccccc-----CCEEEecccC
Confidence 3799999974 3478999853
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.044 Score=47.07 Aligned_cols=68 Identities=6% Similarity=-0.005 Sum_probs=39.6
Q ss_pred eeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCc-cceeeEEEcCCeEEEEEEecCCCChh
Q 046728 27 ILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNL-LGLRGFYAGGDERLIVYDYMPNHSLI 100 (325)
Q Consensus 27 ~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lV~e~~~~gsL~ 100 (325)
-...+|... .++..+++|..............+|..+++.+..-.+ .+++... . -++||||++|.++.
T Consensus 8 ~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 8 LTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVIT 76 (256)
T ss_pred CcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccc
Confidence 344556554 4456788887654222211235679999999853323 3334332 1 36899999886653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.00035 Score=71.85 Aligned_cols=146 Identities=14% Similarity=0.033 Sum_probs=101.3
Q ss_pred HHHHHHHccCCCCccceeeEEEc--CCeEEEEEEecCCCChhhhhccCCCCCCccC-----HHHHH-HHHHHHHhhc---
Q 046728 61 VEVEILGRVRHRNLLGLRGFYAG--GDERLIVYDYMPNHSLITHLHGRLAPDCLLD-----WHRRV-SIAIGSAEGI--- 129 (325)
Q Consensus 61 ~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~-----~~~~~-~~~~~~~~~~--- 129 (325)
.|....+...|+++.....-... ..+.+.+++||.+|.+++.|-+.+.+...+. ...++ .......+..
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 35555666789988877665543 3456899999999999999944433322111 11111 1112221211
Q ss_pred ------CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhC
Q 046728 130 ------ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISA 203 (325)
Q Consensus 130 ------rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg 203 (325)
+++|+.|-++..+-.++++++|+.++....... .....+++-|++|+....-.++.++|+|+.|+.+|...-|
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf-~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF-FGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCchHhh-hhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 599999999999999999999999955443322 2334577778888887777788889999999999999888
Q ss_pred CCCC
Q 046728 204 KKPL 207 (325)
Q Consensus 204 ~~pf 207 (325)
..+|
T Consensus 1437 n~~f 1440 (2724)
T KOG1826|consen 1437 NAYF 1440 (2724)
T ss_pred cHHH
Confidence 8877
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.14 Score=46.85 Aligned_cols=76 Identities=16% Similarity=0.210 Sum_probs=50.1
Q ss_pred hhccCccceeeeeEEEeccCCCCeEEEEEeccc-----C--hhhHHHHHHHHHHHHccC---CCCccceeeEEEcCCeEE
Q 046728 19 QNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-----N--AKAEMEFAVEVEILGRVR---HRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~ 88 (325)
+.||-| ....||.+....+++.|+||.-... . +-...+...|.+.|..+. ..++.+++.+ +....+
T Consensus 32 ~elggG--n~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 32 REIGDG--NLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eEcCCC--ceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 455555 6777888776554468999984310 1 224457777888888873 3456677766 345578
Q ss_pred EEEEecCCCC
Q 046728 89 IVYDYMPNHS 98 (325)
Q Consensus 89 lV~e~~~~gs 98 (325)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999997643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.062 Score=45.51 Aligned_cols=73 Identities=15% Similarity=0.110 Sum_probs=41.2
Q ss_pred hhccCccceee-eeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCC---CccceeeEEEcC---CeEEEEE
Q 046728 19 QNINNGLEILM-LLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHR---NLLGLRGFYAGG---DERLIVY 91 (325)
Q Consensus 19 ~~i~~G~~~~~-~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~~~~~~~~~---~~~~lV~ 91 (325)
+.|+.| |.. .||.+. ..+++|..... .....+.+|.+.+..+... .+.+++...... ...++||
T Consensus 3 ~~~~~g--G~~n~vy~~~-----~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~ 73 (235)
T cd05155 3 EPVDSG--GTDNATFRLG-----DDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY 73 (235)
T ss_pred eeccCC--CcccceEEcC-----CceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence 345555 444 355542 24667875432 2334788899999888521 233333322221 2358999
Q ss_pred EecCCCChh
Q 046728 92 DYMPNHSLI 100 (325)
Q Consensus 92 e~~~~gsL~ 100 (325)
++++|.++.
T Consensus 74 ~~i~G~~l~ 82 (235)
T cd05155 74 RWLEGETAT 82 (235)
T ss_pred EeecCCCCC
Confidence 999987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.059 Score=47.28 Aligned_cols=75 Identities=9% Similarity=0.135 Sum_probs=44.5
Q ss_pred HhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCC--CccceeeE------EEcCCeEEE
Q 046728 18 IQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHR--NLLGLRGF------YAGGDERLI 89 (325)
Q Consensus 18 ~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~------~~~~~~~~l 89 (325)
++.+..| ....+|.+.. ++..+++|.... .....+..|+.++..+.+. .+.+++.. ....+..++
T Consensus 19 i~~i~~G--~~n~~y~v~~--~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~ 91 (296)
T cd05153 19 FEGISAG--IENTNYFVTT--DSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA 91 (296)
T ss_pred eecccCc--cccceEEEEe--CCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence 4445555 4445666643 234688898764 2234567788888887422 24444331 233455789
Q ss_pred EEEecCCCCh
Q 046728 90 VYDYMPNHSL 99 (325)
Q Consensus 90 V~e~~~~gsL 99 (325)
|++|++|.++
T Consensus 92 l~~~i~G~~~ 101 (296)
T cd05153 92 LVEFLAGEHL 101 (296)
T ss_pred EEEeCCCCCC
Confidence 9999988665
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.16 Score=42.95 Aligned_cols=128 Identities=16% Similarity=0.103 Sum_probs=67.2
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEecccChhhH------------------------HHHHHHHHHHHccC--CCC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAE------------------------MEFAVEVEILGRVR--HRN 73 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~------------------------~~~~~E~~~l~~l~--h~~ 73 (325)
-|..|- -..||++.. .++..||+|++........ ....+|+.-|+++. +=.
T Consensus 55 ~istGK--EA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 55 CISTGK--EANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred eecCCc--ceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 444553 344666553 5578999999864321111 12335777777773 223
Q ss_pred ccceeeEEEcCCeEEEEEEecCCCC-hhhhhccC-CCCCCccC----HHHHHHHHHH-HHhhcCCCCCCceeeCCCCceE
Q 046728 74 LLGLRGFYAGGDERLIVYDYMPNHS-LITHLHGR-LAPDCLLD----WHRRVSIAIG-SAEGIADIKASNVLLDTDFEAK 146 (325)
Q Consensus 74 iv~~~~~~~~~~~~~lV~e~~~~gs-L~~~l~~~-~~~~~~~~----~~~~~~~~~~-~~~~~rdlkp~Nil~~~~~~~k 146 (325)
+.+-+++. .-.+||||....- -.=.|++. +....+.. ...++..+++ ....|+||..=|||+. ++.+.
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 33333332 3469999984421 01111111 01111111 1122222222 1123589999999999 78999
Q ss_pred Eeeeccccc
Q 046728 147 VADFGFAKL 155 (325)
Q Consensus 147 L~Dfg~~~~ 155 (325)
++|+|-+..
T Consensus 207 iID~~QaV~ 215 (268)
T COG1718 207 IIDVSQAVT 215 (268)
T ss_pred EEECccccc
Confidence 999986654
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.16 Score=42.87 Aligned_cols=73 Identities=16% Similarity=0.293 Sum_probs=42.2
Q ss_pred hccCccceeeeeEEEeccC-CCCeEEEEEecccChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCCeEEEEEEecCCC
Q 046728 20 NINNGLEILMLLLLLRRET-GDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDERLIVYDYMPNH 97 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lV~e~~~~g 97 (325)
.|..| -+..+|.+.... ++..|++|...... .......+|+.+++.+. +.-..+++.... -.+||||++|.
T Consensus 5 ~l~gG--~tN~~~~v~~~~~~~~~~vlR~~~~~~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 5 RFTGG--ITNKLVKVSNKEDNQDAVLVRVYGNKT-ELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EcCCc--ccceEEEEEcCCCCCCeEEEEEccCCc-cceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 44455 344566654332 25678899765422 22223457899999885 333445544332 24899999886
Q ss_pred Ch
Q 046728 98 SL 99 (325)
Q Consensus 98 sL 99 (325)
++
T Consensus 78 ~l 79 (235)
T cd05157 78 TL 79 (235)
T ss_pred cC
Confidence 65
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=94.51 E-value=0.12 Score=52.41 Aligned_cols=80 Identities=10% Similarity=0.228 Sum_probs=50.6
Q ss_pred HhhccCccceeeeeEEEeccCCC--CeEEEEEecccC-hhhHHHHHHHHHHHHccC-CCCc--cceeeEEEcC---CeEE
Q 046728 18 IQNINNGLEILMLLLLLRRETGD--DQIAVKRLKTLN-AKAEMEFAVEVEILGRVR-HRNL--LGLRGFYAGG---DERL 88 (325)
Q Consensus 18 ~~~i~~G~~~~~~v~~~~~~~~~--~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i--v~~~~~~~~~---~~~~ 88 (325)
++.++.|. +...|......++ ..+++|+..... ......+.+|+.+++.+. |+++ .+++.++.+. ...|
T Consensus 43 v~~l~gG~--sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQ--SNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCC--cCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 55666663 3445554433322 467777764321 122346889999999995 6654 6777777654 4578
Q ss_pred EEEEecCCCCh
Q 046728 89 IVYDYMPNHSL 99 (325)
Q Consensus 89 lV~e~~~~gsL 99 (325)
+||||++|..+
T Consensus 121 lVME~v~G~~~ 131 (822)
T PLN02876 121 YIMEYLEGRIF 131 (822)
T ss_pred EEEEecCCccc
Confidence 99999987543
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.38 E-value=0.59 Score=41.45 Aligned_cols=25 Identities=40% Similarity=0.449 Sum_probs=21.4
Q ss_pred CCCCCCceeeCCCCceEEeeecccc
Q 046728 130 ADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 130 rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
+|+.|.||+++.+...-++||+.+.
T Consensus 192 gD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 192 ADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CCCCCCcEEEECCceEEEEeccccc
Confidence 6999999999976556899998765
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=93.92 E-value=0.48 Score=41.86 Aligned_cols=26 Identities=46% Similarity=0.480 Sum_probs=22.5
Q ss_pred cCCCCCCceeeCCCCceEEeeecccc
Q 046728 129 IADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 129 ~rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
|+|+.+.|++++.++.+.++||+.+.
T Consensus 191 HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 191 HADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCCCcCcEEEECCceEEEeeccccc
Confidence 36999999999988777899998765
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=93.03 E-value=0.068 Score=47.07 Aligned_cols=127 Identities=14% Similarity=0.151 Sum_probs=75.7
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh-------------------h---hHHHHHHHHHHHHccC-C
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA-------------------K---AEMEFAVEVEILGRVR-H 71 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-------------------~---~~~~~~~E~~~l~~l~-h 71 (325)
+.+-.+||.|-.+. +|.+... .|++.++|.=..... + +.-...+|+..|+.|. |
T Consensus 94 ~svGnqIGVGKESD--IY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~ 170 (465)
T KOG2268|consen 94 ESVGNQIGVGKESD--IYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER 170 (465)
T ss_pred hhhccccccccccc--eEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence 45567888885555 5555433 466777874321110 0 1113446999999994 4
Q ss_pred CC-ccceeeEEEcCCeEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHH-hh--cCCCCCCceeeCCCCceEE
Q 046728 72 RN-LLGLRGFYAGGDERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSA-EG--IADIKASNVLLDTDFEAKV 147 (325)
Q Consensus 72 ~~-iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~--~rdlkp~Nil~~~~~~~kL 147 (325)
.. |.+.++ -+..++|||+..|-+|.+.-+-. +.. .-+...+.+....+ || |+|..--||++.+++.+++
T Consensus 171 gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~-d~~--~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~v 243 (465)
T KOG2268|consen 171 GFPVPKPID----HNRHCVVMELVDGYPLRQVRHVE-DPP--TLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVV 243 (465)
T ss_pred CCCCCCccc----ccceeeHHHhhcccceeeeeecC-ChH--HHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEE
Confidence 32 333333 35678999999998887654321 111 11222222222222 22 4899999999999999999
Q ss_pred eeec
Q 046728 148 ADFG 151 (325)
Q Consensus 148 ~Dfg 151 (325)
+||-
T Consensus 244 IDFP 247 (465)
T KOG2268|consen 244 IDFP 247 (465)
T ss_pred eech
Confidence 9994
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=92.85 E-value=1 Score=40.57 Aligned_cols=69 Identities=12% Similarity=0.078 Sum_probs=40.7
Q ss_pred eeeeeEEEeccC----CCCeEEEEEecccChhhHHHHHHHHHHHHccCC-CCccceeeEEEcCCeEEEEEEecCCCChh
Q 046728 27 ILMLLLLLRRET----GDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRH-RNLLGLRGFYAGGDERLIVYDYMPNHSLI 100 (325)
Q Consensus 27 ~~~~v~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lV~e~~~~gsL~ 100 (325)
-+-.+|.+.... +++.|++|.......... ...+|..+++.+.. .--.++++.+.++ .|++|+++.+|.
T Consensus 48 lTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~l~ 121 (344)
T PLN02236 48 MTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHARTLS 121 (344)
T ss_pred ccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCCCC
Confidence 344455554211 246788898765332222 34679999999853 3333566666433 589998776653
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=92.13 E-value=0.95 Score=40.85 Aligned_cols=74 Identities=18% Similarity=0.167 Sum_probs=46.1
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEec----c---cChhhHHHHHHHHHHHHccC--CC-CccceeeEEEcCCeEEE
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLK----T---LNAKAEMEFAVEVEILGRVR--HR-NLLGLRGFYAGGDERLI 89 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~----~---~~~~~~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~l 89 (325)
.||-| -.-.||.+....+++.|+||.=. . .-+-...+..-|...|+... .| .+.+++.+ +.....+
T Consensus 2 EigdG--nlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~ 77 (370)
T TIGR01767 2 EVGDG--NLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVT 77 (370)
T ss_pred cCCCC--ceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--cccccee
Confidence 45555 66678877765444689999642 1 12344456677888888774 45 44455433 3455669
Q ss_pred EEEecCCC
Q 046728 90 VYDYMPNH 97 (325)
Q Consensus 90 V~e~~~~g 97 (325)
|||+++..
T Consensus 78 vMEdL~~~ 85 (370)
T TIGR01767 78 VMEDLSHH 85 (370)
T ss_pred hHhhCccc
Confidence 99998553
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=91.74 E-value=0.59 Score=40.93 Aligned_cols=79 Identities=11% Similarity=-0.018 Sum_probs=43.6
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC---CCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR---HRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lV 90 (325)
++.+.+.--.|.|.....|... .+++.+.+|.-.. .....|..|..-|+.|. .-.+.+++++-...+..++|
T Consensus 16 ~~~i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 16 DFKITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp -----EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred CCceeeeEecCCCChhheEEEE--CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 3334444444444566666665 5567888998762 23346788888888883 34567888887777777999
Q ss_pred EEecCCC
Q 046728 91 YDYMPNH 97 (325)
Q Consensus 91 ~e~~~~g 97 (325)
|||.+.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9998776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.65 E-value=2.2 Score=37.82 Aligned_cols=59 Identities=7% Similarity=0.113 Sum_probs=37.6
Q ss_pred CCeEEEEEec--ccChhhHHHHHHHHHHHHccC--CCCccceeeEEEcCC--eEEEEEEecCCCCh
Q 046728 40 DDQIAVKRLK--TLNAKAEMEFAVEVEILGRVR--HRNLLGLRGFYAGGD--ERLIVYDYMPNHSL 99 (325)
Q Consensus 40 ~~~vaiK~~~--~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~--~~~lV~e~~~~gsL 99 (325)
++..++- .+ ...........+|+.+++.+. ---+.+.++.+.++. ..|.||+|++|..+
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~ 112 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVV 112 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceec
Confidence 5566666 33 122333446667888888884 234455666776665 67999999988433
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=91.28 E-value=4.4 Score=35.22 Aligned_cols=26 Identities=27% Similarity=0.501 Sum_probs=21.3
Q ss_pred CCCCCCceeeCCCCc-eEEeeeccccc
Q 046728 130 ADIKASNVLLDTDFE-AKVADFGFAKL 155 (325)
Q Consensus 130 rdlkp~Nil~~~~~~-~kL~Dfg~~~~ 155 (325)
+|++|.||+++.++. .-|+||+.+..
T Consensus 190 GD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 190 GDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 699999999987555 56999998763
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.09 E-value=0.85 Score=40.17 Aligned_cols=78 Identities=9% Similarity=0.013 Sum_probs=52.7
Q ss_pred HhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-C--CCccceeeEEEc---CCeEEEEE
Q 046728 18 IQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-H--RNLLGLRGFYAG---GDERLIVY 91 (325)
Q Consensus 18 ~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~---~~~~~lV~ 91 (325)
++.||.| ....+|...... + .+++|..+. ......+..|...++.|. + -.|.++++++.. .+..++||
T Consensus 19 ~~~i~~G--~~~~vy~~~~~~-~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 19 VECISEQ--PYAALWALYDSQ-G-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred eeecCCc--cceeEEEEEcCC-C-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 3456666 777777764322 3 466777533 112347888999999984 2 367788877654 35689999
Q ss_pred EecCCCChhh
Q 046728 92 DYMPNHSLIT 101 (325)
Q Consensus 92 e~~~~gsL~~ 101 (325)
|+.+|+++.+
T Consensus 93 E~i~G~~~~~ 102 (297)
T PRK10593 93 ERLRGVSVEA 102 (297)
T ss_pred eccCCEecCC
Confidence 9999988765
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=90.95 E-value=1.1 Score=37.54 Aligned_cols=129 Identities=12% Similarity=0.163 Sum_probs=73.5
Q ss_pred EEEEEecccChh-hHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCCCChhhhhccCCCCCCccCHHHH-HH
Q 046728 43 IAVKRLKTLNAK-AEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRR-VS 120 (325)
Q Consensus 43 vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~-~~ 120 (325)
..+|++....-. ...-+.+++.++.+++ .|+++..- +...+-+++|+|-.-.. . ...+... +.
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----------~-~~N~i~agi~ 152 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----------N-FSNFITAGIK 152 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc----------c-hhHHHHHhHH
Confidence 345655543322 3446677888888876 56666622 33445699999943211 0 0011111 21
Q ss_pred HHHHHHhh------cCCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHH
Q 046728 121 IAIGSAEG------IADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFG 194 (325)
Q Consensus 121 ~~~~~~~~------~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 194 (325)
.+...|. |+|..|+||+-|..|.+||.|-+.-- . .+..|.--| + ...++++++-+|=
T Consensus 153 -~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~-----------~~V~~vN~~-Y--~~lT~~aE~~~fv 215 (308)
T PF07387_consen 153 -DLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--E-----------NQVNMVNIE-Y--ESLTQEAEVKVFV 215 (308)
T ss_pred -HHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhh--h-----------heeeEEeee-c--cccChHHHHHHHH
Confidence 2223331 37999999999999999999976422 1 111222211 1 2356778887887
Q ss_pred HHHHHHHhC
Q 046728 195 VLLLELISA 203 (325)
Q Consensus 195 ~il~el~tg 203 (325)
..+.++...
T Consensus 216 ~s~l~~v~~ 224 (308)
T PF07387_consen 216 KSCLKLVEK 224 (308)
T ss_pred HHHHHHHHH
Confidence 777777653
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=89.44 E-value=0.67 Score=41.71 Aligned_cols=66 Identities=12% Similarity=0.175 Sum_probs=40.7
Q ss_pred eEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhh-----cCCCCCCceeeCCCCceEEeeeccccc
Q 046728 86 ERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEG-----IADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-----~rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
..|++|++- |++|.-.--. .-.+.+.++......+.++.. |||+.-.|||++ .|.+-|+||.+++.
T Consensus 300 y~yl~~kdh-gt~is~ik~~--~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 300 YLYLHFKDH-GTPISIIKAD--RSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred EEEEEEecC-Cceeeeeecc--cHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 346777765 4454321111 112234444444444444433 389999999999 99999999999984
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=88.62 E-value=1.3 Score=40.64 Aligned_cols=75 Identities=13% Similarity=0.124 Sum_probs=47.8
Q ss_pred HhhccCccceeeeeEEEeccCCCCeEEEEEe----cc--cChhhHHHHHHHHHHHHccC--CC-CccceeeEEEcCCeEE
Q 046728 18 IQNINNGLEILMLLLLLRRETGDDQIAVKRL----KT--LNAKAEMEFAVEVEILGRVR--HR-NLLGLRGFYAGGDERL 88 (325)
Q Consensus 18 ~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~----~~--~~~~~~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~ 88 (325)
++.||-| -.-.||.+....++..|+||.= .. .-+-...+..-|...|+.+. .| ++.+++.+ +.....
T Consensus 34 ~~eigdG--nlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~ 109 (409)
T PRK12396 34 CKEIGDG--NLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNC 109 (409)
T ss_pred eeEcCCC--ceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhh
Confidence 4566666 6677887776434567999963 21 12444567777888888874 45 45555544 345566
Q ss_pred EEEEecCC
Q 046728 89 IVYDYMPN 96 (325)
Q Consensus 89 lV~e~~~~ 96 (325)
+|||+++.
T Consensus 110 ~vMEdL~~ 117 (409)
T PRK12396 110 CVMEDLSD 117 (409)
T ss_pred HHHHhCcc
Confidence 88998855
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=87.62 E-value=5.2 Score=35.81 Aligned_cols=54 Identities=11% Similarity=0.270 Sum_probs=33.7
Q ss_pred CeEEEEEecccChhhHHHHHHHHHHHHccCCCCc-cceeeEEEcCCeEEEEEEecCCCCh
Q 046728 41 DQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNL-LGLRGFYAGGDERLIVYDYMPNHSL 99 (325)
Q Consensus 41 ~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lV~e~~~~gsL 99 (325)
..|++++...... ......+|..+++.+..-++ .++++++..+ +|.+|+++.+|
T Consensus 43 ~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~~l 97 (330)
T PLN02421 43 VSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINARTL 97 (330)
T ss_pred ceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCCCC
Confidence 4788888754322 23344678999999854344 3556555322 58899877654
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=86.66 E-value=4.6 Score=37.25 Aligned_cols=73 Identities=14% Similarity=0.166 Sum_probs=45.0
Q ss_pred HhhccCccceeeeeEEEeccCCCCeEEEEEec-----ccC--hhhHHHHHHHHHHHHccC---CCCccceeeEEEcCCeE
Q 046728 18 IQNINNGLEILMLLLLLRRETGDDQIAVKRLK-----TLN--AKAEMEFAVEVEILGRVR---HRNLLGLRGFYAGGDER 87 (325)
Q Consensus 18 ~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~-----~~~--~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~ 87 (325)
.+.||-| -.-.||.+.. ++..|+||.-. ... +....+-..|...|+.+. ..++.+++.+.. +.-
T Consensus 37 ~~eiggG--n~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~ 110 (418)
T PLN02756 37 IKEVGDG--NLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMA 110 (418)
T ss_pred EEEcCCC--ceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCC
Confidence 4455555 5556666664 34568899754 111 123445555677777663 347777887765 446
Q ss_pred EEEEEecCC
Q 046728 88 LIVYDYMPN 96 (325)
Q Consensus 88 ~lV~e~~~~ 96 (325)
+++||++++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 788999976
|
|
| >smart00146 PI3Kc Phosphoinositide 3-kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=84.39 E-value=1.4 Score=36.38 Aligned_cols=35 Identities=29% Similarity=0.340 Sum_probs=29.0
Q ss_pred HHHHHHHhhcCCCCCCceeeCCCCceEEeeecccc
Q 046728 120 SIAIGSAEGIADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 120 ~~~~~~~~~~rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
..++.+.-+++|-.|+||+++.+|.+.-+|||..-
T Consensus 96 ~s~~~YilglgDRh~~NIli~~~G~v~hIDfg~~~ 130 (202)
T smart00146 96 YSVITYILGLGDRHNDNIMLDKTGHLFHIDFGFIL 130 (202)
T ss_pred HHHHHHHhcCCCCCCCcEEEeCCCCEEEEechhhh
Confidence 44555566679999999999999999999999864
|
Phosphoinositide 3-kinase isoforms participate in a variety of processes, including cell motility, the Ras pathway, vesicle trafficking and secretion, and apoptosis. These homologues may be either lipid kinases and/or protein kinases: the former phosphorylate the 3-position in the inositol ring of inositol phospholipids. The ataxia telangiectesia-mutated gene produced, the targets of rapamycin (TOR) and the DNA-dependent kinase have not been found to possess lipid kinase activity. Some of this family possess PI-4 kinase activities. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=84.18 E-value=8.9 Score=34.31 Aligned_cols=69 Identities=19% Similarity=0.263 Sum_probs=41.0
Q ss_pred eeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC---CCCccc---eee----EEEcCCeEEEEEEecCCC
Q 046728 28 LMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR---HRNLLG---LRG----FYAGGDERLIVYDYMPNH 97 (325)
Q Consensus 28 ~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~---~~~----~~~~~~~~~lV~e~~~~g 97 (325)
.-.+|......++. ++|+.... ....++.-|...|..|. .+=.++ .=| .+......+.|++|++|.
T Consensus 38 eN~~f~~~~~~g~~--iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 38 ENSNFRVQTEDGRY--ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred cCceEEEEecCCCe--EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 44566666555443 78888764 44556777788888773 222222 111 122223678999999987
Q ss_pred Chh
Q 046728 98 SLI 100 (325)
Q Consensus 98 sL~ 100 (325)
.+.
T Consensus 114 ~~~ 116 (331)
T COG2334 114 PLE 116 (331)
T ss_pred CcC
Confidence 766
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=84.01 E-value=0.88 Score=36.99 Aligned_cols=26 Identities=19% Similarity=0.291 Sum_probs=22.3
Q ss_pred cCCCCCCceeeCCCCceEEeeeccccc
Q 046728 129 IADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 129 ~rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
|+|+.|.|+++++++ ++|+||+.+..
T Consensus 81 H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 81 HMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred cCCCCCccEEEECCC-EEEEeCCcccC
Confidence 469999999998877 88999998763
|
|
| >cd05168 PI4Kc_III_beta Phosphoinositide 4-kinase (PI4K), Type III, beta isoform, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases | Back alignment and domain information |
|---|
Probab=82.04 E-value=1.8 Score=37.86 Aligned_cols=34 Identities=32% Similarity=0.338 Sum_probs=28.4
Q ss_pred HHHHHHhhcCCCCCCceeeCCCCceEEeeecccc
Q 046728 121 IAIGSAEGIADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 121 ~~~~~~~~~rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
.++.|.-+++|=.++|||++.+|.+.-+|||.+-
T Consensus 137 Svv~YvLGigDRH~~NILi~~~G~liHIDFG~~f 170 (293)
T cd05168 137 SLICYLLQIKDRHNGNILIDNDGHIIHIDFGFML 170 (293)
T ss_pred HHHHHHhhccccCCCceEEcCCCCEEEEehHHhh
Confidence 3444555668999999999999999999999875
|
PI4Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 4-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) to generate PtdIns(4)P, the major precursor in the synthesis of other phosphoinositides including PtdIns(4,5)P2, PtdIns(3,4)P2, and PtdIns(3,4,5)P3. Two isoforms of type III PI4K, alpha and beta, exist in most eukaryotes. PI4KIIIbeta (also called Pik1p in yeast) is a 110 kDa protein that is localized to the Golgi and the nucleus. It is required for maintaining the structural integrity of the Golgi complex (GC), and is a key regulator of protein transport from the GC to the plasma membrane. PI4KII |
| >cd00142 PI3Kc_like Phosphoinositide 3-kinase (PI3K)-like family, catalytic domain; The PI3K-like catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases | Back alignment and domain information |
|---|
Probab=81.65 E-value=1.9 Score=36.11 Aligned_cols=35 Identities=29% Similarity=0.356 Sum_probs=29.2
Q ss_pred HHHHHHHhhcCCCCCCceeeCC-CCceEEeeecccc
Q 046728 120 SIAIGSAEGIADIKASNVLLDT-DFEAKVADFGFAK 154 (325)
Q Consensus 120 ~~~~~~~~~~rdlkp~Nil~~~-~~~~kL~Dfg~~~ 154 (325)
..++.|.-+++|-.|+||+++. +|.+.-+|||.+-
T Consensus 123 ~s~~~YilglgDRh~~NIli~~~~G~~~hIDfg~~~ 158 (219)
T cd00142 123 YSVAGYILGIGDRHPDNIMIDLDTGKLFHIDFGFIF 158 (219)
T ss_pred HHHHHHHhccCCCCCccEEEECCCCeEEEEeeHHhh
Confidence 4455566677999999999998 9999999999764
|
Members of the family include PI3K, phosphoinositide 4-kinase (PI4K), PI3K-related protein kinases (PIKKs), and TRansformation/tRanscription domain-Associated Protein (TRRAP). PI3Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 3-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) or its derivatives, while PI4K catalyze the phosphorylation of the 4-hydroxyl of PtdIns. PIKKs are protein kinases that catalyze the phosphorylation of serine/threonine residues, especially those that are followed by a glutamine. PI3Ks play an important role in a variety of fundamental cellular processes, including cell motility, the |
| >cd05170 PIKKc_SMG1 Suppressor of morphogenetic effect on genitalia-1 (SMG-1), catalytic domain; The SMG-1 catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases | Back alignment and domain information |
|---|
Probab=81.47 E-value=1.8 Score=38.27 Aligned_cols=35 Identities=29% Similarity=0.331 Sum_probs=28.0
Q ss_pred HHHHHHHhhcCCCCCCceeeC-CCCceEEeeecccc
Q 046728 120 SIAIGSAEGIADIKASNVLLD-TDFEAKVADFGFAK 154 (325)
Q Consensus 120 ~~~~~~~~~~rdlkp~Nil~~-~~~~~kL~Dfg~~~ 154 (325)
..++.|.-+++|-.|+|||++ ..|.+.-+|||.+-
T Consensus 204 ~s~~~yilglgDRh~~NIli~~~tG~v~hiDf~~~f 239 (307)
T cd05170 204 MSMIGYVIGLGDRHLDNVLIDLKTGEVVHIDYNVCF 239 (307)
T ss_pred HHHHHHHccCCCCCCccEEEEcCCCcEEEEeeHhhh
Confidence 334445556689999999999 78999999999764
|
SMG-1 is a member of the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). In addition to its catalytic domain, SMG-1 contains a FATC (FRAP, ATM and TRRAP, C-terminal) domain at the C-terminus. SMG-1 plays a critical role in the mRNA surveillance mechanism known as non-sense mediated mRNA decay (NMD). NMD protects the cells from the accumulation of aberrant mRNAs with premature termination codons (PTCs) generated by geno |
| >cd00893 PI4Kc_III Phosphoinositide 4-kinase (PI4K), Type III, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases | Back alignment and domain information |
|---|
Probab=80.83 E-value=2.1 Score=37.40 Aligned_cols=33 Identities=33% Similarity=0.375 Sum_probs=27.7
Q ss_pred HHHHHhhcCCCCCCceeeCCCCceEEeeecccc
Q 046728 122 AIGSAEGIADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 122 ~~~~~~~~rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
++.|.-+++|=.++|||++.+|++.-+|||..-
T Consensus 136 vv~YiLgigDRH~~NILid~~G~liHIDFG~il 168 (289)
T cd00893 136 LLCYLLQIKDRHNGNILLDSDGHIIHIDFGFIL 168 (289)
T ss_pred HHHHHhhccccCCCceEECCCCCEEEEehHHhh
Confidence 344455668999999999999999999999875
|
PI4Ks catalyze the transfer of the gamma-phosphoryl group from ATP to the 4-hydroxyl of the inositol ring of D-myo-phosphatidylinositol (PtdIns) to generate PtdIns(4)P, the major precursor in the synthesis of other phosphoinositides including PtdIns(4,5)P2, PtdIns(3,4)P2, and PtdIns(3,4,5)P3. There are two types of PI4Ks, types II and III. Type II PI4Ks lack the characteristic catalytic kinase domain present in PI3Ks and type III PI4Ks, and are excluded from this family. Two isoforms of type III PI4K, alpha and beta, exist in most eukaryotes. |
| >cd05164 PIKKc Phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily, catalytic domain; The PIKK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases | Back alignment and domain information |
|---|
Probab=80.77 E-value=1.9 Score=36.13 Aligned_cols=35 Identities=29% Similarity=0.362 Sum_probs=28.5
Q ss_pred HHHHHHHhhcCCCCCCceeeCC-CCceEEeeecccc
Q 046728 120 SIAIGSAEGIADIKASNVLLDT-DFEAKVADFGFAK 154 (325)
Q Consensus 120 ~~~~~~~~~~rdlkp~Nil~~~-~~~~kL~Dfg~~~ 154 (325)
..++.+.-+++|-.|+||+++. +|.+.-+|||.+-
T Consensus 126 ~s~~~YvlglgDRh~~NIli~~~tG~v~hIDf~~~~ 161 (222)
T cd05164 126 MSIVGYILGLGDRHLDNILIDRETGEVVHIDFGCIF 161 (222)
T ss_pred HHHHHHHhccCCCCCceEEEECCCCcEEEEccHHhh
Confidence 3445555667899999999998 8999999999764
|
Members include ATM (Ataxia telangiectasia mutated), ATR (Ataxia telangiectasia and Rad3-related), TOR (Target of rapamycin), SMG-1 (Suppressor of morphogenetic effect on genitalia-1), and DNA-PK (DNA-dependent protein kinase). PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). They show strong preference for phosphorylating serine/threonine residues followed by a glutamine and are also referred to as (S/T)-Q-directed kinases. They all contain a FATC (FRAP, ATM and TRRAP, C-terminal) d |
| >cd00892 PIKKc_ATR ATR (Ataxia telangiectasia and Rad3-related), catalytic domain; The ATR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases | Back alignment and domain information |
|---|
Probab=80.46 E-value=2.1 Score=36.31 Aligned_cols=33 Identities=24% Similarity=0.374 Sum_probs=27.6
Q ss_pred HHHHHhhcCCCCCCceeeCC-CCceEEeeecccc
Q 046728 122 AIGSAEGIADIKASNVLLDT-DFEAKVADFGFAK 154 (325)
Q Consensus 122 ~~~~~~~~rdlkp~Nil~~~-~~~~kL~Dfg~~~ 154 (325)
++.|.-+++|-.|+|||++. +|.+.-+|||.+-
T Consensus 136 ~~~YilgigDRh~~NIli~~~tG~~~HIDfg~~~ 169 (237)
T cd00892 136 MVGYILGLGDRHGENILFDSNTGDVVHVDFNCLF 169 (237)
T ss_pred HHHHHhccCCCCcccEEEEcCCCcEEEEehHhhh
Confidence 44555566899999999997 9999999999764
|
ATR is also referred to as Mei-41 (Drosophila), Esr1/Mec1p (Saccharomyces cerevisiae), Rad3 (Schizosaccharomyces pombe), and FRAP-related protein (human). ATR is a member of the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). ATR contains a UME domain of unknown function, a FAT (FRAP, ATM and TRRAP) domain, a catalytic domain, and a FATC domain at the C-terminus. Together with its downstream effector kinase, Chk1, ATR plays a central |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=80.41 E-value=1 Score=37.36 Aligned_cols=25 Identities=36% Similarity=0.659 Sum_probs=18.0
Q ss_pred CCCCCCceee-CCCCceEEeeecccc
Q 046728 130 ADIKASNVLL-DTDFEAKVADFGFAK 154 (325)
Q Consensus 130 rdlkp~Nil~-~~~~~~kL~Dfg~~~ 154 (325)
.|+.|.||++ +.++.++|+||..|.
T Consensus 148 nDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 148 NDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ccCccccEEeccCCCeEEEecHHHHh
Confidence 5999999999 888999999998765
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=80.36 E-value=1.4 Score=38.68 Aligned_cols=56 Identities=14% Similarity=0.280 Sum_probs=35.8
Q ss_pred CCeEEEEEecccChhhHHHHHHHHHHHHccCCCC-ccceeeEEEcCCeEEEEEEecCCCChh
Q 046728 40 DDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRN-LLGLRGFYAGGDERLIVYDYMPNHSLI 100 (325)
Q Consensus 40 ~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lV~e~~~~gsL~ 100 (325)
++.+++|+..... .......+|..++..+.... ..++++.+.. .+|++|++|.++.
T Consensus 29 ~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~G~~l~ 85 (302)
T cd05156 29 PRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIPSRTLT 85 (302)
T ss_pred CCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeCCCcCC
Confidence 5788899875532 33346678999999885322 3355555432 3589998886653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 325 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-46 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-46 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-35 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-34 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-28 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-27 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-27 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-25 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-05 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-05 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-05 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-05 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-04 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-04 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-04 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-04 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-04 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-04 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-04 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 364 bits (936), Expect = e-126
Identities = 103/253 (40%), Positives = 153/253 (60%), Gaps = 16/253 (6%)
Query: 42 QIAVKRLKTLNAKA-EMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
+AVKRLK + E++F EVE++ HRNLL LRGF ERL+VY YM N S+
Sbjct: 56 LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 115
Query: 101 THLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFEAKV 147
+ L R LDW +R IA+GSA G+A D+KA+N+LLD +FEA V
Sbjct: 116 SCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175
Query: 148 ADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPL 207
DFG AKL+ TH+TT V+GT+G++APEY GK S+ DV+ +GV+LLELI+ ++
Sbjct: 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235
Query: 208 E--KLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPEN 265
+ +L ++ WV +++ E + D L+G + ++++ ++ +AL CT S+P
Sbjct: 236 DLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPME 295
Query: 266 RPTMTDVVDWLKG 278
RP M++VV L+G
Sbjct: 296 RPKMSEVVRMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 323 bits (830), Expect = e-110
Identities = 86/250 (34%), Positives = 139/250 (55%), Gaps = 11/250 (4%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
++A+KR +++ EF E+E L RH +L+ L GF +E +++Y YM N +L
Sbjct: 65 KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKR 124
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVADFG 151
HL+G P + W +R+ I IG+A G+ D+K+ N+LLD +F K+ DFG
Sbjct: 125 HLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFG 184
Query: 152 FAKLIPDG-VTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKL 210
+K + TH++T VKGTLGY+ PEY + G++++ DVYSFGV+L E++ A+ + +
Sbjct: 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244
Query: 211 PGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMT 270
++ +W G E I DP L K + L+ A++C + E+RP+M
Sbjct: 245 LPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMG 304
Query: 271 DVVDWLKGGL 280
DV+ L+ L
Sbjct: 305 DVLWKLEYAL 314
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 294 bits (756), Expect = 1e-99
Identities = 77/255 (30%), Positives = 129/255 (50%), Gaps = 21/255 (8%)
Query: 40 DDQIAVKRLKTLNAKA----EMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
+ +AVK+L + + +F E++++ + +H NL+ L GF + GD+ +VY YMP
Sbjct: 54 NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP 113
Query: 96 NHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEA 145
N SL+ L L WH R IA G+A GI DIK++N+LLD F A
Sbjct: 114 NGSLLDRLSCLDGTP-PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTA 172
Query: 146 KVADFGFAKLIPDG-VTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAK 204
K++DFG A+ T MT+R+ GT Y+APE + G+++ D+YSFGV+LLE+I+
Sbjct: 173 KISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGL 231
Query: 205 KPLEKLPGGVKRDIVQWVTPYVQ-KGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNP 263
+++ + ++ + E D ++ + +++M +A +C
Sbjct: 232 PAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKK 288
Query: 264 ENRPTMTDVVDWLKG 278
RP + V L+
Sbjct: 289 NKRPDIKKVQQLLQE 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-60
Identities = 57/274 (20%), Positives = 96/274 (35%), Gaps = 42/274 (15%)
Query: 40 DDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD----ERLIVYDYMP 95
++ +AVK K + EV L ++H N+L G G + ++ +
Sbjct: 47 NEYVAVKIFPI-QDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHE 105
Query: 96 NHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA--------------------DIKAS 135
SL L + + W+ IA A G+A DIK+
Sbjct: 106 KGSLSDFLKANV-----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSK 160
Query: 136 NVLLDTDFEAKVADFGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWG-----KVSDSCD 189
NVLL + A +ADFG A G + T GT Y+APE D
Sbjct: 161 NVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRID 220
Query: 190 VYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPY-----VQKGAFEHIADPRLKGKFN 244
+Y+ G++L EL S + + + + +Q+ P L+ +
Sbjct: 221 MYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQ 280
Query: 245 RDQ-LKSMVLIALRCTDSNPENRPTMTDVVDWLK 277
+ + + C D + E R + V + +
Sbjct: 281 KHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-45
Identities = 70/248 (28%), Positives = 109/248 (43%), Gaps = 31/248 (12%)
Query: 44 AVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
AVK L +A+ EF EV I+ R+RH N++ G IV +Y+ SL
Sbjct: 64 AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA------------DIKASNVLLDTDFEAKVAD 149
LH + LD RR+S+A A+G+ ++K+ N+L+D + KV D
Sbjct: 124 LLH-KSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 150 FGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEK 209
FG ++L + GT ++APE ++ DVYSFGV+L EL + ++P
Sbjct: 183 FGLSRLKASTFLSSKSAA-GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241
Query: 210 LPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTM 269
L +V V K RL + R+ + I C + P RP+
Sbjct: 242 LNPA---QVVAAV---GFKCK-------RL--EIPRNLNPQVAAIIEGCWTNEPWKRPSF 286
Query: 270 TDVVDWLK 277
++D L+
Sbjct: 287 ATIMDLLR 294
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-44
Identities = 69/249 (27%), Positives = 115/249 (46%), Gaps = 37/249 (14%)
Query: 43 IAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITH 102
+A+K++++ + + F VE+ L RV H N++ L G A + +V +Y SL
Sbjct: 34 VAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYG--ACLNPVCLVMEYAEGGSLYNV 89
Query: 103 LHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFE-AKVA 148
LHG P +S + ++G+A D+K N+LL K+
Sbjct: 90 LHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKIC 148
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLE 208
DFG A I THMT KG+ ++APE S+ CDV+S+G++L E+I+ +KP +
Sbjct: 149 DFGTACDIQ---THMTNN-KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 204
Query: 209 KLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPT 268
++ G R + W V G R ++ K + + RC +P RP+
Sbjct: 205 EIGGPAFR--IMWA---VHNGT-------RP--PLIKNLPKPIESLMTRCWSKDPSQRPS 250
Query: 269 MTDVVDWLK 277
M ++V +
Sbjct: 251 MEEIVKIMT 259
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-43
Identities = 55/260 (21%), Positives = 107/260 (41%), Gaps = 48/260 (18%)
Query: 44 AVKRLKTLNAKAEM-------EFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPN 96
A+K L +++ E EF EV I+ + H N++ L G + +V +++P
Sbjct: 48 AIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPC 105
Query: 97 HSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA------------DIKASNVLLDTDFE 144
L L + P + W ++ + + A GI D+++ N+ L + E
Sbjct: 106 GDLYHRLLDKAHP---IKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE 162
Query: 145 -----AKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPE--YAMWGKVSDSCDVYSFGVLL 197
AKVADFG ++ H + + G ++APE A ++ D YSF ++L
Sbjct: 163 NAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMIL 218
Query: 198 LELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALR 257
+++ + P ++ G ++++ ++G R D + +
Sbjct: 219 YTILTGEGPFDEYSYGK----IKFINMIREEGL-------RP--TIPEDCPPRLRNVIEL 265
Query: 258 CTDSNPENRPTMTDVVDWLK 277
C +P+ RP + +V L
Sbjct: 266 CWSGDPKKRPHFSYIVKELS 285
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 9e-43
Identities = 57/286 (19%), Positives = 94/286 (32%), Gaps = 61/286 (21%)
Query: 43 IAVKRLKTLNAKAEMEFAVEVEI--LGRVRHRNLLGL-----RGFYAGGDERLIVYDYMP 95
+AVK N F E I + + H N+ R G E L+V +Y P
Sbjct: 39 VAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYP 95
Query: 96 NHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------------DIKASN 136
N SL +L DW +A G+A D+ + N
Sbjct: 96 NGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRN 150
Query: 137 VLLDTDFEAKVADFGFAKLI-------PDGVTHMTTRVKGTLGYLAPEYAM-------WG 182
VL+ D ++DFG + + P + GT+ Y+APE
Sbjct: 151 VLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXE 210
Query: 183 KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDI-VQWVTPYVQKGAFEHIAD----- 236
D+Y+ G++ E+ L PG + + + T FE +
Sbjct: 211 SALKQVDMYALGLIYWEIFMRCTDL--FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSRE 268
Query: 237 ---PRLKGKFNRDQ--LKSMVLIALRCTDSNPENRPTMTDVVDWLK 277
P+ + + ++S+ C D + E R T + +
Sbjct: 269 KQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-42
Identities = 60/268 (22%), Positives = 100/268 (37%), Gaps = 47/268 (17%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
RETG+ + +K L + + + F EV+++ + H N+L G + +Y+
Sbjct: 32 RETGEV-MVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK 90
Query: 96 NHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEA 145
+L + D W +RVS A A G+A D+ + N L+ +
Sbjct: 91 GGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNV 147
Query: 146 KVADFGFAKLIPDGVTHMTTR-------------VKGTLGYLAPEYAMWGKVSDSCDVYS 192
VADFG A+L+ D T V G ++APE + DV+S
Sbjct: 148 VVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFS 207
Query: 193 FGVLLLELISAKKP---LEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249
FG++L E+I ++ ++ Y
Sbjct: 208 FGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFP------------- 254
Query: 250 SMVLIALRCTDSNPENRPTMTDVVDWLK 277
I +RC D +PE RP+ + WL+
Sbjct: 255 ----ITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-40
Identities = 62/254 (24%), Positives = 106/254 (41%), Gaps = 33/254 (12%)
Query: 41 DQIAVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL-IVYDYMPNH 97
+AVK L + F EV +L + RH N+L G +L IV +
Sbjct: 47 GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG--YSTAPQLAIVTQWCEGS 104
Query: 98 SLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKV 147
SL HLH + + + + IA +A G+ D+K++N+ L D K+
Sbjct: 105 SLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKI 161
Query: 148 ADFGFAKLIPD-GVTHMTTRVKGTLGYLAPE---YAMWGKVSDSCDVYSFGVLLLELISA 203
DFG A +H ++ G++ ++APE S DVY+FG++L EL++
Sbjct: 162 GDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG 221
Query: 204 KKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNP 263
+ P + RD + + V +G+ P L K + K M + C
Sbjct: 222 QLPYSNINN---RDQIIEM---VGRGSLS----PDLS-KVRSNCPKRMKRLMAECLKKKR 270
Query: 264 ENRPTMTDVVDWLK 277
+ RP+ ++ ++
Sbjct: 271 DERPSFPRILAEIE 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-40
Identities = 56/255 (21%), Positives = 97/255 (38%), Gaps = 44/255 (17%)
Query: 43 IAVKRLKT--LNAKAEMEFAVEVEILGRVRHRNLLGLRGF-YAGGDERL-IVYDYMPNHS 98
I VK LK + + +F E L H N+L + G + ++ +MP S
Sbjct: 36 IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGS 95
Query: 99 LITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA------------DIKASNVLLDTDFEAK 146
L LH + ++D + V A+ A G+A + + +V++D D A+
Sbjct: 96 LYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTAR 153
Query: 147 VADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDS----CDVYSFGVLLLELIS 202
++ R+ ++APE A+ K D+ D++SF VLL EL++
Sbjct: 154 ISMADVKF-----SFQSPGRM-YAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVT 206
Query: 203 AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSN 262
+ P L +I V A E + R + + C + +
Sbjct: 207 REVPFADLSNM---EIGMKV-------ALEGL---RP--TIPPGISPHVSKLMKICMNED 251
Query: 263 PENRPTMTDVVDWLK 277
P RP +V L+
Sbjct: 252 PAKRPKFDMIVPILE 266
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-39
Identities = 54/259 (20%), Positives = 96/259 (37%), Gaps = 48/259 (18%)
Query: 44 AVKRLK----TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSL 99
AVK + ++ E ++ ++H N++ LRG +V ++ L
Sbjct: 34 AVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPL 93
Query: 100 ITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA-------------DIKASNVLLDTDFE-- 144
L G+ + V+ A+ A G+ D+K+SN+L+ E
Sbjct: 94 NRVLSGKR-----IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENG 148
Query: 145 ------AKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLL 198
K+ DFG A+ T + G ++APE S DV+S+GVLL
Sbjct: 149 DLSNKILKITDFGLAREWHR--TTKMSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLW 205
Query: 199 ELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRC 258
EL++ + P + G + V L + + C
Sbjct: 206 ELLTGEVPFRGIDGL---AVAYGV---AMNKL-------AL--PIPSTCPEPFAKLMEDC 250
Query: 259 TDSNPENRPTMTDVVDWLK 277
+ +P +RP+ T+++D L
Sbjct: 251 WNPDPHSRPSFTNILDQLT 269
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-39
Identities = 52/271 (19%), Positives = 89/271 (32%), Gaps = 62/271 (22%)
Query: 41 DQIAVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHS 98
++A++ + N F EV + RH N++ G I+ +
Sbjct: 56 GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT 115
Query: 99 LITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVA 148
L + + +LD ++ IA +G+ D+K+ NV D + + +
Sbjct: 116 LYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVIT 171
Query: 149 DFGFAKLI----PDGVTHMTTRVKGTLGYLAPEYAMWGKV---------SDSCDVYSFGV 195
DFG + G L +LAPE S DV++ G
Sbjct: 172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231
Query: 196 LLLELISAKKPLEKLPG---------GVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRD 246
+ EL + + P + P G+K ++ Q
Sbjct: 232 IWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMG---------------------- 269
Query: 247 QLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277
K + I L C E RPT T ++D L+
Sbjct: 270 --KEISDILLFCWAFEQEERPTFTKLMDMLE 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-36
Identities = 60/279 (21%), Positives = 92/279 (32%), Gaps = 60/279 (21%)
Query: 44 AVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYA-------GGDERLIVYDYMPN 96
AVK T +A E+ +RH N+LG F A + ++ DY N
Sbjct: 64 AVKVFFT-TEEASWFRETEIYQTVLMRHENILG---FIAADIKGTGSWTQLYLITDYHEN 119
Query: 97 HSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA------------------DIKASNVL 138
SL +L LD + +A S G+ D+K+ N+L
Sbjct: 120 GSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL 174
Query: 139 LDTDFEAKVADFGFAKLIPDGVTH----MTTRVKGTLGYLAPE---YAMWGKVSDS---C 188
+ + +AD G A TRV GT Y+ PE ++ S
Sbjct: 175 VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRYMPPEVLDESLNRNHFQSYIMA 233
Query: 189 DVYSFGVLLLELISAKKPLEKLPG---------GVKRDIVQWVTPYVQKGAFEHIADPRL 239
D+YSFG++L E+ + K P
Sbjct: 234 DMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKK-----LRPSF 288
Query: 240 KGKFNRDQ-LKSMVLIALRCTDSNPENRPTMTDVVDWLK 277
+++ D+ L+ M + C NP +R T V L
Sbjct: 289 PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-35
Identities = 55/281 (19%), Positives = 94/281 (33%), Gaps = 64/281 (22%)
Query: 44 AVKRLKTLNAKAEMEFAVEVEI--LGRVRHRNLLGLRG----FYAGGDERLIVYDYMPNH 97
AVK + + E + E E+ +RH N+LG + ++ Y
Sbjct: 35 AVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMG 91
Query: 98 SLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA------------------DIKASNVLL 139
SL +L LD + I + A G+A D+K+ N+L+
Sbjct: 92 SLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV 146
Query: 140 DTDFEAKVADFGFAKLI----PDGVTHMTTRVKGTLGYLAPE------YAMWGKVSDSCD 189
+ + +AD G A + RV GT Y+APE D
Sbjct: 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKRVD 205
Query: 190 VYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPY----VQKGAFEHIAD--------P 237
+++FG++L E+ + + P+ +FE + P
Sbjct: 206 IWAFGLVLWEVARRMVSNGIVE--------DYKPPFYDVVPNDPSFEDMRKVVCVDQQRP 257
Query: 238 RLKGKFNRDQ-LKSMVLIALRCTDSNPENRPTMTDVVDWLK 277
+ ++ D L S+ + C NP R T + L
Sbjct: 258 NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 51/280 (18%), Positives = 93/280 (33%), Gaps = 60/280 (21%)
Query: 43 IAVKRLKTLNAKAEMEFAVEVEI--LGRVRHRNLLGLRG----FYAGGDERLIVYDYMPN 96
+AVK + + E + E EI +RH N+LG + +V DY +
Sbjct: 68 VAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 124
Query: 97 HSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA------------------DIKASNVL 138
SL +L+ + + +A+ +A G+A D+K+ N+L
Sbjct: 125 GSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 179
Query: 139 LDTDFEAKVADFGFAKLIPDGVTHMTTRVK---GTLGYLAPE---YAMWGKVSDS---CD 189
+ + +AD G A + GT Y+APE ++ K +S D
Sbjct: 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 239
Query: 190 VYSFGVLLLELISAKKPLEKLPG---------GVKRDIVQWVTPYVQKGAFEHIADPRL- 239
+Y+ G++ E+ + + ++ R
Sbjct: 240 IYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL-------RPN 292
Query: 240 --KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277
+ + L+ M I C +N R T + L
Sbjct: 293 IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 62/255 (24%), Positives = 98/255 (38%), Gaps = 44/255 (17%)
Query: 42 QIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
+AVK + TL + +F E IL + H N++ L G IV + + +
Sbjct: 141 LVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 200
Query: 101 THLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVADF 150
T L L + + +A G+ D+ A N L+ K++DF
Sbjct: 201 TFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDF 257
Query: 151 GFAKLIPDGVTHMTTR-----VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AK 204
G ++ DGV + VK T APE +G+ S DV+SFG+LL E S
Sbjct: 258 GMSREEADGVYAASGGLRQVPVKWT----APEALNYGRYSSESDVWSFGILLWETFSLGA 313
Query: 205 KPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQL--KSMVLIALRCTDSN 262
P L Q +V+KG RL +L ++ + +C
Sbjct: 314 SPYPNLS-------NQQTREFVEKGG-------RLP----CPELCPDAVFRLMEQCWAYE 355
Query: 263 PENRPTMTDVVDWLK 277
P RP+ + + L+
Sbjct: 356 PGQRPSFSTIYQELQ 370
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 68/253 (26%), Positives = 112/253 (44%), Gaps = 39/253 (15%)
Query: 39 GDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHS 98
G ++A+K LK + F E +++ ++RH L+ L + IV +YM S
Sbjct: 290 GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGS 347
Query: 99 LITHLHGR----LAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFE 144
L+ L G L L+D A A G+A D++A+N+L+ +
Sbjct: 348 LLDFLKGETGKYLRLPQLVDM------AAQIASGMAYVERMNYVHRDLRAANILVGENLV 401
Query: 145 AKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-A 203
KVADFG A+LI D K + + APE A++G+ + DV+SFG+LL EL +
Sbjct: 402 CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 461
Query: 204 KKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNP 263
+ P + + V V++G + P + +S+ + +C P
Sbjct: 462 RVPYPGMVN-------REVLDQVERG--YRMPCP-------PECPESLHDLMCQCWRKEP 505
Query: 264 ENRPTMTDVVDWL 276
E RPT + +L
Sbjct: 506 EERPTFEYLQAFL 518
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 53/248 (21%), Positives = 95/248 (38%), Gaps = 38/248 (15%)
Query: 44 AVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHL 103
AVK LK + EF E ++ ++H NL+ L G I+ ++M +L+ +L
Sbjct: 249 AVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 307
Query: 104 HGR----LAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVAD 149
++ LL +A + + ++ A N L+ + KVAD
Sbjct: 308 RECNRQEVSAVVLLY------MATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVAD 361
Query: 150 FGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLE 208
FG ++L+ K + + APE + K S DV++FGVLL E+ + P
Sbjct: 362 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 421
Query: 209 KLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPT 268
+ V ++K + P + + + C NP +RP+
Sbjct: 422 GIDL-------SQVYELLEKD--YRMERP-------EGCPEKVYELMRACWQWNPSDRPS 465
Query: 269 MTDVVDWL 276
++
Sbjct: 466 FAEIHQAF 473
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-25
Identities = 62/263 (23%), Positives = 106/263 (40%), Gaps = 49/263 (18%)
Query: 44 AVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGF-YAGGDERL-IVYDYMPNHSLIT 101
AVK+L+ + +F E+EIL ++H N++ +G Y+ G L ++ +Y+P SL
Sbjct: 43 AVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 102
Query: 102 HLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVA 148
+L R+ LL + +G+ D+ N+L++ + K+
Sbjct: 103 YLQKHKERIDHIKLLQY------TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIG 156
Query: 149 DFGFAKLIPDGVTHMTTRVKGTL--GYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKP 206
DFG K++P + G + APE K S + DV+SFGV+L EL + +
Sbjct: 157 DFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 216
Query: 207 LEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK-------------SMVL 253
+ P R I Q F I + LK + +
Sbjct: 217 SKSPPAEFMRMIGN--DKQGQMIVFHLI-----------ELLKNNGRLPRPDGCPDEIYM 263
Query: 254 IALRCTDSNPENRPTMTDVVDWL 276
I C ++N RP+ D+ +
Sbjct: 264 IMTECWNNNVNQRPSFRDLALRV 286
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 67/249 (26%), Positives = 112/249 (44%), Gaps = 31/249 (12%)
Query: 39 GDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHS 98
G ++A+K LK + F E +++ ++RH L+ L + IV +YM S
Sbjct: 207 GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGS 264
Query: 99 LITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVA 148
L+ L G L + V +A A G+A D++A+N+L+ + KVA
Sbjct: 265 LLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVA 322
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPL 207
DFG A+LI D K + + APE A++G+ + DV+SFG+LL EL + + P
Sbjct: 323 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382
Query: 208 EKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRP 267
+ + V V++G + P + +S+ + +C PE RP
Sbjct: 383 PGMVN-------REVLDQVERG--YRMPCP-------PECPESLHDLMCQCWRKEPEERP 426
Query: 268 TMTDVVDWL 276
T + +L
Sbjct: 427 TFEYLQAFL 435
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-25
Identities = 56/266 (21%), Positives = 97/266 (36%), Gaps = 56/266 (21%)
Query: 44 AVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRG--FYAGGDERLIVYDYMPNHSLIT 101
AVK+L+ + +F E++IL + ++ RG + G +V +Y+P+ L
Sbjct: 56 AVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD 115
Query: 102 HLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVA 148
L RL LL + + +G+ D+ A N+L++++ K+A
Sbjct: 116 FLQRHRARLDASRLLLY------SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIA 169
Query: 149 DFGFAKLIPDGVTHMTTRVKGTL--GYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKP 206
DFG AKL+P + R G + APE S DV+SFGV+L EL +
Sbjct: 170 DFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTY--- 226
Query: 207 LEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK----------------S 250
F + L+
Sbjct: 227 -----CD---------KSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAE 272
Query: 251 MVLIALRCTDSNPENRPTMTDVVDWL 276
+ + C +P++RP+ + + L
Sbjct: 273 VHELMKLCWAPSPQDRPSFSALGPQL 298
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 62/263 (23%), Positives = 108/263 (41%), Gaps = 49/263 (18%)
Query: 44 AVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGF-YAGGDERL-IVYDYMPNHSLIT 101
AVK+L+ + +F E+EIL ++H N++ +G Y+ G L ++ +Y+P SL
Sbjct: 74 AVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 133
Query: 102 HLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVA 148
+L R+ LL + +G+ D+ N+L++ + K+
Sbjct: 134 YLQKHKERIDHIKLLQY------TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIG 187
Query: 149 DFGFAKLIPDGVTHMTTRVKGTL--GYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKP 206
DFG K++P + + G + APE K S + DV+SFGV+L EL + +
Sbjct: 188 DFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 247
Query: 207 LEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKS-------------MVL 253
+ P R I Q F I + LK+ + +
Sbjct: 248 SKSPPAEFMRMIGN--DKQGQMIVFHLI-----------ELLKNNGRLPRPDGCPDEIYM 294
Query: 254 IALRCTDSNPENRPTMTDVVDWL 276
I C ++N RP+ D+ +
Sbjct: 295 IMTECWNNNVNQRPSFRDLALRV 317
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-24
Identities = 56/262 (21%), Positives = 104/262 (39%), Gaps = 40/262 (15%)
Query: 33 LLRRETGDDQIAVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90
+ + +AVK LK + + E E ++ ++ + ++ + G + ++V
Sbjct: 37 YYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI-CEAESWMLV 95
Query: 91 YDYMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVL 138
+ L +L + + +++ +V + G+ D+ A NVL
Sbjct: 96 MEMAELGPLNKYLQQNRHVKDKNIIELVHQV------SMGMKYLEESNFVHRDLAARNVL 149
Query: 139 LDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTL--GYLAPEYAMWGKVSDSCDVYSFGVL 196
L T AK++DFG +K + + + G + APE + K S DV+SFGVL
Sbjct: 150 LVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVL 209
Query: 197 LLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIA 255
+ E S +KP + G ++ ++KG E + P + M +
Sbjct: 210 MWEAFSYGQKPYRGMKG---SEVTA----MLEKG--ERMGCP-------AGCPREMYDLM 253
Query: 256 LRCTDSNPENRPTMTDVVDWLK 277
C + ENRP V L+
Sbjct: 254 NLCWTYDVENRPGFAAVELRLR 275
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-24
Identities = 64/282 (22%), Positives = 123/282 (43%), Gaps = 42/282 (14%)
Query: 33 LLRRETGDDQI--AVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89
+L+ +G ++ A+K LK K ++F E I+G+ H N++ L G + +I
Sbjct: 64 MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123
Query: 90 VYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASN 136
+ +YM N +L L G + L+ G A G+ D+ A N
Sbjct: 124 ITEYMENGALDKFLREKDGEFSVLQLVGM------LRGIAAGMKYLANMNYVHRDLAARN 177
Query: 137 VLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGY--LAPEYAMWGKVSDSCDVYSFG 194
+L++++ KV+DFG ++++ D T G + APE + K + + DV+SFG
Sbjct: 178 ILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFG 237
Query: 195 VLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVL 253
+++ E+++ ++P +L ++++ + G + P D ++
Sbjct: 238 IVMWEVMTYGERPYWELSN---HEVMK----AINDG--FRLPTP-------MDCPSAIYQ 281
Query: 254 IALRCTDSNPENRPTMTDVVDWLKGGLGRRTKDVKDVAGEDD 295
+ ++C RP D+V L L R +K +A D
Sbjct: 282 LMMQCWQQERARRPKFADIVSILD-KLIRAPDSLKTLADFDP 322
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-23
Identities = 55/262 (20%), Positives = 105/262 (40%), Gaps = 39/262 (14%)
Query: 31 LLLLRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89
L + E +A+K L+ + KA E E ++ V + ++ L G +
Sbjct: 35 LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI-CLTSTVQL 93
Query: 90 VYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASN 136
+ MP L+ ++ + LL+W + A+G+ D+ A N
Sbjct: 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDRRLVHRDLAARN 147
Query: 137 VLLDTDFEAKVADFGFAKLIPDG-VTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGV 195
VL+ T K+ DFG AKL+ + K + ++A E + + DV+S+GV
Sbjct: 148 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 207
Query: 196 LLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLI 254
+ EL++ KP + +P +I ++KG E + P + +I
Sbjct: 208 TVWELMTFGSKPYDGIPA---SEISS----ILEKG--ERLPQP-------PICTIDVYMI 251
Query: 255 ALRCTDSNPENRPTMTDVVDWL 276
+C + ++RP +++
Sbjct: 252 MRKCWMIDADSRPKFRELIIEF 273
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-23
Identities = 63/259 (24%), Positives = 106/259 (40%), Gaps = 49/259 (18%)
Query: 39 GDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHS 98
D++A+K ++ A +E +F E E++ ++ H L+ L G +V ++M +
Sbjct: 31 NKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC 89
Query: 99 LITHLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEA 145
L +L G A + LL + + EG+A D+ A N L+ +
Sbjct: 90 LSDYLRTQRGLFAAETLLG------MCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVI 143
Query: 146 KVADFGFAKLIPDGV--THMTTR--VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELI 201
KV+DFG + + D + T+ VK +PE + + S DV+SFGVL+ E+
Sbjct: 144 KVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVFSFSRYSSKSDVWSFGVLMWEVF 199
Query: 202 S-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQL--KSMVLIALRC 258
S K P E V + G RL + +L + I C
Sbjct: 200 SEGKIPYENRSN-------SEVVEDISTGF-------RLY----KPRLASTHVYQIMNHC 241
Query: 259 TDSNPENRPTMTDVVDWLK 277
PE+RP + ++ L
Sbjct: 242 WRERPEDRPAFSRLLRQLA 260
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-23
Identities = 64/265 (24%), Positives = 104/265 (39%), Gaps = 49/265 (18%)
Query: 42 QIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRG--FYAGGDERLIVYDYMPNHS 98
+AVK LK + + E++IL + H +++ +G AG +V +Y+P S
Sbjct: 62 MVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGS 121
Query: 99 LITHLHG-RLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKV 147
L +L + LL + +++ EG+A D+ A NVLLD D K+
Sbjct: 122 LRDYLPRHSIGLAQLLLFAQQI------CEGMAYLHAQHYIHRDLAARNVLLDNDRLVKI 175
Query: 148 ADFGFAKLIPDGVTHMTTRVKGTL--GYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKK 205
DFG AK +P+G + R G + APE K + DV+SFGV L EL++
Sbjct: 176 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCD 235
Query: 206 PLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKS-------------MV 252
+ P I Q + L+ +
Sbjct: 236 SSQSPPTKFLELI---GIAQGQMTVLRLT-----------ELLERGERLPRPDKCPAEVY 281
Query: 253 LIALRCTDSNPENRPTMTDVVDWLK 277
+ C ++ RPT +++ LK
Sbjct: 282 HLMKNCWETEASFRPTFENLIPILK 306
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-23
Identities = 53/262 (20%), Positives = 104/262 (39%), Gaps = 40/262 (15%)
Query: 33 LLRRETGDDQIAVKRLKT-LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91
+ R +A+K LK E E +I+ ++ + ++ L G + ++V
Sbjct: 30 VYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV-CQAEALMLVM 88
Query: 92 DYMPNHSLITHL---HGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVL 138
+ L L + + + +V + G+ D+ A NVL
Sbjct: 89 EMAGGGPLHKFLVGKREEIPVSNVAELLHQV------SMGMKYLEEKNFVHRDLAARNVL 142
Query: 139 LDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTL--GYLAPEYAMWGKVSDSCDVYSFGVL 196
L AK++DFG +K + ++ T R G + APE + K S DV+S+GV
Sbjct: 143 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVT 202
Query: 197 LLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIA 255
+ E +S +KP +K+ G +++ ++++G + + P + + +
Sbjct: 203 MWEALSYGQKPYKKMKG---PEVMA----FIEQG--KRMECP-------PECPPELYALM 246
Query: 256 LRCTDSNPENRPTMTDVVDWLK 277
C E+RP V ++
Sbjct: 247 SDCWIYKWEDRPDFLTVEQRMR 268
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-23
Identities = 54/264 (20%), Positives = 103/264 (39%), Gaps = 51/264 (19%)
Query: 44 AVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRG--FYAGGDERLIVYDYMPNHSLI 100
AVK LK + E+EIL + H N++ +G GG+ ++ +++P+ SL
Sbjct: 54 AVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLK 113
Query: 101 THLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKV 147
+L ++ L + A+ +G+ D+ A NVL++++ + K+
Sbjct: 114 EYLPKNKNKINLKQQLKY------AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKI 167
Query: 148 ADFGFAKLIPDGVTHMTTRVKGTL--GYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKK 205
DFG K I + T + + APE M K + DV+SFGV L EL++
Sbjct: 168 GDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYC- 226
Query: 206 PLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKS-------------MV 252
+ + + + Q + + LK +
Sbjct: 227 --DSDSSPMALFLKMIGPTHGQMTVTRLV-----------NTLKEGKRLPCPPNCPDEVY 273
Query: 253 LIALRCTDSNPENRPTMTDVVDWL 276
+ +C + P NR + ++++
Sbjct: 274 QLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 6e-23
Identities = 52/262 (19%), Positives = 103/262 (39%), Gaps = 40/262 (15%)
Query: 33 LLRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91
+ R +A+K LK E E +I+ ++ + ++ L G + ++V
Sbjct: 356 VYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV-CQAEALMLVM 414
Query: 92 DYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVL 138
+ L L + + + +V + G+ ++ A NVL
Sbjct: 415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQV------SMGMKYLEEKNFVHRNLAARNVL 468
Query: 139 LDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGY--LAPEYAMWGKVSDSCDVYSFGVL 196
L AK++DFG +K + ++ T R G APE + K S DV+S+GV
Sbjct: 469 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVT 528
Query: 197 LLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIA 255
+ E +S +KP +K+ G +++ ++++G + + P + + +
Sbjct: 529 MWEALSYGQKPYKKMKG---PEVMA----FIEQG--KRMECP-------PECPPELYALM 572
Query: 256 LRCTDSNPENRPTMTDVVDWLK 277
C E+RP V ++
Sbjct: 573 SDCWIYKWEDRPDFLTVEQRMR 594
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 7e-23
Identities = 57/256 (22%), Positives = 99/256 (38%), Gaps = 45/256 (17%)
Query: 39 GDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHS 98
G +A+K +K + +E EF E +++ + H L+ L G I+ +YM N
Sbjct: 47 GQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 105
Query: 99 LITHLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEA 145
L+ +L R LL+ + E + D+ A N L++
Sbjct: 106 LLNYLREMRHRFQTQQLLE------MCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVV 159
Query: 146 KVADFGFAKLIPDGVTHMTTRVKGTLGY--LAPEYAMWGKVSDSCDVYSFGVLLLELIS- 202
KV+DFG ++ + D T+ V PE M+ K S D+++FGVL+ E+ S
Sbjct: 160 KVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL 217
Query: 203 AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQL--KSMVLIALRCTD 260
K P E+ ++ +G + R L + + I C
Sbjct: 218 GKMPYERFTN-------SETAEHIAQG-----------LRLYRPHLASEKVYTIMYSCWH 259
Query: 261 SNPENRPTMTDVVDWL 276
+ RPT ++ +
Sbjct: 260 EKADERPTFKILLSNI 275
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 9e-23
Identities = 62/305 (20%), Positives = 124/305 (40%), Gaps = 40/305 (13%)
Query: 31 LLLLRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89
+ + E+ + +K ++ ++ + +G + H +++ L G G +
Sbjct: 33 VWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGL-CPGSSLQL 91
Query: 90 VYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASN 136
V Y+P SL+ H+ G L P LL+W + A+G+ ++ A N
Sbjct: 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYYLEEHGMVHRNLAARN 145
Query: 137 VLLDTDFEAKVADFGFAKLIP-DGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGV 195
VLL + + +VADFG A L+P D + + K + ++A E +GK + DV+S+GV
Sbjct: 146 VLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGV 205
Query: 196 LLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLI 254
+ EL++ +P L ++ ++KG E +A P + + ++
Sbjct: 206 TVWELMTFGAEPYAGLRL---AEVPD----LLEKG--ERLAQP-------QICTIDVYMV 249
Query: 255 ALRCTDSNPENRPTMTDVVDWLKGGLGRRTKDVKDVAGEDDEDNDDNDTDFEERYFKMEQ 314
++C + RPT ++ + + R + E K+E+
Sbjct: 250 MVKCWMIDENIRPTFKELANEFT-RMARDPPRYLVIKRESGPGIAPGPEPHGLTNKKLEE 308
Query: 315 SNIRR 319
+
Sbjct: 309 VELEP 313
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 9e-23
Identities = 58/251 (23%), Positives = 105/251 (41%), Gaps = 35/251 (13%)
Query: 39 GDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHS 98
++AVK +K + + F E ++ ++H L+ L + I+ ++M S
Sbjct: 211 KHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGS 268
Query: 99 LITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVA 148
L+ L + + + AEG+A D++A+N+L+ K+A
Sbjct: 269 LLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIA 326
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGY--LAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKK 205
DFG A++I D T R APE +G + DV+SFG+LL+E+++ +
Sbjct: 327 DFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI 384
Query: 206 PLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPEN 265
P + V +++G + P ++L + I +RC + PE
Sbjct: 385 PYPGMSN-------PEVIRALERG--YRMPRPEN----CPEELYN---IMMRCWKNRPEE 428
Query: 266 RPTMTDVVDWL 276
RPT + L
Sbjct: 429 RPTFEYIQSVL 439
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 62/262 (23%), Positives = 108/262 (41%), Gaps = 39/262 (14%)
Query: 32 LLLRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90
L + +A+K LK K +F E I+G+ H N++ L G +IV
Sbjct: 65 RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 91 YDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNV 137
+YM N SL + L + L+ G A G+ D+ A N+
Sbjct: 125 TEYMENGSLDSFLRKHDAQFTVIQLVGM------LRGIASGMKYLSDMGYVHRDLAARNI 178
Query: 138 LLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL--APEYAMWGKVSDSCDVYSFGV 195
L++++ KV+DFG +++ D T G + +PE + K + + DV+S+G+
Sbjct: 179 LINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238
Query: 196 LLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLI 254
+L E++S ++P ++ Q V V +G + P D ++ +
Sbjct: 239 VLWEVMSYGERPYWEMSN-------QDVIKAVDEG--YRLPPP-------MDCPAALYQL 282
Query: 255 ALRCTDSNPENRPTMTDVVDWL 276
L C + NRP +V L
Sbjct: 283 MLDCWQKDRNNRPKFEQIVSIL 304
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-22
Identities = 67/259 (25%), Positives = 105/259 (40%), Gaps = 49/259 (18%)
Query: 39 GDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHS 98
G +AVK +K + +E EF E + + ++ H L+ G + IV +Y+ N
Sbjct: 31 GQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGC 89
Query: 99 LITHLHGR---LAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEA 145
L+ +L L P LL+ + EG+A D+ A N L+D D
Sbjct: 90 LLNYLRSHGKGLEPSQLLE------MCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCV 143
Query: 146 KVADFGFAKLIPDGVTHMTTR----VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELI 201
KV+DFG + + D + VK + APE + K S DV++FG+L+ E+
Sbjct: 144 KVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFHYFKYSSKSDVWAFGILMWEVF 199
Query: 202 S-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQL--KSMVLIALRC 258
S K P + V V +G RL R L ++ I C
Sbjct: 200 SLGKMPYDLYTN-------SEVVLKVSQGH-------RL----YRPHLASDTIYQIMYSC 241
Query: 259 TDSNPENRPTMTDVVDWLK 277
PE RPT ++ ++
Sbjct: 242 WHELPEKRPTFQQLLSSIE 260
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-22
Identities = 64/260 (24%), Positives = 103/260 (39%), Gaps = 53/260 (20%)
Query: 42 QIAVKRLK---TLNAKAEMEFAVEVEILGRVRHRNLLGLRG------FYAGGDERLIVYD 92
+AVK LK +A +F EV + + HRNL+ L G +V +
Sbjct: 48 SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-------MVTE 100
Query: 93 YMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLL 139
P SL+ L G L + A+ AEG+ D+ A N+LL
Sbjct: 101 LAPLGSLLDRLRKHQGHFLLGTLSRY------AVQVAEGMGYLESKRFIHRDLAARNLLL 154
Query: 140 DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGY--LAPEYAMWGKVSDSCDVYSFGVLL 197
T K+ DFG + +P H + + + APE S + D + FGV L
Sbjct: 155 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 214
Query: 198 LELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIAL 256
E+ + ++P L G I+ + ++G E + P D + + + +
Sbjct: 215 WEMFTYGQEPWIGLNG---SQILHKID---KEG--ERLPRP-------EDCPQDIYNVMV 259
Query: 257 RCTDSNPENRPTMTDVVDWL 276
+C PE+RPT + D+L
Sbjct: 260 QCWAHKPEDRPTFVALRDFL 279
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-22
Identities = 65/262 (24%), Positives = 110/262 (41%), Gaps = 39/262 (14%)
Query: 32 LLLRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90
L D +A+K LK + +F E I+G+ H N++ L G G +IV
Sbjct: 69 RLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128
Query: 91 YDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNV 137
+YM N SL T L G+ L+ G G+ D+ A NV
Sbjct: 129 TEYMENGSLDTFLRTHDGQFTIMQLVGM------LRGVGAGMRYLSDLGYVHRDLAARNV 182
Query: 138 LLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL--APEYAMWGKVSDSCDVYSFGV 195
L+D++ KV+DFG ++++ D T G + APE + S + DV+SFGV
Sbjct: 183 LVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGV 242
Query: 196 LLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLI 254
++ E+++ ++P + RD++ V++G + P ++ +
Sbjct: 243 VMWEVLAYGERPYWNMTN---RDVIS----SVEEG--YRLPAP-------MGCPHALHQL 286
Query: 255 ALRCTDSNPENRPTMTDVVDWL 276
L C + RP + +V L
Sbjct: 287 MLDCWHKDRAQRPRFSQIVSVL 308
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-22
Identities = 49/260 (18%), Positives = 104/260 (40%), Gaps = 38/260 (14%)
Query: 32 LLLRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90
+ + E +A+K K + +F E + + H +++ L G + I+
Sbjct: 35 IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWII 93
Query: 91 YDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNV 137
+ L + L L L+ + A + +A DI A NV
Sbjct: 94 MELCTLGELRSFLQVRKYSLDLASLILY------AYQLSTALAYLESKRFVHRDIAARNV 147
Query: 138 LLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLL 197
L+ ++ K+ DFG ++ + D + ++ K + ++APE + + + + DV+ FGV +
Sbjct: 148 LVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 207
Query: 198 LELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIAL 256
E++ KP + + D++ ++ G E + P + ++ +
Sbjct: 208 WEILMHGVKPFQGVKN---NDVIG----RIENG--ERLPMP-------PNCPPTLYSLMT 251
Query: 257 RCTDSNPENRPTMTDVVDWL 276
+C +P RP T++ L
Sbjct: 252 KCWAYDPSRRPRFTELKAQL 271
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 8e-22
Identities = 55/262 (20%), Positives = 106/262 (40%), Gaps = 39/262 (14%)
Query: 31 LLLLRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89
L + E +A+K L+ + KA E E ++ V + ++ L G +
Sbjct: 35 LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI-CLTSTVQL 93
Query: 90 VYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASN 136
+ MP L+ ++ + LL+W + A+G+ D+ A N
Sbjct: 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDRRLVHRDLAARN 147
Query: 137 VLLDTDFEAKVADFGFAKLIPDG-VTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGV 195
VL+ T K+ DFG AKL+ + K + ++A E + + DV+S+GV
Sbjct: 148 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 207
Query: 196 LLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLI 254
+ EL++ KP + +P +I ++KG E + P + +I
Sbjct: 208 TVWELMTFGSKPYDGIPA---SEISS----ILEKG--ERLPQP-------PICTIDVYMI 251
Query: 255 ALRCTDSNPENRPTMTDVVDWL 276
++C + ++RP +++
Sbjct: 252 MVKCWMIDADSRPKFRELIIEF 273
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 8e-22
Identities = 49/261 (18%), Positives = 104/261 (39%), Gaps = 38/261 (14%)
Query: 32 LLLRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90
+ + E +A+K K + +F E + + H +++ L G + I+
Sbjct: 410 IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWII 468
Query: 91 YDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNV 137
+ L + L L L+ + A + +A DI A NV
Sbjct: 469 MELCTLGELRSFLQVRKFSLDLASLILY------AYQLSTALAYLESKRFVHRDIAARNV 522
Query: 138 LLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLL 197
L+ ++ K+ DFG ++ + D + ++ K + ++APE + + + + DV+ FGV +
Sbjct: 523 LVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 582
Query: 198 LELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIAL 256
E++ KP + + D++ ++ G E + P + ++ +
Sbjct: 583 WEILMHGVKPFQGVKN---NDVIG----RIENG--ERLPMP-------PNCPPTLYSLMT 626
Query: 257 RCTDSNPENRPTMTDVVDWLK 277
+C +P RP T++ L
Sbjct: 627 KCWAYDPSRRPRFTELKAQLS 647
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 9e-22
Identities = 51/251 (20%), Positives = 104/251 (41%), Gaps = 38/251 (15%)
Query: 42 QIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
+AVK K + +F E I+ + H +++ L G + I+ + P L
Sbjct: 42 NVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELG 100
Query: 101 THLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKV 147
+L L L+ + ++ + +A DI N+L+ + K+
Sbjct: 101 HYLERNKNSLKVLTLVLY------SLQICKAMAYLESINCVHRDIAVRNILVASPECVKL 154
Query: 148 ADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKP 206
DFG ++ I D + + + + +++PE + + + + DV+ F V + E++S K+P
Sbjct: 155 GDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
Query: 207 LEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENR 266
L +D++ ++KG + + P + + RC D +P +R
Sbjct: 215 FFWLEN---KDVIG----VLEKG--DRLPKP-------DLCPPVLYTLMTRCWDYDPSDR 258
Query: 267 PTMTDVVDWLK 277
P T++V L
Sbjct: 259 PRFTELVCSLS 269
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-21
Identities = 55/250 (22%), Positives = 97/250 (38%), Gaps = 42/250 (16%)
Query: 44 AVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHL 103
AVK LK + EF E ++ ++H NL+ L G I+ ++M +L+ +L
Sbjct: 42 AVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 100
Query: 104 HGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVADFGFA 153
R + + +A + + D+ A N L+ + KVADFG +
Sbjct: 101 --RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 158
Query: 154 KLIPDGVTHMTTR----VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLE 208
+L+ +K T APE + K S DV++FGVLL E+ + P
Sbjct: 159 RLMTGDTYTAHAGAKFPIKWT----APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 214
Query: 209 KLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVL--IALRCTDSNPENR 266
+ + V ++K R++ R + + + C NP +R
Sbjct: 215 GID-------LSQVYELLEKDY-------RME----RPEGCPEKVYELMRACWQWNPSDR 256
Query: 267 PTMTDVVDWL 276
P+ ++
Sbjct: 257 PSFAEIHQAF 266
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-21
Identities = 60/264 (22%), Positives = 103/264 (39%), Gaps = 55/264 (20%)
Query: 33 LLRRETGDDQIAVK--RLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90
L++ Q +K + +++K E EV +L ++H N++ R + IV
Sbjct: 42 LVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101
Query: 91 YDYMPN---HSLITHLHGRLAP-DCLLDW-----------------HRRVSIAIGSAEGI 129
DY I G L D +LDW HR
Sbjct: 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHR------------ 149
Query: 130 ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCD 189
DIK+ N+ L D ++ DFG A+++ V + GT YL+PE ++ D
Sbjct: 150 -DIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNNKSD 207
Query: 190 VYSFGVLLLELISAKKPLEKL-PGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQL 248
+++ G +L EL + K E + I+ G+F P + ++ D L
Sbjct: 208 IWALGCVLYELCTLKHAFEAGSMKNLVLKII--------SGSF-----PPVSLHYSYD-L 253
Query: 249 KSMVLIALRCTDSNPENRPTMTDV 272
+S+V + NP +RP++ +
Sbjct: 254 RSLVSQLFKR---NPRDRPSVNSI 274
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-21
Identities = 47/259 (18%), Positives = 95/259 (36%), Gaps = 52/259 (20%)
Query: 42 QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
++ +K L + F ++ ++ H++L+ G GDE ++V +++ SL T
Sbjct: 42 EVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDT 101
Query: 102 HLH---GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFE---- 144
+L + L+ A A + ++ A N+LL + +
Sbjct: 102 YLKKNKNCINILWKLEV------AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTG 155
Query: 145 ----AKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKV-SDSCDVYSFGVLLLE 199
K++D G + + + R+ PE K + + D +SFG L E
Sbjct: 156 NPPFIKLSDPGISITVLPK-DILQERIPWV----PPECIENPKNLNLATDKWSFGTTLWE 210
Query: 200 LIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRC 258
+ S KPL L + +Q + + +L + + + C
Sbjct: 211 ICSGGDKPLSALDS---QRKLQ----FYEDRH-------QLP----APKAAELANLINNC 252
Query: 259 TDSNPENRPTMTDVVDWLK 277
D P++RP+ ++ L
Sbjct: 253 MDYEPDHRPSFRAIIRDLN 271
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 6e-21
Identities = 64/253 (25%), Positives = 111/253 (43%), Gaps = 39/253 (15%)
Query: 39 GDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHS 98
G ++AVK LK + + F E ++ +++H+ L+ L + I+ +YM N S
Sbjct: 36 GHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAV-VTQEPIYIITEYMENGS 93
Query: 99 LITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVA 148
L+ L + L ++ + +A AEG+A D++A+N+L+ K+A
Sbjct: 94 LVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIA 151
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGY--LAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKK 205
DFG A+LI D T R APE +G + DV+SFG+LL E+++ +
Sbjct: 152 DFGLARLIED--NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209
Query: 206 PLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVL--IALRCTDSNP 263
P + +++Q +++G R+ R L + C P
Sbjct: 210 PYPGMTN---PEVIQ----NLERGY-------RM----VRPDNCPEELYQLMRLCWKERP 251
Query: 264 ENRPTMTDVVDWL 276
E+RPT + L
Sbjct: 252 EDRPTFDYLRSVL 264
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-21
Identities = 60/295 (20%), Positives = 121/295 (41%), Gaps = 45/295 (15%)
Query: 34 LRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
+ ++ + ++A+K + + + +EF E ++ +++ L G + G L++ +
Sbjct: 49 VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 108
Query: 93 YMPNHSLITHLHGRLAPDCLLDWHRR------VSIAIGSAEGIA----------DIKASN 136
M L ++L + +A A+G+A D+ A N
Sbjct: 109 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 168
Query: 137 VLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL-----APEYAMWGKVSDSCDVY 191
++ DF K+ DFG + I + + KG G L +PE G + DV+
Sbjct: 169 CMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLPVRWMSPESLKDGVFTTYSDVW 224
Query: 192 SFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN-RDQLK 249
SFGV+L E+ + A++P + L + V +V +G L N D L
Sbjct: 225 SFGVVLWEIATLAEQPYQGLS-------NEQVLRFVMEGG-------LLDKPDNCPDMLF 270
Query: 250 SMVLIALRCTDSNPENRPTMTDVVDWLKGGLGRRTKDVKDVAGEDDEDNDDNDTD 304
++ C NP+ RP+ +++ +K + ++V E+++ + + D
Sbjct: 271 ELM---RMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENKLPEPEELD 322
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-20
Identities = 61/268 (22%), Positives = 103/268 (38%), Gaps = 45/268 (16%)
Query: 34 LRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
+ + Q+AVK L + + E++F +E I+ + H+N++ G R I+ +
Sbjct: 54 MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILME 113
Query: 93 YMPNHSLITHLHGR---LAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLL 139
M L + L + L + +A A G DI A N LL
Sbjct: 114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 173
Query: 140 DTDFE---AKVADFGFAKLIPDGVTHMTTRVKGTLGYL-----APEYAMWGKVSDSCDVY 191
AK+ DFG A+ I + KG L PE M G + D +
Sbjct: 174 TCPGPGRVAKIGDFGMARDIYRA----SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 229
Query: 192 SFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN-RDQLK 249
SFGVLL E+ S P P +++++ +V G R+ N +
Sbjct: 230 SFGVLLWEIFSLGYMP---YPSKSNQEVLE----FVTSGG-------RMDPPKNCPGPVY 275
Query: 250 SMVLIALRCTDSNPENRPTMTDVVDWLK 277
++ +C PE+RP +++ ++
Sbjct: 276 RIM---TQCWQHQPEDRPNFAIILERIE 300
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-20
Identities = 55/254 (21%), Positives = 101/254 (39%), Gaps = 46/254 (18%)
Query: 36 RETGDDQIAVK--RLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG---GDERLIV 90
ET + +A + + L F E E+L ++H N++ + G + +++
Sbjct: 48 TETTVE-VAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106
Query: 91 Y-DYMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSAEGIA------------DIKAS 135
+ M + +L T+L + L W R++ +G+ D+K
Sbjct: 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI------LKGLQFLHTRTPPIIHRDLKCD 160
Query: 136 NVLLDT-DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFG 194
N+ + K+ D G A L V GT ++APE K +S DVY+FG
Sbjct: 161 NIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFG 216
Query: 195 VLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLI 254
+ +LE+ +++ P + I + VT V+ +F+ +A P +K I
Sbjct: 217 MCMLEMATSEYPYSECQNA--AQIYRRVTSGVKPASFDKVAIPEVKE------------I 262
Query: 255 ALRCTDSNPENRPT 268
C N + R +
Sbjct: 263 IEGCIRQNKDERYS 276
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 59/265 (22%), Positives = 100/265 (37%), Gaps = 41/265 (15%)
Query: 32 LLLRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER-LI 89
+ + Q A+K L + F E ++ + H N+L L G + +
Sbjct: 41 EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100
Query: 90 VYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLL 139
+ YM + L+ + +P +S + A G+ D+ A N +L
Sbjct: 101 LLPYMCHGDLLQFIR---SPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML 157
Query: 140 DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL-----APEYAMWGKVSDSCDVYSFG 194
D F KVADFG A+ I D + + L A E + + DV+SFG
Sbjct: 158 DESFTVKVADFGLARDILD--REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFG 215
Query: 195 VLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN-RDQLKSMV 252
VLL EL++ P D+ ++ +G RL D L ++
Sbjct: 216 VLLWELLTRGAPP---YRHIDPFDLTH----FLAQGR-------RLPQPEYCPDSLYQVM 261
Query: 253 LIALRCTDSNPENRPTMTDVVDWLK 277
+C +++P RPT +V ++
Sbjct: 262 ---QQCWEADPAVRPTFRVLVGEVE 283
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-20
Identities = 60/276 (21%), Positives = 114/276 (41%), Gaps = 40/276 (14%)
Query: 33 LLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL--IV 90
+ + + +KR F EV ++ H+N++ + ++ +V
Sbjct: 43 AIFIPPREKEETLKR-----------FEREVHNSSQLSHQNIVSM--IDVDEEDDCYYLV 89
Query: 91 YDYMPNHSL--ITHLHGRLAPDCLLDWHRRVSIAIGSA--EGIA--DIKASNVLLDTDFE 144
+Y+ +L HG L+ D +++ ++ I A I DIK N+L+D++
Sbjct: 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT 149
Query: 145 AKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAK 204
K+ DFG AK + + T V GT+ Y +PE A + D+YS G++L E++ +
Sbjct: 150 LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209
Query: 205 KPLE-KLPGGVKRDIVQWVTPYVQKGAFEHIAD--PRLKGKFNRDQLKSMVLIALRCTDS 261
P + + A +HI D P + +D +S+ + LR T+
Sbjct: 210 PPFNGETAVSI---------------AIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEK 254
Query: 262 NPENRP-TMTDVVDWLKGGLGRRTKDVKDVAGEDDE 296
+ NR T+ ++ D L L + + +
Sbjct: 255 DKANRYKTIQEMKDDLSSVLHENRANEDVYELDKMK 290
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 63/287 (21%), Positives = 109/287 (37%), Gaps = 50/287 (17%)
Query: 34 LRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93
L E +AVK LK + A +F E E+L ++H++++ G G L+V++Y
Sbjct: 65 LLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 124
Query: 94 MPNHSLITHL-----------HGRLAPDCLLDWHRRVSIAIGSAEGIA----------DI 132
M + L L G L + +++A A G+ D+
Sbjct: 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDL 184
Query: 133 KASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL-----APEYAMWGKVSDS 187
N L+ K+ DFG ++ I R G L PE ++ K +
Sbjct: 185 ATRNCLVGQGLVVKIGDFGMSRDIYSTD---YYR-VGGRTMLPIRWMPPESILYRKFTTE 240
Query: 188 CDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN-R 245
DV+SFGV+L E+ + K+P +L + +G L+
Sbjct: 241 SDVWSFGVVLWEIFTYGKQPWYQLS-------NTEAIDCITQGR-------ELERPRACP 286
Query: 246 DQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGRRTKDVKDVAG 292
++ +++ C P+ R ++ DV L+ L + DV G
Sbjct: 287 PEVYAIM---RGCWQREPQQRHSIKDVHARLQ-ALAQAPPVYLDVLG 329
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-20
Identities = 58/274 (21%), Positives = 100/274 (36%), Gaps = 52/274 (18%)
Query: 34 LRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93
L +AVK LK A +F E E+L ++H +++ G GD ++V++Y
Sbjct: 39 LSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEY 98
Query: 94 MPNHSLITHLHGR------------LAPDCLLDWHRRVSIAIGSAEGIA----------D 131
M + L L L + + IA A G+ D
Sbjct: 99 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRD 158
Query: 132 IKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL-----APEYAMWGKVSD 186
+ N L+ + K+ DFG ++ + + G L PE M+ K +
Sbjct: 159 LATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RVGGHTMLPIRWMPPESIMYRKFTT 214
Query: 187 SCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNR 245
DV+SFGV+L E+ + K+P +L V + +G L R
Sbjct: 215 ESDVWSFGVILWEIFTYGKQPWFQLS-------NTEVIECITQGR-------VL----ER 256
Query: 246 DQLKSMVL--IALRCTDSNPENRPTMTDVVDWLK 277
++ + + L C P+ R + ++ L
Sbjct: 257 PRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILH 290
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-20
Identities = 61/268 (22%), Positives = 102/268 (38%), Gaps = 45/268 (16%)
Query: 34 LRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
+ + Q+AVK L + + E++F +E I+ + H+N++ G R I+ +
Sbjct: 95 MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLE 154
Query: 93 YMPNHSLITHLHGR---LAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLL 139
M L + L + L + +A A G DI A N LL
Sbjct: 155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 214
Query: 140 DTDFE---AKVADFGFAKLIPDGVTHMTTRVKGTLGYL-----APEYAMWGKVSDSCDVY 191
AK+ DFG A+ I KG L PE M G + D +
Sbjct: 215 TCPGPGRVAKIGDFGMARDIYRA----GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 270
Query: 192 SFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN-RDQLK 249
SFGVLL E+ S P P +++++ +V G R+ N +
Sbjct: 271 SFGVLLWEIFSLGYMP---YPSKSNQEVLE----FVTSGG-------RMDPPKNCPGPVY 316
Query: 250 SMVLIALRCTDSNPENRPTMTDVVDWLK 277
++ +C PE+RP +++ ++
Sbjct: 317 RIM---TQCWQHQPEDRPNFAIILERIE 341
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 8e-20
Identities = 43/269 (15%), Positives = 85/269 (31%), Gaps = 47/269 (17%)
Query: 33 LLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFY----AGGDERL 88
L+ A+KR+ + E E ++ H N+L L + E
Sbjct: 47 LVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106
Query: 89 IVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVL 138
++ + +L + L + + + +G G+ D+K +N+L
Sbjct: 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNIL 166
Query: 139 LDTDFEAKVADFGFAKLIPDGVTHMTTRVK--------GTLGYLAPEYAMW-----GKVS 185
L + + + D G V + T+ Y APE ++ +
Sbjct: 167 LGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE--LFSVQSHCVID 224
Query: 186 DSCDVYSFGVLLLELISAKKPLE--KLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243
+ DV+S G +L ++ + P + G VQ PR
Sbjct: 225 ERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ--------NQLSIPQSPRHS--- 273
Query: 244 NRDQLKSMVLIALRCTDSNPENRPTMTDV 272
L ++ + +P RP + +
Sbjct: 274 --SALWQLLNSMMT---VDPHQRPHIPLL 297
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 89.0 bits (220), Expect = 1e-19
Identities = 67/264 (25%), Positives = 108/264 (40%), Gaps = 36/264 (13%)
Query: 36 RETGDDQIAVKRL-KTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFY------AGGDERL 88
++TG+ Q+A+K+ + L+ K + +E++I+ ++ H N++ R A D L
Sbjct: 36 QDTGE-QVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL 94
Query: 89 IVYDYMPNHSLITHLHGRLAPDCLLDWH-RRVSIAIGSA------EGIA--DIKASNVLL 139
+ +Y L +L+ L + R + I SA I D+K N++L
Sbjct: 95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVL 154
Query: 140 DTDFEA---KVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVL 196
+ K+ D G+AK + G T V GTL YLAPE K + + D +SFG L
Sbjct: 155 QPGPQRLIHKIIDLGYAKELDQG-ELCTEFV-GTLQYLAPELLEQKKYTVTVDYWSFGTL 212
Query: 197 LLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIAL 256
E I+ P VQW V++ + EHI D L V +
Sbjct: 213 AFECITG-----FRPFLPNWQPVQWHG-KVREKSNEHIVV--------YDDLTGAVKFSS 258
Query: 257 RCTDSNPENRPTMTDVVDWLKGGL 280
N + + WL+ L
Sbjct: 259 VLPTPNHLSGILAGKLERWLQCML 282
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 47/254 (18%), Positives = 98/254 (38%), Gaps = 28/254 (11%)
Query: 32 LLLRRETGDDQIAVK--RLKTLNAKAEMEFAV-EVEILGRVRHRNLLGLRGFYAGGDERL 88
G +A+K ++ L + E+++L ++ H N++ + +E
Sbjct: 50 RAACLLDGV-PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108
Query: 89 IVYDYMPNHSLITHL-----HGRLAP-DCLLDWHRRVSIAIGS--AEGIA--DIKASNVL 138
IV + L + RL P + + ++ A+ + + DIK +NV
Sbjct: 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVF 168
Query: 139 LDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLL 198
+ K+ D G + T + + GT Y++PE + D++S G LL
Sbjct: 169 ITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIHENGYNFKSDIWSLGCLLY 227
Query: 199 ELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRC 258
E+ + + P + + +++ + P ++ + L+ +V C
Sbjct: 228 EMAALQSPFYGDKMNLYS-----LCKKIEQCDY----PPLPSDHYSEE-LRQLV---NMC 274
Query: 259 TDSNPENRPTMTDV 272
+ +PE RP +T V
Sbjct: 275 INPDPEKRPDVTYV 288
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 58/261 (22%), Positives = 100/261 (38%), Gaps = 47/261 (18%)
Query: 42 QIAVKRLKTLNA--KAEMEFAVEVEILGRVRHRN---LLG--LRGFYAGGDERLIVYDYM 94
++AVK +K N+ + EF E + H N LLG + G + +++ +M
Sbjct: 64 KVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFM 123
Query: 95 PNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTD 142
L T+L + + + A G+ D+ A N +L D
Sbjct: 124 KYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD 183
Query: 143 FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL-----APEYAMWGKVSDSCDVYSFGVLL 197
VADFG +K I G + +G + + A E + DV++FGV +
Sbjct: 184 MTVCVADFGLSKKIYSGDYY----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTM 239
Query: 198 LELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN-RDQLKSMVLIA 255
E+ + P PG ++ Y+ G RLK + D+L ++
Sbjct: 240 WEIATRGMTP---YPGVQNHEMYD----YLLHGH-------RLKQPEDCLDELYEIM--- 282
Query: 256 LRCTDSNPENRPTMTDVVDWL 276
C ++P +RPT + + L
Sbjct: 283 YSCWRTDPLDRPTFSVLRLQL 303
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 67/266 (25%), Positives = 99/266 (37%), Gaps = 43/266 (16%)
Query: 32 LLLRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGF-YAGGDERLI 89
LL + AVK L + +F E I+ H N+L L G L+
Sbjct: 45 TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104
Query: 90 VYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLL 139
V YM + L + + D + + A+G+ D+ A N +L
Sbjct: 105 VLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKYLASKKFVHRDLAARNCML 161
Query: 140 DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL------APEYAMWGKVSDSCDVYSF 193
D F KVADFG A+ + D + V G A E K + DV+SF
Sbjct: 162 DEKFTVKVADFGLARDMYDKEYY---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 218
Query: 194 GVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN-RDQLKSM 251
GVLL EL++ P P DI Y+ +G RL D L +
Sbjct: 219 GVLLWELMTRGAPP---YPDVNTFDITV----YLLQGR-------RLLQPEYCPDPLYEV 264
Query: 252 VLIALRCTDSNPENRPTMTDVVDWLK 277
+ L+C E RP+ +++V +
Sbjct: 265 M---LKCWHPKAEMRPSFSELVSRIS 287
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 70/248 (28%), Positives = 107/248 (43%), Gaps = 40/248 (16%)
Query: 44 AVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL-IVYDYMPNHSLITH 102
AVK +K +A A+ F E ++ ++RH NL+ L G L IV +YM SL+ +
Sbjct: 220 AVKCIKN-DATAQ-AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY 277
Query: 103 LHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVADFGF 152
L R +L + ++ E + D+ A NVL+ D AKV+DFG
Sbjct: 278 LRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 335
Query: 153 AKLIPDGVTHMTTR--VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEK 209
K T T + VK T APE K S DV+SFG+LL E+ S + P +
Sbjct: 336 TKEASS--TQDTGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 389
Query: 210 LPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTM 269
+P ++ V P V+KG + P ++ + C + RPT
Sbjct: 390 IP-------LKDVVPRVEKG--YKMDAP-------DGCPPAVYDVMKNCWHLDAATRPTF 433
Query: 270 TDVVDWLK 277
+ + L+
Sbjct: 434 LQLREQLE 441
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 67/265 (25%), Positives = 98/265 (36%), Gaps = 41/265 (15%)
Query: 32 LLLRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGF-YAGGDERLI 89
LL + AVK L + +F E I+ H N+L L G L+
Sbjct: 109 TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168
Query: 90 VYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLL 139
V YM + L + + D + + A+G+ D+ A N +L
Sbjct: 169 VLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKFLASKKFVHRDLAARNCML 225
Query: 140 DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL-----APEYAMWGKVSDSCDVYSFG 194
D F KVADFG A+ + D T L A E K + DV+SFG
Sbjct: 226 DEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWMALESLQTQKFTTKSDVWSFG 283
Query: 195 VLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN-RDQLKSMV 252
VLL EL++ P P DI Y+ +G RL D L ++
Sbjct: 284 VLLWELMTRGAPP---YPDVNTFDITV----YLLQGR-------RLLQPEYCPDPLYEVM 329
Query: 253 LIALRCTDSNPENRPTMTDVVDWLK 277
L+C E RP+ +++V +
Sbjct: 330 ---LKCWHPKAEMRPSFSELVSRIS 351
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-19
Identities = 51/259 (19%), Positives = 108/259 (41%), Gaps = 36/259 (13%)
Query: 33 LLRRETGDDQIAVK--RLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRG-FYAGGDERL- 88
+RR++ + K ++ + EV +L ++H N++ + L
Sbjct: 24 KIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83
Query: 89 IVYDYMPN---HSLITHL---HGRLAPDCLLDWHRRVSIAI-------GSAEGIA--DIK 133
IV +Y S+IT L + +L ++++A+ + D+K
Sbjct: 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 134 ASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSF 193
+NV LD K+ DFG A+++ + T V GT Y++PE ++ D++S
Sbjct: 144 PANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRMSYNEKSDIWSL 202
Query: 194 GVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVL 253
G LL EL + P ++++ +++G F R+ +++ + L ++
Sbjct: 203 GCLLYELCALMPPFT---AFSQKELAG----KIREGKF-----RRIPYRYSDE-LNEII- 248
Query: 254 IALRCTDSNPENRPTMTDV 272
R + +RP++ ++
Sbjct: 249 --TRMLNLKDYHRPSVEEI 265
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-19
Identities = 50/266 (18%), Positives = 98/266 (36%), Gaps = 55/266 (20%)
Query: 33 LLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL---- 88
+ +KR+K N KAE E V+ L ++ H N++ G + G D
Sbjct: 29 KAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGCWDGFDYDPETSS 84
Query: 89 ------------IVYDYMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGS--AEGIA 130
I ++ +L + R L L+ +++ + ++ +
Sbjct: 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLI 144
Query: 131 --DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKV--SD 186
D+K SN+ L + K+ DFG + + + KGTL Y++PE
Sbjct: 145 NRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS--KGTLRYMSPE--QISSQDYGK 200
Query: 187 SCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRD 246
D+Y+ G++L EL+ + F + D + F++
Sbjct: 201 EVDLYALGLILAELLHVCDT-----------------AFETSKFFTDLRDGIISDIFDKK 243
Query: 247 QLKSMVLIALRCTDSNPENRPTMTDV 272
K+++ + PE+RP +++
Sbjct: 244 -EKTLL---QKLLSKKPEDRPNTSEI 265
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-19
Identities = 54/263 (20%), Positives = 97/263 (36%), Gaps = 48/263 (18%)
Query: 42 QIAVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRGF------YAGGDERLIVYDY 93
++AVK LK + + EF E + H ++ L G +++ +
Sbjct: 53 KVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPF 112
Query: 94 MPNHSLITHLHGRLAPDC--LLDWHRRVSIAIGSAEGIA----------DIKASNVLLDT 141
M + L L + L V + A G+ D+ A N +L
Sbjct: 113 MKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE 172
Query: 142 DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL-----APEYAMWGKVSDSCDVYSFGVL 196
D VADFG ++ I G + +G L A E + DV++FGV
Sbjct: 173 DMTVCVADFGLSRKIYSGDYY----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVT 228
Query: 197 LLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN-RDQLKSMVLI 254
+ E+++ + P G +I Y+ G RLK +++ ++
Sbjct: 229 MWEIMTRGQTP---YAGIENAEIYN----YLIGGN-------RLKQPPECMEEVYDLM-- 272
Query: 255 ALRCTDSNPENRPTMTDVVDWLK 277
+C ++P+ RP+ T + L+
Sbjct: 273 -YQCWSADPKQRPSFTCLRMELE 294
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 9e-19
Identities = 68/250 (27%), Positives = 106/250 (42%), Gaps = 44/250 (17%)
Query: 44 AVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL-IVYDYMPNHSLITH 102
AVK +K +A A+ F E ++ ++RH NL+ L G L IV +YM SL+ +
Sbjct: 48 AVKCIKN-DATAQ-AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY 105
Query: 103 LHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVADFGF 152
L R +L + ++ E + D+ A NVL+ D AKV+DFG
Sbjct: 106 LRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 163
Query: 153 AKLIPDGVTHMTTR--VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEK 209
K T T + VK T APE K S DV+SFG+LL E+ S + P +
Sbjct: 164 TKEASS--TQDTGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 217
Query: 210 LPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVL--IALRCTDSNPENRP 267
+P ++ V P V+KG ++ + + C + RP
Sbjct: 218 IP-------LKDVVPRVEKGY-------KMD----APDGCPPAVYEVMKNCWHLDAAMRP 259
Query: 268 TMTDVVDWLK 277
+ + + L+
Sbjct: 260 SFLQLREQLE 269
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-18
Identities = 52/266 (19%), Positives = 90/266 (33%), Gaps = 51/266 (19%)
Query: 42 QIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
+A+K LK EF E + R++H N++ L G +++ Y + L
Sbjct: 41 AVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLH 100
Query: 101 THLHGR------------LAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVL 138
L R L+ V + A G+ D+ NVL
Sbjct: 101 EFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL 160
Query: 139 LDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL-----APEYAMWGKVSDSCDVYSF 193
+ K++D G + + + L APE M+GK S D++S+
Sbjct: 161 VYDKLNVKISDLGLFREVYAADYY----KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSY 216
Query: 194 GVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN-RDQLKSM 251
GV+L E+ S +P Q V ++ L + + +
Sbjct: 217 GVVLWEVFSYGLQPYCGYS-------NQDVVEMIRNRQ-------VLPCPDDCPAWVYA- 261
Query: 252 VLIALRCTDSNPENRPTMTDVVDWLK 277
+ + C + P RP D+ L+
Sbjct: 262 --LMIECWNEFPSRRPRFKDIHSRLR 285
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-18
Identities = 47/248 (18%), Positives = 87/248 (35%), Gaps = 33/248 (13%)
Query: 35 RRETGDDQIAVKRLK--TLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVY 91
+E G AVKR K EV +V +H + L + G +
Sbjct: 78 SKEDGR-LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136
Query: 92 DYMPNHSLITHL---HGRLAPDCLLDWHRRVSIAIGS--AEGIA--DIKASNVLLDTDFE 144
+ SL H L + + R +A+ ++G+ D+K +N+ L
Sbjct: 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR 195
Query: 145 AKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAK 204
K+ DFG + +G Y+APE + G + DV+S G+ +LE+
Sbjct: 196 CKLGDFGLLVELGTAGAGEV--QEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNM 252
Query: 205 KPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPE 264
+ G + + P + + L+S++ + + +P+
Sbjct: 253 ELPHGGEG--------------WQQLRQGYLPPEFTAGLSSE-LRSVL---VMMLEPDPK 294
Query: 265 NRPTMTDV 272
R T +
Sbjct: 295 LRATAEAL 302
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 48/252 (19%), Positives = 84/252 (33%), Gaps = 41/252 (16%)
Query: 40 DDQIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNL-----LGLRGFYAGGDERLIVYDY 93
+ +K L + +A+A+ E + L V H ++ G IV +Y
Sbjct: 106 GRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEY 165
Query: 94 MPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSA--EGIA--DIKASNVLLDTDFEAKVAD 149
+ SL +L + + + A+ G+ D+K N++L + + K+ D
Sbjct: 166 VGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLID 224
Query: 150 FGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEK 209
G I + GT G+ APE + + D+Y+ G L L
Sbjct: 225 LGAVSRINS-----FGYLYGTPGFQAPEIVR-TGPTVATDIYTVGRTLAALTLDLPTRN- 277
Query: 210 LPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRP-T 268
G D + P + + R + R D +P R T
Sbjct: 278 ---GRYVDGLPEDDP-----------VLKTYDSYGR--------LLRRAIDPDPRQRFTT 315
Query: 269 MTDVVDWLKGGL 280
++ L G L
Sbjct: 316 AEEMSAQLTGVL 327
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 46/241 (19%), Positives = 89/241 (36%), Gaps = 31/241 (12%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHL--HGRLAPDCLLDWHRRV 119
E++I+ +++ L G DE I+Y+YM N S++ L + +V
Sbjct: 93 ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 120 S------IAIG-----SAEGIA--DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTR 166
+ + + I D+K SN+L+D + K++DFG ++ + D +R
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GSR 211
Query: 167 VKGTLGYLAPEYAMWGKVSD--SCDVYSFGVLLLELISAKKP------LEKLPGGVKRDI 218
GT ++ PE+ + D++S G+ L + P L +L ++
Sbjct: 212 --GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKN 269
Query: 219 VQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WL 276
+++ F ++ + NP R T D + WL
Sbjct: 270 IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDID--FLK-LFLRKNPAERITSEDALKHEWL 326
Query: 277 K 277
Sbjct: 327 A 327
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-18
Identities = 61/249 (24%), Positives = 96/249 (38%), Gaps = 40/249 (16%)
Query: 33 LLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGL--RGFYAGGDERL-- 88
+LR + D R F E + + H ++ + G L
Sbjct: 44 VLRADLARDPSFYLR-----------FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92
Query: 89 IVYDYMPNHSL--ITHLHGRLAPDCLLDWHRRVSIAIGSA--EGIA--DIKASNVLLDTD 142
IV +Y+ +L I H G + P ++ A+ + GI D+K +N+++
Sbjct: 93 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT 152
Query: 143 FEAKVADFGFAKLIPDGVTHMTT--RVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLEL 200
KV DFG A+ I D +T V GT YL+PE A V DVYS G +L E+
Sbjct: 153 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212
Query: 201 ISAKKPLE-KLPGGVKRDIVQWVTPYVQKGAFEHI-ADPRLKGKFNRDQLKSMVLIALRC 258
++ + P P V A++H+ DP + + + L+
Sbjct: 213 LTGEPPFTGDSPVSV---------------AYQHVREDPIPPSARHEGLSADLDAVVLKA 257
Query: 259 TDSNPENRP 267
NPENR
Sbjct: 258 LAKNPENRY 266
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 6e-18
Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 15/183 (8%)
Query: 36 RETGDDQIAVKRL-KTLNAKAEMEFAV--EVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
+++ +A+K L K KA +E + EVEI +RH N+L L G++ ++ +
Sbjct: 31 KQSKF-ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 89
Query: 93 YMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIG--SAEGIA--DIKASNVLLDTDFEAK 146
Y P ++ L + + ++ A+ ++ + DIK N+LL + E K
Sbjct: 90 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELK 149
Query: 147 VADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSD-SCDVYSFGVLLLELISAKK 205
+ADFG++ P GTL YL PE G++ D D++S GVL E + K
Sbjct: 150 IADFGWSVHAPSS-RRTDL--CGTLDYLPPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKP 205
Query: 206 PLE 208
P E
Sbjct: 206 PFE 208
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-17
Identities = 61/266 (22%), Positives = 105/266 (39%), Gaps = 52/266 (19%)
Query: 42 QIAVKRLK-TLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMPNHSL 99
+AVK LK K + E+E++ + +H+N++ L G ++ +Y +L
Sbjct: 115 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 174
Query: 100 ITHL------------HGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNV 137
+L P+ + + VS A G+ D+ A NV
Sbjct: 175 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234
Query: 138 LLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL-----APEYAMWGKVSDSCDVYS 192
L+ + K+ADFG A+ I + + K T G L APE + DV+S
Sbjct: 235 LVTENNVMKIADFGLARDINNIDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 290
Query: 193 FGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN-RDQLKS 250
FGVL+ E+ + P +P V+ + +++G R+ N ++L
Sbjct: 291 FGVLMWEIFTLGGSPYPGIP-------VEELFKLLKEGH-------RMDKPANCTNELYM 336
Query: 251 MVLIALRCTDSNPENRPTMTDVVDWL 276
+ C + P RPT +V+ L
Sbjct: 337 ---MMRDCWHAVPSQRPTFKQLVEDL 359
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 52/287 (18%), Positives = 99/287 (34%), Gaps = 69/287 (24%)
Query: 35 RRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL------ 88
A+K+++ + EV +L + H+ ++ + +
Sbjct: 27 NALDSR-YYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84
Query: 89 -------IVYDYMPNHSLITHLHGR---LAPDCLLDWHRRVSIAIG--SAEGIA--DIKA 134
I +Y N +L +H D R++ A+ ++GI D+K
Sbjct: 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKP 144
Query: 135 SNVLLDTDFEAKVADFGFAKLIPDGV--------------THMTTRVKGTLGYLAPE-YA 179
N+ +D K+ DFG AK + + ++T+ + GT Y+A E
Sbjct: 145 MNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLD 203
Query: 180 MWGKVSDSCDVYSFGVLLLELI-------SAKKPLEKLPGGVKRDIVQWVTPYVQKGAFE 232
G ++ D+YS G++ E+I L+KL + + E
Sbjct: 204 GTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKL----------------RSVSIE 247
Query: 233 HIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLK 277
P + + K +I D +P RP +++ WL
Sbjct: 248 F--PPDFDDNKMKVEKK---IIR-LLIDHDPNKRPGARTLLNSGWLP 288
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-17
Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 15/183 (8%)
Query: 36 RETGDDQIAVKRL-KTLNAKAEMEFAV--EVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
++ +A+K L K+ K +E + E+EI +RH N+L + ++ ++ +
Sbjct: 36 KQNKF-IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94
Query: 93 YMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGS--AEGIA--DIKASNVLLDTDFEAK 146
+ P L L HGR + ++ A+ + DIK N+L+ E K
Sbjct: 95 FAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELK 154
Query: 147 VADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSD-SCDVYSFGVLLLELISAKK 205
+ADFG++ P GTL YL PE GK D D++ GVL E +
Sbjct: 155 IADFGWSVHAPSLRRRTMC---GTLDYLPPEMIE-GKTHDEKVDLWCAGVLCYEFLVGMP 210
Query: 206 PLE 208
P +
Sbjct: 211 PFD 213
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 61/264 (23%), Positives = 104/264 (39%), Gaps = 52/264 (19%)
Query: 44 AVKRLK-TLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
AVK LK K + E+E++ + +H+N++ L G ++ +Y +L
Sbjct: 71 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 130
Query: 102 HL------------HGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLL 139
+L P+ + + VS A G+ D+ A NVL+
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190
Query: 140 DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL-----APEYAMWGKVSDSCDVYSFG 194
+ K+ADFG A+ I + + K T G L APE + DV+SFG
Sbjct: 191 TENNVMKIADFGLARDINNIDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 195 VLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN-RDQLKSMV 252
VL+ E+ + P +P V+ + +++G R+ N ++L
Sbjct: 247 VLMWEIFTLGGSPYPGIP-------VEELFKLLKEGH-------RMDKPANCTNELYM-- 290
Query: 253 LIALRCTDSNPENRPTMTDVVDWL 276
+ C + P RPT +V+ L
Sbjct: 291 -MMRDCWHAVPSQRPTFKQLVEDL 313
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 48/252 (19%), Positives = 84/252 (33%), Gaps = 47/252 (18%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
++TG Q AVK+++ + E E+ + ++ L G G I + +
Sbjct: 80 KQTGF-QCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133
Query: 96 N---HSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTD 142
LI G L D L + + EG+ D+KA NVLL +D
Sbjct: 134 GGSLGQLIKQ-MGCLPEDRALYYLGQA------LEGLEYLHTRRILHGDVKADNVLLSSD 186
Query: 143 -FEAKVADFGFAKLIPDGVTHMTTR----VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLL 197
A + DFG A + + + GT ++APE M D++S ++
Sbjct: 187 GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMM 246
Query: 198 LELISAKKPLEKL-PGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIAL 256
L +++ P + G + I P + +
Sbjct: 247 LHMLNGCHPWTQYFRGPLCLKIASEPPPI-----------REIPPSCA-PLTAQAI---Q 291
Query: 257 RCTDSNPENRPT 268
P +R +
Sbjct: 292 EGLRKEPVHRAS 303
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 43/184 (23%), Positives = 72/184 (39%), Gaps = 25/184 (13%)
Query: 33 LLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG--DERL-I 89
L+ D + R E GR++ +++ + + G D +L +
Sbjct: 66 LMSETLSSDPVFRTR-----------MQREARTAGRLQEPHVVPI---HDFGEIDGQLYV 111
Query: 90 VYDYMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSA--EGIA--DIKASNVLLDTDF 143
+ L L G LAP + R++ A+ +A G D+K N+L+ D
Sbjct: 112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD 171
Query: 144 EAKVADFGFAKLIPD-GVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
A + DFG A D +T GTL Y+APE + D+Y+ +L E ++
Sbjct: 172 FAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLT 230
Query: 203 AKKP 206
P
Sbjct: 231 GSPP 234
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 8e-17
Identities = 30/275 (10%), Positives = 79/275 (28%), Gaps = 61/275 (22%)
Query: 34 LRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93
++ E ++ AK + F +++ + + ++ +R + Y
Sbjct: 120 MKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY 179
Query: 94 M----PNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLL 139
+ L + L H R+ + + +A ++ +++L
Sbjct: 180 PRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL 239
Query: 140 DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEY-----------AMWGKVSDSC 188
D + F DG +++ + G+ PE ++ S
Sbjct: 240 DQRGGVFLTGFEHLV--RDGARVVSS---VSRGFEPPELEARRATISYHRDRRTLMTFSF 294
Query: 189 DVYSFGVLLLELISAKKP--LEKLPGGVKRDI--VQWVTPYVQKGAFEHIADPRLKGKFN 244
D ++ G+++ + A P + GG + + + V+
Sbjct: 295 DAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRA---------------- 338
Query: 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLK 277
L+ E+R ++ +
Sbjct: 339 --------LLE-GFLRYPKEDRLLPLQAMETPEYE 364
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 62/273 (22%), Positives = 105/273 (38%), Gaps = 49/273 (17%)
Query: 34 LRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVY 91
L +E ++AVK LK T +A + E++I+ + +H N++ L G G L++
Sbjct: 70 LGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVIT 129
Query: 92 DYMPNHSLITHLHGR----------LAPDCLLDWHRRVSIAIGSAEGIA----------D 131
+Y L+ L + + + + A+G+A D
Sbjct: 130 EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRD 189
Query: 132 IKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL-----APEYAMWGKVSD 186
+ A NVLL AK+ DFG A+ I + + + L APE +
Sbjct: 190 VAARNVLLTNGHVAKIGDFGLARDIMNDSNY----IVKGNARLPVKWMAPESIFDCVYTV 245
Query: 187 SCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL-KGKFN 244
DV+S+G+LL E+ S P PG + V+ G ++ + F
Sbjct: 246 QSDVWSYGILLWEIFSLGLNP---YPG---ILVNSKFYKLVKDGY-------QMAQPAFA 292
Query: 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277
+ S I C P +RPT + +L+
Sbjct: 293 PKNIYS---IMQACWALEPTHRPTFQQICSFLQ 322
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-16
Identities = 42/195 (21%), Positives = 73/195 (37%), Gaps = 27/195 (13%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAV-EVEILGRVRHRNLLGLRGFYAGGDERLI--VYD 92
++TGD A+K ++ ++ + E E+L ++ H+N++ L R + +
Sbjct: 31 KKTGD-LFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89
Query: 93 YMPNHSLITHLHGRLAPDCLLDWH-RRVSIAIGSA------EGIA--DIKASNVLL---- 139
+ P SL T L L + V + GI +IK N++
Sbjct: 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE 149
Query: 140 DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPE--------YAMWGKVSDSCDVY 191
D K+ DFG A+ + D + GT YL P+ K + D++
Sbjct: 150 DGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLW 207
Query: 192 SFGVLLLELISAKKP 206
S GV + P
Sbjct: 208 SIGVTFYHAATGSLP 222
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 43/194 (22%), Positives = 80/194 (41%), Gaps = 18/194 (9%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
+IA+K + +++ E+ + ++H+N++ G ++ I + +P
Sbjct: 44 LSNQV-RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102
Query: 96 N---HSLITHLHGRLAPDCLL--DWHRRVSIAIGSA----EGIA--DIKASNVLLDT-DF 143
+L+ G L + + + I G I DIK NVL++T
Sbjct: 103 GGSLSALLRSKWGPLKDNEQTIGFYTK--QILEGLKYLHDNQIVHRDIKGDNVLINTYSG 160
Query: 144 EAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKV--SDSCDVYSFGVLLLELI 201
K++DFG +K + T GTL Y+APE G + D++S G ++E+
Sbjct: 161 VLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMA 219
Query: 202 SAKKPLEKLPGGVK 215
+ K P +L
Sbjct: 220 TGKPPFYELGEPQA 233
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 78.6 bits (193), Expect = 2e-16
Identities = 24/261 (9%), Positives = 69/261 (26%), Gaps = 42/261 (16%)
Query: 34 LRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV--- 90
++ E ++ AK + F +++ + + ++ +R
Sbjct: 125 MKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY 184
Query: 91 -YDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLL 139
+ L + L H R+ + + +A ++ +++L
Sbjct: 185 PRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL 244
Query: 140 DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMW-----GKVSDSCDVYSFG 194
D + F R A + ++ + D ++ G
Sbjct: 245 DQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304
Query: 195 VLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD-PRLKGKFNRDQLKSMVL 253
+ + + A P +W+ F + P +++++
Sbjct: 305 LAIYWIWCADLPNT---DDAALGGSEWI--------FRSCKNIP--------QPVRALL- 344
Query: 254 IALRCTDSNPENRPTMTDVVD 274
E+R ++
Sbjct: 345 --EGFLRYPKEDRLLPLQAME 363
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 42/195 (21%), Positives = 72/195 (36%), Gaps = 27/195 (13%)
Query: 36 RETGDDQIAVKRLKTLNAKAEME-FAVEVEILGRVRHRNLLGLRGFYAGGDERLI--VYD 92
++TGD A+K ++ ++ E E+L ++ H+N++ L R + +
Sbjct: 31 KKTGD-LFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89
Query: 93 YMPNHSLITHLHGRLAPDCLLDWH-RRVSIAIGSA------EGIA--DIKASNVLL---- 139
+ P SL T L L + V + GI +IK N++
Sbjct: 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE 149
Query: 140 DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPE--------YAMWGKVSDSCDVY 191
D K+ DFG A+ + D + GT YL P+ K + D++
Sbjct: 150 DGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLW 207
Query: 192 SFGVLLLELISAKKP 206
S GV + P
Sbjct: 208 SIGVTFYHAATGSLP 222
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 57/274 (20%), Positives = 97/274 (35%), Gaps = 68/274 (24%)
Query: 36 RETGDDQIAVK---RLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
+T + A K + L + ++E+ I + H++++G GF+ D +V +
Sbjct: 63 ADTKE-VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 121
Query: 93 YMPNHSLITHL--HGRLAPD---------------CLLDWHRRVSIAIGSAEGIA--DIK 133
SL+ L HR + D+K
Sbjct: 122 LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL----HRN---------RVIHRDLK 168
Query: 134 ASNVLLDTDFEAKVADFGFAKLI-PDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYS 192
N+ L+ D E K+ DFG A + DG GT Y+APE S DV+S
Sbjct: 169 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHSFEVDVWS 226
Query: 193 FGVLLLELISAKKPLE--KLPGGVKRDIVQWVTPYVQKGAF---EHIADPRLKGKFNRDQ 247
G ++ L+ K P E L R ++K + +HI
Sbjct: 227 IGCIMYTLLVGKPPFETSCLKETYLR---------IKKNEYSIPKHINPV------AAS- 270
Query: 248 LKSMVLIALRCTDSNPENRPTMTDVV--DWLKGG 279
LI + ++P RPT+ +++ ++ G
Sbjct: 271 -----LIQ-KMLQTDPTARPTINELLNDEFFTSG 298
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 71/298 (23%), Positives = 115/298 (38%), Gaps = 53/298 (17%)
Query: 44 AVKRLK-TLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
AVK LK K + E+E++ + +H+N++ L G ++ +Y +L
Sbjct: 105 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164
Query: 102 HL------------HGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLL 139
+L + P+ L VS A A G+ D+ A NVL+
Sbjct: 165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224
Query: 140 DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL-----APEYAMWGKVSDSCDVYSFG 194
D K+ADFG A+ I + K T G L APE + DV+SFG
Sbjct: 225 TEDNVMKIADFGLARDIHHIDYY----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 280
Query: 195 VLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN-RDQLKSMV 252
VLL E+ + P PG ++ + +++G R+ N ++L M+
Sbjct: 281 VLLWEIFTLGGSP---YPGVPVEELFK----LLKEGH-------RMDKPSNCTNELYMMM 326
Query: 253 LIALRCTDSNPENRPTMTDVVDWLKGGLGRRTKDVKDVAGEDDEDNDDNDTDFEERYF 310
C + P RPT +V+ L + T + + +D + E YF
Sbjct: 327 ---RDCWHAVPSQRPTFKQLVEDLDRIVA-LTSNQEMGYYHHHHHHDYDIPTTENLYF 380
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-16
Identities = 56/299 (18%), Positives = 98/299 (32%), Gaps = 52/299 (17%)
Query: 33 LLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HRNLLGLRGFYA--------G 83
+ + A+KRL + + EV + ++ H N++ + G
Sbjct: 46 EAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105
Query: 84 GDERLIVYDYMPNHSLI----THLHGRLAPDCLLDWHRRVSIAIG----SAEGIA--DIK 133
E L++ + + G L+ D +L + A+ I D+K
Sbjct: 106 QAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLK 165
Query: 134 ASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVK-----------GTLGYLAPE-YAMW 181
N+LL K+ DFG A I + + + T Y PE ++
Sbjct: 166 VENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY 225
Query: 182 GK--VSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239
+ + D+++ G +L L + P E G R + G +
Sbjct: 226 SNFPIGEKQDIWALGCILYLLCFRQHPFED--GAKLR---------IVNGKYSIPPHDTQ 274
Query: 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGRRTKDVKDVAGEDDEDN 298
F+ LI NPE R ++ +VV L+ R + K E E N
Sbjct: 275 YTVFHS-------LIR-AMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQN 325
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-16
Identities = 57/274 (20%), Positives = 97/274 (35%), Gaps = 68/274 (24%)
Query: 36 RETGDDQIAVK---RLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
+T + A K + L + ++E+ I + H++++G GF+ D +V +
Sbjct: 37 ADTKE-VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 95
Query: 93 YMPNHSLITHL--HGRLAPD---------------CLLDWHRRVSIAIGSAEGIA--DIK 133
SL+ L HR + D+K
Sbjct: 96 LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL----HRN---------RVIHRDLK 142
Query: 134 ASNVLLDTDFEAKVADFGFAKLI-PDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYS 192
N+ L+ D E K+ DFG A + DG GT Y+APE S DV+S
Sbjct: 143 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHSFEVDVWS 200
Query: 193 FGVLLLELISAKKPLE--KLPGGVKRDIVQWVTPYVQKGAF---EHIADPRLKGKFNRDQ 247
G ++ L+ K P E L R ++K + +HI
Sbjct: 201 IGCIMYTLLVGKPPFETSCLKETYLR---------IKKNEYSIPKHINPV------AAS- 244
Query: 248 LKSMVLIALRCTDSNPENRPTMTDVV--DWLKGG 279
LI + ++P RPT+ +++ ++ G
Sbjct: 245 -----LIQ-KMLQTDPTARPTINELLNDEFFTSG 272
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-16
Identities = 61/304 (20%), Positives = 115/304 (37%), Gaps = 54/304 (17%)
Query: 34 LRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVY 91
++++ A+KR+K + +FA E+E+L ++ H N++ L G +
Sbjct: 46 IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 105
Query: 92 DYMPNHSLITHLHGRLAPDCLLDWHRR------------VSIAIGSAEGIA--------- 130
+Y P+ +L+ L + + + A A G+
Sbjct: 106 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIH 165
Query: 131 -DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL-----APEYAMWGKV 184
D+ A N+L+ ++ AK+ADFG ++ + VK T+G L A E +
Sbjct: 166 RDLAARNILVGENYVAKIADFGLSR---GQEVY----VKKTMGRLPVRWMAIESLNYSVY 218
Query: 185 SDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243
+ + DV+S+GVLL E++S P + + + +G RL+
Sbjct: 219 TTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELYEKLPQGY-------RLEKPL 264
Query: 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGRRTKDVKDVAGEDDEDNDDNDT 303
N D + + +C P RP+ ++ L + K + + D
Sbjct: 265 NCDD--EVYDLMRQCWREKPYERPSFAQILVSLN-RMLEERKTYVNTTLYEKFTYAGIDC 321
Query: 304 DFEE 307
EE
Sbjct: 322 SAEE 325
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 6e-16
Identities = 56/319 (17%), Positives = 109/319 (34%), Gaps = 60/319 (18%)
Query: 35 RRETGDDQIAVKR--LKTLNAKAEMEFAVEVEILGRVRHRNL--LGLRGFYAGGDERLIV 90
E A+K L+ + + + E+ L +++ + + L + +V
Sbjct: 76 LNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134
Query: 91 YDYMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSA------EGIA--DIKASNVLLD 140
+ N L + L + P + + A GI D+K +N L+
Sbjct: 135 MEC-GNIDLNSWLKKKKSIDPW----ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 189
Query: 141 TDFEAKVADFGFAKLIPDGVTH-MTTRVKGTLGYLAPE-----------YAMWGKVSDSC 188
D K+ DFG A + T + G + Y+ PE K+S
Sbjct: 190 -DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248
Query: 189 DVYSFGVLLLELISAKKPLEKLPGGVKR--DIVQWVTPYVQKGAFEHIADPRLKGKFNRD 246
DV+S G +L + K P +++ + + I+ F I + L+ D
Sbjct: 249 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE----FPDIPEKDLQ-----D 299
Query: 247 QLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG-------LGRRTKDVKDVAGEDDED 297
LK C +P+ R ++ +++ +++ T+++K V G+
Sbjct: 300 VLK-------CCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGL 352
Query: 298 NDDNDTDFEERYFKMEQSN 316
N N + S
Sbjct: 353 NSPNSILKAAKTLYEHYSG 371
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-16
Identities = 56/282 (19%), Positives = 106/282 (37%), Gaps = 69/282 (24%)
Query: 36 RETGDDQIAVKRL-KTLNAKAEMEFAV--EVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
TG ++A+K + K KA M V EV+I +++H ++L L ++ + +V +
Sbjct: 33 IHTGL-EVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91
Query: 93 YMPNHSLITHLH---GRLAPD---------------CLLDWHRRVSIAIGSAEGIA--DI 132
N + +L + + H GI D+
Sbjct: 92 MCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL----HSH---------GILHRDL 138
Query: 133 KASNVLLDTDFEAKVADFGFA-KLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVY 191
SN+LL + K+ADFG A +L H T GT Y++PE A DV+
Sbjct: 139 TLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISPEIATRSAHGLESDVW 196
Query: 192 SFGVLLLELISAKKPLE--KLPGGVKRDIVQWVTPYVQKGAF---EHIADPRLKGKFNRD 246
S G + L+ + P + + + + V + ++ +D
Sbjct: 197 SLGCMFYTLLIGRPPFDTDTVKNTLNK---------VVLADYEMPSFLSIEA------KD 241
Query: 247 QLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLGRRTKD 286
+ ++ NP +R +++ V+D ++ ++KD
Sbjct: 242 LIHQLL-------RRNPADRLSLSSVLDHPFMSRNSSTKSKD 276
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-16
Identities = 48/274 (17%), Positives = 98/274 (35%), Gaps = 55/274 (20%)
Query: 35 RRETGDDQIAVKR--LKTLNAKAEMEFAVEVEILGRVRHRNL--LGLRGFYAGGDERLIV 90
E A+K L+ + + + E+ L +++ + + L + +V
Sbjct: 48 LNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106
Query: 91 YDYMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSA------EGIA--DIKASNVLLD 140
+ N L + L + P + + A GI D+K +N L+
Sbjct: 107 MECG-NIDLNSWLKKKKSIDPW----ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 161
Query: 141 TDFEAKVADFGFAKLIPDGVTH-MTTRVKGTLGYLAPE-----------YAMWGKVSDSC 188
D K+ DFG A + T + GT+ Y+ PE K+S
Sbjct: 162 -DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 220
Query: 189 DVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNR--- 245
DV+S G +L + K P +++ + + I DP + +F
Sbjct: 221 DVWSLGCILYYMTYGKTPFQQIINQISK--------------LHAIIDPNHEIEFPDIPE 266
Query: 246 DQLKSMVLIALRCTDSNPENRPTMTDVVD--WLK 277
L+ ++ C +P+ R ++ +++ +++
Sbjct: 267 KDLQDVL---KCCLKRDPKQRISIPELLAHPYVQ 297
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 62/251 (24%), Positives = 96/251 (38%), Gaps = 42/251 (16%)
Query: 36 RETGDDQIAVKRLKTLNAKAEME-FAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94
T +A+K + A+ E+E E+ +L + + G Y + I+ +Y+
Sbjct: 44 NRTQK-VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 102
Query: 95 PNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAE---GIA----------DIKASNVLLDT 141
S + L + IA E G+ DIKA+NVLL
Sbjct: 103 GGGSALDLLEPGPLDE--------TQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE 154
Query: 142 DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELI 201
E K+ADFG A + D T V GT ++APE D++S G+ +EL
Sbjct: 155 HGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 213
Query: 202 SAKKPLEKL-PGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTD 260
+ P +L P V I + P L+G +++ LK V C +
Sbjct: 214 RGEPPHSELHPMKVLFLIPKNNP-------------PTLEGNYSKP-LKEFV---EACLN 256
Query: 261 SNPENRPTMTD 271
P RPT +
Sbjct: 257 KEPSFRPTAKE 267
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 55/282 (19%), Positives = 99/282 (35%), Gaps = 59/282 (20%)
Query: 34 LRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
L +AVK LK +A + +F E ++ + N++ L G A G ++++
Sbjct: 71 LLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 130
Query: 93 YMPNHSLITHLHGRLAPDCLLDWHRR--------------------VSIAIGSAEGIA-- 130
YM L L H + IA A G+A
Sbjct: 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 190
Query: 131 --------DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL-----APE 177
D+ N L+ + K+ADFG ++ I + + PE
Sbjct: 191 SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY----KADGNDAIPIRWMPPE 246
Query: 178 YAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD 236
+ + + DV+++GV+L E+ S +P G +++ YV+ G
Sbjct: 247 SIFYNRYTTESDVWAYGVVLWEIFSYGLQP---YYGMAHEEVIY----YVRDGN------ 293
Query: 237 PRLKGKFN-RDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277
L N +L +++ C P +RP+ + L+
Sbjct: 294 -ILACPENCPLELYNLM---RLCWSKLPADRPSFCSIHRILQ 331
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 62/290 (21%), Positives = 104/290 (35%), Gaps = 59/290 (20%)
Query: 34 LRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVY 91
L + +AVK LK + + E+++L + H N++ L G G L++
Sbjct: 47 LIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106
Query: 92 DYMPNHSLITHLHGR--------------LAPDCLLDWHRRVSIAIGSAEGIA------- 130
+Y L+ L + + LD +S + A+G+A
Sbjct: 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC 166
Query: 131 ---DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL-----APEYAMWG 182
D+ A N+LL K+ DFG A+ I + + V L APE
Sbjct: 167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNY----VVKGNARLPVKWMAPESIFNC 222
Query: 183 KVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241
+ DV+S+G+ L EL S P +P K +++G R+
Sbjct: 223 VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK------FYKMIKEGF-------RM-- 267
Query: 242 KFNRDQ----LKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGRRTKDV 287
M I C D++P RPT +V ++ + T +
Sbjct: 268 ----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNHI 313
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 56/320 (17%), Positives = 107/320 (33%), Gaps = 62/320 (19%)
Query: 35 RRETGDDQIAVKR--LKTLNAKAEMEFAVEVEILGRVRHRNL--LGLRGFYAGGDERLIV 90
E A+K L+ + + + E+ L +++ + + L + +V
Sbjct: 29 LNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87
Query: 91 YDYMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSA------EGIA--DIKASNVLLD 140
+ N L + L + P + + A GI D+K +N L+
Sbjct: 88 MEC-GNIDLNSWLKKKKSIDPW----ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 142
Query: 141 TDFEAKVADFGFAKLIPDGVTH-MTTRVKGTLGYLAPE-----------YAMWGKVSDSC 188
D K+ DFG A + T + GT+ Y+ PE K+S
Sbjct: 143 -DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 201
Query: 189 DVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNR--- 245
DV+S G +L + K P + Q I DP + +F
Sbjct: 202 DVWSLGCILYYMTYGKTP--------------FQQIINQISKLHAIIDPNHEIEFPDIPE 247
Query: 246 DQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG-------LGRRTKDVKDVAGEDDE 296
L+ ++ C +P+ R ++ +++ +++ T+++K V G+
Sbjct: 248 KDLQDVL---KCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVG 304
Query: 297 DNDDNDTDFEERYFKMEQSN 316
N N + S
Sbjct: 305 LNSPNSILKAAKTLYEHYSG 324
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-15
Identities = 58/251 (23%), Positives = 100/251 (39%), Gaps = 37/251 (14%)
Query: 43 IAVKRLKTLNAKAEME-FAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSL-- 99
+A+KR+ + M+ E++ + + H N++ + DE +V + S+
Sbjct: 43 VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 102
Query: 100 ---ITHLHGRLAPDCLLDWHRRVSIAIGSAE---GIA----------DIKASNVLLDTDF 143
G L +IA E G+ D+KA N+LL D
Sbjct: 103 IIKHIVAKGEHKSGVL----DESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG 158
Query: 144 EAKVADFGFAKLIPDGVTHMTTRVK----GTLGYLAPEYAMWGKVSDS-CDVYSFGVLLL 198
++ADFG + + G +V+ GT ++APE + D D++SFG+ +
Sbjct: 159 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 218
Query: 199 ELISAKKPLEKL-PGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALR 257
EL + P K P V +Q P ++ G D + K+ + + M+
Sbjct: 219 ELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV----QDKEMLKKYGKS-FRKMI---SL 270
Query: 258 CTDSNPENRPT 268
C +PE RPT
Sbjct: 271 CLQKDPEKRPT 281
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-15
Identities = 56/275 (20%), Positives = 98/275 (35%), Gaps = 52/275 (18%)
Query: 34 LRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRV-RHRNLLGLRGF-YAGGDERLIV 90
+ + +AVK LK E++IL + H N++ L G G +++
Sbjct: 51 IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110
Query: 91 YDYMPNHSLITHL------------HGRLAPDCLLDWHRRVSIAIGSAEGIA-------- 130
++ +L T+L L + + A+G+
Sbjct: 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI 170
Query: 131 --DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL-----APEYAMWGK 183
D+ A N+LL K+ DFG A+ I + V+ L APE
Sbjct: 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRKGDARLPLKWMAPETIFDRV 226
Query: 184 VSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL-KG 241
+ DV+SFGVLL E+ S P + + +++G R+
Sbjct: 227 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGT-------RMRAP 273
Query: 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWL 276
+ ++ + L C P RPT +++V+ L
Sbjct: 274 DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 305
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 8e-15
Identities = 49/187 (26%), Positives = 82/187 (43%), Gaps = 16/187 (8%)
Query: 33 LLRRETGDDQI-AVKRLK--TLNAKAEMEFA-VEVEILGRVRHRNLLGLRGFYAGGDERL 88
+ ++ A K+L+ + + A E +IL +V R ++ L Y D
Sbjct: 201 CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260
Query: 89 IVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIA-IGSA------EGIA--DIKASNVLL 139
+V M L H++ + + A I E I D+K N+LL
Sbjct: 261 LVLTLMNGGDLKFHIY-HMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL 319
Query: 140 DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLE 199
D +++D G A +P+G T + RV GT+GY+APE + + S D ++ G LL E
Sbjct: 320 DDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYE 377
Query: 200 LISAKKP 206
+I+ + P
Sbjct: 378 MIAGQSP 384
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 8e-15
Identities = 58/288 (20%), Positives = 111/288 (38%), Gaps = 59/288 (20%)
Query: 34 LRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
L+ G +AVK LK + + E +L +V H +++ L G + L++ +
Sbjct: 47 LKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVE 106
Query: 93 YMPNHSLITHL--------------------HGRLAPDCLLDWHRRVSIAIGSAEGIA-- 130
Y SL L + L +S A ++G+
Sbjct: 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL 166
Query: 131 --------DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL-----APE 177
D+ A N+L+ + K++DFG ++ + + ++ VK + G + A E
Sbjct: 167 AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY----VKRSQGRIPVKWMAIE 222
Query: 178 YAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD 236
+ DV+SFGVLL E+++ P PG + ++ G
Sbjct: 223 SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP---YPGIPPERLFN----LLKTGH------ 269
Query: 237 PRLKGKFN-RDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGRR 283
R++ N +++ ++ L+C P+ RP D+ L+ + +R
Sbjct: 270 -RMERPDNCSEEMYRLM---LQCWKQEPDKRPVFADISKDLEKMMVKR 313
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 8e-15
Identities = 49/272 (18%), Positives = 88/272 (32%), Gaps = 54/272 (19%)
Query: 36 RETGDDQI-AVKRLKTLNAKAEMEFAV-EVEILGRVRHRNLLGLRGFYAGGDERL----- 88
+ DD A+KR++ N + E + EV+ L ++ H ++ + +
Sbjct: 25 KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84
Query: 89 -------IVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------D 131
I +L ++GR + + + I + AE + D
Sbjct: 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIE-ERERSVCLHIFLQIAEAVEFLHSKGLMHRD 143
Query: 132 IKASNVLLDTDFEAKVADFGFAKLI-----------PDGVTHMTTRVKGTLGYLAPEYAM 180
+K SN+ D KV DFG + P T GT Y++PE
Sbjct: 144 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH 203
Query: 181 WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240
S D++S G++L EL+ + D+ + F + +
Sbjct: 204 GNSYSHKVDIFSLGLILFELLYPFST-QMERVRTLTDV--------RNLKFPPLFTQKYP 254
Query: 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDV 272
MV +P RP ++
Sbjct: 255 ------CEYVMV---QDMLSPSPMERPEAINI 277
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 43/193 (22%), Positives = 83/193 (43%), Gaps = 32/193 (16%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
+ETG A K ++T + + ++ VE+EIL H ++ L G Y + I+ ++ P
Sbjct: 41 KETGA-LAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP 99
Query: 96 NHS---LITHLHGRLAPDCLLDWHRRVSIAIGSAE---GIA----------DIKASNVLL 139
+ ++ L L I + + + D+KA NVL+
Sbjct: 100 GGAVDAIMLELDRGLTEPQ---------IQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM 150
Query: 140 DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDS-----CDVYSFG 194
+ + ++ADFG + + + + GT ++APE M + D+ D++S G
Sbjct: 151 TLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPYDYKADIWSLG 209
Query: 195 VLLLELISAKKPL 207
+ L+E+ + P
Sbjct: 210 ITLIEMAQIEPPH 222
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 72.8 bits (178), Expect = 1e-14
Identities = 24/265 (9%), Positives = 62/265 (23%), Gaps = 37/265 (13%)
Query: 34 LRRETGDDQIAVKRLKTLNAKAEME---FAVEVEILGRVRHRNLLGLRGFYAGGD--ERL 88
L T A RL + + + + + + L L
Sbjct: 109 LHEAT----FAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYL 164
Query: 89 IVYDYMP--NHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASN 136
++ L + L + A N
Sbjct: 165 LLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDN 224
Query: 137 VLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGK--VSDSCDVYSFG 194
+ + D + D + + + Y E+ + + + + G
Sbjct: 225 LFIMPDGRLMLGDVSALWKVGTRGPASS----VPVTYAPREFLNASTATFTHALNAWQLG 280
Query: 195 VLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLI 254
+ + + P + G+K + + + L D +K+++
Sbjct: 281 LSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLP-----DFVKTLI-- 333
Query: 255 ALRCTDSNPENRPTMTDVVD--WLK 277
R + + R + ++
Sbjct: 334 -GRFLNFDRRRRLLPLEAMETPEFL 357
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 45/188 (23%), Positives = 79/188 (42%), Gaps = 15/188 (7%)
Query: 33 LLRRETGDDQI-AVKRLK--TLNAKAEMEFA-VEVEILGRVRHRNLLGLRGFYAGGDERL 88
+ ++ A K+L L + + A VE +IL +V R ++ L + +
Sbjct: 202 FACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261
Query: 89 IVYDYMPNHSLITHLHGRLAPDCLLDWHR------RVSIAIGS--AEGIA--DIKASNVL 138
+V M + H++ + R ++ + I D+K NVL
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVL 321
Query: 139 LDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLL 198
LD D +++D G A + G T GT G++APE + + S D ++ GV L
Sbjct: 322 LDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLY 380
Query: 199 ELISAKKP 206
E+I+A+ P
Sbjct: 381 EMIAARGP 388
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 53/263 (20%), Positives = 92/263 (34%), Gaps = 71/263 (26%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
TG ++A++++ + E+ ++ ++ N++ Y GDE +V +Y+
Sbjct: 42 VATGQ-EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100
Query: 96 NHSL------------------------ITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI 129
SL + LH + HR
Sbjct: 101 GGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI--------HR------------ 140
Query: 130 ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCD 189
DIK+ N+LL D K+ DFGF I + +T V GT ++APE D
Sbjct: 141 -DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 190 VYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD---PRLKGKFNR- 245
++S G++ +E+I + P P A IA P L+
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNEN------------PL---RALYLIATNGTPELQNPEKLS 243
Query: 246 DQLKSMVLIALRCTDSNPENRPT 268
+ + RC + + E R +
Sbjct: 244 AIFRDFL---NRCLEMDVEKRGS 263
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 57/308 (18%), Positives = 107/308 (34%), Gaps = 56/308 (18%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAV-EVEILGRV-RHRNLLGLRGFYAGGDERLIVYDY 93
G +AVKR+ + A+ E+++L H N++ I +
Sbjct: 36 SFQGR-PVAVKRML----IDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90
Query: 94 MPN--HSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDT 141
L+ + L + +S+ A G+A D+K N+L+ T
Sbjct: 91 CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVST 150
Query: 142 -------------DFEAKVADFGFAKLIPDGVTHMTTRVK---GTLGYLAPE-------Y 178
+ ++DFG K + G + T + GT G+ APE
Sbjct: 151 SSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL 210
Query: 179 AMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238
+++ S D++S G + ++S K P G K + +G F
Sbjct: 211 QTKRRLTRSIDIFSMGCVFYYILSKGKH----PFGDKYSRES----NIIRGIFSLDEMKC 262
Query: 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLGRRTKDVKDVAGEDDE 296
L + + LI+ + D +P RPT V+ ++ + + V+ +
Sbjct: 263 LHDRSLIAEATD--LIS-QMIDHDPLKRPTAMKVLRHPLFWPK-SKKLEFLLKVSDRLEI 318
Query: 297 DNDDNDTD 304
+N D +
Sbjct: 319 ENRDPPSA 326
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 54/263 (20%), Positives = 99/263 (37%), Gaps = 71/263 (26%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
+ +G Q+AVK + + EV I+ +H N++ + Y G+E ++ +++
Sbjct: 67 KHSGR-QVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125
Query: 96 NHSL------------------------ITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI 129
+L + +LH G + HR
Sbjct: 126 GGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVI--------HR------------ 165
Query: 130 ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCD 189
DIK+ ++LL D K++DFGF I V + V GT ++APE + D
Sbjct: 166 -DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVD 223
Query: 190 VYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD---PRLKGKFNR- 245
++S G++++E++ + P P A + + D P+LK
Sbjct: 224 IWSLGIMVIEMVDGEPPYFSDS------------PV---QAMKRLRDSPPPKLKNSHKVS 268
Query: 246 DQLKSMVLIALRCTDSNPENRPT 268
L+ + R +P+ R T
Sbjct: 269 PVLRDFL---ERMLVRDPQERAT 288
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-14
Identities = 59/253 (23%), Positives = 97/253 (38%), Gaps = 51/253 (20%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
+ETG +A+K++ + + + E E+ I+ + +++ G Y + IV +Y
Sbjct: 51 KETGQ-IVAIKQVP-VESDLQ-EIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG 107
Query: 96 NHS---LITHLHGRLAPDCLLDWHRRVSIAIGSAE---GIA----------DIKASNVLL 139
S +I + L D IA G+ DIKA N+LL
Sbjct: 108 AGSVSDIIRLRNKTLTEDE---------IATILQSTLKGLEYLHFMRKIHRDIKAGNILL 158
Query: 140 DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLE 199
+T+ AK+ADFG A + D + T + GT ++APE + D++S G+ +E
Sbjct: 159 NTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIE 217
Query: 200 LISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD---PRLKGKFN-RDQLKSMVLIA 255
+ K P + P A I P + D V
Sbjct: 218 MAEGKPPYADIH------------PM---RAIFMIPTNPPPTFRKPELWSDNFTDFV--- 259
Query: 256 LRCTDSNPENRPT 268
+C +PE R T
Sbjct: 260 KQCLVKSPEQRAT 272
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-14
Identities = 55/285 (19%), Positives = 102/285 (35%), Gaps = 64/285 (22%)
Query: 34 LRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVY 91
+ + Q+AVK LK ++ E++++ ++ H N++ L G +++
Sbjct: 69 ISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 128
Query: 92 DYMPNHSLITHLHGR-------------------LAPDCLLDWHRRVSIAIGSAEGIA-- 130
+Y L+ +L + +L + + A A+G+
Sbjct: 129 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL 188
Query: 131 --------DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL-----APE 177
D+ A NVL+ K+ DFG A+ I + V L APE
Sbjct: 189 EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY----VVRGNARLPVKWMAPE 244
Query: 178 YAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD 236
G + DV+S+G+LL E+ S P PG + +Q G
Sbjct: 245 SLFEGIYTIKSDVWSYGILLWEIFSLGVNP---YPG---IPVDANFYKLIQNGF------ 292
Query: 237 PRLKGKFNRDQ----LKSMVLIALRCTDSNPENRPTMTDVVDWLK 277
++ DQ + + +I C + RP+ ++ +L
Sbjct: 293 -KM------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-14
Identities = 66/285 (23%), Positives = 105/285 (36%), Gaps = 58/285 (20%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDERLIVYDYM 94
T + AVK ++ EVE+L + + HRN+L L F+ D +V++ M
Sbjct: 35 LITSQ-EYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKM 93
Query: 95 PNHSLITHLHGRL------APDCLLDWHRRVSIAIGSA------EGIA--DIKASNVLLD 140
S+++H+H R A + D + SA +GIA D+K N+L +
Sbjct: 94 RGGSILSHIHKRRHFNELEASVVVQD--------VASALDFLHNKGIAHRDLKPENILCE 145
Query: 141 T---DFEAKVADFGFAKLIPDGVTH-------MTTRVKGTLGYLAPE-----YAMWGKVS 185
K+ DF I + T G+ Y+APE
Sbjct: 146 HPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMAPEVVEAFSEEASIYD 204
Query: 186 DSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN- 244
CD++S GV+L L+S P G P Q FE I +GK+
Sbjct: 205 KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI----QEGKYEF 260
Query: 245 --------RDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279
K LI+ + + + R + V+ W++G
Sbjct: 261 PDKDWAHISCAAKD--LIS-KLLVRDAKQRLSAAQVLQHPWVQGC 302
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 6e-14
Identities = 46/256 (17%), Positives = 87/256 (33%), Gaps = 49/256 (19%)
Query: 42 QIAVKRLKTLNAKAEMEFAV-EVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMPN--H 97
+AVKR+ FA EV++L H N++ + I +
Sbjct: 50 DVAVKRIL----PECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQ 105
Query: 98 SLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFE--- 144
+ + ++ G+A D+K N+L+
Sbjct: 106 EYVEQKDFAHLGLEPITLLQQT------TSGLAHLHSLNIVHRDLKPHNILISMPNAHGK 159
Query: 145 --AKVADFGFAKLIPDGVTHMTTR--VKGTLGYLAPEY---AMWGKVSDSCDVYSFGVLL 197
A ++DFG K + G + R V GT G++APE + + D++S G +
Sbjct: 160 IKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVF 219
Query: 198 LELISAKKPLEKLP-GGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIAL 256
+IS P G + + + + + + + + R+ LI
Sbjct: 220 YYVISEGSH----PFGKSLQRQANIL---LGACSLDCLHPEKHEDVIARE------LIE- 265
Query: 257 RCTDSNPENRPTMTDV 272
+ +P+ RP+ V
Sbjct: 266 KMIAMDPQKRPSAKHV 281
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 8e-14
Identities = 44/192 (22%), Positives = 70/192 (36%), Gaps = 55/192 (28%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
R TG A+K +K A + E+ +L +++H N++ L Y +V +
Sbjct: 31 RLTGK-LFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS 89
Query: 96 -----------NH--------------SLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA 130
S + +LH GI
Sbjct: 90 GGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---------------------GIV 128
Query: 131 --DIKASNVLLDTDFEA---KVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVS 185
D+K N+L T E + DFG +K+ +G+ M+T GT GY+APE S
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC-GTPGYVAPEVLAQKPYS 185
Query: 186 DSCDVYSFGVLL 197
+ D +S GV+
Sbjct: 186 KAVDCWSIGVIT 197
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 54/275 (19%), Positives = 110/275 (40%), Gaps = 46/275 (16%)
Query: 35 RRETGDDQIAVKRLKTLNAKAEMEFAV--EVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
+ T + A+K ++ + + EV +L + H N++ L F+ +V +
Sbjct: 58 DKVTHV-ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116
Query: 93 YMPNHSLI------THLHGRLAPDCLLDWHRRVSIAIGS--AEGIA--DIKASNVLLDT- 141
L + A + ++V + I D+K N+LL++
Sbjct: 117 CYKGGELFDEIIHRMKFNEVDAAVII----KQVLSGVTYLHKHNIVHRDLKPENLLLESK 172
Query: 142 --DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLE 199
D K+ DFG + + + M R+ GT Y+APE + K + CDV+S GV+L
Sbjct: 173 EKDALIKIVDFGLSAVFENQKK-MKERL-GTAYYIAPE-VLRKKYDEKCDVWSIGVILFI 229
Query: 200 LISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIA---- 255
L++ P G ++I++ V+KG + F+ + K++ A
Sbjct: 230 LLAGYPP---FGGQTDQEILR----KVEKGKYT----------FDSPEWKNVSEGAKDLI 272
Query: 256 LRCTDSNPENRPTMTDVVD--WLKGGLGRRTKDVK 288
+ + + R + ++ W+K ++ ++
Sbjct: 273 KQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIE 307
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 43/176 (24%), Positives = 70/176 (39%), Gaps = 16/176 (9%)
Query: 44 AVKRLK--TLNAKAEMEFA-VEVEILGRV---RHRNLLGLRGFYAGGDERLIVYDYMPNH 97
A+K L + K A E +L V ++ + + D+ + D M
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277
Query: 98 SLITHL--HGRLAPDCLLDWHRRVSIAIGS--AEGIA--DIKASNVLLDTDFEAKVADFG 151
L HL HG + + + + + + + D+K +N+LLD +++D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 152 FAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSD-SCDVYSFGVLLLELISAKKP 206
A H V GT GY+APE G D S D +S G +L +L+ P
Sbjct: 338 LACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 56/298 (18%), Positives = 97/298 (32%), Gaps = 66/298 (22%)
Query: 43 IAVKRLKTLNAKAEMEFAV-EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSL-- 99
+A K + A + E+++L ++G G + E I ++M SL
Sbjct: 61 MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 100 ITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA-----------DIKASNVLLDTDFEAKVA 148
+ GR+ L ++I +G+ D+K SN+L+++ E K+
Sbjct: 121 VLKKAGRIPEQIL------GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 174
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLE 208
DFG + + D + + + V GT Y++PE S D++S G+ L+E+ + P+
Sbjct: 175 DFGVSGQLIDSMAN--SFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 231
Query: 209 KLPGGVKRDIVQWVTPYVQKGAFEHIADP-RLKGKFNRDQLKSMVLIAL----------- 256
+ P R KF D M + L
Sbjct: 232 PPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK 291
Query: 257 ---------------RCTDSNPENRPT----------------MTDVVDWLKGGLGRR 283
+C NP R D WL +G
Sbjct: 292 LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLN 349
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 34/192 (17%), Positives = 66/192 (34%), Gaps = 28/192 (14%)
Query: 43 IAVKRLKTLNAKAEMEFAV--EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
+ V+R+ EM + E+ + H N++ R + +E +V +M S
Sbjct: 55 VTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA- 113
Query: 101 THLHGRLAPDCLLDWHRRVSIAI---GSAEGIA----------DIKASNVLLDTDFEAKV 147
L D + ++IA G + + +KAS++L+ D + +
Sbjct: 114 KDLICTHFMDGM----NELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYL 169
Query: 148 ADFGFAKLIPDGVTHMTTRVK------GTLGYLAPE--YAMWGKVSDSCDVYSFGVLLLE 199
+ + L +L+PE D+YS G+ E
Sbjct: 170 SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229
Query: 200 LISAKKPLEKLP 211
L + P + +P
Sbjct: 230 LANGHVPFKDMP 241
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 67/266 (25%), Positives = 105/266 (39%), Gaps = 51/266 (19%)
Query: 36 RETGDDQIAVKRL--KTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93
TG ++A+K + LN + + EV I+ + H N++ L ++ +Y
Sbjct: 37 ILTGR-EVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95
Query: 94 MPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSA------EGIA--DIKASNVLLDTDF 143
+ +L HGR+ R I SA + I D+KA N+LLD D
Sbjct: 96 ASGGEVFDYLVAHGRMKEK----EARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM 151
Query: 144 EAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSD--SCDVYSFGVLLLELI 201
K+ADFGF+ G + G Y APE GK D DV+S GV+L L+
Sbjct: 152 NIKIADFGFSNEFTVG-GKLDAFC-GAPPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLV 208
Query: 202 SAKKP-----LEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIAL 256
S P L++L V R + + Y+ + LK +++
Sbjct: 209 SGSLPFDGQNLKELRERVLRGKYR-IPFYMSTDC--------------ENLLKRFLVL-- 251
Query: 257 RCTDSNPENRPTMTDVVD--WLKGGL 280
NP R T+ ++ W+ G
Sbjct: 252 -----NPIKRGTLEQIMKDRWINAGH 272
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 55/282 (19%), Positives = 96/282 (34%), Gaps = 80/282 (28%)
Query: 35 RRETGDDQIAVKRL--KTLNAKAEMEFAV----EVEILGRVRHR--NLLGLRGFYAGGDE 86
R +A+K + ++ E+ EV +L +V ++ L ++ D
Sbjct: 64 RVSDNL-PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122
Query: 87 RLIVYDY-MPNHSLITHL--HGRLAPD---------------CLLDWHRRVSIAIGSAEG 128
+++ + P L + G L + C H G
Sbjct: 123 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC----HNC---------G 169
Query: 129 IA--DIKASNVLLDTD-FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVS 185
+ DIK N+L+D + E K+ DFG L+ D T GT Y PE+
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFD-GTRVYSPPEWIR-YHRY 225
Query: 186 D--SCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQ---WVTPYVQKGAFEHIADPRLK 240
S V+S G+LL +++ P E +I++ + V
Sbjct: 226 HGRSAAVWSLGILLYDMVCGDIPFEH-----DEEIIRGQVFFRQRVSSEC---------- 270
Query: 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280
+ LI C P +RPT ++ + W++ L
Sbjct: 271 ----QH------LIR-WCLALRPSDRPTFEEIQNHPWMQDVL 301
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 47/181 (25%), Positives = 74/181 (40%), Gaps = 33/181 (18%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGR-VRHRNLLGLRGFYAGGDERLIVYDYM 94
+ T + AVK + K++ + E+EIL R +H N++ L+ Y G +V + M
Sbjct: 44 KATNM-EFAVKIID----KSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM 98
Query: 95 PNHSL---IT---HLHGRLAPDCLLDWHRRVSIAIGSA------EGIA--DIKASNVLLD 140
L I R A L I +G+ D+K SN+L
Sbjct: 99 KGGELLDKILRQKFFSEREASAVLFT--------ITKTVEYLHAQGVVHRDLKPSNILYV 150
Query: 141 TDFEA----KVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVL 196
+ ++ DFGFAK + + T T ++APE +CD++S GVL
Sbjct: 151 DESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVL 209
Query: 197 L 197
L
Sbjct: 210 L 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 4e-13
Identities = 34/154 (22%), Positives = 53/154 (34%), Gaps = 31/154 (20%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLI------------PDGVTHMTTRVKGTLGYLAPEY 178
D+K SN+ D KV DFG + T +V GT Y++PE
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV-GTKLYMSPEQ 247
Query: 179 AMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238
S D++S G++L EL+ + + + V+ F + +
Sbjct: 248 IHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITD---------VRNLKFPLLFTQK 298
Query: 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDV 272
Q MV +P RP TD+
Sbjct: 299 YP------QEHMMV---QDMLSPSPTERPEATDI 323
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-13
Identities = 42/180 (23%), Positives = 71/180 (39%), Gaps = 31/180 (17%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDERLIVYDYM 94
+++ AVK ++ + E E+ L H N++ L + +V + +
Sbjct: 33 KKSNQ-AFAVK---IISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELL 88
Query: 95 PNHSLITHLHGRL------APDCLLDWHRRVSIAIGSA------EGIA--DIKASNVLL- 139
L + + A + + SA G+ D+K N+L
Sbjct: 89 NGGELFERIKKKKHFSETEASYIMRK--------LVSAVSHMHDVGVVHRDLKPENLLFT 140
Query: 140 --DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLL 197
+ + E K+ DFGFA+L P + T TL Y APE +SCD++S GV+L
Sbjct: 141 DENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 5e-13
Identities = 45/229 (19%), Positives = 71/229 (31%), Gaps = 59/229 (25%)
Query: 36 RETGDD----QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFY---------- 81
+T + +++ +N K EV ++ ++ H N+ L Y
Sbjct: 48 NQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVM 107
Query: 82 ---AGGD--ERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAE--------- 127
GG ++L V+ + C ++ +I
Sbjct: 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQRE 167
Query: 128 --------------------GIA--DIKASNVLLDTDFEA--KVADFGFAKLI----PDG 159
GI DIK N L T+ K+ DFG +K
Sbjct: 168 KLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE 227
Query: 160 VTHMTTRVKGTLGYLAPE--YAMWGKVSDSCDVYSFGVLLLELISAKKP 206
MTT+ GT ++APE CD +S GVLL L+ P
Sbjct: 228 YYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 8e-13
Identities = 56/284 (19%), Positives = 101/284 (35%), Gaps = 82/284 (28%)
Query: 35 RRETGDDQIAVKRL--KTLNAKAEMEFAV----EVEILGRVR----HRNLLGLRGFYAGG 84
R Q+A+K + + + + +V EV +L +V H ++ L ++
Sbjct: 52 RLTDRL-QVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110
Query: 85 DERLIVYDY-MPNHSLITHL--HGRLAPD---------------CLLDWHRRVSIAIGSA 126
+ ++V + +P L ++ G L C H R
Sbjct: 111 EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHC----HSR-------- 158
Query: 127 EGIA--DIKASNVLLDTD-FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGK 183
G+ DIK N+L+D AK+ DFG L+ D T GT Y PE+
Sbjct: 159 -GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFD-GTRVYSPPEWIS-RH 213
Query: 184 VSD--SCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQ---WVTPYVQKGAFEHIADPR 238
V+S G+LL +++ P E+ ++I++ +V
Sbjct: 214 QYHALPATVWSLGILLYDMVCGDIPFER-----DQEILEAELHFPAHVSPDC-------- 260
Query: 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280
LI RC P +RP++ +++ W++
Sbjct: 261 ------CA------LIR-RCLAPKPSSRPSLEEILLDPWMQTPA 291
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 9e-13
Identities = 48/190 (25%), Positives = 81/190 (42%), Gaps = 40/190 (21%)
Query: 36 RETGDDQIAVKRLK------TLNAKAEMEFAV--EVEILGRVRHRNLLGLRGFYAGGDER 87
R+T ++A++ + +A+ V E+EIL ++ H ++ ++ F+ D
Sbjct: 157 RKTCK-KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF---DAE 212
Query: 88 --LIVYDYMPNHSL---ITHLHGRLA-PDCLLDWHRRVSIAIGSA------EGIA--DIK 133
IV + M L + + RL C + + A GI D+K
Sbjct: 213 DYYIVLELMEGGELFDKVVG-NKRLKEATC-----KLYFYQMLLAVQYLHENGIIHRDLK 266
Query: 134 ASNVLLDT---DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPE---YAMWGKVSDS 187
NVLL + D K+ DFG +K++ + + M T GT YLAPE + +
Sbjct: 267 PENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLC-GTPTYLAPEVLVSVGTAGYNRA 324
Query: 188 CDVYSFGVLL 197
D +S GV+L
Sbjct: 325 VDCWSLGVIL 334
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 39/171 (22%), Positives = 73/171 (42%), Gaps = 12/171 (7%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
R TG+ A K + T + + E++ + +RH L+ L + +E +++Y++M
Sbjct: 179 RATGN-NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237
Query: 96 NHSL---ITHLHGRLAPDCLLDWHRRVSIAIGS--AEGIA--DIKASNVLLDTDFEA--K 146
L + H +++ D +++ R+V + D+K N++ T K
Sbjct: 238 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELK 297
Query: 147 VADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLL 197
+ DFG + + GT + APE A V D++S GVL
Sbjct: 298 LIDFGLTAHLDPK-QSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-12
Identities = 38/197 (19%), Positives = 69/197 (35%), Gaps = 60/197 (30%)
Query: 36 RETGDDQIAVKRLKTLNAKAEME-FAVEVEILGRVRHRNLLGLRGFY------------- 81
R +G + +K + ++ ME E+E+L + H N++ + +
Sbjct: 44 RSSGL-ERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC 102
Query: 82 AGGD--ERLIVYDYMPNH--------------SLITHLHGRLAPDCLLDWHRRVSIAIGS 125
GG+ ER++ + + + H +
Sbjct: 103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ------------------- 143
Query: 126 AEGIA--DIKASNVLLDT---DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAM 180
+ D+K N+L K+ DFG A+L T GT Y+APE
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-STNAA-GTALYMAPE-VF 198
Query: 181 WGKVSDSCDVYSFGVLL 197
V+ CD++S GV++
Sbjct: 199 KRDVTFKCDIWSAGVVM 215
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 44/182 (24%), Positives = 71/182 (39%), Gaps = 39/182 (21%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGD-ERL-IVYDYMPNHSLITHL--HGR----------- 106
E++I+ + H L+ L Y+ D E + +V D + L HL +
Sbjct: 65 ELQIMQGLEHPFLVNLW--YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC 122
Query: 107 ---LAPDCLLDWHRRVSIAIGSAEGIA--DIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161
+A D L + I D+K N+LLD + DF A ++P
Sbjct: 123 ELVMALDYL---QNQ---------RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170
Query: 162 HMTTRVKGTLGYLAPEYAMWGKVSD---SCDVYSFGVLLLELISAKKPLEKLPGGVKRDI 218
T + GT Y+APE K + + D +S GV EL+ ++P ++I
Sbjct: 171 ITT--MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI 228
Query: 219 VQ 220
V
Sbjct: 229 VH 230
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 33/238 (13%), Positives = 67/238 (28%), Gaps = 45/238 (18%)
Query: 40 DDQIAVKRLKTLNAKAE---MEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPN 96
D Q+A+ + + E L R+ + + L+V +++
Sbjct: 56 DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRG 115
Query: 97 HSLITHLHGRLAPDCLLDWHRRVSIAIGSA--EGIA--DIKASNVLLDTDFEAKVADFGF 152
SL +P + + ++ A +A G+A S V + D + +A
Sbjct: 116 GSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP-- 173
Query: 153 AKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPG 212
+ + D+ G L L+ + PL
Sbjct: 174 -------------------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLP---- 203
Query: 213 GVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMT 270
V+ ++ +P +RD + +A R + R T
Sbjct: 204 ---EAGVRSGLAPAERDTAGQPIEPA---DIDRDIPFQISAVAARSVQGDGGIRSAST 255
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 48/190 (25%), Positives = 75/190 (39%), Gaps = 37/190 (19%)
Query: 36 RETGDDQIAVK-------RLKTLNAKAEMEFAV--EVEILGRV-RHRNLLGLRGFYAGGD 85
+ T + AVK + E+ A EV+IL +V H N++ L+ Y
Sbjct: 39 KPTCK-EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97
Query: 86 ERLIVYDYMPNHSL---ITHLHGRLA-PDCLLDWHRRVSIAIGSA------EGIA--DIK 133
+V+D M L +T L+ + R++ A+ I D+K
Sbjct: 98 FFFLVFDLMKKGELFDYLTE-KVTLSEKET-----RKIMRALLEVICALHKLNIVHRDLK 151
Query: 134 ASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPE------YAMWGKVSDS 187
N+LLD D K+ DFGF+ + G + GT YLAPE
Sbjct: 152 PENILLDDDMNIKLTDFGFSCQLDPGEK-LREVC-GTPSYLAPEIIECSMNDNHPGYGKE 209
Query: 188 CDVYSFGVLL 197
D++S GV++
Sbjct: 210 VDMWSTGVIM 219
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-12
Identities = 47/177 (26%), Positives = 72/177 (40%), Gaps = 23/177 (12%)
Query: 36 RETGDDQIAVKRL--KTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93
R T + AVK + + K EVE+L ++ H N++ L IV +
Sbjct: 44 RITQQ-EYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102
Query: 94 MPNHSL---IT---HLHGRLAPDCLLDWHRRVSIAIGS--AEGIA--DIKASNVLLDT-- 141
L I A + ++V I I D+K N+LL++
Sbjct: 103 YTGGELFDEIIKRKRFSEHDAARII----KQVFSGITYMHKHNIVHRDLKPENILLESKE 158
Query: 142 -DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLL 197
D + K+ DFG + M R+ GT Y+APE + G + CDV+S GV+L
Sbjct: 159 KDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 50/193 (25%), Positives = 76/193 (39%), Gaps = 26/193 (13%)
Query: 36 RETGDDQI-AVKRLK--TLNAKAEMEFA-VEVEILGRVRHRNLLGLRGFYAGGDE-RL-I 89
+ Q+ A+K + + + E+ E ++L R + L +A DE L +
Sbjct: 81 KMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL--HFAFQDENYLYL 138
Query: 90 VYDYMPNHSLITHLHGRLAPDCLLDWHR----RVSIAIGS--AEGIA--DIKASNVLLDT 141
V +Y L+T L + + R + +AI S G DIK N+LLD
Sbjct: 139 VMEYYVGGDLLTLLS-KFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDR 197
Query: 142 DFEAKVADFGFAK-LIPDGVTHMTTRVKGTLGYLAPE-------YAMWGKVSDSCDVYSF 193
++ADFG L DG V GT YL+PE G CD ++
Sbjct: 198 CGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWAL 256
Query: 194 GVLLLELISAKKP 206
GV E+ + P
Sbjct: 257 GVFAYEMFYGQTP 269
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-12
Identities = 59/262 (22%), Positives = 98/262 (37%), Gaps = 50/262 (19%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLG-----LRGFYAGGDERL- 88
+TG A+K + + E E E+ +L + HRN+ ++ G D++L
Sbjct: 46 VKTGQ-LAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103
Query: 89 IVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAE---GIA----------DIKAS 135
+V ++ S+ + +W IA E G++ DIK
Sbjct: 104 LVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICREILRGLSHLHQHKVIHRDIKGQ 158
Query: 136 NVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDS-----CDV 190
NVLL + E K+ DFG + + V T + GT ++APE + D+ D+
Sbjct: 159 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDL 217
Query: 191 YSFGVLLLELISAKKPLEKL-PGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249
+S G+ +E+ PL + P I + PRLK K + +
Sbjct: 218 WSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA-------------PRLKSKKWSKKFQ 264
Query: 250 SMVLIALRCTDSNPENRPTMTD 271
S + C N RP
Sbjct: 265 SFI---ESCLVKNHSQRPATEQ 283
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 32/192 (16%), Positives = 63/192 (32%), Gaps = 54/192 (28%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
+ TG K + T + E+ I+ ++ H L+ L + E +++ +++
Sbjct: 73 KATGR-VFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131
Query: 96 -----------NHSL---------------ITHLHGRLAPDCLLDWHRRVSIAIGSAEGI 129
++ + + H+H I
Sbjct: 132 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---------------------SI 170
Query: 130 A--DIKASNVLLDTDFEA--KVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVS 185
DIK N++ +T + K+ DFG A + + T + APE V
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTT-ATAEFAAPEIVDREPVG 228
Query: 186 DSCDVYSFGVLL 197
D+++ GVL
Sbjct: 229 FYTDMWAIGVLG 240
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 30/190 (15%), Positives = 56/190 (29%), Gaps = 36/190 (18%)
Query: 48 LKTLNAKAEMEFAV---EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHL- 103
LK EF + +E L + + + ++V + +L+ +
Sbjct: 100 LKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAIN 159
Query: 104 HGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLL-----------DTD 142
+ P+ ++ +S A+ I DIK N +L D
Sbjct: 160 LYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLS 219
Query: 143 FEAKVADFGFA---KLIPDGVTHMTTRVKGTLGYLAPEYAM---WGKVSDSCDVYSFGVL 196
+ D G + KL P G T + T G+ E W D +
Sbjct: 220 AGLALIDLGQSIDMKLFPKGTI-FTAKC-ETSGFQCVEMLSNKPWNY---QIDYFGVAAT 274
Query: 197 LLELISAKKP 206
+ ++
Sbjct: 275 VYCMLFGTYM 284
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 37/194 (19%)
Query: 35 RRETGDDQIAVKRLKTLNAKAEMEFAV--EVEILGRVRHRNLLGLRGFY----------- 81
R T + AVK + +AK + + EVE+L ++ H N++ L
Sbjct: 43 DRITQQ-EYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101
Query: 82 --AGGDERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGS--AEGIA--DIKAS 135
GG+ ++D + A + ++V I I D+K
Sbjct: 102 LYTGGE----LFDEIIKRK---RFSEHDAARII----KQVFSGITYMHKHNIVHRDLKPE 150
Query: 136 NVLLDT---DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYS 192
N+LL++ D + K+ DFG + M R+ GT Y+APE + G + CDV+S
Sbjct: 151 NILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAYYIAPE-VLRGTYDEKCDVWS 207
Query: 193 FGVLLLELISAKKP 206
GV+L L+S P
Sbjct: 208 AGVILYILLSGTPP 221
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 41/192 (21%), Positives = 72/192 (37%), Gaps = 54/192 (28%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
TG ++A K +KT K + E E+ ++ ++ H NL+ L + ++ ++V +Y+
Sbjct: 111 TATGL-KLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169
Query: 96 -----------NHSL---------------ITHLHGRLAPDCLLDWHRRVSIAIGSAEGI 129
+++L I H+H I
Sbjct: 170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---------------------YI 208
Query: 130 A--DIKASNVLLDTDFEA--KVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVS 185
D+K N+L K+ DFG A+ + GT +LAPE + VS
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LKVNF-GTPEFLAPEVVNYDFVS 266
Query: 186 DSCDVYSFGVLL 197
D++S GV+
Sbjct: 267 FPTDMWSVGVIA 278
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-12
Identities = 39/186 (20%), Positives = 72/186 (38%), Gaps = 32/186 (17%)
Query: 36 RETGDD----QIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91
RETG + V + + + + E I ++H +++ L Y+ +V+
Sbjct: 46 RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVF 105
Query: 92 DYMPN----HSLITHLHG------RLAPDCLLDWHRRVSIAIGS--AEGIA--DIKASNV 137
++M ++ +A + R++ A+ I D+K V
Sbjct: 106 EFMDGADLCFEIVKRADAGFVYSEAVASHYM----RQILEALRYCHDNNIIHRDVKPHCV 161
Query: 138 LLDTDFEA---KVADFGFAKLIPDGVTHMTTRVKGTLGYLAPE---YAMWGKVSDSCDVY 191
LL + + K+ FG A + + RV GT ++APE +GK DV+
Sbjct: 162 LLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVKREPYGK---PVDVW 217
Query: 192 SFGVLL 197
GV+L
Sbjct: 218 GCGVIL 223
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 4e-12
Identities = 44/185 (23%), Positives = 71/185 (38%), Gaps = 38/185 (20%)
Query: 36 RETGDDQIAVKRLKT--LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93
+ TG + A K + T L+A+ + E I +++H N++ L +V+D
Sbjct: 28 KTTGL-EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86
Query: 94 MPNHSL---IT---HLHGRLAPDCLLD-------WHRRVSIAIGSAEGIA--DIKASNVL 138
+ L I A C+ H GI ++K N+L
Sbjct: 87 VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---------GIVHRNLKPENLL 137
Query: 139 LDT---DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPE---YAMWGKVSDSCDVYS 192
L + K+ADFG A + D GT GYL+PE + K D+++
Sbjct: 138 LASKAKGAAVKLADFGLAIEVNDSEA-WHGFA-GTPGYLSPEVLKKDPYSK---PVDIWA 192
Query: 193 FGVLL 197
GV+L
Sbjct: 193 CGVIL 197
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-12
Identities = 55/280 (19%), Positives = 93/280 (33%), Gaps = 83/280 (29%)
Query: 62 EVEILGRVRHRNLLGLRGFYA--------------GGDERLIVYDYMPNH---------- 97
E+ IL RV H N++ + + G D ++ ++ H
Sbjct: 79 EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLD----LFAFIDRHPRLDEPLASY 134
Query: 98 ------SLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIADIKASNVLLDTDFEAKVADFG 151
S + +L + HR DIK N+++ DF K+ DFG
Sbjct: 135 IFRQLVSAVGYLRLKDI------IHR-------------DIKDENIVIAEDFTIKLIDFG 175
Query: 152 FAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSD--SCDVYSFGVLLLELISAKKPLEK 209
A + G T GT+ Y APE M G +++S GV L L+ + P +
Sbjct: 176 SAAYLERG-KLFYTFC-GTIEYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEENPFCE 232
Query: 210 LPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTM 269
L + V + A P L K + ++ PE R T+
Sbjct: 233 L-----EETV--------EAAIH---PPYLVSKELMSLVSGLL-------QPVPERRTTL 269
Query: 270 TDVVD--WLKGGLGRRTKDVKDVAGEDDEDNDDNDTDFEE 307
+V W+ + ++V + ++ E
Sbjct: 270 EKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLE 309
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-12
Identities = 47/186 (25%), Positives = 73/186 (39%), Gaps = 41/186 (22%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFY----AGGDERLIV 90
R TG + A+K L + EV+ + +++ + Y G LI+
Sbjct: 51 RRTGQ-KCALKLLY----DSPKARQ-EVDHHWQASGGPHIVCILDVYENMHHGKRCLLII 104
Query: 91 YDYMPNHSLITHLHGRL--------APDCLLDWHRRVSIAIGSA------EGIA--DIKA 134
+ M L + + R A + + D IG+A IA D+K
Sbjct: 105 MECMEGGELFSRIQERGDQAFTEREAAEIMRD--------IGTAIQFLHSHNIAHRDVKP 156
Query: 135 SNVLL---DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVY 191
N+L + D K+ DFGFAK + T T Y+APE K SCD++
Sbjct: 157 ENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYVAPEVLGPEKYDKSCDMW 213
Query: 192 SFGVLL 197
S GV++
Sbjct: 214 SLGVIM 219
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-12
Identities = 41/175 (23%), Positives = 70/175 (40%), Gaps = 21/175 (12%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
+ T + A K++ + F E+EI+ + H N++ L + + +V +
Sbjct: 31 KGTRI-RRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCT 89
Query: 96 NHSL---IT---HLHGRLAPDCLLDWHRRVSIAIGS--AEGIA--DIKASNVLLDT---D 142
L + A + + V A+ +A D+K N L T D
Sbjct: 90 GGELFERVVHKRVFRESDAARIM----KDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPD 145
Query: 143 FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLL 197
K+ DFG A G M T+V GT Y++P+ + G CD +S GV++
Sbjct: 146 SPLKLIDFGLAARFKPGKM-MRTKV-GTPYYVSPQ-VLEGLYGPECDEWSAGVMM 197
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 6e-12
Identities = 49/190 (25%), Positives = 81/190 (42%), Gaps = 40/190 (21%)
Query: 36 RETGDDQIAVKRLK------TLNAKAEMEFAV--EVEILGRVRHRNLLGLRGFYAGGDER 87
R+T ++A+K + +A+ V E+EIL ++ H ++ ++ F+ D
Sbjct: 32 RKTCK-KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF---DAE 87
Query: 88 --LIVYDYMPNHSL---ITHLHGRLA-PDCLLDWHRRVSIAIGSA------EGIA--DIK 133
IV + M L + + RL C + + A GI D+K
Sbjct: 88 DYYIVLELMEGGELFDKVVG-NKRLKEATC-----KLYFYQMLLAVQYLHENGIIHRDLK 141
Query: 134 ASNVLLDTDFEA---KVADFGFAKLIPDGVTHMTTRVKGTLGYLAPE---YAMWGKVSDS 187
NVLL + E K+ DFG +K++ + + M T GT YLAPE + +
Sbjct: 142 PENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLC-GTPTYLAPEVLVSVGTAGYNRA 199
Query: 188 CDVYSFGVLL 197
D +S GV+L
Sbjct: 200 VDCWSLGVIL 209
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 8e-12
Identities = 56/318 (17%), Positives = 101/318 (31%), Gaps = 64/318 (20%)
Query: 36 RETGDDQIAVKRL-KTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94
R T + +AVK + E+ I + H N++ G G+ + + +Y
Sbjct: 29 RVTEE-AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87
Query: 95 PNHSLITHL--HGRLAPD---------------CLLDWHRRVSIAIGSAEGIA--DIKAS 135
L + + H GI DIK
Sbjct: 88 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL----HGI---------GITHRDIKPE 134
Query: 136 NVLLDTDFEAKVADFGFAKLIPDGVT--HMTTRVKGTLGYLAPE------YAMWGKVSDS 187
N+LLD K++DFG A + + GTL Y+APE + +
Sbjct: 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREFH--AEPV-- 189
Query: 188 CDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQ 247
DV+S G++L +++ + P ++ P ++ W + ++
Sbjct: 190 -DVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWK-----EKKTYLNPWKKID-SAPLAL 241
Query: 248 LKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLGRRTKDVKDVAGEDDEDNDDNDTDF 305
L ++ NP R T+ D+ W L + K + +G E
Sbjct: 242 LHKIL-------VENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHI 294
Query: 306 EERYFKMEQSNIRRVAGF 323
+ ++ R G
Sbjct: 295 QSNLDFSPVNSASRTPGS 312
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 8e-12
Identities = 48/187 (25%), Positives = 79/187 (42%), Gaps = 24/187 (12%)
Query: 36 RETGDDQIAVKRLKT--LNAKAEME-FAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
+ TG + AVK + + K + E EV++L ++ H N++ L F+ +V +
Sbjct: 48 KITGQ-ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106
Query: 93 YMPNHSLI------THLHGRLAPDCLLDWHRRVSIAIGS--AEGIA--DIKASNVLLDT- 141
L A + R+V I I D+K N+LL++
Sbjct: 107 VYTGGELFDEIISRKRFSEVDAARII----RQVLSGITYMHKNKIVHRDLKPENLLLESK 162
Query: 142 --DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLE 199
D ++ DFG + M ++ GT Y+APE + G + CDV+S GV+L
Sbjct: 163 SKDANIRIIDFGLSTHFEASKK-MKDKI-GTAYYIAPE-VLHGTYDEKCDVWSTGVILYI 219
Query: 200 LISAKKP 206
L+S P
Sbjct: 220 LLSGCPP 226
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 8e-12
Identities = 54/196 (27%), Positives = 80/196 (40%), Gaps = 34/196 (17%)
Query: 36 RETGDDQI-AVKRLKTLNAKAEMEFAVEVE-------ILGRVRHRNLLGLRGFYAGGD-E 86
+ D++ A+K L K EM E +L + + L YA D
Sbjct: 94 KLKNADKVFAMKILN----KWEMLKRAETACFREERDVLVNGDSKWITTL--HYAFQDDN 147
Query: 87 RL-IVYDYMPNHSLITHLHGRLAPDCLLDWHRR-----VSIAIGS--AEGIA--DIKASN 136
L +V DY L+T L D L + R + IAI S DIK N
Sbjct: 148 NLYLVMDYYVGGDLLTLL--SKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDN 205
Query: 137 VLLDTDFEAKVADFGFAK-LIPDGVTHMTTRVKGTLGYLAPE-----YAMWGKVSDSCDV 190
+L+D + ++ADFG L+ DG + V GT Y++PE G+ CD
Sbjct: 206 ILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDW 264
Query: 191 YSFGVLLLELISAKKP 206
+S GV + E++ + P
Sbjct: 265 WSLGVCMYEMLYGETP 280
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 42/191 (21%), Positives = 80/191 (41%), Gaps = 23/191 (12%)
Query: 33 LLRRETGDDQI-AVKRLKTLNAKAEMEFAVEVE-------ILGRVRHRNLLGLRGFYAGG 84
+L RE + A+K L+ K + +V ++ R+ H + L ++
Sbjct: 47 VLARELATSREYAIKILE----KRHIIKENKVPYVTRERDVMSRLDHPFFVKL--YFTFQ 100
Query: 85 DE-RL-IVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGS--AEGIA--DIKASN 136
D+ +L Y N L+ ++ G C + + A+ +GI D+K N
Sbjct: 101 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 160
Query: 137 VLLDTDFEAKVADFGFAKLIPDGVTHMTTR-VKGTLGYLAPEYAMWGKVSDSCDVYSFGV 195
+LL+ D ++ DFG AK++ GT Y++PE S D+++ G
Sbjct: 161 ILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGC 220
Query: 196 LLLELISAKKP 206
++ +L++ P
Sbjct: 221 IIYQLVAGLPP 231
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 47/189 (24%), Positives = 75/189 (39%), Gaps = 36/189 (19%)
Query: 36 RETGDDQIAVK--RLKTLNAKAEMEFAV------EVEILGRVR-HRNLLGLRGFYAGGDE 86
R TG + AVK + E V E IL +V H +++ L Y
Sbjct: 116 RATGH-EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174
Query: 87 RLIVYDYMPNHSL---ITHLHGRLA-PDCLLDWHRRVSIAIGSA------EGIA--DIKA 134
+V+D M L +T L+ + R + ++ A I D+K
Sbjct: 175 MFLVFDLMRKGELFDYLTE-KVALSEKET-----RSIMRSLLEAVSFLHANNIVHRDLKP 228
Query: 135 SNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPE------YAMWGKVSDSC 188
N+LLD + + +++DFGF+ + G + GT GYLAPE
Sbjct: 229 ENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC-GTPGYLAPEILKCSMDETHPGYGKEV 286
Query: 189 DVYSFGVLL 197
D+++ GV+L
Sbjct: 287 DLWACGVIL 295
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 55/258 (21%), Positives = 93/258 (36%), Gaps = 53/258 (20%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFA---VEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
+ +A+K++ ++ ++ EV L ++RH N + RG Y +V +
Sbjct: 76 VRNSE-VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134
Query: 93 YMPNHS--LITHLHGRLAPDCLLDWHRRVSIAIGSAE---GIA----------DIKASNV 137
Y + L+ L IA + G+A D+KA N+
Sbjct: 135 YCLGSASDLLEVHKKPLQEVE---------IAAVTHGALQGLAYLHSHNMIHRDVKAGNI 185
Query: 138 LLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSD---SCDVYSFG 194
LL K+ DFG A ++ + V GT ++APE + DV+S G
Sbjct: 186 LLSEPGLVKLGDFGSASIM----APANSFV-GTPYWMAPEVILAMDEGQYDGKVDVWSLG 240
Query: 195 VLLLELISAKKPLEKL-PGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVL 253
+ +EL K PL + I Q + P L+ + ++ V
Sbjct: 241 ITCIELAERKPPLFNMNAMSALYHIAQNES-------------PALQSGHWSEYFRNFV- 286
Query: 254 IALRCTDSNPENRPTMTD 271
C P++RPT
Sbjct: 287 --DSCLQKIPQDRPTSEV 302
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 28/180 (15%)
Query: 36 RETGDDQIAVKRLKT--LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93
+ TG + A K + T L+A+ + E I +++H N++ L +V+D
Sbjct: 51 KTTGL-EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 109
Query: 94 MPNHSL---IT---HLHGRLAPDCLLDWHRRVSIAIGS--AEGIA--DIKASNVLLDTDF 143
+ L I A C+ +++ +I + GI ++K N+LL +
Sbjct: 110 VTGGELFEDIVAREFYSEADASHCI----QQILESIAYCHSNGIVHRNLKPENLLLASKA 165
Query: 144 EA---KVADFGFAKLIPDGVTHMTTRVKGTLGYLAPE---YAMWGKVSDSCDVYSFGVLL 197
+ K+ADFG A + D GT GYL+PE + K D+++ GV+L
Sbjct: 166 KGAAVKLADFGLAIEVNDSEA-WHGFA-GTPGYLSPEVLKKDPYSK---PVDIWACGVIL 220
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-11
Identities = 35/142 (24%), Positives = 55/142 (38%), Gaps = 20/142 (14%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPE----YAMWGKVSD 186
D+K SNVL++ + K+ DFG + + D V G Y+APE S
Sbjct: 135 DVKPSNVLINALGQVKMCDFGISGYLVDDVA-KDIDA-GCKPYMAPERINPELNQKGYSV 192
Query: 187 SCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRD 246
D++S G+ ++EL + P + W TP+ Q P+L
Sbjct: 193 KSDIWSLGITMIELAILRFPYDS-----------WGTPFQQLKQVVEEPSPQLPADKFSA 241
Query: 247 QLKSMVLIALRCTDSNPENRPT 268
+ +C N + RPT
Sbjct: 242 EFVDFT---SQCLKKNSKERPT 260
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 53/197 (26%), Positives = 83/197 (42%), Gaps = 39/197 (19%)
Query: 36 RETGDDQI-AVKRLKTLNAKAEMEFAVEVE-------ILGRVRHRNLLGLRGFYAGGDER 87
R ++ A+K L K EM + I+ ++ L FYA D+R
Sbjct: 89 RHKSTRKVYAMKLLS----KFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FYAFQDDR 142
Query: 88 LI--VYDYMPNHSLITHLHGRLAPDCLLDWHR----RVSIAIGS--AEGIA--DIKASNV 137
+ V +YMP L+ + P+ W R V +A+ + + G D+K N+
Sbjct: 143 YLYMVMEYMPGGDLVNLMSNYDVPE---KWARFYTAEVVLALDAIHSMGFIHRDVKPDNM 199
Query: 138 LLDTDFEAKVADFGFAK-LIPDGVTHMTTRVKGTLGYLAPE-------YAMWGKVSDSCD 189
LLD K+ADFG + +G+ T V GT Y++PE +G+ CD
Sbjct: 200 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGR---ECD 255
Query: 190 VYSFGVLLLELISAKKP 206
+S GV L E++ P
Sbjct: 256 WWSVGVFLYEMLVGDTP 272
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 47/186 (25%), Positives = 75/186 (40%), Gaps = 40/186 (21%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFY----AGGDERLIV 90
+ T + + A+K L+ EVE+ R + +++ + Y AG LIV
Sbjct: 84 KRTQE-KFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137
Query: 91 YDYMPNHSLITHLHGRL--------APDCLLDWHRRVSIAIGSA------EGIA--DIKA 134
+ + L + + R A + + IG A IA D+K
Sbjct: 138 MECLDGGELFSRIQDRGDQAFTEREASEIMKS--------IGEAIQYLHSINIAHRDVKP 189
Query: 135 SNVLLDTDFEA---KVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVY 191
N+L + K+ DFGFAK + +TT T Y+APE K SCD++
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYYVAPEVLGPEKYDKSCDMW 247
Query: 192 SFGVLL 197
S GV++
Sbjct: 248 SLGVIM 253
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 5e-11
Identities = 41/198 (20%), Positives = 69/198 (34%), Gaps = 59/198 (29%)
Query: 36 RETGDD----QIAVKRLKTLNAKAEMEFAV-EVEILGRVRHRNLLGLRGFY--------- 81
+ TG + I +RL + E EV IL +RH N++ L +
Sbjct: 27 KGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLI 86
Query: 82 ----AGGD--ERLIVYDYMPNH----------SLITHLHGRLAPDCLLDWHRRVSIAIGS 125
+GG+ + L + + + +LH +
Sbjct: 87 LELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK------------------- 127
Query: 126 AEGIA--DIKASNVLL----DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYA 179
IA D+K N++L + K+ DFG A I G GT ++APE
Sbjct: 128 --RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF-GTPEFVAPEIV 183
Query: 180 MWGKVSDSCDVYSFGVLL 197
+ + D++S GV+
Sbjct: 184 NYEPLGLEADMWSIGVIT 201
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 39/200 (19%), Positives = 66/200 (33%), Gaps = 67/200 (33%)
Query: 36 RETGDDQIAVKRL--KTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93
G + A + K L+A+ + E I ++H N++ L + +++D
Sbjct: 33 VLAGQ-EYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL 91
Query: 94 MPNHSL-------------------------ITHLHGRLAPDCLLDWHRRVSIAIGSAEG 128
+ L + H H G
Sbjct: 92 VTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---------------------G 130
Query: 129 IA--DIKASNVLLDT---DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPE------ 177
+ ++K N+LL + K+ADFG A + GT GYL+PE
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVLRKDP 189
Query: 178 YAMWGKVSDSCDVYSFGVLL 197
Y GK D+++ GV+L
Sbjct: 190 Y---GK---PVDLWACGVIL 203
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 6e-11
Identities = 40/175 (22%), Positives = 64/175 (36%), Gaps = 54/175 (30%)
Query: 62 EVEILGRVRHRNLLGLRGFY-------------AGGD--ERLIVYDYMPNH--------- 97
E+ +L + H N++ L + GG+ E++I
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 98 -SLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA--DIKASNVLLDT---DFEAKVADFG 151
S I +LH I DIK N+LL+ K+ DFG
Sbjct: 156 LSGICYLHKH---------------------NIVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 152 FAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKP 206
+ + R+ GT Y+APE + K ++ CDV+S GV++ L+ P
Sbjct: 195 LSSFFSKDYK-LRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 8e-11
Identities = 65/292 (22%), Positives = 111/292 (38%), Gaps = 64/292 (21%)
Query: 36 RETGDDQIAVKRL-KTLNAKAEMEFAV--EVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
TG ++AVK L + ++ + E++ L RH +++ L + + +V +
Sbjct: 38 ELTGH-KVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96
Query: 93 YMPNHSLITHL--HGRLAPD---------------CLLDWHRRVSIAIGSAEGIA--DIK 133
Y+ L ++ +GRL C HR + D+K
Sbjct: 97 YVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYC----HRH---------MVVHRDLK 143
Query: 134 ASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSD--SCDVY 191
NVLLD AK+ADFG + ++ DG T+ G+ Y APE G++ D++
Sbjct: 144 PENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS-GRLYAGPEVDIW 200
Query: 192 SFGVLLLELISAKKPL--EKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249
S GV+L L+ P + +P K+ + G F P+ LK
Sbjct: 201 SSGVILYALLCGTLPFDDDHVPTLFKK---------ICDGIFY---TPQYLNPSVISLLK 248
Query: 250 SMVLIALRCTDSNPENRPTMTDVV--DWLKGGLGRRTKDVKDVAGEDDEDND 299
M+ +P R T+ D+ +W K L + D++
Sbjct: 249 HML-------QVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDE 293
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 38/175 (21%), Positives = 57/175 (32%), Gaps = 38/175 (21%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDS--- 187
D+K SN+LLD + K+ DFG + + D G Y+APE +
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGRLVDDKA-KDRSA-GCAAYMAPERIDPPDPTKPDYD 207
Query: 188 --CDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN- 244
DV+S G+ L+EL + + P + T + P L G
Sbjct: 208 IRADVWSLGISLVELATGQFPYKN-----------CKTDFEVLTKVLQEEPPLLPGHMGF 256
Query: 245 RDQLKSMVLIALRCTDSNPENRPT----------------MTDVVDWLKGGLGRR 283
+S V C + RP DV W K + +
Sbjct: 257 SGDFQSFV---KDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKT 308
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 41/198 (20%), Positives = 68/198 (34%), Gaps = 59/198 (29%)
Query: 36 RETGDD----QIAVKRLKTLNAKAEMEFAV-EVEILGRVRHRNLLGLRGFY--------- 81
+ TG + I ++ + E EV IL +V H N++ L Y
Sbjct: 34 KSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLI 93
Query: 82 ----AGGD--ERLIVYDYMPNH----------SLITHLHGRLAPDCLLDWHRRVSIAIGS 125
+GG+ + L + + + +LH +
Sbjct: 94 LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK------------------- 134
Query: 126 AEGIA--DIKASNVLL----DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYA 179
IA D+K N++L K+ DFG A I DG GT ++APE
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIF-GTPEFVAPEIV 190
Query: 180 MWGKVSDSCDVYSFGVLL 197
+ + D++S GV+
Sbjct: 191 NYEPLGLEADMWSIGVIT 208
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 2e-10
Identities = 64/273 (23%), Positives = 108/273 (39%), Gaps = 64/273 (23%)
Query: 36 RETGDDQIAVKRL-KTLNAKAEMEFAV--EVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
+ TG ++AVK L + ++ + E++ L RH +++ L + + +V +
Sbjct: 33 QLTGH-KVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91
Query: 93 YMPNHSLITHL--HGRLAPD---------------CLLDWHRRVSIAIGSAEGIA--DIK 133
Y+ L ++ HGR+ C HR + D+K
Sbjct: 92 YVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYC----HRH---------MVVHRDLK 138
Query: 134 ASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSD--SCDVY 191
NVLLD AK+ADFG + ++ DG T+ G+ Y APE G++ D++
Sbjct: 139 PENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS-GRLYAGPEVDIW 195
Query: 192 SFGVLLLELISAKKPL--EKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249
S GV+L L+ P E +P K+ ++ G F P + L
Sbjct: 196 SCGVILYALLCGTLPFDDEHVPTLFKK---------IRGGVFY---IPEYLNRSVATLLM 243
Query: 250 SMVLIALRCTDSNPENRPTMTDVV--DWLKGGL 280
M+ +P R T+ D+ +W K L
Sbjct: 244 HML-------QVDPLKRATIKDIREHEWFKQDL 269
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 59.8 bits (146), Expect = 2e-10
Identities = 42/171 (24%), Positives = 72/171 (42%), Gaps = 36/171 (21%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPN--HSLITHLHGRLAPDC-------L 112
E+ +L ++H+N++ L + +V+++ +G L P+ L
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL 110
Query: 113 LD--------W--HRRVSIAIGSAEGIADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162
L HR D+K N+L++ + E K+A+FG A+ V
Sbjct: 111 LKGLGFCHSRNVLHR-------------DLKPQNLLINRNGELKLANFGLARAFGIPVRC 157
Query: 163 MTTRVKGTLGYLAPEYAMWGKV-SDSCDVYSFGVLLLELISAKKPLEKLPG 212
+ V TL Y P+ K+ S S D++S G + EL +A +PL PG
Sbjct: 158 YSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL--FPG 205
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 34/180 (18%), Positives = 70/180 (38%), Gaps = 25/180 (13%)
Query: 36 RETGDDQIAVKRLKT--LNAKAEMEFAVEVEILGRVRHR-NLLGLRGFYAGGDERLIVYD 92
+ TG + A K LK E E+ +L + ++ L Y E +++ +
Sbjct: 51 KSTGQ-EYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILE 109
Query: 93 YMPN----HSLITHLHGRL----APDCLLDWHRRVSIAIGS--AEGIA--DIKASNVLLD 140
Y + L + + +++ + I D+K N+LL
Sbjct: 110 YAAGGEIFSLCLPELAEMVSENDVIRLI----KQILEGVYYLHQNNIVHLDLKPQNILLS 165
Query: 141 TDFEA---KVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLL 197
+ + K+ DFG ++ I + + GT YLAPE + ++ + D+++ G++
Sbjct: 166 SIYPLGDIKIVDFGMSRKIGHACE-LREIM-GTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 40/181 (22%), Positives = 72/181 (39%), Gaps = 25/181 (13%)
Query: 36 RETGDD----QIAVKRLKTLNAKAEME-FAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90
+ TG + I ++ + E EV IL +V H N++ L Y + +++
Sbjct: 34 KSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI 93
Query: 91 YDYMPNHSL---IT---HLHGRLAPDCLLDWHRRVSIAIGS--AEGIA--DIKASNVLL- 139
+ + L + L A + +++ + + IA D+K N++L
Sbjct: 94 LELVSGGELFDFLAQKESLSEEEATSFI----KQILDGVNYLHTKKIAHFDLKPENIMLL 149
Query: 140 ---DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVL 196
K+ DFG A I DGV GT ++APE + + D++S GV+
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 207
Query: 197 L 197
Sbjct: 208 T 208
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 62/309 (20%), Positives = 99/309 (32%), Gaps = 82/309 (26%)
Query: 36 RETGDDQIAVKRL--KTLNAKAEMEFAV--EVEILGRVRHRNLLGLRGF----------- 80
ET + AVK L K L E V E+++L R+RH+N++ L
Sbjct: 27 SETLC-RRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85
Query: 81 ---YA-GGDERLIVYDYMPNHSLITHLHGRLAPD---------------CLLDWHRRVSI 121
Y G + + D +P R H +
Sbjct: 86 VMEYCVCGMQEM--LDSVP--------EKRFPVCQAHGYFCQLIDGLEYL----HSQ--- 128
Query: 122 AIGSAEGIA--DIKASNVLLDTDFEAKVADFGFAKLIPDGVT-HMTTRVKGTLGYLAPEY 178
GI DIK N+LL T K++ G A+ + +G+ + PE
Sbjct: 129 ------GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 179 AMWGKVSD--SCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD 236
A D++S GV L + + P E D + + + KG++
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-------DNIYKLFENIGKGSYA---I 232
Query: 237 PRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLGRRTKDVKDVAGED 294
P G D LK M+ + P R ++ + W + V D
Sbjct: 233 PGDCGPPLSDLLKGML-------EYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPD 285
Query: 295 DEDNDDNDT 303
+D + T
Sbjct: 286 TKDRWRSMT 294
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 47/178 (26%), Positives = 77/178 (43%), Gaps = 28/178 (15%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
+ T A+K LK + E+ +L R+ H N++ L+ + E +V + +
Sbjct: 75 KGTQK-PYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131
Query: 96 NHSL---IT---HLHGRLAPDCLLDWHRRVSIAIGS--AEGIA--DIKASNVLLDT---D 142
L I + R A D + +++ A+ GI D+K N+L T D
Sbjct: 132 GGELFDRIVEKGYYSERDAADAV----KQILEAVAYLHENGIVHRDLKPENLLYATPAPD 187
Query: 143 FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPE---YAMWGKVSDSCDVYSFGVLL 197
K+ADFG +K++ V M T GT GY APE +G D++S G++
Sbjct: 188 APLKIADFGLSKIVEHQVL-MKTVC-GTPGYCAPEILRGCAYGP---EVDMWSVGIIT 240
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 42/198 (21%), Positives = 67/198 (33%), Gaps = 59/198 (29%)
Query: 36 RETGDD----QIAVKRLKTLNAKAEMEFAV-EVEILGRVRHRNLLGLRGFY--------- 81
+ TG I +R K+ E EV IL ++H N++ L Y
Sbjct: 33 KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 92
Query: 82 ----AGGD--ERLIVYDYMPNH----------SLITHLHGRLAPDCLLDWHRRVSIAIGS 125
AGG+ + L + + + + +LH
Sbjct: 93 LELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL------------------- 133
Query: 126 AEGIA--DIKASNVLLDT----DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYA 179
IA D+K N++L K+ DFG A I G GT ++APE
Sbjct: 134 --QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIF-GTPEFVAPEIV 189
Query: 180 MWGKVSDSCDVYSFGVLL 197
+ + D++S GV+
Sbjct: 190 NYEPLGLEADMWSIGVIT 207
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-10
Identities = 38/160 (23%), Positives = 70/160 (43%), Gaps = 21/160 (13%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERLI--VYDYMPNHSLITHL-HGRLAPDCLLDWHRR 118
E+ IL ++ H N++ L +E + V++ + ++ L+ D + +
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQD 145
Query: 119 VSIAIG--SAEGIA--DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL 174
+ I + I DIK SN+L+ D K+ADFG + ++ V GT ++
Sbjct: 146 LIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV-GTPAFM 204
Query: 175 APE--------YAMWGKVSDSCDVYSFGVLLLELISAKKP 206
APE ++ GK + DV++ GV L + + P
Sbjct: 205 APESLSETRKIFS--GK---ALDVWAMGVTLYCFVFGQCP 239
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 3e-10
Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 45/204 (22%)
Query: 36 RETGDDQI-AVKRLKTLNAKAEMEFAV------EVEILGRVRHRNLLGLRGFYAGGDERL 88
R+ +QI A+K++K L ++E + + E+++L + H N++GL +
Sbjct: 30 RDKNTNQIVAIKKIK-LGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88
Query: 89 IVYDYMPN--HSLITHLHGRLAPD---CLL------------DW--HRRVSIAIGSAEGI 129
+V+D+M +I L P + W HR
Sbjct: 89 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR------------ 136
Query: 130 ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKV-SDSC 188
D+K +N+LLD + K+ADFG AK T +V T Y APE ++
Sbjct: 137 -DLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPELLFGARMYGVGV 194
Query: 189 DVYSFGVLLLELISAKKPLEKLPG 212
D+++ G +L EL+ + P LPG
Sbjct: 195 DMWAVGCILAELLL-RVPF--LPG 215
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-10
Identities = 43/268 (16%), Positives = 83/268 (30%), Gaps = 58/268 (21%)
Query: 34 LRRETGDDQIAVKR--LKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIV 90
++R G A+KR + E EV + +H +++ +A D LI
Sbjct: 31 VKRLDGC-IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89
Query: 91 YDYMPNHSLITHL------HGRLAPDCLLDWHRRVSIAIGS--AEGIA--DIKASNVLLD 140
+Y SL + L D +V + + + DIK SN+ +
Sbjct: 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFIS 149
Query: 141 TD-------------------FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMW 181
K+ D G I +G +LA E
Sbjct: 150 RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQE 204
Query: 182 GKVSDS-CDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240
D+++ + ++ A +PL + +++G PR+
Sbjct: 205 NYTHLPKADIFALALTVVCAAGA-EPLPRNGDQWHE---------IRQGRL-----PRIP 249
Query: 241 GKFNRDQLKSMVLIALRCTDSNPENRPT 268
+++ ++ +PE RP+
Sbjct: 250 QVLSQE-FTELL---KVMIHPDPERRPS 273
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 57/308 (18%), Positives = 104/308 (33%), Gaps = 62/308 (20%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAV--EVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93
+ T + +AVK + A ++ V E+ +RH N++ + I+ +Y
Sbjct: 42 KLTKE-LVAVK---YIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97
Query: 94 MPNHSLITHL--HGRLAPD----------CLLDW-HRRVSIAIGSAEGIA--DIKASNVL 138
L + GR + D + + H I D+K N L
Sbjct: 98 ASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---------QICHRDLKLENTL 148
Query: 139 LDTDFEA--KVADFGFAKLIPDGVTHMTTRVKGTLGYLAPE------YAMWGKVSDSCDV 190
LD K+ DFG++K + + V GT Y+APE Y GK++ DV
Sbjct: 149 LDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAPEVLLRQEYD--GKIA---DV 201
Query: 191 YSFGVLLLELISAKKPLE--KLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQL 248
+S GV L ++ P E + P ++ I + + + I D +
Sbjct: 202 WSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR-----ILSVKY-SIPDDIRISPECCHLI 255
Query: 249 KSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLGRRTKDVKDVAGEDDEDNDDNDTDFE 306
+ ++P R ++ ++ W L + + + E +
Sbjct: 256 SRIF-------VADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDT 308
Query: 307 ERYFKMEQ 314
E
Sbjct: 309 IMQIISEA 316
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-10
Identities = 35/192 (18%), Positives = 63/192 (32%), Gaps = 55/192 (28%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
+ K +K ++ E+ IL RHRN+L L + +E +++++++
Sbjct: 27 TSSKK-TYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84
Query: 96 -----------NHSL---------------ITHLHGRLAPDCLLDWHRRVSIAIGSAEGI 129
L + LH I
Sbjct: 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---------------------NI 123
Query: 130 A--DIKASNVLLDTDFEA--KVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVS 185
DI+ N++ T + K+ +FG A+ + G Y APE VS
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLF-TAPEYYAPEVHQHDVVS 181
Query: 186 DSCDVYSFGVLL 197
+ D++S G L+
Sbjct: 182 TATDMWSLGTLV 193
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 40/179 (22%), Positives = 60/179 (33%), Gaps = 45/179 (25%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDS--- 187
DIK SN+LLD K+ DFG + + D + TR G Y+APE
Sbjct: 151 DIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERIDPSASRQGYDV 208
Query: 188 -CDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD---PRLKGKF 243
DV+S G+ L EL + + P K W + + Q + P+L
Sbjct: 209 RSDVWSLGITLYELATGRFPYPK-----------WNSVFDQ---LTQVVKGDPPQLSNSE 254
Query: 244 NR---DQLKSMVLIALRCTDSNPENRPT----------------MTDVVDWLKGGLGRR 283
R + V C + RP +V ++ L +
Sbjct: 255 EREFSPSFINFV---NLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQM 310
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 8e-10
Identities = 51/275 (18%), Positives = 90/275 (32%), Gaps = 64/275 (23%)
Query: 36 RETGDDQIAVKRL-KTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94
R T + +AVK + E+ I + H N++ G G+ + + +Y
Sbjct: 29 RVTEE-AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87
Query: 95 PNHSLITHL--HGRLAPD---------------CLLDWHRRVSIAIGSAEGIA--DIKAS 135
L + + H GI DIK
Sbjct: 88 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL----HGI---------GITHRDIKPE 134
Query: 136 NVLLDTDFEAKVADFGFAKLIPDGVT--HMTTRVKGTLGYLAPE------YAMWGKVSDS 187
N+LLD K++DFG A + + GTL Y+APE + +
Sbjct: 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREFH--AEPV-- 189
Query: 188 CDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQ 247
DV+S G++L +++ + P ++ P ++ W + ++
Sbjct: 190 -DVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWK-----EKKTYLNPWKKI-DSAPLAL 241
Query: 248 LKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280
L ++ NP R T+ D+ W L
Sbjct: 242 LHKIL-------VENPSARITIPDIKKDRWYNKPL 269
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 9e-10
Identities = 41/166 (24%), Positives = 68/166 (40%), Gaps = 26/166 (15%)
Query: 62 EVEILGRVRHRNLLGLRG-FYAGGDERL-----IVYDYMPNHSLITHLHGRLAPDCLLDW 115
E+ ++ V H+N++GL F IV + M +L ++ L
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-----ANLC-QVIQMELDHE 127
Query: 116 HRRVSI--------AIGSAEGI-ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTR 166
+ + SA I D+K SN+++ +D K+ DFG A+ MT
Sbjct: 128 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPY 186
Query: 167 VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPG 212
V T Y APE + ++ D++S G ++ E+I L PG
Sbjct: 187 V-VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK-GGVL--FPG 228
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 39/166 (23%), Positives = 68/166 (40%), Gaps = 26/166 (15%)
Query: 62 EVEILGRVRHRNLLGLRG-FYAGGDERL-----IVYDYMPNHSLITHLHGRLAPDCLLDW 115
E+ ++ V H+N++ L F +V + M +L ++ L
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-----ANLC-QVIQMELDHE 164
Query: 116 HRRVSI--------AIGSAEGI-ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTR 166
+ + SA I D+K SN+++ +D K+ DFG A+ MT
Sbjct: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPY 223
Query: 167 VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPG 212
V T Y APE + ++ D++S G ++ E++ K L PG
Sbjct: 224 V-VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKIL--FPG 265
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 9e-10
Identities = 64/301 (21%), Positives = 115/301 (38%), Gaps = 85/301 (28%)
Query: 36 RETGDDQIAVKRL-KTLNAKAEMEFAV--EVEILGRVRHRNLLGLRGF------------ 80
+T ++A+K + + L K++M V E+ L +RH +++ L
Sbjct: 31 YKTQQ-KVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89
Query: 81 YAGGDERLIVYDYMPNHSLITHLHGRLAPD---------------CLLDWHRRVSIAIGS 125
YAGG+ ++DY+ R+ D C HR
Sbjct: 90 YAGGE----LFDYIVEK-------KRMTEDEGRRFFQQIICAIEYC----HRH------- 127
Query: 126 AEGIA--DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGK 183
I D+K N+LLD + K+ADFG + ++ DG T+ G+ Y APE GK
Sbjct: 128 --KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVIN-GK 182
Query: 184 VSD--SCDVYSFGVLLLELISAKKPL--EKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239
+ DV+S G++L ++ + P E +P K+ V + P
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK---------VNSCVYV---MPDF 230
Query: 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVV--DWLKGGLGRRTKDVKDVAGEDDED 297
+ ++ M+ ++P R T+ ++ W L + +++V G +
Sbjct: 231 LSPGAQSLIRRMI-------VADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADS 283
Query: 298 N 298
Sbjct: 284 R 284
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 28/167 (16%)
Query: 62 EVEILGRVRHRNLLGLRG-FYAGGDERL-----IVYDYMPNHSLITHLHGRLAPDCLLDW 115
E+ +L +RH N++GL F +V +M T L + + L +
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG-----TDLGKLMKHEKLGED 128
Query: 116 HRRVSI--------AIGSAEGI-ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTR 166
+ + I +A I D+K N+ ++ D E K+ DFG A+ MT
Sbjct: 129 RIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---EMTGY 185
Query: 167 VKGTLGYLAPEYAM-WGKVSDSCDVYSFGVLLLELISAKKPLEKLPG 212
V T Y APE + W + + + D++S G ++ E+I+ K L G
Sbjct: 186 V-VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT-GKTL--FKG 228
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 51/186 (27%), Positives = 78/186 (41%), Gaps = 14/186 (7%)
Query: 33 LLRRETGDDQI-AVKRLK--TLNAKAEMEFA-VEVEILGRVRHRNLLGLRGFYAGGDERL 88
+L +E + A+K LK + AK E+ E +L RH L L+ + D
Sbjct: 165 ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224
Query: 89 IVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIG---SAEGIA--DIKASNVLLDT 141
V +Y L HL + D + + A+ S + + D+K N++LD
Sbjct: 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK 284
Query: 142 DFEAKVADFGFAKL-IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLEL 200
D K+ DFG K I DG T GT YLAPE + D + GV++ E+
Sbjct: 285 DGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 342
Query: 201 ISAKKP 206
+ + P
Sbjct: 343 MCGRLP 348
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 55/302 (18%), Positives = 103/302 (34%), Gaps = 57/302 (18%)
Query: 1 LQNHRNICFLLASPAVFIQNINNGLEILM-------LLLLLRRETGDDQIAVKRLKTLNA 53
+ +H N+ LL A L +++ L LR + + K
Sbjct: 82 IGHHLNVVNLLG--ACTKPG--GPLMVIVEFCKFGNLSTYLRSKRNEFVPYK--TKGARF 135
Query: 54 KAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHLHGR-LAPDCL 112
+ ++ + + + R ++ + + G + L+ L + L
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195
Query: 113 LDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162
+ + +V A+G+ D+ A N+LL K+ DFG A+ I +
Sbjct: 196 ICYSFQV------AKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249
Query: 163 MTTRVKGTLGYL-----APEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKR 216
V+ L APE + DV+SFGVLL E+ S P + +
Sbjct: 250 ----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 304
Query: 217 DIVQWVTPYVQKGAFEHIADPRL-KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDW 275
+++G R+ + ++ L C P RPT +++V+
Sbjct: 305 -----FCRRLKEGT-------RMRAPDYTTPEMYQ---TMLDCWHGEPSQRPTFSELVEH 349
Query: 276 LK 277
L
Sbjct: 350 LG 351
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 4e-09
Identities = 44/171 (25%), Positives = 68/171 (39%), Gaps = 37/171 (21%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPN--HSLITHLHGRLAPD---CLL--- 113
E+ +L + H N++ L +V+++M ++ L L
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 114 ---------DW--HRRVSIAIGSAEGIADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162
HR D+K N+L+++D K+ADFG A+ V
Sbjct: 129 LRGVAHCHQHRILHR-------------DLKPQNLLINSDGALKLADFGLARAFGIPVRS 175
Query: 163 MTTRVKGTLGYLAPEYAMWGKV-SDSCDVYSFGVLLLELISAKKPLEKLPG 212
T V TL Y AP+ M K S S D++S G + E+I+ KPL PG
Sbjct: 176 YTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT-GKPL--FPG 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 52/169 (30%), Positives = 80/169 (47%), Gaps = 27/169 (15%)
Query: 62 EVEILGRVRHRNLLGLRG-FYAGGDERL----IVYDYMPNHSLITHLHGRLAPDCLLDWH 116
E++IL R RH N++G+ A E++ IV D M T L+ L L + H
Sbjct: 75 EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLLKTQHLSNDH 129
Query: 117 RRVSI--------AIGSAEGI-ADIKASNVLLDTDFEAKVADFGFAKLI---PDGVTHMT 164
+ I SA + D+K SN+LL+T + K+ DFG A++ D +T
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 165 TRVKGTLGYLAPEYAM-WGKVSDSCDVYSFGVLLLELISAKKPLEKLPG 212
V T Y APE + + S D++S G +L E++S +P+ PG
Sbjct: 190 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRPI--FPG 234
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 5e-09
Identities = 45/200 (22%), Positives = 75/200 (37%), Gaps = 46/200 (23%)
Query: 33 LLRRETGDDQI-AVKRLKTLNAKAEMEFAVEVE-------ILGRVRHRNLLGLRGFYAGG 84
+L + A+K L K ++ ++E IL V L+ L +
Sbjct: 58 MLVKHKESGNHYAMKILD----KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 85 DERLIVYDYMPNHSLITHL--HGR--------------LAPDCLLDWHRRVSIAIGSAEG 128
+V +Y+ + +HL GR L + L H
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL---HSL---------D 161
Query: 129 IA--DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSD 186
+ D+K N+L+D +V DFGFAK + T + GT LAPE + +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALAPEIILSKGYNK 217
Query: 187 SCDVYSFGVLLLELISAKKP 206
+ D ++ GVL+ E+ + P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 36/168 (21%), Positives = 66/168 (39%), Gaps = 27/168 (16%)
Query: 62 EVEILGRVRHRNLLGLRG-FYAGGDERL----IVYDYMPN--HSLITHLHGRLAPDCLLD 114
E+ +L H N+LGLR F + + +V + M +I ++P
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ---- 134
Query: 115 WHRRVSI--------AIGSAEGI-ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165
H + + + A + D+ N+LL + + + DF A+ + T
Sbjct: 135 -HIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKTH 192
Query: 166 RVKGTLGYLAPEYAM-WGKVSDSCDVYSFGVLLLELISAKKPLEKLPG 212
V Y APE M + + D++S G ++ E+ + +K L G
Sbjct: 193 YV-THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN-RKAL--FRG 236
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 7e-09
Identities = 57/201 (28%), Positives = 88/201 (43%), Gaps = 42/201 (20%)
Query: 32 LLLRRETGDD--QI-AVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYA-GGD 85
L+++ +G D Q+ A+K LK TL + + +E +IL V H ++ L YA +
Sbjct: 41 FLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL--HYAFQTE 98
Query: 86 ERL-IVYDYMPNHSLITHLH--GR--------------LAPDCLLDWHRRVSIAIGSAEG 128
+L ++ D++ L T L LA D L H G
Sbjct: 99 GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL---HSL---------G 146
Query: 129 IA--DIKASNVLLDTDFEAKVADFGFAKL-IPDGVTHMTTRVKGTLGYLAPEYAMWGKVS 185
I D+K N+LLD + K+ DFG +K I GT+ Y+APE +
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHT 204
Query: 186 DSCDVYSFGVLLLELISAKKP 206
S D +SFGVL+ E+++ P
Sbjct: 205 QSADWWSFGVLMFEMLTGTLP 225
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 8e-09
Identities = 47/167 (28%), Positives = 74/167 (44%), Gaps = 28/167 (16%)
Query: 62 EVEILGRVRHRNLLGLRG-FYAGGDERL-----IVYDYMPNHSLITHLHGRLAPDCLLDW 115
E+ +L ++H N++GL F +V M L+ + L D
Sbjct: 78 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDD 132
Query: 116 HRRVSI--------AIGSAEGI-ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTR 166
H + I I SA+ I D+K SN+ ++ D E K+ DFG A+ D MT
Sbjct: 133 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD---EMTGY 189
Query: 167 VKGTLGYLAPEYAM-WGKVSDSCDVYSFGVLLLELISAKKPLEKLPG 212
V T Y APE + W + + D++S G ++ EL++ + L PG
Sbjct: 190 V-ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTL--FPG 232
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 41/164 (25%), Positives = 74/164 (45%), Gaps = 18/164 (10%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPN--HSLITHLHGRLAPDCLLDWHRRV 119
E+ ++ ++H N++ L ++ +V+++M N + P L +
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK- 111
Query: 120 SIAIGSAEGIA----------DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169
+G+A D+K N+L++ + K+ DFG A+ V ++ V
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV- 170
Query: 170 TLGYLAPEYAMWGKV-SDSCDVYSFGVLLLELISAKKPLEKLPG 212
TL Y AP+ M + S S D++S G +L E+I+ KPL PG
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT-GKPL--FPG 211
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 46/212 (21%), Positives = 86/212 (40%), Gaps = 54/212 (25%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEF-AV-EVEILGRVRHRNLLGLRG--------FYAGGD 85
R+TG ++A+K++ N K A+ E++IL ++H N++ L +
Sbjct: 39 RKTGQ-KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97
Query: 86 ERLIVYDYMPNH---SLITHLHGRLAPD---CLL------------DW--HRRVSIAIGS 125
+V+D+ H L++++ + ++ + HR
Sbjct: 98 SIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHR-------- 148
Query: 126 AEGIADIKASNVLLDTDFEAKVADFG----FAKLIPDGVTHMTTRVKGTLGYLAPEYAMW 181
D+KA+NVL+ D K+ADFG F+ T RV TL Y PE +
Sbjct: 149 -----DMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLG 202
Query: 182 GKV-SDSCDVYSFGVLLLELISAKKPLEKLPG 212
+ D++ G ++ E+ + P+ + G
Sbjct: 203 ERDYGPPIDLWGAGCIMAEMW-TRSPI--MQG 231
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 57/186 (30%), Positives = 90/186 (48%), Gaps = 14/186 (7%)
Query: 33 LLRRETGDDQI-AVKRLK--TLNAKAEMEFA-VEVEILGRV-RHRNLLGLRGFYAGGDER 87
+L G D++ AVK LK + ++E VE +L + L L + D
Sbjct: 358 MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417
Query: 88 LIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGS--AEGIA--DIKASNVLLDT 141
V +Y+ L+ H+ GR + + ++I + ++GI D+K NV+LD+
Sbjct: 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS 477
Query: 142 DFEAKVADFGFAKL-IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLEL 200
+ K+ADFG K I DGVT T GT Y+APE + S D ++FGVLL E+
Sbjct: 478 EGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 535
Query: 201 ISAKKP 206
++ + P
Sbjct: 536 LAGQAP 541
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 2e-08
Identities = 55/206 (26%), Positives = 86/206 (41%), Gaps = 58/206 (28%)
Query: 33 LLRRETGDDQI-AVKRLKTLNAKAEMEFAVEVE-------ILGRVRHRNLLGLRGFYAGG 84
L R + + A+K LK K + +VE +L V H ++ + G +
Sbjct: 23 HLIRSRHNGRYYAMKVLK----KEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 78
Query: 85 DERLIVYDYMPNHSLITHL--HGR--------------LAPDCLLDWHRRVSIAIGSAEG 128
+ ++ DY+ L + L R LA + L H +
Sbjct: 79 QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL---HSK---------D 126
Query: 129 IA--DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPE------YAM 180
I D+K N+LLD + K+ DFGFAK +PD +T + GT Y+APE Y
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTKPY-- 180
Query: 181 WGKVSDSCDVYSFGVLLLELISAKKP 206
K S D +SFG+L+ E+++ P
Sbjct: 181 -NK---SIDWWSFGILIYEMLAGYTP 202
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 37/162 (22%), Positives = 65/162 (40%), Gaps = 19/162 (11%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSI 121
EV +L ++H N++ L +V++Y+ + L +L ++ H
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNI---INMHNVKLF 105
Query: 122 AIGSAEGIA----------DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTL 171
G+A D+K N+L++ E K+ADFG A+ V TL
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TL 164
Query: 172 GYLAPEYAMWGKV-SDSCDVYSFGVLLLELISAKKPLEKLPG 212
Y P+ + S D++ G + E+ + +PL PG
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT-GRPL--FPG 203
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 2e-08
Identities = 43/171 (25%), Positives = 72/171 (42%), Gaps = 37/171 (21%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPN--HSLITHLHGRLAPDC-------L 112
E+ IL ++H N++ L ++V++++ L+ G L L
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 113 LD--------W--HRRVSIAIGSAEGIADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162
L+ HR D+K N+L++ + E K+ADFG A+ V
Sbjct: 110 LNGIAYCHDRRVLHR-------------DLKPQNLLINREGELKIADFGLARAFGIPVRK 156
Query: 163 MTTRVKGTLGYLAPEYAMWGKV-SDSCDVYSFGVLLLELISAKKPLEKLPG 212
T + TL Y AP+ M K S + D++S G + E+++ PL PG
Sbjct: 157 YTHEIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPL--FPG 203
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 29/167 (17%)
Query: 62 EVEILGRVRHRNLLGLRG-FYAGGDERL-----IVYDYMPNHSLITHLHGRLAPDCLLDW 115
E+ +L ++H N++GL F R +V +M T L ++ +
Sbjct: 73 ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-----TDLQ-KIMGLKFSEE 126
Query: 116 HRRVSI--------AIGSAEGI-ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTR 166
+ + I SA + D+K N+ ++ D E K+ DFG A+ MT
Sbjct: 127 KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA---EMTGY 183
Query: 167 VKGTLGYLAPEYAM-WGKVSDSCDVYSFGVLLLELISAKKPLEKLPG 212
V T Y APE + W + + D++S G ++ E+++ K L G
Sbjct: 184 V-VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT-GKTL--FKG 226
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 54/193 (27%), Positives = 93/193 (48%), Gaps = 33/193 (17%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAV-EVEILGRVRHRNLLGLRG-FYAGGDERL----- 88
++G+ +A+K++ + F E++I+ ++ H N++ LR FY+ G+++
Sbjct: 76 CDSGEL-VAIKKVL-----QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129
Query: 89 IVYDYMPN--HSLITHLHGRLAPDCLLDWHRRV-------SIA-IGSAEGIA--DIKASN 136
+V DY+P + + H A L + ++ S+A I S GI DIK N
Sbjct: 130 LVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQN 186
Query: 137 VLLDTD-FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAM-WGKVSDSCDVYSFG 194
+LLD D K+ DFG AK + G + + + Y APE + S DV+S G
Sbjct: 187 LLLDPDTAVLKLCDFGSAKQLVRGEP-NVSYI-CSRYYRAPELIFGATDYTSSIDVWSAG 244
Query: 195 VLLLELISAKKPL 207
+L EL+ +P+
Sbjct: 245 CVLAELLL-GQPI 256
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 2/78 (2%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKV--SDSC 188
DIK N+LLD++ + DFG +K T GT+ Y+AP+ G +
Sbjct: 184 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV 243
Query: 189 DVYSFGVLLLELISAKKP 206
D +S GVL+ EL++ P
Sbjct: 244 DWWSLGVLMYELLTGASP 261
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 4e-08
Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 34/176 (19%)
Query: 62 EVEILGRVRHRNLLGLRG-FYAGGDERL----IVYDYMPNHSLITHLHGRLAPDCLLDWH 116
E++IL +H N++ + E I+ + M T LH ++ L D H
Sbjct: 59 EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-----TDLHRVISTQMLSDDH 113
Query: 117 RRVSI--------AIGSAEGI-ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT------ 161
+ I + + I D+K SN+L++++ + KV DFG A++I +
Sbjct: 114 IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 162 ----HMTTRVKGTLGYLAPEYAM-WGKVSDSCDVYSFGVLLLELISAKKPLEKLPG 212
M V T Y APE + K S + DV+S G +L EL ++P+ PG
Sbjct: 174 GQQSGMVEFV-ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI--FPG 225
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 5e-08
Identities = 46/196 (23%), Positives = 82/196 (41%), Gaps = 34/196 (17%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEF-AV-EVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93
++TG +A+K+ + ++ A+ E+++L ++RH NL+ L +V+++
Sbjct: 47 KDTGR-IVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105
Query: 94 MPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDF 143
+ +H+++ L LD+ GI DIK N+L+
Sbjct: 106 V-DHTILDDLELFPNG---LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG 161
Query: 144 EAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPE-------YAMWGKVSDSCDVYSFGVL 196
K+ DFGFA+ + V T Y APE Y + DV++ G L
Sbjct: 162 VVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGDVKY------GKAVDVWAIGCL 214
Query: 197 LLELISAKKPLEKLPG 212
+ E+ +PL PG
Sbjct: 215 VTEMFM-GEPL--FPG 227
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 5e-08
Identities = 56/199 (28%), Positives = 77/199 (38%), Gaps = 41/199 (20%)
Query: 33 LLRRETGDDQI-AVKRLK--TLNAKAEMEFA-VEVEILGRVRHRNLLGLRGFYA-GGDER 87
+L RE + A+K L+ + AK E+ E +L RH L L YA +R
Sbjct: 22 ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL--KYAFQTHDR 79
Query: 88 L-IVYDYMPNHSLITHLH--GR--------------LAPDCLLDWHRRVSIAIGSAEGIA 130
L V +Y L HL A + L H R +
Sbjct: 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL---HSR---------DVV 127
Query: 131 --DIKASNVLLDTDFEAKVADFGFAKL-IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDS 187
DIK N++LD D K+ DFG K I DG T GT YLAPE +
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRA 185
Query: 188 CDVYSFGVLLLELISAKKP 206
D + GV++ E++ + P
Sbjct: 186 VDWWGLGVVMYEMMCGRLP 204
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 6e-08
Identities = 26/82 (31%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
D+K N+L+ + K+ADFG A++ + +T V TL Y APE + + D+
Sbjct: 145 DLKPENILVTSGGTVKLADFGLARIYSYQMA-LTPVVV-TLWYRAPEVLLQSTYATPVDM 202
Query: 191 YSFGVLLLELISAKKPLEKLPG 212
+S G + E+ +KPL G
Sbjct: 203 WSVGCIFAEMFR-RKPL--FCG 221
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 7e-08
Identities = 46/196 (23%), Positives = 83/196 (42%), Gaps = 34/196 (17%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEF-AV-EVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93
R+TG +A+K+ ++ A+ E+ +L +++H NL+ L + +V++Y
Sbjct: 25 RDTGQ-IVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83
Query: 94 MPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDF 143
+H+++ L + H SI + + + D+K N+L+
Sbjct: 84 C-DHTVLHELDRYQRG---VPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS 139
Query: 144 EAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPE-------YAMWGKVSDSCDVYSFGVL 196
K+ DFGFA+L+ + V T Y +PE Y DV++ G +
Sbjct: 140 VIKLCDFGFARLLTGPSDYYDDEV-ATRWYRSPELLVGDTQY------GPPVDVWAIGCV 192
Query: 197 LLELISAKKPLEKLPG 212
EL+S PL PG
Sbjct: 193 FAELLS-GVPL--WPG 205
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 8e-08
Identities = 43/204 (21%), Positives = 87/204 (42%), Gaps = 35/204 (17%)
Query: 36 RETGDDQI-AVKRLKTLNAKAEMEFAV-EVEILGRVRHRNLLGLRG-FYAGGDERL-IVY 91
++ DD+ A+K+++ A E+ +L ++H N++ L+ F + D ++ +++
Sbjct: 43 KDGKDDKDYALKQIEGTGISMS---ACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99
Query: 92 DYMPNHSLITHLH-----GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASN 136
DY H L + L S+ +GI D+K +N
Sbjct: 100 DYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPAN 158
Query: 137 VLLDTDFEA----KVADFGFAKL--IPD-GVTHMTTRVKGTLGYLAPEYAMWGKV-SDSC 188
+L+ + K+AD GFA+L P + + V T Y APE + + + +
Sbjct: 159 ILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAI 217
Query: 189 DVYSFGVLLLELISAKKPLEKLPG 212
D+++ G + EL++ +P+
Sbjct: 218 DIWAIGCIFAELLT-SEPI--FHC 238
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 8e-08
Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 5/82 (6%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
D+K N+L+ + + K+ADFG A++ + +T+ V TL Y APE + + D+
Sbjct: 145 DLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVV-TLWYRAPEVLLQSSYATPVDL 202
Query: 191 YSFGVLLLELISAKKPLEKLPG 212
+S G + E+ +KPL G
Sbjct: 203 WSVGCIFAEMFR-RKPL--FRG 221
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 21/79 (26%), Positives = 39/79 (49%), Gaps = 4/79 (5%)
Query: 131 DIKASNVLLDTDF-EAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAM-WGKVSDSC 188
D+K NV++D + + ++ D+G A+ G RV + + PE + + S
Sbjct: 155 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRV-ASRYFKGPELLVDYQMYDYSL 212
Query: 189 DVYSFGVLLLELISAKKPL 207
D++S G +L +I K+P
Sbjct: 213 DMWSLGCMLASMIFRKEPF 231
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 31/77 (40%), Positives = 42/77 (54%), Gaps = 3/77 (3%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKL-IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCD 189
D+K N+LLD D K+ADFG K + T GT Y+APE + K + S D
Sbjct: 143 DLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVD 200
Query: 190 VYSFGVLLLELISAKKP 206
+SFGVLL E++ + P
Sbjct: 201 WWSFGVLLYEMLIGQSP 217
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 49.8 bits (120), Expect = 4e-07
Identities = 43/167 (25%), Positives = 69/167 (41%), Gaps = 37/167 (22%)
Query: 61 VEVEILGRVRHRNLLGLRGFYA-GGDERL-IVYDYMPNHSLITHLH--GR---------- 106
E IL V+H ++ L YA +L ++ +Y+ L L G
Sbjct: 70 AERNILEEVKHPFIVDL--IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL 127
Query: 107 ----LAPDCLLDWHRRVSIAIGSAEGIA--DIKASNVLLDTDFEAKVADFGFAKL-IPDG 159
+A L H++ GI D+K N++L+ K+ DFG K I DG
Sbjct: 128 AEISMALGHL---HQK---------GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG 175
Query: 160 VTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKP 206
T GT+ Y+APE M + + D +S G L+ ++++ P
Sbjct: 176 TV--THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 25/77 (32%), Positives = 35/77 (45%), Gaps = 3/77 (3%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKL-IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCD 189
D+K N+LLD+ + DFG K I T T+ GT YLAPE + D
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPEVLHKQPYDRTVD 221
Query: 190 VYSFGVLLLELISAKKP 206
+ G +L E++ P
Sbjct: 222 WWCLGAVLYEMLYGLPP 238
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 4e-07
Identities = 33/77 (42%), Positives = 46/77 (59%), Gaps = 3/77 (3%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKL-IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCD 189
D+K NV+LD++ K+ADFG K I DGVT T GT Y+APE + S D
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVD 203
Query: 190 VYSFGVLLLELISAKKP 206
++FGVLL E+++ + P
Sbjct: 204 WWAFGVLLYEMLAGQAP 220
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 5e-07
Identities = 40/179 (22%), Positives = 76/179 (42%), Gaps = 37/179 (20%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERL--------------IVYDYMPNHSLITHLHGRL 107
E++I+ R+ H N++ + +L IV +YM T L L
Sbjct: 58 EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-----TDLANVL 112
Query: 108 APDCLLDWHRRVSI--------AIGSAEGI-ADIKASNVLLDT-DFEAKVADFGFAKLI- 156
LL+ H R+ + I SA + D+K +N+ ++T D K+ DFG A+++
Sbjct: 113 EQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172
Query: 157 --PDGVTHMTTRVKGTLGYLAPEYAM-WGKVSDSCDVYSFGVLLLELISAKKPLEKLPG 212
H++ + T Y +P + + + D+++ G + E+++ K L G
Sbjct: 173 PHYSHKGHLSEGL-VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT-GKTL--FAG 227
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 48/193 (24%), Positives = 87/193 (45%), Gaps = 34/193 (17%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAV-EVEILGRVRHRNLLGLRG-FYAGGDERL----- 88
E+ ++A+K++ + F E++I+ V+H N++ L+ FY+ GD++
Sbjct: 62 VESD--EVAIKKVL-----QDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114
Query: 89 IVYDYMPN--HSLITHLHGRLAPDCLLDWHRRV-------SIAIGSAEGIA--DIKASNV 137
+V +Y+P + H + ++ S+A + GI DIK N+
Sbjct: 115 LVLEYVPETVYRASRHY--AKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNL 172
Query: 138 LLDTD-FEAKVADFGFAK-LIPDGVTHMTTRVKGTLGYLAPEYAM-WGKVSDSCDVYSFG 194
LLD K+ DFG AK LI + + + Y APE + + D++S G
Sbjct: 173 LLDPPSGVLKLIDFGSAKILIAGEP--NVSYI-CSRYYRAPELIFGATNYTTNIDIWSTG 229
Query: 195 VLLLELISAKKPL 207
++ EL+ +PL
Sbjct: 230 CVMAELMQ-GQPL 241
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 6e-07
Identities = 31/77 (40%), Positives = 41/77 (53%), Gaps = 3/77 (3%)
Query: 131 DIKASNVLLDTDFEAKVADFGFAKL-IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCD 189
D+K NVLLD + K+ADFG K I +GVT T GT Y+APE + D
Sbjct: 149 DLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPDYIAPEILQEMLYGPAVD 206
Query: 190 VYSFGVLLLELISAKKP 206
++ GVLL E++ P
Sbjct: 207 WWAMGVLLYEMLCGHAP 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 7e-07
Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 28/193 (14%)
Query: 33 LLRRETGDDQI-AVKRLK--TLNAKAEMEFA-VEVEILGRV-RHRNLLGLRGFYA-GGDE 86
LL R D+I A++ +K +N ++++ E + + H L+GL +
Sbjct: 69 LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL--HSCFQTES 126
Query: 87 RL-IVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIA-IGSA------EGIA--DIKA 134
RL V +Y+ L+ H+ +L + H R A I A GI D+K
Sbjct: 127 RLFFVIEYVNGGDLMFHMQRQRKLPEE-----HARFYSAEISLALNYLHERGIIYRDLKL 181
Query: 135 SNVLLDTDFEAKVADFGFAKL-IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSF 193
NVLLD++ K+ D+G K + G T T+ GT Y+APE S D ++
Sbjct: 182 DNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWAL 239
Query: 194 GVLLLELISAKKP 206
GVL+ E+++ + P
Sbjct: 240 GVLMFEMMAGRSP 252
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 55/193 (28%), Positives = 88/193 (45%), Gaps = 28/193 (14%)
Query: 33 LLRRETGDDQI-AVKRLK--TLNAKAEMEFA-VEVEILGRV-RHRNLLGLRGFYA-GGDE 86
LL R D+I A+K +K +N ++++ E + + H L+GL +
Sbjct: 26 LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL--HSCFQTES 83
Query: 87 RL-IVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIA-IGSA------EGIA--DIKA 134
RL V +Y+ L+ H+ +L + H R A I A GI D+K
Sbjct: 84 RLFFVIEYVNGGDLMFHMQRQRKLPEE-----HARFYSAEISLALNYLHERGIIYRDLKL 138
Query: 135 SNVLLDTDFEAKVADFGFAKL-IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSF 193
NVLLD++ K+ D+G K + G T T+ GT Y+APE S D ++
Sbjct: 139 DNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWAL 196
Query: 194 GVLLLELISAKKP 206
GVL+ E+++ + P
Sbjct: 197 GVLMFEMMAGRSP 209
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 40/197 (20%), Positives = 77/197 (39%), Gaps = 35/197 (17%)
Query: 36 RETGDDQIAVKR--LKTLNAKAEMEFAVEVEILGRVRHRNLLGLR-GFYAGGDERL---- 88
+ TG +A+K+ E++ ++ L + H N++ L+ FY G+
Sbjct: 45 KSTGM-SVAIKKVIQDPRFRNRELQ---IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100
Query: 89 --IVYDYMPN--HSLITHLHGRLAPDCLLDWHRRV----------SIAIGSAEGIA--DI 132
+V +Y+P+ H + +V + + S + DI
Sbjct: 101 LNVVMEYVPDTLHRCCRNY--YRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDI 157
Query: 133 KASNVLLD-TDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAM-WGKVSDSCDV 190
K NVL++ D K+ DFG AK + + + Y APE + + D+
Sbjct: 158 KPHNVLVNEADGTLKLCDFGSAKKLSPS-EPNVAYI-CSRYYRAPELIFGNQHYTTAVDI 215
Query: 191 YSFGVLLLELISAKKPL 207
+S G + E++ +P+
Sbjct: 216 WSVGCIFAEMML-GEPI 231
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 1e-06
Identities = 38/176 (21%), Positives = 68/176 (38%), Gaps = 43/176 (24%)
Query: 62 EVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHL--HGRLAPD---CLL--- 113
EV +L ++HRN++ L+ ++++Y + L ++ + ++ L
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQL 141
Query: 114 ---------DW--HRRVSIAIGSAEGIADIKASNVLLDTDFEA-----KVADFGFAKLIP 157
HR D+K N+LL + K+ DFG A+
Sbjct: 142 INGVNFCHSRRCLHR-------------DLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188
Query: 158 DGVTHMTTRVKGTLGYLAPEYAMWGKV-SDSCDVYSFGVLLLELISAKKPLEKLPG 212
+ T + TL Y PE + + S S D++S + E++ K PL PG
Sbjct: 189 IPIRQFTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM-KTPL--FPG 240
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 40/193 (20%), Positives = 67/193 (34%), Gaps = 46/193 (23%)
Query: 62 EVEILGRVRHRNLLGLRG-FYAGGDERL----IVYDYMPN--HSLITHLHGRLAPDCLLD 114
E+ IL R++ ++ L + IV + + L P L +
Sbjct: 75 EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFK------TPIFLTE 128
Query: 115 WHRRVSI--------AIGSAEGI-ADIKASNVLLDTDFEAKVADFGFAKLI--------- 156
H + + I + I D+K +N LL+ D KV DFG A+ I
Sbjct: 129 EHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188
Query: 157 -------------PDGVTHMTTRVKGTLGYLAPEYAM-WGKVSDSCDVYSFGVLLLELIS 202
+ +T+ V T Y APE + + S D++S G + EL++
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHV-VTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247
Query: 203 AKKPLEKLPGGVK 215
+ P
Sbjct: 248 MLQSHINDPTNRF 260
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 44/184 (23%), Positives = 73/184 (39%), Gaps = 41/184 (22%)
Query: 62 EVEILGRVR-HRNLLGLRG-FYAGGDERL-IVYDYMPNHSLITHLHGRLAPDCLLDWHRR 118
E+ IL + H N++ L A D + +V+DYM T LH + + L H++
Sbjct: 58 EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-----TDLHAVIRANILEPVHKQ 112
Query: 119 VSI--------AIGSAEGI-ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169
+ + S + D+K SN+LL+ + KVADFG ++ +
Sbjct: 113 YVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 170 TLG--------------------YLAPEYAM-WGKVSDSCDVYSFGVLLLELISAKKPLE 208
Y APE + K + D++S G +L E++ KP+
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC-GKPI- 230
Query: 209 KLPG 212
PG
Sbjct: 231 -FPG 233
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 26/79 (32%), Positives = 39/79 (49%), Gaps = 5/79 (6%)
Query: 131 DIKASNVLLD-TDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAM-WGKVSDSC 188
DIK N+L++ D K+ DFG AK + + + Y APE + + + S
Sbjct: 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYI-CSRFYRAPELMLGATEYTPSI 223
Query: 189 DVYSFGVLLLELISAKKPL 207
D++S G + ELI KPL
Sbjct: 224 DLWSIGCVFGELIL-GKPL 241
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 325 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.6 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.28 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.69 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.4 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.23 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.02 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.96 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.53 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.1 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.03 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.73 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.95 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 95.76 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 95.64 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.93 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 92.63 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 92.51 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 92.06 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 89.86 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 89.06 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 83.31 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-55 Score=388.02 Aligned_cols=250 Identities=20% Similarity=0.287 Sum_probs=210.3
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
+.|.++++||+| +++.||++++..+++.||||.+..........+.+|+++|++++|||||++++++.+++.+|||||
T Consensus 74 ~~y~~~~~iG~G--~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEG--STGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEEC--SSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecC--cCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 457888899998 888899999999999999999975544455678899999999999999999999999999999999
Q ss_pred ecCCCChhhhh-ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccC
Q 046728 93 YMPNHSLITHL-HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRV 167 (325)
Q Consensus 93 ~~~~gsL~~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 167 (325)
||+||+|.+++ +..+++..+..++.++..|+.++|.. |||||+|||++.+|.+||+|||+|+.+...... ..+.
T Consensus 152 y~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~ 230 (346)
T 4fih_A 152 FLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKSL 230 (346)
T ss_dssp CCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-BCCC
T ss_pred CCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc-cccc
Confidence 99999999999 45688888999999999999999985 899999999999999999999999877544322 3456
Q ss_pred CCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHH
Q 046728 168 KGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQ 247 (325)
Q Consensus 168 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (325)
+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+.. .....+.. . .......+..+
T Consensus 231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i~~----~-------~~~~~~~~~~~ 296 (346)
T 4fih_A 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRD----N-------LPPRLKNLHKV 296 (346)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHH----S-------SCCCCSCGGGS
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHc----C-------CCCCCCccccC
Confidence 7999999999999999999999999999999999999999764321 11111111 0 00112334567
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 248 LKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 248 ~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
++++.+||.+||..||++|||++++++ ||+..
T Consensus 297 s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 297 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 889999999999999999999999998 88754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=385.55 Aligned_cols=255 Identities=22% Similarity=0.392 Sum_probs=204.3
Q ss_pred ceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC
Q 046728 7 ICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG 84 (325)
Q Consensus 7 ~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (325)
+.|.-=..|.++++||+| +++.||++++..+++.||||.+... ......++.+|+++|++|+|||||++++++.++
T Consensus 18 ~~f~sme~Y~~~~~lG~G--~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 95 (350)
T 4b9d_A 18 LYFQSMEKYVRLQKIGEG--SFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN 95 (350)
T ss_dssp CBCSCCCCEEEEEEC--------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cCCCcccceEEeEEEecC--CCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 444333578999999999 8889999999999999999999643 455567899999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccccc
Q 046728 85 DERLIVYDYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLI 156 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~ 156 (325)
+.+|||||||+||+|.++|+. .+++..++.++.|+..|+.++|.. |||||+|||++.++.+||+|||+|+.+
T Consensus 96 ~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 96 GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175 (350)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceee
Confidence 999999999999999999942 235556788999999999999985 899999999999999999999999876
Q ss_pred CCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccC
Q 046728 157 PDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD 236 (325)
Q Consensus 157 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (325)
..... .....+||+.|+|||++.+..|+.++|||||||++|||+||..||.+... ......+. .+.
T Consensus 176 ~~~~~-~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i~----~~~------ 241 (350)
T 4b9d_A 176 NSTVE-LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM---KNLVLKII----SGS------ 241 (350)
T ss_dssp CHHHH-HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHH----HTC------
T ss_pred cCCcc-cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHH----cCC------
Confidence 53221 22345699999999999999999999999999999999999999975432 11111111 111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 237 PRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 237 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
..+.+..+++++.+||.+||..||++|||++++++ ||+...
T Consensus 242 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 242 ---FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred ---CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence 11234556789999999999999999999999998 887544
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-55 Score=381.27 Aligned_cols=251 Identities=21% Similarity=0.365 Sum_probs=204.2
Q ss_pred cchhHHhhccCccceeeeeEEEecc-----CCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRE-----TGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
+.+.+.++||+| +++.||+++.. .++..||||.++..+....++|.+|+++|++++|||||++++++.+++.+
T Consensus 13 ~~~~l~~~lG~G--~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEG--AFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC----CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeC--CCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 457788999999 78888888754 35778999999877777778999999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcc---------------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEe
Q 046728 88 LIVYDYMPNHSLITHLHG---------------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVA 148 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~---------------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~ 148 (325)
++|||||++|||.++++. .+++..++.++.+++.++.++|.. |||||+|||++.++.+||+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEEC
Confidence 999999999999999953 245556677888999999999875 8999999999999999999
Q ss_pred eeccccccCCCccee-eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccc
Q 046728 149 DFGFAKLIPDGVTHM-TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYV 226 (325)
Q Consensus 149 Dfg~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~ 226 (325)
|||+|+......... .....||+.|+|||++.+..|+.++|||||||++|||+| |..||.+.+.. .+...+.
T Consensus 171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~i~--- 244 (299)
T 4asz_A 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIECIT--- 244 (299)
T ss_dssp CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHH---
T ss_pred CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH---
Confidence 999998765443332 233458999999999999999999999999999999999 89999764432 1111111
Q ss_pred cccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 227 QKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.+ ...+.+..+++++.+||.+||+.||++|||+++|.++|+.+..
T Consensus 245 -~~---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 245 -QG---------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp -HT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cC---------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11 1123445677899999999999999999999999999987653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=378.56 Aligned_cols=242 Identities=18% Similarity=0.266 Sum_probs=204.6
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..|.+++.||+| +++.||++++..+++.||||++.+. .......+.+|+++|++++|||||++++++++++.+|+
T Consensus 32 ~dy~i~~~lG~G--~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 32 EDFKFGKILGEG--SFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp GGEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEecc--cCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 458999999999 8888999999999999999999642 23345688999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc-ce
Q 046728 90 VYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV-TH 162 (325)
Q Consensus 90 V~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~ 162 (325)
|||||+||+|.++++ +.+++..+..++.|+..|++++|.. |||||+|||++.++.+||+|||+|+.+.... ..
T Consensus 110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 999999999999994 5688888999999999999999986 8999999999999999999999999875432 23
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
...+.+||+.|+|||++.+..|+.++||||+||++|+|+||..||.+... ......+. .. ...
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~----~~----------~~~ 252 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GLIFAKII----KL----------EYD 252 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH----HT----------CCC
T ss_pred cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH----cC----------CCC
Confidence 34567899999999999999999999999999999999999999975332 11111111 11 012
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVV 273 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il 273 (325)
.+..+++++.+||.+||..||++|||+++++
T Consensus 253 ~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 FPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 3345678899999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-54 Score=389.45 Aligned_cols=250 Identities=20% Similarity=0.277 Sum_probs=210.5
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
+.|+++++||.| +++.||++++..+++.||||.+..........+.+|+.+|++++|||||+++++|.+.+.+|||||
T Consensus 151 ~~y~~~~~iG~G--~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEG--STGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEEC--SSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccC--cCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 457889999999 888899999999999999999976555555678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccC
Q 046728 93 YMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRV 167 (325)
Q Consensus 93 ~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 167 (325)
||+||+|.++++ ..+++..+..++.++..|+.++|.+ |||||+|||++.+|.+||+|||+|+.+..... .....
T Consensus 229 y~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~ 307 (423)
T 4fie_A 229 FLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 307 (423)
T ss_dssp CCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBCCC
T ss_pred CCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-ccccc
Confidence 999999999994 5688888999999999999999986 89999999999999999999999987654432 23456
Q ss_pred CCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHH
Q 046728 168 KGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQ 247 (325)
Q Consensus 168 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (325)
+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.... .....+.. .. ......+..+
T Consensus 308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i~~----~~-------~~~~~~~~~~ 373 (423)
T 4fie_A 308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRD----NL-------PPRLKNLHKV 373 (423)
T ss_dssp EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHH----SC-------CCCCSCTTSS
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHc----CC-------CCCCcccccC
Confidence 7999999999999999999999999999999999999999754321 11111111 00 0011233456
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 248 LKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 248 ~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
++++.+||.+||..||++|||++++++ ||+..
T Consensus 374 s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 374 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 789999999999999999999999998 88753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=366.50 Aligned_cols=245 Identities=20% Similarity=0.335 Sum_probs=192.5
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|++++.||.| +++.||++++..+++.||||.+.+. ......++.+|+++|++++|||||++++++.+.+.+|+|
T Consensus 14 ~Y~i~~~lG~G--~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 14 NYQIVKTLGEG--SFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp CCEEEEEEEC-----CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CeEEEEEEecC--cCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 68899999999 8888999999999999999999643 234456799999999999999999999999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|||| +|+|.+++. +.+++..+..++.|+..|++++|.+ |||||+|||++.++.+||+|||+|+....... .
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~--~ 168 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF--L 168 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc--c
Confidence 9999 689999993 5688888999999999999999986 89999999999999999999999987654322 3
Q ss_pred ccCCCCcCCCCccccccCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKV-SDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.+.+||+.|+|||++.+..+ +.++||||+||++|+|+||..||.+... ......+. .+ ....
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~---~~~~~~i~----~~----------~~~~ 231 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI---PVLFKNIS----NG----------VYTL 231 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH----HT----------CCCC
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHH----cC----------CCCC
Confidence 34679999999999998776 5799999999999999999999975332 11111111 11 1123
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
+..+++++.+||.+||+.||++|||++++++ ||+.-+
T Consensus 232 p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~~ 270 (275)
T 3hyh_A 232 PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDL 270 (275)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTTC
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccCC
Confidence 3456789999999999999999999999998 997543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-54 Score=379.48 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=196.1
Q ss_pred cchhHHhhccCccceeeeeEEEecc-----CCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRE-----TGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
+.+.+.++||+| +++.||+++.. .+++.||||.++..+....++|.+|+++|++++|||||++++++.+...+
T Consensus 41 ~d~~l~~~LG~G--~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEG--AFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEEC--SSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccC--CCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 356677889998 78888888643 45789999999877777778999999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccC-----------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceE
Q 046728 88 LIVYDYMPNHSLITHLHGR-----------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAK 146 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~k 146 (325)
|+|||||++|+|.++++.. ++....+.++.+++.++.++|.. |||||+|||++.++.+|
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEE
Confidence 9999999999999999542 33334567778888888888874 89999999999999999
Q ss_pred EeeeccccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcc
Q 046728 147 VADFGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTP 224 (325)
Q Consensus 147 L~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~ 224 (325)
|+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |..||...... .....+..
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~i~~ 275 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAIDCITQ 275 (329)
T ss_dssp ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHHHHHHH
T ss_pred EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHHHHHHc
Confidence 9999999876543222 2334569999999999999999999999999999999999 89999764422 11111110
Q ss_pred cccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 225 YVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
+.+.+.+..+++++.+||.+||..||++|||+++|+++|+.+..
T Consensus 276 -------------g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 276 -------------GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp -------------TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -------------CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 11223445677899999999999999999999999999988754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=369.02 Aligned_cols=243 Identities=22% Similarity=0.340 Sum_probs=195.5
Q ss_pred hHHhhccCccceeeeeEEEeccCCCCeEEEEEecc--cChhhHHHHHHHHHHHHccCCCCccceeeEEEc----CCeEEE
Q 046728 16 VFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKT--LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG----GDERLI 89 (325)
Q Consensus 16 ~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 89 (325)
++.++||.| +++.||++.+..+++.||+|.+.. .......+|.+|+++|++++|||||++++++.+ +..+|+
T Consensus 29 ~~~~~iG~G--~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 29 KFDIEIGRG--SFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEC--SSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EeeeEEecC--cCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 667788888 888999999999999999999863 245556789999999999999999999999865 345899
Q ss_pred EEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhh------cCCCCCCceeeCC-CCceEEeeeccccccCCCc
Q 046728 90 VYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEG------IADIKASNVLLDT-DFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 90 V~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~------~rdlkp~Nil~~~-~~~~kL~Dfg~~~~~~~~~ 160 (325)
|||||+||+|.++++ ..+++..+..++.++..|++++|. ||||||+|||++. ++.+||+|||+|+......
T Consensus 107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~ 186 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 186 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCc
Confidence 999999999999994 457777788899999999999985 4899999999984 7899999999998654322
Q ss_pred ceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 161 THMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
..+.+||+.|+|||++.+ .|+.++|||||||++|||+||..||.+.... ......+. ....+
T Consensus 187 ---~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~~~i~------------~~~~~ 248 (290)
T 3fpq_A 187 ---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVT------------SGVKP 248 (290)
T ss_dssp ---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHT------------TTCCC
T ss_pred ---cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HHHHHHHH------------cCCCC
Confidence 334679999999999874 6999999999999999999999999653321 11111111 11111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
...+...++++.+||.+||..||++|||++++++ ||++
T Consensus 249 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 1222345568999999999999999999999998 8864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-53 Score=372.90 Aligned_cols=245 Identities=18% Similarity=0.161 Sum_probs=199.4
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEec
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~ 94 (325)
|.+.++||+| +++.||++++..+++.||||.++... ...+|+.++++++|||||++++++.+++.+|||||||
T Consensus 60 ~~~~~~lG~G--~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 60 MTHQPRVGRG--SFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp EEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred eEeCcEeccC--CCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 5666778888 88889999999999999999997532 2246999999999999999999999999999999999
Q ss_pred CCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC-ceEEeeeccccccCCCcce----e
Q 046728 95 PNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF-EAKVADFGFAKLIPDGVTH----M 163 (325)
Q Consensus 95 ~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~----~ 163 (325)
+||+|.++++ +.+++..+..++.|+..++.++|.+ |||||+|||++.+| .+||+|||+|+.+...... .
T Consensus 133 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~ 212 (336)
T 4g3f_A 133 EGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212 (336)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence 9999999994 4578888899999999999999985 89999999999987 6999999999876543221 1
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
....+||+.|+|||++.+..|+.++|||||||++|||+||..||.+.........+. . . +......
T Consensus 213 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~---~----~-------~~~~~~~ 278 (336)
T 4g3f_A 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA---S----E-------PPPIREI 278 (336)
T ss_dssp -CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH---H----S-------CCGGGGS
T ss_pred CCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH---c----C-------CCCchhc
Confidence 233579999999999999999999999999999999999999997654322211111 0 0 0001123
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
+..+++.+.+||.+||..||++|||+.|+++.|...+
T Consensus 279 ~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 279 PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 4567789999999999999999999999998766554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=374.25 Aligned_cols=250 Identities=21% Similarity=0.324 Sum_probs=197.8
Q ss_pred cchhHHhhccCccceeeeeEEEec-----cCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRR-----ETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~-----~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
+.+.|+++||+| +|+.||+++. ..+++.||||.++.. .....++|.+|+.++++++|||||+++|++.++..
T Consensus 26 ~~~~~~~~lG~G--~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 26 SAVRFMEELGED--RFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp GGEEEEEEEEEC--SSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHCeEeeEeccC--CCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 345778899999 7777888763 245688999999643 33445689999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhccC------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCc
Q 046728 87 RLIVYDYMPNHSLITHLHGR------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFE 144 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~~------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~ 144 (325)
+++|||||++|||.++|+.. ++....+.+..+++.++.++|.. |||||+|||+++++.
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC
Confidence 99999999999999999532 22233456778888888888875 899999999999999
Q ss_pred eEEeeeccccccCCCcc-eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhh
Q 046728 145 AKVADFGFAKLIPDGVT-HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWV 222 (325)
Q Consensus 145 ~kL~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~ 222 (325)
+||+|||+++....... .......||+.|+|||++.+..|+.++|||||||++|||+| |..||.+.... ++...+
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~~~~i 260 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVVEMI 260 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HHHHHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH
Confidence 99999999986644322 22344568999999999999999999999999999999998 89999765431 222211
Q ss_pred cccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 223 TPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
. . +...+.+..+++.+.+||.+||..||++|||+.+|++.|+.+.
T Consensus 261 ~----~---------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 261 R----N---------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp H----T---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred H----c---------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 1 1 1122345567789999999999999999999999999998653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=370.91 Aligned_cols=246 Identities=21% Similarity=0.313 Sum_probs=195.4
Q ss_pred cchhHHhhccCccceeeeeEEEecc---CCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRE---TGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
+.|++++.||+| +++.||++++. .+++.||||.+.+.. .....++.+|+++|++++|||||++++++.+++.+
T Consensus 24 ~~Y~i~~~lG~G--~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQG--SFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECG--GGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecC--CCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 468999999999 78889998874 357899999996432 22334788899999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 88 LIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
|+|||||+||+|.++++ +.+++..+..++.|+..|+.++|.+ |||||+|||++.++.+||+|||+|+.......
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 181 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc
Confidence 99999999999999994 4678888899999999999999986 89999999999999999999999986544322
Q ss_pred eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 162 HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
...+.+||+.|+|||++.+..|+.++||||+||++|||+||..||.+.+.. .....+. . . ..
T Consensus 182 -~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i~----~--------~--~~ 243 (304)
T 3ubd_A 182 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK---ETMTMIL----K--------A--KL 243 (304)
T ss_dssp -CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----H--------C--CC
T ss_pred -cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH---HHHHHHH----c--------C--CC
Confidence 234567999999999999999999999999999999999999999754321 1111111 0 0 11
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH--HHhc
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPT-----MTDVVD--WLKG 278 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~~il~--~l~~ 278 (325)
..+..+++++.+||.+||..||++||| ++++++ ||++
T Consensus 244 ~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 244 GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 234557789999999999999999998 478887 8865
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-52 Score=361.84 Aligned_cols=250 Identities=25% Similarity=0.400 Sum_probs=191.5
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
+.+.+.++||+| +++.||+++.. ..||||.++.. +......|.+|+.+|++++|||||++++++.+ +.+++|
T Consensus 36 ~~l~l~~~iG~G--~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 36 SEVMLSTRIGSG--SFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp TSCCEEEECCCC--SSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEeeEEeeC--CCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 355678889999 78889988754 35999998643 45556789999999999999999999998754 568999
Q ss_pred EEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc-ce
Q 046728 91 YDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV-TH 162 (325)
Q Consensus 91 ~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~ 162 (325)
||||++|+|.++++ ..++...++.++.+++.++.++|.. |||||+|||+++++.+||+|||+|+...... ..
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 99999999999994 3356667778889999999999985 8999999999999999999999998765422 22
Q ss_pred eeccCCCCcCCCCcccccc---CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 163 MTTRVKGTLGYLAPEYAMW---GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
......||+.|+|||++.+ ..|+.++|||||||++|||+||..||.+...... ....+. .+ ...+.
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~--~~~~~~----~~----~~~p~- 258 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ--IIFMVG----RG----YASPD- 258 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHHHH----TT----CCCCC-
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH--HHHHHh----cC----CCCCC-
Confidence 3345679999999999864 3589999999999999999999999976443111 111111 10 00111
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
....+..+++.+.+||.+||..||++|||+.+|++.|+.+
T Consensus 259 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 259 LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1123456778999999999999999999999999977654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=355.63 Aligned_cols=246 Identities=19% Similarity=0.283 Sum_probs=184.6
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC------
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD------ 85 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 85 (325)
..|.+++.||+| +++.||++++..+++.||||.+... ......++.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G--~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRG--GFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEEC--C--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecC--CCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 457889999999 8888999999999999999999743 3445568999999999999999999999986544
Q ss_pred ------eEEEEEEecCCCChhhhhccCCC--CC---CccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeee
Q 046728 86 ------ERLIVYDYMPNHSLITHLHGRLA--PD---CLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADF 150 (325)
Q Consensus 86 ------~~~lV~e~~~~gsL~~~l~~~~~--~~---~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Df 150 (325)
.+|+|||||++|+|.++++.... +. .++.++.|+..|++++|.. |||||+|||++.++.+||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 36899999999999999964322 21 2566889999999999985 899999999999999999999
Q ss_pred ccccccCCCcce-----------eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhh
Q 046728 151 GFAKLIPDGVTH-----------MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIV 219 (325)
Q Consensus 151 g~~~~~~~~~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~ 219 (325)
|+|+........ .....+||+.|+|||++.+..|+.++|||||||++|||++ ||.... ...
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~~ 234 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ERV 234 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HHH
Confidence 999876543221 1233569999999999999999999999999999999996 774311 000
Q ss_pred hhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 220 QWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
..+.. +.... .++.....++.+.+||.+||..||++|||+.++++ ||++
T Consensus 235 ~~~~~---------~~~~~-~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 235 RTLTD---------VRNLK-FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHHH---------HHTTC-CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHHH---------HhcCC-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 00000 00000 01122344567889999999999999999999998 7765
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=365.29 Aligned_cols=252 Identities=22% Similarity=0.280 Sum_probs=198.5
Q ss_pred cchhHHhhccCccceeeeeEEEeccCC-----CCeEEEEEeccc-ChhhHHHHHHHHHHHHccC-CCCccceeeEEEc-C
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETG-----DDQIAVKRLKTL-NAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAG-G 84 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~-----~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~-~ 84 (325)
..|++.+.||+| +|+.||++..... ++.||||.+... .......|.+|+++|++++ |||||++++++.. +
T Consensus 64 ~~~~l~~~LG~G--~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 64 DRLKLGKPLGRG--AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp GGEEEEEEEEEC--SSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHeEEeeEEecC--CCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 357788899999 7777888875543 357999999753 3444568999999999996 5999999999865 4
Q ss_pred CeEEEEEEecCCCChhhhhccC------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC
Q 046728 85 DERLIVYDYMPNHSLITHLHGR------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD 142 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~~~------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~ 142 (325)
..+++|||||++|+|.++|+.. ++...++.++.+++.++.++|.. |||||+|||++++
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 221 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 221 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC
Confidence 5689999999999999999532 23334556777888888888875 8999999999999
Q ss_pred CceEEeeeccccccCCCcc-eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhh
Q 046728 143 FEAKVADFGFAKLIPDGVT-HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQ 220 (325)
Q Consensus 143 ~~~kL~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~ 220 (325)
+.+||+|||+|+....... .......||+.|+|||++.+..|+.++|||||||++|||+| |..||.+...... +..
T Consensus 222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~--~~~ 299 (353)
T 4ase_A 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR 299 (353)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHH
T ss_pred CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH--HHH
Confidence 9999999999987654332 33445568999999999999999999999999999999998 8999976543211 111
Q ss_pred hhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 221 WVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.+. .+.+.+.+..+++++.+||.+||..||++|||+.+|++.|+.++.
T Consensus 300 ~i~-------------~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 300 RLK-------------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp HHH-------------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH-------------cCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 111 111223445667899999999999999999999999998887653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=356.54 Aligned_cols=263 Identities=18% Similarity=0.188 Sum_probs=189.5
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC----eE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD----ER 87 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~ 87 (325)
.+.+.+.++||+| +++.||+++. +|+.||||.+...... ...+..|+..+.+++|||||++++++.+++ .+
T Consensus 2 ar~i~L~~~iG~G--~fG~Vy~~~~--~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 2 ARTIVLQESIGKG--RFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGGEEEEEEEEEC--SSSEEEEEEE--TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CcEEEEEEEEeeC--CCeEEEEEEE--CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4567788899999 7788998875 5789999999753322 223345666667889999999999987653 57
Q ss_pred EEEEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhh------------cCCCCCCceeeCCCCceEEeeecccc
Q 046728 88 LIVYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEG------------IADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~------------~rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
|+|||||++|+|.++++ ..++......+..+++.++.++|. ||||||+|||++.++.+||+|||+++
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999999995 345556667888899999999994 58999999999999999999999998
Q ss_pred ccCCCcce---eeccCCCCcCCCCccccccC------CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccc
Q 046728 155 LIPDGVTH---MTTRVKGTLGYLAPEYAMWG------KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPY 225 (325)
Q Consensus 155 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~------~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 225 (325)
........ ......||+.|+|||++.+. .++.++|||||||++|||+||.+||........... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~-~~~~~~ 235 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY-DLVPSD 235 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT-TTSCSS
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch-hccccc
Confidence 76543322 12345699999999998754 356799999999999999999888754322111000 000000
Q ss_pred cc-ccccccccCccccCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 226 VQ-KGAFEHIADPRLKGKF-----NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 226 ~~-~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
.. ......+....+++.. ..+.+..+.+|+.+||..||++|||+.+|++.|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 00 0000011112222222 2346678999999999999999999999999998765
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=358.35 Aligned_cols=271 Identities=18% Similarity=0.241 Sum_probs=205.0
Q ss_pred ceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEc-
Q 046728 7 ICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG- 83 (325)
Q Consensus 7 ~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 83 (325)
..|.+...|.+++.||.| +++.||++++..+|+.||||++... ......++.+|+++|++++|||||++++++..
T Consensus 48 ~~~~i~~~Y~~~~~lG~G--~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 125 (398)
T 4b99_A 48 VTFDVGDEYEIIETIGNG--AYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPT 125 (398)
T ss_dssp CCCCCCSSEEEEEEEEEC--SSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred CCCCCCCCeEEEEEEecc--cCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecc
Confidence 345566779999999999 8888999999999999999999643 34455688899999999999999999998754
Q ss_pred -----CCeEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecc
Q 046728 84 -----GDERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGF 152 (325)
Q Consensus 84 -----~~~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~ 152 (325)
...+|+|||||. |+|.+++. +.+++..+..++.|+..|+.++|.+ |||||+|||++.++.+||+|||+
T Consensus 126 ~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp SCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred cccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecce
Confidence 367899999995 68999994 4577778899999999999999986 89999999999999999999999
Q ss_pred ccccCCCc---ceeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccc
Q 046728 153 AKLIPDGV---THMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQK 228 (325)
Q Consensus 153 ~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 228 (325)
++.+.... .....+.+||+.|+|||++.+. .++.++||||+||++|||++|.+||.+.........+.........
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 98764321 1223456799999999998865 5689999999999999999999999764322211111111000000
Q ss_pred ccccccc-----------CccccC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 229 GAFEHIA-----------DPRLKG---KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 229 ~~~~~~~-----------~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
..+.... ...... ...+..++++.+||.+||..||++|||++++++ ||+...
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 0000000 000000 001234678999999999999999999999998 998653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=346.41 Aligned_cols=262 Identities=20% Similarity=0.271 Sum_probs=197.4
Q ss_pred cccchhHHhhccCccceeeeeEEEecc---CCCCeEEEEEecccChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCe
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRE---TGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 86 (325)
+...|.++++||+| +++.||++++. .+++.||||.+.... ...++.+|+++|+.+ +||||+++++++.+.+.
T Consensus 19 l~~~Y~i~~~lG~G--~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 19 LSNVFKIEDKIGEG--TFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGTCEEEEEEEEC--SSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred ccCcEEEEEEEecc--cCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 45568899999999 88889998764 457899999986532 345788999999998 69999999999999999
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC-CceEEeeeccccccCCCcc
Q 046728 87 RLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD-FEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~ 161 (325)
+|+|||||++|+|.++++. +++..+..+..|+..|+.++|.+ |||||+|||++.+ +.+||+|||+|+.......
T Consensus 95 ~~lvmE~~~g~~L~~~~~~-l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILNS-LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp EEEEEECCCCCCHHHHHTT-CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred EEEEEeCCCcccHHHHHcC-CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 9999999999999999964 78888899999999999999985 8999999999876 7999999999986543211
Q ss_pred ---------------------------eeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCC
Q 046728 162 ---------------------------HMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGG 213 (325)
Q Consensus 162 ---------------------------~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~ 213 (325)
......+||+.|+|||++.+. .|+.++||||+||++|+|++|..||......
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~ 253 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD 253 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence 112235699999999999875 4899999999999999999999999653321
Q ss_pred ccchhhhhhccc-----------------c-----ccc--------------cccc----ccCccccCCCCHHHHHHHHH
Q 046728 214 VKRDIVQWVTPY-----------------V-----QKG--------------AFEH----IADPRLKGKFNRDQLKSMVL 253 (325)
Q Consensus 214 ~~~~~~~~~~~~-----------------~-----~~~--------------~~~~----~~~~~~~~~~~~~~~~~~~~ 253 (325)
. .....+... . ... .... ..........+...++++.+
T Consensus 254 ~--~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D 331 (361)
T 4f9c_A 254 L--TALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD 331 (361)
T ss_dssp H--HHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred H--HHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence 1 100000000 0 000 0000 00000011123446678999
Q ss_pred HHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 254 IALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 254 li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
||.+||..||++|||++|+++ ||+++
T Consensus 332 Ll~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 332 LLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999998 88763
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=362.39 Aligned_cols=248 Identities=17% Similarity=0.209 Sum_probs=201.8
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHH---HHHHHHHccCCCCccceeeEEEcCCe
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFA---VEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
..|.+++.||.| ++|.||++++..+++.||||++.+.. ......+. .++.+++.++|||||+++++|.+.+.
T Consensus 189 ddf~i~k~LG~G--~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 189 NDFSVHRIIGRG--GFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp GGEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred HHeEEEEEEecc--cCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 358889999999 88899999999999999999996421 11122333 34667778899999999999999999
Q ss_pred EEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 87 RLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
+|+|||||+||+|.++|+ +.+++..+..++.++..|+.++|.+ |||||+|||++.+|.+||+|||+|+......
T Consensus 267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~ 346 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 346 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence 999999999999999994 5688888999999999999999986 8999999999999999999999998765432
Q ss_pred ceeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 161 THMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
..+.+||+.|+|||++.. ..|+.++|||||||++|||++|.+||.+........+..... . .
T Consensus 347 ---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~----~----------~ 409 (689)
T 3v5w_A 347 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----T----------M 409 (689)
T ss_dssp ---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH----H----------C
T ss_pred ---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc----C----------C
Confidence 345679999999999974 579999999999999999999999997543322221111110 0 0
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH--HHhcc
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPT-----MTDVVD--WLKGG 279 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~~il~--~l~~~ 279 (325)
....+..+++++.+||.+||..||++|++ +++|++ ||+++
T Consensus 410 ~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 410 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 12334567789999999999999999998 789998 88764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=363.88 Aligned_cols=250 Identities=19% Similarity=0.301 Sum_probs=208.3
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
..|.+++.||.| +++.||++++..+|+.||+|.+..........+.+|+++|++++|||||+++++|.+...+|+|||
T Consensus 157 ~~Y~i~~~lG~G--~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 157 DHYDIHEELGTG--AFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GTEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cccEEEEEEeec--cCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 467889999999 778899999999999999999987666667789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC--CceEEeeeccccccCCCccee
Q 046728 93 YMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD--FEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 93 ~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~--~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||+||+|.+++. +.+++..+..++.|+..+++++|.+ |||||+|||++.+ +.+||+|||+++.+.....
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~-- 312 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-- 312 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE--
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc--
Confidence 999999999994 3466777888999999999999985 8999999999854 8999999999998765433
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
....+||+.|+|||++.+..|+.++||||+||++|+|++|..||.+.... .....+.. .. .......
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~---~~~~~i~~----~~------~~~~~~~ 379 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNVKS----CD------WNMDDSA 379 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHT----TC------CCCCSGG
T ss_pred eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHh----CC------CCCCccc
Confidence 23457999999999999999999999999999999999999999754321 11111110 00 0111122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
+..+++++.+||.+||..||++|||++++++ ||+..
T Consensus 380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 380 FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence 3456788999999999999999999999999 88753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=318.30 Aligned_cols=253 Identities=18% Similarity=0.242 Sum_probs=207.8
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
....|.+++.||.| +++.||++.+..+++.||+|.+..........+.+|+.++++++||||+++++++.+.+..++|
T Consensus 18 ~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 18 PKKKYTRFEKIGQG--ASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGGTBCCCEEEEEE--TTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceeeeeeeccC--CCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 45678899999998 8888999999999999999999765555566889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 91 YDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 91 ~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
||||++|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||++......... ..
T Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~ 174 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RS 174 (297)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-BC
T ss_pred EECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-cC
Confidence 99999999999995 3466677788899999999999975 799999999999999999999999876544332 33
Q ss_pred cCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCH
Q 046728 166 RVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNR 245 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (325)
...||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..... .. .......+.
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~---~~--------~~~~~~~~~ 240 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA---LYLIA---TN--------GTPELQNPE 240 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHH---HH--------CSCCCSCGG
T ss_pred CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH---hC--------CCCCCCCcc
Confidence 45699999999999999999999999999999999999999965332111 00000 00 001112345
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 246 DQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 246 ~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
..++.+.+||.+||..||++|||++++++ ||+...
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 56788999999999999999999999998 887543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=319.49 Aligned_cols=247 Identities=23% Similarity=0.337 Sum_probs=205.2
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
..|.+++.||.| +++.||++++..+++.||||.+... +.....++.+|+++++.++||||+++++++.+....++|
T Consensus 15 ~~y~~~~~lG~G--~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 15 GNYRLLKTIGKG--NFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp TTEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEeeC--CCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 468899999999 8888999999999999999999643 455567888999999999999999999999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|||+++|+|.+++. +.+++..+..++.++..++.++|.. |||||+|||++.++.+||+|||++........ .
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~ 170 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--L 170 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG--G
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc--c
Confidence 99999999999993 5577778888999999999999985 79999999999999999999999986654322 3
Q ss_pred ccCCCCcCCCCccccccCCCC-CcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVS-DSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
....||+.|+|||++.+..+. .++||||+||++|+|++|..||...... .....+. .+. ...
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~----~~~----------~~~ 233 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK---ELRERVL----RGK----------YRI 233 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----HCC----------CCC
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHH----hCC----------CCC
Confidence 445799999999999887765 6899999999999999999999754321 1111110 110 122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
+...++.+.+||.+||..||++|||++++++ ||+...
T Consensus 234 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 234 PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 3345678999999999999999999999998 887644
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=316.77 Aligned_cols=267 Identities=30% Similarity=0.477 Sum_probs=216.9
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
...|.+.+.||.| +++.||.++. .+++.||+|.+..........+.+|+.++++++||||+++++++.+.+..++||
T Consensus 38 ~~~y~~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 38 TNNFDHKFLIGHG--VFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCSCCCCSCBC--SSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred HhccCccceeecC--CCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 3567888889998 7778898885 458899999987666666778999999999999999999999999999999999
Q ss_pred EecCCCChhhhhccC------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 92 DYMPNHSLITHLHGR------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 92 e~~~~gsL~~~l~~~------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
||+++|+|.+++... ++....+.+..++..++.++|.. |||||+||+++.++.+||+|||++........
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 194 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 999999999999543 33344566777888888888875 79999999999999999999999986543221
Q ss_pred -eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 162 -HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 162 -~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
.......||..|+|||++.+..++.++|||||||++|+|++|..||.............|.........+....++.+.
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (321)
T 2qkw_B 195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA 274 (321)
T ss_dssp CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT
T ss_pred cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhc
Confidence 1223345899999999998889999999999999999999999999876555444444444433334444455555555
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.......+..+.+++.+||..||++|||+.++++.|+..+.
T Consensus 275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 66678899999999999999999999999999999987653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=314.31 Aligned_cols=253 Identities=20% Similarity=0.314 Sum_probs=205.0
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
...|.+.+.||.| +++.||.+.+..+++.||+|.+...+......+.+|++++++++||||+++++++.++...++||
T Consensus 9 ~~~~~~~~~lG~G--~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 9 PSDLIHGEVLGKG--CFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGGEEEEEEEECC--SSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhHeeccceecCC--CCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 4677888999999 88889999999999999999997777777889999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee-
Q 046728 92 DYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM- 163 (325)
Q Consensus 92 e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~- 163 (325)
||+++|+|.++++. .++...++.+..++..++.++|.. |||||+||+++.++.+||+|||++..........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 99999999999953 355566777888999999999975 7999999999999999999999998765432211
Q ss_pred ------------eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccc
Q 046728 164 ------------TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAF 231 (325)
Q Consensus 164 ------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (325)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||............. .
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~--------- 236 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-V--------- 236 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-H---------
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-h---------
Confidence 114568999999999999899999999999999999999999986543211110000 0
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 232 EHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
........+..+++.+.+|+.+||..||++|||+.+++++|+.+.
T Consensus 237 ----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 237 ----RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp ----HHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----hccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000011123345567999999999999999999999999998765
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=311.50 Aligned_cols=262 Identities=22% Similarity=0.360 Sum_probs=205.3
Q ss_pred ceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecc---cChhhHHHHHHHHHHHHccCCCCccceeeEEEc
Q 046728 7 ICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKT---LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG 83 (325)
Q Consensus 7 ~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (325)
+.-.+...|.+++.||.| +++.||++++..+++.||+|.+.. .......++.+|+.++++++||||+++++++.+
T Consensus 5 ~g~~~~~~y~i~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 82 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGG--GMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE 82 (294)
T ss_dssp CSSCEETTEEEEEEEEEE--TTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred hhhHhhccEEEEEEEccC--CCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence 344567789999999999 788899999999999999999853 234555688999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccC
Q 046728 84 GDERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIP 157 (325)
Q Consensus 84 ~~~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~ 157 (325)
.+..++||||+++++|.+++. ..++...++.+..++..++.++|.. |||||+||+++.++.+||+|||++....
T Consensus 83 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 83 DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred CCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999999999994 3467777888999999999999975 7999999999999999999999998765
Q ss_pred CCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 158 DGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 158 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
...........||+.|+|||++.+..++.++||||||+++|+|++|..||........ ...... .. .+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~~~----~~------~~ 230 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIKHIQ----DS------VP 230 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH--HHHHHS----SC------CC
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhh----cc------CC
Confidence 5433334445689999999999988899999999999999999999999975432110 000000 00 01
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcccCC
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRP-TMTDVVDWLKGGLGR 282 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-s~~~il~~l~~~~~~ 282 (325)
......+...++.+.++|.+||..||++|| +++++.+.|+..+..
T Consensus 231 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 231 NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 111122344667899999999999999998 899999999887653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=314.80 Aligned_cols=247 Identities=19% Similarity=0.265 Sum_probs=202.5
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..|.+++.||.| +++.||++++..+++.||+|.+.+. .......+.+|..+++.++||||+++++++.+....|+
T Consensus 5 ~~y~~~~~lG~G--~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 5 NDFDYLKLLGKG--TFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred HHeEEEEEEecC--CCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 467889999999 8888999999999999999999643 23345578899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 90 VYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 90 V~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||||+++|+|.+++. ..+++..+..+..++..++.++|.+ |||||+|||++.++.+||+|||+++....... .
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-~ 161 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-T 161 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-C
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-c
Confidence 999999999999994 4467777788889999999999985 79999999999999999999999986433222 2
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+. . . ....
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~----~--------~--~~~~ 224 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELIL----M--------E--EIRF 224 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----H--------C--CCCC
T ss_pred ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHHHHHH----c--------C--CCCC
Confidence 33456899999999999889999999999999999999999999753321 1111110 0 0 0123
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH--HHhcc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRP-----TMTDVVD--WLKGG 279 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~~ 279 (325)
+...++++.+||.+||..||++|| +++++++ ||+..
T Consensus 225 p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 345678899999999999999999 8999998 77643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=318.50 Aligned_cols=252 Identities=19% Similarity=0.292 Sum_probs=203.6
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChh------hHHHHHHHHHHHHccCCCCccceeeEEEc
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAK------AEMEFAVEVEILGRVRHRNLLGLRGFYAG 83 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (325)
.+...|.+.+.||.| +++.||++++..+++.||+|.+...... ....+.+|+.++++++||||+++++++.+
T Consensus 9 ~~~~~y~~~~~LG~G--~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 9 KVEDFYDIGEELGSG--QFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN 86 (361)
T ss_dssp CGGGTEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ChhhceEEeeEEeeC--cCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence 456678899999999 7888999999999999999999753321 34678999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC----ceEEeeeccc
Q 046728 84 GDERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF----EAKVADFGFA 153 (325)
Q Consensus 84 ~~~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~----~~kL~Dfg~~ 153 (325)
....++|||||++|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999999999999994 3466677888999999999999975 79999999998776 7999999999
Q ss_pred cccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccc
Q 046728 154 KLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEH 233 (325)
Q Consensus 154 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (325)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... ....+. ...+
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~---~~~~i~----~~~~-- 235 (361)
T 2yab_A 167 HEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANIT----AVSY-- 235 (361)
T ss_dssp EECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHH----TTCC--
T ss_pred eEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hcCC--
Confidence 87655322 234569999999999998899999999999999999999999997543211 111110 0000
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 234 IADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
......+...++.+.+||.+||..||++|||+.++++ ||+.
T Consensus 236 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 236 ----DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp ----CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred ----CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 0001112345678999999999999999999999998 7763
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=312.36 Aligned_cols=265 Identities=35% Similarity=0.559 Sum_probs=213.2
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
...|.+.+.||.| +++.||+++. .+++.||||.+.... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 29 ~~~y~~~~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 105 (326)
T 3uim_A 29 SDNFSNKNILGRG--GFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 105 (326)
T ss_dssp TTSSCSTTEEECC--SSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEE
T ss_pred hhccccceeEecC--CCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEE
Confidence 4567888999999 7788998874 458899999997532 22223688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccC------CCCCCccCHHHHHHHHHHHHhhc-------CCCCCCceeeCCCCceEEeeeccccccC
Q 046728 91 YDYMPNHSLITHLHGR------LAPDCLLDWHRRVSIAIGSAEGI-------ADIKASNVLLDTDFEAKVADFGFAKLIP 157 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~~------~~~~~~~~~~~~~~~~~~~~~~~-------rdlkp~Nil~~~~~~~kL~Dfg~~~~~~ 157 (325)
|||+.+|+|.++++.. ++...+..+..++..++.++|.. |||||+|||++.++.+||+|||++....
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 185 (326)
T 3uim_A 106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185 (326)
T ss_dssp EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccC
Confidence 9999999999999643 33334567778888899998875 6999999999999999999999998776
Q ss_pred CCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC--CCCccchhhhhhccccccccccccc
Q 046728 158 DGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKL--PGGVKRDIVQWVTPYVQKGAFEHIA 235 (325)
Q Consensus 158 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (325)
...........||+.|+|||++.+..++.++|||||||++|+|++|..||... ..........|+.............
T Consensus 186 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (326)
T 3uim_A 186 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALV 265 (326)
T ss_dssp SSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSS
T ss_pred cccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhc
Confidence 55444455556999999999998888999999999999999999999999521 1122233334444444444555555
Q ss_pred CccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 236 DPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
...+........++.+.+|+.+||..||++|||+.++++.|+..
T Consensus 266 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 266 DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp CTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred ChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 66666677788899999999999999999999999999999863
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=312.97 Aligned_cols=248 Identities=19% Similarity=0.287 Sum_probs=203.0
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
-.+|.+.+.||.| +++.||++.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++.+....+
T Consensus 8 i~~Y~i~~~lG~G--~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 8 IGPYIIRETLGEG--SFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp ETTEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cCCEEEEEEEecC--CCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 3568899999999 88889999999999999999986421 122347889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhh--ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 89 IVYDYMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 89 lV~e~~~~gsL~~~l--~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
+||||+ +|+|.+++ +..+++..+..++.++..++.++|.. |||||+|||++.++.+||+|||++........
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~- 163 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF- 163 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT-
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc-
Confidence 999999 78999998 35577777888999999999999975 79999999999999999999999987655332
Q ss_pred eeccCCCCcCCCCccccccCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKV-SDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
.....||+.|+|||++.+..+ +.++|||||||++|+|++|..||......... ..+... ..
T Consensus 164 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------------~~i~~~--~~ 225 (336)
T 3h4j_B 164 -LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------------KKVNSC--VY 225 (336)
T ss_dssp -TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------CCCCSS--CC
T ss_pred -cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------HHHHcC--CC
Confidence 234569999999999987776 67999999999999999999999754321111 111111 11
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
..+...++.+.+||.+||..||.+|||++++++ ||+...+
T Consensus 226 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 267 (336)
T 3h4j_B 226 VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLP 267 (336)
T ss_dssp CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCCc
Confidence 233456778999999999999999999999998 9986544
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=313.00 Aligned_cols=258 Identities=19% Similarity=0.321 Sum_probs=204.8
Q ss_pred eeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 8 CFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 8 ~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
...+-..|.+++.||.| +++.||++.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++.++..
T Consensus 2 ~~~~~~~y~i~~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 79 (323)
T 3tki_A 2 AVPFVEDWDLVQTLGEG--AYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI 79 (323)
T ss_dssp CCTTTTCEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCcHhhhceeeeEEecC--CCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence 34566788999999999 78889999999999999999986432 2334578899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 87 RLIVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
.++|||||++|+|.+++.. .+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||++.......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999999999999953 366677888899999999999975 7999999999999999999999998654322
Q ss_pred c-eeeccCCCCcCCCCccccccCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 161 T-HMTTRVKGTLGYLAPEYAMWGKV-SDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 161 ~-~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
. .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ....+.. ..
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~-------------~~ 225 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE-------------KK 225 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHT-------------TC
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhc-------------cc
Confidence 2 22234568999999999987765 6789999999999999999999976443211 1111110 11
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
.........++.+.+||.+||..||++|||++++++ ||+....
T Consensus 226 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 111223456778999999999999999999999998 8876543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=312.83 Aligned_cols=265 Identities=21% Similarity=0.322 Sum_probs=201.0
Q ss_pred ecccchhHHhhccCccceeeeeEEEe----ccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEc--
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLR----RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG-- 83 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 83 (325)
-....|.+++.||.| +++.||+++ +..+++.||+|.+..........+.+|++++++++||||+++++++..
T Consensus 7 ~~~~~~~~~~~lg~G--~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 7 FEERHLKFLQQLGKG--NFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp CCGGGEEEEEEEEEC--SSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred CCHHHhhhhheeecc--CCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 346788999999999 777888887 667789999999987777777889999999999999999999999854
Q ss_pred CCeEEEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccccc
Q 046728 84 GDERLIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLI 156 (325)
Q Consensus 84 ~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~ 156 (325)
....++||||+++|+|.+++.. .++...++.+..++..++.++|.. |||||+||+++.++.+||+|||++...
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 3568999999999999999943 356666778889999999999975 799999999999999999999999876
Q ss_pred CCCcce--eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccc----ccc
Q 046728 157 PDGVTH--MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQ----KGA 230 (325)
Q Consensus 157 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~ 230 (325)
...... ......++..|+|||++.+..++.++||||||+++|+|+||..||...+... ......... ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF----MRMIGNDKQGQMIVFH 240 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH----HHHHCTTCCTHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH----HhhhcCccccchhHHH
Confidence 543221 1223346778999999998899999999999999999999999985422100 000000000 000
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 231 FEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
...........+.+..+++++.+||.+||..||++|||+.++++.|+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00000111122344567789999999999999999999999999988764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=309.37 Aligned_cols=250 Identities=26% Similarity=0.338 Sum_probs=193.2
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
...|.+.+.||.| +++.||+++. .++.||+|.+... ......++.+|+.++++++||||+++++++.+....++
T Consensus 36 ~~~y~i~~~lG~G--~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 36 WCDLNIKEKIGAG--SFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp GGGEEEEEEEEEC--SSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred hhHceeeeEeecC--CCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 3567888999999 7778888865 5788999998643 34555688999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccC-----CCCCCccCHHHHHHHHHHHHhhc------CCCCCCceeeCCCCceEEeeeccccccCC
Q 046728 90 VYDYMPNHSLITHLHGR-----LAPDCLLDWHRRVSIAIGSAEGI------ADIKASNVLLDTDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~~-----~~~~~~~~~~~~~~~~~~~~~~~------rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 158 (325)
||||+++|+|.+++... ++...++.+..++..++.++|.. |||||+||+++.++.+||+|||++.....
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 99999999999999542 56666778888999999999864 69999999999999999999999985543
Q ss_pred CcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 159 GVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 159 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+.. ..
T Consensus 192 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~~~~~------------~~ 255 (309)
T 3p86_A 192 TFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VVAAVGF------------KC 255 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHHHHHH------------SC
T ss_pred ccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh------------cC
Confidence 322 2234568999999999998899999999999999999999999997543211 1111100 01
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.....+..+++.+.+||.+||..||++|||+.++++.|+.+..
T Consensus 256 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 256 KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1123345567789999999999999999999999999988765
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=322.09 Aligned_cols=253 Identities=17% Similarity=0.251 Sum_probs=204.2
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
.+...|.+.+.||.| +++.||++.+..+++.||+|.+.... ......+.+|+.++++++||||+++++++.+....
T Consensus 8 ~~~~~Y~i~~~LG~G--~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 8 RFTEEYQLFEELGKG--AFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH 85 (444)
T ss_dssp HHHHHEEEEEEEEEC----CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred cccCCeEEEEEeccC--CCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence 456778899999999 88889999999999999999996432 34456788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeC---CCCceEEeeeccccccCC
Q 046728 88 LIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLD---TDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~---~~~~~kL~Dfg~~~~~~~ 158 (325)
++|||||.+|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++ .++.+||+|||++.....
T Consensus 86 ~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp EEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 99999999999999984 4466777888999999999999975 79999999998 457899999999986654
Q ss_pred CcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 159 GVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 159 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
.... .....||+.|+|||++.+..++.++||||+||++|+|++|..||...... .....+. .+.+ .
T Consensus 166 ~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~~~~i~----~~~~------~ 231 (444)
T 3soa_A 166 EQQA-WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RLYQQIK----AGAY------D 231 (444)
T ss_dssp TCCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHH----HTCC------C
T ss_pred CCce-eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HHHHHHH----hCCC------C
Confidence 3322 23456999999999999889999999999999999999999999653321 1111111 1111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
...+.+...++++.+||.+||..||++|||+.++++ ||..
T Consensus 232 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 232 FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 112223456788999999999999999999999999 7764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=311.33 Aligned_cols=252 Identities=18% Similarity=0.309 Sum_probs=204.1
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
+...|.+.+.||.| +++.||.+.+..+++.||+|.+... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 3 ~~~~y~~~~~lG~G--~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 3 LYEKYMIAEDLGRG--EFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceEeeeEEecC--CCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 45678889999999 8888999999999999999999753 34455788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC--CCceEEeeeccccccCCCcc
Q 046728 91 YDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT--DFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~--~~~~kL~Dfg~~~~~~~~~~ 161 (325)
||||++|+|.+++.. .+++..+..+..++..++.++|.. |||||+|||++. ++.+||+|||++........
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 999999999999953 356667788899999999999985 799999999987 78999999999987655433
Q ss_pred eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 162 HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
. ....||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+.. .... ...
T Consensus 160 ~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~----~~~~------~~~ 224 (321)
T 1tki_A 160 F--RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIENIMN----AEYT------FDE 224 (321)
T ss_dssp E--EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHH----TCCC------CCH
T ss_pred c--ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHHHc----CCCC------CCh
Confidence 2 2345899999999999888899999999999999999999999754321 11111100 0000 000
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
......++++.+||.+||..||++|||+.++++ ||+...
T Consensus 225 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 111245678999999999999999999999999 988643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=315.16 Aligned_cols=269 Identities=16% Similarity=0.216 Sum_probs=203.2
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
-...|.+++.||.|.++++.||++++..+++.||||.+... .......+.+|+.++++++||||+++++++.+....+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34678999999999888999999999999999999999643 3455567888999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhc----cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 89 IVYDYMPNHSLITHLH----GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~----~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
+|||||++|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||.+.......
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 9999999999999994 3356667788889999999999985 7999999999999999999999886543221
Q ss_pred ce------eeccCCCCcCCCCcccccc--CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccc-----
Q 046728 161 TH------MTTRVKGTLGYLAPEYAMW--GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQ----- 227 (325)
Q Consensus 161 ~~------~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----- 227 (325)
.. ......||..|+|||++.+ ..++.++|||||||++|+|++|..||........... .......
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~ 260 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE--KLNGTVPCLLDT 260 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH--C-----------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH--HhcCCCCccccc
Confidence 11 1122368899999999987 5789999999999999999999999976443221110 0000000
Q ss_pred ----cccc--------------ccc--------cCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 228 ----KGAF--------------EHI--------ADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 228 ----~~~~--------------~~~--------~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
...+ ... .......+.+...++.+.+||.+||..||++|||+.++++ ||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 0000 000 0000011233456778999999999999999999999998 88876
Q ss_pred cC
Q 046728 280 LG 281 (325)
Q Consensus 280 ~~ 281 (325)
..
T Consensus 341 ~~ 342 (389)
T 3gni_B 341 KR 342 (389)
T ss_dssp --
T ss_pred hh
Confidence 53
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=314.37 Aligned_cols=253 Identities=20% Similarity=0.292 Sum_probs=193.1
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
....|.+++.||.| +++.||++++..+++.||+|.+.... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 18 ~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 18 DSDRYDFVKDIGSG--NFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp CTTTEEEEEEESSS--TTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCcEEEEEEeccC--CCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence 34678999999999 77789999999999999999997533 2235788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCc--eEEeeeccccccCCCcce
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFE--AKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~ 162 (325)
||||++|+|.+++. +.+++..+..+..++..++.++|.. |||||+|||++.++. +||+|||+++......
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-- 172 (361)
T 3uc3_A 95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 172 (361)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--
Confidence 99999999999983 4577778889999999999999975 799999999987765 9999999987433221
Q ss_pred eeccCCCCcCCCCccccccCCCCCc-ccchhHHHHHHHHHhCCCCCCCCCCCcc-chhhhhhcccccccccccccCcccc
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDS-CDVYSFGVLLLELISAKKPLEKLPGGVK-RDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
......||+.|+|||++.+..++.+ +|||||||++|+|++|..||........ ....... ......
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~------------~~~~~~ 240 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI------------LSVKYS 240 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHH------------HTTCCC
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHH------------hcCCCC
Confidence 1233468999999999988777665 8999999999999999999976433211 1111111 011111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
.+.....++.+.+||.+||..||++|||+.++++ ||....
T Consensus 241 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 241 IPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282 (361)
T ss_dssp CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence 1122245678999999999999999999999998 886554
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=316.11 Aligned_cols=247 Identities=23% Similarity=0.240 Sum_probs=199.2
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 88 (325)
..|.+++.||.| +++.||++++..+++.||+|.+.+. .......+.+|..+++.+ +||||+++++++.+....|
T Consensus 23 ~~y~~~~~lG~G--~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 23 DNFEFIRVLGKG--SFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp CCEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hheEEEEEEeeC--CCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 468889999999 8888999999999999999999753 233445778899999998 6999999999999999999
Q ss_pred EEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 89 IVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
+|||||++|+|.++++ ..+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||+++...... .
T Consensus 101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~-~ 179 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG-V 179 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC-c
Confidence 9999999999999994 4577777888999999999999985 7999999999999999999999998543322 2
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+. . . ...
T Consensus 180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~i~----~--------~--~~~ 242 (353)
T 3txo_A 180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DLFEAIL----N--------D--EVV 242 (353)
T ss_dssp ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----H--------C--CCC
T ss_pred cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HHHHHHH----c--------C--CCC
Confidence 234457999999999999888999999999999999999999999754321 1111110 0 0 112
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH--HHhcc
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTM------TDVVD--WLKGG 279 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~------~~il~--~l~~~ 279 (325)
.+...++.+.+||.+||..||++||++ +++++ ||+.+
T Consensus 243 ~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 243 YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 234466789999999999999999998 88887 88764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=310.54 Aligned_cols=251 Identities=19% Similarity=0.284 Sum_probs=201.4
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh------hhHHHHHHHHHHHHccCCCCccceeeEEEcC
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA------KAEMEFAVEVEILGRVRHRNLLGLRGFYAGG 84 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (325)
+...|.+.+.||.| +++.||.+++..+++.||+|.+..... .....+.+|+.++++++||||+++++++.+.
T Consensus 9 ~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 9 VDDYYDTGEELGSG--QFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp HHHHEEEEEEEECC--SSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred cccceEeceEEeeC--CCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 45667889999999 888899999999999999999864322 1356789999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC----ceEEeeecccc
Q 046728 85 DERLIVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF----EAKVADFGFAK 154 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~----~~kL~Dfg~~~ 154 (325)
...++|||||++|+|.+++.. .+++..+..+..++..++.++|.. |||||+|||++.++ .+||+|||++.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999999999999953 356667788899999999999975 79999999999887 79999999998
Q ss_pred ccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccc
Q 046728 155 LIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHI 234 (325)
Q Consensus 155 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (325)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+.. ..
T Consensus 167 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~~----~~---- 233 (326)
T 2y0a_A 167 KIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANVSA----VN---- 233 (326)
T ss_dssp ECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHH----TC----
T ss_pred ECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHHh----cC----
Confidence 7654322 233468999999999998899999999999999999999999996543211 1111100 00
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 235 ADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
...........++.+.+||.+||..||++|||+.++++ ||+.
T Consensus 234 --~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 234 --YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp --CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred --CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 00000111234678999999999999999999999998 7754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=312.90 Aligned_cols=251 Identities=19% Similarity=0.250 Sum_probs=202.4
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
+...|.+.+.||.| +++.||.+.+..+++.||+|.+... .......+.+|+.++++++||||+++++++.+....+
T Consensus 27 ~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 27 FSDNYDVKEELGKG--AFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHHEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCeEEeeEEecC--CCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 44568888999998 7888999999999999999999643 3455568889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC---CceEEeeeccccccCCC
Q 046728 89 IVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD---FEAKVADFGFAKLIPDG 159 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~---~~~kL~Dfg~~~~~~~~ 159 (325)
+|||||.+|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++.+ +.+||+|||++......
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999999999999984 3356667788889999999999975 7999999999865 45999999999876543
Q ss_pred cceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 160 VTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 160 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+. .+.+ ..
T Consensus 185 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~i~----~~~~------~~ 249 (362)
T 2bdw_A 185 EA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIK----AGAY------DY 249 (362)
T ss_dssp CS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----HTCC------CC
T ss_pred cc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH----hCCC------CC
Confidence 22 23456999999999999889999999999999999999999999753321 1111111 1111 01
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
....+..+++++.+||.+||..||++|||+.++++ ||..
T Consensus 250 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 250 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 11223456788999999999999999999999998 8864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=305.65 Aligned_cols=247 Identities=20% Similarity=0.246 Sum_probs=193.0
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh--------------------------hhHHHHHHHHHHH
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA--------------------------KAEMEFAVEVEIL 66 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--------------------------~~~~~~~~E~~~l 66 (325)
..|.+.+.||.| +++.||++++..+++.||||.+..... .....+.+|++++
T Consensus 13 ~~y~~~~~lG~G--~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 13 NQYTLKDEIGKG--SYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp TTEEEEEEEEC----CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred cceEEEeEEeec--CCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 568889999999 888899999999999999999864321 1134688999999
Q ss_pred HccCCCCccceeeEEEc--CCeEEEEEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceee
Q 046728 67 GRVRHRNLLGLRGFYAG--GDERLIVYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLL 139 (325)
Q Consensus 67 ~~l~h~~iv~~~~~~~~--~~~~~lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~ 139 (325)
++++||||+++++++.+ ....++||||+++++|.+++. ..+++..+..+..++..++.++|.. |||||+|||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 99999999999999986 567899999999999998874 3466667788889999999999975 7999999999
Q ss_pred CCCCceEEeeeccccccCCCcceeeccCCCCcCCCCccccccCC---CCCcccchhHHHHHHHHHhCCCCCCCCCCCccc
Q 046728 140 DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGK---VSDSCDVYSFGVLLLELISAKKPLEKLPGGVKR 216 (325)
Q Consensus 140 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~ 216 (325)
+.++.+||+|||++......... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... .
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~ 246 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI---M 246 (298)
T ss_dssp CTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH---H
T ss_pred CCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH---H
Confidence 99999999999999876543322 23456999999999998654 36789999999999999999999965321 1
Q ss_pred hhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHh
Q 046728 217 DIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLK 277 (325)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~ 277 (325)
.....+. .. ....+.....++.+.+||.+||..||++|||+.++++ ||+
T Consensus 247 ~~~~~~~----~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 247 CLHSKIK----SQ--------ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHH----HC--------CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHh----cc--------cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 1111100 00 0111122345678999999999999999999999997 764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=307.14 Aligned_cols=246 Identities=22% Similarity=0.300 Sum_probs=199.4
Q ss_pred hHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecC
Q 046728 16 VFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95 (325)
Q Consensus 16 ~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~ 95 (325)
...+.||.| +++.||+++...+++.||||.+..........+.+|+.++++++||||+++++++......++||||++
T Consensus 48 ~~~~~lg~G--~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 48 DSYVKIGEG--STGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp EEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hccEEeccC--CCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 344567777 888899999998999999999976555566788999999999999999999999999999999999999
Q ss_pred CCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCCC
Q 046728 96 NHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGT 170 (325)
Q Consensus 96 ~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t 170 (325)
+++|.+++. ..+++..+..+..++..++.++|.. |||||+||+++.++.+||+|||++......... .....||
T Consensus 126 ~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt 204 (321)
T 2c30_A 126 GGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGT 204 (321)
T ss_dssp SCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-BCCCCSC
T ss_pred CCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc-cccccCC
Confidence 999999985 3466667788888999999999875 799999999999999999999999876543222 2345699
Q ss_pred cCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHH
Q 046728 171 LGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKS 250 (325)
Q Consensus 171 ~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (325)
+.|+|||++.+..++.++||||||+++|+|++|..||...... .....+... . .+ ........++.
T Consensus 205 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~~~~~~~~~----~-----~~--~~~~~~~~~~~ 270 (321)
T 2c30_A 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRLRDS----P-----PP--KLKNSHKVSPV 270 (321)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHS----S-----CC--CCTTGGGSCHH
T ss_pred ccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcC----C-----CC--CcCccccCCHH
Confidence 9999999999888999999999999999999999999653321 111111100 0 00 11123456678
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 251 MVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 251 ~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
+.+||.+||..||++|||+.++++ ||..
T Consensus 271 l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 271 LRDFLERMLVRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred HHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence 999999999999999999999998 7764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=313.73 Aligned_cols=252 Identities=19% Similarity=0.272 Sum_probs=200.9
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-----hhhHHHHHHHHHHHHccCCCCccceeeEEEcC
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-----AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG 84 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (325)
.+...|.+.+.||.| +++.||++.+..+++.||||.+.... ......+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 21 LFEDVYELCEVIGKG--PFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD 98 (351)
T ss_dssp CHHHHEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccccceEEeeEEeeC--CCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 456678899999999 88889999999999999999986321 12356789999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcc------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCc---eEEeeec
Q 046728 85 DERLIVYDYMPNHSLITHLHG------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFE---AKVADFG 151 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~---~kL~Dfg 151 (325)
...|+|||||++|+|.+++.. .+++..+..+..++..++.++|.. |||||+|||++.++. +||+|||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 999999999999999988842 256666778889999999999985 799999999986554 9999999
Q ss_pred cccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccc
Q 046728 152 FAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAF 231 (325)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (325)
++......... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... .....+. .+.+
T Consensus 179 ~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~i~----~~~~ 249 (351)
T 3c0i_A 179 VAIQLGESGLV-AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGII----KGKY 249 (351)
T ss_dssp TCEECCTTSCB-CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHHHH----HTCC
T ss_pred ceeEecCCCee-ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHHHH----cCCC
Confidence 99876653322 2345699999999999988999999999999999999999999975321 1111100 0000
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 232 EHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
. .....+...++.+.+||.+||..||++|||+.++++ ||+.
T Consensus 250 ~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 250 K------MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp C------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred C------CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 0 000111245678999999999999999999999998 8875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=313.29 Aligned_cols=249 Identities=20% Similarity=0.311 Sum_probs=202.9
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..|.+++.||.| +++.||++++..+++.||+|.+.... ......+.+|+++++.++||||+++++++.+....|+
T Consensus 15 ~~y~i~~~LG~G--~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 15 DHFEILRAIGKG--SFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp GGEEEEEEEECC--TTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHeEEEEEEeeC--CCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 468889999999 88889999999999999999986422 2334578899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 90 VYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||||+.+|+|.++++. .+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||++........
T Consensus 93 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-- 170 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-- 170 (384)
T ss_dssp EECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC--
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc--
Confidence 9999999999999953 466677788899999999999975 79999999999999999999999987654322
Q ss_pred eccCCCCcCCCCcccccc---CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 164 TTRVKGTLGYLAPEYAMW---GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.................. .
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--------------~ 236 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT--------------V 236 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC--------------C
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc--------------c
Confidence 344579999999999874 45889999999999999999999999754433222222211110 1
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH--HHhcc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPT-MTDVVD--WLKGG 279 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps-~~~il~--~l~~~ 279 (325)
...+...++.+.+||.+||..||++||+ ++++++ ||+.+
T Consensus 237 ~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 237 VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 1233456778999999999999999998 888886 77654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=314.74 Aligned_cols=250 Identities=21% Similarity=0.299 Sum_probs=197.8
Q ss_pred cchhHHhhccCccceeeeeEEEecc-------CCCCeEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEc
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRE-------TGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAG 83 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~-------~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 83 (325)
..|.+.+.||.| +++.||+++.. .++..||+|.+... .......+.+|+.+++++ +||||+++++++.+
T Consensus 81 ~~~~~~~~LG~G--~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 81 DKLTLGKPLGEG--CFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGEEEEEEESCC--SSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHCEeeeEEeeC--CCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 457788899999 77778888754 33557999999754 344556899999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhccC------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC
Q 046728 84 GDERLIVYDYMPNHSLITHLHGR------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT 141 (325)
Q Consensus 84 ~~~~~lV~e~~~~gsL~~~l~~~------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~ 141 (325)
....|+||||+++|+|.++++.. ++...++.+..++..++.++|.. |||||+|||++.
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 238 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECC
Confidence 99999999999999999999532 22233455778888889998875 799999999999
Q ss_pred CCceEEeeeccccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhh
Q 046728 142 DFEAKVADFGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIV 219 (325)
Q Consensus 142 ~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~ 219 (325)
++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+.....
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~--- 315 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF--- 315 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---
Confidence 999999999999866543221 2223456788999999998899999999999999999999 99999764432111
Q ss_pred hhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 220 QWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
..+. .......+..++..+.+||.+||..||++|||+.++++.|+.++
T Consensus 316 ~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 316 KLLK-------------EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHHH-------------TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHh-------------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1110 01112334456778999999999999999999999999988765
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=321.72 Aligned_cols=252 Identities=19% Similarity=0.218 Sum_probs=203.2
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..|.+++.||.| +++.||++++..+++.||+|.+.+.. ......+.+|..+++.++||||+++++++.+...+|+
T Consensus 69 ~~y~~~~~LG~G--~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 69 EDYEVVKVIGRG--AFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp GGEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEcC--CCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 467788899999 88889999999999999999996421 1122357889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 90 VYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 90 V~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|||||+||+|.++++ ..+++..+..+..++..++.++|.+ |||||+|||++.++.+||+|||+++..........
T Consensus 147 V~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~ 226 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226 (410)
T ss_dssp EECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEEC
T ss_pred EEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccc
Confidence 999999999999995 3466667788889999999999986 79999999999999999999999987766554445
Q ss_pred ccCCCCcCCCCccccccCC----CCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 165 TRVKGTLGYLAPEYAMWGK----VSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~----~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... .....+.... ..+.
T Consensus 227 ~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~----------~~~~ 293 (410)
T 3v8s_A 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMNHK----------NSLT 293 (410)
T ss_dssp CSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTHH----------HHCC
T ss_pred cCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh---hHHHHHHhcc----------cccc
Confidence 5677999999999998655 788999999999999999999999754321 1111110000 0011
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH--HHhcc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPEN--RPTMTDVVD--WLKGG 279 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~~il~--~l~~~ 279 (325)
.+....+++++.+||.+||..+|.+ ||++++|++ ||+..
T Consensus 294 ~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 294 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 1122346678999999999999988 999999998 88764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=307.55 Aligned_cols=244 Identities=23% Similarity=0.330 Sum_probs=201.3
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..|.+++.||.| +++.||+++...+++.||+|.+.... ......+.+|..+++.++||||+++++++.+....|+
T Consensus 6 ~~y~~~~~lG~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 6 QDFQILRTLGTG--SFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp GGEEEEEEEEEC--SSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred HHcEEEEEEeeC--CCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 467889999999 88889999999999999999996432 2334577889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 90 VYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 90 V~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||||+++|+|.++++ ..+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||++......
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---- 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 159 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc----
Confidence 999999999999995 3466667778889999999999975 799999999999999999999999875442
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+ . ... ...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i---~---------~~~--~~~ 222 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTYEKI---L---------NAE--LRF 222 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHH---H---------HCC--CCC
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH---H---------hCC--CCC
Confidence 23456999999999999889999999999999999999999999653221 111110 0 000 122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH--HHhcc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRP-----TMTDVVD--WLKGG 279 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~~ 279 (325)
+...++++.+||.+||..||++|| +++++++ ||+..
T Consensus 223 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 223 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 345667899999999999999999 8999997 87654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=315.61 Aligned_cols=254 Identities=20% Similarity=0.299 Sum_probs=201.2
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 88 (325)
..|.+++.||.| +++.||+++...+++.||+|++.+.. ......+.+|..++.++ +||||+++++++.+...+|
T Consensus 52 ~~y~~~~~LG~G--~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 52 QDFDLLRVIGRG--SYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp GGEEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred hHcEEEEEEeeC--CCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 467889999999 88889999999999999999997532 22334678899999887 8999999999999999999
Q ss_pred EEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 89 IVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
+|||||++|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||+++...... .
T Consensus 130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~ 208 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-D 208 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC-C
Confidence 9999999999999994 4577777888999999999999985 7999999999999999999999998533222 2
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccc--hhhhhhcccccccccccccCcccc
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKR--DIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||......... .....+... +... .
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~--------i~~~--~ 278 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------ILEK--Q 278 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH--------HHHC--C
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH--------Hhcc--c
Confidence 234567999999999999999999999999999999999999999643221110 000001000 0001 1
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH--HHhcc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTM------TDVVD--WLKGG 279 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~------~~il~--~l~~~ 279 (325)
...+..+++++.+||.+||..||++||++ +++++ ||+.+
T Consensus 279 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 279 IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 13345567889999999999999999985 78887 77654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=307.08 Aligned_cols=266 Identities=17% Similarity=0.223 Sum_probs=186.3
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
....|.+++.||.| +++.||++....+++.||+|.+.... ......+.+|+.++++++||||+++++++.+++..++
T Consensus 3 ~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 3 SSSQFKQLEKLGNG--TYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ------------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred cccceeEeeEECCC--CCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 34678999999999 88889999999999999999997432 3334578899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcc--------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccC
Q 046728 90 VYDYMPNHSLITHLHG--------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIP 157 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~--------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~ 157 (325)
||||+. |+|.+++.. .++...+..+..++..++.++|.. |||||+|||++.++.+||+|||++....
T Consensus 81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 999997 599999842 244445566777899999999975 7999999999999999999999998765
Q ss_pred CCcceeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccc--
Q 046728 158 DGVTHMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHI-- 234 (325)
Q Consensus 158 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 234 (325)
..... .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||...........+...........+...
T Consensus 160 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IPVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SCCCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 43222 2234689999999998764 6899999999999999999999999754322111111000000000000000
Q ss_pred -------cCc--------cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 235 -------ADP--------RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 235 -------~~~--------~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
... .+........++.+.+||.+||..||++|||++++++ ||++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 000 0001112235678999999999999999999999998 888654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=310.10 Aligned_cols=252 Identities=26% Similarity=0.375 Sum_probs=200.5
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCC---eEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDD---QIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~---~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
...|.+.+.||.| +++.||+++...+++ .||||.+... .......+.+|+.++++++||||+++++++.+....
T Consensus 48 ~~~y~i~~~lG~G--~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSG--DSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp GGGEEEEEEEEET--TTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred hhHeEEeeEEEeC--CCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 4567888999999 778899888876554 4999999754 455566899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 88 LIVYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
++||||+++|+|.++++ ..++...++.+..++..++.++|.. |||||+|||++.++.++|+|||++.......
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 99999999999999994 2455666778888899999999875 7999999999999999999999998765432
Q ss_pred ce--eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 161 TH--MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 161 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
.. ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||........ ...+. .
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~~~~-------------~ 269 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV---ISSVE-------------E 269 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH---HHHHH-------------T
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHHH-------------c
Confidence 21 1222345778999999998889999999999999999999 9999965432111 11110 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
....+.+..+++.+.+||.+||..||++|||+.++++.|+.+..
T Consensus 270 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11123344567789999999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=304.61 Aligned_cols=265 Identities=18% Similarity=0.223 Sum_probs=198.4
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
.+...|.+++.||.| +++.||+++.. +++.||+|.+... .......+.+|++++++++||||+++++++.+....
T Consensus 18 ~l~~~y~~~~~lG~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 94 (311)
T 3niz_A 18 GLMEKYQKLEKVGEG--TYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94 (311)
T ss_dssp CSSCEEEEEEEEEEC--SSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred chHhhhHhhhhccCC--CCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence 456778999999999 77889999875 4889999998643 233346788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 88 LIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
++|||||++ +|.+++.. .+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||++.......
T Consensus 95 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 95 TLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 999999974 88888843 256666778889999999999975 7999999999999999999999998765432
Q ss_pred ceeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccccc----
Q 046728 161 THMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIA---- 235 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 235 (325)
.. .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...........+....
T Consensus 174 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 174 RS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp C----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred cc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 22 223468999999999876 468999999999999999999999997654433222211111000111110000
Q ss_pred ---------CccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 236 ---------DPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 236 ---------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
............++++.+||.+||..||++|||++++++ ||++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 000000111235678999999999999999999999998 88764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=312.43 Aligned_cols=252 Identities=17% Similarity=0.263 Sum_probs=205.4
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
+...|.+++.||.| +++.||.+....+++.||+|.+..........+.+|+.++++++||||+++++++.+....++|
T Consensus 49 ~~~~y~i~~~LG~G--~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 49 VYDYYDILEELGSG--AFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGGTEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred cccceEEEEEEecC--CCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 34568889999998 7888999999999999999999876666667899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC--CCceEEeeeccccccCCCcc
Q 046728 91 YDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT--DFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~--~~~~kL~Dfg~~~~~~~~~~ 161 (325)
||||.+|+|.+++.. .+++..+..+..++..++.++|.. |||||+|||++. .+.+||+|||++........
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 999999999999953 356667788899999999999975 799999999974 47799999999987765432
Q ss_pred eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 162 HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
. ....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+.. .. .....
T Consensus 207 ~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~i~~----~~------~~~~~ 271 (387)
T 1kob_A 207 V--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKR----CD------WEFDE 271 (387)
T ss_dssp E--EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHH----CC------CCCCS
T ss_pred e--eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHHHHHHh----CC------CCCCc
Confidence 2 223589999999999988899999999999999999999999975332 111111110 00 01112
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
......++++.+||.+||..||++|||+.++++ ||+..
T Consensus 272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 223456778999999999999999999999998 88754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=318.71 Aligned_cols=251 Identities=23% Similarity=0.311 Sum_probs=202.1
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.+.|.+.+.||.| +++.||.++...+++.||||.+... .......+.+|++++++++||||+++++++.+....++|
T Consensus 113 ~~~~~~~~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRG--NFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHeEEeeEeccC--CCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 3567788999999 7888999999888999999998743 334445788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 91 YDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
|||+++|+|.++++. .++...++.+..+++.++.++|.. |||||+|||++.++.+||+|||++..........
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 999999999999952 356667778888999999999975 7999999999999999999999998654432221
Q ss_pred e-ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 164 T-TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 164 ~-~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
. ....++..|+|||++.+..++.++|||||||++|||++ |..||........ ...+. . ..+.
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~---~~~~~----~---------~~~~ 334 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT---REFVE----K---------GGRL 334 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH---HHHHH----T---------TCCC
T ss_pred cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH----c---------CCCC
Confidence 1 11224678999999998889999999999999999998 9999976432111 11111 0 1112
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
+.+..+++.+.+||.+||..||++|||+.++++.|+.+.
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 233456678999999999999999999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=300.72 Aligned_cols=271 Identities=18% Similarity=0.227 Sum_probs=206.7
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCC--e
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD--E 86 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 86 (325)
.+...|.+.+.||.| +++.||+++...+++.||||.+.... ......+.+|++++++++||||+++++++.... .
T Consensus 6 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQG--ATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCC--CCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 456678899999999 88889999999999999999997432 334567889999999999999999999987765 7
Q ss_pred EEEEEEecCCCChhhhhccC-----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceee----CCCCceEEeeeccc
Q 046728 87 RLIVYDYMPNHSLITHLHGR-----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLL----DTDFEAKVADFGFA 153 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~~-----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~----~~~~~~kL~Dfg~~ 153 (325)
.++||||+++++|.+++... ++...++.+..++..++.++|.. |||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 89999999999999999532 56666778888999999999985 7999999999 77888999999999
Q ss_pred cccCCCcceeeccCCCCcCCCCccccc--------cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCcc-chhhhhhcc
Q 046728 154 KLIPDGVTHMTTRVKGTLGYLAPEYAM--------WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVK-RDIVQWVTP 224 (325)
Q Consensus 154 ~~~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~ 224 (325)
........ .....||..|+|||++. +..++.++|||||||++|+|++|..||........ ......+..
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred eecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 87655432 22346899999999986 46788999999999999999999999975443221 111111111
Q ss_pred cccccccc-----------cccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCCCc
Q 046728 225 YVQKGAFE-----------HIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGRRT 284 (325)
Q Consensus 225 ~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~ 284 (325)
........ ....-..........++.+.+||.+||..||++|||++++++...+..-..+
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~~ 312 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGN 312 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC---
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcCC
Confidence 11100000 0001111123457888999999999999999999999999997776544333
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=306.80 Aligned_cols=254 Identities=20% Similarity=0.306 Sum_probs=202.1
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 88 (325)
..|.+++.||.| +++.||+++...+++.||+|.+.+. .......+.+|..+++++ +||||+++++++.+....|
T Consensus 9 ~~y~~~~~lG~G--~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 9 QDFDLLRVIGRG--SYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp GGEEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hheEEEEEEEec--CCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 468889999999 8888999999999999999999743 344456788999999988 8999999999999999999
Q ss_pred EEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 89 IVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
+||||+++|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||+++...... .
T Consensus 87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-~ 165 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-D 165 (345)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-C
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC-C
Confidence 9999999999999994 4577777888999999999999985 7999999999999999999999998543322 1
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccc--hhhhhhcccccccccccccCcccc
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKR--DIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ......... +... .
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------i~~~--~ 235 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------ILEK--Q 235 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH--------HHHC--C
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH--------HHcC--C
Confidence 234457999999999999889999999999999999999999999653221110 000000000 0001 1
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH--HHhcc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTM------TDVVD--WLKGG 279 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~------~~il~--~l~~~ 279 (325)
...+...+..+.+||.+||..||++||++ +++++ ||+..
T Consensus 236 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 236 IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 12334567789999999999999999995 78887 77643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=318.59 Aligned_cols=253 Identities=24% Similarity=0.309 Sum_probs=195.3
Q ss_pred ccchhHHhhccCccceeeeeEEEe-----ccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLR-----RETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD 85 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~-----~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (325)
...|.+++.||.| +++.||+++ +..+++.||||.+... ......++.+|+.++++++||||+++++++.+..
T Consensus 70 ~~~~~~~~~LG~G--~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHG--AFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp GGGEEEEEECCCC--SSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HhHeEEeeEeeeC--CCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 3567888999999 777788888 5566789999999643 4555568889999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhccC---------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC---ceEEee
Q 046728 86 ERLIVYDYMPNHSLITHLHGR---------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF---EAKVAD 149 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~~---------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~---~~kL~D 149 (325)
..++|||||++|+|.++++.. +....++.+..++..++.++|.. |||||+|||++.++ .+||+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECC
Confidence 999999999999999999532 33334556788888888998875 79999999999554 599999
Q ss_pred eccccccCCCc-ceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhccccc
Q 046728 150 FGFAKLIPDGV-THMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQ 227 (325)
Q Consensus 150 fg~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 227 (325)
||+++...... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||....... ....+..
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~~~i~~--- 301 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEFVTS--- 301 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHHT---
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc---
Confidence 99997543211 111223457889999999998899999999999999999998 999997543211 1111110
Q ss_pred ccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCC
Q 046728 228 KGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGR 282 (325)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 282 (325)
......+..+++.+.+||.+||..||++|||+.++++.|+.....
T Consensus 302 ----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 302 ----------GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp ----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----------CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 001122345667899999999999999999999999988876543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=298.58 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=202.3
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
...|.+++.||.| +++.||.++.. ++..||+|.+.... .....+.+|++++++++||||+++++++.+....++||
T Consensus 7 ~~~y~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 7 REEITLLKELGSG--QFGVVKLGKWK-GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp GGGEEEEEEEEEE--TTEEEEEEEET-TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhheeeeeeeccC--CCceEEEEEec-CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 3567889999999 77778888655 46789999997533 33457899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 92 DYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 92 e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||+++++|.+++.. .+++..++.+..++..++.++|.. +||||+||+++.++.++|+|||++...........
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 99999999999943 367777888899999999999975 79999999999999999999999987766544444
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
....+|+.|+|||++.+..++.++||||||+++|+|++ |..||........ ..... . ......
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~----~---------~~~~~~ 226 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV---VLKVS----Q---------GHRLYR 226 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HHHHH----T---------TCCCCC
T ss_pred cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH---HHHHH----c---------CCCCCC
Confidence 44556778999999998889999999999999999999 9999965432111 11000 0 001112
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCC
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGR 282 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 282 (325)
+...++.+.+|+.+||..||++|||+.++++.|+.+..+
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 233456899999999999999999999999999987653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=302.02 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=200.5
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
..|.+++.||.| +++.||++... +++.||+|.+.... .....+.+|+.++++++||||+++++++.+....++|||
T Consensus 10 ~~y~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 10 SELTFVQEIGSG--QFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GGEEEEEEEEEC--SSCEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhceeeheecCC--CccEEEEEEec-CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 568889999999 77889988876 46779999997533 234578999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 93 YMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 93 ~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
|+++++|.++++. .++...++.+..++..++.++|.. |||||+||+++.++.++|+|||++............
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 9999999999943 245556677888899999999875 799999999999999999999999876554333334
Q ss_pred cCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 166 RVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
...+|..|+|||++.+..++.++||||+|+++|+|++ |..||....... ....+.. ......+
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~---~~~~~~~-------------~~~~~~~ 229 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDIST-------------GFRLYKP 229 (269)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHT-------------TCCCCCC
T ss_pred CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHhc-------------CccCCCC
Confidence 4456788999999998899999999999999999999 999997543211 1111100 0111223
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
...++.+.+|+.+||..||++|||+.++++.|+++..
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999987653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=319.69 Aligned_cols=253 Identities=20% Similarity=0.246 Sum_probs=202.3
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..|.+++.||.| +++.||+++...+++.||+|++.+.. ......+.+|..++..++||||+++++++.+...+|+
T Consensus 74 ~~y~~~~~LG~G--~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 74 EDFEILKVIGRG--AFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp GGEEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred hheEEEEEEEeC--CCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 467788899999 88889999999999999999996421 1112247889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 90 VYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
|||||++|+|.++++. .+++..+..+..++..++.++|.+ |||||+|||++.++.+||+|||+++........
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence 9999999999999953 466777788899999999999986 799999999999999999999999877655444
Q ss_pred eeccCCCCcCCCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 163 MTTRVKGTLGYLAPEYAM-----WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
......||+.|+|||++. ...++.++|||||||++|||++|..||....... ....+........
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~---~~~~i~~~~~~~~------- 301 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TYGKIMNHKERFQ------- 301 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHTHHHHCC-------
T ss_pred ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH---HHHhhhhcccccc-------
Confidence 445567999999999987 4568999999999999999999999997543211 1111100000000
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH--HHhcc
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPEN--RPTMTDVVD--WLKGG 279 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~~il~--~l~~~ 279 (325)
.+......++.+.+||.+||..+|++ ||+++++++ ||+.+
T Consensus 302 --~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 302 --FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp --CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred --CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 01111346778999999999998888 999999998 88764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=312.05 Aligned_cols=247 Identities=21% Similarity=0.272 Sum_probs=201.6
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 88 (325)
..|.+.+.||.| +++.||++++..+++.||+|.+.... ......+..|..++..+ +||||+++++++.+....|
T Consensus 17 ~~y~~~~~lG~G--~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 17 EDFILHKMLGKG--SFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp TTEEEEEEEEEC--SSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEeeC--CCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 568889999999 88889999999999999999997531 23345678899999987 8999999999999999999
Q ss_pred EEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 89 IVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
+|||||++|+|.++++ ..+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||+++.......
T Consensus 95 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 173 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA- 173 (345)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC-
Confidence 9999999999999995 4567777888999999999999985 79999999999999999999999985433222
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+.. . ...
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~~------------~--~~~ 236 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIRM------------D--NPF 236 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH------------C--CCC
T ss_pred cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHh------------C--CCC
Confidence 234467999999999999889999999999999999999999999753321 11111100 0 012
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH--HHhcc
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMT-DVVD--WLKGG 279 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~-~il~--~l~~~ 279 (325)
.+...++++.+||.+||..||++||++. ++++ ||+.+
T Consensus 237 ~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 237 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 2344667899999999999999999998 8876 77654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=325.63 Aligned_cols=250 Identities=21% Similarity=0.286 Sum_probs=204.2
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
..|.+.+.||.| +++.||.+....++..||||.+.... .....+.+|+.+|++++||||+++++++.+....++|||
T Consensus 220 ~~~~~~~~lG~G--~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 220 TDITMKHKLGGG--QYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp GGEEEEEESGGG--TTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHceeeeEecCC--CCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 456778889998 77789999988888999999997533 345689999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 93 YMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||++|+|.++++. .++...++.+..++..++.++|.. |||||+|||++.++.+||+|||+++..........
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 376 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 376 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECC
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeec
Confidence 9999999999953 244445567778889999999875 89999999999999999999999987655443333
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
....+++.|+|||++.+..++.++|||||||++|||++ |..||........ ...+. ...+...
T Consensus 377 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~~~~~-------------~~~~~~~ 440 (495)
T 1opk_A 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLE-------------KDYRMER 440 (495)
T ss_dssp TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHH-------------TTCCCCC
T ss_pred CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH-------------cCCCCCC
Confidence 34456788999999998889999999999999999999 9999976443211 11111 1112233
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
+..+++.+.+||.+||..||++|||+.+|++.|+.+..
T Consensus 441 ~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 45567889999999999999999999999999998764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=306.01 Aligned_cols=273 Identities=20% Similarity=0.211 Sum_probs=198.1
Q ss_pred cceeecccchhHH-hhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc-CCCCccceeeEEEc
Q 046728 6 NICFLLASPAVFI-QNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAG 83 (325)
Q Consensus 6 ~~~~~~~~~~~~~-~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 83 (325)
.....+...|.++ +.||.| +++.||.+++..+++.||||.+..........+.+|+++++++ +||||+++++++.+
T Consensus 5 ~~~~~~~~~y~i~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~ 82 (316)
T 2ac3_A 5 SFSGRFEDVYQLQEDVLGEG--AHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE 82 (316)
T ss_dssp SSCCCTTTSCEECCCCCCCC--SSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ccCcccceeEEecCceecCC--ceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3444566677775 678888 8888999999999999999999766555667899999999995 79999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCc---eEEeeecccc
Q 046728 84 GDERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFE---AKVADFGFAK 154 (325)
Q Consensus 84 ~~~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~---~kL~Dfg~~~ 154 (325)
.+..++|||||++|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++.++. +||+|||++.
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 83 EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred CCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 999999999999999999994 3466677788889999999999985 799999999988765 9999999987
Q ss_pred ccCCCcc------eeeccCCCCcCCCCcccccc-----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhc
Q 046728 155 LIPDGVT------HMTTRVKGTLGYLAPEYAMW-----GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVT 223 (325)
Q Consensus 155 ~~~~~~~------~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 223 (325)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||................
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 6542211 11223458999999999875 457899999999999999999999997654322110000000
Q ss_pred ccccccccccccCccccCC--CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 224 PYVQKGAFEHIADPRLKGK--FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
.......+..+.......+ .....++.+.+||.+||..||++|||+.++++ ||+...
T Consensus 243 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 243 PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred hhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 0000000000000000000 01235678999999999999999999999999 887643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=320.43 Aligned_cols=268 Identities=18% Similarity=0.189 Sum_probs=200.8
Q ss_pred eeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC-
Q 046728 8 CFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG- 84 (325)
Q Consensus 8 ~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 84 (325)
.|.+...|.+++.||.| +++.||++.+..+++.||||.+... ......++.+|+.+++.++||||+++++++...
T Consensus 57 ~~~~~~~y~~~~~lG~G--~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 134 (464)
T 3ttj_A 57 TFTVLKRYQNLKPIGSG--AQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 134 (464)
T ss_dssp EEEEETTEEEEEEEEEC--SSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred ceeecCCeEEEEEeecC--CCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence 45667889999999999 8888999999999999999999753 445566888999999999999999999999654
Q ss_pred -----CeEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccc
Q 046728 85 -----DERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 85 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
..+|+||||+.+ +|.+.+...+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||++..
T Consensus 135 ~~~~~~~~~lv~E~~~~-~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 135 TLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred ccccCCeEEEEEeCCCC-CHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 457999999965 68888877777777888999999999999985 79999999999999999999999986
Q ss_pred cCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccc---------
Q 046728 156 IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYV--------- 226 (325)
Q Consensus 156 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~--------- 226 (325)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.......
T Consensus 214 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 214 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ---CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred cCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 65432 2234568999999999999899999999999999999999999997643211111000000000
Q ss_pred -------------cccccccccCccccCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 227 -------------QKGAFEHIADPRLKGK---FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 227 -------------~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
....+.......+... .....++.+.+||.+||..||++|||++++++ ||+...
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence 0000000000000000 01223678999999999999999999999999 888654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=309.29 Aligned_cols=244 Identities=21% Similarity=0.295 Sum_probs=202.3
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
-..|.+++.||.| +++.||++++..+++.||+|.+.... ......+.+|+++++.++||||+++++++.+....|
T Consensus 40 ~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 40 LDQFDRIKTLGTG--SFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp GGGEEEEEEEEEC--SSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHCEEEEEeecC--cCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 3568889999999 88889999999999999999996432 233457889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 89 IVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
+||||+++|+|.+++. ..+++..+..+..++..++.++|.+ |||||+|||++.++.+||+|||+++.....
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--- 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC---
Confidence 9999999999999995 4567777888999999999999985 799999999999999999999999876543
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+. .+ ...
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~----~~----------~~~ 256 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYEKIV----SG----------KVR 256 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----HC----------CCC
T ss_pred -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH---HHHHHHH----cC----------CCC
Confidence 22356899999999999889999999999999999999999999753321 1111110 00 012
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH--HHhc
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPT-----MTDVVD--WLKG 278 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps-----~~~il~--~l~~ 278 (325)
.+...++.+.+||.+||..||++||+ ++++++ ||+.
T Consensus 257 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 23456778999999999999999998 999997 7764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=307.42 Aligned_cols=266 Identities=20% Similarity=0.204 Sum_probs=198.2
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC----
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD---- 85 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 85 (325)
--...|.+.+.||.| +++.||+++.. ++.||||.+.... ........|+.++++++||||+++++++.+..
T Consensus 21 ~~~~~y~~~~~lg~G--~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 21 FQSMPLQLLEVKARG--RFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp ETTEEEEEEEEEECS--TTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cchhhchhhheeccc--CceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence 334688999999999 77778888754 6899999997533 33446667999999999999999999997744
Q ss_pred eEEEEEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc--------------CCCCCCceeeCCCCceEEeee
Q 046728 86 ERLIVYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI--------------ADIKASNVLLDTDFEAKVADF 150 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~--------------rdlkp~Nil~~~~~~~kL~Df 150 (325)
.+++|||||++|+|.++++ ..++...++.+..++..++.++|.. |||||+|||++.++.+||+||
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred eEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 3799999999999999995 4466677788899999999999853 799999999999999999999
Q ss_pred ccccccCCCcce-eeccCCCCcCCCCccccccC-----CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcc
Q 046728 151 GFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWG-----KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTP 224 (325)
Q Consensus 151 g~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-----~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 224 (325)
|++......... ......||+.|+|||++.+. .++.++|||||||++|+|+||..||.................
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 999876543322 22335689999999999863 455688999999999999999999976544322221111100
Q ss_pred ccccccc-ccccCccccCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 225 YVQKGAF-EHIADPRLKGK-----FNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 225 ~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
....... .........+. .....++.+.+||.+||..||++|||+.++++.|+.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0000000 00011111111 12345677999999999999999999999999988754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=301.07 Aligned_cols=260 Identities=18% Similarity=0.239 Sum_probs=198.1
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
.|.+++.||.| +++.||++++..+++.||+|.+... .......+.+|+.++++++||||+++++++.++...++||
T Consensus 3 ~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 3 KYEKLEKIGEG--TYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp SEEEEEEEEEC--SSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CceeeeEecCC--CCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 57788999999 8888999999999999999999643 3344567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 92 DYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 92 e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|||.+ +|.+++. ..+++..+..+..++..++.++|.. |||||+||+++.++.+||+|||++......... .
T Consensus 81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~ 158 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-Y 158 (292)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC-C
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc-c
Confidence 99975 6666662 4566777888999999999999975 799999999999999999999999876543222 2
Q ss_pred ccCCCCcCCCCccccccCC-CCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcc---ccccccccc-------
Q 046728 165 TRVKGTLGYLAPEYAMWGK-VSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTP---YVQKGAFEH------- 233 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~------- 233 (325)
....+|..|+|||++.+.. ++.++|||||||++|+|++|..||..... .......+.. ......+..
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 3346899999999998665 79999999999999999998888643221 1111111000 000000000
Q ss_pred -----ccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 234 -----IADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 234 -----~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
...........+..++.+.+||.+||..||++|||++++++ ||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 00000111223456788999999999999999999999998 88754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=308.07 Aligned_cols=257 Identities=19% Similarity=0.195 Sum_probs=196.8
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-----ChhhHHHHHHHHHHHHccCCCCccceeeEEEc
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-----NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG 83 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (325)
..+...|.+.+.||.| +++.||.+....+++.||+|.+... .......+.+|+.++++++||||+++++++.+
T Consensus 22 ~~~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 22 LELQKKYHLKGAIGQG--SYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp HHHHHHEEEEEEEEEC--SSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhheeecceeeec--CCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 3566778899999999 7778999999999999999998642 34455689999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhccCC------------------------------------------CCCCccCHHHHHHH
Q 046728 84 GDERLIVYDYMPNHSLITHLHGRL------------------------------------------APDCLLDWHRRVSI 121 (325)
Q Consensus 84 ~~~~~lV~e~~~~gsL~~~l~~~~------------------------------------------~~~~~~~~~~~~~~ 121 (325)
....++|||||++|+|.+++.... ++..+..+..++..
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 999999999999999999984210 12224457788889
Q ss_pred HHHHHhhc----CCCCCCceeeCCCC--ceEEeeeccccccCCC---cceeeccCCCCcCCCCcccccc--CCCCCcccc
Q 046728 122 AIGSAEGI----ADIKASNVLLDTDF--EAKVADFGFAKLIPDG---VTHMTTRVKGTLGYLAPEYAMW--GKVSDSCDV 190 (325)
Q Consensus 122 ~~~~~~~~----rdlkp~Nil~~~~~--~~kL~Dfg~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di 190 (325)
++.++|.. |||||+||+++.++ .+||+|||++...... .........||+.|+|||++.+ ..++.++||
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 99999875 79999999998776 8999999999865331 1112334568999999999875 578899999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 046728 191 YSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMT 270 (325)
Q Consensus 191 wSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 270 (325)
|||||++|+|++|..||........ ...+. ... .....+.....++.+.+||.+||..||++|||+.
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~---~~~~~---~~~-------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 326 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADT---ISQVL---NKK-------LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAM 326 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH---HCC-------CCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHH---HHHHH---hcc-------cccCCcccccCCHHHHHHHHHHcCCChhHCCCHH
Confidence 9999999999999999975432111 11100 000 0001112234677899999999999999999999
Q ss_pred HHHH--HHhccc
Q 046728 271 DVVD--WLKGGL 280 (325)
Q Consensus 271 ~il~--~l~~~~ 280 (325)
++++ ||+...
T Consensus 327 ~~l~hp~~~~~~ 338 (345)
T 3hko_A 327 RALQHPWISQFS 338 (345)
T ss_dssp HHHHSHHHHTTS
T ss_pred HHhcChhhccCh
Confidence 9999 998754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=309.12 Aligned_cols=246 Identities=24% Similarity=0.328 Sum_probs=201.2
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 88 (325)
..|.+++.||.| +++.||++++..+++.||+|.+... .......+..|..++..+ +||||+++++++.+....|
T Consensus 20 ~~y~~~~~lG~G--~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 20 TDFNFLMVLGKG--SFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp TTEEEEEEEEEE--TTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred HHcEEEEEEeeC--CCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 568889999999 7888999999999999999999753 223445788899999998 7999999999999999999
Q ss_pred EEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 89 IVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
+||||++||+|.++++ +.+++..++.+..++..++.++|.. |||||+|||++.++.+||+|||+++...... .
T Consensus 98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~ 176 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-V 176 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-c
Confidence 9999999999999995 4577777888999999999999985 7999999999999999999999998543222 1
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+. . . ...
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~i~----~--------~--~~~ 239 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSIM----E--------H--NVA 239 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----H--------C--CCC
T ss_pred ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HHHHHHH----h--------C--CCC
Confidence 234457999999999999889999999999999999999999999753321 1111111 0 0 112
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH--HHhc
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPT-----MTDVVD--WLKG 278 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps-----~~~il~--~l~~ 278 (325)
.+...++++.+||.+||..||++||+ ++++++ ||+.
T Consensus 240 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 240 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 33456789999999999999999995 588887 7764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=297.55 Aligned_cols=256 Identities=18% Similarity=0.248 Sum_probs=205.6
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
.+...|.+.+.||.| +++.||++....++..||+|.+..........+.+|++++++++||||+++++++.+....++
T Consensus 6 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 6 DINQYYTLENTIGRG--SWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp CHHHHEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhEEeeeEEeec--CCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence 356678889999988 888899999999999999999976555556789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceee---CCCCceEEeeeccccccCCCc
Q 046728 90 VYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLL---DTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 90 V~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
||||+++++|.+++. ..+++..+..+..++..++.++|.. +||||+||++ +.++.++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 999999999999884 4466677788999999999999975 7999999999 778899999999998765433
Q ss_pred ceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 161 THMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
. .....+|+.|+|||++.+ .++.++||||||+++|+|++|..||....... ....+. .+... ..
T Consensus 164 ~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~----~~~~~------~~ 227 (277)
T 3f3z_A 164 M--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE---VMLKIR----EGTFT------FP 227 (277)
T ss_dssp C--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HCCCC------CC
T ss_pred c--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH---HHHHHH----hCCCC------CC
Confidence 2 233468999999999875 48999999999999999999999997543211 111110 00000 00
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccCCC
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLGRR 283 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~~~ 283 (325)
.......++.+.+||.+||..||++|||+.++++ ||+......
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~ 272 (277)
T 3f3z_A 228 EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272 (277)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCS
T ss_pred chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccccc
Confidence 0001135678999999999999999999999998 998766543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=307.38 Aligned_cols=267 Identities=17% Similarity=0.201 Sum_probs=199.9
Q ss_pred ceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC
Q 046728 7 ICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG 84 (325)
Q Consensus 7 ~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (325)
..+.+...|.+++.||.| +++.||.+.+..+++.||||.+... ......++.+|+++++.++||||+++++++...
T Consensus 19 ~~~~~~~~y~~~~~lG~G--~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 96 (367)
T 1cm8_A 19 TAWEVRAVYRDLQPVGSG--AYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD 96 (367)
T ss_dssp SEECCBSSEEEEEEC--------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred ceeeecceEEEeEEeeec--CCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecC
Confidence 457778899999999999 8888999999999999999998542 344456888999999999999999999999765
Q ss_pred C------eEEEEEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccc
Q 046728 85 D------ERLIVYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFA 153 (325)
Q Consensus 85 ~------~~~lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~ 153 (325)
. .+|+||||+ +++|.++++ ..+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CccccCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 3 469999999 889999995 4466667788889999999999985 799999999999999999999999
Q ss_pred cccCCCcceeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccc--
Q 046728 154 KLIPDGVTHMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGA-- 230 (325)
Q Consensus 154 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 230 (325)
...... .....+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.........+...........
T Consensus 176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 875432 233568999999999886 6789999999999999999999999975432111111100000000000
Q ss_pred -------------cccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 231 -------------FEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 231 -------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
+........ .......++.+.+||.+||..||++|||++++++ ||+....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 000000000 1112345678999999999999999999999999 8887543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=307.35 Aligned_cols=245 Identities=19% Similarity=0.254 Sum_probs=194.3
Q ss_pred HhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCCC
Q 046728 18 IQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNH 97 (325)
Q Consensus 18 ~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~g 97 (325)
.+.||.| +++.||++....+++.||+|.+..........+.+|++++++++||||+++++++.+....++||||+++|
T Consensus 94 ~~~lG~G--~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 94 TEILGGG--RFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEECC-------CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ceEEecC--cCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 4457777 88899999999999999999998766666778999999999999999999999999999999999999999
Q ss_pred Chhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceee--CCCCceEEeeeccccccCCCcceeeccCC
Q 046728 98 SLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLL--DTDFEAKVADFGFAKLIPDGVTHMTTRVK 168 (325)
Q Consensus 98 sL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~--~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~ 168 (325)
+|.+++.. .+++.....+..++..++.++|.. |||||+|||+ +.++.+||+|||++........ .....
T Consensus 172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~~~ 249 (373)
T 2x4f_A 172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNF 249 (373)
T ss_dssp EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCCCC
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--ccccc
Confidence 99998842 356666777888999999999975 7999999999 5678999999999987654332 22346
Q ss_pred CCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHH
Q 046728 169 GTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQL 248 (325)
Q Consensus 169 ~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (325)
||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+. ...+ .........++
T Consensus 250 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~i~----~~~~------~~~~~~~~~~~ 316 (373)
T 2x4f_A 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE---TLNNIL----ACRW------DLEDEEFQDIS 316 (373)
T ss_dssp SSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHH----HTCC------CSCSGGGTTSC
T ss_pred CCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hccC------CCChhhhccCC
Confidence 8999999999998889999999999999999999999997543211 111100 0000 01111223456
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 249 KSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 249 ~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
+++.+||.+||..||++|||+.++++ ||+..
T Consensus 317 ~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 317 EEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 78999999999999999999999998 88764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=312.10 Aligned_cols=251 Identities=22% Similarity=0.290 Sum_probs=197.5
Q ss_pred cchhHHhhccCccceeeeeEEEe-----ccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCC
Q 046728 13 SPAVFIQNINNGLEILMLLLLLR-----RETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGD 85 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~-----~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 85 (325)
..|.+.+.||.| +++.||+++ +..+++.||||.+... .......+.+|+.+++++ +||||+++++++.+..
T Consensus 22 ~~y~~~~~lG~G--~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 22 DRLKLGKPLGRG--AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp GGEEEEEEEEEC--SSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cceeeceeecCC--CCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 567888999999 788899988 6667789999999753 344456899999999999 7999999999988755
Q ss_pred e-EEEEEEecCCCChhhhhccC----------------------------------------------------------
Q 046728 86 E-RLIVYDYMPNHSLITHLHGR---------------------------------------------------------- 106 (325)
Q Consensus 86 ~-~~lV~e~~~~gsL~~~l~~~---------------------------------------------------------- 106 (325)
. .++|||||++|+|.++++..
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 4 89999999999999999543
Q ss_pred ----------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc-eeeccCCCCc
Q 046728 107 ----------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT-HMTTRVKGTL 171 (325)
Q Consensus 107 ----------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~t~ 171 (325)
++...++.+..++..++.++|.. |||||+|||++.++.+||+|||++........ .......+|.
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~ 259 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCc
Confidence 33334455778888899999875 79999999999999999999999986644322 2233455788
Q ss_pred CCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHH
Q 046728 172 GYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKS 250 (325)
Q Consensus 172 ~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (325)
.|+|||++.+..++.++|||||||++|+|+| |..||........ ....+. .......+...+++
T Consensus 260 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~~~-------------~~~~~~~~~~~~~~ 324 (359)
T 3vhe_A 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLK-------------EGTRMRAPDYTTPE 324 (359)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHHHHH-------------HTCCCCCCTTCCHH
T ss_pred eeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHHHHH-------------cCCCCCCCCCCCHH
Confidence 9999999998899999999999999999998 9999976443211 111100 00111233445678
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 251 MVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 251 ~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
+.+|+.+||..||++|||+.++++.|+.++
T Consensus 325 l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 325 MYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 999999999999999999999999998765
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=315.72 Aligned_cols=252 Identities=20% Similarity=0.244 Sum_probs=200.5
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..|.+++.||.| +++.||+++...+++.||+|++.+.. ......+.+|..++..++||||+++++++.+....|+
T Consensus 61 ~~f~~~~~lG~G--~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 61 DDFEILKVIGRG--AFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp GGEEEEEEEEEC--SSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred hhEEEEEEEeeC--CCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 567888999999 88889999999999999999996522 2223357889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 90 VYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
|||||++|+|.++++. .+++..+..+..++..++.++|.+ |||||+|||++.++.+||+|||+++........
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence 9999999999999953 466677788889999999999985 799999999999999999999999877655444
Q ss_pred eeccCCCCcCCCCccccc-------cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccccc
Q 046728 163 MTTRVKGTLGYLAPEYAM-------WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIA 235 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~-------~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (325)
......||+.|+|||++. ...++.++|||||||++|||++|..||....... ....+...... +.
T Consensus 219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~i~~~~~~-----~~ 290 (412)
T 2vd5_A 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE---TYGKIVHYKEH-----LS 290 (412)
T ss_dssp ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHTHHHH-----CC
T ss_pred ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH---HHHHHHhcccC-----cC
Confidence 444567999999999987 3568999999999999999999999997543211 11111000000 00
Q ss_pred CccccCCCCHHHHHHHHHHHHHccCCCCCCC---CCHHHHHH--HHhcc
Q 046728 236 DPRLKGKFNRDQLKSMVLIALRCTDSNPENR---PTMTDVVD--WLKGG 279 (325)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R---ps~~~il~--~l~~~ 279 (325)
.+..+..+++++.+||.+||. +|++| |+++++++ ||+.+
T Consensus 291 ----~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 291 ----LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp ----CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred ----CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 011123467799999999999 99998 59999998 88764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=305.81 Aligned_cols=248 Identities=19% Similarity=0.246 Sum_probs=192.1
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC----
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD---- 85 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 85 (325)
+-..|.+++.||.| +++.||++++..+++.||||.+... .......+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G--~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 4 YLTDFEPIQCMGRG--GFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHHEEEEEEEECC---CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hhhcCceeeEecCC--CCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 34567888999999 8888999999999999999999743 3345568999999999999999999999986543
Q ss_pred -----------------------------------------------------eEEEEEEecCCCChhhhhccCCCCC--
Q 046728 86 -----------------------------------------------------ERLIVYDYMPNHSLITHLHGRLAPD-- 110 (325)
Q Consensus 86 -----------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~-- 110 (325)
..++|||||++|+|.++++......
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 3799999999999999996432211
Q ss_pred ---CccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc-----------eeeccCCCCcC
Q 046728 111 ---CLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT-----------HMTTRVKGTLG 172 (325)
Q Consensus 111 ---~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-----------~~~~~~~~t~~ 172 (325)
.++.+..++..++.++|.. |||||+|||++.++.+||+|||++........ .......||+.
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 2466888999999999975 79999999999999999999999987765421 11233468999
Q ss_pred CCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHH
Q 046728 173 YLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMV 252 (325)
Q Consensus 173 y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (325)
|+|||++.+..++.++|||||||++|+|++|..|+... ........ . . ..+......++.+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~~~~~----~--------~-~~~~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRIITDVR----N--------L-KFPLLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHHHHHH----T--------T-CCCHHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHHHHhh----c--------c-CCCcccccCChhHH
Confidence 99999999889999999999999999999987765310 00000000 0 0 00111244567789
Q ss_pred HHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 253 LIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 253 ~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
+||.+||..||++|||+.++++ ||++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred HHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 9999999999999999999998 7654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=299.57 Aligned_cols=250 Identities=23% Similarity=0.369 Sum_probs=198.6
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
.+.|.+++.||.| +++.||.++.. ++..||+|.+.... .....+.+|+.++++++||||+++++++.+....++||
T Consensus 23 ~~~y~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 23 PKDLTFLKELGTG--QFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp GGGEEEEEECC-----CEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred HHHHHhHhhcCCC--CCceEEEEEEc-CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 3567888999999 77788888665 56789999997543 23457899999999999999999999999999999999
Q ss_pred EecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 92 DYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 92 e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||+.+++|.+++. ..++...++.+..++..++.++|.. +||||+||+++.++.++|+|||++...........
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 9999999999994 3466667788889999999999975 79999999999999999999999987655433333
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......... ..+.. ......
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~~~-------------~~~~~~ 242 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA---EHIAQ-------------GLRLYR 242 (283)
T ss_dssp TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH---HHHHT-------------TCCCCC
T ss_pred cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH---HHHhc-------------ccCCCC
Confidence 34456788999999998889999999999999999998 99999754321111 11100 011122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
+...++.+.+|+.+||..||++|||+.++++.|+.+..
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 243 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 33445789999999999999999999999999887653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=319.14 Aligned_cols=250 Identities=21% Similarity=0.371 Sum_probs=200.1
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
..|.+.+.||.| +++.||++... ++..||||.+.... .....+.+|+++|++++||||+++++++. ....++|||
T Consensus 188 ~~~~~~~~lG~G--~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 188 ESLKLEKKLGAG--QFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp GGEEEEEEEECC--SSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred HHeEEEEEcccC--CceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 457788899999 77788888765 36789999997533 34668999999999999999999999986 567899999
Q ss_pred ecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 93 YMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||.+|+|.++++. .++...++.+..+++.++.++|.. |||||+|||++.++.+||+|||+++..........
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 342 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 342 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTT
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceecc
Confidence 9999999999953 345556677888999999999975 89999999999999999999999987654322222
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
....+|..|+|||++....++.++|||||||++|||+| |..||....... ....+. ...+.+.
T Consensus 343 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~-------------~~~~~~~ 406 (454)
T 1qcf_A 343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALE-------------RGYRMPR 406 (454)
T ss_dssp CSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHH-------------HTCCCCC
T ss_pred CCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH-------------cCCCCCC
Confidence 33446788999999998899999999999999999999 999997543211 111111 0111233
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCCC
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGRR 283 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 283 (325)
+..+++.+.+||.+||..||++|||+++|++.|+.+....
T Consensus 407 ~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 407 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 4556788999999999999999999999999999877543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=298.26 Aligned_cols=244 Identities=23% Similarity=0.357 Sum_probs=186.5
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC----hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN----AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
..|.+.+.||.| +++.||.+... ++.||+|.+.... ......+.+|+.+++.++||||+++++++.+....+
T Consensus 7 ~~~~~~~~lg~G--~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 7 AELTLEEIIGIG--GFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp TSEEEEEEEEEE--TTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred hheeeeeeeccC--CCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 457788899999 77788888754 7889999986432 223467889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhh-------cCCCCCCceeeCC--------CCceEEeeecc
Q 046728 89 IVYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEG-------IADIKASNVLLDT--------DFEAKVADFGF 152 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~-------~rdlkp~Nil~~~--------~~~~kL~Dfg~ 152 (325)
+||||+++++|.++++ ..+++..++.+..++..++.++|. ||||||+||+++. ++.++|+|||+
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 9999999999999995 446666778889999999999987 6899999999986 67899999999
Q ss_pred ccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccc
Q 046728 153 AKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFE 232 (325)
Q Consensus 153 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (325)
+........ ....||+.|+|||++.+..++.++||||||+++|+|++|..||........ ...
T Consensus 163 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~----------- 225 (271)
T 3dtc_A 163 AREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV---AYG----------- 225 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH---HHH-----------
T ss_pred ccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHh-----------
Confidence 986554322 234589999999999988899999999999999999999999975432111 000
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 046728 233 HIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278 (325)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~ 278 (325)
..........+...++.+.+|+.+||..||++|||+.++++.|+.
T Consensus 226 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 226 -VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp -HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred -hhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 001111223344566789999999999999999999999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=312.30 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=200.1
Q ss_pred ccchhHHhhccCccceeeeeEEEeccC-------CCCeEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRET-------GDDQIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYA 82 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~-------~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 82 (325)
...|.+.+.||.| +++.||+++... .+..||+|.+... ......++.+|+++++++ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G--~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEG--AFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp GGGEEEEEEEEEC--SSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheEeeeEEecC--CCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 3567788899999 778888887543 2357999999753 445557899999999999 8999999999999
Q ss_pred cCCeEEEEEEecCCCChhhhhccC------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeC
Q 046728 83 GGDERLIVYDYMPNHSLITHLHGR------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLD 140 (325)
Q Consensus 83 ~~~~~~lV~e~~~~gsL~~~l~~~------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~ 140 (325)
+....++||||+++|+|.+++... ++...++.+..++..++.++|.. |||||+|||++
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 225 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc
Confidence 999999999999999999999532 44455677888888899888875 79999999999
Q ss_pred CCCceEEeeeccccccCCCcc-eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchh
Q 046728 141 TDFEAKVADFGFAKLIPDGVT-HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDI 218 (325)
Q Consensus 141 ~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~ 218 (325)
.++.+||+|||++........ .......+|..|+|||++.+..++.++|||||||++|+|++ |..||....... .
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~---~ 302 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---L 302 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---H
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence 999999999999986654322 22333457888999999998899999999999999999999 999997543211 1
Q ss_pred hhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 219 VQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
...+.. ......+..+++.+.+||.+||..||++|||+.++++.|+.+..
T Consensus 303 ~~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 303 FKLLKE-------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp HHHHHT-------------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHc-------------CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111110 01112234556789999999999999999999999999988764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=300.61 Aligned_cols=251 Identities=22% Similarity=0.293 Sum_probs=205.1
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
...|.+.+.||.| +++.||.+....++..||+|.+... ......+.+|++++++++||||+++++++.+....++||
T Consensus 12 ~~~~~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 12 RTDITMKHKLGGG--QYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp GGGEEEEEESGGG--TTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccceeEEeecCCC--CceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 4567888899999 7788999999999999999999753 344568899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 92 DYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 92 e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||+++++|.+++.. .++...++.+..++..++.++|.. +||||+||+++.++.++|+|||++..........
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 168 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 168 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEE
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcccc
Confidence 99999999999953 244555667778888899988875 7999999999999999999999998776554444
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
.....+|+.|+|||++.+..++.++||||||+++|+|++ |..||............ . ......
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~---~-------------~~~~~~ 232 (288)
T 3kfa_A 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---E-------------KDYRME 232 (288)
T ss_dssp ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH---H-------------TTCCCC
T ss_pred ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---h-------------ccCCCC
Confidence 444557788999999998899999999999999999999 99999754322111111 0 111122
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.+...++.+.+|+.+||..||++|||+.++++.|+.+..
T Consensus 233 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 334566789999999999999999999999999987664
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=315.75 Aligned_cols=248 Identities=21% Similarity=0.318 Sum_probs=203.3
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
...|.+.+.||.| +++.||++++..+++.||||.+.... ......+.+|+.+++.++||||+++++++.+....+
T Consensus 15 ~~~Y~l~~~LG~G--~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 15 IGHYILGDTLGVG--TFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp ETTEEEEEEEECC--SSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ecCEEEEEEEeeC--CCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3568889999999 78889999999999999999996432 223457889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 89 IVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
+|||||++|+|.+++. +.+++..+..++.++..++.++|.. |||||+|||++.++.+||+|||++........
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~- 171 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF- 171 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC-
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc-
Confidence 9999999999999995 3466777888999999999999975 79999999999999999999999987655332
Q ss_pred eeccCCCCcCCCCccccccCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKV-SDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
.....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .....+ ..+. .
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~i----~~~~----------~ 233 (476)
T 2y94_A 172 -LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLFKKI----CDGI----------F 233 (476)
T ss_dssp -BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHHHHH----HTTC----------C
T ss_pred -ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHHHHH----hcCC----------c
Confidence 234569999999999987765 67999999999999999999999754321 111111 0111 1
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
..+...++.+.+||.+||..||++|||++++++ ||+...
T Consensus 234 ~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 274 (476)
T 2y94_A 234 YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL 274 (476)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence 123345678999999999999999999999998 888654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=303.68 Aligned_cols=252 Identities=20% Similarity=0.306 Sum_probs=201.0
Q ss_pred ccchhHHhhccCccceeeeeEEEec-----cCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRR-----ETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD 85 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~-----~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (325)
.+.|.+.+.||.| +++.||.+.. ..+++.||+|.+... .......+.+|++++++++||||+++++++.+..
T Consensus 22 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEG--EFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp GGGEEEEEEEEEC--SSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeeeccc--CCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 4567888999999 7777888876 345588999999743 4455678899999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhccC--------------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCC
Q 046728 86 ERLIVYDYMPNHSLITHLHGR--------------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKAS 135 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~~--------------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~ 135 (325)
..++||||+++|+|.+++... ++...++.+..++..++.++|.. |||||+
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~ 179 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR 179 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchh
Confidence 999999999999999999532 33345567788888899999875 799999
Q ss_pred ceeeCCCCceEEeeeccccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCC
Q 046728 136 NVLLDTDFEAKVADFGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGG 213 (325)
Q Consensus 136 Nil~~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~ 213 (325)
||+++.++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 259 (314)
T 2ivs_A 180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259 (314)
T ss_dssp GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876543322 2233456788999999998889999999999999999999 99999764432
Q ss_pred ccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 214 VKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
..... +.. ......+...++.+.+|+.+||..||++|||+.++++.|+.++.
T Consensus 260 ~~~~~---~~~-------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 260 RLFNL---LKT-------------GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp GHHHH---HHT-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHH---hhc-------------CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 21111 100 01122334567789999999999999999999999999987654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=303.05 Aligned_cols=248 Identities=20% Similarity=0.285 Sum_probs=190.4
Q ss_pred ccchhHHhhccCccceeeeeEEEecc---CCCCeEEEEEecccC----hhhHHHHHHHHHHHHccCCCCccceeeEEEcC
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRE---TGDDQIAVKRLKTLN----AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG 84 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~---~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (325)
.+.|.+++.||.| +++.||.++.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++.+.
T Consensus 16 ~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 16 PECFELLRVLGKG--GYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp GGGEEEEEEEEEE--TTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred HHHeEEEEEEEeC--CCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 4678899999999 77788888775 578999999997532 23345678899999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCC
Q 046728 85 DERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 158 (325)
...|+|||||++|+|.+++. ..+.+..+..+..++..++.++|.. |||||+|||++.++.+||+|||++.....
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 99999999999999999994 3466667778889999999999975 79999999999999999999999875433
Q ss_pred CcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 159 GVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 159 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+.. .
T Consensus 174 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~----~--------- 236 (327)
T 3a62_A 174 DGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KTIDKILK----C--------- 236 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHH----T---------
T ss_pred CCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHh----C---------
Confidence 222 223456899999999999888999999999999999999999999753321 11111100 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH--HHhcc
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPENRP-----TMTDVVD--WLKGG 279 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~~ 279 (325)
....+...++.+.+||.+||..||++|| +++++++ ||+..
T Consensus 237 -~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 237 -KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred -CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 0122345667899999999999999999 7889998 77653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=294.07 Aligned_cols=253 Identities=19% Similarity=0.243 Sum_probs=204.0
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
+...|.+.+.||.| +++.||.+.+..+++.||+|.+... .......+.+|+.++++++||||+++++++.+....+
T Consensus 4 ~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 4 FSDNYDVKEELGKG--AFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTTEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhhcCc--CCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 46678899999999 7888999999999999999998643 4455568889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCc---eEEeeeccccccCCC
Q 046728 89 IVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFE---AKVADFGFAKLIPDG 159 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~---~kL~Dfg~~~~~~~~ 159 (325)
+||||+++++|.+++. ..+++..+..+..++..++.++|.. |||||+||+++.++. ++|+|||++......
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999999999998884 3466677788889999999999975 799999999986655 999999999876543
Q ss_pred cceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 160 VTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 160 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|..||....... ....+. .+.. ..
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~----~~~~------~~ 226 (284)
T 3kk8_A 162 EA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQIK----AGAY------DY 226 (284)
T ss_dssp CB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HTCC------CC
T ss_pred cc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH---HHHHHH----hccc------cC
Confidence 22 233568999999999998899999999999999999999999996533211 111110 0000 01
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
..+.....++.+.+||.+||..||++|||++++++ ||+...
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 227 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 11222456678999999999999999999999998 887643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=305.38 Aligned_cols=249 Identities=21% Similarity=0.343 Sum_probs=176.6
Q ss_pred hhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCCeEEEEEEecCCC
Q 046728 19 QNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDERLIVYDYMPNH 97 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lV~e~~~~g 97 (325)
+.||.| +++.||++.+..+++.||||.+... ....+.+|+.+++.+. ||||+++++++.+....++|||||++|
T Consensus 17 ~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 17 KPLGEG--SFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp CCSEEE--TTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CccccC--CCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 567777 8888999999999999999999652 3457788999999996 999999999999999999999999999
Q ss_pred Chhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC---ceEEeeeccccccCCCcceeeccCC
Q 046728 98 SLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF---EAKVADFGFAKLIPDGVTHMTTRVK 168 (325)
Q Consensus 98 sL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~---~~kL~Dfg~~~~~~~~~~~~~~~~~ 168 (325)
+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++.++ .+||+|||++......... .....
T Consensus 92 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~ 170 (325)
T 3kn6_A 92 ELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC 170 (325)
T ss_dssp BHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-ccccC
Confidence 9999995 3466777888999999999999975 79999999997665 7999999999866543222 23345
Q ss_pred CCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHH
Q 046728 169 GTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQL 248 (325)
Q Consensus 169 ~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (325)
+|+.|+|||++.+..++.++|||||||++|+|++|..||.....................+.+ ......+...+
T Consensus 171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------~~~~~~~~~~s 244 (325)
T 3kn6_A 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SFEGEAWKNVS 244 (325)
T ss_dssp -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------CCCSHHHHTSC
T ss_pred CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------CCCcccccCCC
Confidence 899999999999889999999999999999999999999764432111111111111111110 00111123467
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 249 KSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 249 ~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
+++.+||.+||..||++|||++++++ ||+..
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred HHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 88999999999999999999999997 88753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=304.65 Aligned_cols=257 Identities=20% Similarity=0.293 Sum_probs=197.9
Q ss_pred cceeecccchhHHhhccCccceeeeeEEEeccCCCCe----EEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeE
Q 046728 6 NICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQ----IAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGF 80 (325)
Q Consensus 6 ~~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~----vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (325)
-+.+.....|.+++.||.| +++.||+++...+++. ||+|.+... ......++.+|+.++++++||||++++++
T Consensus 8 ~~~~l~~~~y~~~~~lG~G--~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 85 (327)
T 3poz_A 8 LLRILKETEFKKIKVLGSG--AFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 85 (327)
T ss_dssp SSEECCGGGEEEEEEEEEE--TTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEE
T ss_pred HHhhcCHHHcccceEEeeC--CCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 3556667789999999999 7788999988777664 588877532 33455689999999999999999999999
Q ss_pred EEcCCeEEEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccc
Q 046728 81 YAGGDERLIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFA 153 (325)
Q Consensus 81 ~~~~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~ 153 (325)
+.+.. .++|++|+.+|+|.+++.. .++...++.+..++..++.++|.. |||||+|||++.++.+||+|||++
T Consensus 86 ~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 86 CLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred EecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcce
Confidence 98765 7899999999999999953 355566778889999999999975 799999999999999999999999
Q ss_pred cccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhccccccccc
Q 046728 154 KLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAF 231 (325)
Q Consensus 154 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (325)
+........ ......+|..|+|||++.+..++.++|||||||++|+|++ |..||...+.........
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~----------- 233 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE----------- 233 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-----------
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-----------
Confidence 876543322 2223446889999999999899999999999999999999 999997654322211111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 232 EHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.......+...+..+.+|+.+||..||++|||+.++++.|+.+..
T Consensus 234 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 234 -----KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -----TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred -----cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111122334566789999999999999999999999998887654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=318.69 Aligned_cols=247 Identities=19% Similarity=0.266 Sum_probs=192.9
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..|.+++.||.| +++.||++++..+++.||||.+... .......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 148 ~~y~~~~~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 148 NEFEYLKLLGKG--TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp GGEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred HHcEEeEEEeeC--cCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 457888999999 8888999999999999999999642 33344577889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhh-----cCCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 90 VYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEG-----IADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 90 V~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~-----~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
|||||++|+|.+++. ..+++..+..+..++..++.++|. ||||||+|||++.++.+||+|||++........
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 304 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA- 304 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc-
Confidence 999999999999994 446677778889999999999997 389999999999999999999999986443222
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+. . . ...
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i~----~--------~--~~~ 367 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELIL----M--------E--EIR 367 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----H--------C--CCC
T ss_pred ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHHHHH----h--------C--CCC
Confidence 2334579999999999998899999999999999999999999996543211 111110 0 0 012
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH--HHhcc
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRP-----TMTDVVD--WLKGG 279 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~~ 279 (325)
.+...++.+.+||.+||..||++|| |++++++ ||+..
T Consensus 368 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 368 FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 2345667899999999999999999 9999998 88764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=298.31 Aligned_cols=260 Identities=18% Similarity=0.250 Sum_probs=191.3
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
.|.+++.||.| +++.||++++ .+++.||+|.+.... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 3 ~y~~~~~lg~G--~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 3 KYHGLEKIGEG--TYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp SEEEEEEEEEE--TTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred cchhhhhcccC--CCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 57788999999 7778999987 568899999986433 223457889999999999999999999999999999999
Q ss_pred EecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 92 DYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 92 e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||+.+ +|.+++. ..+++..+..+..++..++.++|.. |||||+||+++.++.+||+|||++......... .
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~ 157 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-Y 157 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc-c
Confidence 99975 9998884 3355666778889999999999975 799999999999999999999999876533222 2
Q ss_pred ccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccc------c--
Q 046728 165 TRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHI------A-- 235 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~-- 235 (325)
....+|+.|+|||++.+. .++.++|||||||++|+|++|..||...........+...........+... .
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 234589999999998754 5899999999999999999999999754321111100000000000000000 0
Q ss_pred ----CccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 236 ----DPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 236 ----~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
.+..........++.+.+||.+||..||++|||++++++ ||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 000001112346778999999999999999999999998 7764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=299.55 Aligned_cols=257 Identities=20% Similarity=0.249 Sum_probs=192.6
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHc--cCCCCccceeeEEEc---
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGR--VRHRNLLGLRGFYAG--- 83 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~--- 83 (325)
-.+...|.+++.||.| +++.||.++. +++.||||.+... ....+..|.+++.. ++||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G--~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 4 RTVARDITLLECVGKG--RYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CCCGGGCEEEEEEEEC--SSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred ccccCcEEEEEeeccC--CCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 4567788999999999 7778888875 5789999998653 33455667777666 789999999998644
Q ss_pred -CCeEEEEEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHh--------h----cCCCCCCceeeCCCCceEEee
Q 046728 84 -GDERLIVYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAE--------G----IADIKASNVLLDTDFEAKVAD 149 (325)
Q Consensus 84 -~~~~~lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~--------~----~rdlkp~Nil~~~~~~~kL~D 149 (325)
....++||||+++|+|.++++ ..++...++.+..++..++.++| . ||||||+|||++.++.+||+|
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred CCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence 345889999999999999995 34566667888999999999999 3 589999999999999999999
Q ss_pred eccccccCCCccee---eccCCCCcCCCCccccccC------CCCCcccchhHHHHHHHHHhC----------CCCCCCC
Q 046728 150 FGFAKLIPDGVTHM---TTRVKGTLGYLAPEYAMWG------KVSDSCDVYSFGVLLLELISA----------KKPLEKL 210 (325)
Q Consensus 150 fg~~~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~------~~~~~~DiwSlG~il~el~tg----------~~pf~~~ 210 (325)
||++.......... .....||+.|+|||++.+. .++.++|||||||++|+|++| ..||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99997655433322 2234689999999999876 345689999999999999999 7787654
Q ss_pred CCCccch-hhhhhcccccccccccccCcccc-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 211 PGGVKRD-IVQWVTPYVQKGAFEHIADPRLK-GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 211 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
....... ..... ...... .+... .......++.+.+||.+||..||++|||+.++++.|+.+
T Consensus 237 ~~~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPSFEDMRKV--VCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCCHHHHHHH--HTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcchhhhhHH--HhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 3222111 11000 000000 00000 012235778999999999999999999999999998753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=303.57 Aligned_cols=257 Identities=13% Similarity=0.120 Sum_probs=203.9
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEE
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 88 (325)
.+...|.+.+.||.| +++.||++++..+++.||||.+..... ...+.+|+.+++++ +||||+++++++.+....+
T Consensus 6 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 6 MVGPNFRVGKKIGCG--NFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp EETTTEEEEEECCC---CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EEcCCeEEEEEeecc--CCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 356778999999999 778899999999999999999875322 23688899999999 8999999999999999999
Q ss_pred EEEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCc-----eEEeeecccccc
Q 046728 89 IVYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFE-----AKVADFGFAKLI 156 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~-----~kL~Dfg~~~~~ 156 (325)
+||||+ +++|.+++. ..++...++.+..++..++.++|.. |||||+|||++.++. +||+|||++...
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 999999995 4466777788889999999999985 799999999998887 999999999876
Q ss_pred CCCcce------eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccc
Q 046728 157 PDGVTH------MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGA 230 (325)
Q Consensus 157 ~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (325)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..............+........
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 543221 12345699999999999998999999999999999999999999987654333322222211100000
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 231 FEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
. . ......+ ++.+|+..||..||.+||++++|.+.|+....
T Consensus 241 ~-----~----~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 241 I-----E----VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp H-----H----HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred H-----H----HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 0 0 0001133 89999999999999999999999998887653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=302.94 Aligned_cols=270 Identities=17% Similarity=0.193 Sum_probs=198.2
Q ss_pred ceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC
Q 046728 7 ICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG 84 (325)
Q Consensus 7 ~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (325)
..+.+...|.+++.||.| +++.||.+.+..+++.||||.+... .......+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 96 (371)
T 2xrw_A 19 STFTVLKRYQNLKPIGSG--AQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ 96 (371)
T ss_dssp EEEEEETTEEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSC
T ss_pred cccchhhheeEeeeeEec--CCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccc
Confidence 345667889999999999 7888999999999999999999642 345556888999999999999999999999766
Q ss_pred C------eEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccc
Q 046728 85 D------ERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 85 ~------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
. ..++|||||. |+|.+++...++...+..+..++..++.++|.. |||||+|||++.++.+||+|||++.
T Consensus 97 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 97 KSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp CSTTTCCEEEEEEECCS-EEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred cccccccceEEEEEcCC-CCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 5 7899999996 589999977777777888999999999999985 7999999999999999999999998
Q ss_pred ccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhh-h--------cc-
Q 046728 155 LIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQW-V--------TP- 224 (325)
Q Consensus 155 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~-~--------~~- 224 (325)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.. . ..
T Consensus 176 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 176 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred cccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 654322 12334689999999999988999999999999999999999999975432111000000 0 00
Q ss_pred ------------cccccccccccCccccCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 225 ------------YVQKGAFEHIADPRLKGK---FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 225 ------------~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
......+.........+. .....+..+.+||.+||..||++|||++++++ ||+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 327 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence 000000000000000000 11234778999999999999999999999998 9986543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=305.89 Aligned_cols=254 Identities=20% Similarity=0.308 Sum_probs=201.5
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeE
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 87 (325)
..+...|.+.+.||.| +++.||++.+..+++.||+|.+..... ...+|++++.++ +||||+++++++.+....
T Consensus 18 ~~~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVG--SYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp -CHHHHEEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred cCccccEEEEEEEeeC--CCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 3456778899999999 788899999999999999999975332 234688888888 799999999999999999
Q ss_pred EEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC----CceEEeeeccccccC
Q 046728 88 LIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD----FEAKVADFGFAKLIP 157 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~----~~~kL~Dfg~~~~~~ 157 (325)
|+|||||++|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||+... +.+||+|||++....
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999999999994 3466777888999999999999985 7999999998543 359999999998765
Q ss_pred CCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 158 DGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 158 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
.... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||..............+. .+.+
T Consensus 172 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----~~~~------ 240 (342)
T 2qr7_A 172 AENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG----SGKF------ 240 (342)
T ss_dssp CTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH----HCCC------
T ss_pred CCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc----cCCc------
Confidence 4322 2234568999999999988788999999999999999999999997644332222222211 1111
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
......+...++.+.+||.+||..||++|||+.++++ ||...
T Consensus 241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 1112233556789999999999999999999999998 88653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=300.50 Aligned_cols=265 Identities=16% Similarity=0.200 Sum_probs=196.0
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
..|.+++.||.| +++.||+++...+++.||+|.+... .......+.+|+.++++++||||+++++++.+....++|
T Consensus 3 ~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEG--SYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp CCEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEeeEEeec--CCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 467888999999 8888999999999999999988543 333456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||||++++|.++++ ..++...+..+..++..++.++|.. |||||+||+++.++.++|+|||++......... .
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~ 159 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY-Y 159 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc-c
Confidence 99999999988884 3356666778888999999999975 799999999999999999999999876543222 2
Q ss_pred ccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhh-ccc--------ccccccccc
Q 046728 165 TRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWV-TPY--------VQKGAFEHI 234 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~-~~~--------~~~~~~~~~ 234 (325)
....+|..|+|||++.+ ..++.++||||||+++|+|++|..||...........+... ... .....+...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence 23458999999999876 56899999999999999999999999764332211111100 000 000000000
Q ss_pred cCccccCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 235 ADPRLKGK-----FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 235 ~~~~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
..+..... ..+..++.+.+||.+||..||++|||++++++ ||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 00000000 01345678999999999999999999999998 888654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=294.29 Aligned_cols=256 Identities=19% Similarity=0.322 Sum_probs=203.9
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
.+-..|.+++.||.| +++.||.+.+..+++.||+|.+... .......+.+|+.+++.++||||+++++++.+....+
T Consensus 4 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 4 PFVEDWDLVQTLGEG--AYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHHHEEEEEEEEEC--SSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceecceEEEEEeecC--CCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence 455678889999999 7788999999999999999998643 3344568889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc-
Q 046728 89 IVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT- 161 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 161 (325)
+||||+++++|.+++.. .++...++.+..++..++.++|.. +||||+||+++.++.++|+|||++........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 99999999999999954 356667788889999999999875 79999999999999999999999986543221
Q ss_pred eeeccCCCCcCCCCccccccCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 162 HMTTRVKGTLGYLAPEYAMWGKV-SDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
.......||..|+|||++.+..+ +.++||||||+++|+|++|..||........ ....+.. ....
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~-------------~~~~ 227 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE-------------KKTY 227 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHT-------------TCTT
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhh-------------cccc
Confidence 11234568999999999987665 6789999999999999999999976433211 1111110 0001
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
.......++.+.+||.+||..||++|||++++++ ||+....
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 1123456778999999999999999999999998 8776543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=303.56 Aligned_cols=252 Identities=22% Similarity=0.346 Sum_probs=200.7
Q ss_pred cchhHHhhccCccceeeeeEEEe-----ccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCC
Q 046728 13 SPAVFIQNINNGLEILMLLLLLR-----RETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGD 85 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~-----~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 85 (325)
..|.+.+.||.| +++.||.+. +..+++.||+|.+... .......+.+|+.+++++ +||||+++++++.+.+
T Consensus 23 ~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 23 NRLSFGKTLGAG--AFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGEEEEEEEEEC--SSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhHHHhhCcc--CCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 567888999999 777788887 3456789999999753 334556889999999999 8999999999999999
Q ss_pred eEEEEEEecCCCChhhhhccC--------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC
Q 046728 86 ERLIVYDYMPNHSLITHLHGR--------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT 141 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~ 141 (325)
..++||||+++|+|.+++... ++...++.+..++..++.++|.. |||||+||+++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcC
Confidence 999999999999999999532 44455677788888899998875 799999999999
Q ss_pred CCceEEeeeccccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhh
Q 046728 142 DFEAKVADFGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIV 219 (325)
Q Consensus 142 ~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~ 219 (325)
++.+||+|||++......... ......+|..|+|||++.+..++.++||||||+++|+|+| |..||........ ..
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~ 258 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--FY 258 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--HH
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--HH
Confidence 999999999999876554322 2233446788999999998899999999999999999999 9999976543211 11
Q ss_pred hhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 220 QWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.... .......+...++.+.+||.+||..||++|||+.++++.|+....
T Consensus 259 ~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 259 KMIK-------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHHH-------------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhc-------------cCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 1110 011112234456789999999999999999999999999987664
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=305.65 Aligned_cols=250 Identities=20% Similarity=0.282 Sum_probs=186.4
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
+...|.+.+.||.| +++.||+++...+++.||||.+.... ....+.+|+.++++++||||+++++++.+....++|
T Consensus 51 ~~~~y~~~~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 51 LSDFFEVESELGRG--ATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGGTEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCcEEEeeEEeeC--CCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 44568888999999 88889999999999999999997532 345788899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC---CCceEEeeeccccccCCCcc
Q 046728 91 YDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT---DFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~---~~~~kL~Dfg~~~~~~~~~~ 161 (325)
|||+++|+|.+++.. .+++..++.+..++..++.++|.. |||||+|||++. ++.+||+|||++........
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 206 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence 999999999999953 356667788889999999999975 799999999975 78999999999986544321
Q ss_pred eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 162 HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||........ ....+ ..... ....
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~i----~~~~~------~~~~ 272 (349)
T 2w4o_A 207 --MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFRRI----LNCEY------YFIS 272 (349)
T ss_dssp --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHHHH----HTTCC------CCCT
T ss_pred --cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHHHH----HhCCC------ccCC
Confidence 2334689999999999988899999999999999999999999975433110 11100 00000 0111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
+.....+..+.+||.+||..||++|||+.++++ ||..
T Consensus 273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 311 (349)
T 2w4o_A 273 PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311 (349)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 223456778999999999999999999999998 7764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=304.03 Aligned_cols=272 Identities=18% Similarity=0.255 Sum_probs=201.8
Q ss_pred cccceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEE
Q 046728 4 HRNICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFY 81 (325)
Q Consensus 4 ~~~~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (325)
+.++-|..-..|.+++.||.| +++.||.++...+++.||+|.+... .......+.+|+.++++++||||+++++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 93 (331)
T 4aaa_A 16 TENLYFQSMEKYENLGLVGEG--SYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC 93 (331)
T ss_dssp ---CCCBCGGGEEEEEEGGGG--TTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cchhhhhhhhhheeeeEEeec--CCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEe
Confidence 345778888899999999999 7788999999999999999998543 334455788999999999999999999999
Q ss_pred EcCCeEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccc
Q 046728 82 AGGDERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 82 ~~~~~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
.+....++||||+.+++|.+++. ..++...+..+..++..++.++|.. +||||+||+++.++.++|+|||++..
T Consensus 94 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 173 (331)
T 4aaa_A 94 KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART 173 (331)
T ss_dssp EETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred ecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCcee
Confidence 99999999999999988888763 4466667788889999999999975 79999999999999999999999986
Q ss_pred cCCCcceeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhh-hccc--------
Q 046728 156 IPDGVTHMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQW-VTPY-------- 225 (325)
Q Consensus 156 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~-~~~~-------- 225 (325)
....... .....+|..|+|||++.+. .++.++|||||||++|+|++|..||...........+.. ....
T Consensus 174 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 174 LAAPGEV-YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred ecCCccc-cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence 5543222 2334689999999999865 688999999999999999999999976432111110000 0000
Q ss_pred ccccccccccCccccC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 226 VQKGAFEHIADPRLKG-----KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 226 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
.....+.....+.... ...+.+++.+.+||.+||..||++|||+.++++ ||+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 0000000011111111 111345778999999999999999999999998 8875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=309.80 Aligned_cols=251 Identities=23% Similarity=0.363 Sum_probs=189.0
Q ss_pred cchhHHhhccCccceeeeeEEEecc---CCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRE---TGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~---~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
..|.+.+.||.| +++.||.++.. .++..||||.+... .......+.+|+.++++++||||+++++++.+....+
T Consensus 45 ~~~~~~~~lG~G--~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 45 TNISIDKVVGAG--EFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGCCCCEEEEEC--SSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhceeeeEEeeC--CCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 467888899998 77889988766 45678999999753 4455568999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 89 IVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
+||||+++|+|.++++. .++...++.+..++..++.++|.. |||||+|||++.++.+||+|||++........
T Consensus 123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 99999999999999954 345556677888899999999875 79999999999999999999999987654322
Q ss_pred ee--eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 162 HM--TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 162 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
.. .....+++.|+|||++.+..++.++|||||||++|+|++ |..||....... ....+. ..
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~~~i~-------------~~ 266 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VIKAVD-------------EG 266 (373)
T ss_dssp -----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HHHHHH-------------TT
T ss_pred cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH-------------cC
Confidence 11 112235678999999998899999999999999999998 999996543211 111111 11
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
...+.+..++..+.+|+.+||..||++|||+.++++.|+.+..
T Consensus 267 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 1122334566789999999999999999999999998887754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=305.97 Aligned_cols=269 Identities=21% Similarity=0.279 Sum_probs=206.2
Q ss_pred ccchhHHhhccCccceeeeeEEEe----ccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEE--cCC
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLR----RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYA--GGD 85 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~ 85 (325)
...|.+++.||.| +++.||+++ +..+++.||+|.+..........+.+|++++++++||||+++++++. +..
T Consensus 22 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 22 ERHLKYISQLGKG--NFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGGEEEEEEEEEE--TTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhhccCC--CCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 4678999999999 777888888 56778999999998777777778999999999999999999999986 456
Q ss_pred eEEEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCC
Q 046728 86 ERLIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 158 (325)
..++||||+++++|.+++.. .++...++.+..++..++.++|.. +||||+||+++.++.+||+|||++.....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 68999999999999999943 366777788889999999999975 79999999999999999999999987654
Q ss_pred Ccce--eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccC
Q 046728 159 GVTH--MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD 236 (325)
Q Consensus 159 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (325)
.... ......+|..|+|||++.+..++.++||||||+++|+|++|..||........... .................
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCERDVPALSRLLELLE 258 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C----CCHHHHHHHHHH
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-ccccccccHHHHHHHhh
Confidence 3322 22334578889999999988899999999999999999999999864221000000 00000000000000111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCCC
Q 046728 237 PRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGRR 283 (325)
Q Consensus 237 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 283 (325)
.......+..+++.+.+||.+||..||++|||+.++++.|+.+....
T Consensus 259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11223345567789999999999999999999999999999876543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=298.18 Aligned_cols=252 Identities=20% Similarity=0.360 Sum_probs=201.5
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
.+...|.+.+.||.| +++.||++++..+++.||+|.+..........+.+|+.++++++||||+++++++.+....++
T Consensus 6 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 6 NIRKTFIFMEVLGSG--AFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp CHHHHEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred chhccceeeeeccCC--CCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 456778899999999 788899999999999999999986554455678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceee---CCCCceEEeeeccccccCCCc
Q 046728 90 VYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLL---DTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 90 V~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
||||+++++|.+++. ..+++..+..+..++..++.++|.. +||||+||++ +.++.++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 163 (304)
T 2jam_A 84 VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163 (304)
T ss_dssp EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred EEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence 999999999999984 4466677788889999999999985 7999999999 778899999999987544321
Q ss_pred ceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 161 THMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||...... .....+. .+.. ...
T Consensus 164 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~----~~~~------~~~ 227 (304)
T 2jam_A 164 ---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFEKIK----EGYY------EFE 227 (304)
T ss_dssp ---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHH----HCCC------CCC
T ss_pred ---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH----cCCC------CCC
Confidence 12235899999999999888999999999999999999999999754321 1111110 1100 011
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
.+.+...++.+.+||.+||..||++|||++++++ ||+..
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 228 SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 1233456778999999999999999999999998 88754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=306.31 Aligned_cols=252 Identities=20% Similarity=0.329 Sum_probs=198.7
Q ss_pred cchhHHhhccCccceeeeeEEEeccC-----CCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRET-----GDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~-----~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
..|.+++.||.| +++.||+++... +++.||+|.+... .......+.+|+.++++++||||+++++++.+...
T Consensus 47 ~~~~~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 47 NNIEYVRDIGEG--AFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp GGCEEEEEEEEC--SSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHCeeeeeeeec--CCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 567888999998 777888888763 4588999999753 34455689999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhcc--------------------------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCc
Q 046728 87 RLIVYDYMPNHSLITHLHG--------------------------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASN 136 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~--------------------------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~N 136 (325)
.++||||+++|+|.+++.. .++...++.+..++..++.++|.. |||||+|
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N 204 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 204 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcce
Confidence 9999999999999999953 233344566788888888888875 7999999
Q ss_pred eeeCCCCceEEeeeccccccCCCcc-eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCc
Q 046728 137 VLLDTDFEAKVADFGFAKLIPDGVT-HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGV 214 (325)
Q Consensus 137 il~~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~ 214 (325)
|+++.++.+||+|||++........ .......+|..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~- 283 (343)
T 1luf_A 205 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE- 283 (343)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-
T ss_pred EEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH-
Confidence 9999999999999999986543221 12233457889999999998889999999999999999999 99999754321
Q ss_pred cchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCC
Q 046728 215 KRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGR 282 (325)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 282 (325)
.....+. .+. ....+..+++.+.+||.+||..||++|||+.++++.|+.+...
T Consensus 284 --~~~~~~~----~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 284 --EVIYYVR----DGN---------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp --HHHHHHH----TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred --HHHHHHh----CCC---------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 1111110 110 1122345667899999999999999999999999999987753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=308.40 Aligned_cols=268 Identities=20% Similarity=0.229 Sum_probs=191.6
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecc--cChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCC-
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKT--LNAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGD- 85 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~- 85 (325)
.+...|.+++.||.| +++.||++.+..+++.||||.+.. .......++.+|+.+++.+. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 6 HVLRKYELVKKLGKG--AYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HHHTTEEEEEC---------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred cccCceEEEEEeeeC--CCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 455678899999999 888899999999999999999853 24555668889999999997 999999999997544
Q ss_pred -eEEEEEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC
Q 046728 86 -ERLIVYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 86 -~~~lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 159 (325)
.+|+|||||. |+|.++++ ..+++.....+..++..++.++|.. |||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred CEEEEEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 6899999996 59999985 3456666677888999999999975 899999999999999999999999865321
Q ss_pred c--------------------ceeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchh
Q 046728 160 V--------------------THMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDI 218 (325)
Q Consensus 160 ~--------------------~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~ 218 (325)
. ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0 111233569999999999876 5789999999999999999999999976432111111
Q ss_pred hhhhcccccccccccccC------------------ccc------------cCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 046728 219 VQWVTPYVQKGAFEHIAD------------------PRL------------KGKFNRDQLKSMVLIALRCTDSNPENRPT 268 (325)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~------------------~~~------------~~~~~~~~~~~~~~li~~cl~~dp~~Rps 268 (325)
+..............+.. ... ........++.+.+||.+||..||++|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 100000000000000000 000 00011134678999999999999999999
Q ss_pred HHHHHH--HHhccc
Q 046728 269 MTDVVD--WLKGGL 280 (325)
Q Consensus 269 ~~~il~--~l~~~~ 280 (325)
++++++ ||+...
T Consensus 323 ~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 323 ANDALKHPFVSIFH 336 (388)
T ss_dssp HHHHTTSTTTTTTC
T ss_pred HHHHhCCHHHHHhc
Confidence 999998 887644
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=298.07 Aligned_cols=257 Identities=15% Similarity=0.148 Sum_probs=204.7
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 89 (325)
+...|.+.+.||.| +++.||.+.+..+++.||+|.+.... ....+.+|+.+++++ +|+|++++++++.+....++
T Consensus 8 ~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 8 VGVHYKVGRRIGEG--SFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp ETTTEEEEEEEEEC--SSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred cccceEEEEEEeec--CCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 56678999999999 78889999998999999999986432 234678899999999 79999999999999999999
Q ss_pred EEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCc-----eEEeeeccccccC
Q 046728 90 VYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFE-----AKVADFGFAKLIP 157 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~-----~kL~Dfg~~~~~~ 157 (325)
||||+ +++|.+++.. .++...++.+..++..++.++|.. |||||+||+++.++. +||+|||++....
T Consensus 84 v~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999 9999999952 366677888899999999999975 799999999987765 9999999998765
Q ss_pred CCcce------eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccc
Q 046728 158 DGVTH------MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAF 231 (325)
Q Consensus 158 ~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (325)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..............+.........
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 43221 123456899999999999888999999999999999999999999875443322222211111000000
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 232 EHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
......+++.+.+|+.+||..||++|||+++|++.|+.+..
T Consensus 243 ---------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 243 ---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp ---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred ---------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 01112456789999999999999999999999999988764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=301.42 Aligned_cols=252 Identities=19% Similarity=0.288 Sum_probs=201.2
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh------hhHHHHHHHHHHHHccCCCCccceeeEEEc
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA------KAEMEFAVEVEILGRVRHRNLLGLRGFYAG 83 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (325)
.+...|.+.+.||.| +++.||.+++..+++.||+|.+..... .....+.+|+.++++++||||+++++++.+
T Consensus 9 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 9 KVEDFYDIGEELGSG--QFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN 86 (321)
T ss_dssp CHHHHEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhccEEEeeEeeec--CCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 345668889999999 788899999999999999999864322 135678999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC----ceEEeeeccc
Q 046728 84 GDERLIVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF----EAKVADFGFA 153 (325)
Q Consensus 84 ~~~~~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~----~~kL~Dfg~~ 153 (325)
....++||||+++++|.+++.. .+++..++.+..++..++.++|.. |||||+||+++.++ .++|+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999999953 345666788889999999999975 79999999999887 7999999999
Q ss_pred cccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccc
Q 046728 154 KLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEH 233 (325)
Q Consensus 154 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (325)
........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||....... ....+.. ...
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~----~~~-- 235 (321)
T 2a2a_A 167 HEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANITS----VSY-- 235 (321)
T ss_dssp EECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHT----TCC--
T ss_pred eecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHh----ccc--
Confidence 87654322 233468999999999998899999999999999999999999996533211 1111100 000
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 234 IADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
..........++.+.+||.+||..||++|||++++++ ||..
T Consensus 236 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 236 ----DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp ----CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred ----ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 0000111234568999999999999999999999998 7754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=306.74 Aligned_cols=252 Identities=21% Similarity=0.311 Sum_probs=196.3
Q ss_pred cchhHHhhccCccceeeeeEEEec-----cCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCC
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRR-----ETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGD 85 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~-----~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 85 (325)
..|.+.+.||.| +++.||.+.. ..++..||+|.+... .......+.+|+.+++++ +||||+++++++...+
T Consensus 45 ~~y~~~~~lG~G--~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 45 ENLEFGKVLGSG--AFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp GGEEEEEEEEEC--SSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHceeeeeecCC--CCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 456778899999 7777888875 345678999999743 333446889999999999 8999999999999999
Q ss_pred eEEEEEEecCCCChhhhhccC-------------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCc
Q 046728 86 ERLIVYDYMPNHSLITHLHGR-------------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASN 136 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~N 136 (325)
..++||||+++|+|.+++... ++...++.+..++..++.++|.. |||||+|
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N 202 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 202 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhh
Confidence 999999999999999999542 23334556788888899999875 7999999
Q ss_pred eeeCCCCceEEeeeccccccCCCcc-eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCc
Q 046728 137 VLLDTDFEAKVADFGFAKLIPDGVT-HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGV 214 (325)
Q Consensus 137 il~~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~ 214 (325)
|+++.++.++|+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|+| |..||.......
T Consensus 203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 282 (344)
T 1rjb_A 203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282 (344)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH
Confidence 9999999999999999986543322 22333457788999999998899999999999999999998 999997654321
Q ss_pred cchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 215 KRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
. ....+. .......+...++.+.+||.+||..||++|||+.++++.|+....
T Consensus 283 ~--~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 283 N--FYKLIQ-------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp H--HHHHHH-------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred H--HHHHHh-------------cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 1 111110 111122334556789999999999999999999999999998765
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=295.88 Aligned_cols=251 Identities=19% Similarity=0.264 Sum_probs=187.9
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCC---CCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETG---DDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~---~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
...|.+.+.||.| +++.||.+....+ +..||+|.+... .......+.+|+.++++++||||+++++++. .+..
T Consensus 14 ~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 14 RERIELGRCIGEG--QFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp GGGEEEEEEEEEC--SSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred hHHeEEEeEeeec--CCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 4577889999999 7778888877654 456999998753 3455568899999999999999999999984 5678
Q ss_pred EEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 88 LIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
++||||+.+|+|.+++.. .++...++.+..++..++.++|.. |||||+||+++.++.+||+|||++.......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 999999999999999953 355566677888899999999875 7999999999999999999999998765543
Q ss_pred ceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 161 THMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
........+|+.|+|||++.+..++.++||||||+++|+|++ |..||........ ...+. . ..
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~i~----~---------~~ 234 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIE----N---------GE 234 (281)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHH----T---------TC
T ss_pred ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHHHH----c---------CC
Confidence 333333456788999999998889999999999999999997 9999976443211 11110 0 00
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
..+.+..+++.+.+||.+||..||++|||+.++++.|+.+..
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 235 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 112344567889999999999999999999999999987653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=315.31 Aligned_cols=254 Identities=22% Similarity=0.284 Sum_probs=204.2
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
..+...|.+++.||.| +++.||++++..+++.||||.+... .......+.+|+.++++++||||+++++++.+...
T Consensus 18 g~~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 95 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKG--SFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (486)
T ss_dssp CHHHHHEEEEEEEECC--SSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CChhcceEEeEEEeec--CCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence 3567788999999999 8888999999999999999998632 23345688899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeC---CCCceEEeeeccccccC
Q 046728 87 RLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLD---TDFEAKVADFGFAKLIP 157 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~---~~~~~kL~Dfg~~~~~~ 157 (325)
.++|||||.+|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++ .++.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999999999883 4567777888999999999999975 79999999995 45679999999998665
Q ss_pred CCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 158 DGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 158 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
.... .....||+.|+|||++.+ .++.++||||+||++|+|++|..||...... .....+. .+.+
T Consensus 176 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~----~~~~------ 239 (486)
T 3mwu_A 176 QNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKRVE----TGKY------ 239 (486)
T ss_dssp CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----HTCC------
T ss_pred CCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH----hCCC------
Confidence 4322 234569999999999875 6899999999999999999999999754321 1111111 1100
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
....+.+...++.+.+||.+||..||++|||+.++++ ||+...
T Consensus 240 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 240 AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 0111223456788999999999999999999999999 998654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=317.12 Aligned_cols=249 Identities=25% Similarity=0.401 Sum_probs=193.6
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
+.|.+.+.||.| +++.||++.... +..||||.+.... .....+.+|+++|++++||||+++++++.+ ...++|||
T Consensus 184 ~~~~~~~~lG~G--~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 184 ESLRLEVKLGQG--CFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGEEEEEEEEEC--SSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hHceeeeeecCC--CCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 456788889998 777888887654 4679999997533 334689999999999999999999999876 67899999
Q ss_pred ecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 93 YMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
|+++|+|.++++. .++...++.+..+++.++.++|.. |||||+|||++.++.+||+|||++...........
T Consensus 259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 338 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338 (452)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence 9999999999953 256666778889999999999975 79999999999999999999999987654333223
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
....++..|+|||++.+..++.++|||||||++|+|++ |..||....... ....+. ...+.+.
T Consensus 339 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~-------------~~~~~~~ 402 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVE-------------RGYRMPC 402 (452)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHH-------------TTCCCCC
T ss_pred cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH-------------cCCCCCC
Confidence 33456788999999998899999999999999999999 999997543211 111111 0112233
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCC
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGR 282 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 282 (325)
+..+++.+.+||.+||..||++|||++++++.|+.....
T Consensus 403 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 403 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 456678899999999999999999999999999987643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=316.17 Aligned_cols=252 Identities=19% Similarity=0.305 Sum_probs=199.1
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
+...|.+++.||.| +++.||++++..++..||+|.+.... ......+.+|+.+++.++||||+++++++.+....+
T Consensus 35 ~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 35 LSEMYQRVKKLGSG--AYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp HHHHEEEEEEEECC-----EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hhcCeEEeeEEecC--CCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 45568889999999 88889999999999999999997532 333567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC---CceEEeeeccccccCCC
Q 046728 89 IVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD---FEAKVADFGFAKLIPDG 159 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~---~~~kL~Dfg~~~~~~~~ 159 (325)
+|||||++|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++.. +.+||+|||++......
T Consensus 113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 9999999999999884 4466667788999999999999975 7999999999764 45999999999876543
Q ss_pred cceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 160 VTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 160 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
.. .....||+.|+|||++. ..++.++||||+||++|+|++|..||....... ....+. .+.+ ..
T Consensus 193 ~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~----~~~~------~~ 256 (494)
T 3lij_A 193 KK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE---ILRKVE----KGKY------TF 256 (494)
T ss_dssp BC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HTCC------CC
T ss_pred cc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hCCC------CC
Confidence 22 23456999999999986 578999999999999999999999997643211 111111 1100 01
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
..+.+...++.+.+||.+||..||++|||+.++++ ||+...
T Consensus 257 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 257 DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 11222456778999999999999999999999998 887653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=297.52 Aligned_cols=254 Identities=19% Similarity=0.234 Sum_probs=194.0
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
-..|.+.+.||.| +++.||.+....+++.||+|.+... .......+.+|+.++++++||||+++++++......+
T Consensus 33 ~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 33 FGPYRLRRLVGRG--GMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp -CCEEEEEEEEEC--SSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eccEEEEEEEcCC--CCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 3568899999999 7788999999999999999999643 2334468889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 89 IVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
+||||+++++|.+++. ..++...++.+..++..++.++|.. +||||+||+++.++.++|+|||++.........
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 9999999999999995 3466677788899999999999975 799999999999999999999999876554333
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
......++..|+|||++.+..++.++||||||+++|+|++|..||...... ....... .. . .....
T Consensus 191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~----~~-~------~~~~~ 256 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGAHIN----QA-I------PRPST 256 (309)
T ss_dssp ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHHHHH----SC-C------CCGGG
T ss_pred cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHHHhc----cC-C------CCccc
Confidence 333456899999999999888999999999999999999999999753221 1111110 00 0 00112
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcccC
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRP-TMTDVVDWLKGGLG 281 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rp-s~~~il~~l~~~~~ 281 (325)
.+..+++.+.+||.+||..||++|| |++++++.|+..+.
T Consensus 257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 2345567899999999999999999 99999999987764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=300.94 Aligned_cols=262 Identities=20% Similarity=0.308 Sum_probs=199.1
Q ss_pred cchhHHhhccCccceeeeeEEEe----ccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC--C
Q 046728 13 SPAVFIQNINNGLEILMLLLLLR----RETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG--D 85 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~----~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 85 (325)
..|.+++.||.| +++.||+++ +..+++.||+|.+... .......+.+|++++++++||||+++++++.+. .
T Consensus 21 ~~~~~~~~lg~G--~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 21 RFLKRIRDLGEG--HFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGEEEEEEEEEC--SSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhccCCC--CceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 457888999999 778888888 6778899999999743 334456889999999999999999999999876 6
Q ss_pred eEEEEEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCC
Q 046728 86 ERLIVYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 158 (325)
..++||||+++|+|.+++. ..++...++.+..++..++.++|.. +||||+||+++.++.++|+|||++.....
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 6899999999999999993 2356666778888999999999975 79999999999999999999999987765
Q ss_pred Ccc--eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccc---ccccccc
Q 046728 159 GVT--HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYV---QKGAFEH 233 (325)
Q Consensus 159 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~ 233 (325)
... .......+|..|+|||++.+..++.++||||||+++|+|++|..|+..... .......+.. .......
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGGGHHHHHHH
T ss_pred CCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCcccccCHHHHHH
Confidence 432 223345578889999999988899999999999999999999998743110 0000000000 0000000
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 234 IADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
..........+..+++.+.+||.+||..||++|||+.++++.|+.++
T Consensus 255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 00111122344567789999999999999999999999999998754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=303.62 Aligned_cols=242 Identities=21% Similarity=0.282 Sum_probs=193.4
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|..++.||.| +++.||++++..+++.||||.+... .......+.+|+.++++++||||+++++++.+....++|
T Consensus 55 ~y~~~~~lG~G--~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 55 LFSDLREIGHG--SFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HEEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred heeeeeEEccC--CCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 36677889888 8888999999999999999999643 233445788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 91 YDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 91 ~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
|||+. |+|.+++. ..++...+..+..++..++.++|.. |||||+|||++.++.+||+|||++......
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---- 207 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 207 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC----
Confidence 99996 68888873 3456666778888999999999975 799999999999999999999999865432
Q ss_pred eccCCCCcCCCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 164 TTRVKGTLGYLAPEYAM---WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
....||+.|+|||++. ...++.++|||||||++|+|++|..||....... .... .... ...
T Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---~~~~---~~~~---------~~~ 271 (348)
T 1u5q_A 208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYH---IAQN---------ESP 271 (348)
T ss_dssp -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHH---HHHS---------CCC
T ss_pred -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHH---HHhc---------CCC
Confidence 2346899999999985 4578999999999999999999999996543211 1000 0000 001
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
.......++.+.+||.+||..||++|||++++++ |+..
T Consensus 272 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 272 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 1112345678999999999999999999999998 7764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=315.33 Aligned_cols=254 Identities=19% Similarity=0.288 Sum_probs=202.3
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh-------------hhHHHHHHHHHHHHccCCCCccc
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA-------------KAEMEFAVEVEILGRVRHRNLLG 76 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~ 76 (325)
.+...|.++++||.| +++.||++++..+++.||+|.+..... .....+.+|+.++++++||||++
T Consensus 33 ~i~~~Y~~~~~lG~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 110 (504)
T 3q5i_A 33 KIGESYFKVRKLGSG--AYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK 110 (504)
T ss_dssp CGGGTEEEEEEEEC----CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred CcccceEEEeEeccc--CCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 456788999999999 888899999999999999999965321 23457889999999999999999
Q ss_pred eeeEEEcCCeEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC---ceEE
Q 046728 77 LRGFYAGGDERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF---EAKV 147 (325)
Q Consensus 77 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~---~~kL 147 (325)
+++++.+....++|||||++|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++.++ .+||
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 9999999999999999999999999983 4567777888999999999999975 79999999998775 6999
Q ss_pred eeeccccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccc
Q 046728 148 ADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQ 227 (325)
Q Consensus 148 ~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 227 (325)
+|||++........ .....||+.|+|||++. ..++.++||||+||++|+|++|..||....... ....+..
T Consensus 191 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~--- 261 (504)
T 3q5i_A 191 VDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD---IIKKVEK--- 261 (504)
T ss_dssp CCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH---
T ss_pred EECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHc---
Confidence 99999987655322 23456999999999987 568999999999999999999999997643211 1111111
Q ss_pred ccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 228 KGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
+.+. ...+.+...++.+.+||.+||..||.+|||++++++ ||+....
T Consensus 262 -~~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 262 -GKYY------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp -CCCC------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred -CCCC------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 0000 000111345678999999999999999999999998 9986543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=306.74 Aligned_cols=268 Identities=16% Similarity=0.195 Sum_probs=188.8
Q ss_pred ceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC
Q 046728 7 ICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG 84 (325)
Q Consensus 7 ~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (325)
..+.+...|.+++.||.| +++.||.+.+..+++.||||.+... ......++.+|+.+++.++||||+++++++...
T Consensus 23 ~~~~~~~~y~~~~~lG~G--~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 100 (367)
T 2fst_X 23 TIWEVPERYQNLSPVGSG--AYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 100 (367)
T ss_dssp EEEEEETTEEEEEECC------CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred cccCCCCceEEeeEEeec--CCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 467888999999999999 8888999999999999999999642 345566888999999999999999999998654
Q ss_pred ------CeEEEEEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccc
Q 046728 85 ------DERLIVYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFA 153 (325)
Q Consensus 85 ------~~~~lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~ 153 (325)
...++|||++ +++|.++++ ..++...+..+..++..++.++|.. |||||+|||++.++.+||+|||++
T Consensus 101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 101 RSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp SSGGGCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred CccccCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 5679999999 789999885 4466667788889999999999975 799999999999999999999999
Q ss_pred cccCCCcceeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccc
Q 046728 154 KLIPDGVTHMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFE 232 (325)
Q Consensus 154 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (325)
+..... .....+|..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+...........+.
T Consensus 180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 180 RHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred cccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 865432 223468999999999876 578999999999999999999999997643211111110000000000000
Q ss_pred cccCc----------cccC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 233 HIADP----------RLKG----KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 233 ~~~~~----------~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
.+... .... ......++.+.+||.+||..||++|||+.++++ ||+....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 00000 0000 001234578999999999999999999999998 8886543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=292.41 Aligned_cols=247 Identities=24% Similarity=0.379 Sum_probs=198.7
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..|.+.+.||.| +++.||++.+..+++.||+|.+.... ......+.+|+.++++++||||+++++++.+....++
T Consensus 9 ~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 9 EDFEIGRPLGKG--KFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp GGEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccEEEeeEEecC--CCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 567888999999 88889999999999999999986422 2234578899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 90 VYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 90 V~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||||+++|+|.+++. ..++...++.+..++..++.++|.. +||||+||+++.++.++|+|||++.......
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~--- 163 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--- 163 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc---
Confidence 999999999999994 4466667788889999999999975 7999999999999999999999986544322
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.....++..|+|||++.+..++.++||||||+++|+|++|..||......... ..+. . .....
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~----~----------~~~~~ 226 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY---KRIS----R----------VEFTF 226 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHHH----H----------TCCCC
T ss_pred ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH---HHHH----h----------CCCCC
Confidence 23346899999999999888999999999999999999999999753321111 1000 0 01122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
+...++.+.+||.+||..||++|||++++++ ||+....
T Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 227 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 3345678999999999999999999999998 9886543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=297.55 Aligned_cols=267 Identities=19% Similarity=0.223 Sum_probs=193.4
Q ss_pred ceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-----hhhHHHHHHHHHHHHccC---CCCcccee
Q 046728 7 ICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-----AKAEMEFAVEVEILGRVR---HRNLLGLR 78 (325)
Q Consensus 7 ~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~~iv~~~ 78 (325)
+.-.+...|.+++.||.| +++.||++++..+++.||+|.+.... ......+.+|+++++.++ ||||++++
T Consensus 3 ~g~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~ 80 (308)
T 3g33_A 3 LGSMATSRYEPVAEIGVG--AYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLM 80 (308)
T ss_dssp -------CCEEEEEECCS--SSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred CCcccccceEEEEEEecC--CCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEee
Confidence 344567789999999999 88889999999999999999986322 112235667777777764 99999999
Q ss_pred eEEEcCC-----eEEEEEEecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCce
Q 046728 79 GFYAGGD-----ERLIVYDYMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEA 145 (325)
Q Consensus 79 ~~~~~~~-----~~~lV~e~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~ 145 (325)
+++.... ..++||||+. |+|.+++... +++..+..+..++..++.++|.. |||||+|||++.++.+
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 81 DVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp EEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCE
T ss_pred eeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCE
Confidence 9997755 4789999996 5999999543 56667788899999999999975 7999999999999999
Q ss_pred EEeeeccccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccc
Q 046728 146 KVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPY 225 (325)
Q Consensus 146 kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 225 (325)
||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+......
T Consensus 160 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 160 KLADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp EECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EEeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999986654322 23456899999999999889999999999999999999999999754322111111100000
Q ss_pred cccccccccc---Ccccc-------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 226 VQKGAFEHIA---DPRLK-------GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 226 ~~~~~~~~~~---~~~~~-------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
.....+.... ..... ....+..++.+.+||.+||..||++|||+.++++ ||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 0000000000 00000 0011245678999999999999999999999998 7764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=311.75 Aligned_cols=242 Identities=29% Similarity=0.371 Sum_probs=194.1
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC-eEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD-ERLIVY 91 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lV~ 91 (325)
+.|.+.+.||.| +++.||++... ++.||||.++... ....+.+|+.+|++++||||+++++++.+.. ..++||
T Consensus 193 ~~~~~~~~lG~G--~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 193 KELKLLQTIGKG--EFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGEEEEEEEEEC--SSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred HHeEEEeeecCc--CCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 456778899999 77778887654 6799999997643 4468999999999999999999999987665 789999
Q ss_pred EecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 92 DYMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 92 e~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
|||++|+|.++++.. ++...++.+..+++.++.++|.. |||||+|||++.++.+||+|||+++......
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 343 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 343 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc---
Confidence 999999999999532 34555677888999999999975 7999999999999999999999998543321
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
....++..|+|||++.+..++.++|||||||++|||++ |..||...+.......+. .+.+..
T Consensus 344 -~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~----------------~~~~~~ 406 (450)
T 1k9a_A 344 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE----------------KGYKMD 406 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH----------------TTCCCC
T ss_pred -cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----------------cCCCCC
Confidence 12346889999999998899999999999999999998 999997654432211110 111223
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
.+..+++.+.+||.+||..||++|||+.++++.|+.+.
T Consensus 407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 34566789999999999999999999999999998765
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=301.04 Aligned_cols=252 Identities=20% Similarity=0.263 Sum_probs=185.4
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCC---eEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDD---QIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~---~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
...|.+.+.||.| +++.||.++...++. .||+|.+... ......++.+|++++++++||||+++++++.....
T Consensus 22 ~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 22 EQQFTLGRMLGKG--EFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp ---CEEEEEEEEE--TTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred hhHeEEeceeccc--CCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 3567889999999 778899998777764 8999999753 34556789999999999999999999999987765
Q ss_pred E------EEEEEecCCCChhhhhcc--------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEe
Q 046728 87 R------LIVYDYMPNHSLITHLHG--------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVA 148 (325)
Q Consensus 87 ~------~lV~e~~~~gsL~~~l~~--------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~ 148 (325)
. ++||||+.+|+|.+++.. .++...++.+..++..++.++|.. |||||+|||++.++.+||+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEe
Confidence 5 999999999999999942 255566778888999999999975 7999999999999999999
Q ss_pred eeccccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccc
Q 046728 149 DFGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYV 226 (325)
Q Consensus 149 Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~ 226 (325)
|||++......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.............
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~------ 253 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI------ 253 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH------
T ss_pred eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh------
Confidence 99999866543222 1223346788999999998899999999999999999999 899997644321111100
Q ss_pred cccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 227 QKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
. ......+...++.+.+|+.+||..||++|||+.++++.|++++.
T Consensus 254 -~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 254 -G---------GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp -T---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -c---------CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0 00112334566789999999999999999999999999988764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=297.20 Aligned_cols=258 Identities=18% Similarity=0.255 Sum_probs=193.4
Q ss_pred eeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecc---cChhhHHHHHHHHHHHHccCCCCccceeeEEEcC
Q 046728 8 CFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKT---LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG 84 (325)
Q Consensus 8 ~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (325)
.+..-..|.+.+.||.| +++.||.+....+++.||+|.+.. ........+.+|+.++++++||||+++++++...
T Consensus 27 ~~~~~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 104 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRG--QFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED 104 (310)
T ss_dssp TTSSGGGEEEEEEEECC----CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred ccccccceEEEEeecCC--CCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 34445678899999999 888899999989999999999864 2355566889999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhcc------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccc
Q 046728 85 DERLIVYDYMPNHSLITHLHG------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
...++||||+.+++|.+++.. .++...++.+..++..++.++|.. +||||+||+++.++.++|+|||++.
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 184 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence 999999999999999999842 255566777888999999999875 7999999999999999999999988
Q ss_pred ccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccc
Q 046728 155 LIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHI 234 (325)
Q Consensus 155 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (325)
........ .....++..|+|||++.+..++.++||||||+++|+|++|..||........ .....+ ....
T Consensus 185 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~----~~~~---- 254 (310)
T 2wqm_A 185 FFSSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKKI----EQCD---- 254 (310)
T ss_dssp ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HHHHHH----HTTC----
T ss_pred eecCCCcc-ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HHHHHh----hccc----
Confidence 65443221 2234589999999999988899999999999999999999999975432111 111110 0111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 235 ADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.........++.+.+||.+||..||++|||+.++++.|+.+..
T Consensus 255 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 255 ----YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp ----SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 1111123456789999999999999999999999998887654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=308.93 Aligned_cols=269 Identities=17% Similarity=0.183 Sum_probs=187.5
Q ss_pred eeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEc--
Q 046728 8 CFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG-- 83 (325)
Q Consensus 8 ~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 83 (325)
.+.+...|.+++.||.| +++.||++++..+++.||||.+... ......++.+|+.+++.++||||+++++++..
T Consensus 48 ~~~~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 48 DWQIPDRYEIRHLIGTG--SYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD 125 (458)
T ss_dssp SCCSCTTEEECCC---------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred cCccCCCeEEeeEeeec--CCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 35567789999999999 8888999999999999999998642 44556789999999999999999999999843
Q ss_pred ---CCeEEEEEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccc
Q 046728 84 ---GDERLIVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 84 ---~~~~~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
...+|+||||+ +|+|.++++. .+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||+++
T Consensus 126 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 126 VEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp TTTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred cccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccch
Confidence 35689999998 5799999853 366677788999999999999975 8999999999999999999999998
Q ss_pred ccCCCcc--------------------------eeeccCCCCcCCCCcccc-ccCCCCCcccchhHHHHHHHHHh-----
Q 046728 155 LIPDGVT--------------------------HMTTRVKGTLGYLAPEYA-MWGKVSDSCDVYSFGVLLLELIS----- 202 (325)
Q Consensus 155 ~~~~~~~--------------------------~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~el~t----- 202 (325)
....... .......||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 7643211 112334689999999976 45679999999999999999999
Q ss_pred ------CCCCCCCCCCCcc-----------------chhhhhhccc---cccc---------------ccccccCccccC
Q 046728 203 ------AKKPLEKLPGGVK-----------------RDIVQWVTPY---VQKG---------------AFEHIADPRLKG 241 (325)
Q Consensus 203 ------g~~pf~~~~~~~~-----------------~~~~~~~~~~---~~~~---------------~~~~~~~~~~~~ 241 (325)
|.++|.+...... .+....+... .... .+....... ..
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 363 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTD-LA 363 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCC-GG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCC-HH
Confidence 5555543221000 0000000000 0000 000000000 00
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
...+..++.+.+||.+||..||++|||++++++ ||+...
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 112344778999999999999999999999999 998764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=318.65 Aligned_cols=249 Identities=21% Similarity=0.283 Sum_probs=202.6
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..|.+++.||.| +++.||++++..+++.||+|.+.... ......+.+|++++++++||||+++++++.+....|+
T Consensus 184 ~~f~~~~~LG~G--~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 184 NTFRQYRVLGKG--GFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp GGEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEeeC--CCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 457788899998 78889999999999999999996421 2334568899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 90 VYDYMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
||||++||+|.+++... +++..+..+..++..++.++|.+ |||||+|||++.++.+||+|||++........
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~ 341 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence 99999999999998532 56666777888999999999985 79999999999999999999999987654332
Q ss_pred eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhh-hhhcccccccccccccCcccc
Q 046728 162 HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIV-QWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 240 (325)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+ ..+.. ..
T Consensus 342 --~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~--------------~~ 405 (576)
T 2acx_A 342 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--------------VP 405 (576)
T ss_dssp --EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH--------------CC
T ss_pred --ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc--------------cc
Confidence 23347999999999999888999999999999999999999999764332211111 11100 01
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH--HHhcc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRP-----TMTDVVD--WLKGG 279 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~~ 279 (325)
...+..+++++.+||.+||..||++|| +++++++ ||+..
T Consensus 406 ~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 406 EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 123345678999999999999999999 7899998 88753
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=291.42 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=196.0
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhh-------HHHHHHHHHHHHccCCCCccceeeEE
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKA-------EMEFAVEVEILGRVRHRNLLGLRGFY 81 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (325)
......|.+.+.||.| +++.||.++...+++.||+|.+....... ...+.+|+.++++++||||+++++++
T Consensus 15 ~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKG--GFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp BCCSTTEEEEEECCCC--SSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhccceehhccccC--CceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 3445778899999999 78889999999999999999986432211 15788999999999999999999999
Q ss_pred EcCCeEEEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc------CCCCCCceeeCCCCc-----eEE
Q 046728 82 AGGDERLIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI------ADIKASNVLLDTDFE-----AKV 147 (325)
Q Consensus 82 ~~~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~------rdlkp~Nil~~~~~~-----~kL 147 (325)
.+.. ++||||+++|+|.+++.. .++....+.+..++..++.++|.. |||||+||+++.++. +||
T Consensus 93 ~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 93 HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 7655 799999999999998842 345556677888888999988864 699999999987776 999
Q ss_pred eeeccccccCCCcceeeccCCCCcCCCCccccc--cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccc
Q 046728 148 ADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAM--WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPY 225 (325)
Q Consensus 148 ~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 225 (325)
+|||++...... .....||+.|+|||++. ...++.++|||||||++|+|++|..||............. .
T Consensus 171 ~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-~--- 242 (287)
T 4f0f_A 171 ADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM-I--- 242 (287)
T ss_dssp CCCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH-H---
T ss_pred CCCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH-H---
Confidence 999999854332 23456899999999984 4457889999999999999999999997654322111110 0
Q ss_pred ccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 226 VQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
.........+..+++.+.+||.+||..||++|||++++++.|+++
T Consensus 243 ---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 ---------REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ---------HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ---------hccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 011112233456678899999999999999999999999999753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=302.82 Aligned_cols=251 Identities=23% Similarity=0.294 Sum_probs=190.3
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD 85 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (325)
..+...|.+.+.||.| +++.||++++..+++.||||.+... ......++.+|+.++++++||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 8 SHLSDRYELGEILGFG--GMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85 (311)
T ss_dssp SEETTTEEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred ceecCcEEEEEEEccC--CCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence 3466788999999999 8888999999999999999999753 3444567889999999999999999999986654
Q ss_pred e----EEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccc
Q 046728 86 E----RLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 86 ~----~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
. .|+||||+++++|.++++ ..++...++.+..++..++.++|.. |||||+|||++.++.+||+|||++..
T Consensus 86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 3 499999999999999994 4466777888899999999999975 79999999999999999999999986
Q ss_pred cCCCcce--eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccc
Q 046728 156 IPDGVTH--MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEH 233 (325)
Q Consensus 156 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (325)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||........ ...... ..
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~~~----~~---- 235 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHVR----ED---- 235 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHH----CC----
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhc----CC----
Confidence 6543221 22334589999999999988999999999999999999999999965332110 000000 00
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 234 IADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
...........++++.+||.+||..||++||++.+++.
T Consensus 236 ---~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 236 ---PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp ---CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred ---CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 00000111235678999999999999999998777775
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=297.50 Aligned_cols=251 Identities=19% Similarity=0.284 Sum_probs=205.0
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
....|.+.+.||.| +++.||.+.+..+++.||+|.+... .......+.+|+.++++++||||+++++++.+.+..
T Consensus 39 ~~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 39 SRRRYVRGRFLGKG--GFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTEEEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEeeC--CCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 45678889999999 7778999999999999999998643 345566888999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 88 LIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
++||||+.+++|.+++. ..++...++.+..++..++.++|.. +||||+||+++.++.++|+|||++........
T Consensus 117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 99999999999999984 4467777888899999999999975 79999999999999999999999987653322
Q ss_pred eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 162 HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
. .....||..|+|||++.+..++.++||||||+++|+|++|..||....... ....+. .. ..
T Consensus 197 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~----~~----------~~ 258 (335)
T 2owb_A 197 R-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYLRIK----KN----------EY 258 (335)
T ss_dssp C-BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHH----HT----------CC
T ss_pred c-ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHh----cC----------CC
Confidence 2 233468999999999998889999999999999999999999996532111 111000 00 01
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
..+...++.+.+||.+||..||++|||++++++ ||.....
T Consensus 259 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 259 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 122345678999999999999999999999998 8886543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=306.83 Aligned_cols=246 Identities=22% Similarity=0.283 Sum_probs=189.3
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHH-HHccCCCCccceeeEEEcCCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEI-LGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
..|.+++.||.| +++.||++++..+++.||+|.+.+.. ......+..|..+ ++.++||||+++++++.+....|
T Consensus 38 ~~y~~~~~lG~G--~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 38 SDFHFLKVIGKG--SFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp GGEEEEEEEECC--TTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred hheEEEEEEeeC--CCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 568899999999 78889999999999999999996532 2334466677776 56789999999999999999999
Q ss_pred EEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 89 IVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
+||||++||+|.++++ ..+.+..+..+..++..++.++|.+ |||||+|||++.++.+||+|||+++...... .
T Consensus 116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-~ 194 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-S 194 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-C
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC-C
Confidence 9999999999999994 3466667778889999999999985 7999999999999999999999998643322 1
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+. . . ...
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~i~----~--------~--~~~ 257 (373)
T 2r5t_A 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNIL----N--------K--PLQ 257 (373)
T ss_dssp CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH---HHHHHHH----H--------S--CCC
T ss_pred ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHH----h--------c--ccC
Confidence 234457999999999999889999999999999999999999999753321 1111110 0 0 011
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHH--HHhc
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTM----TDVVD--WLKG 278 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~----~~il~--~l~~ 278 (325)
.+...+..+.+||.+||..||.+||++ +++++ ||+.
T Consensus 258 ~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 258 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 233466789999999999999999997 45555 5554
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=297.86 Aligned_cols=242 Identities=19% Similarity=0.238 Sum_probs=188.1
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 89 (325)
..|.++++||.| +++.||+++...+++.||||.+... ......+...|+..+.++ +||||+++++++.++...++
T Consensus 57 ~~y~~~~~LG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHG--SYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHEEEEEEEEEE--TTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hheeeeheeccC--CCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 557788889998 8888999999999999999998642 334444556666666666 89999999999999999999
Q ss_pred EEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 90 VYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 90 V~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
||||+ +++|.+++. ..++...++.+..++..++.++|.. |||||+|||++.++.+||+|||++........
T Consensus 135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~- 212 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA- 212 (311)
T ss_dssp EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC-
Confidence 99999 679999884 2366667778888999999999975 79999999999999999999999987654322
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ... +........
T Consensus 213 -~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~------~~~------------~~~~~~~~~ 272 (311)
T 3p1a_A 213 -GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG------WQQ------------LRQGYLPPE 272 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH------HHH------------HTTTCCCHH
T ss_pred -CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHH------------HhccCCCcc
Confidence 334468999999999875 789999999999999999999776643110 000 001111111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
.+...++.+.+||.+||..||++|||++++++ ||++
T Consensus 273 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 273 FTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 22345678999999999999999999999998 7753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=294.10 Aligned_cols=250 Identities=20% Similarity=0.323 Sum_probs=194.5
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
.+...|.+.+.||.| +++.||+++...++..||+|.+... .......+.+|++++++++||||+++++++.+....+
T Consensus 19 ~i~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 19 TIDDLFIFKRKLGSG--AFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp CHHHHEEEEEEEEEC--SSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ChhhheeecceeccC--CCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence 466778899999999 8888999999999999999998643 2334568899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhc------cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceee---CCCCceEEeeeccccc
Q 046728 89 IVYDYMPNHSLITHLH------GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLL---DTDFEAKVADFGFAKL 155 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~------~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~---~~~~~~kL~Dfg~~~~ 155 (325)
+||||+++|+|.+++. ..+++..++.+..++..++.++|.. |||||+||++ +.++.++|+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 9999999999999883 3356666788889999999999975 7999999999 4557899999999986
Q ss_pred cCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccccc
Q 046728 156 IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIA 235 (325)
Q Consensus 156 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (325)
...... .....+|..|+|||++. ..++.++||||||+++|+|++|..||................
T Consensus 177 ~~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~------------ 241 (285)
T 3is5_A 177 FKSDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE------------ 241 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------
T ss_pred cCCccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC------------
Confidence 544322 23346899999999886 568899999999999999999999997543211111100000
Q ss_pred CccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 236 DPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
... .......++.+.+||.+||..||++|||+.++++ ||++
T Consensus 242 -~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 242 -PNY-AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp -CCC-CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred -ccc-ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 000 0011224568899999999999999999999998 7764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=294.67 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=199.0
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
+.|.+++.||.| +++.||.+... +++.||+|.+..... ....+.+|+.++++++||||+++++++.+....++|||
T Consensus 8 ~~y~~~~~lg~G--~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 8 SELTFVQEIGSG--QFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGEEEEEEEEEE--TTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hheeeeeEecCC--CceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 567889999999 77778888765 567899999975432 34578999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 93 YMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 93 ~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
|+++++|.+++.. .++...++.+..++..++.++|.. +||||+||+++.++.++|+|||++............
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence 9999999999953 255666777888899999999875 799999999999999999999999876543322233
Q ss_pred cCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 166 RVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
...++..|+|||++.+..++.++||||||+++|+|++ |..||....... ....+.. ......+
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~i~~-------------~~~~~~~ 227 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDIST-------------GFRLYKP 227 (267)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHT-------------TCCCCCC
T ss_pred cccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---HHHHHhc-------------CCcCCCC
Confidence 3456788999999998889999999999999999999 899997533211 1111100 0011223
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
...++.+.+|+.+||..||++|||+.++++.|+.+..
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3456789999999999999999999999999987653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=301.97 Aligned_cols=268 Identities=21% Similarity=0.292 Sum_probs=199.7
Q ss_pred cccch-hHHhhccCccceeeeeEEE----eccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEc-
Q 046728 11 LASPA-VFIQNINNGLEILMLLLLL----RRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG- 83 (325)
Q Consensus 11 ~~~~~-~~~~~i~~G~~~~~~v~~~----~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 83 (325)
+...| .+++.||.| +++.||++ .+..+++.||||.+... .......+.+|++++++++||||+++++++.+
T Consensus 28 ~~~r~~~~~~~lG~G--~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEG--HFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CCGGGEEEEEEEEEC--SSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ecHHHHhhhheecCC--CCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 34444 899999999 66667543 45567889999999753 34556689999999999999999999999987
Q ss_pred -CCeEEEEEEecCCCChhhhhcc-CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccC
Q 046728 84 -GDERLIVYDYMPNHSLITHLHG-RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIP 157 (325)
Q Consensus 84 -~~~~~lV~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~ 157 (325)
....++||||+++|+|.+++.. .++...++.+..++..++.++|.. +||||+||+++.++.++|+|||++....
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred CCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 4678999999999999999953 466667788888999999999975 7999999999999999999999998776
Q ss_pred CCcce--eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccccc
Q 046728 158 DGVTH--MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIA 235 (325)
Q Consensus 158 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (325)
..... ......+|..|+|||++.+..++.++||||||+++|+|++|..||........ ....+..............
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHH
Confidence 54322 22334578889999999988899999999999999999999999864221000 0000000000000000111
Q ss_pred CccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 236 DPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
........+..+++.+.+||.+||..||++|||+.++++.|+.+..
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1122233445667899999999999999999999999999887653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=292.27 Aligned_cols=246 Identities=17% Similarity=0.227 Sum_probs=178.3
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..|.+.+.||.| +++.||.++...+++.||+|.+.... .....++.+|+.++++++||||+++++++.+....++
T Consensus 11 ~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 11 EDFKVGNLLGKG--SFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp GGEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccceeeeeecCC--CceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 457888999999 78889999998899999999996432 1224678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 90 VYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
||||+++++|.+++.. .++...++.+..++..++.++|.. +||||+||+++.++.++|+|||++.........
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence 9999999999999954 355666778889999999999975 799999999999999999999999876533221
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
.....+|+.|+|||++.+..++.++||||||+++|+|++|..||.......... ...... ..
T Consensus 169 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---------------~~~~~~--~~ 230 (278)
T 3cok_A 169 -HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN---------------KVVLAD--YE 230 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC--CC
T ss_pred -ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH---------------HHhhcc--cC
Confidence 223458999999999998889999999999999999999999997543211100 000000 11
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
.+...+.++.+||.+||..||++|||++++++ ||..
T Consensus 231 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 231 MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred CccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence 23345678999999999999999999999998 7754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=303.78 Aligned_cols=261 Identities=20% Similarity=0.269 Sum_probs=197.6
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-----CCCccceeeEEEc
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-----HRNLLGLRGFYAG 83 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~ 83 (325)
..+...|.+++.||.| +++.||++++..+++.||||.+.. .......+..|+.+++.+. ||||+++++++..
T Consensus 31 ~~~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDG--TFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp CEETTTEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred eEecCEEEEEEEEccc--CCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 3456778999999999 888899999999999999999975 3444557788999999986 9999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC--------------
Q 046728 84 GDERLIVYDYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT-------------- 141 (325)
Q Consensus 84 ~~~~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~-------------- 141 (325)
.+..++||||+ +++|.+++.. .++...+..+..++..++.++|.. |||||+|||++.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence 99999999999 8999999953 255566778889999999999975 799999999975
Q ss_pred -----------CCceEEeeeccccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 046728 142 -----------DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKL 210 (325)
Q Consensus 142 -----------~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 210 (325)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 788999999999865432 22356899999999999989999999999999999999999999754
Q ss_pred CCCccchhhhhhcccccccc---------cccccCccccCC--------------------CCHHHHHHHHHHHHHccCC
Q 046728 211 PGGVKRDIVQWVTPYVQKGA---------FEHIADPRLKGK--------------------FNRDQLKSMVLIALRCTDS 261 (325)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~--------------------~~~~~~~~~~~li~~cl~~ 261 (325)
........+........... ............ .....++.+.+||.+||..
T Consensus 263 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 342 (360)
T 3llt_A 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI 342 (360)
T ss_dssp SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence 32211111111000000000 000000000000 0011126788999999999
Q ss_pred CCCCCCCHHHHHH--HHh
Q 046728 262 NPENRPTMTDVVD--WLK 277 (325)
Q Consensus 262 dp~~Rps~~~il~--~l~ 277 (325)
||++|||+.++++ ||+
T Consensus 343 dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 343 DPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SGGGSCCHHHHTTSGGGC
T ss_pred ChhhCCCHHHHhcCcccC
Confidence 9999999999997 653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=301.70 Aligned_cols=273 Identities=19% Similarity=0.247 Sum_probs=205.6
Q ss_pred eeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC--
Q 046728 8 CFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG-- 84 (325)
Q Consensus 8 ~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 84 (325)
.+.+...|.+++.||.| +++.||++.+..+++.||||.+... .......+.+|++++++++||||+++++++...
T Consensus 22 ~~~~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 22 VFDVGPRYTNLSYIGEG--AYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp BCCCTTTEEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred eccccccEEEEEEeecC--CCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 46677889999999999 8888999999999999999999743 344456888999999999999999999998654
Q ss_pred ---CeEEEEEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccccc
Q 046728 85 ---DERLIVYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLI 156 (325)
Q Consensus 85 ---~~~~lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~ 156 (325)
...++||||+. |+|.++++ ..++...+..+..++..++.++|.. |||||+|||++.++.+||+|||++...
T Consensus 100 ~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 100 EQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cccceEEEEEcccC-cCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 46899999996 59999985 4466777788899999999999975 799999999999999999999999876
Q ss_pred CCCccee--eccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccc-
Q 046728 157 PDGVTHM--TTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFE- 232 (325)
Q Consensus 157 ~~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 232 (325)
....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...........+.
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 5432211 233468999999998764 458999999999999999999999997644322211111000000000000
Q ss_pred -----------cccCcc-c-cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccCCC
Q 046728 233 -----------HIADPR-L-KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLGRR 283 (325)
Q Consensus 233 -----------~~~~~~-~-~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~~~ 283 (325)
...... . ........++.+.+||.+||..||++|||+.++++ ||+......
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~ 324 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcc
Confidence 000000 0 00011235678999999999999999999999998 998775433
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=304.49 Aligned_cols=243 Identities=21% Similarity=0.301 Sum_probs=198.8
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh--------hhHHHHHHHHHHHHccCCCCccceeeEEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA--------KAEMEFAVEVEILGRVRHRNLLGLRGFYA 82 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (325)
+...|.+++.||.| +++.||++.+..+++.||||.+..... .....+.+|+.++++++||||+++++++.
T Consensus 22 ~~~~y~~~~~lG~G--~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 22 YSQKYSTMSPLGSG--AFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp HHHHEEEEEECSSS--SSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccceEEEeEEEec--CCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 45678888999999 788899999999999999999975321 12336778999999999999999999999
Q ss_pred cCCeEEEEEEecCCC-Chhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccc
Q 046728 83 GGDERLIVYDYMPNH-SLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 83 ~~~~~~lV~e~~~~g-sL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
+....++||||+.+| +|.+++.. .+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||++..
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 999999999999776 99999953 466667778889999999999975 79999999999999999999999987
Q ss_pred cCCCcceeeccCCCCcCCCCccccccCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccc
Q 046728 156 IPDGVTHMTTRVKGTLGYLAPEYAMWGKV-SDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHI 234 (325)
Q Consensus 156 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (325)
...... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ..
T Consensus 180 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------~~-------- 237 (335)
T 3dls_A 180 LERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------TV-------- 237 (335)
T ss_dssp CCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------GT--------
T ss_pred CCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------HH--------
Confidence 655432 223468999999999987776 7789999999999999999999964211 00
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 235 ADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
... ...+...++++.+||.+||..||++|||++++++ ||+...
T Consensus 238 -~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 238 -EAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp -TTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred -hhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 000 0112235678999999999999999999999999 887644
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=304.49 Aligned_cols=272 Identities=19% Similarity=0.219 Sum_probs=200.2
Q ss_pred ceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC
Q 046728 7 ICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG 84 (325)
Q Consensus 7 ~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (325)
-.+.+...|.+++.||.| +++.||.+.+..+++.||||.+... ......++.+|+.++++++||||+++++++...
T Consensus 20 ~~~~i~~~y~~~~~lG~G--~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 97 (432)
T 3n9x_A 20 KNVHVPDNYIIKHLIGRG--SYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPD 97 (432)
T ss_dssp GGCCCCTTEEEEEEEEEE--TTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred CcceecCCEEEEEEEeec--CCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 467888999999999999 7888999999999999999999643 345556899999999999999999999998766
Q ss_pred -----CeEEEEEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccc
Q 046728 85 -----DERLIVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFA 153 (325)
Q Consensus 85 -----~~~~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~ 153 (325)
...|+||||+. |+|.++++. .+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 98 DLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 56899999995 699999964 366777888999999999999985 799999999999999999999999
Q ss_pred cccCCCcce---------------------eeccCCCCcCCCCcccc-ccCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Q 046728 154 KLIPDGVTH---------------------MTTRVKGTLGYLAPEYA-MWGKVSDSCDVYSFGVLLLELISAKKPLEKLP 211 (325)
Q Consensus 154 ~~~~~~~~~---------------------~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 211 (325)
+........ ......||+.|+|||++ ....++.++|||||||++|||++|..||...+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~ 256 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence 876543211 12445789999999986 45679999999999999999998665553321
Q ss_pred CCcc-------------------------chhhhhhcc---cccccccccccC---------ccccCC-----CCHHHHH
Q 046728 212 GGVK-------------------------RDIVQWVTP---YVQKGAFEHIAD---------PRLKGK-----FNRDQLK 249 (325)
Q Consensus 212 ~~~~-------------------------~~~~~~~~~---~~~~~~~~~~~~---------~~~~~~-----~~~~~~~ 249 (325)
.... ......+.. ......+..+.. ...... ..+..++
T Consensus 257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 336 (432)
T 3n9x_A 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD 336 (432)
T ss_dssp GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence 1000 000000000 000000000000 000000 0134577
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 250 SMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 250 ~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
.+.+||.+||..||++|||++++++ ||+....
T Consensus 337 ~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 337 DGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 8999999999999999999999999 9987643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=298.00 Aligned_cols=256 Identities=17% Similarity=0.213 Sum_probs=198.8
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEE----cCC
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYA----GGD 85 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~ 85 (325)
-....|.+++.||.| +++.||++++..+++.||+|.+..........+.+|+.++++++||||+++++++. ...
T Consensus 26 i~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 26 IDNKHYLFIQKLGEG--GFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp ETTEEEEEEEEEEC----CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred ECCeEEEEEEEecCC--CCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 345679999999999 88889999999999999999997666677778999999999999999999999986 345
Q ss_pred eEEEEEEecCCCChhhhhcc------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccc
Q 046728 86 ERLIVYDYMPNHSLITHLHG------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
..++||||+.+|+|.+++.. .+++..++.+..++..++.++|.. |||||+||+++.++.++|+|||++..
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 78999999999999999853 255666777888999999999875 79999999999999999999999875
Q ss_pred cCCCccee--------eccCCCCcCCCCccccccCC---CCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcc
Q 046728 156 IPDGVTHM--------TTRVKGTLGYLAPEYAMWGK---VSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTP 224 (325)
Q Consensus 156 ~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~---~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 224 (325)
........ .....||..|+|||++.+.. ++.++||||||+++|+|++|..||......... ......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~- 261 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALAVQ- 261 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHHHHH-
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhHHhh-
Confidence 43211100 01234689999999987543 688999999999999999999999532110000 000000
Q ss_pred cccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 225 YVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.....+.....++.+.+||.+||..||++|||+.++++.|+.+..
T Consensus 262 ------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 262 ------------NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp ------------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred ------------ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 011112234556789999999999999999999999999987654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=317.01 Aligned_cols=253 Identities=21% Similarity=0.286 Sum_probs=204.1
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
.+...|.+.+.||.| +++.||++++..+++.||||.+... .......+.+|+.++++++||||+++++++.+...
T Consensus 23 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 100 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKG--SFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY 100 (484)
T ss_dssp CHHHHEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cccCceEEeeEEecC--CCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 345678889999999 8888999999999999999998643 23445689999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceee---CCCCceEEeeeccccccC
Q 046728 87 RLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLL---DTDFEAKVADFGFAKLIP 157 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~---~~~~~~kL~Dfg~~~~~~ 157 (325)
.++|||||.+|+|.+++. ..+++..+..+..++..++.++|.+ |||||+|||+ +.++.+||+|||++....
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 999999999999999984 4466667788899999999999975 7999999999 467899999999998765
Q ss_pred CCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 158 DGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 158 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
.... .....||+.|+|||++.+ .++.++||||+||++|+|++|..||...... .....+. .+.+
T Consensus 181 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~----~~~~------ 244 (484)
T 3nyv_A 181 ASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DILKKVE----KGKY------ 244 (484)
T ss_dssp CCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----HCCC------
T ss_pred cccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH----cCCC------
Confidence 5332 233468999999999875 7899999999999999999999999754321 1111111 1100
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
....+.+...++.+.+||.+||..||++|||+.++++ ||+...
T Consensus 245 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 245 TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 0111223456789999999999999999999999998 998654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=303.41 Aligned_cols=265 Identities=15% Similarity=0.188 Sum_probs=192.4
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhh-HHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKA-EMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
.|.+++.||.| +++.||+++...+++.||+|.+....... ...+.+|+.++++++||||+++++++.+....++|||
T Consensus 3 ~y~~~~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 3 TYIKLDKLGEG--TYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp SEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ceEEEEEEcCC--CCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 57788899999 88889999999999999999997533221 1245579999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 93 YMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 93 ~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
|+. |+|.+++.. .++...+..+..++..++.++|.. |||||+||+++.++.+||+|||++......... ..
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~-~~ 158 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-YD 158 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc-cc
Confidence 996 599998843 255566777888999999999975 799999999999999999999999865433222 22
Q ss_pred cCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccccc---------
Q 046728 166 RVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIA--------- 235 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 235 (325)
...+|..|+|||++.+ ..++.++|||||||++|+|++|..||...........+...........+....
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN 238 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence 3458999999999876 568999999999999999999999997643322111111110000011110000
Q ss_pred Ccccc----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccCC
Q 046728 236 DPRLK----GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLGR 282 (325)
Q Consensus 236 ~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~~ 282 (325)
.+... .......++.+.+||.+||..||++|||++++++ ||.+...+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 00000 0111245678999999999999999999999999 99876543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=304.95 Aligned_cols=269 Identities=18% Similarity=0.231 Sum_probs=207.6
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCC--e
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD--E 86 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 86 (325)
.+...|.+.+.||.| +++.||+++...+++.||||.+.... ......+.+|++++++++||||+++++++.... .
T Consensus 6 ~~~~~y~i~~~LG~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQG--ATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcC--CCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 346678899999999 88889999999999999999997432 334567889999999999999999999998755 6
Q ss_pred EEEEEEecCCCChhhhhccC-----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceee----CCCCceEEeeeccc
Q 046728 87 RLIVYDYMPNHSLITHLHGR-----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLL----DTDFEAKVADFGFA 153 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~~-----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~----~~~~~~kL~Dfg~~ 153 (325)
.++|||||++|+|.++++.. ++...++.+..++..++.++|.. |||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 89999999999999999532 56667788889999999999975 7999999999 77788999999999
Q ss_pred cccCCCcceeeccCCCCcCCCCcccccc--------CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCc-cchhhhhhcc
Q 046728 154 KLIPDGVTHMTTRVKGTLGYLAPEYAMW--------GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGV-KRDIVQWVTP 224 (325)
Q Consensus 154 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~ 224 (325)
........ .....||..|+|||++.+ ..++.++|||||||++|+|++|..||....... ....+..+..
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp EECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred eEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 87654322 233568999999999865 456789999999999999999999997643322 1122111111
Q ss_pred ccccccc-----------ccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCC
Q 046728 225 YVQKGAF-----------EHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGR 282 (325)
Q Consensus 225 ~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 282 (325)
....... ................++.+.++|.+||..||++|||++++++.++.++..
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 1111000 000011111234477889999999999999999999999999988887754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=299.44 Aligned_cols=254 Identities=22% Similarity=0.321 Sum_probs=198.6
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeE--EEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQI--AVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~v--aiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 88 (325)
..|.+.+.||.| +++.||.++...++..+ |+|.+... .......+.+|+.+++++ +||||+++++++.+....+
T Consensus 25 ~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEG--NFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGCEEEEEEECG--GGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHccceeeeecC--CCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 578889999999 77889999988888755 99988643 334455788999999999 8999999999999999999
Q ss_pred EEEEecCCCChhhhhcc------------------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceE
Q 046728 89 IVYDYMPNHSLITHLHG------------------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAK 146 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~------------------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~k 146 (325)
+||||+++|+|.+++.. .++...++.+..++..++.++|.. |||||+||+++.++.+|
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEE
Confidence 99999999999999953 245556677888899999999875 79999999999999999
Q ss_pred EeeeccccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhccc
Q 046728 147 VADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPY 225 (325)
Q Consensus 147 L~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~ 225 (325)
|+|||++...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||....... ....+.
T Consensus 183 L~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~~~~-- 255 (327)
T 1fvr_A 183 IADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKLP-- 255 (327)
T ss_dssp ECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHGG--
T ss_pred EcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH---HHHHhh--
Confidence 9999998743321 11222346788999999988889999999999999999998 999996543211 111110
Q ss_pred ccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCCCccc
Q 046728 226 VQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGRRTKD 286 (325)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~~~ 286 (325)
.......+...++.+.+||.+||..||++|||++++++.|+.+.......
T Consensus 256 -----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 305 (327)
T 1fvr_A 256 -----------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 305 (327)
T ss_dssp -----------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred -----------cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCc
Confidence 01112233456678999999999999999999999999998887654443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=292.62 Aligned_cols=253 Identities=19% Similarity=0.290 Sum_probs=199.5
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh------hhHHHHHHHHHHHHccCCCCccceeeEEEcC
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA------KAEMEFAVEVEILGRVRHRNLLGLRGFYAGG 84 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (325)
+...|.+++.||.| +++.||.++...+++.||+|.+..... .....+.+|+.++++++||||+++++++.+.
T Consensus 3 ~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T 3bhy_A 3 VEDHYEMGEELGSG--QFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK 80 (283)
T ss_dssp HHHHEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhhHHhhccc--CceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC
Confidence 34567889999999 788899999999999999999864321 2356889999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC----ceEEeeecccc
Q 046728 85 DERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF----EAKVADFGFAK 154 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~----~~kL~Dfg~~~ 154 (325)
...++||||+++++|.+++. ..++...+..+..++..++.++|.. +||||+||+++.++ .++|+|||++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 99999999999999999994 3466777888999999999999975 79999999998876 79999999998
Q ss_pred ccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccc
Q 046728 155 LIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHI 234 (325)
Q Consensus 155 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (325)
....... .....+++.|+|||++.+..++.++||||||+++|+|++|..||....... ....+.. ..
T Consensus 161 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~----~~---- 227 (283)
T 3bhy_A 161 KIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE---TLTNISA----VN---- 227 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHT----TC----
T ss_pred eccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH---HHHHhHh----cc----
Confidence 7654322 223458999999999998889999999999999999999999997543211 1111000 00
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 235 ADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
...........++.+.+|+.+||..||++|||+.++++ ||+...
T Consensus 228 --~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 228 --YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp --CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred --cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 00000111234568999999999999999999999998 888754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=290.17 Aligned_cols=251 Identities=19% Similarity=0.280 Sum_probs=204.6
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
.....|.+.+.||.| +++.||.++...+++.||+|.+... .......+.+|+.++++++||||+++++++.+.+.
T Consensus 12 ~~~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 89 (294)
T 2rku_A 12 RSRRRYVRGRFLGKG--GFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 89 (294)
T ss_dssp TTTEEEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcccceEEEEEEeec--CCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCE
Confidence 345677889999999 7788999999999999999998643 34556688899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 87 RLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
.++||||+.+++|.+++. ..++...++.+..++..++.++|.. +||||+||+++.++.++|+|||++.......
T Consensus 90 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 90 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 999999999999999984 4466777888899999999999975 7999999999999999999999998765332
Q ss_pred ceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 161 THMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
.. .....+|..|+|||++.+..++.++||||||+++|+|++|..||....... ...... ...
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~------------~~~-- 231 (294)
T 2rku_A 170 ER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYLRIK------------KNE-- 231 (294)
T ss_dssp CC-BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHH------------TTC--
T ss_pred cc-cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHh------------hcc--
Confidence 22 233468999999999998889999999999999999999999996533211 100000 000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
...+...++.+.+||.+||..||++|||++++++ ||.+..
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 232 YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence 1123345678999999999999999999999998 887654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=297.08 Aligned_cols=246 Identities=17% Similarity=0.268 Sum_probs=194.2
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCC-------CeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcC
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGD-------DQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG 84 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (325)
...|.+.+.||.| +++.||++....++ ..||+|.+..........+.+|+.++++++||||+++++++.++
T Consensus 7 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQG--TFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEE--TTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccC--CCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 4567888999999 77788888877766 46999999776666777899999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhccC---CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCc--------eEEee
Q 046728 85 DERLIVYDYMPNHSLITHLHGR---LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFE--------AKVAD 149 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~--------~kL~D 149 (325)
+..++||||+++|+|.+++... ++....+.+..++..++.++|.. |||||+|||++.++. ++|+|
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 9999999999999999999532 55566677888999999999875 799999999988876 99999
Q ss_pred eccccccCCCcceeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccc
Q 046728 150 FGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQK 228 (325)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 228 (325)
||++...... ....+|..|+|||++.+ ..++.++|||||||++|+|++|..|+...... ........ .
T Consensus 165 fg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~~~~~~~---~- 233 (289)
T 4fvq_A 165 PGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--QRKLQFYE---D- 233 (289)
T ss_dssp CCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHHH---T-
T ss_pred CcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch--HHHHHHhh---c-
Confidence 9998754332 12347888999999987 67899999999999999999965444322111 00000000 0
Q ss_pred cccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 229 GAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
....+...++.+.+||.+||..||++|||+.++++.|+.+..
T Consensus 234 -----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 234 -----------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp -----------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred -----------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 001112234578899999999999999999999999998875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=302.55 Aligned_cols=268 Identities=15% Similarity=0.174 Sum_probs=203.4
Q ss_pred ceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC
Q 046728 7 ICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG 84 (325)
Q Consensus 7 ~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (325)
..+.+...|.+.+.||.| +++.||++.+..+++.||||.+... ......++.+|+.+++.++||||+++++++...
T Consensus 36 ~~~~l~~~y~~~~~lG~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 113 (371)
T 4exu_A 36 TAWELPKTYVSPTHVGSG--AYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA 113 (371)
T ss_dssp EEEEEETTEEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred ceecccccEEEEeEEecC--CCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence 457788899999999999 8888999999999999999999743 344456888999999999999999999999877
Q ss_pred CeE------EEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccc
Q 046728 85 DER------LIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 85 ~~~------~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
... ++||||+. ++|.+++...+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||++.
T Consensus 114 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQ-TDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp SSSTTCCCCEEEEECCC-EEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred CCcccceeEEEEEcccc-ccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 654 99999996 699999987788888889999999999999975 7999999999999999999999998
Q ss_pred ccCCCcceeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccc
Q 046728 155 LIPDGVTHMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEH 233 (325)
Q Consensus 155 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (325)
..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..............
T Consensus 193 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 193 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 65432 233468999999999886 6789999999999999999999999975432111110000000000000000
Q ss_pred c-----------cCcccc---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 234 I-----------ADPRLK---GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 234 ~-----------~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
. ...... .......++.+.+||.+||..||++|||+.++++ ||+....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 332 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 332 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence 0 000000 0011234678999999999999999999999998 9986543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=303.78 Aligned_cols=247 Identities=21% Similarity=0.288 Sum_probs=187.7
Q ss_pred hhHH-hhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc-CCCCccceeeEEEc----CCeEE
Q 046728 15 AVFI-QNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAG----GDERL 88 (325)
Q Consensus 15 ~~~~-~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~~~~~ 88 (325)
|.++ +.||.| +++.||++.+..+++.||||++... ..+.+|+.++.++ +||||+++++++.. ...+|
T Consensus 63 y~~~~~~LG~G--~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 63 YKVTSQVLGLG--INGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp EEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ceeccceeeec--cCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 4444 567877 8888999999999999999999642 3566788887554 89999999999875 56689
Q ss_pred EEEEecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC---CCceEEeeeccccccC
Q 046728 89 IVYDYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT---DFEAKVADFGFAKLIP 157 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~---~~~~kL~Dfg~~~~~~ 157 (325)
+|||||++|+|.+++.. .+++..+..+..++..++.++|.+ |||||+|||++. ++.+||+|||+++...
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 99999999999999954 256667788899999999999975 799999999987 7889999999998655
Q ss_pred CCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccc-hhhhhhcccccccccccccC
Q 046728 158 DGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKR-DIVQWVTPYVQKGAFEHIAD 236 (325)
Q Consensus 158 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (325)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......... .....+. .+.+
T Consensus 216 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~----- 284 (400)
T 1nxk_A 216 SHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQY----- 284 (400)
T ss_dssp -------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCC-----
T ss_pred CCCc--cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCcc-----
Confidence 3222 23456899999999999889999999999999999999999999765432211 0111110 0110
Q ss_pred ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 237 PRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 237 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
......+..+++++.+||.+||..||++|||+.++++ ||....
T Consensus 285 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 285 -EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp -CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred -cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 1111223456788999999999999999999999999 887543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=301.13 Aligned_cols=263 Identities=15% Similarity=0.185 Sum_probs=189.7
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
-..|.+++.||.| +++.||++.+..+++.||||.+.... ......+.+|+.++++++||||+++++++.+....++
T Consensus 33 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 33 IDRYRRITKLGEG--TYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp GGGEEEEEEEEEC--SSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhEEEEEEEEec--CCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3468889999999 88889999999999999999996433 2334567789999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceee-----CCCCceEEeeeccccccCC
Q 046728 90 VYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLL-----DTDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~-----~~~~~~kL~Dfg~~~~~~~ 158 (325)
||||+. |+|.+++.. .++...+..+..++..++.++|.. |||||+|||+ +..+.+||+|||++.....
T Consensus 111 v~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp EEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred EEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 999997 599999953 466667788899999999999975 7999999999 4556699999999987654
Q ss_pred CcceeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccc------
Q 046728 159 GVTHMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAF------ 231 (325)
Q Consensus 159 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------ 231 (325)
.... .....+|..|+|||++.+. .++.++|||||||++|+|++|..||...........+...........+
T Consensus 190 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (329)
T 3gbz_A 190 PIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence 3222 2234579999999999864 4899999999999999999999999654321111110000000000000
Q ss_pred -------ccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 232 -------EHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 232 -------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
.......+........++++.+||.+||..||++|||++++++ ||+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 324 (329)
T 3gbz_A 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324 (329)
T ss_dssp TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCC
Confidence 0000011111111225678999999999999999999999998 8875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=293.97 Aligned_cols=253 Identities=20% Similarity=0.267 Sum_probs=205.7
Q ss_pred ceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC
Q 046728 7 ICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD 85 (325)
Q Consensus 7 ~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (325)
+.......|.+++.||.| +++.||.+....+++.||+|.+... .......+.+|+.++++++||||+++++++.+..
T Consensus 16 ~~~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 93 (303)
T 3a7i_A 16 LKADPEELFTKLEKIGKG--SFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT 93 (303)
T ss_dssp CEECGGGTEEEEEEEEEC--SSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred CCCChHHHHHHhhhhccc--CCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 456667778999999999 7888999998899999999999643 2345578999999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 86 ERLIVYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
..++||||+++++|.+++. ..++...+..+..++..++.++|.. +||||+||+++.++.++|+|||++.......
T Consensus 94 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 94 KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp EEEEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999999999999995 3456667778888999999999875 7999999999999999999999998765432
Q ss_pred ceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 161 THMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
.. .....+|..|+|||++.+..++.++||||||+++|+|++|..||....... ....+. .. ..
T Consensus 174 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~----~~---------~~ 236 (303)
T 3a7i_A 174 IK-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VLFLIP----KN---------NP 236 (303)
T ss_dssp CC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHH----HS---------CC
T ss_pred cc-cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HHHHhh----cC---------CC
Confidence 22 234568999999999998889999999999999999999999996533211 111110 00 01
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
...+...+..+.+||.+||..||++|||+.++++ ||..
T Consensus 237 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 237 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 1223345678999999999999999999999998 7764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=302.72 Aligned_cols=267 Identities=18% Similarity=0.200 Sum_probs=203.3
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
......|.+++.||.| +++.||+++...+++.||+|.+... .......+.+|+.++++++||||+++++++.++...
T Consensus 29 ~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 29 ELKDDDFEKISELGAG--NGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCGGGEEEEEEEEEC--SSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred ccccccceeeeeecCC--CCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence 3446678899999999 8888999999999999999999754 455567889999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhh-----cCCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 88 LIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEG-----IADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~-----~rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
++||||+++++|.++++ ..++...+..+..++..++.++|. ||||||+||+++.++.++|+|||++......
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999999999995 346666777888999999999985 3799999999999999999999998754321
Q ss_pred ceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccc----------ccc--
Q 046728 161 THMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPY----------VQK-- 228 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~----------~~~-- 228 (325)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.................. ...
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 122346899999999999888999999999999999999999999753321111000000000 000
Q ss_pred -----------c----ccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 229 -----------G----AFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 229 -----------~----~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
. ....+.............+..+.+||.+||..||++|||++++++ ||+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 0 000000000011112335678999999999999999999999998 887643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=313.70 Aligned_cols=250 Identities=20% Similarity=0.255 Sum_probs=200.3
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..|.+++.||.| +++.||+++...+++.||+|.+.... ......+.+|..++++++||||+++++++.+...+|+
T Consensus 185 ~~f~~~~~LG~G--~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 185 DWFLDFRVLGRG--GFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp GGEEEEEEEEEC--SSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheEEEEEEeeC--CCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 456677889888 88889999999999999999996432 2334578899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcc------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC
Q 046728 90 VYDYMPNHSLITHLHG------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 159 (325)
||||++||+|.+++.. .+++..+..+..++..++.++|.+ |||||+|||++.+|.+||+|||++......
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence 9999999999999853 255556677788999999999985 799999999999999999999999876543
Q ss_pred cceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCcc-chhhhhhcccccccccccccCcc
Q 046728 160 VTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVK-RDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 160 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||........ ......+. . .
T Consensus 343 ~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~----~--------~- 408 (543)
T 3c4z_A 343 QTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL----E--------Q- 408 (543)
T ss_dssp CCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH----H--------C-
T ss_pred Ccc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh----h--------c-
Confidence 322 2345799999999999988999999999999999999999999976432211 11111110 0 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH--HHhcc
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTM-----TDVVD--WLKGG 279 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~-----~~il~--~l~~~ 279 (325)
....+..+++.+.+||.+||..||++||++ +++++ ||+.+
T Consensus 409 -~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 409 -AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred -ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 112334567899999999999999999964 78887 77653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=293.19 Aligned_cols=261 Identities=16% Similarity=0.176 Sum_probs=197.7
Q ss_pred ceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEE-EcCC
Q 046728 7 ICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFY-AGGD 85 (325)
Q Consensus 7 ~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 85 (325)
+...+...|.+.+.||.| +++.||.+++..+++.||+|.+.... ....+.+|+.+++.++|++++..+..+ ....
T Consensus 3 ~~~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (296)
T 4hgt_A 3 MELRVGNRYRLGRKIGSG--SFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGD 78 (296)
T ss_dssp --------CEEEEEEEEC--SSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred cccccCCceEEeeeecCC--CCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCC
Confidence 456678889999999999 88889999999999999999875432 223578899999999887777666654 6778
Q ss_pred eEEEEEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceee---CCCCceEEeeeccccc
Q 046728 86 ERLIVYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLL---DTDFEAKVADFGFAKL 155 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~---~~~~~~kL~Dfg~~~~ 155 (325)
..++||||+ +++|.+++. ..++...++.+..++..++.++|.. |||||+|||+ +.++.+||+|||++..
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 889999999 999999985 3466677788889999999999975 7999999999 7889999999999987
Q ss_pred cCCCcce------eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccc
Q 046728 156 IPDGVTH------MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKG 229 (325)
Q Consensus 156 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 229 (325)
....... ......||..|+|||++.+..++.++|||||||++|+|++|..||......................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 6543221 1234568999999999998899999999999999999999999998755433322222111110000
Q ss_pred ccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 230 AFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.. .......++.+.+|+.+||..||++|||++++++.|+.+..
T Consensus 238 ~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 238 PI---------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp CH---------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hh---------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 00 00112345789999999999999999999999999988764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=302.86 Aligned_cols=263 Identities=21% Similarity=0.324 Sum_probs=200.2
Q ss_pred ccchhHHhhccCccceeeeeEEEe----ccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC--
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLR----RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD-- 85 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 85 (325)
...|.+++.||.| +++.||.++ +..+++.||+|.+..........+.+|+.++++++||||+++++++....
T Consensus 40 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKG--NFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECC--SSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccC--CCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 4557889999999 777788887 56778999999998766677778999999999999999999999986543
Q ss_pred eEEEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCC
Q 046728 86 ERLIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 158 (325)
..++||||+++++|.+++.. .++...++.+..++..++.++|.. +||||+||+++.++.++|+|||++.....
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 68999999999999999953 255566677888899999999875 79999999999999999999999987655
Q ss_pred Cccee--eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccc----ccccc
Q 046728 159 GVTHM--TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQ----KGAFE 232 (325)
Q Consensus 159 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~ 232 (325)
..... .....++..|+|||++.+..++.++||||||+++|+|+||..||...... .......... .....
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH----HHHHHCTTCCTHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH----HHHhhccccchhhhHHHHH
Confidence 43221 22334677899999998888899999999999999999999998642110 0000000000 00000
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 233 HIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
.........+.+..+++.+.+||.+||..||++|||+.++++.|+.+.
T Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 000011112334556788999999999999999999999999988754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=289.19 Aligned_cols=245 Identities=21% Similarity=0.328 Sum_probs=193.5
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEc----CCeE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG----GDER 87 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 87 (325)
.|.+.+.||.| +++.||.+....++..||+|.+... .......+.+|+.++++++||||+++++++.. ....
T Consensus 27 ~~~~~~~lg~G--~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 27 FLKFDIEIGRG--SFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp EEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eEEeeeeccCC--CCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 46777889988 8888999999999999999998642 45556788999999999999999999999865 3558
Q ss_pred EEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc------CCCCCCceeeC-CCCceEEeeeccccccCC
Q 046728 88 LIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI------ADIKASNVLLD-TDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~------rdlkp~Nil~~-~~~~~kL~Dfg~~~~~~~ 158 (325)
++||||+++|+|.+++. ..++...++.+..++..++.++|.. +||||+||+++ .++.++|+|||++.....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 99999999999999995 4466667788899999999999853 79999999998 788999999999976544
Q ss_pred CcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 159 GVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 159 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
... ....||+.|+|||++. ..++.++||||||+++|+|++|..||...... ......... ..
T Consensus 185 ~~~---~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~------------~~ 246 (290)
T 1t4h_A 185 SFA---KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTS------------GV 246 (290)
T ss_dssp TSB---EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHTT------------TC
T ss_pred ccc---ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH--HHHHHHHhc------------cC
Confidence 322 2345899999999887 46899999999999999999999999653321 111111100 00
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
.....+...++.+.+||.+||..||++|||+.++++ ||++
T Consensus 247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 247 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 011122334468999999999999999999999998 7764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=301.39 Aligned_cols=269 Identities=14% Similarity=0.072 Sum_probs=197.4
Q ss_pred CCcccceeecccchhHHhhccCccceeeeeEEEeccC---CCCeEEEEEecccChhh-----------HHHHHHHHHHHH
Q 046728 2 QNHRNICFLLASPAVFIQNINNGLEILMLLLLLRRET---GDDQIAVKRLKTLNAKA-----------EMEFAVEVEILG 67 (325)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~-----------~~~~~~E~~~l~ 67 (325)
+.+..+.......|.+.+.||.| +++.||.+.... ++..||+|.+....... ...+.+|+..++
T Consensus 26 ~~g~~~~~~~~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~ 103 (345)
T 2v62_A 26 PEGKVLDDMEGNQWVLGKKIGSG--GFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103 (345)
T ss_dssp CTTCEEECTTSCEEEEEEEC--------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred CCCCeeccccCceEEEEeeEeec--CCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhc
Confidence 34444555566789999999999 788899999887 67899999987543211 123567889999
Q ss_pred ccCCCCccceeeEEEc----CCeEEEEEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCce
Q 046728 68 RVRHRNLLGLRGFYAG----GDERLIVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNV 137 (325)
Q Consensus 68 ~l~h~~iv~~~~~~~~----~~~~~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Ni 137 (325)
.++||||+++++++.. ....++||||| +++|.+++.. .++...++.+..++..++.++|.. |||||+||
T Consensus 104 ~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 182 (345)
T 2v62_A 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANL 182 (345)
T ss_dssp TCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred cccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHE
Confidence 9999999999999887 67889999999 9999999953 467777888999999999999985 79999999
Q ss_pred eeCCCC--ceEEeeeccccccCCCcce------eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 046728 138 LLDTDF--EAKVADFGFAKLIPDGVTH------MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEK 209 (325)
Q Consensus 138 l~~~~~--~~kL~Dfg~~~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 209 (325)
|++.++ .+||+|||+++........ ......||..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 998777 9999999999866432111 11345689999999999988899999999999999999999999964
Q ss_pred CCCCccchhhhhhcccccccccccccCcccc-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 210 LPGGVKRDIVQWVTPYVQKGAFEHIADPRLK-GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
........ .......... . ...+. .......++.+.+||.+||..||++|||++++++.|+...
T Consensus 263 ~~~~~~~~--~~~~~~~~~~-~----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 263 NLKDPVAV--QTAKTNLLDE-L----PQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp GTTCHHHH--HHHHHHHHHT-T----THHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred cccccHHH--HHHHHhhccc-c----cHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 32211110 0000000000 0 00000 0001145668999999999999999999999999998743
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=291.08 Aligned_cols=243 Identities=20% Similarity=0.254 Sum_probs=194.1
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC--CeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG--DERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 88 (325)
..|.+.+.||.| +++.||.++.. ++.||+|.+... .......+.+|+.++++++||||+++++++.+. ...+
T Consensus 10 ~~y~~~~~lg~G--~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 10 KQLNFLTKLNEN--HSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp GGCEEEEEEEEE--TTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred HHhHHHHHhcCC--CcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 467888999999 77778888864 788999998743 345556899999999999999999999999887 7789
Q ss_pred EEEEecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc------CCCCCCceeeCCCCceEEeeeccccccCC
Q 046728 89 IVYDYMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI------ADIKASNVLLDTDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~------rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 158 (325)
+||||+++|+|.++++.. ++...++.+..++..++.++|.. |||||+||+++.++.++|+|||++.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 999999999999999542 45566788889999999999963 79999999999999999999988764322
Q ss_pred CcceeeccCCCCcCCCCccccccCCCCC---cccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccccc
Q 046728 159 GVTHMTTRVKGTLGYLAPEYAMWGKVSD---SCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIA 235 (325)
Q Consensus 159 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~---~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (325)
....+|+.|+|||++.+..++. ++||||||+++|+|++|..||........ .. ...
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~------------~~~ 224 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI---GM------------KVA 224 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH---HH------------HHH
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH---HH------------HHH
Confidence 2345889999999998765544 79999999999999999999975432111 00 000
Q ss_pred CccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 236 DPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
........+...++.+.+|+.+||..||++|||++++++.|+.+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 225 LEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111122334556778999999999999999999999999998764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=291.03 Aligned_cols=250 Identities=21% Similarity=0.276 Sum_probs=193.9
Q ss_pred ccchhHHhhccCccceeeeeEEEeccC---CCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRET---GDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
...|.+.+.||.| +++.||.+.... ++..||+|.+... .......+.+|+.++++++||||+++++++.+ ...
T Consensus 11 ~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 87 (281)
T 3cc6_A 11 REDVVLNRILGEG--FFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT 87 (281)
T ss_dssp GGGEEEEEEEEEC--SSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred ccceEEEEEEEec--CCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence 4678889999999 777788877443 3456999999754 44556789999999999999999999999865 456
Q ss_pred EEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 88 LIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
++||||+++++|.+++.. .++...++.+..++..++.++|.. +||||+||+++.++.++|+|||++.......
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 899999999999999942 355666777888999999999875 7999999999999999999999998765543
Q ss_pred ceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 161 THMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
........+|..|+|||++.+..++.++||||||+++|+|++ |..||........... +.. . .
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~---~~~----~---------~ 231 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV---LEK----G---------D 231 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH---HHH----T---------C
T ss_pred ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH---Hhc----C---------C
Confidence 333334457888999999988889999999999999999998 9999975433221111 100 0 0
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
..+.+...++.+.+|+.+||..||++|||+.++++.|+.+.
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 232 RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 11223345678999999999999999999999999988764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=299.03 Aligned_cols=252 Identities=21% Similarity=0.315 Sum_probs=197.6
Q ss_pred ccchhHHhhccCccceeeeeEEEecc-------CCCCeEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRE-------TGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYA 82 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~-------~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 82 (325)
...|.+.+.||.| +++.||+++.. .+++.||+|.+... .......+.+|+.+++++ +||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G--~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEG--AFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp GGGEEEEEEEEEC--SSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhHeEEeeEEeec--CceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 3567888999999 77788888764 45678999999753 345566889999999999 8999999999999
Q ss_pred cCCeEEEEEEecCCCChhhhhccC------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeC
Q 046728 83 GGDERLIVYDYMPNHSLITHLHGR------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLD 140 (325)
Q Consensus 83 ~~~~~~lV~e~~~~gsL~~~l~~~------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~ 140 (325)
+....++||||+++|+|.+++... ++...++.+..++..++.++|.. +||||+||+++
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc
Confidence 999999999999999999999543 23334556777888888888875 79999999999
Q ss_pred CCCceEEeeeccccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchh
Q 046728 141 TDFEAKVADFGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDI 218 (325)
Q Consensus 141 ~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~ 218 (325)
.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+... .
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~ 268 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---L 268 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---H
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---H
Confidence 9999999999999876553322 2223346788999999988889999999999999999999 999997543211 1
Q ss_pred hhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 219 VQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
...+.. + .....+..++..+.+||.+||..||++|||+.++++.|+.+..
T Consensus 269 ~~~~~~----~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 269 FKLLKE----G---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHHHH----T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhc----C---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111110 0 0112334566789999999999999999999999999887764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=297.71 Aligned_cols=249 Identities=17% Similarity=0.263 Sum_probs=194.8
Q ss_pred chhHH-hhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEE
Q 046728 14 PAVFI-QNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 14 ~~~~~-~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 89 (325)
.|.+. +.||.| +++.||++....+++.||+|.+... .......+.+|+.+++.+ +||||+++++++.+....++
T Consensus 29 ~y~~~~~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 29 FYILTSKELGRG--KFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HEEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred EEeeccceeCCC--CCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 34444 668887 8888999999999999999998643 233456888999999999 57999999999999999999
Q ss_pred EEEecCCCChhhhhc----cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC---CCceEEeeeccccccCC
Q 046728 90 VYDYMPNHSLITHLH----GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT---DFEAKVADFGFAKLIPD 158 (325)
Q Consensus 90 V~e~~~~gsL~~~l~----~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~---~~~~kL~Dfg~~~~~~~ 158 (325)
|||||.+|+|.+++. ..+++..++.+..++..++.++|.. |||||+||+++. ++.+||+|||++.....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 999999999999984 3355566778889999999999975 799999999987 78999999999987654
Q ss_pred CcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 159 GVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 159 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+... ...
T Consensus 187 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-------------~~~ 251 (327)
T 3lm5_A 187 ACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV-------------NVD 251 (327)
T ss_dssp ---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------------CCC
T ss_pred ccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc-------------ccc
Confidence 322 23346899999999999889999999999999999999999999654321111111000 011
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
.........++.+.+||.+||..||++|||++++++ ||+..
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 252 YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 112233456678999999999999999999999998 88754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=296.47 Aligned_cols=265 Identities=18% Similarity=0.179 Sum_probs=194.8
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChh-----hHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAK-----AEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
...|.+++.||.| +++.||.+....+++.||+|.+...... ....+.+|+.++++++||||+++++++.+...
T Consensus 9 ~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 9 AKRYEKLDFLGEG--QFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ----CEEEEEEEE--TTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred hcccEEEeEEeec--CCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 4678889999999 7888999999999999999999643211 12367889999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC
Q 046728 87 RLIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 159 (325)
.++||||+.+ +|.+++.. .+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||++......
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 9999999975 89888853 367778888999999999999975 799999999999999999999999876543
Q ss_pred cceeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccccc---
Q 046728 160 VTHMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIA--- 235 (325)
Q Consensus 160 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 235 (325)
... .....+|+.|+|||++.+. .++.++|||||||++|+|++|.+||...........+...........+....
T Consensus 166 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (346)
T 1ua2_A 166 NRA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244 (346)
T ss_dssp CCC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred ccc-CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence 222 2335689999999998754 57889999999999999999999986543211111000000000000000000
Q ss_pred ---CccccCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 236 ---DPRLKGK-----FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 236 ---~~~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
....... .....++.+.+||.+||..||++|||+.++++ ||....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 0000000 01344678999999999999999999999998 887643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=299.06 Aligned_cols=257 Identities=20% Similarity=0.291 Sum_probs=197.4
Q ss_pred ceeecccchhHHhhccCccceeeeeEEEeccCCCCeE----EEEEecc-cChhhHHHHHHHHHHHHccCCCCccceeeEE
Q 046728 7 ICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQI----AVKRLKT-LNAKAEMEFAVEVEILGRVRHRNLLGLRGFY 81 (325)
Q Consensus 7 ~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~v----aiK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (325)
+.......|.+++.||.| +++.||+++...+++.| |+|.+.. ........+.+|+.++++++||||+++++++
T Consensus 9 ~~~l~~~~y~~~~~lG~G--~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 86 (327)
T 3lzb_A 9 LRILKETEFKKIKVLGSG--AFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp CEECCTTTEEEEEEEEEC--SSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEE
T ss_pred hcccCHhHceEEEEeeeC--CCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 344456788999999999 88889999988777655 6776643 2344567899999999999999999999999
Q ss_pred EcCCeEEEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccc
Q 046728 82 AGGDERLIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 82 ~~~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
.+.. .++|++|+.+|+|.+++.. .++...++.+..++..++.++|.. |||||+|||++.++.+||+|||++.
T Consensus 87 ~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 87 LTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp ESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred ecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 8765 7899999999999999943 356666788889999999999975 7999999999999999999999998
Q ss_pred ccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccc
Q 046728 155 LIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFE 232 (325)
Q Consensus 155 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (325)
........ ......+|..|+|||++.+..++.++|||||||++|+|++ |..||...+.........
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~------------ 233 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE------------ 233 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH------------
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH------------
Confidence 76543222 1223346778999999998899999999999999999999 999997654322211111
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCC
Q 046728 233 HIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGR 282 (325)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 282 (325)
.....+.+...+..+.+||.+||..||++|||+.++++.|+.+...
T Consensus 234 ----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 234 ----KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ----TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ----cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1111223345667899999999999999999999999999887643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=297.84 Aligned_cols=254 Identities=18% Similarity=0.316 Sum_probs=199.8
Q ss_pred ccchhHHhhccCccceeeeeEEEecc-----CCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRE-----TGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD 85 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (325)
...|.+.+.||.| +++.||.+... .+++.||+|.+... .......+.+|+.++++++||||+++++++.+..
T Consensus 24 ~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 24 REKITMSRELGQG--SFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp GGGEEEEEEEEEC--SSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeEeccC--CceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 4567889999999 67778887665 35678999999743 3445567889999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhcc------------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEee
Q 046728 86 ERLIVYDYMPNHSLITHLHG------------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVAD 149 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~------------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~D 149 (325)
..++||||+++|+|.++++. .++...++.+..++..++.++|.. |||||+||+++.++.+||+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~D 181 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 181 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECc
Confidence 99999999999999999953 224455667788889999999875 79999999999999999999
Q ss_pred eccccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhccccc
Q 046728 150 FGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQ 227 (325)
Q Consensus 150 fg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 227 (325)
||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||....... ....+.
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~~---- 254 (322)
T 1p4o_A 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VLRFVM---- 254 (322)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---HHHHHH----
T ss_pred CccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH---HHHHHH----
Confidence 9999865443222 1223346788999999998889999999999999999999 899986543211 111110
Q ss_pred ccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCCC
Q 046728 228 KGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGRR 283 (325)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~ 283 (325)
... ....+...+..+.+||.+||..||++|||+.++++.|+..+...
T Consensus 255 ~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~ 301 (322)
T 1p4o_A 255 EGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301 (322)
T ss_dssp TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred cCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence 000 11223456678999999999999999999999999999877543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=307.01 Aligned_cols=238 Identities=13% Similarity=0.082 Sum_probs=185.5
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecc---cChhhHHHHHHHHH---HHHccCCCCcccee-------e
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKT---LNAKAEMEFAVEVE---ILGRVRHRNLLGLR-------G 79 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~E~~---~l~~l~h~~iv~~~-------~ 79 (325)
..|.+.+.||.| +++.||.++...+++.||||.+.. ........+.+|+. ++++++||||++++ +
T Consensus 73 ~~y~~~~~lG~G--~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 73 RTLVRGTVLGQE--DPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp EEEEEEEEEEEE--TTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred ceEEEcceeecC--CCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 557888999999 788899999988999999999963 34455678889994 55555799999998 6
Q ss_pred EEEcCCe-----------------EEEEEEecCCCChhhhhcc--CCCC-------CCccCHHHHHHHHHHHHhhc----
Q 046728 80 FYAGGDE-----------------RLIVYDYMPNHSLITHLHG--RLAP-------DCLLDWHRRVSIAIGSAEGI---- 129 (325)
Q Consensus 80 ~~~~~~~-----------------~~lV~e~~~~gsL~~~l~~--~~~~-------~~~~~~~~~~~~~~~~~~~~---- 129 (325)
++.+.+. .|+||||+ +|+|.+++.. .+++ ...+.+..++..++.++|..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 6665532 78999999 6899999953 3444 44566889999999999985
Q ss_pred CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCCCcCCCCccccccC-----------CCCCcccchhHHHHHH
Q 046728 130 ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWG-----------KVSDSCDVYSFGVLLL 198 (325)
Q Consensus 130 rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----------~~~~~~DiwSlG~il~ 198 (325)
|||||+|||++.++.+||+|||++..... ......| +.|+|||++.+. .++.++|||||||++|
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 79999999999999999999999986433 2234457 999999999877 7999999999999999
Q ss_pred HHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HH
Q 046728 199 ELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WL 276 (325)
Q Consensus 199 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l 276 (325)
+|++|..||.......... .+. .....+++.+.+||.+||..||++|||+.++++ ||
T Consensus 305 elltg~~Pf~~~~~~~~~~---------------~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 363 (377)
T 3byv_A 305 WIWCADLPITKDAALGGSE---------------WIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363 (377)
T ss_dssp HHHHSSCCC------CCSG---------------GGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHH
T ss_pred HHHHCCCCCcccccccchh---------------hhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHH
Confidence 9999999996543211110 000 011234578999999999999999999999998 88
Q ss_pred hcc
Q 046728 277 KGG 279 (325)
Q Consensus 277 ~~~ 279 (325)
++.
T Consensus 364 ~~~ 366 (377)
T 3byv_A 364 EQL 366 (377)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=292.49 Aligned_cols=243 Identities=26% Similarity=0.422 Sum_probs=185.4
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
+.|.+.+.||.| +++.||.++.. ++.||+|.+... .....+.+|++++++++||||+++++++.+ ..++|||
T Consensus 8 ~~~~~~~~lg~G--~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e 79 (307)
T 2eva_A 8 KEIEVEEVVGRG--AFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME 79 (307)
T ss_dssp GGEEEEEEEECC--SSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred hHeeeeeEeecC--CCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence 567788999999 77778888754 678999999753 345688999999999999999999998863 4799999
Q ss_pred ecCCCChhhhhccC-----CCCCCccCHHHHHHHHHHHHhh-------cCCCCCCceeeCCCCc-eEEeeeccccccCCC
Q 046728 93 YMPNHSLITHLHGR-----LAPDCLLDWHRRVSIAIGSAEG-------IADIKASNVLLDTDFE-AKVADFGFAKLIPDG 159 (325)
Q Consensus 93 ~~~~gsL~~~l~~~-----~~~~~~~~~~~~~~~~~~~~~~-------~rdlkp~Nil~~~~~~-~kL~Dfg~~~~~~~~ 159 (325)
|+++|+|.++++.. +....++.+..++..++.++|. ||||||+||+++.++. +||+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 99999999999643 2334456777888999999998 4799999999988876 799999999755432
Q ss_pred cceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 160 VTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 160 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
.....||..|+|||++.+..++.++||||||+++|+|++|..||......... ...... . ..
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~----~---------~~ 221 (307)
T 2eva_A 160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IMWAVH----N---------GT 221 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HHHHHH----T---------TC
T ss_pred ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HHHHHh----c---------CC
Confidence 12235899999999999889999999999999999999999999754332111 100000 0 01
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.......+++.+.+|+.+||..||++|||++++++.|+.+..
T Consensus 222 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 222 RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 122334566789999999999999999999999998887653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=297.29 Aligned_cols=251 Identities=21% Similarity=0.346 Sum_probs=198.2
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCe----EEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQ----IAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~----vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
...|.+++.||.| +++.||++....+++. ||+|.+... .......+.+|+.++++++||||+++++++. +..
T Consensus 12 ~~~y~~~~~lG~G--~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 88 (325)
T 3kex_A 12 ETELRKLKVLGSG--VFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS 88 (325)
T ss_dssp TTTEEEEEEEECC--SSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred HhHceeeeeeeec--CCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence 4678889999999 8888999998877765 777777532 2233346778999999999999999999886 456
Q ss_pred EEEEEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC
Q 046728 87 RLIVYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 159 (325)
.++||||+.+|+|.+++. ..++...++.+..++..++.++|.. |||||+|||++.++.+||+|||+++.....
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 899999999999999994 3577788888999999999999985 799999999999999999999999877544
Q ss_pred cce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 160 VTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 160 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
... ......+|..|+|||++.+..++.++|||||||++|+|++ |..||...............
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--------------- 233 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG--------------- 233 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT---------------
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC---------------
Confidence 322 2233457889999999998899999999999999999999 99999765432222111110
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.....+...+..+.+||.+||..||++|||+.++++.|+.+..
T Consensus 234 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 234 -ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp -CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred -CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0112223345578899999999999999999999999987754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=294.84 Aligned_cols=254 Identities=23% Similarity=0.302 Sum_probs=190.1
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc--CCCCccceeeEEEcC----
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV--RHRNLLGLRGFYAGG---- 84 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~~~~~~~~~---- 84 (325)
+...|.+++.||.| +++.||.++.. ++.||||.+.... ...+..|.+++..+ +||||+++++++...
T Consensus 35 ~~~~y~~~~~lg~G--~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 35 IAKQIQMVKQIGKG--RYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHHHCEEEEEEEEE--TTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred cccceEEEeEeecC--CCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 44678889999999 77778888764 7899999986432 33455566666655 899999999999877
Q ss_pred CeEEEEEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhh------------cCCCCCCceeeCCCCceEEeeec
Q 046728 85 DERLIVYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEG------------IADIKASNVLLDTDFEAKVADFG 151 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~------------~rdlkp~Nil~~~~~~~kL~Dfg 151 (325)
...++|||||++|+|.++++ ..++...++.+..++..++.++|. ||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 78999999999999999995 346666778889999999999993 47999999999999999999999
Q ss_pred cccccCCCccee---eccCCCCcCCCCccccccCCCCCc------ccchhHHHHHHHHHhC----------CCCCCCCCC
Q 046728 152 FAKLIPDGVTHM---TTRVKGTLGYLAPEYAMWGKVSDS------CDVYSFGVLLLELISA----------KKPLEKLPG 212 (325)
Q Consensus 152 ~~~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~------~DiwSlG~il~el~tg----------~~pf~~~~~ 212 (325)
++.......... .....||+.|+|||++.+...+.+ +|||||||++|+|+|| ..||.....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 997665432221 224568999999999987766655 9999999999999999 555544322
Q ss_pred CccchhhhhhcccccccccccccCccccCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 213 GVKRDIVQWVTPYVQKGAFEHIADPRLKGKF-----NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
....... .... .......... ...+++.+.+||.+||..||++|||+.++++.|+.+..
T Consensus 268 ~~~~~~~--~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 268 SDPSYED--MREI--------VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp SSCCHHH--HHHH--------HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCchhh--hHHH--------HhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 1111000 0000 0001111111 23678899999999999999999999999999988764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=295.53 Aligned_cols=266 Identities=15% Similarity=0.169 Sum_probs=202.8
Q ss_pred ceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC
Q 046728 7 ICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG 84 (325)
Q Consensus 7 ~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (325)
..+.+...|.+.+.||.| +++.||.+.+..+++.||||.+... ......++.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~l~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 95 (353)
T 3coi_A 18 TAWELPKTYVSPTHVGSG--AYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA 95 (353)
T ss_dssp EEEEEETTEEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred cccccCceEEEeeeEecC--CCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecc
Confidence 456778889999999999 8888999999999999999999643 344456888999999999999999999999876
Q ss_pred Ce------EEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccc
Q 046728 85 DE------RLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 85 ~~------~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
.. .++||||+. ++|.+++...+++..+..+..++..++.++|.. |||||+||+++.++.+||+|||++.
T Consensus 96 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 96 SSLRNFYDFYLVMPFMQ-TDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp SSGGGCCCCEEEEECCS-EEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred cccccceeEEEEecccc-CCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 54 499999996 699999977778888888999999999999975 7999999999999999999999998
Q ss_pred ccCCCcceeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccc---
Q 046728 155 LIPDGVTHMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGA--- 230 (325)
Q Consensus 155 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 230 (325)
..... .....+|..|+|||++.+ ..++.++|||||||++|+|++|..||...........+...........
T Consensus 175 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 175 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred CCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 65432 223468999999999876 6789999999999999999999999976432111110000000000000
Q ss_pred ------------cccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 231 ------------FEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 231 ------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
........ ........++.+.+||.+||..||++|||+.++++ ||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKD-FTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCC-TTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HhhHHHHHHHHhCcCCCCcc-HHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 00000000 01122456789999999999999999999999998 887654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=297.67 Aligned_cols=249 Identities=19% Similarity=0.298 Sum_probs=189.9
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCC--CCccceeeEEEcCCeE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRH--RNLLGLRGFYAGGDER 87 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~ 87 (325)
...|.+++.||.| +++.||++... +++.||||.+... .......+.+|+.++++++| |||+++++++.+....
T Consensus 8 ~~~y~i~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 8 GRIYSILKQIGSG--GSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SCEEEEEEEESCC--SSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cCEEEEEEEEecC--CCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 5568999999999 78889988874 5889999998643 44555688999999999976 9999999999999999
Q ss_pred EEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 88 LIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
++||| +.+++|.+++. ..+++..+..+..++..++.++|.. |||||+|||++ ++.+||+|||++........
T Consensus 85 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 85 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred EEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 99999 55889999995 3456666788889999999999975 79999999997 57899999999987654322
Q ss_pred e-eeccCCCCcCCCCcccccc-----------CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccc
Q 046728 162 H-MTTRVKGTLGYLAPEYAMW-----------GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKG 229 (325)
Q Consensus 162 ~-~~~~~~~t~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 229 (325)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ...
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~----------- 230 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKL----------- 230 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HHH-----------
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-HHH-----------
Confidence 2 2234569999999999864 567889999999999999999999996532210 000
Q ss_pred ccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 230 AFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
.....+......+...++.+.+||.+||..||++|||+.++++ |++..
T Consensus 231 --~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 231 --HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp --HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred --HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 0011111112223334568999999999999999999999998 88743
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=292.19 Aligned_cols=251 Identities=20% Similarity=0.253 Sum_probs=197.8
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
....|.+++.||.| +++.||.+....+++.||+|.+.... ....+.+|+.++++++||||+++++++.+....++|
T Consensus 27 ~~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 27 PEEVFDVLEKLGEG--SYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ---CEEEEEECC------CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhheeeccC--CCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 34567888999998 88889999999999999999997532 345788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 91 YDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 91 ~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
|||+.+++|.+++. ..++...+..+..++..++.++|.. +||||+||+++.++.++|+|||++.........
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~- 181 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK- 181 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC-
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc-
Confidence 99999999999984 3466667788889999999999975 799999999999999999999999866543222
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.....+|..|+|||++.+..++.++||||||+++|+|++|..||....... ...... .. .......
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~----~~-------~~~~~~~ 247 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR---AIFMIP----TN-------PPPTFRK 247 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHH----HS-------CCCCCSS
T ss_pred cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHh----cC-------CCcccCC
Confidence 233468999999999998889999999999999999999999996533211 000000 00 0001112
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
+...+..+.+||.+||..||++|||+.++++ ||+...
T Consensus 248 ~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 248 PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 3445678999999999999999999999998 888654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=291.37 Aligned_cols=261 Identities=16% Similarity=0.172 Sum_probs=202.5
Q ss_pred ceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEE-EcCC
Q 046728 7 ICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFY-AGGD 85 (325)
Q Consensus 7 ~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 85 (325)
+...+...|.+.+.||.| +++.||.+++..+++.||+|.+..... ...+.+|+.+++.++|++++..+..+ ....
T Consensus 3 ~~~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (296)
T 3uzp_A 3 MELRVGNRYRLGRKIGSG--SFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD 78 (296)
T ss_dssp --CEETTTEEEEEEEEEE--TTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred ccceeccEEEEEEEEccC--CCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCC
Confidence 455678889999999999 778899999999999999999865332 23688999999999988777666554 6677
Q ss_pred eEEEEEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeC---CCCceEEeeeccccc
Q 046728 86 ERLIVYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLD---TDFEAKVADFGFAKL 155 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~---~~~~~kL~Dfg~~~~ 155 (325)
..++||||+ +++|.+++. ..++...++.+..++..++.++|.. |||||+|||++ .++.+||+|||++..
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 889999999 899999995 3466667788889999999999975 79999999994 788999999999987
Q ss_pred cCCCcce------eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccc
Q 046728 156 IPDGVTH------MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKG 229 (325)
Q Consensus 156 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 229 (325)
....... ......||..|+|||++.+..++.++|||||||++|+|++|..||..............+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 6553321 1234568999999999998899999999999999999999999998754433222222111100000
Q ss_pred ccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 230 AFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
. ........++.+.+|+.+||..||++|||++++++.|+.+..
T Consensus 238 ~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 238 P---------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp C---------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred c---------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 0 000113355789999999999999999999999999988764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=290.71 Aligned_cols=254 Identities=21% Similarity=0.274 Sum_probs=198.1
Q ss_pred eecccchhHHh-hccCccceeeeeEEEe--ccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC
Q 046728 9 FLLASPAVFIQ-NINNGLEILMLLLLLR--RETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG 84 (325)
Q Consensus 9 ~~~~~~~~~~~-~i~~G~~~~~~v~~~~--~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (325)
+.-...+.+++ .||.| +++.||.+. ...+++.||+|.+... .......+.+|++++++++||||+++++++ ..
T Consensus 5 ~~~~~~~~i~~~~lg~G--~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 5 FLKRDNLLIADIELGCG--NFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp BCCGGGEEEEEEEEECC--TTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred cccHHHhhhhhcccccc--CceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 34445566666 89998 666677775 4456788999999753 445567899999999999999999999999 45
Q ss_pred CeEEEEEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccC
Q 046728 85 DERLIVYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIP 157 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~ 157 (325)
...++||||+.+++|.+++. ..++...++.+..++..++.++|.. +||||+||+++.++.++|+|||++....
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 56899999999999999994 2356666778888999999999875 7999999999999999999999998775
Q ss_pred CCccee--eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccc
Q 046728 158 DGVTHM--TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHI 234 (325)
Q Consensus 158 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (325)
...... .....+|..|+|||++.+..++.++||||||+++|+|++ |..||........ ...+. .
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~i~----~------ 228 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAFIE----Q------ 228 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---HHHHH----T------
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHHh----c------
Confidence 433221 222346788999999988889999999999999999998 9999976443211 11111 0
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 235 ADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
......+...++.+.+||.+||..||++|||+.++++.|+.+..
T Consensus 229 ---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 229 ---GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 01123345567899999999999999999999999998887764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=289.26 Aligned_cols=246 Identities=21% Similarity=0.314 Sum_probs=201.0
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..|.+.+.||.| +++.||.++...+++.||+|.+.... ......+.+|+.++++++||||+++++++.+....++
T Consensus 14 ~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 14 DDFDIGRPLGKG--KFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp GGEEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhceeeheecCC--CCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 467888999999 78889999999999999999986422 2234578899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 90 VYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 90 V~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||||+++|+|.+++. ..+++..+..+..++..++.++|.. +||||+||+++.++.++|+|||++.......
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 168 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--- 168 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC---
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc---
Confidence 999999999999994 3466677788889999999999975 7999999999999999999999987654322
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.....|+..|+|||++.+..++.++||||||+++|+|++|..||........ ...+ ... ....
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~------------~~~--~~~~ 231 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET---HRRI------------VNV--DLKF 231 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHH------------HTT--CCCC
T ss_pred cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH---HHHH------------hcc--ccCC
Confidence 2334689999999999988899999999999999999999999965332111 1000 000 0122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
+...+..+.+||.+||..||++|||++++++ ||+...
T Consensus 232 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 232 PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 3445678999999999999999999999998 888643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=294.78 Aligned_cols=256 Identities=18% Similarity=0.228 Sum_probs=198.9
Q ss_pred eeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 8 CFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 8 ~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
.+.....|.+++.||.| +++.||.++...+++.||+|.+..........+.+|+.++++++||||+++++++.+....
T Consensus 14 ~~~~~~~y~i~~~lg~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 91 (302)
T 2j7t_A 14 DLDPNEVWEIVGELGDG--AFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91 (302)
T ss_dssp SSCGGGTEEEEEEEECS--TTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred ccCCccceeecceeccC--CCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence 45667788999999999 7788999999999999999999866666677899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 88 LIVYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
++||||+++++|.+++. ..++...+..+..++..++.++|.. +||||+||+++.++.++|+|||++.......
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999999999884 3466677788889999999999975 7999999999999999999999875432111
Q ss_pred ceeeccCCCCcCCCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccccc
Q 046728 161 THMTTRVKGTLGYLAPEYAM-----WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIA 235 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (325)
.......||..|+|||++. ...++.++||||||+++|+|++|..||....... ....... .
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~----~------ 237 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VLLKIAK----S------ 237 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHH----S------
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHHHhc----c------
Confidence 1122345899999999983 5678899999999999999999999997543211 1100000 0
Q ss_pred CccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 236 DPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
.......+...+..+.+||.+||..||++|||+.++++ ||+...
T Consensus 238 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 238 -DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp -CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred -CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 00011223456678999999999999999999999998 776543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=300.78 Aligned_cols=251 Identities=23% Similarity=0.326 Sum_probs=197.9
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCC-----eEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCC
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDD-----QIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGD 85 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~-----~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 85 (325)
..|.+.+.||.| +++.||.+....+++ .||+|.+... .......+.+|+.+++++ +||||+++++++.+..
T Consensus 46 ~~~~~~~~lG~G--~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 46 NNLQFGKTLGAG--AFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp TSEEEEEEEEEC--SSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHceeeeEeccC--CCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 457788899999 778899988766554 7999999753 344556889999999999 8999999999999999
Q ss_pred eEEEEEEecCCCChhhhhcc----------------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCce
Q 046728 86 ERLIVYDYMPNHSLITHLHG----------------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEA 145 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~----------------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~ 145 (325)
..++||||+++|+|.+++.. .++...++.+..++..++.++|.. |||||+||+++.++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~ 203 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA 203 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEE
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeE
Confidence 99999999999999999942 134445667788889999999875 7999999999999999
Q ss_pred EEeeeccccccCCCcc-eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhc
Q 046728 146 KVADFGFAKLIPDGVT-HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVT 223 (325)
Q Consensus 146 kL~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~ 223 (325)
||+|||++........ .......+|..|+|||++.+..++.++|||||||++|+|+| |..||........ ......
T Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~~~~~ 281 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--FYKLVK 281 (333)
T ss_dssp EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--HHHHHH
T ss_pred EECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--HHHHHh
Confidence 9999999986543322 12233446788999999998889999999999999999998 9999976433211 111110
Q ss_pred ccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 224 PYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
.......+...++.+.+||.+||..||++|||+.+++++|+...
T Consensus 282 -------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 282 -------------DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp -------------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------------cCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 01111223344678999999999999999999999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=290.14 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=199.0
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
.+.|.+++.||.| +++.||.+... ++..||+|.+.... .....+.+|++++++++||||+++++++. .+..++||
T Consensus 12 ~~~y~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 86 (279)
T 1qpc_A 12 RETLKLVERLGAG--QFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIIT 86 (279)
T ss_dssp GGGEEEEEEEEEE--TTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HHhhhheeeecCC--CCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEE
Confidence 3567889999999 77778888754 56789999997533 33568899999999999999999999986 45589999
Q ss_pred EecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 92 DYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 92 e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||+++++|.+++.. .++...++.+..++..++.++|.. +||||+||+++.++.++|+|||++..........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 99999999999953 366667788889999999999975 7999999999999999999999998776544333
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
.....++..|+|||++.+..++.++||||||+++|+|++ |..||...... .....+.. .....
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~-------------~~~~~ 230 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNLER-------------GYRMV 230 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHT-------------TCCCC
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHHHHhc-------------ccCCC
Confidence 344457788999999988889999999999999999999 89999754321 11111110 01112
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.+...++.+.+|+.+||..||++|||++++++.|+....
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 234556789999999999999999999999998887653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=306.39 Aligned_cols=250 Identities=20% Similarity=0.345 Sum_probs=186.3
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--------hhhHHHHHHHHHHHHccCCCCccceeeEEEc
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--------AKAEMEFAVEVEILGRVRHRNLLGLRGFYAG 83 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (325)
...|.+.+.||.| +++.||++....+++.||+|.+.... ......+.+|+.++++++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G--~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSG--ACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HTTEEEEEEEEEC--SSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hccEEEEeEEeeC--CCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4567788889999 88889999999999999999986421 1122357889999999999999999999854
Q ss_pred CCeEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC---CceEEeeecccc
Q 046728 84 GDERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD---FEAKVADFGFAK 154 (325)
Q Consensus 84 ~~~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~---~~~kL~Dfg~~~ 154 (325)
...++|||||++|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++.+ +.+||+|||+++
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 55899999999999999984 3456667778889999999999975 7999999999754 459999999998
Q ss_pred ccCCCcceeeccCCCCcCCCCcccccc---CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccc
Q 046728 155 LIPDGVTHMTTRVKGTLGYLAPEYAMW---GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAF 231 (325)
Q Consensus 155 ~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (325)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... ...+. .+..
T Consensus 291 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~~i~----~~~~ 362 (419)
T 3i6u_A 291 ILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQIT----SGKY 362 (419)
T ss_dssp SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--HHHHH----TTCC
T ss_pred ecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--HHHHh----cCCC
Confidence 765432 2234568999999999863 56788999999999999999999999754322111 11100 1000
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 232 EHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
. .....+...++.+.+||.+||..||++|||++++++ ||+.
T Consensus 363 ~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 363 N------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp C------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred C------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 0 000111235678999999999999999999999998 7764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=301.70 Aligned_cols=248 Identities=19% Similarity=0.289 Sum_probs=189.7
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccC--CCCccceeeEEEcCCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVR--HRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~ 88 (325)
..|.+++.||.| +++.||++.... ++.||||.+... .......+.+|+.++++++ ||||+++++++.....++
T Consensus 56 ~~y~~~~~LG~G--~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 56 RIYSILKQIGSG--GSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp EEEEEEEEEECC--SSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred CceEEEEEEccC--CCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 458899999999 778899988765 889999998643 4555678999999999996 599999999999999999
Q ss_pred EEEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 89 IVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
+||| +.+++|.+++.. .+++..+..+..++..++.++|.. |||||+|||++ ++.+||+|||++.........
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9999 568899999953 344446677888999999999975 79999999995 579999999999876543222
Q ss_pred -eeccCCCCcCCCCcccccc-----------CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccc
Q 046728 163 -MTTRVKGTLGYLAPEYAMW-----------GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGA 230 (325)
Q Consensus 163 -~~~~~~~t~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (325)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ....
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~~~------- 278 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLH------- 278 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHHH-------
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----HHHH-------
Confidence 2334569999999999864 357889999999999999999999996533210 0000
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 231 FEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
.+..+......+...+..+.+||.+||..||++|||+.++++ ||+..
T Consensus 279 --~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 279 --AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp --HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred --HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 011111111222233568999999999999999999999998 88753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=296.96 Aligned_cols=251 Identities=22% Similarity=0.292 Sum_probs=196.3
Q ss_pred cchhHHhhccCccceeeeeEEEe-----ccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCC
Q 046728 13 SPAVFIQNINNGLEILMLLLLLR-----RETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGD 85 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~-----~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 85 (325)
..|.+.+.||.| +++.||.++ +..+++.||||.+... .......+.+|+.+++++ +||||+++++++....
T Consensus 27 ~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 27 DRLKLGKPLGRG--AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp GGEEEEEEEEEC--SSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred hheeeeeEEcCC--CceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 567888999999 777888887 3456789999999753 344456788999999999 7999999999987654
Q ss_pred -eEEEEEEecCCCChhhhhccC------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC
Q 046728 86 -ERLIVYDYMPNHSLITHLHGR------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD 142 (325)
Q Consensus 86 -~~~lV~e~~~~gsL~~~l~~~------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~ 142 (325)
..++||||+++|+|.+++... ++...++.+..++..++.++|.. |||||+||+++.+
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~ 184 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC
Confidence 589999999999999999543 23344566778888888888875 7999999999999
Q ss_pred CceEEeeeccccccCCCcc-eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhh
Q 046728 143 FEAKVADFGFAKLIPDGVT-HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQ 220 (325)
Q Consensus 143 ~~~kL~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~ 220 (325)
+.+||+|||++........ .......+|..|+|||++.+..++.++||||||+++|+|++ |..||........ ...
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~~~ 262 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR 262 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--HHH
T ss_pred CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH--HHH
Confidence 9999999999986654322 22333457889999999998899999999999999999998 9999976442211 111
Q ss_pred hhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 221 WVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
.+. . ......+...++.+.++|.+||..||++|||+.++++.|+.++
T Consensus 263 ~~~----~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 263 RLK----E---------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp HHH----H---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Hhc----c---------CccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 110 0 0011223345678999999999999999999999999998765
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=293.73 Aligned_cols=266 Identities=15% Similarity=0.206 Sum_probs=205.7
Q ss_pred ccceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-CCCccceeeEEEc
Q 046728 5 RNICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAG 83 (325)
Q Consensus 5 ~~~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 83 (325)
+.+.+.....|.+++.||.| +++.||.+.+..+++.||+|.+.... ...+.+|+.++++++ ||||+++++++.+
T Consensus 28 ~~~~~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 102 (330)
T 3nsz_A 28 HVVEWGNQDDYQLVRKLGRG--KYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKD 102 (330)
T ss_dssp CCCCCEEGGGEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred hhhcccCCCceEEEEEeccc--CCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence 34567778889999999999 88889999999999999999997533 457889999999997 9999999999987
Q ss_pred --CCeEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC-ceEEeeecccccc
Q 046728 84 --GDERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF-EAKVADFGFAKLI 156 (325)
Q Consensus 84 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~-~~kL~Dfg~~~~~ 156 (325)
....++||||+.+++|.++++. +++..+..+..++..++.++|.. |||||+|||++.++ .+||+|||++...
T Consensus 103 ~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 103 PVSRTPALVFEHVNNTDFKQLYQT-LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp TTTCCEEEEEECCCCCCHHHHGGG-CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CCCCceEEEEeccCchhHHHHHHh-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 6678999999999999999864 66677788999999999999985 79999999999776 8999999999876
Q ss_pred CCCcceeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccc--------
Q 046728 157 PDGVTHMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQ-------- 227 (325)
Q Consensus 157 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~-------- 227 (325)
..... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||....... ...........
T Consensus 182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHH
T ss_pred CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH--HHHHHHHHhcCCchhhhHH
Confidence 54332 233468999999999876 568999999999999999999999995432211 00000000000
Q ss_pred -c------ccccc--------ccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 228 -K------GAFEH--------IADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 228 -~------~~~~~--------~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
. ..+.. ..............++.+.+||.+||..||++|||++++++ ||++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 0 00000 00001111223346789999999999999999999999998 888754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=292.12 Aligned_cols=251 Identities=23% Similarity=0.288 Sum_probs=196.7
Q ss_pred ccchhHHh-hccCccceeeeeEEE--eccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 12 ASPAVFIQ-NINNGLEILMLLLLL--RRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 12 ~~~~~~~~-~i~~G~~~~~~v~~~--~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
.+.|.+.+ .||.| +++.||.+ ....+++.||+|.+... ......++.+|++++++++||||+++++++ ....
T Consensus 15 ~~~y~~~~~~lg~G--~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 15 RKLLTLEDKELGSG--NFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp GGGEEEEEEEEEEC--SSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred chhhhhccCccccc--cCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 45667777 89888 67778877 55667889999999743 233456899999999999999999999999 5667
Q ss_pred EEEEEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 87 RLIVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
.++||||+++++|.+++.. .++...++.+..++..++.++|.. +||||+||+++.++.++|+|||++.......
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 8999999999999999953 356667788889999999999985 7999999999999999999999998765543
Q ss_pred cee--eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 161 THM--TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 161 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
... .....++..|+|||++.+..++.++||||||+++|+|++ |..||....... ....+. .+
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~----~~-------- 236 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLE----KG-------- 236 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHH----TT--------
T ss_pred CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH----cC--------
Confidence 322 222346788999999988888999999999999999999 999997643211 111111 00
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.....+...++.+.++|.+||..||++|||+.++++.|+.++.
T Consensus 237 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 237 -ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1122334567789999999999999999999999999988763
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=297.67 Aligned_cols=264 Identities=17% Similarity=0.200 Sum_probs=195.2
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEc-------
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAG------- 83 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------- 83 (325)
..|.+++.||.| +++.||+++...+++.||+|.+.... ......+.+|+.++++++||||+++++++..
T Consensus 17 ~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 17 SKYEKLAKIGQG--TFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGEEEEEECSSC--STTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cceeEEEEEecC--CCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 578889999999 78889999999999999999985432 2334577899999999999999999999877
Q ss_pred -CCeEEEEEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccc
Q 046728 84 -GDERLIVYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 84 -~~~~~lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
....++|||||.+ +|.+.+. ..++...++.+..++..++.++|.. |||||+|||++.++.+||+|||++..
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 3468999999975 7877774 3456667788899999999999975 79999999999999999999999987
Q ss_pred cCCCcc---eeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccc
Q 046728 156 IPDGVT---HMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAF 231 (325)
Q Consensus 156 ~~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (325)
...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...........+
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 253 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 653221 12233468999999999876 45799999999999999999999999764332221111111111111111
Q ss_pred ccccCccc----------cCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 232 EHIADPRL----------KGKFNR-----DQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 232 ~~~~~~~~----------~~~~~~-----~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
........ ...... ..++.+.+||.+||..||++|||++++++ ||...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 10000000 000000 12457899999999999999999999998 88753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=299.23 Aligned_cols=248 Identities=21% Similarity=0.306 Sum_probs=194.8
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--------hhhHHHHHHHHHHHHcc-CCCCccceeeEEEc
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--------AKAEMEFAVEVEILGRV-RHRNLLGLRGFYAG 83 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 83 (325)
..|.+.+.||.| +++.||.+....+|+.||||++.... ......+.+|+.+++++ +||||+++++++..
T Consensus 94 ~~y~~~~~lg~G--~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 94 QKYDPKDVIGRG--VSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhcccceEEecC--CCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 345666788888 88889999998889999999986432 12234677899999999 79999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccC
Q 046728 84 GDERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIP 157 (325)
Q Consensus 84 ~~~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~ 157 (325)
....++||||+++++|.+++. ..++...+..+..++..++.++|.. +||||+|||++.++.++|+|||++....
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 999999999999999999995 3466677788899999999999985 7999999999999999999999998765
Q ss_pred CCcceeeccCCCCcCCCCcccccc------CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccc
Q 046728 158 DGVTHMTTRVKGTLGYLAPEYAMW------GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAF 231 (325)
Q Consensus 158 ~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (325)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+. .+..
T Consensus 252 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~i~----~~~~ 322 (365)
T 2y7j_A 252 PGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LMLRMIM----EGQY 322 (365)
T ss_dssp TTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----HTCC
T ss_pred CCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHH----hCCC
Confidence 4322 234568999999999863 25788999999999999999999999653211 1111110 0000
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHh
Q 046728 232 EHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLK 277 (325)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~ 277 (325)
. ...+.+...+..+.+||.+||..||++|||+.++++ ||+
T Consensus 323 ~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 323 Q------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp C------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred C------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 0 000011234567999999999999999999999998 764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=321.49 Aligned_cols=247 Identities=24% Similarity=0.326 Sum_probs=203.1
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 88 (325)
..|.+++.||.| +++.||+++...+++.||||++.+. .......+..|..++..+ +||+|+++++++.+...+|
T Consensus 341 ~~f~~~~~LG~G--~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 341 TDFNFLMVLGKG--SFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp TTEEEEEESSBT--TTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cceEEEEEEccC--CCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 457888999999 8888999999999999999999742 223345778899999998 7999999999999999999
Q ss_pred EEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 89 IVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
+||||+++|+|.++++ +.+++..++.+..++..++.++|.. |||||+|||++.++.+||+|||+++.......
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~- 497 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV- 497 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC-
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc-
Confidence 9999999999999995 4577777888999999999999986 89999999999999999999999986433222
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
......||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+ .... ..
T Consensus 498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---~~~~~i------------~~~~--~~ 560 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSI------------MEHN--VA 560 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH------------HSSC--CC
T ss_pred ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---HHHHHH------------HhCC--CC
Confidence 234567999999999999999999999999999999999999999754321 111111 1111 12
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH--HHhcc
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTM-----TDVVD--WLKGG 279 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~-----~~il~--~l~~~ 279 (325)
.+..+++++.+||.+||..||++||++ ++|++ ||+.+
T Consensus 561 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 561 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 345677899999999999999999997 88887 77653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=286.02 Aligned_cols=248 Identities=21% Similarity=0.325 Sum_probs=192.6
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
...|.+.+.||.| +++.||.+.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++.+....+
T Consensus 10 ~~~y~i~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (276)
T 2h6d_A 10 IGHYVLGDTLGVG--TFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF 87 (276)
T ss_dssp ETTEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred eccEEEEeeecCC--CCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence 3567889999999 77889999999899999999986432 233457889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 89 IVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
+||||+++++|.+++. ..+++..+..+..++..++.++|.. +||||+||+++.++.++|+|||++........
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 166 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF- 166 (276)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc-
Confidence 9999999999999994 3466667788889999999999975 79999999999999999999999987654322
Q ss_pred eeccCCCCcCCCCccccccCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKV-SDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
.....+++.|+|||++.+..+ +.++||||||+++|+|++|..||...... .....+. ... .
T Consensus 167 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~----~~~----------~ 228 (276)
T 2h6d_A 167 -LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLFKKIR----GGV----------F 228 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----HCC----------C
T ss_pred -eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHhh----cCc----------c
Confidence 223458899999999987665 57999999999999999999999653211 1111111 000 1
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
..+...+..+.+||.+||..||++|||++++++ ||+...
T Consensus 229 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 229 YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 122345678999999999999999999999998 887644
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=298.31 Aligned_cols=254 Identities=24% Similarity=0.330 Sum_probs=193.0
Q ss_pred ecccchhHHhhccCccceeeeeEEEe-----ccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEc
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLR-----RETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG 83 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~-----~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (325)
.....|.+++.||.| +++.||.++ +..+++.||+|.+... ......++.+|+.++++++||||+++++++.+
T Consensus 27 ~~~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 27 VPRKNITLIRGLGHG--AFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CCGGGCEEEEECC----CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CChhheEEEEEEcCC--CCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 356788999999999 777788887 5567889999999643 44556688999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhccC---------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC---CCceEE
Q 046728 84 GDERLIVYDYMPNHSLITHLHGR---------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT---DFEAKV 147 (325)
Q Consensus 84 ~~~~~lV~e~~~~gsL~~~l~~~---------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~---~~~~kL 147 (325)
....++||||+++|+|.+++... ++...++.+..++..++.++|.. |||||+|||++. +..++|
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999999532 33334566778888888888875 799999999984 446999
Q ss_pred eeeccccccCCCcc-eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhccc
Q 046728 148 ADFGFAKLIPDGVT-HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPY 225 (325)
Q Consensus 148 ~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~ 225 (325)
+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... .....+..
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~~- 260 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEFVTS- 260 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHHT-
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHHHHhc-
Confidence 99999975533222 12223457889999999988889999999999999999998 99999654321 11111110
Q ss_pred ccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 226 VQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
+ .....+..+++.+.+||.+||..||++|||+.++++.|+....
T Consensus 261 ---~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 261 ---G---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp ---T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---C---------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 0 0112234566789999999999999999999999998887654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=284.84 Aligned_cols=254 Identities=27% Similarity=0.438 Sum_probs=194.7
Q ss_pred hhccCccceeeeeEEEeccCCCCeEEEEEeccc----ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEec
Q 046728 19 QNINNGLEILMLLLLLRRETGDDQIAVKRLKTL----NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~ 94 (325)
+.||.| +++.||.+.. +++.||+|.+... .......+.+|+.++++++||||+++++++.+....++||||+
T Consensus 37 ~~lg~G--~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 37 NKMGEG--GFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp CEEEEC--SSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred CccccC--CCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 667777 7888998875 5789999998642 2344568899999999999999999999999999999999999
Q ss_pred CCCChhhhhcc-----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc-eee
Q 046728 95 PNHSLITHLHG-----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT-HMT 164 (325)
Q Consensus 95 ~~gsL~~~l~~-----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~ 164 (325)
++|+|.+++.. .++....+.+..++..++.++|.. +||||+||+++.++.++|+|||++........ ...
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 192 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence 99999999852 244445566778888888888875 79999999999999999999999986654322 223
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhh-hhhcccccccccccccCccccCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIV-QWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
....||+.|+|||++.+ .++.++||||||+++|+|++|..||............ ..... ....+.......+ ...
T Consensus 193 ~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-~~~ 268 (307)
T 2nru_A 193 SRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIED--EEKTIEDYIDKKM-NDA 268 (307)
T ss_dssp SSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHT--TSCCHHHHSCSSC-SCC
T ss_pred cccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhh--hhhhhhhhccccc-ccc
Confidence 34568999999998874 5889999999999999999999999765432211111 11000 0111111112211 234
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
+...+..+.+++.+||..||++|||+.++++.|+++.
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 5678889999999999999999999999999998754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=318.52 Aligned_cols=249 Identities=25% Similarity=0.411 Sum_probs=198.9
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
+.|.+.+.||.| +++.||++.... +..||||.+.... .....+.+|+++|++++||||+++++++.+ ...++|||
T Consensus 267 ~~~~~~~~lG~G--~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 267 ESLRLEVKLGQG--CFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GGEEEEEEEEEC--SSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhhheecccC--CCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 456788889998 777888887654 4679999997543 234689999999999999999999999876 67899999
Q ss_pred ecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 93 YMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||.+|+|.++++. .++...++.+..++..++.++|.. |||||+|||++.++.+||+|||++...........
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 421 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 421 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence 9999999999953 256666778889999999999975 79999999999999999999999987654322222
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
....++..|+|||++.+..++.++|||||||++|||++ |..||...... .....+. . ..+.+.
T Consensus 422 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~~i~----~---------~~~~~~ 485 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVE----R---------GYRMPC 485 (535)
T ss_dssp CSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHHHHH----T---------TCCCCC
T ss_pred cCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----c---------CCCCCC
Confidence 33446788999999998899999999999999999999 89999754321 1111111 0 111233
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCC
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGR 282 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 282 (325)
+..++..+.+||.+||..||++|||+++|++.|+.+...
T Consensus 486 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 486 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 445677899999999999999999999999999987753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=295.29 Aligned_cols=251 Identities=22% Similarity=0.372 Sum_probs=191.3
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCC----CeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGD----DQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~----~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
+.|.+.+.||.| +++.||.+....++ ..||+|.+... .......+.+|+.++++++||||+++++++.+....
T Consensus 44 ~~~~~~~~lG~G--~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 44 SCVTRQKVIGAG--EFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp TTEEEEEEEEEC--SSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHhhcccEEecC--CCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 455667889888 77778888766543 35999999753 344556788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc
Q 046728 88 LIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 160 (325)
++||||+++|+|.+++.. .++...++.+..++..++.++|.. |||||+||+++.++.+||+|||++.......
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence 999999999999999953 355666778888999999999875 7999999999999999999999998765432
Q ss_pred ce--eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 161 TH--MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 161 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
.. ......+|..|+|||++.+..++.++||||||+++|+|++ |..||...... .....+. .
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~~~----~--------- 265 (333)
T 1mqb_A 202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMKAIN----D--------- 265 (333)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH----T---------
T ss_pred ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHH----C---------
Confidence 21 1122345778999999998889999999999999999999 99999654321 1111111 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
....+.+...++.+.+|+.+||..||++|||+.++++.|+.+..
T Consensus 266 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 266 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 01112334566789999999999999999999999999988764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=288.59 Aligned_cols=254 Identities=21% Similarity=0.289 Sum_probs=202.2
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---------hhhHHHHHHHHHHHHccC-CCCccceee
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---------AKAEMEFAVEVEILGRVR-HRNLLGLRG 79 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~~iv~~~~ 79 (325)
.+...|.+.+.||.| +++.||.+.+..+++.||||.+.... ......+.+|+++++++. ||||+++++
T Consensus 14 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 14 GFYENYEPKEILGRG--VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp -CTTTEEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred chhhccceeeeecCC--CceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 456788899999999 77889999999999999999996432 223457788999999995 999999999
Q ss_pred EEEcCCeEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccc
Q 046728 80 FYAGGDERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFA 153 (325)
Q Consensus 80 ~~~~~~~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~ 153 (325)
++.+....++||||+++++|.+++. ..+++..++.+..++..++.++|.. +||||+||+++.++.++|+|||++
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 92 TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 9999999999999999999999995 3466677888899999999999986 799999999999999999999999
Q ss_pred cccCCCcceeeccCCCCcCCCCccccc------cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccc
Q 046728 154 KLIPDGVTHMTTRVKGTLGYLAPEYAM------WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQ 227 (325)
Q Consensus 154 ~~~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 227 (325)
........ .....++..|+|||++. ...++.++||||||+++|+|++|..||....... ....+ .
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~----~ 242 (298)
T 1phk_A 172 CQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---MLRMI----M 242 (298)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----H
T ss_pred hhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---HHHHH----h
Confidence 87654322 23346899999999885 3467889999999999999999999996533211 11100 0
Q ss_pred ccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 228 KGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
.+.. ....+.....+..+.+||.+||..||++|||+.++++ ||+...
T Consensus 243 ~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 243 SGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp HTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred cCCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 0000 0111223456788999999999999999999999998 877544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=299.22 Aligned_cols=270 Identities=16% Similarity=0.095 Sum_probs=198.5
Q ss_pred CcccceeecccchhHHhhccCccceeeeeEEEeccCC-----CCeEEEEEecccChhhH-----------HHHHHHHHHH
Q 046728 3 NHRNICFLLASPAVFIQNINNGLEILMLLLLLRRETG-----DDQIAVKRLKTLNAKAE-----------MEFAVEVEIL 66 (325)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~-----~~~vaiK~~~~~~~~~~-----------~~~~~E~~~l 66 (325)
.|..+.-.....|.+.+.||.| +++.||++....+ ++.||||.+........ ..+..|+..+
T Consensus 25 ~g~~i~~~~~~~y~~~~~lG~G--~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~ 102 (364)
T 3op5_A 25 VGEIITDMAAAAWKVGLPIGQG--GFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102 (364)
T ss_dssp TTCEEECTTCCEEEEEEECCCC---CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred CCcEeeccCCCeEEEEEEEecC--CCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHH
Confidence 3444444566688999999999 7888999977664 58899999875432211 1233466677
Q ss_pred HccCCCCccceeeEEEcC----CeEEEEEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCC
Q 046728 67 GRVRHRNLLGLRGFYAGG----DERLIVYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKAS 135 (325)
Q Consensus 67 ~~l~h~~iv~~~~~~~~~----~~~~lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~ 135 (325)
+.++||||+++++++... ...++||||| +++|.+++. ..++...++.+..++..++.++|.. |||||+
T Consensus 103 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~ 181 (364)
T 3op5_A 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKAS 181 (364)
T ss_dssp TTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred hhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHH
Confidence 788999999999998664 4579999999 999999994 3467777888999999999999975 899999
Q ss_pred ceeeC--CCCceEEeeeccccccCCCccee------eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCC
Q 046728 136 NVLLD--TDFEAKVADFGFAKLIPDGVTHM------TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPL 207 (325)
Q Consensus 136 Nil~~--~~~~~kL~Dfg~~~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 207 (325)
|||++ .++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|+|+||..||
T Consensus 182 Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf 261 (364)
T 3op5_A 182 NLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261 (364)
T ss_dssp GEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99998 88999999999998665322111 12345999999999999888999999999999999999999999
Q ss_pred CCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 208 EKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
......... ......... .....+.+..+ .....++++.+|+..||..||++|||+.+|++.|+.++.
T Consensus 262 ~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 262 EDNLKDPKY--VRDSKIRYR-ENIASLMDKCF---PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp GGGTTCHHH--HHHHHHHHH-HCHHHHHHHHS---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cccccCHHH--HHHHHHHhh-hhHHHHHHHhc---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 753322111 110000000 00111111100 012345789999999999999999999999999887764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=300.94 Aligned_cols=267 Identities=15% Similarity=0.109 Sum_probs=201.5
Q ss_pred CCcccceeecccchhHHhhccCccceeeeeEEEeccC--------CCCeEEEEEecccChhhHHHHHHHHHHHHccCCCC
Q 046728 2 QNHRNICFLLASPAVFIQNINNGLEILMLLLLLRRET--------GDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRN 73 (325)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~ 73 (325)
+.|+.+.-.....|.+.+.||.| +++.||.++... .++.||+|.+... ..+.+|++++++++|||
T Consensus 31 ~~g~~i~~~~~~~y~~~~~lg~G--~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~n 103 (352)
T 2jii_A 31 PTGTVLTDKSGRQWKLKSFQTRD--NQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPL 103 (352)
T ss_dssp CTTCEEECTTSCEEEEEEEEEEE--TTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHH
T ss_pred CCCceeecccCCeEEEEEEecCC--CCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccc
Confidence 44555555556789999999999 777899998877 4789999999753 36788999999999999
Q ss_pred ccc---------------eeeEEEc-CCeEEEEEEecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----
Q 046728 74 LLG---------------LRGFYAG-GDERLIVYDYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI---- 129 (325)
Q Consensus 74 iv~---------------~~~~~~~-~~~~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~---- 129 (325)
|++ +++++.. +...++||||+ +++|.+++.. .++...++.+..++..++.++|..
T Consensus 104 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH 182 (352)
T 2jii_A 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVH 182 (352)
T ss_dssp HHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred hhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence 988 5666655 67889999999 9999999953 467777888999999999999975
Q ss_pred CCCCCCceeeCCCC--ceEEeeeccccccCCCcce------eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHH
Q 046728 130 ADIKASNVLLDTDF--EAKVADFGFAKLIPDGVTH------MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELI 201 (325)
Q Consensus 130 rdlkp~Nil~~~~~--~~kL~Dfg~~~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 201 (325)
|||||+|||++.++ .+||+|||++......... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 183 ~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 262 (352)
T 2jii_A 183 GNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL 262 (352)
T ss_dssp SCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 79999999999988 8999999999866532211 112346899999999999888999999999999999999
Q ss_pred hCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 202 SAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 202 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
+|..||....... ............. ...+... .......++.+.+||.+||..||++|||++++++.|+.+..
T Consensus 263 ~g~~pf~~~~~~~-~~~~~~~~~~~~~--~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 263 YGFLPWTNCLPNT-EDIMKQKQKFVDK--PGPFVGP---CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp HSCCTTGGGTTCH-HHHHHHHHHHHHS--CCCEECT---TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred hCCCCcccCCcCH-HHHHHHHHhccCC--hhhhhhh---ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 9999997643211 1111111100000 0000000 01112346789999999999999999999999999988764
Q ss_pred C
Q 046728 282 R 282 (325)
Q Consensus 282 ~ 282 (325)
.
T Consensus 337 ~ 337 (352)
T 2jii_A 337 D 337 (352)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=300.37 Aligned_cols=252 Identities=20% Similarity=0.300 Sum_probs=197.6
Q ss_pred cchhHHhhccCccceeeeeEEEecc---CCCCeEEEEEecccC----hhhHHHHHHHHHHHHcc-CCCCccceeeEEEcC
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRE---TGDDQIAVKRLKTLN----AKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGG 84 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~---~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 84 (325)
..|.+++.||.| +++.||+++.. .+++.||||.+.... ......+.+|+++++++ +||||+++++++...
T Consensus 54 ~~y~~~~~lG~G--~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 54 ENFELLKVLGTG--AYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp GGEEEEEEEEET--TTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cceEEEEEeccC--CCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 578899999999 77788888874 478999999986421 22334677899999999 699999999999999
Q ss_pred CeEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCC
Q 046728 85 DERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 158 (325)
...++||||+++|+|.+++. ..+++..+..+..++..++.++|.. |||||+|||++.++.+||+|||++.....
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence 99999999999999999994 4466677788888999999999975 79999999999999999999999987654
Q ss_pred CcceeeccCCCCcCCCCccccccC--CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccC
Q 046728 159 GVTHMTTRVKGTLGYLAPEYAMWG--KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD 236 (325)
Q Consensus 159 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (325)
..........||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+. .... .
T Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~~~-~-------- 280 (355)
T 1vzo_A 212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRIL-K-------- 280 (355)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHH-H--------
T ss_pred CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH--HHHh-c--------
Confidence 333333445699999999999853 47889999999999999999999997543221111110 0000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH--HHhcc
Q 046728 237 PRLKGKFNRDQLKSMVLIALRCTDSNPENRP-----TMTDVVD--WLKGG 279 (325)
Q Consensus 237 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~~ 279 (325)
.....+...+..+.+||.+||..||++|| |++++++ ||+..
T Consensus 281 --~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 281 --SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred --cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 01123345667899999999999999999 9999998 77643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=288.76 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=186.4
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
....|.+.+.||.| +++.||.++.. ..||+|.+... .......+.+|+.++++++||||++++++. .....+
T Consensus 22 ~~~~y~~~~~lG~G--~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 22 PDGQITVGQRIGSG--SFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp CTTSCEEEEEEEEC--SSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred CccceeeeeEecCC--CCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 34568889999999 77888888754 35999998643 445567899999999999999999999964 556789
Q ss_pred EEEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc-
Q 046728 89 IVYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV- 160 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 160 (325)
+|||||.+++|.+++. ..++...++.+..++..++.++|.. |||||+||+++.++.++|+|||++.......
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 9999999999999994 2345556677888999999999975 7999999999999999999999997654321
Q ss_pred ceeeccCCCCcCCCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 161 THMTTRVKGTLGYLAPEYAM---WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
........||+.|+|||++. +..++.++||||||+++|+|++|..||....... .....+. ..... +
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~----~~~~~----~ 245 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVG----RGSLS----P 245 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHHH----HTSCC----C
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHhc----ccccC----c
Confidence 12223346899999999986 5567889999999999999999999997643311 1111111 11100 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
. .......+++.+.+||.+||..||++|||+.++++.|+++..
T Consensus 246 ~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 246 D-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp C-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred c-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0 112234566789999999999999999999999999987654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=290.74 Aligned_cols=247 Identities=19% Similarity=0.299 Sum_probs=196.0
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEE--cCCeE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYA--GGDER 87 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~ 87 (325)
...|.+++.||.| +++.||.++...+++.||+|.+... .......+.+|+.++++++||||+++++++. .....
T Consensus 5 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTG--SYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp GGGEEEEEEEEEC--SSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred hhheeeehhccCC--CCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 4567889999999 7788999999999999999999643 3455668899999999999999999999874 36789
Q ss_pred EEEEEecCCCChhhhhccC------CCCCCccCHHHHHHHHHHHHhh---------cCCCCCCceeeCCCCceEEeeecc
Q 046728 88 LIVYDYMPNHSLITHLHGR------LAPDCLLDWHRRVSIAIGSAEG---------IADIKASNVLLDTDFEAKVADFGF 152 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~~------~~~~~~~~~~~~~~~~~~~~~~---------~rdlkp~Nil~~~~~~~kL~Dfg~ 152 (325)
++||||+++++|.+++... ++...++.+..++..++.++|. |+||||+||+++.++.++|+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999999999999431 5666678888999999999985 379999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccc
Q 046728 153 AKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFE 232 (325)
Q Consensus 153 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (325)
+......... .....+|..|+|||++.+..++.++||||||+++|+|++|..||...... .....+. .+.
T Consensus 163 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~i~----~~~-- 232 (279)
T 2w5a_A 163 ARILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIR----EGK-- 232 (279)
T ss_dssp HHHC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----HTC--
T ss_pred heeecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHHHHHh----hcc--
Confidence 9876543221 22345899999999999888999999999999999999999999754321 1111111 111
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 233 HIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
....+...++.+.+||.+||..||++|||++++++.+.
T Consensus 233 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 233 -------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred -------cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 11223456678999999999999999999999998543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=290.00 Aligned_cols=244 Identities=17% Similarity=0.176 Sum_probs=194.9
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCC
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGD 85 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 85 (325)
..+...|.+++.||.| +++.||.+....+++.||+|.+... ......++.+|+..+..+ +||||+++++++.+.+
T Consensus 7 ~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 7 SRYTTEFHELEKIGSG--EFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp CHHHHHEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred ccccchhhhhhhhcCC--CceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 3456778889999999 7788999999999999999998743 344456788899999999 8999999999999999
Q ss_pred eEEEEEEecCCCChhhhhc------cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC-------------
Q 046728 86 ERLIVYDYMPNHSLITHLH------GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD------------- 142 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~------~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~------------- 142 (325)
..++||||+++++|.+++. ..+++..++.+..++..++.++|.. |||||+||+++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 9999999999999999995 3366777888999999999999975 7999999999844
Q ss_pred ------CceEEeeeccccccCCCcceeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCcc
Q 046728 143 ------FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVK 215 (325)
Q Consensus 143 ------~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~ 215 (325)
..++|+|||.+....... ...+|..|+|||++.+. .++.++|||||||++|+|++|.+|+....
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---- 235 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---- 235 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred cccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence 479999999998765432 23589999999999865 55679999999999999999988764321
Q ss_pred chhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 216 RDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
....+ ..+. ....+...++.+.+||.+||..||++|||+.++++ ||..
T Consensus 236 --~~~~~----~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 236 --QWHEI----RQGR---------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp --HHHHH----HTTC---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred --HHHHH----HcCC---------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 00000 0111 11223456678999999999999999999999998 7664
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=297.79 Aligned_cols=250 Identities=9% Similarity=0.004 Sum_probs=179.2
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHcc--CCCCcccee-------eEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRV--RHRNLLGLR-------GFYA 82 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l--~h~~iv~~~-------~~~~ 82 (325)
|.+.+.||.| +++.||++.+..+++.||||.+.... ......+.+|+.+++.+ +||||++++ +++.
T Consensus 64 y~~~~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 64 LKLVEPLRVG--DRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeccCC--CCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 7788999999 88889999999999999999997643 23445677785555544 699987755 4544
Q ss_pred cC-----------------CeEEEEEEecCCCChhhhhcc---CCCCCCc------cCHHHHHHHHHHHHhhc----CCC
Q 046728 83 GG-----------------DERLIVYDYMPNHSLITHLHG---RLAPDCL------LDWHRRVSIAIGSAEGI----ADI 132 (325)
Q Consensus 83 ~~-----------------~~~~lV~e~~~~gsL~~~l~~---~~~~~~~------~~~~~~~~~~~~~~~~~----rdl 132 (325)
.. ...|+|||||. |+|.++++. .+..... +.+..++..++.++|.+ |||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 33 33799999998 899999953 2333333 35558999999999985 799
Q ss_pred CCCceeeCCCCceEEeeeccccccCCCcceeeccCCCCcCCCCcccccc--CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 046728 133 KASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMW--GKVSDSCDVYSFGVLLLELISAKKPLEKL 210 (325)
Q Consensus 133 kp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~ 210 (325)
||+|||++.++.+||+|||++....... ....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999998764321 13346799999999987 67899999999999999999999999765
Q ss_pred CCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 211 PGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
......... ..............+....+++.+.+||.+||..||++|||+.++++ ||++.
T Consensus 297 ~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 297 TPGIKGSWK--------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp CTTCTTCCC--------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred Ccccccchh--------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 432111000 00000111111222223456789999999999999999999999998 88764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=304.64 Aligned_cols=263 Identities=16% Similarity=0.236 Sum_probs=195.5
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc------CCCCccceeeEEEcC
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV------RHRNLLGLRGFYAGG 84 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~ 84 (325)
+...|.+++.||.| +++.||++.+..+++.||||.+.. .......+.+|+.+++.+ +|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G--~fg~V~~a~~~~~~~~vAvK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKG--SFGQVVKAYDHKVHQHVALKMVRN-EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp ETTTEEEEEEEEES--SSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred ccCcEEEEEEcccC--ccEEEEEEEECCCCcEEEEEEECC-ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 44568899999999 888899999999999999999975 344455777888888887 577999999999999
Q ss_pred CeEEEEEEecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCc--eEEeeecccc
Q 046728 85 DERLIVYDYMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFE--AKVADFGFAK 154 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~--~kL~Dfg~~~ 154 (325)
...++||||+. ++|.+++... ++...+..+..++..++.++|.. |||||+|||++.++. +||+|||++.
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999999995 6999998432 45556777888999999999975 899999999999887 9999999997
Q ss_pred ccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcc----------
Q 046728 155 LIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTP---------- 224 (325)
Q Consensus 155 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~---------- 224 (325)
..... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||...........+.....
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~ 326 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTB
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 65432 2235689999999999988999999999999999999999999976432211111100000
Q ss_pred -----ccccccccc------ccC------------cccc---------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 046728 225 -----YVQKGAFEH------IAD------------PRLK---------GKFNRDQLKSMVLIALRCTDSNPENRPTMTDV 272 (325)
Q Consensus 225 -----~~~~~~~~~------~~~------------~~~~---------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~i 272 (325)
......+.. ..+ .... .......++.+.+||.+||..||++|||++++
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~ 406 (429)
T 3kvw_A 327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA 406 (429)
T ss_dssp TTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHH
Confidence 000000000 000 0000 00111225679999999999999999999999
Q ss_pred HH--HHhcccC
Q 046728 273 VD--WLKGGLG 281 (325)
Q Consensus 273 l~--~l~~~~~ 281 (325)
++ ||+....
T Consensus 407 L~Hpw~~~~~~ 417 (429)
T 3kvw_A 407 LRHPWLRRRLP 417 (429)
T ss_dssp HTSTTTC----
T ss_pred hCChhhccCCC
Confidence 99 9886553
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=293.10 Aligned_cols=259 Identities=19% Similarity=0.282 Sum_probs=178.7
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
...|.+.+.||.| +++.||.+....+++.||||.+.... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 14 RDDYELQEVIGSG--ATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCEEEEECC-----CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred hhhhhhhheeccc--cceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 4568889999999 78889999998889999999986432 34456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcc----------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccccc
Q 046728 91 YDYMPNHSLITHLHG----------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLI 156 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~----------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~ 156 (325)
|||+++++|.+++.. .++...++.+..++..++.++|.. +||||+||+++.++.++|+|||++...
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 999999999999842 245556777888999999999875 799999999999999999999999866
Q ss_pred CCCcc----eeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccc
Q 046728 157 PDGVT----HMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAF 231 (325)
Q Consensus 157 ~~~~~----~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (325)
..... .......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.......... .... ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~-----~~~ 244 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM--LTLQ-----NDP 244 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH--HHHT-----SSC
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH--HHhc-----cCC
Confidence 53221 11223468999999999875 468999999999999999999999997644321110 0000 000
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 232 EHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
................++.+.+||.+||..||++|||+.++++ ||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 0000000111222345678999999999999999999999998 77654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=287.92 Aligned_cols=250 Identities=22% Similarity=0.270 Sum_probs=191.3
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCC---eEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE-EE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDD---QIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER-LI 89 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~---~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~l 89 (325)
|...+.||.| +++.||.+....+++ .||+|.+... .......+.+|+.++++++||||+++++++.+.+.. ++
T Consensus 23 ~~~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 23 THSDRVIGKG--HFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEE--TTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EccCceeccC--CCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 3445788888 777888887655544 7999999753 345556889999999999999999999999876655 99
Q ss_pred EEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc-
Q 046728 90 VYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT- 161 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 161 (325)
||||+.+|+|.++++. .++...++.+..++..++.++|.. |||||+||+++.++.+||+|||++........
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 9999999999999953 234455667888899999999875 79999999999999999999999986544321
Q ss_pred --eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 162 --HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 162 --~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
.......+|..|+|||.+.+..++.++||||||+++|+|++|..||..... .......... ..
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~-------------~~ 245 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTHFLAQ-------------GR 245 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHHHHT-------------TC
T ss_pred ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHHHhhc-------------CC
Confidence 112234578899999999988999999999999999999996555433221 1111111110 01
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
....+...++.+.+|+.+||..||++|||+.++++.|+++..
T Consensus 246 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 246 RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 112234456789999999999999999999999998887654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=294.45 Aligned_cols=254 Identities=20% Similarity=0.257 Sum_probs=195.2
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHc--cCCCCccceeeEEEcCC---
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGR--VRHRNLLGLRGFYAGGD--- 85 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~--- 85 (325)
+...|.+.+.||.| +++.||.++. +++.||||.+... ....+.+|.+++.. ++||||+++++++....
T Consensus 40 ~~~~y~~~~~lg~G--~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 40 IARTIVLQESIGKG--RFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHCEEEEEEEEE--TTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred ccccEEEEeeecCC--CCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 44677888999999 7777888876 4789999999642 34567788898887 68999999999998876
Q ss_pred -eEEEEEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHh--------h----cCCCCCCceeeCCCCceEEeeec
Q 046728 86 -ERLIVYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAE--------G----IADIKASNVLLDTDFEAKVADFG 151 (325)
Q Consensus 86 -~~~lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~--------~----~rdlkp~Nil~~~~~~~kL~Dfg 151 (325)
..++||||+++|+|.++++ ..++...++.+..++..++.++| . ||||||+|||++.++.+||+|||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred ceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 7899999999999999995 34666677889999999999999 3 48999999999999999999999
Q ss_pred cccccCCCcce---eeccCCCCcCCCCccccccCC------CCCcccchhHHHHHHHHHhC----------CCCCCCCCC
Q 046728 152 FAKLIPDGVTH---MTTRVKGTLGYLAPEYAMWGK------VSDSCDVYSFGVLLLELISA----------KKPLEKLPG 212 (325)
Q Consensus 152 ~~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~------~~~~~DiwSlG~il~el~tg----------~~pf~~~~~ 212 (325)
++......... ......||..|+|||++.+.. ++.++|||||||++|+|+|| ..||.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 99866544322 223456899999999988652 33689999999999999999 778765432
Q ss_pred CccchhhhhhcccccccccccccCccccCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 213 GVKRDIVQWVTPYVQKGAFEHIADPRLKGKF-----NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
...... .+ ... +......... ....+..+.+||.+||..||++|||+.++++.|+.+..
T Consensus 273 ~~~~~~-~~-~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 273 SDPSVE-EM-RKV--------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp SSCCHH-HH-HHH--------HTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcccHH-HH-HHH--------HHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 211100 00 000 0011111111 23567789999999999999999999999999987654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=289.47 Aligned_cols=245 Identities=20% Similarity=0.309 Sum_probs=190.1
Q ss_pred HhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCCC
Q 046728 18 IQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNH 97 (325)
Q Consensus 18 ~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~g 97 (325)
...||.| +++.||.+....+++.||+|.+..........+.+|+.+++.++||||+++++++.+....++||||++++
T Consensus 27 ~~~lg~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 104 (295)
T 2clq_A 27 RVVLGKG--TYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGG 104 (295)
T ss_dssp BCEEEEC--SSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred cEEEeec--CcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCC
Confidence 3478887 88889999999999999999998766666678999999999999999999999999999999999999999
Q ss_pred ChhhhhccC-----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC-CCceEEeeeccccccCCCcceeeccC
Q 046728 98 SLITHLHGR-----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT-DFEAKVADFGFAKLIPDGVTHMTTRV 167 (325)
Q Consensus 98 sL~~~l~~~-----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~ 167 (325)
+|.+++... +++..+..+..++..++.++|.. +||||+||+++. ++.++|+|||++......... ....
T Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~ 183 (295)
T 2clq_A 105 SLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC-TETF 183 (295)
T ss_dssp EHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCC
T ss_pred CHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc-cccc
Confidence 999999543 22334455678889999999875 799999999987 899999999999876543221 2344
Q ss_pred CCCcCCCCccccccCC--CCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCH
Q 046728 168 KGTLGYLAPEYAMWGK--VSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNR 245 (325)
Q Consensus 168 ~~t~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (325)
.||..|+|||++.+.. ++.++||||||+++|+|++|..||........ ....... .......+.
T Consensus 184 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~------------~~~~~~~~~ 249 (295)
T 2clq_A 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--AMFKVGM------------FKVHPEIPE 249 (295)
T ss_dssp CCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--HHHHHHH------------HCCCCCCCT
T ss_pred CCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--HHHhhcc------------ccccccccc
Confidence 6899999999987653 78899999999999999999999964322110 0000000 001122344
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 246 DQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 246 ~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
..++.+.+||.+||..||++|||+.++++ ||+..
T Consensus 250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 250 SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp TSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 56778999999999999999999999997 77643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=290.35 Aligned_cols=251 Identities=21% Similarity=0.257 Sum_probs=186.2
Q ss_pred ccchhHHhhccCccceeeeeEEEeccC---CCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRET---GDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
...|.+.+.||.| +++.||.+.... +++.||+|.+... .......+.+|+.++++++||||+++++++.+...
T Consensus 33 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 33 RNLLILGKILGEG--EFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp GGGEEEEEEEEC---CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred HHHeeeccceeec--CCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 3567888999999 677788776554 4558999998643 34555688999999999999999999999877553
Q ss_pred -----EEEEEEecCCCChhhhhc--------cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEee
Q 046728 87 -----RLIVYDYMPNHSLITHLH--------GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVAD 149 (325)
Q Consensus 87 -----~~lV~e~~~~gsL~~~l~--------~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~D 149 (325)
.++||||+++|+|.+++. ..++...++.+..++..++.++|.. |||||+||+++.++.+||+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECS
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEee
Confidence 599999999999999983 2244556677888888899999875 79999999999999999999
Q ss_pred eccccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhccccc
Q 046728 150 FGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQ 227 (325)
Q Consensus 150 fg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 227 (325)
||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......... ....
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~~~---- 263 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY---DYLL---- 263 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---HHHH----
T ss_pred cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH---HHHH----
Confidence 9999866543221 1223346788999999998889999999999999999999 89998754332111 1100
Q ss_pred ccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 228 KGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
. ......+...++.+.+||.+||..||++|||+.++++.|+.+.
T Consensus 264 ~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 264 H---------GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp T---------TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred c---------CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 0011233456678999999999999999999999999988765
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=292.56 Aligned_cols=269 Identities=16% Similarity=0.231 Sum_probs=196.0
Q ss_pred eeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEE-----
Q 046728 8 CFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYA----- 82 (325)
Q Consensus 8 ~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 82 (325)
.+.+...|.+++.||.| +++.||.+....+++.||+|.+...+......+.+|+.++++++||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCG--GNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp CEEETTTEEEEEECC-------CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred cCccCCceeEEEEeccC--CCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence 56788899999999999 88889999999999999999998767777788999999999999999999999874
Q ss_pred ---------cCCeEEEEEEecCCCChhhhhcc-CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeC-CCCceEE
Q 046728 83 ---------GGDERLIVYDYMPNHSLITHLHG-RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLD-TDFEAKV 147 (325)
Q Consensus 83 ---------~~~~~~lV~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~-~~~~~kL 147 (325)
+....++||||+. |+|.+++.. .+++..++.+..++..++.++|.. |||||+||+++ .++.+||
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CCC----CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 3467899999997 699999953 455666777888999999999975 79999999997 5679999
Q ss_pred eeeccccccCCCcce--eeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcc
Q 046728 148 ADFGFAKLIPDGVTH--MTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTP 224 (325)
Q Consensus 148 ~Dfg~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 224 (325)
+|||++......... ......+|..|+|||++.+ ..++.++|||||||++|+|++|..||...........+....+
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999999866432111 1223357889999998865 5788999999999999999999999975432111100000000
Q ss_pred cccccc-------ccc-----ccCccc-cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 225 YVQKGA-------FEH-----IADPRL-KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 225 ~~~~~~-------~~~-----~~~~~~-~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
...... ... ...+.. ........+..+.+||.+||..||++|||++++++ ||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 000000 000 000000 00011245678999999999999999999999998 88753
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=286.97 Aligned_cols=242 Identities=29% Similarity=0.372 Sum_probs=188.1
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcC-CeEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG-DERLIVY 91 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lV~ 91 (325)
+.|.+.+.||.| +++.||.++. .++.||+|.+.... ....+.+|+.++++++||||+++++++.+. ...++||
T Consensus 21 ~~y~~~~~lg~G--~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 21 KELKLLQTIGKG--EFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGEEEEEEEEEC--SSCEEEEEEE--TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhceEEeEEecC--CCceEEEEEE--cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 678899999999 7777888865 37899999997532 456789999999999999999999997554 5789999
Q ss_pred EecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 92 DYMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 92 e~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||+++++|.+++... ++...++.+..++..++.++|.. +||||+||+++.++.++|+|||++.......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 171 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 171 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc---
Confidence 999999999999532 56666778889999999999975 7999999999999999999999987554321
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
....++..|+|||++.+..++.++||||||+++|+|++ |..||...+.... ...+. ......
T Consensus 172 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~~-------------~~~~~~ 234 (278)
T 1byg_A 172 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVE-------------KGYKMD 234 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHHT-------------TTCCCC
T ss_pred -cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHh-------------cCCCCC
Confidence 22347889999999998889999999999999999998 9999975432111 11110 111123
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
.+...++.+.++|.+||..||++|||+.++++.|+.+.
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 34456778999999999999999999999999988754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=286.87 Aligned_cols=253 Identities=23% Similarity=0.263 Sum_probs=192.7
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCC---CCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEE-EcCC
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETG---DDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFY-AGGD 85 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~---~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 85 (325)
....|.+.+.||.| +++.||.+....+ ...||+|.+... .......+.+|+.++++++||||+++++++ ..+.
T Consensus 23 ~~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 23 SSLIVHFNEVIGRG--HFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GGEEEEEEEEEEEE--TTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred cceehhhcceeeec--CCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 34557788999999 7777888875443 346899998753 445567899999999999999999999985 4556
Q ss_pred eEEEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCC
Q 046728 86 ERLIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 158 (325)
..++||||+.+|+|.++++. .++...++.+..++..++.++|.. |||||+||+++.++.+||+|||++.....
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 78999999999999999953 244455667788899999999875 79999999999999999999999986654
Q ss_pred Ccce---eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccc
Q 046728 159 GVTH---MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHI 234 (325)
Q Consensus 159 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (325)
.... ......+|+.|+|||.+.+..++.++||||||+++|+|++ +.+||..............
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~------------- 247 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------------- 247 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT-------------
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc-------------
Confidence 3221 1223456788999999998899999999999999999999 5666654332211111100
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 235 ADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
......+...++.+.+++.+||..||++|||+.++++.|+.+..
T Consensus 248 ---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 248 ---GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00112233456789999999999999999999999999987764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=285.28 Aligned_cols=251 Identities=18% Similarity=0.205 Sum_probs=193.5
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC----hhhHHHHHHHHHHHHccCCCCccceeeEEE--cC
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN----AKAEMEFAVEVEILGRVRHRNLLGLRGFYA--GG 84 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~ 84 (325)
+...|.+.+.||.| +++.||.+.+..+++.||+|.+.... ......+.+|++++++++||||+++++++. +.
T Consensus 3 l~~~y~i~~~lg~G--~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (305)
T 2wtk_C 3 LIGKYLMGDLLGEG--SYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK 80 (305)
T ss_dssp --CCBCCCCEEEEC--SSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC--
T ss_pred cccceeEeeEEecC--CCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Confidence 34578899999999 88889999999999999999996432 234568899999999999999999999984 45
Q ss_pred CeEEEEEEecCCCChhhhhc----cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccccc
Q 046728 85 DERLIVYDYMPNHSLITHLH----GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLI 156 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~----~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~ 156 (325)
...++||||+.++ |.+++. ..++...+..+..++..++.++|.. +||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 6789999999875 777663 2355556677888999999999975 799999999999999999999999876
Q ss_pred CCCc-ceeeccCCCCcCCCCccccccCC--CCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccc
Q 046728 157 PDGV-THMTTRVKGTLGYLAPEYAMWGK--VSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEH 233 (325)
Q Consensus 157 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (325)
.... ........+|..|+|||++.+.. ++.++||||||+++|+|++|..||..... ......+. ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i~----~~~--- 229 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI---YKLFENIG----KGS--- 229 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHH----HCC---
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH---HHHHHHHh----cCC---
Confidence 5321 12223456899999999987643 36799999999999999999999975321 11111110 100
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 234 IADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
...+...++.+.+||.+||..||++|||++++++ ||+....
T Consensus 230 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 230 -------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp -------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred -------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 1122345678999999999999999999999998 8886554
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=289.23 Aligned_cols=247 Identities=20% Similarity=0.284 Sum_probs=198.2
Q ss_pred cceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEc--
Q 046728 6 NICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG-- 83 (325)
Q Consensus 6 ~~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 83 (325)
++.-.+...|.+++.||.| +++.||.++...+++.||+|.+.... ..+.+|++++++++||||+++++++..
T Consensus 4 ~~~~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 77 (284)
T 2a19_B 4 TVDKRFGMDFKEIELIGSG--GFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFD 77 (284)
T ss_dssp CCCHHHHHHEEEEEEEECS--SSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEE
T ss_pred cccchhccccceeeeeccC--CceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccc
Confidence 3444567778899999999 77889999999899999999997543 256789999999999999999998854
Q ss_pred --------------CCeEEEEEEecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC
Q 046728 84 --------------GDERLIVYDYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT 141 (325)
Q Consensus 84 --------------~~~~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~ 141 (325)
....++||||+++|+|.+++.. .++...++.+..++..++.++|.. +||||+||+++.
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVD 157 (284)
T ss_dssp EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE
T ss_pred cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcC
Confidence 3457999999999999999942 355556677888999999999975 799999999999
Q ss_pred CCceEEeeeccccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhh
Q 046728 142 DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQW 221 (325)
Q Consensus 142 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~ 221 (325)
++.++|+|||++........ .....+|+.|+|||++.+..++.++||||||+++|+|++|..||.... ....
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~~~~- 229 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----KFFT- 229 (284)
T ss_dssp TTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----HHHH-
T ss_pred CCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----HHHH-
Confidence 99999999999987655322 223458999999999998889999999999999999999998874210 0000
Q ss_pred hcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 222 VTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.+... ..+...+..+.+||.+||..||++|||+.++++.|+.+..
T Consensus 230 -----------~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 230 -----------DLRDG----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp -----------HHHTT----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred -----------Hhhcc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 00001 1123345678999999999999999999999998886653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=288.52 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=193.0
Q ss_pred eeecccchhHHhhccCccceeeeeEEEeccC-CC--CeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEE
Q 046728 8 CFLLASPAVFIQNINNGLEILMLLLLLRRET-GD--DQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFY 81 (325)
Q Consensus 8 ~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~-~~--~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (325)
.......|.+++.||.| +++.||.+.... ++ ..||+|.+... .......+.+|++++++++||||+++++++
T Consensus 13 ~~~~~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDG--SFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 90 (291)
T ss_dssp EECCGGGEEEEEECC------CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccchhHeeeeeeecCC--CceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 44456789999999999 777888887543 23 36899998643 334566889999999999999999999999
Q ss_pred EcCCeEEEEEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccc
Q 046728 82 AGGDERLIVYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 82 ~~~~~~~lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
.+.. .++||||+++++|.+++. ..++...+..+..++..++.++|.. +||||+||+++.++.++|+|||++.
T Consensus 91 ~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 91 LTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp CSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccc
Confidence 8765 889999999999999994 3366677788889999999999975 7999999999999999999999998
Q ss_pred ccCCCcce--eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhccccccccc
Q 046728 155 LIPDGVTH--MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAF 231 (325)
Q Consensus 155 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (325)
........ ......+|..|+|||++.+..++.++||||||+++|+|++ |..||....... ....+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~--------- 237 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKI--------- 237 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH---------
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH---HHHHH---------
Confidence 76543322 1223457778999999988888999999999999999999 999997543211 11111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 232 EHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.......+.+...++.+.++|.+||..||++|||+.+++++|++...
T Consensus 238 ---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 238 ---DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ---HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ---HccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 01111122334567789999999999999999999999999987664
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=292.72 Aligned_cols=251 Identities=19% Similarity=0.265 Sum_probs=191.0
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc-CCCCccceeeEEEc------
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAG------ 83 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~------ 83 (325)
....|.+++.||.| +++.||.++...+++.||+|.+.... .....+.+|+.+++++ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 22 PAGIFELVELVGNG--TYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CTTTEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred CCCcEEEEEEeccC--CCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 34567889999999 77889999999999999999997533 3345788999999999 79999999999976
Q ss_pred CCeEEEEEEecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccc
Q 046728 84 GDERLIVYDYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 84 ~~~~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
....++||||+.+|+|.+++.. .+++..+..+..++..++.++|.. +||||+||+++.++.++|+|||++..
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence 4678999999999999999953 355556677888999999999975 79999999999999999999999886
Q ss_pred cCCCcceeeccCCCCcCCCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccc
Q 046728 156 IPDGVTHMTTRVKGTLGYLAPEYAM-----WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGA 230 (325)
Q Consensus 156 ~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (325)
...... ......+|..|+|||++. +..++.++|||||||++|+|++|..||....... ...... ...
T Consensus 179 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~----~~~ 250 (326)
T 2x7f_A 179 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR---ALFLIP----RNP 250 (326)
T ss_dssp -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHH----HSC
T ss_pred cCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHhh----cCc
Confidence 543221 123346899999999987 4568899999999999999999999996533211 110000 000
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 231 FEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
. ........++.+.+||.+||..||++|||+.++++ ||+...
T Consensus 251 ~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 251 A--------PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp C--------CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred c--------ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 0 01112345678999999999999999999999998 887643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=297.53 Aligned_cols=260 Identities=16% Similarity=0.194 Sum_probs=192.9
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEc--------
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG-------- 83 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------- 83 (325)
...|.+.+.||.| +++.||.+.+..+++.||||.+..... ...+|+++++.++||||+++++++..
T Consensus 6 ~~~y~~~~~lG~G--~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 6 SKKYSLGKTLGTG--SFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp CTTEEEEEEEECC---CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cceEEEEEEEEec--cCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4568889999999 888899999999999999999864321 23369999999999999999999843
Q ss_pred ------------------------------CCeEEEEEEecCCCChhhhhc------cCCCCCCccCHHHHHHHHHHHHh
Q 046728 84 ------------------------------GDERLIVYDYMPNHSLITHLH------GRLAPDCLLDWHRRVSIAIGSAE 127 (325)
Q Consensus 84 ------------------------------~~~~~lV~e~~~~gsL~~~l~------~~~~~~~~~~~~~~~~~~~~~~~ 127 (325)
....++||||++ |+|.+.+. ..++...+..+..++..++.++|
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 334889999997 58877774 33555667778889999999999
Q ss_pred hc----CCCCCCceeeC-CCCceEEeeeccccccCCCcceeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHH
Q 046728 128 GI----ADIKASNVLLD-TDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELI 201 (325)
Q Consensus 128 ~~----rdlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~ 201 (325)
.. |||||+|||++ .++.+||+|||++........ .....+|..|+|||++.+. .++.++||||+||++|+|+
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 75 79999999997 688999999999987654332 2334689999999998765 4899999999999999999
Q ss_pred hCCCCCCCCCCCccchhhhhh------------cccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 046728 202 SAKKPLEKLPGGVKRDIVQWV------------TPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTM 269 (325)
Q Consensus 202 tg~~pf~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 269 (325)
+|..||.+.........+... .+......+............+...++.+.+||.+||..||++|||+
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 999999764322111111000 00000011111111111222334467789999999999999999999
Q ss_pred HHHHH--HHhccc
Q 046728 270 TDVVD--WLKGGL 280 (325)
Q Consensus 270 ~~il~--~l~~~~ 280 (325)
.++++ ||+.+.
T Consensus 317 ~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 317 YEAMAHPFFDHLR 329 (383)
T ss_dssp HHHHTSGGGHHHH
T ss_pred HHHhcCHHHHHHH
Confidence 99998 887654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=313.24 Aligned_cols=242 Identities=21% Similarity=0.287 Sum_probs=188.2
Q ss_pred hccCccceeeeeEEEecc--CCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecCC
Q 046728 20 NINNGLEILMLLLLLRRE--TGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPN 96 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~--~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~~ 96 (325)
.||.| +++.||++... .++..||||.++.. .......+.+|+++|++++||||+++++++.+ +..++|||||.+
T Consensus 343 ~LG~G--~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~ 419 (613)
T 2ozo_A 343 ELGCG--NFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG 419 (613)
T ss_dssp EEEEC--SSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred EEecC--CCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence 57777 77777776543 45678999999753 33456789999999999999999999999976 568999999999
Q ss_pred CChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee--eccC
Q 046728 97 HSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM--TTRV 167 (325)
Q Consensus 97 gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~ 167 (325)
|+|.+++.. .++...++.+..++..++.++|.. |||||+|||++.++.+||+|||+++......... ....
T Consensus 420 g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 499 (613)
T 2ozo_A 420 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 499 (613)
T ss_dssp CBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------------
T ss_pred CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCC
Confidence 999999953 355566777888899999999975 7999999999999999999999998765432211 1222
Q ss_pred CCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHH
Q 046728 168 KGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRD 246 (325)
Q Consensus 168 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (325)
.+|+.|+|||++.+..++.++|||||||++|||++ |..||........ ...+. . +.+...+..
T Consensus 500 ~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~~~i~----~---------~~~~~~p~~ 563 (613)
T 2ozo_A 500 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAFIE----Q---------GKRMECPPE 563 (613)
T ss_dssp --CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH---HHHHH----T---------TCCCCCCTT
T ss_pred CCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HHHHH----c---------CCCCCCCCc
Confidence 35688999999998899999999999999999998 9999976543221 11111 0 112233456
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 247 QLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 247 ~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
+++.+.+||.+||..||++|||+.++++.|+...
T Consensus 564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 564 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 7789999999999999999999999999888765
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=293.01 Aligned_cols=248 Identities=19% Similarity=0.200 Sum_probs=181.1
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-CCCccceeeEEE--------
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HRNLLGLRGFYA-------- 82 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~-------- 82 (325)
...|.+.+.||.| +++.||++++..+++.||+|.+..........+.+|+.+++++. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEG--GFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECC--SSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccC--CceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 3467889999999 88889999999999999999997666666778999999999995 999999999984
Q ss_pred cCCeEEEEEEecCCCChhhhhcc-----CCCCCCccCHHHHHHHHHHHHhh------cCCCCCCceeeCCCCceEEeeec
Q 046728 83 GGDERLIVYDYMPNHSLITHLHG-----RLAPDCLLDWHRRVSIAIGSAEG------IADIKASNVLLDTDFEAKVADFG 151 (325)
Q Consensus 83 ~~~~~~lV~e~~~~gsL~~~l~~-----~~~~~~~~~~~~~~~~~~~~~~~------~rdlkp~Nil~~~~~~~kL~Dfg 151 (325)
.....++||||+. |+|.+++.. .++...++.+..++..++.++|. ||||||+|||++.++.+||+|||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 3345789999995 799998842 35666778888999999999985 37999999999999999999999
Q ss_pred cccccCCCcce-----------eeccCCCCcCCCCcccc---ccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccch
Q 046728 152 FAKLIPDGVTH-----------MTTRVKGTLGYLAPEYA---MWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRD 217 (325)
Q Consensus 152 ~~~~~~~~~~~-----------~~~~~~~t~~y~aPE~~---~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~ 217 (325)
++......... ......+|+.|+|||++ .+..++.++|||||||++|+|++|..||........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-- 261 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI-- 261 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh--
Confidence 99876543221 11134589999999998 456788899999999999999999999964322100
Q ss_pred hhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 218 IVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.............+..+.+||.+||..||++|||+.++++.|+.+..
T Consensus 262 -----------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 262 -----------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ---------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00001111122233468899999999999999999999999887754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=315.87 Aligned_cols=242 Identities=23% Similarity=0.288 Sum_probs=189.2
Q ss_pred hccCccceeeeeEEE--eccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEecC
Q 046728 20 NINNGLEILMLLLLL--RRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~--~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~~ 95 (325)
.||.| +++.||++ ....+++.||||+++.. +.....++.+|+++|++++||||+++++++.. ...++|||||+
T Consensus 376 ~LG~G--~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 376 ELGSG--NFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEC--SSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred EeccC--CCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 57777 77778877 55566789999999743 33446789999999999999999999999975 45889999999
Q ss_pred CCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce--eeccC
Q 046728 96 NHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH--MTTRV 167 (325)
Q Consensus 96 ~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~ 167 (325)
+|+|.++++. .++...++.+..++..++.++|.. |||||+|||++.++.+||+|||+++........ .....
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 532 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 532 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCC
Confidence 9999999953 356666788889999999999975 799999999999999999999999876543321 12233
Q ss_pred CCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHH
Q 046728 168 KGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRD 246 (325)
Q Consensus 168 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (325)
.+|+.|+|||++.+..++.++|||||||++|||++ |..||........ ...+. .......+..
T Consensus 533 ~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~~~i~-------------~~~~~~~p~~ 596 (635)
T 4fl3_A 533 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TAMLE-------------KGERMGCPAG 596 (635)
T ss_dssp --CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHH-------------TTCCCCCCTT
T ss_pred CCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH-------------cCCCCCCCCC
Confidence 46788999999998899999999999999999998 9999976443211 11111 0111233455
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 247 QLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 247 ~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
+++++.+||.+||..||++|||+.+|++.|+...
T Consensus 597 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 597 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 6789999999999999999999999999888653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=297.69 Aligned_cols=249 Identities=24% Similarity=0.297 Sum_probs=183.1
Q ss_pred hhHHhhccCccceeeeeEEEeccCC---CCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEc-CCeEEE
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETG---DDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG-GDERLI 89 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~---~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l 89 (325)
|.+.+.||.| +++.||.+....+ +..||+|.+... ......++.+|+.++++++||||+++++++.. ....++
T Consensus 91 ~~~~~~LG~G--~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 91 VHFNEVIGRG--HFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEECC--SSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eecCcEeeeC--CCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 4566789998 7777888775433 346899998643 34556789999999999999999999998654 567899
Q ss_pred EEEecCCCChhhhhccC---CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 90 VYDYMPNHSLITHLHGR---LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
||||+++|+|.++++.. ++...++.+..++..++.++|.. |||||+|||++.++.+||+|||+++........
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 99999999999999532 33445566778889999999875 799999999999999999999999865433211
Q ss_pred ---eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCcc
Q 046728 163 ---MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPR 238 (325)
Q Consensus 163 ---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (325)
......+|..|+|||++.+..++.++|||||||++|+|+| |.+||.......... ... .+
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~---~~~----~~--------- 312 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLL----QG--------- 312 (373)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH---HHH----TT---------
T ss_pred cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH---HHH----cC---------
Confidence 1223346788999999998899999999999999999999 677876543322111 110 00
Q ss_pred ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 239 LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.....+..++..+.++|.+||..||++|||+.++++.|+.+..
T Consensus 313 ~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 313 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0112234456789999999999999999999999998887764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=294.80 Aligned_cols=272 Identities=19% Similarity=0.244 Sum_probs=202.6
Q ss_pred cceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC
Q 046728 6 NICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG 84 (325)
Q Consensus 6 ~~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (325)
.+.+.+...|.+.+.||.| +++.||.+.+..+++.||||.+... ......++.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~i~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 81 (353)
T 2b9h_A 4 RIVYNISSDFQLKSLLGEG--AYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPD 81 (353)
T ss_dssp TCCCCSCTTEEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred ccccccccceEEeeEEcCC--CCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccc
Confidence 4677888999999999999 7888999999999999999999643 344556788999999999999999999987654
Q ss_pred -----CeEEEEEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccc
Q 046728 85 -----DERLIVYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 85 -----~~~~lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
...++||||+. |+|.+++. ..++...+..+..++..++.++|.. |||||+||+++.++.+||+|||++.
T Consensus 82 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 82 SFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp CSTTCCCEEEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ccCccceEEEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 67899999996 69999885 4466777788899999999999985 7999999999999999999999998
Q ss_pred ccCCCcce---------eeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcc
Q 046728 155 LIPDGVTH---------MTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTP 224 (325)
Q Consensus 155 ~~~~~~~~---------~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 224 (325)
........ ......||..|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 76542211 1122468999999998764 6788999999999999999999999975432111000000000
Q ss_pred ccc-ccccccccC--------------ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 225 YVQ-KGAFEHIAD--------------PRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 225 ~~~-~~~~~~~~~--------------~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
... ......... ...........++.+.+||.+||..||++|||+.++++ ||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 000 000000000 00000011345678999999999999999999999998 887654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=291.13 Aligned_cols=251 Identities=22% Similarity=0.346 Sum_probs=191.8
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--------hhhHHHHHHHHHHHHccCCCCccceeeEEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--------AKAEMEFAVEVEILGRVRHRNLLGLRGFYA 82 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (325)
+...|.+.+.||.| +++.||.+.+..+++.||||.+.... ......+.+|++++++++||||+++++++.
T Consensus 8 l~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 8 LRDEYIMSKTLGSG--ACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHEEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhceeEeeEEecC--CCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 45678889999999 78889999999999999999986432 122235788999999999999999999987
Q ss_pred cCCeEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCc---eEEeeeccc
Q 046728 83 GGDERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFE---AKVADFGFA 153 (325)
Q Consensus 83 ~~~~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~---~kL~Dfg~~ 153 (325)
... .++||||+++++|.+++. ..+++..+..+..++..++.++|.. |||||+||+++.++. +||+|||++
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 665 899999999999999984 3455666777888999999999975 799999999987654 999999999
Q ss_pred cccCCCcceeeccCCCCcCCCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccc
Q 046728 154 KLIPDGVTHMTTRVKGTLGYLAPEYAM---WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGA 230 (325)
Q Consensus 154 ~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (325)
........ .....||..|+|||++. ...++.++|||||||++|+|++|..||......... ...+. .+.
T Consensus 165 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~----~~~ 236 (322)
T 2ycf_A 165 KILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQIT----SGK 236 (322)
T ss_dssp EECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--HHHHH----HTC
T ss_pred eecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--HHHHH----hCc
Confidence 87654322 22345899999999974 456889999999999999999999999764332111 11100 000
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 231 FEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
.. .....+...++.+.+||.+||..||++|||+.++++ ||+.
T Consensus 237 ~~------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 237 YN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp CC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred cc------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 00 000111235678999999999999999999999997 6653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=288.86 Aligned_cols=263 Identities=16% Similarity=0.231 Sum_probs=198.6
Q ss_pred ecccchhHHhhccCccceeeeeEEEec-cCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCC------CccceeeEEE
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRR-ETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHR------NLLGLRGFYA 82 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~ 82 (325)
.+...|.+++.||.| +++.||.+.. ..+++.||+|.+... ......+.+|+++++.++|+ +++++++++.
T Consensus 11 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 11 VLSARYEIVDTLGEG--AFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp EETTTEEEEEEEEEE--TTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred CccCceEEEEEEecC--CCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 356788999999999 7778999887 567889999999753 34456788899999998655 4999999999
Q ss_pred cCCeEEEEEEecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC-------------
Q 046728 83 GGDERLIVYDYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT------------- 141 (325)
Q Consensus 83 ~~~~~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~------------- 141 (325)
+....++||||+ +++|.+++.. .++...+..+..++..++.++|.. |||||+|||++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999999 8899999953 244556778889999999999975 799999999987
Q ss_pred ------CCceEEeeeccccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCcc
Q 046728 142 ------DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVK 215 (325)
Q Consensus 142 ------~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~ 215 (325)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 668999999999865432 2234689999999999988999999999999999999999999975433221
Q ss_pred chhhhhhcccccccc----------------ccc----------ccCc-cccCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 046728 216 RDIVQWVTPYVQKGA----------------FEH----------IADP-RLKGKFNRDQLKSMVLIALRCTDSNPENRPT 268 (325)
Q Consensus 216 ~~~~~~~~~~~~~~~----------------~~~----------~~~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps 268 (325)
...+........... +.. ...+ ..........++.+.+||.+||..||++|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 111111000000000 000 0000 0001123456788999999999999999999
Q ss_pred HHHHHH--HHhccc
Q 046728 269 MTDVVD--WLKGGL 280 (325)
Q Consensus 269 ~~~il~--~l~~~~ 280 (325)
+.++++ ||+...
T Consensus 323 ~~ell~hp~f~~~~ 336 (339)
T 1z57_A 323 LREALKHPFFDLLK 336 (339)
T ss_dssp HHHHTTSGGGGGGG
T ss_pred HHHHhcCHHHHHHh
Confidence 999997 887643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=293.40 Aligned_cols=256 Identities=19% Similarity=0.281 Sum_probs=195.4
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChh-----------------hHHHHHHHHHHHHccCCCCc
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAK-----------------AEMEFAVEVEILGRVRHRNL 74 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~~i 74 (325)
...|.+++.||.| +++.||.++. +++.||+|.+...... ....+.+|+.++++++||||
T Consensus 30 ~~~y~~~~~lg~G--~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 30 INDYRIIRTLNQG--KFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp ETTEEEEEEEECC--SSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cCceEEEEEEcCC--CCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 3678999999999 7778999887 7899999998642211 11688999999999999999
Q ss_pred cceeeEEEcCCeEEEEEEecCCCChhhh------hcc----CCCCCCccCHHHHHHHHHHHHhh-c----CCCCCCceee
Q 046728 75 LGLRGFYAGGDERLIVYDYMPNHSLITH------LHG----RLAPDCLLDWHRRVSIAIGSAEG-I----ADIKASNVLL 139 (325)
Q Consensus 75 v~~~~~~~~~~~~~lV~e~~~~gsL~~~------l~~----~~~~~~~~~~~~~~~~~~~~~~~-~----rdlkp~Nil~ 139 (325)
+++++++.+.+..++||||+++|+|.++ +.. .++...++.+..++..++.++|. . +||||+||++
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 9999999999999999999999999999 532 34555667788899999999998 4 7999999999
Q ss_pred CCCCceEEeeeccccccCCCcceeeccCCCCcCCCCccccccC-CCCC-cccchhHHHHHHHHHhCCCCCCCCCCCccch
Q 046728 140 DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWG-KVSD-SCDVYSFGVLLLELISAKKPLEKLPGGVKRD 217 (325)
Q Consensus 140 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~-~~DiwSlG~il~el~tg~~pf~~~~~~~~~~ 217 (325)
+.++.++|+|||++...... ......+|..|+|||++.+. .++. ++||||||+++|+|++|..||...... ..
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~ 260 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VE 260 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HH
Confidence 99999999999999876443 23345689999999999876 5666 999999999999999999999764331 11
Q ss_pred hhhhhccccccccccc----cc---CccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 218 IVQWVTPYVQKGAFEH----IA---DPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 218 ~~~~~~~~~~~~~~~~----~~---~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
....+.... ..+.. .. ............++.+.+||.+||..||++|||+.++++ ||+.
T Consensus 261 ~~~~i~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 261 LFNNIRTKN--IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HHHHHTSCC--CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHhccC--cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 111111100 00000 00 000000111446778999999999999999999999998 7764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=284.37 Aligned_cols=254 Identities=22% Similarity=0.281 Sum_probs=201.0
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
..+...|.+++.||.| +++.||.++...+++.||+|.+... .......+.+|++++++++||||+++++++.+...
T Consensus 18 ~~~~~~y~i~~~lg~G--~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 18 GTFAERYNIVCMLGKG--SFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp HHHHHHEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred HHHhhcceeeEEEcCC--CCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 3456788999999999 7788999999989999999998642 23445688999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC---CceEEeeeccccccC
Q 046728 87 RLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD---FEAKVADFGFAKLIP 157 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~---~~~kL~Dfg~~~~~~ 157 (325)
.++||||+++++|.+++. ..++...++.+..++..++.++|.. +||||+||+++.+ +.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999999999999883 4566777788899999999999976 7999999999754 469999999998665
Q ss_pred CCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 158 DGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 158 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
.... .....+|..|+|||++.+ .++.++||||||+++|+|++|..||...... .....+. .+...
T Consensus 176 ~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~----~~~~~----- 240 (287)
T 2wei_A 176 QNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKRVE----TGKYA----- 240 (287)
T ss_dssp CCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----HCCCC-----
T ss_pred CCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHH----cCCCC-----
Confidence 4322 122347889999999875 5889999999999999999999999754321 1111110 11100
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
...+....+++.+.+||.+||..||++|||+.++++ ||+...
T Consensus 241 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 241 -FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp -CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred -CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 001112345678999999999999999999999998 887643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=293.46 Aligned_cols=260 Identities=20% Similarity=0.284 Sum_probs=199.5
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC--------CCCccceeeEE
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR--------HRNLLGLRGFY 81 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--------h~~iv~~~~~~ 81 (325)
.+...|.+++.||.| +++.||++++..+++.||||.+.. .......+.+|+.+++.++ ||||+++++++
T Consensus 34 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 34 LFNGRYHVIRKLGWG--HFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp EETTTEEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred hcCCeEEEEEEeeec--CCeeEEEEEecCCCeEEEEEEEec-CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 456789999999999 888899999999999999999975 3445568889999999985 78899999998
Q ss_pred E----cCCeEEEEEEecCCCChhhhhc----cCCCCCCccCHHHHHHHHHHHHhhc-----CCCCCCceeeCCCC-----
Q 046728 82 A----GGDERLIVYDYMPNHSLITHLH----GRLAPDCLLDWHRRVSIAIGSAEGI-----ADIKASNVLLDTDF----- 143 (325)
Q Consensus 82 ~----~~~~~~lV~e~~~~gsL~~~l~----~~~~~~~~~~~~~~~~~~~~~~~~~-----rdlkp~Nil~~~~~----- 143 (325)
. +....++||||+ +++|.+++. ..++...++.+..++..++.++|.. |||||+|||++.++
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhh
Confidence 7 566789999999 667777763 2366667888999999999999964 69999999998775
Q ss_pred --------------------------------------------ceEEeeeccccccCCCcceeeccCCCCcCCCCcccc
Q 046728 144 --------------------------------------------EAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYA 179 (325)
Q Consensus 144 --------------------------------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 179 (325)
.+||+|||++...... .....||..|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 7999999999876432 2234689999999999
Q ss_pred ccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccc---c-------------------cccccccccCc
Q 046728 180 MWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPY---V-------------------QKGAFEHIADP 237 (325)
Q Consensus 180 ~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~---~-------------------~~~~~~~~~~~ 237 (325)
.+..++.++|||||||++|+|++|..||.................. . ..+.+..+...
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 9889999999999999999999999999765443321111000000 0 00000000000
Q ss_pred c---------ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHh
Q 046728 238 R---------LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLK 277 (325)
Q Consensus 238 ~---------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~ 277 (325)
. -....+...++.+.+||.+||..||++|||+.++++ ||+
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0 011234677889999999999999999999999998 765
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=294.54 Aligned_cols=266 Identities=16% Similarity=0.204 Sum_probs=188.6
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-----------ChhhHHHHHHHHHHHHccCCCCcccee
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-----------NAKAEMEFAVEVEILGRVRHRNLLGLR 78 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 78 (325)
.+...|.+.+.||.| +++.||.+.+.. ++.||||.+... ......++.+|+.++++++||||++++
T Consensus 19 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 95 (362)
T 3pg1_A 19 AMQSPYTVQRFISSG--SYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR 95 (362)
T ss_dssp HTTCSCEEEEEEEEE--TTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred HhccceEEeEEeccC--CCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence 356788999999999 777899888755 899999998532 122346889999999999999999999
Q ss_pred eEEEc-----CCeEEEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceE
Q 046728 79 GFYAG-----GDERLIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAK 146 (325)
Q Consensus 79 ~~~~~-----~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~k 146 (325)
+++.. ....++||||+. |+|.+++.. .++...+..+..++..++.++|.. |||||+||+++.++.+|
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred eeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEE
Confidence 99843 346899999997 689888843 356667778889999999999975 79999999999999999
Q ss_pred EeeeccccccCCCcceeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhh-hhhcc
Q 046728 147 VADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIV-QWVTP 224 (325)
Q Consensus 147 L~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~-~~~~~ 224 (325)
|+|||++........ .....+|..|+|||++.+ ..++.++|||||||++|+|++|..||...........+ .....
T Consensus 175 l~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 175 ICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp ECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 999999975443222 233468899999999876 67899999999999999999999999754321111100 00000
Q ss_pred ccc-------c----cccccccCc---cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 225 YVQ-------K----GAFEHIADP---RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 225 ~~~-------~----~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
... . ......... ..........++.+.+||.+||..||++|||+.++++ ||+....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 000 0 000000000 0000111234678999999999999999999999998 9988754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=295.62 Aligned_cols=261 Identities=19% Similarity=0.237 Sum_probs=189.1
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC-----
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD----- 85 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 85 (325)
....|.+++.||.| +++.||+++...+++ ||+|.+..... ...+|+++++.++||||+++++++....
T Consensus 38 ~~~~Y~~~~~lG~G--~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 38 REIAYTNCKVIGNG--SFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEEE--TTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred ccceEEEeEEEeeC--CCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 34568899999999 788899998877665 88888754221 1236999999999999999999985433
Q ss_pred -eEEEEEEecCCCChhhhh------ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeC-CCCceEEeeeccc
Q 046728 86 -ERLIVYDYMPNHSLITHL------HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLD-TDFEAKVADFGFA 153 (325)
Q Consensus 86 -~~~lV~e~~~~gsL~~~l------~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~-~~~~~kL~Dfg~~ 153 (325)
..++|||||.+ ++...+ ...++...+..+..++..++.++|.. |||||+|||++ .++.+||+|||++
T Consensus 111 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 111 VFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 27899999976 444333 23455566778889999999999985 79999999998 7899999999999
Q ss_pred cccCCCcceeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhh-----------
Q 046728 154 KLIPDGVTHMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQW----------- 221 (325)
Q Consensus 154 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~----------- 221 (325)
+....... .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+..
T Consensus 190 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 190 KILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp EECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 87654332 2234689999999998765 589999999999999999999999976432211111100
Q ss_pred -hcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 222 -VTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 222 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
..+......+............+...++++.+||.+||..||++|||+.++++ ||+++..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 00000011111111111111122346678999999999999999999999998 8887543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=292.63 Aligned_cols=263 Identities=16% Similarity=0.169 Sum_probs=181.9
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe------
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE------ 86 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------ 86 (325)
..|.+.+.||.| +++.||++++..+++.||||.+... .....+..++++.+..++||||+++++++.....
T Consensus 23 ~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 23 DRFQVERMAGQG--TFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp TTEEEC------------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred cceEEEEEEecC--CCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 457888999999 8888999999999999999998643 2333466778888899999999999999865433
Q ss_pred -EEEEEEecCCCChhhhhc------cCCCCCCccCHHHHHHHHHHHHh--h----cCCCCCCceeeCC-CCceEEeeecc
Q 046728 87 -RLIVYDYMPNHSLITHLH------GRLAPDCLLDWHRRVSIAIGSAE--G----IADIKASNVLLDT-DFEAKVADFGF 152 (325)
Q Consensus 87 -~~lV~e~~~~gsL~~~l~------~~~~~~~~~~~~~~~~~~~~~~~--~----~rdlkp~Nil~~~-~~~~kL~Dfg~ 152 (325)
.++||||+.+ +|.+.+. ..++...+..+..++..++.++| . ||||||+|||++. ++.+||+|||+
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 100 YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 7899999976 5555442 22344455678889999999999 4 3799999999996 89999999999
Q ss_pred ccccCCCcceeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccc-
Q 046728 153 AKLIPDGVTHMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGA- 230 (325)
Q Consensus 153 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~- 230 (325)
+........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+...........
T Consensus 179 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 179 AKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp CBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 987654332 2334689999999998755 489999999999999999999999976432211111100000000000
Q ss_pred ---------cccccC-----ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 231 ---------FEHIAD-----PRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 231 ---------~~~~~~-----~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
...... ...........++.+.+||.+||..||++|||+.++++ ||++...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 000000 00011122335788999999999999999999999998 9987654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=284.29 Aligned_cols=249 Identities=20% Similarity=0.236 Sum_probs=182.0
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhH-HHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAE-MEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~-~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
...|.+++.||.| +++.||++++..+++.||+|.+... ..... ..+.++...++.++||||+++++++.+....++
T Consensus 6 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 6 ADDLEPIMELGRG--AYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp GGGEEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred HHhhhhHHhcCCC--CCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 3567889999999 8888999999999999999999753 22222 334455556788899999999999999999999
Q ss_pred EEEecCCCChhhhhc------cCCCCCCccCHHHHHHHHHHHHhhc-----CCCCCCceeeCCCCceEEeeeccccccCC
Q 046728 90 VYDYMPNHSLITHLH------GRLAPDCLLDWHRRVSIAIGSAEGI-----ADIKASNVLLDTDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 90 V~e~~~~gsL~~~l~------~~~~~~~~~~~~~~~~~~~~~~~~~-----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 158 (325)
||||+. |+|.++++ ..+++..++.+..++..++.++|.. |||||+||+++.++.+||+|||++.....
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 999996 58888773 2456666778889999999999864 79999999999999999999999986654
Q ss_pred CcceeeccCCCCcCCCCcccc----ccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccc
Q 046728 159 GVTHMTTRVKGTLGYLAPEYA----MWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHI 234 (325)
Q Consensus 159 ~~~~~~~~~~~t~~y~aPE~~----~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (325)
... .....||+.|+|||++ .+..++.++||||||+++|+|++|..||........ ....... .
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~----~------ 229 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLKQVVE----E------ 229 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHHHHHH----S------
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHHHHhc----c------
Confidence 322 2234689999999996 455788899999999999999999999965322110 0100000 0
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 235 ADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
..........++.+.+||.+||..||++|||+.++++ ||+..
T Consensus 230 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 230 ---PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp ---CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ---CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 0011112345678999999999999999999999998 88754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=298.21 Aligned_cols=262 Identities=18% Similarity=0.280 Sum_probs=176.9
Q ss_pred cchhHHh-hccCccceeeeeEEEecc--CCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEc--CCeE
Q 046728 13 SPAVFIQ-NINNGLEILMLLLLLRRE--TGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG--GDER 87 (325)
Q Consensus 13 ~~~~~~~-~i~~G~~~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 87 (325)
..|.+.. +||.| +++.||+++.. .+++.||||.+.... ....+.+|+.++++++||||+++++++.. ....
T Consensus 20 ~~y~~~g~~lG~G--~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRG--TYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-------EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeec--CCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 3344433 57777 88889999855 568899999997532 22467889999999999999999999954 6789
Q ss_pred EEEEEecCCCChhhhhcc-----------CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceee----CCCCceEEe
Q 046728 88 LIVYDYMPNHSLITHLHG-----------RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLL----DTDFEAKVA 148 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~-----------~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~----~~~~~~kL~ 148 (325)
++||||+. |+|.+++.. .+++..++.+..++..++.++|.. |||||+|||+ +.++.+||+
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99999996 588888731 255566778889999999999975 7999999999 677899999
Q ss_pred eeccccccCCCcc--eeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccc------hhh
Q 046728 149 DFGFAKLIPDGVT--HMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKR------DIV 219 (325)
Q Consensus 149 Dfg~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~------~~~ 219 (325)
|||++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|..||......... ...
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 9999987654221 122345689999999999874 5899999999999999999999999754331100 000
Q ss_pred hhhc---ccccccccccc-------------cCccccC--------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH-
Q 046728 220 QWVT---PYVQKGAFEHI-------------ADPRLKG--------KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD- 274 (325)
Q Consensus 220 ~~~~---~~~~~~~~~~~-------------~~~~~~~--------~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~- 274 (325)
..+. .......+..+ ....... ......++.+.+||.+||..||++|||++++++
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 00000000000 0000000 000112567899999999999999999999999
Q ss_pred -HHhcc
Q 046728 275 -WLKGG 279 (325)
Q Consensus 275 -~l~~~ 279 (325)
||.+.
T Consensus 335 p~f~~~ 340 (405)
T 3rgf_A 335 PYFLED 340 (405)
T ss_dssp GGGTSS
T ss_pred hhhccC
Confidence 88764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=290.64 Aligned_cols=262 Identities=19% Similarity=0.171 Sum_probs=184.1
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHH--HHccCCCCccceeeEEEc-----CC
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEI--LGRVRHRNLLGLRGFYAG-----GD 85 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~--l~~l~h~~iv~~~~~~~~-----~~ 85 (325)
..|.+++.||.| +++.||.++. +++.||||.+.... ...+..|.++ +..++||||+++++.+.. ..
T Consensus 13 ~~y~~~~~lg~G--~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 13 DNLKLLELIGRG--RYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TSEEEEEEEEEC--SSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred HHhheeeecccC--CCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 567889999999 7777888864 67899999997532 2344444444 445799999999986532 23
Q ss_pred eEEEEEEecCCCChhhhhcc-CCCCCCccCHHHHHHHHHHHHhhc-------------CCCCCCceeeCCCCceEEeeec
Q 046728 86 ERLIVYDYMPNHSLITHLHG-RLAPDCLLDWHRRVSIAIGSAEGI-------------ADIKASNVLLDTDFEAKVADFG 151 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~-------------rdlkp~Nil~~~~~~~kL~Dfg 151 (325)
.+++|||||++|+|.++++. ..+......+..++..++.++|.. |||||+|||++.++.+||+|||
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred eEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 57899999999999999953 344455677888999999999843 7999999999999999999999
Q ss_pred cccccCCCcc-------eeeccCCCCcCCCCcccccc-------CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCcc-c
Q 046728 152 FAKLIPDGVT-------HMTTRVKGTLGYLAPEYAMW-------GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVK-R 216 (325)
Q Consensus 152 ~~~~~~~~~~-------~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-~ 216 (325)
++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ .
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 9987654221 11223468999999999986 3456789999999999999999777654322111 1
Q ss_pred hhhhh-hccccccc-----ccccccCcccc--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 217 DIVQW-VTPYVQKG-----AFEHIADPRLK--GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 217 ~~~~~-~~~~~~~~-----~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
..... ........ .......+.+. .......++.+.+||.+||..||++|||+.++++.|+.++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 10000 00000000 00000001111 11224577889999999999999999999999999888763
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=295.35 Aligned_cols=260 Identities=21% Similarity=0.249 Sum_probs=188.9
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcC------C
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG------D 85 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~ 85 (325)
...|.+.+.||.| +++.||+++...+++.||||.+..... ...+|++++++++||||+++++++... .
T Consensus 53 ~~~y~~~~~lG~G--~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 53 EVSYTDTKVIGNG--SFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred cceEEeeeEEeeC--CCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 3457889999999 888899999999999999999865321 234699999999999999999988432 2
Q ss_pred eEEEEEEecCCCChhhhhc------cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC-CceEEeeecccc
Q 046728 86 ERLIVYDYMPNHSLITHLH------GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD-FEAKVADFGFAK 154 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~------~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~-~~~kL~Dfg~~~ 154 (325)
.+++||||+.+ +|.+.+. ..++...+..+..++..++.++|.. |||||+|||++.+ +.+||+|||+++
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 36799999975 6766653 2345555677888999999999975 7999999999955 678999999998
Q ss_pred ccCCCcceeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccc-hhhhhh----------
Q 046728 155 LIPDGVTHMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKR-DIVQWV---------- 222 (325)
Q Consensus 155 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~-~~~~~~---------- 222 (325)
....... .....+|+.|+|||++.+. .++.++|||||||++|||++|..||.+....... .++...
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 7654322 2234689999999998764 7899999999999999999999999764321111 111000
Q ss_pred -cccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 223 -TPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 223 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
.+......+..+....+....+...++++.+||.+||..||++|||+.++++ ||+...
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 0000000010000000001122345678999999999999999999999998 887654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=286.66 Aligned_cols=257 Identities=18% Similarity=0.210 Sum_probs=175.8
Q ss_pred cceeecccchhHHh-hccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEc-
Q 046728 6 NICFLLASPAVFIQ-NINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG- 83 (325)
Q Consensus 6 ~~~~~~~~~~~~~~-~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 83 (325)
+..+.+...|.+++ .||.| +++.||++.+..+++.||||.+... ... ..+....++.++||||+++++++..
T Consensus 21 ~~~~~~~~~y~i~~~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~-~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~ 94 (336)
T 3fhr_A 21 PKKYAVTDDYQLSKQVLGLG--VNGKVLECFHRRTGQKCALKLLYDS-PKA---RQEVDHHWQASGGPHIVCILDVYENM 94 (336)
T ss_dssp CBCSCGGGTEEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEESS-HHH---HHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCCccccceeEecceeeeeC--CCeEEEEEEECCCCCEEEEEEecCc-HHH---HHHHHHHHHhcCCCChHHHHHHHhhc
Confidence 35678888889876 48988 8888999999999999999999652 221 2223334566799999999999876
Q ss_pred ---CCeEEEEEEecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC---CCceEEee
Q 046728 84 ---GDERLIVYDYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT---DFEAKVAD 149 (325)
Q Consensus 84 ---~~~~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~---~~~~kL~D 149 (325)
....++|||||++|+|.+++.. .+++..++.+..++..++.++|.. |||||+||+++. ++.+||+|
T Consensus 95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEec
Confidence 4458999999999999999954 356667788889999999999975 799999999976 45599999
Q ss_pred eccccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccc
Q 046728 150 FGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKG 229 (325)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 229 (325)
||++....... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||............. .....
T Consensus 175 fg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~- 247 (336)
T 3fhr_A 175 FGFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRIRL- 247 (336)
T ss_dssp CTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred cccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhhhc-
Confidence 99998654322 223458999999999988888999999999999999999999997644322110000 00000
Q ss_pred ccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 230 AFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
.......+.....++.+.+||.+||..||++|||+.++++ ||+...
T Consensus 248 -----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 248 -----GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred -----cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 0011112223456788999999999999999999999999 998654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=298.50 Aligned_cols=257 Identities=18% Similarity=0.227 Sum_probs=201.4
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCC-CCccceeeEEEcCCeEE
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRH-RNLLGLRGFYAGGDERL 88 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 88 (325)
.+...|.+.+.||.| +++.||++.+..+++.||||++...... .++.+|+.+++.++| +++..+..+.......+
T Consensus 4 ~i~~~y~i~~~LG~G--~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSG--SFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp EETTTEECCCCCEEC--SSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred CcCCcEEEEEEEeeC--CCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 456778999999999 8888999999999999999988643322 357889999999976 56666666677788899
Q ss_pred EEEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceee---CCCCceEEeeeccccccCC
Q 046728 89 IVYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLL---DTDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~---~~~~~~kL~Dfg~~~~~~~ 158 (325)
+||||+ +++|.+++. ..++...++.++.++..++.++|.. |||||+|||+ +.++.+||+|||+++....
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 999999994 3466777888899999999999975 7999999999 5788999999999987654
Q ss_pred Ccce------eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccc
Q 046728 159 GVTH------MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFE 232 (325)
Q Consensus 159 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (325)
.... ......||..|+|||++.+..++.++|||||||++|+|++|..||..............+..........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 3321 1224569999999999999899999999999999999999999998765443333322221111100000
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 233 HIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
.....+++++.+||..||..||++||++.+|++.|+.++
T Consensus 239 ---------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 239 ---------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp ---------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred ---------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 011234578999999999999999999999999888764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=282.38 Aligned_cols=250 Identities=21% Similarity=0.322 Sum_probs=187.7
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEc------
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG------ 83 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------ 83 (325)
.+...|.+++.||.| +++.||.+++..+++.||||.+.. .......+.+|+.++++++||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 3 RYASDFEEIAVLGQG--AFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHHHEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred cccccchhhheeccC--CcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 356678889999999 888899999999999999999965 34455688999999999999999999998865
Q ss_pred -------CCeEEEEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEee
Q 046728 84 -------GDERLIVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVAD 149 (325)
Q Consensus 84 -------~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~D 149 (325)
....++||||+++|+|.+++.. .++...++.+..++..++.++|.. +||||+||+++.++.++|+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence 3567999999999999999953 233445667888999999999975 79999999999999999999
Q ss_pred eccccccCCCc-------------ceeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCcc
Q 046728 150 FGFAKLIPDGV-------------THMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVK 215 (325)
Q Consensus 150 fg~~~~~~~~~-------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~ 215 (325)
||++....... ........||..|+|||++.+. .++.++|||||||++|+|++ ||.... ..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~~ 234 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--ER 234 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--HH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--hH
Confidence 99998654321 1112234588999999998754 68899999999999999998 553211 00
Q ss_pred chhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHh
Q 046728 216 RDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLK 277 (325)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~ 277 (325)
......+. .. ........+...++.+.+||.+||..||++|||+.++++ ||.
T Consensus 235 ~~~~~~~~----~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (303)
T 1zy4_A 235 VNILKKLR----SV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP 288 (303)
T ss_dssp HHHHHHHH----ST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSC
T ss_pred HHHHHhcc----cc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcC
Confidence 11111100 00 111122334455678999999999999999999999998 664
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=289.60 Aligned_cols=261 Identities=15% Similarity=0.181 Sum_probs=194.5
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-CC-----CccceeeEEEcC
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HR-----NLLGLRGFYAGG 84 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~iv~~~~~~~~~ 84 (325)
+...|.+.+.||.| +++.||++....+++.||||.+.. .......+..|+.+++.++ |+ +++++++++...
T Consensus 52 ~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 52 WMDRYEIDSLIGKG--SFGQVVKAYDRVEQEWVAIKIIKN-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp ETTTEEEEEEEEEE--TTEEEEEEEETTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeeEEEEEEEeec--CCEEEEEEEEcCCCcEEEEEEEec-cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 34678889999999 788899999999999999999975 3444567788999999885 55 499999999999
Q ss_pred CeEEEEEEecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhh------cCCCCCCceeeC--CCCceEEeeecc
Q 046728 85 DERLIVYDYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEG------IADIKASNVLLD--TDFEAKVADFGF 152 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~------~rdlkp~Nil~~--~~~~~kL~Dfg~ 152 (325)
...++||||+. |+|.+++.. .++...+..+..++..++.++|. ||||||+|||++ .++.+||+|||+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 99999999995 599999953 25556677888999999999984 489999999995 477899999999
Q ss_pred ccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccc-------
Q 046728 153 AKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPY------- 225 (325)
Q Consensus 153 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~------- 225 (325)
+...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||...........+......
T Consensus 208 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (382)
T 2vx3_A 208 SCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283 (382)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred ceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9876543 22356899999999999889999999999999999999999999754321111111000000
Q ss_pred -----------ccccccccc---------cCccc--------------------cCCCCHHHHHHHHHHHHHccCCCCCC
Q 046728 226 -----------VQKGAFEHI---------ADPRL--------------------KGKFNRDQLKSMVLIALRCTDSNPEN 265 (325)
Q Consensus 226 -----------~~~~~~~~~---------~~~~~--------------------~~~~~~~~~~~~~~li~~cl~~dp~~ 265 (325)
.....+... ..+.. .........+.+.+||.+||..||++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 363 (382)
T 2vx3_A 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKT 363 (382)
T ss_dssp TCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTT
T ss_pred hhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhh
Confidence 000000000 00000 00011233468999999999999999
Q ss_pred CCCHHHHHH--HHhcc
Q 046728 266 RPTMTDVVD--WLKGG 279 (325)
Q Consensus 266 Rps~~~il~--~l~~~ 279 (325)
|||+.++++ ||+..
T Consensus 364 Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 364 RIQPYYALQHSFFKKT 379 (382)
T ss_dssp SCCHHHHTTSGGGCC-
T ss_pred CCCHHHHhcCcccccC
Confidence 999999998 88653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=285.01 Aligned_cols=266 Identities=19% Similarity=0.228 Sum_probs=195.5
Q ss_pred ecccchhHHhhccCccceeeeeEEEecc-CCCCeEEEEEecccC--hhhHHHHHHHHHHHHcc---CCCCccceeeEEE-
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRE-TGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRV---RHRNLLGLRGFYA- 82 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~- 82 (325)
.....|.+++.||.| +++.||.++.. .+++.||+|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 8 RADQQYECVAEIGEG--AYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp CGGGTEEEEEEEEEE--TTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred Cchhceeeeeeeccc--ccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 455778999999999 77889999885 668899999986422 22223566777777766 8999999999987
Q ss_pred ----cCCeEEEEEEecCCCChhhhhccC----CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeee
Q 046728 83 ----GGDERLIVYDYMPNHSLITHLHGR----LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADF 150 (325)
Q Consensus 83 ----~~~~~~lV~e~~~~gsL~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Df 150 (325)
.....++||||+. |+|.+++... ++...++.+..++..++.++|.. +||||+||+++.++.++|+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence 5567899999997 6999998532 55666777888999999999975 799999999999999999999
Q ss_pred ccccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccc
Q 046728 151 GFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGA 230 (325)
Q Consensus 151 g~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (325)
|++....... ......+|..|+|||++.+..++.++||||||+++|+|++|..||...........+...........
T Consensus 165 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 165 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 9998654322 22335689999999999988899999999999999999999999975432111110000000000000
Q ss_pred ccc----------ccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 231 FEH----------IADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 231 ~~~----------~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
+.. ..............+..+.+||.+||..||++|||+.++++ ||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 000 00000011223456778999999999999999999999997 887654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=285.87 Aligned_cols=263 Identities=19% Similarity=0.302 Sum_probs=197.0
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-----------CCCccceeeE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-----------HRNLLGLRGF 80 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~~~~~ 80 (325)
...|.+++.||.| +++.||++++..+++.||||.+.. .......+.+|+.++++++ ||||++++++
T Consensus 18 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWG--HFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeec--CCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 4578999999999 888899999999999999999975 3444567888999999886 8999999999
Q ss_pred EEcCC----eEEEEEEecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc-----CCCCCCceeeC------C
Q 046728 81 YAGGD----ERLIVYDYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI-----ADIKASNVLLD------T 141 (325)
Q Consensus 81 ~~~~~----~~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~-----rdlkp~Nil~~------~ 141 (325)
+.... ..++||||+ +++|.+++.. .++...+..+..++..++.++|.. |||||+|||++ .
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence 87643 688999999 8899999853 255556778889999999999874 69999999994 4
Q ss_pred CCceEEeeeccccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhh
Q 046728 142 DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQW 221 (325)
Q Consensus 142 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~ 221 (325)
.+.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||..............
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 457999999999866542 2234689999999999988999999999999999999999999976543211110000
Q ss_pred hcccc----------------------cccccccccCc---------cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 046728 222 VTPYV----------------------QKGAFEHIADP---------RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMT 270 (325)
Q Consensus 222 ~~~~~----------------------~~~~~~~~~~~---------~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 270 (325)
..... ..+.+..+... ......+...++.+.+||.+||..||++|||+.
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 00000 00000000000 001234567888999999999999999999999
Q ss_pred HHHH--HHhcccCC
Q 046728 271 DVVD--WLKGGLGR 282 (325)
Q Consensus 271 ~il~--~l~~~~~~ 282 (325)
++++ ||+.....
T Consensus 330 ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 330 GLVNHPWLKDTLGM 343 (373)
T ss_dssp HHHTCGGGTTCTTC
T ss_pred HHhhChhhhcccCc
Confidence 9998 99876543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=282.10 Aligned_cols=251 Identities=21% Similarity=0.305 Sum_probs=173.4
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHH-HHHccCCCCccceeeEEEcCCeEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVE-ILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
..|.+++.||.| +++.||.+....+++.||||.+... ......++..|.. +++.++||||+++++++.+.+..++|
T Consensus 22 ~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 22 EDLKDLGEIGRG--AYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSEEC-CEEEEC--SSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHhhehheeccC--CCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 567889999999 7888999999999999999999753 3344445666666 67778999999999999999999999
Q ss_pred EEecCCCChhhhhc-------cCCCCCCccCHHHHHHHHHHHHhhc-----CCCCCCceeeCCCCceEEeeeccccccCC
Q 046728 91 YDYMPNHSLITHLH-------GRLAPDCLLDWHRRVSIAIGSAEGI-----ADIKASNVLLDTDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 91 ~e~~~~gsL~~~l~-------~~~~~~~~~~~~~~~~~~~~~~~~~-----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 158 (325)
|||+.+ +|.+++. ..++...+..+..++..++.++|.. |||||+||+++.++.+||+|||++.....
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 999975 8877773 3345555677888888888888864 79999999999999999999999986654
Q ss_pred CcceeeccCCCCcCCCCcccc----ccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccc
Q 046728 159 GVTHMTTRVKGTLGYLAPEYA----MWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHI 234 (325)
Q Consensus 159 ~~~~~~~~~~~t~~y~aPE~~----~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (325)
... .....||..|+|||++ .+..++.++||||||+++|+|++|..||........ ...... .+
T Consensus 179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~-~~----- 245 (327)
T 3aln_A 179 SIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQVV-KG----- 245 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCC-CS-----
T ss_pred ccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHHHh-cC-----
Confidence 322 2233589999999998 455688999999999999999999999975322100 000000 00
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 235 ADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
..+.+........++.+.+||.+||..||++|||+.++++ ||...
T Consensus 246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 0111111222346678999999999999999999999998 77653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=309.67 Aligned_cols=249 Identities=19% Similarity=0.274 Sum_probs=192.5
Q ss_pred cchhHHhhccCccceeeeeEEEeccCC---CCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETG---DDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~---~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
..|.+.+.||.| +++.||.+....+ +..||+|.+... .......+.+|+.++++++||||+++++++. .+..+
T Consensus 390 ~~y~i~~~LG~G--~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 390 ERIELGRCIGEG--QFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp GGEEEEEEEECC--SSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccEEEeeEEeeC--CCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 446778889999 7777888876543 457999998753 3444568999999999999999999999985 45689
Q ss_pred EEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 89 IVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
+||||+++|+|.++++. .++...++.+..++..++.++|.. |||||+|||++.++.+||+|||++........
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~ 546 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence 99999999999999953 244455667788899999999975 79999999999999999999999987655433
Q ss_pred eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 162 HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
.......+|+.|+|||++.+..++.++|||||||++|+|++ |..||....... ....+.. ...
T Consensus 547 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~~i~~-------------~~~ 610 (656)
T 2j0j_A 547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIEN-------------GER 610 (656)
T ss_dssp -------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHH-------------TCC
T ss_pred eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHc-------------CCC
Confidence 33334457789999999998899999999999999999997 999997543211 1111110 011
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
.+.+..+++.+.+||.+||..||++|||+.++++.|+.++
T Consensus 611 ~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 611 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2234456778999999999999999999999999998765
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=285.49 Aligned_cols=244 Identities=13% Similarity=0.139 Sum_probs=190.2
Q ss_pred ccchhHHhhccCccceeeeeEEE-----eccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC---CCCccceeeEEEc
Q 046728 12 ASPAVFIQNINNGLEILMLLLLL-----RRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR---HRNLLGLRGFYAG 83 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~ 83 (325)
...|.+.+.||.| +++.||++ .+..+++.||+|.+.... ...+..|.++++.++ |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G--~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEG--AFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEEC--SSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeecc--CCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 3457888899999 88889999 467788999999997643 346777888888886 9999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhc-------cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC-----------
Q 046728 84 GDERLIVYDYMPNHSLITHLH-------GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT----------- 141 (325)
Q Consensus 84 ~~~~~lV~e~~~~gsL~~~l~-------~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~----------- 141 (325)
.+..++|||||++|+|.++++ ..+++..++.+..++..++.++|.. |||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence 999999999999999999994 2355556788889999999999975 899999999988
Q ss_pred CCceEEeeeccccccCC-CcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhh
Q 046728 142 DFEAKVADFGFAKLIPD-GVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQ 220 (325)
Q Consensus 142 ~~~~kL~Dfg~~~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~ 220 (325)
++.+||+|||++..... ..........||..|+|||++.+..++.++|||||||++|+|+||..||.........
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---- 294 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---- 294 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE----
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee----
Confidence 89999999999975432 1222334457999999999999989999999999999999999999999543221100
Q ss_pred hhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHhcccC
Q 046728 221 WVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENR-PTMTDVVDWLKGGLG 281 (325)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R-ps~~~il~~l~~~~~ 281 (325)
....+ . . ...++.+.+++..|+..+|.+| |+++++.+.|+..+.
T Consensus 295 ------~~~~~--------~-~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 295 ------PEGLF--------R-R--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp ------ECSCC--------T-T--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ------echhc--------c-c--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 00000 0 0 1235678889999999999999 577777777776553
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=284.83 Aligned_cols=264 Identities=15% Similarity=0.196 Sum_probs=198.2
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCC-CeEEEEEecccChhhHHHHHHHHHHHHccCCCC------ccceeeEE
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGD-DQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRN------LLGLRGFY 81 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~------iv~~~~~~ 81 (325)
-.+...|.+++.||.| +++.||.+....++ +.||+|.+.. .......+.+|+.++++++|++ ++.+++++
T Consensus 15 ~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEG--TFGKVVECLDHARGKSQVALKIIRN-VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp CEETTTEEEEEEEEEE--TTEEEEEEEETTTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred ceecccEEEEEEeecc--CCeEEEEEEecCCCceEEEEEEEcc-cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 3467889999999999 77889999887766 6899999975 3444567888999999997655 89999999
Q ss_pred EcCCeEEEEEEecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceee--------------
Q 046728 82 AGGDERLIVYDYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLL-------------- 139 (325)
Q Consensus 82 ~~~~~~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~-------------- 139 (325)
......++||||+ +++|.+++.. .++...++.+..++..++.++|.. |||||+|||+
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence 9999999999999 6688777742 355666778889999999999975 7999999999
Q ss_pred -----CCCCceEEeeeccccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCc
Q 046728 140 -----DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGV 214 (325)
Q Consensus 140 -----~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~ 214 (325)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 567889999999998654322 23468999999999998899999999999999999999999997543221
Q ss_pred cchhhhhhcccccccccccc---------------------------cCccccCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 046728 215 KRDIVQWVTPYVQKGAFEHI---------------------------ADPRLKGKFNRDQLKSMVLIALRCTDSNPENRP 267 (325)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 267 (325)
....+............... .............+..+.+||.+||..||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 11111111000000000000 000000112234567899999999999999999
Q ss_pred CHHHHHH--HHhccc
Q 046728 268 TMTDVVD--WLKGGL 280 (325)
Q Consensus 268 s~~~il~--~l~~~~ 280 (325)
|+.++++ ||+...
T Consensus 327 t~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 327 TLAEALLHPFFAGLT 341 (355)
T ss_dssp CHHHHTTSGGGGGCC
T ss_pred CHHHHhcChhhcCCC
Confidence 9999997 888653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=280.44 Aligned_cols=249 Identities=18% Similarity=0.291 Sum_probs=188.1
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccC--CCCccceeeEEEcCCeE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVR--HRNLLGLRGFYAGGDER 87 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~ 87 (325)
...|.+++.||.| +++.||.+.... ++.||+|.+... .......+.+|+.++++++ ||||+++++++.+....
T Consensus 27 ~~~y~~~~~lg~G--~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 27 GRIYSILKQIGSG--GSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp TEEEEEEEEEECC--SSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred cceEEEEEEecCC--CCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 4568899999999 777899888754 889999998643 4455678899999999996 69999999999999999
Q ss_pred EEEEEecCCCChhhhhcc--CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 88 LIVYDYMPNHSLITHLHG--RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
++||| +.+++|.+++.. .++...++.+..++..++.++|.. |||||+||++++ +.+||+|||++........
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCccc
Confidence 99999 558899999953 355556777888999999999975 799999999965 8999999999986654322
Q ss_pred e-eeccCCCCcCCCCcccccc-----------CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccc
Q 046728 162 H-MTTRVKGTLGYLAPEYAMW-----------GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKG 229 (325)
Q Consensus 162 ~-~~~~~~~t~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 229 (325)
. ......||..|+|||++.+ ..++.++||||||+++|+|++|..||........ .. .
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~----~------ 250 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-KL----H------ 250 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HH----H------
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH-HH----H------
Confidence 1 1233468999999999875 3678899999999999999999999965332110 00 0
Q ss_pred ccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 230 AFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
...........+...+..+.+||.+||..||++|||+.++++ ||+..
T Consensus 251 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 251 ---AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp ---HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred ---HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 011111111222334568999999999999999999999998 88753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=300.86 Aligned_cols=255 Identities=22% Similarity=0.271 Sum_probs=194.1
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEc------
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG------ 83 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------ 83 (325)
...+|.+.+.||.| +++.||.+.+..+++.||||.+... .......+.+|+.++++++||||+++++++..
T Consensus 12 ~~grY~i~~~LG~G--~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 12 TCGPWEMKERLGTG--GFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp -----CCCCCCCBC--SSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCeEEEEEEeeC--CCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 34678999999999 7788999999999999999998753 45556789999999999999999999998765
Q ss_pred CCeEEEEEEecCCCChhhhhcc-----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCc---eEEeeec
Q 046728 84 GDERLIVYDYMPNHSLITHLHG-----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFE---AKVADFG 151 (325)
Q Consensus 84 ~~~~~lV~e~~~~gsL~~~l~~-----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~---~kL~Dfg 151 (325)
....++|||||++|+|.+++.. .+++..++.+..++..++.++|.. |||||+||+++.++. ++|+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 6678999999999999999954 367777888999999999999975 799999999987664 9999999
Q ss_pred cccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccc-----
Q 046728 152 FAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYV----- 226 (325)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~----- 226 (325)
++........ .....||..|+|||++.+..++.++|||||||++|+|++|..||..... ...|.....
T Consensus 170 ~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 170 YAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSNE 242 (676)
T ss_dssp CCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC-----
T ss_pred cccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccch
Confidence 9987654332 2335689999999999988999999999999999999999999965311 011100000
Q ss_pred -------cccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 227 -------QKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 227 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
..+..................++.+.+||.+||..||++|||+.++++
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~ 297 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN 297 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhc
Confidence 000000000111112344668899999999999999999999988664
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=288.25 Aligned_cols=249 Identities=19% Similarity=0.263 Sum_probs=182.7
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEE
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 88 (325)
.+...+...+.||.| +++.||.+ +..+++.||||.+... ....+.+|+.+++++ +||||+++++++.+....+
T Consensus 12 ~l~~~~~~~~~LG~G--~~g~V~~~-~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 85 (434)
T 2rio_A 12 SLKNLVVSEKILGYG--SSGTVVFQ-GSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY 85 (434)
T ss_dssp SCSSCEEEEEEEEEC--STTCEEEE-EESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred hhhheeeccCeEeeC--CCeEEEEE-EEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence 344555667889999 66667654 4567899999998652 234678899999987 8999999999999999999
Q ss_pred EEEEecCCCChhhhhccCC---------CCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC-------------
Q 046728 89 IVYDYMPNHSLITHLHGRL---------APDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD------------- 142 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~------------- 142 (325)
+|||||. |+|.+++.... ....++.+..++..++.++|.. |||||+|||++.+
T Consensus 86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCc
Confidence 9999995 69999995431 1122345889999999999985 7999999999654
Q ss_pred CceEEeeeccccccCCCcce---eeccCCCCcCCCCcccccc-------CCCCCcccchhHHHHHHHHHh-CCCCCCCCC
Q 046728 143 FEAKVADFGFAKLIPDGVTH---MTTRVKGTLGYLAPEYAMW-------GKVSDSCDVYSFGVLLLELIS-AKKPLEKLP 211 (325)
Q Consensus 143 ~~~kL~Dfg~~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el~t-g~~pf~~~~ 211 (325)
+.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||....
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 47999999999877653322 1234569999999999875 568899999999999999999 999996533
Q ss_pred CCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHh
Q 046728 212 GGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLK 277 (325)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~ 277 (325)
... .... . +.. ..+..........++++.+||.+||..||++|||+.++++ ||.
T Consensus 245 ~~~-~~i~---~-----~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~ 300 (434)
T 2rio_A 245 SRE-SNII---R-----GIF---SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300 (434)
T ss_dssp THH-HHHH---H-----TCC---CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred hhH-HHHh---c-----CCC---CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccC
Confidence 211 1110 0 000 0111122234577889999999999999999999999997 664
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=277.00 Aligned_cols=249 Identities=18% Similarity=0.212 Sum_probs=176.1
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-hhhH-HHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-AKAE-MEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~-~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
..|.+++.||.| +++.||.++...+++.||||.+.... .... ..+.++..+++.++||||+++++++.+....++|
T Consensus 25 ~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 25 NDLENLGEMGSG--TCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GGEEEEEEC--------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred ccccccceeeec--CCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 467788899998 88889999999999999999997532 2222 3444555678888999999999999999999999
Q ss_pred EEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhh-c----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 91 YDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEG-I----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 91 ~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~-~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
|||+ ++.+..+.. ..+++..+..+..++..++.++|. + +||||+||+++.++.+||+|||++........
T Consensus 103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA- 180 (318)
T ss_dssp ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc-
Confidence 9999 555555442 446666777888999999999986 2 79999999999999999999999976544322
Q ss_pred eeccCCCCcCCCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 163 MTTRVKGTLGYLAPEYAM-----WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
.....+|+.|+|||++. ...++.++||||||+++|+|++|..||...... ........ .. .
T Consensus 181 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~---~~-~------- 246 (318)
T 2dyl_A 181 -KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLTKVL---QE-E------- 246 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHHH---HS-C-------
T ss_pred -ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHHHHHh---cc-C-------
Confidence 22345899999999984 456788999999999999999999999753221 11111100 00 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
....+.....++.+.+||.+||..||.+|||++++++ ||+..
T Consensus 247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 247 PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred CCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 0001112245678999999999999999999999998 77754
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=284.31 Aligned_cols=249 Identities=20% Similarity=0.213 Sum_probs=186.7
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
..|.+.+.||.| +++.||.++... .||+|.+... .......+.+|+.++++++||||+++++++.+....++|
T Consensus 33 ~~~~~~~~lg~G--~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 33 EQLEIGELIGKG--RFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCEECCCBCCCS--SSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred HHeEEeeEeccC--CceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 567889999999 777788887543 4999998643 223334677899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc--
Q 046728 91 YDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT-- 161 (325)
Q Consensus 91 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 161 (325)
|||+.+++|.+++.. .++...++.+..++..++.++|.. +||||+||+++ ++.++|+|||++........
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~ 186 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR 186 (319)
T ss_dssp CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence 999999999999953 356677788899999999999975 79999999998 67999999999875432111
Q ss_pred --eeeccCCCCcCCCCcccccc---------CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccc
Q 046728 162 --HMTTRVKGTLGYLAPEYAMW---------GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGA 230 (325)
Q Consensus 162 --~~~~~~~~t~~y~aPE~~~~---------~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (325)
.......|+..|+|||++.+ ..++.++||||||+++|+|++|..||........ ...+. .+.
T Consensus 187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~----~~~ 259 (319)
T 2y4i_B 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI---IWQMG----TGM 259 (319)
T ss_dssp -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH---HHHHH----TTC
T ss_pred cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHhc----cCC
Confidence 11223458899999999874 3468899999999999999999999975432111 11110 000
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCC
Q 046728 231 FEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGR 282 (325)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 282 (325)
. ........+..+.+|+.+||..||++|||+.++++.|+.+..+
T Consensus 260 ~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 260 K--------PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp C--------CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred C--------CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 0 0011123455799999999999999999999999999988754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=284.81 Aligned_cols=243 Identities=23% Similarity=0.363 Sum_probs=196.8
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh------hhHHHHHHHHHHHHccC--CCCccceeeEE
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA------KAEMEFAVEVEILGRVR--HRNLLGLRGFY 81 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~--h~~iv~~~~~~ 81 (325)
.+...|.+.+.||.| +++.||.+....+++.||||.+..... .....+.+|+.++++++ ||||+++++++
T Consensus 40 ~~~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 40 PLESQYQVGPLLGSG--GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp CCTTTEEEEEECSSS--SSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred CccCceEEEEEEeeC--CCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 456778999999999 888899999999999999999964321 12245678999999996 69999999999
Q ss_pred EcCCeEEEEEEecCC-CChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeC-CCCceEEeeeccc
Q 046728 82 AGGDERLIVYDYMPN-HSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLD-TDFEAKVADFGFA 153 (325)
Q Consensus 82 ~~~~~~~lV~e~~~~-gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~-~~~~~kL~Dfg~~ 153 (325)
.+....++|||++.+ ++|.+++. ..+++..++.+..++..++.++|.. |||||+|||++ .++.+||+|||++
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 999999999999976 89999994 4466667778889999999999975 79999999998 7789999999999
Q ss_pred cccCCCcceeeccCCCCcCCCCccccccCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccc
Q 046728 154 KLIPDGVTHMTTRVKGTLGYLAPEYAMWGKV-SDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFE 232 (325)
Q Consensus 154 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (325)
....... .....||..|+|||++.+..+ +.++||||||+++|+|++|..||..... .. ...
T Consensus 198 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~--------~~~-- 259 (320)
T 3a99_A 198 ALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----II--------RGQ-- 259 (320)
T ss_dssp EECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HH--------HCC--
T ss_pred ccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----hh--------ccc--
Confidence 8765432 223458999999999987665 6789999999999999999999954210 00 000
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 233 HIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
...+...++.+.+||.+||..||++|||++++++ ||+...
T Consensus 260 --------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 260 --------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp --------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred --------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 0112335578999999999999999999999998 887654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=280.73 Aligned_cols=243 Identities=22% Similarity=0.357 Sum_probs=187.5
Q ss_pred ecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh------hhHHHHHHHHHHHHcc----CCCCccceee
Q 046728 10 LLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA------KAEMEFAVEVEILGRV----RHRNLLGLRG 79 (325)
Q Consensus 10 ~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l----~h~~iv~~~~ 79 (325)
.+...|.+.+.||.| +++.||.+++..+++.||+|.+..... .....+.+|+.+++++ +||||+++++
T Consensus 28 ~~~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKG--GFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -----CEEEEEEEEE--TTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhceEEeeEEEcC--CCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 456678999999998 778899999999999999999965322 1223456799999998 8999999999
Q ss_pred EEEcCCeEEEEEEe-cCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeC-CCCceEEeeec
Q 046728 80 FYAGGDERLIVYDY-MPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLD-TDFEAKVADFG 151 (325)
Q Consensus 80 ~~~~~~~~~lV~e~-~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~-~~~~~kL~Dfg 151 (325)
++.+.+..++|||| +.+++|.+++. ..++...++.+..++..++.++|.. +||||+||+++ .++.++|+|||
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 99999999999999 78899999994 3466677788889999999999975 79999999998 88999999999
Q ss_pred cccccCCCcceeeccCCCCcCCCCccccccCCCC-CcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccc
Q 046728 152 FAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVS-DSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGA 230 (325)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (325)
++....... .....++..|+|||++.+..+. .++||||||+++|+|++|..||.... ... ..
T Consensus 186 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~--------~~- 248 (312)
T 2iwi_A 186 SGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EIL--------EA- 248 (312)
T ss_dssp SCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH--------HT-
T ss_pred hhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HHh--------hh-
Confidence 998765432 2334589999999998876664 48999999999999999999996421 000 00
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 231 FEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
....+...+..+.+||.+||..||++|||++++++ ||+...
T Consensus 249 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 249 ---------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp ---------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred ---------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 01122345678999999999999999999999998 776543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=285.74 Aligned_cols=245 Identities=17% Similarity=0.202 Sum_probs=179.8
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
..|...+.||.| +++.|+ ++...+++.||||.+..... ..+.+|+++++++ +||||+++++++.+....|+||
T Consensus 24 ~~y~~~~~LG~G--~~G~V~-~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 24 ISFCPKDVLGHG--AEGTIV-YRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEEEC--GGGCEE-EEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEecCCeeecC--cCEEEE-EEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 357778899999 555555 35567789999999865322 2356799999999 7999999999999999999999
Q ss_pred EecCCCChhhhhccC---CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC-----CCceEEeeeccccccCCC
Q 046728 92 DYMPNHSLITHLHGR---LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT-----DFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 92 e~~~~gsL~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~-----~~~~kL~Dfg~~~~~~~~ 159 (325)
|||. |+|.+++... ..+..+..+..++..++.++|.. |||||+|||++. ...++|+|||+++.....
T Consensus 98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 9995 6999999532 33445678899999999999985 799999999953 235889999999876543
Q ss_pred cc--eeeccCCCCcCCCCcccccc---CCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhccccccccccc
Q 046728 160 VT--HMTTRVKGTLGYLAPEYAMW---GKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEH 233 (325)
Q Consensus 160 ~~--~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (325)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.......... . ......
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~---~----~~~~~~-- 247 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI---L----LGACSL-- 247 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH---H----TTCCCC--
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH---H----hccCCc--
Confidence 22 22334569999999999973 467789999999999999999 899985432211100 0 000000
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 234 IADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
. ........+..+.+||.+||..||++|||++++++ ||..
T Consensus 248 ---~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 248 ---D--CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp ---T--TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ---c--ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 0 01122456677899999999999999999999997 6543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=268.35 Aligned_cols=230 Identities=13% Similarity=0.070 Sum_probs=181.7
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
+...|.+.+.||.| +++.||++++..+++.||||.+.... ......+.+|+.++.+++||||+++++++.+.+..
T Consensus 29 ~~~~y~i~~~lg~G--~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 106 (286)
T 3uqc_A 29 ANGRYRLLIFHGGV--PPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG 106 (286)
T ss_dssp TTTTEEEEEEEEBS--TTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred ecCcEEEEEEEccc--CCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcE
Confidence 44678889999999 78889999999999999999997432 44456889999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 88 LIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
|+||||++|++|.++++.......+..+..++..++.++|.. |||||+|||++.++.++|++++
T Consensus 107 ~lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred EEEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------------
Confidence 999999999999999976555556677889999999999975 7999999999999999998443
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCc-cccCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP-RLKGK 242 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 242 (325)
|++ .++.++|||||||++|+|+||..||............ . ...... .....
T Consensus 175 ---------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~--------~~~~~~~~~~~~ 227 (286)
T 3uqc_A 175 ---------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---E--------RDTAGQPIEPAD 227 (286)
T ss_dssp ---------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---C--------BCTTSCBCCHHH
T ss_pred ---------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---H--------HHhccCCCChhh
Confidence 233 3688999999999999999999999764331110000 0 000000 00001
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCC
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGR 282 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 282 (325)
....+++.+.+||.+||..||++| |+.++++.|+.....
T Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 228 IDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred cccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 123466789999999999999999 999999999887643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=296.19 Aligned_cols=236 Identities=22% Similarity=0.260 Sum_probs=187.0
Q ss_pred cccchhHHhhccCccceeeeeEEEeccC-CCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe--
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRET-GDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE-- 86 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 86 (325)
+...|.+++.||.| +++.||++.... +++.||||.+... .......+.+|++++++++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G--~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 78 VAGQYEVKGCIAHG--GLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp ETTTEEEEEEEEEE--TTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred eCCceEEEEEEeeC--CCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 45678899999998 888899998876 6899999998643 44556688899999999999999999999987655
Q ss_pred ---EEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC
Q 046728 87 ---RLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 87 ---~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 159 (325)
.|+||||++|++|.+++...++...++.+..++..++.++|.. |||||+|||++.+ .+||+|||++......
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp CEEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred CceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 7999999999999999977778788888999999999999985 7999999999885 8999999999876543
Q ss_pred cceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 160 VTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 160 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
....||+.|+|||++.+. ++.++|||||||++|+|++|..||...... . +.
T Consensus 235 -----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------------~----~~---- 285 (681)
T 2pzi_A 235 -----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD---------------G----LP---- 285 (681)
T ss_dssp -----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS---------------S----CC----
T ss_pred -----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc---------------c----cc----
Confidence 334689999999998764 488999999999999999999887532110 0 00
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHhc
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPT-MTDVVDWLKG 278 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps-~~~il~~l~~ 278 (325)
........++.+.+||.+||..||++||+ ++++...|..
T Consensus 286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00111234568999999999999999996 5555554443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=262.52 Aligned_cols=229 Identities=20% Similarity=0.280 Sum_probs=174.2
Q ss_pred cccchhHH-hhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHH-HccCCCCccceeeEEEc----C
Q 046728 11 LASPAVFI-QNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEIL-GRVRHRNLLGLRGFYAG----G 84 (325)
Q Consensus 11 ~~~~~~~~-~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~----~ 84 (325)
+-..|.++ +.||.| +++.||.+.+..+++.||+|.+... ..+.+|+.++ +.++||||+++++++.. .
T Consensus 15 ~~~~y~~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLG--INGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGGTEEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccchhhcCcccccC--CCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 44455565 668888 8888999999999999999999652 3566788888 45589999999999876 6
Q ss_pred CeEEEEEEecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC---CCceEEeeeccc
Q 046728 85 DERLIVYDYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT---DFEAKVADFGFA 153 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~---~~~~kL~Dfg~~ 153 (325)
...++||||+++|+|.+++.. .+++..++.+..++..++.++|.. |||||+||+++. ++.++|+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 778999999999999999953 356667788889999999999975 799999999998 788999999988
Q ss_pred cccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccc
Q 046728 154 KLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEH 233 (325)
Q Consensus 154 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (325)
.... +..++.++|||||||++|+|++|..||.......... .....
T Consensus 168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-----------~~~~~ 213 (299)
T 3m2w_A 168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-----------GMKTR 213 (299)
T ss_dssp EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-----------CSCCS
T ss_pred cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-----------HHHHH
Confidence 6432 1346789999999999999999999996543211100 00000
Q ss_pred ccCccccC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 234 IADPRLKG--KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 234 ~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
+....... ......++.+.+||.+||..||++|||+.++++ ||....
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 11111000 011345778999999999999999999999998 887654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=273.80 Aligned_cols=236 Identities=14% Similarity=0.051 Sum_probs=171.7
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCC-CCcccee------------
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRH-RNLLGLR------------ 78 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h-~~iv~~~------------ 78 (325)
+.+.+.||.| +++.||++.+..+++.||||++.... ......+.+|+.+++.++| +|...+.
T Consensus 80 ~~~~~~LG~G--~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 80 LVRGTVLGQE--DPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred EEEecccccC--CCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4556778888 88889999999999999999987332 2235678899999999976 3221111
Q ss_pred ---------eEEEc-----CCeEEEEEEecCCCChhhhhc---------cCCCCCCccCHHHHHHHHHHHHhhc----CC
Q 046728 79 ---------GFYAG-----GDERLIVYDYMPNHSLITHLH---------GRLAPDCLLDWHRRVSIAIGSAEGI----AD 131 (325)
Q Consensus 79 ---------~~~~~-----~~~~~lV~e~~~~gsL~~~l~---------~~~~~~~~~~~~~~~~~~~~~~~~~----rd 131 (325)
.++.. ...++++|+++ +++|.++++ ..++....+.+..++..++.++|.. ||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 11111 22367888877 679999883 1133334566678888999999875 89
Q ss_pred CCCCceeeCCCCceEEeeeccccccCCCcceeeccCCCCcCCCCcccc----------ccCCCCCcccchhHHHHHHHHH
Q 046728 132 IKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYA----------MWGKVSDSCDVYSFGVLLLELI 201 (325)
Q Consensus 132 lkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~----------~~~~~~~~~DiwSlG~il~el~ 201 (325)
|||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|+|+
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999998865432 334457 999999999 5556788999999999999999
Q ss_pred hCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 202 SAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 202 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
+|..||........ ...+.. ....+++.+.+||.+||..||++|||+.++++ ||+.+
T Consensus 312 tg~~Pf~~~~~~~~---------------~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 312 CADLPNTDDAALGG---------------SEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp HSSCCCCTTGGGSC---------------SGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HCCCCCCCcchhhh---------------HHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 99999965332111 111111 11234578999999999999999999999886 56554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=268.56 Aligned_cols=239 Identities=13% Similarity=0.165 Sum_probs=177.0
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--------hhhHHHHHHHHHHHHccC---------CCCc
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--------AKAEMEFAVEVEILGRVR---------HRNL 74 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~~i 74 (325)
...|.+++.||.| +++.||+++. +++.||||.+.... ......+.+|+.+++.++ ||||
T Consensus 19 ~~~y~~~~~lG~G--~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 19 TEKLQRCEKIGEG--VFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp HHHHHTCEEEEEE--TTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccchheeeeccc--CceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3678899999999 7778999886 57999999997432 233467889999999886 6666
Q ss_pred cceeeE-----------------EEc-------------CCeEEEEEEecCCCChhhhh-ccCCCCCCccCHHHHHHHHH
Q 046728 75 LGLRGF-----------------YAG-------------GDERLIVYDYMPNHSLITHL-HGRLAPDCLLDWHRRVSIAI 123 (325)
Q Consensus 75 v~~~~~-----------------~~~-------------~~~~~lV~e~~~~gsL~~~l-~~~~~~~~~~~~~~~~~~~~ 123 (325)
+++.++ +.+ ....|+|||||++|++.+.+ +..+++..+..+..|+..++
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 655554 333 67899999999999766655 45567778899999999999
Q ss_pred HHHh-hc----CCCCCCceeeCCCC--------------------ceEEeeeccccccCCCcceeeccCCCCcCCCCccc
Q 046728 124 GSAE-GI----ADIKASNVLLDTDF--------------------EAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEY 178 (325)
Q Consensus 124 ~~~~-~~----rdlkp~Nil~~~~~--------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~ 178 (325)
.++| .+ |||||+|||++.++ .+||+|||+++..... ...||+.|+|||+
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhh
Confidence 9999 64 89999999999887 8999999999866542 2368999999999
Q ss_pred cccCCCCCcccchhHHHH-HHHHHhCCCCCCCCCCCccchhhhhhccccccccccc-ccCccccCCCCHHHHHHHHHHHH
Q 046728 179 AMWGKVSDSCDVYSFGVL-LLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEH-IADPRLKGKFNRDQLKSMVLIAL 256 (325)
Q Consensus 179 ~~~~~~~~~~DiwSlG~i-l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~ 256 (325)
+.+.. +.++||||++++ .+++++|..||... .|.... ....... ..........+...++++.+||.
T Consensus 249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 317 (336)
T 2vuw_A 249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYL-TDKMLKQMTFKTKCNTPAMKQIKRKIQEFHR 317 (336)
T ss_dssp GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHH-HHHHHHTCCCSSCCCSHHHHHHHHHHHHHHH
T ss_pred hcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHH-HHhhhhhhccCcccchhhhhhcCHHHHHHHH
Confidence 98665 889999998776 77788899998431 000000 0000000 00011111234578899999999
Q ss_pred HccCCCCCCCCCHHHHH-H--HH
Q 046728 257 RCTDSNPENRPTMTDVV-D--WL 276 (325)
Q Consensus 257 ~cl~~dp~~Rps~~~il-~--~l 276 (325)
+||..| |+++++ + ||
T Consensus 318 ~~L~~d-----sa~e~l~~Hp~f 335 (336)
T 2vuw_A 318 TMLNFS-----SATDLLCQHSLF 335 (336)
T ss_dssp HGGGSS-----SHHHHHHHCGGG
T ss_pred HHhccC-----CHHHHHhcCCCc
Confidence 999977 999999 5 55
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-29 Score=237.62 Aligned_cols=177 Identities=15% Similarity=0.051 Sum_probs=125.1
Q ss_pred eeeeeEEEeccCCCCeEEEEEeccc----------ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEEEEEEecC
Q 046728 27 ILMLLLLLRRETGDDQIAVKRLKTL----------NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMP 95 (325)
Q Consensus 27 ~~~~v~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lV~e~~~ 95 (325)
+.+.+..+++...|+.+|+|.+... ......+|.+|+++|+++ .|+||++++++++++...||||||++
T Consensus 246 ~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~ 325 (569)
T 4azs_A 246 AGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLP 325 (569)
T ss_dssp ------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCC
T ss_pred CcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCC
Confidence 5556677777778999999999642 123345789999999999 69999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCCCc
Q 046728 96 NHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTL 171 (325)
Q Consensus 96 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~t~ 171 (325)
|++|.++|...-.. ....+..|+..++.++|.+ |||||+|||++.+|.+||+|||+++........ ..+.+||+
T Consensus 326 G~~L~d~i~~~~~l-~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~-~~t~vGTp 403 (569)
T 4azs_A 326 GRLLSDMLAAGEEI-DREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW-PTNLVQSF 403 (569)
T ss_dssp SEEHHHHHHTTCCC-CHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC-SHHHHHHH
T ss_pred CCcHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc-ccCceech
Confidence 99999999643222 2346889999999999985 899999999999999999999999876543322 33456999
Q ss_pred CCCCccccccCCCCCcccchhHHHHHHHHHhCCCC
Q 046728 172 GYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKP 206 (325)
Q Consensus 172 ~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~p 206 (325)
.|+|||++.+ .+..++|+||+|++++++.++..|
T Consensus 404 ~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 404 FVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHHHHHHC------------------CCCCTTHHH
T ss_pred hhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 9999999975 567789999999998877655444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6e-24 Score=200.50 Aligned_cols=178 Identities=16% Similarity=0.106 Sum_probs=138.8
Q ss_pred HhhccCccceeeeeEEEeccCCCCeEEEEEecccC---h-----hhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 18 IQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---A-----KAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 18 ~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
.+.||.| +++.||++ ...++.+++|...... . ...+++.+|++++++++||||+++..+.......|+
T Consensus 341 ~~~LG~G--~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 341 EHLIGKG--AEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCEEeeC--CCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 3567777 88889988 3456789999864321 1 123468899999999999999966666667778899
Q ss_pred EEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee--
Q 046728 90 VYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM-- 163 (325)
Q Consensus 90 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~-- 163 (325)
|||||++++|.++++. ...+..++..++.++|.. |||||+|||++. .+||+|||+++.........
T Consensus 417 VmE~~~ggsL~~~l~~------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~ 488 (540)
T 3en9_A 417 MMSYINGKLAKDVIED------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVD 488 (540)
T ss_dssp EEECCCSEEHHHHSTT------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHH
T ss_pred EEECCCCCCHHHHHHH------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccc
Confidence 9999999999999965 578999999999999985 899999999999 99999999999876532211
Q ss_pred ----eccCCCCcCCCCcccccc--CCCCCcccchhHHHHHHHHHhCCCCC
Q 046728 164 ----TTRVKGTLGYLAPEYAMW--GKVSDSCDVYSFGVLLLELISAKKPL 207 (325)
Q Consensus 164 ----~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf 207 (325)
.....||+.|+|||++.. ..|+..+|+||..+-..+...++.+|
T Consensus 489 ~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 489 LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 124568999999999986 56788899999999888887777765
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=3.2e-20 Score=161.03 Aligned_cols=150 Identities=13% Similarity=0.019 Sum_probs=115.5
Q ss_pred HHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh------------------hhHHHHHHHHHHHHccCCCCcccee
Q 046728 17 FIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA------------------KAEMEFAVEVEILGRVRHRNLLGLR 78 (325)
Q Consensus 17 ~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~~iv~~~ 78 (325)
+.+.||.| +++.||.+.. .+++.||+|.+..... .....+.+|++++++++ | +++.
T Consensus 94 ~~~~iG~G--~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 94 IGKLMGEG--KESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp EEEEEEEC--SSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred ecCEeccC--CCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 34889888 7788999998 7789999999964321 23457889999999999 5 6677
Q ss_pred eEEEcCCeEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccc
Q 046728 79 GFYAGGDERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 79 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
+++.. +..++||||++||+|.+ +. ......+..++..++.++|.+ |||||+|||++ ++.++|+|||++.
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~----~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~ 240 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VR----VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 240 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CC----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred eEEec-cceEEEEEecCCCcHHH-cc----hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence 76544 45699999999999998 52 234567889999999999975 79999999999 9999999999986
Q ss_pred ccCCCcceeeccCCCCcCCCCcccccc----------CCCCCcccchhH
Q 046728 155 LIPDGVTHMTTRVKGTLGYLAPEYAMW----------GKVSDSCDVYSF 193 (325)
Q Consensus 155 ~~~~~~~~~~~~~~~t~~y~aPE~~~~----------~~~~~~~DiwSl 193 (325)
. +..+.|||++.. ..|+..+|+|++
T Consensus 241 ~--------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 241 E--------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp E--------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred E--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 3 234688998753 234555666543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=9.2e-16 Score=131.27 Aligned_cols=132 Identities=13% Similarity=0.094 Sum_probs=98.0
Q ss_pred hHHhhccCccceeeeeEEEeccCCCCe--EEEEEecccChh------------------------hHHHHHHHHHHHHcc
Q 046728 16 VFIQNINNGLEILMLLLLLRRETGDDQ--IAVKRLKTLNAK------------------------AEMEFAVEVEILGRV 69 (325)
Q Consensus 16 ~~~~~i~~G~~~~~~v~~~~~~~~~~~--vaiK~~~~~~~~------------------------~~~~~~~E~~~l~~l 69 (325)
.+.+.||.| +++.||.+....+|+. ||||.+...... ....+.+|+.++..+
T Consensus 50 ~i~~~ig~G--~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 50 AMGGVISTG--KEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEC--SSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeec--ceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 455678887 8888999988677888 999987542111 123678899999999
Q ss_pred CCCCc--cceeeEEEcCCeEEEEEEecCC-C----ChhhhhccCCCCCCccCHHHHHHHHHHHHh-h----cCCCCCCce
Q 046728 70 RHRNL--LGLRGFYAGGDERLIVYDYMPN-H----SLITHLHGRLAPDCLLDWHRRVSIAIGSAE-G----IADIKASNV 137 (325)
Q Consensus 70 ~h~~i--v~~~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~----~rdlkp~Ni 137 (325)
+|+++ ..+++. ...++||||+.+ | +|.++... .++..+..+..++..++.++| . ||||||.||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NI 202 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNI 202 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHE
Confidence 88764 333332 356899999932 3 66666532 234566788899999999999 5 489999999
Q ss_pred eeCCCCceEEeeecccccc
Q 046728 138 LLDTDFEAKVADFGFAKLI 156 (325)
Q Consensus 138 l~~~~~~~kL~Dfg~~~~~ 156 (325)
|++. .++|+|||++...
T Consensus 203 Ll~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 203 MYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EESS--SEEECCCTTCEET
T ss_pred EEcC--cEEEEECcccccC
Confidence 9998 9999999998754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.28 E-value=1e-12 Score=117.52 Aligned_cols=131 Identities=11% Similarity=0.016 Sum_probs=88.5
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh-----------------h-----hHHHHHHHHHHHHccCCC
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA-----------------K-----AEMEFAVEVEILGRVRHR 72 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-----------------~-----~~~~~~~E~~~l~~l~h~ 72 (325)
|.+.+.||.| +++.||.+... +|+.||||+++.... . ......+|...|.++.+.
T Consensus 97 Y~I~~~IG~G--k~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 97 YSVGSRIGVG--KESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SEEEEEEEEC--SSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEecCEeeeC--CceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 5567788888 88889999874 588999998742100 0 001123567777777544
Q ss_pred CccceeeEEEcCCeEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC-----
Q 046728 73 NLLGLRGFYAGGDERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF----- 143 (325)
Q Consensus 73 ~iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~----- 143 (325)
++. +...+.. ...++||||+.|++|.+... ...+..+..++..++.++|.. |||||.|||+++++
T Consensus 174 gv~-vp~p~~~-~~~~LVME~i~G~~L~~l~~----~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~ 247 (397)
T 4gyi_A 174 GFP-VPEPIAQ-SRHTIVMSLVDALPMRQVSS----VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP 247 (397)
T ss_dssp TCS-CCCEEEE-ETTEEEEECCSCEEGGGCCC----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred CCC-CCeeeec-cCceEEEEecCCccHhhhcc----cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence 432 1111111 12479999999988877653 234456778888888888874 79999999998765
Q ss_pred -----ceEEeeecccc
Q 046728 144 -----EAKVADFGFAK 154 (325)
Q Consensus 144 -----~~kL~Dfg~~~ 154 (325)
.+.|+||+-+.
T Consensus 248 ~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 248 SSITLTPIIIXFPQMV 263 (397)
T ss_dssp TSEEEEEEECCCTTCE
T ss_pred cccccceEEEEeCCcc
Confidence 38899998554
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.00 E-value=9.9e-10 Score=93.67 Aligned_cols=133 Identities=8% Similarity=0.007 Sum_probs=92.3
Q ss_pred hhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCCeEEEEEEe
Q 046728 15 AVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDERLIVYDY 93 (325)
Q Consensus 15 ~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lV~e~ 93 (325)
|.+...++.| +...||.+... ++.+++|............+.+|+.+++.+. +..+.+++++..+....|+||||
T Consensus 16 ~~~~~~~~g~--s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 16 YRCVKDTEGM--SPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp SEEEECCSCC--SSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ceeEeeccCC--CCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 4445555555 44567777633 5789999986422122346888999999994 67788999999888899999999
Q ss_pred cCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhh---------------------------------------------
Q 046728 94 MPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEG--------------------------------------------- 128 (325)
Q Consensus 94 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------------------------- 128 (325)
++|.+|.+.+.. ......+..++..++..+|.
T Consensus 92 i~G~~l~~~~~~---~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 92 ADGVLCSEEYED---EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp CSSEEHHHHCCT---TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred cCCeehhhccCC---cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 999998775421 11122344444444444444
Q ss_pred ------------------cCCCCCCceeeCCCCceEEeeecccc
Q 046728 129 ------------------IADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 129 ------------------~rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
|+|++|.||++++...+.|+||+.+.
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 47999999999876556799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.69 E-value=4.2e-08 Score=83.09 Aligned_cols=70 Identities=14% Similarity=0.100 Sum_probs=52.1
Q ss_pred eeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCC--ccceeeEEEcCCeEEEEEEecCCCChh
Q 046728 27 ILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRN--LLGLRGFYAGGDERLIVYDYMPNHSLI 100 (325)
Q Consensus 27 ~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lV~e~~~~gsL~ 100 (325)
....||.+.. .++..+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++||||++|.+|.
T Consensus 32 ~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 32 SDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp SSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred CCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 4466777753 45678999997653 2246778999999995434 556888888878899999999998874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.40 E-value=5e-07 Score=80.53 Aligned_cols=79 Identities=5% Similarity=0.119 Sum_probs=52.1
Q ss_pred HhhccCccceeeeeEEEeccCCCCeEEEEEec--ccC-hhhHHHHHHHHHHHHccC--CCCccceeeEEEcC---CeEEE
Q 046728 18 IQNINNGLEILMLLLLLRRETGDDQIAVKRLK--TLN-AKAEMEFAVEVEILGRVR--HRNLLGLRGFYAGG---DERLI 89 (325)
Q Consensus 18 ~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~---~~~~l 89 (325)
++.++.| .+..+|.+... +..+++|... ... ......+.+|+.+++.+. +..+.+++.++.+. ...|+
T Consensus 43 ~~~l~~G--~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 43 VEQFKGG--QSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EEECCC---CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred EEEcCCc--ccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 4556666 55567766643 4578888875 321 122347788999999996 45678888887766 44899
Q ss_pred EEEecCCCChh
Q 046728 90 VYDYMPNHSLI 100 (325)
Q Consensus 90 V~e~~~~gsL~ 100 (325)
||||++|.++.
T Consensus 119 vme~v~G~~l~ 129 (359)
T 3dxp_A 119 IMEFVSGRVLW 129 (359)
T ss_dssp EEECCCCBCCC
T ss_pred EEEecCCeecC
Confidence 99999987774
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.23 E-value=4.3e-07 Score=79.00 Aligned_cols=74 Identities=12% Similarity=0.072 Sum_probs=45.9
Q ss_pred hhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-CCC--ccceeeEEEcCC---eEEEEEE
Q 046728 19 QNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HRN--LLGLRGFYAGGD---ERLIVYD 92 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~--iv~~~~~~~~~~---~~~lV~e 92 (325)
+.++.| ....+|.+. ..+++|.... ......+.+|+.+++.+. +.. +.+++....... ..|+||+
T Consensus 26 ~~~~~G--~~n~v~~v~-----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 26 EISGEG--NDCIAYEIN-----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CEEEEC--SSEEEEEST-----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred EecCCC--CcceEEEEC-----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 345556 444566553 4688998653 244567889999999883 332 333433332222 3479999
Q ss_pred ecCCCChhh
Q 046728 93 YMPNHSLIT 101 (325)
Q Consensus 93 ~~~~gsL~~ 101 (325)
+++|.+|.+
T Consensus 97 ~i~G~~l~~ 105 (304)
T 3sg8_A 97 KIKGVPLTP 105 (304)
T ss_dssp CCCCEECCH
T ss_pred ccCCeECCc
Confidence 999977754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=5.9e-05 Score=64.02 Aligned_cols=71 Identities=13% Similarity=0.151 Sum_probs=54.0
Q ss_pred eeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCCeEEEEEEecCCCChhhh
Q 046728 29 MLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDERLIVYDYMPNHSLITH 102 (325)
Q Consensus 29 ~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lV~e~~~~gsL~~~ 102 (325)
..+|......++..+++|.-.. .....+..|...|+.+. +--|.+++++..+.+..++|||+++|.++.+.
T Consensus 39 ~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~ 110 (272)
T 4gkh_A 39 ATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV 110 (272)
T ss_dssp CEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred CeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence 3567776667778899998754 23446788999999884 33367888888888999999999998776544
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.53 E-value=0.0003 Score=61.03 Aligned_cols=73 Identities=12% Similarity=0.143 Sum_probs=48.1
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCC---CccceeeEEE-cCCeEEEEEEecC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHR---NLLGLRGFYA-GGDERLIVYDYMP 95 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~~~~~~~-~~~~~~lV~e~~~ 95 (325)
.++.| ....+|.+ +..+++|.-. .......+..|..+|+.+.+. .|.+++.+.. .....++||+|++
T Consensus 26 ~l~~G--~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 26 SLGEG--FRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEC--SSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred ecCCC--cceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 34555 33345555 4567888853 234456888999999999642 2455555553 3455789999999
Q ss_pred CCChhh
Q 046728 96 NHSLIT 101 (325)
Q Consensus 96 ~gsL~~ 101 (325)
|.++.+
T Consensus 97 G~~l~~ 102 (306)
T 3tdw_A 97 GQILGE 102 (306)
T ss_dssp SEECHH
T ss_pred CeECch
Confidence 977754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0013 Score=59.13 Aligned_cols=76 Identities=14% Similarity=0.123 Sum_probs=45.7
Q ss_pred HhhccCccceeeeeEEEeccCCCCeEEEEEecccCh-------hhHHHHHHHHHHHHccC-C-CC-ccceeeEEEcCCeE
Q 046728 18 IQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA-------KAEMEFAVEVEILGRVR-H-RN-LLGLRGFYAGGDER 87 (325)
Q Consensus 18 ~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~E~~~l~~l~-h-~~-iv~~~~~~~~~~~~ 87 (325)
++.+|.| ....||.+....+++.|++|....... ....++..|.++++.+. + |. +.+++.+ +....
T Consensus 35 ~~~lg~G--~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~ 110 (397)
T 2olc_A 35 CQEIGDG--NLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA 110 (397)
T ss_dssp EEECCSS--SSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred EEECCCC--ceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCcc
Confidence 3456666 666788876555678899998642111 12345677999998874 2 33 3355543 34556
Q ss_pred EEEEEecCCC
Q 046728 88 LIVYDYMPNH 97 (325)
Q Consensus 88 ~lV~e~~~~g 97 (325)
++|||++++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 8999999763
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0021 Score=52.15 Aligned_cols=134 Identities=11% Similarity=0.060 Sum_probs=78.3
Q ss_pred Chhhhhc---cCCCCCCccCHHHHHHHHHHHHhh----c-CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccCCC
Q 046728 98 SLITHLH---GRLAPDCLLDWHRRVSIAIGSAEG----I-ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKG 169 (325)
Q Consensus 98 sL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~----~-rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 169 (325)
||.+.++ ..+++.+++.+..|....+.-... . +=+.|..|++..+|.|...+ ..+. ..
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~ 99 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------AG 99 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------cc
Confidence 6777773 456666667666666555444311 1 23345777777777776553 1100 12
Q ss_pred CcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHHHH
Q 046728 170 TLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249 (325)
Q Consensus 170 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (325)
...+.+||... ...+.+.=|||||+++|.-+--..| ...+..+++
T Consensus 100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~----------------------------------e~eE~eLS~ 144 (229)
T 2yle_A 100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK----------------------------------ENEERELSP 144 (229)
T ss_dssp -------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC----------------------------------TTEEECCCH
T ss_pred ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC----------------------------------cccchhhCH
Confidence 33467888764 3445677799999999987653332 122345667
Q ss_pred HHHHHHHHccCC-------------------------CCCCCCCHHHHHHHHhccc
Q 046728 250 SMVLIALRCTDS-------------------------NPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 250 ~~~~li~~cl~~-------------------------dp~~Rps~~~il~~l~~~~ 280 (325)
.+..||..|... .+..|+|.++|++.=...+
T Consensus 145 ~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl 200 (229)
T 2yle_A 145 PLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHL 200 (229)
T ss_dssp HHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTTS
T ss_pred HHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhhc
Confidence 788888888755 3468899999998655544
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.95 E-value=0.038 Score=48.01 Aligned_cols=26 Identities=23% Similarity=0.212 Sum_probs=23.0
Q ss_pred cCCCCCCceeeCCCCceEEeeecccc
Q 046728 129 IADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 129 ~rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
|+|+++.||+++.++.+.|+||+.+.
T Consensus 226 HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 226 HQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCCCCcccEEEeCCCcEEEEehhhcc
Confidence 47999999999888889999998765
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=95.76 E-value=0.0069 Score=53.37 Aligned_cols=80 Identities=10% Similarity=0.146 Sum_probs=48.6
Q ss_pred hhc-cCccceeeeeEEEecc--C----CCCeEEEEEecccC---hhhHHHHHHHHHHHHccC-C--CCccceeeEEEcC-
Q 046728 19 QNI-NNGLEILMLLLLLRRE--T----GDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVR-H--RNLLGLRGFYAGG- 84 (325)
Q Consensus 19 ~~i-~~G~~~~~~v~~~~~~--~----~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~- 84 (325)
+.| +.| ....+|.+... . ++..+++|...... ......+..|+.+++.+. + -.+.+++.+..+.
T Consensus 26 ~~l~~~G--~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 26 SGVDSTG--MSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEECTTS--SEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EECCCCC--ccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 344 455 44455655432 1 14678888765321 001235778899998884 3 3466777776554
Q ss_pred --CeEEEEEEecCCCChh
Q 046728 85 --DERLIVYDYMPNHSLI 100 (325)
Q Consensus 85 --~~~~lV~e~~~~gsL~ 100 (325)
...++||||++|.++.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 3568999999887654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.93 E-value=0.058 Score=48.65 Aligned_cols=26 Identities=23% Similarity=0.358 Sum_probs=22.7
Q ss_pred cCCCCCCceeeCCCCceEEeeeccccc
Q 046728 129 IADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 129 ~rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
|+|++|.|||++.++ +.++||+.+..
T Consensus 236 HGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 236 HGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred ecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 379999999998776 99999988774
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=92.63 E-value=0.54 Score=40.47 Aligned_cols=73 Identities=12% Similarity=0.126 Sum_probs=53.2
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC---CCCccceeeEEEcCCeEEEEEEecCC
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR---HRNLLGLRGFYAGGDERLIVYDYMPN 96 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lV~e~~~~ 96 (325)
.|+.| ....+|.+.. ++..+++|..... ....+..|...|+.|. ...+.+++.+.......++||||+++
T Consensus 43 ~l~gG--~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 43 KLYSG--EMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EECCS--SSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred EeCCc--cceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 34444 5566776663 4567889987542 3457888999999883 35677888888777889999999998
Q ss_pred CCh
Q 046728 97 HSL 99 (325)
Q Consensus 97 gsL 99 (325)
.++
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.51 E-value=1.1 Score=38.32 Aligned_cols=74 Identities=11% Similarity=0.131 Sum_probs=39.1
Q ss_pred hccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-----CCCcccee-e--EEEcCCeEEEEE
Q 046728 20 NINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-----HRNLLGLR-G--FYAGGDERLIVY 91 (325)
Q Consensus 20 ~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~-~--~~~~~~~~~lV~ 91 (325)
.|+.| ....+|.+.... + .+++|..... .....+..|..++..+. -|.++... | +....+..++||
T Consensus 29 ~i~~G--~~n~~~~v~~~~-g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 29 GIAEG--VENSNFLLHTTK-D-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EECC-----EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred ccCCC--cccceEEEEeCC-c-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 34444 445566665432 3 6789988652 11224556777777763 23333211 1 122345678999
Q ss_pred EecCCCCh
Q 046728 92 DYMPNHSL 99 (325)
Q Consensus 92 e~~~~gsL 99 (325)
+|.+|.++
T Consensus 103 ~~l~G~~~ 110 (322)
T 2ppq_A 103 SFLEGMWL 110 (322)
T ss_dssp ECCCCBCC
T ss_pred EeCCCcCC
Confidence 99988653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=92.06 E-value=0.42 Score=42.40 Aligned_cols=55 Identities=11% Similarity=0.195 Sum_probs=35.6
Q ss_pred CCeEEEEEecccChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCCeEEEEEEecCCCCh
Q 046728 40 DDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDERLIVYDYMPNHSL 99 (325)
Q Consensus 40 ~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lV~e~~~~gsL 99 (325)
++.+++++.... ......+.+|..+++.+. +.-..++++.+.+ .+||||.+|.+|
T Consensus 82 ~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l 137 (379)
T 3feg_A 82 PREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPL 137 (379)
T ss_dssp CSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEEC
T ss_pred CCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccC
Confidence 467889886332 223445668999999884 4334566666543 299999988554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=89.86 E-value=1.1 Score=38.96 Aligned_cols=74 Identities=11% Similarity=0.095 Sum_probs=43.2
Q ss_pred HhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC---CCCccceeeE------EEcCCeEE
Q 046728 18 IQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR---HRNLLGLRGF------YAGGDERL 88 (325)
Q Consensus 18 ~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~------~~~~~~~~ 88 (325)
++.+..|.+..-.+|.+.... + .+++|....... ..|+..++.|. -|++.+.+.. .......+
T Consensus 26 ~~~l~~G~g~~N~vy~v~~~~-g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~ 97 (339)
T 3i1a_A 26 AQFIQGGADTNAFAYQADSES-K-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKI 97 (339)
T ss_dssp EEEETTTSCSSCEEEEEECSS-C-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEE
T ss_pred eEEeeccCccccceEEEEeCC-C-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEE
Confidence 344555544456677776433 4 789998765331 34555665552 2224444422 23456789
Q ss_pred EEEEecCCCCh
Q 046728 89 IVYDYMPNHSL 99 (325)
Q Consensus 89 lV~e~~~~gsL 99 (325)
+||+|.+|..+
T Consensus 98 ~l~~~i~G~~~ 108 (339)
T 3i1a_A 98 IAYPFIHAPNG 108 (339)
T ss_dssp EEEECCCCCBT
T ss_pred EEEeccCCCcC
Confidence 99999988655
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=89.06 E-value=0.53 Score=40.05 Aligned_cols=71 Identities=8% Similarity=0.062 Sum_probs=39.7
Q ss_pred HhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCc-cceeeEEEcCCeEEEEEEec-C
Q 046728 18 IQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNL-LGLRGFYAGGDERLIVYDYM-P 95 (325)
Q Consensus 18 ~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lV~e~~-~ 95 (325)
++.|+.| .+..+|.+ ..+++|+....... .....+|+.+++.+....+ .++++. +...-++|+||+ +
T Consensus 23 i~~l~gG--~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 23 PLERLGG--LTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAG 91 (301)
T ss_dssp CEEEESC--SSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTT
T ss_pred eeEcCCc--ccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCC
Confidence 4556666 44455655 45888887642211 1123568888887742222 355543 344457899999 6
Q ss_pred CCCh
Q 046728 96 NHSL 99 (325)
Q Consensus 96 ~gsL 99 (325)
|.++
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 6444
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=83.31 E-value=1.9 Score=36.26 Aligned_cols=75 Identities=13% Similarity=0.151 Sum_probs=47.4
Q ss_pred HhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-C-C-CccceeeEEEcCCeEEEEEEec
Q 046728 18 IQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-H-R-NLLGLRGFYAGGDERLIVYDYM 94 (325)
Q Consensus 18 ~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h-~-~iv~~~~~~~~~~~~~lV~e~~ 94 (325)
++.+|.| ....+|.+. ..+|+.|++|.-..........+..|+..|+.|. . + .+.+++++ +.-++||||.
T Consensus 20 v~~~g~G--~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l 92 (288)
T 3f7w_A 20 VAERGHS--HRWHLYRVE-LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWV 92 (288)
T ss_dssp EEEEEEE--TTEEEEEEE-ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECC
T ss_pred EEecCCC--CCeEEEEEE-ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEee
Confidence 4455555 555677665 3467889999876433333346778999999884 2 1 23444443 2247899999
Q ss_pred CCCCh
Q 046728 95 PNHSL 99 (325)
Q Consensus 95 ~~gsL 99 (325)
.++..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 325 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-50 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-46 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-46 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-44 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-42 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-42 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-42 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-41 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-40 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-40 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-39 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-38 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-38 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-38 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-37 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-37 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-37 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-36 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-33 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-32 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-31 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-30 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-30 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-29 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-28 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-28 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-27 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-27 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-26 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-26 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-26 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-25 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-25 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-25 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-25 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-25 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-24 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-22 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-21 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-21 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-18 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-18 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-17 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-17 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-16 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-13 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-50
Identities = 59/254 (23%), Positives = 105/254 (41%), Gaps = 31/254 (12%)
Query: 40 DDQIAVKRLKT--LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNH 97
+AVK L + F EV +L + RH N+L G+ + IV +
Sbjct: 30 HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGS 88
Query: 98 SLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKV 147
SL HLH + + + + IA +A+G+ D+K++N+ L D K+
Sbjct: 89 SLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKI 145
Query: 148 ADFGFAKLIPDG-VTHMTTRVKGTLGYLAPEYAM---WGKVSDSCDVYSFGVLLLELISA 203
DFG A + +H ++ G++ ++APE S DVY+FG++L EL++
Sbjct: 146 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 205
Query: 204 KKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNP 263
+ P + + + V +G P L K + K+M + C
Sbjct: 206 QLPYSNI------NNRDQIIFMVGRG----YLSPDLS-KVRSNCPKAMKRLMAECLKKKR 254
Query: 264 ENRPTMTDVVDWLK 277
+ RP ++ ++
Sbjct: 255 DERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 4e-46
Identities = 61/252 (24%), Positives = 110/252 (43%), Gaps = 29/252 (11%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
G ++AVK LK + + F E ++ +++H+ L+ L + I+ +YM
Sbjct: 33 YYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90
Query: 96 NHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEA 145
N SL+ L L ++ + +A AEG+A D++A+N+L+
Sbjct: 91 NGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSC 148
Query: 146 KVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKK 205
K+ADFG A+LI D K + + APE +G + DV+SFG+LL E+++ +
Sbjct: 149 KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208
Query: 206 PLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPEN 265
PG +++Q + R+ + + + + C PE+
Sbjct: 209 IPY--PGMTNPEVIQNLE-----------RGYRM--VRPDNCPEELYQLMRLCWKERPED 253
Query: 266 RPTMTDVVDWLK 277
RPT + L+
Sbjct: 254 RPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 6e-46
Identities = 56/252 (22%), Positives = 105/252 (41%), Gaps = 29/252 (11%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
D++A+K ++ A +E +F E E++ ++ H L+ L G +V+++M
Sbjct: 25 YWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83
Query: 96 NHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEA 145
+ L +L + L + + + EG+A D+ A N L+ +
Sbjct: 84 HGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVI 140
Query: 146 KVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKK 205
KV+DFG + + D +T K + + +PE + + S DV+SFGVL+ E+ S K
Sbjct: 141 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 200
Query: 206 PLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPEN 265
++V+ ++ + PRL + I C PE+
Sbjct: 201 IPY--ENRSNSEVVEDIS------TGFRLYKPRLAS-------THVYQIMNHCWKERPED 245
Query: 266 RPTMTDVVDWLK 277
RP + ++ L
Sbjct: 246 RPAFSRLLRQLA 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-45
Identities = 66/252 (26%), Positives = 113/252 (44%), Gaps = 29/252 (11%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
G ++A+K LK + F E +++ ++RH L+ L + + IV +YM
Sbjct: 37 TWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94
Query: 96 NHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEA 145
SL+ L G + V +A A G+A D++A+N+L+ +
Sbjct: 95 KGSLLDFLKGETGKYL--RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 152
Query: 146 KVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKK 205
KVADFG A+LI D K + + APE A++G+ + DV+SFG+LL EL + +
Sbjct: 153 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 212
Query: 206 PLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPEN 265
PG V R+++ V + + + +S+ + +C PE
Sbjct: 213 VPY--PGMVNREVLDQV-------------ERGYRMPCPPECPESLHDLMCQCWRKEPEE 257
Query: 266 RPTMTDVVDWLK 277
RPT + +L+
Sbjct: 258 RPTFEYLQAFLE 269
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 5e-45
Identities = 53/254 (20%), Positives = 94/254 (37%), Gaps = 33/254 (12%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMP 95
+ G +A+K +K + +E EF E +++ + H L+ L G I+ +YM
Sbjct: 24 KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82
Query: 96 NHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEA 145
N L+ +L + + + E + D+ A N L++
Sbjct: 83 NGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVV 139
Query: 146 KVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKK 205
KV+DFG ++ + D + K + + PE M+ K S D+++FGVL+ E+ S K
Sbjct: 140 KVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 199
Query: 206 PL--EKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNP 263
I Q + Y A E + I C
Sbjct: 200 MPYERFTNSETAEHIAQGLRLYRPHLASEKVYT-----------------IMYSCWHEKA 242
Query: 264 ENRPTMTDVVDWLK 277
+ RPT ++ +
Sbjct: 243 DERPTFKILLSNIL 256
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-44
Identities = 55/249 (22%), Positives = 107/249 (42%), Gaps = 31/249 (12%)
Query: 43 IAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+A+K LK K ++F E I+G+ H N++ L G + +I+ +YM N +L
Sbjct: 39 VAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK 98
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVADFG 151
L + D + V + G A G+ D+ A N+L++++ KV+DFG
Sbjct: 99 FLREK---DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG 155
Query: 152 FAKLIPDG--VTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEK 209
++++ D T+ T+ K + + APE + K + + DV+SFG+++ E+++ +
Sbjct: 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER--- 212
Query: 210 LPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTM 269
+ I + + D ++ + ++C RP
Sbjct: 213 -----------PYWELSNHEVMKAI-NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKF 260
Query: 270 TDVVDWLKG 278
D+V L
Sbjct: 261 ADIVSILDK 269
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 149 bits (376), Expect = 2e-43
Identities = 50/253 (19%), Positives = 95/253 (37%), Gaps = 28/253 (11%)
Query: 35 RRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94
+ +AVK LK + E EF E ++ ++H NL+ L G I+ ++M
Sbjct: 37 VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95
Query: 95 PNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFE 144
+L+ +L + + +A + + D+ A N L+ +
Sbjct: 96 TYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 153
Query: 145 AKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAK 204
KVADFG ++L+ K + + APE + K S DV++FGVLL E+ +
Sbjct: 154 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 213
Query: 205 KPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPE 264
P + + + + + + + + C NP
Sbjct: 214 MSPY---------------PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS 258
Query: 265 NRPTMTDVVDWLK 277
+RP+ ++ +
Sbjct: 259 DRPSFAEIHQAFE 271
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 1e-42
Identities = 63/249 (25%), Positives = 100/249 (40%), Gaps = 34/249 (13%)
Query: 40 DDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL-IVYDYMPNHS 98
+++AVK +K N F E ++ ++RH NL+ L G L IV +YM S
Sbjct: 30 GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 87
Query: 99 LITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVA 148
L+ +L R +L + ++ E + D+ A NVL+ D AKV+
Sbjct: 88 LVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVS 145
Query: 149 DFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLE 208
DFG K K + + APE K S DV+SFG+LL E+ S +
Sbjct: 146 DFGLTKEASS----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 201
Query: 209 KLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPT 268
R ++ V P V+KG K ++ + C + RP+
Sbjct: 202 ------PRIPLKDVVPRVEKG---------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPS 246
Query: 269 MTDVVDWLK 277
+ + L+
Sbjct: 247 FLQLREQLE 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-42
Identities = 65/260 (25%), Positives = 101/260 (38%), Gaps = 33/260 (12%)
Query: 33 LLRRETGDDQIAVKRLKTLNAKAEME-FAVEVEILGRVRHRNLLGLRGFYAGGDER-LIV 90
LL + AVK L + E+ F E I+ H N+L L G + L+V
Sbjct: 48 LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107
Query: 91 YDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLD 140
YM + L + + + A+G+ D+ A N +LD
Sbjct: 108 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD 164
Query: 141 TDFEAKVADFGFAKLIPDG---VTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLL 197
F KVADFG A+ + D H T K + ++A E K + DV+SFGVLL
Sbjct: 165 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 224
Query: 198 LELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALR 257
EL++ P P DI ++ + E+ DP + + L+
Sbjct: 225 WELMTRGAPPY--PDVNTFDITVYLLQGRRLLQPEYCPDP-------------LYEVMLK 269
Query: 258 CTDSNPENRPTMTDVVDWLK 277
C E RP+ +++V +
Sbjct: 270 CWHPKAEMRPSFSELVSRIS 289
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 146 bits (369), Expect = 2e-42
Identities = 55/259 (21%), Positives = 109/259 (42%), Gaps = 35/259 (13%)
Query: 36 RETGDDQI--AVKRLKT-LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
+ G +I A+K LK+ K +F E I+G+ H N++ L G +I+ +
Sbjct: 48 KLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITE 107
Query: 93 YMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTD 142
+M N SL + L + V + G A G+ D+ A N+L++++
Sbjct: 108 FMENGSLDSFLRQNDGQF---TVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN 164
Query: 143 FEAKVADFGFAKLIPDGVTHMTTR----VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLL 198
KV+DFG ++ + D + T K + + APE + K + + DV+S+G+++
Sbjct: 165 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMW 224
Query: 199 ELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRC 258
E++S + +D++ + + + D ++ + L C
Sbjct: 225 EVMSYGERP--YWDMTNQDVINAI-------------EQDYRLPPPMDCPSALHQLMLDC 269
Query: 259 TDSNPENRPTMTDVVDWLK 277
+ +RP +V+ L
Sbjct: 270 WQKDRNHRPKFGQIVNTLD 288
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-42
Identities = 49/274 (17%), Positives = 93/274 (33%), Gaps = 42/274 (15%)
Query: 40 DDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD----ERLIVYDYMP 95
+++AVK + + E+ +RH N+LG + + +V DY
Sbjct: 26 GEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84
Query: 96 NHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA------------------DIKASNV 137
+ SL +L+ + + +A+ +A G+A D+K+ N+
Sbjct: 85 HGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 139
Query: 138 LLDTDFEAKVADFGFAKLIP---DGVTHMTTRVKGTLGYLAPEY------AMWGKVSDSC 188
L+ + +AD G A D + GT Y+APE +
Sbjct: 140 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 199
Query: 189 DVYSFGVLLLELISAKKPLEKLPGG----VKRDIVQWVTPYVQKGAFEHIADPRLKGKF- 243
D+Y+ G++ E+ ++K E P + ++
Sbjct: 200 DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQ 259
Query: 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277
+ + L+ M I C +N R T + L
Sbjct: 260 SCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (365), Expect = 8e-42
Identities = 47/268 (17%), Positives = 91/268 (33%), Gaps = 47/268 (17%)
Query: 42 QIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100
+AVK LK +A + +F E ++ + N++ L G A G ++++YM L
Sbjct: 45 MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 104
Query: 101 THLHGR--------------------LAPDCLLDWHRRVSIAIGSAEGIA---------- 130
L L ++ IA A G+A
Sbjct: 105 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDG-VTHMTTRVKGTLGYLAPEYAMWGKVSDSCD 189
D+ N L+ + K+ADFG ++ I + ++ PE + + + D
Sbjct: 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 224
Query: 190 VYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249
V+++GV+L E+ S + ++ D + +
Sbjct: 225 VWAYGVVLWEIFSYGLQ--------------PYYGMAHEEVIYYVRDGNIL-ACPENCPL 269
Query: 250 SMVLIALRCTDSNPENRPTMTDVVDWLK 277
+ + C P +RP+ + L+
Sbjct: 270 ELYNLMRLCWSKLPADRPSFCSIHRILQ 297
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 8e-41
Identities = 52/258 (20%), Positives = 96/258 (37%), Gaps = 34/258 (13%)
Query: 34 LRRETGDDQIAVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91
+ + +AVK LK + + E E ++ ++ + ++ + G + ++V
Sbjct: 28 YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVM 86
Query: 92 DYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDT 141
+ L +L + + + + G+ D+ A NVLL T
Sbjct: 87 EMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT 142
Query: 142 DFEAKVADFGFAKLIPDGVTHMTTR--VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLE 199
AK++DFG +K + + + K + + APE + K S DV+SFGVL+ E
Sbjct: 143 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 202
Query: 200 LISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCT 259
S + + VT ++KG + + M + C
Sbjct: 203 AFSYGQKP------YRGMKGSEVTAMLEKG---------ERMGCPAGCPREMYDLMNLCW 247
Query: 260 DSNPENRPTMTDVVDWLK 277
+ ENRP V L+
Sbjct: 248 TYDVENRPGFAAVELRLR 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-40
Identities = 47/257 (18%), Positives = 95/257 (36%), Gaps = 43/257 (16%)
Query: 42 QIAVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYA----GGDERLIVYDYMP 95
++A L+ L F E E+L ++H N++ + G ++V + M
Sbjct: 36 EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 95
Query: 96 NHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA------------DIKASNVLL-DTD 142
+ +L T+L ++ S +G+ D+K N+ +
Sbjct: 96 SGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPT 151
Query: 143 FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
K+ D G A L V GT ++APE K +S DVY+FG+ +LE+ +
Sbjct: 152 GSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMAT 207
Query: 203 AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSN 262
++ P + + + F++ + + I C N
Sbjct: 208 SEYP--------------YSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQN 253
Query: 263 PENRPTMTDVVD--WLK 277
+ R ++ D+++ + +
Sbjct: 254 KDERYSIKDLLNHAFFQ 270
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-40
Identities = 55/276 (19%), Positives = 99/276 (35%), Gaps = 42/276 (15%)
Query: 30 LLLLLRRETGDDQIAVKRLK-TLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDER 87
L++ + +AVK LK + + E+++L + H N++ L G G
Sbjct: 44 AYGLIKSDAAM-TVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102
Query: 88 LIVYDYMPNHSLITHLHGR--------------LAPDCLLDWHRRVSIAIGSAEGIA--- 130
L++ +Y L+ L + + LD +S + A+G+A
Sbjct: 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA 162
Query: 131 -------DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM-TTRVKGTLGYLAPEYAMWG 182
D+ A N+LL K+ DFG A+ I + ++ + + ++APE
Sbjct: 163 SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC 222
Query: 183 KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242
+ DV+S+G+ L EL S F + +
Sbjct: 223 VYTFESDVWSYGIFLWELFSLGSS--------------PYPGMPVDSKFYKMIKEGFRML 268
Query: 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278
M I C D++P RPT +V ++
Sbjct: 269 SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-40
Identities = 49/280 (17%), Positives = 100/280 (35%), Gaps = 48/280 (17%)
Query: 31 LLLLRRETGDDQIAVKRL-KTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERL 88
+ + Q+AVK L + ++ E++++ ++ H N++ L G
Sbjct: 58 AYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 117
Query: 89 IVYDYMPNHSLITHLHGR-------------------LAPDCLLDWHRRVSIAIGSAEGI 129
++++Y L+ +L + +L + + A A+G+
Sbjct: 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM 177
Query: 130 A----------DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT-TRVKGTLGYLAPEY 178
D+ A NVL+ K+ DFG A+ I ++ + + ++APE
Sbjct: 178 EFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES 237
Query: 179 AMWGKVSDSCDVYSFGVLLLELISAKK-PLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237
G + DV+S+G+LL E+ S P +P F +
Sbjct: 238 LFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP---------------VDANFYKLIQN 282
Query: 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277
K + + +I C + RP+ ++ +L
Sbjct: 283 GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 5e-40
Identities = 51/258 (19%), Positives = 98/258 (37%), Gaps = 32/258 (12%)
Query: 33 LLRRETGDDQIAVKRLKTLNAKAEME-FAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91
+ R +A+K LK KA+ E E +I+ ++ + ++ L G + ++V
Sbjct: 29 VYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 87
Query: 92 DYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDT 141
+ L L G+ + + + G+ D+ A NVLL
Sbjct: 88 EMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN 144
Query: 142 DFEAKVADFGFAKLIPDGVTHMTTR--VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLE 199
AK++DFG +K + ++ T R K L + APE + K S DV+S+GV + E
Sbjct: 145 RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWE 204
Query: 200 LISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCT 259
+S + +++ ++ R+ + + + + C
Sbjct: 205 ALSYGQKP--YKKMKGPEVMAFIE-----------QGKRM--ECPPECPPELYALMSDCW 249
Query: 260 DSNPENRPTMTDVVDWLK 277
E+RP V ++
Sbjct: 250 IYKWEDRPDFLTVEQRMR 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (350), Expect = 7e-40
Identities = 47/265 (17%), Positives = 95/265 (35%), Gaps = 38/265 (14%)
Query: 33 LLRRETGDDQIAVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL-- 88
+RR++ + K L ++ + EV +L ++H N++
Sbjct: 22 KIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81
Query: 89 IVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA---------------DIK 133
IV +Y L + + LD + + + D+K
Sbjct: 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 141
Query: 134 ASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSF 193
+NV LD K+ DFG A+++ T GT Y++PE ++ D++S
Sbjct: 142 PANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSL 200
Query: 194 GVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVL 253
G LL EL + P + G R+ +++ D+L ++
Sbjct: 201 GCLLYELCALMPPFTAF------------SQKELAGKIREGKFRRIPYRYS-DELNEII- 246
Query: 254 IALRCTDSNPENRPTMTDVVD--WL 276
R + +RP++ ++++ +
Sbjct: 247 --TRMLNLKDYHRPSVEEILENPLI 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 8e-40
Identities = 49/285 (17%), Positives = 99/285 (34%), Gaps = 48/285 (16%)
Query: 35 RRETGDDQIAVKRL-KTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93
+ +A K + + + E+++L ++G G + E I ++
Sbjct: 26 SHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85
Query: 94 MPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA-----------DIKASNVLLDTD 142
M SL L + ++I +G+ D+K SN+L+++
Sbjct: 86 MDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR 141
Query: 143 FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
E K+ DFG + + D M GT Y++PE S D++S G+ L+E+
Sbjct: 142 GEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 198
Query: 203 AKKPLE-------------KLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249
+ P+ ++ G + TP ++ + P + D +
Sbjct: 199 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV 258
Query: 250 SMVLIAL--------------RCTDSNPENRPTMTDVVD--WLKG 278
+ L +C NP R + ++ ++K
Sbjct: 259 NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-39
Identities = 60/260 (23%), Positives = 94/260 (36%), Gaps = 34/260 (13%)
Query: 34 LRRETGDDQ-IAVKRLK---TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89
+G +AVK LK +A +F EV + + HRNL+ L G + +
Sbjct: 29 WDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-M 87
Query: 90 VYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLL 139
V + P SL+ L A+ AEG+ D+ A N+LL
Sbjct: 88 VTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL 144
Query: 140 DTDFEAKVADFGFAKLIPDGVTH--MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLL 197
T K+ DFG + +P H M K + APE S + D + FGV L
Sbjct: 145 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 204
Query: 198 LELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALR 257
E+ + + G + I + D + + + ++
Sbjct: 205 WEMFTYGQEPWIGLNGSQ--------------ILHKIDKEGERLPRPEDCPQDIYNVMVQ 250
Query: 258 CTDSNPENRPTMTDVVDWLK 277
C PE+RPT + D+L
Sbjct: 251 CWAHKPEDRPTFVALRDFLL 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-38
Identities = 54/267 (20%), Positives = 106/267 (39%), Gaps = 42/267 (15%)
Query: 36 RETGDDQ-IAVKRLKTLNAKAEM-EFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYD 92
++ G A+KR+K +K + +FA E+E+L ++ H N++ L G + +
Sbjct: 32 KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 91
Query: 93 YMPNHSLITHLHGRLAPD------------CLLDWHRRVSIAIGSAEGIA---------- 130
Y P+ +L+ L + L + + A A G+
Sbjct: 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR 151
Query: 131 DIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDV 190
D+ A N+L+ ++ AK+ADFG ++ V R + ++A E + + + DV
Sbjct: 152 DLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR--LPVRWMAIESLNYSVYTTNSDV 209
Query: 191 YSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKS 250
+S+GVLL E++S G ++ + + RL + +
Sbjct: 210 WSYGVLLWEIVSLGGT--PYCGMTCAELYEKLP-----------QGYRL--EKPLNCDDE 254
Query: 251 MVLIALRCTDSNPENRPTMTDVVDWLK 277
+ + +C P RP+ ++ L
Sbjct: 255 VYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-38
Identities = 50/283 (17%), Positives = 113/283 (39%), Gaps = 36/283 (12%)
Query: 34 LRRETGDDQIAVKRL-KTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
+ ++ + ++A+K + + + + +EF E ++ +++ L G + G L++ +
Sbjct: 44 VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 103
Query: 93 YMPNHSLITHLH------GRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASN 136
M L ++L + + +A A+G+A D+ A N
Sbjct: 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 163
Query: 137 VLLDTDFEAKVADFGFAKLIPDG-VTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGV 195
++ DF K+ DFG + I + + + +++PE G + DV+SFGV
Sbjct: 164 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 223
Query: 196 LLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIA 255
+L E+ + + + + V +V +G D + + +
Sbjct: 224 VLWEIATLAEQPY------QGLSNEQVLRFVMEGGLLDKPD---------NCPDMLFELM 268
Query: 256 LRCTDSNPENRPTMTDVVDWLKGGLGRRTKDVKDVAGEDDEDN 298
C NP+ RP+ +++ +K + ++V+ E+N
Sbjct: 269 RMCWQYNPKMRPSFLEIISSIKEEM---EPGFREVSFYYSEEN 308
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 2e-38
Identities = 59/259 (22%), Positives = 99/259 (38%), Gaps = 39/259 (15%)
Query: 35 RRETGDDQIAVKRLK---TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91
R + +A+K L A E + EVEI +RH N+L L G++ ++
Sbjct: 26 REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85
Query: 92 DYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDT 141
+Y P ++ L D R + A ++ DIK N+LL +
Sbjct: 86 EYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS 141
Query: 142 DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELI 201
E K+ADFG++ P + GTL YL PE + D++S GVL E +
Sbjct: 142 AGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 198
Query: 202 SAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDS 261
K P ++ + ++ R++ F + + R
Sbjct: 199 VGKPP---FEANTYQETYKRIS--------------RVEFTFPDFVTEGARDLISRLLKH 241
Query: 262 NPENRPTMTDVVD--WLKG 278
NP RP + +V++ W+
Sbjct: 242 NPSQRPMLREVLEHPWITA 260
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (339), Expect = 7e-38
Identities = 52/261 (19%), Positives = 95/261 (36%), Gaps = 42/261 (16%)
Query: 35 RRETGDDQIAVKRLK---TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91
R + +A+K++ + + + EV L ++RH N + RG Y +V
Sbjct: 35 RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94
Query: 92 DYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDT 141
+Y + + L ++ G+ +G+A D+KA N+LL
Sbjct: 95 EYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE 150
Query: 142 DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMW---GKVSDSCDVYSFGVLLL 198
K+ DFG A ++ GT ++APE + G+ DV+S G+ +
Sbjct: 151 PGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205
Query: 199 ELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRC 258
EL K PL + P L+ + ++ V C
Sbjct: 206 ELAERKPPLFNM------------NAMSALYHIAQNESPALQSGHWSEYFRNFV---DSC 250
Query: 259 TDSNPENRPTMTDVVD--WLK 277
P++RPT ++ ++
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVL 271
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (337), Expect = 9e-38
Identities = 47/261 (18%), Positives = 98/261 (37%), Gaps = 35/261 (13%)
Query: 35 RRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94
+ + A K + T + + ++ VE++IL H N++ L + + I+ ++
Sbjct: 32 QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91
Query: 95 PNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFE 144
++ + P L + + + + + D+KA N+L D +
Sbjct: 92 AGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD 148
Query: 145 AKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMW-----GKVSDSCDVYSFGVLLLE 199
K+ADFG + + + + GT ++APE M DV+S G+ L+E
Sbjct: 149 IKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE 207
Query: 200 LISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCT 259
+ + P +L V + K +A P K + +C
Sbjct: 208 MAEIEPPHHELN-------PMRVLLKIAKSEPPTLAQP----SRWSSNFKDFL---KKCL 253
Query: 260 DSNPENRPTMTDVVD--WLKG 278
+ N + R T + ++ ++
Sbjct: 254 EKNVDARWTTSQLLQHPFVTV 274
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 1e-37
Identities = 47/249 (18%), Positives = 95/249 (38%), Gaps = 35/249 (14%)
Query: 43 IAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+A+K L+ + KA E E ++ V + ++ L G +LI MP L+
Sbjct: 41 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQ-LMPFGCLLD 99
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVADFG 151
++ + ++ + A+G+ D+ A NVL+ T K+ DFG
Sbjct: 100 YVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG 156
Query: 152 FAKLI-PDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKL 210
AKL+ + + K + ++A E + + DV+S+GV + EL++
Sbjct: 157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---- 212
Query: 211 PGGVKRDIVQWVTPY--VQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPT 268
PY + I + + + +I ++C + ++RP
Sbjct: 213 -------------PYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPK 259
Query: 269 MTDVVDWLK 277
+++
Sbjct: 260 FRELIIEFS 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-37
Identities = 46/255 (18%), Positives = 96/255 (37%), Gaps = 33/255 (12%)
Query: 35 RRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94
TG ++A++++ + E+ ++ ++ N++ Y GDE +V +Y+
Sbjct: 41 DVATGQ-EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99
Query: 95 PNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFE 144
SL + + ++ + + DIK+ N+LL D
Sbjct: 100 AGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS 154
Query: 145 AKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAK 204
K+ DFGF I + +T V GT ++APE D++S G++ +E+I +
Sbjct: 155 VKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
Query: 205 KPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPE 264
P ++ + + + + + RC D + E
Sbjct: 214 PP--------------YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVE 259
Query: 265 NRPTMTDVVD--WLK 277
R + +++ +LK
Sbjct: 260 KRGSAKELLQHQFLK 274
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 5e-37
Identities = 46/261 (17%), Positives = 89/261 (34%), Gaps = 33/261 (12%)
Query: 35 RRETGDDQIAVKRL-KTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93
++ +AVK + E+ I + H N++ G G+ + + +Y
Sbjct: 25 VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84
Query: 94 MPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDF 143
L + + + G+ DIK N+LLD
Sbjct: 85 CSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD 140
Query: 144 EAKVADFGFAKLI-PDGVTHMTTRVKGTLGYLAPEYAMWGKVSD-SCDVYSFGVLLLELI 201
K++DFG A + + + ++ GTL Y+APE + DV+S G++L ++
Sbjct: 141 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 200
Query: 202 SAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDS 261
+ + P ++ W ++ I +++ +
Sbjct: 201 A-GELPWDQPSDSCQEYSDWKEKKTYLNPWKKID----------SAPLALL---HKILVE 246
Query: 262 NPENRPTMTDVVD--WLKGGL 280
NP R T+ D+ W L
Sbjct: 247 NPSARITIPDIKKDRWYNKPL 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 2e-36
Identities = 48/246 (19%), Positives = 93/246 (37%), Gaps = 30/246 (12%)
Query: 43 IAVKRLKTLNAKAEME-FAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLIT 101
+A+K K + + E F E + + H +++ L G + I+ + L +
Sbjct: 38 VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 96
Query: 102 HLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFEAKVADFG 151
L R LD + A + +A DI A NVL+ ++ K+ DFG
Sbjct: 97 FLQVRKYS---LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 153
Query: 152 FAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLP 211
++ + D + ++ K + ++APE + + + + DV+ FGV + E++
Sbjct: 154 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF--- 210
Query: 212 GGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTD 271
Q V G E+ + + + +C +P RP T+
Sbjct: 211 --------QGVKNNDVIGRIENGERLPMPPNCPPT----LYSLMTKCWAYDPSRRPRFTE 258
Query: 272 VVDWLK 277
+ L
Sbjct: 259 LKAQLS 264
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 125 bits (316), Expect = 3e-34
Identities = 53/259 (20%), Positives = 94/259 (36%), Gaps = 33/259 (12%)
Query: 35 RRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94
R TG+ A K + T + + E++ + +RH L+ L + +E +++Y++M
Sbjct: 47 ERATGN-NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105
Query: 95 PNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDF- 143
L + + V +G+ D+K N++ T
Sbjct: 106 SGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS 162
Query: 144 -EAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
E K+ DFG + + T GT + APE A V D++S GVL L+S
Sbjct: 163 NELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 220
Query: 203 AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSN 262
P V+ + AF I+ + K + + ++
Sbjct: 221 GLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS----------EDGKDFI---RKLLLAD 267
Query: 263 PENRPTMTDVVD--WLKGG 279
P R T+ ++ WL G
Sbjct: 268 PNTRMTIHQALEHPWLTPG 286
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-33
Identities = 59/261 (22%), Positives = 102/261 (39%), Gaps = 40/261 (15%)
Query: 42 QIAVKRLKT-LNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIVYDYMPNHSL 99
++AVK LK+ K + E+E++ + +H+N++ L G ++ +Y +L
Sbjct: 47 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 106
Query: 100 ITHLHGR------------LAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNV 137
+L R P+ L VS A A G+ D+ A NV
Sbjct: 107 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 166
Query: 138 LLDTDFEAKVADFGFAKLIPDGVTHMTTRVK-GTLGYLAPEYAMWGKVSDSCDVYSFGVL 196
L+ D K+ADFG A+ I + T + ++APE + DV+SFGVL
Sbjct: 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 226
Query: 197 LLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIAL 256
L E+ + PG ++ + + R+ + + ++
Sbjct: 227 LWEIFTLGGSPY--PGVPVEELFKLLK-----------EGHRM--DKPSNCTNELYMMMR 271
Query: 257 RCTDSNPENRPTMTDVVDWLK 277
C + P RPT +V+ L
Sbjct: 272 DCWHAVPSQRPTFKQLVEDLD 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-32
Identities = 53/262 (20%), Positives = 89/262 (33%), Gaps = 40/262 (15%)
Query: 42 QIAVKRLK-TLNAKAEMEFAVEVEILGRVRHRNLLGLRG--FYAGGDERLIVYDYMPNHS 98
+AVK LK E++IL + H + G +++ ++ +
Sbjct: 45 TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 104
Query: 99 LITHLHGR------------LAPDCLLDWHRRVSIAIGSAEGIA----------DIKASN 136
L T+L + L + + A+G+ D+ A N
Sbjct: 105 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164
Query: 137 VLLDTDFEAKVADFGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGV 195
+LL K+ DFG A+ I + + L ++APE + DV+SFGV
Sbjct: 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 224
Query: 196 LLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIA 255
LL E+ S I + +++G D M
Sbjct: 225 LLWEIFSLGASPYP-----GVKIDEEFCRRLKEGTRMRAPD---------YTTPEMYQTM 270
Query: 256 LRCTDSNPENRPTMTDVVDWLK 277
L C P RPT +++V+ L
Sbjct: 271 LDCWHGEPSQRPTFSELVEHLG 292
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 117 bits (295), Expect = 4e-31
Identities = 47/258 (18%), Positives = 88/258 (34%), Gaps = 32/258 (12%)
Query: 35 RRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94
+ K + T + E+ I+ ++ H L+ L + E +++ +++
Sbjct: 49 VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108
Query: 95 PNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDT--D 142
L + + ++ + EG+ DIK N++ +T
Sbjct: 109 SGGELFDRIAAEDYK---MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKA 165
Query: 143 FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
K+ DFG A + + T + APE V D+++ GVL L+S
Sbjct: 166 SSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 223
Query: 203 AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSN 262
P G + +Q V F+ A + + K +
Sbjct: 224 GLSP---FAGEDDLETLQNVKR--CDWEFDEDAFSSVS-----PEAKDFI---KNLLQKE 270
Query: 263 PENRPTMTDVVD--WLKG 278
P R T+ D ++ WLKG
Sbjct: 271 PRKRLTVHDALEHPWLKG 288
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-30
Identities = 43/251 (17%), Positives = 89/251 (35%), Gaps = 27/251 (10%)
Query: 35 RRETGDDQIAVKRLK---TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91
R + A+K L+ + E +++ R+ H + L + ++
Sbjct: 28 RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87
Query: 92 DYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGIA----DIKASNVLLDTDFEA 145
Y N L+ ++ G C + + A+ G D+K N+LL+ D
Sbjct: 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHI 147
Query: 146 KVADFGFAKLI-PDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAK 204
++ DFG AK++ P+ GT Y++PE S D+++ G ++ +L++
Sbjct: 148 QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 207
Query: 205 KPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPE 264
P G + I Q + +L+ F + + +
Sbjct: 208 PP---FRAGNEYLIFQKII--------------KLEYDFPEKFFPKARDLVEKLLVLDAT 250
Query: 265 NRPTMTDVVDW 275
R ++ +
Sbjct: 251 KRLGCEEMEGY 261
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 2e-30
Identities = 50/267 (18%), Positives = 97/267 (36%), Gaps = 33/267 (12%)
Query: 35 RRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94
+ K +K + ++ E+ IL RHRN+L L + +E +++++++
Sbjct: 25 VETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83
Query: 95 PNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDFE 144
+ ++ L+ VS E + DI+ N++ T
Sbjct: 84 SGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRS 140
Query: 145 A--KVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
+ K+ +FG A+ + G Y APE VS + D++S G L+ L+S
Sbjct: 141 STIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198
Query: 203 AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSN 262
P + + + AF+ I+ + V R
Sbjct: 199 GINPFLAETNQQIIENIMNAEYTFDEEAFKEIS----------IEAMDFV---DRLLVKE 245
Query: 263 PENRPTMTDVVD--WLKGGLGRRTKDV 287
++R T ++ + WLK + R + V
Sbjct: 246 RKSRMTASEALQHPWLKQKIERVSTKV 272
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (278), Expect = 5e-29
Identities = 49/280 (17%), Positives = 95/280 (33%), Gaps = 35/280 (12%)
Query: 19 QNINNGLEILMLL--------LLLRRETGDDQIAVKRL-KTLNAKAEMEFAVEVEILGRV 69
++I + + +L +L + +A+K + K E E+ +L ++
Sbjct: 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI 64
Query: 70 RHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSAE 127
+H N++ L Y G ++ + L + G +V A+
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 128 -------GIADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAM 180
+ LD D + ++DFG +K+ G + + GT GY+APE
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGYVAPEVLA 182
Query: 181 WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240
S + D +S GV+ L+ P + + ++ I+
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS----- 237
Query: 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278
D K + + +PE R T + W+ G
Sbjct: 238 -----DSAKDFI---RHLMEKDPEKRFTCEQALQHPWIAG 269
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-28
Identities = 52/273 (19%), Positives = 96/273 (35%), Gaps = 36/273 (13%)
Query: 35 RRETGDDQIAVKRLK-----TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89
R + + +A+K++K E+++L + H N++GL + +
Sbjct: 18 RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 77
Query: 90 VYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLL 139
V+D+M + +L + + + +G+ D+K +N+LL
Sbjct: 78 VFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL 133
Query: 140 DTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSD-SCDVYSFGVLLL 198
D + K+ADFG AK T +V T Y APE ++ D+++ G +L
Sbjct: 134 DENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARMYGVGVDMWAVGCILA 192
Query: 199 ELISAKKPLE------------KLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRD 246
EL+ L + G + + F+ L F+
Sbjct: 193 ELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAA 252
Query: 247 QLKSMVLIALRCTDSNPENRPTMTDVVD--WLK 277
+ LI NP R T T + +
Sbjct: 253 GDDLLDLIQ-GLFLFNPCARITATQALKMKYFS 284
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 107 bits (268), Expect = 7e-28
Identities = 56/265 (21%), Positives = 97/265 (36%), Gaps = 40/265 (15%)
Query: 35 RRETGDDQIAVKRLK---TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFY----AGGDER 87
R +AVK L+ + + F E + + H ++ + G
Sbjct: 27 RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86
Query: 88 LIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNV 137
IV +Y+ +L +H + + R + + + + + D+K +N+
Sbjct: 87 YIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANI 142
Query: 138 LLDTDFEAKVADFGFAKLIPDGVTHM--TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGV 195
++ KV DFG A+ I D + T V GT YL+PE A V DVYS G
Sbjct: 143 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 202
Query: 196 LLLELISAKKPLEKL-PGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLI 254
+L E+++ + P P V V+ DP + + +
Sbjct: 203 VLYEVLTGEPPFTGDSPVSVAYQHVR--------------EDPIPPSARHEGLSADLDAV 248
Query: 255 ALRCTDSNPENRPTMTDVV--DWLK 277
L+ NPENR + D ++
Sbjct: 249 VLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 8e-28
Identities = 53/286 (18%), Positives = 103/286 (36%), Gaps = 41/286 (14%)
Query: 19 QNINNGLEILMLL--------LLLRRETGDDQIAVKRLKTLNAKAEM------EFAVEVE 64
+N+++ + L R ++ Q A K +K K+ + EV
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 65 ILGRVRHRNLLGLRGFYAGGDERLIVYDYMPNHSLITHL--HGRLAPDCLLDWHRRVSIA 122
IL ++H N++ L Y + +++ + + L L L + ++ +++
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 123 IGSAEG----IADIKASNVLLDTD----FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYL 174
+ D+K N++L K+ DFG A I G + + GT ++
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFV 183
Query: 175 APEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHI 234
APE + + D++S GV+ L+S P V V + F +
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243
Query: 235 ADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278
+ K + R +P+ R T+ D + W+K
Sbjct: 244 S----------ALAKDFI---RRLLVKDPKKRMTIQDSLQHPWIKP 276
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 1e-27
Identities = 57/315 (18%), Positives = 109/315 (34%), Gaps = 34/315 (10%)
Query: 35 RRETGDDQIAVKRLKTLNAKAEME-FAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93
++A+K++ + + E++IL R RH N++G+ + Y
Sbjct: 28 YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87
Query: 94 MPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDF 143
+ H + L+ L L G+ D+K SN+LL+T
Sbjct: 88 LVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC 146
Query: 144 EAKVADFGFAKLIPDGVTHMT--TRVKGTLGYLAPEYAMWGKVSD-SCDVYSFGVLLLEL 200
+ K+ DFG A++ H T T Y APE + K S D++S G +L E+
Sbjct: 147 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 206
Query: 201 ISAKKP-------------LEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQ 247
+S + L L + D+ + + ++
Sbjct: 207 LSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPN 266
Query: 248 LKSMVL-IALRCTDSNPENRPTMTDVVD--WLKGGLGRRTKDVKDVAGEDDEDNDDNDTD 304
S L + + NP R + + +L+ + + + + D + DD
Sbjct: 267 ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLP-- 324
Query: 305 FEERYFKMEQSNIRR 319
+E+ ++ R
Sbjct: 325 -KEKLKELIFEETAR 338
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 104 bits (260), Expect = 9e-27
Identities = 56/271 (20%), Positives = 94/271 (34%), Gaps = 48/271 (17%)
Query: 35 RRETGDDQIAVKRLKTLNA---------KAEMEFAVEVEILGRVR-HRNLLGLRGFYAGG 84
+ T + AVK + + EV+IL +V H N++ L+ Y
Sbjct: 24 HKPTCK-EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82
Query: 85 DERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKA 134
+V+D M L +L ++ L I E I D+K
Sbjct: 83 TFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALLEVICALHKLNIVHRDLKP 138
Query: 135 SNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWG------KVSDSC 188
N+LLD D K+ DFGF+ + G V GT YLAPE
Sbjct: 139 ENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEV 196
Query: 189 DVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQL 248
D++S GV++ L++ P + ++ ++ + D +
Sbjct: 197 DMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS----------DTV 246
Query: 249 KSMVLIALRCTDSNPENRPTMTDVVD--WLK 277
K +V R P+ R T + + + +
Sbjct: 247 KDLV---SRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 1e-26
Identities = 40/271 (14%), Positives = 89/271 (32%), Gaps = 32/271 (11%)
Query: 35 RRETGDDQIAVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
+ TG+ +A+K+++ T E+ +L + H N++ L ++ +V++
Sbjct: 23 NKLTGE-VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81
Query: 93 YMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTD 142
++ + + S +G+A D+K N+L++T+
Sbjct: 82 FLHQDLK---KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE 138
Query: 143 FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
K+ADFG A+ V T V S + D++S G + E+++
Sbjct: 139 GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198
Query: 203 AKKP-------------LEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249
+ L + + K +F A
Sbjct: 199 RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDED 258
Query: 250 SMVLIALRCTDSNPENRPTMTDVVD--WLKG 278
L++ + +P R + + + +
Sbjct: 259 GRSLLS-QMLHYDPNKRISAKAALAHPFFQD 288
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 2e-26
Identities = 46/272 (16%), Positives = 85/272 (31%), Gaps = 31/272 (11%)
Query: 36 RETGDDQIAVKRLKTLNAKAEMEFAVEVEI-----LGRVRHRNLLGLRGFYAGGDERLIV 90
+ G +A+KR++ + M + E+ L H N++ L
Sbjct: 29 LKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88
Query: 91 YDYMPNHSLI--THLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVL 138
+ + + P+ + + G+ D+K N+L
Sbjct: 89 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNIL 148
Query: 139 LDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLL 198
+ + + K+ADFG A++ T V TL Y APE + + D++S G +
Sbjct: 149 VTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 206
Query: 199 ELISAKKPLEK----------LPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQL 248
E+ K L W H + KF D
Sbjct: 207 EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID 266
Query: 249 KSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278
+ + L+C NP R + + + +
Sbjct: 267 ELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 4e-26
Identities = 56/261 (21%), Positives = 93/261 (35%), Gaps = 39/261 (14%)
Query: 35 RRETGDDQIAVKRLK---TLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERLIV 90
+ + A+K LK L VE +L H L + + + V
Sbjct: 22 EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81
Query: 91 YDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLD 140
+Y+ L+ H+ D R A G+ D+K N+LLD
Sbjct: 82 MEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD 137
Query: 141 TDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLEL 200
D K+ADFG K G T GT Y+APE + K + S D +SFGVLL E+
Sbjct: 138 KDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEM 196
Query: 201 ISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTD 260
+ + P G + ++ + + +P ++ K ++ ++
Sbjct: 197 LIGQSP---FHGQDEEELFHSI----------RMDNPFYPRWLEKE-AKDLL---VKLFV 239
Query: 261 SNPENRPTMTDVV---DWLKG 278
PE R + + +
Sbjct: 240 REPEKRLGVRGDIRQHPLFRE 260
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 101 bits (253), Expect = 2e-25
Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 14/181 (7%)
Query: 35 RRETGDDQIAVKRLK---TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91
R G A+K LK + K E +L V H ++ + G + + ++
Sbjct: 25 SRHNGR-YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83
Query: 92 DYMPNHSLITHLHGRLAPDCLLDWHRRVSIAI----GSAEGIA--DIKASNVLLDTDFEA 145
DY+ L + L + + + ++ I D+K N+LLD +
Sbjct: 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHI 143
Query: 146 KVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKK 205
K+ DFGFAK +PD +T + GT Y+APE + S D +SFG+L+ E+++
Sbjct: 144 KITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
Query: 206 P 206
P
Sbjct: 200 P 200
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 3e-25
Identities = 53/274 (19%), Positives = 95/274 (34%), Gaps = 38/274 (13%)
Query: 35 RRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER------L 88
++G+ +A+K++ + + E++I+ ++ H N++ LR F+ E+
Sbjct: 41 LCDSGE-LVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95
Query: 89 IVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVL 138
+V DY+P H A L +A DIK N+L
Sbjct: 96 LVLDYVPETVYRVARHYSRAKQTL-PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 139 LDTD-FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLL 197
LD D K+ DFG AK + G + + + S DV+S G +L
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213
Query: 198 LELISAKKPLE------------KLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNR 245
EL+ + K+ G R+ ++ + P + F I F
Sbjct: 214 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 273
Query: 246 DQLKSMVLIALRCTDSNPENRPTMTDVVD--WLK 277
+ + R + P R T + +
Sbjct: 274 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 4e-25
Identities = 65/312 (20%), Positives = 115/312 (36%), Gaps = 45/312 (14%)
Query: 35 RRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFY----AGGDERLI 89
+ T + + A+K L+ + EVE+ R + +++ + Y AG LI
Sbjct: 33 NKRTQE-KFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 86
Query: 90 VYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLL 139
V + + L + + R D I E I D+K N+L
Sbjct: 87 VMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 144
Query: 140 DTDFE---AKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVL 196
+ K+ DFGFAK + T T Y+APE K SCD++S GV+
Sbjct: 145 TSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVI 202
Query: 197 LLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIAL 256
+ L+ P I + ++ G +E P + +++K ++
Sbjct: 203 MYILLCGYPP---FYSNHGLAISPGMKTRIRMGQYEF---PNPEWSEVSEEVKMLI---R 253
Query: 257 RCTDSNPENRPTMTDVVD--WLKGG--LGRRTKDVKDVAGEDDEDNDDNDTDFEERYFKM 312
+ P R T+T+ ++ W+ + + V ED E +D + M
Sbjct: 254 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATM 313
Query: 313 ----EQSNIRRV 320
EQ I+++
Sbjct: 314 RVDYEQIKIKKI 325
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 99.6 bits (247), Expect = 6e-25
Identities = 43/268 (16%), Positives = 93/268 (34%), Gaps = 30/268 (11%)
Query: 36 RETGDDQIAVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93
+ + A+K+++ + E+ IL ++H N++ L ++V+++
Sbjct: 22 QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81
Query: 94 MPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTDF 143
+ L+ S + GIA D+K N+L++ +
Sbjct: 82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG 137
Query: 144 EAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISA 203
E K+ADFG A+ V T + K S + D++S G + E+++
Sbjct: 138 ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197
Query: 204 KKP------------LEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSM 251
+ ++ G VT + + +P F + +S
Sbjct: 198 TPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESG 257
Query: 252 VLIALRCTDSNPENRPTMTDVVD--WLK 277
+ + + +P R T ++ + K
Sbjct: 258 IDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 100 bits (251), Expect = 7e-25
Identities = 47/252 (18%), Positives = 85/252 (33%), Gaps = 39/252 (15%)
Query: 35 RRETGDDQIAVKRLKTLNAKAE------MEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88
+ +TG A+K L K + + + + ++ ++ + + D+
Sbjct: 25 KADTGK-MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83
Query: 89 IVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVL 138
+ D M L HL + A G+ D+K +N+L
Sbjct: 84 FILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 139
Query: 139 LDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSD-SCDVYSFGVLL 197
LD +++D G A H + GT GY+APE G D S D +S G +L
Sbjct: 140 LDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCML 196
Query: 198 LELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALR 257
+L+ P + K +I + L F+ +L+S++
Sbjct: 197 FKLLRGHSPFRQHKTKDKHEIDRMTLTM----------AVELPDSFS-PELRSLL---EG 242
Query: 258 CTDSNPENRPTM 269
+ R
Sbjct: 243 LLQRDVNRRLGC 254
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 98.8 bits (245), Expect = 2e-24
Identities = 38/263 (14%), Positives = 75/263 (28%), Gaps = 35/263 (13%)
Query: 35 RRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLL-GLRGFYAGGDERLIVYDY 93
+++A+K + +E +I ++ + +R A GD ++V +
Sbjct: 27 TDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84
Query: 94 MPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVL---LD 140
+ + +A I D+K N L
Sbjct: 85 LGPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK 140
Query: 141 TDFEAKVADFGFAKLIPDGVTH------MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFG 194
+ DFG AK D TH + GT Y + + + S D+ S G
Sbjct: 141 KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLG 200
Query: 195 VLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLI 254
+L+ P + L KR + ++ E +
Sbjct: 201 YVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE---------VLCKGYPSEFATY 251
Query: 255 ALRCTDSNPENRPTMTDVVDWLK 277
C +++P + + +
Sbjct: 252 LNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 3e-24
Identities = 53/268 (19%), Positives = 96/268 (35%), Gaps = 55/268 (20%)
Query: 35 RRETGDDQIAVKRLKTLNAKAEME------FAVEVEILGRVR--HRNLLGLRGFYAGGDE 86
R + + +A+K ++ E +EV +L +V ++ L ++ D
Sbjct: 24 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83
Query: 87 RLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASN 136
+++ + L + L S E + DIK N
Sbjct: 84 FVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 140
Query: 137 VLLDTD-FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSD-SCDVYSFG 194
+L+D + E K+ DFG L+ D + T GT Y PE+ + + S V+S G
Sbjct: 141 ILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 197
Query: 195 VLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLI 254
+LL +++ P FEH + ++G+ Q S
Sbjct: 198 ILLYDMVCGDIP------------------------FEH-DEEIIRGQVFFRQRVSSECQ 232
Query: 255 AL--RCTDSNPENRPTMTDVVD--WLKG 278
L C P +RPT ++ + W++
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPWMQD 260
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.6 bits (239), Expect = 8e-24
Identities = 41/270 (15%), Positives = 86/270 (31%), Gaps = 31/270 (11%)
Query: 35 RRETGDDQIAVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
+ + +A+KR++ + E+ +L ++H+N++ L + +V++
Sbjct: 22 KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81
Query: 93 YMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTD 142
+ LD S +G+ D+K N+L++ +
Sbjct: 82 FCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN 137
Query: 143 FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
E K+A+FG A+ V + V S S D++S G + EL +
Sbjct: 138 GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197
Query: 203 AKKPL-------------EKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLK 249
A +PL +L G + +T +
Sbjct: 198 AGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNA 257
Query: 250 SMVLIALRCTDSNPENRPTMTDVVD--WLK 277
+ + NP R + + + +
Sbjct: 258 TGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 92.6 bits (229), Expect = 2e-22
Identities = 32/265 (12%), Positives = 65/265 (24%), Gaps = 37/265 (13%)
Query: 35 RRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLL-GLRGFYAGGDERLIVYDY 93
+ Q+A+K + + E + + + F G ++V D
Sbjct: 25 TNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82
Query: 94 MPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLD--- 140
+ + A + DIK N L+
Sbjct: 83 LGP----SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPN 138
Query: 141 --TDFEAKVADFGFAKLIPDGVT------HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYS 192
V DFG K D VT + GT Y++ + + S D+ +
Sbjct: 139 SKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEA 198
Query: 193 FGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMV 252
G + + + P + L + + + Q + +
Sbjct: 199 LGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR---------ELCAGFPEEFY 249
Query: 253 LIALRCTDSNPENRPTMTDVVDWLK 277
+ + P +
Sbjct: 250 KYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.0 bits (230), Expect = 3e-22
Identities = 49/275 (17%), Positives = 98/275 (35%), Gaps = 40/275 (14%)
Query: 35 RRETGDDQIAVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER----- 87
R+TG ++A+K++ + E++IL ++H N++ L
Sbjct: 31 HRKTGQ-KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89
Query: 88 ---LIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSA------EGIA--DIKASN 136
+V+D+ + + + +RV + + I D+KA+N
Sbjct: 90 GSIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVMQMLLNGLYYIHRNKILHRDMKAAN 147
Query: 137 VLLDTDFEAKVADFGFAKLIPDGVT---HMTTRVKGTLGYLAPEYAMWGK-VSDSCDVYS 192
VL+ D K+ADFG A+ + T TL Y PE + + D++
Sbjct: 148 VLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG 207
Query: 193 FGVLLLELISAKKP------------LEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240
G ++ E+ + + +L G + ++ V Y E + + K
Sbjct: 208 AGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRK 267
Query: 241 GKFN-RDQLKSMVLIAL--RCTDSNPENRPTMTDV 272
K + ++ + L + +P R D
Sbjct: 268 VKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (227), Expect = 1e-21
Identities = 56/297 (18%), Positives = 108/297 (36%), Gaps = 34/297 (11%)
Query: 35 RRETGDDQIAVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
TG ++A+K+L + E+ +L +RH N++GL + + D
Sbjct: 39 DGRTGA-KVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97
Query: 93 YMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTD 142
+ + G+L L R + +G+ D+K N+ ++ D
Sbjct: 98 FYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED 157
Query: 143 FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
E K+ DFG A+ MT V W + + + D++S G ++ E+I+
Sbjct: 158 CELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 214
Query: 203 AKKP------------LEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKS 250
K + K+ G + VQ + K + + + K + S
Sbjct: 215 GKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNAS 274
Query: 251 MVLIAL--RCTDSNPENRPTMTDVVD--WLKGGLGRRTKDVKDVAGEDDEDNDDNDT 303
+ + L + + E R T + + + + T+D V DD +D + T
Sbjct: 275 PLAVNLLEKMLVLDAEQRVTAGEALAHPYFES--LHDTEDEPQVQKYDDSFDDVDRT 329
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.6 bits (224), Expect = 2e-21
Identities = 44/185 (23%), Positives = 64/185 (34%), Gaps = 19/185 (10%)
Query: 35 RRETGDDQIAVKRLK---TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91
+ TG A+K L+ + E +L RH L L+ + D V
Sbjct: 26 EKATGR-YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84
Query: 92 DYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDT 141
+Y L HL + R + DIK N++LD
Sbjct: 85 EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK 140
Query: 142 DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELI 201
D K+ DFG K M T GT YLAPE + D + GV++ E++
Sbjct: 141 DGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
Query: 202 SAKKP 206
+ P
Sbjct: 200 CGRLP 204
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (199), Expect = 5e-18
Identities = 59/252 (23%), Positives = 91/252 (36%), Gaps = 31/252 (12%)
Query: 33 LLRRETGDDQIAVKRLK----TLNAKAEMEFAVEVEILGRVRHR-NLLGLRGFYAGGDER 87
+ +TG A+K LK AK E ++L +R L+ L + +
Sbjct: 46 ISGHDTGK-LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 104
Query: 88 LIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAE----GIA--DIKASNVLLDT 141
++ DY+ L THL R I + GI DIK N+LLD+
Sbjct: 105 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS 164
Query: 142 DFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDS--CDVYSFGVLLLE 199
+ + DFG +K T GT+ Y+AP+ G D +S GVL+ E
Sbjct: 165 NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 224
Query: 200 LISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIAL--R 257
L++ P +K + I+ LK + Q S + L R
Sbjct: 225 LLTGASPFTVDG---------------EKNSQAEISRRILKSEPPYPQEMSALAKDLIQR 269
Query: 258 CTDSNPENRPTM 269
+P+ R
Sbjct: 270 LLMKDPKKRLGC 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 80.3 bits (197), Expect = 8e-18
Identities = 47/268 (17%), Positives = 101/268 (37%), Gaps = 36/268 (13%)
Query: 35 RRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDERLI--VY 91
T ++++ VK LK + K + E++IL +R N++ L R V+
Sbjct: 55 INITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111
Query: 92 DYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAE----GIADIKASNVLLDTDF-EAK 146
+++ N L+ L + + + A+ D+K NV++D + + +
Sbjct: 112 EHVNNTDFK-QLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLR 170
Query: 147 VADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAM-WGKVSDSCDVYSFGVLLLELISAKK 205
+ D+G A+ G + + + PE + + S D++S G +L +I K+
Sbjct: 171 LIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
Query: 206 PL-------EKLPGGVKRDIVQWVTPYVQKGAFEHIAD-PRLKGKFNRDQLKSMVLIAL- 256
P ++L K + + Y+ K E + G+ +R + + V
Sbjct: 229 PFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQ 288
Query: 257 ------------RCTDSNPENRPTMTDV 272
+ + ++R T +
Sbjct: 289 HLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 80.2 bits (197), Expect = 1e-17
Identities = 60/298 (20%), Positives = 106/298 (35%), Gaps = 52/298 (17%)
Query: 35 RRETGDDQIAVKRL---KTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91
+E+G+ A+K L K + K E IL V L+ L + +V
Sbjct: 62 HKESGN-HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 92 DYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAE--GIA--DIKASNVLLDTDFEA 145
+Y+ + +HL GR + + ++ + + D+K N+L+D
Sbjct: 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYI 180
Query: 146 KVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKK 205
+V DFGFAK + T + GT LAPE + + + D ++ GVL+ E+ +
Sbjct: 181 QVTDFGFAKRVK----GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 206 PLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPEN 265
P I + + R F+ D + + +
Sbjct: 237 P---FFADQPIQIYEKI----------VSGKVRFPSHFSSD----LKDLLRNLLQVDLTK 279
Query: 266 R-----PTMTDV--------VDWLKGGLGRRTKD---VKDVAGEDDEDNDDNDTDFEE 307
R + D+ DW+ + +R + + G D N D D+EE
Sbjct: 280 RFGNLKNGVNDIKNHKWFATTDWIA--IYQRKVEAPFIPKFKGPGDTSNFD---DYEE 332
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (196), Expect = 1e-17
Identities = 49/301 (16%), Positives = 103/301 (34%), Gaps = 35/301 (11%)
Query: 35 RRETGDDQIAVKRLKT--LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92
+TG ++AVK+L + E+ +L ++H N++GL + D
Sbjct: 39 DTKTGL-RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97
Query: 93 YMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASNVLLDTD 142
L+ + L + G+ D+K SN+ ++ D
Sbjct: 98 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 157
Query: 143 FEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS 202
E K+ DFG A+ D MT V W + + D++S G ++ EL++
Sbjct: 158 CELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
Query: 203 AKKP------------LEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKS 250
+ + +L G ++++ ++ + + + N +
Sbjct: 215 GRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGAN 274
Query: 251 MVLIAL--RCTDSNPENRPTMTDVVD--WLKGGLGRRTKDVKDVAGEDDEDNDDNDTDFE 306
+ + L + + + R T + + D + VA D+ + D +
Sbjct: 275 PLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY---HDPDDEPVADPYDQSFESRDLLID 331
Query: 307 E 307
E
Sbjct: 332 E 332
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.1 bits (186), Expect = 3e-16
Identities = 52/323 (16%), Positives = 104/323 (32%), Gaps = 56/323 (17%)
Query: 35 RRETGDDQIAVKRLK--TLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG------GDE 86
D +A+K+L N E+ ++ V H+N++ L + +
Sbjct: 37 YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96
Query: 87 RLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA----------DIKASN 136
+V + M + D R + GI D+K SN
Sbjct: 97 VYLVMELMDANLCQVIQMEL-------DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 149
Query: 137 VLLDTDFEAKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVL 196
+++ +D K+ DFG A+ + M T T Y APE + ++ D++S G +
Sbjct: 150 IVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 207
Query: 197 LLELISAKKP-----------------------LEKLPGGVKRDIVQWVTPYVQKGAFEH 233
+ E++ K K R+ V+ Y +
Sbjct: 208 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267
Query: 234 IADPRLKGKFNRDQLKSMVLIAL--RCTDSNPENRPTMTDVVD--WLKGGLGRRTKDVKD 289
D ++LK+ L + +P R ++ D + ++ +V+
Sbjct: 268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV--WYDPAEVEA 325
Query: 290 VAGEDDEDNDDNDTDFEERYFKM 312
+ + D E + ++
Sbjct: 326 PPPQIYDKQLDEREHTIEEWKEL 348
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 66.2 bits (160), Expect = 7e-13
Identities = 54/307 (17%), Positives = 97/307 (31%), Gaps = 59/307 (19%)
Query: 35 RRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY--D 92
+ + +A+K ++ E E+++L RV + A +L+ +
Sbjct: 33 KDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91
Query: 93 YMPNHSLITHLHGRLAPDCLLDWHRR----------VSIAIGSAEGIA-----------D 131
PN + + L + L + I+ G+ D
Sbjct: 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTD 151
Query: 132 IKASNVLLDT-DFEAKVADFGFAKLIPDGVTHMTTR-VKGTLGYLAPEYAMWGKVSDSCD 189
IK NVL++ D + A L T Y +PE + D
Sbjct: 152 IKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGAD 211
Query: 190 VYSFGVLLLELISAKKP----------------------LEKLPGGVKRDIVQWVTPYVQ 227
++S L+ ELI+ L +LP + R+ T +
Sbjct: 212 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNS 271
Query: 228 KGAFEHIADPRL---------KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WL 276
+G +I+ + K KF++D+ K + +P R +V+ WL
Sbjct: 272 RGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 331
Query: 277 KGGLGRR 283
K LG
Sbjct: 332 KDTLGME 338
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 37.5 bits (86), Expect = 0.001
Identities = 22/137 (16%), Positives = 39/137 (28%), Gaps = 24/137 (17%)
Query: 36 RETGDDQIAVKRLKTLNA----------KAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD 85
+ VK K + ++ F+V R R L L+G
Sbjct: 20 YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAV--- 76
Query: 86 ERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGIA--------DIKASNV 137
VY + N L+ + + ++ V I D+ NV
Sbjct: 77 --PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNV 134
Query: 138 LLDTDFEAKVADFGFAK 154
L+ + + DF +
Sbjct: 135 LVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 325 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.73 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.87 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.84 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.34 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 92.73 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 91.5 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-53 Score=367.69 Aligned_cols=249 Identities=18% Similarity=0.255 Sum_probs=209.3
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
+.|+++++||+| +++.||++++..+++.||||.+........+.+.+|++++++++||||+++++++.+.+.+|+|||
T Consensus 20 ~~Y~~~~~iG~G--~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQG--ASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCS--SSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecC--cCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 468999999999 888899999999999999999976555556789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeeccC
Q 046728 93 YMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTRV 167 (325)
Q Consensus 93 ~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 167 (325)
||+||+|.+++. +.+++..+..++.|+..|+.++|.. |||||+|||++.++.+||+|||+++........ ....
T Consensus 98 y~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~-~~~~ 176 (293)
T d1yhwa1 98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTM 176 (293)
T ss_dssp CCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-BCCC
T ss_pred ecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccc-cccc
Confidence 999999999884 5577788899999999999999985 899999999999999999999999877544322 3445
Q ss_pred CCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCHHH
Q 046728 168 KGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQ 247 (325)
Q Consensus 168 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (325)
.||+.|+|||++.+..++.++|||||||++|+|+||..||.+.... ...... ... .......+..+
T Consensus 177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~~---~~~--------~~~~~~~~~~~ 242 (293)
T d1yhwa1 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYLI---ATN--------GTPELQNPEKL 242 (293)
T ss_dssp CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHH---HHH--------CSCCCSSGGGS
T ss_pred ccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH---HHHHHH---HhC--------CCCCCCCcccC
Confidence 7999999999999999999999999999999999999999653321 111110 000 11112334567
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 248 LKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 248 ~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
++++.+||.+||..||++|||++++++ ||+.
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 789999999999999999999999998 8864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=365.74 Aligned_cols=254 Identities=19% Similarity=0.324 Sum_probs=205.1
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
+-..|++++.||+| +++.||++++..+++.||||.+.... .....++.+|++++++++||||+++++++.+++..|+
T Consensus 3 f~~dy~~~~~lG~G--~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEG--AYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcceEEEEEEecC--cCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 34568899999999 78889999999999999999997533 3344578899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc-e
Q 046728 90 VYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT-H 162 (325)
Q Consensus 90 V~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~ 162 (325)
|||||++|+|.++++ ..+++..+..++.|+..|++++|.+ |||||+|||++.++.+||+|||+|+....... .
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999999999995 3477778889999999999999985 89999999999999999999999987654322 2
Q ss_pred eeccCCCCcCCCCccccccCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKV-SDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
......||+.|+|||++.+..+ +.++||||+||++|+|+||..||........... .. .......
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~-~~-------------~~~~~~~ 226 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-DW-------------KEKKTYL 226 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH-HH-------------HTTCTTS
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH-HH-------------hcCCCCC
Confidence 2344679999999999988776 5689999999999999999999976443221111 00 0111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
..+...++++.+||.+||..||++|||++++++ ||+..+
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 223456788999999999999999999999998 887544
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=358.50 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=206.0
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD 85 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (325)
|++ ..|.+.+.||+| +++.||++++..+++.||+|.+... .......+.+|++++++++||||+++++++.+++
T Consensus 3 ~~l-~dy~i~~~iG~G--~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 79 (263)
T d2j4za1 3 WAL-EDFEIGRPLGKG--KFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 79 (263)
T ss_dssp CCG-GGEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cch-hHeEEEEEEecC--CCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence 444 458889999999 7888999999999999999998642 2334567889999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC
Q 046728 86 ERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 159 (325)
..|+|||||++|+|.+++. ..+++..+..++.|+..|+.++|.. |||||+|||++.++.+||+|||++......
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999999999994 4577888899999999999999975 899999999999999999999999866543
Q ss_pred cceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 160 VTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 160 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+. ..
T Consensus 160 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~------------~~-- 219 (263)
T d2j4za1 160 R---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYKRIS------------RV-- 219 (263)
T ss_dssp C---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHH------------TT--
T ss_pred c---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH---HHHHHHH------------cC--
Confidence 2 23456999999999999989999999999999999999999999653321 1111110 11
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
....+...++++.+||.+||..||++|||++++++ ||.+
T Consensus 220 ~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 220 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 11233456788999999999999999999999998 8864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=361.12 Aligned_cols=244 Identities=20% Similarity=0.328 Sum_probs=193.1
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEc--CCeE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG--GDER 87 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 87 (325)
.+.|++++.||+| +++.||++++..+++.||+|.+... +......+.+|++++++++||||+++++++.+ ...+
T Consensus 3 ~edy~~~~~iG~G--~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 3 AEDYEVLYTIGTG--SYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGGEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred chhCEEeEEEecC--CCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 3568899999999 7888999999999999999998643 34455678899999999999999999999865 4568
Q ss_pred EEEEEecCCCChhhhhc------cCCCCCCccCHHHHHHHHHHHHhh---------cCCCCCCceeeCCCCceEEeeecc
Q 046728 88 LIVYDYMPNHSLITHLH------GRLAPDCLLDWHRRVSIAIGSAEG---------IADIKASNVLLDTDFEAKVADFGF 152 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~------~~~~~~~~~~~~~~~~~~~~~~~~---------~rdlkp~Nil~~~~~~~kL~Dfg~ 152 (325)
|+|||||++|+|.+++. ..+++..++.++.|+..|++++|. ||||||+|||++.++.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 99999999999999984 346777889999999999999985 699999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccc
Q 046728 153 AKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFE 232 (325)
Q Consensus 153 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (325)
++........ .....||+.|+|||++.+..++.++|||||||++|+|+||..||...+.. .....+. .+.+
T Consensus 161 a~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~~i~----~~~~- 231 (269)
T d2java1 161 ARILNHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIR----EGKF- 231 (269)
T ss_dssp HHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHH----HTCC-
T ss_pred eeecccCCCc-cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHHHHHH----cCCC-
Confidence 9977553322 33456999999999999889999999999999999999999999754321 1111111 1111
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 233 HIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
...+..+++++.+||.+||..||++|||++++++
T Consensus 232 --------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 --------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1233456789999999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-52 Score=361.22 Aligned_cols=252 Identities=21% Similarity=0.268 Sum_probs=206.3
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
+.|.+.++||+| +++.||++....+++.||||.++.. ....+++.+|+++|++++|||||++++++.+++..++|||
T Consensus 17 ~~~~~~~~iG~G--~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 17 TDITMKHKLGGG--QYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp GGEEEEEETTTT--TTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHeEEeeEEeeC--CCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 467788999999 7888999999999999999999753 3345689999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 93 YMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||++|+|.+++.. .+++..++.+..+++.|+.++|.. |||||+|||++.++.+||+|||+++..........
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~ 173 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 173 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEE
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceee
Confidence 9999999999843 244455667788999999999985 89999999999999999999999998766554444
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
....|++.|+|||++.+..++.++|||||||++|||++|..||..... .......+. ...+.+.+
T Consensus 174 ~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~~~i~-------------~~~~~~~~ 238 (287)
T d1opja_ 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLE-------------KDYRMERP 238 (287)
T ss_dssp TTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHHH-------------TTCCCCCC
T ss_pred ccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHHHHHh-------------cCCCCCCC
Confidence 445688999999999999999999999999999999997766643221 111111111 11223445
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCC
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGR 282 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 282 (325)
..+++++.+||.+||..||++|||+++|+++|+.+...
T Consensus 239 ~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 56778999999999999999999999999999987643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=361.50 Aligned_cols=248 Identities=18% Similarity=0.216 Sum_probs=204.5
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEe
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDY 93 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~ 93 (325)
.|++++.||.| +++.||++++..+++.||||.+........+.+.+|+++|++++|||||++++++.+.+..++||||
T Consensus 13 ~Y~i~~~iG~G--~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 13 FWEIIGELGDG--AFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp TEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CeEEeEEEeeC--CCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 47888999998 7888999999999999999999876666677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeecc
Q 046728 94 MPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTR 166 (325)
Q Consensus 94 ~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 166 (325)
|++|+|.+++. ..+++..+..++.|+..|++++|.+ |||||+|||++.++.+||+|||+|....... .....
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~~ 169 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDS 169 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHTC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-ccccc
Confidence 99999999973 3477788899999999999999985 8999999999999999999999997653321 12234
Q ss_pred CCCCcCCCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccC
Q 046728 167 VKGTLGYLAPEYAM-----WGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKG 241 (325)
Q Consensus 167 ~~~t~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
..||+.|+|||++. ...|+.++|||||||++|+|+||..||.+...... ...+. .. .....
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~~~i~----~~-------~~~~~ 235 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---LLKIA----KS-------EPPTL 235 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHHHH----HS-------CCCCC
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---HHHHH----cC-------CCCCC
Confidence 57999999999984 44688999999999999999999999976432111 11110 00 01112
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 242 KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 242 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
..+...++++.+||.+||+.||++|||++++++ ||+.
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 334567789999999999999999999999998 7753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-51 Score=351.30 Aligned_cols=242 Identities=21% Similarity=0.335 Sum_probs=193.8
Q ss_pred hHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEc----CCeEEE
Q 046728 16 VFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG----GDERLI 89 (325)
Q Consensus 16 ~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 89 (325)
+|.++||+| +++.||++.+..+++.||+|.+... .......+.+|+++|++++|||||++++++.+ +..+|+
T Consensus 12 ~~~~~iG~G--~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 12 KFDIEIGRG--SFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEC--SSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EeeeEEecC--cCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 666788888 8888999999999999999998643 44556688999999999999999999999865 345799
Q ss_pred EEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhh------cCCCCCCceeeC-CCCceEEeeeccccccCCCc
Q 046728 90 VYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEG------IADIKASNVLLD-TDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 90 V~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~------~rdlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~ 160 (325)
|||||++|+|.++++ ..+++..+..+..++..+++++|. ||||||+|||++ .++.+||+|||+++......
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~ 169 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 169 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc
Confidence 999999999999994 456777788899999999999985 389999999996 57899999999998654432
Q ss_pred ceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 161 THMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||...... ......+. .....
T Consensus 170 ---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~~~~~i~------------~~~~~ 231 (270)
T d1t4ha_ 170 ---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVT------------SGVKP 231 (270)
T ss_dssp ---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHT------------TTCCC
T ss_pred ---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HHHHHHHH------------cCCCC
Confidence 234579999999999874 6999999999999999999999999754321 11111111 11111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHh
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLK 277 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~ 277 (325)
...+...++++.+||.+||+.||++|||++++++ ||+
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 1223345678999999999999999999999998 764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-51 Score=359.32 Aligned_cols=251 Identities=20% Similarity=0.324 Sum_probs=190.3
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC-hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN-AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
+...|++++.||+| +++.||++++..+++.||||.+.... ......+.+|+.+|++++||||+++++++.+++.+|+
T Consensus 7 i~d~Y~~~~~lG~G--~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 7 IRDIYDFRDVLGTG--AFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp GGGTEEEEEESBSG--GGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccceEEEEEEeec--cCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34557889999999 78889999999999999999997533 2334577889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeC---CCCceEEeeeccccccCCCc
Q 046728 90 VYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLD---TDFEAKVADFGFAKLIPDGV 160 (325)
Q Consensus 90 V~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~---~~~~~kL~Dfg~~~~~~~~~ 160 (325)
|||||+||+|.+++. +.+++..+..++.++..|+.++|.. |||||+|||+. .++.+||+|||+++......
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 999999999999994 4577888889999999999999985 89999999995 57899999999998665432
Q ss_pred ceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 161 THMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 161 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... .....+. .. .....
T Consensus 165 ~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~----~~------~~~~~ 229 (307)
T d1a06a_ 165 V--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFEQIL----KA------EYEFD 229 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHH----TT------CCCCC
T ss_pred e--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHh----cc------CCCCC
Confidence 2 33456999999999999999999999999999999999999999753321 1111111 00 01112
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
.+.+..+++++.+||.+||..||++|||++++++ ||+.
T Consensus 230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 2334567789999999999999999999999998 8864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=362.54 Aligned_cols=262 Identities=19% Similarity=0.232 Sum_probs=203.3
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
...|+++++||+| +++.||++++..+++.||+|.++.. ......++.+|+++|++++|||||++++++.+...+|+|
T Consensus 5 ~d~y~~~~~iG~G--~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAG--NGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECC--SSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEecC--CCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3467889999999 8888999999999999999999753 344456889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhh-c----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEG-I----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~-~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||||+||+|.++++ +.+++..+..+..|+..|++++|. + |||||+|||++.++.+||+|||+|...... .
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---~ 159 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 159 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---T
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC---c
Confidence 99999999999994 457778888999999999999984 3 899999999999999999999999865432 2
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhh-hccccc--------cc-c---
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQW-VTPYVQ--------KG-A--- 230 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~-~~~~~~--------~~-~--- 230 (325)
.....||+.|+|||++.+..|+.++||||+||++|||++|..||.............. ...... .. .
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence 2345799999999999999999999999999999999999999976433211100000 000000 00 0
Q ss_pred --------------cccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 231 --------------FEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 231 --------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
.................+.++.+||.+||..||++|||++++++ ||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 00000000000111234678999999999999999999999998 8875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=353.70 Aligned_cols=248 Identities=26% Similarity=0.374 Sum_probs=188.3
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
+.|++++.||+| +++.||+++.. +++.||||.++.. .....++.+|++++++++||||+++++++.+++..++|||
T Consensus 5 ~~~~~~~~iG~G--~fg~Vy~~~~~-~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSG--QFGLVHLGYWL-NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp SCEEEEEEEECC--SSCCEEEEEET-TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHcEEEEEEeeC--CCeEEEEEEEC-CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 467888999999 77779988765 4578999999753 3345689999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 93 YMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 93 ~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
||++|+|.+++.. .++....+.++.+++.++.++|.. |||||+|||++.++.+||+|||+++...........
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 9999999999843 244455677888999999999875 899999999999999999999999877654444444
Q ss_pred cCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhC-CCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 166 RVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISA-KKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
...||+.|+|||++.+..++.++|||||||++|||+|+ .+||..... ......+.. ..+...+
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~~i~~-------------~~~~~~p 224 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDIST-------------GFRLYKP 224 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHHHHHH-------------TCCCCCC
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHHHHHh-------------cCCCCCc
Confidence 45689999999999999999999999999999999995 555543221 111111111 1112233
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
..+++++.+||.+||..||++|||+++|++.|+++.
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 455678999999999999999999999999998764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=357.62 Aligned_cols=243 Identities=18% Similarity=0.264 Sum_probs=199.5
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
+.|.+++.||+| +++.||++++..+++.||||++... .......+.+|+++|++++||||+++++++.+++.+|+
T Consensus 8 ~dy~i~~~lG~G--~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 8 EDFKFGKILGEG--SFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGEEEEEEEEEC--SSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCEEEEEEeeC--CCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 458899999999 8888999999999999999999642 23344678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCc-ce
Q 046728 90 VYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGV-TH 162 (325)
Q Consensus 90 V~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~ 162 (325)
|||||++|+|.+++. +.+++..+..++.++..+++++|.. |||||+|||+++++.+||+|||+|+.+.... ..
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 999999999999984 5678888889999999999999985 8999999999999999999999998775432 22
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
......||+.|+|||++.+..++.++|||||||++|+|+||..||...... .....+ ... ...
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i------------~~~--~~~ 228 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---LIFQKI------------IKL--EYD 228 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH------------HTT--CCC
T ss_pred ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---HHHHHH------------HcC--CCC
Confidence 334457999999999999999999999999999999999999999753321 111111 111 112
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD 274 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~ 274 (325)
.+..+++++.+||.+||+.||++|||++|+++
T Consensus 229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 33456788999999999999999999999754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.9e-51 Score=356.02 Aligned_cols=244 Identities=20% Similarity=0.270 Sum_probs=199.9
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
+.|+.+++||+| +++.||++++..+++.||||.+.... ....+.+.+|+++|++++|||||++++++.+++..|+
T Consensus 15 ~~y~~l~~lG~G--~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHG--SFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HHEEEEEEEEEC--SSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred HhcEeeEEEecC--CCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence 347888999999 78889999999999999999986432 3444578899999999999999999999999999999
Q ss_pred EEEecCCCChhhhh--ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 90 VYDYMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 90 V~e~~~~gsL~~~l--~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
|||||.+|+|..++ +..+++..+..++.++..|+.++|.. |||||+|||++.++.+||+|||++......
T Consensus 93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---- 168 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (309)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC----
Confidence 99999999987766 35577888899999999999999975 899999999999999999999999865432
Q ss_pred eccCCCCcCCCCcccccc---CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 164 TTRVKGTLGYLAPEYAMW---GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
....||+.|+|||++.+ +.|+.++|||||||++|+|++|..||.+.... .....+ . . ....
T Consensus 169 -~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~---~~~~~i---~-~--------~~~~ 232 (309)
T d1u5ra_ 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHI---A-Q--------NESP 232 (309)
T ss_dssp -CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHH---H-H--------SCCC
T ss_pred -CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH---HHHHHH---H-h--------CCCC
Confidence 33569999999999864 45889999999999999999999999753321 111110 0 0 1111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
...+...++.+.+||.+||..||++|||++++++ ||..
T Consensus 233 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 1223446778999999999999999999999998 8864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.4e-50 Score=357.96 Aligned_cols=251 Identities=17% Similarity=0.258 Sum_probs=209.0
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
-..|++++.||+| +++.||++++..+++.||||.+..........+.+|+.+|++++|||||++++++.++..+|+||
T Consensus 28 ~d~Y~i~~~lG~G--~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSG--AFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecC--CCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3458899999999 88889999999999999999998766666678889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeC--CCCceEEeeeccccccCCCcce
Q 046728 92 DYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLD--TDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 92 e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~--~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
|||+||+|.+++.. .+++..++.++.++..|+.++|.. |||||+|||++ .++.+||+|||++........
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~- 184 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI- 184 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc-
Confidence 99999999988742 477888899999999999999985 89999999998 578999999999998765433
Q ss_pred eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCC
Q 046728 163 MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGK 242 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
.....||+.|+|||++.+..++.++|||||||++|+|+||..||.+..... ....+.. . .......
T Consensus 185 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~i~~----~------~~~~~~~ 250 (352)
T d1koba_ 185 -VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNVKR----C------DWEFDED 250 (352)
T ss_dssp -EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHH----C------CCCCCSS
T ss_pred -eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh----C------CCCCCcc
Confidence 233468999999999999999999999999999999999999997543211 1111110 0 0111223
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 243 FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 243 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
.+..+++++.+||.+||..||.+|||++++++ ||+..
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 33567789999999999999999999999998 88754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.1e-50 Score=359.00 Aligned_cols=250 Identities=18% Similarity=0.297 Sum_probs=207.6
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
..|.+++.||.| +++.||++++..+|+.||||.+........+.+.+|+++|++++|||||++++++.+.+.+|+|||
T Consensus 26 ~~Y~i~~~lG~G--~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 26 DHYDIHEELGTG--AFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GTEEEEEEEEEE--TTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cCeEEEEEEecC--cCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467889999999 788899999999999999999987666667789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeC--CCCceEEeeeccccccCCCccee
Q 046728 93 YMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLD--TDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 93 ~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~--~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||+||+|.+++. +.+++..+..++.++..|+.++|.+ |||||+|||++ .++.+||+|||++........
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~-- 181 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-- 181 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC--
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc--
Confidence 999999999983 3477888899999999999999985 89999999996 457899999999987765433
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... .....+. ... .......
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~----~~~------~~~~~~~ 248 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNVK----SCD------WNMDDSA 248 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----HTC------CCSCCGG
T ss_pred cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHH----hCC------CCCCccc
Confidence 23356899999999999989999999999999999999999999754321 1111111 000 0111122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
...+++++.+||.+||..||++|||++++++ ||+..
T Consensus 249 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 249 FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 3456788999999999999999999999999 88754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=343.72 Aligned_cols=246 Identities=24% Similarity=0.375 Sum_probs=201.8
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
+.|++.++||+| +++.||+++.. +++.||||.++... .....+.+|+.++++++||||+++++++.++..+++|||
T Consensus 4 ~~~~~~~~iG~G--~fg~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTG--QFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEE--TTEEEEEEEET-TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred HHCEEeEEEecC--CCeEEEEEEEC-CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 467889999999 77778988864 67889999998643 334689999999999999999999999999999999999
Q ss_pred ecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 93 YMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 93 ~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
||++|+|.+++. ..+.....+.+..+++.++.++|.. |||||+||+++.++.+||+|||+++...........
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 999999999973 3345556778888999999999975 799999999999999999999999876655444444
Q ss_pred cCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 166 RVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
...+|..|+|||++.+..++.++|||||||++|||+| |..||....... ....+.. ..+...+
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~~~i~~-------------~~~~~~p 223 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEHIAQ-------------GLRLYRP 223 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHHT-------------TCCCCCC
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HHHHHHh-------------CCCCCCc
Confidence 5668999999999999999999999999999999998 799997654321 1111111 1122334
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~ 278 (325)
...++++.+||.+||+.||++|||+++|++.|..
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 5566789999999999999999999999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=350.46 Aligned_cols=251 Identities=19% Similarity=0.283 Sum_probs=204.7
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC------hhhHHHHHHHHHHHHccCCCCccceeeEEEcC
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN------AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG 84 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (325)
+...|.+.+.||+| +++.||++++..+|+.||||.+.+.. ....+.+.+|+++|++++|||||++++++.+.
T Consensus 8 i~d~Y~~~~~lG~G--~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (293)
T d1jksa_ 8 VDDYYDTGEELGSG--QFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 85 (293)
T ss_dssp GGGTEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred cccCEEEeEEEecC--CCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 45668999999999 88889999999999999999986422 22356899999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC----ceEEeeecccc
Q 046728 85 DERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF----EAKVADFGFAK 154 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~----~~kL~Dfg~~~ 154 (325)
...|+|||||++|+|.++++ +.+++..+..++.++..|+.++|.. |||||+|||++.++ .+||+|||++.
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 99999999999999999994 4577888899999999999999985 89999999998776 49999999998
Q ss_pred ccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccc
Q 046728 155 LIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHI 234 (325)
Q Consensus 155 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (325)
....... .....||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+... ....+. ...
T Consensus 166 ~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~----~~~---- 232 (293)
T d1jksa_ 166 KIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANVS----AVN---- 232 (293)
T ss_dssp ECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----TTC----
T ss_pred hcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---HHHHHH----hcC----
Confidence 7654332 234568999999999998899999999999999999999999997543211 111110 000
Q ss_pred cCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 235 ADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
.......+...++.+.+||.+||..||++|||++++++ ||+.
T Consensus 233 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 233 --YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp --CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred --CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 00011112345678999999999999999999999998 8864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-50 Score=352.70 Aligned_cols=251 Identities=22% Similarity=0.360 Sum_probs=191.3
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCC---eEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDD---QIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~---~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
+.|.+.+.||+| +++.||+++...+++ .||||.+... .....+.|.+|+++|++++|||||++++++.+++..+
T Consensus 26 ~~~~~~~~lG~G--~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAG--EFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGEEEEEEEEEC--SSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhcEEeeEEeeC--CCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 456777889998 778899998776654 5899988643 4555678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 89 IVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
+|||||++|+|.+++.. .++...++.+..+++.++.++|.. |||||+|||++.++.+||+|||+++.......
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence 99999999999998853 355666778889999999999985 89999999999999999999999987654322
Q ss_pred ee----eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccC
Q 046728 162 HM----TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD 236 (325)
Q Consensus 162 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (325)
.. .....+|+.|+|||++.+..++.++|||||||++|||+| |..||.+.... .....+.
T Consensus 184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~i~------------- 247 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINAIE------------- 247 (299)
T ss_dssp ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH-------------
T ss_pred cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHHHH-------------
Confidence 21 222357899999999998899999999999999999998 89999764321 1111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 237 PRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 237 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
...+.+.+..+++.+.+||.+||..||++|||+.+|++.|+.++.
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 248 QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 111223445677899999999999999999999999999987653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=349.12 Aligned_cols=248 Identities=23% Similarity=0.360 Sum_probs=198.7
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
+.|.+.+.||+| +++.||++... +++.||||.+.... ...+.+.+|++++++++|||||++++++.+ +..++|||
T Consensus 13 ~~~~~~~~iG~G--~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 13 ETLKLVERLGAG--QFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGEEEEEEEEEE--TTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHeEEeEEEecC--CCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 467888999999 77789988854 56789999997533 345689999999999999999999998754 56799999
Q ss_pred ecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 93 YMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||++|+|.+++.. .++...++.++.+++.+++++|.. |||||+|||++.++.+||+|||+++..........
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 9999999998842 356667788889999999999985 89999999999999999999999998766555545
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
....||+.|+|||++.+..++.++|||||||++|||+||..||..... .......+. ...+...+
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~i~-------------~~~~~~~p 232 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNLE-------------RGYRMVRP 232 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH-------------TTCCCCCC
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHHHHH-------------hcCCCCCc
Confidence 556789999999999988999999999999999999996555433221 111111111 11122334
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
..+++++.+||.+||+.||++|||+++|++.|+...
T Consensus 233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 556788999999999999999999999999887654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-50 Score=353.42 Aligned_cols=246 Identities=20% Similarity=0.261 Sum_probs=205.7
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
.|.+++.||+| +++.||++++..+++.||||++.+. ......++.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 6 dy~~~~~lG~G--~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 6 DFDYLKLLGKG--TFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GEEEEEEEEEC--SSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcEEEEEEecC--cCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 57889999999 7888999999999999999999743 233456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 91 YDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 91 ~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||||+||+|.++++ ..+++..+..++.++..|+.++|.+ |||||+|||++.+|.+||+|||+|+....... ..
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~-~~ 162 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 162 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-CB
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc-cc
Confidence 99999999999994 5577778889999999999999986 89999999999999999999999986544322 23
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
...+||+.|+|||++.+..|+.++||||+||++|||++|..||.+..... ...... . . ....+
T Consensus 163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~~i~----~--------~--~~~~p 225 (337)
T d1o6la_ 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELIL----M--------E--EIRFP 225 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----H--------C--CCCCC
T ss_pred ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HHHHHh----c--------C--CCCCC
Confidence 44679999999999999999999999999999999999999997643211 111110 0 0 12334
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH--HHhcc
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPT-----MTDVVD--WLKGG 279 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps-----~~~il~--~l~~~ 279 (325)
..+++++.+||.+||..||++||+ ++++++ ||++.
T Consensus 226 ~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 567789999999999999999995 899997 77653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=354.16 Aligned_cols=248 Identities=21% Similarity=0.310 Sum_probs=196.8
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCC-----eEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCC
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDD-----QIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGD 85 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~-----~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 85 (325)
..|.+.+.||+| +++.||+++....++ .||+|.+... .......+.+|+.+++++ +|||||++++++.+.+
T Consensus 37 ~~~~l~~~lG~G--~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSG--AFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGEEEEEEEEEC--SSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeC--CCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 457888999999 788899988765543 6999998643 334445788999999998 8999999999999999
Q ss_pred eEEEEEEecCCCChhhhhccC-------------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCc
Q 046728 86 ERLIVYDYMPNHSLITHLHGR-------------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASN 136 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~N 136 (325)
..++|||||++|+|.++++.. ++...++.++.+++.++.++|.. |||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 999999999999999999532 23344566788888888888875 8999999
Q ss_pred eeeCCCCceEEeeeccccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCc
Q 046728 137 VLLDTDFEAKVADFGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGV 214 (325)
Q Consensus 137 il~~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~ 214 (325)
||++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+...
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~ 274 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999866543322 2334557999999999999999999999999999999998 899997654321
Q ss_pred cchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 046728 215 KRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLK 277 (325)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~ 277 (325)
. .... .....+.+.+..+++++.+||.+||+.||++|||+++|++.|.
T Consensus 275 ~--~~~~-------------~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 275 N--FYKL-------------IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp H--HHHH-------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H--HHHH-------------HhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1 1111 1111223445567789999999999999999999999999885
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-50 Score=343.95 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=191.4
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV 90 (325)
+.|.+.+.||+| +++.||+++.. ..||||.++.. +......|.+|+.+|++++|||||++++++. ...+++|
T Consensus 8 ~~~~~~~~lG~G--~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv 81 (276)
T d1uwha_ 8 GQITVGQRIGSG--SFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIV 81 (276)
T ss_dssp TCCCCCSEEEEC--SSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ccEEEEEEEeeC--CCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEE
Confidence 457888999999 77789988643 35999998633 4556678999999999999999999999875 4568999
Q ss_pred EEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc-e
Q 046728 91 YDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT-H 162 (325)
Q Consensus 91 ~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~ 162 (325)
||||++|+|.++++ ..++...++.+..+++.++.++|.. |||||+|||++.++.+||+|||+|+....... .
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 99999999999994 3356666788889999999999975 89999999999999999999999987654322 2
Q ss_pred eeccCCCCcCCCCcccccc---CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 163 MTTRVKGTLGYLAPEYAMW---GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 163 ~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
......||+.|+|||++.+ ..|+.++|||||||++|||+||..||.+...... ....+. .+. ..+.
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~~~~~~----~~~----~~p~- 230 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIFMVG----RGY----LSPD- 230 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHHHH----HTS----CCCC-
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--HHHHHh----cCC----CCCc-
Confidence 2344579999999999864 3578899999999999999999999976543211 111111 100 0010
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
....+..+++++.+||.+||..||++|||+.+|++.|+.+.
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11233456778999999999999999999999999887654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-49 Score=347.42 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=204.0
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD 85 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (325)
|++ +.|.+++.||+| +++.||++++..+++.||||++.+. .......+.+|+.++++++||||+++++++.+..
T Consensus 1 ~sl-~dy~i~~~lG~G--~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 77 (316)
T d1fota_ 1 YSL-QDFQILRTLGTG--SFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 77 (316)
T ss_dssp CCG-GGEEEEEEEEEC--SSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred Cch-hHeEEEEEEecC--cCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC
Confidence 344 358899999999 8888999999999999999999642 2334567889999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC
Q 046728 86 ERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 159 (325)
..|+|||||+||+|..++. ..+.+..+..+..++..++.++|.. |||||+|||++.+|.+||+|||+++.....
T Consensus 78 ~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999999999984 3455556677889999999999985 899999999999999999999999876543
Q ss_pred cceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 160 VTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 160 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
. ....||+.|+|||++.+..++.++|||||||++|+|+||..||.+.... .....+. . .
T Consensus 158 ~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i~----~--------~-- 216 (316)
T d1fota_ 158 T----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTYEKIL----N--------A-- 216 (316)
T ss_dssp B----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHH----H--------C--
T ss_pred c----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH---HHHHHHH----c--------C--
Confidence 2 3457999999999999889999999999999999999999999753321 1111110 0 0
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH--HHhcc
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRP-----TMTDVVD--WLKGG 279 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~~ 279 (325)
....+..+++++.++|.+||..||++|+ |++++++ ||++.
T Consensus 217 ~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 217 ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 1123345677899999999999999996 8999998 88764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=342.07 Aligned_cols=242 Identities=23% Similarity=0.299 Sum_probs=191.2
Q ss_pred hhccCccceeeeeEEEec--cCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEEec
Q 046728 19 QNINNGLEILMLLLLLRR--ETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYDYM 94 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~--~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e~~ 94 (325)
++||+| +++.||++.. ..+++.||||.++.. +.....++.+|+++|++++|||||++++++.++ ..++|||||
T Consensus 13 k~iG~G--~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSG--NFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMA 89 (277)
T ss_dssp EEEEEC--SSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred CCcccC--CCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcC
Confidence 368888 7777888753 445678999999642 344456899999999999999999999998654 578999999
Q ss_pred CCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee--ecc
Q 046728 95 PNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM--TTR 166 (325)
Q Consensus 95 ~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~--~~~ 166 (325)
++|+|.++++ ..+++..++.+..+++.++.++|.. |||||+|||++.++.+||+|||+++......... ...
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence 9999999995 3466777888999999999999985 8999999999999999999999998765443322 233
Q ss_pred CCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCCH
Q 046728 167 VKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNR 245 (325)
Q Consensus 167 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (325)
..||+.|+|||++.+..++.++|||||||++|||+| |..||.+.... .....+. . +.+.+.+.
T Consensus 170 ~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~~i~----~---------~~~~~~p~ 233 (277)
T d1xbba_ 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAMLE----K---------GERMGCPA 233 (277)
T ss_dssp -CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHH----T---------TCCCCCCT
T ss_pred cCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHHHHH----c---------CCCCCCCc
Confidence 468999999999998899999999999999999998 89999764421 1111111 1 11223445
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 246 DQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 246 ~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
.+++++.+||.+||..||++|||+.+|++.|+..
T Consensus 234 ~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 6778999999999999999999999998877654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=340.63 Aligned_cols=248 Identities=21% Similarity=0.281 Sum_probs=196.9
Q ss_pred chhHHh-hccCccceeeeeEEEecc--CCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 14 PAVFIQ-NINNGLEILMLLLLLRRE--TGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 14 ~~~~~~-~i~~G~~~~~~v~~~~~~--~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
.+.+.+ +||.| +++.||++... .++..||||.++.. ......+|.+|+++|++++|||||++++++.+ +.+|+
T Consensus 9 ~~~~~~~~iG~G--~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 9 NLLIADIELGCG--NFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GEEEEEEEEECC--TTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CeEECCcEEecc--cCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 344555 48888 77778887543 44567999999743 45556789999999999999999999999875 45899
Q ss_pred EEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce
Q 046728 90 VYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH 162 (325)
Q Consensus 90 V~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 162 (325)
|||||++|+|.+++. ..++...++.+..+++.++.++|.. |||||+|||++.++.+||+|||+++.+......
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 165 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence 999999999999973 3466677788899999999999985 899999999999999999999999977654332
Q ss_pred --eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 163 --MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 163 --~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
......||+.|+|||++.+..++.++|||||||++|||+| |..||....... ....+. . +.
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~~~i~----~---------~~ 229 (285)
T d1u59a_ 166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIE----Q---------GK 229 (285)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHH----T---------TC
T ss_pred cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HHHHHH----c---------CC
Confidence 2233458899999999998899999999999999999998 899997654321 111111 1 11
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
+.+.+..+++++.+||.+||..||++|||+.+|++.|+...
T Consensus 230 ~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 230 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 22345567789999999999999999999999999887543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.3e-49 Score=337.78 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=205.3
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---------hhhHHHHHHHHHHHHccC-CCCccceeeE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---------AKAEMEFAVEVEILGRVR-HRNLLGLRGF 80 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~~iv~~~~~ 80 (325)
|.+.|++++.||+| +++.||++++..+++.||||++.... .....++.+|+.++++++ ||||++++++
T Consensus 1 f~~~y~~~~~iG~G--~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 78 (277)
T d1phka_ 1 FYENYEPKEILGRG--VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 78 (277)
T ss_dssp CTTTEEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred CcccCEEceEEecC--cCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEee
Confidence 34678899999999 78889999999999999999986432 122346888999999996 9999999999
Q ss_pred EEcCCeEEEEEEecCCCChhhhh--ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccc
Q 046728 81 YAGGDERLIVYDYMPNHSLITHL--HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 81 ~~~~~~~~lV~e~~~~gsL~~~l--~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
+.+++.+|+|||||++|||.+++ ++.+++..+..++.|+..|+.++|.. |||||+|||++.++.+||+|||+++
T Consensus 79 ~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 79 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhee
Confidence 99999999999999999999999 45678888999999999999999986 7999999999999999999999999
Q ss_pred ccCCCcceeeccCCCCcCCCCcccccc------CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccc
Q 046728 155 LIPDGVTHMTTRVKGTLGYLAPEYAMW------GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQK 228 (325)
Q Consensus 155 ~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 228 (325)
....... .....||..|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..... ..+ ..
T Consensus 159 ~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~---~~i----~~ 229 (277)
T d1phka_ 159 QLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML---RMI----MS 229 (277)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH----HH
T ss_pred EccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH---HHH----Hh
Confidence 7765332 234569999999999863 34688999999999999999999999764421111 111 01
Q ss_pred cccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 229 GAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
+. .....+....+++++.+||.+||..||++|||++++++ ||++
T Consensus 230 ~~------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 230 GN------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TC------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CC------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 10 11122334567889999999999999999999999998 8864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=340.02 Aligned_cols=251 Identities=21% Similarity=0.332 Sum_probs=189.5
Q ss_pred chhHHhhccCccceeeeeEEEeccCCC----CeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGD----DQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~----~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
.|++.+.||+| +++.||++....++ ..||||.+... ......+|.+|++++++++|||||++++++.+....+
T Consensus 8 ~~~~~~~iG~G--~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 8 CVTRQKVIGAG--EFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TEEEEEEEEEC--SSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HeEeeeEEeeC--CCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35667889998 77778887765543 46999999643 4455568999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 89 IVYDYMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
+|||||.+|++.+++.. .++....+.+..+++.++.++|.. |||||+|||++.++.+||+|||+++.......
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 99999999999988842 345556677888888888988874 89999999999999999999999987654322
Q ss_pred e--eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccc
Q 046728 162 H--MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRL 239 (325)
Q Consensus 162 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (325)
. ......||+.|+|||++.+..++.++|||||||++|||+++..||..... .......+. .+.
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~~~i~-------------~~~ 230 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMKAIN-------------DGF 230 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHH-------------TTC
T ss_pred cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHHHHHHh-------------ccC
Confidence 1 22334589999999999999999999999999999999997666543221 111111111 112
Q ss_pred cCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 240 KGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 240 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
+.+.+..+++++.+||.+||..||++|||+.+|++.|+.+..
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 234445677889999999999999999999999999987653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=339.07 Aligned_cols=250 Identities=19% Similarity=0.265 Sum_probs=189.9
Q ss_pred cchhHHhhccCccceeeeeEEEeccCC---CCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETG---DDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~---~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (325)
..|.+.+.||+| +++.||++....+ +..||||.+... .......+.+|++++++++||||+++++++. .+..+
T Consensus 7 ~~~~l~~~iG~G--~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 7 ERIELGRCIGEG--QFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGEEEEEEEEEC--SSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHeEEEEEEeeC--CCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 478889999999 7788888876654 346899998643 4455568999999999999999999999986 46789
Q ss_pred EEEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 89 IVYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
+|||||++|+|.+++. ..+++..++.+..++..++.++|.. |||||+||+++.++.+||+|||+++.......
T Consensus 84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 9999999999999873 2356666788889999999999985 89999999999999999999999987765444
Q ss_pred eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 162 HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
.......||+.|+|||++.+..++.++|||||||++|||+| |.+||........ ...+. . ..+
T Consensus 164 ~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~~~i~----~---------~~~ 227 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIE----N---------GER 227 (273)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHH----T---------TCC
T ss_pred eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH---HHHHH----c---------CCC
Confidence 44455568999999999999999999999999999999998 8999976543221 11111 0 112
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
.+.+..+++++.+||.+||..||++|||+++|++.|+.++.
T Consensus 228 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 228 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 23455677899999999999999999999999999887653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.4e-48 Score=345.98 Aligned_cols=247 Identities=17% Similarity=0.208 Sum_probs=198.6
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC---hhhHHHHH---HHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN---AKAEMEFA---VEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
.|.+++.||.| +++.||++++..+++.||||.+.... ......+. +|+++++.++|||||++++++.+.+.+
T Consensus 5 dy~i~~~lG~G--~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 5 DFSVHRIIGRG--GFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp TEEEEEEEEEC--SSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hCeeeeEEecC--CCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 47888999999 88889999999999999999986321 11222333 356777778899999999999999999
Q ss_pred EEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcc
Q 046728 88 LIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVT 161 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 161 (325)
|+|||||+||+|.+++. ..+.+..+..++.++..|+.++|.. |||||+|||++.++.+||+|||+|+......
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~- 161 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 161 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc-
Confidence 99999999999999994 4466677888999999999999986 8999999999999999999999998765432
Q ss_pred eeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCcccc
Q 046728 162 HMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLK 240 (325)
Q Consensus 162 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
.....||+.|+|||++.. ..++.++|||||||++|+|+||..||................ ...
T Consensus 162 --~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~--------------~~~ 225 (364)
T d1omwa3 162 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--------------TMA 225 (364)
T ss_dssp --CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS--------------SCC
T ss_pred --ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--------------cCC
Confidence 234569999999999874 468999999999999999999999997654432222111110 001
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH--HHhcc
Q 046728 241 GKFNRDQLKSMVLIALRCTDSNPENRPT-----MTDVVD--WLKGG 279 (325)
Q Consensus 241 ~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~~il~--~l~~~ 279 (325)
...+..+++++.+||.+||..||++||| ++++++ ||+++
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 226 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 1233456788999999999999999999 799998 87754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=338.56 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=193.7
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
..|++.+.||+| +++.||+++...+ +.||||.++... ...+.|.+|+.++++++|||||++++++. .+..++|||
T Consensus 17 ~~~~i~~~iG~G--~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~E 91 (285)
T d1fmka3 17 ESLRLEVKLGQG--CFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 91 (285)
T ss_dssp GGEEEEEEEEEC--SSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred HHEEEeeEEeeC--CCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEE
Confidence 467888999999 7788999987654 579999997533 34568999999999999999999999985 456899999
Q ss_pred ecCCCChhhhhc----cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 93 YMPNHSLITHLH----GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~----~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||++|+|..++. ..++...++.+..+++.++.++|.. |||||+|||++.++.+||+|||+++..........
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 999999999884 3466777888889999999999975 79999999999999999999999987655444444
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKFN 244 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
....+|+.|+|||++....++.++|||||||++|||+||..||..... .......+. ...+.+.+
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i~-------------~~~~~~~~ 236 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVE-------------RGYRMPCP 236 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH-------------TTCCCCCC
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHH-------------hcCCCCCC
Confidence 445689999999999999999999999999999999997666544222 111122111 11122345
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 245 RDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 245 ~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
..+++++.+||.+||+.||++|||+++|+++|+....
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 5677899999999999999999999999999998664
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=342.27 Aligned_cols=250 Identities=18% Similarity=0.304 Sum_probs=203.8
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
..|++.+.||+| +++.||++.+..+++.||||.++.... ....+.+|+++|++++||||+++++++.+++.+|+|||
T Consensus 5 ~rY~i~~~lG~G--~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 5 EKYMIAEDLGRG--EFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTEEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cceEEEEEEecC--CCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 457889999999 888899999999999999999986443 34578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc---CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCC--CceEEeeeccccccCCCccee
Q 046728 93 YMPNHSLITHLHG---RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTD--FEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 93 ~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~--~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||+||+|.++++. .+++..+..++.++..|+.++|.+ |||||+|||++.+ ..+||+|||++........
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~-- 159 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-- 159 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE--
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCc--
Confidence 9999999999953 467788899999999999999986 8999999999854 5799999999987655433
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.....+|+.|+|||.+.+..++.++||||+||++|+|++|..||....... ....+. ...+ ......
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~~~~i~----~~~~------~~~~~~ 226 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENIM----NAEY------TFDEEA 226 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHH----HTCC------CCCHHH
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hCCC------CCChhh
Confidence 233468999999999998899999999999999999999999997643211 111110 0000 000111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
+..+++++.+||.+||..||++|||++++++ ||++..
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 265 (321)
T d1tkia_ 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence 1245678999999999999999999999998 887643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-48 Score=345.70 Aligned_cols=244 Identities=20% Similarity=0.295 Sum_probs=204.6
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (325)
..|.+++.||+| +++.||++++..+++.||||.+... .......+.+|+++|+.++||||+++++++.+....++
T Consensus 41 d~y~i~~~lG~G--~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 41 DQFDRIKTLGTG--SFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGEEEEEEEEEC--SSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCeEEEEEeecC--cCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 468899999999 8888999999999999999998642 22334578899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 90 VYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 90 V~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
||||+.+|+|.+++. +.+++..+..+..++..|+.++|.+ |||||+|||++.++.+||+|||+++......
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~--- 195 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--- 195 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB---
T ss_pred ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc---
Confidence 999999999999993 5678888899999999999999985 8999999999999999999999999765432
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
....||+.|+|||++.+..++.++|||||||++|+|+||..||.+... ......+. .. ....
T Consensus 196 -~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~i~----~~----------~~~~ 257 (350)
T d1rdqe_ 196 -WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIV----SG----------KVRF 257 (350)
T ss_dssp -CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH----HC----------CCCC
T ss_pred -ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH---HHHHHHHh----cC----------CCCC
Confidence 345699999999999999999999999999999999999999975332 11111111 00 1122
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH--HHhcc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRP-----TMTDVVD--WLKGG 279 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~~ 279 (325)
+..+++++.+||.+||..||.+|+ |++++++ ||+..
T Consensus 258 p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 345678999999999999999994 8999998 77653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=344.23 Aligned_cols=246 Identities=22% Similarity=0.270 Sum_probs=200.7
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHH-ccCCCCccceeeEEEcCCeEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILG-RVRHRNLLGLRGFYAGGDERLI 89 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~l 89 (325)
.|.+++.||.| +++.||++++..+++.||||++.+. .......+..|..++. .++||||+++++++.++...|+
T Consensus 3 dy~i~~~iG~G--~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 3 DFILHKMLGKG--SFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp TEEEEEEEEEC--SSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CeEEeeEEecC--CCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 47888999999 7788999999999999999999642 1233446667777665 6899999999999999999999
Q ss_pred EEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 90 VYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 90 V~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
|||||++|+|.++++ ..+++..+..++.+++.|+.++|.. |||||+|||++.++.+||+|||+++........
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~- 159 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK- 159 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC-
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccccc-
Confidence 999999999999994 4577778899999999999999986 899999999999999999999999866543322
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.....||+.|+|||++.+..++.++||||+||++|+|+||..||.+..... ....+. .. ....
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i~----~~----------~~~~ 222 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSIR----MD----------NPFY 222 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HC----------CCCC
T ss_pred ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHH----cC----------CCCC
Confidence 334569999999999999999999999999999999999999997543211 111110 00 1123
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH--HHhcc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMT-DVVD--WLKGG 279 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~-~il~--~l~~~ 279 (325)
+..+++++.+||.+||..||++|||+. ++++ ||++.
T Consensus 223 p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 223 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 445678899999999999999999996 7876 77653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=335.63 Aligned_cols=259 Identities=18% Similarity=0.188 Sum_probs=193.5
Q ss_pred HhhccCccceeeeeEEEeccCCCCeEEEEEecccChh-----hHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEEE
Q 046728 18 IQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAK-----AEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVYD 92 (325)
Q Consensus 18 ~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~e 92 (325)
++.||.| +++.||++++..+++.||||.++..... ....+.+|++++++++|||||++++++.+++..|+|||
T Consensus 3 l~~lG~G--~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 3 LDFLGEG--QFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEE--TTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred ceEeccC--cCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 4678888 7888999999999999999998643221 12368899999999999999999999999999999999
Q ss_pred ecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeecc
Q 046728 93 YMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTTR 166 (325)
Q Consensus 93 ~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 166 (325)
||.++++..+.. ..+++..+..+..|+..|+.++|.. |||||+|||++.++.+||+|||+++........ ...
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-~~~ 159 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YTH 159 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-CCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc-ccc
Confidence 998887776663 4577888899999999999999986 899999999999999999999999876554322 234
Q ss_pred CCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccccc-------Ccc
Q 046728 167 VKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIA-------DPR 238 (325)
Q Consensus 167 ~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~ 238 (325)
..||+.|+|||++... .++.++||||+||++|+|+||..||...........+...........+.... ...
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 5689999999998754 57899999999999999999999997543211111110000000000000000 000
Q ss_pred ccCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 239 LKGK----FNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 239 ~~~~----~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
.... .....++++.+||.+||..||++|||++|+++ ||++.
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0000 01234678999999999999999999999998 88753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=339.08 Aligned_cols=247 Identities=21% Similarity=0.261 Sum_probs=195.9
Q ss_pred cchhHHh-hccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHcc-CCCCccceeeEEEc----CCe
Q 046728 13 SPAVFIQ-NINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAG----GDE 86 (325)
Q Consensus 13 ~~~~~~~-~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~~~ 86 (325)
..|.+++ .||.| +++.||++++..+++.||||.++.. ..+.+|+.++.++ +||||++++++|.+ ...
T Consensus 11 ~~y~i~~~~lG~G--~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 11 DDYKVTSQVLGLG--INGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GTEEEEEEEEEEC--SSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cCEEEeeEEeeec--cCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 4567765 48888 8888999999999999999999652 3567899987655 89999999999875 456
Q ss_pred EEEEEEecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC---CCceEEeeeccccc
Q 046728 87 RLIVYDYMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT---DFEAKVADFGFAKL 155 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~---~~~~kL~Dfg~~~~ 155 (325)
+|+|||||+||+|.++++. .+++..+..++.++..|+.++|.. |||||+|||++. .+.+||+|||+++.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence 8999999999999999953 366777889999999999999985 899999999985 46799999999987
Q ss_pred cCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccccc
Q 046728 156 IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIA 235 (325)
Q Consensus 156 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (325)
...... .....||+.|+|||++.+..|+.++|||||||++|+|+||..||.+.......... ...+.
T Consensus 164 ~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~-----------~~~i~ 230 (335)
T d2ozaa1 164 TTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-----------KTRIR 230 (335)
T ss_dssp CCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------CCC
T ss_pred ccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH-----------HHHHh
Confidence 665432 33457999999999999989999999999999999999999999764432211100 00111
Q ss_pred Ccc--ccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 236 DPR--LKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 236 ~~~--~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
... ...+....+++++.+||.+||..||++|||+.++++ ||.+.
T Consensus 231 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 231 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 111 111223467889999999999999999999999998 88653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.4e-48 Score=332.69 Aligned_cols=253 Identities=23% Similarity=0.294 Sum_probs=195.9
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC--
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD-- 85 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 85 (325)
+...|.+.+.||+| +++.||++++..+++.||||.++.. +.....++.+|++++++++||||+++++++....
T Consensus 5 l~drY~i~~~lG~G--~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 5 LSDRYELGEILGFG--GMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82 (277)
T ss_dssp ETTTEEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred ccceeEEeEEEeeC--CCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC
Confidence 45568899999999 8888999999999999999999643 3445568899999999999999999999987643
Q ss_pred --eEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccC
Q 046728 86 --ERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIP 157 (325)
Q Consensus 86 --~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~ 157 (325)
.+|+|||||+||+|.+++. +.+++..++.++.|+..++.++|.. |||||+|||++.++..+|+|||.+....
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence 3789999999999999884 4577888899999999999999985 8999999999999999999999987654
Q ss_pred CCcc--eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccccc
Q 046728 158 DGVT--HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIA 235 (325)
Q Consensus 158 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (325)
.... .......||+.|+|||++.+..++.++|||||||++|+|+||..||....... ... ......
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~---~~~~~~------ 230 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS---VAY---QHVRED------ 230 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH---HHHHCC------
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH---HHH---HHHhcC------
Confidence 3322 22334569999999999998899999999999999999999999997543211 110 000000
Q ss_pred CccccCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhc
Q 046728 236 DPRLKGKFNRDQLKSMVLIALRCTDSNPENRP-TMTDVVDWLKG 278 (325)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-s~~~il~~l~~ 278 (325)
+.........+++++.+||.+||..||++|| |+++++..|..
T Consensus 231 -~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 231 -PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp -CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 0011122345678899999999999999999 89999886554
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-48 Score=338.69 Aligned_cols=250 Identities=20% Similarity=0.301 Sum_probs=195.1
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCC----eEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDD----QIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~----~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
...|++++.||+| ++|.||++....+++ .||+|.+... +....+++.+|+.++++++|||||++++++.++ .
T Consensus 8 ~~dy~~~~~lG~G--~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 8 ETEFKKIKVLGSG--AFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTTEEEEEEEEEC--SSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHHCEEeeEEecC--CCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 3458899999999 788899998877765 5888888642 345567899999999999999999999999865 5
Q ss_pred EEEEEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCC
Q 046728 87 RLIVYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 159 (325)
.+++++|+.+|+|.+++. ..++...++.++.+++.|+.++|.+ |||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 678889999999999884 2355556777889999999999975 899999999999999999999999977654
Q ss_pred cce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCc
Q 046728 160 VTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADP 237 (325)
Q Consensus 160 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (325)
... ......||+.|+|||++.++.++.++|||||||++|||+| |.+||...+.......+. .
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~----------------~ 228 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE----------------K 228 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH----------------H
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH----------------c
Confidence 332 2333458999999999999999999999999999999998 788887654322211111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 238 RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
+.+.+.+..+++++.+||.+||..||++|||+.+|++.|+.+.
T Consensus 229 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 1122344567789999999999999999999999999777654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=330.87 Aligned_cols=240 Identities=29% Similarity=0.376 Sum_probs=188.3
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEc-CCeEEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG-GDERLIVYD 92 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lV~e 92 (325)
.|++++.||+| +++.||+++. .+..||||.++.. ...+.+.+|++++++++||||+++++++.+ .+.+++|||
T Consensus 8 ~~~~~~~lG~G--~fg~Vy~~~~--~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 8 ELKLLQTIGKG--EFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GEEEEEEEEEC--SSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HeEEeEEEecC--CCeEEEEEEE--CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 46788999999 7777888876 3678999999753 334578999999999999999999999854 466899999
Q ss_pred ecCCCChhhhhcc----CCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceee
Q 046728 93 YMPNHSLITHLHG----RLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMT 164 (325)
Q Consensus 93 ~~~~gsL~~~l~~----~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 164 (325)
||++|+|.+++.. .++....+.+..+++.|+.++|.. |||||+|||++.++.+||+|||+++..... .
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~ 157 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----Q 157 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC----C
Confidence 9999999999943 266777888999999999999985 799999999999999999999999865432 2
Q ss_pred ccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 165 TRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 165 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
....+|..|+|||++.+..++.++|||||||++|||+| |.+||...+... ...++. ...+.+.
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i~-------------~~~~~~~ 221 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVE-------------KGYKMDA 221 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHT-------------TTCCCCC
T ss_pred ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH-------------cCCCCCC
Confidence 23357889999999998999999999999999999998 688876543321 122111 1123344
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcc
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGG 279 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~ 279 (325)
+...++++.+||.+||..||++|||+.++++.|+.+
T Consensus 222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 556678999999999999999999999999999865
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=333.78 Aligned_cols=249 Identities=25% Similarity=0.372 Sum_probs=191.3
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCC-C--CeEEEEEeccc---ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETG-D--DQIAVKRLKTL---NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD 85 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~-~--~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (325)
.+.|++++.||+| +++.||+++.... + ..||||.++.. .....++|.+|+.+|++++||||+++++++.+ .
T Consensus 7 ~~d~~~~~~iG~G--~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 7 EKDLRLLEKLGDG--SFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp GGGEEEEEECC------CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hHHeEEEEEEecC--CCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 4668899999999 7777888865433 2 36899998643 33445689999999999999999999999975 4
Q ss_pred eEEEEEEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCC
Q 046728 86 ERLIVYDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 158 (325)
..++|||||++|++.+++. ..++...++.+..+++.|+.++|.. |||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 6789999999999998883 3477777888999999999999985 89999999999999999999999997755
Q ss_pred Ccce--eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhhhccccccccccccc
Q 046728 159 GVTH--MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIA 235 (325)
Q Consensus 159 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (325)
.... ......++..|+|||++.+..++.++|||||||++|||+| |..||.+.... ....++ .
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~~~~i------------~ 228 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKI------------D 228 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH------------H
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HHHHHH------------H
Confidence 4322 2233457889999999999899999999999999999998 89999754321 111111 1
Q ss_pred CccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 046728 236 DPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKG 278 (325)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~ 278 (325)
....+.+.+..+++.+.+||.+||..||++|||+.+|++.|++
T Consensus 229 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1222334445667889999999999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.7e-48 Score=337.54 Aligned_cols=249 Identities=20% Similarity=0.306 Sum_probs=196.7
Q ss_pred chhHHhhccCccceeeeeEEEecc-----CCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRE-----TGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDER 87 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (325)
.|.+++.||.| ++|.||+++.. .+++.||||.++.. ......++.+|++++++++||||+++++++.+....
T Consensus 14 ~~~~~~~lG~G--~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 14 NIEYVRDIGEG--AFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GCEEEEEEEEC--SSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HcEEeEEEeeC--CCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 47889999999 77778888754 34578999999743 344566899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccC--------------------------CCCCCccCHHHHHHHHHHHHhh----cCCCCCCce
Q 046728 88 LIVYDYMPNHSLITHLHGR--------------------------LAPDCLLDWHRRVSIAIGSAEG----IADIKASNV 137 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~~--------------------------~~~~~~~~~~~~~~~~~~~~~~----~rdlkp~Ni 137 (325)
++||||+++|+|.++++.. ++...++.+..+++.+++++|. ||||||+||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NI 171 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 171 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccce
Confidence 9999999999999999532 2333456677788888888887 489999999
Q ss_pred eeCCCCceEEeeeccccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCC-CCCCCCCCCcc
Q 046728 138 LLDTDFEAKVADFGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAK-KPLEKLPGGVK 215 (325)
Q Consensus 138 l~~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~-~pf~~~~~~~~ 215 (325)
|++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++|. +||...+..
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~-- 249 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE-- 249 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH--
Confidence 9999999999999999866443222 233456889999999999999999999999999999999985 567543321
Q ss_pred chhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 216 RDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
.....+. . . ...+.+..+++++.+||.+||+.||++|||+.+|++.|+.+.
T Consensus 250 -e~~~~v~----~--------~-~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 250 -EVIYYVR----D--------G-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp -HHHHHHH----T--------T-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -HHHHHHH----c--------C-CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1111111 1 1 112334566788999999999999999999999999999765
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=334.05 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=195.1
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCC--eEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCCeEE
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDD--QIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGDERL 88 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~--~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 88 (325)
..|++.+.||+| +++.||++....++. .||||.+... .......+.+|+++|+++ +||||+++++++.+.+..+
T Consensus 10 ~~~~~~~~iG~G--~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEG--NFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECG--GGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeC--CCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 356778899999 777789888877765 5788887543 344556899999999999 7999999999999999999
Q ss_pred EEEEecCCCChhhhhccC------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceE
Q 046728 89 IVYDYMPNHSLITHLHGR------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAK 146 (325)
Q Consensus 89 lV~e~~~~gsL~~~l~~~------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~k 146 (325)
+|||||++|+|.++++.. ++....+.+..+++.++.++|.. |||||+|||++.++.+|
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceE
Confidence 999999999999999532 34444566777888888888874 89999999999999999
Q ss_pred EeeeccccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCC-CCCCCCCCCccchhhhhhccc
Q 046728 147 VADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAK-KPLEKLPGGVKRDIVQWVTPY 225 (325)
Q Consensus 147 L~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~-~pf~~~~~~~~~~~~~~~~~~ 225 (325)
|+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|. +||...+. ..+...+.
T Consensus 168 l~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~~~i~-- 240 (309)
T d1fvra_ 168 IADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLP-- 240 (309)
T ss_dssp ECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHGG--
T ss_pred Eccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHHHHHHH--
Confidence 99999998554322 122345899999999999999999999999999999999975 56654332 11111111
Q ss_pred ccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCCCcc
Q 046728 226 VQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGRRTK 285 (325)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~~~~ 285 (325)
.+.+.+.+..+++++.+||.+||+.||++|||+++|++.|+.+......
T Consensus 241 -----------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~ 289 (309)
T d1fvra_ 241 -----------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289 (309)
T ss_dssp -----------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred -----------hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence 1112344556778999999999999999999999999999887754443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=331.18 Aligned_cols=264 Identities=17% Similarity=0.170 Sum_probs=187.8
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC----eE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD----ER 87 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~ 87 (325)
...+.+.+.||.| +++.||+++. +|+.||||.+...... ......|+..+++++||||+++++++.+.. .+
T Consensus 2 ~~~~~l~~~iG~G--~fg~Vy~~~~--~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 2 ARTIVLQESIGKG--RFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGGEEEEEEEECC--SSSEEEEEEE--TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CcEEEEEEEEeeC--CCeEEEEEEE--CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4567788899988 7777898874 5789999999653221 222334555566789999999999987543 57
Q ss_pred EEEEEecCCCChhhhhcc-CCCCCCccCHHHHHHHHHHHHhh------------cCCCCCCceeeCCCCceEEeeecccc
Q 046728 88 LIVYDYMPNHSLITHLHG-RLAPDCLLDWHRRVSIAIGSAEG------------IADIKASNVLLDTDFEAKVADFGFAK 154 (325)
Q Consensus 88 ~lV~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~------------~rdlkp~Nil~~~~~~~kL~Dfg~~~ 154 (325)
|+|||||++|+|.++++. .++....+.+..+++.++.++|. ||||||+|||++.++.+||+|||+++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999999999963 34555566788888999999985 68999999999999999999999998
Q ss_pred ccCCCcce---eeccCCCCcCCCCccccccCC------CCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccc
Q 046728 155 LIPDGVTH---MTTRVKGTLGYLAPEYAMWGK------VSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPY 225 (325)
Q Consensus 155 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~------~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 225 (325)
........ ......||+.|+|||++.+.. ++.++|||||||++|||+||..||..................
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 76543322 233467999999999987542 567899999999999999999888654332211110000000
Q ss_pred ccccccccccCccccCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 226 VQKGAFEHIADPRLKGKF-----NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
..............++.. ....+..+.+|+.+||..||++|||+.+|++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 000000011111111111 2345567999999999999999999999999988765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=332.72 Aligned_cols=258 Identities=21% Similarity=0.266 Sum_probs=191.3
Q ss_pred cceeecc-cchhHHhhccCccceeeeeEEEeccC-----CCCeEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccce
Q 046728 6 NICFLLA-SPAVFIQNINNGLEILMLLLLLRRET-----GDDQIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGL 77 (325)
Q Consensus 6 ~~~~~~~-~~~~~~~~i~~G~~~~~~v~~~~~~~-----~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~ 77 (325)
+-.|.+. ..|.+.+.||+| +++.||+++... +++.||||.++.. .......+.+|..++.++ +|+||+.+
T Consensus 5 ~~~wei~~~~y~~~~~iG~G--~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRG--AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEEC--SSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CccccccHHHEEEeeEEeec--CCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 3344443 468899999999 777788887543 3468999999743 344456788888888887 69999999
Q ss_pred eeEEEcC-CeEEEEEEecCCCChhhhhccC------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCC
Q 046728 78 RGFYAGG-DERLIVYDYMPNHSLITHLHGR------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKA 134 (325)
Q Consensus 78 ~~~~~~~-~~~~lV~e~~~~gsL~~~l~~~------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp 134 (325)
++++... ..+++|||||++|+|.++++.. ++...++.+..+++.++.++|.. |||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp 162 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 162 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCc
Confidence 9987654 5689999999999999999432 33445667788899999999975 89999
Q ss_pred CceeeCCCCceEEeeeccccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhC-CCCCCCCCC
Q 046728 135 SNVLLDTDFEAKVADFGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISA-KKPLEKLPG 212 (325)
Q Consensus 135 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg-~~pf~~~~~ 212 (325)
+|||++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+|+ .+||.....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999866543322 23345699999999999999999999999999999999986 567765432
Q ss_pred CccchhhhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 213 GVKRDIVQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
... ....+. .+.+...+...++++.+||.+||..||++|||++++++.|+.++
T Consensus 243 ~~~--~~~~~~-------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 243 DEE--FCRRLK-------------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp SHH--HHHHHH-------------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH--HHHHHh-------------cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 211 111111 11122334556778999999999999999999999999998765
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=329.11 Aligned_cols=262 Identities=15% Similarity=0.186 Sum_probs=196.1
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
.|++++.||.| +++.||++++..+++.||||.+.... .....++.+|+++|++++||||+++++++.++...|+||
T Consensus 3 ~Y~~~~~lG~G--~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 3 NFQKVEKIGEG--TYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TEEEEEEEEEC--SSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCEeccEEecC--cCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 57788999999 88889999999999999999996432 233468889999999999999999999999999999999
Q ss_pred EecCCCChhhhh----ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCccee
Q 046728 92 DYMPNHSLITHL----HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHM 163 (325)
Q Consensus 92 e~~~~gsL~~~l----~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 163 (325)
|||.+ ++.+++ ...+++..+..++.|+..+++++|.. |||||+|||++.++.+||+|||+++........
T Consensus 81 e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~- 158 (298)
T d1gz8a_ 81 EFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT- 158 (298)
T ss_dssp ECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC-
T ss_pred eecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc-
Confidence 99965 555544 23477788899999999999999985 899999999999999999999999876544332
Q ss_pred eccCCCCcCCCCccccccCC-CCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccc------c--
Q 046728 164 TTRVKGTLGYLAPEYAMWGK-VSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEH------I-- 234 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~-- 234 (325)
.....||+.|+|||++.... ++.++||||+||++|+|++|..||...........+...........+.. .
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 33446999999999887665 47899999999999999999999975432111000000000000000000 0
Q ss_pred -cCccccC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 235 -ADPRLKG---KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 235 -~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
....... ......++++.+||.+||..||++|||++++++ ||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0000000 011245678999999999999999999999998 88764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-47 Score=329.76 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=197.9
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCC-------CeEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGD-------DQIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYA 82 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~-------~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 82 (325)
...|.+.+.||.| +++.||+++....+ ..||||.+... .......+.+|...+.++ +|||||++++++.
T Consensus 12 ~~~~~l~~~iG~G--~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEG--AFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-------CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeec--CCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 4577888999998 88889998866554 36999999753 345557888999999998 8999999999999
Q ss_pred cCCeEEEEEEecCCCChhhhhccC------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeC
Q 046728 83 GGDERLIVYDYMPNHSLITHLHGR------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLD 140 (325)
Q Consensus 83 ~~~~~~lV~e~~~~gsL~~~l~~~------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~ 140 (325)
++...++|||||++|+|.+++..+ ++...++.+..+++.|++++|.. |||||+|||++
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence 999999999999999999999532 45556778889999999999984 89999999999
Q ss_pred CCCceEEeeeccccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchh
Q 046728 141 TDFEAKVADFGFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDI 218 (325)
Q Consensus 141 ~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~ 218 (325)
.++.+||+|||++......... ......+|+.|+|||.+.++.|+.++|||||||++|||++ |.+||...+.. .+
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~~ 246 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---EL 246 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---HH
Confidence 9999999999999866543222 2344568899999999999999999999999999999998 68888654421 11
Q ss_pred hhhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 219 VQWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
...+. .+.+...+..+++++.+||.+||+.||++|||+.+|++.|++++
T Consensus 247 ~~~i~-------------~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 247 FKLLK-------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHH-------------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHH-------------cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 11111 11122344556788999999999999999999999999998765
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=330.78 Aligned_cols=252 Identities=22% Similarity=0.337 Sum_probs=199.2
Q ss_pred cchhHHhhccCccceeeeeEEEec-----cCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHcc-CCCCccceeeEEEcCC
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRR-----ETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRV-RHRNLLGLRGFYAGGD 85 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~-----~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 85 (325)
..+.+.++||.| +++.||+++. ..+++.||||+++.. .......+.+|+.+++++ +|||||++++++.+..
T Consensus 23 ~~~~l~~~iG~G--~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 23 NRLSFGKTLGAG--AFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGEEEEEEEEEC--SSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeec--CCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 566778899999 7777888864 345678999999753 344556889999999999 6999999999999999
Q ss_pred eEEEEEEecCCCChhhhhccC--------------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC
Q 046728 86 ERLIVYDYMPNHSLITHLHGR--------------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT 141 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~ 141 (325)
..++|||||++|+|.++++.. ++...++.+..+++.++.++|.. |||||+||+++.
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc
Confidence 999999999999999998532 33445666888889999999875 899999999999
Q ss_pred CCceEEeeeccccccCCCcc-eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCccchhh
Q 046728 142 DFEAKVADFGFAKLIPDGVT-HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELIS-AKKPLEKLPGGVKRDIV 219 (325)
Q Consensus 142 ~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~ 219 (325)
++.++++|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+| |.+||...+..... .
T Consensus 181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~--~ 258 (311)
T d1t46a_ 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF--Y 258 (311)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH--H
T ss_pred cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH--H
Confidence 99999999999997765433 23344568999999999999999999999999999999999 55555443322111 0
Q ss_pred hhhcccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 220 QWVTPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
. +.....+...+...++.+.+||.+||..||++|||+.+|++.|++.+.
T Consensus 259 ~-------------~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 259 K-------------MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp H-------------HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-------------HHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 1 111122233344567889999999999999999999999999987654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=327.98 Aligned_cols=242 Identities=23% Similarity=0.373 Sum_probs=196.9
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccCh------hhHHHHHHHHHHHHccC--CCCccceeeEEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNA------KAEMEFAVEVEILGRVR--HRNLLGLRGFYA 82 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~ 82 (325)
+...|.+.+.||+| +++.||++++..+++.||||.+..... ....++.+|+.++++++ ||||+++++++.
T Consensus 2 l~~~Y~i~~~lG~G--~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~ 79 (273)
T d1xwsa_ 2 LESQYQVGPLLGSG--GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 79 (273)
T ss_dssp CTTTEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCCeEEEeEEEeeC--CCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe
Confidence 45678899999999 778899999999999999999864211 11235678999999996 899999999999
Q ss_pred cCCeEEEEEEecCC-CChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC-CCceEEeeecccc
Q 046728 83 GGDERLIVYDYMPN-HSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT-DFEAKVADFGFAK 154 (325)
Q Consensus 83 ~~~~~~lV~e~~~~-gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~-~~~~kL~Dfg~~~ 154 (325)
+.+..++||||+.+ +++.+++. ..+++..+..+..|+..|+.++|.. |||||+|||++. ++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 80 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccce
Confidence 99999999999976 57888873 4577788889999999999999985 899999999985 4799999999998
Q ss_pred ccCCCcceeeccCCCCcCCCCccccccCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccc
Q 046728 155 LIPDGVTHMTTRVKGTLGYLAPEYAMWGKV-SDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEH 233 (325)
Q Consensus 155 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (325)
...... .....||+.|+|||++.+..+ +.++||||+||++|+|+||..||.... .+. .+
T Consensus 160 ~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~--------~~---- 219 (273)
T d1xwsa_ 160 LLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII--------RG---- 219 (273)
T ss_dssp ECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH--------HC----
T ss_pred eccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHh--------hc----
Confidence 654432 234579999999999987765 567999999999999999999996421 000 00
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 234 IADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
....+..+++++.+||.+||..||++|||++++++ ||+...
T Consensus 220 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 220 ------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp ------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 01122345678999999999999999999999998 887643
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=329.26 Aligned_cols=267 Identities=17% Similarity=0.213 Sum_probs=201.9
Q ss_pred cceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEc
Q 046728 6 NICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG 83 (325)
Q Consensus 6 ~~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (325)
...+.+.+.|.++++||.| +++.||++.+..+++.||||.+... +....+++.+|+++|++++|||||+++++|..
T Consensus 11 ~~~~~~~~~Y~~i~~lG~G--~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~ 88 (346)
T d1cm8a_ 11 KTAWEVRAVYRDLQPVGSG--AYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTP 88 (346)
T ss_dssp SSEECCBSSEEEEEEC--------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECS
T ss_pred CceeecCCcEEEEEEEecC--CCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEecc
Confidence 3457788999999999999 8888999999999999999999743 44555688999999999999999999999976
Q ss_pred CC------eEEEEEEecCCCChhhhh-ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecc
Q 046728 84 GD------ERLIVYDYMPNHSLITHL-HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGF 152 (325)
Q Consensus 84 ~~------~~~lV~e~~~~gsL~~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~ 152 (325)
.+ .+|+||||| +.+|..++ +..+++..+..++.++..|+.++|.+ |||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 89 DETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CSSTTTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CccccccceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccc
Confidence 54 479999999 66787777 45688888999999999999999985 89999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccc---
Q 046728 153 AKLIPDGVTHMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQK--- 228 (325)
Q Consensus 153 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~--- 228 (325)
+....... ....||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+...................
T Consensus 168 a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 168 ARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 98765432 345689999999998764 5689999999999999999999999764321111111000000000
Q ss_pred ------------cccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 229 ------------GAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 229 ------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
..........+ .......++.+.+||.+||..||++|||++++++ ||+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00000000000 1122345678999999999999999999999999 998764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-46 Score=324.72 Aligned_cols=246 Identities=24% Similarity=0.293 Sum_probs=189.3
Q ss_pred hhccCccceeeeeEEEeccCCC---CeEEEEEecc-cChhhHHHHHHHHHHHHccCCCCccceeeEEEc-CCeEEEEEEe
Q 046728 19 QNINNGLEILMLLLLLRRETGD---DQIAVKRLKT-LNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG-GDERLIVYDY 93 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~~~~---~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lV~e~ 93 (325)
++||.| +++.||+++...++ ..||||.++. .+.....+|.+|+++|++++||||+++++++.+ +...++||||
T Consensus 33 ~~iG~G--~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 33 EVIGRG--HFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEE--TTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred eEEeec--CCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 567777 77789888765543 3689999974 356666789999999999999999999999765 5689999999
Q ss_pred cCCCChhhhhccCC---CCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcce---e
Q 046728 94 MPNHSLITHLHGRL---APDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTH---M 163 (325)
Q Consensus 94 ~~~gsL~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~---~ 163 (325)
|++|+|.++++... .....+.+..+++.++.++|.. |||||+|||+++++.+||+|||+++........ .
T Consensus 111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~ 190 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 190 (311)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTC
T ss_pred eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccccee
Confidence 99999999996432 2234556777888888888874 899999999999999999999999876543222 2
Q ss_pred eccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccCccccCCC
Q 046728 164 TTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIADPRLKGKF 243 (325)
Q Consensus 164 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
.....||..|+|||.+.+..++.++||||||+++|||+||..||...... .+...++. . +.+...
T Consensus 191 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i~----~---------g~~~~~ 255 (311)
T d1r0pa_ 191 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLL----Q---------GRRLLQ 255 (311)
T ss_dssp TTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH----T---------TCCCCC
T ss_pred cccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHHH----c---------CCCCCC
Confidence 23346899999999999999999999999999999999988877543221 11111111 0 112233
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 244 NRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 244 ~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
+...++++.+||.+||..||++|||+.+|++.|+++..
T Consensus 256 p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 44566789999999999999999999999999988764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=326.11 Aligned_cols=264 Identities=18% Similarity=0.209 Sum_probs=194.1
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCC-CCeEEEEEeccc--ChhhHHHHHHHHHHHHcc---CCCCccceeeEEEc--
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETG-DDQIAVKRLKTL--NAKAEMEFAVEVEILGRV---RHRNLLGLRGFYAG-- 83 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~-~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~-- 83 (325)
.+.|+++++||.| +++.||++++..+ ++.||||.+... .......+.+|+++++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G--~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 6 DQQYECVAEIGEG--AYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGTEEEEEEEEEE--TTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred cCCEEEEEEEecc--cCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 4678999999999 7888999998655 667999998632 222233566788877766 79999999999853
Q ss_pred ---CCeEEEEEEecCCCChhhhh---ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccc
Q 046728 84 ---GDERLIVYDYMPNHSLITHL---HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFA 153 (325)
Q Consensus 84 ---~~~~~lV~e~~~~gsL~~~l---~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~ 153 (325)
....+++||||.++++.... ...+++..+..+..++..|++++|.+ |||||+|||++..+.+||+|||++
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 34678999999887665444 23456666778999999999999986 899999999999999999999998
Q ss_pred cccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccc-
Q 046728 154 KLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFE- 232 (325)
Q Consensus 154 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 232 (325)
....... ......||+.|+|||++.+..|+.++||||+||++|||+||..||.+.........+...........+.
T Consensus 164 ~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 164 RIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp CCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred hhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence 8654332 2345679999999999999999999999999999999999999997543221111111000000000000
Q ss_pred ---------cccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 233 ---------HIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 233 ---------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
...............++.+.+||.+||..||++|||++++++ ||+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 000011111223456778999999999999999999999998 88764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=327.89 Aligned_cols=272 Identities=18% Similarity=0.238 Sum_probs=201.1
Q ss_pred eeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCC-
Q 046728 8 CFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGD- 85 (325)
Q Consensus 8 ~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 85 (325)
+|.++..|.+++.||+| +++.||++.+..+++.||||.+... .....+++.+|+++|++++||||+++++++....
T Consensus 3 ~~~i~~rY~~~~~LG~G--~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 3 VFDVGPRYTNLSYIGEG--AYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp CCCCCTTEEEEEECC-----CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred ccCcCCCeEEEEEEeec--cCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence 46778889999999999 7788999999999999999999753 3455668899999999999999999999986543
Q ss_pred ---eEEEEEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccC
Q 046728 86 ---ERLIVYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIP 157 (325)
Q Consensus 86 ---~~~lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~ 157 (325)
..+++++|+.+|+|.+++. ..+++..+..++.|+..|+.++|.. |||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 81 EQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp TTCCCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cccceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 2345555667999999994 5688888899999999999999985 8999999999999999999999998665
Q ss_pred CCcce--eeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccc---
Q 046728 158 DGVTH--MTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAF--- 231 (325)
Q Consensus 158 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 231 (325)
..... ......||+.|+|||++.. ..++.++||||+||++|+|++|..||........................
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 43222 2344568999999999854 46788999999999999999999999654321111111000000000000
Q ss_pred ------c-cccCccccC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 232 ------E-HIADPRLKG----KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 232 ------~-~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
. ....+.... ......++++.+||.+||..||.+|||++++++ ||+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 0 000000000 011244568999999999999999999999998 8876544
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=325.32 Aligned_cols=252 Identities=17% Similarity=0.297 Sum_probs=196.9
Q ss_pred cchhHHhhccCccceeeeeEEEeccC-----CCCeEEEEEeccc-ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCe
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRET-----GDDQIAVKRLKTL-NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDE 86 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~-----~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (325)
..+.+.+.||+| +++.||++.... ++..||||.+... .......+.+|++++++++||||+++++++.....
T Consensus 20 ~~~~l~~~lG~G--~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 20 EKITMSRELGQG--SFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGEEEEEEEEEC--SSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeC--CCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 566788899999 777788776542 3578999999743 44555678999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhccC------------CCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeee
Q 046728 87 RLIVYDYMPNHSLITHLHGR------------LAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADF 150 (325)
Q Consensus 87 ~~lV~e~~~~gsL~~~l~~~------------~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Df 150 (325)
.++|||||++|+|.+++... ++...+..+..+++.++.++|.. |||||+|||++.++.+||+||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeec
Confidence 99999999999999998421 12233456777788888888875 799999999999999999999
Q ss_pred ccccccCCCcce-eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhC-CCCCCCCCCCccchhhhhhcccccc
Q 046728 151 GFAKLIPDGVTH-MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISA-KKPLEKLPGGVKRDIVQWVTPYVQK 228 (325)
Q Consensus 151 g~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~ 228 (325)
|+++........ ......+|+.|+|||.+.+..++.++|||||||++|||+|| ..||...+... ....+
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~---~~~~i------ 248 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VLRFV------ 248 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---HHHHH------
T ss_pred ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH---HHHHH------
Confidence 999866543332 23344689999999999999999999999999999999998 46775433211 11111
Q ss_pred cccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccCC
Q 046728 229 GAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLGR 282 (325)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~~ 282 (325)
.+. ...+.+..+++.+.+||.+||+.||++|||+++|++.|+..+..
T Consensus 249 ------~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 249 ------MEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp ------HTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ------HhC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 111 11233455678899999999999999999999999999987653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-45 Score=319.72 Aligned_cols=260 Identities=18% Similarity=0.221 Sum_probs=193.6
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccC--hhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN--AKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
.|.++++||.| +++.||++++. +++.||||.+.... .....++.+|+.+|++++||||+++++++.+.+..+++|
T Consensus 3 ~Y~~~~~iG~G--~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 3 KYHGLEKIGEG--TYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp SEEEEEEEEEE--TTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceeccEEecC--CCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 57789999988 77889999875 67999999996532 333568999999999999999999999999999999999
Q ss_pred EecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 92 DYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 92 e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
+|+.++++..+.+ +.+++..+..++.++..+++++|.+ |||||+|||++.++.+||+|||.+......... ..
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~ 158 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YT 158 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc-cc
Confidence 9998776666653 4577788889999999999999986 899999999999999999999999876544332 23
Q ss_pred cCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccc------c------
Q 046728 166 RVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAF------E------ 232 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~------ 232 (325)
...+++.|+|||.+.+. .++.++||||+||++|||++|..||.+.........+...........+ .
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 34589999999998754 5689999999999999999999999754321111100000000000000 0
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHh
Q 046728 233 HIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLK 277 (325)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~ 277 (325)
....+..........++.+.+||.+||..||++|||++|+++ ||+
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 000000011223445678999999999999999999999996 776
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=323.42 Aligned_cols=268 Identities=18% Similarity=0.216 Sum_probs=198.2
Q ss_pred eeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEc--
Q 046728 8 CFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG-- 83 (325)
Q Consensus 8 ~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 83 (325)
.|++-+.|.++++||.| +++.||++++..+++.||||++... +.....++.+|+.++++++||||++++++|..
T Consensus 12 ~f~i~~~Y~i~~~LG~G--~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~ 89 (355)
T d2b1pa1 12 TFTVLKRYQNLKPIGSG--AQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_dssp EEEEETTEEEEEECSCC----CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred ceeecCCeEEEEEeecC--cCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccc
Confidence 56777889999999999 8888999999999999999999743 34555688999999999999999999999963
Q ss_pred ----CCeEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccc
Q 046728 84 ----GDERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 84 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
...+|+|||||.+ ++.+.+...+++..+..++.++..++.++|.. |||||+|||++.++.++++|||+++.
T Consensus 90 ~~~~~~~~~iv~Ey~~~-~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 90 TLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred ccccCceeEEEEeccch-HHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhc
Confidence 4678999999965 66667777788888999999999999999986 79999999999999999999999886
Q ss_pred cCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhh---------hhc---
Q 046728 156 IPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQ---------WVT--- 223 (325)
Q Consensus 156 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~---------~~~--- 223 (325)
..... ......+|+.|+|||++.+..++.++||||+||++|+|++|..||.+.........+. +..
T Consensus 169 ~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 169 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred ccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 65432 2334568999999999999899999999999999999999999996543211110000 000
Q ss_pred c----------cccccccccccCcccc---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 224 P----------YVQKGAFEHIADPRLK---GKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 224 ~----------~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
. ................ .......++++.+||.+||..||++|||++++++ ||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 0 0000000000001111 1112456788999999999999999999999998 998643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=320.85 Aligned_cols=262 Identities=20% Similarity=0.216 Sum_probs=193.1
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCccceeeEEEcC------C
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG------D 85 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~ 85 (325)
...|+.+++||+| +++.||++++..+++.||||.+..... ...+|+++|++++||||+++++++... .
T Consensus 19 ~~~Y~~~k~LG~G--~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 19 EVSYTDTKVIGNG--SFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEEEE--TTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred cCCcEeeeEEeeC--cCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 4457788899999 788899999999999999999975332 234699999999999999999998542 3
Q ss_pred eEEEEEEecCCCChhhhh-----ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC-ceEEeeeccccc
Q 046728 86 ERLIVYDYMPNHSLITHL-----HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF-EAKVADFGFAKL 155 (325)
Q Consensus 86 ~~~lV~e~~~~gsL~~~l-----~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~-~~kL~Dfg~~~~ 155 (325)
.+++|||||+++.+.... ...+++..+..++.++..|+.++|.+ |||||+|||++.++ .+||+|||++..
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 478999999765333222 22366667788999999999999986 89999999999775 899999999987
Q ss_pred cCCCcceeeccCCCCcCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhh------------h
Q 046728 156 IPDGVTHMTTRVKGTLGYLAPEYAMW-GKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQW------------V 222 (325)
Q Consensus 156 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~------------~ 222 (325)
...... .....||..|+|||.+.+ ..++.++||||+||++|||++|..||...........+.. .
T Consensus 173 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 173 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 655432 233568999999998765 4689999999999999999999999975432111111100 0
Q ss_pred cccccccccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcccC
Q 046728 223 TPYVQKGAFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGLG 281 (325)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~~ 281 (325)
........+................++++.+||.+||..||++|||+.|+++ ||++...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 0000011111111111111223456778999999999999999999999998 9987654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4e-44 Score=316.97 Aligned_cols=267 Identities=15% Similarity=0.209 Sum_probs=205.1
Q ss_pred cceeecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-CCCccceeeEEEcC
Q 046728 6 NICFLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGG 84 (325)
Q Consensus 6 ~~~~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 84 (325)
.+.|.....|+++++||.| +++.||++++..+++.||||+++... ..++.+|+++|++++ ||||+++++++...
T Consensus 28 ~~~~~~~d~y~i~~~LG~G--~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 28 VVEWGNQDDYQLVRKLGRG--KYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp CCCCCCGGGEEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred ccCCCCCcCeEEEEEEecC--cCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 4566677789999999999 88889999999999999999997533 457889999999995 99999999999754
Q ss_pred --CeEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCC-ceEEeeeccccccC
Q 046728 85 --DERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDF-EAKVADFGFAKLIP 157 (325)
Q Consensus 85 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~-~~kL~Dfg~~~~~~ 157 (325)
...++|||||.+++|..+.+ .+++..+..++.|+..|++++|.+ |||||+|||++.++ .+||+|||+|....
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~~-~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLYQ-TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTTT-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred CCCceeEEEeecCCCcHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceecc
Confidence 56899999999999988764 478888899999999999999986 89999999998655 69999999998765
Q ss_pred CCcceeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccch--hhh---------hhcc-
Q 046728 158 DGVTHMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRD--IVQ---------WVTP- 224 (325)
Q Consensus 158 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~--~~~---------~~~~- 224 (325)
.... .....+|+.|+|||.+.+. .++.++||||+||++|+|++|..||.......... +.. +...
T Consensus 182 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 182 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 4332 3345689999999998765 47899999999999999999999997543321100 000 0000
Q ss_pred -ccccccccccc--------CccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 225 -YVQKGAFEHIA--------DPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 225 -~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
......+.... ............++++.+||.+||..||++|||++++++ ||++..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 00000000000 011112233456788999999999999999999999998 887643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=322.55 Aligned_cols=252 Identities=20% Similarity=0.297 Sum_probs=200.8
Q ss_pred cchhHHhhccCccceeeeeEEEecc---CCCCeEEEEEeccc----ChhhHHHHHHHHHHHHccCC-CCccceeeEEEcC
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRE---TGDDQIAVKRLKTL----NAKAEMEFAVEVEILGRVRH-RNLLGLRGFYAGG 84 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~---~~~~~vaiK~~~~~----~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~ 84 (325)
+.|.+++.||+| +++.||++++. .+|+.||||.++.. +.....++.+|++++++++| |||+++++++.+.
T Consensus 24 ~~y~~~~~IG~G--~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 24 ENFELLKVLGTG--AYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp GGEEEEEEEEET--TTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred hceEEEEEEecC--CCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 568899999999 77778888763 45889999998642 22334578889999999965 8999999999999
Q ss_pred CeEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCC
Q 046728 85 DERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPD 158 (325)
Q Consensus 85 ~~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 158 (325)
...++|||||.+|+|.+++. ..+.+..+..++.|+..|++++|.. |||||+|||++.++.+||+|||++.....
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 99999999999999999994 4456677788999999999999985 79999999999999999999999987765
Q ss_pred CcceeeccCCCCcCCCCccccccC--CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccccccC
Q 046728 159 GVTHMTTRVKGTLGYLAPEYAMWG--KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEHIAD 236 (325)
Q Consensus 159 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (325)
..........|++.|+|||.+.+. .++.++|||||||++|+|++|..||...........+.....
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~------------ 249 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL------------ 249 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH------------
T ss_pred cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc------------
Confidence 544444556799999999998754 467899999999999999999999976543322211111000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH--HHhcc
Q 046728 237 PRLKGKFNRDQLKSMVLIALRCTDSNPENRP-----TMTDVVD--WLKGG 279 (325)
Q Consensus 237 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~~il~--~l~~~ 279 (325)
....+.+...++++.+||.+||..||++|| |++|+++ ||+.+
T Consensus 250 -~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 250 -KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp -HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred -cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 001233456788999999999999999999 4899997 88653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=318.58 Aligned_cols=264 Identities=15% Similarity=0.148 Sum_probs=192.8
Q ss_pred cchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEc-------
Q 046728 13 SPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAG------- 83 (325)
Q Consensus 13 ~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------- 83 (325)
+.|+++++||+| +++.||++++..+++.||||++... ......++.+|+++|++++|||++++++++..
T Consensus 10 ~rY~i~~~LG~G--~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 10 SKYEKLAKIGQG--TFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGEEEEEEEEEC--SSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred CCEEEEEEEecC--cCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 678899999999 7778999999999999999998543 33445678899999999999999999999855
Q ss_pred -CCeEEEEEEecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccccc
Q 046728 84 -GDERLIVYDYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLI 156 (325)
Q Consensus 84 -~~~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~ 156 (325)
....|+|||||.++++..+.. ..+.+..+..++.|+..++.++|.. |||||+|||++.++.+||+|||++...
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 345799999998776655543 3456667788899999999999985 899999999999999999999999876
Q ss_pred CCCcce---eeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccc
Q 046728 157 PDGVTH---MTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFE 232 (325)
Q Consensus 157 ~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (325)
...... ......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.........+.............
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 543221 22334689999999998755 68999999999999999999999997543222211111111100000000
Q ss_pred ccc---------CccccCCCC------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhc
Q 046728 233 HIA---------DPRLKGKFN------RDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKG 278 (325)
Q Consensus 233 ~~~---------~~~~~~~~~------~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~ 278 (325)
... ......... ...++.+.+||.+||..||++|||++++++ ||++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 000 000000000 112457789999999999999999999998 8874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=311.26 Aligned_cols=261 Identities=17% Similarity=0.220 Sum_probs=202.1
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcCCeEEEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGGDERLIVY 91 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lV~ 91 (325)
.|.++++||.| +++.||++++..+++.||||+++.. ......++.+|+.+++.++||||+++++++.+....++|+
T Consensus 3 ry~~i~~LG~G--~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 3 KYEKLEKIGEG--TYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp SEEEEEEEEEC--SSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEeeeEEecC--cCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 57889999999 7788999999999999999998643 3455678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhc--cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccccCCCcceeec
Q 046728 92 DYMPNHSLITHLH--GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLIPDGVTHMTT 165 (325)
Q Consensus 92 e~~~~gsL~~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 165 (325)
+++.+++|..+++ +.+.+..+..+..|+..++.++|.. |||||+|||++.++.+||+|||.++........ ..
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~-~~ 159 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YS 159 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC-CC
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc-ce
Confidence 9999988888773 4456667788999999999999985 899999999999999999999999977654332 22
Q ss_pred cCCCCcCCCCccccccCC-CCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcc---cccc------------c
Q 046728 166 RVKGTLGYLAPEYAMWGK-VSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTP---YVQK------------G 229 (325)
Q Consensus 166 ~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~---~~~~------------~ 229 (325)
...++..|+|||++.... ++.++||||+||++|+|++|..||..... .......+.. .... .
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 334778899999887654 68899999999999999999999754222 1111111000 0000 0
Q ss_pred ccccccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcc
Q 046728 230 AFEHIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGG 279 (325)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~ 279 (325)
..................++.+.+||.+||+.||.+|||++|+++ ||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 000000111112233556788999999999999999999999998 88764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=319.64 Aligned_cols=266 Identities=15% Similarity=0.154 Sum_probs=198.2
Q ss_pred eecccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEeccc--ChhhHHHHHHHHHHHHccCCCCccceeeEEEcC--
Q 046728 9 FLLASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTL--NAKAEMEFAVEVEILGRVRHRNLLGLRGFYAGG-- 84 (325)
Q Consensus 9 ~~~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 84 (325)
|.+...|.++++||.| +++.||++++..+++.||||++... +.....++.+|+++|++++|||++++++++...
T Consensus 14 ~~~~~rY~i~~~LG~G--~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 14 WEVPERYQNLSPVGSG--AYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp EEEETTEEEEEECGGG--TTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ccCCCCeEEEEEEecC--CCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 6677889999999999 8888999999999999999999743 344556888999999999999999999998643
Q ss_pred ---CeEEEEEEecCCCChhhhhc-cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeecccccc
Q 046728 85 ---DERLIVYDYMPNHSLITHLH-GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKLI 156 (325)
Q Consensus 85 ---~~~~lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~~ 156 (325)
...++||+|+.+|+|.++++ +.+++..+..++.++..|++++|.. |||||+|||++.++.+|++|||++...
T Consensus 92 ~~~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 92 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred cccCceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc
Confidence 33466677788999999994 5688888899999999999999985 899999999999999999999998754
Q ss_pred CCCcceeeccCCCCcCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccc----
Q 046728 157 PDGVTHMTTRVKGTLGYLAPEYAMWG-KVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAF---- 231 (325)
Q Consensus 157 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---- 231 (325)
... .....||..|+|||.+.+. .++.++||||+||++|+|++|..||.+.........+............
T Consensus 172 ~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 172 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp TGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred Ccc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence 332 2345688999999987765 4688999999999999999999999754321111111000000000000
Q ss_pred -------ccccCccccC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhccc
Q 046728 232 -------EHIADPRLKG---KFNRDQLKSMVLIALRCTDSNPENRPTMTDVVD--WLKGGL 280 (325)
Q Consensus 232 -------~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~--~l~~~~ 280 (325)
.......... ......++.+.+||.+||..||++|||++++++ ||++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 0000000000 001235678999999999999999999999999 998754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.3e-43 Score=305.93 Aligned_cols=256 Identities=15% Similarity=0.149 Sum_probs=201.1
Q ss_pred ccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCCeEEEE
Q 046728 12 ASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 12 ~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lV 90 (325)
+..|.+++.||.| +++.||++++..+++.||||++..... ...+.+|++.++.+. |+|++.+++++..+...++|
T Consensus 4 g~~Y~i~~~iG~G--~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEG--SFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEEC--SSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecC--CCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 5678899999999 888899999999999999999865322 235778999999996 59999999999999999999
Q ss_pred EEecCCCChhhhhc---cCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC-----CCceEEeeeccccccCC
Q 046728 91 YDYMPNHSLITHLH---GRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT-----DFEAKVADFGFAKLIPD 158 (325)
Q Consensus 91 ~e~~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~-----~~~~kL~Dfg~~~~~~~ 158 (325)
|||| +++|.++++ ..++......+..++..++.++|.. |||||+|||++. ++.++|+|||+++....
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9999 789999884 3456666777888899999999975 899999999974 56899999999987654
Q ss_pred Ccc------eeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhcccccccccc
Q 046728 159 GVT------HMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFE 232 (325)
Q Consensus 159 ~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (325)
... .......||+.|+|||++.+..++.++|||||||++|||+||..||.+............+.........
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~- 237 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL- 237 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH-
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh-
Confidence 321 1233456999999999999989999999999999999999999999865543333222221111110000
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcccC
Q 046728 233 HIADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGLG 281 (325)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~~ 281 (325)
. .....+++++.+++..||..+|++||+.+.+.+.|++++.
T Consensus 238 ----~----~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 238 ----R----ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp ----H----HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred ----H----HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 0 1112345789999999999999999999999998887764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-43 Score=306.14 Aligned_cols=256 Identities=17% Similarity=0.178 Sum_probs=193.0
Q ss_pred cccchhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccCCCCc-cceeeEEEcCCeEEE
Q 046728 11 LASPAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVRHRNL-LGLRGFYAGGDERLI 89 (325)
Q Consensus 11 ~~~~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~l 89 (325)
++..|++++.||+| +++.||++++..+++.||||++..... ..++..|++++++++|+|+ +.+..++.+....++
T Consensus 5 vg~rY~l~~~iG~G--~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 5 VGNRYRLGRKIGSG--SFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp ETTTEEEEEEEEEC--SSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred ECCEEEEeEEEeeC--CCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 34468889999999 888899999999999999999875322 2367889999999976654 555566678888999
Q ss_pred EEEecCCCChhhhh---ccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCC---CCceEEeeeccccccCCC
Q 046728 90 VYDYMPNHSLITHL---HGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDT---DFEAKVADFGFAKLIPDG 159 (325)
Q Consensus 90 V~e~~~~gsL~~~l---~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~---~~~~kL~Dfg~~~~~~~~ 159 (325)
||||| +++|.+.+ ...++...+..+..++..+++++|.. |||||+|||++. +..++|+|||+++.....
T Consensus 81 vme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 81 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 99999 56776666 24567777888889999999999985 899999999864 457999999999977543
Q ss_pred cce------eeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhhhccccccccccc
Q 046728 160 VTH------MTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQWVTPYVQKGAFEH 233 (325)
Q Consensus 160 ~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (325)
... ......||+.|+|||++.+..++.++|||||||++|||+||..||......................
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~---- 235 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST---- 235 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS----
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC----
Confidence 221 2234569999999999999899999999999999999999999997654433222221111100000
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhccc
Q 046728 234 IADPRLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVVDWLKGGL 280 (325)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il~~l~~~~ 280 (325)
+ .......+++++.+||..||..||++||+++++.+.|+...
T Consensus 236 ---~--~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 236 ---P--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp ---C--HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred ---C--hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 0 00112345678999999999999999999999988887654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-37 Score=277.53 Aligned_cols=261 Identities=20% Similarity=0.274 Sum_probs=187.3
Q ss_pred chhHHhhccCccceeeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-----------CCCccceeeEEE
Q 046728 14 PAVFIQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-----------HRNLLGLRGFYA 82 (325)
Q Consensus 14 ~~~~~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~~~~~~~ 82 (325)
.|+++++||.| +++.||++++..+++.||||+++. .......+.+|+++++.++ |+||+++++++.
T Consensus 14 rY~i~~~LG~G--~fg~Vy~~~~~~~g~~vAvKvi~~-~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 14 RYILVRKLGWG--HFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TEEEEEEEEEC--SSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cEEEEEEEeeC--CCeEEEEEEECCCCCEEEEEEEec-cccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 47889999999 888899999999999999999976 3344567788999988875 578999998875
Q ss_pred c--CCeEEEEEEecCCCChhhhh-----ccCCCCCCccCHHHHHHHHHHHHhh-c----CCCCCCceeeCCCC------c
Q 046728 83 G--GDERLIVYDYMPNHSLITHL-----HGRLAPDCLLDWHRRVSIAIGSAEG-I----ADIKASNVLLDTDF------E 144 (325)
Q Consensus 83 ~--~~~~~lV~e~~~~gsL~~~l-----~~~~~~~~~~~~~~~~~~~~~~~~~-~----rdlkp~Nil~~~~~------~ 144 (325)
. ....+++|.++..+...... ...+.+..+..++.++..|+.++|. + |||||+|||++.++ .
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence 4 45667777777655433222 2334555677888999999999986 3 89999999997654 3
Q ss_pred eEEeeeccccccCCCcceeeccCCCCcCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCccchhhhh---
Q 046728 145 AKVADFGFAKLIPDGVTHMTTRVKGTLGYLAPEYAMWGKVSDSCDVYSFGVLLLELISAKKPLEKLPGGVKRDIVQW--- 221 (325)
Q Consensus 145 ~kL~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~--- 221 (325)
++++|||.+...... .....||+.|+|||++....++.++||||+||++++|++|..||..............
T Consensus 171 ~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 899999999865432 2345699999999999988999999999999999999999999976433221111000
Q ss_pred -hcc-----------------ccc-ccccccccCc---------cccCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 046728 222 -VTP-----------------YVQ-KGAFEHIADP---------RLKGKFNRDQLKSMVLIALRCTDSNPENRPTMTDVV 273 (325)
Q Consensus 222 -~~~-----------------~~~-~~~~~~~~~~---------~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~il 273 (325)
+.. ... ......+... ..........++.+.+||.+||..||.+|||+++++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 000 000 0000000000 002234467788999999999999999999999999
Q ss_pred H--HHhcccC
Q 046728 274 D--WLKGGLG 281 (325)
Q Consensus 274 ~--~l~~~~~ 281 (325)
+ ||++...
T Consensus 327 ~Hp~f~~~~~ 336 (362)
T d1q8ya_ 327 NHPWLKDTLG 336 (362)
T ss_dssp TCGGGTTCTT
T ss_pred cCcccCCCCC
Confidence 8 9986553
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.73 E-value=2.7e-18 Score=138.34 Aligned_cols=155 Identities=12% Similarity=0.016 Sum_probs=110.1
Q ss_pred HhhccCccceeeeeEEEeccCCCCeEEEEEecccC------------------hhhHHHHHHHHHHHHccCCCCccceee
Q 046728 18 IQNINNGLEILMLLLLLRRETGDDQIAVKRLKTLN------------------AKAEMEFAVEVEILGRVRHRNLLGLRG 79 (325)
Q Consensus 18 ~~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~------------------~~~~~~~~~E~~~l~~l~h~~iv~~~~ 79 (325)
-++||+| +++.||.+... +|+.||||++.... .........|...+.++.|++++..++
T Consensus 5 g~~IG~G--~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 5 GKLMGEG--KESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEC--SSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred CCEeeeC--cceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 3578888 88889998764 57899999874211 011224456889999999999998876
Q ss_pred EEEcCCeEEEEEEecCCCChhhhhccCCCCCCccCHHHHHHHHHHHHhhc----CCCCCCceeeCCCCceEEeeeccccc
Q 046728 80 FYAGGDERLIVYDYMPNHSLITHLHGRLAPDCLLDWHRRVSIAIGSAEGI----ADIKASNVLLDTDFEAKVADFGFAKL 155 (325)
Q Consensus 80 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----rdlkp~Nil~~~~~~~kL~Dfg~~~~ 155 (325)
+.. .++||||+++..+.+ +....+..+..++..++.++|.+ |||||+|||++++ .++|+|||.+..
T Consensus 82 ~~~----~~lvme~~~~~~~~~-----l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~ 151 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR-----VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVE 151 (191)
T ss_dssp EET----TEEEEECCCCEEGGG-----CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEE
T ss_pred ecC----CEEEEEeeccccccc-----hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCccc
Confidence 532 379999998866544 34455677889999999999985 7999999999865 589999999876
Q ss_pred cCCCcceeeccCCCCcCCCC------ccccccCCCCCcccchhHHH
Q 046728 156 IPDGVTHMTTRVKGTLGYLA------PEYAMWGKVSDSCDVYSFGV 195 (325)
Q Consensus 156 ~~~~~~~~~~~~~~t~~y~a------PE~~~~~~~~~~~DiwSlG~ 195 (325)
....... .|.. .+.+ ...|+.++|+||+.-
T Consensus 152 ~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 152 VGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAID 187 (191)
T ss_dssp TTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHH
T ss_pred CCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHH
Confidence 5432211 0111 0111 246789999999853
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.87 E-value=3.6e-05 Score=62.99 Aligned_cols=73 Identities=5% Similarity=-0.042 Sum_probs=51.4
Q ss_pred eeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCCeEEEEEEecCCCChhhh
Q 046728 28 LMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDERLIVYDYMPNHSLITH 102 (325)
Q Consensus 28 ~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lV~e~~~~gsL~~~ 102 (325)
...+|... .+++.+++|............+..|...+..+. +--+.+++.+..+++..++||++.+|.++.+.
T Consensus 27 ~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 27 PAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp SSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred CCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence 35666554 456678899886544334446777888888774 43466778888888899999999988776443
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.84 E-value=0.0046 Score=49.52 Aligned_cols=69 Identities=13% Similarity=0.077 Sum_probs=46.9
Q ss_pred eeeeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC--CCCccceeeEEEcCCeEEEEEEecCCCChh
Q 046728 28 LMLLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR--HRNLLGLRGFYAGGDERLIVYDYMPNHSLI 100 (325)
Q Consensus 28 ~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lV~e~~~~gsL~ 100 (325)
...||.+.. .++..+++|.-.... ...+..|...++.+. .-.+.+++.+..+++..++||++++|.++.
T Consensus 24 ~~~v~r~~~-~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 24 DAAVFRLSA-QGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp SCEEEEEEC-TTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred CCeEEEEEe-CCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 345666653 445668889865432 225677888888774 223567788878888899999999886553
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.34 E-value=0.0047 Score=53.26 Aligned_cols=76 Identities=14% Similarity=0.107 Sum_probs=45.1
Q ss_pred hhccCccceeeeeEEEeccCCCCeEEEEEecc----c---ChhhHHHHHHHHHHHHccC-C-C-CccceeeEEEcCCeEE
Q 046728 19 QNINNGLEILMLLLLLRRETGDDQIAVKRLKT----L---NAKAEMEFAVEVEILGRVR-H-R-NLLGLRGFYAGGDERL 88 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~~~~~~vaiK~~~~----~---~~~~~~~~~~E~~~l~~l~-h-~-~iv~~~~~~~~~~~~~ 88 (325)
+.||.| ..-.||.+....+++.|++|.-.. . .+....+...|...++.+. + | .+.+++.+ +....+
T Consensus 32 ~eig~G--~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~ 107 (392)
T d2pula1 32 QEIGDG--NLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 107 (392)
T ss_dssp EECCSS--SSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEeCCC--ceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCE
Confidence 456655 666788888777788999996421 0 1122345667888888773 2 3 44555543 455668
Q ss_pred EEEEecCCCC
Q 046728 89 IVYDYMPNHS 98 (325)
Q Consensus 89 lV~e~~~~gs 98 (325)
+|||++.+..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 9999997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=92.73 E-value=0.18 Score=41.49 Aligned_cols=66 Identities=6% Similarity=0.031 Sum_probs=41.4
Q ss_pred eeEEEeccCCCCeEEEEEecccChhhHHHHHHHHHHHHccC-C--C--Ccccee--eEEEcCCeEEEEEEecCCC
Q 046728 30 LLLLLRRETGDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-H--R--NLLGLR--GFYAGGDERLIVYDYMPNH 97 (325)
Q Consensus 30 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h--~--~iv~~~--~~~~~~~~~~lV~e~~~~g 97 (325)
.||.++. .+|+.+++|.... ...+..++..|...+..|. + | ..+..- ..+......+.|+++..|.
T Consensus 37 ~vy~v~~-~dg~~~VlK~~rp-~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 37 RVYQFQD-EDRRRFVVKFYRP-ERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp EEEEECC-TTCCCEEEEEECT-TTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred eeEEEEc-CCCCEEEEEEeCC-CCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 4666654 4577889998754 2334557788888888873 1 2 112211 1245567788999999774
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=91.50 E-value=0.31 Score=41.29 Aligned_cols=73 Identities=19% Similarity=0.324 Sum_probs=43.3
Q ss_pred hhccCccceeeeeEEEeccC-------CCCeEEEEEecccChhhHHHHHHHHHHHHccC-CCCccceeeEEEcCCeEEEE
Q 046728 19 QNINNGLEILMLLLLLRRET-------GDDQIAVKRLKTLNAKAEMEFAVEVEILGRVR-HRNLLGLRGFYAGGDERLIV 90 (325)
Q Consensus 19 ~~i~~G~~~~~~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lV 90 (325)
+.|+-| -+=.+|++.... ..+.|++.+... . .......+|..+++.+. +.-..++++++.+ .+|
T Consensus 48 ~~l~GG--ltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 48 SRIKGG--MSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEECCC--TTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEcCCc--cccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 345545 444455554332 234566666542 2 22335667999999984 5445577777643 689
Q ss_pred EEecCCCCh
Q 046728 91 YDYMPNHSL 99 (325)
Q Consensus 91 ~e~~~~gsL 99 (325)
++|.+|.+|
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987544
|